PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Service, S; DeYoung, J; Karayiorgou, M; Roos, JL; Pretorious, H; Bedoya, G; Ospina, J; Ruiz-Linares, A; Macedo, A; Palha, JA; Heutink, P; Aulchenko, Y; Oostra, B; van Duijn, C; Jarvelin, MR; Varilo, T; Peddle, L; Rahman, P; Piras, G; Monne, M; Murray, S; Galver, L; Peltonen, L; Sabatti, C; Collins, A; Freimer, N				Service, S; DeYoung, J; Karayiorgou, M; Roos, JL; Pretorious, H; Bedoya, G; Ospina, J; Ruiz-Linares, A; Macedo, A; Palha, JA; Heutink, P; Aulchenko, Y; Oostra, B; van Duijn, C; Jarvelin, MR; Varilo, T; Peddle, L; Rahman, P; Piras, G; Monne, M; Murray, S; Galver, L; Peltonen, L; Sabatti, C; Collins, A; Freimer, N			Magnitude and distribution of linkage disequilibrium in population isolates and implications for genome-wide association studies	NATURE GENETICS			English	Article							ALLELIC ASSOCIATION; AFRIKANERS; MAP; CHROMOSOMES; DEMOGRAPHY; DISEASE	The genome-wide distribution of linkage disequilibrium (LD) determines the strategy for selecting markers for association studies, but it varies between populations. We assayed LD in large samples (200 individuals) from each of 11 well-described population isolates and an outbred European-derived sample, using SNP markers spaced across chromosome 22. Most isolates show substantially higher levels of LD than the outbred sample and many fewer regions of very low LD (termed 'holes'). Young isolates known to have had relatively few founders show particularly extensive LD with very few holes; these populations offer substantial advantages for genome-wide association mapping.	Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, So Calif Genotyping Consortium, Los Angeles, CA 90095 USA; Rockefeller Univ, New York, NY 10021 USA; Univ Pretoria, Dept Psychiat, ZA-0001 Pretoria, South Africa; Weskoppies Hosp, ZA-0001 Pretoria, South Africa; Univ Antioquia, Mol Genet Lab, Medellin, Colombia; Univ Antioquia, Dept Psychiat, Medellin, Colombia; UCL, Galton Lab, Dept Biol, London NW1 2HE, England; Univ Coimbra, Fac Med, Inst Med Psychol, P-3000033 Coimbra, Portugal; Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, P-4704553 Braga, Portugal; Vrije Univ Amsterdam, Dept Human Genet, Sect Med Genom, NL-1081 BT Amsterdam, Netherlands; Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, NL-1081 BT Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, NL-1081 BT Amsterdam, Netherlands; Erasmus MC, Genet Epidemiol Unit, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Univ Oulu, Dept Publ Hlth Sci & Gen Practice, SF-90220 Oulu, Finland; Imperial Coll London, Dept Epidemiol & Publ Hlth, London W2 1PG, England; Univ Helsinki, Dept Med Genet, FIN-00290 Helsinki, Finland; Biomedicum, Natl Publ Hlth Inst, Dept Mol Med, Helsinki 00290, Finland; Newfound Genom, St John, NF A1C 2H5, Canada; Mem Univ Newfoundland, St John, NF A1C 5S7, Canada; San Francesco Hosp, Div Haematol, Nuoro, Italy; Illumina Inc, San Diego, CA 92121 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA; Univ Southampton, Southampton Gen Hosp, Human Genet Res Div, Southampton SO16 6YA, Hants, England; Univ Calif Los Angeles, Jane & Terry Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Rockefeller University; University of Pretoria; Universidad de Antioquia; Universidad de Antioquia; University of London; University College London; Universidade de Coimbra; Universidade do Minho; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Oulu; Imperial College London; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Memorial University Newfoundland; Illumina; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Southampton; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Freimer, N (corresponding author), Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA.	nfreimer@mednet.ucla.edu	Collins, Andrew/S-2196-2019; Collins, Andrew/A-6595-2010; macedo, antónio/AFQ-1570-2022; Ruiz-Linares, Andres/AAR-1104-2021; Palha, Joana Almeida/C-2745-2009; macedo santos, antónio/M-5737-2013; macedo, antónio/AFQ-1571-2022; Aulchenko, Yurii/M-8270-2013	Collins, Andrew/0000-0001-7108-0771; Collins, Andrew/0000-0001-7108-0771; macedo, antónio/0000-0003-2180-2718; Ruiz-Linares, Andres/0000-0001-8372-1011; Palha, Joana Almeida/0000-0002-8866-368X; macedo santos, antónio/0000-0003-2180-2718; macedo, antónio/0000-0003-2180-2718; Aulchenko, Yurii/0000-0002-7899-1575; Van Duijn, Cornelia/0000-0002-2374-9204; Roos, Johannes/0000-0002-0572-1072; MONNE, MARIA/0000-0003-4978-4427; Varilo, Teppo/0000-0002-5839-8854; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Piras, Giovanna/0000-0003-4550-6606; Heutink, Peter/0000-0001-5218-1737	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Aulchenko YS, 2004, EUR J HUM GENET, V12, P527, DOI 10.1038/sj.ejhg.5201188; Carvajal-Carmona LG, 2003, HUM GENET, V112, P534, DOI 10.1007/s00439-002-0899-8; Collins A, 1998, P NATL ACAD SCI USA, V95, P1741, DOI 10.1073/pnas.95.4.1741; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; De la Vega FM, 2005, GENOME RES, V15, P454, DOI 10.1101/gr.3241705; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gordon D, 2000, GENOMICS, V66, P87, DOI 10.1006/geno.2000.6190; Groenewald JZ, 1998, AM J HUM GENET, V62, P1254, DOI 10.1086/301833; Hall D, 2002, GENOME RES, V12, P956, DOI 10.1101/gr.136202; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; Maniatis N, 2004, AM J HUM GENET, V74, P846, DOI 10.1086/383589; Maniatis N, 2002, P NATL ACAD SCI USA, V99, P2228, DOI 10.1073/pnas.042680999; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Morton NE, 2001, P NATL ACAD SCI USA, V98, P5217, DOI 10.1073/pnas.091062198; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Service SK, 2001, HUM MOL GENET, V10, P545, DOI 10.1093/hmg/10.5.545; Stumpf MPH, 2003, CURR BIOL, V13, P1, DOI 10.1016/S0960-9822(02)01404-5; Tapper WJ, 2003, ANN HUM GENET, V67, P487, DOI 10.1046/j.1469-1809.2003.00050.x; Teare MD, 2002, ANN HUM GENET, V66, P223, DOI 10.1017/S0003480002001082; Tenesa A, 2004, HUM MOL GENET, V13, P25, DOI 10.1093/hmg/ddh001; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Varilo T, 2003, HUM MOL GENET, V12, P51, DOI 10.1093/hmg/ddg005; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501	30	190	193	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2006	38	5					556	560		10.1038/ng1770	http://dx.doi.org/10.1038/ng1770			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16582909				2022-12-27	WOS:000237147500017
J	Ferrante, MI; Zullo, A; Barra, A; Bimonte, S; Messaddeq, N; Studer, M; Dolle, P; Franco, B				Ferrante, MI; Zullo, A; Barra, A; Bimonte, S; Messaddeq, N; Studer, M; Dolle, P; Franco, B			Oral-facial-digital type I protein is required for primary cilia formation and left-right axis specification	NATURE GENETICS			English	Article							INTRAFLAGELLAR TRANSPORT PROTEINS; MOUSE; HEDGEHOG; MICE; GLI3; LIMB; MORPHOGENESIS; ACTIVATOR; GRADIENT; GENES	The oral-facial-digital type I (OFD1) syndrome ( OMIM 311200) is a human developmental disorder; affected individuals have craniofacial and digital abnormalities and, in 15% of cases, polycystic kidney(1,2). The disease is inherited as an X-linked dominant male-lethal trait. Using a Cre-loxP system, we generated knockout animals lacking Ofd1 and reproduced the main features of the disease, albeit with increased severity, possibly owing to differences of X inactivation patterns between human and mouse. We found failure of left-right axis specification in mutant male embryos, and ultrastructural analysis showed a lack of cilia in the embryonic node. Formation of cilia was defective in cystic kidneys from heterozygous females, implicating ciliogenesis as a mechanism underlying cyst development. In addition, we found impaired patterning of the neural tube and altered expression of the 5' Hoxa and Hoxd genes in the limb buds of mice lacking Ofd1, suggesting that Ofd1 could have a role beyond primary cilium organization and assembly.	Telethon Inst Genet & Med, I-80131 Naples, Italy; Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Univ Naples Federico II, Dept Pediat, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Naples Federico II	Franco, B (corresponding author), Telethon Inst Genet & Med, Via P Castellino 111, I-80131 Naples, Italy.	franco@tigem.it	Studer, Michele/P-4580-2016; Dolle, Pascal/A-8037-2010; FRANCO, Brunella/S-2882-2018	Studer, Michele/0000-0001-7105-2957; Dolle, Pascal/0000-0002-9294-9090; bimonte, sabrina/0000-0002-5408-9675; Ferrante, Maria Immacolata/0000-0002-8102-8018; FRANCO, Brunella/0000-0001-5588-4569	Telethon [TGM06S01, TGM06A01] Funding Source: Medline	Telethon(Fondazione Telethon)		Agulnik AI, 1999, MAMM GENOME, V10, P926, DOI 10.1007/s003359901116; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Beales PL, 2005, CURR OPIN GENET DEV, V15, P315, DOI 10.1016/j.gde.2005.04.006; Choi DS, 1997, DEVELOPMENT, V124, P1745; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; de Conciliis L, 1998, GENOMICS, V51, P243, DOI 10.1006/geno.1998.5348; Feather SA, 1997, NEPHROL DIAL TRANSPL, V12, P1354, DOI 10.1093/ndt/12.7.1354; Ferrante MI, 2003, GENOMICS, V81, P560, DOI 10.1016/S0888-7543(03)00091-0; Ferrante MI, 2001, AM J HUM GENET, V68, P569, DOI 10.1086/318802; Garcia-Garcia MJ, 2005, P NATL ACAD SCI USA, V102, P5913, DOI 10.1073/pnas.0501071102; Gorlin R.J., 1990, BIRTH DEFECTS ENCY, VII, P1309; Grove EA, 1998, DEVELOPMENT, V125, P2315; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Harlow E., 1988, ANTIBODIES LAB MANUA; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Jensen CG, 2004, CELL BIOL INT, V28, P101, DOI 10.1016/j.cellbi.2003.11.007; Joyner AL, 1993, GENE TARGETING PRACT; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Masuya H, 1997, DEV BIOL, V182, P42, DOI 10.1006/dbio.1996.8457; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; OBrien TP, 1996, GENETICS, V143, P447; Pennekamp P, 2002, CURR BIOL, V12, P938, DOI 10.1016/S0960-9822(02)00869-2; Romio L, 2004, J AM SOC NEPHROL, V15, P2556, DOI 10.1097/01.ASN.0000140220.46477.5C; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Stamataki D, 2005, GENE DEV, V19, P626, DOI 10.1101/gad.325905; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620	30	230	236	2	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					112	117		10.1038/ng1684	http://dx.doi.org/10.1038/ng1684			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16311594				2022-12-27	WOS:000234227200026
J	Bell, DW; Gore, I; Okimoto, RA; Godin-Heymann, N; Sordella, R; Mulloy, R; Sharma, SV; Brannigan, BW; Mohapatra, G; Settleman, J; Haber, DA				Bell, DW; Gore, I; Okimoto, RA; Godin-Heymann, N; Sordella, R; Mulloy, R; Sharma, SV; Brannigan, BW; Mohapatra, G; Settleman, J; Haber, DA			Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR	NATURE GENETICS			English	Article							ACQUIRED-RESISTANCE; KINASE INHIBITORS; TYROSINE KINASE; RECEPTOR GENE; GEFITINIB; SENSITIVITY; ERLOTINIB	Somatic activating mutations in EGFR identify a subset of non-small cell lung cancer that respond to tyrosine kinase inhibitors. Acquisition of drug resistance is linked to a specific secondary somatic mutation, EGFR T790M. Here we describe a family with multiple cases of non-small cell lung cancer associated with germline transmission of this mutation. Four of six tumors analyzed showed a secondary somatic activating EGFR mutation, arising in cis with the germline EGFR mutation T790M. These observations implicate altered EGFR signaling in genetic susceptibility to lung cancer.	Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; St Vincents Hosp, Bruno Canc Ctr, Birmingham, AL 35205 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Pathol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Haber, DA (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, 13th St, Charlestown, MA 02129 USA.	haber@helix.mgh.harvard.edu						Blencke S, 2004, CHEM BIOL, V11, P691, DOI 10.1016/j.chembiol.2004.02.029; Blencke S, 2003, J BIOL CHEM, V278, P15435, DOI 10.1074/jbc.M211158200; Daub H, 2004, NAT REV DRUG DISCOV, V3, P1001, DOI 10.1038/nrd1579; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Yamamoto M, 2004, BIOCHEM BIOPH RES CO, V319, P1272, DOI 10.1016/j.bbrc.2004.05.113; Zhang C, 2005, NAT METHODS, V2, P435, DOI 10.1038/NMETH764	15	363	394	0	21	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2005	37	12					1315	1316		10.1038/ng1671	http://dx.doi.org/10.1038/ng1671			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16258541				2022-12-27	WOS:000233657300008
J	Chia, R; Achilli, F; Festing, MFW; Fisher, EMC				Chia, R; Achilli, F; Festing, MFW; Fisher, EMC			The origins and uses of mouse outbred stocks	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; INBRED STRAINS; LABORATORY-ANIMALS; SHEEP ERYTHROCYTES; ANTIBODY-SYNTHESIS; GENETIC-ANALYSIS; SWISS MICE; LINES; SKIN; CARCINOGENESIS	Outbred mouse stocks, often used in genetics, toxicology and pharmacology research, have been generated in rather haphazard ways. Understanding the characteristics of these stocks and their advantages and disadvantages is important for experimental design. In many studies these mice are used inappropriately, wasting animals' lives and resources on suboptimal experiments. Recently, however, researchers from the field of complex trait analysis have capitalized on the genetics of outbred stocks to refine the identification of quantitative trait loci. Here we assess the most widely used outbred stocks of mice and present guidelines for their use.	Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England	University of London; University College London; University of Leicester	Fisher, EMC (corresponding author), Inst Neurol, Dept Neurodegenerat Dis, Queen Sq, London WC1N 3BG, England.	e.fisher@prion.ucl.ac.uk	Fisher, Elizabeth MC/C-2168-2008	Fisher, Elizabeth MC/0000-0003-2850-9936; Chia, Ruth/0000-0002-4709-7423				Anghileri LJ, 2005, INT J RADIAT BIOL, V81, P205, DOI 10.1080/09553000500076957; BAKER D, 1990, J NEUROIMMUNOL, V28, P261, DOI 10.1016/0165-5728(90)90019-J; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BENSON LM, 1977, LAB ANIM SCI, V27, P333; BIOZZI G, 1979, IMMUNOLOGY, V36, P427; BOUCHER W, 1990, J MATH BIOL, V28, P293, DOI 10.1007/BF00178778; BOUTWELL RK, 1964, PROG EXP TUMOR RES, V4, P207; Caballero A, 2000, GENET RES, V75, P331, DOI 10.1017/S0016672399004449; CHAPIN RE, 1993, FUND APPL TOXICOL, V21, P8, DOI 10.1006/faat.1993.1065; CRABBE JC, 1994, SCIENCE, V264, P1715, DOI 10.1126/science.8209252; CUI SL, 1993, LAB ANIM, V27, P116, DOI 10.1258/002367793780810397; Darvasi A, 2005, TRENDS GENET, V21, P373, DOI 10.1016/j.tig.2005.05.003; DEFRIES JC, 1989, ALCOHOL CLIN EXP RES, V13, P196, DOI 10.1111/j.1530-0277.1989.tb00310.x; Dell Ralph B, 2002, ILAR J, V43, P207; Demarest K, 2001, BEHAV GENET, V31, P79, DOI 10.1023/A:1010261909853; DiGiovanni J, 1995, Prog Clin Biol Res, V391, P195; Falconer D. S., 1981, INTRO QUANTITATIVE G; FEINGOLD N, 1976, EUR J IMMUNOL, V6, P43, DOI 10.1002/eji.1830060110; FELTON RP, 1989, J TOXICOL ENV HEALTH, V26, P399, DOI 10.1080/15287398909531264; FESTING M, 1972, Z VERSUCHSTIERKD, V14, P215; FESTING M F, 1974, Laboratory Animals (London), V8, P291, DOI 10.1258/002367774780943689; FESTING M F, 1974, Laboratory Animals (London), V8, P265, DOI 10.1258/002367774780943751; Festing MFW, 2003, TRENDS PHARMACOL SCI, V24, P341, DOI 10.1016/S0165-6147(03)00159-7; FESTING MFW, 1995, J NATL CANCER I, V87, P1715, DOI 10.1093/jnci/87.22.1715; Festing MFW, 1999, NEUROBIOL AGING, V20, P237; Festing MFW, 2001, FOOD CHEM TOXICOL, V39, P375, DOI 10.1016/S0278-6915(00)00149-6; FESTING MFW, 1993, INT INDEX LAB ANIMAL; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Garland T, 2002, EVOLUTION, V56, P1267; Grahame NJ, 1999, BEHAV GENET, V29, P47, DOI 10.1023/A:1021489922751; GROEN A, 1979, LAB ANIM, V13, P81, DOI 10.1258/002367779780943387; HASEMAN JK, 1979, J TOXICOL ENV HEALTH, V5, P89, DOI 10.1080/15287397909529728; HAUSCHKA TS, 1973, PERSPECTIVES CANC RE, V25, P319; HAYAKAWA J, 1980, LAB ANIM-UK, V14, P233, DOI 10.1258/002367780780937625; Hennings H, 1997, MOL CARCINOGEN, V20, P143, DOI 10.1002/(SICI)1098-2744(199709)20:1<143::AID-MC16>3.0.CO;2-1; Hitzemann R, 2002, GENES BRAIN BEHAV, V1, P214, DOI 10.1034/j.1601-183X.2002.10403.x; HOGER H, 1992, EXP ANIM TOKYO, V41, P215, DOI 10.1538/expanim1978.41.2_215; Holt M, 2004, MAMM GENOME, V15, P951, DOI 10.1007/s00335-004-3030-8; HORNADY MH, 2001, SCIENCES NEW YORK, V1, P108; Horvat S, 2000, MAMM GENOME, V11, P2, DOI 10.1007/s003350010002; JAY GE, 1955, P SOC EXP BIOL MED, V90, P378; KATOH H, 1990, LAB ANIM SCI, V40, P490; Kirkpatrick BW, 1998, MAMM GENOME, V9, P97, DOI 10.1007/s003359900696; KLUGE R, 1994, J EXP ANIM SCI, V36, P179; Ku SK, 2002, ANAT HISTOL EMBRYOL, V31, P78, DOI 10.1046/j.1439-0264.2002.00362.x; LYNCH CJ, 1969, LAB ANIM CARE, V19, P214; Manenti G, 2003, CARCINOGENESIS, V24, P1143, DOI 10.1093/carcin/bgg065; Mathews CE, 2004, DIABETES, V53, pS125, DOI 10.2337/diabetes.53.2007.S125; MCCLEARN GE, 2005, CONTRIBUTIONS BEHAV, P3; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; NEI M, 1978, GENETICS, V89, P583; NOBUNAGA T, 1973, LAB ANIM SCI, V23, P803; Nomura T, 1996, GENET SEL EVOL, V28, P141, DOI 10.1051/gse:19960202; PADEH B, 1974, BEHAV GENET, V4, P383, DOI 10.1007/BF01066158; PAPAIOANNOU VE, 1980, LAB ANIM, V14, P11, DOI 10.1258/002367780780943015; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Poiley S M, 1972, Lab Anim Sci, V22, P758; RICE MC, 1980, NATURE, V283, P157, DOI 10.1038/283157a0; RUSSELL RJ, 1993, LAB ANIM SCI, V43, P460; SCHLAGER G, 1994, GENETIC HYPERTENSION, P158; Serfilippi LM, 2004, COMPARATIVE MED, V54, P69; Stahl W, 2002, PARASITOL RES, V88, P507, DOI 10.1007/s00436-002-0618-3; Strivens M, 2004, GENETICA, V122, P89, DOI 10.1007/s10709-004-1435-7; Tabakoff B, 2003, J NEUROSCI, V23, P4491; Talbot CJ, 2003, MAMM GENOME, V14, P223, DOI 10.1007/s00335-002-3059-5; Talbot CJ, 1999, NAT GENET, V21, P305, DOI 10.1038/6825; Teppner I, 2004, LAB ANIM-UK, V38, P406, DOI 10.1258/0023677041958882; Tinston DJ, 1981, CTLP547 IMP CHEM IND; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450	69	254	275	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1181	1186		10.1038/ng1665	http://dx.doi.org/10.1038/ng1665			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16254564				2022-12-27	WOS:000233045200014
J	Munoz, P; Blanco, R; Flores, JM; Blasco, MA				Munoz, P; Blanco, R; Flores, JM; Blasco, MA			XPF nuclease-dependent telomere loss and increased DNA damage in mice overexpressing TRF2 result in premature aging and cancer	NATURE GENETICS			English	Article							NUCLEOTIDE EXCISION-REPAIR; XERODERMA-PIGMENTOSUM; EXPRESSION; DEFICIENT; ABNORMALITIES; PROTEINS; DEFECTS; LACKING; LENGTH; TUMORS	TRF2 is a telomere-binding protein that has a role in telomere protection. We generated mice that overexpress TRF2 in the skin. These mice had a severe phenotype in the skin in response to light, consisting of premature skin deterioration, hyperpigmentation and increased skin cancer, which resembles the human syndrome xeroderma pigmentosum. Keratinocytes from these mice were hypersensitive to ultraviolet irradiation and DNA crosslinking agents. The skin cells of these mice had marked telomere shortening, loss of the telomeric G-strand overhang and increased chromosomal instability. Telomere loss in these mice was mediated by XPF, a structure-specific nuclease involved in ultraviolet-induced damage repair and mutated in individuals with xeroderma pigmentosum. These findings suggest that TRF2 provides a crucial link between telomere function and ultraviolet-induced damage repair, whose alteration underlies genomic instability, cancer and aging. Finally, we show that a number of human skin tumors have increased expression of TRF2, further highlighting a role for TRF2 in skin cancer.	Spanish Natl Canc Ctr, Telomeres & Telomeres Grp, Mol Oncol Program, Madrid, Spain; Univ Complutense Madrid, Fac Vet, Anim Surg & Med Dept, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Complutense University of Madrid	Blasco, MA (corresponding author), Spanish Natl Canc Ctr, Telomeres & Telomeres Grp, Mol Oncol Program, Madrid, Spain.	mblasco@cnio.es	Blasco, Maria A./M-1694-2014	Blasco, Maria A./0000-0002-4211-233X				Berneburg M, 2001, ADV GENET, V43, P71, DOI 10.1016/S0065-2660(01)43004-5; Bessler M, 2004, CURR OPIN PEDIATR, V16, P23, DOI 10.1097/00008480-200402000-00006; BRADLEY SM, 1993, SOLID STATE NUCL MAG, V2, P37, DOI 10.1016/0926-2040(93)90061-Q; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118; Dantzer F, 2004, MOL CELL BIOL, V24, P1595, DOI 10.1128/MCB.24.4.1595-1607.2004; de Boer J, 2000, CARCINOGENESIS, V21, P453, DOI 10.1093/carcin/21.3.453; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Espejel S, 2004, EMBO REP, V5, P503, DOI 10.1038/sj.embor.7400127; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Gonzalez-Suarez E, 2000, NAT GENET, V26, P114, DOI 10.1038/79089; Gonzalez-Suarez E, 2002, MOL CELL BIOL, V22, P7291, DOI 10.1128/MCB.22.20.7291-7301.2002; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Goytisolo FA, 2002, ONCOGENE, V21, P584, DOI 10.1038/sj.onc.1205085; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Matsutani N, 2001, INT J ONCOL, V19, P507; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Modesti M, 2001, CURR BIOL, V11, pR229, DOI 10.1016/S0960-9822(01)00112-9; Mu D, 2000, MOL CELL BIOL, V20, P2446, DOI 10.1128/MCB.20.7.2446-2454.2000; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; NAKANE H, 1995, NATURE, V377, P165, DOI 10.1038/377165a0; Oh BK, 2005, AM J PATHOL, V166, P73, DOI 10.1016/S0002-9440(10)62233-X; Petit C, 1999, BIOCHIMIE, V81, P15, DOI 10.1016/S0300-9084(99)80034-0; SANDS AT, 1995, NATURE, V377, P162, DOI 10.1038/377162a0; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	34	181	185	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1063	1071		10.1038/ng1633	http://dx.doi.org/10.1038/ng1633			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16142233				2022-12-27	WOS:000232185600017
J	Meetei, AR; Medhurst, AL; Ling, C; Xue, YT; Singh, TR; Bier, P; Steltenpool, J; Stone, S; Dokal, I; Mathew, CG; Hoatlin, M; Joenje, H; de Winter, JP; Wang, WD				Meetei, AR; Medhurst, AL; Ling, C; Xue, YT; Singh, TR; Bier, P; Steltenpool, J; Stone, S; Dokal, I; Mathew, CG; Hoatlin, M; Joenje, H; de Winter, JP; Wang, WD			A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M	NATURE GENETICS			English	Article							HOMOLOGOUS RECOMBINATION; ENDONUCLEASE; HELICASE; GENE; DEFICIENT; MUTATION; COMPLEX; GENOME; ATPASE; BRCA2	Fanconi anemia is a genetic disease characterized by genomic instability and cancer predisposition(1). Nine genes involved in Fanconi anemia have been identified; their products participate in a DNA damage - response network involving BRCA1 and BRCA2 ( refs. 2,3). We previously purified a Fanconi anemia core complex containing the FANCL ubiquitin ligase and six other Fanconi anemia associated proteins(4 - 6). Each protein in this complex is essential for monoubiquitination of FANCD2, a key reaction in the Fanconi anemia DNA damage - response pathway(2,7). Here we show that another component of this complex, FAAP250, is mutant in individuals with Fanconi anemia of a new complementation group ( FA- M). FAAP250 or FANCM has sequence similarity to known DNA- repair proteins, including archaeal Hef, yeast MPH1 and human ERCC4 or XPF. FANCM can dissociate DNA triplex, possibly owing to its ability to translocate on duplex DNA. FANCM is essential for monoubiquitination of FANCD2 and becomes hyperphosphorylated in response to DNA damage. Our data suggest an evolutionary link between Fanconi anemia associated proteins and DNA repair; FANCM may act as an engine that translocates the Fanconi anemia core complex along DNA.	Vrije Univ Amsterdam Med Ctr, Dept Clin Genet & Human Genet, NL-1081 BT Amsterdam, Netherlands; Cincinnati Childrens Hosp, Div Expt Hematol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; NIA, Genet Lab, NIH, Baltimore, MD 21224 USA; Oregon Hlth & Sci Univ, Div Mol Med & Mol & Med Genet NRC3, Portland, OR 97239 USA; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Haematol, London, England; Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Oregon Health & Science University; Imperial College London; University of London; King's College London	de Winter, JP (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet & Human Genet, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	j.dewinter@vumc.nl; wangw@grc.nia.nih.gov	Ittershagen, Stacie/X-7658-2019; Mathew, Christopher G/G-3434-2015; Wang, Weidong/AAV-2446-2021	Mathew, Christopher G/0000-0003-4178-1838; Dokal, Inderjeet/0000-0003-4462-4782; Ittershagen, Stacie (Stone)/0000-0003-3834-176X; Wang, Weidong/0000-0002-0658-7928; singh, thiyam/0000-0002-0441-6818	NATIONAL CANCER INSTITUTE [R01CA112775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000688] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [R01 CA112775] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1223, DOI 10.1093/nar/27.5.1223; Bruun D, 2003, DNA REPAIR, V2, P1007, DOI 10.1016/S1568-7864(03)00112-5; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Demuth I, 2004, ONCOGENE, V23, P8611, DOI 10.1038/sj.onc.1207895; Enzlin JH, 2002, EMBO J, V21, P2045, DOI 10.1093/emboj/21.8.2045; Garcia-Cabeza I, 2001, BMC PSYCHIATRY, V1, DOI 10.1186/1471-244X-1-7; Havas K, 2000, CELL, V103, P1133, DOI 10.1016/S0092-8674(00)00215-4; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Komori K, 2004, J BIOL CHEM, V279, P53175, DOI 10.1074/jbc.M409243200; Komori K, 2002, GENES GENET SYST, V77, P227, DOI 10.1266/ggs.77.227; Levitus M, 2004, BLOOD, V103, P2498, DOI 10.1182/blood-2003-08-2915; LEVITUS M, 2005, J NAT GENET, V37, P934, DOI DOI 10.1038/NG1625; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Meetei AR, 2004, NAT GENET, V36, P1219, DOI 10.1038/ng1458; Mu D, 1996, J BIOL CHEM, V271, P8285, DOI 10.1074/jbc.271.14.8285; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Prakash R, 2005, J BIOL CHEM, V280, P7854, DOI 10.1074/jbc.M413898200; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Scheller J, 2000, GENETICS, V155, P1069; Schurer KA, 2004, GENETICS, V166, P1673, DOI 10.1534/genetics.166.4.1673; Sgouros J, 1999, TRENDS BIOCHEM SCI, V24, P95, DOI 10.1016/S0968-0004(99)01355-9; Sijbers AM, 1996, CELL, V86, P811, DOI 10.1016/S0092-8674(00)80155-5; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; Taniguchi T, 2002, BLOOD, V100, P2457, DOI 10.1182/blood-2002-03-0860; Van Komen S, 2000, MOL CELL, V6, P563, DOI 10.1016/S1097-2765(00)00055-1; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; ZAVITZ KH, 1992, J BIOL CHEM, V267, P6933	30	339	360	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					958	963		10.1038/ng1626	http://dx.doi.org/10.1038/ng1626			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16116422	Green Accepted			2022-12-27	WOS:000231591900020
J	Dorus, S; Evans, PD; Wyckoff, GJ; Choi, SS; Lahn, BT				Dorus, S; Evans, PD; Wyckoff, GJ; Choi, SS; Lahn, BT			Rate of molecular evolution of the seminal protein gene SEMG2 correlates with levels of female promiscuity	NATURE GENETICS			English	Article							SPERM COMPETITION; COPULATORY PLUGS; SELECTION; MOTILITY	Postcopulatory sperm competition is a key aspect of sexual selection and is believed to drive the rapid evolution of both reproductive physiology and reproduction-related genes(1-4). It is well-established that mating behavior determines the intensity of sperm competition, with polyandry (i.e., female promiscuity) leading to fiercer sperm competition than monandry(1-3). Studies in mammals, particularly primates, showed that, owing to greater sperm competition, polyandrous taxa generally have physiological traits that make them better adapted for fertilization than monandrous species, including bigger testes, larger seminal vesicles, higher sperm counts, richer mitochondrial loading in sperm and more prominent semen coagulation(2,5-8). Here, we show that the degree of polyandry can also impact the dynamics of molecular evolution. Specifically, we show that the evolution of SEMG2, the gene encoding semenogelin II, a main structural component of semen coagulum, is accelerated in polyandrous primates relative to monandrous primates. Our study showcases the intimate relationship between sexual selection and the molecular evolution of reproductive genes.	Univ Chicago, Howard Hughes Med Inst, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago	Lahn, BT (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Human Genet, 5841 S Maryland Ave, Chicago, IL 60637 USA.	blahn@bsd.uchicago.edu		Wyckoff, Gerald/0000-0003-2604-2666				Anderson MJ, 2002, NATURE, V416, P496, DOI 10.1038/416496a; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; BLANDAU RJ, 1945, AM J ANAT, V77, P253, DOI 10.1002/aja.1000770205; CONOWAY CH, 1965, J MAMMAL, V45, P577; DEWSBURY DA, 1988, J MAMMAL, V69, P854, DOI 10.2307/1381648; Dixson A, 2002, ANN REV SEX RES, V12, P121; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Dixson AF, 2002, FOLIA PRIMATOL, V73, P63, DOI 10.1159/000064784; DUNBAR RIM, 1976, ANIM BEHAV, V24, P84, DOI 10.1016/S0003-3472(76)80102-9; Goodall J., 1986, CHIMPANZEES GOMBE PA; HARCOURT AH, 1981, NATURE, V293, P55, DOI 10.1038/293055a0; Hasegawa T., 1990, P115; Jensen-Seaman MI, 2003, J MOL EVOL, V57, P261, DOI 10.1007/s00239-003-2474-x; Karr TL, 1999, CURR BIOL, V9, pR787, DOI 10.1016/S0960-9822(00)80014-7; Kingan SB, 2003, J MOL EVOL, V57, P159, DOI 10.1007/s00239-002-2463-0; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; LILJA H, 1987, J CLIN INVEST, V80, P281, DOI 10.1172/JCI113070; MANSON JH, 1994, PRIMATES, V35, P417, DOI 10.1007/BF02381951; MATTHEWS MK, 1978, PHYSIOL BEHAV, V20, P303, DOI 10.1016/0031-9384(78)90224-X; MICHENER GR, 1984, CAN J ZOOL, V62, P267, DOI 10.1139/z84-043; Nielsen R, 1998, GENETICS, V148, P929; Robert M, 1996, BIOL REPROD, V55, P813, DOI 10.1095/biolreprod55.4.813; Rodman P.S., 1987, P146; STRIER KB, 1992, FACES FOREST ENDANGE; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tokuda K., 1968, Primates, V9, P283, DOI 10.1007/BF01730975; VANNOORDWIJK MA, 1985, Z TIERPSYCHOL, V70, P277; VOSS R, 1979, Occasional Papers of the Museum of Zoology University of Michigan, P1; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957	30	194	203	0	58	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2004	36	12					1326	1329		10.1038/ng1471	http://dx.doi.org/10.1038/ng1471			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15531881				2022-12-27	WOS:000225354100022
J	Segal, E; Friedman, N; Koller, D; Regev, A				Segal, E; Friedman, N; Koller, D; Regev, A			A module map showing conditional activity of expression modules in cancer	NATURE GENETICS			English	Article							GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; MICROARRAY DATA; METASTASIS; KINASE; TUMOR; BONE; ORGANIZATION; PROGRESSION	DNA microarrays are widely used to study changes in gene expression in tumors, but such studies are typically system-specific and do not address the commonalities and variations between different types of tumor. Here we present an integrated analysis of 1,975 published microarrays spanning 22 tumor types. We describe expression profiles in different tumors in terms of the behavior of modules, sets of genes that act in concert to carry out a specific function. Using a simple unified analysis, we extract modules and characterize gene-expression profiles in tumors as a combination of activated and deactivated modules. Activation of some modules is specific to particular types of tumor; for example, a growth-inhibitory module is specifically repressed in acute lymphoblastic leukemias and may underlie the deregulated proliferation in these cancers. Other modules are shared across a diverse set of clinical conditions, suggestive of common tumor progression mechanisms. For example, the bone osteoblastic module spans a variety of tumor types and includes both secreted growth factors and their receptors. Our findings suggest that there is a single mechanism for both primary tumor proliferation and metastasis to bone. Our analysis presents multiple research directions for diagnostic, prognostic and therapeutic studies.	Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91904 Jerusalem, Israel; Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA	Stanford University; Hebrew University of Jerusalem; Harvard University	Koller, D (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.	koller@cs.stanford.edu; aregev@agr.harvard.edu	Segal, Eran/AAF-4855-2019; Friedman, Nir/H-9692-2012	Friedman, Nir/0000-0002-9678-3550; Segal, Eran/0000-0002-6859-1164				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Boot AM, 1999, EUR J CANCER, V35, P1693, DOI 10.1016/S0959-8049(99)00143-4; Chu YF, 1996, J BIOL CHEM, V271, P6497, DOI 10.1074/jbc.271.11.6497; Dahlquist KD, 2002, NAT GENET, V31, P19, DOI 10.1038/ng0502-19; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferrari N, 2003, J LEUKOCYTE BIOL, V74, P302, DOI 10.1189/jlb.1102581; Furukawa T, 2003, AM J PATHOL, V162, P1807, DOI 10.1016/S0002-9440(10)64315-5; Ge BX, 2003, J BIOL CHEM, V278, P2286, DOI 10.1074/jbc.M210918200; Granata OM, 2002, MOL CELL ENDOCRINOL, V193, P51, DOI 10.1016/S0303-7207(02)00095-3; Hynes RO, 2003, CELL, V113, P821, DOI 10.1016/S0092-8674(03)00468-9; Iguchi H, 2002, J EXP CLIN CANC RES, V21, P309; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kim SC, 1999, BLOOD, V93, P3893, DOI 10.1182/blood.V93.11.3893.407k14_3893_3899; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lione AM, 2000, J NEUROCHEM, V75, P934, DOI 10.1046/j.1471-4159.2000.0750934.x; Mita H, 2002, MOL CELL BIOL, V22, P4544, DOI 10.1128/MCB.22.13.4544-4555.2002; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Reinholz MM, 2002, BREAST CANCER RES TR, V74, P255, DOI 10.1023/A:1016339120506; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shi CS, 2001, J BIOL CHEM, V276, P24293, DOI 10.1074/jbc.M100089200; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tanay A, 2004, P NATL ACAD SCI USA, V101, P2981, DOI 10.1073/pnas.0308661100; Ugolini F, 1999, ONCOGENE, V18, P1903, DOI 10.1038/sj.onc.1202739	30	533	571	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2004	36	10					1090	1098		10.1038/ng1434	http://dx.doi.org/10.1038/ng1434			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	15448693	Green Accepted, Bronze			2022-12-27	WOS:000224156500018
J	Cho, E; Feng, Y; Rauskolb, C; Maitra, S; Fehon, R; Irvine, KD				Cho, Eunjoo; Feng, Yongqiang; Rauskolb, Cordelia; Maitra, Sushmita; Fehon, Rick; Irvine, Kenneth D.			Delineation of a Fat tumor suppressor pathway	NATURE GENETICS			English	Article							PLANAR CELL POLARITY; PROMOTES APOPTOSIS; DROSOPHILA-MELANOGASTER; PROLIFERATION CONTROL; CUBITUS INTERRUPTUS; EXPANDED FUNCTION; PROTEIN-KINASE; DOUBLE-TIME; CYCLE EXIT; GROWTH	Recent studies in Drosophila melanogaster of the protocadherins Dachsous and Fat suggest that they act as ligand and receptor, respectively, for an intercellular signaling pathway that influences tissue polarity, growth and gene expression, but the basis for signaling downstream of Fat has remained unclear. Here, we characterize functional relationships among D. melanogaster tumor suppressors and identify the kinases Discs overgrown and Warts as components of a Fat signaling pathway. fat, discs overgrown and warts regulate a common set of downstream genes in multiple tissues. Genetic experiments position the action of discs overgrown upstream of the Fat pathway component dachs, whereas warts acts downstream of dachs. Warts protein coprecipitates with Dachs, and Warts protein levels are influenced by fat, dachs and discs overgrown in vivo, consistent with its placement as a downstream component of the pathway. The tumor suppressors Merlin, expanded, hippo, salvador and mob as tumor suppressor also share multiple Fat pathway phenotypes but regulate Warts activity independently. Our results functionally link what had been four disparate groups of D. melanogaster tumor suppressors, establish a basic framework for Fat signaling from receptor to transcription factor and implicate Warts as an integrator of multiple growth control signals.	Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Chicago	Irvine, KD (corresponding author), Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA.	irvine@waksman.rutgers.edu	Feng, Yongqiang/AAR-7719-2021; Feng, Yongqiang/N-2731-2018	Feng, Yongqiang/0000-0002-2320-5063; Feng, Yongqiang/0000-0002-2320-5063	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM63057] Funding Source: Medline; NINDS NIH HHS [NS034783] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS034783, R01NS034783] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Blaumueller CM, 2000, MECH DEVELOP, V92, P251, DOI 10.1016/S0925-4773(00)00246-X; BOEDIGHEIMER M, 1993, DEVELOPMENT, V118, P1291; BRYANT PJ, 1988, DEV BIOL, V129, P541, DOI 10.1016/0012-1606(88)90399-5; Buckles GR, 2001, DEVELOPMENT, V128, P3533; Casal J, 2002, CURR BIOL, V12, P1189, DOI 10.1016/S0960-9822(02)00974-0; Cho E, 2004, DEVELOPMENT, V131, P4489, DOI 10.1242/dev.01315; CLARK HF, 1995, GENE DEV, V9, P1530, DOI 10.1101/gad.9.12.1530; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Edwards KM, 2004, ONCOGENE, V23, P5263, DOI 10.1038/sj.onc.1207686; Fanto M, 2003, DEVELOPMENT, V130, P763, DOI 10.1242/dev.00304; Garoia F, 2005, MECH DEVELOP, V122, P175, DOI 10.1016/j.mod.2004.10.007; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jaiswal M, 2006, DEVELOPMENT, V133, P925, DOI 10.1242/dev.02243; Jia JH, 2005, DEV CELL, V9, P819, DOI 10.1016/j.devcel.2005.10.006; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168; Klein TJ, 2006, CURR BIOL, V16, P1337, DOI 10.1016/j.cub.2006.06.030; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Matakatsu H, 2006, DEVELOPMENT, V133, P2315, DOI 10.1242/dev.02401; McCartney BM, 2000, DEVELOPMENT, V127, P1315; McCartney BM, 1996, J CELL BIOL, V133, P843, DOI 10.1083/jcb.133.4.843; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Rauskolb C, 1999, DEV BIOL, V210, P339, DOI 10.1006/dbio.1999.9273; Simon MA, 2004, DEVELOPMENT, V131, P6175, DOI 10.1242/dev.01550; Strutt H, 2004, DEVELOPMENT, V131, P881, DOI 10.1242/dev.00996; Strutt H, 2002, DEV CELL, V3, P851, DOI 10.1016/S1534-5807(02)00363-5; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; WATSON KL, 1994, J CELL SCI, P19; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Zeidler MP, 2000, DEV BIOL, V228, P181, DOI 10.1006/dbio.2000.9940; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zilian O, 1999, DEVELOPMENT, V126, P5409	49	347	354	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1142	1150		10.1038/ng1887	http://dx.doi.org/10.1038/ng1887			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16980976				2022-12-27	WOS:000241251100013
J	Mahadevan, MS; Yadava, RS; Yu, Q; Balijepalli, S; D Frenzel-McCardell, C; Bourne, TD; Phillips, LH				Mahadevan, Mani S.; Yadava, Ramesh S.; Yu, Qing; Balijepalli, Sadguna; D Frenzel-McCardell, Carla; Bourne, T. David; Phillips, Lawrence H.			Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy	NATURE GENETICS			English	Article							3 UNTRANSLATED REGION; TRINUCLEOTIDE REPEAT; MIS-REGULATION; NUCLEAR FOCI; PROTEIN; MUSCLEBLIND; SEQUENCE; DMPK; OVEREXPRESSION; TRANSCRIPTS	Myotonic dystrophy (DM1), the most common muscular dystrophy in adults, is caused by an expanded (CTG)(n) tract in the 3' UTR of the gene encoding myotonic dystrophy protein kinase ( DMPK) 1, which results in nuclear entrapment of the 'toxic' mutant RNA and interacting RNA-binding proteins ( such as MBNL1) in ribonuclear inclusions(2). It is unclear if therapy aimed at eliminating the toxin would be beneficial. To address this, we generated transgenic mice expressing the DMPK 3' UTR as part of an inducible RNA transcript encoding green fluorescent protein (GFP). We were surprised to find that mice overexpressing a normal DMPK 3' UTR mRNA reproduced cardinal features of myotonic dystrophy, including myotonia, cardiac conduction abnormalities, histopathology and RNA splicing defects in the absence of detectable nuclear inclusions. However, we observed increased levels of CUG-binding protein (CUG-BP1) in skeletal muscle, as seen in individuals with DM1. Notably, these effects were reversible in both mature skeletal and cardiac muscles by silencing transgene expression. These results represent the first in vivo proof of principle for a therapeutic strategy for treatment of myotonic dystrophy by ablating or silencing expression of the toxic RNA molecules.	Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA; Univ Wisconsin, Dept Med, Madison, WI 53705 USA; Univ Virginia, Dept Neurol, Charlottesville, VA 22908 USA	University of Virginia; University of Wisconsin System; University of Wisconsin Madison; University of Virginia	Mahadevan, MS (corresponding author), Univ Virginia, Dept Pathol, POB 800904, Charlottesville, VA 22908 USA.	mahadevan@virginia.edu	Yadava, Ramesh S/AAZ-3099-2021; Bourne, Tom/I-6478-2012	Yadava, Ramesh S/0000-0002-0092-5033; Bourne, Tom/0000-0003-1421-6059	NIAMS NIH HHS [R01 AR052771, R01 AR052771-02, R01 AR045992] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045992, R01AR052771] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Amack JD, 1999, HUM MOL GENET, V8, P1975, DOI 10.1093/hmg/8.11.1975; Amack JD, 2001, HUM MOL GENET, V10, P1879, DOI 10.1093/hmg/10.18.1879; Berul CI, 2000, J INTERV CARD ELECTR, V4, P351, DOI 10.1023/A:1009842114968; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Day JW, 2005, NEUROMUSCULAR DISORD, V15, P5, DOI 10.1016/j.nmd.2004.09.012; Furling D, 2001, NEUROMUSCULAR DISORD, V11, P728, DOI 10.1016/S0960-8966(01)00226-7; Ho TH, 2005, J CELL SCI, V118, P2923, DOI 10.1242/jcs.02404; Ho TH, 2005, HUM MOL GENET, V14, P1539, DOI 10.1093/hmg/ddi162; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Houseley JM, 2005, HUM MOL GENET, V14, P873, DOI 10.1093/hmg/ddi080; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Langlois MA, 2003, MOL THER, V7, P670, DOI 10.1016/S1525-0016(03)00068-6; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAHADEVAN MS, 1993, HUM MOL GENET, V2, P299, DOI 10.1093/hmg/2.3.299; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2005, CIRC RES, V97, P1152, DOI 10.1161/01.RES.0000193598.89753.e3; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Margolis JM, 2006, HUM MOL GENET, V15, P1808, DOI 10.1093/hmg/ddl103; MELACINI P, 1995, J AM COLL CARDIOL, V25, P239, DOI 10.1016/0735-1097(94)00351-P; O'Cochlain DF, 2004, HUM MOL GENET, V13, P2505, DOI 10.1093/hmg/ddh266; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Seznec H, 2001, HUM MOL GENET, V10, P2717, DOI 10.1093/hmg/10.23.2717; Storbeck CJ, 2004, HUM MOL GENET, V13, P589, DOI 10.1093/hmg/ddh064; Storbeck CJ, 1998, J BIOL CHEM, V273, P9139, DOI 10.1074/jbc.273.15.9139; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Timchenko NA, 2004, J BIOL CHEM, V279, P13129, DOI 10.1074/jbc.M312923200	30	144	148	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					1066	1070		10.1038/ng1857	http://dx.doi.org/10.1038/ng1857			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16878132	Green Accepted			2022-12-27	WOS:000240112100026
J	Balasubramanian, S; Sureshkumar, S; Agrawal, M; Michael, TP; Wessinger, C; Maloof, JN; Clark, R; Warthmann, N; Chory, J; Weigel, D				Balasubramanian, Sureshkumar; Sureshkumar, Sridevi; Agrawal, Mitesh; Michael, Todd P.; Wessinger, Carrie; Maloof, Julin N.; Clark, Richard; Warthmann, Norman; Chory, Joanne; Weigel, Detlef			The PHYTOCHROME C photoreceptor gene mediates natural variation in flowering and growth responses of Arabidopsis thaliana	NATURE GENETICS			English	Article							REGULATORY ACTIVITY; LATITUDINAL CLINE; TERMINAL-DOMAIN; TIME; LIGHT; TRAIT; FRIGIDA; LOCI; REVEALS; RECOMBINANT	Light has an important role in modulating seedling growth and flowering time. We show that allelic variation at the PHYTOCHROME C ( PHYC) photoreceptor locus affects both traits in natural populations of A. thaliana. Two functionally distinct PHYC haplotype groups are distributed in a latitudinal cline dependent on FRIGIDA, a locus that together with FLOWERING LOCUS C explains a large portion of the variation in A. thaliana flowering time(1). In a genome-wide scan for association of 65 loci with latitude, there was an excess of significant P values, indicative of population structure. Nevertheless, PHYC was the most strongly associated locus across 163 strains, suggesting that PHYC alleles are under diversifying selection in A. thaliana. Our work, together with previous findings(2-5), suggests that photoreceptor genes are major agents of natural variation in plant flowering and growth response.	Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA	Max Planck Society; Salk Institute; Howard Hughes Medical Institute; Salk Institute; University of California System; University of California Davis	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	weigel@weigelworld.org	Warthmann, Norman/E-1069-2011; Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/C-1418-2008; Balasubramanian, Sureshkumar/AAS-6919-2020	Warthmann, Norman/0000-0002-1178-8409; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Balasubramanian, Sureshkumar/0000-0002-1057-2606; Maloof, Julin/0000-0002-9623-2599; Michael, Todd/0000-0001-6272-2875	NIGMS NIH HHS [R01 GM062932, GM62932] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062932] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alonso-Blanco C, 1998, GENETICS, V149, P749; Aukerman MJ, 1997, PLANT CELL, V9, P1317, DOI 10.1105/tpc.9.8.1317; Borevitz JO, 2002, GENETICS, V160, P683; Caicedo AL, 2004, P NATL ACAD SCI USA, V101, P15670, DOI 10.1073/pnas.0406232101; Devos KM, 2005, PLANT MOL BIOL, V58, P625, DOI 10.1007/s11103-005-6801-z; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; El-Lithy ME, 2004, PLANT PHYSIOL, V135, P444, DOI 10.1104/pp.103.036822; Franklin KA, 2003, PLANT CELL, V15, P1981, DOI 10.1105/tpc.015164; Halliday KJ, 1997, PLANT J, V12, P1079, DOI 10.1046/j.1365-313X.1997.12051079.x; Johanson U, 2000, SCIENCE, V290, P344, DOI 10.1126/science.290.5490.344; Lempe J, 2005, PLOS GENET, V1, P109, DOI 10.1371/journal.pgen.0010006; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; Mathews S, 1999, SCIENCE, V286, P947, DOI 10.1126/science.286.5441.947; Monte E, 2003, PLANT CELL, V15, P1962, DOI 10.1105/tpc.012971; Olsen KM, 2004, GENETICS, V167, P1361, DOI 10.1534/genetics.103.024950; Qin MM, 1997, PLANT J, V12, P1163, DOI 10.1046/j.1365-313X.1997.12051163.x; REED JW, 1993, PLANT CELL, V5, P147, DOI 10.1105/tpc.5.2.147; Schmid K, 2006, THEOR APPL GENET, V112, P1104, DOI 10.1007/s00122-006-0212-7; Shindo C, 2005, PLANT PHYSIOL, V138, P1163, DOI 10.1104/pp.105.061309; Stinchcombe JR, 2004, P NATL ACAD SCI USA, V101, P4712, DOI 10.1073/pnas.0306401101; Takano M, 2005, PLANT CELL, V17, P3311, DOI 10.1105/tpc.105.035899; WAGNER D, 1995, P NATL ACAD SCI USA, V92, P8596, DOI 10.1073/pnas.92.19.8596; Wang XS, 2004, GENOME RES, V14, P1767, DOI 10.1101/gr.2668204; Weinig C, 2002, GENETICS, V162, P1875; Werner JD, 2005, GENETICS, V170, P1197, DOI 10.1534/genetics.104.036533; Werner JD, 2005, P NATL ACAD SCI USA, V102, P2460, DOI 10.1073/pnas.0409474102; White GM, 2004, MOL BIOL EVOL, V21, P716, DOI 10.1093/molbev/msh067; Wolyn DJ, 2004, GENETICS, V167, P907, DOI 10.1534/genetics.103.024810; XU Y, 1995, PLANT CELL, V7, P1433, DOI 10.1105/tpc.7.9.1433	30	166	171	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2006	38	6					711	715		10.1038/ng1818	http://dx.doi.org/10.1038/ng1818			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16732287	Green Accepted			2022-12-27	WOS:000237954800028
J	Sung, SB; He, YH; Eshoo, TW; Tamada, Y; Johnson, L; Nakahigashi, K; Goto, K; Jacobsen, SE; Amasino, RM				Sung, Sibum; He, Yuehui; Eshoo, Tifani W.; Tamada, Yosuke; Johnson, Lianna; Nakahigashi, Kenji; Goto, Koji; Jacobsen, Steve E.; Amasino, Richard M.			Epigenetic maintenance of the vernalized state in Arabidopsis thaliana requires LIKE HETEROCHROMATIN PROTEIN 1	NATURE GENETICS			English	Article							HISTONE H3 METHYLATION; FLOWERING-LOCUS-C; POLYCOMB-GROUP PROTEINS; WINTER-ANNUAL HABIT; GENE; CHROMATIN; HOMOLOG; HP1; REPRESSOR; LYSINE-9	Vernalization is the process by which sensing a prolonged exposure to winter cold leads to competence to flower in the spring. In winter annual Arabidopsis thaliana accessions, flowering is suppressed in the fall by expression of the potent floral repressor FLOWERING LOCUS C (FLC) 1. Vernalization promotes flowering via epigenetic repression of FLC2. Repression is accompanied by a series of histone modifications of FLC chromatin that include dimethylation of histone H3 at Lys9 (H3K9) and Lys27 (H3K27) 3,4. Here, we report that A. thaliana LIKE HETEROCHROMATIN PROTEIN 1 (LHP1) is necessary to maintain the epigenetically repressed state of FLC upon return to warm conditions typical of spring. LHP1 is enriched at FLC chromatin after prolonged exposure to cold, and LHP1 activity is needed to maintain the increased levels of H3K9 dimethylation at FLC chromatin that are characteristic of the vernalized state.	Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Res Inst Biol Sci, Okayama 7161241, Japan	University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Amasino, RM (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	amasino@biochem.wisc.edu	HE, Yuehui/H-9795-2012; Sung, Sibum/AAM-6500-2020; Tamada, Yosuke/A-4144-2010; HE, Yuehui/Y-8792-2018	HE, Yuehui/0000-0003-3304-4555; HE, Yuehui/0000-0003-3304-4555; ANTON, TIFANI/0000-0002-9297-4042; Tamada, Yosuke/0000-0002-4845-4867	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060398, R37GM060398] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM060398] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; Baumbusch LO, 2001, NUCLEIC ACIDS RES, V29, P4319, DOI 10.1093/nar/29.21.4319; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; Gaudin V, 2001, DEVELOPMENT, V128, P4847; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; He YH, 2004, GENE DEV, V18, P2774, DOI 10.1101/gad.1244504; Huang T, 2005, SCIENCE, V309, P1694, DOI 10.1126/science.1117768; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Kim SY, 2005, PLANT CELL, V17, P3301, DOI 10.1105/tpc.105.034645; Kotake T, 2003, PLANT CELL PHYSIOL, V44, P555, DOI 10.1093/pcp/pcg091; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; LEE I, 1995, PLANT PHYSIOL, V108, P157, DOI 10.1104/pp.108.1.157; Libault M, 2005, PLANTA, V222, P910, DOI 10.1007/s00425-005-0129-4; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Liu LP, 2005, NAT GENET, V37, P1361, DOI 10.1038/ng1662; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Michaels SD, 2000, PLANT CELL ENVIRON, V23, P1145, DOI 10.1046/j.1365-3040.2000.00643.x; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Nakahigashi K, 2005, PLANT CELL PHYSIOL, V46, P1747, DOI 10.1093/pcp/pci195; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schubert D, 2005, CURR OPIN PLANT BIOL, V8, P553, DOI 10.1016/j.pbi.2005.07.005; Sheldon CC, 2002, PLANT CELL, V14, P2527, DOI 10.1105/tpc.004564; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Sung S, 2005, ANNU REV PLANT BIOL, V56, P491, DOI 10.1146/annurev.arplant.56.032604.144307; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Zemach A, 2006, PLANT CELL, V18, P133, DOI 10.1105/tpc.105.036855	30	234	253	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					706	710		10.1038/ng1795	http://dx.doi.org/10.1038/ng1795			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16682972				2022-12-27	WOS:000237954800027
J	Repping, S; van Daalen, SKM; Brown, LG; Korver, CM; Lange, J; Marszalek, JD; Pyntikova, T; van der Veen, F; Skaletsky, H; Page, DC; Rozen, S				Repping, S; van Daalen, SKM; Brown, LG; Korver, CM; Lange, J; Marszalek, JD; Pyntikova, T; van der Veen, F; Skaletsky, H; Page, DC; Rozen, S			High mutation rates have driven extensive structural polymorphism among human Y chromosomes	NATURE GENETICS			English	Article							AZFC REGION; SEQUENCE; DELETION; FAMILY	Although much structural polymorphism in the human genome has been catalogued(1-5), the kinetics of underlying change remain largely unexplored. Because human Y chromosomes are clonally inherited, it has been possible to capture their detailed relationships in a robust, worldwide genealogical tree(6,7). Examination of structural variation across this tree opens avenues for investigating rates of underlying mutations. We selected one Y chromosome from each of 47 branches of this tree and searched for large-scale variation. Four chromosomal regions showed extensive variation resulting from numerous large-scale mutations. Within the tree encompassed by the studied chromosomes, the distal-Yq heterochromatin changed length >= 12 times, the TSPY gene array changed length >= 23 times, the 3.6-Mb IR3/IR3 region changed orientation >= 12 times and the AZFc region was rearranged >= 20 times. After determining the total time spanned by all branches of this tree (similar to 1.3 million years or 52,000 generations), we converted these mutation counts to lower bounds on rates: >= 2.3x10(-4), >= 4.4x10(-4), >= 2.3x10(-4) and >= 3.8x10(-4) large-scale mutations per father-to-son Y transmission, respectively. Thus, high mutation rates have driven extensive structural polymorphism among human Y chromosomes. At the same time, we found limited variation in the copy number of Y-linked genes, which raises the possibility of selective constraints.	MIT, Whitehead Inst Biomed Res, Howard Hughes Med Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynecol, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Amsterdam; Academic Medical Center Amsterdam	Page, DC (corresponding author), MIT, Whitehead Inst Biomed Res, Howard Hughes Med Inst, Cambridge, MA 02142 USA.	page_admin@wi.mit.edu	Rozen, Steven G./J-5939-2013	Rozen, Steven G./0000-0002-4288-0056; Repping, Sjoerd/0000-0002-6959-149X				AFFARA NA, 1986, NUCLEIC ACIDS RES, V14, P5375, DOI 10.1093/nar/14.13.5375; BERNSTEIN R, 1986, HUM GENET, V74, P223; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; de Llanos M, 2005, HUM REPROD, V20, P216, DOI 10.1093/humrep/deh582; Ellis N, 2002, GENOME RES, V12, P339; Ferlin A, 2005, J MED GENET, V42, P209, DOI 10.1136/jmg.2004.025833; GRACE HJ, 1972, J MED GENET, V9, P293, DOI 10.1136/jmg.9.3.293; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kucklenbroich K, 2005, HUM REPROD, V20, P191, DOI 10.1098/humrep/deh558; Lynch M, 2005, MOL HUM REPROD, V11, P507, DOI 10.1093/molehr/gah191; Machev N, 2004, J MED GENET, V41, P814, DOI 10.1136/jmg.2004.022111; MANZ E, 1993, GENOMICS, V17, P726, DOI 10.1006/geno.1993.1393; PAGE DC, 1986, COLD SPRING HARB SYM, V51, P229, DOI 10.1101/SQB.1986.051.01.028; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Repping S, 2004, GENOMICS, V83, P1046, DOI 10.1016/j.ygeno.2003.12.018; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; SANKOFF D, 1975, SIAM J APPL MATH, V28, P35, DOI 10.1137/0128004; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; SCHNEDL W, 1971, HUMANGENETIK, V12, P188, DOI 10.1007/BF00702774; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; TYLERSMITH C, 1988, J MOL BIOL, V203, P837, DOI 10.1016/0022-2836(88)90110-6; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880	30	204	214	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2006	38	4					463	467		10.1038/ng1754	http://dx.doi.org/10.1038/ng1754			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	026LN	16501575				2022-12-27	WOS:000236340500020
J	Lerner-Ellis, JP; Tirone, JC; Pawelek, PD; Dore, C; Atkinson, JL; Watkins, D; Morel, CF; Fujiwara, TM; Moras, E; Hosack, AR; Dunbar, GV; Antonicka, H; Forgetta, V; Dobson, CM; Leclerc, D; Gravel, RA; Shoubridge, EA; Coulton, JW; Lepage, P; Rommens, JM; Morgan, K; Rosenblatt, DS				Lerner-Ellis, JP; Tirone, JC; Pawelek, PD; Dore, C; Atkinson, JL; Watkins, D; Morel, CF; Fujiwara, TM; Moras, E; Hosack, AR; Dunbar, GV; Antonicka, H; Forgetta, V; Dobson, CM; Leclerc, D; Gravel, RA; Shoubridge, EA; Coulton, JW; Lepage, P; Rommens, JM; Morgan, K; Rosenblatt, DS			Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type	NATURE GENETICS			English	Article							C-TERMINAL DOMAIN; HAPLOTYPE RECONSTRUCTION; COBALAMIN METABOLISM; CRYSTAL-STRUCTURE; INBORN ERROR; PROTEIN; TONB; REVEALS	Methylmalonic aciduria and homocystinuria, cblC type ( OMIM 277400), is the most common inborn error of vitamin B-12 ( cobalamin) metabolism, with about 250 known cases. Affected individuals have developmental, hematological, neurological, metabolic, ophthalmologic and dermatologic clinical findings(1). Although considered a disease of infancy or childhood, some individuals develop symptoms in adulthood(2). The cblC locus was mapped to chromosome region 1p by linkage analysis(3). We refined the chromosomal interval using homozygosity mapping and haplotype analyses and identified the MMACHC gene. In 204 individuals, 42 different mutations were identified, many consistent with a loss of function of the protein product. One mutation, 271dupA, accounted for 40% of all disease alleles. Transduction of wild-type MMACHC into immortalized cblC fibroblast cell lines corrected the cellular phenotype. Molecular modeling predicts that the C-terminal region of the gene product folds similarly to TonB, a bacterial protein involved in energy transduction for cobalamin uptake.	McGill Univ, Dept Human Genet, Montreal, PQ H3G 1B1, Canada; McGill Univ, Ctr Hlth, Div Med Genet, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	McGill University; McGill University; McGill University; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; University of Calgary	Rosenblatt, DS (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ H3G 1B1, Canada.	david.rosenblatt@mcgill.ca	Lerner-Ellis, Jordan/J-5559-2016; Leclerc, Daniel/AAB-4524-2021; Pawelek, Peter/E-7950-2014; Leclerc, Daniel/B-6375-2012; Rommens, Johanna/AAT-7465-2021	Leclerc, Daniel/0000-0002-9766-8941; Pawelek, Peter/0000-0002-8361-6593; Forgetta, Vincenzo/0000-0002-6061-4720; Antonicka, Hana/0000-0002-2525-2867				Andersson HC, 1998, J PEDIATR-US, V132, P121, DOI 10.1016/S0022-3476(98)70496-2; ATKINSON J, 2003, THESIS U TORONTO; BELL PE, 1990, J BACTERIOL, V172, P3826, DOI 10.1128/jb.172.7.3826-3829.1990; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cadieux N, 1999, P NATL ACAD SCI USA, V96, P10673, DOI 10.1073/pnas.96.19.10673; Carmel R., 2001, HOMOCYSTEINE HLTH DI; Chang CS, 2001, J BIOL CHEM, V276, P27535, DOI 10.1074/jbc.M102778200; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Horton P, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P147; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P1878, DOI 10.1107/S0907444999010495; Kodding J, 2005, J BIOL CHEM, V280, P3022, DOI 10.1074/jbc.M411155200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; MELLMAN I, 1979, J BIOL CHEM, V254, P1847; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; Peacock RS, 2005, J MOL BIOL, V345, P1185, DOI 10.1016/j.jmb.2004.11.026; Pezacka E. H., 1994, ADV THOMAS ADDISONS, P315; Rosenblatt D. S., 2001, METABOLIC MOL BASES, V8th, P3897; ROSENBLATT DS, 1985, SCIENCE, V228, P1319, DOI 10.1126/science.4001945; Rosenblatt DS, 1997, J INHERIT METAB DIS, V20, P528, DOI 10.1023/A:1005353530303; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Templeton AR, 2000, AM J HUM GENET, V66, P69, DOI 10.1086/302699; Watkins D, 1998, CLIN INVEST MED, V21, P151; Watkins D, 2000, J MED GENET, V37, P510, DOI 10.1136/jmg.37.7.510; Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541	29	251	294	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					93	100		10.1038/ng1683	http://dx.doi.org/10.1038/ng1683			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16311595				2022-12-27	WOS:000234227200023
J	Herron, BJ; Liddell, RA; Parker, A; Grant, S; Kinne, J; Fisher, JK; Siracusa, LD				Herron, BJ; Liddell, RA; Parker, A; Grant, S; Kinne, J; Fisher, JK; Siracusa, LD			A mutation in stratifin is responsible for the repeated epilation (Er) phenotype in mice	NATURE GENETICS			English	Article							14-3-3-SIGMA; CANCER; MUTANT; MOUSE	Stratifin (Sfn, also called 14-3-3 sigma) is highly expressed in differentiating epidermis and mediates cell cycle arrest. Sfn is repressed in cancer, but its function during development is uncharacterized. We identified an insertion mutation in the gene Sfn in repeated epilation (Er) mutant mice by positional cloning. Er/+ mice expressed a truncated Sfn protein, which probably contributes to the defects in Er/Er and Er/+ epidermis and to cancer development in Er/+ mice.	New York State Dept Hlth, Wadsworth Ctr, Genom Inst, Albany, NY 12180 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	State University of New York (SUNY) System; Wadsworth Center; Jefferson University	Herron, BJ (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Genom Inst, 465 Jordan Rd, Albany, NY 12180 USA.	bherron@wadsworth.org						Benzinger A, 2005, MOL CELL PROTEOMICS, V4, P785, DOI 10.1074/mcp.M500021-MCP200; Dellambra E, 2000, J CELL BIOL, V149, P1117, DOI 10.1083/jcb.149.5.1117; FISHER C, 1987, J CELL BIOL, V105, P1807, DOI 10.1083/jcb.105.4.1807; GUENET JL, 1994, HDB MOUSE MUTATION S, P399; Hermeking H, 2003, NAT REV CANCER, V3, P931, DOI 10.1038/nrc1230; Hunsicker PR, 1960, MOUSE NEWSLETT, V23, P58; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; LUTZNER MA, 1985, JNCI-J NATL CANCER I, V75, P161; O'Shaughnessy RFL, 2004, INT J DEV BIOL, V48, P171, DOI 10.1387/ijdb.15272382; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Wilker EW, 2005, J BIOL CHEM, V280, P18891, DOI 10.1074/jbc.M500982200; Xing HM, 2000, EMBO J, V19, P349, DOI 10.1093/emboj/19.3.349	12	59	59	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2005	37	11					1210	1212		10.1038/ng1652	http://dx.doi.org/10.1038/ng1652			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16200063				2022-12-27	WOS:000233045200019
J	Campbell, CD; Ogburn, EL; Lunetta, KL; Lyon, HN; Freedman, ML; Groop, LC; Altshuler, D; Ardlie, KG; Hirschhorn, JN				Campbell, CD; Ogburn, EL; Lunetta, KL; Lyon, HN; Freedman, ML; Groop, LC; Altshuler, D; Ardlie, KG; Hirschhorn, JN			Demonstrating stratification in a European American population	NATURE GENETICS			English	Article							GENETIC ASSOCIATION; STRUCTURED POPULATIONS; QUANTITATIVE TRAITS; GENOMIC CONTROL; DISEQUILIBRIUM; INFERENCE; VARIANTS; MARKERS; DISEASE; CANCER	Population stratification occurs in case-control association studies when allele frequencies differ between cases and controls because of ancestry. Stratification may lead to false positive associations, although this issue remains controversial(1-4). Empirical studies have found little evidence of stratification in European-derived populations, but potentially significant levels of stratification could not be ruled out(5-7). We studied a European American panel discordant for height, a heritable trait that varies widely across Europe(8). Genotyping 178 SNPs and applying standard analytical methods(6,9-11) yielded no evidence of stratification. But a SNP in the gene LCT that varies widely in frequency across Europe(12) was strongly associated with height (P < 10(-6)). This apparent association was largely or completely due to stratification; rematching individuals on the basis of European ancestry greatly reduced the apparent association, and no association was observed in Polish or Scandinavian individuals. The failure of standard methods to detect this stratification indicates that new methods may be required.	Childrens Hosp, Program Genom, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Genom Collaborat Inc, Cambridge, MA 02139 USA; Harvard Univ, Broad Inst, Cambridge, MA 02139 USA; MIT, Broad Inst, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Hematol Oncol, Boston, MA 02114 USA; Lund Univ, Univ Hosp, Dept Clin Sci Diabet & Endocrinol, Malmo, Sweden	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Lund University; Skane University Hospital	Hirschhorn, JN (corresponding author), Childrens Hosp, Program Genom, 300 Longwood Ave, Boston, MA 02115 USA.	joelh@broad.mit.edu	Altshuler, David M/A-4476-2009	Altshuler, David M/0000-0002-7250-4107; Lunetta, Kathryn/0000-0002-9268-810X				Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Allison DB, 1997, AM J HUM GENET, V60, P676; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; CavalliSforza LL, 1997, P NATL ACAD SCI USA, V94, P7719, DOI 10.1073/pnas.94.15.7719; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Hinds DA, 2004, AM J HUM GENET, V74, P317, DOI 10.1086/381716; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pfaff CL, 2002, GENET EPIDEMIOL, V22, P196, DOI 10.1002/gepi.0126; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; THOMAS DC, 2002, BIOMARKERS PREV, V11, P505; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513	29	329	337	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2005	37	8					868	872		10.1038/ng1607	http://dx.doi.org/10.1038/ng1607			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16041375				2022-12-27	WOS:000230880400017
J	Spitz, F; Herkenne, C; Morris, MA; Duboule, D				Spitz, F; Herkenne, C; Morris, MA; Duboule, D			Inversion-induced disruption of the Hoxd cluster leads to the partition of regulatory landscapes	NATURE GENETICS			English	Article							GLOBAL CONTROL REGION; GENE-EXPRESSION; MICE DEFICIENT; CRE-LOXP; COMPLEX; MURINE; RANGE; ORGANIZATION; COLINEARITY; CHROMOSOMES	The developmental regulation of vertebrate Hox gene transcription relies on the interplay between local and long-range controls. To study this complex genomic organization, we designed a strategy combining meiotic and targeted recombinations to induce large chromosomal rearrangements in vivo without manipulating embryonic stem cells. With this simple approach (called STRING), we engineered a large 7-cM inversion, which split the Hoxd cluster into two independent pieces. Expression analyses showed a partition of global enhancers, allowing for their precise topographic allocation on either side of the cluster. Such a functional organization probably contributed to keeping these genes clustered in the course of vertebrate evolution. This approach can be used to study the relationship between genome architecture and gene expression, such as the effects of genome rearrangements in human diseases or during evolution.	Univ Geneva, Dept Zool & Anim Biol, Natl Res Ctr Frontiers Genet, CH-1211 Geneva, Switzerland; Univ Geneva, Sch Med, Dept Med Genet & Dev, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Serv Med Genet, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Natl Res Ctr Frontiers Genet, Quai Ernest Ansermet 30, CH-1211 Geneva, Switzerland.	Denis.Duboule@zoo.unige.ch	Morris, Michael/AAD-2458-2022	Morris, Michael/0000-0002-9660-505X; duboule, denis/0000-0001-9961-2960; Spitz, Francois/0000-0002-1960-829X				AKAM M, 1989, CELL, V57, P347, DOI 10.1016/0092-8674(89)90909-4; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; Duboule D, 1998, CURR OPIN GENET DEV, V8, P514, DOI 10.1016/S0959-437X(98)80004-X; GAUNT SJ, 1988, DEVELOPMENT, V104, P169; Gimond C, 1998, J CELL BIOL, V143, P253, DOI 10.1083/jcb.143.1.253; Gould A, 1997, GENE DEV, V11, P900, DOI 10.1101/gad.11.7.900; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kmita M, 2000, NAT GENET, V26, P451, DOI 10.1038/82593; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Kondo T, 1998, MOL CELL, V1, P289, DOI 10.1016/S1097-2765(00)80029-5; Kulnane LS, 2002, MAMM GENOME, V13, P223, DOI 10.1007/s00335-001-2128-5; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Monge I, 2003, DEV BIOL, V256, P212, DOI 10.1016/S0012-1606(02)00136-7; Puech A, 2000, P NATL ACAD SCI USA, V97, P10090, DOI 10.1073/pnas.97.18.10090; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Spitz F, 2002, GENOMICS, V79, P493, DOI 10.1006/geno.2002.6735; Spitz F, 2001, GENE DEV, V15, P2209, DOI 10.1101/gad.205701; VOGELS R, 1993, DEVELOPMENT, V118, P71; Wittig BM, 2000, J EXP MED, V191, P2053, DOI 10.1084/jem.191.12.2053; Yu YJ, 2001, NAT REV GENET, V2, P780, DOI 10.1038/35093564; Zakany J, 1997, EMBO J, V16, P4393, DOI 10.1093/emboj/16.14.4393; Zhang F, 1997, MECH DEVELOP, V67, P49, DOI 10.1016/S0925-4773(97)00104-4; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000; Zuniga AE, 2004, GENE DEV, V18, P1553, DOI 10.1101/gad.299904	29	116	121	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2005	37	8					889	893		10.1038/ng1597	http://dx.doi.org/10.1038/ng1597			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	15995706				2022-12-27	WOS:000230880400021
J	Francino, MP				Francino, MP			An adaptive radiation model for the origin of new gene functions	NATURE GENETICS			English	Article							OLFACTORY RECEPTOR GENES; AMPLIFICATION-MUTAGENESIS; TRANSFERRED GENES; NATURAL-SELECTION; GENOME EVOLUTION; FAMILY; DUPLICATION; BACTERIAL; MUTATION; GROWTH	Current models for the evolution of new gene functions after gene duplication presume that the duplication events themselves have no effect on fitness. But those duplications that result in new gene functions are likely to be positively selected from their inception. The evolution of new function may start with the amplification of an existing gene with some level of preadaptation for that function, followed by a period of competitive evolution among the gene copies, resulting in the preservation of the most effective variant and the 'pseudogenization' and eventual loss of the rest.	Lawrence Berkeley Natl Lab, DOE Joint Genome Inst, Evolutionary Genom Dept, Walnut Creek, CA 94598 USA; Lawrence Berkeley Natl Lab, Genom Div, Walnut Creek, CA USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Francino, MP (corresponding author), Lawrence Berkeley Natl Lab, DOE Joint Genome Inst, Evolutionary Genom Dept, 2800 Mitchell Dr, Walnut Creek, CA 94598 USA.	mpfrancino@lbl.gov	Francino, M.Pilar/H-9090-2015	Francino, M.Pilar/0000-0002-4510-5653				Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; CAIRNS J, 1991, GENETICS, V128, P695; Chan KMA, 2002, SYST BIOL, V51, P855, DOI 10.1080/10635150290155836; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Eldredge N., 1972, P82; Force A, 1999, GENETICS, V151, P1531; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Gevers D, 2004, TRENDS MICROBIOL, V12, P148, DOI 10.1016/j.tim.2004.02.007; Gilad Y, 2000, NAT GENET, V26, P221, DOI 10.1038/79957; Gilad Y, 2003, AM J HUM GENET, V73, P489, DOI 10.1086/378132; Gilad Y, 2003, MOL BIOL EVOL, V20, P307, DOI 10.1093/molbev/msg013; GINGERICH PD, 1983, SCIENCE, V222, P159, DOI 10.1126/science.222.4620.159; Guillemaud T, 1999, HEREDITY, V83, P87, DOI 10.1038/sj.hdy.6885370; Hall BG, 2003, GENETICA, V118, P143, DOI 10.1023/A:1024149508376; Harrison PM, 2002, J MOL BIOL, V318, P1155, DOI 10.1016/S0022-2836(02)00109-2; Hendrickson H, 2002, P NATL ACAD SCI USA, V99, P2164, DOI 10.1073/pnas.032680899; Holloway AK, 2004, MOL BIOL EVOL, V21, P1625, DOI 10.1093/molbev/msh195; Hooper SD, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r48; Hooper SD, 2003, MOL BIOL EVOL, V20, P945, DOI 10.1093/molbev/msg101; Hughes AL, 1999, CELL MOL LIFE SCI, V56, P94, DOI 10.1007/s000180050010; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Huynen MA, 1998, MOL BIOL EVOL, V15, P583, DOI 10.1093/oxfordjournals.molbev.a025959; Jablonski David, 1996, P256; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Jordan IK, 2001, GENOME RES, V11, P555, DOI 10.1101/gr.GR-1660R; Karev GP, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-18; Karev GP, 2003, BIOINFORMATICS, V19, P1889, DOI 10.1093/bioinformatics/btg351; Kim SJ, 1999, BIOTECHNOL BIOENG, V64, P741, DOI 10.1002/(SICI)1097-0290(19990920)64:6<741::AID-BIT14>3.0.CO;2-X; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; LANDE R, 1976, EVOLUTION, V30, P314, DOI 10.1111/j.1558-5646.1976.tb00911.x; Lespinet O, 2002, GENOME RES, V12, P1048, DOI 10.1101/gr.174302; Liu Y, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r64; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; LYNCH M, 1990, AM NAT, V136, P727, DOI 10.1086/285128; Mefford HC, 2001, HUM MOL GENET, V10, P2363, DOI 10.1093/hmg/10.21.2363; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Newman T, 2003, GENOME RES, V13, P781, DOI 10.1101/gr.769003; Ohno S., 1970, EVOLUTION GENE DUPLI; Qian J, 2001, J MOL BIOL, V313, P673, DOI 10.1006/jmbi.2001.5079; Reams AB, 2003, MOL MICROBIOL, V47, P1291, DOI 10.1046/j.1365-2958.2003.03342.x; Riehle MM, 2001, P NATL ACAD SCI USA, V98, P525, DOI 10.1073/pnas.021448998; Romero D, 1997, ANNU REV GENET, V31, P91, DOI 10.1146/annurev.genet.31.1.91; Roth JR, 2004, J BACTERIOL, V186, P4855, DOI 10.1128/JB.186.15.4855-4860.2004; Roth JR, 2004, RES MICROBIOL, V155, P342, DOI 10.1016/j.resmic.2004.01.016; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Stanley S. M., 1979, MACROEVOLUTION PATTE; Trask BJ, 1998, HUM MOL GENET, V7, P2007, DOI 10.1093/hmg/7.13.2007; TURELLI M, 1988, EVOLUTION, V42, P1085, DOI [10.2307/2408923, 10.1111/j.1558-5646.1988.tb02526.x]; Wagner A, 2002, GENOME BIOL, V3; Wagner PJ, 1996, EVOLUTION, V50, P990, DOI 10.1111/j.1558-5646.1996.tb02341.x; Young JM, 2002, HUM MOL GENET, V11, P1153, DOI 10.1093/hmg/11.10.1153; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zhong SB, 2004, P NATL ACAD SCI USA, V101, P11719, DOI 10.1073/pnas.0404397101	59	141	145	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					573	577		10.1038/ng1579	http://dx.doi.org/10.1038/ng1579			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15920518	Green Submitted			2022-12-27	WOS:000229495300007
J	Sakuntabhai, A; Turbpaiboon, C; Casademont, I; Chuansumrit, A; Lowhnoo, T; Kajaste-Rudnitski, A; Kalayanarooj, SM; Tangnararatchakit, K; Tangthawornchaikul, N; Vasanawathana, S; Chaiyaratana, W; Yenchitsomanus, PT; Suriyaphol, P; Avirutnan, P; Chokephaibulkit, K; Matsuda, F; Yoksan, S; Jacob, Y; Lathrop, GM; Malasit, P; Despres, P; Julier, C				Sakuntabhai, A; Turbpaiboon, C; Casademont, I; Chuansumrit, A; Lowhnoo, T; Kajaste-Rudnitski, A; Kalayanarooj, SM; Tangnararatchakit, K; Tangthawornchaikul, N; Vasanawathana, S; Chaiyaratana, W; Yenchitsomanus, PT; Suriyaphol, P; Avirutnan, P; Chokephaibulkit, K; Matsuda, F; Yoksan, S; Jacob, Y; Lathrop, GM; Malasit, P; Despres, P; Julier, C			A variant in the CD209 promoter is associated with severity of dengue disease	NATURE GENETICS			English	Article							SP1 BINDING-SITE; DC-SIGN; HEMORRHAGIC-FEVER; MYCOBACTERIUM-TUBERCULOSIS; INCREASED RISK; BONE-DENSITY; INFECTIONS; POLYMORPHISMS; PATHOGENESIS; CORRELATE	Dengue fever and dengue hemorrhagic fever are mosquito-borne viral diseases. Dendritic cell - specific ICAM-3 grabbing nonintegrin (DC-SIGN1, encoded by CD209), an attachment receptor of dengue virus, is essential for productive infection of dendritic cells(1,2). Here, we report strong association between a promoter variant of CD209, DCSIGN1-336, and risk of dengue fever compared with dengue hemorrhagic fever or population controls. The G allele of the variant DCSIGN1-336 was associated with strong protection against dengue fever in three independent cohorts from Thailand, with a carrier frequency of 4.7% in individuals with dengue fever compared with 22.4% in individuals with dengue hemorrhagic fever ( odds ratio for risk of dengue hemorrhagic fever versus dengue fever: 5.84, P = 1.4 x 10(-7)) and 19.5% in controls ( odds ratio for protection: 4.90, P = 2 x 10(-6)). This variant affects an Sp1-like binding site and transcriptional activity in vitro. These results indicate that CD209 has a crucial role in dengue pathogenesis, which discriminates between severe dengue fever and dengue hemorrhagic fever. This may have consequences for therapeutic and preventive strategies.	Inst Pasteur, INSERM E102, F-75724 Paris, France; Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pediat, Bangkok 10400, Thailand; Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pediat, Bangkok 10400, Thailand; Ctr Natl Genotypage, F-91057 Evry, France; Mahidol Univ, Ramathibodi Hosp, Fac Med, Res Ctr, Bangkok 10400, Thailand; Inst Pasteur, F-75724 Paris, France; Mahidol Univ, Med Mol Biol Unit, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand; Natl Sci & Technol Dev Agcy NSTDA, Med Biotechnol Unit, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani 12120, Thailand; Khon Kaen Univ, Minist Publ Hlth, Dept Pediat, Khon Kaen 40000, Thailand; Mahidol Univ, Siriraj Hosp, Dept Pediat, Fac Med, Bangkok 10700, Thailand; Mahidol Univ, Ctr Vaccine Dev, Inst Sci & Technol Res & Dev, Nakhon Pathom 73170, Thailand; Inst Pasteur, Genet Papillomavirus & Canc Humain, F-75724 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Mahidol University; Mahidol University; Mahidol University; CEA; UDICE-French Research Universities; Universite Paris Saclay; Mahidol University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Khon Kaen University; Ministry of Public Health - Thailand; Mahidol University; Mahidol University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Julier, C (corresponding author), Inst Pasteur, INSERM E102, 28 Rue Docteur Roux, F-75724 Paris, France.	cjulier@pasteur.fr	JULIER, Cécile/M-9824-2017; Matsuda, Fumihiko/B-9893-2009	JULIER, Cécile/0000-0002-1538-0240; Kalayanarooj, Siripen/0000-0002-3568-0929; Kajaste-Rudnitski, Anna/0000-0003-1549-2426; Jacob, Yves/0000-0001-9125-2374				Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; CHIEWSILP P, 1981, AM J TROP MED HYG, V30, P1100, DOI 10.4269/ajtmh.1981.30.1100; Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x; Grant SFA, 1996, NAT GENET, V14, P203, DOI 10.1038/ng1096-203; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Harendza S, 2003, J BIOL CHEM, V278, P20490, DOI 10.1074/jbc.M211536200; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; Klimstra WB, 2003, J VIROL, V77, P12022, DOI 10.1128/JVI.77.22.12022-12032.2003; Liu HB, 2003, GENE, V313, P149, DOI 10.1016/S0378-1119(03)00674-7; Liu WL, 2004, J BIOL CHEM, V279, P18748, DOI 10.1074/jbc.M311227200; Loke H, 2002, AM J TROP MED HYG, V67, P102, DOI 10.4269/ajtmh.2002.67.102; Loke H, 2001, J INFECT DIS, V184, P1369, DOI 10.1086/324320; Mann V, 2001, J CLIN INVEST, V107, P899, DOI 10.1172/JCI10347; Martin MP, 2004, J VIROL, V78, P14053, DOI 10.1128/JVI.78.24.14053-14056.2004; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Mummidi S, 2001, J BIOL CHEM, V276, P33196, DOI 10.1074/jbc.M009807200; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; PEREZ MLP, 1987, HAEMATOLOGIA, V20, P83; Rothman AL, 2003, ADV VIRUS RES, V60, P397, DOI 10.1016/S0065-3527(03)60010-2; Sibley K, 2003, CANCER RES, V63, P4327; Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Takahashi Masazumi, 2003, J Bioinform Comput Biol, V1, P253, DOI 10.1142/S021972000300006X; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; van Kooyk Y, 2003, TRENDS MOL MED, V9, P153, DOI 10.1016/S1471-4914(03)00027-3; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; WHO, 1997, DENG HAEM FEV DIAGN; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004	30	226	248	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2005	37	5					507	513		10.1038/ng1550	http://dx.doi.org/10.1038/ng1550			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15838506	Bronze, Green Published			2022-12-27	WOS:000228862300020
J	Aligianis, IA; Johnson, CA; Gissen, P; Chen, DR; Hampshire, D; Hoffmann, K; Maina, EN; Morgan, NV; Tee, L; Morton, J; Ainsworth, JR; Horn, D; Rosser, E; Cole, TRP; Stolte-Dijkstra, I; Fieggen, K; Clayton-Smith, J; Megarbane, A; Shield, JP; Newbury-Ecob, R; Dobyns, WB; Graham, JM; Kjaer, KW; Warburg, M; Bond, J; Trembath, RC; Harris, LW; Takai, Y; Mundlos, S; Tannahill, D; Woods, CG; Maher, ER				Aligianis, IA; Johnson, CA; Gissen, P; Chen, DR; Hampshire, D; Hoffmann, K; Maina, EN; Morgan, NV; Tee, L; Morton, J; Ainsworth, JR; Horn, D; Rosser, E; Cole, TRP; Stolte-Dijkstra, I; Fieggen, K; Clayton-Smith, J; Megarbane, A; Shield, JP; Newbury-Ecob, R; Dobyns, WB; Graham, JM; Kjaer, KW; Warburg, M; Bond, J; Trembath, RC; Harris, LW; Takai, Y; Mundlos, S; Tannahill, D; Woods, CG; Maher, ER			Mutations of the catalytic subunit of RAB3GAP cause Warburg Micro syndrome	NATURE GENETICS			English	Article							GTPASE-ACTIVATING PROTEIN; CONGENITAL CATARACT; OPTIC ATROPHY; RETARDATION; SUBFAMILY	Warburg Micro syndrome (WARBM1) is a severe autosomal recessive disorder characterized by developmental abnormalities of the eye and central nervous system and by microgenitalia. We identified homozygous inactivating mutations in RAB3GAP, encoding RAB3 GTPase activating protein, a key regulator of the Rab3 pathway implicated in exocytic release of neurotransmitters and hormones, in 12 families with Micro syndrome. We hypothesize that the underlying pathogenesis of Micro syndrome is a failure of exocytic release of ocular and neurodevelopmental trophic factors.	Univ Birmingham, Sect Med & Mol Genet, Birmingham B15 2TT, W Midlands, England; Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; Wellcome Trust Sanger Inst, Embryo Gene Express Patterns, Cambridge CB10 1SA, England; St James Univ Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; Humboldt Univ, Charite Univ Hosp, Inst Med Genet, D-13353 Berlin, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Birmingham Midlands Eye Hosp, Birmingham, W Midlands, England; Birmingham Childrens Hosp, Birmingham, W Midlands, England; Great Ormond St Hosp Sick Children, NE Thames Reg Genet Serv, London WC1N 1EH, England; Univ Groningen Hosp, Dept Clin Genet, NL-9700 RB Groningen, Netherlands; Univ Cape Town, Div Human Genet, ZA-7925 Cape Town, South Africa; St Marys Hosp, Acad Dept Med Genet, Manchester M13 0JH, Lancs, England; St Joseph Univ, Fac Med, Med Genet Unit, Beirut, Lebanon; Univ Bristol, Bristol, Avon, England; St Michaels Hosp, Dept Clin Genet, Bristol BS2 8EG, Avon, England; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Calif Los Angeles, Cedars Sinai Med Ctr, David Geffen Sch Med,Med Genet Inst, Steven Spielberg Pediat Res Ctr,SHARES Child Disa, Los Angeles, CA 90048 USA; Univ Copenhagen, Gentofte Hosp, Wilhelm Johannsen Ctr Funct Genome Res, DK-1168 Copenhagen, Denmark; Univ Copenhagen, Gentofte Hosp, Div Pediat Ophthalmol & Handicaps, DK-1168 Copenhagen, Denmark; Univ Leicester, Div Med Genet, Dept Med, Leicester LE1 7RH, Leics, England; Univ Leicester, Div Med Genet, Dept Genet, Leicester LE1 7RH, Leics, England; Osaka Univ, Sch Med, Fac Med, Dept Mol Biol & Biochem, Suita, Osaka 5650871, Japan	University of Birmingham; Birmingham Women's Hospital; Wellcome Trust Sanger Institute; Saint James's University Hospital; University of Leeds; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; University of Birmingham; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Groningen; University of Cape Town; University of Manchester; University of Bristol; University of Chicago; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Leicester; University of Leicester; Osaka University	Maher, ER (corresponding author), Univ Birmingham, Sect Med & Mol Genet, Birmingham B15 2TT, W Midlands, England.	e.r.maher@bham.ac.uk	Gissen, Paul/A-4352-2010; Shield, Julian PH/D-6297-2014; Mundlos, Stefan/ABH-9585-2020; Morgan, Neil V/A-5475-2009; Dobyns, William/AAI-2768-2020; MAHER, EAMONN R/A-9507-2008; woods, christopher g/A-1361-2010; Dobyns, William Brian/ABC-6525-2021; Graham, John M./J-1429-2019; Megarbane, Andre/ABD-5574-2021; Hampshire, Daniel/Q-3540-2019	Gissen, Paul/0000-0002-9712-6122; Shield, Julian PH/0000-0003-2601-7575; Morgan, Neil V/0000-0001-6433-5692; Dobyns, William/0000-0002-7681-2844; MAHER, EAMONN R/0000-0002-6226-6918; Harris, Laura/0000-0003-4312-7223; Mundlos, Stefan/0000-0002-9788-3166; Tannahill, David/0000-0002-3811-6864; Johnson, Colin/0000-0002-2979-8234; fieggen, karen/0000-0002-2910-6306; Trembath, Richard/0000-0003-0550-3400				Ainsworth JR, 2001, OPHTHALMOLOGY, V108, P491, DOI 10.1016/S0161-6420(00)00540-6; DI GG, 2004, BRAIN RES DEV BRAIN, V150, P17; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; Graham JM, 2004, AM J MED GENET A, V128A, P235, DOI 10.1002/ajmg.a.30060; Hiesinger PR, 1999, J NEUROSCI, V19, P7548, DOI 10.1523/JNEUROSCI.19-17-07548.1999; Jelitai M, 2004, J NEUROSCI RES, V76, P801, DOI 10.1002/jnr.20106; Li L, 2003, CELL MOL LIFE SCI, V60, P942, DOI 10.1007/s00018-003-2240-7; Megarbane A, 1999, J MED GENET, V36, P637; Nagano F, 1998, J BIOL CHEM, V273, P24781, DOI 10.1074/jbc.273.38.24781; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; WARBURG M, 1993, AM J DIS CHILD, V147, P1309, DOI 10.1001/archpedi.1993.02160360051017; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	15	159	164	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					221	223		10.1038/ng1517	http://dx.doi.org/10.1038/ng1517			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15696165				2022-12-27	WOS:000227297800012
J	Johnson, TM; Hammond, EM; Giaccia, A; Attardi, LD				Johnson, TM; Hammond, EM; Giaccia, A; Attardi, LD			The p53(QS) transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethality	NATURE GENETICS			English	Article							CELL-CYCLE ARREST; P53 TUMOR-SUPPRESSOR; WILD-TYPE P53; P53-DEPENDENT APOPTOSIS; DNA-DAMAGE; TRANSCRIPTIONAL ACTIVATION; MICE; HYPOXIA; TARGET; PERP	The role of transcriptional activation in p53 function is highly controversial. To define this role in vivo, we generated a Trp53 knock-in construct encoding a protein carrying mutations of two residues that are crucial for transactivation (L25Q, W26S). Here we show that these mutations have selective effects on the biological functions of p53. Although its ability to activate various p53 target genes is largely compromised, the p53(QS) protein retains the ability to transactivate the gene Bax. The ability of the p53(QS) mutant protein to elicit a DNA damage-induced G1 cell cycle-arrest response is also partially impaired. p53(QS) has selective defects in its ability to induce apoptosis: it is completely unable to activate apoptosis in response to DNA damage, is partially unable to do so when subjected to serum deprivation and retains substantial apoptotic activity upon exposure to hypoxia. These findings suggest that p53 acts through distinct, stimulus-specific pathways to induce apoptosis. The importance of the biological activity of p53(QS) in vivo is underscored by our finding that expression of p53(QS), which cannot bind mdm2, induces embryonic lethality. Taken together, these results suggest that p53 has different mechanisms of action depending on specific contextual cues, which may help to clarify the function of p53 in preventing cancer.	Stanford Univ, Sch Med, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Attardi, LD (corresponding author), Stanford Univ, Sch Med, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA 94305 USA.	attardi@stanford.edu		Hammond, Ester/0000-0002-2335-3146	NIAMS NIH HHS [R01 AR065403] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065403] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Adelman DM, 2000, GENE DEV, V14, P3191, DOI 10.1101/gad.853700; Adimoolam S, 2002, P NATL ACAD SCI USA, V99, P12985, DOI 10.1073/pnas.202485699; AKAZAWA S, 1994, METABOLISM, V43, P830, DOI 10.1016/0026-0495(94)90262-3; Attardi LD, 2000, GENE DEV, V14, P704; Attardi LD, 2004, ONCOGENE, V23, P973, DOI 10.1038/sj.onc.1207026; ATTARDI LD, 1996, EMBO J, V15, P3702; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Chao C, 2000, EMBO J, V19, P4967, DOI 10.1093/emboj/19.18.4967; Chavez-Reyes A, 2003, CANCER RES, V63, P8664; Chen JD, 1996, MOL CELL BIOL, V16, P2445; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FISCHER B, 1993, J REPROD FERTIL, V99, P673, DOI 10.1530/jrf.0.0990673; Friedlander P, 1996, MOL CELL BIOL, V16, P4961; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Ihrie RA, 2003, CURR BIOL, V13, P1985, DOI 10.1016/j.cub.2003.10.055; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jimenez GS, 2000, NAT GENET, V26, P37, DOI 10.1038/79152; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kokontis JM, 2001, ONCOGENE, V20, P659, DOI 10.1038/sj.onc.1204139; Koumenis C, 2001, MOL CELL BIOL, V21, P1297, DOI 10.1128/MCB.21.4.1297-1310.2001; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; LOWE SW, 1993, GENE DEV, V7, P535, DOI 10.1101/gad.7.4.535; Ludwig RL, 1996, MOL CELL BIOL, V16, P4952; LUNA RMD, 1995, NATURE, V378, P203; McCurrach ME, 1997, P NATL ACAD SCI USA, V94, P2345, DOI 10.1073/pnas.94.6.2345; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Reczek EE, 2003, MOL CANCER RES, V1, P1048; SABBATINI P, 1995, GENE DEV, V9, P2184, DOI 10.1101/gad.9.17.2184; Shibue T, 2003, GENE DEV, V17, P2233, DOI 10.1101/gad.1103603; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Uesugi M, 1999, P NATL ACAD SCI USA, V96, P14801, DOI 10.1073/pnas.96.26.14801; Venot C, 1999, ONCOGENE, V18, P2405, DOI 10.1038/sj.onc.1202539; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WAGNER AJ, 1994, GENE DEV, V8, P2817, DOI 10.1101/gad.8.23.2817; Zhu JH, 1998, J BIOL CHEM, V273, P13030, DOI 10.1074/jbc.273.21.13030	47	115	116	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					145	152		10.1038/ng1498	http://dx.doi.org/10.1038/ng1498			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	15654339				2022-12-27	WOS:000226690100020
J	Horike, S; Cai, ST; Miyano, M; Cheng, JF; Kohwi-Shigematsu, T				Horike, S; Cai, ST; Miyano, M; Cheng, JF; Kohwi-Shigematsu, T			Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome	NATURE GENETICS			English	Article							CPG-BINDING PROTEIN; DNA METHYLATION; MONOCHROMOSOMAL HYBRIDS; HISTONE METHYLATION; IN-VIVO; MECP2; GENE; BRAIN; IDENTIFICATION; EXPRESSION	Mutations in MECP2 are associated with Rett syndrome, an X-linked neurodevelopmental disorder. To identify genes targeted by Mecp2, we sequenced 100 in vivo Mecp2-binding sites in mouse brain. Several sequences mapped to an imprinted gene cluster on chromosome 6, including Dlx5 and Dlx6, whose transcription was roughly two times greater in brains of Mecp2-null mice compared with those of wild-type mice. The maternally expressed gene DLX5 showed a loss of imprinting in lymphoblastoid cells from individuals with Rett syndrome. Because Dlx5 regulates production of enzymes that synthesize gamma-aminobutyric acid (GABA), loss of imprinting of Dlx5 may alter GABAergic neuron activity in individuals with Rett syndrome. In mouse brain, Dlx5 imprinting was relaxed, yet Mecp2-mediated silent-chromatin structure existed at the Dlx5-Dlx6 locus in brains of wild-type, but not Mecp2-null, mice. Mecp2 targeted histone deacetylase 1 to a sharply defined, similar to1-kb region at the Dlx5-Dlx6 locus and promoted repressive histone methylation at Lys9 at this site. Chromatin immunoprecipitation-combined loop assays showed that Mecp2 mediated the silent chromatin-derived 11-kb chromatin loop at the Dlx5-Dlx6 locus. This loop was absent in chromatin of brains of Mecp2-null mice, and Dlx5-Dlx6 interacted with far distant sequences, forming distinct active chromatin-associated loops. These results show that formation of a silent-chromatin loop is a new mechanism underlying gene regulation by Mecp2.	Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kohwi-Shigematsu, T (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, 1 Cyclotron Rd,Mail Stop 84-171, Berkeley, CA 94720 USA.	terumiks@lbl.gov	MIYANO, MASARU/I-1353-2015; Horike, Shin-ichi/C-4319-2015	Horike, Shin-ichi/0000-0002-4256-9129; Cheng, Jan-Fang/0000-0001-7315-7613				Alvarez JD, 2000, GENE DEV, V14, P521; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Balmer D, 2002, HUM GENET, V110, P545, DOI 10.1007/s00439-002-0724-4; Budden SS, 2001, BRAIN DEV-JPN, V23, pS133, DOI 10.1016/S0387-7604(01)00338-2; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dragich J, 2000, HUM MOL GENET, V9, P2365, DOI 10.1093/hmg/9.16.2365; Drewell RA, 2002, NUCLEIC ACIDS RES, V30, P1139, DOI 10.1093/nar/30.5.1139; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hoshiya H, 2003, J HUM GENET, V48, P208, DOI 10.1007/s10038-003-0006-6; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones BE, 1998, EXTREMOPHILES, V2, P191, DOI 10.1007/s007920050060; Kimura H, 2003, J BIOL CHEM, V278, P4806, DOI 10.1074/jbc.M209923200; Kimura MI, 2004, J HUM GENET, V49, P273, DOI 10.1007/s10038-004-0139-2; Kohwi-Shigematsu T, 1998, METHOD CELL BIOL, V53, P323; Kriaucionis S, 2003, HUM MOL GENET, V12, pR221, DOI 10.1093/hmg/ddg286; Lalande M, 1999, Adv Neurol, V79, P421; Lalande M, 1996, ANNU REV GENET, V30, P173, DOI 10.1146/annurev.genet.30.1.173; Lee MP, 1999, P NATL ACAD SCI USA, V96, P5203, DOI 10.1073/pnas.96.9.5203; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Mitsuya K, 1999, HUM MOL GENET, V8, P1209, DOI 10.1093/hmg/8.7.1209; Mizuno Y, 2002, BIOCHEM BIOPH RES CO, V290, P1499, DOI 10.1006/bbrc.2002.6370; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Okita C, 2003, GENOMICS, V81, P556, DOI 10.1016/S0888-7543(03)00052-1; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Palferman S, 2001, AM J HUM GENET, V69, P570; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; Shahbazian MD, 2002, AM J HUM GENET, V71, P1259, DOI 10.1086/345360; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Stuhmer T, 2002, DEVELOPMENT, V129, P245; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Traynor Jeff, 2002, BMC Med Genet, V3, P12, DOI 10.1186/1471-2350-3-12; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; Weitzel JM, 1997, MOL CELL BIOL, V17, P5656, DOI 10.1128/MCB.17.9.5656; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084	50	432	459	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2005	37	1					31	40		10.1038/ng1491	http://dx.doi.org/10.1038/ng1491			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15608638				2022-12-27	WOS:000225997500018
J	Meetei, AR; Levitus, M; Xue, YT; Medhurst, AL; Zwaan, M; Ling, C; Rooimans, MA; Bier, P; Hoatlin, M; Pals, G; de Winter, JP; Wang, WD; Joenje, H				Meetei, AR; Levitus, M; Xue, YT; Medhurst, AL; Zwaan, M; Ling, C; Rooimans, MA; Bier, P; Hoatlin, M; Pals, G; de Winter, JP; Wang, WD; Joenje, H			X-linked inheritance of Fanconi anemia complementation group B	NATURE GENETICS			English	Article							NUCLEAR-COMPLEX; CHROMOSOME; INACTIVATION; MOUSE; FEMALE; COMMON; BRCA2	Fanconi anemia is an autosomal recessive syndrome characterized by diverse clinical symptoms, hypersensitivity to DNA crosslinking agents, chromosomal instability and susceptibility to cancer(1,2). Fanconi anemia has at least 11 complementation groups (A, B, C, D1, D2, E, F, G, I, J, L)(3,4); the genes mutated in 8 of these have been identified. The gene BRCA2 was suggested to underlie complementation group B, but the evidence is inconclusive(5). Here we show that the protein defective in individuals with Fanconi anemia belonging to complementation group B is an essential component of the nuclear protein 'core complex' responsible for monoubiquitination of FANCD2, a key event in the DNA-damage response pathway associated with Fanconi anemia and BRCA(3,6,7). Unexpectedly, the gene encoding this protein, FANCB, is localized at Xp22.31 and subject to X-chromosome inactivation. X-linked inheritance has important consequences for genetic counseling of families with Fanconi anemia belonging to complementation group B. Its presence as a single active copy and essentiality for a functional Fanconi anemia-BRCA pathway make FANCB a potentially vulnerable component of the cellular machinery that maintains genomic integrity.	NIA, Genet Lab, NIH, Baltimore, MD 21224 USA; Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, NL-1081 BT Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Pediat & Hematol Oncol, NL-1007 MB Amsterdam, Netherlands; Oregon Hlth & Sci Univ, Div Mol Med & Mol Med Genet, Portland, OR 97239 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Oregon Health & Science University	Wang, WD (corresponding author), NIA, Genet Lab, NIH, 333 Cassell Dr,TRIAD Ctr Room 3000, Baltimore, MD 21224 USA.	wangw@grc.nia.nih.gov; joenje@vumc.nl	Wang, Weidong/AAV-2446-2021; Pals, Gerard/A-5198-2011	Pals, Gerard/0000-0003-4091-7115; Wang, Weidong/0000-0002-0658-7928	NATIONAL INSTITUTE ON AGING [ZIAAG000688, Z01AG000688] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Andreu N, 2003, BLOOD CELL MOL DIS, V31, P332, DOI 10.1016/S1079-9796(03)00168-2; Apostolou S, 1996, NAT GENET, V14, P324, DOI 10.1038/ng1196-324; Brown CJ, 2003, TRENDS GENET, V19, P432, DOI 10.1016/S0168-9525(03)00177-X; Bruun D, 2003, DNA REPAIR, V2, P1007, DOI 10.1016/S1568-7864(03)00112-5; Carrel L, 1999, P NATL ACAD SCI USA, V96, P14440, DOI 10.1073/pnas.96.25.14440; Cumming RC, 2001, NAT MED, V7, P814, DOI 10.1038/89937; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; de Winter JP, 2000, HUM MOL GENET, V9, P2665, DOI 10.1093/hmg/9.18.2665; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Heine-Suner D, 2003, AM J MED GENET A, V122A, P108, DOI 10.1002/ajmg.a.20160; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Lee JT, 2003, CURR BIOL, V13, pR242, DOI 10.1016/S0960-9822(03)00162-3; Levitus M, 2004, BLOOD, V103, P2498, DOI 10.1182/blood-2003-08-2915; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; MONK M, 1979, NATURE, V281, P311, DOI 10.1038/281311a0; RUSSELL LB, 1961, SCIENCE, V133, P1795, DOI 10.1126/science.133.3467.1795; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; Tanaka M, 2003, AM J PATHOL, V163, P295, DOI 10.1016/S0002-9440(10)63653-X; Taniguchi T, 2003, NAT MED, V9, P568, DOI 10.1038/nm852; Tischkowitz M, 2003, BRIT J HAEMATOL, V123, P469, DOI 10.1046/j.1365-2141.2003.04640.x	25	226	244	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1219	1224		10.1038/ng1458	http://dx.doi.org/10.1038/ng1458			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15502827	Bronze			2022-12-27	WOS:000224832800027
J	Sharp, AJ; Hansen, S; Selzer, RR; Cheng, Z; Regan, R; Hurst, JA; Stewart, H; Price, SM; Blair, E; Hennekam, RC; Fitzpatrick, CA; Segraves, R; Richmond, TA; Guiver, C; Albertson, DG; Pinkel, D; Eis, PS; Schwartz, S; Knight, SJL; Eichler, EE				Sharp, Andrew J.; Hansen, Sierra; Selzer, Rebecca R.; Cheng, Ze; Regan, Regina; Hurst, Jane A.; Stewart, Helen; Price, Sue M.; Blair, Edward; Hennekam, Raoul C.; Fitzpatrick, Carrie A.; Segraves, Rick; Richmond, Todd A.; Guiver, Cheryl; Albertson, Donna G.; Pinkel, Daniel; Eis, Peggy S.; Schwartz, Stuart; Knight, Samantha J. L.; Eichler, Evan E.			Discovery of previously unidentified genomic disorders from the duplication architecture of the human genome	NATURE GENETICS			English	Article							SEGMENTAL DUPLICATIONS; MENTAL-RETARDATION; SOTOS-SYNDROME; REARRANGEMENTS; RECOMBINATION; BREAKPOINTS; MICRODELETION; POLYMORPHISM; MOSAICISM; INVERSION	Genomic disorders are characterized by the presence of flanking segmental duplications that predispose these regions to recurrent rearrangement. Based on the duplication architecture of the genome, we investigated 130 regions that we hypothesized as candidates for previously undescribed genomic disorders(1). We tested 290 individuals with mental retardation by BAC array comparative genomic hybridization and identified 16 pathogenic rearrangements, including de novo microdeletions of 17q21.31 found in four individuals. Using oligonucleotide arrays, we refined the breakpoints of this microdeletion, defining a 478-kb critical region containing six genes that were deleted in all four individuals. We mapped the breakpoints of this deletion and of four other pathogenic rearrangements in 1q21.1, 15q13, 15q24 and 17q12 to flanking segmental duplications, suggesting that these are also sites of recurrent rearrangement. In common with the 17q21.31 deletion, these breakpoint regions are sites of copy number polymorphism in controls, indicating that these may be inherently unstable genomic regions.	Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; NimbleGen Syst Inc, Madison, WI 53711 USA; Churchill Hosp, Wellcome Trust Ctr Human Genet, Oxford Genet Knowledge Pk, Oxford OX3 7BN, England; Churchill Hosp, Oxford Radcliffe Hosp NHS Trust, Dept Clin Genet, Oxford OX3 7LJ, England; UCL, Inst Child Hlth, Clin & Mol Genet Unit, London WC1E 6BT, England; Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Canc Res, San Francisco, CA 94143 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Roche Holding; Roche NimbleGen; University of Oxford; Wellcome Centre for Human Genetics; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of London; University College London; University of Amsterdam; Academic Medical Center Amsterdam; University of Chicago; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, 1705 NE Pacific St, Seattle, WA 98195 USA.	eee@gs.washington.edu	Sharp, Andrew/A-5783-2008	Eis, Peggy/0000-0002-3075-8707; Knight, Samantha/0000-0002-6047-3462	NICHD NIH HHS [HD043569] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043569] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Evans W, 2004, NEUROSCI LETT, V369, P183, DOI 10.1016/j.neulet.2004.05.119; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Gimelli G, 2003, HUM MOL GENET, V12, P849, DOI 10.1093/hmg/ddg101; Heilstedt HA, 2003, AM J HUM GENET, V72, P1200, DOI 10.1086/375179; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Juyal RC, 1996, AM J MED GENET, V66, P193, DOI 10.1002/(SICI)1096-8628(19961211)66:2<193::AID-AJMG13>3.3.CO;2-9; Kato T, 2006, SCIENCE, V311, P971, DOI 10.1126/science.1121452; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Kurotaki N, 2005, HUM MOL GENET, V14, P535, DOI 10.1093/hmg/ddi050; Liehr T, 1996, HUM GENET, V98, P22, DOI 10.1007/s004390050154; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Visser R, 2005, AM J HUM GENET, V76, P52, DOI 10.1086/426950; Zhou Y, 2005, P NATL ACAD SCI USA, V102, P4051, DOI 10.1073/pnas.0407957102	28	451	465	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					1038	1042		10.1038/ng1862	http://dx.doi.org/10.1038/ng1862			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16906162				2022-12-27	WOS:000240112100021
J	To, MD; Perez-Losada, J; Mao, JH; Hsu, J; Jacks, T; Balmain, A				To, Minh D.; Perez-Losada, Jesus; Mao, Jian-Hua; Hsu, Jeff; Jacks, Tyler; Balmain, Allan			A functional switch from lung cancer resistance to susceptibility at the Pas1 locus in Kras2(LA2) mice	NATURE GENETICS			English	Article							K-RAS; TUMOR SUSCEPTIBILITY; MODIFIER LOCI; MOUSE; CARCINOGENESIS; MUTATION; SKIN; PROTOONCOGENE; PROGRESSION; ACTIVATION	Pulmonary adenoma susceptibility 1 (Pas1) is the major mouse lung cancer susceptibility locus on chromosome 6 (ref. 1). Kras2 is a common target of somatic mutation in chemically induced mouse lung tumors(2,3) and is a candidate Pas1 gene(4). M. spretus mice (SPRET/Ei) carry a Pas1 resistance haplotype for chemically induced lung tumors(5). We demonstrate that the SPRET/Ei Pas1 allele is switched from resistance to susceptibility by fixation of the parental origin of the mutant Kras2 allele. This switch correlates with low expression of endogenous Kras2 in SPRET/Ei. We propose that the Pas1 modifier effect is due to Kras2, and that a sensitive balance between the expression levels of wild-type and mutant alleles determines lung tumor susceptibility. These data demonstrate that cancer predisposition should also be considered in the context of somatic events and could have major implications for the design of human association studies to identify cancer susceptibility genes.	Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94115 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Ctr Canc Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Balmain, A (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94115 USA.	abalmain@cc.ucsf.edu	Pérez-Losada, Jesús/A-5883-2019; Mao, Jian-Hua/EIZ-8595-2022	Pérez-Losada, Jesús/0000-0003-2400-624X; Mao, Jian-Hua/0000-0001-9320-6021	NCI NIH HHS [U01CA84306, U01 CA084244, R01 CA111834-04, R01 CA111834-02, R01 CA111834-03, R01 CA111834, R01 CA111834-01A2, U01 CA084306, U01CA84244, U01 CA141455] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA141455, U01CA084244, U01CA084306, R01CA111834] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Czarnomska A, 2003, CANCER RES, V63, P4533; Demant P, 2003, NAT REV GENET, V4, P721, DOI 10.1038/nrg1157; Diaz R, 2005, INT J CANCER, V113, P241, DOI 10.1002/ijc.20563; Dragani TA, 2000, CANCER RES, V60, P5017; Dragani TA, 2003, CANCER RES, V63, P3011; GARIBOLDI M, 1993, NAT GENET, V3, P132, DOI 10.1038/ng0293-132; GUERRERO I, 1985, P NATL ACAD SCI USA, V82, P7810, DOI 10.1073/pnas.82.23.7810; HENNINGS H, 1993, CARCINOGENESIS, V14, P2353, DOI 10.1093/carcin/14.11.2353; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Li J, 2003, ONCOGENE, V22, P1243, DOI 10.1038/sj.onc.1206192; Manenti G, 2004, ONCOGENE, V23, P4495, DOI 10.1038/sj.onc.1207584; MANENTI G, 1995, GENOMICS, V29, P438, DOI 10.1006/geno.1995.9984; Manenti G, 1997, CANCER RES, V57, P4164; Maria DA, 2003, ONCOGENE, V22, P426, DOI 10.1038/sj.onc.1206157; NAGASE H, 1995, NAT GENET, V10, P424, DOI 10.1038/ng0895-424; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; RYAN J, 1987, J NATL CANCER I, V79, P1351; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Wang M, 2003, CANCER RES, V63, P3317; Wang M, 2005, ONCOGENE, V24, P1958, DOI 10.1038/sj.onc.1208295; Wang Y, 2001, EXP LUNG RES, V27, P255, DOI 10.1080/019021401300054028; Yanagitani N, 2002, CARCINOGENESIS, V23, P1177, DOI 10.1093/carcin/23.7.1177; YOU M, 1992, CARCINOGENESIS, V13, P1583, DOI 10.1093/carcin/13.9.1583; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070; YOU M, 1992, P NATL ACAD SCI USA, V89, P5804, DOI 10.1073/pnas.89.13.5804; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721; Zhang ZQ, 2003, P NATL ACAD SCI USA, V100, P12642, DOI 10.1073/pnas.2133947100	30	60	60	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2006	38	8					926	930		10.1038/ng1836	http://dx.doi.org/10.1038/ng1836			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16823377	Green Accepted			2022-12-27	WOS:000239325700023
J	Kassen, R; Bataillon, T				Kassen, R; Bataillon, T			Distribution of fitness effects among beneficial mutations before selection in experimental populations of bacteria	NATURE GENETICS			English	Article							ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; ADAPTATION; EVOLUTION; VIRUS; MECHANISMS; LANDSCAPE; MUTANTS	The extent to which a population diverges from its ancestor through adaptive evolution depends on variation supplied by novel beneficial mutations. Extending earlier work(1,2), recent theory makes two predictions that seem to be robust to biological details: the distribution of fitness effects among beneficial mutations before selection should be (i) exponential and (ii) invariant, meaning it is always exponential regardless of the fitness rank of the wild-type allele(3,4). Here we test these predictions by assaying the fitness of 665 independently derived single-step mutations in the bacterium Pseudomonas fluorescens across a range of environments. We show that the distribution of fitness effects among beneficial mutations is indistinguishable from an exponential despite marked variation in the fitness rank of the wild type across environments. These results suggest that the initial step in adaptive evolution-the production of novel beneficial mutants from which selection sorts-is very general, being characterized by an approximately exponential distribution with many mutations of small effect and few of large effect. We also document substantial variation in the pleiotropic costs of antibiotic resistance, a result that may have implications for strategies aimed at eliminating resistant pathogens in animal and human populations.	Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Ctr Adv Res Environm Genom, Ottawa, ON K1N 6N5, Canada; Unite Mixte Rech 1097, Montpellier, France	University of Ottawa; University of Ottawa	Kassen, R (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada.	rkassen@uottawa.ca	Bataillon, Thomas/AAK-1822-2020; Bataillon, Thomas/AAJ-7652-2020	Bataillon, Thomas/0000-0002-4730-2538				Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; Bagel S, 1999, ANTIMICROB AGENTS CH, V43, P868, DOI 10.1128/AAC.43.4.868; BENNETT AF, 1993, EVOLUTION INT J ORG, V46, P16; Fisher RA, 1930, GENETICAL THEORY NAT; GILLESPIE JH, 1984, EVOLUTION, V38, P1116, DOI 10.1111/j.1558-5646.1984.tb00380.x; Hawkey PM, 2003, J ANTIMICROB CHEMOTH, V51, P29, DOI 10.1093/jac/dkg207; HEISIG P, 1994, ANTIMICROB AGENTS CH, V38, P1284, DOI 10.1128/AAC.38.6.1284; Holder KK, 2001, GENETICS, V159, P1393; Imhof M, 2001, P NATL ACAD SCI USA, V98, P1113, DOI 10.1073/pnas.98.3.1113; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Luria SE, 1943, GENETICS, V28, P491; Orr HA, 2003, GENETICS, V163, P1519; Orr HA, 2002, EVOLUTION, V56, P1317, DOI 10.1111/j.0014-3820.2002.tb01446.x; Reynolds MG, 2000, GENETICS, V156, P1471; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Rozen DE, 2002, CURR BIOL, V12, P1040, DOI 10.1016/S0960-9822(02)00896-5; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Schrag SJ, 1997, P ROY SOC B-BIOL SCI, V264, P1287, DOI 10.1098/rspb.1997.0178; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Wolfram S., 1996, MATH BOOK; YOSHIDA H, 1990, ANTIMICROB AGENTS CH, V34, P1273, DOI 10.1128/AAC.34.6.1273	23	178	179	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2006	38	4					484	488		10.1038/ng1751	http://dx.doi.org/10.1038/ng1751			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	026LN	16550173				2022-12-27	WOS:000236340500024
J	Kissler, S; Stern, P; Takahashi, K; Hunter, K; Peterson, LB; Wicker, LS				Kissler, S; Stern, P; Takahashi, K; Hunter, K; Peterson, LB; Wicker, LS			In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes	NATURE GENETICS			English	Article							INTRACELLULAR PARASITES; RHEUMATOID-ARTHRITIS; NATURAL-RESISTANCE; AUTOIMMUNE-DISEASE; LENTIVIRAL VECTORS; MAMMALIAN-CELLS; GENE; POLYMORPHISM; EXPRESSION; PROMOTER	Type 1 diabetes is an autoimmune disease influenced by multiple genetic loci. Although more than 20 insulin-dependent diabetes (Idd) loci have been implicated in the nonobese diabetic (NOD) mouse model(1,2), few causal gene variants have been identified(3,4). Here we show that RNA interference(5,6) (RNAi) can be used to probe candidate genes in this disease model. Slc11a1 encodes a phagosomal ion transporter, Nramp1, that affects resistance to intracellular pathogens and influences antigen presentation(7-9). This gene is the strongest candidate among the 42 genes in the Idd5.2 region; a naturally occurring mutation in the protective Idd5.2 haplotype results in loss of function of the Nramp1 protein(10). Using lentiviral transgenesis(11), we generated NOD mice in which Slc11a1 is silenced by RNAi. Silencing reduced the frequency of type 1 diabetes, mimicking the protective Idd5.2 region. Our results demonstrate a role for Slc11a1 in modifying susceptibility to type 1 diabetes and illustrate that RNAi can be used to study causal genes in a mammalian model organism.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Harvard Univ, Massachusetts Gen Hosp Children, Sch Med, Lab Dev Immunol, Boston, MA 02114 USA; Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Diabet & Inflammat Lab, Cambridge CB2 2XY, England; Merck Res Labs, Dept Pharmacol, Rahway, NJ 07065 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; University of Cambridge; Merck & Company	Kissler, S (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02139 USA.	skissler@mit.edu	Wicker, Linda S/F-7384-2010	/0000-0003-3062-7800	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hill NJ, 2000, DIABETES, V49, P1744, DOI 10.2337/diabetes.49.10.1744; Jackson AL, 2004, TRENDS GENET, V20, P521, DOI 10.1016/j.tig.2004.08.006; Kanagawa O, 2000, J IMMUNOL, V164, P3919, DOI 10.4049/jimmunol.164.7.3919; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; KLEHR D, 1991, BIOCHEMISTRY-US, V30, P1264, DOI 10.1021/bi00219a015; Kwaks THJ, 2003, NAT BIOTECHNOL, V21, P553, DOI 10.1038/nbt814; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; MAKINO S, 1980, Experimental Animals (Tokyo), V29, P1; Nishino M, 2005, METABOLISM, V54, P628, DOI 10.1016/j.metabol.2004.12.006; Qiu S, 2005, NUCLEIC ACIDS RES, V33, P1834, DOI 10.1093/nar/gki324; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rubio CA, 2003, EUR J CLIN INVEST, V33, P406, DOI 10.1046/j.1365-2362.2003.01151.x; Sanjeevi CB, 2000, ARTHRITIS RHEUM-US, V43, P1397, DOI 10.1002/1529-0131(200006)43:6<1397::AID-ANR25>3.0.CO;2-6; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Searle S, 1999, J MED GENET, V36, P295; Shaw MA, 1996, J MED GENET, V33, P672, DOI 10.1136/jmg.33.8.672; Steinman L, 2005, TRENDS IMMUNOL, V26, P565, DOI 10.1016/j.it.2005.08.014; Takahashi K, 2004, TISSUE ANTIGENS, V63, P231, DOI 10.1111/j.1399-0039.2004.000172.x; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; Vijayakrishnan L, 2004, IMMUNITY, V20, P563, DOI 10.1016/S1074-7613(04)00110-4; Wicker LS, 2004, J IMMUNOL, V173, P164, DOI 10.4049/jimmunol.173.1.164; Wojciechowski W, 1999, J IMMUNOL, V163, P2688	29	100	102	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2006	38	4					479	483		10.1038/ng1766	http://dx.doi.org/10.1038/ng1766			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	026LN	16550170				2022-12-27	WOS:000236340500023
J	Drake, JA; Bird, C; Nemesh, J; Thomas, DJ; Newton-Cheh, C; Reymond, A; Excoffier, L; Attar, H; Antonarakis, SE; Dermitzakis, ET; Hirschhorn, JN				Drake, JA; Bird, C; Nemesh, J; Thomas, DJ; Newton-Cheh, C; Reymond, A; Excoffier, L; Attar, H; Antonarakis, SE; Dermitzakis, ET; Hirschhorn, JN			Conserved noncoding sequences are selectively constrained and not mutation cold spots	NATURE GENETICS			English	Article							NON-GENIC SEQUENCES; NONGENIC SEQUENCES; DISEASE; IDENTIFICATION; DELETIONS; ELEMENTS; REGIONS; NUMBER	Noncoding genetic variants are likely to influence human biology and disease, but recognizing functional noncoding variants is difficult. Approximately 3% of noncoding sequence is conserved among distantly related mammals(1-4), suggesting that these evolutionarily conserved noncoding regions (CNCs) are selectively constrained and contain functional variation. However, CNCs could also merely represent regions with lower local mutation rates. Here we address this issue and show that CNCs are selectively constrained in humans by analyzing HapMap genotype data. Specifically, new ( derived) alleles of SNPs within CNCs are rarer than new alleles in nonconserved regions (P = 3 x 10(-18)), indicating that evolutionary pressure has suppressed CNC-derived allele frequencies. Intronic CNCs and CNCs near genes show greater allele frequency shifts, with magnitudes comparable to those for missense variants. Thus, conserved noncoding variants are more likely to be functional. Allele frequency distributions highlight selectively constrained genomic regions that should be intensively surveyed for functionally important variation.	Childrens Hosp, Program Genom, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02139 USA; MIT, Cambridge, MA 02139 USA; Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; Univ Bern, Inst Zool, CH-3012 Bern, Switzerland; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Wellcome Trust Sanger Institute; University of California System; University of California Santa Cruz; Harvard University; Massachusetts General Hospital; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Geneva; University of Bern; Harvard University; Harvard Medical School	Hirschhorn, JN (corresponding author), Childrens Hosp, Program Genom, 300 Longwood Ave, Boston, MA 02115 USA.	md4@sanger.ac.uk; joelh@broad.mit.edu	Antonarakis, Stylianos E/N-8866-2014; Excoffier, Laurent/D-3498-2013; Kutalik, Zoltan/HHZ-5697-2022; Dermitzakis, Emmanouil/B-7687-2013	Antonarakis, Stylianos E/0000-0001-8907-5823; Excoffier, Laurent/0000-0002-7507-6494; Kutalik, Zoltan/0000-0001-8285-7523; Reymond, Alexandre/0000-0003-1030-8327; Fosker, Christine/0000-0002-3799-9474	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Beysen D, 2005, AM J HUM GENET, V77, P205, DOI 10.1086/432083; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; CHARLESWORTH B, 1993, GENETICS, V134, P1289; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Dermitzakis ET, 2004, GENOME RES, V14, P852, DOI 10.1101/gr.1934904; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Fay JC, 2001, GENETICS, V158, P1227; Frazer KA, 2004, GENOME RES, V14, P367, DOI 10.1101/gr.1961204; Hirakawa M, 2002, NUCLEIC ACIDS RES, V30, P158, DOI 10.1093/nar/30.1.158; Keightley PD, 2005, GENOME RES, V15, P1373, DOI 10.1101/gr.3942005; Keightley PD, 2005, PLOS BIOL, V3, P282, DOI 10.1371/journal.pbio.0030042; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; Kryukov GV, 2005, HUM MOL GENET, V14, P2221, DOI 10.1093/hmg/ddi226; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; MARUYAMA T, 1985, GENETICS, V111, P675; Nobrega MA, 2004, NATURE, V431, P988, DOI 10.1038/nature03022; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zar JH, 1999, BIOSTATISTICAL ANAL	30	175	180	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					223	227		10.1038/ng1710	http://dx.doi.org/10.1038/ng1710			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16380714				2022-12-27	WOS:000234953200019
J	Chan, VSF; Chan, KYK; Chen, YX; Poon, LLM; Cheung, ANY; Zheng, BJ; Chan, KH; Mak, W; Ngan, HYS; Xu, XN; Screaton, G; Tam, PKH; Austyn, JM; Chan, LC; Yip, SP; Peiris, M; Khoo, US; Lin, CLS				Chan, VSF; Chan, KYK; Chen, YX; Poon, LLM; Cheung, ANY; Zheng, BJ; Chan, KH; Mak, W; Ngan, HYS; Xu, XN; Screaton, G; Tam, PKH; Austyn, JM; Chan, LC; Yip, SP; Peiris, M; Khoo, US; Lin, CLS			Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection	NATURE GENETICS			English	Article							ACUTE RESPIRATORY SYNDROME; RECEPTOR-BINDING DOMAIN; LECTINS DC-SIGN; DENDRITIC CELL; SPIKE GLYCOPROTEIN; ENDOTHELIAL-CELLS; STRUCTURAL BASIS; HONG-KONG; IN-SITU; IDENTIFICATION	Severe acute respiratory syndrome (SARS) is caused by infection of a previously undescribed coronavirus (CoV). L-SIGN, encoded by CLEC4M ( also known as CD209L), is a SARS-CoV binding receptor that has polymorphism in its extracellular neck region encoded by the tandem repeat domain in exon 4. Our genetic risk association study shows that individuals homozygous for CLEC4M tandem repeats are less susceptible to SARS infection. L-SIGN is expressed in both non-SARS and SARS-CoV-infected lung. Compared with cells heterozygous for L-SIGN, cells homozygous for L-SIGN show higher binding capacity for SARS-CoV, higher proteasome-dependent viral degradation and a lower capacity for trans infection. Thus, homozygosity for L-SIGN plays a protective role during SARS infection.	Univ Hong Kong, Queen Mary Hosp, Hong Kong Jockey Club Clin Res Ctr, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Hong Kong Jockey Club Clin Res Ctr, Dept Surg, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Hong Kong Jockey Club Clin Res Ctr, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Hong Kong Jockey Club Clin Res Ctr, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Hong Kong Jockey Club Clin Res Ctr, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; Univ Oxford, Weatherall Inst Mol Med, Human Immunol Unit, Oxford, England; Univ London Imperial Coll Sci & Technol, Div Med, London, England; Univ Oxford, Nuffield Dept Surg, Oxford, England; Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Oxford; Imperial College London; University of Oxford; Hong Kong Polytechnic University	Khoo, US (corresponding author), Univ Hong Kong, Queen Mary Hosp, Hong Kong Jockey Club Clin Res Ctr, Dept Pathol, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	uskhoo@pathology.hku.hk; clin@hkucc.hku.hk	Chan, Kwok Hung/ABD-5399-2021; Poon, Leo Lit Man/C-4382-2009; Khoo, Ui Soon/C-4293-2009; Poon, Leo/AAP-6887-2020; Khoo, Ui Soon/K-2041-2019; Chan, Kelvin/HGA-3097-2022; Khoo, Ui Soon/C-1345-2014; Yip, Shea Ping/A-1185-2016; /C-4405-2009; Peiris, Joseph Sriyal Malik/C-4380-2009; Cheung, Annie Nga Yin/C-4231-2009; /B-3419-2011	Poon, Leo Lit Man/0000-0002-9101-7953; Khoo, Ui Soon/0000-0003-2200-7505; Khoo, Ui Soon/0000-0003-2200-7505; Yip, Shea Ping/0000-0002-2170-8185; /0000-0001-6231-3035; Screaton, Gavin/0000-0002-3549-4309; Ngan, Hextan Y S/0000-0003-3945-159X; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Cheung, Annie Nga Yin/0000-0002-1584-7568; /0000-0001-6985-6227	Medical Research Council [G0400720] Funding Source: Medline; MRC [G0400720] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Bonavia A, 2003, J VIROL, V77, P2530, DOI 10.1128/JVI.77.4.2530-2538.2003; Breslin JJ, 2003, J VIROL, V77, P4435, DOI 10.1128/JVI.77.7.4435-4438.2003; Chan-Yeung M, 2004, INT J OCCUP ENV HEAL, V10, P421, DOI 10.1179/oeh.2004.10.4.421; Drosten C, 2004, J CLIN MICROBIOL, V42, P2043, DOI 10.1128/JCM.42.5.2043-2047.2004; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Erler JT, 2004, MOL CELL BIOL, V24, P2875, DOI 10.1128/MCB.24.7.2875-2889.2004; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Guan M, 2004, CLIN DIAGN LAB IMMUN, V11, P699, DOI 10.1128/CDLI.11.4.699-703.2004; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Jeffers SA, 2004, P NATL ACAD SCI USA, V101, P15748, DOI 10.1073/pnas.0403812101; Kliger Y, 2003, BMC MICROBIOL, V3, DOI 10.1186/1471-2180-3-20; Koppel EA, 2004, IMMUNOBIOLOGY, V209, P117, DOI 10.1016/j.imbio.2004.03.003; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lichterfeld M, 2003, CLIN IMMUNOL, V107, P55, DOI 10.1016/S1521-6616(02)00050-5; Lin G, 2003, J VIROL, V77, P1337, DOI 10.1128/JVI.77.2.1337-1346.2003; Lin Marie, 2003, BMC Med Genet, V4, P9, DOI 10.1186/1471-2350-4-9; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.78.21.12090-12095.2004; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; NARDONE LL, 1979, BIOCHIM BIOPHYS ACTA, V573, P276, DOI 10.1016/0005-2760(79)90061-4; Ng MHL, 2004, J INFECT DIS, V190, P515, DOI 10.1086/421523; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Poon LLM, 2003, CLIN CHEM, V49, P953, DOI 10.1373/49.6.953; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Soilleux EJ, 2003, CLIN SCI, V104, P437, DOI 10.1042/CS20020092; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; To K, 2004, J PATHOL, V202, P157, DOI 10.1002/path.1510; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; Xiong HQ, 2002, GENOMICS, V80, P96, DOI 10.1006/geno.2002.6802; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004	37	110	118	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					38	46		10.1038/ng1698	http://dx.doi.org/10.1038/ng1698			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16369534	Bronze, Green Published			2022-12-27	WOS:000234227200015
J	Bruce, LJ; Robinson, HC; Guizouarn, H; Borgese, F; Harrison, P; King, MJ; Goede, JS; Coles, SE; Gore, DM; Lutz, HU; Ficarella, R; Layton, DM; Iolascon, A; Ellory, JC; Stewart, GW				Bruce, LJ; Robinson, HC; Guizouarn, H; Borgese, F; Harrison, P; King, MJ; Goede, JS; Coles, SE; Gore, DM; Lutz, HU; Ficarella, R; Layton, DM; Iolascon, A; Ellory, JC; Stewart, GW			Monovalent cation leaks in human red cells caused by single amino-acid substitutions in the transport domain of the band 3 chloride-bicarbonate exchanger, AE1	NATURE GENETICS			English	Article							HEREDITARY STOMATOCYTOSIS; ANION-EXCHANGER; CRYOHYDROCYTOSIS FORM; HUMAN-ERYTHROCYTES; BRITISH FAMILIES; SICKLE CELLS; GENE DEFECTS; SPHEROCYTOSIS; MECHANISM; PROTEIN	We identified 11 human pedigrees with dominantly inherited hemolytic anemias in both the hereditary stomatocytosis and spherocytosis classes. Affected individuals in these families had an increase in membrane permeability to Na and K that is particularly marked at 0 degrees C. We found that disease in these pedigrees was associated with a series of single amino-acid substitutions in the intramembrane domain of the erythrocyte band 3 anion exchanger, AE1. Anion movements were reduced in the abnormal red cells. The 'leak' cation fluxes were inhibited by SITS, dipyridamole and NS1652, chemically diverse inhibitors of band 3. Expression of the mutated genes in Xenopus laevis oocytes induced abnormal Na and K fluxes in the oocytes, and the induced Cl transport was low. These data are consistent with the suggestion that the substitutions convert the protein from an anion exchanger into an unregulated cation channel.	UCL, Dept Med, London WC1E 6JJ, England; Natl Blood Serv, Bristol Inst Transfus Sci, Bristol BS10 5ND, Avon, England; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Univ Nice, Lab Physiol Membranes Cellulaires, CNRS, FRE 2721, F-06108 Nice, France; Univ Zurich Hosp, Dept Internal Med, Div Hematol, CH-8091 Zurich, Switzerland; ETH Honggerberg, Inst Biochem, CH-8093 Zurich, Switzerland; Telethon Inst Genet & Med, I-80131 Naples, Italy; Hammersmith Hosp, Imperial Coll, Dept Haematol, London W12 0HS, England; Univ Naples Federico 2, CEINGE Biotecnol Avanzante, Dept Biochem & Med Biotechnol, I-80131 Naples, Italy	University of London; University College London; University of Oxford; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Imperial College London; CEINGE Biotecnologie Avanzate; University of Naples Federico II	Stewart, GW (corresponding author), UCL, Dept Med, Univ St, London WC1E 6JJ, England.	g.stewart@ucl.ac.uk	Iolascon, Achille/A-4461-2014; Coles, Simon/A-1795-2009	Coles, Simon/0000-0001-8414-9272; Bruce, Lesley/0000-0001-5922-7072; Guizouarn, Helene/0000-0002-8757-6672; BORGESE, Franck/0000-0001-7718-2111	Telethon [GGP02202] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Telethon(Fondazione Telethon); Wellcome Trust(Wellcome TrustEuropean Commission)		Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Bennekou P, 2000, BLOOD, V95, P1842, DOI 10.1182/blood.V95.5.1842.005a37_1842_1848; Bruce LJ, 1998, BIOCHEM CELL BIOL, V76, P723, DOI 10.1139/bcb-76-5-723; BRUCE LJ, 1994, J BIOL CHEM, V269, P16155; Bruce LJ, 1999, BBA-BIOMEMBRANES, V1416, P258, DOI 10.1016/S0005-2736(98)00231-4; Coles SE, 1999, BRIT J HAEMATOL, V104, P275, DOI 10.1046/j.1365-2141.1999.01191.x; Coles SE, 1999, BRIT J HAEMATOL, V105, P1055, DOI 10.1046/j.1365-2141.1999.01444.x; DeFelice LJ, 2004, TRENDS NEUROSCI, V27, P352, DOI 10.1016/j.tins.2004.04.007; Dhermy D, 1997, BRIT J HAEMATOL, V98, P32, DOI 10.1046/j.1365-2141.1997.1893005.x; Eber S, 2004, SEMIN HEMATOL, V41, P118, DOI 10.1053/j.seminhematol.2004.01.002; Fricke B, 2003, BLOOD, V102, P2268, DOI 10.1182/blood-2002-06-1705; Fricke B, 2004, BRIT J HAEMATOL, V125, P796, DOI 10.1111/j.1365-2141.2004.04965.x; Gore D. M., 2002, British Journal of Haematology, V117, P9; Gore DA, 2004, BRIT J HAEMATOL, V125, P521, DOI 10.1111/j.1365-2141.2004.04944.x; Guizouarn H, 2001, J PHYSIOL-LONDON, V535, P497, DOI 10.1111/j.1469-7793.2001.t01-1-00497.x; Haines PG, 2001, BRIT J HAEMATOL, V113, P932, DOI 10.1046/j.1365-2141.2001.02792.x; Jarolim P, 1996, BLOOD, V88, P4366; JOHNSON RM, 1993, BIOCHIM BIOPHYS ACTA, V1148, P7, DOI 10.1016/0005-2736(93)90154-R; Joiner CH, 2001, BLOOD, V97, P3976, DOI 10.1182/blood.V97.12.3976; JOINER CH, 1990, BLOOD, V76, P212; JONES GS, 1985, J GEN PHYSIOL, V86, P721, DOI 10.1085/jgp.86.5.721; KNAUF PA, 2003, RED CELL MEMBRANE TR, P253; Lew VL, 2005, PHYSIOL REV, V85, P179, DOI 10.1152/physrev.00052.2003; Meredith D, 2004, J BIOL CHEM, V279, P15795, DOI 10.1074/jbc.M313922200; Popov M, 1999, BIOCHEM J, V339, P269, DOI 10.1042/0264-6021:3390269; Stewart GN, 1904, AM J PHYSIOL, V11, P0250; Stewart GW, 1996, BRIT J HAEMATOL, V93, P303, DOI 10.1046/j.1365-2141.1996.4881033.x; Stuart MJ, 2004, LANCET, V364, P1343, DOI 10.1016/S0140-6736(04)17192-4; TOSTESON MT, 1991, J GEN PHYSIOL, V98, P969, DOI 10.1085/jgp.98.5.969; YANNOUKAKOS D, 1991, BLOOD, V78, P1117	30	117	122	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2005	37	11					1258	1263		10.1038/ng1656	http://dx.doi.org/10.1038/ng1656			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16227998				2022-12-27	WOS:000233045200027
J	Maitra, A; Arking, DE; Shivapurkar, N; Ikeda, M; Stastny, V; Kassauei, K; Sui, GP; Cutler, DJ; Liu, Y; Brimble, SN; Noaksson, K; Hyllner, J; Schulz, TC; Zeng, XM; Freed, WJ; Crook, J; Abraham, S; Colman, A; Sartipy, P; Matsui, SI; Carpenter, M; Gazdar, AF; Rao, M; Chakravarti, A				Maitra, A; Arking, DE; Shivapurkar, N; Ikeda, M; Stastny, V; Kassauei, K; Sui, GP; Cutler, DJ; Liu, Y; Brimble, SN; Noaksson, K; Hyllner, J; Schulz, TC; Zeng, XM; Freed, WJ; Crook, J; Abraham, S; Colman, A; Sartipy, P; Matsui, SI; Carpenter, M; Gazdar, AF; Rao, M; Chakravarti, A			Genomic alterations in cultured human embryonic stem cells	NATURE GENETICS			English	Article							EPIGENETIC INACTIVATION; METHYLATION; CANCER; GENE; AMPLIFICATION; TUMORIGENESIS; MUTATIONS; PHENOTYPE; FREQUENT; TUMORS	Cultured human embryonic stem cell (hESC) lines are an invaluable resource because they provide a uniform and stable genetic system for functional analyses and therapeutic applications. Nevertheless, these dividing cells, like other cells, probably undergo spontaneous mutation at a rate of 10(-9) per nucleotide. Because each mutant has only a few progeny, the overall biological properties of the cell culture are not altered unless a mutation provides a survival or growth advantage. Clonal evolution that leads to emergence of a dominant mutant genotype may potentially affect cellular phenotype as well. We assessed the genomic fidelity of paired early- and late-passage hESC lines in the course of tissue culture. Relative to early-passage lines, eight of nine late-passage hESC lines had one or more genomic alterations commonly observed in human cancers, including aberrations in copy number (45%), mitochondrial DNA sequence (22%) and gene promoter methylation (90%), although the latter was essentially restricted to 2 of 14 promoters examined. The observation that hESC lines maintained in vitro develop genetic and epigenetic alterations implies that periodic monitoring of these lines will be required before they are used in in vivo applications and that some late-passage hESC lines may be unusable for therapeutic purposes.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21205 USA; Univ Texas, Hamon Ctr Therapeut Oncol Res, Dallas, TX USA; NIA, Neurosci Lab, Baltimore, MD 21224 USA; BresaGen Inc, Athens, GA USA; Cellartis AB, Gothenburg, Sweden; NIDA, Cellular Neurobiol Branch, Baltimore, MD USA; ES Cell Int, Singapore, Singapore; SUNY Buffalo, Roswell Pk Canc Inst, Buffalo, NY 14260 USA; Robarts Res Inst, London, ON N6A 5C1, Canada	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Texas System; University of Texas Dallas; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Takara Bio Inc.; Cellartis; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Western University (University of Western Ontario)	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, 733 N Broadway Res Bldg, Baltimore, MD 21205 USA.	raomah@grc.nia.nih.gov; aravinda@jhmi.edu	Crook, Jeremy Micah/AAH-8441-2020	Crook, Jeremy Micah/0000-0002-6415-1639; Constable, Sandii/0000-0002-3809-4976	NATIONAL INSTITUTE ON AGING [ZIAAG000688, Z01AG000688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000472, Z01DA000472] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Buzzard JJ, 2004, NAT BIOTECHNOL, V22, P381, DOI 10.1038/nbt0404-381; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hodgson JG, 2003, BREAST CANCER RES TR, V78, P337, DOI 10.1023/A:1023085825042; Huang Jing, 2004, Human Genomics, V1, P287; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; Pfeifer GP, 2002, BIOL CHEM, V383, P907, DOI 10.1515/BC.2002.097; Popescu NC, 2002, J CELL MOL MED, V6, P151, DOI 10.1111/j.1582-4934.2002.tb00183.x; Reddy J, 2005, ONCOGENE, V24, P732, DOI 10.1038/sj.onc.1208032; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Sait SNJ, 2002, GENE CHROMOSOME CANC, V34, P42, DOI 10.1002/gcc.10038; Shivapurkar N, 2004, INT J CANCER, V109, P786, DOI 10.1002/ijc.20041; Toyooka KO, 2002, AM J PATHOL, V161, P629, DOI 10.1016/S0002-9440(10)64218-6; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598	26	458	501	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1099	1103		10.1038/ng1631	http://dx.doi.org/10.1038/ng1631			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16142235				2022-12-27	WOS:000232185600021
J	Rhodes, DR; Chinnaiyan, AM				Rhodes, DR; Chinnaiyan, AM			Integrative analysis of the cancer transcriptome	NATURE GENETICS			English	Article							GENE-EXPRESSION DATA; MICROARRAY DATA; SIGNATURE; ONTOLOGY; DATABASE; PREDICTION; PROFILES; METAANALYSIS; VALIDATION; PATTERNS	DNA microarrays have been widely applied to the study of human cancer, delineating myriad molecular subtypes of cancer, many of which are associated with distinct biological underpinnings, disease progression and treatment response. These primary analyses have begun to decipher the molecular heterogeneity of cancer, but integrative analyses that evaluate cancer transcriptome data in the context of other data sources are often capable of extracting deeper biological insight from the data. Here we discuss several such integrative computational and analytical approaches, including meta-analysis, functional enrichment analysis, interactome analysis, transcriptional network analysis and integrative model system analysis.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Bioinformat, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Rhodes, DR (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu						Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Jiang HY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-81; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Parkinson H, 2005, NUCLEIC ACIDS RES, V33, pD553; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2002, CANCER RES, V62, P4427; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; RHODES DR, IN PRESS NAT GENET; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shen RL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-94; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Volinia S, 2004, NUCLEIC ACIDS RES, V32, pW492, DOI 10.1093/nar/gkh443; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	42	234	261	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37			S			S31	S37		10.1038/ng1570	http://dx.doi.org/10.1038/ng1570			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	932YF	15920528	Bronze			2022-12-27	WOS:000229590000007
J	Yu, L; Liu, CH; Vandeusen, J; Becknell, B; Dai, ZY; Wu, YZ; Raval, A; Liu, TH; Ding, W; Mao, C; Liu, SJ; Smith, LT; Lee, S; Rassenti, L; Marcucci, G; Byrd, J; Caligiuri, MA; Plass, C				Yu, L; Liu, CH; Vandeusen, J; Becknell, B; Dai, ZY; Wu, YZ; Raval, A; Liu, TH; Ding, W; Mao, C; Liu, SJ; Smith, LT; Lee, S; Rassenti, L; Marcucci, G; Byrd, J; Caligiuri, MA; Plass, C			Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia	NATURE GENETICS			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; EPIGENETIC ALTERATIONS; TRANSGENIC MICE; LIVER-TUMORS; CPG ISLANDS; SLIT2 GENE; EXPRESSION; CELLS; APOPTOSIS; PROTEINS	DNA methylation is associated with malignant transformation, but limitations imposed by genetic variability, tumor heterogeneity, availability of paired normal tissues and methodologies for global assessment of DNA methylation have limited progress in understanding the extent of epigenetic events in the initiation and progression of human cancer and in identifying genes that undergo methylation during cancer. We developed a mouse model of T/natural killer acute lymphoblastic leukemia that is always preceded by polyclonal lymphocyte expansion to determine how aberrant promoter DNA methylation and consequent gene silencing might be contributing to leukemic transformation. We used restriction landmark genomic scanning with this mouse model of preleukemia reproducibly progressing to leukemia to show that specific genomic methylation is associated with only the leukemic phase and is not random. We also identified Idb4 as a putative tumor-suppressor gene that is methylated in most mouse and human leukemias but in only a minority of other human cancers.	Ohio State Univ, Div Human Canc Genet, Tzagournis Med Res Facil 464A, Columbus, OH 43210 USA; Ohio State Univ, Div Hematol Oncol, Columbus, OH 43210 USA; Gen Hosp PLA 301, Dept Hematol, Beijing, Peoples R China; Univ Calif San Diego, Dept Med, Div Hematol Oncol, San Diego, CA 92103 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Canc Leukemia Grp B, Chicago, IL USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California San Diego; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Plass, C (corresponding author), Ohio State Univ, Div Human Canc Genet, Tzagournis Med Res Facil 464A, 420 W 12th Ave, Columbus, OH 43210 USA.	plass-1@medctr.osu.edu	Reever, Larson/H-9685-2019; Plass, Christoph/H-7192-2014; Xiao, Yang/B-5668-2012	Reever, Larson/0000-0002-5692-4793; Yu, Li/0000-0001-6872-2665				Akama TO, 1997, CANCER RES, V57, P3294; Andres-Barquin PJ, 1999, EXP CELL RES, V247, P347, DOI 10.1006/excr.1998.4360; Beger C, 2001, P NATL ACAD SCI USA, V98, P130, DOI 10.1073/pnas.98.1.130; Bellido M, 2003, HAEMATOLOGICA, V88, P994; BENEZRA R, 1994, CELL, V79, P1057, DOI 10.1016/0092-8674(94)90036-1; Bounpheng MA, 1999, FASEB J, V13, P2257, DOI 10.1096/fasebj.13.15.2257; Chan ASW, 2003, ONCOGENE, V22, P6946, DOI 10.1038/sj.onc.1206799; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Costello JF, 2002, METHODS, V27, P144, DOI 10.1016/S1046-2023(02)00067-1; Dai ZY, 2002, GENOME RES, V12, P1591, DOI 10.1101/gr.197402; Dai ZY, 2001, NEOPLASIA, V3, P314, DOI 10.1038/sj.neo.7900162; Dallol A, 2003, ONCOGENE, V22, P4611, DOI 10.1038/sj.onc.1206687; Dallol A, 2003, CANCER RES, V63, P1054; Dallol A, 2002, CANCER RES, V62, P5874; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Filmus J, 2001, GLYCOBIOLOGY, V11, p19R, DOI 10.1093/glycob/11.3.19R; FREUND RJ, 1997, STAT METHODS; Gilliland DG, 2002, CANCER CELL, V1, P417, DOI 10.1016/S1535-6108(02)00081-8; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; Jen Y, 1996, DEV DYNAM, V207, P235; JEN Y, 1992, GENE DEV, V6, P1466, DOI 10.1101/gad.6.8.1466; Jen Y, 1997, DEV DYNAM, V208, P92, DOI 10.1002/(SICI)1097-0177(199701)208:1<92::AID-AJA9>3.0.CO;2-X; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kee Y, 2001, MECH DEVELOP, V109, P341, DOI 10.1016/S0925-4773(01)00576-7; KREIDER BL, 1992, SCIENCE, V255, P1700, DOI 10.1126/science.1372755; Lasorella A, 2001, ONCOGENE, V20, P8326, DOI 10.1038/sj.onc.1205093; Lasorella A, 1996, MOL CELL BIOL, V16, P2570; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Paine-Saunders S, 1999, GENOMICS, V57, P455, DOI 10.1006/geno.1999.5793; Rush LJ, 2004, CANCER RES, V64, P2424, DOI 10.1158/0008-5472.CAN-03-2870; Rush LJ, 2001, BLOOD, V97, P3226, DOI 10.1182/blood.V97.10.3226; SHOJI W, 1994, J BIOL CHEM, V269, P5078; Smiraglia DJ, 1999, GENOMICS, V58, P254, DOI 10.1006/geno.1999.5840; Tateno M, 2001, CANCER RES, V61, P1144; Wang B, 2003, CANCER CELL, V4, P19, DOI 10.1016/S1535-6108(03)00164-8; Welcsh PL, 2002, P NATL ACAD SCI USA, V99, P7560, DOI 10.1073/pnas.062181799; WENDELHANSEN V, 1994, LEUKEMIA, V8, P476; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Yu L, 2004, GENOMICS, V84, P647, DOI 10.1016/j.ygeno.2004.06.010; Zhu WG, 2001, ONCOGENE, V20, P7787, DOI 10.1038/sj.onc.1204970; Zhu WG, 2001, CANCER RES, V61, P1327	45	147	188	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					265	274		10.1038/ng1521	http://dx.doi.org/10.1038/ng1521			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15723065				2022-12-27	WOS:000227297800017
J	Ueda, HR; Hayashi, S; Chen, WB; Sano, M; Machida, M; Shigeyoshi, Y; Iino, M; Hashimoto, S				Ueda, HR; Hayashi, S; Chen, WB; Sano, M; Machida, M; Shigeyoshi, Y; Iino, M; Hashimoto, S			System-level identification of transcriptional circuits underlying mammalian circadian clocks	NATURE GENETICS			English	Article							PERIOD HOMOLOGS; EXPRESSION; PROTEIN; OSCILLATION; COMPONENT; CLONING; MOUSE; LIMB; PAR	Mammalian circadian clocks consist of complexly integrated regulatory loops(1-5), making it difficult to elucidate them without both the accurate measurement of system dynamics and the comprehensive identification of network circuits(6). Toward a system-level understanding of this transcriptional circuitry, we identified clock-controlled elements on 16 clock and clock-controlled genes in a comprehensive surveillance of evolutionarily conserved cis elements and measurement of their transcriptional dynamics. Here we report the roles of E/E' boxes, DBP/E4BP4 binding elements(7) and RevErbA/ROR binding elements(8) in nine, seven and six genes, respectively. Our results indicate that circadian transcriptional circuits are governed by two design principles: regulation of E/E boxes and RevErbA/ROR binding elements follows a repressor-precedes-activator pattern, resulting in delayed transcriptional activity, whereas regulation of DBP/E4BP4 binding elements follows a repressor-antiphasic-to-activator mechanism, which generates high-amplitude transcriptional activity. Our analysis further suggests that regulation of E/E boxes is a topological vulnerability in mammalian circadian clocks, a concept that has been functionally verified using in vitro phenotype assay systems.	Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Mol Med Labs, Tsukuba, Ibaraki 3058585, Japan; RIKEN, Ctr Dev Biol, Lab Syst Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; Univ Tokyo, Grad Sch Med, Dept Pharmacol, Tokyo 1130033, Japan; Natl Inst Adv Ind Sci & technol, Res Ctr Glycosci, Tsukuba, Ibaraki 3058566, Japan; Kinki Univ, Sch Med, Dept Anat & Neurobiol, Osakasayama, Osaka 5898511, Japan	Astellas Pharmaceuticals; RIKEN; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Kindai University (Kinki University)	Ueda, HR (corresponding author), Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Mol Med Labs, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	uedah-tky@umin.ac.jp	Ueda, Hiroki R/C-5037-2014	Ueda, Hiroki R/0000-0001-8342-9176				Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Falvey E, 1996, BIOL CHEM, V377, P797; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Mitsui S, 2001, GENE DEV, V15, P995, DOI 10.1101/gad.873501; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; WUARIN J, 1990, CELL, V63, P1257, DOI 10.1016/0092-8674(90)90421-A; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	30	603	619	1	49	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					187	192		10.1038/ng1504	http://dx.doi.org/10.1038/ng1504			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	15665827				2022-12-27	WOS:000226690100027
J	Royal, CDM; Dunston, GM				Royal, CDM; Dunston, GM			Changing the paradigm from 'race' to human genome variation	NATURE GENETICS			English	Article							HUMAN GENETIC DIVERSITY	Knowledge from the Human Genome Project and research on human genome variation increasingly challenges the applicability of the term 'race' to human population groups, raising questions about the validity of inferences made about 'race' in the biomedical and scientific literature. Despite the acknowledged contradictions in contemporary science, population-based genetic variation is continually used to explain differences in health between 'racial' and 'ethnic' groups. In this commentary we posit that resolution of apparent paradoxes in relating biology to 'race' and genetics requires thinking 'outside of the box'.	Howard Univ, Natl Human Genome Ctr, Coll Med, Washington, DC 20059 USA	Howard University	Royal, CDM (corresponding author), Howard Univ, Natl Human Genome Ctr, Coll Med, 2216 6th St NW,Suite 207, Washington, DC 20059 USA.	croyal@howard.edu						Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BRACE CL, 1964, CURR ANTHROPOL, V5, P313, DOI 10.1086/200502; BURCHARD EG, 2003, NEW ENGL J MED, V248, P117; CITRIN T, 2003, GENOMICS POPULATION; COOPER R, 1984, AM HEART J, V108, P715, DOI 10.1016/0002-8703(84)90662-8; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; DOBZHANSKY T, 1963, CURR ANTHROPOL, V4, P360, DOI 10.1086/200401; DUNSTON GM, 2004, PRAEGER HDB BLACK AM, P757; Duster Troy, 2003, BACKDOOR EUGENICS; EDMONSON MS, 1965, CURR ANTHROPOL, V6, P167, DOI 10.1086/200579; ELLISON GTH, 2002, CRITICAL PUBLIC HLTH, V12, P265; Foster MW, 2002, GENOME RES, V12, P844, DOI 10.1101/gr.99202; Frank R, 2001, DEMOGRAPHY, V38, P563, DOI 10.2307/3088319; GATES RR, 1963, CURR ANTHROPOL, V4, P208, DOI 10.1086/200362; Goodman AH, 2000, AM J PUBLIC HEALTH, V90, P1699, DOI 10.2105/AJPH.90.11.1699; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Kittles RA, 2003, ANNU REV GENOM HUM G, V4, P33, DOI 10.1146/annurev.genom.4.070802.110356; Kuhn TS, 1962, STRUCTURE SCI REVOLU; Lee S S, 2001, Yale J Health Policy Law Ethics, V1, P33; LIVINGSTONE FB, 1958, CURR ANTHROPOL, V3, P279; NASH M, 1962, CURR ANTHROPOL, V3, P285, DOI 10.1086/200294; NEWMAN MT, 1963, CURR ANTHROPOL, V4, P189, DOI 10.1086/200360; Phimister EG, 2003, NEW ENGL J MED, V348, P1081, DOI 10.1056/NEJMp030028; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Smedley A, 1999, RACE N AM ORIGIN EVO; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; WIERCINSKI A, 1962, CURR ANTHROPOL, V3, P2, DOI 10.1086/200244	30	70	73	0	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11		S			S5	S7		10.1038/ng1454	http://dx.doi.org/10.1038/ng1454			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867PH	15508004	Bronze			2022-12-27	WOS:000224854000003
J	Ramirez, A; Heimbach, A; Gruendemann, J; Stiller, B; Hampshire, D; Cid, LP; Goebel, I; Mubaidin, AF; Wriekat, AL; Roeper, J; Al-Din, A; Hillmer, AM; Karsak, M; Liss, B; Woods, CG; Behrens, MI; Kubisch, C				Ramirez, Alfredo; Heimbach, Andre; Gruendemann, Jan; Stiller, Barbara; Hampshire, Dan; Cid, L. Pablo; Goebel, Ingrid; Mubaidin, Ammar F.; Wriekat, Abdul-Latif; Roeper, Jochen; Al-Din, Amir; Hillmer, Axel M.; Karsak, Meliha; Liss, Birgit; Woods, C. Geoffrey; Behrens, Maria I.; Kubisch, Christian			Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase	NATURE GENETICS			English	Article							PALLIDO-PYRAMIDAL DEGENERATION; SUPRANUCLEAR UPGAZE PARESIS; ALPHA-SYNUCLEIN; DISEASE; DEGRADATION; GENE; ALZHEIMERS; UBIQUITIN; NEURONS; BIOLOGY	Neurodegenerative disorders such as Parkinson and Alzheimer disease cause motor and cognitive dysfunction and belong to a heterogeneous group of common and disabling disorders(1). Although the complex molecular pathophysiology of neurodegeneration is largely unknown, major advances have been achieved by elucidating the genetic defects underlying mendelian forms of these diseases(2). This has led to the discovery of common pathophysiological pathways such as enhanced oxidative stress, protein misfolding and aggregation and dysfunction of the ubiquitin-proteasome system(3-6). Here, we describe loss-of-function mutations in a previously uncharacterized, predominantly neuronal P-type ATPase gene, ATP13A2, underlying an autosomal recessive form of early-on-set parkinsonism with pyramidal degeneration and dementia (PARK9, Kufor-Rakeb syndrome(7,8)). Whereas the wild-type protein was located in the lysosome of transiently transfected cells, the unstable truncated mutants were retained in the endoplasmic reticulum and degraded by the proteasome. Our findings link a class of proteins with unknown function and substrate specificity(9) to the protein networks implicated in neurodegeneration and parkinsonism.	Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; Univ Cologne, Inst Genet, D-50931 Cologne, Germany; Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; Univ Marburg, Inst Physiol, D-35037 Marburg, Germany; Univ Leeds, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; Ctr Estudios Cient, Valdivia 5099100, Chile; King Hussein Med Ctr, Dept Neurol, Amman 11947, Jordan; Pinderfields Gen Hosp, Dept Neurol, Wakefield WF1 4DG, England; Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; Univ Bonn, Life & Brain Ctr, Dept Mol Psychiat, D-53127 Bonn, Germany; Cambridge Inst Med Res, Cambridge CB2 2QQ, England; Univ Chile, Dept Neurol & Neurosurg, Santiago 8207257, Chile	University of Cologne; University of Cologne; University of Cologne; University of Bonn; Philipps University Marburg; University of Leeds; Pinderfields Hospital; University of Bonn; University of Bonn; University of Cambridge; Universidad de Chile	Kubisch, C (corresponding author), Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany.	christian.kubisch@uk-koeln.de	woods, christopher g/A-1361-2010; Kubisch, Christian/F-1893-2011; Hillmer, Axel M/N-2927-2014; Hillmer, Axel M/B-7485-2015; Ramirez, Alfredo/S-5126-2019; Behrens, Maria I I/I-1083-2013	Kubisch, Christian/0000-0003-4220-0978; Hillmer, Axel M/0000-0002-3381-7266; Hillmer, Axel M/0000-0002-3381-7266; Ramirez, Alfredo/0000-0003-4991-763X; Behrens, Maria I I/0000-0003-0964-426X; Grundemann, Jan/0000-0002-3149-0001; liss, Birgit/0000-0002-6733-9207; Roeper, Jochen/0000-0003-2145-8742; Karsak, Meliha/0000-0001-6612-6317; Cid, Pablo/0000-0003-0394-0498	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aharon-Peretz J, 2004, NEW ENGL J MED, V351, P1972, DOI 10.1056/NEJMoa033277; ALDIN ASN, 1994, ACTA NEUROL SCAND, V89, P347; Auer H, 2003, NAT GENET, V35, P292, DOI 10.1038/ng1203-292; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; Hampshire DJ, 2001, J MED GENET, V38, P680, DOI 10.1136/jmg.38.10.680; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Kwasnicka-Crawford DA, 2005, GENOMICS, V86, P182, DOI 10.1016/j.ygeno.2005.04.002; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Liss B, 1999, J NEUROSCI, V19, P8839, DOI 10.1523/JNEUROSCI.19-20-08839.1999; Liss B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf088; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schultheis PJ, 2004, BIOCHEM BIOPH RES CO, V323, P731, DOI 10.1016/j.bbrc.2004.08.156; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Williams DR, 2005, MOVEMENT DISORD, V20, P1264, DOI 10.1002/mds.20511	30	831	867	4	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1184	1191		10.1038/ng1884	http://dx.doi.org/10.1038/ng1884			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16964263				2022-12-27	WOS:000241251100019
J	Friesen, TL; Stukenbrock, EH; Liu, ZH; Meinhardt, S; Ling, H; Faris, JD; Rasmussen, JB; Solomon, PS; McDonald, BA; Oliver, RP				Friesen, Timothy L.; Stukenbrock, Eva H.; Liu, Zhaohui; Meinhardt, Steven; Ling, Hua; Faris, Justin D.; Rasmussen, Jack B.; Solomon, Peter S.; McDonald, Bruce A.; Oliver, Richard P.			Emergence of a new disease as a result of interspecific virulence gene transfer	NATURE GENETICS			English	Article							PYRENOPHORA-TRITICI-REPENTIS; QUANTITATIVE TRAIT LOCI; STAGONOSPORA-NODORUM; TAN SPOT; FILAMENTOUS FUNGI; CAUSAL AGENT; WHEAT; EVOLUTION; TOXIN; SENSITIVITY	New diseases of humans, animals and plants emerge regularly. Enhanced virulence on a new host can be facilitated by the acquisition of novel virulence factors. Interspecific gene transfer is known to be a source of such virulence factors in bacterial pathogens (often manifested as pathogenicity islands in the recipient organism(1)) and it has been speculated that interspecific transfer of virulence factors may occur in fungal pathogens(2). Until now, no direct support has been available for this hypothesis. Here we present evidence that a gene encoding a critical virulence factor was transferred from one species of fungal pathogen to another. This gene transfer probably occurred just before 1941, creating a pathogen population with significantly enhanced virulence and leading to the emergence of a new damaging disease of wheat.	Murdoch Univ, Div Hlth Sci, Australian Ctr Necrotroph Fungal Pathogens, Western Australian State Agr Biotechnol Ctr, Murdoch, WA 6150, Australia; USDA ARS, Cereal Crops Res Unit, Red Valley Agr Res Ctr, No Crop Sci Lab, Fargo, ND 58105 USA; ETH, Inst Integrat Biol, CH-8092 Zurich, Switzerland; N Dakota State Univ, Dept Plant Pathol, Fargo, ND 58105 USA; N Dakota State Univ, Dept Chem, Fargo, ND 58105 USA	Murdoch University; United States Department of Agriculture (USDA); Swiss Federal Institutes of Technology Domain; ETH Zurich; North Dakota State University Fargo; North Dakota State University Fargo	Oliver, RP (corresponding author), Murdoch Univ, Div Hlth Sci, Australian Ctr Necrotroph Fungal Pathogens, Western Australian State Agr Biotechnol Ctr, Murdoch, WA 6150, Australia.	roliver@murdoch.edu.au	Solomon, Peter/C-9301-2009; Oliver, Richard P/D-1166-2009; Holtgrewe Stukenbrock, Eva/I-4333-2016; McDonald, Bruce A/A-2748-2008	Solomon, Peter/0000-0002-5130-7307; Holtgrewe Stukenbrock, Eva/0000-0001-8590-3345; McDonald, Bruce A/0000-0002-5332-2172; Faris, Justin/0000-0002-9653-3287				Barrus M. F., 1942, PLANT DIS REPORTER, V26, P246; Bearchell SJ, 2005, P NATL ACAD SCI USA, V102, P5438, DOI 10.1073/pnas.0501596102; Ciuffetti LM, 1997, PLANT CELL, V9, P135, DOI 10.1105/tpc.9.2.135; DUFF A. D. S., 1954, East African Agricultural Journal, V19, P225; Faris JD, 1996, PHYTOPATHOLOGY, V86, P459, DOI 10.1094/Phyto-86-459; Friesen TL, 2005, PHYTOPATHOLOGY, V95, P1144, DOI 10.1094/PHYTO-95-1144; Friesen TL, 2004, THEOR APPL GENET, V109, P464, DOI 10.1007/s00122-004-1678-9; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; Hosford RM., 1982, TAN SPOT WHEAT RELAT, P1; Johnson A. G., 1942, PLANT DIS REPORTER, V26, P246; Kempken F, 1998, BIOESSAYS, V20, P652, DOI 10.1002/(SICI)1521-1878(199808)20:8&lt;652::AID-BIES8&gt;3.0.CO;2-K; Lamari L, 1998, CAN J PLANT PATHOL, V20, P396, DOI 10.1080/07060669809500410; Lichter A, 2002, FUNGAL GENET BIOL, V37, P180, DOI 10.1016/S1087-1845(02)00500-5; Liu ZH, 2005, THEOR APPL GENET, V111, P782, DOI 10.1007/s00122-005-2064-y; Liu ZH, 2004, PHYTOPATHOLOGY, V94, P1061, DOI 10.1094/PHYTO.2004.94.10.1061; Liu ZH, 2004, PHYTOPATHOLOGY, V94, P1056, DOI 10.1094/PHYTO.2004.94.10.1056; MEEHAN F, 1947, SCIENCE, V106, P270, DOI 10.1126/science.106.2751.270-a; Nei M., 1987, MOL EVOLUTIONARY GEN; Panaccione DG, 2001, P NATL ACAD SCI USA, V98, P12820, DOI 10.1073/pnas.221198698; Roca MG, 2005, FEMS MICROBIOL LETT, V249, P191, DOI 10.1016/j.femsle.2005.06.048; Rosewich UL, 2000, ANNU REV PHYTOPATHOL, V38, P325, DOI 10.1146/annurev.phyto.38.1.325; Schurch S, 2004, MOL PLANT MICROBE IN, V17, P1114, DOI 10.1094/MPMI.2004.17.10.1114; Shaukat A., 2002, Plant Protection Science, V38, P302; Solomon PS, 2006, MOL PLANT PATHOL, V7, P147, DOI [10.1111/j.1364-3703.2006.00326.x, 10.1111/J.1364-3703.2006.00326.X]; Solomon PS, 2003, PHYSIOL MOL PLANT P, V63, P191, DOI 10.1016/j.pmpp.2003.12.003; TATUM LA, 1971, SCIENCE, V171, P1113, DOI 10.1126/science.171.3976.1113; Terauchi R, 2000, MOL GEN GENET, V263, P554, DOI 10.1007/s004380051201; TOMAS A, 1990, MOL PLANT MICROBE IN, V3, P221, DOI 10.1094/MPMI-3-221; VALDER P. G., 1953, PROC LINN SOC N S WALES, V77, P323; Walton JD, 2000, FUNGAL GENET BIOL, V30, P167, DOI 10.1006/fgbi.2000.1224	30	502	520	2	86	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2006	38	8					953	956		10.1038/ng1839	http://dx.doi.org/10.1038/ng1839			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16832356				2022-12-27	WOS:000239325700028
J	Clark, RM; Wagler, TN; Quijada, P; Doebley, J				Clark, RM; Wagler, TN; Quijada, P; Doebley, J			A distant upstream enhancer at the maize domestication gene tb1 has pleiotropic effects on plant and inflorescent architecture	NATURE GENETICS			English	Article							MORPHOLOGICAL DIFFERENCES; QUANTITATIVE TRAITS; GENOME EVOLUTION; FLOWERING PLANTS; FRUIT SIZE; TEOSINTE; ORIGIN; MECHANISMS; EXPRESSION; DOMINANCE	Although quantitative trait locus (QTL) mapping has been successful in describing the genetic architecture of complex traits(1-4), the molecular basis of quantitative variation is less well understood, especially in plants such as maize that have large genome sizes. Regulatory changes at the teosinte branched1 (tb1) gene have been proposed to underlie QTLs of large effect for morphological differences that distinguish maize (Zea mays ssp. mays) from its wild ancestors, the teosintes (Z. mays ssp. parviglumis and mexicana)(1,5-7). We used a fine mapping approach to show that intergenic sequences similar to 58-69 kb 5' to the tb1 cDNA confer pleiotropic effects on Z. mays morphology. Moreover, using an allele-specific expression assay, we found that sequences > 41 kb upstream of tb1 act in cis to alter tb1 transcription. Our findings show that the large stretches of noncoding DNA that comprise the majority of many plant genomes can be a source of variation affecting gene expression and quantitative phenotypes.	Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Doebley, J (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	jdoebley@wisc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM065008, R01GM058816] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-58816, F32 GM-65008] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alonso-Blanco C, 2005, INT J DEV BIOL, V49, P717, DOI 10.1387/ijdb.051994ca; Bennetzen JL, 2005, ANN BOT-LONDON, V95, P127, DOI 10.1093/aob/mci008; Clark RM, 2004, P NATL ACAD SCI USA, V101, P700, DOI 10.1073/pnas.2237049100; DOEBLEY J, 1990, P NATL ACAD SCI USA, V87, P9888, DOI 10.1073/pnas.87.24.9888; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1993, GENETICS, V134, P559; DOEBLEY J, 1991, GENETICS, V129, P285; DOEBLEY J, 1995, GENETICS, V141, P333; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Lukens LN, 1999, GENET RES, V74, P291, DOI 10.1017/S0016672399004073; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Meagher TR, 2005, NEW PHYTOL, V168, P71, DOI 10.1111/j.1469-8137.2005.01527.x; Rostoks N, 2002, FUNCT INTEGR GENOMIC, V2, P51, DOI 10.1007/s10142-002-0055-5; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Sheehan MJ, 2004, GENETICS, V167, P1395, DOI 10.1534/genetics.103.026096; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Stam M, 2002, GENETICS, V162, P917; Tanksley SD, 2004, PLANT CELL, V16, pS181, DOI 10.1105/tpc.018119; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wendel JF, 2002, GENETICA, V115, P37, DOI 10.1023/A:1016020030189; Wicker T, 2005, PLANT J, V41, P184, DOI 10.1111/j.1365-313X.2004.02285.x; Wicker T, 2001, PLANT J, V26, P307, DOI 10.1046/j.1365-313X.2001.01028.x	29	282	307	1	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					594	597		10.1038/ng1784	http://dx.doi.org/10.1038/ng1784			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16642024				2022-12-27	WOS:000237147500024
J	Ueki, K; Okada, T; Hu, J; Liew, CW; Assmann, A; Dahlgren, GM; Peters, JL; Shackman, JG; Zhang, M; Artner, I; Satin, LS; Stein, R; Holzenberger, M; Kennedy, RT; Kahn, CR; Kulkarni, RN				Ueki, K; Okada, T; Hu, J; Liew, CW; Assmann, A; Dahlgren, GM; Peters, JL; Shackman, JG; Zhang, M; Artner, I; Satin, LS; Stein, R; Holzenberger, M; Kennedy, RT; Kahn, CR; Kulkarni, RN			Total insulin and IGF-I resistance in pancreatic beta cells causes overt diabetes	NATURE GENETICS			English	Article							RECEPTOR SUBSTRATE-1; PROTEIN-KINASE; ROLES; HYPERINSULINEMIA; SECRETION; KNOCKOUT; CHANNELS; DISTINCT; LACKING; DEATH	An appropriate beta cell mass is pivotal for the maintenance of glucose homeostasis(1). Both insulin and IGF-1 are important in regulation of beta cell growth and function ( reviewed in ref. 2). To define the roles of these hormones directly, we created a mouse model lacking functional receptors for both insulin and IGF-1 only in beta cells (beta DKO), as the hormones have overlapping mechanisms of action and activate common downstream proteins. Notably, bDKO mice were born with a normal complement of islet cells, but 3 weeks after birth, they developed diabetes, in contrast to mild phenotypes observed in single mutants(3,4). Normoglycemic 2-week-old beta DKO mice manifest reduced beta cell mass, reduced expression of phosphorylated Akt and the transcription factor MafA, increased apoptosis in islets and severely compromised b cell function. Analyses of compound knockouts showed a dominant role for insulin signaling in regulating beta cell mass. Together, these data provide compelling genetic evidence that insulin and IGF-I-dependent pathways are not critical for development of beta cells but that a loss of action of these hormones in b cells leads to diabetes. We propose that therapeutic improvement of insulin and IGF-I signaling in beta cells might protect against type 2 diabetes.	Harvard Univ, Sch Med, Joslin Diabet Ctr, Dept Med, Boston, MA 02215 USA; Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA; Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; Hop St Antoine, INSERM U515, F-75571 Paris 12, France	Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Virginia Commonwealth University; Vanderbilt University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Kulkarni, RN (corresponding author), Harvard Univ, Sch Med, Joslin Diabet Ctr, Dept Med, Boston, MA 02215 USA.	Rohit.Kulkarni@joslin.harvard.edu	Kennedy, Robert/G-9095-2016; Holzenberger, Martin/N-9732-2018; Kahn, Ronald/AAY-2435-2021	Kennedy, Robert/0000-0003-2447-7471; Kahn, Ronald/0000-0002-7583-9228; Holzenberger, Martin/0000-0003-4869-725X; Assmann, Anke/0000-0003-0298-3410; Liew, Chong Wee/0000-0001-9904-0958; Artner, Isabella/0000-0002-2895-5664	NIDDK NIH HHS [R01 DK066207, R01 DK067536, R01 DK046960, P01 DK042502] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046960, R03DK066207, P01DK042502, R01DK067536] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Aspinwall CA, 2000, J BIOL CHEM, V275, P22331, DOI 10.1074/jbc.M909647199; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Fisher SJ, 2003, J CLIN INVEST, V111, P463, DOI 10.1172/JCI16426; Goforth PB, 2002, J GEN PHYSIOL, V120, P307, DOI 10.1085/jgp.20028581; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Kennedy RT, 2002, DIABETES, V51, pS152, DOI 10.2337/diabetes.51.2007.S152; Kido Y, 2002, J BIOL CHEM, V277, P36740, DOI 10.1074/jbc.M206314200; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kokkotou EG, 2001, ENDOCRINOLOGY, V142, P680, DOI 10.1210/en.142.2.680; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Kulkarni RN, 2003, DIABETES, V52, P1528, DOI 10.2337/diabetes.52.6.1528; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kulkarni RN, 1999, J CLIN INVEST, V104, pR69, DOI 10.1172/JCI8339; Louvi A, 1997, DEV BIOL, V189, P33, DOI 10.1006/dbio.1997.8666; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Olbrot M, 2002, P NATL ACAD SCI USA, V99, P6737, DOI 10.1073/pnas.102168499; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Williams DC, 2005, J BIOL CHEM, V280, P29269, DOI 10.1074/jbc.M504642200; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Wolfer DP, 2002, TRENDS NEUROSCI, V25, P336, DOI 10.1016/S0166-2236(02)02192-6; Xavier GD, 2004, BIOCHEM J, V377, P149, DOI 10.1042/BJ20031260; Xuan SH, 2002, J CLIN INVEST, V110, P1011, DOI 10.1172/JCI200215276; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005; Zhang M, 2005, J GEN PHYSIOL, V126, P353, DOI 10.1085/jgp.200509312	30	207	215	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					583	588		10.1038/ng1787	http://dx.doi.org/10.1038/ng1787			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16642022				2022-12-27	WOS:000237147500022
J	Ikeda, Y; Dick, KA; Weatherspoon, MR; Gincel, D; Armbrust, KR; Dalton, JC; Stevanin, G; Durr, A; Zuhlke, C; Burk, K; Clark, HB; Brice, A; Rothstein, JD; Schut, LJ; Day, JW; Ranum, LPW				Ikeda, Y; Dick, KA; Weatherspoon, MR; Gincel, D; Armbrust, KR; Dalton, JC; Stevanin, G; Durr, A; Zuhlke, C; Burk, K; Clark, HB; Brice, A; Rothstein, JD; Schut, LJ; Day, JW; Ranum, LPW			Spectrin mutations cause spinocerebellar ataxia type 5	NATURE GENETICS			English	Article							GLUTAMATE-RECEPTOR GENE; PURKINJE-CELLS; TRANSPORT; DISEASE; PATHOGENESIS; MEMBRANE; DYNACTIN; FEATURES; LURCHER; NEURONS	We have discovered that beta-III spectrin (SPTBN2) mutations cause spinocerebellar ataxia type 5 (SCA5) in an 11-generation American kindred descended from President Lincoln's grandparents and two additional families. Two families have separate in-frame deletions of 39 and 15 bp, and a third family has a mutation in the actin/ARP1 binding region. beta-III spectrin is highly expressed in Purkinje cells and has been shown to stabilize the glutamate transporter EAAT4 at the surface of the plasma membrane. We found marked differences in EAAT4 and GluR delta 2 by protein blot and cell fractionation in SCA5 autopsy tissue. Cell culture studies demonstrate that wild-type but not mutant beta-III spectrin stabilizes EAAT4 at the plasma membrane. Spectrin mutations are a previously unknown cause of ataxia and neurodegenerative disease that affect membrane proteins involved in glutamate signaling.	Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; Johns Hopkins Univ, Dept Neurol & Neurosci, Baltimore, MD 21287 USA; Univ Paris 06, INSERM, UMR679, F-75013 Paris, France; Hop La Pitie Salpetriere, Dept Genet Cytogenet & Embryol, AP HP, F-75013 Paris, France; Med Univ Lubeck, Inst Human Genet, D-23538 Lubeck, Germany; Univ Tubingen, Dept Neurol, D-72076 Tubingen, Germany; Univ Tubingen, Inst Brain Res, D-72076 Tubingen, Germany; Centra Care Clin, St Cloud, MN 56303 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Lubeck; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Ranum, LPW (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 321 Church St SE, Minneapolis, MN 55455 USA.	ranum001@umn.edu	rothstein, jeffrey d/C-9470-2013; Stevanin, Giovanni/E-5038-2016; Brice, Alexis/A-2170-2009; brice, alexis/AAE-8275-2019	Stevanin, Giovanni/0000-0001-9368-8657; brice, alexis/0000-0002-0941-3990; Day, John/0000-0002-0086-9529; Armbrust, Karen/0000-0001-9381-4756				Burk K, 2004, NEUROLOGY, V62, P327, DOI 10.1212/01.WNL.0000103293.63340.C1; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gold DA, 2003, NEURON, V40, P1119, DOI 10.1016/S0896-6273(03)00769-4; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Knight MA, 2004, BRAIN, V127, P1172, DOI 10.1093/brain/awh139; KRAWCZAK M, 1991, HUM GENET, V86, P425; Lalouette A, 1998, GENOMICS, V50, P9, DOI 10.1006/geno.1998.5314; Lee SH, 2001, NEUROPHARMACOLOGY, V41, P680, DOI 10.1016/S0028-3908(01)00124-1; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Liquori C, 2002, CEREBELLUM ITS DISOR, P445; MCKUSICK VA, 1991, NATURE, V352, P279, DOI 10.1038/352279a0; Ohara O, 1998, MOL BRAIN RES, V57, P181, DOI 10.1016/S0169-328X(98)00068-0; PAPADOPOULOS N, 1995, NAT GENET, V11, P99, DOI 10.1038/ng0995-99; PARK EC, 1986, GENETICS, V113, P821; Parkinson NJ, 2001, NAT GENET, V29, P61, DOI 10.1038/ng710; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Raiteri L, 2002, PROG NEUROBIOL, V68, P287, DOI 10.1016/S0301-0082(02)00059-X; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; Serra HG, 2004, HUM MOL GENET, V13, P2535, DOI 10.1093/hmg/ddh268; Stankewich MC, 1998, P NATL ACAD SCI USA, V95, P14158, DOI 10.1073/pnas.95.24.14158; Stevanin G, 2004, ANN NEUROL, V55, P97, DOI 10.1002/ana.10798; Stevanin G, 1999, NEUROLOGY, V53, P1355, DOI 10.1212/WNL.53.6.1355; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Welsh JP, 2002, ADV NEUROL, V89, P331; Worth PF, 1999, AM J HUM GENET, V65, P420, DOI 10.1086/302495; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	30	252	264	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					184	190		10.1038/ng1728	http://dx.doi.org/10.1038/ng1728			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16429157				2022-12-27	WOS:000234953200012
J	Gupta, PB; Kuperwasser, C; Brunet, JP; Ramaswamy, S; Kuo, WL; Gray, JW; Naber, SP; Weinberg, RA				Gupta, PB; Kuperwasser, C; Brunet, JP; Ramaswamy, S; Kuo, WL; Gray, JW; Naber, SP; Weinberg, RA			The melanocyte differentiation program predisposes to metastasis after neoplastic transformation	NATURE GENETICS			English	Article							TYROSINE KINASE RECEPTOR; NEURAL CREST; MALIGNANT-MELANOMA; LESS-THAN-OR-EQUAL-TO-1 MM; TUMOR PROGRESSION; EPITHELIAL-CELLS; NERVOUS-SYSTEM; BREAST-CANCER; GENE-TRANSFER; LYMPH-NODES	The aggressive clinical behavior of melanoma suggests that the developmental origins of melanocytes in the neural crest might be relevant to their metastatic propensity. Here we show that primary human melanocytes, transformed using a specific set of introduced genes, form melanomas that frequently metastasize to multiple secondary sites, whereas human fibroblasts and epithelial cells transformed using an identical set of genes generate primary tumors that rarely do so. Notably, these melanomas have a metastasis spectrum similar to that observed in humans with melanoma. These observations indicate that part of the metastatic proclivity of melanoma is attributable to lineage-specific factors expressed in melanocytes and not in other cell types analyzed. Analysis of microarray data from human nevi shows that the expression pattern of Slug, a master regulator of neural crest cell specification and migration, correlates with those of other genes that are important for neural crest cell migrations during development. Moreover, Slug is required for the metastasis of the transformed melanoma cells. These findings indicate that melanocyte-specific factors present before neoplastic transformation can have a pivotal role in governing melanoma progression.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Tufts Univ, Sch Med, New England Med Ctr, Dept Anat & Cellular Biol, Boston, MA 02111 USA; Tufts Univ, Sch Med, New England Med Ctr, Dept Radiat Oncol, Boston, MA 02111 USA; MIT, Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Tufts Univ, Sch Med, New England Med Ctr, Dept Pathol, Boston, MA 02111 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Tufts Medical Center; Tufts University	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu			NCI NIH HHS [R01 CA078461] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA078461] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartkova J, 1996, CANCER RES, V56, P5475; Beddingfield FC, 2003, ONCOLOGIST, V8, P459, DOI 10.1634/theoncologist.8-5-459; Bedrosian I, 2000, ANN SURG ONCOL, V7, P262, DOI 10.1007/s10434-000-0262-z; BORTOLANI A, 1994, ANN PLAS SURG, V33, P426, DOI 10.1097/00000637-199410000-00013; Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825; Bronner-Fraser Marianne, 1993, Trends in Cell Biology, V3, P392, DOI 10.1016/0962-8924(93)90089-J; Carl TF, 1999, DEV BIOL, V213, P101, DOI 10.1006/dbio.1999.9320; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; Corsetti RL, 2000, ANN SURG ONCOL, V7, P456, DOI 10.1007/s10434-000-0456-4; Counter CM, 1998, P NATL ACAD SCI USA, V95, P14723, DOI 10.1073/pnas.95.25.14723; Cruz J, 2003, ONCOLOGY-BASEL, V65, P72, DOI 10.1159/000071207; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Elsayed AM, 1996, AM J GASTROENTEROL, V91, P1001; GIORDANO S, 1989, NATURE, V339, P155, DOI 10.1038/339155a0; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hajra KM, 2002, CANCER RES, V62, P1613; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Ikeda K, 1996, NEUROREPORT, V7, P1713; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; JOHNSON WT, 1969, CANCER, V23, P747, DOI 10.1002/1097-0142(196903)23:3<747::AID-CNCR2820230331>3.0.CO;2-9; Kuperwasser C, 2000, CANCER RES, V60, P2723; Kuperwasser C, 2000, AM J PATHOL, V157, P2151, DOI 10.1016/S0002-9440(10)64853-5; LaBonne C, 2000, DEV BIOL, V221, P195, DOI 10.1006/dbio.2000.9609; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Li G, 2001, ONCOGENE, V20, P8125, DOI 10.1038/sj.onc.1205034; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; NATALI PG, 1993, BRIT J CANCER, V68, P746, DOI 10.1038/bjc.1993.422; NESBIT M, 1998, CUTANEOUS MELANOMA, P463; Omholt K, 2003, CLIN CANCER RES, V9, P6483; Petersen SL, 1996, ENDOCRINOLOGY, V137, P234, DOI 10.1210/en.137.1.234; PHILLIPS DL, 1987, J CLIN GASTROENTEROL, V9, P563, DOI 10.1097/00004836-198710000-00017; Rich JN, 2001, CANCER RES, V61, P3556; SHAW HM, 1987, ARCH SURG-CHICAGO, V122, P1147; Snijders AM, 2003, ONCOGENE, V22, P4370, DOI 10.1038/sj.onc.1206482; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; SUBRAMONY C, 1985, AM J CLIN PATHOL, V84, P220, DOI 10.1093/ajcp/84.2.220; Tietze MK, 2000, MOL MED TODAY, V6, P408, DOI 10.1016/S1357-4310(00)01781-0	42	359	363	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1047	1054		10.1038/ng1634	http://dx.doi.org/10.1038/ng1634			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16142232	Green Accepted			2022-12-27	WOS:000232185600015
J	Weber, M; Davies, JJ; Wittig, D; Oakeley, EJ; Haase, M; Lam, WL; Schubeler, D				Weber, M; Davies, JJ; Wittig, D; Oakeley, EJ; Haase, M; Lam, WL; Schubeler, D			Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells	NATURE GENETICS			English	Article							INACTIVE X-CHROMOSOME; HUMAN GENOME; METHYLTRANSFERASE GENE; REGULATORY NETWORKS; HIGH-RESOLUTION; CPG ISLANDS; EXPRESSION; CANCER; CHROMATIN; MOUSE	Cytosine methylation is required for mammalian development and is often perturbed in human cancer. To determine how this epigenetic modification is distributed in the genomes of primary and transformed cells, we used an immunocapturing approach followed by DNA microarray analysis to generate methylation profiles of all human chromosomes at 80-kb resolution and for a large set of CpG islands. In primary cells we identified broad genomic regions of differential methylation with higher levels in gene-rich neighborhoods. Female and male cells had indistinguishable profiles for autosomes but differences on the X chromosome. The inactive X chromosome ( Xi) was hypermethylated at only a subset of gene-rich regions and, unexpectedly, overall hypomethylated relative to its active counterpart. The chromosomal methylation profile of transformed cells was similar to that of primary cells. Nevertheless, we detected large genomic segments with hypomethylation in the transformed cell residing in gene-poor areas. Furthermore, analysis of 6,000 CpG islands showed that only a small set of promoters was methylated differentially, suggesting that aberrant methylation of CpG island promoters in malignancy might be less frequent than previously hypothesized.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; Tech Univ Dresden, Dept Pathol, D-8027 Dresden, Germany	Friedrich Miescher Institute for Biomedical Research; British Columbia Cancer Agency; Technische Universitat Dresden	Schubeler, D (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	dirk@fmi.ch	Weber, Michael/P-1914-2016; jia, xu/A-8386-2016	Weber, Michael/0000-0003-3484-5821; 				Adorjan P, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.5.e21; Bernardino J, 2000, CHROMOSOME RES, V8, P513, DOI 10.1023/A:1009271706488; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Chadwick BP, 2004, P NATL ACAD SCI USA, V101, P17450, DOI 10.1073/pnas.0408021101; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; CROSS SH, 1994, NAT GENET, V6, P236, DOI 10.1038/ng0394-236; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; GIACALONE J, 1992, NAT GENET, V1, P137, DOI 10.1038/ng0592-137; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; GROOT GSP, 1979, BIOCHIM BIOPHYS ACTA, V564, P355, DOI 10.1016/0005-2787(79)90233-8; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Louro R, 2004, BIOCHEM BIOPH RES CO, V316, P618, DOI 10.1016/j.bbrc.2004.02.091; MIGEON BR, 1994, TRENDS GENET, V10, P230, DOI 10.1016/0168-9525(94)90169-4; Oakes CC, 2003, P NATL ACAD SCI USA, V100, P1775, DOI 10.1073/pnas.0437971100; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Rabinowicz PD, 2003, GENOME RES, V13, P2658, DOI 10.1101/gr.1784803; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Salem CE, 2000, INT J CANCER, V87, P179, DOI 10.1002/1097-0215(20000715)87:2<179::AID-IJC4>3.0.CO;2-X; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Svoboda P, 2004, NUCLEIC ACIDS RES, V32, P3601, DOI 10.1093/nar/gkh697; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; VIEGASPEQUIGNOT E, 1988, P NATL ACAD SCI USA, V85, P7657, DOI 10.1073/pnas.85.20.7657; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Watson JEV, 2004, ONCOGENE, V23, P3487, DOI 10.1038/sj.onc.1207474; Weber M, 2001, MECH DEVELOP, V101, P133, DOI 10.1016/S0925-4773(00)00573-6; White EJ, 2004, P NATL ACAD SCI USA, V101, P17771, DOI 10.1073/pnas.0408170101; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yan PS, 2000, CLIN CANCER RES, V6, P1432; Yen PS, 2000, BRIT J CANCER, V82, P514, DOI 10.1054/bjoc.1999.0955	50	1265	1383	5	149	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2005	37	8					853	862		10.1038/ng1598	http://dx.doi.org/10.1038/ng1598			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16007088				2022-12-27	WOS:000230880400015
J	Zsurka, G; Kraytsberg, Y; Kudina, T; Kornblum, C; Elger, CE; Khrapko, K; Kunz, WS				Zsurka, G; Kraytsberg, Y; Kudina, T; Kornblum, C; Elger, CE; Khrapko, K; Kunz, WS			Recombination of mitochondrial DNA in skeletal muscle of individuals with multiple mitochondrial DNA heteroplasmy	NATURE GENETICS			English	Article							PATERNAL INHERITANCE; MTDNA; MUTATIONS	Experimental evidence for human mitochondrial DNA ( mtDNA) recombination was recently obtained in an individual with paternal inheritance of mtDNA(1) and in an in vitro cell culture system(2). Whether mtDNA recombination is a common event in humans remained to be determined. To detect mtDNA recombination in human skeletal muscle, we analyzed the distribution of alleles in individuals with multiple mtDNA heteroplasmy using single-cell PCR and allele-specific PCR. In all ten individuals who carried a heteroplasmic D-loop mutation and a distantly located tRNA point mutation or a large deletion, we observed a mixture of four allelic combinations (tetraplasmy), a hallmark of recombination. Twelve of 14 individuals with closely located heteroplasmic D-loop mutation pairs contained a mixture of only three types of mitochondrial genomes (triplasmy), consistent with the absence of recombination between adjacent markers. These findings indicate that mtDNA recombination is common in human skeletal muscle.	Univ Bonn, Med Ctr, Dept Epileptol, D-5300 Bonn, Germany; Harvard Univ, Sch Med, Boston, MA USA; Univ Bonn, Med Ctr, Dept Neurol, D-5300 Bonn, Germany	University of Bonn; Harvard University; Harvard Medical School; University of Bonn	Kunz, WS (corresponding author), Univ Bonn, Med Ctr, Dept Epileptol, D-5300 Bonn, Germany.	khrapko@hms.harvard.edu; wolfram.kunz@ukb.uni-bonn.de	Khrapko, Konstantin/A-3244-2009; Kunz, Wolfram/K-1232-2019	Kunz, Wolfram/0000-0003-1113-3493; Zsurka, Gabor/0000-0002-6379-849X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019787] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG019787, R01 AG018388] Funding Source: Medline; NIEHS NIH HHS [R01 ES011343] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arctander P, 1999, SCIENCE, V284, P2090; Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524; Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460; Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859; D'Aurelio M, 2004, HUM MOL GENET, V13, P3171, DOI 10.1093/hmg/ddh326; Elson JL, 2001, AM J HUM GENET, V68, P145, DOI 10.1086/316938; Filosto M, 2003, ANN NEUROL, V54, P524, DOI 10.1002/ana.10709; Hagelberg E, 2003, TRENDS GENET, V19, P84, DOI 10.1016/S0168-9525(02)00048-3; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Jorde L B, 2000, Science, V288, P1931; Khrapko K, 2003, MUTAT RES-FUND MOL M, V522, P13, DOI 10.1016/S0027-5107(02)00306-8; Kivisild T, 2000, Science, V288, P1931; Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342; Merriweather DA, 1999, SCIENCE, V285, P837; Nekhaeva E, 2002, P NATL ACAD SCI USA, V99, P5521, DOI 10.1073/pnas.072670199; Ohno K, 1996, ANN NEUROL, V39, P761, DOI 10.1002/ana.410390612; PAABO S, 1990, J BIOL CHEM, V265, P4718; Rokas A, 2003, TRENDS ECOL EVOL, V18, P411, DOI 10.1016/S0169-5347(03)00125-3; Sato A, 2005, P NATL ACAD SCI USA, V102, P6057, DOI 10.1073/pnas.0408666102; Schwartz M, 2004, J NEUROL SCI, V218, P99, DOI 10.1016/j.jns.2003.11.008; Schwartz M, 2002, NEW ENGL J MED, V347, P576, DOI 10.1056/NEJMoa020350; Sharma A, 2000, SCIENCE, V288, P977; Smith JM, 2002, MOL BIOL EVOL, V19, P2330, DOI 10.1093/oxfordjournals.molbev.a004058; Zsurka G, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.022566	25	50	50	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2005	37	8					873	877		10.1038/ng1606	http://dx.doi.org/10.1038/ng1606			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16025113	Green Accepted			2022-12-27	WOS:000230880400018
J	Billings, PR				Billings, PR			Genetic nondiscrimination	NATURE GENETICS			English	Editorial Material							DISCRIMINATION	The identification and investigation of sentinel cases has illuminated genetic discrimination in the US. Its occurrence impedes applications of biotechnology and is a primary focus of public policy activity at the federal level. Continued research and informed responses may make genetic nondiscrimination more likely.	Lab Corp Amer Holdings, Res Triangle Pk, NC 27709 USA; Univ Calif Berkeley, Dept Anthropol, Berkeley, CA 94707 USA	University of California System; University of California Berkeley	Billings, PR (corresponding author), Lab Corp Amer Holdings, Res Triangle Pk, NC 27709 USA.	billinp@labcorp.com						BILLINGS PR, 1992, AM J HUM GENET, V50, P476; Billings PR, 2000, GENET MED, V2, P207, DOI 10.1097/00125817-200007000-00001; HOOK EB, 1992, AM J HUM GENET, V51, P897; HUDSON KL, 1995, SCIENCE, V270, P391, DOI 10.1126/science.270.5235.391; LEHRMAN S, 1994, NATURE, V371, P468, DOI 10.1038/371468a0; MURRAY T, 1993, GENETIC INFORMATION; SZEKELY P, 2002, REUTERS         0508	7	14	14	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2005	37	6					559	560		10.1038/ng0605-559	http://dx.doi.org/10.1038/ng0605-559			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15920511				2022-12-27	WOS:000229495300003
J	Fraser, HB				Fraser, HB			Modularity and evolutionary constraint on proteins	NATURE GENETICS			English	Article							COEVOLUTION; EXPRESSION	Modularity, which has been found in the functional and physical protein interaction networks of many organisms, has been postulated to affect both the mode and tempo of evolution. Here I show that in the yeast Saccharomyces cerevisiae, protein interaction hubs situated in single modules are highly constrained, whereas those connecting different modules are more plastic. This pattern of change could reflect a tendency for evolutionary innovations to occur by altering the proteins and interactions between rather than within modules, in a manner somewhat similar to the evolution of new proteins through the shuffling of conserved protein domains.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Fraser, HB (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	hunter@ocf.berkeley.edu						DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; Fisher RA, 1930, GENETICAL THEORY NAT; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fraser HB, 2004, P NATL ACAD SCI USA, V101, P9033, DOI 10.1073/pnas.0402591101; Gerhart J, 1997, CELLS EMBRYOS EVOLUT; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hirsh AE, 2005, MOL BIOL EVOL, V22, P174, DOI 10.1093/molbev/msh265; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Needham J, 1933, BIOL REV BIOL P CAMB, V8, P180, DOI 10.1111/j.1469-185X.1933.tb01153.x; Schlosser G, 2002, THEOR BIOSCI, V121, P1, DOI 10.1078/1431-7613-00049; Schlosser G., 2004, MODULARITY DEV EVOLU; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Waxman D, 1998, SCIENCE, V279, P1210, DOI 10.1126/science.279.5354.1210	15	130	136	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					351	352		10.1038/ng1530	http://dx.doi.org/10.1038/ng1530			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15750592				2022-12-27	WOS:000228040000016
J	Entesarian, M; Matsson, H; Klar, J; Bergendal, B; Olson, L; Arakaki, R; Hayashi, Y; Ohuchi, H; Falahat, B; Bolstad, AI; Jonsson, R; Wahren-Herlenius, M; Dahl, N				Entesarian, M; Matsson, H; Klar, J; Bergendal, B; Olson, L; Arakaki, R; Hayashi, Y; Ohuchi, H; Falahat, B; Bolstad, AI; Jonsson, R; Wahren-Herlenius, M; Dahl, N			Mutations in the gene encoding fibroblast growth factor 10 are associated with aplasia of lacrimal and salivary glands	NATURE GENETICS			English	Article							FIBROBLAST GROWTH FACTOR-10; SJOGRENS-SYNDROME; MAJOR SALIVARY; FGF10; CLASSIFICATION; CRITERIA; IIIB; LIMB	Autosomal dominant aplasia of lacrimal and salivary glands (ALSG; OMIM 180920 and OMIM 103420) is a rare condition characterized by irritable eyes and dryness of the mouth. We mapped ALSG to 5p13. 2- 5q13. 1, which coincides with the gene fibroblast growth factor 10 (FGF10). In two extended pedigrees, we identified heterozygous mutations in FGF10 in all individuals with ALSG. Fgf10(+/-) mice have a phenotype similar to ALSG, providing a model for this disorder. We suggest that haploinsufficiency for FGF10 during a crucial stage of development results in ALSG.	Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, SE-75185 Uppsala, Sweden; Inst Postgrad Dent Educ, Natl Oral Disabil Ctr, SE-55111 Jonkoping, Sweden; Inst Postgrad Dent Educ, Dept Pediat Dent, SE-55111 Jonkoping, Sweden; Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 7708506, Japan; Univ Tokushima, Fac Engn, Dept Biol Sci & Technol, Tokushima 7708506, Japan; Inst Postgrad Dent Educ, Dept Maxillofacial Radiol, SE-55111 Jonkoping, Sweden; Univ Bergen, Fac Dent, Dept Odontol Periodont, N-5009 Bergen, Norway; Univ Bergen, Gade Inst, N-5021 Bergen, Norway; Karolinska Inst, Dept Med, SE-17176 Stockholm, Sweden	Uppsala University; Jonkoping University; Jonkoping University; Tokushima University; Tokushima University; Jonkoping University; University of Bergen; University of Bergen; Karolinska Institutet	Dahl, N (corresponding author), Uppsala Univ, Dept Genet & Pathol, Rudbeck Lab, SE-75185 Uppsala, Sweden.	niklas.dahl@genpat.uu.se	Klar, Joakim/H-2900-2019; Matsson, Hans/A-2502-2013; Matsson, Hans/A-5787-2019; Wahren-Herlenius, Marie/AAN-6942-2021	Klar, Joakim/0000-0003-4185-7409; Matsson, Hans/0000-0002-8193-4029; Matsson, Hans/0000-0001-6161-1559; Wahren-Herlenius, Marie/0000-0002-0915-7245				Bagai S, 2002, J BIOL CHEM, V277, P23828, DOI 10.1074/jbc.M201658200; Bolstad AI, 2002, ARTHRITIS RES, V4, P353, DOI 10.1186/ar599; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; Emoto H, 1997, J BIOL CHEM, V272, P23191, DOI 10.1074/jbc.272.37.23191; Ferreira APS, 2000, AM J MED GENET, V94, P32, DOI 10.1002/1096-8628(20000904)94:1<32::AID-AJMG7>3.0.CO;2-F; Makarenkova HP, 2000, DEVELOPMENT, V127, P2563; MILUNSKY JM, 1990, AM J MED GENET, V37, P371, DOI 10.1002/ajmg.1320370316; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; VITALI C, 1993, ARTHRITIS RHEUM, V36, P340, DOI 10.1002/art.1780360309; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wiedemann HR, 1997, AM J MED GENET, V68, P222, DOI 10.1002/(SICI)1096-8628(19970120)68:2<222::AID-AJMG20>3.0.CO;2-V; Yeh BK, 2003, P NATL ACAD SCI USA, V100, P2266, DOI 10.1073/pnas.0436500100; Young W, 2001, ORAL SURG ORAL MED O, V92, P38, DOI 10.1067/moe.2001.113549	15	117	121	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					125	127		10.1038/ng1507	http://dx.doi.org/10.1038/ng1507			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	15654336				2022-12-27	WOS:000226690100017
J	Roca, AL; Georgiadis, N; O'Brien, SJ				Roca, AL; Georgiadis, N; O'Brien, SJ			Cytonuclear genomic dissociation in African elephant species	NATURE GENETICS			English	Article							MITOCHONDRIAL; NUCLEAR	African forest and savanna elephants are distinct species separated by a hybrid zone(1-4). Because hybridization can affect the systematic and conservation status of populations, we examined gene flow between forest and savanna elephants at 21 African locations. We detected cytonuclear dissociation, indicative of different evolutionary histories for nuclear and mitochondrial genomes. Both paternally (n = 205 males) and biparentally (n = 2, 123 X-chromosome segments) inherited gene sequences indicated that there was deep genetic separation between forest and savanna elephants. Yet in some savanna locales distant from present-day forest habitats, many individuals with savanna-specific nuclear genotypes carried maternally transmitted forest elephant mitochondrial DNA. This extreme cytonuclear dissociation implies that there were ancient episodes of hybridization between forest females and savanna males, which are larger and reproductively dominant to forest or hybrid males(1,2,5-7). Recurrent backcrossing of female hybrids to savanna bulls replaced the forest nuclear genome. The persistence of residual forest elephant mitochondria in savanna elephant herds renders evolutionary interpretations based on mitochondrial DNA alone misleading and preserves a genomic record of ancient habitat changes.	SAIC Frederick, Basic Res Program, Lab Genom Divers, Frederick, MD 21702 USA; Mpala Res Ctr, Nanyuki, Kenya; NCI, Lab Genom Divers, Frederick, MD 21702 USA	Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	O'Brien, SJ (corresponding author), SAIC Frederick, Basic Res Program, Lab Genom Divers, Frederick, MD 21702 USA.	obrien@ncifcrf.gov	OBRIEN, STEPHEN/ABD-1346-2020	Roca, Alfred/0000-0001-9217-5593; OBRIEN, STEPHEN/0000-0001-7857-0757	NATIONAL CANCER INSTITUTE [ZIABC005367, Z01BC005367] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barriel V, 1999, CR ACAD SCI III-VIE, V322, P447, DOI 10.1016/S0764-4469(99)80093-6; Blanc J.J., 2003, AFRICAN ELEPHANT STA; Blaxter M, 2003, NATURE, V421, P122, DOI 10.1038/421122a; Comstock KE, 2002, MOL ECOL, V11, P2489, DOI 10.1046/j.1365-294X.2002.01615.x; Coyne J.A., 2004, SPECIATION; Debruyne R, 2004, CLADISTICS, V20, P80; Eggert LS, 2002, P ROY SOC B-BIOL SCI, V269, P1993, DOI 10.1098/rspb.2002.2070; GACKHAUS D, 1958, SAUGETIERK MITT, V6, P166; GEORGIADIS N, 1994, J HERED, V85, P100, DOI 10.1093/oxfordjournals.jhered.a111405; Groves Colin P., 2000, Elephant, V2, P4; Grubb Peter, 2000, Elephant, V2, P1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Maglio V.J., 1973, Transactions Am phil Soc, V63, P1, DOI 10.2307/1006229; Maley J, 1998, REV PALAEOBOT PALYNO, V99, P157, DOI 10.1016/S0034-6667(97)00047-X; Murphy WJ, 1999, GENOME RES, V9, P1223, DOI 10.1101/gr.9.12.1223; Nagao Y, 1998, GENES GENET SYST, V73, P21, DOI 10.1266/ggs.73.21; Nyakaana S, 1999, MOL ECOL, V8, P1105, DOI 10.1046/j.1365-294x.1999.00661.x; Nyakaana S, 2002, HEREDITY, V89, P90, DOI 10.1038/sj.hdy.6800110; Nyakaana S, 2001, ANIM CONSERV, V4, P231, DOI 10.1017/S1367943001001275; Poole JH, 1999, ANIM BEHAV, V58, P185, DOI 10.1006/anbe.1999.1117; Roca A. L., 2002, PACHYDERM, V33, P93; Roca AL, 2001, SCIENCE, V293, P1473, DOI 10.1126/science.1059936; Rohwer S, 2001, EVOLUTION, V55, P405; Shaw PA, 1997, S AFR J SCI, V93, P273; Silver Lee M., 1995; Slotow R, 2000, NATURE, V408, P425, DOI 10.1038/35044191; Sukumar R., 2003, LIVING ELEPHANTS EVO; Thompson L. G., 2002, Science, V298, P589, DOI 10.1126/science.1073198; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; White F., 1983, VEGETATION AFRICA DE, P356	30	170	177	1	43	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2005	37	1					96	100		10.1038/ng1485	http://dx.doi.org/10.1038/ng1485			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15592471				2022-12-27	WOS:000225997500027
J	Churchill, G; Airey, DC; Allayee, H; Angel, JM; Attie, AD; Beatty, J; Beavis, WD; Belknap, JK; Bennett, B; Berrettini, W; Bleich, A; Bogue, M; Broman, KW; Buck, KJ; Buckler, E; Burmeister, M; Chesler, EJ; Cheverud, JM; Clapcote, S; Cook, MN; Cox, RD; Crabbe, JC; Crusio, WE; Darvasi, A; Deschnepper, CF; Doerge, RW; Farber, CR; Forejt, J; Gaile, D; Garlow, SJ; Geiger, H; Gershenfeld, H; Gordon, T; Gu, J; Gu, WK; de Haan, G; Hayes, NL; Heller, C; Himmelbauer, H; Hitzemann, R; Hunter, K; Hsu, HC; Iraqi, FA; Ivandic, B; Jacob, HJ; Jansen, RC; Jjepsen, KJ; Johnson, DK; Johnson, TE; Kempermann, G; Kendziorski, C; Kotb, M; Kooy, RF; Llamas, B; Lammert, F; Lassalle, JM; Lowenstein, PR; Lu, L; Lusiss, A; Manly, KF; Marcucio, R; Matthews, D; Medrano, JF; Miller, DR; Mittleman, G; Mock, BA; Mogil, JS; Montagutelli, X; Morahan, G; Morris, DG; Mott, R; Nadeau, JH; Nagase, H; Nowakowski, RS; O'Hara, BF; Osadchuk, AV; Page, GP; Paigen, B; Paigen, K; Palmer, AA; Pan, HJ; Peltonen-Palotie, L; Peirce, J; Pomp, D; Pravenec, M; Prows, DR; Qi, ZH; Reeves, RH; Roder, J; Rosen, GD; Schadt, EE; Schalkwyk, LC; Seltzer, Z; Shimomura, K; Shou, SM; Sillanpaa, MJ; Siracusa, LD; Snoeck, HW; Spearow, JL; Svenson, K; Tarantino, LM; Threadgill, D; Toth, LA; Valdar, W; de Villena, FPM; Warden, C; Whatley, S; Williams, RW; Wiltshire, T; Yi, NJ; Zhang, DB; Zhang, M; Zou, F				Churchill, G; Airey, DC; Allayee, H; Angel, JM; Attie, AD; Beatty, J; Beavis, WD; Belknap, JK; Bennett, B; Berrettini, W; Bleich, A; Bogue, M; Broman, KW; Buck, KJ; Buckler, E; Burmeister, M; Chesler, EJ; Cheverud, JM; Clapcote, S; Cook, MN; Cox, RD; Crabbe, JC; Crusio, WE; Darvasi, A; Deschnepper, CF; Doerge, RW; Farber, CR; Forejt, J; Gaile, D; Garlow, SJ; Geiger, H; Gershenfeld, H; Gordon, T; Gu, J; Gu, WK; de Haan, G; Hayes, NL; Heller, C; Himmelbauer, H; Hitzemann, R; Hunter, K; Hsu, HC; Iraqi, FA; Ivandic, B; Jacob, HJ; Jansen, RC; Jjepsen, KJ; Johnson, DK; Johnson, TE; Kempermann, G; Kendziorski, C; Kotb, M; Kooy, RF; Llamas, B; Lammert, F; Lassalle, JM; Lowenstein, PR; Lu, L; Lusiss, A; Manly, KF; Marcucio, R; Matthews, D; Medrano, JF; Miller, DR; Mittleman, G; Mock, BA; Mogil, JS; Montagutelli, X; Morahan, G; Morris, DG; Mott, R; Nadeau, JH; Nagase, H; Nowakowski, RS; O'Hara, BF; Osadchuk, AV; Page, GP; Paigen, B; Paigen, K; Palmer, AA; Pan, HJ; Peltonen-Palotie, L; Peirce, J; Pomp, D; Pravenec, M; Prows, DR; Qi, ZH; Reeves, RH; Roder, J; Rosen, GD; Schadt, EE; Schalkwyk, LC; Seltzer, Z; Shimomura, K; Shou, SM; Sillanpaa, MJ; Siracusa, LD; Snoeck, HW; Spearow, JL; Svenson, K; Tarantino, LM; Threadgill, D; Toth, LA; Valdar, W; de Villena, FPM; Warden, C; Whatley, S; Williams, RW; Wiltshire, T; Yi, NJ; Zhang, DB; Zhang, M; Zou, F		Complex Trait Consortium	The Collaborative Cross, a community resource for the genetic analysis of complex traits	NATURE GENETICS			English	Article							ENVIRONMENT; STRAINS; MICE	The goal of the Complex Trait Consortium is to promote the development of resources that can be used to understand, treat and ultimately prevent pervasive human diseases. Existing and proposed mouse resources that are optimized to study the actions of isolated genetic loci on a fixed background are less effective for studying intact polygenic networks and interactions among genes, environments, pathogens and other factors. The Collaborative Cross will provide a common reference panel specifically designed for the integrative analysis of complex systems and will change the way we approach human health and disease.	Jackson Lab, Bar Harbor, ME 04609 USA; Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; Univ So Calif, Keck Sch Med, Los Angeles, CA USA; Univ Texas, MD Anderson Canc Ctr, Sci Pk Res Div, Smithville, TX USA; Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; Natl Ctr Genome Resources, Santa Fe, NM USA; Oregon Hlth & Sci Univ, Vet Affairs Med Ctr, Portland, OR 97201 USA; Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Hannover Med Sch, Inst Lab Anim Sci & Cent Anim Facil, D-3000 Hannover, Germany; Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; Vet Affairs Med Ctr, Dept Behav Neurosci, Portland, OR USA; Cornell Univ, Inst Genom Divers, Ithaca, NY USA; Univ Michigan, Mental Hlth Res Inst, Ann Arbor, MI USA; Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; Univ Memphis, Dept Psychol, Memphis, TN 38152 USA; QTL & Modifier Loci Grp, MRC Mammalian Genet Unit, Harwell, Oxon, England; Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Worcester, MA USA; Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Evolut Systemat & Ecol, IL-91905 Jerusalem, Israel; Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; Purdue Univ, Dept Stat, W Lafayette, IN 47907 USA; Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; ASCR, Inst Genet Mol, Videnska, Czech Republic; SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Biostat, Buffalo, NY 14260 USA; Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; Univ Cincinnati, Med Ctr, Div Expt Hematol, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45267 USA; Univ Texas SW, Dallas, TX USA; NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA; Univ Tennessee, Ctr Hlth Sci, Dept Orthopaed Surg Campbell Clin, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Ctr Genom & Bioinformat, Dept Pathol, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Ctr Dis Connect Tissues, Memphis, TN 38163 USA; Univ Groningen, Dept Stem Cell Biol, NL-9700 AB Groningen, Netherlands; Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; Stanford Univ, Stanford, CA 94305 USA; Max Planck Inst Mol Genet, Berlin, Germany; NIH, Bethesda, MD 20892 USA; Univ Alabama Birmingham, Clin Immunol & Rheumatol, Birmingham, AL USA; Int Livestock Res Inst, Nairobi, Kenya; Heidelberg Univ, Dept Med 3, Heidelberg, Germany; Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; Groningen Bioinformat Ctr, Inst Math & Comp Sci, Groningen, Netherlands; Mt Sinai Sch Med, Dept Orthopaed, New York, NY USA; Oak Ridge Natl Lab, Div Life Sci, Mammalian Genet Grp, Oak Ridge, TN USA; Charite Univ Med Berlin, Max Delbruck Ctr Mol Med, Dept Expt Neurol, Berlin, Germany; Univ Wisconsin, Med Sci Ctr, Dept Biostat & Med Informat, Madison, WI USA; Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA; Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA; Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; Univ Aachen, Univ Hosp Aachen, Dept Med 3, Aachen, Germany; Univ Toulouse 3, Ctr Rech Cognit Anim, F-31062 Toulouse, France; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90024 USA; Cedars Sinai Med Ctr, Gene Therapeut Res Inst, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Ctr Hlth Sci, Dept Med, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Ctr Hlth Sci, Dept MIMG, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Ctr Hlth Sci, Dept Human Genet, Los Angeles, CA 90024 USA; Univ Calif San Francisco, San Francisco Gen Hosp, Dept Orthopaed Surg, San Francisco, CA USA; NCI, CCR, NIH, Bethesda, MD 20892 USA; McGill Univ, Dept Psychol, Montreal, PQ, Canada; McGill Univ, Ctr Res Pain, Montreal, PQ, Canada; Inst Pasteur, Unite Genet Mammiferes, Paris, France; Western Australian Inst Med Res, Ctr Diabet Res, Perth, WA, Australia; Yale Univ, Sch Med Pulm & Crit Care Med, New Haven, CT USA; Wellcome Trust Ctr Human Genet, Oxford, England; Case Western Reserve Univ, Cleveland, OH 44106 USA; Roswell Pk Canc Inst, Buffalo, NY 14263 USA; Univ Kentucky, Lexington, KY USA; Russian Acad Sci, Inst Cytol & Genet, Novosibirsk 630090, Russia; Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; Columbia Genome Ctr, New York, NY USA; Univ Helsinki, Dept Med Genet, Natl Publ Hlth Inst, Biomedicum Helsinki,Dept Mol Med, FIN-00014 Helsinki, Finland; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA; Univ Nebraska, Dept Anim Sci, Lincoln, NE USA; Acad Sci Czech Republ, Inst Physiol, Prague, Czech Republic; Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH USA; Univ Cincinnati, Coll Med, Cincinnati, OH USA; Vanderbilt Univ, Med Ctr, Div Nephrol, Nashville, TN USA; Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; McKusick Nathans Inst Genet Med, Baltimore, MD USA; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON, Canada; Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; Rosetta Inpharmat LLC Merck & Co, Res Genet, Seattle, WA USA; Inst Psychiat, SGDP Ctr, London, England; Univ Toronto, Ctr Study Pain, Pain Genet & Phenom Res Unit, Toronto, ON, Canada; Program Neurosci, Toronto, ON, Canada; Northwestern Univ, Ctr Funct Genom, Evanston, IL USA; Shriners Hosp Crippled Children, Res Ctr, Portland, OR USA; Univ Helsinki, Rolf Nevanlinna Inst, Dept Math & Stat, FIN-00014 Helsinki, Finland; Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; Mt Sinai Sch Med, Dept Cell & Gene Med, New York, NY USA; Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; Novartis Res Fdn, Genom Inst, San Diego, CA USA; Univ N Carolina, Dept Genet, Chapel Hill, NC USA; So Illinois Univ, Sch Med, Springfield, IL USA; KCL Inst Psychiat, Dept Neurosci, London, England; Univ Rochester, Med Ctr, Rochester, NY 14642 USA; Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; Univ N Carolina, Sch Publ Hlth, Dept Biostat, Chapel Hill, NC USA	Jackson Laboratory; Vanderbilt University; University of Southern California; University of Texas System; UTMD Anderson Cancer Center; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Los Angeles; National Center for Genome Resources (NCGR); Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Colorado System; University of Colorado Boulder; University of Pennsylvania; Hannover Medical School; Johns Hopkins University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cornell University; University of Michigan System; University of Michigan; University of Tennessee System; University of Tennessee Health Science Center; Washington University (WUSTL); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Memphis; MRC Harwell; University of Massachusetts System; University of Massachusetts Worcester; Hebrew University of Jerusalem; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Davis; Czech Academy of Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Emory University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Texas System; University of Texas Southwestern Medical Center Dallas; New York University; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Groningen; Rutgers State University New Brunswick; Rutgers State University Medical Center; Stanford University; Max Planck Society; National Institutes of Health (NIH) - USA; University of Alabama System; University of Alabama Birmingham; CGIAR; International Livestock Research Institute (ILRI); Ruprecht Karls University Heidelberg; Medical College of Wisconsin; University of Groningen; Icahn School of Medicine at Mount Sinai; United States Department of Energy (DOE); Oak Ridge National Laboratory; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wisconsin System; University of Wisconsin Madison; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Antwerp; RWTH Aachen University; RWTH Aachen University Hospital; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); McGill University; McGill University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Western Australia; Yale University; University of Oxford; Wellcome Centre for Human Genetics; Case Western Reserve University; Roswell Park Cancer Institute; University of Kentucky; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; University of Alabama System; University of Alabama Birmingham; Columbia University; Finland National Institute for Health & Welfare; University of Helsinki; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Nebraska System; University of Nebraska Lincoln; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Vanderbilt University; Johns Hopkins University; University of Toronto; Harvard University; Beth Israel Deaconess Medical Center; Merck & Company; University of London; King's College London; University of Toronto; Northwestern University; University of Helsinki; Jefferson University; Icahn School of Medicine at Mount Sinai; University of California System; University of California Davis; Novartis; University of North Carolina; University of North Carolina Chapel Hill; Southern Illinois University System; Southern Illinois University; University of London; King's College London; University of Rochester; Cornell University; University of North Carolina; University of North Carolina Chapel Hill	Churchill, G (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	garyc@jax.org	Forejt, Jiri/AAF-5276-2019; Llamas, Bastien/Y-2781-2018; de Haan, Gerald/AAF-8963-2019; Chesler, Elissa/K-4641-2019; Gershenfeld, Howard K/HGF-0536-2022; Spearow, Jimmy/AAL-2798-2020; Crusio, Wim/ABD-5214-2021; Roder, John/G-6468-2013; Jansen, Ritsert C/C-1160-2013; Matthews, Douglas/F-6867-2012; Schalkwyk, Leonard C/A-2150-2010; Threadgill, David W/N-4425-2013; Mogil, Jeffrey/AAA-9611-2019; Crusio, Wim/A-7070-2008; Crusio, Wim/ABE-1287-2021; Forejt, Jiri/G-7719-2012; Mock, Beverly A/B-3110-2015; Kooy, Frank/F-5276-2014; de Haan, Gerald/D-2081-2015; Churchill, Gary/AAY-7496-2020; Morahan, Grant/T-7501-2019; Buckler, Edward/L-7651-2019; Pravenec, Michal/B-1666-2012; Buckler, Edward/GPS-4932-2022; Palmer, Abraham/L-2158-2014; Llamas, Bastien/AAK-1693-2021; Kempermann, Gerd/F-5416-2010; Burmeister, Margit/A-3157-2013; Nowakowski, Richard/C-3217-2016; Valdar, William/AAE-4354-2019; Deschepper, Christian/J-4783-2015; Williams, Robert W./H-8789-2016	Forejt, Jiri/0000-0002-2793-3623; Llamas, Bastien/0000-0002-5550-9176; de Haan, Gerald/0000-0001-9706-0138; Chesler, Elissa/0000-0002-5642-5062; Crusio, Wim/0000-0001-6638-202X; Jansen, Ritsert C/0000-0003-2977-9110; Schalkwyk, Leonard C/0000-0001-7030-5756; Threadgill, David W/0000-0003-3538-1635; Mogil, Jeffrey/0000-0003-1359-5720; Crusio, Wim/0000-0001-6638-202X; Forejt, Jiri/0000-0002-2793-3623; Mock, Beverly A/0000-0003-2479-4549; Kooy, Frank/0000-0003-2024-0485; de Haan, Gerald/0000-0001-9706-0138; Churchill, Gary/0000-0001-9190-9284; Buckler, Edward/0000-0002-3100-371X; Pravenec, Michal/0000-0001-9197-5871; Palmer, Abraham/0000-0003-3634-0747; Llamas, Bastien/0000-0002-5550-9176; Kempermann, Gerd/0000-0002-5304-4061; Burmeister, Margit/0000-0002-1914-2434; Deschepper, Christian/0000-0001-6234-4667; Williams, Robert W./0000-0001-8924-4447; Rosen, Glenn/0000-0001-8281-5446; Broman, Karl/0000-0002-4914-6671; Gershenfeld, Howard/0000-0002-4107-1513; Nowakowski, Richard/0000-0002-5006-3670; Cox, Roger/0000-0001-7170-5014; Farber, Charles/0000-0002-6748-4711; Page, Grier/0000-0003-2582-3786; Mott, Richard/0000-0002-1022-9330; /0000-0001-7147-8237; Sillanpaa, Mikko J./0000-0003-2808-2768; Marcucio, Ralph/0000-0002-0537-818X; Himmelbauer, Heinz/0000-0001-8897-2928	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073760] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P60AA010760] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL073760] Funding Source: Medline; NIAAA NIH HHS [P60 AA010760] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Belknap JK, 1998, BEHAV GENET, V28, P29, DOI 10.1023/A:1021404714631; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chesler EJ, 2003, NEUROINFORMATICS, V1, P343, DOI 10.1385/NI:1:4:343; CLARK AG, 1999, LIMITS KNOWLEDGE EVO; Gibson G, 2002, GENET RES, V80, P1, DOI 10.1017/S0016672302005839; Hartwell L, 2004, SCIENCE, V303, P774, DOI 10.1126/science.1094731; Jansen RC, 2003, NAT REV GENET, V4, P145, DOI 10.1038/nrg996; JANSEN RC, 1995, THEOR APPL GENET, V91, P33, DOI 10.1007/BF00220855; JIN C, IN PRESS GENETICS; Nadeau JH, 2003, GENOME RES, V13, P2082, DOI 10.1101/gr.1186603; Reifsnyder PC, 2000, GENOME RES, V10, P1568, DOI 10.1101/gr.147000; Shimomura K, 2001, GENOME RES, V11, P959, DOI 10.1101/gr.171601; SILLANPAA MJ, IN PRESS ANN HUM GEN; Threadgill DW, 2002, MAMM GENOME, V13, P175, DOI 10.1007/s00335-001-4001-Y; Williams SM, 2004, BIOESSAYS, V26, P170, DOI 10.1002/bies.10401; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867	16	736	755	1	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1133	1137		10.1038/ng1104-1133	http://dx.doi.org/10.1038/ng1104-1133			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15514660	Bronze			2022-12-27	WOS:000224832800005
J	Noma, K; Sugiyama, T; Cam, H; Verdel, A; Zofall, M; Jia, ST; Moazed, D; Grewal, SIS				Noma, K; Sugiyama, T; Cam, H; Verdel, A; Zofall, M; Jia, ST; Moazed, D; Grewal, SIS			RITS acts in cis to promote RNA interference-mediated transcriptional and post-transcriptional silencing	NATURE GENETICS			English	Article							FISSION YEAST CENTROMERES; HISTONE H3 METHYLATION; EPIGENETIC CONTROL; HETEROCHROMATIN DOMAIN; LYSINE-9 METHYLATION; DROSOPHILA; DNA; PLANTS; RECOGNITION; PATHWAYS	RNA interference is a conserved mechanism by which double-stranded RNA is processed into short interfering RNAs (siRNAs) that can trigger both post-transcriptional and transcriptional gene silencing. In fission yeast, the RNA-induced initiation of transcriptional gene silencing (RITS) complex contains Dicer-generated siRNAs and is required for heterochromatic silencing. Here we show that BITS components, including Argonaute protein, bind to all known heterochromatic loci. At the mating-type region, BITS is recruited to the centromere-homologous repeat cenH in a Dicer-dependent manner, whereas the spreading of BITS across the entire 20-kb silenced domain, as well as its subsequent maintenance, requires heterochromatin machinery including Swi6 and occurs even in the absence of Dicer. Furthermore, our analyses suggest that RNA interference machinery operates in cis as a stable component of heterochromatic domains with BITS tethered to silenced loci by methylation of histone H3 at Lys9. This tethering promotes the processing of transcripts and generation of additional siRNAs for heterochromatin maintenance.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School	Grewal, SIS (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov	Verdel, André/M-5201-2013	VERDEL, Andre/0000-0001-6048-3794; Sugiyama, Tomoyasu/0000-0001-5704-6606	NATIONAL CANCER INSTITUTE [ZIABC010523, Z01BC010523] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Grewal SIS, 1997, GENETICS, V146, P1221; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hall Ira M., 2003, P205; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hsieh J, 2000, ANNU REV GENET, V34, P187, DOI 10.1146/annurev.genet.34.1.187; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nakayama J, 2001, EMBO J, V20, P2857, DOI 10.1093/emboj/20.11.2857; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Provost P, 2002, P NATL ACAD SCI USA, V99, P16648, DOI 10.1073/pnas.212633199; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Selker EU, 2003, NATURE, V422, P893, DOI 10.1038/nature01564; STEINER NC, 1994, CELL, V79, P865, DOI 10.1016/0092-8674(94)90075-2; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	35	305	319	0	8	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2004	36	11					1174	1180		10.1038/ng1452	http://dx.doi.org/10.1038/ng1452			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15475954	Bronze			2022-12-27	WOS:000224832800020
J	Wright, AF; Jacobson, SG; Cideciyan, AV; Roman, AJ; Shu, XH; Vlachantoni, D; McInnes, RR; Riemersma, RA				Wright, AF; Jacobson, SG; Cideciyan, AV; Roman, AJ; Shu, XH; Vlachantoni, D; McInnes, RR; Riemersma, RA			Lifespan and mitochondrial control of neurodegeneration	NATURE GENETICS			English	Article							HYDROGEN-PEROXIDE PRODUCTION; FREE-RADICAL PRODUCTION; ONE-HIT MODEL; CELL-DEATH; OXIDATIVE STRESS; SUPEROXIDE; APOPTOSIS; MECHANISMS; LONGEVITY; MEMBRANES	We examine the allometric (comparative scaling) relationships between rates of neurodegeneration resulting from equivalent mutations in a diverse group of genes from five mammalian species with different maximum lifespan potentials. In both retina and brain, rates of neurodegeneration vary by as much as two orders of magnitude and are strongly correlated with maximum lifespan potential and rates of formation of mitochondrial reactive oxygen and nitrogen species (RONS). Cell death in these disorders is directly or indirectly regulated by the intrinsic mitochondrial cell death pathway. Mitochondria are the main source of RONS production and integrate cellular stress signals to coordinate the intrinsic pathway. We propose that these two functions are intimately related and that steady-state RONS-mediated signaling or damage to the mitochondrial stress-integration machinery is the principal factor setting the probability of cell death in response to a diverse range of cellular stressors. This provides a new and unifying framework for investigating neurodegenerative disorders.	Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA; Hosp Sick Children, Program Genet & Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Pediat, Toronto, ON, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Univ Edinburgh, Dept Biochem, Cardiovasc Res Unit, Edinburgh EH8 9YL, Midlothian, Scotland; Univ Tromso, Dept Med Physiol, N-9001 Tromso, Norway	University of Edinburgh; University of Pennsylvania; Pennsylvania Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Edinburgh; UiT The Arctic University of Tromso	Wright, AF (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	alan.wright@hgu.mrc.ac.uk	Cideciyan, Artur V/A-1075-2007	Cideciyan, Artur V/0000-0002-2018-0905; Jacobson, Samuel/0000-0003-2122-169X				Abraham MC, 2004, TRENDS CELL BIOL, V14, P184, DOI 10.1016/j.tcb.2004.03.002; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Antebi A, 2004, DEV CELL, V6, P315, DOI 10.1016/S1534-5807(04)00068-1; Barja G, 1998, ANN NY ACAD SCI, V854, P224, DOI 10.1111/j.1749-6632.1998.tb09905.x; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P7103, DOI 10.1073/pnas.95.12.7103; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; Clarke G, 2001, HUM MOL GENET, V10, P2269, DOI 10.1093/hmg/10.20.2269; Comfort A., 1979, BIOL SENESCENCE; Daiger Stephen P, 2004, Novartis Found Symp, V255, P17; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dunnett SB, 1999, NATURE, V399, pA32, DOI 10.1038/399a032; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Gal A, 1997, PROG RETIN EYE RES, V16, P51, DOI 10.1016/S1350-9462(96)00021-3; Hafezi F, 2000, BRIT J OPHTHALMOL, V84, P922, DOI 10.1136/bjo.84.8.922; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Hulbert AJ, 1999, J THEOR BIOL, V199, P257, DOI 10.1006/jtbi.1999.0955; Hulbert AJ, 2000, ANNU REV PHYSIOL, V62, P207, DOI 10.1146/annurev.physiol.62.1.207; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Katz, 1972, BIOL DATA BOOK; KU HH, 1993, MECH AGEING DEV, V72, P67, DOI 10.1016/0047-6374(93)90132-B; KU HH, 1993, FREE RADICAL BIO MED, V15, P621, DOI 10.1016/0891-5849(93)90165-Q; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Nijhawan D, 2000, ANNU REV NEUROSCI, V23, P73, DOI 10.1146/annurev.neuro.23.1.73; OLSHANSKY SJ, 1990, SCIENCE, V250, P634, DOI 10.1126/science.2237414; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Pacione LR, 2003, ANNU REV NEUROSCI, V26, P657, DOI 10.1146/annurev.neuro.26.041002.131416; PAMPLONA R, 2002, ANN NY ACAD SCI, V959, P476; Partridge L, 1997, BETWEEN ZEUS AND THE SALMON, P78; Perez-Campo R, 1998, J COMP PHYSIOL B, V168, P149, DOI 10.1007/s003600050131; Porter RK, 1996, AM J PHYSIOL-REG I, V271, pR1550, DOI 10.1152/ajpregu.1996.271.6.R1550; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Reme CE, 1998, PROG RETIN EYE RES, V17, P443, DOI 10.1016/S1350-9462(98)00009-3; Sampayo JN, 2003, BIOCHEM SOC T, V31, P1305; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Shiva S, 2004, BIOCHEM SOC SYMP, V71, P107; SOHAL RS, 1990, MECH AGEING DEV, V53, P209, DOI 10.1016/0047-6374(90)90039-I; SOHAL RS, 1989, MECH AGEING DEV, V49, P129, DOI 10.1016/0047-6374(89)90096-1; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Turmaine M, 2000, P NATL ACAD SCI USA, V97, P8093, DOI 10.1073/pnas.110078997; Turner N, 2003, NATURWISSENSCHAFTEN, V90, P521, DOI 10.1007/s00114-003-0470-z; Wolf BB, 2002, CURR BIOL, V12, pR177, DOI 10.1016/S0960-9822(02)00736-4; Yu L, 2004, CELL CYCLE, V3, P1124	50	84	92	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1153	1158		10.1038/ng1448	http://dx.doi.org/10.1038/ng1448			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15514669	Bronze			2022-12-27	WOS:000224832800016
J	Yalcin, B; Willis-Owen, SAG; Fullerton, J; Meesaq, A; Deacon, RM; Rawlins, JNP; Copley, RR; Morris, AP; Flint, J; Mott, R				Yalcin, B; Willis-Owen, SAG; Fullerton, J; Meesaq, A; Deacon, RM; Rawlins, JNP; Copley, RR; Morris, AP; Flint, J; Mott, R			Genetic dissection of a behavioral quantitative trait locus shows that Rgs2 modulates anxiety in mice	NATURE GENETICS			English	Article							RUNX1 BINDING-SITE; HAPLOTYPE RECONSTRUCTION; INBRED STRAINS; BRISTLE NUMBER; QTL ANALYSIS; SUSCEPTIBILITY; POLYMORPHISMS; ARCHITECTURE; REGULATOR; CANCER	Here we present a strategy to determine the genetic basis of variance in complex phenotypes that arise from natural, as opposed to induced, genetic variation in mice. We show that a commercially available strain of outbred mice, MF1, can be treated as an ultrafine mosaic of standard inbred strains and accordingly used to dissect a known quantitative trait locus influencing anxiety. We also show that this locus can be subdivided into three regions, one of which contains Rgs2, which encodes a regulator of G protein signaling. We then use quantitative complementation to show that Rgs2 is a quantitative trait gene. This combined genetic and functional approach should be applicable to the analysis of any quantitative trait.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Flint, J (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	jf@well.ox.ac.uk; rmott@well.ox.ac.uk	Fullerton, Janice/F-8485-2013; Yalcin, Binnaz/ABB-7735-2020; Yalcin, Binnaz/P-5482-2016	Fullerton, Janice/0000-0003-4014-4490; Yalcin, Binnaz/0000-0002-1924-6807; Yalcin, Binnaz/0000-0002-1924-6807; Flint, Jonathan/0000-0002-9427-4429; Mott, Richard/0000-0002-1022-9330; Willis-Owen, Saffron/0000-0003-2633-1150				Aitman TJ, 1997, NAT GENET, V16, P197, DOI 10.1038/ng0697-197; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Contet C, 2001, BEHAV BRAIN RES, V124, P33, DOI 10.1016/S0166-4328(01)00231-5; De Luca M, 2003, NAT GENET, V34, P429, DOI 10.1038/ng1218; Dong MQ, 2000, GENE DEV, V14, P2003; Fijneman RJA, 1996, NAT GENET, V14, P465, DOI 10.1038/ng1296-465; Flint J, 2004, MAMM GENOME, V15, P77, DOI 10.1007/s00335-003-3033-x; Flint J, 2003, J NEUROBIOL, V54, P46, DOI 10.1002/neu.10161; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Gershenfeld HK, 1997, GENOMICS, V46, P1, DOI 10.1006/geno.1997.5002; Grafstein-Dunn E, 2001, MOL BRAIN RES, V88, P113, DOI 10.1016/S0169-328X(01)00038-9; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Henderson ND, 2004, BEHAV GENET, V34, P267, DOI 10.1023/B:BEGE.0000017872.25069.44; Heximer SP, 2003, J CLIN INVEST, V111, P445, DOI 10.1172/JC1200315598; HIGGS DR, 1990, GENE DEV, V4, P1588, DOI 10.1101/gad.4.9.1588; Hitzemann R, 2002, GENES BRAIN BEHAV, V1, P214, DOI 10.1034/j.1601-183X.2002.10403.x; Huang ZP, 2003, REPRODUCTION, V126, P309, DOI 10.1530/rep.0.1260309; LAI CG, 1994, SCIENCE, V266, P1697, DOI 10.1126/science.7992053; Legare ME, 2000, GENOME RES, V10, P42; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Long AD, 1996, GENETICS, V144, P1497; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; MCCLEARN G. E., 1970, Contributions to behavior-genetic analysis., P3; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; PLOMIN R, 1991, BEHAV GENET, V21, P99, DOI 10.1007/BF01066330; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tafti M, 2003, NAT GENET, V34, P320, DOI 10.1038/ng1174; Talbot CJ, 2003, MAMM GENOME, V14, P223, DOI 10.1007/s00335-002-3059-5; Talbot CJ, 1999, NAT GENET, V21, P305, DOI 10.1038/6825; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Turri MG, 2004, MAMM GENOME, V15, P69, DOI [10.1007/S00335-003-3032-y, 10.1007/s00335-003-3032-y]; Turri MG, 2001, GENETICS, V158, P1217; Turri MG, 2001, CURR BIOL, V11, P725, DOI 10.1016/S0960-9822(01)00206-8; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; van Wezel T, 1999, CANCER RES, V59, P4216; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wandstrat A, 2001, NAT IMMUNOL, V2, P802, DOI 10.1038/ni0901-802; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100; Yalcin B, 2004, P NATL ACAD SCI USA, V101, P9734, DOI 10.1073/pnas.0401189101; Zhang YM, 2003, NAT GENET, V34, P181, DOI 10.1038/ng1166	48	232	236	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1197	1202		10.1038/ng1450	http://dx.doi.org/10.1038/ng1450			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15489855	Bronze			2022-12-27	WOS:000224832800023
J	Janssens, H; Hou, SL; Jaeger, J; Kim, AR; Myasnikova, E; Sharp, D; Reinitz, J				Janssens, Hilde; Hou, Shuling; Jaeger, Johannes; Kim, Ah-Ram; Myasnikova, Ekaterina; Sharp, David; Reinitz, John			Quantitative and predictive model of transcriptional control of the Drosophila melanogaster even skipped gene	NATURE GENETICS			English	Article							SEGMENTATION GENES; EXPRESSION; STRIPE; DNA; ENHANCERS; PATTERNS; PROTEIN; REQUIREMENT; GRADIENTS; ELEMENTS	Here we present a quantitative and predictive model of the transcriptional readout of the proximal 1.7 kb of the control region of the Drosophila melanogaster gene even skipped ( eve). The model is based on the positions and sequence of individual binding sites on the DNA and quantitative, time-resolved expression data at cellular resolution. These data demonstrated new expression features, first reported here. The model correctly predicts the expression patterns of mutations in trans, as well as point mutations, insertions and deletions in cis. It also shows that the nonclassical expression of stripe 7 driven by this fragment is activated by the protein Caudal (Cad), and repressed by the proteins Tailless (TII) and Giant (Gt).	SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA; Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA; St Petersburg State Polytech Univ, Ctr Adv Studies, Dept Computat Biol, St Petersburg 195251, Russia; Los Alamos Natl Lab, Chief Sci Off, Los Alamos, NM 87545 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; United States Department of Energy (DOE); Los Alamos National Laboratory; Peter the Great St. Petersburg Polytechnic University; United States Department of Energy (DOE); Los Alamos National Laboratory	Reinitz, J (corresponding author), SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA.	reinitz@odd.bio.sunysb.edu	Myasnikova, Ekaterina/I-2711-2017	Jaeger, Johannes/0000-0002-2568-2103; Kim, Ah-Ram/0000-0002-7860-9137	NCRR NIH HHS [2 R01 RR07801, R01 RR007801] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR007801] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Arnosti DN, 1996, DEVELOPMENT, V122, P205; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Berman BP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r61; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; CAPOVILLA M, 1992, DEVELOPMENT, V114, P99; Clyde DE, 2003, NATURE, V426, P849, DOI 10.1038/nature02189; EISNER J, 1996, SINGULAR SPECTRUM AN; Fujioka M, 1995, DEVELOPMENT, V121, P4371; GOTO T, 1989, CELL, V57, P413, DOI 10.1016/0092-8674(89)90916-1; GRAY S, 1994, GENE DEV, V8, P1829, DOI 10.1101/gad.8.15.1829; HARDING K, 1989, EMBO J, V8, P1205, DOI 10.1002/j.1460-2075.1989.tb03493.x; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hughes SC, 1999, METH MOL B, V122, P93; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Janssens H, 2005, DEV GENES EVOL, V215, P374, DOI 10.1007/s00427-005-0484-y; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; Lam J, 1988, 8816 YAL EL ENG DEP; Lam J, 1988, 8817 YAL EL ENG DEP; Ludwig MZ, 2005, PLOS BIOL, V3, P588, DOI 10.1371/journal.pbio.0030093; Myasnikova E, 2005, DEV GENES EVOL, V215, P320, DOI 10.1007/s00427-005-0472-2; Myasnikova E, 2001, BIOINFORMATICS, V17, P3, DOI 10.1093/bioinformatics/17.1.3; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; PANKRATZ MJ, 1989, NATURE, V341, P337, DOI 10.1038/341337a0; Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30; REINITZ J, 1995, MECH DEVELOP, V49, P133, DOI 10.1016/0925-4773(94)00310-J; Reinitz John, 2003, ComPlexUs, V1, P54, DOI 10.1159/000070462; ROTHE M, 1994, MECH DEVELOP, V46, P169, DOI 10.1016/0925-4773(94)90069-8; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; SMALL S, 1993, DEVELOPMENT, V119, P767; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; Small S, 1996, DEV BIOL, V175, P314, DOI 10.1006/dbio.1996.0117; STANOJEVIC D, 1989, NATURE, V341, P331, DOI 10.1038/341331a0; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; STEINGRIMSSON E, 1991, SCIENCE, V254, P418, DOI 10.1126/science.1925599; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Wu XL, 2001, DEV BIOL, V237, P79, DOI 10.1006/dbio.2001.0355; Yuh CH, 2001, DEVELOPMENT, V128, P617	38	152	156	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1159	1165		10.1038/ng1886	http://dx.doi.org/10.1038/ng1886			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16980977				2022-12-27	WOS:000241251100015
J	Krutzfeldt, J; Poy, MN; Stoffel, M				Kruetzfeldt, Jan; Poy, Matthew N.; Stoffel, Markus			Strategies to determine the biological function of microRNAs	NATURE GENETICS			English	Article							HUMAN LUNG CANCERS; SMALL RNAS; IN-VIVO; GENE; EXPRESSION; IDENTIFICATION; MIRNAS; DICER; LET-7; MORPHOGENESIS	MicroRNAs (miRNAs) are regulators of gene expression that control many biological processes in development, differentiation, growth and metabolism. Their expression levels, small size, abundance of repetitive copies in the genome and mode of action pose unique challenges in studies elucidating the function of miRNAs. New technologies for identification, expression profiling and target gene validation, as well as manipulation of miRNA expression in vivo, will facilitate the study of their contribution to biological processes and disease. Such information will be crucial to exploit the emerging knowledge of miRNAs for the development of new human therapeutic applications.	[Kruetzfeldt, Jan; Poy, Matthew N.; Stoffel, Markus] Rockefeller Univ, Lab Metab Dis, New York, NY 10021 USA	Rockefeller University	Krutzfeldt, J (corresponding author), Rockefeller Univ, Lab Metab Dis, 1230 York Ave, New York, NY 10021 USA.	stoffel@rockefeller.edu	Poy, Matthew/F-6914-2017	Poy, Matthew/0000-0002-4904-2426; Stoffel, Markus/0000-0003-1304-5817				Ambros Victor, 2004, Methods Mol Biol, V265, P131; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; HAYASHITA Y, 2005, CANCER RES, V65, P9628, DOI [DOI 10.1158/0008-5472.CAN-05-2352, 10.1158/0008-5472.CAN-05-2352]; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Johnson SM, 2003, DEV BIOL, V259, P364, DOI 10.1016/S0012-1606(03)00202-1; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Michael MZ, 2003, MOL CANCER RES, V1, P882; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Ying SY, 2005, BIOCHEM BIOPH RES CO, V335, P1, DOI 10.1016/j.bbrc.2005.06.130; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	64	195	222	0	15	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38			6			S14	S19		10.1038/ng1799	http://dx.doi.org/10.1038/ng1799			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V44DK	16736018				2022-12-27	WOS:000202983200004
J	Valente, EM; Silhavy, JL; Brancati, F; Barrano, G; Krishnaswami, SR; Castori, M; Lancaster, MA; Boltshauser, E; Boccone, L; Al-Gazali, L; Fazzi, E; Signorini, S; Louie, CM; Bellacchio, E; Bertini, E; Dallapiccola, B; Gleeson, JG				Valente, Enza Maria; Silhavy, Jennifer L.; Brancati, Francesco; Barrano, Giuseppe; Krishnaswami, Suguna Rani; Castori, Marco; Lancaster, Madeline A.; Boltshauser, Eugen; Boccone, Loredana; Al-Gazali, Lihadh; Fazzi, Elisa; Signorini, Sabrina; Louie, Carrie M.; Bellacchio, Emanuele; Bertini, Enrico; Dallapiccola, Bruno; Gleeson, Joseph G.		JSRD Study Grp	Mutations in CEP290, which encodes a centrosomal protein, cause pleiotropic forms of Joubert syndrome	NATURE GENETICS			English	Article							ABNORMAL EYE-MOVEMENTS; EPISODIC HYPERPNEA; CEREBELLAR VERMIS; RETARDATION; DISORDERS; DISEASE; ATAXIA	Joubert syndrome-related disorders (JSRD) are a group of syndromes sharing the neuroradiological features of cerebellar vermis hypoplasia and a peculiar brainstem malformation known as the 'molar tooth sign'. We identified mutations in the CEP290 gene in five families with variable neurological, retinal and renal manifestations. CEP290 expression was detected mostly in proliferating cerebellar granule neuron populations and showed centrosome and ciliary localization, linking JSRDs to other human ciliopathies.	Mendel Inst Med Genet & Twin Res, Ist Ricovero & Cura Carattere Sci, I-00198 Rome, Italy; Univ Calif San Diego, Dept Neurosci, Lab Neurogenet, La Jolla, CA 92093 USA; G Annunzio Univ, Dept Biomed Sci, I-66013 Chieti, Italy; G DAnnunzio Univ Fdn, Aging Res Ctr, I-66013 Chieti, Italy; Univ Roma La Sapienza, Dept Expt Med & Pathol, I-00187 Rome, Italy; Childrens Univ Hosp, Dept Neurol, CH-8032 Zurich, Switzerland; Osped Microcitemico, I-09120 Cagliari, Italy; United Emirates Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates; Univ Pavia, IRCCS C Mondino Fdn, Dept Child Neurol & Psychiat, I-27100 Pavia, Italy; IRCCS, Bambino Gesu Hosp, Dept Lab Med, Mol Med Unit, I-00165 Rome, Italy	University of California System; University of California San Diego; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; Sapienza University Rome; University Children's Hospital Zurich; United Arab Emirates University; IRCCS Fondazione Casimiro Mondino; University of Pavia; IRCCS Bambino Gesu	Valente, EM (corresponding author), Mendel Inst Med Genet & Twin Res, Ist Ricovero & Cura Carattere Sci, Viale Regina Margherita 261, I-00198 Rome, Italy.	e.valente@css-mendel.it; jogleeson@ucsd.edu	Bertini, Enrico/A-2284-2014; Valente, Enza Maria/G-2942-2017; Fazzi, Elisa/J-6076-2016; Brancati, Francesco/AAC-3778-2022; Bertini, Enrico/ABG-1278-2020; Castori, Marco/K-1099-2016; Bellacchio, Emanuele/AAH-9255-2019; Romano, Corrado/B-9695-2008; Signorini, Sabrina Giovanna/AAA-8467-2019; Dallapiccola, Bruno/K-8692-2016	Bertini, Enrico/0000-0001-9276-4590; Valente, Enza Maria/0000-0002-0600-6820; Fazzi, Elisa/0000-0003-4805-7906; Brancati, Francesco/0000-0003-3624-2354; Castori, Marco/0000-0002-6069-0993; Romano, Corrado/0000-0003-1049-0683; Bellacchio, Emanuele/0000-0002-2757-849X; Lancaster, Madeline/0000-0003-2324-8853; Dallapiccola, Bruno/0000-0002-5031-1013; Boccone, Loredana/0000-0002-0168-0322	NINDS NIH HHS [R01 NS048453] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048453] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; BOLTSHAUSER E, 1977, NEUROPADIATRIE, V8, P57, DOI 10.1055/s-0028-1091505; Chen DH, 2001, BIOCHEM BIOPH RES CO, V280, P99, DOI 10.1006/bbrc.2000.4087; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Doxsey S, 2001, NAT REV MOL CELL BIO, V2, P688, DOI 10.1038/35089575; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Gleeson JG, 2004, AM J MED GENET A, V125A, P125, DOI 10.1002/ajmg.a.20437; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; JOUBERT M, 1969, NEUROLOGY, V19, P813, DOI 10.1212/WNL.19.9.813; Katsanis N, 2006, NAT GENET, V38, P135, DOI 10.1038/ng0206-135; Louie CM, 2005, HUM MOL GENET, V14, pR235, DOI 10.1093/hmg/ddi264; Maria BL, 1997, J CHILD NEUROL, V12, P423, DOI 10.1177/088307389701200703; Valente EM, 2005, ANN NEUROL, V57, P513, DOI 10.1002/ana.20422	14	288	300	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					623	625		10.1038/ng1805	http://dx.doi.org/10.1038/ng1805			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16682970				2022-12-27	WOS:000237954800014
J	Spinazzola, A; Viscomi, C; Fernandez-Vizarra, E; Carrara, F; D'Adamo, P; Calvo, S; Marsano, RM; Donnini, C; Weiher, H; Strisciuglio, P; Parini, R; Sarzi, E; Chan, A; DiMauro, S; Rotig, A; Gasparini, P; Ferrero, I; Mootha, VK; Tiranti, V; Zeviani, M				Spinazzola, A; Viscomi, C; Fernandez-Vizarra, E; Carrara, F; D'Adamo, P; Calvo, S; Marsano, RM; Donnini, C; Weiher, H; Strisciuglio, P; Parini, R; Sarzi, E; Chan, A; DiMauro, S; Rotig, A; Gasparini, P; Ferrero, I; Mootha, VK; Tiranti, V; Zeviani, M			MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; KIDNEY-DISEASE; GENE MPV17; MUTATIONS; IMPORT; DEFICIENCY; KINASE; CHAIN	The mitochondrial (mt) DNA depletion syndromes (MDDS) are genetic disorders characterized by a severe, tissue-specific decrease of mtDNA copy number, leading to organ failure. There are two main clinical presentations: myopathic (OMIM 609560) and hepatocerebral(1) (OMIM 251880). Known mutant genes, including TK2 (ref. 2), SUCLA2 (ref. 3), DGUOK (ref. 4) and POLG(5,6), account for only a fraction of MDDS cases(7). We found a new locus for hepatocerebral MDDS on chromosome 2p21-23 and prioritized the genes on this locus using a new integrative genomics strategy. One of the top-scoring candidates was the human ortholog of the mouse kidney disease gene Mpv17 (ref. 8). We found disease-segregating mutations in three families with hepatocerebral MDDS and demonstrated that, contrary to the alleged peroxisomal localization of the MPV17 gene product(9), MPV17 is a mitochondrial inner membrane protein, and its absence or malfunction causes oxidative phosphorylation (OXPHOS) failure and mtDNA depletion, not only in affected individuals but also in Mpv17(-/-) mice.	Natl Neurol Inst C Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, I-20126 Milan, Italy; Telethon Inst Genet Med TIGEM, Linkage Unit & Serv, I-80131 Naples, Italy; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Syst Biol, Cambridge, MA 02138 USA; MIT, Broad Inst, Cambridge, MA 02446 USA; Harvard Univ, Cambridge, MA 02446 USA; Univ Parma, Dept Genet Anthropol Evolut, I-43100 Parma, Italy; Univ Appl Sci Bonn Rhein Sieg, D-53359 Bonn, Germany; Univ Catanzaro Magna Graecia, Dept Clin & Expt Med, I-88100 Catanzaro, Italy; Milano Bicocca State Univ, Univ Hosp, Pediat Unit, Pierfranco & Luisa Mariani Ctr Study Childrens Me, I-20052 Monza, Italy; Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France; Hop Necker Enfants Malad, INSERM Unit U393, F-75015 Paris, France; Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada; Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Univ Trieste, Dept Med Genet, I-34137 Trieste, Italy	IRCCS Istituto Neurologico Besta; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Parma; Hochschule Bonn Rhein Sieg; Magna Graecia University of Catanzaro; University of Milano-Bicocca; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Alberta; Columbia University; University of Trieste	Zeviani, M (corresponding author), Natl Neurol Inst C Besta, Unit Mol Neurogenet, Pierfranco & Luisa Mariani Ctr Study Childrens Mi, I-20126 Milan, Italy.	zeviani@istituto-besta.it	Tiranti, Valeria/AFN-5783-2022; Rötig, Agnès/G-9592-2017; Spinazzola, Antonella/P-5298-2017; Parini, Rossella/J-9202-2018; Zeviani, Massimo/K-2891-2014; Zeviani, Massimo/AAU-2632-2021; viscomi, Carlo/R-1940-2016; Fernandez-Vizarra, Erika/AAE-5600-2020; Spinazzola, Antonella/P-5791-2019; Marsano, René Massimiliano/B-9640-2012; Gasparini, Paolo/B-6173-2014; d'Adamo, Adamo Pio/G-4064-2011; Donnini, Claudia/B-5548-2015; Tiranti, Valeria/J-8233-2016	Tiranti, Valeria/0000-0002-3584-7338; Rötig, Agnès/0000-0003-0589-0703; Spinazzola, Antonella/0000-0003-4242-8091; Parini, Rossella/0000-0003-4505-1306; Zeviani, Massimo/0000-0002-9067-5508; Spinazzola, Antonella/0000-0003-4242-8091; Marsano, René Massimiliano/0000-0001-8450-1010; d'Adamo, Adamo Pio/0000-0001-9367-4909; Donnini, Claudia/0000-0002-4901-2358; Tiranti, Valeria/0000-0002-3584-7338; Sarzi, Emmanuelle/0000-0002-7623-6699; Viscomi, Carlo/0000-0001-6050-0566; Fernandez-Vizarra, Erika/0000-0002-2469-142X; Gasparini, Paolo/0000-0002-0859-0856	Telethon [TGM03P12, GGP030039, TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; Fontanesi F, 2004, HUM MOL GENET, V13, P923, DOI 10.1093/hmg/ddh108; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gallet PF, 1999, BBA-BIOMEMBRANES, V1418, P61, DOI 10.1016/S0005-2736(99)00022-X; GOTTESBERGE AMM, 1996, EUR ARCH OTO-RHINO-L, V253, P470; HAMMEN PK, 1994, BIOCHEMISTRY-US, V33, P8610, DOI 10.1021/bi00194a028; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; MOUNOLOU JC, 1966, BIOCHEM BIOPH RES CO, V24, P218, DOI 10.1016/0006-291X(66)90723-6; Nguyen KV, 2005, NEUROLOGY, V65, P1493, DOI 10.1212/01.wnl.0000182814.55361.70; OHBA M, 1987, EMBO J, V6, P2117, DOI 10.1002/j.1460-2075.1987.tb02478.x; OTSUKA M, 1988, NUCLEIC ACIDS RES, V16, P10916, DOI 10.1093/nar/16.22.10916; Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580; Rehling P, 2003, J MOL BIOL, V326, P639, DOI 10.1016/S0022-2836(02)01440-7; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284; Spinazzola A, 2005, GENE, V354, P162, DOI 10.1016/j.gene.2005.03.025; Tiranti V, 1999, HUM MOL GENET, V8, P2533, DOI 10.1093/hmg/8.13.2533; Tiranti V, 2004, AM J HUM GENET, V74, P239, DOI 10.1086/381653; Trott A, 2004, EUKARYOT CELL, V3, P620, DOI 10.1128/EC.3.3.620-631.2004; WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A; ZWACKA RM, 1994, EMBO J, V13, P5129, DOI 10.1002/j.1460-2075.1994.tb06842.x	30	310	317	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					570	575		10.1038/ng1765	http://dx.doi.org/10.1038/ng1765			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16582910	Green Published			2022-12-27	WOS:000237147500020
J	Maley, CC; Galipeau, PC; Finley, JC; Wongsurawat, VJ; Li, XH; Sanchez, CA; Paulson, TG; Blount, PL; Risques, RA; Rabinovitch, PS; Reid, BJ				Maley, CC; Galipeau, PC; Finley, JC; Wongsurawat, VJ; Li, XH; Sanchez, CA; Paulson, TG; Blount, PL; Risques, RA; Rabinovitch, PS; Reid, BJ			Genetic clonal diversity predicts progression to esophageal adenocarcinoma	NATURE GENETICS			English	Article							BARRETTS-ESOPHAGUS; NEOPLASTIC PROGRESSION; GENOMIC INSTABILITY; CANCER; SURVEILLANCE; EVOLUTION; EPITHELIUM; EXPANSION; DYSPLASIA; LESIONS	Neoplasms are thought to progress to cancer through genetic instability generating cellular diversity(1,2) and clonal expansions driven by selection for mutations in cancer genes(3,4). Despite advances in the study of molecular biology of cancer genes(5), relatively little is known about evolutionary mechanisms that drive neoplastic progression. It is unknown, for example, which may be more predictive of future progression of a neoplasm: genetic homogenization of the neoplasm, possibly caused by a clonal expansion, or the accumulation of clonal diversity. Here, in a prospective study, we show that clonal diversity measures adapted from ecology and evolution can predict progression to adenocarcinoma in the premalignant condition known as Barrett's esophagus, even when controlling for established genetic risk factors, including lesions in TP53 (p53; ref. 6) and ploidy abnormalities(7). Progression to cancer through accumulation of clonal diversity, on which natural selection acts, may be a fundamental principle of neoplasia with important clinical implications.	Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	The Wistar Institute; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Maley, CC (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	cmaley@alum.mit.edu	Reid, Brian John/AFT-8587-2022	Reid, Brian John/0000-0002-9613-979X; Galipeau, Patricia/0000-0001-7961-7430	NCI NIH HHS [P01 CA91955, K01 CA89267-02, K07 CA89147-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K01CA089267, P01CA091955, K07CA089147] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barrett MT, 1999, NAT GENET, V22, P106, DOI 10.1038/8816; Boland CR, 1998, CANCER RES, V58, P5248; Breivik J, 2005, SEMIN CANCER BIOL, V15, P51, DOI 10.1016/j.semcancer.2004.09.008; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Conio M, 2003, AM J GASTROENTEROL, V98, P1931, DOI 10.1016/S0002-9270(03)00629-4; Doak SH, 2003, GUT, V52, P623, DOI 10.1136/gut.52.5.623; Gonzalez-Garcia I, 2002, P NATL ACAD SCI USA, V99, P13085, DOI 10.1073/pnas.202139299; HAGGITT RC, 1994, HUM PATHOL, V25, P982, DOI 10.1016/0046-8177(94)90057-4; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Levine DS, 2000, AM J GASTROENTEROL, V95, P1152; Macdonald CE, 2000, BMJ-BRIT MED J, V321, P1252, DOI 10.1136/bmj.321.7271.1252; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Maley CC, 2004, CANCER RES, V64, P3414, DOI 10.1158/0008-5472.CAN-03-3249; Maley CC, 2004, CANCER RES, V64, P7629, DOI 10.1158/0008-5472.CAN-04-1738; Nei M., 1987, MOL EVOLUTIONARY GEN; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; Palanca-Wessels MCA, 2003, CARCINOGENESIS, V24, P1183, DOI 10.1093/carcin/bgg076; Rabinovitch PS, 2001, AM J GASTROENTEROL, V96, P3071, DOI 10.1111/j.1572-0241.2001.05261.x; RABINOVITCH PS, 1989, LAB INVEST, V60, P65; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Reid BJ, 2001, AM J GASTROENTEROL, V96, P2839; Rocco JW, 2001, EXP CELL RES, V264, P42, DOI 10.1006/excr.2000.5149; Rudolph RE, 2000, ANN INTERN MED, V132, P612, DOI 10.7326/0003-4819-132-8-200004180-00003; Sampliner RE, 2002, AM J GASTROENTEROL, V97, P1888; Shackney SE, 1997, CYTOMETRY, V29, P1; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Sieber OM, 2003, NAT REV CANCER, V3, P701, DOI 10.1038/nrc1170; Tsao JL, 2000, P NATL ACAD SCI USA, V97, P1236, DOI 10.1073/pnas.97.3.1236; Wong DJ, 2001, CANCER RES, V61, P8284	30	523	538	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2006	38	4					468	473		10.1038/ng1768	http://dx.doi.org/10.1038/ng1768			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	026LN	16565718				2022-12-27	WOS:000236340500021
J	Ono, R; Nakamura, K; Inoue, K; Naruse, M; Usami, T; Wakisaka-Saito, N; Hino, T; Suzuki-Migishima, R; Ogonuki, N; Miki, H; Kohda, T; Ogura, A; Yokoyama, M; Kaneko-Ishino, T; Ishino, F				Ono, R; Nakamura, K; Inoue, K; Naruse, M; Usami, T; Wakisaka-Saito, N; Hino, T; Suzuki-Migishima, R; Ogonuki, N; Miki, H; Kohda, T; Ogura, A; Yokoyama, M; Kaneko-Ishino, T; Ishino, F			Deletion of Peg10, an imprinted gene acquired from a retrotransposon, causes early embryonic lethality	NATURE GENETICS			English	Article							TRANSPOSABLE ELEMENTS; MAMMALIAN GENOMES; RETROVIRAL GAG; IDENTIFICATION; EVOLUTION; ORIGIN; SYNCYTIN; FAMILY; GROWTH; MICE	By comparing mammalian genomes, we and others have identified actively transcribed Ty3/gypsy retrotransposon-derived genes with highly conserved DNA sequences and insertion sites(1-6). To elucidate the functions of evolutionarily conserved retrotransposon-derived genes in mammalian development, we produced mice that lack one of these genes, Peg10 ( paternally expressed 10)(1-3,7), which is a paternally expressed imprinted gene on mouse proximal chromosome 6. The Peg10 knockout mice showed early embryonic lethality owing to defects in the placenta. This indicates that Peg10 is critical for mouse parthenogenetic development and provides the first direct evidence of an essential role of an evolutionarily conserved retrotransposon-derived gene in mammalian development.	Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320011, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Epigenet, Chiyoda Ku, Tokyo 1010062, Japan; Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan; RIKEN, BioResouce Ctr, Tsukuba, Ibaraki 3050074, Japan; Tokyo Med & Dent Univ, Med Res Inst, Fac Recombinant Mice, Chiyoda Ku, Tokyo 1010062, Japan; Tokyo Inst Technol, Ctr Biol Resources & Informat, Div Gene Res, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Tokai Univ, Sch Hlth Sci, Kanagawa 2591193, Japan	Japan Science & Technology Agency (JST); Tokyo Medical & Dental University (TMDU); Mitsubishi Kagaku Institute of Life Sciences (MITILS); RIKEN; Tokyo Medical & Dental University (TMDU); Tokyo Institute of Technology; Tokai University	Kaneko-Ishino, T (corresponding author), Japan Sci & Technol Agcy, CREST, 4-1-8 Hon Machi, Kawaguchi, Saitama 3320011, Japan.	tkanekoi@is.icc.u-tokai.ac.jp; fishino.epgn@mri.tmd.ac.jp	Ishino（Kaneko-Ishino）, Tomoko/AGY-0742-2022; Ogura, Atsuo/J-3916-2014; Kohda, Takashi/C-2879-2014	Ogura, Atsuo/0000-0003-0447-1988; Kohda, Takashi/0000-0002-6856-5601				Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; BEECHEY C, 2003, MOUSE IMPRINTING DAT; Brandt J, 2005, GENE, V345, P101, DOI 10.1016/j.gene.2004.11.022; Butler M, 2001, J MOL EVOL, V52, P260, DOI 10.1007/s002390010154; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Dupressoir A, 2005, P NATL ACAD SCI USA, V102, P725, DOI 10.1073/pnas.0406509102; GUILLEMOT F, 1995, NAT GENET, V9, P235, DOI 10.1038/ng0395-235; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Lux A, 2005, J BIOL CHEM, V280, P8482, DOI 10.1074/jbc.M409197200; Lynch C, 2003, CURR BIOL, V13, P1518, DOI 10.1016/S0960-9822(03)00618-3; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Nagasaki K, 1999, CANCER LETT, V140, P227, DOI 10.1016/S0304-3835(99)00087-7; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nakamura TM, 1998, CELL, V92, P587, DOI 10.1016/S0092-8674(00)81123-X; Okabe H, 2003, CANCER RES, V63, P3043; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Ono R, 2001, GENOMICS, V73, P232, DOI 10.1006/geno.2001.6494; Poulter R, 1998, GENE, V215, P241, DOI 10.1016/S0378-1119(98)00296-0; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Shigemoto K, 2001, NUCLEIC ACIDS RES, V29, P4079, DOI 10.1093/nar/29.19.4079; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; STURM KS, 1994, DEV DYNAM, V201, P11, DOI 10.1002/aja.1002010103; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; TOH H, 1985, NATURE, V318, P388, DOI 10.1038/318388a0; Tsou AP, 2003, J BIOMED SCI, V10, P625, DOI 10.1159/000073528; Volff JN, 2001, MOL BIOL EVOL, V18, P266, DOI 10.1093/oxfordjournals.molbev.a003801	30	286	304	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					101	106		10.1038/ng1699	http://dx.doi.org/10.1038/ng1699			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16341224				2022-12-27	WOS:000234227200024
J	Dunoyer, P; Himber, C; Voinnet, O				Dunoyer, P; Himber, C; Voinnet, O			DICER-LIKE 4 is required for RNA interference and produces the 21-nucleotide small interfering RNA component of the plant cell-to-cell silencing signal	NATURE GENETICS			English	Article							TRANS-ACTING SIRNAS; GENE; ARABIDOPSIS; VIRUS; BIOGENESIS; MICRORNAS; ELEGANS; SGS3	In RNA interference(1,2), the RNase-III enzyme Dicer(3) processes exogenous double-stranded RNA into small interfering RNAs (siRNAs). siRNAs guide RNA-induced silencing complexes to cleave homologous transcripts, enabling gene-specific knockdown(4). In plants, double-stranded RNA is processed into siRNA species of 21 nucleotides (nt) and 24 nt (ref. 5), but, unlike in nematodes(6), the Dicer enzymes involved in this processing have not been identified. Additionally, in both plants and nematodes, systemic signals(7-10) with RNA components convey the sequence-specific effects of RNA interference between cells. Here, we describe Arabidopsis thaliana mutants with altered silencing cell-to-cell movement beyond the vasculature. At least three SILENCING MOVEMENT DEFICIENT genes (SMD1, SMD2 and SMD3) are required for trafficking, the extent of which correlates with siRNA levels in the veins. Five alleles defective in synthesis of 21-nt, but not 24-nt, siRNAs carry mutations in Dicer-like 4 (DCL4) that are involved in biogenesis of trans-acting siRNAs(11,12). We show that the biogenesis and function of trans-acting siRNA can be genetically uncoupled from a bona fide DCL4-dependent pathway that accounts for RNA interference and for production of the 21-nt siRNA component of the plant cell-to-cell silencing signal.	CNRS, UPR 2357, Inst Biol Mol Plantes, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Voinnet, O (corresponding author), CNRS, UPR 2357, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	olivier.voinnet@ibmp-ulp.u-strasbg.fr		Voinnet, Olivier/0000-0001-6982-9544				Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Szittya G, 2002, PLANT CELL, V14, P359, DOI 10.1105/tpc.010366; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Waterhouse PM, 2003, NAT REV GENET, V4, P29, DOI 10.1038/nrg982; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	25	314	340	1	46	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2005	37	12					1356	1360		10.1038/ng1675	http://dx.doi.org/10.1038/ng1675			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16273107				2022-12-27	WOS:000233657300016
J	Clayton, DG; Walker, NM; Smyth, DJ; Pask, R; Cooper, JD; Maier, LM; Smink, LJ; Lam, AC; Ovington, NR; Stevens, HE; Nutland, S; Howson, JMM; Faham, M; Moorhead, M; Jones, HB; Falkowski, M; Hardenbol, P; Willis, TD; Todd, JA				Clayton, DG; Walker, NM; Smyth, DJ; Pask, R; Cooper, JD; Maier, LM; Smink, LJ; Lam, AC; Ovington, NR; Stevens, HE; Nutland, S; Howson, JMM; Faham, M; Moorhead, M; Jones, HB; Falkowski, M; Hardenbol, P; Willis, TD; Todd, JA			Population structure, differential bias and genomic control in a large-scale, case-control association study	NATURE GENETICS			English	Article								The main problems in drawing causal inferences from epidemiological case-control studies are confounding by unmeasured extraneous factors, selection bias and differential misclassification of exposure(1). In genetics the first of these, in the form of population structure, has dominated recent debate(2-4). Population structure explained part of the significant +11.2% inflation of test statistics we observed in an analysis of 6,322 nonsynonymous SNPs in 816 cases of type 1 diabetes and 877 population-based controls from Great Britain. The remainder of the inflation resulted from differential bias in genotype scoring between case and control DNA samples, which originated from two laboratories, causing false-positive associations. To avoid excluding SNPs and losing valuable information, we extended the genomic control method(2-5) by applying a variable downweighting to each SNP.	Univ Cambridge, Cambridge Inst Med Res, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Cambridge CB2 2XY, England; ParAllele BioSci, San Francisco, CA 94080 USA	University of Cambridge	Clayton, DG (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Wellcome Trust MRC Bldg, Cambridge CB2 2XY, England.	david.clayton@cimr.cam.ac.uk; john.todd@cimr.cam.ac.uk	Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148; Walker, Neil/0000-0001-9796-7688; Howson, Joanna/0000-0001-7618-0050; smyth, deborah/0000-0002-6330-2669	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Lowe CE, 2004, GENES IMMUN, V5, P301, DOI 10.1038/sj.gene.6364064; MANTEL N, 1963, J AM STAT ASSOC, V58, P690; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MOORHEAD M, IN PRESS EUR J HUM G; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522	16	421	433	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1243	1246		10.1038/ng1653	http://dx.doi.org/10.1038/ng1653			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16228001				2022-12-27	WOS:000233045200024
J	Ren, ZH; Gao, JP; Li, LG; Cai, XL; Huang, W; Chao, DY; Zhu, MZ; Wang, ZY; Luan, S; Lin, HX				Ren, ZH; Gao, JP; Li, LG; Cai, XL; Huang, W; Chao, DY; Zhu, MZ; Wang, ZY; Luan, S; Lin, HX			A rice quantitative trait locus for salt tolerance encodes a sodium transporter	NATURE GENETICS			English	Article							HIGH-AFFINITY POTASSIUM; HKT TRANSPORTERS; K+ NUTRITION; NA+; GENE; ATHKT1; ROOTS; ANTIPORTER; SEQUENCE; GENOME	Many important agronomic traits in crop plants, including stress tolerance, are complex traits controlled by quantitative trait loci (QTLs). Isolation of these QTLs holds great promise to improve world agriculture but is a challenging task. We previously mapped a rice QTL, SKC1, that maintained K+ homeostasis in the salt-tolerant variety under salt stress(1), consistent with the earlier finding that K+ homeostasis is important in salt tolerance(2,3). To understand the molecular basis of this QTL, we isolated the SKC1 gene by map-based cloning and found that it encoded a member of HKT-type transporters. SKC1 is preferentially expressed in the parenchyma cells surrounding the xylem vessels. Voltage-clamp analysis showed that SKC1 protein functions as a Na+-selective transporter. Physiological analysis suggested that SKC1 is involved in regulating K+/Na+ homeostasis under salt stress, providing a potential tool for improving salt tolerance in crops.	Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl key Lab Plant Mol Genet, Shanghai 200032, Peoples R China; Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China; Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; UC Berkeley Ctr Mol Life Sci, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, SHARF Lab, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Berkeley; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Lin, HX (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl key Lab Plant Mol Genet, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	sluan@nature.berkeley.edu; hxlin@sibs.ac.cn	Chao, Daiyin/A-5213-2013; Lin, Hong-Xuan/AEQ-6607-2022; Chao, Dai-Yin/H-1357-2012; Ren, Zhonghai/N-6944-2019	Lin, Hong-Xuan/0000-0002-2818-023X; Ren, Zhonghai/0000-0002-0759-3668; Gao, Ji-Ping/0000-0002-8968-4423; cai, xiu ling/0000-0001-8333-4556; ?, ??/0000-0003-2832-4800				Akbar M., 1986, PROGR RAINFED LOWLAN; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Berthomieu P, 2003, EMBO J, V22, P2004, DOI 10.1093/emboj/cdg207; Deckert G, 1998, NATURE, V392, P353, DOI 10.1038/32831; EPSTEIN E, 1961, PLANT PHYSIOL, V36, P437, DOI 10.1104/pp.36.4.437; Garciadeblas B, 2003, PLANT J, V34, P788, DOI 10.1046/j.1365-313X.2003.01764.x; Gassmann W, 1996, PLANT J, V10, P869, DOI 10.1046/j.1365-313X.1996.10050869.x; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Horie T, 2001, PLANT J, V27, P129, DOI 10.1046/j.1365-313x.2001.01077.x; Kato Y, 2001, P NATL ACAD SCI USA, V98, P6488, DOI 10.1073/pnas.101556598; Lagarde D, 1996, PLANT J, V9, P195, DOI 10.1046/j.1365-313X.1996.09020195.x; LANDER ES, 1989, GENETICS, V121, P185; LIMAN ER, 1991, NATURE, V353, P752, DOI 10.1038/353752a0; Lin HX, 2004, THEOR APPL GENET, V108, P253, DOI 10.1007/s00122-003-1421-y; Liu K, 2001, PLANT CELL, V13, P1453, DOI 10.1105/tpc.13.6.1453; Maathuis FJM, 1999, ANN BOT-LONDON, V84, P123, DOI 10.1006/anbo.1999.0912; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; MOONS A, 1995, PLANT PHYSIOL, V107, P177, DOI 10.1104/pp.107.1.177; Qi Z, 2004, PLANT PHYSIOL, V136, P2548, DOI 10.1104/pp.104.049213; RUBIO F, 1995, SCIENCE, V270, P1660, DOI 10.1126/science.270.5242.1660; Rus A, 2004, PLANT PHYSIOL, V136, P2500, DOI 10.1104/pp.104.042234; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; Schachtman D, 1999, TRENDS PLANT SCI, V4, P281, DOI 10.1016/S1360-1385(99)01428-4; SCHACHTMAN DP, 1994, NATURE, V370, P655, DOI 10.1038/370655a0; Shi HZ, 2000, P NATL ACAD SCI USA, V97, P6896, DOI 10.1073/pnas.120170197; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Subramanian VS, 2001, AM J PHYSIOL-GASTR L, V281, pG1477, DOI 10.1152/ajpgi.2001.281.6.G1477; Uozumi N, 2000, PLANT PHYSIOL, V122, P1249, DOI 10.1104/pp.122.4.1249; Wang TB, 1998, PLANT PHYSIOL, V118, P651, DOI 10.1104/pp.118.2.651; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	30	883	1054	18	324	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1141	1146		10.1038/ng1643	http://dx.doi.org/10.1038/ng1643			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16155566				2022-12-27	WOS:000232185600029
J	Vogt, G; Chapgier, A; Yang, K; Chuzhanova, N; Feinberg, J; Fieschi, C; Boisson-Dupuis, S; Alcais, A; Filipe-Santos, O; Bustamante, J; de Beaucoudrey, L; Al-Mohsen, I; Al-Hajjar, S; Al-Ghonaium, A; Adimi, P; Mirsaeidi, M; Khalilzadeh, S; Rosenzweig, S; Martin, OD; Bauer, TR; Puck, JM; Ochs, HD; Furthner, D; Engelhorn, C; Mansouri, D; Holland, SM; Schreiber, RD; Abel, L; Cooper, DN; Soudais, C; Casanova, JL				Vogt, G; Chapgier, A; Yang, K; Chuzhanova, N; Feinberg, J; Fieschi, C; Boisson-Dupuis, S; Alcais, A; Filipe-Santos, O; Bustamante, J; de Beaucoudrey, L; Al-Mohsen, I; Al-Hajjar, S; Al-Ghonaium, A; Adimi, P; Mirsaeidi, M; Khalilzadeh, S; Rosenzweig, S; Martin, OD; Bauer, TR; Puck, JM; Ochs, HD; Furthner, D; Engelhorn, C; Mansouri, D; Holland, SM; Schreiber, RD; Abel, L; Cooper, DN; Soudais, C; Casanova, JL			Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations	NATURE GENETICS			English	Article							INTERFERON-GAMMA-RECEPTOR; BACILLE CALMETTE-GUERIN; EXTRA N-GLYCOSYLATION; FUNCTIONAL-CHARACTERIZATION; 1 DEFICIENCY; CD40 LIGAND; IFN-GAMMA; MYCOBACTERIAL; SUBSTITUTION; DYSFIBRINOGEN	Mutations involving gains of glycosylation have been considered rare, and the pathogenic role of the new carbohydrate chains has never been formally established. We identified three children with mendelian susceptibility to mycobacterial disease who were homozygous with respect to a missense mutation in IFNGR2 creating a new N- glycosylation site in the IFN gamma R2 chain. The resulting additional carbohydrate moiety was both necessary and sufficient to abolish the cellular response to IFN gamma. We then searched the Human Gene Mutation Database for potential gain- of- N- glycosylation missense mutations; of 10,047 mutations in 577 genes encoding proteins trafficked through the secretory pathway, we identified 142 candidate mutations ( similar to 1.4%) in 77 genes ( similar to 13.3%). Six mutant proteins bore new N- linked carbohydrate moieties. Thus, an unexpectedly high proportion of mutations that cause human genetic disease might lead to the creation of new N- glycosylation sites. Their pathogenic effects may be a direct consequence of the addition of N- linked carbohydrate.	Univ Paris 05, Necker Med Sch, INSERM, U550,Lab Human Genet Infect Dis, F-75015 Paris, France; Shanghai Med Univ 2, Ruijin Hosp, French Chinese Lab Genom & Life Sci, Shanghai, Peoples R China; Cardiff Univ, Biostat & Bioinformat Unit, Cardiff CF14 4XN, Wales; Cardiff Univ, Inst Med Genet, Cardiff CF14 4XN, Wales; Hop St Louis, Dept Immunopathol, F-75010 Paris, France; King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Pediat Infect Dis Unit, Riyadh 11211, Saudi Arabia; King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Immunol Unit, Riyadh 11211, Saudi Arabia; Shaheed Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis, Tehran 19556, Iran; NIH, Lab Clin Infect Dis, Bethesda, MD 20892 USA; Hosp Santa Creu & Sant Pau, Serv Immunol, Barcelona, Spain; NCI, NIH, Bethesda, MD 20892 USA; NHGRI, NIH, Bethesda, MD 20892 USA; Univ Washington, Dept Pediat, Seattle, WA 98109 USA; Klinikum Wels, Dept Pediat, A-4600 Wels, Austria; Hosp Sick Children, Dept Pediat, D-80337 Munich, Germany; Washington Univ, Dept Pathol & Immunol, St Louis, MO 63110 USA; Hop Necker Enfants Malad, Pediat Immunol & Hematol Unit, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Shanghai Jiao Tong University; Cardiff University; Cardiff University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Shahid Beheshti University Medical Sciences; National Institutes of Health (NIH) - USA; Hospital of Santa Creu i Sant Pau; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Washington; University of Washington Seattle; Washington University (WUSTL); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Casanova, JL (corresponding author), Univ Paris 05, Necker Med Sch, INSERM, U550,Lab Human Genet Infect Dis, 156 Rue Vaugirard, F-75015 Paris, France.	casanova@necker.fr	Mirsaeidi, Mehdi/A-6448-2008; Schreiber, Robert D/A-1276-2013; Casanova, Jean-Laurent/I-3418-2017; Cooper, David N/H-4384-2011; Schreiber, Robert/Q-7550-2019; adimi-naghan, parisa/G-5849-2017; de la Calle-Martin, Oscar/Q-3353-2016; Mirsaeidi, Mehdi/D-8164-2011; Boisson-Dupuis, Stéphanie/I-2040-2017; Boisson-Dupuis, Stephanie/AAF-5066-2021; Alcais, Alexandre/J-5882-2017; adimi, Parisa/AAN-1103-2020; Abel, Laurent/H-8888-2017; Bustamante, Jacinta/H-7877-2017; mansouri, davood/G-6471-2017; Vogt, Guillaume/L-6046-2015; soudais, claire/F-9756-2016	Schreiber, Robert D/0000-0001-6311-0432; Cooper, David N/0000-0002-8943-8484; adimi-naghan, parisa/0000-0002-4201-2822; de la Calle-Martin, Oscar/0000-0001-9717-053X; Boisson-Dupuis, Stéphanie/0000-0002-7115-116X; Alcais, Alexandre/0000-0002-1012-2226; Abel, Laurent/0000-0001-7016-6493; Bustamante, Jacinta/0000-0002-3439-2482; mansouri, davood/0000-0002-0564-8282; Vogt, Guillaume/0000-0001-8192-1247; soudais, claire/0000-0002-4387-6649; Chuzhanova, Nadia/0000-0002-4655-3618; Casanova, Jean-Laurent/0000-0002-7782-4169; Chapgier, Ariane/0000-0002-1734-0744; khalilzadeh, soheila/0000-0002-3365-2449; Schreiber, Robert/0000-0003-1590-2341; Mirsaeidi, Mehdi/0000-0001-5298-8442	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000647, ZIAAI000647] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alder NN, 2004, J BIOL CHEM, V279, P22787, DOI 10.1074/jbc.R400002200; ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; Altare F, 1998, J CLIN INVEST, V102, P2035, DOI 10.1172/JCI4950; Altare F, 1998, SCIENCE, V280, P1432, DOI 10.1126/science.280.5368.1432; ALY AM, 1992, P NATL ACAD SCI USA, V89, P4933, DOI 10.1073/pnas.89.11.4933; Asano N, 2003, GLYCOBIOLOGY, V13, p93R, DOI 10.1093/glycob/cwg090; BACK AL, 1993, BIOCHEM BIOPH RES CO, V193, P912, DOI 10.1006/bbrc.1993.1712; Bajorath J, 1996, PROTEIN SCI, V5, P531; Becchis M, 1999, BREAST CANCER RES TR, V54, P101, DOI 10.1023/A:1006100929670; Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Clementi R, 2001, J MED GENET, V38, P643, DOI 10.1136/jmg.38.9.643; de Jong R, 1998, SCIENCE, V280, P1435; de la Calle-Martin O, 2001, J CLIN INVEST, V108, P117, DOI 10.1172/JCI10993; Doffinger R, 2000, J INFECT DIS, V181, P379, DOI 10.1086/315197; Dorman SE, 2004, LANCET, V364, P2113, DOI 10.1016/S0140-6736(04)17552-1; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Dupuis S, 2001, SCIENCE, V293, P300, DOI 10.1126/science.1061154; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Feinberg J, 2004, EUR J IMMUNOL, V34, P3276, DOI 10.1002/eji.200425221; Fieschi C, 2004, BLOOD, V104, P2095, DOI 10.1182/blood-2004-02-0584; Fitches AC, 2001, THROMB HAEMOSTASIS, V86, P1023; Hamano A, 2004, BLOOD, V103, P3045, DOI 10.1182/blood-2003-07-2569; Hammerle MM, 2000, GLYCOCONJUGATE J, V17, P807, DOI 10.1023/A:1010992827511; Jouanguy E, 2000, J CLIN INVEST, V105, P1429, DOI 10.1172/JCI9166; Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; KAUDEWITZ H, 1986, FIBRINOGEN FIBRIN FO, V4, P91; Lonnqvist L, 1996, GENOMICS, V36, P468, DOI 10.1006/geno.1996.0492; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Lu Y, 1998, J BIOL CHEM, V273, P568, DOI 10.1074/jbc.273.1.568; MAEKAWA H, 1991, J BIOL CHEM, V266, P11575; MAEKAWA H, 1992, J CLIN INVEST, V90, P67, DOI 10.1172/JCI115857; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Manna PR, 2002, HUM MOL GENET, V11, P301, DOI 10.1093/hmg/11.3.301; Molday Robert S, 2004, Novartis Found Symp, V255, P95; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; PARAD RB, 1990, P NATL ACAD SCI USA, V87, P6786, DOI 10.1073/pnas.87.17.6786; Pariyarath R, 1996, FEBS LETT, V397, P79, DOI 10.1016/S0014-5793(96)01134-9; Puck JM, 1997, BLOOD, V89, P1968; Ridgway HJ, 1997, BRIT J HAEMATOL, V99, P562; Rosenzweig SD, 2004, J IMMUNOL, V173, P4000, DOI 10.4049/jimmunol.173.6.4000; Steen M, 2004, BLOOD, V103, P3381, DOI 10.1182/blood-2003-06-2092; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Sugo T, 1999, BLOOD, V94, P3806, DOI 10.1182/blood.V94.11.3806.423a17_3806_3813; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; YAMAZUMI K, 1989, J CLIN INVEST, V83, P1590, DOI 10.1172/JCI114056	50	162	167	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					692	700		10.1038/ng1581	http://dx.doi.org/10.1038/ng1581			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15924140				2022-12-27	WOS:000230196400015
J	Kopelman, NM; Lancet, D; Yanai, I				Kopelman, NM; Lancet, D; Yanai, I			Alternative splicing and gene duplication are inversely correlated evolutionary mechanisms	NATURE GENETICS			English	Article							EXON DUPLICATION; COMPLEMENTARY; EXPRESSION; ORIGIN	Gene duplication and alternative splicing are distinct evolutionary mechanisms that provide the raw material for new biological functions. We explored their relationships in human and mouse and found an inverse correlation between the size of a gene's family and its use of alternatively spliced isoforms. A cross-organism analysis suggests that selection for genome-wide genic proliferation might be interchangeably met by either evolutionary mechanism.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Yanai, I (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	yanai@mcb.harvard.edu		Yanai, Itai/0000-0002-8438-2741				Ast G, 2004, NAT REV GENET, V5, P773, DOI 10.1038/nrg1451; Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803; Force A, 1999, GENETICS, V151, P1531; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kondrashov FA, 2001, HUM MOL GENET, V10, P2661, DOI 10.1093/hmg/10.23.2661; Letunic I, 2002, HUM MOL GENET, V11, P1561, DOI 10.1093/hmg/11.13.1561; Lister JA, 2001, DEV BIOL, V237, P333, DOI 10.1006/dbio.2001.0379; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Makova KD, 2003, GENOME RES, V13, P1638, DOI 10.1101/gr.1133803; Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159; Ohno S., 1970, EVOLUTION GENE DUPLI; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Thanaraj TA, 2004, NUCLEIC ACIDS RES, V32, pD64, DOI 10.1093/nar/gkh030	15	124	126	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					588	589		10.1038/ng1575	http://dx.doi.org/10.1038/ng1575			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15895079				2022-12-27	WOS:000229495300010
J	Pinkel, D; Albertson, DG				Pinkel, D; Albertson, DG			Array comparative genomic hybridization and its applications in cancer	NATURE GENETICS			English	Article							DNA COPY-NUMBER; MICROARRAY ANALYSIS; IN-SITU; BREAST-CANCER; SEGMENTAL DUPLICATIONS; PCR AMPLIFICATION; CGH; RESOLUTION; GENE; TUMOR	Alteration in DNA copy number is one of the many ways in which gene expression and function may be modified. Some variations are found among normal individuals, others occur in the course of normal processes in some species and still others participate in causing various disease states. For example, many defects in human development are due to gains and losses of chromosomes and chromosomal segments that occur before or shortly after fertilization, and DNA dosage-alteration changes occurring in somatic cells are frequent contributors to cancer. Detecting these aberrations and interpreting them in the context of broader knowledge facilitates the identification of crucial genes and pathways involved in biological processes and disease. Over the past several years, array comparative genomic hybridization has proven its value for analyzing DNA copy-number variations. Here, we discuss the state of the art of array comparative genomic hybridization and its applications in cancer, emphasizing general concepts rather than specific results.	Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco	Pinkel, D (corresponding author), Univ Calif San Francisco, Dept Lab Med, Box 0808, San Francisco, CA 94143 USA.	pinkel@cc.ucsf.edu; albertson@cc.ucsf.edu						Albertson DG, 2003, HUM MOL GENET, V12, pR145, DOI 10.1093/hmg/ddg261; Albertson DG, 2003, BREAST CANCER RES TR, V78, P289, DOI 10.1023/A:1023025506386; Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; Barrett MT, 2004, P NATL ACAD SCI USA, V101, P17765, DOI 10.1073/pnas.0407979101; BOCKER T, 1999, BIOCHIM BIOPHYS ACTA, V1423, P1; Brennan C, 2004, CANCER RES, V64, P4744, DOI 10.1158/0008-5472.CAN-04-1241; Callagy G, 2005, J PATHOL, V205, P388, DOI 10.1002/path.1694; Carvalho B, 2004, J CLIN PATHOL, V57, P644, DOI 10.1136/jcp.2003.013029; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Cox C, 2005, P NATL ACAD SCI USA, V102, P4542, DOI 10.1073/pnas.0408593102; Daigo Y, 2001, AM J PATHOL, V158, P1623, DOI 10.1016/S0002-9440(10)64118-1; Daruwala RS, 2004, P NATL ACAD SCI USA, V101, P16292, DOI 10.1073/pnas.0407247101; DeVries S, 2005, J MOL DIAGN, V7, P65, DOI 10.1016/S1525-1578(10)60010-4; Dhami P, 2005, AM J HUM GENET, V76, P750, DOI 10.1086/429588; DUMANOIR S, 1993, HUM GENET, V90, P590, DOI 10.1007/BF00202476; Eichler EE, 2001, GENOME RES, V11, P653, DOI 10.1101/gr.188901; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Esteller M, 2000, EUR J CANCER, V36, P2294, DOI 10.1016/S0959-8049(00)00303-8; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Fridlyand J, 2004, J MULTIVARIATE ANAL, V90, P132, DOI 10.1016/j.jmva.2004.02.008; Fukiya S, 2004, J BACTERIOL, V186, P3911, DOI 10.1128/JB.186.12.3911-3921.2004; Guillaud-Bataille M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh108; Heidenblad M, 2005, ONCOGENE, V24, P1794, DOI 10.1038/sj.onc.1208383; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Hyman E, 2002, CANCER RES, V62, P6240; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Karhu R, 1999, GENE CHROMOSOME CANC, V24, P112, DOI 10.1002/(SICI)1098-2264(199902)24:2<112::AID-GCC3>3.0.CO;2-U; Lage JM, 2003, GENOME RES, V13, P294, DOI 10.1101/gr.377203; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; Liu DX, 2004, DIAGN MOL PATHOL, V13, P105, DOI 10.1097/00019606-200406000-00007; Locke DP, 2004, J MED GENET, V41, P175, DOI 10.1136/jmg.2003.013813; Lucito R, 2000, GENOME RES, V10, P1726, DOI 10.1101/gr.138300; Lupski JR, 1996, AM J HUM GENET, V58, P21; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Mantripragada KK, 2004, INT J MOL MED, V13, P273; Martinez-Climent JA, 2003, BLOOD, V101, P3109, DOI 10.1182/blood-2002-07-2119; Mohapatra G, 1997, GENE CHROMOSOME CANC, V20, P311, DOI 10.1002/(SICI)1098-2264(199712)20:4<311::AID-GCC1>3.0.CO;2-4; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Paris PL, 2004, HUM MOL GENET, V13, P1303, DOI 10.1093/hmg/ddh155; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; PINKEL D, IN PRESS ANN REV GEN; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Press MF, 2002, J CLIN ONCOL, V20, P3095, DOI 10.1200/JCO.2002.09.094; RUBIOMOSCARDO F, 2005, BLOOD           0217, DOI DOI 10.1182/BLOOD-2004-10-3907; Schwaenen C, 2004, P NATL ACAD SCI USA, V101, P1039, DOI 10.1073/pnas.0304717101; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Smirnov DA, 2004, GENE CHROMOSOME CANC, V40, P72, DOI 10.1002/gcc.20015; Snijders AM, 2003, ONCOGENE, V22, P4370, DOI 10.1038/sj.onc.1206482; Snijders AM, 2005, GENOME RES, V15, P302, DOI 10.1101/gr.2902505; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; SNIJDERS AM, 2005, ONCOGENE        0411, DOI DOI 10.1038/SJ.ONC.1208601; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Tanabe C, 2003, GENE CHROMOSOME CANC, V38, P168, DOI 10.1002/gcc.10269; UTERMANN G, 1987, J CLIN INVEST, V80, P458, DOI 10.1172/JCI113093; Waldman FM, 2000, JNCI-J NATL CANCER I, V92, P313, DOI 10.1093/jnci/92.4.313; Wang G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh070; Wang G, 2004, GENOME RES, V14, P2357, DOI 10.1101/gr.2813404; Wang LF, 2004, CURR DRUG TARGETS, V5, P1, DOI 10.2174/1389450043490668; Wang P, 2005, BIOSTATISTICS, V6, P45, DOI 10.1093/biostatistics/kxh017; Watanabe T, 2004, YEAST, V21, P351, DOI 10.1002/yea.1103; Weiss MM, 2004, CELL ONCOL, V26, P307; Zardo G, 2002, NAT GENET, V32, P453, DOI 10.1038/ng1007; Zhang XX, 2005, AM J HUM GENET, V76, P312, DOI 10.1086/427762; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; Zhou XF, 2004, HUM GENET, V115, P327, DOI 10.1007/s00439-004-1163-1	75	411	447	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37			S			S11	S17		10.1038/ng1569	http://dx.doi.org/10.1038/ng1569			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	932YF	15920524	Bronze			2022-12-27	WOS:000229590000004
J	Swanberg, M; Lidman, O; Padyukov, L; Eriksson, P; Akesson, E; Jagodic, M; Lobell, A; Khademi, M; Borjesson, O; Lindgren, CM; Lundman, P; Brookes, AJ; Kere, J; Luthman, H; Alfredsson, L; Hillert, J; Klareskog, L; Hamsten, A; Piehl, F; Olsson, T				Swanberg, M; Lidman, O; Padyukov, L; Eriksson, P; Akesson, E; Jagodic, M; Lobell, A; Khademi, M; Borjesson, O; Lindgren, CM; Lundman, P; Brookes, AJ; Kere, J; Luthman, H; Alfredsson, L; Hillert, J; Klareskog, L; Hamsten, A; Piehl, F; Olsson, T			MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction	NATURE GENETICS			English	Article							CLASS-II TRANSACTIVATOR; CENTRAL-NERVOUS-SYSTEM; ANTIGEN PRESENTATION; TH2 BIAS; GENE; POPULATION; CELLS; CIITA; NEURODEGENERATION; ENCEPHALOMYELITIS	Antigen presentation to T cells by MHC molecules is essential for adaptive immune responses. To determine the exact position of a gene affecting expression of MHC molecules, we finely mapped a previously defined rat quantitative trait locus regulating MHC class II on microglia in an advanced intercross line. We identified a small interval including the gene MHC class II transactivator (Mhc2ta) and, using a map over six inbred strains combined with gene sequencing and expression analysis, two conserved Mhc2ta haplotypes segregating with MHC class II levels. In humans, a - 168A --> G polymorphism in the type III promoter of the MHC class II transactivator (MHC2TA) was associated with increased susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction, as well as lower expression of MHC2TA after stimulation of leukocytes with interferon-gamma. We conclude that polymorphisms in Mhc2ta and MHC2TA result in differential MHC molecule expression and are associated with susceptibility to common complex diseases with inflammatory components.	Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden; Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; Karolinska Inst, Atherosclerosis Res Unit, King Gustaf V Res Inst, Stockholm, Sweden; Huddinge Univ Hosp, Karolinska Inst, Dept Neurol, S-14186 Huddinge, Sweden; Huddinge Univ Hosp, Karolinska Inst, Novum, Dept Biosci, S-14186 Huddinge, Sweden; Danderyd Hosp, Dept Med, Stockholm, Sweden; Karolinska Inst, Ctr Genom & Bioinformat, Stockholm, Sweden; Lund Univ, Dept Clin Sci, Malmo, Sweden; Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Lund University; Karolinska Institutet	Olsson, T (corresponding author), Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden.	tomas.olsson@cmm.ki.se	Padyukov, Leonid/A-4890-2009; Kere, Juha/AAX-9117-2021; Piehl, Fredrik/E-3451-2013; Kere, Juha/A-9179-2008; Alfredsson, Lars/AAC-9007-2019	Padyukov, Leonid/0000-0003-2950-5670; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Alfredsson, Lars/0000-0003-1688-6697; Khademi, Mohsen/0000-0003-0801-1444; Swanberg, Maria/0000-0002-1829-1008; Olsson, Tomas/0000-0002-2938-1877; Piehl, Fredrik/0000-0001-8329-5219; Klareskog, Lars/0000-0001-9601-6186; Lindgren, Cecilia/0000-0002-4903-9374; Eriksson, Per/0000-0002-5635-2692	Wellcome Trust [090532] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baumgart M, 1998, P NATL ACAD SCI USA, V95, P6936, DOI 10.1073/pnas.95.12.6936; Boss JM, 2003, CURR OPIN IMMUNOL, V15, P105, DOI 10.1016/S0952-7915(02)00015-8; Cao D, 2003, EUR J IMMUNOL, V33, P215, DOI 10.1002/immu.200390024; CHANG CH, 1995, J EXP MED, V181, P765, DOI 10.1084/jem.181.2.765; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; Dahlman I, 1999, J IMMUNOL, V162, P2581; DARVASI A, 1995, GENETICS, V141, P1199; Eriksson P, 2004, ARTERIOSCL THROM VAS, V24, P551, DOI 10.1161/01.ATV.0000117180.57731.36; Flugel A, 2001, IMMUNITY, V14, P547, DOI 10.1016/s1074-7613(01)00143-1; Hammarberg H, 2000, J NEUROSCI, V20, P5283, DOI 10.1523/JNEUROSCI.20-14-05283.2000; Hegde NR, 2003, TRENDS IMMUNOL, V24, P278, DOI 10.1016/S1471-4906(03)00099-1; Jagodic M, 2004, J IMMUNOL, V173, P1366, DOI 10.4049/jimmunol.173.2.1366; Janitz M, 2001, EXP CLIN IMMUNOGENET, V18, P199, DOI 10.1159/000049198; Jobs M, 2003, GENOME RES, V13, P916, DOI 10.1101/gr.801103; Jurinke Christian, 2002, Methods Mol Biol, V187, P179; KERN I, 1995, INT IMMUNOL, V7, P1295, DOI 10.1093/intimm/7.8.1295; Khademi M, 2004, J IMMUNOL, V172, P7169, DOI 10.4049/jimmunol.172.11.7169; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Lidman O, 2003, J NEUROSCI, V23, P9817; Lundberg C, 2001, J COMP NEUROL, V431, P75; MAEHLEN J, 1988, NEUROSCI LETT, V92, P8, DOI 10.1016/0304-3940(88)90733-1; Mallat Z, 2003, CIRCULATION, V108, P1232, DOI 10.1161/01.CIR.0000089083.61317.A1; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Nagarajan UM, 2002, J IMMUNOL, V169, P5078, DOI 10.4049/jimmunol.169.9.5078; Olsson T, 2003, TRENDS IMMUNOL, V24, P5, DOI 10.1016/S1471-4906(02)00003-0; Otten LA, 1998, EUR J IMMUNOL, V28, P473, DOI 10.1002/(SICI)1521-4141(199802)28:02<473::AID-IMMU473>3.0.CO;2-E; Otten LA, 2003, J IMMUNOL, V170, P1150, DOI 10.4049/jimmunol.170.3.1150; Padyukov L, 2004, ARTHRITIS RHEUM, V50, P3085, DOI 10.1002/art.20553; Patarroyo JC, 2002, GENES IMMUN, V3, P34, DOI 10.1038/sj.gene.6363808; Piehl F, 1999, J NEUROIMMUNOL, V101, P87, DOI 10.1016/S0165-5728(99)00136-8; Rasmussen HB, 2001, HUM IMMUNOL, V62, P371, DOI 10.1016/S0198-8859(01)00215-4; Sartoris S, 2000, HUM IMMUNOL, V61, P599, DOI 10.1016/S0198-8859(00)00121-X; Schneider S., 2000, ARLEQUIN SOFTWARE PO; SEDGWICK JD, 1993, J EXP MED, V177, P1145, DOI 10.1084/jem.177.4.1145; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; STREIT WJ, 1989, J NEUROIMMUNOL, V21, P117, DOI 10.1016/0165-5728(89)90167-7; Stuve O, 2002, J IMMUNOL, V169, P6720, DOI 10.4049/jimmunol.169.12.6720; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Tompkins SM, 2002, J IMMUNOL, V168, P4173, DOI 10.4049/jimmunol.168.8.4173; Turesson C, 2004, ANN RHEUM DIS, V63, P952, DOI 10.1136/ard.2003.018101; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158	49	244	258	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2005	37	5					486	494		10.1038/ng1544	http://dx.doi.org/10.1038/ng1544			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15821736				2022-12-27	WOS:000228862300017
J	Van Driessche, N; Demsar, J; Booth, EO; Hill, P; Juvan, P; Zupan, B; Kuspa, A; Shaulsky, G				Van Driessche, N; Demsar, J; Booth, EO; Hill, P; Juvan, P; Zupan, B; Kuspa, A; Shaulsky, G			Epistasis analysis with global transcriptional phenotypes	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; GENE-EXPRESSION PATTERNS; DEPENDENT PROTEIN-KINASE; HUNCHBACK MESSENGER-RNA; DICTYOSTELIUM DEVELOPMENT; CELL-DIFFERENTIATION; DROSOPHILA EMBRYOS; DISCOIDEUM; CAMP; PUMILIO	Classical epistasis analysis can determine the order of function of genes in pathways using morphological, biochemical and other phenotypes. It requires knowledge of the pathway's phenotypic output and a variety of experimental expertise and so is unsuitable for genome-scale analysis. Here we used microarray profiles of mutants as phenotypes for epistasis analysis. Considering genes that regulate activity of protein kinase A in Dictyostelium, we identified known and unknown epistatic relationships and reconstructed a genetic network with microarray phenotypes alone. This work shows that microarray data can provide a uniform, quantitative tool for large-scale genetic network analysis.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Grad Program Dev Biol, Houston, TX 77030 USA; Univ Ljubljana, Fac Comp & Informat Sci, Ljubljana, Slovenia; Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Grad Program Struct Computat Biol & Mol Biophys, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; University of Ljubljana; Baylor College of Medicine; Baylor College of Medicine	Shaulsky, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	gadi@bcm.tmc.edu	Zupan, Blaz/L-1595-2019	Shaulsky, Gad/0000-0002-0532-0551; Juvan, Peter/0000-0003-2873-5247; Kuspa, Adam/0000-0002-9156-149X; Zupan, Blaz/0000-0002-5864-7056	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD039691] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD039691] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABE K, 1983, DEV BIOL, V95, P200, DOI 10.1016/0012-1606(83)90018-0; Alizadeh AA, 2000, CURR OPIN IMMUNOL, V12, P219, DOI 10.1016/S0952-7915(99)00078-3; ANJARD C, 1992, DEVELOPMENT, V115, P785; Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; AVERY L, 1992, TRENDS GENET, V8, P312, DOI 10.1016/0168-9525(92)90263-4; DEGUNZBURG J, 1986, EMBO J, V5, P363, DOI 10.1002/j.1460-2075.1986.tb04220.x; DEMSAR J, 2001, MEDINFO, V10, P956; Efron B, 1996, P NATL ACAD SCI USA, V93, P13429, DOI 10.1073/pnas.93.23.13429; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Katoh M, 2004, P NATL ACAD SCI USA, V101, P7005, DOI 10.1073/pnas.0306983101; Kibler K, 2003, DEV BIOL, V264, P506, DOI 10.1016/j.ydbio.2003.08.025; Kibler K, 2003, DEV BIOL, V259, P193, DOI 10.1016/S0012-1606(03)00204-5; King RD, 2004, NATURE, V427, P247, DOI 10.1038/nature02236; Kniesmeijer Joke, 1987, PAROOL 1109; Loomis WF, 1998, MICROBIOL MOL BIOL R, V62, P684, DOI 10.1128/MMBR.62.3.684-694.1998; Loomis WF., 1975, DICTYOSTELIUM DISCOI; MANN SKO, 1992, P NATL ACAD SCI USA, V89, P10701, DOI 10.1073/pnas.89.22.10701; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Shaulsky G, 2002, PROTIST, V153, P93, DOI 10.1078/1434-4610-00087; SHAULSKY G, 1993, DEV BIOL, V160, P85, DOI 10.1006/dbio.1993.1288; Shaulsky G, 1998, DEVELOPMENT, V125, P691; Shaulsky G, 1996, P NATL ACAD SCI USA, V93, P15260, DOI 10.1073/pnas.93.26.15260; SIMON MN, 1992, NATURE, V356, P171, DOI 10.1038/356171a0; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; Souza GM, 1998, DEVELOPMENT, V125, P2291; Souza GM, 1999, DEVELOPMENT, V126, P3263; Spassov DS, 2003, IUBMB LIFE, V55, P359, DOI 10.1080/15216540310001603093; Thomason PA, 1998, EMBO J, V17, P2838, DOI 10.1093/emboj/17.10.2838; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Van Driessche N, 2002, DEVELOPMENT, V129, P1543; Wang B, 2002, EUKARYOT CELL, V1, P126, DOI 10.1128/EC.1.1.126-136.2002; Wang B, 1997, SCIENCE, V277, P251, DOI 10.1126/science.277.5323.251; WETTERAUER BW, 1995, BBA-MOL CELL RES, V1265, P97, DOI 10.1016/0167-4889(94)00241-6; WHARTON RP, 1991, CELL, V67, P955, DOI 10.1016/0092-8674(91)90368-9; Wharton RP, 1998, MOL CELL, V1, P863, DOI 10.1016/S1097-2765(00)80085-4; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zupan B, 2003, BIOINFORMATICS, V19, P383, DOI 10.1093/bioinformatics/btf871	47	76	80	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2005	37	5					471	477		10.1038/ng1545	http://dx.doi.org/10.1038/ng1545			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15821735				2022-12-27	WOS:000228862300015
J	Yu, XC; Minter-Dykhouse, K; Malureanu, L; Zhao, WM; Zhang, DW; Merkle, CJ; Ward, IM; Saya, H; Fang, GW; van Deursen, J; Chen, JJ				Yu, XC; Minter-Dykhouse, K; Malureanu, L; Zhao, WM; Zhang, DW; Merkle, CJ; Ward, IM; Saya, H; Fang, GW; van Deursen, J; Chen, JJ			Chfr is required for tumor suppression and Aurora A regulation	NATURE GENETICS			English	Article							SPINDLE ASSEMBLY CHECKPOINT; MITOTIC STRESS CHECKPOINT; CENTROSOME AMPLIFICATION; EPIGENETIC INACTIVATION; LUNG-CANCER; CPG ISLAND; GENE; KINASE; HYPERMETHYLATION; PROTEIN	Tumorigenesis is a consequence of loss of tumor suppressors and activation of oncogenes. Expression of the mitotic checkpoint protein Chfr is lost in 20 - 50% of primary tumors and tumor cell lines. To explore whether downregulation of Chfr contributes directly to tumorigenesis, we generated Chfr knockout mice. Chfr-deficient mice are cancer-prone, develop spontaneous tumors and have increased skin tumor incidence after treatment with dimethylbenz( a) anthracene. Chfr deficiency leads to chromosomal instability in embryonic fibroblasts and regulates the mitotic kinase Aurora A, which is frequently upregulated in a variety of tumors. Chfr physically interacts with Aurora A and ubiquitinates Aurora A both in vitro and in vivo. Collectively, our data suggest that Chfr is a tumor suppressor and ensures chromosomal stability by controlling the expression levels of key mitotic proteins such as Aurora A.	Mayo Clin & Mayo Fdn, Dept Oncol, Rochester, MN 55905 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Kumamoto Univ, Dept Tumor Genet & Biol, Kumamoto 8608556, Japan	Mayo Clinic; Stanford University; Kumamoto University	Chen, JJ (corresponding author), Mayo Clin & Mayo Fdn, Dept Oncol, 200 1st St SW, Rochester, MN 55905 USA.	chen.junjie@mayo.edu	Saya, Hideyuki/J-4325-2013; Minter Dykhouse, Katherine/L-4573-2013	Minter Dykhouse, Katherine/0000-0003-4363-5826				Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chan Gordon K, 2003, Prog Cell Cycle Res, V5, P431; Chaturvedi P, 2002, CANCER RES, V62, P1797; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Corn PG, 2003, CARCINOGENESIS, V24, P47, DOI 10.1093/carcin/24.1.47; Erson AE, 2004, MOL CARCINOGEN, V39, P26, DOI 10.1002/mc.10161; Ewart-Toland A, 2003, NAT GENET, V34, P403, DOI 10.1038/ng1220; Guertin DA, 2002, DEV CELL, V3, P779, DOI 10.1016/S1534-5807(02)00367-2; Imai Y, 1999, JPN J CANCER RES, V90, P837, DOI 10.1111/j.1349-7006.1999.tb00824.x; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; Littlepage LE, 2002, P NATL ACAD SCI USA, V99, P15440, DOI 10.1073/pnas.202606599; Mariatos G, 2003, CANCER RES, V63, P7185; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Mizuno K, 2002, ONCOGENE, V21, P2328, DOI 10.1038/sj.onc.1205402; Murone M, 1996, EMBO J, V15, P6605, DOI 10.1002/j.1460-2075.1996.tb01051.x; Satoh A, 2003, CANCER RES, V63, P8606; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Shibata Y, 2002, CARCINOGENESIS, V23, P1695, DOI 10.1093/carcin/23.10.1695; Stavridi ES, 2002, STRUCTURE, V10, P891, DOI 10.1016/S0969-2126(02)00776-1; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Toyota M, 2003, P NATL ACAD SCI USA, V100, P7818, DOI 10.1073/pnas.1337066100; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	30	159	167	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2005	37	4					401	406		10.1038/ng1538	http://dx.doi.org/10.1038/ng1538			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15793587				2022-12-27	WOS:000228040000023
J	Loeys, BL; Chen, JJ; Neptune, ER; Judge, DP; Podowski, M; Holm, T; Meyers, J; Leitch, CC; Katsanis, N; Sharifi, N; Xu, FL; Myers, LA; Spevak, PJ; Cameron, DE; De Backer, J; Hellemans, J; Chen, Y; Davis, EC; Webb, CL; Kress, W; Coucke, P; Rifkin, DB; De Paepe, AM; Dietz, HC				Loeys, BL; Chen, JJ; Neptune, ER; Judge, DP; Podowski, M; Holm, T; Meyers, J; Leitch, CC; Katsanis, N; Sharifi, N; Xu, FL; Myers, LA; Spevak, PJ; Cameron, DE; De Backer, J; Hellemans, J; Chen, Y; Davis, EC; Webb, CL; Kress, W; Coucke, P; Rifkin, DB; De Paepe, AM; Dietz, HC			A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2	NATURE GENETICS			English	Article							GROWTH-FACTOR-BETA; MARFAN-SYNDROME; TRANSGENIC MICE; ACTIVATION; RECEPTOR; FIBRILLIN; GENE; INACTIVATION; PATHOGENESIS; EXPRESSION	We report heterozygous mutations in the genes encoding either type I or type II transforming growth factor beta receptor in ten families with a newly described human phenotype that includes widespread perturbations in cardiovascular, craniofacial, neurocognitive and skeletal development. Despite evidence that receptors derived from selected mutated alleles cannot support TGFbeta signal propagation, cells derived from individuals heterozygous with respect to these mutations did not show altered kinetics of the acute phase response to administered ligand. Furthermore, tissues derived from affected individuals showed increased expression of both collagen and connective tissue growth factor, as well as nuclear enrichment of phosphorylated Smad2, indicative of increased TGFbeta signaling. These data definitively implicate perturbation of TGFbeta signaling in many common human phenotypes, including craniosynostosis, cleft palate, arterial aneurysms, congenital heart disease and mental retardation, and suggest that comprehensive mechanistic insight will require consideration of both primary and compensatory events.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Div Pediat Cardiol, Baltimore, MD USA; Johns Hopkins Univ, Sch Med, Div Cardiac Surg, Baltimore, MD USA; Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Med, New York, NY 10016 USA; McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; Northwestern Univ, Childrens Mem Hosp, Sch Med, Div Cardiol, Chicago, IL 60614 USA; Univ Wurzburg, Inst Human Genet, D-8700 Wurzburg, Germany	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Ghent University; Ghent University Hospital; New York University; New York University; McGill University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; University of Wurzburg	Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	hdietz@jhmi.edu	De Backer, Julie/B-2897-2014; Davis, Elaine/F-3449-2012; Coucke, Paul J/AAO-2954-2020; Katsanis, Nicholas/E-1837-2012; Loeys, Bart/B-3236-2017	De Backer, Julie/0000-0001-8878-1507; Coucke, Paul J/0000-0001-7119-586X; Loeys, Bart/0000-0003-3703-9518; Judge, Daniel/0000-0002-3407-0248; Katsanis, Nicholas/0000-0002-2480-0171				Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Azhar M, 2003, CYTOKINE GROWTH F R, V14, P391, DOI 10.1016/S1359-6101(03)00044-3; Bottinger EP, 1997, EMBO J, V16, P2621, DOI 10.1093/emboj/16.10.2621; Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000; Cohen MM, 2003, AM J MED GENET A, V116A, P1, DOI 10.1002/ajmg.a.10750; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Denton CP, 2003, J BIOL CHEM, V278, P25109, DOI 10.1074/jbc.M300636200; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Grady WM, 1999, CANCER RES, V59, P320; Greally MT, 1998, AM J MED GENET, V76, P202, DOI 10.1002/(SICI)1096-8628(19980319)76:3<202::AID-AJMG2>3.0.CO;2-S; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Kaartinen V, 2003, NAT GENET, V33, P331, DOI 10.1038/ng0303-331; Koli K, 2004, J CELL BIOL, V167, P123, DOI 10.1083/jcb.200403067; Kouchoukos NT, 1997, NEW ENGL J MED, V336, P1876, DOI 10.1056/NEJM199706263362606; Leask A, 2001, J CLIN PATHOL-MOL PA, V54, P180, DOI 10.1136/mp.54.3.180; Loeys B, 2004, HUM MUTAT, V24, P140, DOI 10.1002/humu.20070; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Sanford LP, 1997, DEVELOPMENT, V124, P2659; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x	26	1159	1208	2	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					275	281		10.1038/ng1511	http://dx.doi.org/10.1038/ng1511			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15731757	Green Published			2022-12-27	WOS:000227297800018
J	Fong, SS; Palsson, BO				Fong, SS; Palsson, BO			Metabolic gene-deletion strains of Escherichia coli evolve to computationally predicted growth phenotypes	NATURE GENETICS			English	Article							ADAPTIVE EVOLUTION; CAPABILITIES; MG1655; MODELS	Genome-scale metabolic models have a promising ability to describe cellular phenotypes accurately. Here we show that strains of Escherichia coli carrying a deletion of a single metabolic gene increase their growth rates (by 87% on average) during adaptive evolution and that the endpoint growth rates can be predicted computationally in 39 of 50 (78%) strains tested. These results show that computational models can be used to predict the eventual effects of genetic modifications.	Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Palsson, BO (corresponding author), Univ Calif San Diego, Dept Bioengn, 9500 Gilman Dr, La Jolla, CA 92093 USA.	palsson@ucsd.edu		Palsson, Bernhard/0000-0003-2357-6785				COOPER RA, 1970, FEBS LETT, V11, P273, DOI 10.1016/0014-5793(70)80546-4; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Edwards J., 1999, METABOLIC ENG; Edwards JS, 2000, BMC BIOINFORMATICS, V1, DOI 10.1186/1471-2105-1-1; Edwards JS, 2000, P NATL ACAD SCI USA, V97, P5528, DOI 10.1073/pnas.97.10.5528; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Fong SS, 2003, J BACTERIOL, V185, P6400, DOI 10.1128/JB.185.21.6400-6408.2003; Forster Jochen, 2003, OMICS A Journal of Integrative Biology, V7, P193, DOI 10.1089/153623103322246584; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Price ND, 2003, TRENDS BIOTECHNOL, V21, P162, DOI 10.1016/S0167-7799(03)00030-1; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54	12	225	272	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2004	36	10					1056	1058		10.1038/ng1432	http://dx.doi.org/10.1038/ng1432			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	15448692	Bronze			2022-12-27	WOS:000224156500011
J	Chin, K; de Solorzano, CO; Knowles, D; Jones, A; Chou, W; Rodriguez, EG; Kuo, WL; Ljung, BM; Chew, K; Myambo, K; Miranda, M; Krig, S; Garbe, J; Stampfer, M; Yaswen, P; Gray, JW; Lockett, SJ				Chin, K; de Solorzano, CO; Knowles, D; Jones, A; Chou, W; Rodriguez, EG; Kuo, WL; Ljung, BM; Chew, K; Myambo, K; Miranda, M; Krig, S; Garbe, J; Stampfer, M; Yaswen, P; Gray, JW; Lockett, SJ			In situ analyses of genome instability in breast cancer	NATURE GENETICS			English	Article							MAMMARY EPITHELIAL-CELLS; TELOMERE DYSFUNCTION; HYBRIDIZATION; CARCINOMA; AMPLIFICATION; EXPRESSION; EVOLUTION; OCCURS; MICE	Transition through telomere crisis is thought to be a crucial event in the development of most breast carcinomas. Our goal in this study was to determine where this occurs in the context of histologically defined breast cancer progression. To this end, we assessed genome instability (using fluorescence in situ hybridization) and other features associated with telomere crisis in normal ductal epithelium, usual ductal hyperplasia, ductal carcinoma in situ and invasive cancer. We modeled this process in vitro by measuring these same features in human mammary epithelial cell cultures during ZNF217-mediated transition through telomere crisis and immortalization. Taken together, the data suggest that transition through telomere crisis and immortalization in breast cancer occurs during progression from usual ductal hyperplasia to ductal carcinoma in situ.	Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Engn, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Gray, JW (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	jwgray@lbl.gov	Gray, Joe/AAX-9549-2020; Ortiz-de-Solorzano, Carlos/G-3278-2010	Ortiz-de-Solorzano, Carlos/0000-0001-8720-0205	NATIONAL CANCER INSTITUTE [R01CA101359, R01CA090421] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA090421, R01 CA101359] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; de Solorzano CO, 1999, J MICROSC-OXFORD, V193, P212, DOI 10.1046/j.1365-2818.1999.00463.x; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herbert BS, 2001, BREAST CANCER RES, V3, P146, DOI 10.1186/bcr288; Holst CR, 2003, CANCER RES, V63, P1596; ISOLA JJ, 1995, AM J PATHOL, V147, P905; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; KALLIONIEMI OP, 1992, P NATL ACAD SCI USA, V89, P5321, DOI 10.1073/pnas.89.12.5321; Kelland LR, 2001, LANCET ONCOL, V2, P95, DOI 10.1016/S1470-2045(00)00226-6; Kim MM, 2001, P NATL ACAD SCI USA, V98, P7982, DOI 10.1073/pnas.131211098; Kuukasjarvi T, 1997, CANCER RES, V57, P1597; Kuukasjarvi T, 1997, AM J PATHOL, V150, P1465; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Meeker AK, 2004, AM J PATHOL, V164, P925, DOI 10.1016/S0002-9440(10)63180-X; Nishizaki T, 1997, GENE CHROMOSOME CANC, V19, P267, DOI 10.1002/(SICI)1098-2264(199708)19:4<267::AID-GCC9>3.0.CO;2-V; Nonet GH, 2001, CANCER RES, V61, P1250; O'Connell P, 1998, JNCI-J NATL CANCER I, V90, P697, DOI 10.1093/jnci/90.9.697; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Takimoto R, 2002, CANCER BIOL THER, V1, P47, DOI 10.4161/cbt.1.1.41; THOMPSON CT, 1994, AM J PATHOL, V144, P237; Waldman FM, 2000, JNCI-J NATL CANCER I, V92, P313, DOI 10.1093/jnci/92.4.313; Yashima K, 1998, CLIN CANCER RES, V4, P229	30	290	304	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					984	988		10.1038/ng1409	http://dx.doi.org/10.1038/ng1409			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15300252	Bronze			2022-12-27	WOS:000223658100025
J	O'Sullivan, JM; Tan-Wong, SM; Morillon, A; Lee, B; Coles, J; Mellor, J; Proudfoot, NJ				O'Sullivan, JM; Tan-Wong, SM; Morillon, A; Lee, B; Coles, J; Mellor, J; Proudfoot, NJ			Gene loops juxtapose promoters and terminators in yeast	NATURE GENETICS			English	Article							RNA-POLYMERASE-II; 3 END; TRANSCRIPTION; SSU72; POLYADENYLATION; ARCHITECTURE; ELONGATION; COMPLEXES	Mechanistic analysis of transcriptional initiation and termination by RNA polymerase II (PolII) indicates that some factors are common to both processes(1,2). Here we show that two long genes of Saccharomyces cerevisiae, FMP27 and SEN1, exist in a looped conformation, effectively bringing together their promoter and terminator regions. We also show that PolII is located at both ends of FMP27 when this gene is transcribed from a GAL1 promoter under induced and noninduced conditions. Under these conditions, the C-terminal domain of the large subunit of PolII is phosphorylated at Ser5. Notably, inactivation of Kin28p causes a loss of both Ser5 phosphorylation and the loop conformation. These data suggest that gene loops are involved in the early stages of transcriptional activation. They also predict a previously unknown structural dimension to gene regulation, in which both ends of the transcription unit are defined before and during the transcription cycle.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Oxford, Dept Biochem, Oxford OX1 3RE, England	University of Oxford; University of Oxford	Proudfoot, NJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	nicholas.proudfoot@path.ox.ac.uk	O'Sullivan, Justin/HDO-1639-2022; Morillon, Antonin/M-4751-2017	O'Sullivan, Justin/0000-0003-2927-450X; Morillon, Antonin/0000-0002-0575-5264; Proudfoot, Nicholas/0000-0001-8646-3222				Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bhat PJ, 2001, MOL MICROBIOL, V40, P1059, DOI 10.1046/j.1365-2958.2001.02421.x; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Calvo O, 2001, MOL CELL, V7, P1013, DOI 10.1016/S1097-2765(01)00236-2; Calvo O, 2003, GENE DEV, V17, P1321, DOI 10.1101/gad.1093603; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Dieci G, 2003, TRENDS BIOCHEM SCI, V28, P202, DOI 10.1016/S0968-0004(03)00054-9; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756; Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141; He XY, 2003, GENE DEV, V17, P1030, DOI 10.1101/gad.1075203; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Morillon A, 2003, CELL, V115, P425, DOI 10.1016/S0092-8674(03)00880-8; Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1	27	270	276	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					1014	1018		10.1038/ng1411	http://dx.doi.org/10.1038/ng1411			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15314641	Bronze			2022-12-27	WOS:000223658100031
J	Keurentjes, JJB; Fu, JY; de Vos, CHR; Lommen, A; Hall, RD; Bino, RJ; van der Plas, LHW; Jansen, RC; Vreugdenhil, D; Koornneef, M				Keurentjes, Joost J. B.; Fu, Jingyuan; Ric de Vos, C. H.; Lommen, Arjen; Hall, Robert D.; Bino, Raoul J.; van der Plas, Linus H. W.; Jansen, Ritsert C.; Vreugdenhil, Dick; Koornneef, Maarten			The genetics of plant metabolism	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; INTEGRATIVE GENOMICS APPROACH; ARABIDOPSIS-THALIANA; SECONDARY METABOLISM; SHOOT DEVELOPMENT; EXPRESSION; DIVERSIFICATION; CONSTRUCTION; METABOLOMICS; ASSOCIATIONS	Variation for metabolite composition and content is often observed in plants. However, it is poorly understood to what extent this variation has a genetic basis. Here, we describe the genetic analysis of natural variation in the metabolite composition in Arabidopsis thaliana. Instead of focusing on specific metabolites, we have applied empirical untargeted metabolomics using liquid chromatography-time of flight mass spectrometry (LC-QTOF MS). This uncovered many qualitative and quantitative differences in metabolite accumulation between A. thaliana accessions. Only 13.4% of the mass peaks were detected in all 14 accessions analyzed. Quantitative trait locus (QTL) analysis of more than 2,000 mass peaks, detected in a recombinant inbred line (RIL) population derived from the two most divergent accessions, enabled the identification of QTLs for about 75% of the mass signals. More than one-third of the signals were not detected in either parent, indicating the large potential for modification of metabolic composition through classical breeding.	Univ Wageningen & Res Ctr, Genet Lab, NL-6703 BD Wageningen, Netherlands; Univ Wageningen & Res Ctr, Lab Plant Physiol, NL-6703 BD Wageningen, Netherlands; Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen Bioinformat Ctr, NL-9751 NN Haren, Netherlands; Plant Res Int, NL-6708 PB Wageningen, Netherlands; Ctr Biosyst Genom, NL-6708 PB Wageningen, Netherlands; RIKILT, Inst Food Safety, NL-6700 AE Wageningen, Netherlands; Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany	Wageningen University & Research; Wageningen University & Research; University of Groningen; Centre for BioSystems Genomics; Wageningen University & Research; Max Planck Society	Koornneef, M (corresponding author), Univ Wageningen & Res Ctr, Genet Lab, Arboretumlaan 4, NL-6703 BD Wageningen, Netherlands.	maarten.koornneef@wur.nl	Jansen, Ritsert C/C-1160-2013; Fu, JY/GRR-6179-2022; HALL, ROBERT D/B-8707-2015; De Vos, Ric/F-5012-2017; Fu, Jingyuan/E-8980-2012; Fu, Jingyuan/ABE-6868-2020	Jansen, Ritsert C/0000-0003-2977-9110; HALL, ROBERT D/0000-0002-5786-768X; Fu, Jingyuan/0000-0001-5578-1236; Keurentjes, Joost/0000-0001-8918-0711; Koornneef, Maarten/0000-0002-7759-4869				Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; Alonso-Blanco C, 1998, PLANT J, V14, P259, DOI 10.1046/j.1365-313X.1998.00115.x; Bentsink L, 2000, PLANT PHYSIOL, V124, P1595, DOI 10.1104/pp.124.4.1595; Bing N, 2005, GENETICS, V170, P533, DOI 10.1534/genetics.105.041103; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Broman KW, 2003, GENETICS, V163, P1169; D'Auria JC, 2005, CURR OPIN PLANT BIOL, V8, P308, DOI 10.1016/j.pbi.2005.03.012; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; DeCook R, 2006, GENETICS, V172, P1155, DOI 10.1534/genetics.105.042275; Dixon RA, 2005, CURR OPIN PLANT BIOL, V8, P329, DOI 10.1016/j.pbi.2005.03.008; Hobbs DH, 2004, PLANT PHYSIOL, V136, P3341, DOI 10.1104/pp.104.049486; JANSEN RC, 1993, GENETICS, V135, P205; Jansen RC, 2003, NAT REV GENET, V4, P145, DOI 10.1038/nrg996; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Kliebenstein DJ, 2001, GENETICS, V159, P359; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.010416; Lall S, 2004, GENETICS, V167, P1883, DOI 10.1534/genetics.103.025213; Li Y, 2001, J BIOL CHEM, V276, P4338, DOI 10.1074/jbc.M007447200; Lim EK, 2004, BIOTECHNOL BIOENG, V87, P623, DOI 10.1002/bit.20154; Loudet O, 2003, PLANT PHYSIOL, V131, P345, DOI 10.1104/pp.102.010785; Lumba S, 2005, CURR OPIN PLANT BIOL, V8, P501, DOI 10.1016/j.pbi.2005.07.015; McCullagh P., 1989, GENERALIZED LINEAR M, DOI DOI 10.1007/978-1-4899-3242-6; Mita S, 1997, PLANT J, V11, P841, DOI 10.1046/j.1365-313X.1997.11040841.x; Mitchell-Olds T, 1998, GENETICS, V149, P739; Oksman-Caldentey KM, 2005, CURR OPIN BIOTECH, V16, P174, DOI 10.1016/j.copbio.2005.02.007; Reichelt M, 2002, PHYTOCHEMISTRY, V59, P663, DOI 10.1016/S0031-9422(02)00014-6; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tikunov Y, 2005, PLANT PHYSIOL, V139, P1125, DOI 10.1104/pp.105.068130; Vorst O, 2005, METABOLOMICS, V1, P169, DOI 10.1007/s11306-005-4432-7; Windsor AJ, 2005, PHYTOCHEMISTRY, V66, P1321, DOI 10.1016/j.phytochem.2005.04.016; WINK M, 1988, THEOR APPL GENET, V75, P225, DOI 10.1007/BF00303957; Zhu J, 2004, CYTOGENET GENOME RES, V105, P363, DOI 10.1159/000078209	39	358	381	1	124	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					842	849		10.1038/ng1815	http://dx.doi.org/10.1038/ng1815			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16751770	Green Published			2022-12-27	WOS:000238669300023
J	Henderson, IR; Zhang, XY; Lu, C; Johnson, L; Meyers, BC; Green, PJ; Jacobsen, SE				Henderson, Ian R.; Zhang, Xiaoyu; Lu, Cheng; Johnson, Lianna; Meyers, Blake C.; Green, Pamela J.; Jacobsen, Steven E.			Dissecting Arabidopsis thaliana DICER function in small RNA processing, gene silencing and DNA methylation patterning	NATURE GENETICS			English	Article							TRANS-ACTING SIRNAS; INTERFERING RNA; DE-NOVO; BIOGENESIS; GENOME; METHYLTRANSFERASE; DICER-LIKE-4; MAINTENANCE; COMPONENT	Small RNAs have several important biological functions(1). MicroRNAs (miRNAs) and trans-acting small interfering RNAs (tasiRNAs) regulate mRNA stability and translation, and siRNAs cause post-transcriptional gene silencing of transposons, viruses and transgenes and are important in both the establishment and maintenance of cytosine DNA methylation(2). Here, we study the role of the four Arabidopsis thaliana DICER-LIKE genes (DCL1-DCL4) in these processes. Sequencing of small RNAs from a dcl2 dcl3 dcl4 triple mutant showed markedly reduced tasiRNA and siRNA production and indicated that DCL1, in addition to its role as the major enzyme for processing miRNAs, has a previously unknown role in the production of small RNAs from endogenous inverted repeats. DCL2, DCL3 and DCL4 showed functional redundancy in siRNA and tasiRNA production and in the establishment and maintenance of DNA methylation. Our studies also suggest that asymmetric DNA methylation can be maintained by pathways that do not require siRNAs.	Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Delaware Biotechnol Inst, Newark, DE 19714 USA; Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19714 USA; Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of Delaware; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu	Zhang, xiaoyu/GXA-3206-2022; Henderson, Ian/A-2174-2012; Meyers, Blake/B-6535-2012	Meyers, Blake/0000-0003-3436-6097; Henderson, Ian/0000-0001-5066-1489	NIGMS NIH HHS [GM60398] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM060398, R01GM060398] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Liu B, 2005, PLANT PHYSIOL, V139, P296, DOI 10.1104/pp.105.063420; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Pradhan S, 1999, J BIOL CHEM, V274, P33002, DOI 10.1074/jbc.274.46.33002; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; SCHANK RC, 1991, J LEARN SCI, V1, P7; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Valoczi A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh171; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	29	438	456	4	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2006	38	6					721	725		10.1038/ng1804	http://dx.doi.org/10.1038/ng1804			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16699516				2022-12-27	WOS:000237954800030
J	Rohmann, E; Brunner, HG; Kayserili, H; Uyguner, O; Nurnberg, G; Lew, ED; Dobbie, A; Eswarakumar, VP; Uzumcu, A; Ulubil-Emeroglu, M; Leroy, JG; Li, Y; Becker, C; Lehnerdt, K; Cremers, CWRJ; Yuksel-Apak, M; Nurnberg, P; Kubisch, C; Schlessinger, J; van Bokhoven, H; Wollnik, B				Rohmann, E; Brunner, HG; Kayserili, H; Uyguner, O; Nurnberg, G; Lew, ED; Dobbie, A; Eswarakumar, VP; Uzumcu, A; Ulubil-Emeroglu, M; Leroy, JG; Li, Y; Becker, C; Lehnerdt, K; Cremers, CWRJ; Yuksel-Apak, M; Nurnberg, P; Kubisch, C; Schlessinger, J; van Bokhoven, H; Wollnik, B			Mutations in different components of FGF signaling in LADD syndrome	NATURE GENETICS			English	Article							DENTO-DIGITAL SYNDROME; PATERNAL ORIGIN; RECEPTORS; ANOMALIES	Lacrimo-auriculo-dento-digital (LADD) syndrome is characterized by lacrimal duct aplasia, malformed ears and deafness, small teeth and digital anomalies. We identified heterozygous mutations in the tyrosine kinase domains of the genes encoding fibroblast growth factor receptors 2 and 3 (FGFR2, FGFR3) in LADD families, and in one further LADD family, we detected a mutation in the gene encoding fibroblast growth factor 10 (FGF10), a known FGFR ligand. These findings increase the spectrum of anomalies associated with abnormal FGF signaling.	Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; Radboud Univ Nijmegen Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34390 Istanbul, Turkey; Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany; RZPD Deutsch Ressourcenzentrum Genomforsch GmbH, D-14059 Berlin, Germany; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; St Jamess Univ Hosp, Genet Serv, Leeds LS9 7TS, W Yorkshire, England; Istanbul Univ, Istanbul Fac Med, Dept Ear Nose & Throat, TR-34390 Istanbul, Turkey; State Univ Ghent Hosp, Dept Med Genet, B-9000 Ghent, Belgium; Klinikum Dortmund, HNO Abt, D-44137 Dortmund, Germany; Univ Cologne, Inst Genet, D-5000 Cologne, Germany	University of Cologne; University of Cologne; Radboud University Nijmegen; Istanbul University; University of Cologne; Yale University; Saint James's University Hospital; University of Leeds; Istanbul University; Ghent University; Ghent University Hospital; Klinikum Dortmund; University of Cologne	Wollnik, B (corresponding author), Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany.	bwollnik@uni-koeln.de	van Bokhoven, Hans/D-8764-2012; Kubisch, Christian/F-1893-2011; Cremers, C.W.R.J./L-4254-2015; UYGUNER, OYA Z/Y-3899-2018; Wollnik, Bernd/GRY-6062-2022; Bokhoven, J.H.L.M. van van/H-8015-2014; Brunner, Han/C-9928-2013	Kubisch, Christian/0000-0003-4220-0978; Wollnik, Bernd/0000-0003-2589-0364; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Eswarakumar, Jacob/0000-0003-0784-0507; Eswarakumar, V.P./0000-0001-7941-8714; Uyguner, Zehra Oya/0000-0002-2035-4338	NIAMS NIH HHS [R01-AR051886, R01-AR051448] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051448, R01AR051886] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BAMFORTH JS, 1992, AM J MED GENET, V43, P932, DOI 10.1002/ajmg.1320430605; Coumoul X, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni100; Entesarian M, 2005, NAT GENET, V37, P125, DOI 10.1038/ng1507; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Glaser RL, 2000, AM J HUM GENET, V66, P768, DOI 10.1086/302831; Gorivodsky M, 2003, DEVELOPMENT, V130, P5471, DOI 10.1242/dev.00795; HOLLISTER DW, 1973, J PEDIATR-US, V83, P438, DOI 10.1016/S0022-3476(73)80268-9; Kan S, 2002, AM J HUM GENET, V70, P472, DOI 10.1086/338758; Legeai-Mallet L, 2004, BONE, V34, P26, DOI 10.1016/j.bone.2003.09.002; LEVY WJ, 1967, AM J OPHTHALMOL, V63, P978, DOI 10.1016/0002-9394(67)90043-8; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; Steinberg Z, 2005, DEVELOPMENT, V132, P1223, DOI 10.1242/dev.01690; Wilkie AOM, 2005, CYTOKINE GROWTH F R, V16, P187, DOI 10.1016/j.cytogfr.2005.03.001; Wilkie AOM, 2002, AM J MED GENET, V112, P266, DOI 10.1002/ajmg.10775	14	139	148	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2006	38	4					414	417		10.1038/ng1757	http://dx.doi.org/10.1038/ng1757			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	026LN	16501574				2022-12-27	WOS:000236340500012
J	Gandhi, TKB; Zhong, J; Mathivanan, S; Karthick, L; Chandrika, KN; Mohan, SS; Sharma, S; Pinkert, S; Nagaraju, S; Periaswamy, B; Mishra, G; Nandakumar, K; Shen, BY; Deshpande, N; Nayak, R; Sarker, M; Boeke, JD; Parmigiani, G; Schultz, J; Bader, JS; Pandey, A				Gandhi, TKB; Zhong, J; Mathivanan, S; Karthick, L; Chandrika, KN; Mohan, SS; Sharma, S; Pinkert, S; Nagaraju, S; Periaswamy, B; Mishra, G; Nandakumar, K; Shen, BY; Deshpande, N; Nayak, R; Sarker, M; Boeke, JD; Parmigiani, G; Schultz, J; Bader, JS; Pandey, A			Analysis of the human protein interactome and comparison with yeast, worm and fly interaction datasets	NATURE GENETICS			English	Article							INTERACTION MAPS; ATPASE SUBUNITS; IDENTIFICATION; DATABASE; NETWORK; COMPLEX; GENES; PROTEASOME; CLONING; MEMBER	We present the first analysis of the human proteome with regard to interactions between proteins. We also compare the human interactome with the available interaction datasets from yeast (Saccharomyces cerevisiae), worm (Caenorhabditis elegans) and fly (Drosophila melanogaster). Of > 70,000 binary interactions, only 42 were common to human, worm and fly, and only 16 were common to all four datasets. An additional 36 interactions were common to fly and worm but were not observed in humans, although a coimmunoprecipitation assay showed that 9 of the interactions do occur in humans. A re-examination of the connectivity of essential genes in yeast and humans indicated that the available data do not support the presumption that the number of interaction partners can accurately predict whether a gene is essential. Finally, we found that proteins encoded by genes mutated in inherited genetic disorders are likely to interact with proteins known to cause similar disorders, suggesting the existence of disease subnetworks. The human interaction map constructed from our analysis should facilitate an integrative systems biology approach to elucidating the cellular networks that contribute to health and disease states.	Inst Bioinformat, Bangalore 560066, Karnataka, India; Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA; Univ Wurzburg, Biozentrum, Dept Bioinformat, D-97074 Wurzburg, Germany; Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; Johns Hopkins Univ, High Throughput Biol Ctr, Baltimore, MD USA; Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD USA; Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Wurzburg; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Pandey, A (corresponding author), Inst Bioinformat, Int Technol Pk, Bangalore 560066, Karnataka, India.	pandey@jhmi.edu	Bader, Joel/A-1818-2009; Zhong, Jun/D-1662-2010; Pinkert, Stefan/A-5534-2009; Mathivanan, Suresh/D-2045-2009; Schultz, Joerg/B-9346-2008; Pandey, Akhilesh/B-4127-2009	Bader, Joel/0000-0002-6020-4625; Zhong, Jun/0000-0003-3148-4143; Mathivanan, Suresh/0000-0002-7290-5795; Pandey, Akhilesh/0000-0001-9943-6127; T. K. Boopathy, Gandhi/0000-0002-1821-9540; Deshpande, Chandrika/0000-0002-5557-519X; Nandakumar, Kannabiran/0000-0001-7185-8483; Boeke, Jef/0000-0001-5322-4946	NCRR NIH HHS [U54RR020839] Funding Source: Medline; NIGMS NIH HHS [R41 GM073492, R01 GM067761] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R41GM073492, R01GM067761] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Arking DE, 2004, CIRC RES, V94, P712, DOI 10.1161/01.RES.0000123861.16082.95; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Coulomb S, 2005, P ROY SOC B-BIOL SCI, V272, P1721, DOI 10.1098/rspb.2005.3128; Cox DR., 1970, ANAL BINARY DATA; Egan J.P., 1975, SIGNAL DETECTION THE; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fujiwara T, 1996, FEBS LETT, V387, P184, DOI 10.1016/0014-5793(96)00489-9; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gorbea C, 2000, J BIOL CHEM, V275, P875, DOI 10.1074/jbc.275.2.875; Guldener U, 2005, NUCLEIC ACIDS RES, V33, pD364, DOI 10.1093/nar/gki053; HAFT CR, 1994, J BIOL CHEM, V269, P26286; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hazbun TR, 2001, P NATL ACAD SCI USA, V98, P4277, DOI 10.1073/pnas.091096398; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hollander M, 1973, NONPARAMETRIC STAT M, P27; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Ishizuka T, 2001, MOL ENDOCRINOL, V15, P1329, DOI 10.1210/me.15.8.1329; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kataoka N, 2001, EMBO J, V20, P6424, DOI 10.1093/emboj/20.22.6424; Legrain P, 2000, FEBS LETT, V480, P32, DOI 10.1016/S0014-5793(00)01774-9; Lehner B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r63; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Mrowka R, 2001, GENOME RES, V11, P1971, DOI 10.1101/gr.206701; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Pandey A, 2002, ONCOGENE, V21, P3939, DOI 10.1038/sj.onc.1205478; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Richmond C, 1997, J BIOL CHEM, V272, P13403, DOI 10.1074/jbc.272.20.13403; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; STAYON CA, 2004, GENOME BIOL, V5, pR96; Sun WY, 2004, CANCER LETT, V212, P83, DOI 10.1016/j.canlet.2004.03.023; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Wojcik J, 2002, J MOL BIOL, V323, P763, DOI 10.1016/S0022-2836(02)01009-4; Zanzoni A, 2002, FEBS LETT, V513, P135, DOI 10.1016/S0014-5793(01)03293-8; Zaza G, 2004, BLOOD, V104, P1435, DOI 10.1182/blood-2003-12-4306	48	349	362	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					285	293		10.1038/ng1747	http://dx.doi.org/10.1038/ng1747			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16501559				2022-12-27	WOS:000235589600007
J	Ioannidis, JPA; Gwinn, M; Little, J; Higgins, JPT; Bernstein, JL; Boffetta, P; Bondy, M; Bray, MS; Brenchley, PE; Buffler, PA; Casas, JP; Chokkalingam, A; Danesh, J; Smith, GD; Dolan, S; Duncan, R; Gruis, NA; Hartge, P; Hashibe, M; Hunter, DJ; Jarvelin, MR; Malmer, B; Maraganore, DM; Newton-Bishop, JA; O'Brien, TR; Petersen, G; Riboli, E; Salanti, G; Seminara, D; Smeeth, L; Taioli, E; Timpson, N; Uitterlinden, AG; Vineis, P; Wareham, N; Winn, DM; Zimmern, R; Khoury, MJ				Ioannidis, JPA; Gwinn, M; Little, J; Higgins, JPT; Bernstein, JL; Boffetta, P; Bondy, M; Bray, MS; Brenchley, PE; Buffler, PA; Casas, JP; Chokkalingam, A; Danesh, J; Smith, GD; Dolan, S; Duncan, R; Gruis, NA; Hartge, P; Hashibe, M; Hunter, DJ; Jarvelin, MR; Malmer, B; Maraganore, DM; Newton-Bishop, JA; O'Brien, TR; Petersen, G; Riboli, E; Salanti, G; Seminara, D; Smeeth, L; Taioli, E; Timpson, N; Uitterlinden, AG; Vineis, P; Wareham, N; Winn, DM; Zimmern, R; Khoury, MJ		Human Genome Epidemiology Network; Network Investigtor Networks	A road map for efficient and reliable human genome epidemiology	NATURE GENETICS			English	Editorial Material							GENETIC EPIDEMIOLOGY; RANDOMIZED-TRIALS; PUBLICATION; ASSOCIATION; GUIDELINES; BIAS; ENVIRONMENT; FALSE	Networks of investigators have begun sharing best practices, tools and methods for analysis of associations between genetic variation and common diseases. A Network of Investigator Networks has been set up to drive the process, sponsored by the Human Genome Epidemiology Network. A workshop is planned to develop consensus guidelines for reporting results of genetic association studies. Published literature databases will be integrated, and unpublished data, including 'negative' studies, will be captured by online journals and through investigator networks. Systematic reviews will be expanded to include more meta-analyses of individual-level data and prospective meta-analyses. Field synopses will offer regularly updated overviews.	Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece; Fdn Res & Technol Hellas, Biomed Res Inst, GR-45110 Ioannina, Greece; Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; Ctr Dis Control & Prevent, Off Genom & Dis Prevent, Atlanta, GA 30333 USA; Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON K1H 8M5, Canada; Univ Cambridge, MRC, Biostat Unit, Cambridge CB2 2SR, England; Strangeways Res Lab, Publ Hlth Genet Unit, Cambridge CB1 8RN, England; Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; Int Agcy Res Canc, F-69008 Lyon, France; Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA; Royal Infirm, Manchester Inst Nephrol & Transplantat, Renal Res Labs, Manchester M13 9WL, Lancs, England; Univ Calif Berkeley, Berkeley, CA 94720 USA; Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; March Dimes, White Plains, NY 10605 USA; WHO, CH-1211 Geneva, Switzerland; Leiden Univ Med Ctr, Dept Dermatol, NL-2333 AL Leiden, Netherlands; NCI, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ London Imperial Coll Sci & Technol, Dept Epidemiol & Publ Hlth, London W2 1PG, England; Univ Oulu, Dept Publ Hlth Sci & Gen Practice, Oulu, Finland; Umea Univ Hosp, Dept Radiat Sci, Umea, Sweden; Mayo Clin, Dept Neurol, Rochester, MN 55905 USA; CR UK Clin Ctr, Genet Epidemiol Div, Leeds LS8 7FT, W Yorkshire, England; Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15232 USA; Erasmus MC, Dept Internal Med, NL-3000 DR Rotterdam, Netherlands; Erasmus MC, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Inst Sci Interchange Fdn, Turin, Italy; MRC, Epidemiol Unit, Elsie Widdowson Labs, Cambridge CB1 9NL, England	University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); Tufts University; Centers for Disease Control & Prevention - USA; University of Ottawa; MRC Biostatistics Unit; University of Cambridge; Memorial Sloan Kettering Cancer Center; World Health Organization; International Agency for Research on Cancer (IARC); University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; United States Department of Agriculture (USDA); University of California System; University of California Berkeley; University of London; London School of Hygiene & Tropical Medicine; University of Cambridge; University of Bristol; World Health Organization; Leiden University; Leiden University Medical Center (LUMC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; Imperial College London; University of Oulu; Umea University; Mayo Clinic; Mayo Clinic; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Davey Smith, George/A-7407-2013; Boffetta, Paolo/AAI-7767-2021; Timpson, Nicholas John/O-7548-2015; Little, Julian/AAR-6117-2020; Higgins, Julian PT/H-4008-2011; Ioannidis, John P. A./G-9836-2011; Attrill, Lauren/V-1688-2018; Fox, Laura J/C-6249-2016; Smeeth, Liam/X-5862-2018	Davey Smith, George/0000-0002-1407-8314; Boffetta, Paolo/0000-0002-3811-2791; Timpson, Nicholas John/0000-0002-7141-9189; Little, Julian/0000-0001-5026-5531; Higgins, Julian PT/0000-0002-8323-2514; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Brenchley, Paul/0000-0003-1290-9919; Gruis, Nelleke/0000-0002-5210-9150; Smeeth, Liam/0000-0002-9168-6022; Newton-Bishop, Julia/0000-0001-9147-6802; Salanti, Georgia/0000-0002-3830-8508; s, hema/0000-0002-3440-9475; Riboli, Elio/0000-0001-6795-6080	NATIONAL CANCER INSTITUTE [Z01CP010170] Funding Source: NIH RePORTER; MRC [G108/492] Funding Source: UKRI; Medical Research Council [MC_U106179471, G108/492] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; [Anonymous], 2005, NAT GENET, V37, P1153, DOI 10.1038/ng1105-1153; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Cooper DN, 2002, HUM GENET, V110, P207, DOI 10.1007/s00439-001-0672-4; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; Freimer NB, 2005, HUM MOL GENET, V14, P2481, DOI 10.1093/hmg/ddi251; Greenland S, 2005, J R STAT SOC A STAT, V168, P267, DOI 10.1111/j.1467-985X.2004.00349.x; Huizinga TWJ, 2004, ARTHRITIS RHEUM, V50, P2066, DOI 10.1002/art.20360; IOANNIDIS JP, IN PRESS INT J EPIDE; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2005, AM J EPIDEMIOL, V162, P302, DOI 10.1093/aje/kwi201; Ioannidis JPA, 2002, AM J EPIDEMIOL, V156, P204, DOI 10.1093/aje/kwf031; Little J, 2003, AM J EPIDEMIOL, V157, P667, DOI 10.1093/aje/kwg048; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Pan ZL, 2005, PLOS MED, V2, P1309, DOI 10.1371/journal.pmed.0020334; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Patterson M, 2005, PLOS BIOL, V3, P1511, DOI 10.1371/journal.pbio.0030327; Rebbeck TR, 2004, CANCER EPIDEM BIOMAR, V13, P1985; Thorn CF, 2005, METH MOL B, V311, P179; von Elm E, 2004, BMJ-BRIT MED J, V329, P868, DOI 10.1136/bmj.329.7471.868; Wacholder S, 2005, CANCER EPIDEM BIOMAR, V14, P1361, DOI 10.1158/1055-9965.EPI-05-0404; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Weiss ST, 2001, AM J RESP CRIT CARE, V164, P2014, DOI 10.1164/ajrccm.164.11.2110043b	24	174	179	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					3	5		10.1038/ng0106-3	http://dx.doi.org/10.1038/ng0106-3			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16468121				2022-12-27	WOS:000234227200002
J	Raeder, H; Johansson, S; Holm, PI; Haldorsen, IS; Mas, E; Sbarra, V; Nermoen, I; Eide, SA; Grevle, L; Bjorkhaug, L; Sagen, JV; Aksnes, L; Sovik, O; Lombardo, D; Molven, A; Njolstad, PR				Raeder, H; Johansson, S; Holm, PI; Haldorsen, IS; Mas, E; Sbarra, V; Nermoen, I; Eide, SA; Grevle, L; Bjorkhaug, L; Sagen, JV; Aksnes, L; Sovik, O; Lombardo, D; Molven, A; Njolstad, PR			Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction	NATURE GENETICS			English	Article							SALT-DEPENDENT LIPASE; CARBOXYL ESTER LIPASE; FECAL ELASTASE-1 CONCENTRATIONS; SITE-DIRECTED MUTAGENESIS; STIMULATED LIPASE; CHOLESTEROL ESTERASE; GENE; MICE; MELLITUS; AGENESIS	Dysfunction of the exocrine pancreas is observed in diabetes, but links between concurrent exocrine and endocrine pancreatic disease and contributing genetic factors are poorly characterized. We studied two families with diabetes and exocrine pancreatic dysfunction by genetic, physiological and in vitro functional studies. A genome-wide screen in Family 1 linked diabetes to chromosome 9q34 ( maximal lod score 5.07). Using fecal elastase deficiency as a marker of exocrine pancreatic dysfunction refined the critical chromosomal region to 1.16 Mb ( maximal lod score 11.6). Here, we identified a single-base deletion in the variable number of tandem repeats (VNTR)-containing exon 11 of the carboxyl ester lipase (CEL) gene, a major component of pancreatic juice and responsible for the duodenal hydrolysis of cholesterol esters. Screening subjects with maturity-onset diabetes of the young identified Family 2, with another single-base deletion in CEL and a similar phenotype with beta-cell failure and pancreatic exocrine disease. The in vitro catalytic activities of wild-type and mutant CEL protein were comparable. The mutant enzyme was, however, less stable and secreted at a lower rate. Furthermore, we found some evidence for an association between common insertions in the CEL VNTR and exocrine dysfunction in a group of 182 unrelated subjects with diabetes ( odds ratio 4.2 (1.6, 11.5)). Our findings link diabetes to the disrupted function of a lipase in the pancreatic acinar cells.	Univ Bergen, Dept Clin Med, Sect Pediat, Bergen, Norway; Univ Bergen, Dept Clin Med, Sect Med Genet & Mol Med, Bergen, Norway; Univ Bergen, Dept Internal Med, Endocrinol Sect, Bergen, Norway; Haukeland Univ Hosp, Hormone Lab, N-5021 Bergen, Norway; Univ Bergen, Dept Surg, Sect Radiol, N-5014 Bergen, Norway; INSERM, U559, Fac Med Timone, F-13258 Marseille, France; Akershus Univ Hosp, Dept Endocrinol, Oslo, Norway; Univ Bergen, Gade Inst, Sect Pathol, Bergen, Norway; Haukeland Univ Hosp, Dept Pathol, N-5021 Bergen, Norway; Haukeland Univ Hosp, Dept Pediat, N-5021 Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Oslo; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Njolstad, PR (corresponding author), Univ Bergen, Dept Clin Med, Sect Pediat, Bergen, Norway.	pal.njolstad@uib.no	Raeder, Helge/AFQ-6279-2022; Mas, Eric/AAC-9837-2022; Raeder, Helge/ABE-3601-2020; Johansson, Stefan/C-4394-2011; Bjørkhaug, Lise/AAA-4356-2021; Mas, Eric/O-9569-2017	Johansson, Stefan/0000-0002-2298-7008; Bjørkhaug, Lise/0000-0002-9695-4559; Mas, Eric/0000-0002-8925-9195; Haldorsen, Ingfrid S./0000-0001-9313-7564				Aubert E, 2002, J BIOL CHEM, V277, P34987, DOI 10.1074/jbc.M202893200; Aubert-Jousset E, 2004, J BIOL CHEM, V279, P39697, DOI 10.1074/jbc.M407646200; Auge N, 2003, CIRCULATION, V108, P86, DOI 10.1161/01.CIR.0000079101.69806.47; Bellanne-Chantelot C, 2004, ANN INTERN MED, V140, P510, DOI 10.7326/0003-4819-140-7-200404060-00009; Bengtsson-Ellmark SH, 2004, EUR J HUM GENET, V12, P627, DOI 10.1038/sj.ejhg.5201204; Bjorkhaug L, 2003, J CLIN ENDOCR METAB, V88, P920, DOI 10.1210/jc.2002-020945; Cavalot F, 2004, DIABETES CARE, V27, P2052, DOI 10.2337/diacare.27.8.2052; DIPERSIO LP, 1990, J BIOL CHEM, V265, P16801; DOWNS D, 1994, BIOCHEMISTRY-US, V33, P7979, DOI 10.1021/bi00192a001; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Gleghorn L, 2005, AM J HUM GENET, V77, P484, DOI 10.1086/444401; Goda K, 2001, ACTA DIABETOL, V38, P145, DOI 10.1007/s005920170012; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Hardt PD, 2003, PANCREATOLOGY, V3, P395, DOI 10.1159/000073655; Haumaitre C, 2005, P NATL ACAD SCI USA, V102, P1490, DOI 10.1073/pnas.0405776102; HENDERSON JR, 1969, LANCET, V2, P469; Herman Gail E, 2002, ILAR J, V43, P55; Higuchi S, 2002, J HUM GENET, V47, P213, DOI 10.1007/s100380200027; Howles PN, 1996, J BIOL CHEM, V271, P7196, DOI 10.1074/jbc.271.12.7196; Hui DY, 2002, J LIPID RES, V43, P2017, DOI 10.1194/jlr.R200013-JLR200; Icks A, 2001, Z GASTROENTEROL, V39, P823, DOI 10.1055/s-2001-17867; Iglesias A, 2004, J CLIN INVEST, V113, P1398, DOI 10.1172/JCI200418879; Kim SK, 2002, NAT GENET, V30, P430, DOI 10.1038/ng860; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Lindquist S, 2002, EUR J BIOCHEM, V269, P759, DOI 10.1046/j.0014-2956.2001.02666.x; Lombardo D, 2001, BBA-MOL CELL BIOL L, V1533, P1, DOI 10.1016/S1388-1981(01)00130-5; Lombardo F, 2003, EUR J ENDOCRINOL, V149, P53, DOI 10.1530/eje.0.1490053; Mitchell RMS, 2003, LANCET, V361, P1447, DOI 10.1016/S0140-6736(03)13139-X; Panicot L, 1999, DIABETES, V48, P2316, DOI 10.2337/diabetes.48.12.2316; Poorkhalkali N, 1998, HISTOCHEM CELL BIOL, V110, P367, DOI 10.1007/s004180050297; Rathmann W, 2001, SCAND J GASTROENTERO, V36, P1056; Sellick GS, 2004, NAT GENET, V36, P1301, DOI 10.1038/ng1475; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; VAXILLAIRE M, 1995, NAT GENET, V9, P418, DOI 10.1038/ng0495-418; Verine A, 2001, J BIOL CHEM, V276, P12356, DOI 10.1074/jbc.M008658200; Wang Feng, 2003, Mol Cancer, V2, P4, DOI 10.1186/1476-4598-2-4; Weng W, 1999, BIOCHEMISTRY-US, V38, P4143, DOI 10.1021/bi981679a	38	215	232	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					54	62		10.1038/ng1708	http://dx.doi.org/10.1038/ng1708			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16369531				2022-12-27	WOS:000234227200017
J	Guasch, G; Fuchs, E				Guasch, G; Fuchs, E			Mice in the world of stem cell biology	NATURE GENETICS			English	Review							HAIR FOLLICLE MORPHOGENESIS; HEMATOPOIETIC STEM; SELF-RENEWAL; NUCLEAR TRANSFER; BETA-CATENIN; SOMATIC-CELLS; GENE-THERAPY; MOUSE; DIFFERENTIATION; IDENTIFICATION	The ability of embryos to diversify and of some adult tissues to regenerate throughout life is directly attributable to stem cells. These cells have the capacity to self-renew-that is, to divide and to create additional stem cells-and to differentiate along a specific lineage. The differentiation of pluripotent embryonic stem cells along specific cell lineages has been used to understand the molecular mechanisms involved in tissue development. The often endless capacity of embryonic stem cells to generate differentiated cell types positions the field of stem cells at the nexus between developmental biologists, who are fascinated by the properties of these cells, and clinicians, who are excited about the prospects of bringing stem cells from bench to bedside to treat degenerative disorders and injuries for which there are currently no cures. Here we highlight the importance of mice in stem cell biology and in bringing the world one step closer to seeing these cells brought to fruition in modern medicine.	Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, 1230 York Ave Box 300, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, 1230 York Ave Box 300, New York, NY 10021 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Guasch, Geraldine/0000-0001-7362-9318	NIAMS NIH HHS [R01 AR050452-04, R01 AR050452] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Buchstaller J, 2004, J NEUROSCI, V24, P2357, DOI 10.1523/JNEUROSCI.4083-03.2004; BUCKNER CD, 1970, BLOOD-J HEMATOL, V35, P741, DOI 10.1182/blood.V35.6.741.741; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chinzei R, 2002, HEPATOLOGY, V36, P22, DOI 10.1053/jhep.2002.34136; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Dinsmore J, 1996, CELL TRANSPLANT, V5, P131, DOI 10.1016/0963-6897(95)02040-3; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; FORD CE, 1956, NATURE, V177, P452, DOI 10.1038/177452a0; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; GOODMAN JOAN WRIGHT, 1962, BLOOD JOUR HEMATOL, V19, P702; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; HARRISON DE, 1980, BLOOD, V55, P77; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Hwang WS, 2005, SCIENCE, V308, P1777, DOI 10.1126/science.1112286; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kleber M, 2004, CURR OPIN CELL BIOL, V16, P681, DOI 10.1016/j.ceb.2004.08.006; Klug MG, 1996, J CLIN INVEST, V98, P216, DOI 10.1172/JCI118769; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; LOEFFLER M, 1993, J THEOR BIOL, V160, P471, DOI 10.1006/jtbi.1993.1031; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; LUBIN I, 1991, SCIENCE, V252, P427, DOI 10.1126/science.1826797; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Min JY, 2002, J APPL PHYSIOL, V92, P288, DOI 10.1152/jappl.2002.92.1.288; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Quesenberry PJ, 2005, EXP HEMATOL, V33, P9, DOI 10.1016/j.exphem.2004.10.012; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rideout WM, 2002, CELL, V109, P17, DOI 10.1016/S0092-8674(02)00681-5; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; THOMPSON S, 1989, CELL, V56, P313, DOI 10.1016/0092-8674(89)90905-7; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Yamamoto H, 2003, HEPATOLOGY, V37, P983, DOI 10.1053/jhep.2003.50202; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	74	21	22	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1201	1206		10.1038/ng1667	http://dx.doi.org/10.1038/ng1667			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16254567	Green Accepted			2022-12-27	WOS:000233045200017
J	Wolf, SM				Wolf, SM			Are we making progress in the debate over racial and ethnic categories in biomedical research?	NATURE GENETICS			English	Editorial Material									Univ Minnesota, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Wolf, SM (corresponding author), Univ Minnesota, N140 Mondale Hall,229 19th Ave S, Minneapolis, MN 55455 USA.	swolf@umn.edu							0	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2005	37	8					789	790		10.1038/ng0805-789	http://dx.doi.org/10.1038/ng0805-789			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16049501				2022-12-27	WOS:000230880400004
J	Wong, S; Wolfe, KH				Wong, S; Wolfe, KH			Birth of a metabolic gene cluster in yeast by adaptive gene relocation	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; RECRUITMENT; LINKAGE	Although most eukaryotic genomes lack operons, they contain some physical clusters of genes that are related in function despite being unrelated in sequence(1-5). How these clusters are formed during evolution is unknown. The DAL cluster is the largest metabolic gene cluster in yeast and consists of six adjacent genes encoding proteins that enable Saccharomyces cerevisiae to use allantoin as a nitrogen source(6). We show here that the DAL cluster was assembled, quite recently in evolutionary terms, through a set of genomic rearrangements that happened almost simultaneously. Six of the eight genes involved in allantoin degradation, which were previously scattered around the genome, became relocated to a single subtelomeric site in an ancestor of S. cerevisiae and Saccharomyces castellii. These genomic rearrangements coincided with a biochemical reorganization of the purine degradation pathway, which switched to importing allantoin instead of urate. This change eliminated urate oxidase, one of several oxygen- consuming enzymes that were lost by yeasts that can grow vigorously in anaerobic conditions. The DAL cluster is located in a domain of modified chromatin involving both H2A. Z histone exchange and Hst1- Sum1 - mediated histone deacetylation, and it may be a coadapted gene complex formed by epistatic selection.	Univ Dublin Trinity Coll, Smurfit Inst, Dept Genet, Dublin 2, Ireland	Trinity College Dublin	Wolfe, KH (corresponding author), Univ Dublin Trinity Coll, Smurfit Inst, Dept Genet, Dublin 2, Ireland.	khwolfe@tcd.ie	Wolfe, Kenneth H/B-4653-2009	Wolfe, Kenneth/0000-0003-4992-4979				Blumenthal T, 2003, NAT REV GENET, V4, P110, DOI 10.1038/nrg995; Bursell, 1967, ADV INSECT PHYSIOL, V4, P33, DOI [10.1016/S0065-2806(08)60207-6, DOI 10.1016/S0065-2806(08)60207-6]; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Cooper TG, 1996, MYCOTA, V3, P139; Daran-Lapujade P, 2003, FEMS YEAST RES, V4, P259, DOI 10.1016/S1567-1356(03)00156-9; Deak T., 1996, HDB FOOD SPOILAGE YE; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; HARTIG A, 1992, NUCLEIC ACIDS RES, V20, P5677, DOI 10.1093/nar/20.21.5677; Hittinger CT, 2004, P NATL ACAD SCI USA, V101, P14144, DOI 10.1073/pnas.0404319101; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Hurst LD, 2002, TRENDS GENET, V18, P604, DOI 10.1016/S0168-9525(02)02813-5; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Kwast KE, 2002, J BACTERIOL, V184, P250, DOI 10.1128/JB.184.1.250-265.2002; LARUE TA, 1968, CAN J MICROBIOL, V14, P79, DOI 10.1139/m68-012; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; NEI M, 1967, GENETICS, V57, P625; Pal C, 2003, NAT GENET, V33, P392, DOI 10.1038/ng1111; People M., 1997, PLANT METABOLISM, P525; Pierce M, 2003, MOL CELL BIOL, V23, P4814, DOI 10.1128/MCB.23.14.4814-4825.2003; Piskur J, 2004, MOL MICROBIOL, V53, P381, DOI 10.1111/j.1365-2958.2004.04182.x; Qi X, 2004, P NATL ACAD SCI USA, V101, P8233, DOI 10.1073/pnas.0401301101; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; TAKADA Y, 1987, J BACTERIOL, V169, P2284, DOI 10.1128/jb.169.5.2284-2286.1987; van der Klei IJ, 1997, TRENDS MICROBIOL, V5, P502, DOI 10.1016/S0966-842X(97)01156-6	30	151	153	3	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					777	782		10.1038/ng1584	http://dx.doi.org/10.1038/ng1584			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15951822				2022-12-27	WOS:000230196400028
J	Desrosiers, MP; Kielczewska, A; Loredo-Osti, JC; Adam, SG; Makrigiannis, AP; Lemieux, S; Pham, T; Lodoen, MB; Morgan, K; Lanier, LL; Vidal, SM				Desrosiers, MP; Kielczewska, A; Loredo-Osti, JC; Adam, SG; Makrigiannis, AP; Lemieux, S; Pham, T; Lodoen, MB; Morgan, K; Lanier, LL; Vidal, SM			Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection	NATURE GENETICS			English	Article							GENE-COMPLEX; VIRAL-INFECTIONS; BAC CONTIG; RECEPTOR; LY49; MAP; RECOGNITION; MICE; HLA; LIGAND	Experimental infection with mouse cytomegalovirus ( MCMV) has been used to elucidate the intricate host-pathogen mechanisms that determine innate resistance to infection. Linkage analyses in F-2 progeny from MCMV-resistant MA/My (H2(k)) and MCMV-susceptible BALB/c (H2(d)) and BALB. K ( H2k) mouse strains indicated that only the combination of alleles encoded by a gene in the Klra ( also called Ly49) cluster on chromosome 6, and one in the major histocompatibility complex (H2) on chromosome 17, is associated with virus resistance. We found that natural killer cell - activating receptor Ly49P specifically recognized MCMV-infected cells, dependent on the presence of the H2k haplotype. This binding was blocked using antibodies to H-2D(k) but not antibodies to H-2K(k). These results are suggestive of a new natural killer cell mechanism implicated in MCMV resistance, which depends on the functional interaction of the Ly49P receptor and the major histocompatibility complex class I molecule H-2D(k) on MCMV-infected cells.	McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; McGill Univ, McGill Ctr Study Host Resistance, Montreal, PQ H3G 1A4, Canada; Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; Univ Quebec, INRS, Laval, PQ H7V 1B7, Canada; Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; McGill Univ, Dept Med, Montreal, PQ, Canada; McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Quebec; Institut national de la recherche scientifique (INRS); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; McGill University; McGill University	Vidal, SM (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada.	silvia.vidal@mcgill.ca	Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952; Makrigiannis, Andrew/0000-0002-7258-9411; Pham, Trung/0000-0003-2724-2547	NCI NIH HHS [R01 CA089294] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA089294] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arase H, 2004, REV MED VIROL, V14, P83, DOI 10.1002/rmv.422; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Belkin D, 2003, J IMMUNOL, V171, P3056, DOI 10.4049/jimmunol.171.6.3056; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Britt W. J., 1996, FIELDS VIROLOGY, P2493; Brown MG, 1997, IMMUNOL REV, V155, P53, DOI 10.1111/j.1600-065X.1997.tb00939.x; Brown MG, 1997, GENOMICS, V42, P16, DOI 10.1006/geno.1997.4721; CHALMER JE, 1977, J GEN VIROL, V37, P107, DOI 10.1099/0022-1317-37-1-107; Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006; Depatie C, 1997, GENOMICS, V39, P154, DOI 10.1006/geno.1996.4498; Depatie C, 1999, INT IMMUNOL, V11, P1541, DOI 10.1093/intimm/11.9.1541; Depatie C, 2000, GENOMICS, V66, P161, DOI 10.1006/geno.2000.6186; Franksson L, 1999, EUR J IMMUNOL, V29, P2748, DOI 10.1002/(SICI)1521-4141(199909)29:09<2748::AID-IMMU2748>3.0.CO;2-C; GRUNDY JE, 1981, INFECT IMMUN, V32, P277, DOI 10.1128/IAI.32.1.277-286.1981; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Lee SH, 2001, IMMUNOGENETICS, V53, P501, DOI 10.1007/s002510100359; Long EO, 1999, ANNU REV IMMUNOL, V17, P875, DOI 10.1146/annurev.immunol.17.1.875; Makrigiannis AP, 1999, J IMMUNOL, V163, P4931; Makrigiannis AP, 2002, GENOMICS, V79, P437, DOI 10.1006/geno.2002.6724; Makrigiannis AP, 2001, J IMMUNOL, V166, P5034, DOI 10.4049/jimmunol.166.8.5034; Manly KF, 1999, MAMM GENOME, V10, P327, DOI 10.1007/s003359900997; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Nakamura MC, 2000, J EXP MED, V192, P447, DOI 10.1084/jem.192.3.447; Nakamura MC, 2001, IMMUNOL REV, V181, P138, DOI 10.1034/j.1600-065X.2001.1810111.x; Peng SL, 1996, BIOTECHNIQUES, V21, P362; Peruzzi M, 1996, J EXP MED, V184, P1585, DOI 10.1084/jem.184.4.1585; Pierce CA, 2004, EDUC PSYCHOL MEAS, V64, P916, DOI 10.1177/0013164404264848; Radaev S, 2003, ANNU REV BIOPH BIOM, V32, P93, DOI 10.1146/annurev.biophys.32.110601.142347; Reusser PE, 2002, SWISS MED WKLY, V132, P374; Scalzo AA, 2000, METH MOL B, V121, P163; SCALZO AA, 1992, J IMMUNOL, V149, P581; SCALZO AA, 1990, J EXP MED, V171, P1469, DOI 10.1084/jem.171.5.1469; SCALZO AA, 1995, GENOMICS, V27, P435, DOI 10.1006/geno.1995.1074; Silver ET, 2000, J IMMUNOL, V165, P1771, DOI 10.4049/jimmunol.165.4.1771; Silver ET, 2001, J IMMUNOL, V166, P2333, DOI 10.4049/jimmunol.166.4.2333; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Soderberg-Naucler C, 2001, TRANSPLANTATION, V71, pSS24; Trincado DE, 2001, J PAEDIATR CHILD H, V37, P187, DOI 10.1046/j.1440-1754.2001.00645.x; Trowsdale J, 2001, IMMUNOL REV, V181, P20, DOI 10.1034/j.1600-065X.2001.1810102.x; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055	42	125	127	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					593	599		10.1038/ng1564	http://dx.doi.org/10.1038/ng1564			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15895081	Green Accepted			2022-12-27	WOS:000229495300012
J	Binder, EB; Salyakina, D; Lichtner, P; Wochnik, GM; Ising, M; Putz, B; Papiol, S; Seaman, S; Lucae, S; Kohli, MA; Nickel, T; Kunzel, HE; Fuchs, B; Majer, M; Pfennig, A; Kern, N; Brunner, J; Modell, S; Baghai, T; Deiml, T; Zill, P; Bondy, B; Rupprecht, R; Messer, T; Kohnlein, O; Dabitz, H; Bruckl, T; Muller, N; Pfister, H; Lieb, R; Mueller, JC; Lohmussaar, E; Strom, TM; Bettecken, T; Meitinger, T; Uhr, M; Rein, T; Holsboer, F; Muller-Myhsok, B				Binder, EB; Salyakina, D; Lichtner, P; Wochnik, GM; Ising, M; Putz, B; Papiol, S; Seaman, S; Lucae, S; Kohli, MA; Nickel, T; Kunzel, HE; Fuchs, B; Majer, M; Pfennig, A; Kern, N; Brunner, J; Modell, S; Baghai, T; Deiml, T; Zill, P; Bondy, B; Rupprecht, R; Messer, T; Kohnlein, O; Dabitz, H; Bruckl, T; Muller, N; Pfister, H; Lieb, R; Mueller, JC; Lohmussaar, E; Strom, TM; Bettecken, T; Meitinger, T; Uhr, M; Rein, T; Holsboer, F; Muller-Myhsok, B			Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment	NATURE GENETICS			English	Article							CORTICOTROPIN-RELEASING-FACTOR; PITUITARY-ADRENOCORTICAL REGULATION; HORMONE-RECEPTOR 1; GLUCOCORTICOID-RECEPTOR; IMMUNOPHILIN FKBP51; STEROID-RECEPTORS; MAJOR DEPRESSION; DISORDERS; BINDING; ANXIETY	The stress hormone-regulating hypothalamic-pituitary-adrenal (HPA) axis has been implicated in the causality1 as well as the treatment of depression(2). To investigate a possible association between genes regulating the HPA axis and response to antidepressants and susceptibility for depression, we genotyped single-nucleotide polymorphisms in eight of these genes in depressed individuals and matched controls. We found significant associations of response to antidepressants and the recurrence of depressive episodes with single-nucleotide polymorphisms in FKBP5, a glucocorticoid receptor-regulating cochaperone of hsp-90, in two independent samples. These single-nucleotide polymorphisms were also associated with increased intracellular FKBP5 protein expression, which triggers adaptive changes in glucocorticoid receptor and, thereby, HPA-axis regulation. Individuals carrying the associated genotypes had less HPA-axis hyperactivity during the depressive episode. We propose that the FKBP5 variant-dependent alterations in HPA-axis regulation could be related to the faster response to antidepressant drug treatment and the increased recurrence of depressive episodes observed in this subgroup of depressed individuals. These findings support a central role of genes regulating the HPA axis in the causality of depression and the mechanism of action of antidepressant drugs.	Max Planck Inst Psychiat, D-80804 Munich, Germany; Tech Univ, Inst Human Genet, D-85764 Neuherberg, Germany; GSF Natl res Ctr Environm & Hlth, D-85764 Neuherberg, Germany; Univ Barcelona, Fac Biol, Unitat Antropol, E-08028 Barcelona, Spain; Univ Munich, Dept Psychiat, D-80336 Munich, Germany; Bezirkskrankenhaus Augsburg, D-86156 Augsburg, Germany; Klinikum Ingolstadt, D-85049 Ingolstadt, Germany	Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Barcelona; University of Munich	Binder, EB (corresponding author), Max Planck Inst Psychiat, D-80804 Munich, Germany.	ebinder@genetics.emory.edu	Org, Elin/AAJ-9631-2021; Binder, Elisabeth B/K-8905-2014; Meitinger, Thomas/O-1318-2015; Pütz, Benno/P-2630-2016; Müller-Myhsok, Bertram/A-3289-2013	Pütz, Benno/0000-0002-2208-209X; Meitinger, Thomas/0000-0002-8838-8403; Org, Elin/0000-0001-8688-9717; Seaman, Shaun/0000-0003-3726-5937; Papiol, Sergi/0000-0001-9366-8728; Salyakina, Daria/0000-0003-3283-3691; Baghai, Thomas C/0000-0002-7873-4130; Rein, Theo/0000-0003-2850-4289				[Anonymous], 1932, STAT METHODS RES WOR; Barden N, 1997, NEUROENDOCRINOLOGY, V66, P212, DOI 10.1159/000127240; Cheung J, 2000, MOL ENDOCRINOL, V14, P939, DOI 10.1210/me.14.7.939; Davies TH, 2002, J BIOL CHEM, V277, P4597, DOI 10.1074/jbc.C100531200; Denny WB, 2000, ENDOCRINOLOGY, V141, P4107, DOI 10.1210/en.141.11.4107; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; HEUSER I, 1994, J PSYCHIAT RES, V28, P341, DOI 10.1016/0022-3956(94)90017-5; HOLSBOER F, 1995, NEUROENDOCRINOLOGY, V62, P340, DOI 10.1159/000127023; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Holsboer F, 1996, ENDOCR REV, V17, P187, DOI 10.1210/er.17.2.187; LEWONTIN RC, 1988, GENETICS, V120, P849; Muller MB, 2003, NAT NEUROSCI, V6, P1100, DOI 10.1038/nn1123; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; NEMEROFF CB, 1988, PHARMACOPSYCHIATRY, V21, P76, DOI 10.1055/s-2007-1014652; Nemeroff CB, 2002, NAT NEUROSCI, V5, P1068, DOI 10.1038/nn943; NEMEROFF CB, 1988, ARCH GEN PSYCHIAT, V45, P577; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; Pariante CM, 2001, BIOL PSYCHIAT, V49, P391, DOI 10.1016/S0006-3223(00)01088-X; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Purba JS, 1996, ARCH GEN PSYCHIAT, V53, P137; Reynolds PD, 1998, LAB ANIM SCI, V48, P364; Scammell JG, 2001, GEN COMP ENDOCR, V124, P152, DOI 10.1006/gcen.2001.7696; Schiene-Fischer C, 2001, FEBS LETT, V495, P1, DOI 10.1016/S0014-5793(01)02326-2; Schmidt U, 2003, J BIOL CHEM, V278, P4926, DOI 10.1074/jbc.M212000200; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Vermeer H, 2003, J CLIN ENDOCR METAB, V88, P277, DOI 10.1210/jc.2002-020354; Wittchen H-U., 1999, INT J METHODS PSYCHI, V8, P59, DOI [10.1002/mpr.57, DOI 10.1002/MPR.57]; Zobel AW, 2001, J PSYCHIAT RES, V35, P83, DOI 10.1016/S0022-3956(01)00013-9	30	698	722	0	39	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2004	36	12					1319	1325		10.1038/ng1479	http://dx.doi.org/10.1038/ng1479			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15565110				2022-12-27	WOS:000225354100021
J	Jorde, LB; Wooding, SP				Jorde, LB; Wooding, SP			Genetic variation, classification and 'race'	NATURE GENETICS			English	Article							EVOLUTIONARY HISTORY; POPULATION-STRUCTURE; DEMOGRAPHIC HISTORY; POSITIVE SELECTION; SEQUENCE VARIATION; HUMAN-DIVERSITY; HIGH-RESOLUTION; WHITE PATIENTS; ALU-INSERTION; MITOCHONDRIAL	New genetic data has enabled scientists to re-examine the relationship between human genetic variation and 'race'. We review the results of genetic analyses that show that human genetic variation is geographically structured, in accord with historical patterns of gene flow and genetic drift. Analysis of many loci now yields reasonably accurate estimates of genetic similarity among individuals, rather than populations. Clustering of individuals is correlated with geographic origin or ancestry. These clusters are also correlated with some traditional concepts of race, but the correlations are imperfect because genetic variation tends to be distributed in a continuous, overlapping fashion among populations. Therefore, ancestry, or even race, may in some cases prove useful in the biomedical setting, but direct assessment of disease-related genetic variation will ultimately yield more accurate and beneficial information.	Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Jorde, LB (corresponding author), Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA.	lbj@genetics.utah.edu						Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BARMSHAD MJ, 2003, AM J HUM GENET, V72, P578; Blumenbach Johann Friedrich, 1969, NATURAL VARIETIES MA; Bouchard TJ, 2001, BEHAV GENET, V31, P243; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; BOYD WC, 1950, GENETICS RACES MAN I; Bradford LD, 2002, PHARMACOGENOMICS, V3, P229, DOI 10.1517/14622416.3.2.229; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; Cavalli-Sforza L.L., 1971, GENETICS HUMAN POPUL; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Cooper RS, 1999, SCI AM, V280, P56, DOI 10.1038/scientificamerican0299-56; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Darwin C., 1871, P423; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Edwards AWF, 2003, BIOESSAYS, V25, P798, DOI 10.1002/bies.10315; Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626; Excoffier L, 2003, SCIENCE, V300; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; Feldman MW, 2003, NATURE, V424, P374, DOI 10.1038/424374a; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fischer A, 2004, MOL BIOL EVOL, V21, P799, DOI 10.1093/molbev/msh083; Foster MW, 2002, GENOME RES, V12, P844, DOI 10.1101/gr.99202; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gilad Y, 2002, P NATL ACAD SCI USA, V99, P862, DOI 10.1073/pnas.022614799; Haga SB, 2003, SCIENCE, V301, P466, DOI 10.1126/science.1087004; Harpending H, 2002, P NATL ACAD SCI USA, V99, P10, DOI 10.1073/pnas.012612799; Harpending HC, 1998, P NATL ACAD SCI USA, V95, P1961, DOI 10.1073/pnas.95.4.1961; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; Jorde LB, 1998, BIOESSAYS, V20, P126, DOI 10.1002/(SICI)1521-1878(199802)20:2<126::AID-BIES5>3.0.CO;2-R; Jorde LB, 2001, HUM MOL GENET, V10, P2199, DOI 10.1093/hmg/10.20.2199; Kunz R, 1997, HYPERTENSION, V30, P1331, DOI 10.1161/01.HYP.30.6.1331; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; LI WH, 1991, GENETICS, V129, P513; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; Nakajima T, 2004, AM J HUM GENET, V74, P898, DOI 10.1086/420793; NEI M, 1989, HUM HERED, V39, P276, DOI 10.1159/000153872; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Pritchard JK, 2000, GENETICS, V155, P945; Risch N., 2002, GENOME BIOL, V3, pcomm, DOI [10.1186/gb-2002-3-7-comment2007, 10.1186/GB-2002-3-7-COMMENT2007]; Romualdi C, 2002, GENOME RES, V12, P602, DOI 10.1101/gr.214902; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Roses AD, 2000, NATURE, V405, P857, DOI 10.1038/35015728; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sakate R, 2003, GENOME RES, V13, P1022, DOI 10.1101/gr.783103; Sankar P, 2002, SCIENCE, V298, P1337, DOI 10.1126/science.1074447; Schneider JA, 2003, MECH AGEING DEV, V124, P17, DOI 10.1016/S0047-6374(02)00165-3; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Sehgal AR, 2004, HYPERTENSION, V43, P566, DOI 10.1161/01.HYP.0000118019.28487.9c; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Shriver Mark D, 2004, Hum Genomics, V1, P274; Smedley A, 1999, RACE N AM ORIGIN EVO; Strickland TL, 1997, ARCH FAM MED, V6, P371, DOI 10.1001/archfami.6.4.371; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; TISHKOFF X, 2004, NAT GENET S, V36; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Varner RV, 1998, PSYCHIAT QUART, V69, P117, DOI 10.1023/A:1024762503100; Watkins WS, 2003, GENOME RES, V13, P1607, DOI 10.1101/gr.894603; Watkins WS, 2001, AM J HUM GENET, V68, P738, DOI 10.1086/318793; Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021; Wildman DE, 2002, BIOESSAYS, V24, P490, DOI 10.1002/bies.10103; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Wood AJJ, 2001, NEW ENGL J MED, V344, P1393, DOI 10.1056/NEJM200105033441811; Yu N, 2002, GENETICS, V161, P269	74	363	381	3	68	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11		S			S28	S33		10.1038/ng1435	http://dx.doi.org/10.1038/ng1435			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867PH	15508000	Bronze			2022-12-27	WOS:000224854000008
J	Keita, SOY; Kittles, RA; Royal, CDM; Bonney, GE; Furbert-Harris, P; Dunston, GM; Rotimi, CN				Keita, SOY; Kittles, RA; Royal, CDM; Bonney, GE; Furbert-Harris, P; Dunston, GM; Rotimi, CN			Conceptualizing human variation	NATURE GENETICS			English	Article							LINKAGE-DISEQUILIBRIUM; HUMAN-POPULATIONS; GENETIC DIVERSITY; ASSOCIATION; RACE; DISEASE; GENOME	What is the relationship between the patterns of biological and sociocultural variation in extant humans? Is this relationship accurately described, or best explained, by the term 'race' and the schema of 'racial' classification? What is the relationship between 'race', genetics and the demographic groups of society? Can extant humans be categorized into units that can scientifically be called 'races'? These questions underlie the discussions that address the explanations for the observed differences in many domains between named demographic groups across societies. These domains include disease incidence and prevalence and other variables studied by biologists and social scientists. Here, we offer a perspective on understanding human variation by exploring the meaning and use of the term 'race' and its relationship to a range of data. The quest is for a more useful approach with which to understand human biological variation, one that may provide better research designs and inform public policy.	Howard Univ, Coll Med, Natl Human Genome Ctr, Washington, DC 20060 USA; Smithsonian Inst, Dept Anthropol, Washington, DC 20560 USA; Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	Howard University; Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Ohio; Ohio State University	Kittles, RA (corresponding author), Howard Univ, Coll Med, Natl Human Genome Ctr, Washington, DC 20060 USA.	kittles-1@medctr.osu.edu						ALLEN M, 1993, J FORENSIC SCI, V38, P554; Andreasen RO, 1998, BRIT J PHILOS SCI, V49, P199, DOI 10.1093/bjps/49.2.199; Andreasen RO, 2000, PHILOS SCI, V67, pS653, DOI 10.1086/392853; Avise J.C., 1990, Oxford Surveys in Evolutionary Biology, V7, P45; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; BROWN WH, 1953, SYST ZOOL, V3, P174; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; DENIKER J, 2000, RACES MAN; Garn S. M., 1961, HUMAN RACES; GORDON HYMIE, 1965, S AFR MED J, V39, P533; Keita SOY, 1997, AM ANTHROPOL, V99, P534, DOI 10.1525/aa.1997.99.3.534; Keita SOY, 2001, AM J HUM BIOL, V13, P569, DOI 10.1002/ajhb.1095; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; LATTER BDH, 1980, AM NAT, V116, P220, DOI 10.1086/283624; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Lewontin RC, 1984, NOT OUR GENES; LIVINGSTONE FB, 1962, CURR ANTHROPOL, V3, P279, DOI 10.1086/200290; Long JC, 2003, HUM BIOL, V75, P449, DOI 10.1353/hub.2003.0058; MAYR E., 1991, PRINCIPLES SYSTEMATI, V2nd; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; NEI M, 1993, MOL BIOL EVOL, V10, P927; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rout Leslie B., 1976, AFRICAN EXPERIENCE S; Ruvolo M, 1997, ANNU REV ANTHROPOL, V26, P515, DOI 10.1146/annurev.anthro.26.1.515; Sallout B, 2003, J Obstet Gynaecol, V23, P555; Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604; Stanford JL, 1999, NIH PUB, V99-4543; Stepan N, 1982, IDEA RACE SCI GREAT; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; WILSON EO, 1953, SYST ZOOL, V2, P97, DOI 10.2307/2411818	36	100	103	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11		S			S17	S20		10.1038/ng1455	http://dx.doi.org/10.1038/ng1455			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867PH	15507998	Bronze			2022-12-27	WOS:000224854000006
J	Bhende, PM; Seaman, WT; Delecluse, HJ; Kenney, SC				Bhende, PM; Seaman, WT; Delecluse, HJ; Kenney, SC			The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome	NATURE GENETICS			English	Article							EPSTEIN-BARR-VIRUS; LATENT MEMBRANE-PROTEIN; NUCLEAR ANTIGEN-2; DNA METHYLATION; BRLF1 PROMOTER; BZLF1 PROTEIN; TRANSCRIPTION; ZTA; TRANSACTIVATOR; ACETYLATION	DNA methylation promotes gene silencing, yet the Epstein-Barr virus immediate-early protein, BZLF1 (Z), converts the virus from the latent to the lytic form of infection even when the viral genome is highly methylated. Here we show that methylation of CpG motifs in Z-responsive elements of the viral BRLF1 immediate-early promoter enhances Z binding to, and activation of, this promoter. Demethylation of the viral genome impairs Z activation of lytic viral genes. Z is the first transcription factor that preferentially binds to, and activates, a methylated promoter. These results identify an unexpected mechanism by which Epstein-Barr virus circumvents the inhibitory effects of viral genome methylation.	Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA; Univ N Carolina, Dept Microbiol, Chapel Hill, NC USA; Univ N Carolina, Dept Immunol, Chapel Hill, NC USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; German Canc Res Ctr, Dept Virus Associated Tumours, D-6900 Heidelberg, Germany	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Helmholtz Association; German Cancer Research Center (DKFZ)	Kenney, SC (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA.	shann@med.unc.edu		Delecluse, Henri-Jacques/0000-0002-1744-6274				Adamson AL, 1999, J VIROL, V73, P6551, DOI 10.1128/JVI.73.8.6551-6558.1999; Adamson AL, 1998, VIROLOGY, V251, P187, DOI 10.1006/viro.1998.9396; Adamson AL, 2000, J VIROL, V74, P1224, DOI 10.1128/JVI.74.3.1224-1233.2000; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; CHANG YN, 1990, J VIROL, V64, P3358, DOI 10.1128/JVI.64.7.3358-3369.1990; CHEVALLIERGRECO A, 1986, EMBO J, V5, P3243, DOI 10.1002/j.1460-2075.1986.tb04635.x; COUNTRYMAN J, 1985, P NATL ACAD SCI USA, V82, P4085, DOI 10.1073/pnas.82.12.4085; Deng Z, 2003, MOL CELL BIOL, V23, P2633, DOI 10.1128/MCB.23.8.2633-2644.2003; ERNBERG I, 1989, J GEN VIROL, V70, P2989, DOI 10.1099/0022-1317-70-11-2989; FARRELL PJ, 1989, EMBO J, V8, P127, DOI 10.1002/j.1460-2075.1989.tb03356.x; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; FLEMINGTON E, 1990, P NATL ACAD SCI USA, V87, P9459, DOI 10.1073/pnas.87.23.9459; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jenkins PJ, 2000, J VIROL, V74, P710, DOI 10.1128/JVI.74.2.710-720.2000; Kieff E., 1996, FIELDS VIROLOGY, V2, P2343; Liu PF, 2003, VIROLOGY, V310, P199, DOI 10.1016/S0042-6822(03)00145-4; MASUCCI MG, 1989, J VIROL, V63, P3135, DOI 10.1128/JVI.63.7.3135-3141.1989; PACKHAM G, 1990, J VIROL, V64, P2110, DOI 10.1128/JVI.64.5.2110-2116.1990; Paulson EJ, 1999, J VIROL, V73, P9959, DOI 10.1128/JVI.73.12.9959-9968.1999; Ragoczy T, 1998, J VIROL, V72, P7978, DOI 10.1128/JVI.72.10.7978-7984.1998; Ragoczy T, 2001, J VIROL, V75, P5240, DOI 10.1128/JVI.75.11.5240-5251.2001; RICKINSON AB, 1996, FIELDS VIROLOGY, P2397; Robertson KD, 2002, ONCOGENE, V21, P5361, DOI 10.1038/sj.onc.1205609; Robertson KD, 1997, BLOOD, V90, P4480, DOI 10.1182/blood.V90.11.4480.4480_4480_4484; TAKADA K, 1986, J VIROL, V57, P1016, DOI 10.1128/JVI.57.3.1016-1022.1986; THOMPSON JP, 1986, P NATL ACAD SCI USA, V83, P7688, DOI 10.1073/pnas.83.20.7688; Wade PA, 2001, BIOESSAYS, V23, P1131, DOI 10.1002/bies.10008; Zalani S, 1996, P NATL ACAD SCI USA, V93, P9194, DOI 10.1073/pnas.93.17.9194	30	142	148	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2004	36	10					1099	1104		10.1038/ng1424	http://dx.doi.org/10.1038/ng1424			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	15361873	Bronze			2022-12-27	WOS:000224156500019
J	He, XC; Zhang, JW; Tong, WG; Tawfik, O; Ross, J; Scoville, DH; Tian, Q; Zeng, X; He, X; Wiedemann, LM; Mishina, Y; Li, LH				He, XC; Zhang, JW; Tong, WG; Tawfik, O; Ross, J; Scoville, DH; Tian, Q; Zeng, X; He, X; Wiedemann, LM; Mishina, Y; Li, LH			BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling	NATURE GENETICS			English	Article							MORPHOGENETIC PROTEIN-RECEPTOR; TUMOR-SUPPRESSOR; JUVENILE POLYPOSIS; TRANSCRIPTIONAL ACTIVATION; NEGATIVE REGULATION; GERMLINE MUTATIONS; PTEN; GENE; TRANSDUCTION; GROWTH	In humans, mutations in BMPR1A, SMAD4 and PTEN are responsible for juvenile polyposis syndrome(1), juvenile intestinal polyposis(2) and Cowden disease(3), respectively. The development of polyposis is a common feature of these diseases, suggesting that there is an association between BMP and PTEN pathways(4,5). The mechanistic link between BMP and PTEN pathways and the related etiology of juvenile polyposis is unresolved. Here we show that conditional inactivation of Bmpr1a in mice disturbs homeostasis of intestinal epithelial regeneration with an expansion of the stem and progenitor cell populations, eventually leading to intestinal polyposis resembling human juvenile polyposis syndrome. We show that BMP signaling suppresses Wnt signaling to ensure a balanced control of stem cell self-renewal. Mechanistically, PTEN, through phosphatidylinosital-3 kinase-Akt, mediates the convergence of the BMP and Wnt pathways on control of beta-catenin. Thus, BMP signaling may control the duplication of intestinal stem cells, thereby preventing crypt fission and the subsequent increase in crypt number.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; Inst Systemsbiol, Seattle, WA 98103 USA; Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; NIEHS, Reprod & Dev Toxicol Lab, Res Triangle Pk, NC 27709 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Li, LH (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	lil@stowers-institute.org	Wiedemann, Leanne/E-3316-2010	Wiedemann, Leanne/0000-0002-0964-4676; Li, Linheng/0000-0001-9963-430X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES071004] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Besson A, 1999, EUR J BIOCHEM, V263, P605, DOI 10.1046/j.1432-1327.1999.00542.x; Brittan M, 2002, J PATHOL, V197, P492, DOI 10.1002/path.1155; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Itoh S, 2000, EUR J BIOCHEM, V267, P6954, DOI 10.1046/j.1432-1327.2000.01828.x; Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; Mutter GL, 2001, AM J PATHOL, V158, P1895, DOI 10.1016/S0002-9440(10)64656-1; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Potten CS, 2002, J CELL SCI, V115, P2381; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Roberts DJ, 2000, DEV DYNAM, V219, P109, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1047>3.3.CO;2-Y; ROTH KA, 1991, P NATL ACAD SCI USA, V88, P9407, DOI 10.1073/pnas.88.21.9407; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Waite KA, 2003, HUM MOL GENET, V12, P679, DOI 10.1093/hmg/ddg069; Waite KA, 2003, NAT REV GENET, V4, P763, DOI 10.1038/nrg1178; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	30	782	825	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2004	36	10					1117	1121		10.1038/ng1430	http://dx.doi.org/10.1038/ng1430			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	15378062	Bronze			2022-12-27	WOS:000224156500022
J	Auwerx, J; Avner, P; Baldock, R; Ballabio, A; Balling, R; Barbacid, M; Berns, A; Bradley, A; Brown, S; Carmeliet, P; Chambon, P; Cox, R; Davidson, D; Davies, K; Duboule, D; Forejt, J; Granucci, F; Hastie, N; de Angelis, MH; Jackson, I; Kioussis, D; Kollias, G; Lathrop, M; Lendahl, U; Malumbres, M; von Melchner, H; Muller, W; Partanen, J; Ricciardi-Castagnoli, P; Rigby, P; Rosen, B; Rosenthal, N; Skarnes, B; Stewart, AF; Thornton, J; Tocchini-Valentini, G; Wagner, E; Wahli, W; Wurst, W				Auwerx, J; Avner, P; Baldock, R; Ballabio, A; Balling, R; Barbacid, M; Berns, A; Bradley, A; Brown, S; Carmeliet, P; Chambon, P; Cox, R; Davidson, D; Davies, K; Duboule, D; Forejt, J; Granucci, F; Hastie, N; de Angelis, MH; Jackson, I; Kioussis, D; Kollias, G; Lathrop, M; Lendahl, U; Malumbres, M; von Melchner, H; Muller, W; Partanen, J; Ricciardi-Castagnoli, P; Rigby, P; Rosen, B; Rosenthal, N; Skarnes, B; Stewart, AF; Thornton, J; Tocchini-Valentini, G; Wagner, E; Wahli, W; Wurst, W		European Mouse Mutagenesis Consort	The European dimension for the mouse genome mutagenesis program	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; SITE-SPECIFIC RECOMBINATION; GENE-EXPRESSION; MUTANT MICE; LARGE-SCALE; ESTABLISHMENT; CONSTRUCTS; RESOURCE; WIDE	The European Mouse Mutagenesis Consortium is the European initiative contributing to the international effort on functional annotation of the mouse genome. Its objectives are to establish and integrate mutagenesis platforms, gene expression resources, phenotyping units, storage and distribution centers and bioinformatics resources. The combined efforts will accelerate our understanding of gene function and of human health and disease.	GSF Natl Res Ctr Environm & Hlth, Inst Dev Genet, D-85764 Munich, Germany; IGBMC, Strasbourg, France; Inst Pasteur, Unite Genet Mol Murine, Paris, France; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; TIGEM Inst, Naples, Italy; Gesell Biotechnol Forsch mbH, Mol Biotechnol, Braunschweig, Germany; CNIO, Madrid, Spain; Netherlands Canc Inst, Amsterdam, Netherlands; Sanger Ctr, Cambridge, England; MRC, Mouse Genome Ctr, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; Univ Louvain, Ctr Transgene Technol & Gene Therapy, Louvain, Belgium; Univ Oxford, Dept Human Anat & Genet, MRC, Funct Genet Unit, Oxford, England; Univ Geneva, Dept Zool, Geneva, Switzerland; ASCR, Inst Mol Genet, Prague, Czech Republic; Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy; GSF Natl Res Ctr Environm & Hlth GmbH, Inst Expt Genet, Munich, Germany; Natl Inst Med Res, MRC, Div Mol Immunol, London NW7 1AA, England; Biomed Sci Res Ctr Alexander Fleming, Athens, Greece; Ctr Natl Genotypage, Consortium Natl Rech Genom, Evry, France; Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; Ctr Nacl Invest Oncol, Madrid, Spain; Goethe Univ Frankfurt, D-6000 Frankfurt, Germany; Gesell Biotechnol Forsch mbH, Expt Immunol, Braunschweig, Germany; Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England; Wellcome Trust Sanger Inst, Cambridge, England; EMBL Monterotondo, Mouse Biol Programme, Rome, Italy; Tech Univ Dresden, BioInnovat Zentrum, D-01307 Dresden, Germany; European Bioinformat Inst, Cambridge, England; CNR, Ist Biol Cellulare, I-00137 Rome, Italy; Univ Vienna, Res Inst Mol Pathol, Vienna, Austria; Univ Lausanne, Inst Biol Anim, CH-1015 Lausanne, Switzerland	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Edinburgh; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Gesellschaft fur Biotechnologische Forschung mbH; Centro Nacional de Investigaciones Oncologicas (CNIO); Netherlands Cancer Institute; Wellcome Trust Sanger Institute; MRC Harwell; University of Oxford; University of Geneva; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; University of Milano-Bicocca; MRC National Institute for Medical Research; Alexander Fleming Biomedical Sciences Research Center; CEA; UDICE-French Research Universities; Universite Paris Saclay; Karolinska Institutet; Goethe University Frankfurt; Gesellschaft fur Biotechnologische Forschung mbH; University of Helsinki; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Technische Universitat Dresden; European Molecular Biology Laboratory (EMBL); Consiglio Nazionale delle Ricerche (CNR); University of Vienna; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Lausanne	Wurst, W (corresponding author), GSF Natl Res Ctr Environm & Hlth, Inst Dev Genet, Ingolstadter Landstr 1, D-85764 Munich, Germany.	wurst@gsf.de	Balling, Rudi/E-9680-2010; Holt, Janet E/B-2415-2013; Wahli, Walter/I-3194-2019; Castagnoli, Paola/E-8288-2010; Forejt, Jiri/G-7719-2012; GRANUCCI, Francesca/K-6150-2019; Stewart, A. Francis/E-7789-2010; Carmeliet, Peter/AAQ-5140-2020; Malumbres, Marcos/E-8834-2011; Muller, Werner/B-9044-2008; Kollias, George/A-7079-2012; Forejt, Jiri/AAF-5276-2019; de Angelis, Martin Hrabe/F-5531-2012; Wahli, Walter/B-1398-2009; BALLABIO, Andrea/AAL-2672-2020	Balling, Rudi/0000-0003-2902-5650; Forejt, Jiri/0000-0002-2793-3623; Carmeliet, Peter/0000-0001-7961-1821; Malumbres, Marcos/0000-0002-0829-6315; Muller, Werner/0000-0002-1297-9725; Kollias, George/0000-0003-1867-3150; Forejt, Jiri/0000-0002-2793-3623; de Angelis, Martin Hrabe/0000-0002-7898-2353; Wahli, Walter/0000-0002-5966-9089; BALLABIO, Andrea/0000-0003-1381-4604; Rosenthal, Nadia/0000-0002-7599-7365; Gkoutos, Georgios/0000-0002-2061-091X; duboule, denis/0000-0001-9961-2960; Wurst, Wolfgang/0000-0003-4422-7410; Bradley, Allan/0000-0002-2349-8839; Lendahl, Urban/0000-0001-9543-8141; Baldock, Richard/0000-0003-0332-6877; Cox, Roger/0000-0001-7170-5014; Thornton, Janet/0000-0003-0824-4096; Jackson, Ian/0000-0001-6526-0688; granucci, francesca/0000-0002-7046-4914; Auwerx, Johan/0000-0002-5065-5393	MRC [MC_U127527203] Funding Source: UKRI; Medical Research Council [MC_U127527203] Funding Source: Medline; Telethon [TGM06S01, TGM03S01] Funding Source: Medline; Wellcome Trust [077188] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Telethon(Fondazione Telethon); Wellcome Trust(Wellcome Trust)		ANGRAND PO, 1999, NUCLEIC ACIDS RES, V27, pE136; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Battey J, 1999, NAT GENET, V21, P73, DOI 10.1038/5012; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Gitton Y, 2002, NATURE, V420, P586, DOI 10.1038/nature01178; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hansen J, 2003, P NATL ACAD SCI USA, V100, P9918, DOI 10.1073/pnas.1633296100; LOGIE C, 1995, P NATL ACAD SCI USA, V92, P5940, DOI 10.1073/pnas.92.13.5940; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Nadeau JH, 2001, SCIENCE, V291, P1251, DOI 10.1126/science.1058244; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Reymond A, 2002, NATURE, V420, P582, DOI 10.1038/nature01178; RIELE HT, 1992, P NATL ACAD SCI USA, V89, P5128, DOI 10.1073/pnas.89.11.5128; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Wiles MV, 2000, NAT GENET, V24, P13, DOI 10.1038/71622; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	28	150	166	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					925	927		10.1038/ng0904-925	http://dx.doi.org/10.1038/ng0904-925			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15340424	Green Published, Green Accepted			2022-12-27	WOS:000223658100006
J	Boyadjiev, SA; Fromme, JC; Ben, J; Chong, SS; Nauta, C; Hur, DJ; Zhang, G; Hamamoto, S; Schekman, R; Ravazzola, M; Orci, L; Eyaid, W				Boyadjiev, Simeon A.; Fromme, J. Christopher; Ben, Jin; Chong, Samuel S.; Nauta, Christopher; Hur, David J.; Zhang, George; Hamamoto, Susan; Schekman, Randy; Ravazzola, Mariella; Orci, Lelio; Eyaid, Wafaa			Cranio-lenticulo-sutural dysplasia is caused by a SEC23A mutation leading to abnormal endoplasmic-reticulumto-Golgi trafficking	NATURE GENETICS			English	Article							MEMBRANE-PROTEINS; CARGO SELECTION; COPII VESICLES; ER; TRANSPORT; COAT; COMPLEX; EXPORT; YEAST; DISORDERS	Cranio-lenticulo-sutural dysplasia (CLSD) is an autosomal recessive syndrome characterized by late-closing fontanels, sutural cataracts, facial dysmorphisms and skeletal defects mapped to chromosome 14q13-q21 (ref. 1). Here we show, using a positional cloning approach, that an F382L amino acid substitution in SEC23A segregates with this syndrome. SEC23A is an essential component of the COPII-coated vesicles that transport secretory proteins from the endoplasmic reticulum to the Golgi complex. Electron microscopy and immunofluorescence show that there is gross dilatation of the endoplasmic reticulum in fibroblasts from individuals affected with CLSD. These cells also exhibit cytoplasmic mislocalization of SEC31. Cell-free vesicle budding assays show that the F382L substitution results in loss of SEC23A function. A phenotype reminiscent of CLSD is observed in zebrafish embryos injected with sec23a-blocking morpholinos. Our observations suggest that disrupted endoplasmic reticulum export of the secretory proteins required for normal morphogenesis accounts for CLSD.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Univ Calif Davis, Dept Pediat, Genet Sect, Sacramento, CA 95817 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 119074, Singapore; Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland; King Fahad Cent Hosp, Dept Pediat, Riyadh 11426, Saudi Arabia	Johns Hopkins University; University of California System; University of California Davis; Howard Hughes Medical Institute; University of California System; University of California Berkeley; National University of Singapore; University of Geneva	Boyadjiev, SA (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	simeon.boyd@ucdmc.ucdavis.edu	Hur, David J./AAV-8648-2020; Chong, Samuel S./D-8098-2015	Hur, David J./0000-0002-5604-3670; Chong, Samuel S./0000-0002-1872-5937; Fromme, J. Christopher/0000-0002-8837-0473	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R03DE016342] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE00462, DE16342] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Antonny B, 2001, CURR OPIN CELL BIOL, V13, P438, DOI 10.1016/S0955-0674(00)00234-9; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Ben J, 2005, GENE EXPR PATTERNS, V5, P629, DOI 10.1016/j.modgep.2005.03.002; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bottomley MJ, 2001, CURR BIOL, V11, P1114, DOI 10.1016/S0960-9822(01)00317-7; Boyadjiev SA, 2003, HUM GENET, V113, P1, DOI 10.1007/s00439-003-0932-6; Fisher L. W., 1989, CONNECT TISSUE RES, V21, P43; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200; Matsuoka K, 2000, METHODS, V20, P417, DOI 10.1006/meth.2000.0955; Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; NOVICK P, 1983, J CELL BIOL, V96, P541, DOI 10.1083/jcb.96.2.541; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Pagano A, 1999, J BIOL CHEM, V274, P7833, DOI 10.1074/jbc.274.12.7833; Roberts B, 2003, MOL BIOL CELL, V14, P4414, DOI 10.1091/mbc.E03-03-0162; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Tiller GE, 2001, AM J HUM GENET, V68, P1398, DOI 10.1086/320594; WILSON R, 1995, BIOCHEM J, V307, P679, DOI 10.1042/bj3070679; Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153	27	218	223	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2006	38	10					1192	1197		10.1038/ng1876	http://dx.doi.org/10.1038/ng1876			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16980979				2022-12-27	WOS:000241251100020
J	Chan, TL; Yuen, ST; Kong, CK; Chan, YW; Chan, ASY; Ng, WF; Tsui, WY; Lo, MWS; Tam, WY; Li, VSW; Leung, SY				Chan, Tsun Leung; Yuen, Siu Tsan; Kong, Chi Kwan; Chan, Yee Wai; Chan, Annie S. Y.; Ng, Wai Fu; Tsui, Wai Yin; Lo, Michelle W. S.; Tam, Wing Yip; Li, Vivian S. W.; Leung, Suet Yi			Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer	NATURE GENETICS			English	Article							MICROSATELLITE INSTABILITY; PROMOTER HYPERMETHYLATION; METHYLATION; HMLH1; MLH1; EXPRESSION; MUTATIONS; GENE	Epimutations in the germline, such as methylation of the MLH1 gene, may contribute to hereditary cancer syndrome in human, but their transmission to offspring has never been documented. Here we report a family with inheritance, in three successive generations, of germline allele-specific and mosaic hypermethylation of the MSH2 gene, without evidence of DNA mismatch repair gene mutation. Three siblings carrying the germline methylation developed early-onset colorectal or endometrial cancers, all with microsatellite instability and MSH2 protein loss. Clonal bisulfite sequencing and pyrosequencing showed different methylation levels in different somatic tissues, with the highest level recorded in rectal mucosa and colon cancer tissue, and the lowest in blood leukocytes. This mosaic state of germline methylation with different tissue distribution could act as the first hit and provide a mechanism for genetic disease inheritance that may deviate from the mendelian pattern and be overlooked in conventional leukocyte-based genetic diagnosis strategy.	Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hereditary Gastrointestinal Canc Genet Diag Lab, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Queen Mary Hosp, Hereditary Gastrointestinal Canc Registry, Hong Kong, Hong Kong, Peoples R China; St Pauls Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; Yan Chai Hosp, Dept Pathol, Tsuen Wah, Hong Kong, Peoples R China; Yan Chai Hosp, Dept Surg, Tsuen Wah, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Hong Kong St. Paul's Hospital	Yuen, ST (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hereditary Gastrointestinal Canc Genet Diag Lab, Hong Kong, Hong Kong, Peoples R China.	styuen@hkucc.hku.hk; suetyi@hkucc.hku.hk	Yuen, Siu/K-6311-2014; Leung, Suet Yi/C-4340-2009; Khoo, Ui Soon/C-4293-2009; Leung, Suet Yi/T-9620-2019	Khoo, Ui Soon/0000-0003-2200-7505; Leung, Suet Yi/0000-0001-8614-4619; Tam, Terence/0000-0001-9714-5879; Li, Vivian/0000-0003-2041-0085				Chan ASW, 2003, ONCOGENE, V22, P6946, DOI 10.1038/sj.onc.1206799; Chan TL, 2003, CANCER RES, V63, P4878; Chan TL, 1999, JNCI-J NATL CANCER I, V91, P1221, DOI 10.1093/jnci/91.14.1221; Chan TL, 2004, AM J HUM GENET, V74, P1035, DOI 10.1086/383591; Chong SY, 2004, CURR OPIN GENET DEV, V14, P692, DOI 10.1016/j.gde.2004.09.001; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Gazzoli I, 2002, CANCER RES, V62, P3925; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Hitchins M, 2005, GASTROENTEROLOGY, V129, P1392, DOI 10.1053/j.gastro.2005.09.003; Kane MF, 1997, CANCER RES, V57, P808; Leung SY, 1999, CANCER RES, V59, P159; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Miyakura Y, 2004, CLIN GASTROENTEROL H, V2, P147, DOI 10.1016/S1542-3565(03)00314-8; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Rijcken FEM, 2002, GUT, V50, P382, DOI 10.1136/gut.50.3.382; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Tost J, 2003, BIOTECHNIQUES, V35, P152, DOI 10.2144/03351md02; Yuen ST, 2002, ONCOGENE, V21, P7585, DOI 10.1038/sj.onc.1205968	20	232	245	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1178	1183		10.1038/ng1866	http://dx.doi.org/10.1038/ng1866			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16951683	Green Published			2022-12-27	WOS:000241251100018
J	Zara, F; Biancheri, R; Bruno, C; Bordo, L; Assereto, S; Gazzerro, E; Sotgia, F; Wang, XB; Gianotti, S; Stringara, S; Pedemonte, M; Uziel, G; Rossi, A; Schenone, A; Tortori-Donati, P; van der Knaap, MS; Lisanti, MP; Minetti, C				Zara, Federico; Biancheri, Roberta; Bruno, Claudio; Bordo, Laura; Assereto, Stefania; Gazzerro, Elisabetta; Sotgia, Federica; Wang, Xiao Bo; Gianotti, Stefania; Stringara, Silvia; Pedemonte, Marina; Uziel, Graziella; Rossi, Andrea; Schenone, Angelo; Tortori-Donati, Paolo; van der Knaap, Marjo S.; Lisanti, Michael P.; Minetti, Carlo			Deficiency of hyccin, a newly identified membrane protein, causes hypomyelination and congenital cataract	NATURE GENETICS			English	Article							MUTATIONS; GENE; DIFFERENTIATION; DISEASE; CATENIN	We describe a new autosomal recessive white matter disorder ('hypomyelination and congenital cataract') characterized by hypomyelination of the central and peripheral nervous system, progressive neurological impairment and congenital cataract. We identified mutations in five affected families, resulting in a deficiency of hyccin, a newly identified 521 - amino acid membrane protein. Our study highlights the essential role of hyccin in central and peripheral myelination.	G Gaslini Inst Children, Muscular & Neurodegenerat Dis Unit, Genoa, Italy; Univ Genoa, I-16126 Genoa, Italy; Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; C Besta Inst, Div Child Neuropsychiat, Milan, Italy; G Gaslini Inst Children, Dept Pediat Neuroradiol, Genoa, Italy; Univ Genoa, Dept Neurosci Ophthalmol & Genet, Genoa, Italy; Vrije Univ Amsterdam, Med Ctr, Dept Child Neurol, Amsterdam, Netherlands	University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; Jefferson University; Jefferson University; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; Vrije Universiteit Amsterdam	Zara, F (corresponding author), G Gaslini Inst Children, Muscular & Neurodegenerat Dis Unit, Genoa, Italy.	federicozara@ospedale-gaslini.ge.it; minettic@unige.it	Minetti, Carlo/K-4666-2018; schenone, angelo/I-3194-2012; Lisanti, Michael P/C-6866-2013; Rossi, Andrea/A-4146-2011; Lisanti, Michael/B-6131-2018; Bruno, Claudio/A-3148-2015; Zara, Federico/U-3477-2017	Minetti, Carlo/0000-0002-0640-1804; schenone, angelo/0000-0002-2604-7830; Rossi, Andrea/0000-0001-8575-700X; Lisanti, Michael/0000-0003-2034-1382; Bruno, Claudio/0000-0002-3426-2901; Zara, Federico/0000-0001-9744-5222; Pedemonte, Marina/0000-0001-8410-6918; Sotgia, Federica/0000-0003-2826-4529	Telethon [GTF04002] Funding Source: Medline	Telethon(Fondazione Telethon)		BERGOFFEN J, 1993, SCIENCE, V262, P2039, DOI 10.1126/science.8266101; Kasai M, 2005, GENES CELLS, V10, P777, DOI 10.1111/j.1365-2443.2005.00876.x; Kawasoe T, 2000, CANCER RES, V60, P3354; Lyu J, 2004, DEVELOPMENT, V131, P1813, DOI 10.1242/dev.01060; Mackay D, 1999, AM J HUM GENET, V64, P1357, DOI 10.1086/302383; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Schiffmann R, 2004, CURR OPIN NEUROL, V17, P187, DOI 10.1097/00019052-200404000-00017; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; Shimizu T, 2005, DEV BIOL, V282, P397, DOI 10.1016/j.ydbio.2005.03.020; Stump RJW, 2003, DEV BIOL, V259, P48, DOI 10.1016/S0012-1606(03)00179-9; Uhlenberg B, 2004, AM J HUM GENET, V75, P251, DOI 10.1086/422763; van der Knaap MS, 2002, AM J NEURORADIOL, V23, P1466; van der Knaap MS, 1999, RADIOLOGY, V213, P121, DOI 10.1148/radiology.213.1.r99se01121	13	69	71	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2006	38	10					1111	1113		10.1038/ng1870	http://dx.doi.org/10.1038/ng1870			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16951682	Green Published			2022-12-27	WOS:000241251100009
J	Lehner, B; Crombie, C; Tischler, J; Fortunato, A; Fraser, AG				Lehner, Ben; Crombie, Catriona; Tischler, Julia; Fortunato, Angelo; Fraser, Andrew G.			Systematic mapping of genetic interactions in Caenorhabditis elegans identifies common modifiers of diverse signaling pathways	NATURE GENETICS			English	Article							ENHANCED RNA INTERFERENCE; C-ELEGANS; SPLIT-ENDS; MORPHOLOGICAL EVOLUTION; COMPLEX; COMPONENT; PROTEIN; SCREEN; RAS; CAPACITOR	Most heritable traits, including disease susceptibility, are affected by interactions between multiple genes. However, we understand little about how genes interact because very few possible genetic interactions have been explored experimentally. We have used RNA interference in Caenorhabditis elegans to systematically test similar to 65,000 pairs of genes for their ability to interact genetically. We identify similar to 350 genetic interactions between genes functioning in signaling pathways that are mutated in human diseases, including components of the EGF/Ras, Notch and Wnt pathways. Most notably, we identify a class of highly connected 'hub' genes: inactivation of these genes can enhance the phenotypic consequences of mutation of many different genes. These hub genes all encode chromatin regulators, and their activity as genetic hubs seems to be conserved across animals. We propose that these genes function as general buffers of genetic variation and that these hub genes may act as modifier genes in multiple, mechanistically unrelated genetic diseases in humans.	Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England	Wellcome Trust Sanger Institute	Fraser, AG (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England.	agf@sanger.ac.uk	Lehner, Ben/L-3413-2014; Fortunato, Angelo/AAI-1120-2019; Lehner, Ben/ABH-6562-2020	Lehner, Ben/0000-0002-8817-1124; Fortunato, Angelo/0000-0001-7363-0423; Lehner, Ben/0000-0002-8817-1124; Fraser, Andrew/0000-0001-9939-6014	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bach EA, 2003, GENETICS, V165, P1149; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Baugh LR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r45; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; CARRERA I, 2003, DROS RES C, V44, pA346; Ceol CJ, 2004, DEV CELL, V6, P563, DOI 10.1016/S1534-5807(04)00065-6; Ch'ng Q, 1999, DEVELOPMENT, V126, P3303; Chen FL, 2000, CURR BIOL, V10, P943, DOI 10.1016/S0960-9822(00)00625-4; CLARK DV, 1995, MOL GEN GENET, V247, P367, DOI 10.1007/BF00293205; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Feng Y, 2003, CANCER RES, V63, P8726; Gause M, 2006, MOL CELL BIOL, V26, P2347, DOI 10.1128/MCB.26.6.2347-2359.2006; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Herman MA, 1999, DEVELOPMENT, V126, P1055; Howard RM, 2002, GENE DEV, V16, P1815, DOI 10.1101/gad.998402; Inoue T, 2002, MECH DEVELOP, V119, pS203, DOI 10.1016/S0925-4773(03)00117-5; JANODY F, 2002, DROS RES C, V43, P90; Jiang LI, 1999, GENE DEV, V13, P877, DOI 10.1101/gad.13.7.877; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kinchen JM, 2005, CURR TOP DEV BIOL, V65, P1; Kokel M, 1998, GENE DEV, V12, P1425, DOI 10.1101/gad.12.10.1425; Kuang B, 2000, DEVELOPMENT, V127, P1517; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Lehner B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r4; Lin HV, 2003, DEVELOPMENT, V130, P3125, DOI 10.1242/dev.00527; Ludewig AH, 2004, GENE DEV, V18, P2120, DOI 10.1101/gad.312604; Moghal N, 2003, DEVELOPMENT, V130, P57, DOI 10.1242/dev.00189; Oswald F, 2002, EMBO J, V21, P5417, DOI 10.1093/emboj/cdf549; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rebay I, 2000, GENETICS, V154, P695; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Shi YH, 2001, GENE DEV, V15, P1140, DOI 10.1101/gad.871201; Solari F, 2000, CURR BIOL, V10, P223, DOI 10.1016/S0960-9822(00)00343-2; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Staehling-Hampton K, 1999, GENETICS, V153, P275; SUNDARAM MV, WORMBOOK; Taubert S, 2004, MOL CELL BIOL, V24, P4546, DOI 10.1128/MCB.24.10.4546-4556.2004; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; van Haaften G, 2004, P NATL ACAD SCI USA, V101, P12992, DOI 10.1073/pnas.0403131101; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wiellette EL, 1999, DEVELOPMENT, V126, P5373; Xiao H, 2003, J BIOL CHEM, V278, P11197, DOI 10.1074/jbc.M210816200; Zhang H, 2001, DEVELOPMENT, V128, P767	48	346	361	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2006	38	8					896	903		10.1038/ng1844	http://dx.doi.org/10.1038/ng1844			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16845399				2022-12-27	WOS:000239325700018
J	Bender, A; Krishnan, KJ; Morris, CM; Taylor, GA; Reeve, AK; Perry, RH; Jaros, E; Hersheson, JS; Betts, J; Klopstock, T; Taylor, RW; Turnbull, DM				Bender, A; Krishnan, KJ; Morris, CM; Taylor, GA; Reeve, AK; Perry, RH; Jaros, E; Hersheson, JS; Betts, J; Klopstock, T; Taylor, RW; Turnbull, DM			High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease	NATURE GENETICS			English	Article							CYTOCHROME-C-OXIDASE; MUTATIONS; CELLS; POLYMERASE; AGE	Here we show that in substantia nigra neurons from both aged controls and individuals with Parkinson disease, there is a high level of deleted mitochondrial DNA (mtDNA) (controls, 43.3% +/- 9.3%; individuals with Parkinson disease, 52.3% +/- 9.3%). These mtDNA mutations are somatic, with different clonally expanded deletions in individual cells, and high levels of these mutations are associated with respiratory chain deficiency. Our studies suggest that somatic mtDNA deletions are important in the selective neuronal loss observed in brain aging and in Parkinson disease.	Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Newcastle Gen Hosp, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Newcastle Gen Hosp, Dept Neuropathol, Inst Hlth Elderly, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Univ Munich, Klinikum Grosshadern, Dept Neurol, D-81377 Munich, Germany	Newcastle University - UK; Newcastle General Hospital; Newcastle University - UK; Newcastle General Hospital; Newcastle University - UK; University of Munich	Turnbull, DM (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Mitochondrial Res Grp, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	d.m.turnbull@ncl.ac.uk	Bender, Andreas/A-7401-2012	Morris, Christopher/0000-0002-3749-0993; Reeve, Amy/0000-0002-4474-2204; Bender, Andreas/0000-0002-6328-7104	Alzheimers Research UK [ART-PG2003-3] Funding Source: researchfish; Medical Research Council [G0700718] Funding Source: Medline; Wellcome Trust [074454] Funding Source: Medline	Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; Cottrell DA, 2001, NEUROBIOL AGING, V22, P265, DOI 10.1016/S0197-4580(00)00234-7; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Greene JG, 2005, NEUROBIOL DIS, V18, P19, DOI 10.1016/j.nbd.2004.10.003; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6; JOHNSON MA, 1983, J NEUROL SCI, V60, P31, DOI 10.1016/0022-510X(83)90125-9; KRAYTSBERG Y, 2006, NAT GENET; Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3; MULLERHOCKER J, 1989, AM J PATHOL, V134, P1167; SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13; Smeyne RJ, 2005, MOL BRAIN RES, V134, P57, DOI 10.1016/j.molbrainres.2004.09.017; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517	15	1086	1128	1	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					515	517		10.1038/ng1769	http://dx.doi.org/10.1038/ng1769			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16604074				2022-12-27	WOS:000237147500009
J	Hashimoto, N; Kido, Y; Uchida, T; Asahara, SI; Shigeyama, Y; Matsuda, T; Takeda, A; Tsuchihashi, D; Nishizawa, A; Ogawa, W; Fujimoto, Y; Okamura, H; Arden, KC; Herrera, PL; Noda, T; Kasuga, M				Hashimoto, N; Kido, Y; Uchida, T; Asahara, SI; Shigeyama, Y; Matsuda, T; Takeda, A; Tsuchihashi, D; Nishizawa, A; Ogawa, W; Fujimoto, Y; Okamura, H; Arden, KC; Herrera, PL; Noda, T; Kasuga, M			Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass	NATURE GENETICS			English	Article							FORKHEAD TRANSCRIPTION FACTOR; INSULIN-RECEPTOR SUBSTRATE-2; PROTEIN-KINASE; MICE LACKING; FACTOR FOXO1; SIZE; DISRUPTION; RESISTANCE; GROWTH; TISSUE	The total mass of islets of Langerhans is reduced in individuals with type 2 diabetes(1), possibly contributing to the pathogenesis of this condition. Although the regulation of islet mass is complex, recent studies have suggested the importance of a signaling pathway that includes the insulin or insulin-like growth factor-1 receptors, insulin receptor substrate and phosphatidylinositol ( PI) 3-kinase(2-4). 3-Phosphoinositide dependent protein kinase 1 (PDK1) is a serine-threonine kinase that mediates signaling downstream of PI 3-kinase. Here we show that mice that lack PDK1 specifically in pancreatic beta cells (beta Pdk1(-/-) mice) develop progressive hyperglycemia as a result of a loss of islet mass. The mice show reductions in islet density as well as in the number and size of beta cells. Haploinsufficiency of the gene for the transcription factor Foxo1 resulted in a marked increase in the number, but not the size, of beta cells and resulted in the restoration of glucose homeostasis in beta bPdk1(-/-) mice. These results suggest that PDK1 is important in maintenance of pancreatic beta cell mass and glucose homeostasis.	Kobe Univ, Grad Sch Med, Dept Clin Mol Med, Div Diabet & Digest & Kidney Dis, Kobe, Hyogo 6500017, Japan; Kobe Univ, Grad Sch Med, Dept Brain Sci, Div Mol Brain Sci, Kobe, Hyogo 6500017, Japan; Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva 4, Switzerland; Inst Canc Res, Dept Cell Biol, Tokyo 1358550, Japan	Kobe University; Kobe University; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of Geneva; Japanese Foundation for Cancer Research	Kasuga, M (corresponding author), Kobe Univ, Grad Sch Med, Dept Clin Mol Med, Div Diabet & Digest & Kidney Dis, Kobe, Hyogo 6500017, Japan.	kasuga@med.kobe-u.ac.jp	OGAWA, Wataru/AAQ-9586-2020; Noda, Tetsuo/B-1667-2016	Herrera Merino, Pedro Luis/0000-0003-0771-9504				Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Hashimoto N, 2005, J CLIN INVEST, V115, P138, DOI 10.1172/JCI200522232; Herrera PL, 2000, DEVELOPMENT, V127, P2317; INOUE H, IN PRESS CELL METAB; Ishihara H, 2004, HUM MOL GENET, V13, P1159, DOI 10.1093/hmg/ddh125; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kozma SC, 2002, BIOESSAYS, V24, P65, DOI 10.1002/bies.10031; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lawlor MA, 2002, EMBO J, V21, P3728, DOI 10.1093/emboj/cdf387; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Mora A, 2003, EMBO J, V22, P4666, DOI 10.1093/emboj/cdg469; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Uchida T, 2005, NAT MED, V11, P175, DOI 10.1038/nm1187; UEKI K, 2006, NAT GENET; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116	28	174	184	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					589	593		10.1038/ng1774	http://dx.doi.org/10.1038/ng1774			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16642023				2022-12-27	WOS:000237147500023
J	Waters, MF; Minassian, NA; Stevanin, G; Figueroa, KP; Bannister, JPA; Nolte, D; Mock, AF; Evidente, VGH; Fee, DB; Muller, U; Durr, A; Brice, A; Papazian, DM; Pulst, SM				Waters, MF; Minassian, NA; Stevanin, G; Figueroa, KP; Bannister, JPA; Nolte, D; Mock, AF; Evidente, VGH; Fee, DB; Muller, U; Durr, A; Brice, A; Papazian, DM; Pulst, SM			Mutations in voltage-gated potassium channel KCNC3 cause degenerative and developmental central nervous system phenotypes	NATURE GENETICS			English	Article							CEREBELLAR PURKINJE-CELLS; SHAKER K+ CHANNEL; MICE LACKING; KV3.3; SUBUNIT; DYSFUNCTION; ACTIVATION; RESIDUES; SEGMENTS; NEURONS	Potassium channel mutations have been described in episodic neurological diseases(1). We report that K+ channel mutations cause disease phenotypes with neurodevelopmental and neurodegenerative features. In a Filipino adult-onset ataxia pedigree, the causative gene maps to 19q13, overlapping the SCA13 disease locus described in a French pedigree with childhood-onset ataxia and cognitive delay(2). This region contains KCNC3 (also known as Kv3.3), encoding a voltage-gated Shaw channel with enriched cerebellar expression(3). Sequencing revealed two missense mutations, both of which alter KCNC3 function in Xenopus laevis expression systems. KCNC3(R420H), located in the voltage-sensing domain(4), had no channel activity when expressed alone and had a dominant-negative effect when co-expressed with the wild-type channel. KCNC3(F448L) shifted the activation curve in the negative direction and slowed channel closing. Thus, KCNC3(R420H) and KCNC3(F448L) are expected to change the output characteristics of fast-spiking cerebellar neurons, in which KCNC channels confer capacity for high-frequency firing. Our results establish a role for KCNC3 in phenotypes ranging from developmental disorders to adult-onset neurodegeneration and suggest voltage-gated K+ channels as candidates for additional neurodegenerative diseases.	Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Burns & Allen Res Inst, Rose Moss Lab Parkinsons & Neurodegenerat Dis, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90024 USA; Hop La Pitie Salpetriere, Assistance Publ Hop Paris, Dept Genet Cytogenet & Embryol, F-75013 Paris, France; Hop La Pitie Salpetriere, INSERM, U679, F-75013 Paris, France; Univ Giessen, Inst Humangenet, D-35392 Giessen, Germany; Mayo Clin, Dept Neurol, Scottsdale, AZ 85259 USA; Univ Kentucky, Coll Med, Dept Neurol, Lexington, KY 40536 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Justus Liebig University Giessen; Mayo Clinic; Mayo Clinic Phoenix; University of Kentucky; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Pulst, SM (corresponding author), Cedars Sinai Med Ctr, Div Neurol, Los Angeles, CA 90048 USA.	stefan.pulst@cshs.org	Stevanin, Giovanni/E-5038-2016; Brice, Alexis/A-2170-2009; brice, alexis/AAE-8275-2019	Stevanin, Giovanni/0000-0001-9368-8657; brice, alexis/0000-0002-0941-3990	NIGMS NIH HHS [R01 GM043459-17, R01GM43459, R01 GM043459-16, R01GM66686, T32GM065823, R01 GM043459] Funding Source: Medline; PHS HHS [R01N533123] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043459, T32GM065823, R01GM066686] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Angulo E, 2004, J NEUROCHEM, V91, P547, DOI 10.1111/j.1471-4159.2004.02771.x; Ariano MA, 2005, J NEUROPHYSIOL, V93, P2565, DOI 10.1152/jn.00791.2004; Baranauskas G, 1999, J NEUROSCI, V19, P6394; DEMIERA EV, 1992, BIOCHEM BIOPH RES CO, V186, P1681; DUPRAT F, 1995, P NATL ACAD SCI USA, V92, P11796, DOI 10.1073/pnas.92.25.11796; Espinosa F, 2001, J NEUROSCI, V21, P6657, DOI 10.1523/JNEUROSCI.21-17-06657.2001; GHANSHANI S, 1992, GENOMICS, V12, P190, DOI 10.1016/0888-7543(92)90365-Y; GOLDMANWOHL DS, 1994, J NEUROSCI, V14, P511; Graves TD, 2005, POSTGRAD MED J, V81, P20, DOI 10.1136/pgmj.2004.022012; Herman-Bert A, 2000, AM J HUM GENET, V67, P229, DOI 10.1086/302958; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Martina M, 2003, J NEUROSCI, V23, P5698; Matsukawa H, 2003, J NEUROSCI, V23, P7677; McKay BE, 2005, J PHYSIOL-LONDON, V567, P829, DOI 10.1113/jphysiol.2005.089383; McKay BE, 2004, EUR J NEUROSCI, V20, P729, DOI 10.1111/j.1460-9568.2004.03539.x; McMahon A, 2004, EUR J NEUROSCI, V19, P3317, DOI 10.1111/j.0953-816X.2004.03385.x; PULST SM, 2003, GENETICS MOVEMENT DI, pCH2; Rae JL, 2000, EXP EYE RES, V70, P339, DOI 10.1006/exer.1999.0796; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; Schulteis CT, 1998, J BIOL CHEM, V273, P26210, DOI 10.1074/jbc.273.40.26210; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; Shieh CC, 1997, J GEN PHYSIOL, V109, P767, DOI 10.1085/jgp.109.6.767; Silverman WR, 2000, J GEN PHYSIOL, V116, P663, DOI 10.1085/jgp.116.5.663; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Waters MF, 2005, NEUROLOGY, V65, P1111, DOI 10.1212/01.wnl.0000177490.05162.41; WEISER M, 1994, J NEUROSCI, V14, P949, DOI 10.1523/JNEUROSCI.14-03-00949.1994	30	214	232	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2006	38	4					447	451		10.1038/ng1758	http://dx.doi.org/10.1038/ng1758			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	026LN	16501573				2022-12-27	WOS:000236340500017
J	Shiba, H; Kakizaki, T; Iwano, M; Tarutani, Y; Watanabe, M; Isogai, A; Takayama, S				Shiba, H; Kakizaki, T; Iwano, M; Tarutani, Y; Watanabe, M; Isogai, A; Takayama, S			Dominance relationships between self-incompatibility alleles controlled by DNA methylation	NATURE GENETICS			English	Article							NUCLEOLAR DOMINANCE; BRASSICA; TRANSCRIPTION; PROMOTER; BINDING; HYBRID; POLLEN	In crucifers, the pollen S-determinant gene, SP11, is sporophytically expressed in the anther tapetum, and the pollen self-incompatibility phenotype is determined by the dominance relationships between the two S-haplotypes it carries. We report here that 5' promoter sequences of recessive SP11 alleles are specifically methylated in the tapetum before the initiation of SP11 transcription. These results suggest that tissue-specific monoallelic de novo DNA methylation is involved in determining the dominance interactions that determine the cruciferous self-incompatibility phenotype.	Grad Sch Biol Sci, Nara Inst Sci & Technol, Ikoma 6300101, Japan; Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; Tohoku Univ, Grad Sch Life Sci, Aoba Ku, Tohoku 9808577, Japan	Nara Institute of Science & Technology; Iwate University; Tohoku University	Shiba, H (corresponding author), Grad Sch Biol Sci, Nara Inst Sci & Technol, 8916-5 Takayama, Ikoma 6300101, Japan.	hshiba@salk.edu; takayama@bs.naist.jp	KAKIZAKI, Tomohiro/E-6304-2011; Watanabe, Masao/E-6300-2011; Isogai, Akira/O-8897-2017; Watanabe, Masao/N-1465-2019	KAKIZAKI, Tomohiro/0000-0002-3636-6616; Watanabe, Masao/0000-0002-9419-5149; Isogai, Akira/0000-0001-8095-0441; Watanabe, Masao/0000-0002-9419-5149				Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; Brennan AC, 2003, PHILOS T ROY SOC B, V358, P1047, DOI 10.1098/rstb.2003.1300; Chen ZJ, 1998, P NATL ACAD SCI USA, V95, P14891, DOI 10.1073/pnas.95.25.14891; Frieman M, 1999, GENETICS, V152, P451; Hatakeyama K, 1998, HEREDITY, V80, P241, DOI 10.1046/j.1365-2540.1998.00295.x; Kakizaki T, 2003, PLANT CELL PHYSIOL, V44, P70, DOI 10.1093/pcp/pcg009; Kim SY, 1997, PLANT J, V11, P1237, DOI 10.1046/j.1365-313X.1997.11061237.x; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Shiba H, 2002, PLANT CELL, V14, P491, DOI 10.1105/tpc.010378; Shimizu KK, 2004, SCIENCE, V306, P2081, DOI 10.1126/science.1103776; Shiota K, 2004, CYTOGENET GENOME RES, V105, P325, DOI 10.1159/000078205; Zhu WG, 2003, MOL CELL BIOL, V23, P4056, DOI 10.1128/MCB.23.12.4056-4065.2003	15	71	77	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					297	299		10.1038/ng1734	http://dx.doi.org/10.1038/ng1734			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16444272				2022-12-27	WOS:000235589600009
J	Yoshiura, K; Kinoshita, A; Ishida, T; Ninokata, A; Ishikawa, T; Kaname, T; Bannai, M; Tokunaga, K; Sonoda, S; Komaki, R; Ihara, M; Saenko, VA; Alipov, GK; Sekine, I; Komatsu, K; Takahashi, H; Nakashima, M; Sosonkina, N; Mapendano, CK; Ghadami, M; Nomura, M; Liang, DS; Miwa, N; Kim, DK; Garidkhuu, A; Natsume, N; Ohta, T; Tomita, H; Kaneko, A; Kikuchi, M; Russomando, G; Hirayama, K; Ishibashi, M; Takahashi, A; Saitou, N; Murray, JC; Saito, S; Nakamura, Y; Niikawa, N				Yoshiura, K; Kinoshita, A; Ishida, T; Ninokata, A; Ishikawa, T; Kaname, T; Bannai, M; Tokunaga, K; Sonoda, S; Komaki, R; Ihara, M; Saenko, VA; Alipov, GK; Sekine, I; Komatsu, K; Takahashi, H; Nakashima, M; Sosonkina, N; Mapendano, CK; Ghadami, M; Nomura, M; Liang, DS; Miwa, N; Kim, DK; Garidkhuu, A; Natsume, N; Ohta, T; Tomita, H; Kaneko, A; Kikuchi, M; Russomando, G; Hirayama, K; Ishibashi, M; Takahashi, A; Saitou, N; Murray, JC; Saito, S; Nakamura, Y; Niikawa, N			A SNP in the ABCC11 gene is the determinant of human earwax type	NATURE GENETICS			English	Article							BINDING CASSETTE TRANSPORTER; CERUMEN; SUPERFAMILY; MRP8; WET; DNA	Human earwax consists of wet and dry types. Dry earwax is frequent in East Asians, whereas wet earwax is common in other populations. Here we show that a SNP, 538G -> A (rs17822931), in the ABCC11 gene is responsible for determination of earwax type. The AA genotype corresponds to dry earwax, and GA and GG to wet type. A 27-bp deletion in ABCC11 exon 29 was also found in a few individuals of Asian ancestry. A functional assay demonstrated that cells with allele A show a lower excretory activity for cGMP than those with allele G. The allele A frequency shows a north-south and east-west downward geographical gradient; worldwide, it is highest in Chinese and Koreans, and a common dry-type haplotype is retained among various ethnic populations. These suggest that the allele A arose in northeast Asia and thereafter spread through the world. The 538G -> A SNP is the first example of DNA polymorphism determining a visible genetic trait.	Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki, Japan; Japan Sci & Technol, CREST, Kawaguchi, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo, Japan; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biomol Engn, Yokohama, Kanagawa, Japan; Univ Ryukyus, Sch Med, Dept Med Genet, Okinawa, Japan; Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan; Kagoshima Univ, Ctr Res & Dev, Kagoshima, Japan; Kanebo Cosmet Inc, Cosmet Lab, Odawara, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiat Biophys, Nagasaki, Japan; Nagasaki Univ, Grad Sch Biomed Sci, Int Hlth Radiat Res, Nagasaki, Japan; Cent S Univ, Xiangya Hosp, Natl Lab Med Genet China, Changsha, Peoples R China; Keimyung Univ, Sch Med, Hanvit Inst Med Genet, Dept Anat, Taegu, South Korea; Aichi Gakuin Univ, Grad Sch Dent, Nagoya, Aichi, Japan; Hlth Sci Univ Hokkaido, Res Inst Personalized Hlth Sci, Ishikari, Hokkaido, Japan; Univ Calif Irvine, Human Genet Lab, Dept Psychiat & Human Behav, Irvine, CA USA; Karolinska Univ Hosp, Malaria Res Lab, Stockholm, Sweden; Nagasaki Univ, Inst Trop Med, Dept Mol Immunogenet, Nagasaki, Japan; Univ Nacl Asuncion, Inst Invest Ciencias Salud, Dept Biol Mol, Asuncion, Paraguay; Natl Inst Genet, Div Populat Genet, Mishima, Shizuoka, Japan; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; RIKEN, SNP Res Ctr, Lab SNP Anal, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan	Nagasaki University; Japan Science & Technology Agency (JST); University of Tokyo; Tokyo Institute of Technology; University of the Ryukyus; University of Tokyo; Kagoshima University; Kanebo Cosmetics Inc.; Nagasaki University; Nagasaki University; Central South University; Keimyung University; Aichi Gakuin University; Health Sciences University of Hokkaido; University of California System; University of California Irvine; Karolinska Institutet; Karolinska University Hospital; Nagasaki University; Research Institute for Health Sciences (IICS); Universidad Nacional de Asuncion; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Iowa; RIKEN; University of Tokyo	Yoshiura, K (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Human Genet, Nagasaki, Japan.	kyoshi@net.nagasaki-u.ac.jp	Hirayama, Kenji/AAN-7065-2021; Liang, Desheng/ABH-2349-2021; Garidkhuu, Ariuntuul/AAG-1846-2020	Liang, Desheng/0000-0002-9451-8585; Hirayama, Kenji/0000-0001-9467-1777; Garidkhuu, Ariuntuul/0000-0003-1635-0729; Tomita, Hiroaki/0000-0003-2628-880X; Takahashi, Aya/0000-0002-8391-7417; , Akira/0000-0003-2411-3352				ADACHI B, 1937, Z RASSENK, V6, P273; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bang YH, 1996, PLAST RECONSTR SURG, V98, P288, DOI 10.1097/00006534-199608000-00012; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bera TK, 2001, MOL MED, V7, P509, DOI 10.1007/BF03401856; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Burkhart CN, 2001, OTOL NEUROTOL, V22, P715, DOI 10.1097/00129492-200111000-00002; Chen ZS, 2005, MOL PHARMACOL, V67, P545, DOI 10.1124/mol.104.007138; Dillehay TD, 2003, NATURE, V425, P23, DOI 10.1038/425023a; Diller KC, 2002, MOL BIOL EVOL, V19, P2342, DOI 10.1093/oxfordjournals.molbev.a004061; Guo YP, 2003, J BIOL CHEM, V278, P29509, DOI 10.1074/jbc.M304059200; ING R, 1973, LANCET, V1, P41; Ishikawa T, 2005, METHOD ENZYMOL, V400, P485, DOI 10.1016/S0076-6879(05)00027-3; Masuzaki H, 2004, J MED GENET, V41, P289, DOI 10.1136/jmg.2003.015784; MATSUNAGA E, 1962, ANN HUM GENET, V25, P273, DOI 10.1111/j.1469-1809.1962.tb01766.x; Mitomo H, 2003, BIOCHEM J, V373, P767, DOI 10.1042/BJ20030150; OMOTO K, 1973, ISRAEL J MED SCI, V9, P1195; PETRAKIS NL, 1971, AM J PHYS ANTHROPOL, V35, P141, DOI 10.1002/ajpa.1330350117; PETRAKIS NL, 1967, SCIENCE, V158, P1192, DOI 10.1126/science.158.3805.1192; PETRAKIS NL, 1971, SCIENCE, V173, P347, DOI 10.1126/science.173.3994.347; Shimizu H, 2003, GENE, V310, P17, DOI 10.1016/S0378-1119(03)00504-3; SHUGYO Y, 1988, AM J ANAT, V181, P377, DOI 10.1002/aja.1001810405; Shulenin S, 2004, NEW ENGL J MED, V350, P1296, DOI 10.1056/NEJMoa032178; Tammur J, 2001, GENE, V273, P89, DOI 10.1016/S0378-1119(01)00572-8; Tokunaga K, 2001, HUM IMMUNOL, V62, P1001, DOI 10.1016/S0198-8859(01)00301-9; Tomita H, 2002, LANCET, V359, P2000, DOI 10.1016/S0140-6736(02)08835-9; Yabuuchi H, 2001, BIOCHEM BIOPH RES CO, V288, P933, DOI 10.1006/bbrc.2001.5865; Yamazaki K, 1998, GENETICA, V104, P235, DOI 10.1023/A:1026433925744	28	176	192	1	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					324	330		10.1038/ng1733	http://dx.doi.org/10.1038/ng1733			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16444273				2022-12-27	WOS:000235589600014
J	Pal, C; Papp, B; Lercher, MJ				Pal, C; Papp, B; Lercher, MJ			Adaptive evolution of bacterial metabolic networks by horizontal gene transfer	NATURE GENETICS			English	Article							ESCHERICHIA-COLI K-12; SACCHAROMYCES-CEREVISIAE; GENOME EVOLUTION; YEAST; ORGANIZATION; DUPLICATION; SCENARIOS; ENZYMES; MODELS; FLUX	Numerous studies have considered the emergence of metabolic pathways(1), but the modes of recent evolution of metabolic networks are poorly understood. Here, we integrate comparative genomics with flux balance analysis to examine (i) the contribution of different genetic mechanisms to network growth in bacteria, (ii) the selective forces driving network evolution and (iii) the integration of new nodes into the network. Most changes to the metabolic network of Escherichia coli in the past 100 million years are due to horizontal gene transfer, with little contribution from gene duplicates. Networks grow by acquiring genes involved in the transport and catalysis of external nutrients, driven by adaptations to changing environments. Accordingly, horizontally transferred genes are integrated at the periphery of the network, whereas central parts remain evolutionarily stable. Genes encoding physiologically coupled reactions are often transferred together, frequently in operons. Thus, bacterial metabolic networks evolve by direct uptake of peripheral reactions in response to changed environments.	European Mol Biol Lab, D-69012 Heidelberg, Germany; Eotvos Lorand Univ, MTA, Theoret Biol & Ecol Res Grp, H-1117 Budapest, Hungary; Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	European Molecular Biology Laboratory (EMBL); Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand University; University of Manchester; University of Bath	Lercher, MJ (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69012 Heidelberg, Germany.	lercher@embl.de	asif, huma/C-1441-2012; Lercher, Martin/K-7939-2013	Lercher, Martin/0000-0003-3940-1621; Papp, Balazs/0000-0003-3093-8852				Alves R, 2002, J MOL BIOL, V320, P751, DOI 10.1016/S0022-2836(02)00546-6; Boussau B, 2004, P NATL ACAD SCI USA, V101, P9722, DOI 10.1073/pnas.0400975101; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Hooper SD, 2003, MOL BIOL EVOL, V20, P945, DOI 10.1093/molbev/msg101; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Lawrence JG, 2003, MOL MICROBIOL, V50, P739, DOI 10.1046/j.1365-2958.2003.03778.x; LAWRENCE JG, 1991, J MOL EVOL, V33, P241, DOI 10.1007/BF02100675; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Mirkin BG, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-2; Ochman H, 1994, EXS, V69, P479; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Reed JL, 2004, GENOME RES, V14, P1797, DOI 10.1101/gr.2546004; Rison SCG, 2002, J MOL BIOL, V318, P911, DOI 10.1016/S0022-2836(02)00140-7; Salgado H, 2004, NUCLEIC ACIDS RES, V32, pD303, DOI 10.1093/nar/gkh140; Schmidt S, 2003, TRENDS BIOCHEM SCI, V28, P336, DOI 10.1016/S0968-0004(03)00114-2; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Snel B, 2004, GENOME RES, V14, P391, DOI 10.1101/gr.1969504; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Taoka M, 2004, MOL CELL PROTEOMICS, V3, P780, DOI 10.1074/mcp.M400030-MCP200; Teichmann SA, 2001, J MOL BIOL, V311, P693, DOI 10.1006/jmbi.2001.4912; Thatcher JW, 1998, P NATL ACAD SCI USA, V95, P253, DOI 10.1073/pnas.95.1.253; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005	30	351	361	2	72	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2005	37	12					1372	1375		10.1038/ng1686	http://dx.doi.org/10.1038/ng1686			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16311593				2022-12-27	WOS:000233657300019
J	Lim, JE; Jin, O; Bennett, C; Morgan, K; Wang, FD; Trenor, CC; Fleming, MD; Andrews, NC				Lim, JE; Jin, O; Bennett, C; Morgan, K; Wang, FD; Trenor, CC; Fleming, MD; Andrews, NC			A mutation in Sec15l1 causes anemia in hemoglobin deficit (hbd) mice	NATURE GENETICS			English	Article							TRANSFERRIN RECEPTOR; RAT RETICULOCYTES; EPITHELIAL-CELLS; EXOCYST COMPLEX; RAB11; MEMBRANE; DELIVERY; PATHWAY; MOUSE; IRON	Hemoglobin deficit (hbd) mice carry a spontaneous mutation that impairs erythroid iron assimilation but does not cause other defects. Normal delivery of iron to developing erythroid precursors is highly dependent on the transferrin cycle. Through genetic mapping and complementation experiments, we show that the hbd mutation is an in-frame deletion of a conserved exon of the mouse gene Sec15l1, encoding one of two Sec15 proteins implicated in the mammalian exocyst complex. Sec15l1 is linked to the transferrin cycle through its interaction with Rab11, a GTPase involved in vesicular trafficking. We propose that inactivation of Sec15l1 alters recycling of transferrin cycle endosomes and increases the release of transferrin receptor exocytic vesicles. This in turn decreases erythroid iron uptake. Determining the molecular basis of the hbd phenotype provides new insight into the intricate mechanisms necessary for normal erythroid iron uptake and the function of a mammalian exocyst protein.	Childrens Hosp, Div Hematol Oncol, Karp Family Res Labs RM 8 125, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Andrews, NC (corresponding author), Childrens Hosp, Div Hematol Oncol, Karp Family Res Labs RM 8 125, Boston, MA 02115 USA.	nancy_andrews@hms.harvard.edu	Wang, Fudi/L-7888-2018	Wang, Fudi/0000-0001-8730-0003; Andrews, Nancy/0000-0003-0243-4462; Fleming, Mark/0000-0003-0948-4024				Andrews HK, 2002, TRAFFIC, V3, P906, DOI 10.1034/j.1600-0854.2002.31206.x; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; BANNERMAN RM, 1986, P SOC EXP BIOL MED, V182, P52, DOI 10.3181/00379727-182-42307; Bloom ML, 1998, MAMM GENOME, V9, P666, DOI 10.1007/s003359900841; Brymora A, 2001, J BIOL CHEM, V276, P29792, DOI 10.1074/jbc.C100320200; Chen J, 2005, BLOOD, V106, P328, DOI 10.1182/blood-2004-09-3686; Friedrich GA, 1997, DEV BIOL, V192, P364, DOI 10.1006/dbio.1997.8727; GARRICK LM, 1987, EXP HEMATOL, V15, P671; Grindstaff KK, 1998, CELL, V93, P731, DOI 10.1016/S0092-8674(00)81435-X; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; HARDING C, 1984, EUR J CELL BIOL, V35, P256; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; JOHNSTONE RM, 1991, J CELL PHYSIOL, V147, P27, DOI 10.1002/jcp.1041470105; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Mehta SQ, 2005, NEURON, V46, P219, DOI 10.1016/j.neuron.2005.02.029; Murthy M, 2003, NEURON, V37, P433, DOI 10.1016/S0896-6273(03)00031-X; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x; Savina A, 2002, J CELL SCI, V115, P2505; SCHEUFLER VH, 1969, Z VERSUCHSTIERKD, V11, P348; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; TORRANCE J, 1980, TISSUE IRON STORES; Trenor CC, 2000, BLOOD, V96, P1113, DOI 10.1182/blood.V96.3.1113.015k03_1113_1118; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Yeaman C, 2004, J CELL SCI, V117, P559, DOI 10.1242/jcs.00893; Zhang J, 2004, BLOOD, V104, P1679, DOI 10.1182/blood-2004-04-1362; Zhang XM, 2004, J BIOL CHEM, V279, P43027, DOI 10.1074/jbc.M402264200	29	77	83	2	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1270	1273		10.1038/ng1659	http://dx.doi.org/10.1038/ng1659			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16227995				2022-12-27	WOS:000233045200029
J	Ule, J; Ule, A; Spencer, J; Williams, A; Hu, JS; Cline, M; Wang, H; Clark, T; Fraser, C; Ruggiu, M; Zeeberg, BR; Kane, D; Weinstein, JN; Blume, J; Darnell, RB				Ule, J; Ule, A; Spencer, J; Williams, A; Hu, JS; Cline, M; Wang, H; Clark, T; Fraser, C; Ruggiu, M; Zeeberg, BR; Kane, D; Weinstein, JN; Blume, J; Darnell, RB			Nova regulates brain-specific splicing to shape the synapse	NATURE GENETICS			English	Article							RNA-BINDING PROTEIN; MESSENGER-RNAS; GENOME; CAMKII; DOMAIN; IDENTIFICATION; EXPRESSION; PLASTICITY; SEQUENCE; ISOFORMS	Alternative RNA splicing greatly increases proteome diversity and may thereby contribute to tissue-specific functions. We carried out genome-wide quantitative analysis of alternative splicing using a custom Affymetrix microarray to assess the role of the neuronal splicing factor Nova in the brain. We used a stringent algorithm to identify 591 exons that were differentially spliced in the brain relative to immune tissues, and 6.6% of these showed major splicing defects in the neocortex of Nova2(-/-) mice. We tested 49 exons with the largest predicted Nova-dependent splicing changes and validated all 49 by RT-PCR. We analyzed the encoded proteins and found that all those with defined brain functions acted in the synapse (34 of 40, including neurotransmitter receptors, cation channels, adhesion and scaffold proteins) or in axon guidance ( 8 of 40). Moreover, of the 35 proteins with known interaction partners, 74% (26) interact with each other. Validating a large set of Nova RNA targets has led us to identify a multi-tiered network in which Nova regulates the exon content of RNAs encoding proteins that interact in the synapse.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA; Univ Amsterdam, Fac Econ & Econometr, NL-1012 WX Amsterdam, Netherlands; Affymetrix Inc, Emeryville, CA USA; NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA; SRA Int Inc, Fairfax, VA 22033 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; University of Amsterdam; Affymetrix; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); SRA International	Darnell, RB (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	darnelr@rockefeller.edu	Darnell, Robert B/B-9022-2008; zeeberg, barry/AAO-1246-2020; Ule, Jernej/C-6315-2013	Darnell, Robert B/0000-0002-5134-8088; Ule, Jernej/0000-0002-2452-4277; Blume, John/0000-0003-3026-953X; Ruggiu, Matteo/0000-0002-6404-1210; Spencer-Segal, Joanna/0000-0003-0467-2173; Clark, Tyson/0000-0002-7779-3227; Weinstein, John/0000-0001-9401-6908	NATIONAL CANCER INSTITUTE [Z01BC007349] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; ARGO F, 2004, CELL, V119, P257; Balla Z, 2002, J BIOL CHEM, V277, P21306, DOI 10.1074/jbc.M200553200; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; Buckanovich RJ, 1997, MOL CELL BIOL, V17, P3194, DOI 10.1128/MCB.17.6.3194; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Dateki M, 2005, J BIOL CHEM, V280, P20503, DOI 10.1074/jbc.M414033200; Dredge BK, 2005, EMBO J, V24, P1608, DOI 10.1038/sj.emboj.7600630; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Gao WQ, 1998, MOL CELL NEUROSCI, V11, P247, DOI 10.1006/mcne.1998.0696; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HEDLEY ML, 1991, CELL, V65, P579, DOI 10.1016/0092-8674(91)90090-L; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Hieronymus H, 2003, NAT GENET, V33, P155, DOI 10.1038/ng1080; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; HUANG CS, IN PRESS CELL; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kim S, 2003, NUCLEIC ACIDS RES, V31, P1955, DOI 10.1093/nar/gkg286; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; Le K, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh173; Lewis HA, 2000, CELL, V100, P323, DOI 10.1016/S0092-8674(00)80668-6; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Lu CS, 2003, NEURON, V40, P1185, DOI 10.1016/S0896-6273(03)00786-4; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; NAGOSHI RN, 1988, CELL, V53, P229, DOI 10.1016/0092-8674(88)90384-4; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Parra M, 2004, GENOMICS, V84, P637, DOI 10.1016/j.ygeno.2004.06.004; SCHISCHMANOFF PO, 1995, J BIOL CHEM, V270, P21243, DOI 10.1074/jbc.270.36.21243; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Waggoner SA, 2003, MOL CELL BIOL, V23, P7055, DOI 10.1128/MCB.23.19.7055-7067.2003; Wang H, 2003, BIOINFORMATICS, V19, pi315, DOI 10.1093/bioinformatics/btg1044; Wheeler R, 2002, LECT NOTES COMPUT SC, V2452, P201; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yang YYL, 1998, P NATL ACAD SCI USA, V95, P13254, DOI 10.1073/pnas.95.22.13254; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	50	378	391	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2005	37	8					844	852		10.1038/ng1610	http://dx.doi.org/10.1038/ng1610			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16041372				2022-12-27	WOS:000230880400014
J	Li, Z; Godinho, FJ; Klusmann, JH; Garriga-Canut, M; Yu, CN; Orkin, SH				Li, Z; Godinho, FJ; Klusmann, JH; Garriga-Canut, M; Yu, CN; Orkin, SH			Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; MEGAKARYOBLASTIC LEUKEMIA; GENE; MUTATIONS; DIFFERENTIATION; EXPRESSION; SPECIFICITY; INSIGHTS; BINDING; RESCUE	Acquired mutations in the hematopoietic transcription factor GATA binding protein-1 (GATA1) are found in megakaryoblasts from nearly all individuals with Down syndrome with transient myeloproliferative disorder (TMD, also called transient leukemia) and the related acute megakaryoblastic leukemia (DS-AMKL, also called DS-AML M7)(1-6). These mutations lead to production of a variant GATA1 protein ( GATA1s) that is truncated at its N terminus. To understand the biological properties of GATA1s and its relation to DS-AMKL and TMD, we used gene targeting to generate Gata1 alleles that express GATA1s in mice. We show that the dominant action of GATA1s leads to hyperproliferation of a unique, previously unrecognized yolk sac and fetal liver progenitor, which we propose accounts for the transient nature of TMD and the restriction of DS-AMKL to infants. Our observations raise the possibility that the target cells in other leukemias of infancy and early childhood are distinct from those in adult leukemias and underscore the interplay between specific oncoproteins and potential target cells.	Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute	Orkin, SH (corresponding author), Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	orkin@bloodgroup.tch.harvard.edu	Klusmann, Jan-Henning/M-9655-2015	Klusmann, Jan-Henning/0000-0002-1070-0727; Yu, Channing/0000-0002-3231-2565				Ahmed M, 2004, BLOOD, V103, P2480, DOI 10.1182/blood-2003-10-3383; BLOBEL GA, 1995, MOL CELL BIOL, V15, P626; Crispino JD, 2005, PEDIATR BLOOD CANCER, V44, P40, DOI 10.1002/pbc.20066; Crispino JD, 1999, MOL CELL, V3, P219, DOI 10.1016/S1097-2765(00)80312-3; Gagneten S, 1997, NUCLEIC ACIDS RES, V25, P3326, DOI 10.1093/nar/25.16.3326; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Gurbuxani S, 2004, BLOOD, V103, P399, DOI 10.1182/blood-2003-05-1556; Hitzler JK, 2003, BLOOD, V101, P4301, DOI 10.1182/blood-2003-01-0013; Hitzler JK, 2005, NAT REV CANCER, V5, P11, DOI 10.1038/nrc1525; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; McDevitt MA, 1997, P NATL ACAD SCI USA, V94, P7976, DOI 10.1073/pnas.94.15.7976; Mundschau G, 2003, BLOOD, V101, P4298, DOI 10.1182/blood-2002-12-3904; Rainis L, 2003, BLOOD, V102, P981, DOI 10.1182/blood-2002-11-3599; Rylski M, 2003, MOL CELL BIOL, V23, P5031, DOI 10.1128/MCB.23.14.5031-5042.2003; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shimizu R, 2001, EMBO J, V20, P5250, DOI 10.1093/emboj/20.18.5250; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; VISVADER JE, 1995, MOL CELL BIOL, V15, P634; Vyas P, 2000, P NATL ACAD SCI USA, V97, P13696, DOI 10.1073/pnas.250476397; Vyas P, 1999, BLOOD, V93, P2867; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; Xu G, 2003, BLOOD, V102, P2960, DOI 10.1182/blood-2003-02-0390	29	210	217	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					613	619		10.1038/ng1566	http://dx.doi.org/10.1038/ng1566			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15895080				2022-12-27	WOS:000229495300015
J	Aharoni, A; Gaidukov, L; Khersonsky, O; Gould, SM; Roodveldt, C; Tawfik, DS				Aharoni, A; Gaidukov, L; Khersonsky, O; Gould, SM; Roodveldt, C; Tawfik, DS			The 'evolvability' of promiscuous protein functions	NATURE GENETICS			English	Article							CONFORMATIONAL DIVERSITY; CATALYTIC PROMISCUITY; DIRECTED EVOLUTION; ENZYME; SPECIFICITY; SUBSTRATE; PARAOXONASES; MECHANISM; BINDING; FAMILY	How proteins with new functions (e. g., drug or antibiotic resistance or degradation of man-made chemicals) evolve in a matter of months or years is still unclear. This ability is dependent on the induction of new phenotypic traits by a small number of mutations (plasticity). But mutations often have deleterious effects on functions that are essential for survival. How are these seemingly conflicting demands met at the single-protein level? Results from directed laboratory evolution experiments indicate that the evolution of a new function is driven by mutations that have little effect on the native function but large effects on the promiscuous functions that serve as starting point. Thus, an evolving protein can initially acquire increased fitness for a new function without losing its original function. Gene duplication and the divergence of a completely new protein may then follow.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tawfik@weizmann.ac.il	Roodveldt, Cintia/I-9118-2014	Roodveldt, Cintia/0000-0003-4124-8769; Aharoni, Amir/0000-0003-2701-6996				Aharoni A, 2004, P NATL ACAD SCI USA, V101, P482, DOI 10.1073/pnas.2536901100; Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; BONE R, 1989, NATURE, V339, P191, DOI 10.1038/339191a0; BORNSCHEUER UT, 2004, ANGEW CHEM INT EDIT, V43, P2; Chong YH, 2004, FRONT BIOSCI-LANDMRK, V9, P164, DOI 10.2741/1220; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Draganov DI, 2004, N-S ARCH PHARMACOL, V369, P78, DOI 10.1007/s00210-003-0833-1; Earl DJ, 2004, P NATL ACAD SCI USA, V101, P11531, DOI 10.1073/pnas.0404656101; Giraud A, 2001, SCIENCE, V291, P2606, DOI 10.1126/science.1056421; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; James LC, 2003, PROTEIN SCI, V12, P2183, DOI 10.1110/ps.03172703; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; James LC, 2001, PROTEIN SCI, V10, P2600, DOI 10.1110/ps.ps.14601; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; KREBS JF, 1993, J BIOL CHEM, V268, P27458; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Matsumura I, 2001, J MOL BIOL, V305, P331, DOI 10.1006/jmbi.2000.4259; Miller BG, 2004, BIOCHEMISTRY-US, V43, P6387, DOI 10.1021/bi049424m; O'Brien PJ, 1999, CHEM BIOL, V6, pR91, DOI 10.1016/S1074-5521(99)80033-7; Pata JD, 2004, P NATL ACAD SCI USA, V101, P10548, DOI 10.1073/pnas.0404151101; Perona JJ, 1997, J BIOL CHEM, V272, P29987, DOI 10.1074/jbc.272.48.29987; Radman M, 1999, ANN NY ACAD SCI, V870, P146, DOI 10.1111/j.1749-6632.1999.tb08874.x; Raushel FM, 2000, ADV ENZYMOL RAMB, V74, P51; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Taverna DM, 2002, J MOL BIOL, V315, P479, DOI 10.1006/jmbi.2001.5226; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Wouters MA, 2003, MOL CELL, V12, P343, DOI 10.1016/S1097-2765(03)00308-3; Yang KC, 2004, P NATL ACAD SCI USA, V101, P7919, DOI 10.1073/pnas.0400664101	30	633	643	4	129	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2005	37	1					73	76		10.1038/ng1482	http://dx.doi.org/10.1038/ng1482			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15568024				2022-12-27	WOS:000225997500023
J	Segre, D; DeLuna, A; Church, GM; Kishony, R				Segre, D; DeLuna, A; Church, GM; Kishony, R			Modular epistasis in yeast metabolism	NATURE GENETICS			English	Article							DELETERIOUS MUTATIONS; NETWORK; ORGANIZATION; PRINCIPLES; EVOLUTION; STRAINS; BIOLOGY; FLUX	Epistatic interactions, manifested in the effects of mutations on the phenotypes caused by other mutations, may help uncover the functional organization of complex biological networks(1-3). Here, we studied system-level epistatic interactions by computing growth phenotypes of all single and double knockouts of 890 metabolic genes in Saccharomyces cerevisiae, using the framework of flux balance analysis(4). A new scale for epistasis identified a distinctive trimodal distribution of these epistatic effects, allowing gene pairs to be classified as buffering, aggravating or noninteracting(2,5). We found that the ensuing epistatic interaction network(6) could be organized hierarchically into function-enriched modules that interact with each other 'monochromatically' (i.e., with purely aggravating or purely buffering epistatic links). This property extends the concept of epistasis from single genes to functional units and provides a new definition of biological modularity, which emphasizes interactions between, rather than within, functional modules. Our approach can be used to infer functional gene modules from purely phenotypic epistasis measurements.	Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Lipper Ctr Computat Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kishony, R (corresponding author), Harvard Univ, Bauer Ctr Genom Res, 7 Divin Ave, Cambridge, MA 02138 USA.	rkishony@cgr.harvard.edu	DeLuna, Alexander/H-9986-2016; Segrè, Daniel/A-1993-2009	DeLuna, Alexander/0000-0002-9236-2804; Segrè, Daniel/0000-0003-4859-1914; church, george/0000-0001-6232-9969				Anholt RRH, 2003, NAT GENET, V35, P180, DOI 10.1038/ng1240; Burch CL, 2003, J EVOLUTION BIOL, V16, P1223, DOI 10.1046/j.1420-9101.2003.00632.x; DYKHUIZEN DE, 1987, GENETICS, V115, P25; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Elena SF, 1999, J MOL EVOL, V49, P703, DOI 10.1007/PL00000082; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Kaufman A, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P332; Kishony Roy, 2003, J Biol, V2, P14, DOI 10.1186/1475-4924-2-14; Klamt S, 2004, BIOINFORMATICS, V20, P226, DOI 10.1093/bioinformatics/btg395; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Papin JA, 2004, TRENDS BIOCHEM SCI, V29, P641, DOI 10.1016/j.tibs.2004.10.001; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Phillips PC., 2000, EPISTASIS EVOLUTIONA, P20; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Remold SK, 2004, NAT GENET, V36, P423, DOI 10.1038/ng1324; Salthe S., 1985, EVOLVING HIERARCHICA; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Wloch DM, 2001, J EVOLUTION BIOL, V14, P310, DOI 10.1046/j.1420-9101.2001.00267.x; You LC, 2002, GENETICS, V160, P1273	30	439	452	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2005	37	1					77	83		10.1038/ng1489	http://dx.doi.org/10.1038/ng1489			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15592468				2022-12-27	WOS:000225997500024
J	Turner, JMA; Mahadevaiah, SK; Fernandez-Capetillo, O; Nussenzweig, A; Xu, XL; Deng, CX; Burgoyne, PS				Turner, JMA; Mahadevaiah, SK; Fernandez-Capetillo, O; Nussenzweig, A; Xu, XL; Deng, CX; Burgoyne, PS			Silencing of unsynapsed meiotic chromosomes in the mouse	NATURE GENETICS			English	Article							X-CHROMOSOME; SYNAPTONEMAL COMPLEXES; MICE; BRCA1; MEIOSIS; PROTEIN; CELLS; SPERMATOGENESIS; ASSOCIATION; MUTATION	In Neurospora, DNA unpaired in meiosis both is silenced and induces silencing of all DNA homologous to it. This process, called meiotic silencing by unpaired DNA, is thought to protect the host genome from invasion by transposable elements. We now show that silencing of unpaired (unsynapsed) chromosome regions also takes place in the mouse during both male and female meiosis. The tumor suppressor protein BRCA1 is implicated in this silencing, mirroring its role in the meiotic silencing of the X and Y chromosomes in normal male meiosis. These findings impact on the interpretation of the relationship between synaptic errors and sterility in mammals and extend our understanding of the biology of Brca1.	Natl Inst Med Res, MRC, Div Stem Cell Res & Dev Genet, London NW7 1AA, England; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NIDDKD, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA	MRC National Institute for Medical Research; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Turner, JMA (corresponding author), Natl Inst Med Res, MRC, Div Stem Cell Res & Dev Genet, Mill Hill, London NW7 1AA, England.	jturner@nimr.mrc.ac.uk	deng, chuxia/N-6713-2016; Fernandez-Capetillo, Oscar/H-3508-2015	Fernandez-Capetillo, Oscar/0000-0002-2690-6885	MRC [MC_U117532009] Funding Source: UKRI; Medical Research Council [MC_U117532009, MC_U117588498] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010283, Z01BC010283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK056001, ZIADK056001] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON LK, 1988, CHROMOSOMA, V96, P295, DOI 10.1007/BF00286917; Ashley T, 2000, Results Probl Cell Differ, V28, P131; BAARENDS WM, IN PRESS MOL CELL BI; Bean CJ, 2004, NAT GENET, V36, P100, DOI 10.1038/ng1283; Boer P. de, 1989, Fertility and chromosome pairing: recent studies in plants and animals., P37; Burgoyne P S, 1984, Symp Soc Exp Biol, V38, P349; Burgoyne P. S., 1993, Chromosomes today: volume 11., P243; BURGOYNE PS, 1985, J REPROD FERTIL, V75, P633, DOI 10.1530/jrf.0.0750633; Burgoyne PS, 2000, CYTOGENET CELL GENET, V91, P57, DOI 10.1159/000056819; BURGOYNE PS, 1981, J REPROD FERTIL, V61, P207, DOI 10.1530/jrf.0.0610207; Fernandez-Capetillo O, 2003, J CELL BIOL, V163, P15, DOI 10.1083/jcb.200305124; FORD CE, 1964, CYTOGENETICS, V3, P295, DOI 10.1159/000129819; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Keegan KS, 1996, GENE DEV, V10, P2423, DOI 10.1101/gad.10.19.2423; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; LYON MF, 1973, GENET RES, V21, P185, DOI 10.1017/S0016672300013355; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; MAHADEVAIAH SK, 1993, J REPROD FERTIL, V97, P151, DOI 10.1530/jrf.0.0970151; MIKLOS GLG, 1974, CYTOGENET CELL GENET, V13, P558, DOI 10.1159/000130307; Moens PB, 1999, CHROMOSOMA, V108, P95, DOI 10.1007/s004120050356; Moens PB, 2002, J CELL SCI, V115, P1611; MOORE GPM, 1971, EXP CELL RES, V68, P462, DOI 10.1016/0014-4827(71)90176-5; Odorisio T, 1998, NAT GENET, V18, P257, DOI 10.1038/ng0398-257; Peters AHFM, 1997, CHROMOSOME RES, V5, P313, DOI 10.1023/B:CHRO.0000038762.60086.ef; Plug AW, 1998, J CELL SCI, V111, P413; Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Shiu PKT, 2001, CELL, V107, P905, DOI 10.1016/S0092-8674(01)00609-2; SPEED RM, 1986, CHROMOSOMA, V94, P115, DOI 10.1007/BF00286989; Turner JMA, 2000, CHROMOSOMA, V109, P426, DOI 10.1007/s004120000097; TURNER JMA, IN PRESS CURR BIOL; Wang PJ, 2004, TRENDS ENDOCRIN MET, V15, P79, DOI 10.1016/j.tem.2004.01.007; Xu LH, 1997, GENE DEV, V11, P106, DOI 10.1101/gad.11.1.106; Xu XL, 2003, DEVELOPMENT, V130, P2001, DOI 10.1242/dev.00410; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	39	424	442	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2005	37	1					41	47		10.1038/ng1484	http://dx.doi.org/10.1038/ng1484			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15580272				2022-12-27	WOS:000225997500019
J	Barrett, PL; Fleming, JT; Gobel, V				Barrett, PL; Fleming, JT; Gobel, V			Targeted gene alteration in Caenorhabditis elegans by gene conversion	NATURE GENETICS			English	Article							SEQUENCE-TAGGED SITES; INDUCED GAP REPAIR; DROSOPHILA-MELANOGASTER; GERM-LINE; DNA TRANSFORMATION; REVERSE GENETICS; C-ELEGANS; TRANSPOSON; ELEMENT; TC1	Now that some genomes have been completely sequenced, the ability to direct specific mutations into genomes is particularly desirable. Here we present a method to create mutations in the Caenorhabditis elegans genome efficiently through transgene-directed, transposon-mediated gene conversion. Engineered deletions targeted into two genes show that the frequency of obtaining the desired mutation was higher using this approach than using standard transposon insertion-deletion approaches. We also targeted an engineered green fluorescent protein insertion-replacement cassette to one of these genes, thereby confirming that custom alleles of different types can be created in vitro to make the corresponding mutations in vivo. This approach should also be applicable to heterologous transposons in C elegans and other organisms, including vertebrates.	Massachusetts Gen Hosp, Lab Dev Immunol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gobel, V (corresponding author), Massachusetts Gen Hosp, Lab Dev Immunol, Boston, MA 02114 USA.							Anderson P, 1995, METHOD CELL BIOL, V48, P31; BARRETT PL, 1999, THESIS HARVARD U; Berezikov E, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh033; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; BROVERMAN S, 1993, P NATL ACAD SCI USA, V90, P4359, DOI 10.1073/pnas.90.10.4359; COLLINS J, 1987, NATURE, V328, P726, DOI 10.1038/328726a0; Dupuy AJ, 2002, P NATL ACAD SCI USA, V99, P4495, DOI 10.1073/pnas.062630599; Engels WR, 1996, CURR TOP MICROBIOL, V204, P103; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Horie K, 2003, MOL CELL BIOL, V23, P9189, DOI 10.1128/MCB.23.24.9189-9207.2003; Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119; JOHNSONSCHLITZ DM, 1993, MOL CELL BIOL, V13, P7006, DOI 10.1128/MCB.13.11.7006; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Korswagen HC, 1996, P NATL ACAD SCI USA, V93, P14680, DOI 10.1073/pnas.93.25.14680; Le QH, 2001, GENETICS, V158, P1081; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; Liu Shumo, 2002, BMC Biotechnol, V2, P13, DOI 10.1186/1472-6750-2-13; Martin E, 2002, GENETICS, V162, P521; Mello C, 1995, METHOD CELL BIOL, V48, P451; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Plasterk RHA, 1995, METHOD CELL BIOL, V48, P59; PLASTERK RHA, 1992, EMBO J, V11, P287, DOI 10.1002/j.1460-2075.1992.tb05051.x; Plasterk Ronald H.A., 1997, Cold Spring Harbor Monograph Series, V33, P97; Raz E, 1998, CURR BIOL, V8, P82, DOI 10.1016/S0960-9822(98)70038-7; Rezsohazy R, 1997, NUCLEIC ACIDS RES, V25, P4048, DOI 10.1093/nar/25.20.4048; Rushforth AM, 1996, MOL CELL BIOL, V16, P422; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; STINCHCOMB DT, 1985, MOL CELL BIOL, V5, P3484, DOI 10.1128/MCB.5.12.3484; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; WILLIAMS BD, 1992, GENETICS, V131, P609; Williams BD, 1995, METHOD CELL BIOL, V48, P81; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	37	22	23	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1231	1237		10.1038/ng1459	http://dx.doi.org/10.1038/ng1459			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15502826	Bronze			2022-12-27	WOS:000224832800029
J	Rotimi, CN				Rotimi, CN			Are medical and nonmedical uses of large-scale genomic markers conflating genetics and 'race'?	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; APOLIPOPROTEIN-E; COMPLEX DISEASE; SUSCEPTIBILITY; GENES; DIVERSITY; RISK; POLYMORPHISM; ASSOCIATION; ETHNICITY		Howard Univ, Coll Med, Natl Human Genome Ctr, Washington, DC 20059 USA	Howard University	Rotimi, CN (corresponding author), Howard Univ, Coll Med, Natl Human Genome Ctr, Washington, DC 20059 USA.	crotimi@howard.edu						Allen M, 2003, NAT GENET, V35, P258, DOI 10.1038/ng1256; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; [Anonymous], 2002, NAT BIOTECHNOL, V20, P637, DOI 10.1038/nbt0702-637; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; Bell J, 2004, NATURE, V429, P453, DOI 10.1038/nature02624; Beutler E, 1996, BLOOD CELL MOL DIS, V22, P49, DOI 10.1006/bcmd.1996.0008; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Braun L, 2002, PERSPECT BIOL MED, V45, P159, DOI 10.1353/pbm.2002.0023; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Cardon LR, 2003, TRENDS GENET, V19, P135, DOI 10.1016/S0168-9525(03)00022-2; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Clark AG, 2003, CURR OPIN GENET DEV, V13, P296, DOI 10.1016/S0959-437X(03)00056-X; Clayton EW, 2002, J LAW MED ETHICS, V30, P290, DOI 10.1111/j.1748-720X.2002.tb00395.x; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Cooper RS, 2003, ANN INTERN MED, V138, P576, DOI 10.7326/0003-4819-138-7-200304010-00014; Dahlback B, 1997, REV INVEST CLIN, V49, P3; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Deloukas P, 2004, PHARMACOGENOMICS J, V4, P88, DOI 10.1038/sj.tpj.6500226; DORMAN JS, 1990, P NATL ACAD SCI USA, V87, P7370, DOI 10.1073/pnas.87.19.7370; DUSTER T, 2003, SAN FRANCISCO CHRONI; Elias, 1992, GENE MAPPING USING L, P94; ELLISON GTH, 2002, PSYCHOPATHOLOGY SOCI, P130; ELLISON GTH, 2002, CRITICAL PUBLIC HLTH, V12, P265; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; Foster MW, 2002, GENOME RES, V12, P844, DOI 10.1101/gr.99202; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goldstein DB, 2001, CURR BIOL, V11, pR576, DOI 10.1016/S0960-9822(01)00348-7; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Juengst ET, 1998, AM J HUM GENET, V63, P673, DOI 10.1086/302032; Kahn J, 2003, PERSPECT BIOL MED, V46, P473, DOI 10.1353/pbm.2003.0087; KAHN J, 2004, YALE J HLTH POLICY L, V6, P1; Kevles, 1995, NAME EUGENICS GENETI; Kittles RA, 2003, ANNU REV GENOM HUM G, V4, P33, DOI 10.1146/annurev.genom.4.070802.110356; LAZAROU J, 1998, JAMA-J AM MED ASSOC, V15, P200; LUZZATTO L, 1995, METABOLIC MOL BASES, P3367; Nebert D. W., 2001, Pharmacogenomics Journal, V1, P19; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; OLSON S, 2001, ATLANTIC MONTHLY APR; Pollack A., 2003, NY TIMES; Pollack A., 2004, NY TIMES; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; RISCH N, 2002, GENOME BIOL, V1, P3; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sankar P, 2002, SCIENCE, V298, P1337, DOI 10.1126/science.1074447; Shriver MD, 2004, NAT REV GENET, V5, P611, DOI 10.1038/nrg1405; Smedley A, 1999, RACE N AM ORIGIN EVO; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Taylor AL, 2002, J NATL MED ASSOC, V94, P762; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; VANDEVIJVER MJ, 2002, NEW ENGL J MED, V25, P347; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Witzig R, 1996, ANN INTERN MED, V125, P675, DOI 10.7326/0003-4819-125-8-199610150-00008; Yu N, 2002, MOL BIOL EVOL, V19, P2131, DOI 10.1093/oxfordjournals.molbev.a004038; [No title captured]; 2003, NAT GENET, V29, P239	71	54	55	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11		S			S43	S47		10.1038/ng1439	http://dx.doi.org/10.1038/ng1439			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867PH	15508002	Bronze			2022-12-27	WOS:000224854000010
J	Fan, YL; Esmail, MA; Ansley, SJ; Blacque, OE; Boroevich, K; Ross, AJ; Moore, SJ; Badano, JL; May-Simera, H; Compton, DS; Green, JS; Lewis, RA; van Haelst, MM; Parfrey, PS; Baillie, DL; Beales, PL; Katsanis, N; Davidson, WS; Leroux, MR				Fan, YL; Esmail, MA; Ansley, SJ; Blacque, OE; Boroevich, K; Ross, AJ; Moore, SJ; Badano, JL; May-Simera, H; Compton, DS; Green, JS; Lewis, RA; van Haelst, MM; Parfrey, PS; Baillie, DL; Beales, PL; Katsanis, N; Davidson, WS; Leroux, MR			Mutations in a member of the Ras superfamily of small GTP-binding proteins causes Bardet-Biedl syndrome	NATURE GENETICS			English	Article							INTRAFLAGELLAR TRANSPORT; FAMILY; IDENTIFICATION; LOCALIZATION; REGION; LOCUS; CYCLE; ARF	RAB, ADP-ribosylation factors (ARFs) and ARF-like (ARL) proteins belong to the Ras superfamily of small GTP-binding proteins and are essential for various membrane-associated intracellular trafficking processes(1,2). None of the similar to50 known members of this family are linked to human disease. Using a bioinformatic screen for ciliary genes in combination with mutational analyses, we identified ARL6 as the gene underlying Bardet-Biedl syndrome type 3, a multisystemic disorder characterized by obesity, blindness, polydactyly, renal abnormalities and cognitive impairment(3,4). We uncovered four different homozygous substitutions in ARL6 in four unrelated families affected with Bardet-Biedl syndrome, two of which disrupt a threonine residue important for GTP binding(5) and function(5-7) of several related small GTP-binding proteins. Analysis of the Caenorhabditis elegans ARL6 homolog indicates that it is specifically expressed in ciliated cells, and that, in addition to the postulated cytoplasmic functions of ARL proteins, it undergoes intraflagellar transport. These findings implicate a small GTP-binding protein in ciliary transport and the pathogenesis of a pleiotropic disorder.	Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; Johns Hopkins Univ, Inst Med Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21205 USA; UCL, Inst Child Hlth, Mol Med Unit, London WC1 1EH, England; Mem Univ Newfoundland, Dept Clin Epidemiol, St John, NF, Canada; Mem Univ Newfoundland, Dept Med Genet, St John, NF, Canada; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Med, Houston, TX 77030 USA; Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands	Simon Fraser University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; University of London; University College London; Memorial University Newfoundland; Memorial University Newfoundland; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Erasmus University Rotterdam	Davidson, WS (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	wdavidso@sfu.ca; leroux@sfu.ca	Blacque, Oliver/AAL-8860-2021; Katsanis, Nicholas/E-1837-2012; Beales, Philip L/C-7367-2009	Blacque, Oliver/0000-0003-1598-2695; Badano, Jose/0000-0002-0706-8652; Boroevich, Keith/0000-0001-7095-7332; May-Simera, Helen/0000-0002-9477-4036; Katsanis, Nicholas/0000-0002-2480-0171				Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Beales PL, 1999, J MED GENET, V36, P437; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Cuvillier A, 2000, J CELL SCI, V113, P2065; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Engel T, 2004, FEBS LETT, V566, P241, DOI 10.1016/j.febslet.2004.04.048; Ghadami M, 2000, AM J MED GENET, V94, P433, DOI 10.1002/1096-8628(20001023)94:5<433::AID-AJMG17>3.0.CO;2-X; Grayson C, 2002, HUM MOL GENET, V11, P3065, DOI 10.1093/hmg/11.24.3065; Haycraft CJ, 2003, EXP CELL RES, V284, P251, DOI 10.1016/S0014-4827(02)00089-7; Hickson GRX, 2003, MOL BIOL CELL, V14, P2908, DOI 10.1091/mbc.E03-03-0160; Huang CF, 2003, MOL BIOL CELL, V14, P3834, DOI 10.1091/mbc.E03-01-0013; Huber H, 1996, PLANT MOL BIOL, V31, P279, DOI 10.1007/BF00021790; Ingley E, 1999, FEBS LETT, V459, P69, DOI 10.1016/S0014-5793(99)01188-6; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2004, HUM MOL GENET, V13, pR65, DOI 10.1093/hmg/ddh092; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lu L, 2001, J CELL SCI, V114, P4543; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Pasqualato S, 2001, EMBO REP, V2, P234, DOI 10.1093/embo-reports/kve043; Pazour GJ, 2002, TRENDS CELL BIOL, V12, P551, DOI 10.1016/S0962-8924(02)02410-8; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; SHEFFIELD VC, 1994, HUM MOL GENET, V3, P1331, DOI 10.1093/hmg/3.8.1331; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Young TL, 1998, AM J MED GENET, V78, P461, DOI 10.1002/(SICI)1096-8628(19980806)78:5<461::AID-AJMG12>3.0.CO;2-D	28	256	272	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					989	993		10.1038/ng1414	http://dx.doi.org/10.1038/ng1414			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15314642	Bronze			2022-12-27	WOS:000223658100026
J	Delmaghani, S; del Castillo, FJ; Michel, V; Leibovici, M; Aghaie, A; Ron, U; Van Laer, L; Ben-Tal, N; Van Camp, G; Weil, D; Langa, F; Lathrop, M; Avan, P; Petit, C				Delmaghani, Sedigheh; del Castillo, Francisco J.; Michel, Vincent; Leibovici, Michel; Aghaie, Asadollah; Ron, Uri; Van Laer, Lut; Ben-Tal, Nir; Van Camp, Guy; Weil, Dominique; Langa, Francina; Lathrop, Mark; Avan, Paul; Petit, Christine			Mutations in the gene encoding pejvakin, a newly identified protein of the afferent auditory pathway, cause DFNB59 auditory neuropathy	NATURE GENETICS			English	Article							HEARING IMPAIRMENT; OTOFERLIN; SYSTEM; INNER; MICE; OTOF	Auditory neuropathy is a particular type of hearing impairment in which neural transmission of the auditory signal is impaired, while cochlear outer hair cells remain functional. Here we report on DFNB59, a newly identified gene on chromosome 2q31.1-q31.3 mutated in four families segregating autosomal recessive auditory neuropathy. DFNB59 encodes pejvakin, a 352-residue protein. Pejvakin is a paralog of DFNA5, a protein of unknown function also involved in deafness. By immunohistofluorescence, pejvakin is detected in the cell bodies of neurons of the afferent auditory pathway. Furthermore, Dfnb59 knock-in mice, homozygous for the R183W variant identified in one DFNB59 family, show abnormal auditory brainstem responses indicative of neuronal dysfunction along the auditory pathway. Unlike previously described sensorineural deafness genes, all of which underlie cochlear cell pathologies, DFNB59 is the first human gene implicated in nonsyndromic deafness due to a neuronal defect.	Inst Pasteur, INSERM, Unite Genet Deficits Sensoriels, U587, F-75724 Paris 15, France; Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel; Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium; Inst Pasteur, Ctr Ingn Genet Murine, Paris, France; Ctr Natl Genotypage, Evry, France; Univ Auvergne, Lab Biophys Sensorielle, Fac Med, Clermont Ferrand, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Tel Aviv University; University of Antwerp; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CEA; UDICE-French Research Universities; Universite Paris Saclay; Universite Clermont Auvergne (UCA)	Petit, C (corresponding author), Inst Pasteur, INSERM, Unite Genet Deficits Sensoriels, U587, 25,Rue Dr Roux, F-75724 Paris 15, France.	cpetit@pasteur.fr	Van Camp, Guy/F-3386-2013; AVAN, Paul/J-6878-2015; Leibovici, Michel/ABB-6745-2020; del Castillo, Francisco J./A-6467-2013	Van Camp, Guy/0000-0001-5105-9000; AVAN, Paul/0000-0003-1054-1479; del Castillo, Francisco J./0000-0003-0467-4320; Petit, Christine/0000-0002-9069-002X; Ben-Tal, Nir/0000-0001-6901-832X; Delmaghani, Sedigheh/0000-0003-2092-5097; Aghaie, Asadollah Alain/0000-0002-3247-7087; Vincent, Michel/0000-0002-7025-4343				Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Cohen-Salmon M, 1997, P NATL ACAD SCI USA, V94, P14450, DOI 10.1073/pnas.94.26.14450; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Cone-Wesson Barbara, 2000, CURR OPIN OTOLARYNGO, V8, P421; Dirks DD, 2000, EAR: COMPREHENSIVE OTOLOGY, P231; Durrant JD, 1998, J ACOUST SOC AM, V104, P370, DOI 10.1121/1.423293; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Katoh M, 2004, INT J ONCOL, V25, P765; Kemp DT, 2002, BRIT MED BULL, V63, P223, DOI 10.1093/bmb/63.1.223; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kress C, 1998, MAMM GENOME, V9, P998, DOI 10.1007/s003359900914; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; LIBERMAN MC, 1982, SCIENCE, V216, P1239, DOI 10.1126/science.7079757; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lunny DP, 2005, J INVEST DERMATOL, V124, P615, DOI 10.1111/j.0022-202X.2005.23623.x; MATISE MP, 1999, GENE TARGETING PRACT, P101; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Pulleyn LJ, 2000, EUR J HUM GENET, V8, P991, DOI 10.1038/sj.ejhg.5200567; Rance Gary, 2005, Trends Amplif, V9, P1, DOI 10.1177/108471380500900102; Rapin I, 2003, INT J PEDIATR OTORHI, V67, P707, DOI 10.1016/S0165-5876(03)00103-4; Rodriguez-Ballesteros M, 2003, HUM MUTAT, V22, P451, DOI 10.1002/humu.10274; Romand R, 1997, PROG NEUROBIOL, V51, P1, DOI 10.1016/S0301-0082(96)00043-3; Rouiller EM, 1997, CENTRAL AUDITORY SYS, P3; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Runkel F, 2004, GENOMICS, V84, P824, DOI 10.1016/j.ygeno.2004.07.003; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; Sininger Yvonne S., 2002, Seminars in Hearing, V23, P193, DOI 10.1055/s-2002-34456; Starr A., 2000, Journal of Basic and Clinical Physiology and Pharmacology, V11, P215; Starr A, 1996, BRAIN, V119, P741, DOI 10.1093/brain/119.3.741; STEEL KP, 1996, WHATS WRONG MY MOUSE, P26; Van Laer L, 2005, NEUROBIOL DIS, V19, P386, DOI 10.1016/j.nbd.2005.01.019; Van Laer L, 1998, NAT GENET, V20, P194; Varga R, 2003, J MED GENET, V40, P45, DOI 10.1136/jmg.40.1.45; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	40	191	232	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					770	778		10.1038/ng1829	http://dx.doi.org/10.1038/ng1829			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16804542				2022-12-27	WOS:000238669300012
J	Bar-Even, A; Paulsson, J; Maheshri, N; Carmi, M; O'Shea, E; Pilpel, Y; Barkai, N				Bar-Even, Arren; Paulsson, Johan; Maheshri, Narendra; Carmi, Miri; O'Shea, Erin; Pilpel, Yitzhak; Barkai, Naama			Noise in protein expression scales with natural protein abundance	NATURE GENETICS			English	Article							STOCHASTIC GENE-EXPRESSION; ESCHERICHIA-COLI; SINGLE-CELL; GLOBAL ANALYSIS; NETWORKS; YEAST; FLUCTUATIONS; POPULATION; MECHANISMS; MODEL	Noise in gene expression is generated at multiple levels, such as transcription and translation, chromatin remodeling and pathway-specific regulation. Studies of individual promoters have suggested different dominating noise sources, raising the question of whether a general trend exists across a large number of genes and conditions. We examined the variation in the expression levels of 43 Saccharomyces cerevisiae proteins, in cells grown under 11 experimental conditions. For all classes of genes and under all conditions, the expression variance was approximately proportional to the mean; the same scaling was observed at steady state and during the transient responses to the perturbations. Theoretical analysis suggests that this scaling behavior reflects variability in mRNA copy number, resulting from random 'birth and death' of mRNA molecules or from promoter fluctuations. Deviation of coexpressed genes from this general trend, including high noise in stress-related genes and low noise in proteasomal genes, may indicate fluctuations in pathway-specific regulators or a differential activation pattern of the underlying gene promoters.	Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA; Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England; Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Weizmann Inst Sci, Phys Complex Syst, IL-76100 Rehovot, Israel	Harvard University; University of Cambridge; Harvard University; Howard Hughes Medical Institute; Weizmann Institute of Science	Pilpel, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	pilpel@weizmann.ac.il; naama.barkai@weizmann.ac.il		Bar-Even, Arren/0000-0002-1039-4328				Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Berg OG, 2000, BIOPHYS J, V79, P1228, DOI 10.1016/S0006-3495(00)76377-6; BERG OG, 1978, J THEOR BIOL, V71, P587, DOI 10.1016/0022-5193(78)90326-0; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Colman-Lerner A, 2005, NATURE, V437, P699, DOI 10.1038/nature03998; de Menezes MA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.068701; de Menezes MA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.028701; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lobner-Olesen A, 1999, EMBO J, V18, P1712, DOI 10.1093/emboj/18.6.1712; MALONEY PC, 1973, J MOL BIOL, V73, P77, DOI 10.1016/0022-2836(73)90160-5; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814; NEWMAN JRS, IN PRESS NATURE; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Paulsson J, 2005, PHYS LIFE REV, V2, P157, DOI 10.1016/j.plrev.2005.03.003; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; RIGNEY DR, 1977, J THEOR BIOL, V69, P761, DOI 10.1016/0022-5193(77)90381-2; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; SPUDICH JL, 1976, NATURE, V262, P467, DOI 10.1038/262467a0; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; VOLFSON D, 2005, NATURE; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799	40	588	590	3	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2006	38	6					636	643		10.1038/ng1807	http://dx.doi.org/10.1038/ng1807			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16715097				2022-12-27	WOS:000237954800016
J	Barrett, JC; Cardon, LR				Barrett, Jeffrey C.; Cardon, Lon R.			Evaluating coverage of genome-wide association studies	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; COMPLEX DISEASE; POLYMORPHISM; FUTURE; POWER	Genome-wide association studies involving hundreds of thousands of SNPs in thousands of cases and controls are now underway. The first of many analytical challenges in these studies involves the choice of SNPs to genotype. It is not practical to construct a different panel of tag SNPs for each study, so the first generation of genome-wide scans will use predefined, commercially available marker panels, which will in part dictate their success or failure. We compare different approaches in use today, and show that although many of them provide substantial coverage of common variation in non-African populations, the precise extent is strongly dependent on the frequencies of alleles of interest and on specific considerations of study design. Overall, despite substantial differences in genotyping technologies, marker selection strategies and number of markers assayed, the first-generation high-throughput platforms all offer similar levels of genome coverage.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Cardon, LR (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	lon.cardon@well.ox.ac.uk		Barrett, Jeffrey/0000-0002-1152-370X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; DALY M, 2006, NAT GENET       0521; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Dong SL, 2001, GENOME RES, V11, P1418, DOI 10.1101/gr.171101; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Jorgenson E, 2006, AM J HUM GENET, V78, P884, DOI 10.1086/503751; Ke XY, 2005, HUM MOL GENET, V14, P2757, DOI 10.1093/hmg/ddi309; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Palmer LJ, 2005, LANCET, V366, P1223, DOI 10.1016/S0140-6736(05)67485-5; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522	19	308	338	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					659	662		10.1038/ng1801	http://dx.doi.org/10.1038/ng1801			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16715099				2022-12-27	WOS:000237954800019
J	Berezikov, E; Cuppen, E; Plasterk, RHA				Berezikov, Eugene; Cuppen, Edwin; Plasterk, Ronald H. A.			Approaches to microRNA discovery	NATURE GENETICS			English	Article							NONCODING RNAS; COMPUTATIONAL IDENTIFICATION; MAMMALIAN MICRORNAS; GENE-EXPRESSION; PREDICTION; ZEBRAFISH; SEQUENCE; CONSERVATION; PRECURSORS; MIRNAS	MicroRNAs (miRNAs) are noncoding RNAs that can regulate gene expression. Several hundred genes encoding miRNAs have been experimentally identified in animals, and many more are predicted by computational methods. How can new miRNAs be discovered and distinguished from other types of small RNA? Here we summarize current methods for identifying and validating miRNAs and discuss criteria used to define an miRNA.	[Berezikov, Eugene; Cuppen, Edwin; Plasterk, Ronald H. A.] Netherlands Inst Dev Biol, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Berezikov, E (corresponding author), Netherlands Inst Dev Biol, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.knaw.nl	Cuppen, Edwin/H-2389-2016; Cuppen, Edwin/F-5696-2011; Berezikov, Eugene/D-3363-2013	Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Berezikov, Eugene/0000-0002-1145-2884				Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Adai A, 2005, GENOME RES, V15, P78, DOI 10.1101/gr.2908205; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2005, HUM MOL GENET, V14, pR183, DOI 10.1093/hmg/ddi271; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chan CS, 2005, PLOS COMPUT BIOL, V1, P564, DOI 10.1371/journal.pcbi.0010069; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Devor EJ, 2006, J HERED, V97, P186, DOI 10.1093/jhered/esj022; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fu HJ, 2005, FEBS LETT, V579, P3849, DOI 10.1016/j.febslet.2005.05.064; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hsu PWC, 2006, NUCLEIC ACIDS RES, V34, pD135, DOI 10.1093/nar/gkj135; Huttenhofer A, 2006, NUCLEIC ACIDS RES, V34, P635, DOI 10.1093/nar/gkj469; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Legendre M, 2005, BIOINFORMATICS, V21, P841, DOI 10.1093/bioinformatics/bti073; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meyers BC, 2006, CURR OPIN BIOTECH, V17, P139, DOI 10.1016/j.copbio.2006.01.008; Missal K, 2005, BIOINFORMATICS, V21, P77, DOI 10.1093/bioinformatics/bti1113; Missal K, 2006, J EXP ZOOL PART B, V306B, P379, DOI 10.1002/jez.b.21086; Nam JW, 2005, NUCLEIC ACIDS RES, V33, P3570, DOI 10.1093/nar/gki668; Nelson JM, 2006, J CORP FINANC, V12, P187, DOI 10.1016/j.jcorpfin.2005.07.002; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Ohler U, 2004, RNA, V10, P1309, DOI 10.1261/rna.5206304; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; PFEFFER S, 2003, CURRENT PROTOCOLS MO; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Sewer A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-267; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Telernan AA, 2006, GENE DEV, V20, P417, DOI 10.1101/gad.374406; Wang XW, 2005, BIOINFORMATICS, V21, P3610, DOI 10.1093/bioinformatics/bti562; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Washietl S, 2005, P NATL ACAD SCI USA, V102, P2454, DOI 10.1073/pnas.0409169102; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474	76	335	399	3	52	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38			6			S2	S7		10.1038/ng1794	http://dx.doi.org/10.1038/ng1794			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V44DK	16736019				2022-12-27	WOS:000202983200002
J	Toydemir, RM; Rutherford, A; Whitby, FG; Jorde, LB; Carey, JC; Bamshad, MJ				Toydemir, RM; Rutherford, A; Whitby, FG; Jorde, LB; Carey, JC; Bamshad, MJ			Mutations in embryonic myosin heavy chain (MYH3) cause Freeman- Sheldon syndrome and Sheldon-Hall syndrome	NATURE GENETICS			English	Article							MUSCLE ALPHA-ACTIN; DISTAL ARTHROGRYPOSES; MISSENSE MUTATION; MYOPATHY; GENE; CARDIOMYOPATHY; COMPLEX; VARIANT; ERRORS; LOCUS	The genetic basis of most conditions characterized by congenital contractures is largely unknown. Here we show that mutations in the embryonic myosin heavy chain (MYH3) gene cause Freeman-Sheldon syndrome (FSS), one of the most severe multiple congenital contracture (that is, arthrogryposis) syndromes, and nearly one-third of all cases of Sheldon-Hall syndrome (SHS), the most common distal arthrogryposis. FSS and SHS mutations affect different myosin residues, demonstrating that MYH3 genotype is predictive of phenotype. A structure-function analysis shows that nearly all of the MYH3 mutations are predicted to interfere with myosin's catalytic activity. These results add to the growing body of evidence showing that congenital contractures are a shared outcome of prenatal defects in myofiber force production. Elucidation of the genetic basis of these syndromes redefines congenital contractures as unique defects of the sarcomere and provides insights about what has heretofore been a poorly understood group of disorders.	Univ Washington, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT USA; Univ Utah, Dept Pediat, Salt Lake City, UT USA; Univ Utah, Dept Biochem, Salt Lake City, UT USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Bamshad, MJ (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	mbamshad@u.washington.edu	Toydemir, Reha/U-9739-2019	Toydemir, Reha M./0000-0002-0797-1999				Agrawal PB, 2004, ANN NEUROL, V56, P86, DOI 10.1002/ana.20157; Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Bamshad M, 1996, AM J MED GENET, V65, P277, DOI 10.1002/(SICI)1096-8628(19961111)65:4<277::AID-AJMG6>3.0.CO;2-M; Bamshad M, 1996, AM J MED GENET, V65, P282, DOI 10.1002/(SICI)1096-8628(19961111)65:4<282::AID-AJMG7>3.0.CO;2-R; BURIAN F, 1963, Br J Plast Surg, V16, P140, DOI 10.1016/S0007-1226(63)80095-8; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ELLER M, 1989, FEBS LETT, V256, P21, DOI 10.1016/0014-5793(89)81710-7; Freeman E A, 1938, Arch Dis Child, V13, P277; Hall J, 1992, PRINCIPLES PRACTICE, P989; HALL JG, 1982, AM J MED GENET, V11, P185, DOI 10.1002/ajmg.1320110208; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KARSCHMIZRACHI I, 1989, NUCLEIC ACIDS RES, V17, P6167, DOI 10.1093/nar/17.15.6167; Krakowiak PA, 1997, AM J HUM GENET, V60, P426; LORENZ M, 1995, J MOL BIOL, V246, P108, DOI 10.1006/jmbi.1994.0070; Martinsson T, 2000, P NATL ACAD SCI USA, V97, P14614, DOI 10.1073/pnas.250289597; Meredith C, 2004, AM J HUM GENET, V75, P703, DOI 10.1086/424760; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Stevenson DA, 2006, PEDIATRICS, V117, P754, DOI 10.1542/peds.2005-1219; Sung SS, 2003, AM J HUM GENET, V73, P212, DOI 10.1086/376418; Sung SS, 2003, AM J HUM GENET, V72, P681, DOI 10.1086/368294; Swank DM, 2001, J BIOL CHEM, V276, P15117, DOI 10.1074/jbc.M008379200; Tajsharghi H, 2003, ANN NEUROL, V54, P494, DOI 10.1002/ana.10693; Veugelers M, 2004, NEW ENGL J MED, V351, P460, DOI 10.1056/NEJMoa040584; Wallgren-Pettersson C, 2004, NEUROMUSCULAR DISORD, V14, P461, DOI 10.1016/j.nmd.2004.03.006; Wells L, 1996, EMBO J, V15, P4454, DOI 10.1002/j.1460-2075.1996.tb00822.x	29	168	174	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					561	565		10.1038/ng1775	http://dx.doi.org/10.1038/ng1775			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16642020				2022-12-27	WOS:000237147500018
J	Adler, AS; Lin, MH; Horlings, H; Nuyten, DSA; van de Vijver, MJ; Chang, HY				Adler, AS; Lin, MH; Horlings, H; Nuyten, DSA; van de Vijver, MJ; Chang, HY			Genetic regulators of large-scale transcriptional signatures in cancer	NATURE GENETICS			English	Article							MYC PROTEIN STABILITY; HUMAN BREAST-TUMORS; DNA COPY NUMBER; C-MYC; EXPRESSION SIGNATURE; UBIQUITIN LIGASES; HUMAN FIBROBLASTS; GROWTH-FACTOR; DEGRADATION; TRANSFORMATION	Gene expression signatures encompassing dozens to hundreds of genes have been associated with many important parameters of cancer, but mechanisms of their control are largely unknown. Here we present a method based on genetic linkage that can prospectively identify functional regulators driving large-scale transcriptional signatures in cancer. Using this method we show that the wound response signature, a poor-prognosis expression pattern of 512 genes in breast cancer, is induced by coordinate amplifications of MYC and CSN5 (also known as JAB1 or COPS5). This information enabled experimental recapitulation, functional assessment and mechanistic elucidation of the wound signature in breast epithelial cells.	Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA; Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands	Stanford University; Stanford University; Netherlands Cancer Institute	Chang, HY (corresponding author), Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA.	howchang@stanford.edu		van de Vijver, Marc/0000-0002-0385-4787; Adler, Adam/0000-0001-9301-0037	NCI NIH HHS [CA09302, T32 CA009302] Funding Source: Medline; NIAMS NIH HHS [AR050007, K08 AR050007] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR050007] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Alt JR, 2003, EMBO J, V22, P1442, DOI 10.1093/emboj/cdg133; Amati B, 2004, P NATL ACAD SCI USA, V101, P8843, DOI 10.1073/pnas.0403046101; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bemis L, 2004, GENE DEV, V18, P739, DOI 10.1101/gad.1180104; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chi JT, 2003, P NATL ACAD SCI USA, V100, P6343, DOI 10.1073/pnas.1037853100; Cooper L, 2005, GENOME BIOL, V6; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Felsher DW, 2000, P NATL ACAD SCI USA, V97, P10544, DOI 10.1073/pnas.190327097; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Ginzinger DG, 2000, CANCER RES, V60, P5405; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; Kim BC, 2004, MOL CELL BIOL, V24, P2251, DOI 10.1128/MCB.24.6.2251-2262.2004; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Liu ET, 2003, CURR OPIN GENET DEV, V13, P97, DOI 10.1016/S0959-437X(03)00008-X; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; SOULE HD, 1990, CANCER RES, V50, P6075; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wang ZGC, 2004, CANCER RES, V64, P64, DOI 10.1158/0008-5472.CAN-03-2570; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wee S, 2005, NAT CELL BIOL, V7, P387, DOI 10.1038/ncb1241; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6	47	173	179	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2006	38	4					421	430		10.1038/ng1752	http://dx.doi.org/10.1038/ng1752			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	026LN	16518402	Green Accepted			2022-12-27	WOS:000236340500014
J	Williamson, CM; Turner, MD; Ball, ST; Nottingham, WT; Glenister, P; Fray, M; Tymowska-Lalanne, Z; Plagge, A; Powles-Glover, N; Kelsey, G; Maconochie, M; Peters, J				Williamson, CM; Turner, MD; Ball, ST; Nottingham, WT; Glenister, P; Fray, M; Tymowska-Lalanne, Z; Plagge, A; Powles-Glover, N; Kelsey, G; Maconochie, M; Peters, J			Identification of an imprinting control region affecting the expression of all transcripts in the Gnas cluster	NATURE GENETICS			English	Article							XL-ALPHA-S; G-PROTEIN; ANTISENSE; NESP; SUBUNIT; MICE; MARK	Genomic imprinting results in allele-specific silencing according to parental origin(1). Silencing is brought about by imprinting control regions (ICRs) that are differentially marked in gametogenesis(2). The group of imprinted transcripts in the mouse Gnas cluster (Nesp, Nespas, Gnasxl, Exon1A and Gnas) provides a model for analyzing the mechanisms of imprint regulation. We previously identified an ICR that specifically regulates the tissue-specific imprinted expression of the Gnas gene(3). Here we identify a second ICR at the Gnas cluster. We show that a paternally derived targeted deletion of the germline differentially methylated region (DMR) associated with the antisense Nespas transcript unexpectedly affects both the expression of all transcripts in the cluster and methylation of two DMRs. Our results establish that the Nespas DMR is the principal ICR at the Gnas cluster and functions bidirectionally as a switch for modulating expression of the antagonistically acting genes Gnasxl and Gnas. Uniquely, the Nespas DMR acts on the downstream ICR at exon 1A to regulate tissue-specific imprinting of the Gnas gene.	MRC, Mammalian Genet Unit, Harwell OX11 0RD, Oxon, England; Babraham Inst, Cambridge CB2 4AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Peters, J (corresponding author), MRC, Mammalian Genet Unit, Harwell OX11 0RD, Oxon, England.	j.peters@har.mrc.ac.uk	Williamson, Christine/GSE-3696-2022; Plagge, Antonius/AAH-3877-2019; Turner, Martin/N-9976-2014	Plagge, Antonius/0000-0001-6592-1343; Turner, Martin/0000-0002-3801-9896; Kelsey, Gavin/0000-0002-9762-5634	Medical Research Council [MC_UP_1502/1, MC_U142636336] Funding Source: Medline; MRC [MC_UP_1502/1, MC_U142636336] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abramowitz J, 2004, P NATL ACAD SCI USA, V101, P8366, DOI 10.1073/pnas.0308758101; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Bastepe M, 2003, J CLIN INVEST, V112, P1255, DOI 10.1172/JCI200319159; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Cattanach BM, 2000, HUM MOL GENET, V9, P2263, DOI 10.1093/oxfordjournals.hmg.a018917; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; Coombes C, 2003, MOL CELL BIOL, V23, P5475, DOI 10.1128/MCB.23.16.5475-5488.2003; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Ischia R, 1997, J BIOL CHEM, V272, P11657; Judson H, 2002, NATURE, V416, P539, DOI 10.1038/416539a; KEHLENBACH RH, 1994, NATURE, V372, P804; Kelsey G, 1999, GENOMICS, V62, P129, DOI 10.1006/geno.1999.6022; Li T, 2000, GENOMICS, V69, P295, DOI 10.1006/geno.2000.6337; Liu J, 2000, MOL CELL BIOL, V20, P5808, DOI 10.1128/MCB.20.16.5808-5817.2000; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; Liu J, 2005, P NATL ACAD SCI USA, V102, P5513, DOI 10.1073/pnas.0408262102; Liu J, 2005, HUM MOL GENET, V14, P95, DOI 10.1093/hmg/ddi009; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; RIVERAPEREZ JA, 1995, DEVELOPMENT, V121, P3005; Skinner JA, 2002, GENOMICS, V80, P373, DOI 10.1006/geno.2002.6842; Sleutels F, 2002, NATURE, V415, P810, DOI 10.1038/415810a; Spahn L, 2003, NAT GENET, V35, P11, DOI 10.1038/ng0903-11; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; Williamson CM, 2004, NAT GENET, V36, P894, DOI 10.1038/ng1398; Williamson CM, 2002, MAMM GENOME, V13, P74, DOI 10.1007/s00335-001-2102-2; Wroe SF, 2000, P NATL ACAD SCI USA, V97, P3342, DOI 10.1073/pnas.050015397; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	30	147	162	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					350	355		10.1038/ng1731	http://dx.doi.org/10.1038/ng1731			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16462745				2022-12-27	WOS:000235589600018
J	Zhu, LM; Vranckx, R; Van Kien, PK; Lalande, A; Boisset, N; Mathieu, F; Wegman, M; Glancy, L; Gasc, JM; Brunotte, FO; Bruneval, P; Wolf, JE; Michel, JB; Jeunemaitre, X				Zhu, LM; Vranckx, R; Van Kien, PK; Lalande, A; Boisset, N; Mathieu, F; Wegman, M; Glancy, L; Gasc, JM; Brunotte, FO; Bruneval, P; Wolf, JE; Michel, JB; Jeunemaitre, X			Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus	NATURE GENETICS			English	Article							HEAVY-CHAIN ISOFORMS; COILED-COILS; LOCUS; ANEURYSM/DISSECTION; DISEASE	We have recently described two kindreds presenting thoracic aortic aneurysm and/or aortic dissection ( TAAD) and patent ductus arteriosus (PDA)(1,2) and mapped the disease locus to 16p12.2-p13.13 (ref. 3). We now demonstrate that the disease is caused by mutations in the MYH11 gene affecting the C-terminal coiled-coil region of the smooth muscle myosin heavy chain, a specific contractile protein of smooth muscle cells (SMC). All individuals bearing the heterozygous mutations, even if asymptomatic, showed marked aortic stiffness. Examination of pathological aortas showed large areas of medial degeneration with very low SMC content. Abnormal immunological recognition of SM-MHC and the colocalization of wild-type and mutant rod proteins in SMC, in conjunction with differences in their coimmunoprecipitation capacities, strongly suggest a dominant-negative effect. Human MYH11 gene mutations provide the first example of a direct change in a specific SMC protein leading to an inherited arterial disease.	Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Genet, F-75015 Paris, France; INSERM, U36, F-75005 Paris, France; INSERM, U772, F-75005 Paris, France; Coll France, F-75005 Paris, France; Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, French Chinese Genom Pole, Shanghai, Peoples R China; INSERM, U698, Paris, France; Univ Paris 07, Fac Med Xavier Bichat, F-75018 Paris, France; Univ Bourgogne, Lab Physiopathol & Pharmacol Cardiovasc Expt, F-21000 Dijon, France; CHU Dijon, Serv Cardiol 2, F-21000 Dijon, France; CHU Dijon, Ctr Imagerie Resonance Magnet, F-21000 Dijon, France; CNRS, UMR 158, Lab Elect & Informat Image, F-21000 Dijon, France; CNRS, UMR 7590, Dept Biol Struct, IMPMC, F-75005 Paris, France; Univ Paris 06, F-75005 Paris, France; Louisiana State Univ, Hlth Sci Ctr, Dept Med, Cardiol Sect, New Orleans, LA 70112 USA; Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Serv Anatomopathol, F-75015 Paris, France; Univ Paris 05, Fac Med, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Shanghai Jiao Tong University; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Jeunemaitre, X (corresponding author), Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Genet, F-75015 Paris, France.	xavier.jeunemaitre@epg.aphp.fr	JEUNEMAITRE, Xavier/AAQ-4853-2021; Mathieu, Flavie/M-9855-2017; Michel, Jean-Baptiste/AAH-9336-2020; ZHU, Limin/AAZ-9201-2020; Lalande, Alain/T-1050-2017	JEUNEMAITRE, Xavier/0000-0001-5925-381X; Mathieu, Flavie/0000-0002-3386-0299; Lalande, Alain/0000-0002-7970-366X; KHAU VAN KIEN, Philippe/0000-0001-7754-969X				AIKAWA M, 1993, CIRC RES, V73, P1000, DOI 10.1161/01.RES.73.6.1000; Babu GJ, 2000, MICROSC RES TECHNIQ, V50, P532, DOI 10.1002/1097-0029(20000915)50:6<532::AID-JEMT10>3.0.CO;2-E; Boileau C, 2005, CURR OPIN CARDIOL, V20, P194, DOI 10.1097/01.hco.0000162398.21972.cd; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Coady MA, 1999, ARCH SURG-CHICAGO, V134, P361, DOI 10.1001/archsurg.134.4.361; Franke JD, 2005, BLOOD, V105, P161, DOI 10.1182/blood-2004-06-2067; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Glancy DL, 2001, AM J CARDIOL, V87, P813, DOI 10.1016/S0002-9149(00)01515-0; Guo DC, 2001, CIRCULATION, V103, P2461; Hasham SN, 2003, CIRCULATION, V107, P3184, DOI 10.1161/01.CIR.0000078634.33124.95; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; HORNBLAD PY, 1967, CARDIOLOGIA, V51, P262, DOI 10.1159/000165823; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lalande A, 2002, INVEST RADIOL, V37, P685, DOI 10.1097/00004424-200212000-00008; Laurent S, 2005, HYPERTENSION, V45, P1050, DOI 10.1161/01.HYP.0000164580.39991.3d; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mani A, 2002, P NATL ACAD SCI USA, V99, P15054, DOI 10.1073/pnas.192582999; Meloni I, 2001, Hum Mutat, V18, P85, DOI 10.1002/humu.1157; Meredith C, 2004, AM J HUM GENET, V75, P703, DOI 10.1086/424760; Morano I, 2000, NAT CELL BIOL, V2, P371, DOI 10.1038/35014065; NACHTIGAL M, 1989, IN VITRO CELL DEV B, V25, P892; Pannu H, 2005, CIRCULATION, V112, P513, DOI 10.1161/CIRCULATIONAHA.105.537340; Quevillon-Cheruel S, 1999, FEBS LETT, V454, P303, DOI 10.1016/S0014-5793(99)00827-3; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Slomp J, 1997, ARTERIOSCL THROM VAS, V17, P1003, DOI 10.1161/01.ATV.17.5.1003; Straussman R, 2005, J MOL BIOL, V353, P613, DOI 10.1016/j.jmb.2005.08.010; Van Kien PK, 2005, CIRCULATION, V112, P200, DOI 10.1161/CIRCULATIONAHA.104.506345; Van Kien PK, 2004, EUR J HUM GENET, V12, P173, DOI 10.1038/sj.ejhg.5201119; Vaughan CJ, 2001, CIRCULATION, V103, P2469	30	407	421	2	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					343	349		10.1038/ng1721	http://dx.doi.org/10.1038/ng1721			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16444274				2022-12-27	WOS:000235589600017
J	Monsuur, AJ; de Bakker, PIW; Alizadeh, BZ; Zhernakova, A; Bevova, MR; Strengman, E; Franke, L; van't Slot, R; van Belzen, MJ; Lavrijsen, ICM; Diosdado, B; Daly, MJ; Mulder, CJJ; Mearin, ML; Meijer, JWR; Meijer, GA; van Oort, E; Wapenaar, MC; Koeleman, BPC; Wijmenga, C				Monsuur, AJ; de Bakker, PIW; Alizadeh, BZ; Zhernakova, A; Bevova, MR; Strengman, E; Franke, L; van't Slot, R; van Belzen, MJ; Lavrijsen, ICM; Diosdado, B; Daly, MJ; Mulder, CJJ; Mearin, ML; Meijer, JWR; Meijer, GA; van Oort, E; Wapenaar, MC; Koeleman, BPC; Wijmenga, C			Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect	NATURE GENETICS			English	Article							EPITHELIAL BARRIER; PREVALENCE; MAPS	Celiac disease is probably the best-understood immune-related disorder. The disease presents in the small intestine and results from the interplay between multiple genes and gluten, the triggering environmental factor(1). Although HLA class II genes explain 40% of the heritable risk, non-HLA genes accounting for most of the familial clustering have not yet been identified. Here we report significant and replicable association (P = 2.1 x 10(-6)) to a common variant located in intron 28 of the gene myosin IXB (MYO9B), which encodes an unconventional myosin molecule that has a role in actin remodeling of epithelial enterocytes(2,3). Individuals homozygous with respect to the at-risk allele have a 2.3-times higher risk of celiac disease ( P = 1.55 x 10(-5)). This result is suggestive of a primary impairment of the intestinal barrier in the etiology of celiac disease, which may explain why immunogenic gluten peptides are able to pass through the epithelial barrier.	Univ Med Ctr Utrecht, DBG Dept Med Genet, Complex Genet Sect, NL-3584 CG Utrecht, Netherlands; Harvard Univ, Broad Inst, Cambridge, MA 02141 USA; MIT, Broad Inst, Cambridge, MA 02141 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; VU Univ Med Ctr, Dept Gastroenterol, NL-1007 MB Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Pediat, NL-2300 RC Leiden, Netherlands; Rijnstate Hosp, Dept Pathol, NL-6800 TA Arnhem, Netherlands; VU Univ Med ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Rijnstate Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Wijmenga, C (corresponding author), Univ Med Ctr Utrecht, DBG Dept Med Genet, Complex Genet Sect, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	t.n.wijmenga@med.uu.nl	Wijmenga, Cisca/D-2173-2009; Alizadeh, Behrooz Z Ziad/J-2921-2017; de Bakker, Paul IW/B-8730-2009; Daly, Mark J/B-2453-2017; Wijmenga, Cisca/AAE-7719-2019; Zhernakova, Alexandra/ABA-9372-2020; Franke, Lude/P-7036-2016	Alizadeh, Behrooz Z Ziad/0000-0002-1415-8007; de Bakker, Paul IW/0000-0001-7735-7858; Daly, Mark J/0000-0002-0949-8752; Wijmenga, Cisca/0000-0002-5635-1614; Meijer, Gerrit/0000-0003-0330-3130; Zhernakova, Alexandra/0000-0002-4574-0841; Franke, Lude/0000-0002-5159-8802				Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Babron MC, 2003, EUR J HUM GENET, V11, P828, DOI 10.1038/sj.ejhg.5201051; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bitti PP, 2001, GENET EPIDEMIOL, V20, P271, DOI 10.1002/1098-2272(200102)20:2<271::AID-GEPI9>3.0.CO;2-L; Bruewer M, 2004, AM J PHYSIOL-CELL PH, V287, pC327, DOI 10.1152/ajpcell.00087.2004; Catassi C, 2001, EUR J GASTROEN HEPAT, V13, P1123; Chiano MN, 1998, ANN HUM GENET, V62, P55, DOI 10.1046/j.1469-1809.1998.6210055.x; DEBAKKER PI, 2005, NAT GENET       1023; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; FALCHUK ZM, 1972, LANCET, V2, P1310; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Green PHR, 2005, GASTROENTEROLOGY, V128, pS74, DOI 10.1053/j.gastro.2005.02.016; Greenland, 1998, MODERN EPIDEMIOLOGY, P47; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Muller RT, 1997, MOL BIOL CELL, V8, P2039, DOI 10.1091/mbc.8.10.2039; Post PL, 2002, J BIOL CHEM, V277, P11679, DOI 10.1074/jbc.M111173200; Rewers M, 2005, GASTROENTEROLOGY, V128, pS47, DOI 10.1053/j.gastro.2005.02.030; SCHULZKE JD, 1995, GUT, V37, P777, DOI 10.1136/gut.37.6.777; Smecuol E, 2005, CLIN GASTROENTEROL H, V3, P335, DOI 10.1016/S1542-3565(04)00778-5; Uil JJ, 1996, EUR J GASTROEN HEPAT, V8, P219, DOI 10.1097/00042737-199603000-00006; Van Belzen MJ, 2003, GASTROENTEROLOGY, V125, P1032, DOI 10.1016/S0016-5085(03)01205-8; van Heel DA, 2005, BEST PRACT RES CL GA, V19, P323, DOI 10.1016/j.bpg.2005.01.001; VANELBURG RM, 1993, GUT, V34, P354, DOI 10.1136/gut.34.3.354	24	176	185	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2005	37	12					1341	1344		10.1038/ng1680	http://dx.doi.org/10.1038/ng1680			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16282976				2022-12-27	WOS:000233657300013
J	Kun, A; Santos, M; Szathmary, E				Kun, A; Santos, M; Szathmary, E			Real ribozymes suggest a relaxed error threshold	NATURE GENETICS			English	Article							RNA; ADDITIVITY; EVOLUTION; PROTEIN	The error threshold for replication, the critical copying fidelity below which the fittest genotype deterministically disappears, limits the length of the genome that can be maintained by selection. Primordial replication must have been error- prone, and so early replicators are thought to have been necessarily short(1). The error threshold also depends on the fitness landscape. In an RNA world(2), many neutral and compensatory mutations can raise the threshold, below which the functional phenotype(3), rather than a particular sequence, is still present(4,5). Here we show, on the basis of comparative analysis of two extensively mutagenized ribozymes, that with a copying fidelity of 0.999 per digit per replication the phenotypic error threshold rises well above 7,000 nucleotides, which permits the selective maintenance of a functionally rich riboorganism(6) with a genome of more than 100 different genes, the size of a tRNA. This requires an order of magnitude of improvement in the accuracy of in vitro - generated polymerase ribozymes(7,8). Incidentally, this genome size coincides with that estimated for a minimal cell achieved by top- down analysis(9), omitting the genes dealing with translation.	Collegium Budapest, Inst Adv Study, H-1014 Budapest, Hungary; Eotvos Lorand Univ, Dept Plant Taxon & Ecol, H-1117 Budapest, Hungary; Univ Autonoma Barcelona, Dept Genet & Microbiol, Grp Biol Evolut, E-08193 Barcelona, Spain; Eotvos Lorand Univ, Hungarian Acad Sci, Res Grp Ecol & Theoret Biol, H-1117 Budapest, Hungary	Eotvos Lorand University; Autonomous University of Barcelona; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand University	Szathmary, E (corresponding author), Collegium Budapest, Inst Adv Study, Szentharomsag 2, H-1014 Budapest, Hungary.	szathmary@colbud.hu	Szathmáry, Eörs/A-5007-2011; Szathmary, Eors/AAS-1202-2021; Kun, Ádám/A-5571-2011; Santos, Mauro/A-8044-2008	Szathmary, Eors/0000-0001-5227-2997; Kun, Ádám/0000-0002-8409-8521; Santos, Mauro/0000-0002-6478-6570				BEATTIE TL, 1995, P NATL ACAD SCI USA, V92, P4686, DOI 10.1073/pnas.92.10.4686; BENNER SA, 1987, COLD SPRING HARB SYM, V52, P53, DOI 10.1101/SQB.1987.052.01.009; BUTCHER SE, 1994, BIOCHEMISTRY-US, V33, P992, DOI 10.1021/bi00170a018; BUTCHER SE, 1994, J MOL BIOL, V244, P52, DOI 10.1006/jmbi.1994.1703; Domingo Esteban, 1994, P161; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; EIGEN M, 1989, ADV CHEM PHYS, V75, P149; Fedor MJ, 2000, J MOL BIOL, V297, P269, DOI 10.1006/jmbi.2000.3560; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; Jeffares DC, 1998, J MOL EVOL, V46, P18, DOI 10.1007/PL00006280; Johnston WK, 2001, SCIENCE, V292, P1319, DOI 10.1126/science.1060786; Lafontaine DA, 2002, BIOCHEM SOC T, V30, P1170, DOI 10.1042/bst0301170; LEHMAN N, 1993, CURR BIOL, V3, P723, DOI 10.1016/0960-9822(93)90019-K; Muller UF, 2003, CHEM BIOL, V10, P799, DOI 10.1016/S1074-5521(03)00171-6; Reidys C, 2001, B MATH BIOL, V63, P57, DOI 10.1006/bulm.2000.0206; SANDBERG WS, 1993, P NATL ACAD SCI USA, V90, P8367, DOI 10.1073/pnas.90.18.8367; Santos M, 2004, J MOL EVOL, V59, P507, DOI 10.1007/s00239-004-2642-7; Skinner MM, 1996, P NATL ACAD SCI USA, V93, P10753, DOI 10.1073/pnas.93.20.10753; SMITH JM, 1983, PROC R SOC SER B-BIO, V219, P315, DOI 10.1098/rspb.1983.0076; SMITH JM, 1979, NATURE, V280, P445, DOI 10.1038/280445a0; Szathmary E, 1995, MAJOR TRANSITIONS EV; TAKEDA Y, 1989, P NATL ACAD SCI USA, V86, P439, DOI 10.1073/pnas.86.2.439; Takeuchi N, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-9	27	92	95	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					1008	1011		10.1038/ng1621	http://dx.doi.org/10.1038/ng1621			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16127452				2022-12-27	WOS:000231591900029
J	Chudnovsky, Y; Adams, AE; Robbins, PB; Lin, Q; Khavari, PA				Chudnovsky, Y; Adams, AE; Robbins, PB; Lin, Q; Khavari, PA			Use of human tissue to assess the oncogenic activity of melanoma-associated mutations	NATURE GENETICS			English	Article							MALIGNANT-MELANOMA; BRAF MUTATIONS; GENE; TUMORIGENESIS; PROGRESSION; EXPRESSION; CANCER	Multiple genetic alterations occur in melanoma, a lethal skin malignancy of increasing incidence(1,2). These include mutations that activate Ras and two of its effector cascades, Raf and phosphoinositide 3- kinase ( PI3K). Induction of Ras and Raf can be caused by active N- Ras and B- Raf mutants as well as by gene amplification(3-5). Activation of PI3K pathway components occurs by PTEN loss and by AKT3 amplification(6-8). Melanomas also commonly show impairment of the p16(INK4A)- CDK4- Rb and ARF- HDM2- p53 tumor suppressor pathways. CDKN2A mutations can produce p16(INK4A) and ARF protein loss(5,9-11). Rb bypass can also occur through activating CDK4 mutations as well as by CDK4 amplification(5,12). In addition to ARF deletion, p53 pathway disruption can result from dominant negative TP53 mutations(5,13). TERT amplification also occurs in melanoma(5). The extent to which these mutations can induce human melanocytic neoplasia is unknown. Here we characterize pathways sufficient to generate human melanocytic neoplasia and show that genetically altered human tissue facilitates functional analysis of mutations observed in human tumors.	Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Khavari, PA (corresponding author), Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA.	khavari@CMGM.stanford.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043799] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR043799, R01 AR043799-07] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALBINO AP, 1994, MELANOMA RES, V4, P35, DOI 10.1097/00008390-199402000-00006; Beer S, 2004, PLOS BIOL, V2, P1785, DOI 10.1371/journal.pbio.0020332; Brooke S, 2004, EXP CELL RES, V298, P549, DOI 10.1016/j.yexcr.2004.04.035; Chang S, 2002, P NATL ACAD SCI USA, V99, P12520, DOI 10.1073/pnas.212514699; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deng H, 1998, BIOTECHNIQUES, V25, P274, DOI 10.2144/98252gt02; Gilchrest BA, 1999, NEW ENGL J MED, V340, P1341, DOI 10.1056/NEJM199904293401707; Hamad NM, 2002, GENE DEV, V16, P2045, DOI 10.1101/gad.993902; Hayward NK, 2003, ONCOGENE, V22, P3053, DOI 10.1038/sj.onc.1206445; Hsu MY, 2000, J CELL SCI, V113, P1535; HUSSUSSIAN CJ, 1994, NAT GENET, V8, P15, DOI 10.1038/ng0994-15; Kamb A, 1994, Nat Genet, V8, P23; Kannan K, 2003, P NATL ACAD SCI USA, V100, P1221, DOI 10.1073/pnas.0336397100; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Randerson-Moor JA, 2001, HUM MOL GENET, V10, P55, DOI 10.1093/hmg/10.1.55; Rodolfo M, 2004, CANCER LETT, V214, P133, DOI 10.1016/j.canlet.2004.06.049; Schaffer JV, 2004, J AM ACAD DERMATOL, V51, pS65, DOI 10.1016/j.jaad.2004.01.030; Sharpless NE, 2003, ONCOGENE, V22, P5055, DOI 10.1038/sj.onc.1206809; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Weitzman JB, 1999, NATURE, V400, P401, DOI 10.1038/22637; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Wu H, 2003, ONCOGENE, V22, P3113, DOI 10.1038/sj.onc.1206451	30	144	146	0	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2005	37	7					745	749		10.1038/ng1586	http://dx.doi.org/10.1038/ng1586			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15951821	Green Accepted			2022-12-27	WOS:000230196400022
J	Gunderson, KL; Steemers, FJ; Lee, G; Mendoza, LG; Chee, MS				Gunderson, KL; Steemers, FJ; Lee, G; Mendoza, LG; Chee, MS			A genome-wide scalable SNP genotyping assay using microarray technology	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LARGE-SCALE IDENTIFICATION; MUTATION DETECTION; PRIMER EXTENSION; DNA ARRAYS; HYBRIDIZATION; AMPLIFICATION; PROBES	Oligonucleotide probe arrays have enabled massively parallel analysis of gene expression levels from a single cDNA sample. Application of microarray technology to analyzing genomic DNA has been stymied by the sequence complexity of the entire human genome. A robust, single base - resolution direct genomic assay would extend the reach of microarray technology. We developed an array-based whole-genome genotyping assay that does not require PCR and enables effectively unlimited multiplexing. The assay achieves a high signal-to-noise ratio by combining specific hybridization of picomolar concentrations of whole genome - amplified DNA to arrayed probes with allele-specific primer extension and signal amplification. As proof of principle, we genotyped several hundred previously characterized SNPs. The conversion rate, call rate and accuracy were comparable to those of high-performance PCR-based genotyping assays.	Illumina Inc, San Diego, CA 92121 USA; Ambion Inc, Austin, TX 78744 USA; Prognosys Biosci Inc, San Diego, CA 92121 USA	Illumina	Gunderson, KL (corresponding author), Illumina Inc, 9885 Town Ctr Dr, San Diego, CA 92121 USA.	kgunderson@illumina.com			NATIONAL CANCER INSTITUTE [R43CA103406] Funding Source: NIH RePORTER; NCI NIH HHS [R43 CA103406] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOBROW MN, 1989, J IMMUNOL METHODS, V125, P979; Borevitz JO, 2003, GENOME RES, V13, P513, DOI 10.1101/gr.541303; Carvalho B, 2004, J CLIN PATHOL, V57, P644, DOI 10.1136/jcp.2003.013029; Chen Y, 2004, J AM CHEM SOC, V126, P3016, DOI 10.1021/ja039355j; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; DI X, 2005, BIOINFORMATICS   JAN; Erdogan F, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e36; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gunderson KL, 2004, GENOME RES, V14, P870, DOI 10.1101/gr.2255804; Gunderson KL, 1998, GENOME RES, V8, P1142, DOI 10.1101/gr.8.11.1142; Hacker GW, 1998, EUR J HISTOCHEM, V42, P111; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Judson R, 2002, PHARMACOGENOMICS, V3, P379, DOI 10.1517/14622416.3.3.379; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kwok Pui-Yan, 2003, Current Issues in Molecular Biology, V5, P43; Lucito R, 1998, P NATL ACAD SCI USA, V95, P4487, DOI 10.1073/pnas.95.8.4487; Matsuzaki H, 2004, GENOME RES, V14, P414, DOI 10.1101/gr.2014904; Pastinen T, 1997, GENOME RES, V7, P606, DOI 10.1101/gr.7.6.606; Pastinen T, 2000, GENOME RES, V10, P1031, DOI 10.1101/gr.10.7.1031; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Rao KVN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng066; Shumaker JM, 1996, HUM MUTAT, V7, P346, DOI 10.1002/(SICI)1098-1004(1996)7:4<346::AID-HUMU9>3.3.CO;2-9; Simpson CL, 2004, BIOTECHNIQUES, V37, P996, DOI 10.2144/04376BIN03; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Storhoff JJ, 2002, P SOC PHOTO-OPT INS, V4937, P1, DOI 10.1117/12.476069; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wang G, 2004, GENOME RES, V14, P2357, DOI 10.1101/gr.2813404; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; WU DY, 1989, DNA-J MOLEC CELL BIO, V8, P135, DOI 10.1089/dna.1.1989.8.135	35	460	543	1	67	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2005	37	5					549	554		10.1038/ng1547	http://dx.doi.org/10.1038/ng1547			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15838508				2022-12-27	WOS:000228862300027
J	Ching, YH; Ghosh, TK; Cross, SJ; Packham, EA; Honeyman, L; Loughna, S; Robinson, TE; Dearlove, AM; Ribas, G; Bonser, AJ; Thomas, NR; Scotter, AJ; Caves, LSD; Tyrrell, GP; Newbury-Ecob, RA; Munnich, A; Bonnet, D; Brook, JD				Ching, YH; Ghosh, TK; Cross, SJ; Packham, EA; Honeyman, L; Loughna, S; Robinson, TE; Dearlove, AM; Ribas, G; Bonser, AJ; Thomas, NR; Scotter, AJ; Caves, LSD; Tyrrell, GP; Newbury-Ecob, RA; Munnich, A; Bonnet, D; Brook, JD			Mutation in myosin heavy chain 6 causes atrial septal defect	NATURE GENETICS			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; HOLT-ORAM-SYNDROME; BINDING-SITE; EXPRESSION; TBX5; HEART; PATTERNS; SEQUENCE; TISSUE; GATA4	Atrial septal defect is one of the most common forms of congenital heart malformation. We identified a new locus linked with atrial septal defect on chromosome 14q12 in a large family with dominantly inherited atrial septal defect. The underlying mutation is a missense substitution, I820N, in alpha-myosin heavy chain (MYH6), a structural protein expressed at high levels in the developing atria, which affects the binding of the heavy chain to its regulatory light chain. The cardiac transcription factor TBX5 strongly regulates expression of MYH6, but mutant forms of TBX5, which cause Holt-Oram syndrome, do not. Morpholino knock-down of expression of the chick MYH6 homolog eliminates the formation of the atrial septum without overtly affecting atrial chamber formation. These data provide evidence for a link between a transcription factor, a structural protein and congenital heart disease.	Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England; Univ Nottingham, Queens Med Ctr, Ctr Biochem & Cell Biol, Nottingham NG7 2UH, England; MRC UK HGMP Resource Ctr, Cambridge CB10 1SB, England; Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; Univ York, Dept Chem, York YO10 5YW, N Yorkshire, England; Royal Hosp Sick Children, Dept Clin Genet, Bristol BS2 8JJ, Avon, England; Hop Necker Enfants Malad, INSERM, Dept Pediat, U 393, F-75743 Paris, France; Hop Necker Enfants Malad, Serv Cardiol Pediat, F-75743 Paris, France	University of Nottingham; University of Nottingham; University of Nottingham; University of York - UK; University of York - UK; Bristol Royal Hospital For Children; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Brook, JD (corresponding author), Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England.	david.brook@nottingham.ac.uk	Ribas-Despuig, Gloria/M-6190-2017; Ribas, Gloria/K-3379-2013	Ribas, Gloria/0000-0001-6883-4130; Loughna, Siobhan/0000-0002-3277-1438; Brook, John David/0000-0002-5946-6740; Warner, Louise/0000-0001-9161-3272; Bowcock, Anne/0000-0001-8691-9090				ARRECHEDERA H, 1987, J MOL CELL CARDIOL, V19, P641, DOI 10.1016/S0022-2828(87)80372-3; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Becker DL, 1999, EXP NEUROL, V156, P326, DOI 10.1006/exnr.1999.7027; BECKER W, 1999, VAR FODA, V1, P24; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Charron P, 1998, EUR HEART J, V19, P1377, DOI 10.1053/euhj.1998.1049; DEGROOT IJM, 1987, ANAT EMBRYOL, V176, P515; FAGERSTAM LG, 1992, J CHROMATOGR, V597, P397, DOI 10.1016/0021-9673(92)80137-J; Franco D, 1998, CARDIOVASC RES, V38, P25, DOI 10.1016/S0008-6363(97)00321-0; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Ghosh TK, 2001, HUM MOL GENET, V10, P1983, DOI 10.1093/hmg/10.18.1983; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; KURABAYASHI M, 1988, J CLIN INVEST, V82, P524, DOI 10.1172/JCI113627; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Lee Y, 1998, MOL CELL BIOL, V18, P3120, DOI 10.1128/MCB.18.6.3120; Li QY, 1997, NAT GENET, V15, P21; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Niimura H, 2002, CIRCULATION, V105, P446, DOI 10.1161/hc0402.102990; Oana S, 1998, BIOL CELL, V90, P605; Poetter K, 1996, NAT GENET, V13, P63, DOI 10.1038/ng0596-63; Reiser PJ, 2001, AM J PHYSIOL-HEART C, V280, pH1814, DOI 10.1152/ajpheart.2001.280.4.H1814; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; XIE X, 1994, NATURE, V368, P306, DOI 10.1038/368306a0	30	197	210	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					423	428		10.1038/ng1526	http://dx.doi.org/10.1038/ng1526			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15735645				2022-12-27	WOS:000228040000027
J	Tanaka, H; Bergstrom, DA; Yao, MC; Tapscott, SJ				Tanaka, H; Bergstrom, DA; Yao, MC; Tapscott, SJ			Widespread and nonrandom distribution of DNA palindromes in cancer cells provides a structural platform for subsequent gene amplification	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; SHORT INVERTED REPEATS; HAMSTER CELLS; SOLID TUMORS; FUSION GENE; CHROMOSOMES; TETRAHYMENA; MECHANISMS; EXPRESSION; INDUCTION	Breakage-fusion-bridge cycles contribute to chromosome instability and generate large DNA palindromes that facilitate gene amplification in human cancers. The prevalence of large DNA palindromes in cancer is not known. Here, by using a new microarray-based approach called genome-wide analysis of palindrome formation, we show that palindromes occur frequently and are widespread in human cancers. Individual tumors seem to have a nonrandom distribution of palindromes in their genomes, and a subset of palindromic loci is associated with gene amplification. This indicates that the location of palindromes in the cancer genome can serve as a structural platform that supports subsequent gene amplification. Genome-wide analysis of palindrome formation is a new approach to identify structural chromosome aberrations associated with cancer.	Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98104 USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Acad Sinica, Inst Mol Biol, Taipei, Taiwan	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Academia Sinica - Taiwan	Tapscott, SJ (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Mailstop C3-168,1100 Fairview Ave N, Seattle, WA 98109 USA.	mcyao@imb.sinica.edu.tw; stapscot@fhcrc.org	Tanaka, Hisashi/ABE-7637-2020	Tanaka, Hisashi/0000-0001-9223-4186; Tapscott, Stephen/0000-0002-0319-0968				Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Albrecht EB, 2000, MOL BIOL CELL, V11, P873, DOI 10.1091/mbc.11.3.873; Anderson J, 1999, GENE CHROMOSOME CANC, V26, P275, DOI 10.1002/(SICI)1098-2264(199912)26:4<275::AID-GCC1>3.0.CO;2-3; Bailey SM, 1999, P NATL ACAD SCI USA, V96, P14899, DOI 10.1073/pnas.96.26.14899; Barber G, 2004, CALL CENT MAG, V17, P10; Bernasconi M, 1996, P NATL ACAD SCI USA, V93, P13164, DOI 10.1073/pnas.93.23.13164; Butler DK, 1996, CELL, V87, P1115, DOI 10.1016/S0092-8674(00)81805-X; BUTLER DK, 1995, MOL CELL BIOL, V15, P7117; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Ciullo M, 2002, HUM MOL GENET, V11, P2887, DOI 10.1093/hmg/11.23.2887; Coquelle A, 1997, CELL, V89, P215, DOI 10.1016/S0092-8674(00)80201-9; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; Fan X, 2003, AM J PATHOL, V162, P1763, DOI 10.1016/S0002-9440(10)64311-8; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; FORD M, 1986, CELL, V45, P425, DOI 10.1016/0092-8674(86)90328-4; Gisselsson D, 2001, AM J PATHOL, V158, P199, DOI 10.1016/S0002-9440(10)63958-2; Gisselsson D, 2000, P NATL ACAD SCI USA, V97, P5357, DOI 10.1073/pnas.090013497; Graf L, 2002, BLOOD, V100, P1509, DOI 10.1182/blood-2002-03-0844; Grondin K, 1996, MOL CELL BIOL, V16, P3587; HECHT F, 1984, SCIENCE, V226, P1445, DOI 10.1126/science.6438800; Hellman A, 2002, CANCER CELL, V1, P89, DOI 10.1016/S1535-6108(02)00017-X; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; ISHHOROWICZ D, 1980, J MOL BIOL, V142, P231, DOI 10.1016/0022-2836(80)90047-9; Kuwahara Y, 2004, GENE CHROMOSOME CANC, V41, P125, DOI 10.1002/gcc.20075; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; MA C, 1988, MOL CELL BIOL, V8, P2316, DOI 10.1128/MCB.8.6.2316; MA C, 1993, GENE DEV, V7, P605, DOI 10.1101/gad.7.4.605; Maringele L, 2004, GENE DEV, V18, P2663, DOI 10.1101/gad.316504; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; Metcalfe JA, 1996, NAT GENET, V13, P350, DOI 10.1038/ng0796-350; Michiels EMC, 2002, J PEDIAT HEMATOL ONC, V24, P205, DOI 10.1097/00043426-200203000-00009; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; RUIZ JC, 1988, MOL CELL BIOL, V8, P4302, DOI 10.1128/MCB.8.10.4302; Shlomit R, 2000, CANCER GENET CYTOGEN, V121, P67, DOI 10.1016/S0165-4608(00)00218-1; Skytting B, 1999, J NATL CANCER I, V91, P974, DOI 10.1093/jnci/91.11.974; SMITH KA, 1992, P NATL ACAD SCI USA, V89, P5427, DOI 10.1073/pnas.89.12.5427; Smogorzewska A, 2002, CURR BIOL, V12, P1635, DOI 10.1016/S0960-9822(02)01179-X; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Swisshelm K, 1999, GENE, V226, P285, DOI 10.1016/S0378-1119(98)00553-8; Tanaka H, 2002, P NATL ACAD SCI USA, V99, P8772, DOI 10.1073/pnas.132275999; Tlsty TD, 1997, CURR TOP MICROBIOL, V221, P37; TOLEDO F, 1992, EMBO J, V11, P2665, DOI 10.1002/j.1460-2075.1992.tb05332.x; YAO MC, 1990, CELL, V63, P763, DOI 10.1016/0092-8674(90)90142-2; YASUDA LF, 1991, CELL, V67, P505, DOI 10.1016/0092-8674(91)90525-4; Yokota N, 2002, INT J CANCER, V101, P198, DOI 10.1002/ijc.10559; YonedaKato N, 1996, ONCOGENE, V12, P265	49	84	86	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					320	327		10.1038/ng1515	http://dx.doi.org/10.1038/ng1515			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15711546				2022-12-27	WOS:000227297800025
J	Simpson, MA; Cross, H; Proukakis, C; Priestman, DA; Neville, DCA; Reinkensmeier, G; Wang, H; Wiznitzer, M; Gurtz, K; Verganelaki, A; Pryde, A; Patton, MA; Dwek, RA; Butters, TD; Platt, FM; Crosby, AH				Simpson, MA; Cross, H; Proukakis, C; Priestman, DA; Neville, DCA; Reinkensmeier, G; Wang, H; Wiznitzer, M; Gurtz, K; Verganelaki, A; Pryde, A; Patton, MA; Dwek, RA; Butters, TD; Platt, FM; Crosby, AH			Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase	NATURE GENETICS			English	Article							HUMAN SERUM; GANGLIOSIDES; GLYCOSPHINGOLIPIDS; BIOSYNTHESIS; COMPLEX	We identified an autosomal recessive infantile-onset symptomatic epilepsy syndrome associated with developmental stagnation and blindness. Assuming a founder effect in a large Old Order Amish pedigree, we carried out a genome-wide screen for linkage and identified a single region of homozygosity on chromosome 2p12-p11.2 spanning 5.1 cM (maximum lod score of 6.84). We sequenced genes in the region and identified a nonsense mutation in SIAT9, which is predicted to result in the premature termination of the GM3 synthase enzyme (also called lactosylceramide alpha-2,3 sialyltransferase). GM3 synthase is a member of the sialyltransferase family and catalyzes the initial step in the biosynthesis of most complex gangliosides from lactosylceramide. Biochemical analysis of plasma glycosphingolipids confirmed that affected individuals lack GM3 synthase activity, as marked by a complete lack of GM3 ganglioside and its biosynthetic derivatives and an increase in lactosylceramide and its alternative derivatives. Although the relationship between defects in ganglioside catabolism and a range of lysosomal storage diseases is well documented, this is the first report, to our knowledge, of a disruption of ganglioside biosynthesis associated with human disease.	Univ London St Georges Hosp, Sch Med, Dept Med Genet, London SW17 0RE, England; Univ Arizona, Sch Med, Dept Ophthalmol, Tucson, AZ USA; Univ Oxford, Dept Biochem, Glycobiol Inst, Oxford OX1 3QU, England; Rainbow Babies & Childrens Hosp, Cleveland, OH 44106 USA; Windows Hope Genet Studies, Kimmeridge Trail, OH 44065 USA	St Georges University London; University of Arizona; University of Oxford; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital	Crosby, AH (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Med Genet, Cranmer Terrace, London SW17 0RE, England.	acrosby@sghms.ac.uk	Crosby, Andrew H/E-2218-2015; Proukakis, Christos/G-4548-2013; Simpson, Michael/F-4737-2011; proukakis, christos/ABE-3447-2020; Platt, Frances/G-1004-2010	Crosby, Andrew H/0000-0003-3667-9054; Simpson, Michael/0000-0002-8539-8753; proukakis, christos/0000-0001-6423-6539; Platt, Frances/0000-0001-7614-0403; Verganelaki, Argyro/0000-0001-8748-1078; Neville, David/0000-0003-2385-8993				Datta AK, 2001, J BIOL CHEM, V276, P15200, DOI 10.1074/jbc.M010542200; Gardiner RM, 2000, J NEUROL, V247, P327, DOI 10.1007/s004150050598; Hakomori S, 2000, GLYCOCONJUGATE J, V17, P627, DOI 10.1023/A:1011086929064; Inoue M, 2002, J BIOL CHEM, V277, P29881, DOI 10.1074/jbc.M201631200; IZUMI T, 1993, PEDIATR NEUROL, V9, P293, DOI 10.1016/0887-8994(93)90066-L; Kawai H, 2001, J BIOL CHEM, V276, P6885, DOI 10.1074/jbc.C000847200; Kobayashi T, 2000, GLYCOCONJUGATE J, V17, P163, DOI 10.1023/A:1026528921085; KUNDU SK, 1985, ARCH BIOCHEM BIOPHYS, V238, P388, DOI 10.1016/0003-9861(85)90179-1; MAX SR, 1974, NEW ENGL J MED, V291, P929, DOI 10.1056/NEJM197410312911802; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Negroni E, 1996, GLYCOCONJUGATE J, V13, P347, DOI 10.1007/BF00731466; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Proia RL, 2003, PHILOS T R SOC B, V358, P879, DOI 10.1098/rstb.2003.1268; Sandhoff K, 2003, PHILOS T R SOC B, V358, P847, DOI 10.1098/rstb.2003.1265; Schapiro FB, 1998, AM J PHYSIOL-CELL PH, V274, pC319, DOI 10.1152/ajpcell.1998.274.2.C319; SENN HJ, 1992, ATHEROSCLEROSIS, V94, P109, DOI 10.1016/0021-9150(92)90235-9; Wraith J E, 2002, Semin Neonatol, V7, P75, DOI 10.1053/siny.2001.0088; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yu R K, 1975, Trans Am Neurol Assoc, V100, P261; YU RK, 1987, YALE J BIOL MED, V60, P107; ZEBDA N, 1995, FEBS LETT, V362, P161, DOI 10.1016/0014-5793(95)00234-Z; ZELLER CB, 1992, AM J PHYSIOL, V262, pC1341, DOI 10.1152/ajpcell.1992.262.6.C1341	22	267	279	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1225	1229		10.1038/ng1460	http://dx.doi.org/10.1038/ng1460			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15502825	Bronze			2022-12-27	WOS:000224832800028
J	Li, JZ; Jiang, T; Mao, JH; Balmain, A; Peterson, L; Harris, C; Rao, PH; Havlak, P; Gibbs, R; Cai, WW				Li, JZ; Jiang, T; Mao, JH; Balmain, A; Peterson, L; Harris, C; Rao, PH; Havlak, P; Gibbs, R; Cai, WW			Genomic segmental polymorphisms in inbred mouse strains	NATURE GENETICS			English	Article							DUPLICATIONS; MICROARRAYS	By analyzing genomic copy-number differences using high-resolution mouse whole-genome BAC arrays, we uncover substantial differences in regional DNA content between inbred strains of mice. The identification of these apparently common segmental polymorphisms suggests that these differences can contribute to genetic variability and pathologic susceptibility.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine; University of California System; University of California San Francisco; Baylor College of Medicine; Baylor College of Medicine	Cai, WW (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	wcai@bcm.tmc.edu	Mao, Jian-Hua/EIZ-8595-2022	Mao, Jian-Hua/0000-0001-9320-6021; Peterson, Leif/0000-0002-1187-0883				Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; Bailey JA, 2004, GENOME RES, V14, P789, DOI 10.1101/gr.2238404; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Cai WW, 2002, NAT BIOTECHNOL, V20, P393, DOI 10.1038/nbt0402-393; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r47; Der-Sarkissian H, 2002, GENOME RES, V12, P1673, DOI 10.1101/gr.322802; Gregory SG, 2002, NATURE, V418, P743, DOI 10.1038/nature00957; Havlak P, 2004, GENOME RES, V14, P721, DOI 10.1101/gr.2264004; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Peterson LE, 2002, COMPUT METH PROG BIO, V69, P179, DOI 10.1016/S0169-2607(01)00189-4; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100	12	78	79	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					952	954		10.1038/ng1417	http://dx.doi.org/10.1038/ng1417			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15322544	Bronze			2022-12-27	WOS:000223658100019
J	Vissers, LELM; van Ravenswaaij, CMA; Admiraal, R; Hurst, JA; de Vries, BBA; Janssen, IM; van der Vliet, WA; Huys, EHLPG; de Jong, PJ; Hamel, BCJ; Schoenmakers, EFPM; Brunner, HG; Veltman, JA; van Kessel, AG				Vissers, LELM; van Ravenswaaij, CMA; Admiraal, R; Hurst, JA; de Vries, BBA; Janssen, IM; van der Vliet, WA; Huys, EHLPG; de Jong, PJ; Hamel, BCJ; Schoenmakers, EFPM; Brunner, HG; Veltman, JA; van Kessel, AG			Mutations in a new member of the chromodomain gene family cause CHARGE syndrome	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; ASSOCIATION; PROTEINS; EXCLUSION	CHARGE syndrome is a common cause of congenital anomalies affecting several tissues in a nonrandom fashion. We report a 2.3-Mb de novo overlapping microdeletion on chromosome 8q12 identified by array comparative genomic hybridization in two individuals with CHARGE syndrome. Sequence analysis of genes located in this region detected mutations in the gene CHD7 in 10 of 17 individuals with CHARGE syndrome without microdeletions, accounting for the disease in most affected individuals.	Univ Med Ctr Nijmegen, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands; Churchill Hosp, Dept Clin Genet, Oxford OX3 7LJ, England; Childrens Hosp, Oakland Res Inst, BACPAC Resources, Oakland, CA 94609 USA	Radboud University Nijmegen; Radboud University Nijmegen; University of Oxford; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute	Veltman, JA (corresponding author), Univ Med Ctr Nijmegen, Dept Human Genet, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.veltman@antrg.umcn.nl	van Kessel, Ad Geurts/A-2810-2010; Janssen, Irene M/V-3667-2018; Veltman, Joris A/F-5128-2010; Brunner, Han/C-9928-2013; Vissers, Lisenka ELM/A-2598-2015; Admiraal, R.J.C./L-4171-2015	Veltman, Joris A/0000-0002-3218-8250; Vissers, Lisenka ELM/0000-0001-6470-5497; 				Cavalli G, 1998, CURR OPIN CELL BIOL, V10, P354, DOI 10.1016/S0955-0674(98)80011-2; de Lonlay-Debeney P, 1997, J MED GENET, V34, P986, DOI 10.1136/jmg.34.12.986; DEKOK YJM, 1995, SCIENCE, V267, P685, DOI 10.1126/science.7839145; HURST JA, 1991, J MED GENET, V28, P54, DOI 10.1136/jmg.28.1.54; Johnson D, 1998, AM J HUM GENET, V63, P1282, DOI 10.1086/302122; Kallen K, 1999, TERATOLOGY, V60, P334; Lalani SR, 2003, AM J MED GENET A, V118A, P260, DOI 10.1002/ajmg.a.20002; Martin DM, 2002, AM J MED GENET, V111, P27, DOI 10.1002/ajmg.10473; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; PAGON RA, 1981, J PEDIATR-US, V99, P223, DOI 10.1016/S0022-3476(81)80454-4; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Sanlaville D, 2002, CLIN GENET, V61, P135, DOI 10.1034/j.1399-0004.2002.610208.x; Tellier AL, 2000, AM J MED GENET, V93, P85, DOI 10.1002/1096-8628(20000717)93:2<85::AID-AJMG1>3.0.CO;2-B; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Woodage T, 1997, P NATL ACAD SCI USA, V94, P11472, DOI 10.1073/pnas.94.21.11472	15	830	856	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					955	957		10.1038/ng1407	http://dx.doi.org/10.1038/ng1407			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15300250	Bronze			2022-12-27	WOS:000223658100020
J	Carter, SL; Eklund, AC; Kohane, IS; Harris, LN; Szallasi, Z				Carter, Scott L.; Eklund, Aron C.; Kohane, Isaac S.; Harris, Lyndsay N.; Szallasi, Zoltan			A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers	NATURE GENETICS			English	Article							BREAST-CANCER; GENOMIC INSTABILITY; SPINDLE MIDZONE; SURVIVAL; TUMORS; CLASSIFICATION; PROGRESSION; METASTASIS; SUBCLASSES; PROGNOSIS	We developed a computational method to characterize aneuploidy in tumor samples based on coordinated aberrations in expression of genes localized to each chromosomal region. We summarized the total level of chromosomal aberration in a given tumor in a univariate measure termed total functional aneuploidy. We identified a signature of chromosomal instability from specific genes whose expression was consistently correlated with total functional aneuploidy in several cancer types. Net overexpression of this signature was predictive of poor clinical outcome in 12 cancer data sets(1-12) representing six cancer types. Also, the signature of chromosomal instability was higher in metastasis samples than in primary tumors and was able to stratify grade 1 and grade 2 breast tumors according to clinical outcome. These results provide a means to assess the potential role of chromosomal instability in determining malignant potential over a broad range of tumors.	Harvard Univ, Childrens Hosp, Sch Med, Harvard Mit Div Hlth Sci & Technol,Informat Progr, Boston, MA 02115 USA; Brigham & Womens Hosp, Lab Funct Geonom, Cambridge, MA 02139 USA; Yale Univ, Sch Med, Breast Dis Unit, New Haven, CT 06520 USA; Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Yale University; Technical University of Denmark	Szallasi, Z (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Harvard Mit Div Hlth Sci & Technol,Informat Progr, Boston, MA 02115 USA.	zszallasi@chip.org	Kohane, Isaac Kohane/K-3716-2012; Teh, Muy-Teck/B-9284-2016	Kohane, Isaac Kohane/0000-0003-2192-5160; Teh, Muy-Teck/0000-0002-7725-8355; Szallasi, Zoltan/0000-0001-5395-7509; Eklund, Aron Charles/0000-0003-0861-1001	NCI NIH HHS [1P01CA-092644-01] Funding Source: Medline; NLM NIH HHS [5U54LM008748-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA092644] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; Diaz LA, 2005, SEMIN CANCER BIOL, V15, P67, DOI 10.1016/j.semcancer.2004.09.009; Draviam VM, 2004, CURR OPIN GENET DEV, V14, P120, DOI 10.1016/j.gde.2004.02.007; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gollin SM, 2005, SEMIN CANCER BIOL, V15, P33, DOI 10.1016/j.semcancer.2004.09.004; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Heidebrecht HJ, 2003, MOL CANCER RES, V1, P271; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Lopez-Rios F, 2006, CANCER RES, V66, P2970, DOI 10.1158/0008-5472.CAN-05-3907; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Nutt CL, 2003, CANCER RES, V63, P1602; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Roschke AV, 2003, CANCER RES, V63, P8634; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059	29	792	817	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2006	38	9					1043	1048		10.1038/ng1861	http://dx.doi.org/10.1038/ng1861			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16921376				2022-12-27	WOS:000240112100022
J	Grant, SFA; Thorleifsson, G; Reynisdottir, I; Benediktsson, R; Manolescu, A; Sainz, J; Helgason, A; Stefansson, H; Emilsson, V; Helgadottir, A; Styrkarsdottir, U; Magnusson, KP; Walters, GB; Palsdottir, E; Jonsdottir, T; Gudmundsdottir, T; Gylfason, A; Saemundsdottir, J; Wilensky, RL; Reilly, MP; Rader, DJ; Bagger, Y; Christiansen, C; Gudnason, V; Sigurdsson, G; Thorsteinsdottir, U; Gulcher, JR; Kong, A; Stefansson, K				Grant, SFA; Thorleifsson, G; Reynisdottir, I; Benediktsson, R; Manolescu, A; Sainz, J; Helgason, A; Stefansson, H; Emilsson, V; Helgadottir, A; Styrkarsdottir, U; Magnusson, KP; Walters, GB; Palsdottir, E; Jonsdottir, T; Gudmundsdottir, T; Gylfason, A; Saemundsdottir, J; Wilensky, RL; Reilly, MP; Rader, DJ; Bagger, Y; Christiansen, C; Gudnason, V; Sigurdsson, G; Thorsteinsdottir, U; Gulcher, JR; Kong, A; Stefansson, K			Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes	NATURE GENETICS			English	Article							BETA-CATENIN; LINKAGE; POLYMORPHISM; MELLITUS; DISEASE; MODELS; TCF-4; ONSET	We have previously reported suggestive linkage of type 2 diabetes mellitus to chromosome 10q(1). We genotyped 228 microsatellite markers in Icelandic individuals with type 2 diabetes and controls throughout a 10.5-Mb interval on 10q. A microsatellite, DG10S478, within intron 3 of the transcription factor 7-like 2 gene (TCF7L2; formerly TCF4) was associated with type 2 diabetes (P = 2.1 X 10(-9)). This was replicated in a Danish cohort (P = 4.8 X 10(-3)) and in a US cohort (P = 3.3 X 10(-9)). Compared with non-carriers, heterozygous and homozygous carriers of the at-risk alleles (38% and 7% of the population, respectively) have relative risks of 1.45 and 2.41. This corresponds to a population attributable risk of 21%. The TCF7L2 gene product is a high mobility group box-containing transcription factor previously implicated in blood glucose homeostasis. It is thought to act through regulation of proglucagon gene expression in enteroendocrine cells via the Wnt signaling pathway(2).	deCODE Genet, IS-101 Reykjavik, Iceland; Iceland Heart Assoc, IS-201 Kopavogur, Iceland; Natl Univ Hosp Reykjavik, IS-108 Reykjavik, Iceland; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Ctr Clin & Basic Res AS, DK-2750 Ballerup, Denmark	Icelandic Heart Association; Landspitali National University Hospital; University of Pennsylvania; Center Clinical & Basic Research	Grant, SFA (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	struan.grant@decode.is; kstefans@decode.is	Gudnason, Vilmundur/AAE-7126-2019; Manolescu, Andrei/G-4565-2014; Stefansson, Kari/AAE-7187-2019; Helgason, Agnar/K-1522-2015; Benediktsson, Rafn/R-2457-2018; Magnusson, Kristinn/A-6479-2011; Magnusson, Kristinn P Pétur/X-4907-2019; Walters, G. Bragi/L-4215-2013; Gudnason, Vilmundur/K-6885-2015	Gudnason, Vilmundur/0000-0001-5696-0084; Manolescu, Andrei/0000-0002-0713-4664; Benediktsson, Rafn/0000-0002-2954-9801; Magnusson, Kristinn/0000-0003-4528-6826; Magnusson, Kristinn P Pétur/0000-0003-4528-6826; Walters, G. Bragi/0000-0002-5415-6487; Gudnason, Vilmundur/0000-0001-5696-0084; Emilsson, Valur/0000-0001-9982-0524; Styrkarsdottir, Unnur/0000-0001-8146-8278; Kong, Augustine/0000-0001-8193-5438; Helgason, Agnar/0000-0002-8545-3767; Stefansson, Hreinn/0000-0002-9331-6666; Reilly, Muredach/0000-0002-3035-9386; Reynisdottir, Inga/0000-0002-9730-7476; Grant, Struan/0000-0003-2025-5302				Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Duval A, 2000, CANCER RES, V60, P3872; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; LEWONTIN RC, 1964, GENETICS, V50, P757; MANTEL N, 1959, J NATL CANCER I, V22, P719; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Noble JA, 2003, DIABETES, V52, P1579, DOI 10.2337/diabetes.52.6.1579; Prunier C, 2004, GROWTH FACTORS, V22, P141, DOI 10.1080/08977190410001720860; Reynisdottir I, 2003, AM J HUM GENET, V73, P323, DOI 10.1086/377139; RICH SS, 1990, DIABETES, V39, P1315, DOI 10.2337/diabetes.39.11.1315; Tanko LB, 2003, BONE, V32, P8, DOI 10.1016/S8756-3282(02)00918-3; Wolfrum C, 2004, NATURE, V432, P1027, DOI 10.1038/nature03047; Wong NACS, 2002, AM J PATHOL, V160, P389, DOI 10.1016/S0002-9440(10)64856-0; Yi FH, 2005, J BIOL CHEM, V280, P1457, DOI 10.1074/jbc.M411487200; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	25	1597	1703	2	89	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					320	323		10.1038/ng1732	http://dx.doi.org/10.1038/ng1732			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16415884				2022-12-27	WOS:000235589600013
J	Niihori, T; Aoki, Y; Narumi, Y; Neri, G; Cave, H; Verloes, A; Okamoto, N; Hennekam, RCM; Gillessen-Kaesbach, G; Wieczorek, D; Kavamura, MI; Kurosawa, K; Ohashi, H; Wilson, L; Heron, D; Bonneau, D; Corona, G; Kaname, T; Naritomi, K; Baumann, C; Matsumoto, N; Kato, K; Kure, S; Matsubara, Y				Niihori, T; Aoki, Y; Narumi, Y; Neri, G; Cave, H; Verloes, A; Okamoto, N; Hennekam, RCM; Gillessen-Kaesbach, G; Wieczorek, D; Kavamura, MI; Kurosawa, K; Ohashi, H; Wilson, L; Heron, D; Bonneau, D; Corona, G; Kaname, T; Naritomi, K; Baumann, C; Matsumoto, N; Kato, K; Kure, S; Matsubara, Y			Germline KRAS and BRAF mutations in cardio-facio-cutaneous syndrome	NATURE GENETICS			English	Article							CARDIOFACIOCUTANEOUS CFC SYNDROME; PTPN11 MUTATIONS; B-RAF; COSTELLO-SYNDROME; CANCER	Cardio-facio-cutaneous (CFC) syndrome is characterized by a distinctive facial appearance, heart defects and mental retardation. It phenotypically overlaps with Noonan and Costello syndrome, which are caused by mutations in PTPN11 and HRAS, respectively. In 43 individuals with CFC, we identified two heterozygous KRAS mutations in three individuals and eight BRAF mutations in 16 individuals, suggesting that dysregulation of the RAS-RAF-ERK pathway is a common molecular basis for the three related disorders.	Tohoku Univ, Sch Med, Dept Med Genet, Sendai, Miyagi, Japan; Catholic Univ, Ist Genet Med, Rome, Italy; Hop Robert Debre, APHP, Dept Genet, Paris, France; Osaka Med Ctr, Dept Planning & Res, Osaka, Japan; Res Inst Maternal & Child Hlth, Osaka, Japan; Inst Child Hlth, Clin & Mol Genet Unit, London, England; Acad Med Ctr, Dept Pediat, Amsterdam, Netherlands; Univ Essen Gesamthsch, Inst Human Genet, Essen, Germany; UNIFESP, Ctr Med Genet, Sao Paulo, Brazil; Kanagawa Childrens Med Ctr, Div Med Genet, Yokohama, Kanagawa, Japan; Saitama Childrens Med Ctr, Div Med Genet, Saitama, Japan; Great Ormond St Hosp Sick Children, London, England; Pitie Salpetriere Univ Hosp, Dept Genet, Paris, France; Univ Hosp, Dept Genet, Angers, France; Azienda Osped Univ G Martino, Dipartimento Sci Pediat Med & Chirurg, Unita Operat Complessa Patol Neonatale & Terapia, Messina, Italy; Univ Ryukyus, Sch Med, Dept Med Genet, Okinawa, Japan; Yokohama City Univ, Grad Sch Med, Dept Human Genet, Yokohama, Kanagawa, Japan; Tohoku Univ, Comprehens Res & Educ Ctr Planning Drug Dev & Cli, Cent COE Program 21, Sendai, Miyagi, Japan	Tohoku University; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Osaka Medical Center for Cancer & Cardiovascular Diseases; University of London; University College London; University of Amsterdam; Academic Medical Center Amsterdam; University of Duisburg Essen; Universidade Federal de Sao Paulo (UNIFESP); Saitama Children's Medical Center; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; AOU Policlinico Gaetano Martino; University of the Ryukyus; Yokohama City University; Tohoku University	Aoki, Y (corresponding author), Tohoku Univ, Sch Med, Dept Med Genet, Sendai, Miyagi, Japan.	aokiy@mail.tains.tohoku.ac.jp	/AAK-8500-2021; Bonneau, Dominique/K-6110-2015; Kurosawa, Kenji/B-6561-2016; Niihori, Tetsuya/ABE-2350-2021; VERLOES, Alain/E-7287-2014	Kurosawa, Kenji/0000-0002-6817-7748; Niihori, Tetsuya/0000-0002-2118-9776; VERLOES, Alain/0000-0003-4819-0264; Cave, Helene/0000-0003-2840-1511				Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Ikenoue T, 2004, CANCER RES, V64, P3428, DOI 10.1158/0008-5472.CAN-03-3591; Ion A, 2002, HUM GENET, V111, P421, DOI 10.1007/s00439-002-0803-6; Kavamura MI, 2003, EUR J HUM GENET, V11, P64, DOI 10.1038/sj.ejhg.5200911; Mercer KE, 2003, BBA-REV CANCER, V1653, P25, DOI 10.1016/S0304-419X(03)00016-7; Musante L, 2003, EUR J HUM GENET, V11, P201, DOI 10.1038/sj.ejhg.5200935; NERI G, 1991, AM J MED GENET, V39, P367, DOI 10.1002/ajmg.1320390323; REYNOLDS JF, 1986, AM J MED GENET, V25, P413, DOI 10.1002/ajmg.1320250303; Tartaglia M, 2005, EUR J MED GENET, V48, P81, DOI 10.1016/j.ejmg.2005.03.001; Van den Berg H, 1999, J MED GENET, V36, P799, DOI 10.1136/jmg.36.10.799; van Eeghen AM, 1999, AM J MED GENET, V82, P187, DOI 10.1002/(SICI)1096-8628(19990115)82:2<187::AID-AJMG17>3.0.CO;2-2; Wieczorek D, 1997, CLIN GENET, V52, P37; Winkler DG, 1998, J BIOL CHEM, V273, P21578, DOI 10.1074/jbc.273.34.21578	15	417	460	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					294	296		10.1038/ng1749	http://dx.doi.org/10.1038/ng1749			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16474404				2022-12-27	WOS:000235589600008
J	Chen, JF; Mandel, EM; Thomson, JM; Wu, QL; Callis, TE; Hammond, SM; Conlon, FL; Wang, DZ				Chen, JF; Mandel, EM; Thomson, JM; Wu, QL; Callis, TE; Hammond, SM; Conlon, FL; Wang, DZ			The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation	NATURE GENETICS			English	Article							SERUM RESPONSE FACTOR; GENE-EXPRESSION; SMALL RNAS; C-ELEGANS; TARGETS; GROWTH; MORPHOGENESIS; DEACETYLASES; ASSOCIATION; INHIBITION	Understanding the molecular mechanisms that regulate cellular proliferation and differentiation is a central theme of developmental biology. MicroRNAs ( miRNAs) are a class of regulatory RNAs of similar to 22 nucleotides that post-transcriptionally regulate gene expression(1,2). Increasing evidence points to the potential role of miRNAs in various biological processes(3-8). Here we show that miRNA-1 (miR-1) and miRNA- 133 (miR-133), which are clustered on the same chromosomal loci, are transcribed together in a tissue-specific manner during development. miR-1 and miR-133 have distinct roles in modulating skeletal muscle proliferation and differentiation in cultured myoblasts in vitro and in Xenopus laevis embryos in vivo. miR-1 promotes myogenesis by targeting histone deacetylase 4 (HDAC4), a transcriptional repressor of muscle gene expression. By contrast, miR-133 enhances myoblast proliferation by repressing serum response factor (SRF). Our results show that two mature miRNAs, derived from the same miRNA polycistron and transcribed together, can carry out distinct biological functions. Together, our studies suggest a molecular mechanism in which miRNAs participate in transcriptional circuits that control skeletal muscle gene expression and embryonic development.	Univ N Carolina, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wang, DZ (corresponding author), Univ N Carolina, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC 27599 USA.	dawang@med.unc.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075256] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL075256] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Brown DD, 2005, DEVELOPMENT, V132, P553, DOI 10.1242/dev.01596; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Conlon FL, 1996, DEVELOPMENT, V122, P2427; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kroll KL, 1996, DEVELOPMENT, V122, P3173; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Soulez M, 1996, MOL CELL BIOL, V16, P6065; Thomson JM, 2004, NAT METHODS, V1, P47, DOI 10.1038/NMETH704; Wang D, 2002, COLD SPRING HARB SYM, V67, P97, DOI 10.1101/sqb.2002.67.97; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	30	2097	2328	3	225	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2006	38	2					228	233		10.1038/ng1725	http://dx.doi.org/10.1038/ng1725			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16380711	Green Accepted, Green Submitted			2022-12-27	WOS:000234953200020
J	Conrad, DF; Andrews, TD; Carter, NP; Hurles, ME; Pritchard, JK				Conrad, DF; Andrews, TD; Carter, NP; Hurles, ME; Pritchard, JK			A high-resolution survey of deletion polymorphism in the human genome	NATURE GENETICS			English	Article							SEGMENTAL DUPLICATIONS; IDENTIFICATION; REARRANGEMENTS; EVOLUTION	Recent work has shown that copy number polymorphism is an important class of genetic variation in human genomes(1-4). Here we report a new method that uses SNP genotype data from parent-offspring trios to identify polymorphic deletions. We applied this method to data from the International HapMap Project(5) to produce the first high-resolution population surveys of deletion polymorphism. Approximately 100 of these deletions have been experimentally validated using comparative genome hybridization on tiling-resolution oligonucleotide microarrays. Our analysis identifies a total of 586 distinct regions that harbor deletion polymorphisms in one or more of the families. Notably, we estimate that typical individuals are hemizygous for roughly 30 - 50 deletions larger than 5 kb, totaling around 550 - 750 kb of euchromatic sequence across their genomes. The detected deletions span a total of 267 known and predicted genes. Overall, however, the deleted regions are relatively gene-poor, consistent with the action of purifying selection against deletions. Deletion polymorphisms may well have an important role in the genetics of complex traits; however, they are not directly observed in most current gene mapping studies. Our new method will permit the identification of deletion polymorphisms in high-density SNP surveys of trio or other family data.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Sanger Inst, Wellcome Trust, Genome Dynam & Evolut Grp, Cambridge CB10 1SA, England	University of Chicago; Wellcome Trust Sanger Institute	Pritchard, JK (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St, Chicago, IL 60637 USA.	pritch@uchicago.edu	Andrews, Dan/ABG-4815-2020	Andrews, Dan/0000-0003-3922-6376	NIGMS NIH HHS [GM07197] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Amos CI, 2003, HUM HERED, V56, P107, DOI 10.1159/000073738; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bhangale TR, 2005, HUM MOL GENET, V14, P59, DOI 10.1093/hmg/ddi006; Carter NP, 2004, NAT GENET, V36, P931, DOI 10.1038/ng0904-931; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Emes RD, 2003, HUM MOL GENET, V12, P701, DOI 10.1093/hmg/ddg078; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Gardner R. J, 2004, CHROMOSOMES ABNORMAL; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; HINDS DA, 2005, NAT GENET       1204; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; MCCARROLL SA, 2005, NAT GENET       1204; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Petrov DA, 2002, THEOR POPUL BIOL, V61, P531, DOI 10.1006/tpbi.2002.1605; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727; Yu CE, 2002, AM J HUM GENET, V71, P100, DOI 10.1086/341291	24	503	538	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					75	81		10.1038/ng1697	http://dx.doi.org/10.1038/ng1697			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16327808				2022-12-27	WOS:000234227200020
J	Li, L; Wang, XF; Stolc, V; Li, XY; Zhang, DF; Su, N; Tongprasit, W; Li, SG; Cheng, ZK; Wang, J; Deng, XW				Li, L; Wang, XF; Stolc, V; Li, XY; Zhang, DF; Su, N; Tongprasit, W; Li, SG; Cheng, ZK; Wang, J; Deng, XW			Genome-wide transcription analyses in rice using tiling microarrays	NATURE GENETICS			English	Article							ORYZA-SATIVA L.; EXPRESSION ANALYSIS; DRAFT SEQUENCE; CHROMOSOME-4	Sequencing and computational annotation revealed several features, including high gene numbers(1-6), unusual composition of the predicted genes(1,7) and a large number of genes lacking homology to known genes(8,9), that distinguish the rice ( Oryza sativa) genome from that of other fully sequenced model species. We report here a full-genome transcription analysis of the indica rice subspecies using high-density oligonucleotide tiling microarrays. Our results provided expression data support for the existence of 35,970 (81.9%) annotated gene models and identified 5,464 unique transcribed intergenic regions that share similar compositional properties with the annotated exons and have significant homology to other plant proteins. Elucidating and mapping of all transcribed regions revealed an association between global transcription and cytological chromosome features, and an overall similarity of transcriptional activity between duplicated segments of the genome. Collectively, our results provide the first whole-genome transcription map useful for further understanding the rice genome.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Natl Inst Biol Sci, Beijing 102206, Peoples R China; Peking Univ, Coll Life Sci, Peking Yale Joint Res Ctr Plant Mol Genet & Agrob, Beijing 100871, Peoples R China; Chinese Acad Sci, Beijing Inst Genom, Beijing 101300, Peoples R China; NASA, Genome Res Facil, Ames Res Ctr, Moffett Field, CA 94035 USA; China Bioway Biotech Grp Co Ltd, Natl Ctr Crop Design, Beijing 100085, Peoples R China; Chinese Acad Sci, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; Eloret Corp, Sunnyvale, CA 94087 USA	Yale University; National Institute of Biological Sciences, Beijing; Peking University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Deng, XW (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	xingwang.deng@yale.edu	Deng, Xing Wang/ABF-4107-2020; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Wang, Jun/0000-0002-8540-8931; Wang, Xiangfeng/0000-0002-6406-5597; Wang, Jun/0000-0002-2113-5874				Bedell JA, 2005, PLOS BIOL, V3, P103, DOI 10.1371/journal.pbio.0030013; Bennetzen JL, 2004, CURR OPIN PLANT BIOL, V7, P732, DOI 10.1016/j.pbi.2004.09.003; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Cheng ZK, 2001, GENOME RES, V11, P2133, DOI 10.1101/gr.194601; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Feng Q, 2002, NATURE, V420, P316, DOI 10.1038/nature01183; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Jabbari K, 2004, TRENDS PLANT SCI, V9, P281, DOI 10.1016/j.tplants.2004.04.006; Jiao YL, 2005, PLANT CELL, V17, P1641, DOI 10.1105/tpc.105.031575; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; KIKUCHI S, 2003, SCIENCE, V300, P1566; Li C, 2004, THEOR APPL GENET, V108, P392, DOI 10.1007/s00122-003-1457-z; Li L, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r52; Messing J, 2004, P NATL ACAD SCI USA, V101, P14349, DOI 10.1073/pnas.0406163101; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Wong GKS, 2002, GENOME RES, V12, P851, DOI 10.1101/gr.189102; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yu YS, 2003, SCIENCE, V300, P1566, DOI 10.1126/science.1083523	30	115	128	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					124	129		10.1038/ng1704	http://dx.doi.org/10.1038/ng1704			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16369532				2022-12-27	WOS:000234227200028
J	Senderek, J; Krieger, M; Stendel, C; Bergmann, C; Moser, M; Breitbach-Faller, N; Rudnik-Schoneborn, S; Blaschek, A; Wolf, NI; Harting, I; North, K; Smith, J; Muntoni, F; Brockington, M; Quijano-Roy, S; Renault, F; Herrmann, R; Hendershot, LM; Schroder, JM; Lochmuller, H; Topaloglu, H; Voit, T; Weis, J; Ebinger, F; Zerres, K				Senderek, J; Krieger, M; Stendel, C; Bergmann, C; Moser, M; Breitbach-Faller, N; Rudnik-Schoneborn, S; Blaschek, A; Wolf, NI; Harting, I; North, K; Smith, J; Muntoni, F; Brockington, M; Quijano-Roy, S; Renault, F; Herrmann, R; Hendershot, LM; Schroder, JM; Lochmuller, H; Topaloglu, H; Voit, T; Weis, J; Ebinger, F; Zerres, K			Mutations in SIL1 cause Marinesco-Sjogren syndrome, a cerebellar ataxia with cataract and myopathy	NATURE GENETICS			English	Article							ENDOPLASMIC-RETICULUM STRESS; PROTEIN TRANSLOCATION; NUCLEOTIDE EXCHANGE; BIP	SIL1 ( also called BAP) acts as a nucleotide exchange factor for the Hsp70 chaperone BiP ( also called GRP78), which is a key regulator of the main functions of the endoplasmic reticulum. We found nine distinct mutations that would disrupt the SIL1 protein in individuals with Marinesco-Sjogren syndrome, an autosomal recessive cerebellar ataxia complicated by cataracts, developmental delay and myopathy. Identification of SIL1 mutations implicates Marinesco-Sjogren syndrome as a disease of endoplasmic reticulum dysfunction and suggests a role for this organelle in multisystem disorders.	Rhein Westfal TH Aachen, Dept Human Genet, Aachen, Germany; Max Planck Inst Biochem, D-82152 Martinsried, Germany; Esslingen Community Hosp, Dept Pediat, Esslingen, Germany; Univ Heidelberg, Childrens Hosp, Dept Pediat, D-6900 Heidelberg, Germany; Univ Heidelberg, Dept Neuroradiol, Heidelberg, Germany; Childrens Hosp Westmead, Inst Neuromuscular Res, Sydney, NSW, Australia; Univ London Imperial Coll Sci Technol & Med, Dubowitz Neuromuscular Ctr, London, England; Hop Raymond Poincare, Serv Pediat, Garches, France; Grp Hosp Pitie Salpetriere, Inst Myol, INSERM, U582, F-75634 Paris, France; Hop Enfants Armand Trousseau, Unite Neurophysiol, Paris, France; Univ Hosp Essen, Dept Pediat & Pediat Neurol, Essen, Germany; St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; Rhein Westfal TH Aachen, Dept Neuropathol, Aachen, Germany; Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany; Hacettepe Univ, Dept Pediat Neurol, Ankara, Turkey	RWTH Aachen University; Max Planck Society; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Sydney; Imperial College London; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Duisburg Essen; St Jude Children's Research Hospital; RWTH Aachen University; University of Munich; Hacettepe University	Senderek, J (corresponding author), Rhein Westfal TH Aachen, Dept Human Genet, Aachen, Germany.	jsenderek@ukaachen.de	Wolf, Nicole I/H-3943-2014; Senderek, Jan/F-8405-2015; Quijano-Roy, Susana/GRF-6829-2022; Ebinger, Friedrich/AAO-7697-2020; North, Kathryn N/K-6476-2012; Weis, Joachim/G-1984-2014; Rudnik-Schöneborn, Sabine/F-8473-2015; Hendershot, Linda/N-8124-2018; TOPALOGLU, HALUK AYDIN/I-9318-2013	Wolf, Nicole I/0000-0003-1721-0728; Senderek, Jan/0000-0002-8263-1783; North, Kathryn N/0000-0003-0841-8009; Weis, Joachim/0000-0003-3280-6773; Hendershot, Linda/0000-0002-5473-0274; Lochmuller, Hanns/0000-0003-2324-8001				Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174; Boisrame A, 1996, J BIOL CHEM, V271, P11668, DOI 10.1074/jbc.271.20.11668; Chung KT, 2002, J BIOL CHEM, V277, P47557, DOI 10.1074/jbc.M208377200; Hendershot LM, 2004, MT SINAI J MED, V71, P289; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Kitao Y, 2004, J NEUROSCI, V24, P1486, DOI 10.1523/JNEUROSCI.4029-03.2004; Lagier-Tourenne C, 2003, EUR J HUM GENET, V11, P770, DOI 10.1038/sj.ejhg.5201068; Marinesco G, 1931, ENCEPHALE, V26, P97; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; SEWRY CA, 1988, ANN NEUROL, V24, P576, DOI 10.1002/ana.410240416; Shomura Y, 2005, MOL CELL, V17, P367, DOI 10.1016/j.molcel.2004.12.023; Suzuki Y, 1997, ACTA NEUROPATHOL, V94, P410, DOI 10.1007/s004010050727; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; Varon R, 2003, NAT GENET, V35, P185, DOI 10.1038/ng1243	15	173	180	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2005	37	12					1312	1314		10.1038/ng1678	http://dx.doi.org/10.1038/ng1678			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16282977				2022-12-27	WOS:000233657300007
J	de Bakker, PIW; Yelensky, R; Pe'er, I; Gabriel, SB; Daly, MJ; Altshuler, D				de Bakker, PIW; Yelensky, R; Pe'er, I; Gabriel, SB; Daly, MJ; Altshuler, D			Efficiency and power in genetic association studies	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; LINKAGE-DISEQUILIBRIUM; TAGGING SNPS; GENOTYPE DATA; UNRELATED INDIVIDUALS; HAPLOTYPE DIVERSITY; TAG SNPS; SELECTION; TESTS	We investigated selection and analysis of tag SNPs for genome-wide association studies by specifically examining the relationship between investment in genotyping and statistical power. Do pairwise or multimarker methods maximize efficiency and power? To what extent is power compromised when tags are selected from an incomplete resource such as HapMap? We addressed these questions using genotype data from the HapMap ENCODE project, association studies simulated under a realistic disease model, and empirical correction for multiple hypothesis testing. We demonstrate a haplotype-based tagging method that uniformly outperforms single-marker tests and methods for prioritization that markedly increase tagging efficiency. Examining all observed haplotypes for association, rather than just those that are proxies for known SNPs, increases power to detect rare causal alleles, at the cost of reduced power to detect common causal alleles. Power is robust to the completeness of the reference panel from which tags are selected. These findings have implications for prioritizing tag SNPs and interpreting association studies.	Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02138 USA; MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Daly, MJ (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, 185 Cambridge St,CPZN-6818, Boston, MA 02114 USA.	mjdaly@chgr.mgh.harvard.edu; altshuler@molbio.mgh.harvard.edu	Altshuler, David M/A-4476-2009; Daly, Mark J/B-2453-2017; de Bakker, Paul IW/B-8730-2009	Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; de Bakker, Paul IW/0000-0001-7735-7858				Ahmadi KR, 2005, NAT GENET, V37, P84, DOI 10.1038/ng1488; Ao SI, 2005, BIOINFORMATICS, V21, P1735, DOI 10.1093/bioinformatics/bti201; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Fan RZ, 2003, AM J HUM GENET, V72, P850, DOI 10.1086/373966; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goldstein DB, 2003, TRENDS GENET, V19, P615, DOI 10.1016/j.tig.2003.09.006; Halldorsson BV, 2004, GENOME RES, V14, P1633, DOI 10.1101/gr.2570004; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hu XL, 2004, HUM HERED, V57, P156, DOI 10.1159/000079246; *INT HAPMAP CONS, IN PRESS NATURE; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Ke XY, 2003, BIOINFORMATICS, V19, P287, DOI 10.1093/bioinformatics/19.2.287; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Meng ZL, 2003, AM J HUM GENET, V73, P115, DOI 10.1086/376561; Nejentsev S, 2004, HUM MOL GENET, V13, P1633, DOI 10.1093/hmg/ddh169; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Rinaldo A, 2005, GENET EPIDEMIOL, V28, P193, DOI 10.1002/gepi.20056; Roeder K, 2005, GENET EPIDEMIOL, V28, P207, DOI 10.1002/gepi.20050; SCHAFFNER SF, IN PRESS GENOME RES; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Stram DO, 2003, HUM HERED, V55, P27, DOI 10.1159/000071807; Wang WYS, 2003, HUM MOL GENET, V12, P3145, DOI 10.1093/hmg/ddg337; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Weale ME, 2003, AM J HUM GENET, V73, P551, DOI 10.1086/378098; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zhang K, 2005, BIOINFORMATICS, V21, P131, DOI 10.1093/bioinformatics/bth482	36	1435	1468	1	84	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1217	1223		10.1038/ng1669	http://dx.doi.org/10.1038/ng1669			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16244653				2022-12-27	WOS:000233045200021
J	Batourina, E; Tsai, S; Lambert, S; Sprenkle, P; Viana, R; Dutta, S; Hensle, T; Wang, FW; Niederreither, K; McMahon, AP; Carroll, TJ; Mendelsohn, CL				Batourina, E; Tsai, S; Lambert, S; Sprenkle, P; Viana, R; Dutta, S; Hensle, T; Wang, FW; Niederreither, K; McMahon, AP; Carroll, TJ; Mendelsohn, CL			Apoptosis induced by vitamin A signaling is crucial for connecting the ureters to the bladder	NATURE GENETICS			English	Article							RETINOIC ACID; BUD; KIDNEY; ORGANOGENESIS; EXPRESSION; RECEPTORS; PROTEIN; VAGINA; CELLS; DUCTS	Removal of toxic substances from the blood depends on patent connections between the kidney, ureters and bladder that are established when the ureter is transposed from its original insertion site in the male genital tract to the bladder. This transposition is thought to occur as the trigone forms from the common nephric duct and incorporates into the bladder. Here we re-examine this model in the context of normal and abnormal development. We show that the common nephric duct does not differentiate into the trigone but instead undergoes apoptosis, a crucial step for ureter transposition controlled by vitamin A-induced signals from the primitive bladder. Ureter abnormalities occur in 1-2% of the human population and can cause obstruction and end-stage renal disease. These studies provide an explanation for ureter defects underlying some forms of obstruction in humans and redefine the current model of ureter maturation.	Columbia Univ, Dept Urol, New York, NY 10032 USA; Baylor Coll Med, Ctr Cardiovasc Dev, Dept Med, Houston, TX 77030 USA; Baylor Coll Med, Ctr Cardiovasc Dev, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; UT SW Med Ctr, Dept Internal Med Nephrol & Mol Biol, Dallas, TX 75390 USA	Columbia University; Baylor College of Medicine; Baylor College of Medicine; Harvard University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mendelsohn, CL (corresponding author), Columbia Univ, Dept Urol, 650 W 168th St, New York, NY 10032 USA.	clm20@columbia.edu	McMahon, Andrew P/ABE-7520-2020; Mendelsohn, Cathy/H-4280-2016	Mendelsohn, Cathy/0000-0002-4026-4073	NIDDK NIH HHS [R01 DK061459-09, R01 DK080004, R01 DK061459-07S1, R01 DK061459-06, R01 DK061459-08, R56 DK082963, R01 DK061459-02, R01 DK061459-01A1S1, R01 DK061459-07, R01 DK061459-01A1, R01 DK061459, R01 DK061459-03, R01 DK061459-04, R01 DK061459-05, R56 DK082963-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095057, R01DK061459, R56DK082963, R01DK080004] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Batourina E, 2002, NAT GENET, V32, P109, DOI 10.1038/ng952; BOK G, 1983, J EMBRYOL EXP MORPH, V73, P275; Brophy PD, 2001, DEVELOPMENT, V128, P4747; Dickman ED, 1997, DEVELOPMENT, V124, P3111; Duester G, 2003, CHEM-BIOL INTERACT, V143, P201, DOI 10.1016/S0009-2797(02)00204-1; Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X; HUTCH JA, 1972, ANATOMY PHYSL BLADDE; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Kochhar DM, 1996, CHEM-BIOL INTERACT, V100, P1, DOI 10.1016/0009-2797(95)03681-4; Kume T, 2000, DEVELOPMENT, V127, P1387; Larsen WJ, 2001, HUMAN EMBRYOLOGY, V3; MACKIE GG, 1975, J UROLOGY, V114, P274, DOI 10.1016/S0022-5347(17)67007-1; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MAUCH RB, 1985, ANAT EMBRYOL, V172, P75, DOI 10.1007/BF00318946; Mendelsohn C, 1999, DEVELOPMENT, V126, P1139; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; MEYER R, 1946, ANAT REC, V96, P355, DOI 10.1002/ar.1090960403; Mic FA, 2002, DEVELOPMENT, V129, P2271; Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256; Napoli JL, 2000, PROG NUCLEIC ACID RE, V63, P139, DOI 10.1016/S0079-6603(08)60722-9; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Shakya R, 2005, DEV CELL, V8, P65, DOI 10.1016/j.devcel.2004.11.008; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 1999, DEV GENET, V24, P241; STEPHENS FD, 1983, CONGENITAL MALFORMAT; TANAGHO EA, 1981, DEV URETER; Thomas John C, 2005, Curr Urol Rep, V6, P146, DOI 10.1007/s11934-005-0084-4; Watanabe T, 2004, DEV BIOL, V271, P98, DOI 10.1016/j.ydbio.2004.03.025; Willhite CC, 2000, TOXICOL APPL PHARM, V164, P171, DOI 10.1006/taap.1999.8866; WILSON JG, 1948, AM J ANAT, V83, P357, DOI 10.1002/aja.1000830303; YASUDA Y, 1986, TERATOLOGY, V34, P37, DOI 10.1002/tera.1420340106; Yu J, 2002, DEVELOPMENT, V129, P5301; Yu OH, 2004, AM J PHYSIOL-RENAL, V287, pF1123, DOI 10.1152/ajprenal.00444.2003; Yucel S, 2004, J UROLOGY, V171, P1890, DOI 10.1097/01.ju.0000124106.16505.df	36	107	108	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1082	1089		10.1038/ng1645	http://dx.doi.org/10.1038/ng1645			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16186816				2022-12-27	WOS:000232185600019
J	Castigli, E; Wilson, SA; Garibyan, L; Rachid, R; Bonilla, F; Schneider, L; Geha, RS				Castigli, E; Wilson, SA; Garibyan, L; Rachid, R; Bonilla, F; Schneider, L; Geha, RS			TACI is mutant in common variable immunodeficiency and IgA deficiency	NATURE GENETICS			English	Article							B-CELL HOMEOSTASIS; MOLECULAR ANALYSIS; APRIL; GENE; SUSCEPTIBILITY; ACTIVATION; RECEPTOR; BINDING; BAFF; AUTOIMMUNITY	The tumor necrosis factor receptor family member TACI (transmembrane activator and calcium-modulator and cyclophilin ligand interactor) mediates isotype switching in B cells. We found that 4 of 19 unrelated individuals with common variable immunodeficiency (CVID) and 1 of 16 individuals with IgA deficiency (IgAD) had a missense mutation in one allele of TNFRSF13B (encoding TACI). One of the four individuals with CVID had a single nucleotide insertion in the other TNFRSF13B allele. None of these mutations were present in 50 healthy subjects. TNFRSF13B mutations cosegregated with the phenotype of CVID or IgAD in family members of four index individuals that we studied. B cells from individuals with TACI mutations expressed TACI but did not produce IgG and IgA in response to the TACI ligand APRIL, probably reflecting impaired isotype switching. These results suggest that TACI mutations can result in CVID and IgAD.	Childrens Hosp, Div Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Geha, RS (corresponding author), Childrens Hosp, Div Immunol, 300 Longwood Ave, Boston, MA 02115 USA.	raif.geha@childrens.harvard.edu	Garibyan, Lilit/AAR-1638-2020					Asano T, 2004, CLIN EXP IMMUNOL, V136, P284, DOI 10.1111/j.1365-2249.2004.02440.x; Burrows PD, 1997, ADV IMMUNOL, V65, P245, DOI 10.1016/S0065-2776(08)60744-0; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Cunningham-Rundles C, 2002, AM J HEMATOL, V69, P171, DOI 10.1002/ajh.10050; Cunningham-Rundles C, 2001, J CLIN IMMUNOL, V21, P303, DOI 10.1023/A:1012241117984; De la Concha EG, 2002, J IMMUNOL, V169, P4637, DOI 10.4049/jimmunol.169.8.4637; Di Renzo M, 2004, CLIN EXP MED, V3, P211, DOI 10.1007/s10238-004-0027-2; Eastwood D, 2004, CLIN EXP IMMUNOL, V137, P584, DOI 10.1111/j.1365-2249.2004.02581.x; FARRINGTON M, 1994, P NATL ACAD SCI USA, V91, P1099, DOI 10.1073/pnas.91.3.1099; Ferrari S, 2001, P NATL ACAD SCI USA, V98, P12614, DOI 10.1073/pnas.221456898; Geha RS, 2003, NAT REV IMMUNOL, V3, P721, DOI 10.1038/nri1181; Gorelik L, 2003, J EXP MED, V198, P937, DOI 10.1084/jem.20030789; Grimbacher B, 2004, CURR ALLERGY ASTHM R, V4, P349, DOI 10.1007/s11882-004-0083-4; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Hendriks J, 2005, CELL DEATH DIFFER, V12, P637, DOI 10.1038/sj.cdd.4401647; Hymowitz SG, 2005, J BIOL CHEM, V280, P7218, DOI 10.1074/jbc.M411714200; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; ISLAM KB, 1994, J IMMUNOL, V152, P1442; KANEKO H, 1990, SCAND J IMMUNOL, V32, P483, DOI 10.1111/j.1365-3083.1990.tb03188.x; Kokron CM, 2004, AN ACAD BRAS CIENC, V76, P707, DOI 10.1590/S0001-37652004000400007; Kralovicova J, 2003, J IMMUNOL, V170, P2765, DOI 10.4049/jimmunol.170.5.2765; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Mackay F, 2004, CURR OPIN PHARMACOL, V4, P347, DOI 10.1016/j.coph.2004.02.009; Mackay F, 2002, CURR OPIN IMMUNOL, V14, P783, DOI 10.1016/S0952-7915(02)00407-7; MacLennan ICM, 2002, IMMUNITY, V17, P235, DOI 10.1016/S1074-7613(02)00398-9; RAMESH N, 1995, CLIN IMMUNOL IMMUNOP, V76, pS208, DOI 10.1016/S0090-1229(95)90252-X; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schroeder HW, 2004, J INVEST MED, V52, P90, DOI 10.1136/jim-52-02-17; Schroeder HW, 2000, CLIN REV ALLERG IMMU, V19, P127, DOI 10.1385/CRIAI:19:2:127; Seshasayee D, 2003, IMMUNITY, V18, P279, DOI 10.1016/S1074-7613(03)00025-6; VOLANAKIS JE, 1992, J CLIN INVEST, V89, P1914, DOI 10.1172/JCI115797; von Bulow GU, 2000, MAMM GENOME, V11, P628, DOI 10.1007/s003350010125; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Weston SA, 2001, CLIN EXP IMMUNOL, V124, P465, DOI 10.1046/j.1365-2249.2001.01556.x; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790	37	497	510	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2005	37	8					829	834		10.1038/ng1601	http://dx.doi.org/10.1038/ng1601			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16007086				2022-12-27	WOS:000230880400012
J	Ko, MA; Rosario, CO; Hudson, JW; Kulkarni, S; Pollett, A; Dennis, JW; Swallow, CJ				Ko, MA; Rosario, CO; Hudson, JW; Kulkarni, S; Pollett, A; Dennis, JW; Swallow, CJ			Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis	NATURE GENETICS			English	Article							HEPATOCELLULAR-CARCINOMA; CENTROSOME HYPERAMPLIFICATION; CHROMOSOME INSTABILITY; TUMOR-DEVELOPMENT; MICE; CANCER; CELLS; P53; SUPPRESSOR; EXPRESSION	The polo-like kinase Plk4 (also called Sak) is required for late mitotic progression, cell survival and postgastrulation embryonic development(1). Here we identified a phenotype resulting from Plk4 haploinsufficiency in Plk4 heterozygous cells and mice. Plk4(+/-) embryonic fibroblasts had increased centrosomal amplification, multipolar spindle formation and aneuploidy compared with wild-type cells. The incidence of spontaneous liver and lung cancers was similar to 15 times high in elderly Plk4(+/-) mice than in Plk4(+/+) littermates. Using the in vivo model of partial hepatectomy to induce synchronous cell cycle entry, we determined that the precise regulation of cyclins D1, E and B1 and of Cdk1 was impaired in Plk4(+/-) regenerating liver, and p53 activation and p21 and BubR1 expression were suppressed. These defects were associated with progressive cell cycle delays, increased spindle irregularities and accelerated hepatocellular carcinogenesis in Plk4(+/-) mice. Loss of heterozygosity occurs frequently (similar to 60%) at polymorphic markers adjacent to the PLK4 locus in human hepatoma. Reduced Plk4 gene dosage increases the probability of mitotic errors and cancer development.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Surg, Toronto, ON, Canada; Univ Toronto, Dept Microbiol & Med Genet, Toronto, ON, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; Univ Windsor, Dept Biol Sci, Windsor, ON N9B 3P4, Canada; Univ Toronto, Dept Pathol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Windsor; University of Toronto	Dennis, JW (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave,R988, Toronto, ON M5G 1X5, Canada.	dennis@mshri.on.ca	Pollett, Aaron/AAQ-2540-2021; Pollett, Aaron/J-2308-2016; Dennis, James/E-7268-2013	Pollett, Aaron/0000-0001-5121-8788; Pollett, Aaron/0000-0001-5121-8788; 				Anzola M, 2004, J VIRAL HEPATITIS, V11, P383, DOI 10.1111/j.1365-2893.2004.00521.x; Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Bai F, 2003, MOL CELL BIOL, V23, P1269, DOI 10.1128/MCB.23.4.1269-1277.2003; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Black D, 2004, J SURG RES, V117, P306, DOI 10.1016/j.jss.2003.10.026; Blagden SP, 2003, NAT CELL BIOL, V5, P505, DOI 10.1038/ncb0603-505; Bluteau O, 2002, ONCOGENE, V21, P1225, DOI 10.1038/sj.onc.1205197; Carroll PE, 1999, ONCOGENE, V18, P1935, DOI 10.1038/sj.onc.1202515; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Fode C, 1996, MOL CELL BIOL, V16, P4665; Galjart N, 2003, CURR OPIN CELL BIOL, V15, P48, DOI 10.1016/S0955-0674(02)00007-8; Hammond C, 1999, HEPATOLOGY, V29, P1479, DOI 10.1002/hep.510290513; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Hixon ML, 2000, J CLIN INVEST, V106, P1011, DOI 10.1172/JCI8252; Hudson JW, 2001, CURR BIOL, V11, P441, DOI 10.1016/S0960-9822(01)00117-8; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Jackson RJ, 2003, CANCER RES, V63, P3021; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Philipp-Staheli J, 2001, EXP CELL RES, V264, P148, DOI 10.1006/excr.2000.5143; Seike M, 2002, LUNG CANCER-J IASLC, V38, P229, DOI 10.1016/S0169-5002(02)00218-0; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Swallow CJ, 2005, ONCOGENE, V24, P306, DOI 10.1038/sj.onc.1208275; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Tsai KY, 2002, P NATL ACAD SCI USA, V99, P16865, DOI 10.1073/pnas.262499599; Weinberg RA, 1997, CELL, V88, P573, DOI 10.1016/S0092-8674(00)81897-8; Yeh SH, 2001, GASTROENTEROLOGY, V121, P699, DOI 10.1053/gast.2001.27211	30	165	172	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2005	37	8					883	888		10.1038/ng1605	http://dx.doi.org/10.1038/ng1605			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16025114				2022-12-27	WOS:000230880400020
J	Segal, E; Friedman, N; Kaminski, N; Regev, A; Koller, D				Segal, E; Friedman, N; Kaminski, N; Regev, A; Koller, D			From signatures to models: understanding cancer using microarrays	NATURE GENETICS			English	Article							HUMAN BREAST-CANCER; GENE-EXPRESSION; CELL-CYCLE; REGULATORY NETWORKS; TRANSCRIPTION FACTORS; LUNG ADENOCARCINOMA; BINDING-SITES; C-MYC; GENOME; PATTERNS	Genomics has the potential to revolutionize the diagnosis and management of cancer by offering an unprecedented comprehensive view of the molecular underpinnings of pathology. Computational analysis is essential to transform the masses of generated data into a mechanistic understanding of disease. Here we review current research aimed at uncovering the modular organization and function of transcriptional networks and responses in cancer. We first describe how methods that analyze biological processes in terms of higher-level modules can identify robust signatures of disease mechanisms. We then discuss methods that aim to identify the regulatory mechanisms underlying these modules and processes. Finally, we show how comparative analysis, combining human data with model organisms, can lead to more robust findings. We conclude by discussing the challenges of generalizing these methods from cells to tissues and the opportunities they offer to improve cancer diagnosis and management.	Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA; Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA; Univ Pittsburgh, Pittsburgh, PA 15260 USA; Hebrew Univ Jerusalem, Sch Engn & Comp Sci, Jerusalem, Israel	Rockefeller University; Stanford University; Harvard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Hebrew University of Jerusalem	Segal, E (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10021 USA.	koller@cs.stanford.edu	Segal, Eran/AAF-4855-2019; Friedman, Nir/H-9692-2012	Friedman, Nir/0000-0002-9678-3550; Kaminski, Naftali/0000-0001-5917-4601; Segal, Eran/0000-0002-6859-1164				Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Behrens J, 2004, INT J DEV BIOL, V48, P477, DOI 10.1387/ijdb.041815jb; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898; Caetano MS, 2002, FASEB J, V16, P1940, DOI 10.1096/fj.02-0282fje; Chang CF, 2004, NUCLEIC ACIDS RES, V32, P1798, DOI 10.1093/nar/gkh507; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Desai KV, 2002, P NATL ACAD SCI USA, V99, P6967, DOI 10.1073/pnas.102172399; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Fuller AP, 2003, J MAMMARY GLAND BIOL, V8, P335, DOI 10.1023/B:JOMG.0000010033.49464.0c; Garber K, 2004, SCIENCE, V303, P1754, DOI 10.1126/science.303.5665.1754; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartemink Alexander J, 2002, Pac Symp Biocomput, P437; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Hulboy DL, 2001, MOL CELL BIOL, V21, P5478, DOI 10.1128/MCB.21.16.5478-5487.2001; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Kalir S, 2004, CELL, V117, P713, DOI 10.1016/j.cell.2004.05.010; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Khan J, 1999, ELECTROPHORESIS, V20, P223, DOI 10.1002/(SICI)1522-2683(19990201)20:2<223::AID-ELPS223>3.0.CO;2-A; Kobayashi K, 2004, ONCOGENE, V23, P3089, DOI 10.1038/sj.onc.1207433; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lander ES, 1999, NAT GENET, V21, P3, DOI 10.1038/4427; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lossos IS, 2002, P NATL ACAD SCI USA, V99, P8886, DOI 10.1073/pnas.132253599; Lu P, 2003, P NATL ACAD SCI USA, V100, P10370, DOI 10.1073/pnas.1832361100; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; Mecham BH, 2004, PHYSIOL GENOMICS, V18, P308, DOI 10.1152/physiolgenomics.00066.2004; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nachman I, 2004, BIOINFORMATICS, V20, P248, DOI 10.1093/bioinformatics/bth941; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Pe'er Dana, 2002, Bioinformatics, V18 Suppl 1, pS258; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Pritsker M, 2004, GENOME RES, V14, P99; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Ronen M, 2002, P NATL ACAD SCI USA, V99, P10555, DOI 10.1073/pnas.152046799; Rostomily RC, 1997, CANCER RES, V57, P3526; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; Segal E, 2003, BIOINFORMATICS, V19, pi273, DOI 10.1093/bioinformatics/btg1038; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; SEGAL E, 2004, RECOMB 2004 P 8 ANN, P141; SEGAL E, 2002, P 6 INT C RES COMP M, P263; SEGAL E, 2004, THESIS STANFORD U; Sharan R, 2004, NUCLEIC ACIDS RES, V32, pW253, DOI 10.1093/nar/gkh385; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431	69	265	289	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37			S			S38	S45		10.1038/ng1561	http://dx.doi.org/10.1038/ng1561			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	932YF	15920529	Bronze			2022-12-27	WOS:000229590000008
J	Giorgini, F; Guidetti, P; Nguyen, QV; Bennett, SC; Muchowski, PJ				Giorgini, F; Guidetti, P; Nguyen, QV; Bennett, SC; Muchowski, PJ			A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease	NATURE GENETICS			English	Article							INCLUSION-BODY FORMATION; MUTANT HUNTINGTIN; POLYGLUTAMINE AGGREGATION; QUINOLINIC ACID; IN-VIVO; TOXICITY; MODEL; BRAIN; INHIBITION; EXPANSIONS	Huntington disease is a fatal neurodegenerative disorder caused by expansion of a polyglutamine tract in the protein huntingtin (Htt)(1), which leads to its aggregation in nuclear and cytoplasmic inclusion bodies(2). We recently identified 52 loss-of-function mutations in yeast genes that enhance the toxicity of a mutant Htt fragment(3). Here we report the results from a genome-wide loss-of-function suppressor screen in which we identified 28 gene deletions that suppress toxicity of a mutant Htt fragment. The suppressors are known or predicted to have roles in vesicle transport, vacuolar degradation, transcription and prion-like aggregation. Among the most potent suppressors was Bna4 ( kynurenine 3-monooxygenase), an enzyme in the kynurenine pathway of tryptophan degradation that has been linked directly to the pathophysiology of Huntington disease in humans by a mechanism that may involve reactive oxygen species(4). This finding is suggestive of a conserved mechanism of polyglutamine toxicity from yeast to humans and identifies new candidate therapeutic targets for the treatment of Huntington disease.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Catonsville, MD 21228 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA; Univ Washington, Ctr Neurogenet & Neurotherapeut, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Muchowski, PJ (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	mucho@u.washington.edu		Giorgini, Flaviano/0000-0001-7881-9508	NINDS NIH HHS [R01 NS047237] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047237] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Goda K, 1999, ADV EXP MED BIOL, V467, P397; Guidetti P, 2000, NEUROSCI LETT, V283, P233, DOI 10.1016/S0304-3940(00)00956-3; Guidetti P, 2004, NEUROBIOL DIS, V17, P455, DOI 10.1016/j.nbd.2004.07.006; Guidetti P, 1999, EUR J NEUROSCI, V11, P3857, DOI 10.1046/j.1460-9568.1999.00806.x; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mallory MJ, 2003, J BIOL CHEM, V278, P44727, DOI 10.1074/jbc.M308632200; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Moroni F, 1999, ADV EXP MED BIOL, V467, P199; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Perez-Severiano F, 2004, NEUROCHEM RES, V29, P729, DOI 10.1023/B:NERE.0000018843.83770.4b; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Richter A, 2003, EUR J PHARMACOL, V478, P47, DOI 10.1016/j.ejphar.2003.08.038; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; Ryu JK, 2004, EXP NEUROL, V187, P150, DOI 10.1016/j.expneurol.2004.01.006; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Schwarcz R, 2004, CURR OPIN PHARMACOL, V4, P12, DOI 10.1016/j.coph.2003.10.006; Schwarcz R, 2002, J PHARMACOL EXP THER, V303, P1, DOI 10.1124/jpet.102.034439; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	30	265	274	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2005	37	5					526	531		10.1038/ng1542	http://dx.doi.org/10.1038/ng1542			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15806102	Green Accepted			2022-12-27	WOS:000228862300023
J	Ptak, SE; Hinds, DA; Koehler, K; Nickel, B; Patil, N; Ballinger, DG; Przeworski, M; Frazer, KA; Paabo, S				Ptak, SE; Hinds, DA; Koehler, K; Nickel, B; Patil, N; Ballinger, DG; Przeworski, M; Frazer, KA; Paabo, S			Fine-scale recombination patterns differ between chimpanzees and humans	NATURE GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MEIOTIC RECOMBINATION; LINKAGE-DISEQUILIBRIUM; HUMAN GENOME; HAPLOTYPE RECONSTRUCTION; DNA-SEQUENCES; HOTSPOT; CROSSOVERS; SAMPLES; SITES	Recombination rates seem to vary extensively along the human genome. Pedigree analysis suggests that rates vary by an order of magnitude when measured at the megabase scale(1), and at a finer scale, sperm typing studies point to the existence of recombination hotspots(2). These are short regions ( 1 - 2 kb) in which recombination rates are 10 - 1,000 times higher than the background rate. Less is known about how recombination rates change over time. Here we determined to what degree recombination rates are conserved among closely related species by estimating recombination rates from 14 Mb of linkage disequilibrium data in central chimpanzee and human populations. The results suggest that recombination hotspots are not conserved between the two species and that recombination rates in larger ( 50 kb) genomic regions are only weakly conserved. Therefore, the recombination landscape has changed markedly between the two species.	Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Perlegen Sci Inc, Mountain View, CA 94043 USA; Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Max Planck Society; Brown University	Ptak, SE (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutscher Pl 6, D-04103 Leipzig, Germany.	ptak@email.eva.mpg.de		Hinds, David/0000-0002-4911-803X; Frazer, Kelly/0000-0002-6060-8902				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Britten RJ, 2002, P NATL ACAD SCI USA, V99, P13633, DOI 10.1073/pnas.172510699; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Cullen M, 2002, AM J HUM GENET, V71, P759, DOI 10.1086/342973; de Massy B, 2003, TRENDS GENET, V19, P514, DOI 10.1016/S0168-9525(03)00201-4; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Fearnhead P, 2003, THEOR POPUL BIOL, V64, P67, DOI 10.1016/S0040-5809(03)00041-8; Fischer A, 2004, MOL BIOL EVOL, V21, P799, DOI 10.1093/molbev/msh083; Haring SJ, 2003, GENETICS, V165, P101; HINDS DA, IN PRESS SCIENCE; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Li N, 2003, GENETICS, V165, P2213; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; Ptak SE, 2004, PLOS BIOL, V2, P849, DOI 10.1371/journal.pbio.0020155; Ptak SE, 2004, GENETICS, V167, P387, DOI 10.1534/genetics.167.1.387; SHIROISHI T, 1991, EMBO J, V10, P681, DOI 10.1002/j.1460-2075.1991.tb07997.x; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stumpf MPH, 2003, NAT REV GENET, V4, P959, DOI 10.1038/nrg1227; Wall JD, 2003, AM J HUM GENET, V73, P1330, DOI 10.1086/380311	28	219	228	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2005	37	4					429	434		10.1038/ng1529	http://dx.doi.org/10.1038/ng1529			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15723063				2022-12-27	WOS:000228040000028
J	Zuchner, S; Noureddine, M; Kennerson, M; Verhoeven, K; Claeys, K; De Jonghe, P; Merory, J; Oliveira, SA; Speer, MC; Stenger, JE; Walizada, G; Zhu, DQ; Pericak-Vance, MA; Nicholson, G; Timmerman, V; Vance, JM				Zuchner, S; Noureddine, M; Kennerson, M; Verhoeven, K; Claeys, K; De Jonghe, P; Merory, J; Oliveira, SA; Speer, MC; Stenger, JE; Walizada, G; Zhu, DQ; Pericak-Vance, MA; Nicholson, G; Timmerman, V; Vance, JM			Mutations in the pleckstrin homology domain of dynamin 2 cause dominant intermediate Charcot-Marie-Tooth disease	NATURE GENETICS			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; NEUROPATHY; IDENTIFICATION; LOCALIZATION; MICROTUBULES; MECHANISM; MUTANT; MAPS; FORM	Charcot-Marie-Tooth (CMT) disease is a clinically and genetically heterogeneous group of peripheral neuropathies. Different chromosomal loci have been linked with three autosomal dominant, `intermediate' types of CMT: DI-CMTA(1),DI-CMTB2 and DI-CMTC3. We refined the locus associated with DI-CMTB on chromosome 19p12- 13. 2 to 4.2 Mb in three unrelated families with CMT originating from Australia, Belgium and North America. After screening candidate genes, we identified unique mutations in dynamin 2 (DNM2) in all families. DNM2 belongs to the family of large GTPases and is part of the cellular fusion-fission apparatus(4). In transiently transfected cell lines, mutations of DNM2 substantially diminish binding of DNM2 to membranes by altering the conformation of the beta3/beta4 loop of the pleckstrin homology domain. Additionally, in the Australian and Belgian pedigrees, which carry two different mutations affecting the same amino acid, Lys558, CMT cosegregated with neutropenia, which has not previously been associated with CMT neuropathies.	Duke Univ, Med Ctr, Dept Human Genet, Durham, NC 27710 USA; Rhein Westfal TH Aachen, Univ Hosp, Dept Neuropathol, D-52074 Aachen, Germany; ANZAC Res Inst, Northcott Neurosci Lab, Sydney, NSW, Australia; Concord Hosp, Mol Med Lab, Concord, NSW, Australia; Univ Antwerp VIB, Dept Mol Genet, B-2020 Antwerp, Belgium; Univ Antwerp Hosp, Div Neurol, Antwerp, Belgium; Heidelberg Repatriat Hosp, Dept Neurol, Heidelberg West, Vic 3081, Australia	Duke University; RWTH Aachen University; RWTH Aachen University Hospital; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp	Zuchner, S (corresponding author), Duke Univ, Med Ctr, Dept Human Genet, Durham, NC 27710 USA.		Oliveira, Sofia/F-3386-2010; Research Institute, ANZAC/CAE-9030-2022	Vance, Jeffery/0000-0003-3815-8199; Claeys, Kristl/0000-0001-9937-443X; Oliveira, Sofia A/0000-0001-7919-4191; Kennerson, Marina/0000-0003-3332-5074; Nicholson, Garth/0000-0001-9694-066X				Achiriloaie M, 1999, MOL CELL BIOL, V19, P1410; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; HARLAN JE, 1994, NATURE, V371, P168, DOI 10.1038/371168a0; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Jordanova A, 2003, AM J HUM GENET, V73, P1423, DOI 10.1086/379792; Kennerson ML, 2001, AM J HUM GENET, V69, P883, DOI 10.1086/323743; Kozlov MM, 1999, BIOPHYS J, V77, P604, DOI 10.1016/S0006-3495(99)76917-1; Lee A, 1999, CURR BIOL, V9, P261, DOI 10.1016/S0960-9822(99)80115-8; Muhlberg AB, 2000, METHODS, V20, P475, DOI 10.1006/meth.2000.0960; SCAIFE R, 1990, J CELL BIOL, V111, P3023, DOI 10.1083/jcb.111.6.3023; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Speer MC, 2002, NEUROGENETICS, V4, P83, DOI 10.1007/s10048-002-0139-3; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Vance JM, 2000, ARCH NEUROL-CHICAGO, V57, P638, DOI 10.1001/archneur.57.5.638; Verhoeven K, 2001, AM J HUM GENET, V69, P889, DOI 10.1086/323742; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002; Zhu DQ, 2003, NEUROGENETICS, V4, P179, DOI 10.1007/s10048-003-0147-y; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	27	259	270	1	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2005	37	3					289	294		10.1038/ng1514	http://dx.doi.org/10.1038/ng1514			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15731758				2022-12-27	WOS:000227297800020
J	Esumi, S; Kakazu, N; Taguchi, Y; Hirayama, T; Sasaki, A; Hirabayashi, T; Koide, T; Kitsukawa, T; Hamada, S; Yagi, T				Esumi, S; Kakazu, N; Taguchi, Y; Hirayama, T; Sasaki, A; Hirabayashi, T; Koide, T; Kitsukawa, T; Hamada, S; Yagi, T			Monoallelic yet combinatorial expression of variable exons of the protocadherin-alpha gene cluster in single neurons	NATURE GENETICS			English	Article							GENOMIC ORGANIZATION; MOLECULAR-MECHANISMS; GAMMA-PROTOCADHERINS; FAMILY; DIVERSITY; PATTERNS; CELLS; TRANSCRIPTS; SELECTION; PROMOTER	Diverse protocadherin-alpha genes (Pcdha, also called cadherin-related neuronal receptor or CNR) are expressed in the vertebrate brain. Their genomic organization involves multiple variable exons and a set of constant exons, similar to the immunoglobulin (Ig) and T-cell receptor (TCR) genes. This diversity can be used to distinguish neurons. Using polymorphisms that distinguish the C57BL/6 and MSM mouse strains, we analyzed the allelic expression of the Pcdha gene cluster in individual neurons. Single-cell analysis of Purkinje cells using multiple RT-PCR reactions showed the monoallelic and combinatorial expression of each variable exon in the Pcdha genes. This report is the first description to our knowledge of the allelic expression of a diversified receptor family in the central nervous system. The allelic and combinatorial expression of distinct variable exons of the Pcdha genes is a potential mechanism for specifying neuron identity in the brain.	Osaka Univ, Grad Sch Frontier Biosci, Labs Integrated Biol, KOKORO Biol Grp, Suita, Osaka 5650871, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Kawaguchi, Saitama 3320012, Japan; Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kamigyo Ku, Kyoto 6028566, Japan; Natl Inst Physiol Sci, Dept Informat Physiol, Div Neurobiol & Behav Genet, Okazaki, Aichi 4448585, Japan; Natl Inst Genet, Mouse Genom Resource Lab, Mishima, Shizuoka 4118540, Japan; Natl Inst Basic Biol, Div Brain Biol, Okazaki, Aichi 4440867, Japan	Osaka University; Japan Science & Technology Agency (JST); Kyoto Prefectural University of Medicine; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Yagi, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Labs Integrated Biol, KOKORO Biol Grp, 1-3 Yamadaoka, Suita, Osaka 5650871, Japan.	yagi@fbs.osaka-u.ac.jp	Kitsukawa, Takashi/X-3176-2018					CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; EFSTRATIADIS A, 1994, CURR OPIN GENET DEV, V4, P265, DOI 10.1016/S0959-437X(05)80054-1; Hamada S, 2001, NEUROSCI RES, V41, P207, DOI 10.1016/S0168-0102(01)00281-4; HELD W, 1995, NATURE, V376, P355, DOI 10.1038/376355a0; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; LYON MF, 1986, NATURE, V320, P313, DOI 10.1038/320313b0; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Oberdick J, 1998, TRENDS NEUROSCI, V21, P383, DOI 10.1016/S0166-2236(98)01325-3; PERNIS B, 1965, J EXP MED, V122, P853, DOI 10.1084/jem.122.5.853; Phillips GR, 2003, J NEUROSCI, V23, P5096; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rhoades KL, 2000, CURR BIOL, V10, P789, DOI 10.1016/S0960-9822(00)00565-0; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Serafini T, 1999, CELL, V98, P133, DOI 10.1016/S0092-8674(00)81008-9; Singh N, 2003, J EXP MED, V197, P743, DOI 10.1084/jem.20021392; Sugino H, 2004, BIOCHEM BIOPH RES CO, V316, P437, DOI 10.1016/j.bbrc.2004.02.067; Sugino H, 2000, GENOMICS, V63, P75, DOI 10.1006/geno.1999.6066; Tada MN, 2004, GENE, V340, P197, DOI 10.1016/j.gene.2004.07.014; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Wu Q, 2000, P NATL ACAD SCI USA, V97, P3124, DOI 10.1073/pnas.060027397; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yagi T, 1999, BIOCHEM PHARMACOL, V57, P845; Yagi T, 2000, GENE DEV, V14, P1169; Yanase H, 2004, GENOMICS, V83, P717, DOI 10.1016/j.ygeno.2003.09.022	27	191	196	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					171	176		10.1038/ng1500	http://dx.doi.org/10.1038/ng1500			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	15640798				2022-12-27	WOS:000226690100024
J	Hasson, P; Egoz, N; Winkler, C; Volohonsky, G; Jia, ST; Dinur, T; Volk, T; Courey, AJ; Paroush, Z				Hasson, P; Egoz, N; Winkler, C; Volohonsky, G; Jia, ST; Dinur, T; Volk, T; Courey, AJ; Paroush, Z			EGFR signaling attenuates Groucho-dependent repression to antagonize Notch transcriptional output	NATURE GENETICS			English	Article							RECEPTOR TYROSINE KINASE; DROSOPHILA EMBRYO; PATHWAYS; RECRUITMENT; ACTIVATION; EXPRESSION; COREPRESSORS; INTERACTS; PROTEINS; BRINKER	Crosstalk between signaling pathways is crucial for the generation of complex and varied transcriptional networks. Antagonism between the EGF-receptor (EGFR) and Notch pathways in particular is well documented, although the underlying mechanism is poorly understood. The global corepressor Groucho (Gro) and its transducin-like Enhancer-of-split (TLE) mammalian homologs mediate repression by a myriad of repressors, including effectors of the Notch, Wnt (Wg) and TGF-beta (Dpp) signaling cascades(1-8). Given that there are genetic interactions between gro and components of the EGFR pathway(9) (ref. 9 and P. H. et al., unpublished results), we tested whether Gro is at a crossroad between this and other pathways. Here we show that phosphorylation of Gro in response to MAPK activation weakens its repressor capacity, attenuating Gro-dependent transcriptional silencing by the Enhancer-of-split proteins, effectors of the Notch cascade. Thus, Gro is a new junction between signaling pathways, enabling EGFR signaling to antagonize transcriptional output by Notch and potentially other Gro-dependent pathways.	Hebrew Univ Jerusalem, Fac Med, Dept Biochem, IL-91120 Jerusalem, Israel; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; University of California System; University of California Los Angeles; Weizmann Institute of Science	Paroush, Z (corresponding author), Hebrew Univ Jerusalem, Fac Med, Dept Biochem, POB 12272, IL-91120 Jerusalem, Israel.	zparoush@cc.huji.ac.il			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044522] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM044522] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barolo S, 2002, GENE DEV, V16, P1964, DOI 10.1101/gad.987402; Bianchi-Frias D, 2004, PLOS BIOL, V2, P975, DOI 10.1371/journal.pbio.0020178; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Courey AJ, 2001, GENE DEV, V15, P2786; Culi J, 2001, DEVELOPMENT, V128, P299; deCelis JF, 1997, DEVELOPMENT, V124, P1919; DECELIS JF, 1995, DEVELOPMENT, V121, P3467; Giagtzoglou N, 2003, DEVELOPMENT, V130, P259, DOI 10.1242/dev.00206; Hasson P, 2001, EMBO J, V20, P5725, DOI 10.1093/emboj/20.20.5725; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Nuthall HN, 2002, J BIOL CHEM, V277, P51049, DOI 10.1074/jbc.M111660200; Parkhurst SM, 1998, TRENDS GENET, V14, P130, DOI 10.1016/S0168-9525(98)01407-3; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Price JV, 1997, GENETICS, V147, P1139; Queenan AM, 1997, DEVELOPMENT, V124, P3871; Rohrbaugh M, 2002, CURR BIOL, V12, P576, DOI 10.1016/S0960-9822(02)00743-1; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Shaye DD, 2002, NATURE, V420, P686, DOI 10.1038/nature01234; Simon MA, 2000, CELL, V103, P13, DOI 10.1016/S0092-8674(00)00100-8; Simpson P, 1997, CURR OPIN GENET DEV, V7, P537, DOI 10.1016/S0959-437X(97)80083-4; Wang SH, 2000, GENE DEV, V14, P2271, DOI 10.1101/gad.827000; Wessells RJ, 1999, DEV BIOL, V216, P243, DOI 10.1006/dbio.1999.9459; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zecca M, 2002, DEVELOPMENT, V129, P1357; Zhang HL, 1999, P NATL ACAD SCI USA, V96, P535, DOI 10.1073/pnas.96.2.535; Zhang HL, 2001, GENE DEV, V15, P261, DOI 10.1101/gad.861201; zur Lage P, 1999, DEVELOPMENT, V126, P3149	30	104	105	0	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2005	37	1					101	105		10.1038/ng1486	http://dx.doi.org/10.1038/ng1486			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15592470				2022-12-27	WOS:000225997500028
J	Derti, A; Roth, FP; Church, GM; Wu, CT				Derti, Adnan; Roth, Frederick P.; Church, George M.; Wu, C-ting			Mammalian ultraconserved elements are strongly depleted among segmental duplications and copy number variants	NATURE GENETICS			English	Article							STRUCTURAL VARIATION; VERTEBRATE; GENE; SEQUENCES; TRANSVECTION; POLYMORPHISM; ENHANCER; GENOMES; REGIONS; MOUSE	An earlier search in the human, mouse and rat genomes for sequences that are 100% conserved in orthologous segments and >= 200 bp in length identified 481 distinct sequences(1). These human-mouse-rat sequences, which represent ultraconserved elements (UCEs), are believed to be important for functions involving DNA binding, RNA processing and the regulation of transcription and development. In vivo and additional computational studies of UCEs and other highly conserved sequences are consistent with these functional associations, with some observations indicating enhancer-like activity for these elements(1-9). Here, we show that UCEs are significantly depleted among segmental duplications and copy number variants. Notably, of the UCEs that are found in segmental duplications or copy number variants, the majority overlap exons, indicating, along with other findings presented, that UCEs overlapping exons represent a distinct subset.	Harvard Univ, Sch Med, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Mol Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Lipper Ctr Computat Genet, Boston, MA 02115 USA; Boston Univ, Bioinformat Program, Boston, MA 02215 USA; Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Boston University; Harvard University; Dana-Farber Cancer Institute	Wu, CT (corresponding author), Harvard Univ, Sch Med, Div Genet, Boston, MA 02115 USA.	twu@genetics.med.harvard.edu	Roth, Frederick P/H-6308-2011	Roth, Frederick/0000-0002-6628-649X; church, george/0000-0001-6232-9969	NHGRI NIH HHS [HG003224, HG0017115] Funding Source: Medline; NIGMS NIH HHS [GM61936] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061936] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r47; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Dermitzakis ET, 2004, GENOME RES, V14, P852, DOI 10.1101/gr.1934904; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Eichler EE, 2006, NAT GENET, V38, P9, DOI 10.1038/ng0106-9; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Goode DK, 2005, GENOMICS, V86, P172, DOI 10.1016/j.ygeno.2005.04.006; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kennison JA, 2002, ADV GENET, V46, P399; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007	28	84	87	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1216	1220		10.1038/ng1888	http://dx.doi.org/10.1038/ng1888			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16998490				2022-12-27	WOS:000241251100024
J	Weisenberger, DJ; D Siegmund, K; Campan, M; Young, J; Long, TI; Faasse, MA; Kang, GH; Widschwendter, M; Weener, D; Buchanan, D; Koh, H; Simms, L; Barker, M; Leggett, B; Levine, J; Kim, M; French, AJ; Thibodeau, SN; Jass, J; Haile, R; Laird, PW				Weisenberger, Daniel J.; D Siegmund, Kimberly; Campan, Mihaela; Young, Joanne; Long, Tiffany I.; Faasse, Mark A.; Kang, Gyeong Hoon; Widschwendter, Martin; Weener, Deborah; Buchanan, Daniel; Koh, Hoey; Simms, Lisa; Barker, Melissa; Leggett, Barbara; Levine, Joan; Kim, Myungjin; French, Amy J.; Thibodeau, Stephen N.; Jass, Jeremy; Haile, Robert; Laird, Peter W.			CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer	NATURE GENETICS			English	Article							DNA METHYLATION; TRANSFORMATION; PROFILES	Aberrant DNA methylation of CpG islands has been widely observed in human colorectal tumors and is associated with gene silencing when it occurs in promoter areas. A subset of colorectal tumors has an exceptionally high frequency of methylation of some CpG islands, leading to the suggestion of a distinct trait referred to as 'CpG island methylator phenotype', or 'CIMP'(1,2). However, the existence of CIMP has been challenged(3,4). To resolve this continuing controversy, we conducted a systematic, stepwise screen of 195 CpG island methylation markers using MethyLight technology, involving 295 primary human colorectal tumors and 16,785 separate quantitative analyses. We found that CIMP-positive (CIMP+) tumors convincingly represent a distinct subset, encompassing almost all cases of tumors with BRAF mutation (odds ratio = 203). Sporadic cases of mismatch repair deficiency occur almost exclusively as a consequence of CIMP-associated methylation of MLH1. We propose a robust new marker panel to classify CIMP+ tumors.	Univ So Calif, Dept Surg, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA; Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA; Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; Queensland Inst Med Res, Mol Canc Epidemiol Lab, Herston, Qld 4006, Australia; Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea; UCL, Dept Gynaecol Oncol, Inst Womens Hlth, London WC1E 6DH, England; Royal Brisbane & Womens Hosp Res Fdn, Conjoint Gastroenterol Lab, Clin Res Ctr, Herston, Qld 4006, Australia; McGill Univ, Dept Pathol, Montreal, PQ H3A 2B4, Canada; Mayo Clin & Mayo Fdn, Dept Lab Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Pathol, Rochester, MN 55905 USA	University of Southern California; University of Southern California; University of Southern California; QIMR Berghofer Medical Research Institute; Seoul National University (SNU); Seoul National University Hospital; University of London; University College London; Royal Brisbane & Women's Hospital; McGill University; Mayo Clinic; Mayo Clinic	Laird, PW (corresponding author), Univ So Calif, Dept Surg, Norris Comprehens Canc Ctr, Los Angeles, CA 90089 USA.	plaird@usc.edu	Young, Joanne P/B-9981-2011; Young, Joanne P/H-7774-2014; Kang, Gyeong Hoon/F-1051-2010; Faasse, Mark/AAD-4049-2019; Weisenberger, Daniel/AAA-8314-2020; Leggett, Barbara A/D-3579-2011; Laird, Peter W/G-8683-2012	Kang, Gyeong Hoon/0000-0003-2380-6675; Weisenberger, Daniel/0000-0001-8303-2603; Laird, Peter W/0000-0001-9117-3641; Simms, Lisa/0000-0002-5387-7397; Young, Joanne/0000-0002-1514-1522; Buchanan, Daniel/0000-0003-2225-6675; Leggett, Barbara/0000-0003-2062-7380; Widschwendter, Martin/0000-0002-7778-8380; Faasse, Mark/0000-0002-1524-7239	NCI NIH HHS [R01 CA075090, U01 CA074794, U01 CA097735, U01 CA074783, U01 CA074800] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA074794, R01CA075090, U01CA097735, U01CA074783, U01CA074800] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anacleto C, 2005, NEOPLASIA, V7, P331, DOI 10.1593/neo.04502; Bakin AV, 1999, SCIENCE, V283, P387, DOI 10.1126/science.283.5400.387; Breiman L., 1984, CLASSIFICATION REGRE; Eads CA, 2001, CANCER RES, V61, P3410; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Hastie T, 2001, GENOME BIOL, V2; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Laird PW, 2005, HUM MOL GENET, V14, pR65, DOI 10.1093/hmg/ddi113; McLachlan G., 2000, WILEY SER PROB STAT; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Ordway JM, 2004, ONCOGENE, V23, P3737, DOI 10.1038/sj.onc.1207483; Samowitz WS, 2005, GASTROENTEROLOGY, V129, P837, DOI 10.1053/j.gastro.2005.06.020; Toyota M, 2000, P NATL ACAD SCI USA, V97, P710, DOI 10.1073/pnas.97.2.710; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Whitehall VLJ, 2002, CANCER RES, V62, P6011; Widschwendter M, 2004, CANCER RES, V64, P3807, DOI 10.1158/0008-5472.CAN-03-3852; Yamashita K, 2003, CANCER CELL, V4, P121, DOI 10.1016/S1535-6108(03)00190-9; Young J, 2001, AM J PATHOL, V159, P2107, DOI 10.1016/S0002-9440(10)63062-3; Young J, 2005, CLIN GASTROENTEROL H, V3, P254, DOI 10.1016/S1542-3565(04)00673-1	24	1429	1483	2	108	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					787	793		10.1038/ng1834	http://dx.doi.org/10.1038/ng1834			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16804544				2022-12-27	WOS:000238669300014
J	Shore, EM; Xu, MQ; Feldman, GJ; Fenstermacher, DA; Brown, MA; Kaplan, FS				Shore, EM; Xu, MQ; Feldman, GJ; Fenstermacher, DA; Brown, MA; Kaplan, FS		FOP Int Res Consortium	A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva	NATURE GENETICS			English	Article							DISORDER; INHIBITOR	Fibrodysplasia ossificans progressiva (FOP) is a rare autosomal dominant disorder of skeletal malformations and progressive extraskeletal ossification. We mapped FOP to chromosome 2q23-24 by linkage analysis and identified an identical heterozygous mutation (617G -> A; R206H) in the glycine-serine (GS) activation domain of ACVR1, a BMP type I receptor, in all affected individuals examined. Protein modeling predicts destabilization of the GS domain, consistent with constitutive activation of ACVR1 as the underlying cause of the ectopic chondrogenesis, osteogenesis and joint fusions seen in FOP.	Univ Penn, Sch Med, Ctr Res FOP & Related Disorders, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Biomed Informat Facil, Philadelphia, PA 19104 USA; Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Brisbane, Qld 4102, Australia; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Queensland; University of Pennsylvania	Kaplan, FS (corresponding author), Univ Penn, Sch Med, Ctr Res FOP & Related Disorders, Philadelphia, PA 19104 USA.	Frederick.Kaplan@uphs.upenn.edu	Brown, Matthew A/E-5749-2010; Shore, Eileen/D-2593-2009	Brown, Matthew A/0000-0003-0538-8211; 	NIAMS NIH HHS [R01 AR041916, R01-AR41916] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041916] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ahn J, 2003, J BONE JOINT SURG AM, V85A, P667, DOI 10.2106/00004623-200304000-00013; ATTISANO L, 1993, CELL, V75, P671, DOI 10.1016/0092-8674(93)90488-C; de la Pena LS, 2005, J BONE MINER RES, V20, P1168, DOI 10.1359/JBMR.050305; Feldman G, 2000, AM J HUM GENET, V66, P128, DOI 10.1086/302724; Fiori JL, 2006, J BONE MINER RES, V21, P902, DOI 10.1359/JBMR.060215; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; Kaplan F.S., 2002, CONNECTIVE TISSUE IT, P827; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Payne TL, 2001, MECH DEVELOP, V100, P275, DOI 10.1016/S0925-4773(00)00541-4; Shafritz AB, 1996, NEW ENGL J MED, V335, P555, DOI 10.1056/NEJM199608223350804; Shore EM, 2005, CLIN REV BONE MINER, V3, P201, DOI 10.1385/BMM:3:3-4:201; Wang TW, 1996, CELL, V86, P435, DOI 10.1016/S0092-8674(00)80116-6; Xu MQ, 2000, CLIN GENET, V58, P291, DOI 10.1034/j.1399-0004.2000.580407.x; Xu MQ, 2002, AM J MED GENET, V109, P161, DOI 10.1002/ajmg.10288; Zhang DH, 2003, J BONE MINER RES, V18, P1593, DOI 10.1359/jbmr.2003.18.9.1593	15	807	860	2	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					525	527		10.1038/ng1783	http://dx.doi.org/10.1038/ng1783			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16642017				2022-12-27	WOS:000237147500012
J	Coucke, PJ; Willaert, A; Wessels, MW; Callewaert, B; Zoppi, N; De Backer, J; Fox, JE; Mancini, GMS; Kambouris, M; Gardella, R; Facchetti, F; Willems, PJ; Forsyth, R; Dietz, HC; Barlati, S; Colombi, M; Loeys, B; De Paepe, A				Coucke, PJ; Willaert, A; Wessels, MW; Callewaert, B; Zoppi, N; De Backer, J; Fox, JE; Mancini, GMS; Kambouris, M; Gardella, R; Facchetti, F; Willems, PJ; Forsyth, R; Dietz, HC; Barlati, S; Colombi, M; Loeys, B; De Paepe, A			Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome	NATURE GENETICS			English	Article							FANCONI-BICKEL-SYNDROME; SMOOTH-MUSCLE-CELLS; SLC2A10 GLUT10; CANDIDATE GENE; GROWTH-FACTORS; FAMILY; VERSICAN; SEQUENCE; TRAITS	Arterial tortuosity syndrome (ATS) is an autosomal recessive disorder characterized by tortuosity, elongation, stenosis and aneurysm formation in the major arteries owing to disruption of elastic fibers in the medial layer of the arterial wall(1). Previously, we used homozygosity mapping to map a candidate locus in a 4.1-Mb region on chromosome 20q13.1 (ref. 2). Here, we narrowed the candidate region to 1.2 Mb containing seven genes. Mutations in one of these genes, SLC2A10, encoding the facilitative glucose transporter GLUT10, were identified in six ATS families. GLUT10 deficiency is associated with upregulation of the TGF beta pathway in the arterial wall, a finding also observed in Loeys-Dietz syndrome, in which aortic aneurysms associate with arterial tortuosity(3). The identification of a glucose transporter gene responsible for altered arterial morphogenesis is notable in light of the previously suggested link between GLUT10 and type 2 diabetes(4,5). Our data could provide new insight on the mechanisms causing microangiopathic changes associated with diabetes and suggest that therapeutic compounds intervening with TGF beta signaling represent a new treatment strategy.	Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3015 GD Rotterdam, Netherlands; Univ Brescia, Dept Biomed Sci & Biotechnol, Div Biol & Genet, I-25123 Brescia, Italy; N Shore Univ Hosp, Dept Pediat, Manhasset, NY 11030 USA; Yale Univ, Sch Med, New Haven, CT 06510 USA; Univ Brescia, Dept Pathol, Brescia, Italy; GENDIA, B-2000 Antwerp, Belgium; Ghent Univ, Dept Pathol, B-9000 Ghent, Belgium; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	Ghent University; Erasmus University Rotterdam; Erasmus MC; University of Brescia; Northwell Health; North Shore University Hospital; Yale University; University of Brescia; Ghent University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Coucke, PJ (corresponding author), Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium.	paul.coucke@ugent.be	Loeys, Bart/B-3236-2017; Forsyth, Ramses/X-8635-2019; Facchetti, Fabio/E-7190-2010; Barlati, Sergio/A-2666-2010; Callewaert, Bert/J-6357-2014; Coucke, Paul J/AAO-2954-2020; Willaert, Andy/AAZ-9111-2020; De Backer, Julie/B-2897-2014	Loeys, Bart/0000-0003-3703-9518; Forsyth, Ramses/0000-0001-8337-5382; Facchetti, Fabio/0000-0003-4975-2388; Callewaert, Bert/0000-0002-9743-4205; Coucke, Paul J/0000-0001-7119-586X; De Backer, Julie/0000-0001-8878-1507; Willaert, Andy/0000-0002-9543-1932; ZOPPI, Nicoletta/0000-0003-0197-8927; Colombi, Marina/0000-0002-3105-5990				Andersen G, 2003, DIABETES, V52, P2445, DOI 10.2337/diabetes.52.9.2445; Barrett MP, 1999, CURR OPIN CELL BIOL, V11, P496, DOI 10.1016/S0955-0674(99)80072-6; BEUREN AJ, 1969, CIRCULATION, V39, P109, DOI 10.1161/01.CIR.39.1.109; Chiarelli F, 2000, HORM RES, V53, P53, DOI 10.1159/000023515; Colombi M, 2003, J BIOL CHEM, V278, P14346, DOI 10.1074/jbc.M211997200; Coucke PJ, 2003, J MED GENET, V40, P747, DOI 10.1136/jmg.40.10.747; Dawson PA, 2001, MOL GENET METAB, V74, P186, DOI 10.1006/mgme.2001.3212; ERTUGRUL A, 1967, CIRCULATION, V36, P400, DOI 10.1161/01.CIR.36.3.400; Fischer JW, 2001, ARTERIOSCL THROM VAS, V21, P777, DOI 10.1161/01.ATV.21.5.777; Franceschini P, 2000, AM J MED GENET, V91, P141, DOI 10.1002/(SICI)1096-8628(20000313)91:2<141::AID-AJMG13>3.0.CO;2-6; Gardella R, 2004, AM J MED GENET A, V126A, P221, DOI 10.1002/ajmg.a.20589; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Le Saux O, 2000, NAT GENET, V25, P223, DOI 10.1038/76102; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; McVie-Wylie AJ, 2001, GENOMICS, V72, P113, DOI 10.1006/geno.2000.6457; Mohlke KL, 2005, MOL GENET METAB, V85, P323, DOI 10.1016/j.ymgme.2005.04.011; Pletcher BA, 1996, AM J MED GENET, V66, P121, DOI 10.1002/(SICI)1096-8628(19961211)66:2<121::AID-AJMG1>3.3.CO;2-X; Sakamoto O, 2000, PEDIATR RES, V48, P586, DOI 10.1203/00006450-200011000-00005; Santer R, 1997, NAT GENET, V17, P324, DOI 10.1038/ng1197-324; Scheepers A, 2004, JPEN-PARENTER ENTER, V28, P364, DOI 10.1177/0148607104028005364; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; Seidner G, 1998, NAT GENET, V18, P188, DOI 10.1038/ng0298-188; TANIZAWA Y, 1994, DIABETOLOGIA, V37, P420, DOI 10.1007/BF00408481; Wahab NA, 2000, J AM SOC NEPHROL, V11, P1607, DOI 10.1681/ASN.V1191607; Wessels MW, 2004, AM J MED GENET A, V131A, P134, DOI 10.1002/ajmg.a.30272; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Wood IS, 2003, BIOCHEM BIOPH RES CO, V308, P43, DOI 10.1016/S0006-291X(03)01322-6	27	249	261	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2006	38	4					452	457		10.1038/ng1764	http://dx.doi.org/10.1038/ng1764			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	026LN	16550171	Green Published			2022-12-27	WOS:000236340500018
J	Loh, YH; Wu, Q; Chew, JL; Vega, VB; Zhang, WW; Chen, X; Bourque, G; George, J; Leong, B; Liu, J; Wong, KY; Sung, KW; Lee, CWH; Zhao, XD; Chiu, KP; Lipovich, L; Kuznetsov, VA; Robson, P; Stanton, LW; Wei, CL; Ruan, YJ; Lim, B; Ng, HH				Loh, YH; Wu, Q; Chew, JL; Vega, VB; Zhang, WW; Chen, X; Bourque, G; George, J; Leong, B; Liu, J; Wong, KY; Sung, KW; Lee, CWH; Zhao, XD; Chiu, KP; Lipovich, L; Kuznetsov, VA; Robson, P; Stanton, LW; Wei, CL; Ruan, YJ; Lim, B; Ng, HH			The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells	NATURE GENETICS			English	Article							FACTOR-BINDING-SITES; SELF-RENEWAL; HUMAN RIF1; PROTEIN; GENE; SOX2; EXPRESSION; OCT-3/4; DIFFERENTIATION; IDENTIFICATION	Oct4 and Nanog are transcription factors required to maintain the pluripotency and self-renewal of embryonic stem (ES) cells. Using the chromatin immunoprecipitation paired-end ditags method, we mapped the binding sites of these factors in the mouse ES cell genome. We identified 1,083 and 3,006 high-confidence binding sites for Oct4 and Nanog, respectively. Comparative location analyses indicated that Oct4 and Nanog overlap substantially in their targets, and they are bound to genes in different configurations. Using de novo motif discovery algorithms, we defined the cis-acting elements mediating their respective binding to genomic sites. By integrating RNA interference-mediated depletion of Oct4 and Nanog with microarray expression profiling, we demonstrated that these factors can activate or suppress transcription. We further showed that common core downstream targets are important to keep ES cells from differentiating. The emerging picture is one in which Oct4 and Nanog control a cascade of pathways that are intricately connected to govern pluripotency, self-renewal, genome surveillance and cell fate determination.	Genome Inst Singapore, Cloning & Sequencing Grp, Singapore 138672, Singapore; Genome Inst Singapore, Informat & Math Sci Grp, Singapore 138672, Singapore; Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; Harvard Univ, Sch Med, Harvard Inst Med, Boston, MA 02115 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; Harvard University; Harvard Medical School	Ruan, YJ (corresponding author), Genome Inst Singapore, Cloning & Sequencing Grp, Singapore 138672, Singapore.	ruanyj@gis.a-star.edu.sg; nghh@gis.a-star.edu.sg	Chen, Xi/C-6889-2012; Loh, Yuin-Han/E-1096-2014; Chiu, Kuo-Ping/AAG-8855-2020; Bourque, Guillaume/AFR-2927-2022; Ng, Huck Hui/A-1135-2009; George, Joshy/K-4841-2019; Yang, Chen/G-1379-2010; Robson, Paul/A-3464-2009; Lipovich, Leonard/B-2355-2019	Loh, Yuin-Han/0000-0002-4715-6454; Chiu, Kuo-Ping/0000-0001-9144-0674; Bourque, Guillaume/0000-0002-3933-9656; Robson, Paul/0000-0002-0191-3958; Lipovich, Leonard/0000-0002-0531-3570; Sung, Wing-Kin/0000-0001-7806-7086; George, Joshy/0000-0001-8510-8229; Chen, Xi/0000-0002-7995-6202; NG, HUCK HUI/0000-0001-6352-8417; Wu, Qiang/0000-0003-2049-1639	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047636] Funding Source: NIH RePORTER; NIAID NIH HHS [AI54973] Funding Source: Medline; NIDDK NIH HHS [DK47636] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams IR, 2004, DEV DYNAM, V229, P733, DOI 10.1002/dvdy.10471; Affolter M, 1990, CURR OPIN CELL BIOL, V2, P485, DOI 10.1016/0955-0674(90)90132-X; Ambrosetti DC, 2000, J BIOL CHEM, V275, P23387, DOI 10.1074/jbc.M000932200; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brandenberger Ralph, 2004, BMC Developmental Biology, V4, P1; Buck MJ, 2004, GENOMICS, V83, P349, DOI 10.1016/j.ygeno.2003.11.004; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Donovan PJ, 2001, NATURE, V414, P92, DOI 10.1038/35102154; Down TA, 2005, NUCLEIC ACIDS RES, V33, P1445, DOI 10.1093/nar/gki282; Guo Y, 2002, P NATL ACAD SCI USA, V99, P3663, DOI 10.1073/pnas.062041099; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Kim JW, 2005, NAT METHODS, V2, P47, DOI 10.1038/NMETH726; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; KORNBERG TB, 1993, J BIOL CHEM, V268, P26813; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Loebel DAF, 2003, DEV BIOL, V264, P1, DOI 10.1016/S0012-1606(03)00390-7; Luo JM, 1997, NATURE, V388, P778, DOI 10.1038/42022; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mitsunaga K, 2004, MECH DEVELOP, V121, P237, DOI 10.1016/j.mod.2004.01.006; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pavesi G., 2001, BIOINFORMATICS, V17, pS207; Pera MF, 2000, J CELL SCI, V113, P5; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Pollack JR, 2002, NAT GENET, V32, P515, DOI 10.1038/ng1035; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Wei CL, 2005, STEM CELLS, V23, P166, DOI 10.1634/stemcells.2004-0162; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Xu LF, 2004, J CELL BIOL, V167, P819, DOI 10.1083/jcb.200408181; Yeom YI, 1996, DEVELOPMENT, V122, P881	46	1827	1938	4	204	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2006	38	4					431	440		10.1038/ng1760	http://dx.doi.org/10.1038/ng1760			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	026LN	16518401				2022-12-27	WOS:000236340500015
J	Mak, HY; Nelson, LS; Basson, M; Johnson, CD; Ruvkun, G				Mak, HY; Nelson, LS; Basson, M; Johnson, CD; Ruvkun, G			Polygenic control of Caenorhabditis elegans fat storage	NATURE GENETICS			English	Article							C-ELEGANS; CHEMOSENSORY NEURONS; SENSORY PERCEPTION; LARVAL DEVELOPMENT; GENE FAMILY; TUBBY; PROTEIN; MUTATION; HOMOLOG; INSULIN	Tubby mice(1) and individuals with Bardet-Biedl syndrome(2) have defects in ciliated neuron function and obesity, suggesting an as-yet unknown metabolic signaling axis from ciliated neurons to fat storage tissues. Here we show coordinate regulation of Caenorhabditis elegans fat storage by orthologues of these genes acting in ciliated neurons and by a 3-ketoacyl-coA thiolase (encoded by kat-1) that acts in fat storage tissue. A genetic screen for markedly enhanced fat storage in tub-1 mutants led to the isolation only of kat-1 alleles, which impair fatty acid beta-oxidation. kat-1 acts in the intestine, the major C. elegans fat storage tissue, and is transcriptionally upregulated in animals with high fat storage. A genetic screen for synergistic increase in fat storage of a kat-1 mutant identified bbs-1. bbs-1 acts in 15 ciliated neurons that are poised to sense external and internal nutrient levels, supporting a model in which bbs-1 and tub-1 in ciliated neurons form part of an ancient, conserved neuroendocrine axis. This pathway also includes genes encoding intraflagellar transport proteins and cyclic nucleotide gated channels, demonstrating that C. elegans fat storage is under polygenic control.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Axys Pharmaceut, San Francisco, CA 94080 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu		Mak, Ho Yi/0000-0002-1500-5328	NIDDK NIH HHS [R01 DK070147] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070147] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Fujiwara M, 1999, DEVELOPMENT, V126, P4839; Haycraft CJ, 2001, DEVELOPMENT, V128, P1493; Ikeda A, 2002, J CELL SCI, V115, P9; Katsanis N, 2001, HUM MOL GENET, V10, P2293, DOI 10.1093/hmg/10.20.2293; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Mathieu M, 1997, J MOL BIOL, V273, P714, DOI 10.1006/jmbi.1997.1331; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; Perens EA, 2005, DEV CELL, V8, P893, DOI 10.1016/j.devcel.2005.03.009; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Qin HM, 2001, CURR BIOL, V11, P457, DOI 10.1016/S0960-9822(01)00122-1; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Sahly I, 1998, HUM MOL GENET, V7, P1437, DOI 10.1093/hmg/7.9.1437; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Stubdal H, 2000, MOL CELL BIOL, V20, P878, DOI 10.1128/MCB.20.3.878-882.2000; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878	30	146	158	3	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					363	368		10.1038/ng1739	http://dx.doi.org/10.1038/ng1739			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16462744				2022-12-27	WOS:000235589600020
J	Murdoch, S; Djuric, U; Mazhar, B; Seoud, M; Khan, R; Kuick, R; Bagga, R; Kircheisen, R; Ao, A; Ratti, B; Hanash, S; Rouleau, GA; Slim, R				Murdoch, S; Djuric, U; Mazhar, B; Seoud, M; Khan, R; Kuick, R; Bagga, R; Kircheisen, R; Ao, A; Ratti, B; Hanash, S; Rouleau, GA; Slim, R			Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans	NATURE GENETICS			English	Article							NITRIC-OXIDE; MICE; PREGNANCY; PROTEIN; LOCUS	Hydatidiform mole (HM) is an abnormal human pregnancy with no embryo and cystic degeneration of placental villi. We report five mutations in the maternal gene NALP7 in individuals with familial and recurrent HMs. NALP7 is a member of the CATERPILLER protein family involved in inflammation and apoptosis. NALP7 is the first maternal effect gene identified in humans and is also responsible for recurrent spontaneous abortions, stillbirths and intrauterine growth retardation.	McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ H3G 1A4, Canada; McGill Univ, Ctr Hlth, Dept Obstet & Gynecol, Montreal, PQ H3G 1A4, Canada; Pakistan Inst Med Sci, Dept Obstet & Gynecol, Maternal & Child Hlth Ctr Unit 11, Islamabad, Pakistan; Amer Univ Beirut, Dept Obstet & Gynecol, Beirut, Lebanon; Univ Michigan, Dept Pediat & Commun Dis, Ann Arbor, MI 48109 USA; Postgrad Inst Med Educ & Res, Dept Obstet & Gynecol, Chandigarh 160012, India; Inst Klin Genet, D-55131 Mainz, Germany; Notre Dame Hosp, Ctr Study Brain Dis, Montreal, PQ H2L 4M1, Canada	McGill University; McGill University; Pakistan Institute of Medical Sciences; American University of Beirut; University of Michigan System; University of Michigan; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Universite de Montreal	Slim, R (corresponding author), McGill Univ, Ctr Hlth, Dept Human Genet, Montreal, PQ H3G 1A4, Canada.	rima.slim@muhc.mcgill.ca	ao, asangla/Q-5454-2019; Slim, Rima/J-4104-2019; Bagga, Rashmi/Y-1680-2019	Slim, Rima/0000-0002-4060-2159; Bagga, Rashmi/0000-0003-2693-2343; Djuric, Ugljesa/0000-0003-0027-3079				Agarwal P, 2004, ACTA OBSTET GYN SCAN, V83, P213, DOI 10.1111/j.0001-6349.2004.077b.x; Chiu PM, 2001, HISTOPATHOLOGY, V38, P243, DOI 10.1046/j.1365-2559.2001.01065.x; Deb Kaushik, 2004, Archives of Gynecology and Obstetrics, V270, P133, DOI 10.1007/s00404-004-0623-0; Harma M, 2004, EUR J GYNAECOL ONCOL, V25, P333; Hodges MD, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e95; Karmakar S, 2002, AM J REPROD IMMUNOL, V48, P210, DOI 10.1034/j.1600-0897.2002.01151.x; Kinoshita T, 2005, J BIOL CHEM, V280, P21720, DOI 10.1074/jbc.M410057200; Mazhar S, 1995, J PAKISTAN I MED SCI, V6, P383; Moglabey YB, 1999, HUM MOL GENET, V8, P667, DOI 10.1093/hmg/8.4.667; Ogando DG, 2003, REPRODUCTION, V125, P95, DOI 10.1530/rep.0.1250095; Okada K, 2004, CANCER SCI, V95, P949, DOI 10.1111/j.1349-7006.2004.tb03182.x; Savion S, 2002, AM J REPROD IMMUNOL, V47, P118, DOI 10.1034/j.1600-0897.2002.1o027.x; Strakova Z, 2002, J REPROD IMMUNOL, V55, P35, DOI 10.1016/S0165-0378(01)00141-3; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019	15	325	352	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					300	302		10.1038/ng1740	http://dx.doi.org/10.1038/ng1740			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16462743				2022-12-27	WOS:000235589600010
J	Vang, T; Congia, M; Macis, MD; Musumeci, L; Orru, V; Zavattari, P; Nika, K; Tautz, L; Tasken, K; Cucca, F; Mustelin, T; Bottini, N				Vang, T; Congia, M; Macis, MD; Musumeci, L; Orru, V; Zavattari, P; Nika, K; Tautz, L; Tasken, K; Cucca, F; Mustelin, T; Bottini, N			Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; T-CELLS; GENE; PTPN22; ARTHRITIS; MUTATION; DISEASE; MICE; PEP	A SNP in the gene PTPN22 is associated with type 1 diabetes, rheumatoid arthritis, lupus, Graves thyroiditis, Addison disease and other autoimmune disorders. T cells from carriers of the predisposing allele produce less interleukin-2 upon TCR stimulation, and the encoded phosphatase has higher catalytic activity and is a more potent negative regulator of T lymphocyte activation. We conclude that the autoimmune-predisposing allele is a gain-of-function mutant.	Burnham Inst, Program Inflammatory Dis Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; Univ Sassari, Dipartimento Sci Biomed, Cattedra Genet Med, I-07100 Sassari, Italy; Univ Cagliari, Osped Microcitemico, Dipartimento Sci Biomed & Biotecnol, I-09121 Cagliari, Italy; Univ So Calif, Keck Sch Med, Dept Orthopaed Surg, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90033 USA; Univ Oslo, Ctr Biotechnol, N-0317 Oslo, Norway	Sanford Burnham Prebys Medical Discovery Institute; University of Sassari; University of Cagliari; University of Southern California; University of Southern California; University of Oslo	Bottini, N (corresponding author), Burnham Inst, Program Inflammatory Dis Res, Infect & Inflammatory Dis Ctr, 10901 N torrey Pines Rd, La Jolla, CA 92037 USA.	nunzio@usc.edu	Valeria, Orru/AAY-3805-2020; Congia, Mauro/AAC-2718-2019; Tautz, Lutz/M-9989-2014; Ingegnoli, Francesca/B-6226-2017	Tautz, Lutz/0000-0002-4075-6238; CUCCA, Francesco/0000-0002-7414-1995; Nika, Konstantina/0000-0002-9620-0263; Ingegnoli, Francesca/0000-0002-6727-1273; Orru, Valeria/0000-0002-6047-4625; Tasken, Kjetil/0000-0003-2841-4697; Congia, Mauro/0000-0003-1688-304X; Mustelin, Tomas/0000-0001-5912-8840	Telethon [GJT030477] Funding Source: Medline	Telethon(Fondazione Telethon)		Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Gottlieb PA, 2002, MOL PATHOLOGY AUTOIM, P588; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Ladner MB, 2005, HUM IMMUNOL, V66, P60, DOI 10.1016/j.humimm.2004.09.016; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Salojin KV, 1998, IMMUNOL TODAY, V19, P468, DOI 10.1016/S0167-5699(98)01326-7; Siminovitch KA, 2004, NAT GENET, V36, P1248, DOI 10.1038/ng1204-1248; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Vang T, 2004, EUR J IMMUNOL, V34, P2191, DOI 10.1002/eji.200425036	15	540	554	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2005	37	12					1317	1319		10.1038/ng1673	http://dx.doi.org/10.1038/ng1673			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16273109				2022-12-27	WOS:000233657300009
J	Frey, BJ; Mohammad, N; Morris, QD; Zhang, W; Robinson, MD; Mnaimneh, S; Chang, R; Pan, Q; Sat, E; Rossant, J; Bruneau, BG; Aubin, JE; Blencowe, BJ; Hughes, TR				Frey, BJ; Mohammad, N; Morris, QD; Zhang, W; Robinson, MD; Mnaimneh, S; Chang, R; Pan, Q; Sat, E; Rossant, J; Bruneau, BG; Aubin, JE; Blencowe, BJ; Hughes, TR			Genome-wide analysis of mouse transcripts using exon microarrays and factor graphs	NATURE GENETICS			English	Article							EXPRESSION; ANNOTATION; SEQUENCE	Recent mammalian microarray experiments detected widespread transcription and indicated that there may be many undiscovered multiple- exon protein- coding genes. To explore this possibility, we labeled cDNA from unamplified, polyadenylation- selected RNA samples from 37 mouse tissues to microarrays encompassing 1.14 million exon probes. We analyzed these data using GenRate, a Bayesian algorithm that uses a genome- wide scoring function in a factor graph to infer genes. At a stringent exon false detection rate of 2.7%, GenRate detected 12,145 gene- length transcripts and confirmed 81% of the 10,000 most highly expressed known genes. Notably, our analysis showed that most of the 155,839 exons detected by GenRate were associated with known genes, providing microarray- based evidence that most multiple- exon genes have already been identified. GenRate also detected tens of thousands of potential new exons and reconciled discrepancies in current cDNA databases by ` stitching' new transcribed regions into previously annotated genes.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Toronto, ON M5S 3G4, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Hughes, TR (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.	frey@psi.toronto.edu; t.hughes@utoronto.ca	Robinson, Mark D./O-2254-2019; Robinson, Mark D/A-6432-2015; Morris, Quaid/ABE-8343-2020	Robinson, Mark D./0000-0002-3048-5518; Robinson, Mark D/0000-0002-3048-5518; Morris, Quaid/0000-0002-2760-6999; Bruneau, Benoit/0000-0002-0804-7597; Aubin, Jane E./0000-0002-7268-5235				Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Garbarino JE, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-18; Hubbard T, 2005, NUCLEIC ACIDS RES, V33, pD447, DOI 10.1093/nar/gki138; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Krogh A, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P179; Kschischang FR, 2001, IEEE T INFORM THEORY, V47, P498, DOI 10.1109/18.910572; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pontius J., 2003, NCBI HDB, P1; Pruitt KD, 2003, NUCLEIC ACIDS RES, V31, P34, DOI 10.1093/nar/gkg111; Rinn JL, 2003, GENE DEV, V17, P529, DOI 10.1101/gad.1055203; Schadt EE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r73; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Wang J, 2004, NATURE, V431, DOI 10.1038/nature03016; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wong GKS, 2001, GENOME RES, V11, P1975, DOI 10.1101/gr.202401; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Xu Y, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P344; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	25	34	36	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					991	996		10.1038/ng1630	http://dx.doi.org/10.1038/ng1630			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16127451				2022-12-27	WOS:000231591900026
J	Raefski, AS; O'Neill, MJ				Raefski, AS; O'Neill, MJ			Identification of a cluster of X-linked imprinted genes in mice	NATURE GENETICS			English	Article							TURNERS-SYNDROME; CHROMOSOME; MOUSE; ORIGIN; INACTIVATION; EXPRESSION; DISORDER; AUTISM	Complete or partial monosomy with respect to the X chromosome is the genetic basis of Turner syndrome in human females. Individuals with Turner syndrome have a spectrum of anatomical, physiological and behavioral phenotypes with expressivity dependent on the extent of monosomy and the parental origin of the single X-1. Parent- of- origin influences on social cognition in Turner syndrome might be due to the presence of imprinted genes on the X-2. Imprinting of X-linked genes has also been implicated in the male prevalence of autistic spectrum disorders(3), in male sexual orientation(4,5) and in the developmental delay of XO mouse embryos(6-8). The only molecular evidence for X-chromosome imprinting, however, concerns X-chromosome inactivation in specific circumstances(9,10) and does not account for these phenotypes. Using a mouse model for Turner syndrome, we searched for locus-specific imprinting of X-linked genes in developing brain. We identified a cluster of X-linked genes containing at least three genes that show transcriptional repression of paternal alleles. Imprinting of these three genes, Xlr3b, Xlr4b and Xlr4c, is independent of X-chromosome inactivation and has a dynamic and complex pattern of tissue and stage specificity.	Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA	University of Connecticut	O'Neill, MJ (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, 354 Mansfield Rd,U-2131, Storrs, CT 06269 USA.	moneill@uconnvm.uconn.edu						ALLENET B, 1995, MAMM GENOME, V6, P640, DOI 10.1007/BF00352372; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; BERGSAGEL PL, 1994, GENE, V150, P345, DOI 10.1016/0378-1119(94)90450-2; Bocklandt S, 2003, J Endocrinol Invest, V26, P8; BURGOYNE PS, 1983, J REPROD FERTIL, V68, P387, DOI 10.1530/jrf.0.0680387; Burgoyne PS, 2000, CYTOGENET CELL GENET, V91, P57, DOI 10.1159/000056819; COHEN DI, 1985, NATURE, V314, P369, DOI 10.1038/314369a0; Escalier D, 2002, BIOL REPROD, V67, P1646, DOI 10.1095/biolreprod.102.006973; EVANS EP, 1975, NATURE, V256, P40, DOI 10.1038/256040a0; GARCHON HJ, 1989, J CELL BIOL, V108, P779, DOI 10.1083/jcb.108.3.779; Green R, 2000, J THEOR BIOL, V202, P55, DOI 10.1006/jtbi.1999.1039; Jamieson RV, 1998, DEV BIOL, V201, P13, DOI 10.1006/dbio.1998.8972; Lee JT, 2000, CELL, V103, P17, DOI 10.1016/S0092-8674(00)00101-X; Li YH, 1998, NAT GENET, V20, P309, DOI 10.1038/3129; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ranke MB, 2001, LANCET, V358, P309, DOI 10.1016/S0140-6736(01)05487-3; SHARMAN GB, 1971, NATURE, V230, P231, DOI 10.1038/230231a0; Skuse DH, 2000, PEDIATR RES, V47, P9, DOI 10.1203/00006450-200001000-00006; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; THORNHILL AR, 1993, DEVELOPMENT, V118, P171; Wakefield MJ, 1997, P NATL ACAD SCI USA, V94, P9665, DOI 10.1073/pnas.94.18.9665	23	107	110	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					620	624		10.1038/ng1567	http://dx.doi.org/10.1038/ng1567			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15908953				2022-12-27	WOS:000229495300016
J	Bahcall, O				Bahcall, O			Copy number and HIV/AIDS	NATURE GENETICS			English	News Item														Bahcall, Orli/0000-0002-2891-1637					0	0	0	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2005	37	2					124	124						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	15702498				2022-12-27	WOS:000226690100016
J	Bradshaw, PS; Stavropoulos, DJ; Meyn, MS				Bradshaw, PS; Stavropoulos, DJ; Meyn, MS			Human telomeric protein TRF2 associates with genomic double-strand breaks as an early response to DNA damage	NATURE GENETICS			English	Article							ATM; END; BINDING	DNA damage surveillance networks in human cells can activate DNA repair, cell cycle checkpoints and apoptosis in response to fewer than four double-strand breaks (DSBs) per genome(1,2). These same networks tolerate telomeres, in part because the protein TRF2 prevents recognition of telomeric ends as DSBs 3 by facilitating their organization into T loops(4-6). We now show that TRF2 associates with photo-induced DSBs in nontelomeric DNA in human fibroblasts within 2 s of irradiation. Unlike gammaH2AX, a common marker for DSB damage, TRF2 forms transient foci that colocalize closely with DSBs. The TRF2 DSB response requires the TRF2 basic domain but not its Myb domain and occurs in the absence of functional ATM and DNA-PK protein kinases, MRE11/Rad50/NBS1 complex and Ku70, WRN and BLM repair proteins. Furthermore, overexpression of TRF2 inhibits DSB-induced phosphorylation of ATM signaling targets. Our results implicate TRF2 in an initial stage of DSB recognition and processing that occurs before association of ATM with DSBs and activation of the ATM-dependent DSB response network.	Hosp Sick Children, Res Inst, Program Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Paediat, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Meyn, MS (corresponding author), Hosp Sick Children, Res Inst, Program Genet & Genom Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	meyn@sickkids.ca						Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bouffler SD, 1998, MUTAT RES-FUND MOL M, V404, P199, DOI 10.1016/S0027-5107(98)00114-6; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Doherty AJ, 2001, CURR BIOL, V11, pR920, DOI 10.1016/S0960-9822(01)00555-3; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Karlseder J, 2004, PLOS BIOL, V2, P1150, DOI 10.1371/journal.pbio.0020240; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim JS, 2002, J BIOL CHEM, V277, P45149, DOI 10.1074/jbc.M209123200; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; MEYN MS, 1995, CANCER RES, V55, P5991; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Ouellette MM, 2000, HUM MOL GENET, V9, P403, DOI 10.1093/hmg/9.3.403; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Song K, 2000, FEBS LETT, V481, P81, DOI 10.1016/S0014-5793(00)01958-X; Stansel RM, 2001, EMBO J, V20, P5532; Stavropoulos DJ, 2002, HUM MOL GENET, V11, P3135, DOI 10.1093/hmg/11.25.3135; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Yoshimura SH, 2004, GENES CELLS, V9, P205, DOI 10.1111/j.1356-9597.2004.00719.x; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	27	185	196	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					193	197		10.1038/ng1506	http://dx.doi.org/10.1038/ng1506			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	15665826				2022-12-27	WOS:000226690100028
J	Bastepe, M; Frohlich, LF; Linglart, A; Abu-Zahra, HS; Tojo, K; Ward, LM; Juppner, H				Bastepe, M; Frohlich, LF; Linglart, A; Abu-Zahra, HS; Tojo, K; Ward, LM; Juppner, H			Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib	NATURE GENETICS			English	Article							G-PROTEINS; LOCUS; GENE; IDENTIFICATION; TRANSCRIPT; ANTISENSE; ELEMENT; CLUSTER; DEFECT; MARK	Epigenetic defects in the imprinted GNAS cluster are associated with pseudohypoparathyroidism type Ib. In two kindreds with this disorder, we now report deletions that remove the differentially methylated region encompassing exon NESP55 and exons 3 and 4 of the antisense transcript. When inherited from a female, either deletion abolishes all maternal GNAS imprints and derepresses maternally silenced transcripts, suggesting that the deleted region contains a cis-acting element that controls imprinting of the maternal GNAS allele.	Massachusetts Gen Hosp, Dept Med, Endocrine Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Jikei Univ, Sch Med, Dept Internal Med, Div Diabet & Endocrinol, Tokyo, Japan; Childrens Hosp Eastern Ontario, Div Endocrinol & Metab, Ottawa, ON, Canada; Massachusetts Gen Hosp, Massgen Hosp Children, Pediat Nephrol Unit, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Jikei University; University of Ottawa; Children's Hospital of Eastern Ontario; Harvard University; Massachusetts General Hospital	Bastepe, M (corresponding author), Massachusetts Gen Hosp, Dept Med, Endocrine Unit, Boston, MA 02114 USA.	bastepe@helix.mgh.harvard.edu; jueppner@helix.mgh.harvard.edu	Linglart, Agnès/A-8047-2016; Ward, Leanne Marie/AAF-8482-2020; Bastepe, Murat/GQQ-3389-2022	Linglart, Agnès/0000-0003-3455-002X; Ward, Leanne Marie/0000-0003-1557-9185; Bastepe, Murat/0000-0002-2643-3504				Bastepe M, 2003, J CLIN INVEST, V112, P1255, DOI 10.1172/JCI200319159; Bastepe M, 2001, HUM MOL GENET, V10, P1231, DOI 10.1093/hmg/10.12.1231; Bastepe M, 2001, AM J HUM GENET, V68, P1283, DOI 10.1086/320117; Coombes C, 2003, MOL CELL BIOL, V23, P5475, DOI 10.1128/MCB.23.16.5475-5488.2003; Hayward BE, 2000, HUM MOL GENET, V9, P835, DOI 10.1093/hmg/9.5.835; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P10038, DOI 10.1073/pnas.95.17.10038; Liu J, 2000, MOL CELL BIOL, V20, P5808, DOI 10.1128/MCB.20.16.5808-5817.2000; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; Peters J, 1999, P NATL ACAD SCI USA, V96, P3830, DOI 10.1073/pnas.96.7.3830; Plagge A, 2004, NAT GENET, V36, P818, DOI 10.1038/ng1397; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Williamson CM, 2004, NAT GENET, V36, P894, DOI 10.1038/ng1398; Wroe SF, 2000, P NATL ACAD SCI USA, V97, P3342, DOI 10.1073/pnas.050015397; Yu SH, 1998, P NATL ACAD SCI USA, V95, P8715, DOI 10.1073/pnas.95.15.8715	15	185	194	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2005	37	1					25	27		10.1038/ng1487	http://dx.doi.org/10.1038/ng1487			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15592469				2022-12-27	WOS:000225997500016
J	Huusko, P; Ponciano-Jackson, D; Wolf, M; Kiefer, JA; Azorsa, DO; Tuzmen, S; Weaver, D; Robbins, C; Moses, T; Allinen, M; Hautaniemi, S; Chen, YD; Elkahloun, A; Basik, M; Bova, GS; Bubendorf, L; Lugli, A; Sauter, G; Schleutker, J; Ozcelik, H; Elowe, S; Pawson, T; Trent, JM; Carpten, JD; Kallioniemi, OP; Mousses, S				Huusko, P; Ponciano-Jackson, D; Wolf, M; Kiefer, JA; Azorsa, DO; Tuzmen, S; Weaver, D; Robbins, C; Moses, T; Allinen, M; Hautaniemi, S; Chen, YD; Elkahloun, A; Basik, M; Bova, GS; Bubendorf, L; Lugli, A; Sauter, G; Schleutker, J; Ozcelik, H; Elowe, S; Pawson, T; Trent, JM; Carpten, JD; Kallioniemi, OP; Mousses, S			Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer	NATURE GENETICS			English	Article							GENE-EXPRESSION PATTERNS; COPY-NUMBER; RECEPTORS; EPHRIN-B2	The identification of tumor-suppressor genes in solid tumors by classical cancer genetics methods is difficult and slow. We combined nonsense-mediated RNA decay microarrays(1) and array-based comparative genomic hybridization(2,3) for the genome-wide identification of genes with biallelic inactivation involving nonsense mutations and loss of the wild-type allele. This approach enabled us to identify previously unknown mutations in the receptor tyrosine kinase gene EPHB2. The DU 145 prostate cancer cell line, originating from a brain metastasis, carries a truncating mutation of EPHB2 and a deletion of the remaining allele. Additional frameshift, splice site, missense and nonsense mutations are present in clinical prostate cancer samples. Transfection of DU 145 cells, which lack functional EphB2, with wild-type EPHB2 suppresses clonogenic growth. Taken together with studies indicating that EphB2 may have an essential role in cell migration and maintenance of normal tissue architecture, our findings suggest that mutational inactivation of EPHB2 may be important in the progression and metastasis of prostate cancer.	Translat Genom Res Inst, Genet Basis Human Dis Res Div, Phoenix, AZ 85004 USA; Univ Turku, Turku 20521, Finland; VTT Tech Res Ctr Finland, Turku 20521, Finland; NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; Tampere Univ Technol, Inst Signal Proc, FIN-33101 Tampere, Finland; Jewish Gen Hosp, Dept Oncol, Montreal, PQ H3T 1E2, Canada; Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA; Univ Basel, Inst Pathol, CH-4003 Basel, Switzerland; Univ Tampere, Inst Med Technol, Canc Genet Lab, Tampere 33520, Finland; Tampere Univ Hosp, Tampere 33520, Finland; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Translational Genomics Research Institute; University of Turku; VTT Technical Research Center Finland; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Tampere University; McGill University; Johns Hopkins University; Johns Hopkins University; University of Basel; Tampere University; Tampere University; Tampere University Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Kallioniemi, OP (corresponding author), Translat Genom Res Inst, Canc Durg Dev Lab, 20 Firstfield Rd,Suite 110, Gaithersburg, MD 20878 USA.	smousses@tgen.org; olli.kallioniemi@vtt.fi	Pawson, Tony J/E-4578-2013; Ozcelik, Hilmi/A-3952-2011; Kallioniemi, Olli P/H-5111-2011; Thomson, Axel/A-7893-2013; Tüzmen, Şükrü/AAH-9916-2021; Jeff/ABB-2636-2021; Bubendorfl, Lukas/H-5880-2011; Hautaniemi, Sampsa/CAG-0362-2022; Tuzmen, Sukru/I-5663-2013; Bubendorf, Lukas/G-5299-2015; Hautaniemi, Sampsa/A-3122-2009	Kallioniemi, Olli P/0000-0002-3231-0332; Tüzmen, Şükrü/0000-0003-4822-396X; Jeff/0000-0002-1238-3120; Hautaniemi, Sampsa/0000-0002-7749-2694; Tuzmen, Sukru/0000-0003-4822-396X; Bubendorf, Lukas/0000-0001-5970-1803; Hautaniemi, Sampsa/0000-0002-7749-2694; Bova, George/0000-0003-1639-3104; Schleutker, Johanna/0000-0002-1863-0305				Barrios A, 2003, CURR BIOL, V13, P1571, DOI 10.1016/j.cub.2003.08.030; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Chen Y, 1997, J Biomed Opt, V2, P364, DOI 10.1117/12.281504; Chen YD, 2002, BIOINFORMATICS, V18, P1207, DOI 10.1093/bioinformatics/18.9.1207; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; DeRisi J, 1996, NAT GENET, V14, P457; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Gale NW, 2001, DEV BIOL, V230, P151, DOI 10.1006/dbio.2000.0112; Gibbs M, 1999, AM J HUM GENET, V64, P776, DOI 10.1086/302287; Hyman E, 2002, CANCER RES, V62, P6240; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; KNUDSON AG, 1985, CANCER RES, V45, P1437; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; Mellitzer G, 2000, CURR OPIN NEUROBIOL, V10, P400, DOI 10.1016/S0959-4388(00)00095-7; Monni O, 2001, P NATL ACAD SCI USA, V98, P5711, DOI 10.1073/pnas.091582298; Mousses S, 2000, PRACT APPROACH SER, P113; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515	21	152	176	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					979	983		10.1038/ng1408	http://dx.doi.org/10.1038/ng1408			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15300251	Green Published, Bronze			2022-12-27	WOS:000223658100024
J	Lalioti, MD; Zhang, JH; Volkman, HM; Kahle, KT; Hoffmann, KE; Toka, HR; Nelson-Williams, C; Ellison, DH; Flavell, R; Booth, CJ; Lu, Y; Geller, DS; Lifton, RP				Lalioti, Maria D.; Zhang, Junhui; Volkman, Heather M.; Kahle, Kristopher T.; Hoffmann, Kristin E.; Toka, Hakan R.; Nelson-Williams, Carol; Ellison, David H.; Flavell, Richard; Booth, Carmen J.; Lu, Yin; Geller, David S.; Lifton, Richard P.			Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule	NATURE GENETICS			English	Article							NA-CL COTRANSPORTER; TRANSPORT PATHWAYS; CALCIUM-METABOLISM; HUMAN HYPERTENSION; MUTANT WNK4; HYPERKALEMIA; SODIUM; MICE; REABSORPTION; MUTATIONS	The mechanisms that govern homeostasis of complex systems have been elusive but can be illuminated by mutations that disrupt system behavior. Mutations in the gene encoding the kinase WNK4 cause pseudohypoaldosteronism type II (PHAII), a syndrome featuring hypertension and hyperkalemia. We show that physiology in mice transgenic for genomic segments harboring wild-type (TgWnk4(WT)) or PHAII mutant (TgWnk4(PHAII)) Wnk4 is changed in opposite directions: TgWnk4(PHAII) mice have higher blood pressure, hyperkalemia, hypercalciuria and marked hyperplasia of the distal convoluted tubule (DCT), whereas the opposite is true in TgWnk4(WT) mice. Genetic deficiency for the Na-Cl cotransporter of the DCT (NCC) reverses phenotypes seen in TgWnk4PHAII mice, demonstrating that the effects of the PHAII mutation are due to altered NCC activity. These findings establish that Wnk4 is a molecular switch that regulates the balance between NaCl reabsorption and K+ secretion by altering the mass and function of the DCT through its effect on NCC.	Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Med, Nephrol Sect, New Haven, CT 06520 USA; Oregon Hlth Sci Univ, Div Nephrol & Hypertens, Portland, OR 97239 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University; Oregon Health & Science University; Howard Hughes Medical Institute; Yale University; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06520 USA.	richard.lifton@yale.edu	, David/X-5730-2019; Toka, Hakan/AAQ-2162-2021	Ellison, David/0000-0003-2915-265X				Brooks HL, 2002, HYPERTENSION, V39, P470, DOI 10.1161/hy02t2.102959; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; Chrast R, 1999, TRANSGENIC RES, V8, P147, DOI 10.1023/A:1008858014473; GORDON RD, 1986, AUST NZ J MED, V16, P183, DOI 10.1111/j.1445-5994.1986.tb01145.x; Hansen PB, 2004, ACTA PHYSIOL SCAND, V181, P431, DOI 10.1111/j.1365-201X.2004.01315.x; Kahle KT, 2005, TRENDS ENDOCRIN MET, V16, P98, DOI 10.1016/j.tem.2005.02.012; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P14877, DOI 10.1073/pnas.0406172101; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; KAISSLING B, 1985, AM J PHYSIOL, V248, P374; Kim GH, 1998, P NATL ACAD SCI USA, V95, P14552, DOI 10.1073/pnas.95.24.14552; Lalioti MD, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e14; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; LIND L, 1993, J HUM HYPERTENS, V7, P53; Loffing J, 2004, J AM SOC NEPHROL, V15, P2276, DOI 10.1097/01.ASN.0000138234.18569.63; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; Mayan H, 2004, J CLIN ENDOCR METAB, V89, P4025, DOI 10.1210/jc.2004-0037; MUJAIS SK, 1986, J CLIN INVEST, V77, P315, DOI 10.1172/JCI112293; Nijenhuis T, 2005, J CLIN INVEST, V115, P1651, DOI 10.1172/JCI24134; PAVER WK, 1964, MED J AUSTRALIA, V35, P305; Reilly RF, 2000, PHYSIOL REV, V80, P277, DOI 10.1152/physrev.2000.80.1.277; Rubera I, 2003, J CLIN INVEST, V112, P554, DOI 10.1172/JCI200316956; SCHAMBELAN M, 1981, KIDNEY INT, V19, P716, DOI 10.1038/ki.1981.72; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Wang T, 1996, AM J PHYSIOL-RENAL, V271, pF143, DOI 10.1152/ajprenal.1996.271.1.F143; Weinstein AM, 2005, AM J PHYSIOL-RENAL, V289, pF699, DOI 10.1152/ajprenal.00043.2005; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; YAMAKAWA H, 1992, HYPERTENSION, V19, P528, DOI 10.1161/01.HYP.19.6.528; Yamauchi K, 2004, P NATL ACAD SCI USA, V101, P4690, DOI 10.1073/pnas.0306924101; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443	33	286	290	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2006	38	10					1124	1132		10.1038/ng1877	http://dx.doi.org/10.1038/ng1877			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16964266				2022-12-27	WOS:000241251100011
J	Maller, J; George, S; Purcell, S; Fagerness, J; Altshuler, D; Daly, MJ; Seddon, JM				Maller, Julian; George, Sarah; Purcell, Shaun; Fagerness, Jes; Altshuler, David; Daly, Mark J.; Seddon, Johanna M.			Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration	NATURE GENETICS			English	Article							COMPLEMENT FACTOR-H; BODY-MASS INDEX; FAMILIAL AGGREGATION; EXTENDED FAMILIES; GENOMEWIDE-SCAN; MACULOPATHY; ASSOCIATION; SUSCEPTIBILITY; HAPLOTYPE; POLYMORPHISM	Age-related macular degeneration (AMD) is a common, late-onset disease with seemingly typical complexity: recurrence ratios for siblings of an affected individual are three- to sixfold higher than in the general population, and family-based analysis has resulted in only modestly significant evidence for linkage. In a case-control study drawn from a US-based population of European descent, we have identified a previously unrecognized common, noncoding variant in CFH, the gene encoding complement factor H, that substantially increases the influence of this locus on AMD, and we have strongly replicated the associations of four other previously reported common alleles in three genes ( P values ranging from 10(-6) to 10(-70)). Despite excellent power to detect epistasis, we observed purely additive accumulation of risk from alleles at these genes. We found no differences in association of these loci with major phenotypic categories of advanced AMD. Genotypes at these five common SNPs define a broad spectrum of interindividual disease risk and explain about half of the classical sibling risk of AMD in our study population.	Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Epidemiol Unit, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Seddon, JM (corresponding author), Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Epidemiol Unit, 243 Charles St, Boston, MA 02114 USA.	mjdaly@chgr.mgh.harvard.edu; johanna_seddon@meei.harvard.edu	Altshuler, David M/A-4476-2009; maller, julian B/A-9323-2009; Daly, Mark J/B-2453-2017	Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; Maller, Julian/0000-0002-1565-9559	NCRR NIH HHS [U54 RR020278] Funding Source: Medline; NEI NIH HHS [EY11309] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Cordell HJ, 2006, GENET EPIDEMIOL, V30, P259, DOI 10.1002/gepi.20142; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HEIBA IM, 1994, GENET EPIDEMIOL, V11, P51, DOI 10.1002/gepi.1370110106; Iyengar SK, 2004, AM J HUM GENET, V74, P20, DOI 10.1086/380912; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Seddon JM, 2006, OPHTHALMOLOGY, V113, P260, DOI 10.1016/j.ophtha.2005.11.001; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1728, DOI 10.1001/archopht.121.12.1728; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P785, DOI 10.1001/archopht.121.6.785; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; Sham PC, 2004, BEHAV GENET, V34, P207, DOI 10.1023/B:BEGE.0000013734.39266.a3; Snow KK, 2002, AM J OPHTHALMOL, V134, P842, DOI 10.1016/S0002-9394(02)01755-5; Weeks DE, 2001, AM J OPHTHALMOL, V132, P682, DOI 10.1016/S0002-9394(01)01214-4	28	468	502	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2006	38	9					1055	1059		10.1038/ng1873	http://dx.doi.org/10.1038/ng1873			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16936732				2022-12-27	WOS:000240112100024
J	Schwartz, YB; Kahn, TG; Nix, DA; Li, XY; Bourgon, R; Biggin, M; Pirrotta, V				Schwartz, Yuri B.; Kahn, Tatyana G.; Nix, David A.; Li, Xiao-Yong; Bourgon, Richard; Biggin, Mark; Pirrotta, Vincenzo			Genome-wide analysis of Polycomb targets in Drosophila melanogaster	NATURE GENETICS			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; EMBRYONIC STEM-CELLS; BITHORAX COMPLEX; RESPONSE ELEMENT; BINDING-SITES; GENES; ZESTE; CHROMATIN; PROTEINS; ENHANCER	Polycomb group (PcG) complexes are multiprotein assemblages that bind to chromatin and establish chromatin states leading to epigenetic silencing(1,2). PcG proteins regulate homeotic genes in flies and vertebrates, but little is known about other PcG targets and the role of the PcG in development, differentiation and disease. Here, we determined the distribution of the PcG proteins PC, E(Z) and PSC and of trimethylation of histone H3 Lys27 (me3K27) in the D. melanogaster genome. At more than 200 PcG target genes, binding sites for the three PcG proteins colocalize to presumptive Polycomb response elements (PREs). In contrast, H3 me3K27 forms broad domains including the entire transcription unit and regulatory regions. PcG targets are highly enriched in genes encoding transcription factors, but they also include genes coding for receptors, signaling proteins, morphogens and regulators representing all major developmental pathways.	Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Drosophila Transcript Network Project, Genom Div, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	Rutgers State University New Brunswick; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Pirrotta, V (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, 604 Allison Rd, Piscataway, NJ 08854 USA.	pirrotta@biology.rutgers.edu		Bourgon, Richard/0000-0002-5890-4374	NIGMS NIH HHS [GM704403] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barges S, 2000, DEVELOPMENT, V127, P779; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bloyer S, 2003, DEV BIOL, V261, P426, DOI 10.1016/S0012-1606(03)00314-2; BRUNK BP, 1991, NATURE, V353, P351, DOI 10.1038/353351a0; Busturia A, 1997, DEVELOPMENT, V124, P4343; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; CHIANG A, 1995, DEVELOPMENT, V121, P1681; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Jagla K, 2001, BIOESSAYS, V23, P125, DOI 10.1002/1521-1878(200102)23:2<125::AID-BIES1019>3.3.CO;2-3; JONES RS, 1990, GENETICS, V126, P185; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Mihaly J, 1997, DEVELOPMENT, V124, P1809; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; PHILLIPS MD, 1990, GENETICS, V125, P91; Pirrotta V, 1997, CURR OPIN GENET DEV, V7, P249, DOI 10.1016/S0959-437X(97)80135-9; RASTELLI L, 1993, EMBO J, V12, P1513, DOI 10.1002/j.1460-2075.1993.tb05795.x; Reim I, 2003, DEVELOPMENT, V130, P3187, DOI 10.1242/dev.00548; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Saurin AJ, 2001, NATURE, V412, P655, DOI 10.1038/35088096; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Sengupta AK, 2004, DEVELOPMENT, V131, P1959, DOI 10.1242/dev.01084; Shimell MJ, 2000, DEV BIOL, V218, P38, DOI 10.1006/dbio.1999.9576; Strutt H, 1997, MOL CELL BIOL, V17, P6773, DOI 10.1128/MCB.17.12.6773	30	464	490	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2006	38	6					700	705		10.1038/ng1817	http://dx.doi.org/10.1038/ng1817			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16732288	Green Submitted			2022-12-27	WOS:000237954800026
J	Bitoun, M; Maugenre, S; Jeannet, PY; Lacene, E; Ferrer, X; Laforet, P; Martin, JJ; Laporte, J; Lochmuller, H; Beggs, AH; Fardeau, M; Eymard, B; Romero, NB; Guicheney, P				Bitoun, M; Maugenre, S; Jeannet, PY; Lacene, E; Ferrer, X; Laforet, P; Martin, JJ; Laporte, J; Lochmuller, H; Beggs, AH; Fardeau, M; Eymard, B; Romero, NB; Guicheney, P			Mutations in dynamin 2 cause dominant centronuclear myopathy	NATURE GENETICS			English	Article							DISEASE	Autosomal dominant centronuclear myopathy is a rare congenital myopathy characterized by delayed motor milestones and muscular weakness. In 11 families affected by centronuclear myopathy, we identified recurrent and de novo missense mutations in the gene dynamin 2 (DNM2, 19p13.2), which encodes a protein involved in endocytosis and membrane trafficking, actin assembly and centrosome cohesion. The transfected mutants showed reduced labeling in the centrosome, suggesting that DNM2 mutations might cause centronuclear myopathy by interfering with centrosome function.	UPMC, Grp Hosp Pitie Salpetriere, IFR14, Inst Myol,INSERM,U582, F-75651 Paris, France; CHU Vaudois, Dept Pediat, Neuropediat Unit, CH-1011 Lausanne, Switzerland; CHU Haut Leveque, Dept Neurol, Bordeaux, France; Born Bunge Inst, Neuropathol Lab, Antwerp, Belgium; Coll France, ULP, INSERM, CNRS,IGBMC,Dept Mol Pathol, Illkirch Graffenstaden, France; Univ Munich, Dept Neurol, Friedrich Baur Inst, D-8000 Munich, Germany; Harvard Univ, Sch Med, Childrens Hosp Boston, Div Genet, Boston, MA USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Munich; Harvard University; Boston Children's Hospital; Harvard Medical School	Guicheney, P (corresponding author), UPMC, Grp Hosp Pitie Salpetriere, IFR14, Inst Myol,INSERM,U582, 47 Blvd Hop, F-75651 Paris, France.	p.guicheney@myologie.chups.jussieu.fr	Laporte, Jocelyn/H-6801-2016; Guicheney, Pascale/D-1034-2017; Bitoun, Marc/M-4720-2017; laporte, jocelyn/J-7008-2012; laporte, jocelyn/O-4888-2019	Guicheney, Pascale/0000-0002-7663-2050; Bitoun, Marc/0000-0002-4188-7918; Beggs, Alan/0000-0001-8818-0568; Lochmuller, Hanns/0000-0003-2324-8001				Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; FARDEAU M, 1994, MYOLOGY, P1500; Jeannet PY, 2004, NEUROLOGY, V62, P1484, DOI 10.1212/01.WNL.0000124388.67003.56; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Reinsch S, 1998, J CELL SCI, V111, P2283; Smirnova E, 1999, J BIOL CHEM, V274, P14942, DOI 10.1074/jbc.274.21.14942; SPIRO AJ, 1966, ARCH NEUROL-CHICAGO, V14, P1, DOI 10.1001/archneur.1966.00470070005001; TASSIN AM, 1985, J CELL BIOL, V100, P35, DOI 10.1083/jcb.100.1.35; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Yoo JY, 2005, BIOCHEM BIOPH RES CO, V328, P424, DOI 10.1016/j.bbrc.2004.12.179; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	15	303	310	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1207	1209		10.1038/ng1657	http://dx.doi.org/10.1038/ng1657			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16227997	Green Submitted			2022-12-27	WOS:000233045200018
J	Silva, JM; Li, MZ; Chang, K; Ge, W; Golding, MC; Rickles, RJ; Siolas, D; Hu, G; Paddison, PJ; Schlabach, MR; Sheth, N; Bradshaw, J; Burchard, J; Kulkarni, A; Cavet, G; Sachidanandam, R; McCombie, WR; Cleary, MA; Elledge, SJ; Hannon, GJ				Silva, JM; Li, MZ; Chang, K; Ge, W; Golding, MC; Rickles, RJ; Siolas, D; Hu, G; Paddison, PJ; Schlabach, MR; Sheth, N; Bradshaw, J; Burchard, J; Kulkarni, A; Cavet, G; Sachidanandam, R; McCombie, WR; Cleary, MA; Elledge, SJ; Hannon, GJ			Second-generation shRNA libraries covering the mouse and human genomes	NATURE GENETICS			English	Article							SHORT HAIRPIN RNAS; MAMMALIAN-CELLS; ESCHERICHIA-COLI; MICROPROCESSOR COMPLEX; CAENORHABDITIS-ELEGANS; INTERFERING RNAS; NUCLEAR EXPORT; MESSENGER-RNAS; POLYMERASE-II; C-ELEGANS	Loss-of-function phenotypes often hold the key to understanding the connections and biological functions of biochemical pathways. We and others previously constructed libraries of short hairpin RNAs that allow systematic analysis of RNA interference-induced phenotypes in mammalian cells. Here we report the construction and validation of second-generation short hairpin RNA expression libraries designed using an increased knowledge of RNA interference biochemistry. These constructs include silencing triggers designed to mimic a natural microRNA primary transcript, and each target sequence was selected on the basis of thermodynamic criteria for optimal small RNA performance. Biochemical and phenotypic assays indicate that the new libraries are substantially improved over first-generation reagents. We generated large-scale-arrayed, sequence-verified libraries comprising more than 140,000 second-generation short hairpin RNA expression plasmids, covering a substantial fraction of all predicted genes in the human and mouse genomes. These libraries are available to the scientific community.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Genet,Ctr Genet & Genom, Boston, MA 02115 USA; Watson Sch Biol Sci, Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Rosetta Inpharmat LLC, Seattle, WA 98109 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Cold Spring Harbor Laboratory; Merck & Company	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Genet,Ctr Genet & Genom, Room 158D,NRB,77 Ave Louis Pasteur, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu; hannon@cshl.edu	Hu, Guang/E-7474-2016; sachidanandam, ravi/Q-6916-2019; Hannon, Gregory/AAB-3568-2019	Hu, Guang/0000-0003-0437-4723; sachidanandam, ravi/0000-0001-9844-4459; GOLDING, MICHAEL/0000-0003-1631-2175; McCombie, W. Richard/0000-0003-1899-0682	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM008444] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; CHALKER AF, 1988, GENE, V71, P201, DOI 10.1016/0378-1119(88)90092-3; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; Dasgupta R, 2004, ONCOGENE, V23, P8359, DOI 10.1038/sj.onc.1208028; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; ELLEDGE SJ, 1985, J BACTERIOL, V162, P777, DOI 10.1128/JB.162.2.777-783.1985; Fraser A, 2004, ONCOGENE, V23, P8346, DOI 10.1038/sj.onc.1208044; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kawasaki H, 2003, NUCLEIC ACIDS RES, V31, P700, DOI 10.1093/nar/gkg158; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li MZ, 2005, NAT GENET, V37, P311, DOI 10.1038/ng1505; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Nakayashiki H, 2005, FUNGAL GENET BIOL, V42, P275, DOI 10.1016/j.fgb.2005.01.002; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Silva J, 2004, ONCOGENE, V23, P8401, DOI 10.1038/sj.onc.1208176; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Tang GL, 2004, TRENDS BIOTECHNOL, V22, P463, DOI 10.1016/j.tibtech.2004.07.009; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zheng LX, 2004, P NATL ACAD SCI USA, V101, P135, DOI 10.1073/pnas.2136685100	46	501	560	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2005	37	11					1281	1288		10.1038/ng1650	http://dx.doi.org/10.1038/ng1650			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16200065				2022-12-27	WOS:000233045200031
J	Itoh, T; Toyoda, A; Taylor, TD; Sakaki, Y; Hattori, M				Itoh, T; Toyoda, A; Taylor, TD; Sakaki, Y; Hattori, M			Identification of large ancient duplications associated with human gene deserts	NATURE GENETICS			English	Article							SEGMENTAL DUPLICATIONS; DNA-SEQUENCE; HUMAN GENOME; EVOLUTION	We identified 15 regions of >1 Mb in the human genome composed of large ancient local duplications corresponding to gene deserts. We detected these intrachromosomal duplications in mouse and dog but not in chicken; they present as patches of similarity as low as 60%. These findings suggest that some human gene deserts originated from duplications of segments lacking genes in a mammalian common ancestor.	Mitsubishi Res Inst Inc, Adv Sci & Technol Res Ctr, Tokyo 1008141, Japan; RIKEN Genom Sci Ctr, Genome Core Technol Facil, Kanagawa 2300045, Japan; RIKEN Genom Sci Ctr, Computat & Expt Syst Biol Grp, Kanagawa 2300045, Japan; Kitasato Univ, Kitasato Inst Life Sci, Kanagawa 2288555, Japan	Mitsubishi Research Institute; RIKEN; RIKEN; Kitasato University	Hattori, M (corresponding author), Mitsubishi Res Inst Inc, Adv Sci & Technol Res Ctr, Tokyo 1008141, Japan.	takehiko@mri.co.jp; hattori@gsc.riken.jp	Hattori, Masahira/C-6958-2016; Itoh, Takehiko/E-8873-2014; Taylor, Todd/A-7121-2009; Hattori, Masahira/AAD-3785-2019	Hattori, Masahira/0000-0001-9467-0344; Itoh, Takehiko/0000-0002-6113-557X; Taylor, Todd/0000-0003-4247-6253; 				Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Grimwood J, 2004, NATURE, V428, P529, DOI 10.1038/nature02399; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hillier LW, 2005, NATURE, V434, P724, DOI 10.1038/nature03466; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Nobrega MA, 2004, NATURE, V431, P988, DOI 10.1038/nature03022; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; Samonte RV, 2002, NAT REV GENET, V3, P65, DOI 10.1038/nrg705; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	14	4	4	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1041	1043		10.1038/ng1648	http://dx.doi.org/10.1038/ng1648			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16186813				2022-12-27	WOS:000232185600013
J	Park, YG; Zhao, XH; Lesueur, F; Lowy, DR; Lancaster, M; Pharoah, P; Qian, XL; Hunter, KW				Park, YG; Zhao, XH; Lesueur, F; Lowy, DR; Lancaster, M; Pharoah, P; Qian, XL; Hunter, KW			Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1	NATURE GENETICS			English	Article							GTPASE-ACTIVATING PROTEIN; GENE-EXPRESSION; BREAST-CANCER; MAMMARY-TUMOR; IMPORTANT DETERMINANT; RAP1 ACTIVATION; SUPPRESSOR GENE; MULTIPLE CROSS; NEW-GENERATION; CELL-ADHESION	We previously identified loci in the mouse genome that substantially influence the metastatic efficiency of mammary tumors. Here, we present data supporting the idea that the signal transduction molecule, Sipa1, is a candidate for underlying the metastasis efficiency modifier locus Mtes1. Analysis of candidate genes identified a nonsynonymous amino acid polymorphism in Sipa1 that affects the Sipa1 Rap-GAP function. Spontaneous metastasis assays using cells ectopically expressing Sipa1 or cells with knocked-down Sipa1 expression showed that metastatic capacity was correlated with cellular Sipa1 levels. We examined human expression data and found that they were consistent with the idea that Sipa1 concentration has a role in metastasis. Taken together, these data suggest that the Sipa1 polymorphism is one of the genetic polymorphisms underlying the Mtes1 locus. This report is also the first demonstration, to our knowledge, of a constitutional genetic polymorphism affecting tumor metastasis.	NCI, Lab Populat Genet, Bethesda, MD 20892 USA; Univ Cambridge, Hutchinson MRC Res Ctr, Dept Oncol, Cambridge CB2 2XZ, England; NCI, Cellular Oncol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hunter, KW (corresponding author), NCI, Lab Populat Genet, Bldg 41,Room 702,41 Lib Dr, Bethesda, MD 20892 USA.	hunterk@mail.nih.gov	Lesueur, Fabienne/R-2178-2017; Pharoah, Paul/V-6658-2019	Lesueur, Fabienne/0000-0001-7404-4549; Pharoah, Paul/0000-0001-8494-732X	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [Z01 CP010146-06] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC008905, Z01CP010146] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bailly S, 1996, MOL IMMUNOL, V33, P999, DOI 10.1016/S0161-5890(96)00042-9; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bois P, 1998, GENOMICS, V50, P317, DOI 10.1006/geno.1998.5329; Day N, 1999, BRIT J CANCER, V80, P95; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Farina A, 2004, MOL CELL BIOL, V24, P9059, DOI 10.1128/MCB.24.20.9059-9069.2004; Gao QS, 1999, MOL CELL BIOL, V19, P733; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gould KA, 1996, GENETICS, V144, P1777; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; HATTORI M, 1995, MOL CELL BIOL, V15, P552, DOI 10.1128/MCB.15.1.552; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Heimann R, 2000, CANCER RES, V60, P298; Hitzemann R, 2003, MAMM GENOME, V14, P733, DOI 10.1007/s00335-003-2277-9; Hitzemann R, 2002, GENES BRAIN BEHAV, V1, P214, DOI 10.1034/j.1601-183X.2002.10403.x; Hogue CWV, 1997, TRENDS BIOCHEM SCI, V22, P314, DOI 10.1016/S0968-0004(97)01093-1; Hunter K, 2003, NAT GENET, V34, P23, DOI 10.1038/ng0503-23b; Hunter KW, 2004, BRIT J CANCER, V90, P752, DOI 10.1038/sj.bjc.6601590; Hunter KW, 2003, CANCER LETT, V200, P97, DOI 10.1016/S0304-3835(03)00420-8; Hunter KW, 2001, CANCER RES, V61, P8866; Ishida D, 2003, CANCER CELL, V4, P55, DOI 10.1016/S1535-6108(03)00163-6; Khanna C, 2005, CARCINOGENESIS, V26, P513, DOI 10.1093/carcin/bgh261; Kurachi H, 1997, J BIOL CHEM, V272, P28081, DOI 10.1074/jbc.272.44.28081; LaTulippe E, 2002, CANCER RES, V62, P4499; Le Voyer T, 2000, MAMM GENOME, V11, P883, DOI 10.1007/s003350010163; Lifsted T, 1998, INT J CANCER, V77, P640, DOI 10.1002/(SICI)1097-0215(19980812)77:4<640::AID-IJC26>3.0.CO;2-8; LIOTTA LA, 1993, PRINCIPLES MOL CELL, P134; Miele ME, 1996, MOL CARCINOGEN, V15, P284, DOI 10.1002/(SICI)1098-2744(199604)15:4<284::AID-MC6>3.0.CO;2-G; Nakamura Y, 1998, J HUM GENET, V43, P149, DOI 10.1007/s100380050059; Noda Y, 2004, FEBS LETT, V568, P139, DOI 10.1016/j.febslet.2004.05.021; Ohba Y, 2001, EMBO J, V20, P3333, DOI 10.1093/emboj/20.13.3333; Park YG, 2003, GENOME RES, V13, P118, DOI 10.1101/gr.786403; Park YG, 2002, MAMM GENOME, V13, P289, DOI 10.1007/s00335-001-2151-6; Pei XF, 2004, IN VITRO CELL DEV-AN, V40, P14; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Seftor EA, 2002, CLIN EXP METASTAS, V19, P233, DOI 10.1023/A:1015591624171; Sekita N, 2001, JPN J CANCER RES, V92, P947, DOI 10.1111/j.1349-7006.2001.tb01185.x; Seraj MJ, 2000, CANCER RES, V60, P2764; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Snove O, 2004, BIOCHEM BIOPH RES CO, V319, P256, DOI 10.1016/j.bbrc.2004.04.175; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Tsukamoto N, 1999, J BIOL CHEM, V274, P18463, DOI 10.1074/jbc.274.26.18463; van Ham M, 2003, MOL BIOL REP, V30, P69, DOI 10.1023/A:1023941703493; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7	49	137	145	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1055	1062		10.1038/ng1635	http://dx.doi.org/10.1038/ng1635			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16142231	Green Accepted			2022-12-27	WOS:000232185600016
J	Hu, M; Yao, J; Cai, L; Bachman, KE; van den Brule, F; Velculescu, V; Polyak, K				Hu, M; Yao, J; Cai, L; Bachman, KE; van den Brule, F; Velculescu, V; Polyak, K			Distinct epigenetic changes in the stromal cells of breast cancers	NATURE GENETICS			English	Article							HUMAN COLON-CARCINOMA; CPG ISLANDS; ALTERED METHYLATION; PROTEOGLYCAN GENE; DNA METHYLATION; HYPOMETHYLATION; EXPRESSION; HIN-1; TRANSCRIPTOME; EPIGENOMICS	Increasing evidence suggests that changes in the cellular microenvironment contribute to tumorigenesis, but the molecular basis of these alterations is not well understood. Although epigenetic modifications of the neoplastic cells in tumors have been firmly implicated in tumorigenesis(1), it is not known whether epigenetic modifications occur in the non-neoplastic stromal cells. To address this question in an unbiased and genome-wide manner, we developed a new method, methylation-specific digital karyotyping, and applied it to epithelial and myoepithelial cells, stromal fibroblasts from normal breast tissue, and in situ and invasive breast carcinomas. Our analyses showed that distinct epigenetic alterations occur in all three cell types during breast tumorigenesis in a tumor stage- and cell type-specific manner, suggesting that epigenetic changes have a role in the maintenance of the abnormal cellular microenvironment in breast cancer.	Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA; Univ Liege, Lab Biol & Dev Biol, B-4000 Liege, Belgium; Johns Hopkins Univ, Sidney Kimmel Canc Ctr, Baltimore, MD 21231 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University System of Maryland; University of Maryland Baltimore; University of Liege; Johns Hopkins University	Polyak, K (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	Kornelia_Polyak@dfci.harvard.edu	Velculescu, Victor/ABF-4846-2020	Velculescu, Victor/0000-0003-1195-438X; Cai, Li/0000-0003-3344-337X				ADANY R, 1991, BIOCHEM J, V276, P301, DOI 10.1042/bj2760301; ADANY R, 1990, BIOCHEM BIOPH RES CO, V171, P1402, DOI 10.1016/0006-291X(90)90841-A; ADANY R, 1990, J BIOL CHEM, V265, P11389; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Bocker W, 2002, LAB INVEST, V82, P737, DOI 10.1097/01.LAB.0000017371.72714.C5; Cai L, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r51; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Dai ZY, 2002, GENOME RES, V12, P1591, DOI 10.1101/gr.197402; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Huang THM, 1999, HUM MOL GENET, V8, P459, DOI 10.1093/hmg/8.3.459; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kremenskoy M, 2003, BIOCHEM BIOPH RES CO, V311, P884, DOI 10.1016/j.bbrc.2003.10.078; Krop I, 2004, MOL CANCER RES, V2, P489; Krop IE, 2001, P NATL ACAD SCI USA, V98, P9796, DOI 10.1073/pnas.171138398; Paz MF, 2003, HUM MOL GENET, V12, P2209, DOI 10.1093/hmg/ddg226; Plass C, 2002, HUM MOL GENET, V11, P2479, DOI 10.1093/hmg/11.20.2479; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Shi HD, 2002, CANCER RES, V62, P3214; Shigematsu H, 2005, INT J CANCER, V113, P600, DOI 10.1002/ijc.20622; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Wang TL, 2002, P NATL ACAD SCI USA, V99, P16156, DOI 10.1073/pnas.202610899	29	408	432	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2005	37	8					899	905		10.1038/ng1596	http://dx.doi.org/10.1038/ng1596			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16007089				2022-12-27	WOS:000230880400023
J	Christophorou, MA; Martin-Zanca, D; Soucek, L; Lawlor, ER; Brown-Swigart, L; Verschuren, EW; Evan, GI				Christophorou, MA; Martin-Zanca, D; Soucek, L; Lawlor, ER; Brown-Swigart, L; Verschuren, EW; Evan, GI			Temporal dissection of p53 function in vitro and in vivo	NATURE GENETICS			English	Article							RADIATION-INDUCED APOPTOSIS; MOUSE EMBRYO FIBROBLASTS; TIME QUANTITATIVE PCR; P53-DEFICIENT MICE; CELLULAR SENESCENCE; INDUCTION; ACTIVATION; RAS; TAMOXIFEN; RESPONSES	To investigate the functions of the p53 tumor suppressor, we created a new knock- in gene replacement mouse model in which the endogenous Trp53 gene is substituted by one encoding p53ER(TAM), a p53 fusion protein whose function is completely dependent on ectopic provision of 4- hydroxytamoxifen. We show here that both tissues in vivo and cells in vitro derived from such mice can be rapidly toggled between wild- type and p53 knockout states. Using this rapid perturbation model, we define the kinetics, dependence, persistence and reversibility of p53- mediated responses to DNA damage in tissues in vivo and to activation of the Ras oncoprotein and stress in vitro. This is the first example to our knowledge of a new class of genetic model that allows the specific, rapid and reversible perturbation of the function of a single endogenous gene in vivo.	Univ Calif San Francisco, Ctr Comprehens Canc, Canc Res Inst, San Francisco, CA 94143 USA; Univ Salamanca, CSIC, Inst Microbiol Bioquim, Salamanca 37007, Spain	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca	Evan, GI (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, Canc Res Inst, San Francisco, CA 94143 USA.	gevan@cc.ucsf.edu	Soucek, Laura/AAG-7393-2019; Soucek, Laura/AAG-8377-2019	Soucek, Laura/0000-0002-4750-7971; Christophorou, Maria/0000-0001-5455-7283; Verschuren, Emmy/0000-0001-5771-9129				Adimoolam S, 2003, DNA REPAIR, V2, P947, DOI 10.1016/S1568-7864(03)00087-9; Attardi LD, 2004, ONCOGENE, V23, P973, DOI 10.1038/sj.onc.1207026; BIENZ B, 1984, EMBO J, V3, P2179, DOI 10.1002/j.1460-2075.1984.tb02110.x; Botchkarev VA, 2000, CANCER RES, V60, P5002; Cui Y. F., 1995, Journal of Environmental Pathology Toxicology and Oncology, V14, P159; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Fei PW, 2002, CANCER RES, V62, P7316; Fei PW, 2003, ONCOGENE, V22, P5774, DOI 10.1038/sj.onc.1206677; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Fukatsu K, 1997, SEN-I GAKKAISHI, V53, P15, DOI 10.2115/fiber.53.15; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Hanawalt PC, 2003, MUTAT RES-REV MUTAT, V544, P107, DOI 10.1016/j.mrrev.2003.06.002; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HARVEY M, 1993, ONCOGENE, V8, P2457; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Hayflick L, 2003, EXP GERONTOL, V38, P1231, DOI 10.1016/j.exger.2003.09.003; Kemp CJ, 2001, CANCER RES, V61, P327; Komarova EA, 2000, ONCOGENE, V19, P3791, DOI 10.1038/sj.onc.1203717; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; MIDGLEY CA, 1995, J CELL SCI, V108, P1843; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; POTTEN CS, 1994, INT J RADIAT BIOL, V65, P71, DOI 10.1080/09553009414550101; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Song SY, 1999, AM J PATHOL, V155, P1121, DOI 10.1016/S0002-9440(10)65215-7; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Vater CA, 1996, ONCOGENE, V13, P739; White INH, 2003, CURR DRUG METAB, V4, P223, DOI 10.2174/1389200033489451	31	150	150	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					718	726		10.1038/ng1572	http://dx.doi.org/10.1038/ng1572			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15924142				2022-12-27	WOS:000230196400018
J	Slotkin, RK; Freeling, M; Lisch, D				Slotkin, RK; Freeling, M; Lisch, D			Heritable transposon silencing initiated by a naturally occurring transposon inverted duplication	NATURE GENETICS			English	Article							RNA INTERFERENCE; DELETION DERIVATIVES; CYTOSINE METHYLATION; MUTATOR TRANSPOSONS; DNA METHYLATION; TANDEM REPEATS; C-ELEGANS; ARABIDOPSIS; GENE; ELEMENTS	It has been suggested that gene silencing evolved as a defense against genomic parasites such as transposons(1). This idea is based on analysis of mutations that reactivate transposons that are stably silenced(2-9): they affect maintenance rather than initiation of silencing. Here we describe the cloning and characterization of a naturally occurring locus able to heritably silence the otherwise highly active MuDR transposon in maize. This locus, Mu killer (Muk), results from the inverted duplication of a partially deleted autonomous MuDR element located at the breakpoint of a genomic deletion. Muk produces a hybrid hairpin transcript that is processed into small RNAs, which are amplified when the target MuDR transcript is present. Muk provides the first example of a naturally occurring transposon derivative capable of initiating the heritable silencing of an active transposon family. Further, transposon-generated inverted duplications may be important for the generation of double-stranded RNAs used in gene silencing.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Lisch, D (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA.	dlisch@uclink.berkeley.edu	Lisch, Damon/A-9414-2010; Slotkin, R. Keith/H-6965-2013	Slotkin, R. Keith/0000-0001-9582-3533; Lisch, Damon/0000-0002-8693-8651				Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kidwell MG, 2000, TRENDS ECOL EVOL, V15, P95, DOI 10.1016/S0169-5347(99)01817-0; Kim SH, 2003, PLANT CELL, V15, P2430, DOI 10.1105/tpc.014605; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lisch D, 2002, TRENDS PLANT SCI, V7, P498, DOI 10.1016/S1360-1385(02)02347-6; Lisch D, 1999, GENETICS, V151, P331; Luff B, 1999, MOL CELL, V3, P505, DOI 10.1016/S1097-2765(00)80478-5; Martienssen RA, 2003, NAT GENET, V35, P213, DOI 10.1038/ng1252; Melquist S, 2003, GENE DEV, V17, P2036, DOI 10.1101/gad.1081603; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Puig M, 2004, P NATL ACAD SCI USA, V101, P9013, DOI 10.1073/pnas.0403090101; Rudenko GN, 2001, PLANT CELL, V13, P553, DOI 10.1105/tpc.13.3.553; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Slotkin RK, 2003, GENETICS, V165, P781; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695; Zilberman D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-249	28	123	132	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					641	644		10.1038/ng1576	http://dx.doi.org/10.1038/ng1576			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15908951				2022-12-27	WOS:000229495300020
J	Krek, A; Grun, D; Poy, MN; Wolf, R; Rosenberg, L; Epstein, EJ; MacMenamin, P; da Piedade, I; Gunsalus, KC; Stoffel, M; Rajewsky, N				Krek, A; Grun, D; Poy, MN; Wolf, R; Rosenberg, L; Epstein, EJ; MacMenamin, P; da Piedade, I; Gunsalus, KC; Stoffel, M; Rajewsky, N			Combinatorial microRNA target predictions	NATURE GENETICS			English	Article								MicroRNAs are small noncoding RNAs that recognize and bind to partially complementary sites in the 3' untranslated regions of target genes in animals and, by unknown mechanisms, regulate protein production of the target transcript(1-3). Different combinations of microRNAs are expressed in different cell types and may coordinately regulate cell-specific target genes. Here, we present PicTar, a computational method for identifying common targets of microRNAs. Statistical tests using genome-wide alignments of eight vertebrate genomes, PicTar's ability to specifically recover published microRNA targets, and experimental validation of seven predicted targets suggest that PicTar has an excellent success rate in predicting targets for single microRNAs and for combinations of microRNAs. We find that vertebrate microRNAs target, on average, roughly 200 transcripts each. Furthermore, our results suggest widespread coordinate control executed by microRNAs. In particular, we experimentally validate common regulation of Mtpn by miR-375, miR-124 and let-7b and thus provide evidence for coordinate microRNA control in mammals.	NYU, Dept Biol, Ctr Comparat Funct Genom, New York, NY 10003 USA; NYU, Dept Phys, New York, NY 10003 USA; Rockefeller Univ, Lab Metab Dis, New York, NY 10021 USA	New York University; New York University; Rockefeller University	Rajewsky, N (corresponding author), NYU, Dept Biol, Ctr Comparat Funct Genom, 100 Washington Sq E, New York, NY 10003 USA.	nikolaus.rajewsky@nyu.edu	Poy, Matthew/F-6914-2017; ravegnini, gloria/K-1330-2016	Poy, Matthew/0000-0002-4904-2426; ravegnini, gloria/0000-0002-7774-402X; Stoffel, Markus/0000-0003-1304-5817; Rajewsky, Nikolaus/0000-0002-4785-4332				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Banerjee D, 2002, BIOESSAYS, V24, P119, DOI 10.1002/bies.10046; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Enright AJ, 2004, GENOME BIOL, V5; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hobert O, 2004, TRENDS BIOCHEM SCI, V29, P462, DOI 10.1016/j.tibs.2004.07.001; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060	26	3695	3967	2	215	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2005	37	5					495	500		10.1038/ng1536	http://dx.doi.org/10.1038/ng1536			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15806104				2022-12-27	WOS:000228862300018
J	Cazalet, C; Rusniok, C; Bruggemann, H; Zidane, N; Magnier, A; Ma, L; Tichit, M; Jarraud, S; Bouchier, C; Vandenesch, F; Kunst, F; Etienne, J; Glaser, P; Buchrieser, C				Cazalet, C; Rusniok, C; Bruggemann, H; Zidane, N; Magnier, A; Ma, L; Tichit, M; Jarraud, S; Bouchier, C; Vandenesch, F; Kunst, F; Etienne, J; Glaser, P; Buchrieser, C			Evidence in the Legionella pneumophila genome for exploitation of host cell functions and high genome plasticity	NATURE GENETICS			English	Article							LEGIONNAIRES-DISEASE; SEQUENCE-ANALYSIS; ESCHERICHIA-COLI; VIRULENCE SYSTEM; SECRETION SYSTEM; PROTEIN; STRAINS; GENE; AGROBACTERIUM; PLASMID	Legionella pneumophila, the causative agent of Legionnaires' disease, replicates as an intracellular parasite of amoebae and persists in the environment as a free-living microbe. Here we have analyzed the complete genome sequences of L. pneumophila Paris (3,503,610 bp, 3,077 genes), an endemic strain that is predominant in France, and Lens (3,345,687 bp, 2,932 genes), an epidemic strain responsible for a major outbreak of disease in France. The L. pneumophila genomes show marked plasticity, with three different plasmids and with about 13% of the sequence differing between the two strains. Only strain Paris contains a type V secretion system, and its Lvh type IV secretion system is encoded by a 36-kb region that is either carried on a multicopy plasmid or integrated into the chromosome. Genetic mobility may enhance the versatility of L. pneumophila. Numerous genes encode eukaryotic-like proteins or motifs that are predicted to modulate host cell functions to the pathogen's advantage. The genome thus reflects the history and lifestyle of L. pneumophila, a human pathogen of macrophages that coevolved with fresh-water amoebae.	Inst Pasteur, Lab Genom Microorganismes Pathogenes, F-75724 Paris 15, France; Inst Pasteur, CNRS, URA 2171, F-75724 Paris 15, France; Fac Med, Ctr Natl Reference Legionella, INSERM, Lab Bacteriol,E 0230,IFR 62, F-69372 Lyon, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Buchrieser, C (corresponding author), Inst Pasteur, Lab Genom Microorganismes Pathogenes, 28 Rue Dr Roux, F-75724 Paris 15, France.	cbuch@pasteur.fr	ETIENNE, Jerome/C-5471-2014; Jarraud, Sophie/AAE-2345-2019; Glaser, Philippe/O-2641-2015; Jarraud, Sophie/M-4551-2014; Vandenesch, Francois/C-7209-2014	ETIENNE, Jerome/0000-0002-3348-3315; Jarraud, Sophie/0000-0001-5750-0215; Glaser, Philippe/0000-0003-4156-2782; Jarraud, Sophie/0000-0001-5750-0215; Vandenesch, Francois/0000-0001-9412-7106; Buchrieser, Carmen/0000-0003-3477-9190; Bruggemann, Holger/0000-0001-7433-0190				Atlas RM, 1999, ENVIRON MICROBIOL, V1, P283, DOI 10.1046/j.1462-2920.1999.00046.x; Aurell H, 2003, J CLIN MICROBIOL, V41, P3320, DOI 10.1128/JCM.41.7.3320-3322.2003; Barz C, 2000, FEBS LETT, V482, P139, DOI 10.1016/S0014-5793(00)02045-7; BENZ I, 1992, MOL MICROBIOL, V6, P1539, DOI 10.1111/j.1365-2958.1992.tb00875.x; BEZANSON G, 1994, CAN J MICROBIOL, V40, P426, DOI 10.1139/m94-070; Biederbick A, 1999, J CELL SCI, V112, P2473; Brassinga AKC, 2003, J BACTERIOL, V185, P4630, DOI 10.1128/JB.185.15.4630-4637.2003; BROWN A, 1982, J CLIN MICROBIOL, V16, P230, DOI 10.1128/JCM.16.2.230-235.1982; Buchrieser C, 1999, INFECT IMMUN, V67, P4851, DOI 10.1128/IAI.67.9.4851-4861.1999; Caturegli P, 2000, INFECT IMMUN, V68, P5277, DOI 10.1128/IAI.68.9.5277-5283.2000; Cirillo SLG, 2000, MICROBIOL-SGM, V146, P1345, DOI 10.1099/00221287-146-6-1345; Cirillo SLG, 2002, MICROBIOL-SGM, V148, P1667, DOI 10.1099/00221287-148-6-1667; Cirillo SLG, 2001, INFECT IMMUN, V69, P508, DOI 10.1128/IAI.69.1.508-517.2001; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Conover GM, 2003, MOL MICROBIOL, V48, P305, DOI 10.1046/j.1365-2958.2003.03400.x; Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Desvaux M, 2004, RES MICROBIOL, V155, P53, DOI 10.1016/j.resmic.2003.10.002; Doyle RM, 2002, INT J MED MICROBIOL, V292, P227, DOI 10.1078/1438-4221-00210; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Fields BS, 2002, LEGIONELLA, P135; Frangeul L, 2004, BIOINFORMATICS, V20, P790, DOI 10.1093/bioinformatics/btg490; Glaser P, 2001, SCIENCE, V294, P849; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; Hryniewicz-Jankowska A, 2002, FOLIA HISTOCHEM CYTO, V40, P239; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; Kipreos ET, 2000, GENOME BIOL, V1, DOI 10.1186/gb-2000-1-5-reviews3002; Klemm P, 2004, MOL MICROBIOL, V51, P283, DOI 10.1046/j.1365-2958.2003.03833.x; Li GC, 2001, DEVELOPMENT, V128, P3473; Luneberg E, 2001, MOL MICROBIOL, V39, P1259, DOI 10.1111/j.1365-2958.2001.02314.x; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; Miyamoto H, 2003, J BACTERIOL, V185, P6712, DOI 10.1128/JB.185.22.6712-6718.2003; Molofsky AB, 2004, MOL MICROBIOL, V53, P29, DOI 10.1111/j.1365-2958.2004.04129.x; Molofsky AB, 2003, MOL MICROBIOL, V50, P445, DOI 10.1046/j.1365-2958.2003.03706.x; Morozova I, 2004, PLASMID, V51, P127, DOI 10.1016/j.plasmid.2003.12.004; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Rankin S, 2002, INFECT IMMUN, V70, P3637, DOI 10.1128/IAI.70.7.3637-3648.2002; Reiss U, 2004, J BIOL CHEM, V279, P1281, DOI 10.1074/jbc.M309646200; Schrammeijer B, 2001, CURR BIOL, V11, P258, DOI 10.1016/S0960-9822(01)00069-0; Segal G, 1999, MOL MICROBIOL, V34, P799, DOI 10.1046/j.1365-2958.1999.01642.x; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Smith RS, 2004, INFECT IMMUN, V72, P1677, DOI 10.1128/IAI.72.3.1677-1684.2004; Steinert M, 2002, FEMS MICROBIOL REV, V26, P149, DOI 10.1111/j.1574-6976.2002.tb00607.x; Stone BJ, 1999, J BACTERIOL, V181, P1395, DOI 10.1128/JB.181.5.1395-1402.1999; Vergunst AC, 2000, SCIENCE, V290, P979, DOI 10.1126/science.290.5493.979; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Yu VL, 2002, J INFECT DIS, V186, P127, DOI 10.1086/341087	50	485	1266	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1165	1173		10.1038/ng1447	http://dx.doi.org/10.1038/ng1447			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15467720	Bronze			2022-12-27	WOS:000224832800019
J	Tishkoff, SA; Kidd, KK				Tishkoff, SA; Kidd, KK			Implications of biogeography of human populations for 'race' and medicine	NATURE GENETICS			English	Article							RECENT POSITIVE SELECTION; LOW NUCLEOTIDE DIVERSITY; HUMAN GENETIC DIVERSITY; LINKAGE DISEQUILIBRIUM; SEQUENCE VARIATION; HUMAN GENOME; EVOLUTIONARY HISTORY; BALANCING SELECTION; HAPLOTYPE VARIATION; NATURAL-SELECTION	In this review, we focus on the biogeographical distribution of genetic variation and address whether or not populations cluster according to the popular concept of 'race'. We show that racial classifications are inadequate descriptors of the distribution of genetic variation in our species. Although populations do cluster by broad geographic regions, which generally correspond to socially recognized races, the distribution of genetic variation is quasicontinuous in clinal patterns related to geography. The broad global pattern reflects the accumulation of genetic drift associated with a recent African origin of modern humans, followed by expansion out of Africa and across the rest of the globe. Because disease genes may be geographically restricted due to mutation, genetic drift, migration and natural selection, knowledge of individual ancestry will be important for biomedical studies. Identifiers based on race will often be insufficient.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA	University System of Maryland; University of Maryland College Park; Yale University	Kidd, KK (corresponding author), Univ Maryland, Dept Biol, Bldg 144, College Pk, MD 20742 USA.	tishkoff@umd.edu; kenneth.kidd@yale.edu						Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Bamshad MJ, 2002, P NATL ACAD SCI USA, V99, P10539, DOI 10.1073/pnas.162046399; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Britten RJ, 2002, P NATL ACAD SCI USA, V99, P13633, DOI 10.1073/pnas.172510699; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Calafell F, 1998, EUR J HUM GENET, V6, P38, DOI 10.1038/sj.ejhg.5200151; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chakravarti A, 2001, NATURE, V409, P822, DOI 10.1038/35057281; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Fischer A, 2004, MOL BIOL EVOL, V21, P799, DOI 10.1093/molbev/msh083; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GOULD SJ, 1981, MISMEASURE MAN; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Kaessmann H, 2001, NAT GENET, V27, P155, DOI 10.1038/84773; Kang AM, 1999, BIOL PSYCHIAT, V46, P151, DOI 10.1016/S0006-3223(99)00101-8; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; KIDD K, 2001, NEW DIMENSIONS BIOET, P11; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; Kidd KK, 2004, J HERED, V95, P406, DOI 10.1093/jhered/esh060; Kittles RA, 2003, ANNU REV GENOM HUM G, V4, P33, DOI 10.1146/annurev.genom.4.070802.110356; LI WH, 1991, GENETICS, V129, P513; Long JC, 2003, HUM BIOL, V75, P449, DOI 10.1353/hub.2003.0058; Marks J., 1995, HUMAN BIODIVERSITY G; NEEL JV, 1962, AM J HUM GENET, V14, P353; Ohashi J, 2004, AM J HUM GENET, V74, P1198, DOI 10.1086/421330; Oota H, 2004, ANN HUM GENET, V68, P93, DOI 10.1046/j.1529-8817.2003.00060.x; Osier MV, 2002, AM J PHYS ANTHROPOL, V119, P77, DOI 10.1002/ajpa.10094; Osier MV, 2002, AM J HUM GENET, V71, P84, DOI 10.1086/341290; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Pritchard JK, 2000, GENETICS, V155, P945; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Risch N, 2003, AM J HUM GENET, V72, P812, DOI 10.1086/373882; RISCH N, 2002, GENOME BIOL, V12, P602; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Saunders MA, 2002, GENETICS, V162, P1849; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; STRINGER CB, 1988, SCIENCE, V239, P1263, DOI 10.1126/science.3125610; Tishkoff SA, 2000, AM J HUM GENET, V67, P901, DOI 10.1086/303068; Tishkoff SA, 2003, CURR OPIN GENET DEV, V13, P569, DOI 10.1016/j.gde.2003.10.010; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Verrelli BC, 2004, AM J HUM GENET, V75, P363, DOI 10.1086/423287; Verrelli BC, 2002, AM J HUM GENET, V71, P1112, DOI 10.1086/344345; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Wolpoff MH, 1996, SCIENCE, V274, P704; Wooding SP, 2002, AM J HUM GENET, V71, P528, DOI 10.1086/342260; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; Yu N, 2003, GENETICS, V164, P1511; Zhao H, 1999, ANN HUM GENET, V63, P167, DOI 10.1046/j.1469-1809.1999.6320167.x	70	278	296	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11		S			S21	S27		10.1038/ng1438	http://dx.doi.org/10.1038/ng1438			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867PH	15507999	Bronze			2022-12-27	WOS:000224854000007
J	Burdick, JT; Chen, WM; Abecasis, GR; Cheung, VG				Burdick, Joshua T.; Chen, Wei-Min; Abecasis, Goncalo R.; Cheung, Vivian G.			In silico method for inferring genotypes in pedigrees	NATURE GENETICS			English	Article						`	LINKAGE ANALYSIS; GENOME; MAP	Our genotype inference method combines sparse marker data from a linkage scan and high-resolution SNP genotypes for several individuals to infer genotypes for related individuals. We illustrate the method's utility by inferring over 53 million SNP genotypes for 78 children in the Centre d'Etude du Polymorphisme Humain families. The method can be used to obtain high-density genotypes in different family structures, including nuclear families commonly used in complex disease gene mapping studies.	Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania	Cheung, VG (corresponding author), Univ Penn, Dept Pediat, 3516 Civic Ctr Blvd, Philadelphia, PA 19104 USA.	vcheung@mail.med.upenn.edu	Chen, Wei-Min/A-8469-2009; Cheung, Vivian G./AAT-3115-2020; Abecasis, Goncalo R/B-7840-2010	Abecasis, Goncalo/0000-0003-1509-1825	NIEHS NIH HHS [R01 ES015733, R01 ES015733-03, R01 ES015733-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM081930-08, R01 GM081930, R01 GM081930-09] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081930] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Matise TC, 2003, AM J HUM GENET, V73, P271, DOI 10.1086/377137; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; *SAGE, 2003, STAT AN GEN EP; Sobel E, 1996, AM J HUM GENET, V58, P1323; Syvanen AC, 2005, NAT GENET, V37, pS5, DOI 10.1038/ng1558	14	96	101	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2006	38	9					1002	1004		10.1038/ng1863	http://dx.doi.org/10.1038/ng1863			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16921375	Green Accepted			2022-12-27	WOS:000240112100016
J	Ropero, S; Fraga, MF; Ballestar, E; Hamelin, R; Yamamoto, H; Boix-Chornet, M; Caballero, R; Alaminos, M; Setien, F; Paz, MF; Herranz, M; Palacios, J; Arango, D; Orntoft, TF; Aaltonen, LA; Schwartz, S; Esteller, M				Ropero, S; Fraga, MF; Ballestar, E; Hamelin, R; Yamamoto, H; Boix-Chornet, M; Caballero, R; Alaminos, M; Setien, F; Paz, MF; Herranz, M; Palacios, J; Arango, D; Orntoft, TF; Aaltonen, LA; Schwartz, S; Esteller, M			A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition	NATURE GENETICS			English	Article							MICROSATELLITE INSTABILITY; CELLS; ACETYLATION	Disruption of histone acetylation patterns is a common feature of cancer cells, but very little is known about its genetic basis. We have identified truncating mutations in one of the primary human histone deacetylases, HDAC2, in sporadic carcinomas with microsatellite instability and in tumors arising in individuals with hereditary nonpolyposis colorectal cancer syndrome. The presence of the HDAC2 frameshift mutation causes a loss of HDAC2 protein expression and enzymatic activity and renders these cells more resistant to the usual antiproliferative and proapoptotic effects of histone deacetylase inhibitors. As such drugs may serve as therapeutic agents for cancer, our findings support the use of HDAC2 mutational status in future pharmacogenetic treatment of these individuals.	Spanish Natl Canc Ctr CNIO, Canc Epigenet Lab, Madrid 28029, Spain; Ctr Etud Polymorphisme Humain, INSERM U434, F-75010 Paris, France; Sapporo Med Univ, Dept Internal Med 1, Sapporo, Hokkaido 0608543, Japan; Spanish Natl Canc Ctr CNIO, Lab Breast & Gynaecol Canc, Madrid 28029, Spain; Hosp Univ Vall Hebron, Ctr Invest Bioquim & Biol Mol, Barcelona 08035, Spain; Aarhus Univ Hosp Skejby, Mol Diagnost Lab, Dept Clin Biochem, DK-8200 Aarhus N, Denmark; Univ Helsinki, Biomedicum Helsinki, Dept Med Genet, Helsinki, Finland	Centro Nacional de Investigaciones Oncologicas (CNIO); Institut National de la Sante et de la Recherche Medicale (Inserm); Sapporo Medical University; Centro Nacional de Investigaciones Oncologicas (CNIO); Hospital Universitari Vall d'Hebron; Aarhus University; University of Helsinki	Esteller, M (corresponding author), Spanish Natl Canc Ctr CNIO, Canc Epigenet Lab, Madrid 28029, Spain.	mesteller@cnio.es	Fraga, Mario F/H-7824-2017; ALAMINOS, MIGUEL/N-9960-2016; Esteller, Manel/L-5956-2014; Ballestar, Esteban/ABG-8561-2020; Arango, Diego/AFW-0125-2022; Arango, Diego/M-5667-2016; Aaltonen, Lauri/A-5375-2010; Schwartz, Simo/H-7776-2012	Fraga, Mario F/0000-0001-8450-2603; ALAMINOS, MIGUEL/0000-0003-4876-2672; Esteller, Manel/0000-0003-4490-6093; Arango, Diego/0000-0003-2953-3284; Arango, Diego/0000-0003-2953-3284; Aaltonen, Lauri/0000-0001-6839-4286; Schwartz, Simo/0000-0001-8297-7971; Ballestar, Esteban/0000-0002-1400-2440				Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Bannister AJ, 2004, METHOD ENZYMOL, V376, P269; Espada J, 2004, J BIOL CHEM, V279, P37175, DOI 10.1074/jbc.M404842200; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Ionov Y, 2004, P NATL ACAD SCI USA, V101, P1273, DOI 10.1073/pnas.0307276101; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Marks PA, 2005, CELL CYCLE, V4, P549, DOI 10.4161/cc.4.4.1564; Myzak MC, 2006, FASEB J, V20, P506, DOI 10.1096/fj.05-4785fje; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; TURNER BM, 1989, EUR J BIOCHEM, V179, P131, DOI 10.1111/j.1432-1033.1989.tb14530.x; Wang DF, 2005, J MED CHEM, V48, P6936, DOI 10.1021/jm0505011	20	209	221	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					566	569		10.1038/ng1773	http://dx.doi.org/10.1038/ng1773			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16642021				2022-12-27	WOS:000237147500019
J	Stoetzel, C; Laurier, V; Davis, EE; Muller, J; Rix, S; Badano, JL; Leitch, CC; Salem, N; Chouery, E; Corbani, S; Jalk, N; Vicaire, S; Sarda, P; Hamel, C; Lacombe, D; Holder, M; Odent, S; Holder, S; Brooks, AS; Elcioglu, NH; Da Silva, E; Rossillion, B; Sigaudy, S; de Ravel, TJL; Lewis, RA; Leheup, B; Verloes, A; Amati-Bonneau, P; Megarbane, A; Poch, O; Bonneau, D; Beales, PL; Mandel, JL; Katsanis, N; Dollfus, H				Stoetzel, C; Laurier, V; Davis, EE; Muller, J; Rix, S; Badano, JL; Leitch, CC; Salem, N; Chouery, E; Corbani, S; Jalk, N; Vicaire, S; Sarda, P; Hamel, C; Lacombe, D; Holder, M; Odent, S; Holder, S; Brooks, AS; Elcioglu, NH; Da Silva, E; Rossillion, B; Sigaudy, S; de Ravel, TJL; Lewis, RA; Leheup, B; Verloes, A; Amati-Bonneau, P; Megarbane, A; Poch, O; Bonneau, D; Beales, PL; Mandel, JL; Katsanis, N; Dollfus, H			BBS10 encodes a vertebrate-specific chaperonin-like protein and is a major BBS locus	NATURE GENETICS			English	Article							BARDET-BIEDL-SYNDROME; GENE; DISORDER; GENOMICS	Bardet-Biedl syndrome (BBS) is a genetically heterogeneous ciliopathy. Although nine BBS genes have been cloned, they explain only 40-50% of the total mutational load. Here we report a major new BBS locus, BBS10, that encodes a previously unknown, rapidly evolving vertebrate-specific chaperonin-like protein. We found BBS10 to be mutated in about 20% of an unselected cohort of families of various ethnic origins, including some families with mutations in other BBS genes, consistent with oligogenic inheritance. In zebrafish, mild suppression of bbs10 exacerbated the phenotypes of other bbs morphants.	Univ Strasbourg 1, Fac Med Strasbourg, Med Genet Lab, EA 3949, F-67085 Strasbourg, France; Hop Univ Strasbourg, Serv Genet Med, F-67098 Strasbourg, France; Hop Univ Strasbourg, Ctr Reference Affect Genet Ophtalmol, F-67098 Strasbourg, France; Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Ophthalmol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Univ Strasbourg 1, Coll France, Inst Genet & Biol Mol & Cellulaire, CNRS,INSERM, F-67404 Illkirch Graffenstaden, France; Communaute Urbaine Strasbourg, Strasbourg, France; Ctr Rech Publ Sante, Lab Biol Mol Anal Genet & Modelisat, L-1911 Luxembourg, Luxembourg; UCL, Mol Med Unit, Inst Child Hlth, London WC1N 1EH, England; Univ St Joseph, Fac Med, Unite Genet Med, Beirut 1000, Lebanon; CHU Montpellier, Hop Arnaud de Villeneuve, Serv Genet Med, F-34295 Montpellier, France; CHU Montpellier, Hop St Eloi, Inst Neurosci Montpellier, F-34295 Montpellier, France; CHU, Hop Pellegrin, Serv Genet Med, F-33076 Bordeaux, France; CHU Lille, Hop Jeanne de Flandres, Serv Genet Clin, F-59037 Lille, France; CHU Hop Sud, Unite Genet Med, F-35203 Rennes, France; Northwick Pk & St Marks NHS Trust, Kennedy Galton Ctr, Harrow HA1 3UJ, Middx, England; Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; Marmara Univ Hosp, Dept Pediat Genet, TR-34668 Istanbul, Turkey; Univ Hosp Coimbra, Dept Ophthalmol, P-3041853 Coimbra, Portugal; Univ Geneva, Hop Cantonal, Serv Ophtalmol, CH-1211 Geneva, Switzerland; CHU Timone, Serv Genet Med, F-13385 Marseille, France; Univ Hosp Gasthuisberg, Ctr Human Genet, B-3000 Louvain, Belgium; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; CHU Enfants Brabois, Serv Genet, F-54500 Vandoeuvre Les Nancy, France; Hop Robert Debre, Unite Genet Clin, F-75935 Paris, France; CHU Angers, Serv Genet, F-49933 Angers, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Luxembourg Institute of Health; University of London; University College London; Saint Joseph University Beirut; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; CHU Bordeaux; Universite de Lille - ISITE; CHU Lille; CHU Rennes; Imperial College London; Erasmus University Rotterdam; Erasmus MC; Marmara University; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); University of Geneva; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; KU Leuven; University Hospital Leuven; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Dollfus, H (corresponding author), Univ Strasbourg 1, Fac Med Strasbourg, Med Genet Lab, EA 3949, F-67085 Strasbourg, France.	helene.dollfus@medecine.u-strasbg.fr	Megarbane, Andre/ABD-5574-2021; Muller, Jean/L-7412-2018; Katsanis, Nicholas/E-1837-2012; /AAK-8500-2021; Beales, Philip L/C-7367-2009; Bonneau, Dominique/K-6110-2015; amati-bonneau, patrizia/K-6198-2015; Mandel, Jean Louis/Q-2668-2016; VERLOES, Alain/E-7287-2014	Muller, Jean/0000-0002-7682-559X; Davis, Erica/0000-0002-2412-8397; Mandel, Jean Louis/0000-0002-0535-6589; Dollfus, Helene/0000-0002-2249-895X; Katsanis, Nicholas/0000-0002-2480-0171; Badano, Jose/0000-0002-0706-8652; de Ravel, Thomy/0000-0002-3361-3781; VERLOES, Alain/0000-0003-4819-0264; Silva, Eduardo/0000-0002-2739-9854; Lacombe, Didier/0000-0002-8956-2207	Medical Research Council [G0801843] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Beales PL, 2005, CURR OPIN GENET DEV, V15, P315, DOI 10.1016/j.gde.2005.04.006; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Hichri H, 2005, EUR J HUM GENET, V13, P607, DOI 10.1038/sj.ejhg.5201372; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2004, HUM MOL GENET, V13, pR65, DOI 10.1093/hmg/ddh092; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Nishimura DY, 2005, AM J HUM GENET, V77, P1021, DOI 10.1086/498323; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644	15	206	212	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2006	38	5					521	524		10.1038/ng1771	http://dx.doi.org/10.1038/ng1771			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16582908				2022-12-27	WOS:000237147500011
J	Gold, B; Merriam, JE; Zernant, J; Hancox, LS; Taiber, AJ; Gehrs, K; Cramer, K; Neel, J; Bergeron, J; Barile, GR; Smith, RT; Dean, M; Allikmets, R				Gold, B; Merriam, JE; Zernant, J; Hancox, LS; Taiber, AJ; Gehrs, K; Cramer, K; Neel, J; Bergeron, J; Barile, GR; Smith, RT; Dean, M; Allikmets, R		AMD Genetics Clin Study Grp	Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration	NATURE GENETICS			English	Article							FACTOR-H POLYMORPHISM; DISEASE; DRUSEN; MACULOPATHY; DEFICIENCY; SUSCEPTIBILITY; EPIDEMIOLOGY; HAPLOTYPE; ETIOLOGY; VARIANT	Age-related macular degeneration (AMD) is the most common form of irreversible blindness in developed countries(1,2). Variants in the factor H gene (CFH, also known as HF1), which encodes a major inhibitor of the alternative complement pathway, are associated with the risk for developing AMD(3-8). Here we test the hypothesis that variation in genes encoding other regulatory proteins of the same pathway is associated with AMD. We screened factor B (BF) and complement component 2 (C2) genes, located in the major histocompatibility complex class III region, for genetic variation in two independent cohorts comprising similar to 900 individuals with AMD and similar to 400 matched controls. Haplotype analyses identify a statistically significant common risk haplotype (H1) and two protective haplotypes. The L9H variant of BF and the E318D variant of C2 (H10), as well as a variant in intron 10 of C2 and the R32Q variant of BF (H7), confer a significantly reduced risk of AMD (odds ratio=0.45 and 0.36, respectively). Combined analysis of the C2 and BF haplotypes and CFH variants shows that variation in the two loci can predict the clinical outcome in 74% of the affected individuals and 56% of the controls. These data expand and refine our understanding of the genetic risk for AMD.	Columbia Univ, Dept Ophthalmol, New York, NY 10032 USA; NCI, Lab Genom Divers, Frederick, MD 21702 USA; Univ Iowa, Ctr Macular Degenerat, Dept Ophthalmol & Visual Sci, Iowa City, IA 52240 USA; Sapio Sci LLC, York, PA 17402 USA; SAIC Frederick, Frederick, MD 21702 USA; Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Iowa; Science Applications International Corporation (SAIC); SAIC-Frederick; Columbia University	Allikmets, R (corresponding author), Columbia Univ, Dept Ophthalmol, New York, NY 10032 USA.	dean@ncifcrf.gov; rla22@columbia.edu	Mohammed, Imran/J-8271-2012; Allikmets, Rando/ABD-4533-2021; Dean, Michael C/G-8172-2012; Dean, Michael/R-7501-2019	Mohammed, Imran/0000-0002-8412-0768; Dean, Michael C/0000-0003-2234-0631; smith, theodore/0000-0002-1693-943X; Hancox, Lisa/0000-0003-1940-2619; Gehrs, Karen/0000-0003-4510-9678	NATIONAL CANCER INSTITUTE [Z01BC005652] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011515, R01EY015520, R01EY013435] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N01-CO-124000] Funding Source: Medline; NEI NIH HHS [R01 EY015520-02, R01 EY015520-05, R01 EY013435, R01 EY015520-01A2, R01 EY015520, EY13435, EY11515, R01 EY015520-03, R01 EY011515, R01 EY015520-04] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Alper CA, 2003, J CLIN IMMUNOL, V23, P297, DOI 10.1023/A:1024540917593; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Bok D, 2005, P NATL ACAD SCI USA, V102, P7053, DOI 10.1073/pnas.0502819102; Conley YP, 2005, HUM MOL GENET, V14, P1991, DOI 10.1093/hmg/ddi204; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; DAVIS CA, 1980, J LAB CLIN MED, V96, P633; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Goverdhan SV, 2005, INVEST OPHTH VIS SCI, V46, P1726, DOI 10.1167/iovs.04-0928; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hayashi M, 2004, Ophthalmic Genet, V25, P111; Holers VM, 2004, MOL IMMUNOL, V41, P147, DOI 10.1016/j.molimm.2004.03.012; Johnson LV, 2001, EXP EYE RES, V73, P887, DOI 10.1006/exer.2001.1094; KINOSHITA T, 1991, IMMUNOL TODAY, V12, P291, DOI 10.1016/0167-5699(91)90001-A; Klaver CCW, 2001, INVEST OPHTH VIS SCI, V42, P2237; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Larsen CE, 2004, CURR OPIN IMMUNOL, V16, P660, DOI 10.1016/j.coi.2004.07.014; LOKKI ML, 1991, IMMUNOGENETICS, V34, P242, DOI 10.1007/BF00215259; MORGAN BP, 1991, IMMUNOL TODAY, V12, P301, DOI 10.1016/0167-5699(91)90003-C; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; RAUM D, 1979, AM J HUM GENET, V31, P35; Stewart CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/gr.2188104; van Leeuwen R, 2003, EUR J EPIDEMIOL, V18, P845, DOI 10.1023/A:1025643303914; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426	30	860	935	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2006	38	4					458	462		10.1038/ng1750	http://dx.doi.org/10.1038/ng1750			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	026LN	16518403	Green Accepted			2022-12-27	WOS:000236340500019
J	Greenway, MJ; Andersen, PM; Russ, C; Ennis, S; Cashman, S; Donaghy, C; Patterson, V; Swingler, R; Kieran, D; Prehn, J; Morrison, KE; Green, A; Acharya, KR; Brown, RH; Hardiman, O				Greenway, MJ; Andersen, PM; Russ, C; Ennis, S; Cashman, S; Donaghy, C; Patterson, V; Swingler, R; Kieran, D; Prehn, J; Morrison, KE; Green, A; Acharya, KR; Brown, RH; Hardiman, O			ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis	NATURE GENETICS			English	Article							HUMAN ANGIOGENIN; VEGF; DELIVERY; PROTEIN; ALS	We recently identified angiogenin (ANG) as a candidate susceptibility gene for amyotrophic lateral sclerosis (ALS), a neurodegenerative disorder characterized by adult-onset loss of motor neurons. We now report the finding of seven missense mutations in 15 individuals, of whom four had familial ALS and 11 apparently 'sporadic' ALS. Our findings provide further evidence that variations in hypoxia-inducible genes have an important role in motor neuron degeneration.	Royal Coll Surgeons Ireland, Dept Clin Neurol Sci, Dublin 2, Ireland; Our Ladys Hosp Sick Children, Natl Ctr Med Genet, Dublin, Ireland; Umea Univ, Dept Neurol, S-90187 Umea, Sweden; Massachusetts Gen Hosp, Day Neuromuscular Res Lab, Boston, MA 02114 USA; Univ Coll Dublin, Sch Med & Med Sci, Conway Inst, Dublin, Ireland; Royal Victoria Hosp, Dept Neurol, Belfast BT12 6BA, Antrim, North Ireland; Univ Dundee, Ninewells Hosp, Dept Neurol, Dundee, Scotland; Royal Coll Surgeons Ireland, Dept Physiol, Dublin 2, Ireland; Univ Birmingham, Dept Clin Neurosci, Birmingham, W Midlands, England; Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Beaumont Hosp, Dept Neurol, Dublin 9, Ireland	Royal College of Surgeons - Ireland; Our Ladys Children Hospital Crumlin; Umea University; Harvard University; Massachusetts General Hospital; University College Dublin; University of Dundee; Royal College of Surgeons - Ireland; University of Birmingham; University of Bath	Greenway, MJ (corresponding author), Royal Coll Surgeons Ireland, Dept Clin Neurol Sci, Dublin 2, Ireland.	mattgreenway@rcsi.ie; ohard@iol.ie	Green, Andrew/AAJ-7592-2020; Hardiman, Orla/Y-3441-2019; Prehn, Jochen HM/A-3928-2010	Hardiman, Orla/0000-0003-2610-1291; Prehn, Jochen HM/0000-0003-3479-7794; Ennis, Sean/0000-0002-4330-1386; Green, Andrew/0000-0002-1077-7417; Morrison, Karen Elaine/0000-0003-0216-5717; Acharya, K. Ravi/0000-0002-3009-4058	Wellcome Trust [067288] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ACHARYA KR, 1994, P NATL ACAD SCI USA, V91, P2915, DOI 10.1073/pnas.91.8.2915; Achilli F, 2005, AMYOTROPH LATERAL SC, V6, P111, DOI 10.1080/14660820510035351; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; BOND MD, 1990, BIOCHEMISTRY-US, V29, P3341, DOI 10.1021/bi00465a028; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; Greenway MJ, 2004, NEUROLOGY, V63, P1936, DOI 10.1212/01.WNL.0000144344.39103.F6; Hayward C, 1999, NEUROLOGY, V52, P1899, DOI 10.1212/WNL.52.9.1899; Kishimoto K, 2005, ONCOGENE, V24, P445, DOI 10.1038/sj.onc.1208223; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; MOROIANU J, 1994, P NATL ACAD SCI USA, V91, P1677, DOI 10.1073/pnas.91.5.1677; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; SHAPIRO R, 1989, BIOCHEMISTRY-US, V28, P7401, DOI 10.1021/bi00444a038; SHAPIRO R, 1989, BIOCHEMISTRY-US, V28, P1726, DOI 10.1021/bi00430a045; SHAPIRO R, 1992, BIOCHEMISTRY-US, V31, P12477, DOI 10.1021/bi00164a026; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360	15	523	557	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2006	38	4					411	413		10.1038/ng1742	http://dx.doi.org/10.1038/ng1742			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	026LN	16501576				2022-12-27	WOS:000236340500011
J	Mager, J; Bartolomei, MS				Mager, J; Bartolomei, MS			Strategies for dissecting epigenetic mechanisms in the mouse	NATURE GENETICS			English	Article							ENHANCER-BLOCKING ACTIVITY; DNA METHYLATION; HISTONE MACROH2A1; X-INACTIVATION; GENE; GENOME; CHROMATIN; CHROMOSOME; EXPRESSION; CTCF	Epigenetics generally refers to heritable changes in gene expression that are independent of nucleotide sequence. With complete genome sequences in hand, understanding the epigenetic control of genomes is the next step towards comprehending how the same DNA sequence gives rise to different cells, lineages and organs. Epigenetics also contributes to individual variation in normal biology and in disease states. The mouse provides a unique opportunity to understand how epigenetic differences contribute to both development and disease in a tractable mammalian system. Here we discuss current approaches and protocols used to study epigenetics in the mouse, including loss-of-function studies, mutagenesis screens, somatic cell nuclear transfer, genomics and proteomics.	Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Bartolomei, MS (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.	bartolom@mail.med.upenn.edu						Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Blewitt ME, 2005, P NATL ACAD SCI USA, V102, P7629, DOI 10.1073/pnas.0409375102; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Buck MJ, 2004, GENOMICS, V83, P349, DOI 10.1016/j.ygeno.2003.11.004; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen TP, 2004, CURR TOP DEV BIOL, V60, P55; Costanzi C, 1998, NATURE, V393, P599, DOI 10.1038/31275; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Engel N, 2004, NAT GENET, V36, P883, DOI 10.1038/ng1399; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Gebuhr TC, 2000, GENESIS, V26, P189, DOI 10.1002/(SICI)1526-968X(200003)26:3<189::AID-GENE4>3.0.CO;2-5; Goetze S, 2005, MOL CELL BIOL, V25, P2260, DOI 10.1128/MCB.25.6.2260-2272.2005; Grunau C, 2000, HUM MOL GENET, V9, P2651, DOI 10.1093/hmg/9.18.2651; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Hernadez-Munoz I, 2005, P NATL ACAD SCI USA, V102, P7635, DOI 10.1073/pnas.0408918102; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Hutchins AS, 2002, MOL CELL, V10, P81, DOI 10.1016/S1097-2765(02)00564-6; Huttenhofer A, 2005, TRENDS GENET, V21, P289, DOI 10.1016/j.tig.2005.03.007; Jiao YL, 2005, PLANT CELL, V17, P1641, DOI 10.1105/tpc.105.031575; Jorgensen HF, 2002, MENT RETARD DEV D R, V8, P87, DOI 10.1002/mrdd.10021; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; Labrador M, 2002, CELL, V111, P151, DOI 10.1016/S0092-8674(02)01004-8; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Luger K, 2003, CURR OPIN GENET DEV, V13, P127, DOI 10.1016/S0959-437X(03)00026-1; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Mann MRW, 2003, BIOL REPROD, V69, P902, DOI 10.1095/biolreprod.103.017293; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; MICHAUD EJ, 1994, GENE DEV, V8, P1463, DOI 10.1101/gad.8.12.1463; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; Murrell A, 2005, HUM MOL GENET, V14, pR3, DOI 10.1093/hmg/ddi110; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Nakao M, 2001, BRAIN DEV-JPN, V23, pS174, DOI 10.1016/S0387-7604(01)00348-5; Ogonuki N, 2002, NAT GENET, V30, P253, DOI 10.1038/ng841; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Rakyan V, 2003, CURR BIOL, V13, pR6, DOI 10.1016/S0960-9822(02)01377-5; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Rangwala SH, 2004, CURR OPIN GENET DEV, V14, P686, DOI 10.1016/j.gde.2004.09.009; RINCHIK EM, 1993, GENETICS, V135, P1107; Roberts E, 1935, AM NAT, V69, P181, DOI 10.1086/280590; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Rousseaux S, 2005, GENE, V345, P139, DOI 10.1016/j.gene.2004.12.004; RUSSELL LB, 1991, MUTAT RES, V248, P203, DOI 10.1016/0027-5107(91)90102-T; Sado T, 2000, DEV BIOL, V225, P294, DOI 10.1006/dbio.2000.9823; Sarma K, 2005, NAT REV MOL CELL BIO, V6, P139, DOI 10.1038/nrm1567; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Taverner NV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-210; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; Vasicek TJ, 1997, GENETICS, V147, P777; Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184; Wang CW, 2004, J ASSIST REPROD GEN, V21, P163, DOI 10.1023/B:JARG.0000031249.37862.3a; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; Weston RJ, 2004, J ESSENT OIL RES, V16, P453, DOI 10.1080/10412905.2004.9698770; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305; Zheng CY, 2003, BIOPOLYMERS, V68, P539, DOI 10.1002/bip.10303	75	29	32	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1194	1200		10.1038/ng1664	http://dx.doi.org/10.1038/ng1664			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16254566				2022-12-27	WOS:000233045200016
J	Aoki, Y; Niihori, T; Kawame, H; Kurosawa, K; Filocamo, M; Kato, K; Suzuki, Y; Kure, S; Matsubara, Y				Aoki, Y; Niihori, T; Kawame, H; Kurosawa, K; Filocamo, M; Kato, K; Suzuki, Y; Kure, S; Matsubara, Y			Germline mutations in HRAS proto-oncogene cause Costello syndrome	NATURE GENETICS			English	Article							NOONAN-SYNDROME; H-RAS; PTPN11; ONCOGENES; LEUKEMIA; GENE	Costello syndrome is a multiple congenital anomaly and mental retardation syndrome characterized by coarse face, loose skin, cardiomyopathy and predisposition to tumors. We identified four heterozygous de novo mutations of HRAS in 12 of 13 affected individuals, all of which were previously reported as somatic and oncogenic mutations in various tumors. Our observations suggest that germline mutations in HRAS perturb human development and increase susceptibility to tumors.	Tohoku Univ, Sch Med, Dept Med Genet, Sendai, Miyagi 9808574, Japan; Nagano Childrens Hosp, Div Med Genet, Nagano, Japan; Kanagawa Childrens Med Ctr, Div Med Genet, Yokohama, Kanagawa, Japan; Saitama Childrens Med Ctr, Div Med Genet, Saitama, Japan; Kanagawa Childrens Med Ctr, Div Pathol, Yokohama, Kanagawa, Japan; IRCCS G Gaslini, Lab Diag Prepostnatale Malattie Metab, Genoa, Italy; Tohoku Univ, 21st Century COE Program Comprehens Res & Educ Ct, Sendai, Miyagi 980, Japan	Tohoku University; Saitama Children's Medical Center; University of Genoa; IRCCS Istituto Giannina Gaslini; Tohoku University	Aoki, Y (corresponding author), Tohoku Univ, Sch Med, Dept Med Genet, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	aokiy@mail.tains.tohoku.ac.jp	Kurosawa, Kenji/B-6561-2016; Niihori, Tetsuya/ABE-2350-2021; Filocamo, Mirella/AAG-3948-2021	Kurosawa, Kenji/0000-0002-6817-7748; Niihori, Tetsuya/0000-0002-2118-9776; Filocamo, Mirella/0000-0001-5505-8507	Telethon [GTF04002] Funding Source: Medline	Telethon(Fondazione Telethon)		BOS JL, 1989, CANCER RES, V49, P4682; COLBY WW, 1986, MOL CELL BIOL, V6, P730, DOI 10.1128/MCB.6.2.730; COSTELLO JM, 1971, NEW ZEAL MED J, V74, P397; FASANO O, 1984, P NATL ACAD SCI-BIOL, V81, P4008, DOI 10.1073/pnas.81.13.4008; Gripp KW, 2002, AM J MED GENET, V108, P80, DOI 10.1002/ajmg.10241; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hennekam RCM, 2003, AM J MED GENET C, V117C, P42, DOI 10.1002/ajmg.c.10019; LAND H, 1983, SCIENCE, V222, P771, DOI 10.1126/science.6356358; Niihori T, 2005, J HUM GENET, V50, P192, DOI 10.1007/s10038-005-0239-7; Oliva JL, 2004, J BIOL CHEM, V279, P33480, DOI 10.1074/jbc.M404058200; SEEBURG PH, 1984, NATURE, V312, P71, DOI 10.1038/312071a0; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, CLIN GENET, V63, P423, DOI 10.1034/j.1399-0004.2003.00076.x; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Troger B, 2003, AM J MED GENET A, V121A, P82, DOI 10.1002/ajmg.a.20122	15	487	502	1	28	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2005	37	10					1038	1040		10.1038/ng1641	http://dx.doi.org/10.1038/ng1641			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16170316				2022-12-27	WOS:000232185600012
J	Cheng, Q; Yang, WJ; Raimondi, SC; Pui, CH; Relling, MV; Evans, WE				Cheng, Q; Yang, WJ; Raimondi, SC; Pui, CH; Relling, MV; Evans, WE			Karyotypic abnormalities create discordance of germline genotype and cancer cell phenotypes	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; THIOPURINE S-METHYLTRANSFERASE; METHOTREXATE-POLYGLUTAMATE ACCUMULATION; IN-VIVO; CATALYTIC-ACTIVITY; MERCAPTOPURINE; PHARMACOGENOMICS; POLYMORPHISM; DISPOSITION; ABERRATIONS	The nature of mendelian inheritance assumes that all tissues in which a phenotype of interest is expressed have a uniform diploid karyotype, which is often not the case in cancer cells. Owing to nonrandom gains of chromosomes, trisomies are present in many cases of leukemia and other malignances. We used polymorphisms in the genes encoding thiopurine S-methyltransferase (TPMT), gamma-glutamyl hydrolase (GGH) and the reduced folate carrier (SLC19A1) to assess the nature of chromosomal acquisition and its influence on genotype-phenotype concordance in cancer cells. TPMT and GGH activities in somatic cells were concordant with germline genotypes, whereas activities in leukemia cells were determined by chromosomal number and whether the acquired chromosomes contained a wild-type or variant allele. Leukemia cells that had acquired an additional chromosome containing a wild-type TPMT or GGH allele had significantly lower accumulation of thioguanine nucleotides or methotrexate polyglutamates, respectively. Among these genes, there was a comparable number of acquired chromosomes with wild-type and variant alleles. Therefore, chromosomal gain can alter the concordance of germline genotype and cancer cell phenotypes, indicating that allele-specific quantitative genotyping may be required to define cancer pharmacogenomics unequivocally.	St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Hematol Malignancies Program, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Evans, WE (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Hematol Malignancies Program, 332 N Lauderdale St, Memphis, TN 38105 USA.	william.evans@stjude.org	Raimondi, Susana C/N-8166-2018; Pui, Ching-Hon/N-8076-2018; Evans, William E./C-2069-2012	Pui, Ching-Hon/0000-0003-0303-5658; Evans, William E./0000-0002-9333-5322				Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Baak JPA, 2003, EUR J CANCER, V39, P1199, DOI 10.1016/S0959-8049(03)00265-X; Bardi G, 2004, J CLIN ONCOL, V22, P2623, DOI 10.1200/JCO.2004.11.014; Belkov VM, 1999, BLOOD, V93, P1643, DOI 10.1182/blood.V93.5.1643.405k06_1643_1650; Chango A, 2000, MOL GENET METAB, V70, P310, DOI 10.1006/mgme.2000.3034; Cheng Q, 2004, PHARMACOGENETICS, V14, P557, DOI 10.1097/01.fpc.0000114761.78957.7e; Dervieux T, 2002, CLIN CHEM, V48, P61; Draviam VM, 2004, CURR OPIN GENET DEV, V14, P120, DOI 10.1016/j.gde.2004.02.007; Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; FitzPatrick DR, 2002, HUM MOL GENET, V11, P3249, DOI 10.1093/hmg/11.26.3249; Gollin SM, 2004, CURR OPIN ONCOL, V16, P25, DOI 10.1097/00001622-200401000-00006; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; KRYNETSKI EY, 1995, MOL PHARMACOL, V47, P1141; LILLEYMAN JS, 1994, LANCET, V343, P1188, DOI 10.1016/S0140-6736(94)92400-7; Masson E, 1996, J CLIN INVEST, V97, P73, DOI 10.1172/JCI118409; Masuda A, 2002, ONCOGENE, V21, P6884, DOI 10.1038/sj.onc.1205566; Mayr D, 2002, MODERN PATHOL, V15, P951, DOI 10.1097/01.MP.0000024290.55261.14; Mitelman F, 1995, INT SYSTEM HUMAN CYT; Panetta JC, 2002, CLIN CANCER RES, V8, P2423; Paulsson K, 2003, BLOOD, V102, P3010, DOI 10.1182/blood-2003-05-1444; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Pui C.-H., 2004, Annals of Hematology, V83, pS124; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; Rajagopalan H, 2004, NATURE, V432, P338, DOI 10.1038/nature03099; Rivera GK, 2005, CANCER-AM CANCER SOC, V103, P368, DOI 10.1002/cncr.20743; SYNOLD TW, 1994, J CLIN INVEST, V94, P1996, DOI 10.1172/JCI117552; Tai HL, 1996, AM J HUM GENET, V58, P694; Verdorfer I, 2001, INT J ONCOL, V19, P1263; Yates CR, 1997, ANN INTERN MED, V126, P608, DOI 10.7326/0003-4819-126-8-199704150-00003	30	64	65	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2005	37	8					878	882		10.1038/ng1612	http://dx.doi.org/10.1038/ng1612			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16041371				2022-12-27	WOS:000230880400019
J	Jonathan, C; Pertsemlidis, A; Kotowski, IK; Graham, R; Christine, KG; Garcia, CK; Hobbs, HH				Jonathan, C; Pertsemlidis, A; Kotowski, IK; Graham, R; Christine, KG; Garcia, CK; Hobbs, HH			Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9	NATURE GENETICS			English	Article							PLANT STEROLS; PLASMA-LEVELS; RECEPTOR; MICE	The low-density lipoprotein receptor (LDLR) prevents hypercholesterolemia and atherosclerosis by removing low-density lipoprotein (LDL) from circulation. Mutations in the genes encoding either LDLR1 or its ligand (APOB)(2) cause severe hypercholesterolemia. Missense mutations in PCSK9, encoding a serine protease in the secretory pathway(3), also cause hypercholesterolemia(4). These mutations are probably gain-of-function mutations, as overexpression of PCSK9 in the liver of mice produces hypercholesterolemia(5-7) by reducing LDLR number. To test whether loss-of-function mutations in PCSK9 have the opposite effect, we sequenced the coding region of PCSK9 in 128 subjects (50% African American) with low plasma levels of LDL and found two nonsense mutations (Y142X and C679X). These mutations were common in African Americans (combined frequency, 2%) but rare in European Americans (<0.1%) and were associated with a 40% reduction in plasma levels of LDL cholesterol. These data indicate that common sequence variations have large effects on plasma cholesterol levels in selected populations.	Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hobbs, HH (corresponding author), Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, 5323 Harry Hines, Dallas, TX 75390 USA.	helen.hobbs@utsouthwestern.edu	Pertsemlidis, Alexander/Q-7899-2017	Pertsemlidis, Alexander/0000-0003-1624-9372				Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; HOFER F, 1994, P NATL ACAD SCI USA, V91, P1839, DOI 10.1073/pnas.91.5.1839; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; INNERARITY TL, 1990, J LIPID RES, V31, P1337; Leren TP, 2004, CLIN GENET, V65, P419, DOI 10.1111/j.0009-9163.2004.0238.x; MARCOVINA SM, 1995, CLIN CHEM, V41, P246; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; MIETTINEN TA, 1990, AM J EPIDEMIOL, V131, P20, DOI 10.1093/oxfordjournals.aje.a115479; Mostaza JM, 1997, AM J CARDIOL, V79, P1298, DOI 10.1016/S0002-9149(97)00109-4; OTVOS JD, 1997, HDB LIPOPROTEIN TEST, P497; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Shioji K, 2004, J HUM GENET, V49, P109, DOI 10.1007/s10038-003-0114-3; Timms KM, 2004, HUM GENET, V114, P349, DOI 10.1007/s00439-003-1071-9; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wilund KR, 2004, ARTERIOSCL THROM VAS, V24, P2326, DOI 10.1161/01.ATV.0000149140.00499.92	21	497	539	2	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					161	165		10.1038/ng1509	http://dx.doi.org/10.1038/ng1509			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	15654334				2022-12-27	WOS:000226690100022
J	Descargues, P; Deraison, C; Bonnart, C; Kreft, M; Kishibe, M; Ishida-Yamamoto, A; Elias, P; Barrandon, Y; Zambruno, G; Sonnenberg, A; Hovnanian, A				Descargues, P; Deraison, C; Bonnart, C; Kreft, M; Kishibe, M; Ishida-Yamamoto, A; Elias, P; Barrandon, Y; Zambruno, G; Sonnenberg, A; Hovnanian, A			Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity	NATURE GENETICS			English	Article							SERINE PROTEINASE-INHIBITOR; CORNEUM CHYMOTRYPTIC ENZYME; STRATUM-CORNEUM; BARRIER FUNCTION; PERMEABILITY BARRIER; SUBTILISIN-A; LEKTI; EXPRESSION; SKIN; DESQUAMATION	Mutations in SPINK5, encoding the serine protease inhibitor LEKTI, cause Netherton syndrome, a severe autosomal recessive genodermatosis. Spink5(-/-) mice faithfully replicate key features of Netherton syndrome, including altered desquamation, impaired keratinization, hair malformation and a skin barrier defect. LEKTI deficiency causes abnormal desmosome cleavage in the upper granular layer through degradation of desmoglein 1 due to stratum corneum tryptic enzyme and stratum corneum chymotryptic enzyme-like hyperactivity. This leads to defective stratum corneum adhesion and resultant loss of skin barrier function. Profilaggrin processing is increased and implicates LEKTI in the cornification process. This work identifies LEKTI as a key regulator of epidermal protease activity and degradation of desmoglein 1 as the primary pathogenic event in Netherton syndrome.	Univ Toulouse 3, INSERM, U563, F-31059 Toulouse 3, France; Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 0788510, Japan; Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Dermatol, San Francisco, CA 94121 USA; Swiss Fed Inst Technol, Sch Life Sci, Lab Stem Cell Dynam, CH-1015 Lausanne, Switzerland; IRCCS, Ist Dermopat Immacolata, Lab Mol & Cell Biol, I-00167 Rome, Italy; Hop Purpan, Dept Med Genet, F-31059 Toulouse 3, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Netherlands Cancer Institute; Asahikawa Medical College; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; IRCCS Istituto Dermopatico dell'Immacolata (IDI); CHU de Toulouse	Hovnanian, A (corresponding author), Univ Toulouse 3, INSERM, U563, Pl Dr Baylac, F-31059 Toulouse 3, France.	alain.hovnanian@toulouse.inserm.fr	Hovnanian, Alain/I-4711-2017; Zambruno, Giavanna/K-2933-2018; deraison, celine/P-6255-2016; BONNART, Chrystelle/A-1309-2011	Hovnanian, Alain/0000-0003-3412-7512; deraison, celine/0000-0002-9013-4592; Zambruno, Giovanna/0000-0002-1295-056X				Amagai M, 2000, NAT MED, V6, P1275, DOI 10.1038/81385; BARRANDON Y, 1988, J INVEST DERMATOL, V91, P315, DOI 10.1111/1523-1747.ep12475646; Bernard BA, 2003, J AM ACAD DERMATOL, V48, pS120, DOI 10.1067/mjd.2003.279; Bitoun E, 2003, HUM MOL GENET, V12, P2417, DOI 10.1093/hmg/ddg247; Bitoun E, 2002, J INVEST DERMATOL, V118, P352, DOI 10.1046/j.1523-1747.2002.01603.x; Brattsand M, 1999, J BIOL CHEM, V274, P30033, DOI 10.1074/jbc.274.42.30033; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Chavanas S, 2000, NAT GENET, V25, P141, DOI 10.1038/75977; COMEL M, 1949, Dermatologica, V98, P133; deWolf K, 1996, DERMATOLOGY, V192, P400, DOI 10.1159/000246431; Ding X, 1999, J INVEST DERMATOL, V112, P739, DOI 10.1046/j.1523-1747.1999.00585.x; Ekholm IE, 2000, J INVEST DERMATOL, V114, P56, DOI 10.1046/j.1523-1747.2000.00820.x; ELIAS PM, 1991, ADV LIPID RES, V24, P1; ELIAS PM, 2004, J INVEST DERMATOL, V122, pR6; Fartasch M, 1999, ARCH DERMATOL, V135, P823, DOI 10.1001/archderm.135.7.823; Franzke CW, 1996, J BIOL CHEM, V271, P21886, DOI 10.1074/jbc.271.36.21886; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; HANSSON L, 1994, J BIOL CHEM, V269, P19420; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Hausser I, 1996, PEDIATR DERMATOL, V13, P183, DOI 10.1111/j.1442-200X.1996.tb02615.x; ISHIDAYAMAMOTO A, IN PRESS J INVEST DE; ITO M, 1984, J INVEST DERMATOL, V83, P1, DOI 10.1111/1523-1747.ep12261618; Jayakumar A, 2004, PROTEIN EXPRES PURIF, V35, P93, DOI 10.1016/j.pep.2003.12.004; JUDGE MR, 1994, BRIT J DERMATOL, V131, P615, DOI 10.1111/j.1365-2133.1994.tb04971.x; Kljuic A, 2003, EXP DERMATOL, V12, P20, DOI 10.1034/j.1600-0625.2003.120103.x; Komatsu N, 2002, J INVEST DERMATOL, V118, P436, DOI 10.1046/j.0022-202x.2001.01663.x; Kreutzmann P, 2004, J CHROMATOGR B, V803, P75, DOI 10.1016/j.jchromb.2003.07.016; Kuramoto N, 2002, J CLIN INVEST, V109, P243, DOI 10.1172/JCI200213563; Levy-Nissenbaum E, 2003, NAT GENET, V34, P151, DOI 10.1038/ng1163; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; Magert HJ, 1999, J BIOL CHEM, V274, P21499, DOI 10.1074/jbc.274.31.21499; Magert HJ, 2002, INT J BIOCHEM CELL B, V34, P573, DOI 10.1016/S1357-2725(01)00179-0; Magert HJ, 2002, EUR J MED RES, V7, P49; Mitsudo K, 2003, BIOCHEMISTRY-US, V42, P3874, DOI 10.1021/bi027029v; NETHERTON EW, 1958, ARCH DERMATOL, V78, P483, DOI 10.1001/archderm.1958.01560100059009; Pulkkinen L, 2003, EXP DERMATOL, V12, P11, DOI 10.1034/j.1600-0625.2003.120102.x; Raghunath M, 2004, J INVEST DERMATOL, V123, P474, DOI 10.1111/j.0022-202X.2004.23220.x; RESING KA, 1984, J CELL BIOL, V99, P1372, DOI 10.1083/jcb.99.4.1372; Scheimberg I, 1996, PEDIATR PATHOL LAB M, V16, P359, DOI 10.1080/15513819609168677; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Simon M, 1997, J BIOL CHEM, V272, P31770, DOI 10.1074/jbc.272.50.31770; SMITH DL, 1995, BRIT J DERMATOL, V133, P153; Sprecher E, 2001, J INVEST DERMATOL, V117, P179, DOI 10.1046/j.1523-1747.2001.01389.x; STEVANOVIC DV, 1969, BRIT J DERMATOL, V81, P851, DOI 10.1111/j.1365-2133.1969.tb15956.x; SUZUKI Y, 1994, ARCH DERMATOL RES, V286, P249, DOI 10.1007/BF00387596; TRAUPE H, 1989, ICHTYOSIS GUIDE CLIN; Van Gysel D, 2001, DERMATOLOGY, V202, P99, DOI 10.1159/000051607; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Vasioukhin V, 2001, NAT CELL BIOL, V3, P1076, DOI 10.1038/ncb1201-1076; Yang T, 2004, GENE DEV, V18, P2354, DOI 10.1101/gad.1232104	50	284	293	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2005	37	1					56	65		10.1038/ng1493	http://dx.doi.org/10.1038/ng1493			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15619623				2022-12-27	WOS:000225997500021
J	Lee, JS; Chu, IS; Mikaelyan, A; Calvisi, DF; Heo, J; Reddy, JK; Thorgeirsson, SS				Lee, JS; Chu, IS; Mikaelyan, A; Calvisi, DF; Heo, J; Reddy, JK; Thorgeirsson, SS			Application of comparative functional genomics to identify best-fit mouse models to study human cancer	NATURE GENETICS			English	Article							ACTIVATED RECEPTOR-ALPHA; GROWTH-FACTOR-ALPHA; ACYL-COA OXIDASE; PEROXISOME PROLIFERATOR; HEPATOCELLULAR-CARCINOMA; C-MYC; TRANSGENIC MICE; CELL LYMPHOMA; LIVER-TUMORS; HEPATOCARCINOGENESIS	Genetically modified mice have been extensively used for analyzing the molecular events that occur during tumor development. In many, if not all, cases, however, it is uncertain to what extent the mouse models reproduce features observed in the corresponding human conditions(1-3). This is due largely to lack of precise methods for direct and comprehensive comparison at the molecular level of the mouse and human tumors. Here we use global gene expression patterns of 68 hepatocellular carcinomas (HCCs) from seven different mouse models and 91 human HCCs from predefined subclasses(4) to obtain direct comparison of the molecular features of mouse and human HCCs. Gene expression patterns in HCCs from Myc, E2f1 and Myc E2f1 transgenic mice were most similar to those of the better survival group of human HCCs, whereas the expression patterns in HCCs from Myc Tgfa transgenic mice and in diethylnitrosamine-induced mouse HCCs were most similar to those of the poorer survival group of human HCCs. Gene expression patterns in HCCs from Acox1(-/-) mice and in ciprofibrate-induced HCCs were least similar to those observed in human HCCs. We conclude that our approach can effectively identify appropriate mouse models to study human cancers.	NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Northwestern University; Feinberg School of Medicine	Thorgeirsson, SS (corresponding author), NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	snorri_thorgeirsson@nih.gov						Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; BENTLEY P, 1993, FOOD CHEM TOXICOL, V31, P857, DOI 10.1016/0278-6915(93)90225-N; Calvisi DF, 2004, GASTROENTEROLOGY, V126, P1374, DOI 10.1053/j.gastro.2004.02.014; Conner EA, 2000, ONCOGENE, V19, P5054, DOI 10.1038/sj.onc.1203885; Conner EA, 2003, BIOCHEM BIOPH RES CO, V302, P114, DOI 10.1016/S0006-291X(03)00125-6; Cooper GM, 2003, CURR OPIN GENET DEV, V13, P604, DOI 10.1016/j.gde.2003.10.001; Eddy SR, 2002, CELL, V109, P137, DOI 10.1016/S0092-8674(02)00727-4; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639; Gonzalez FJ, 1998, J NATL CANCER I, V90, P1702, DOI 10.1093/jnci/90.22.1702; Hann B, 2001, CURR OPIN CELL BIOL, V13, P778, DOI 10.1016/S0955-0674(00)00283-0; Hardison RC, 2000, TRENDS GENET, V16, P369, DOI 10.1016/S0168-9525(00)02081-3; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KING JL, 1969, SCIENCE, V164, P788, DOI 10.1126/science.164.3881.788; Klausner RD, 1999, ONCOGENE, V18, P5249, DOI 10.1038/sj.onc.1203089; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Meyer K, 2003, CARCINOGENESIS, V24, P975, DOI 10.1093/carcin/bgg040; MURAKAMI H, 1993, CANCER RES, V53, P1719; POIRIER LA, 1975, J NATL CANCER I, V54, P137, DOI 10.1093/jnci/54.1.137; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; RAO MS, 1984, CANCER RES, V44, P1072; REDDY JK, 1983, CRC CR REV TOXICOL, V12, P1, DOI 10.3109/10408448309029317; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; Sambrook J., 1989, MOL CLONING LABORATO, V2, P916; Sargent LM, 1999, AM J PATHOL, V154, P1047, DOI 10.1016/S0002-9440(10)65357-6; Schaner ME, 2003, MOL BIOL CELL, V14, P4376, DOI 10.1091/mbc.e03-05-0279; Shirahashi H, 2002, LIVER, V22, P413, DOI 10.1034/j.1600-0676.2002.01541.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ureta-Vidal A, 2003, NAT REV GENET, V4, P251, DOI 10.1038/nrg1043	30	371	377	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2004	36	12					1306	1311		10.1038/ng1481	http://dx.doi.org/10.1038/ng1481			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15565109				2022-12-27	WOS:000225354100019
J	Kern, AD; Kondrashov, FA				Kern, AD; Kondrashov, FA			Mechanisms and convergence of compensatory evolution in mammalian mitochondrial tRNAs	NATURE GENETICS			English	Article							MUTATIONS; SUBSTITUTIONS; NUCLEAR	The function of protein and RNA molecules depends on complex epistatic interactions between sites. Therefore, the deleterious effect of a mutation can be suppressed by a compensatory second-site substitution(1,2). In relating a list of 86 pathogenic mutations in human tRNAs encoded by mitochondrial genes to the sequences of their mammalian orthologs, we noted that 52 pathogenic mutations were present in normal tRNAs of one or several nonhuman mammals. We found at least five mechanisms of compensation for 32 pathogenic mutations that destroyed a Watson-Crick pair in one of the four tRNA stems: restoration of the affected Watson-Crick interaction (25 cases), strengthening of another pair (4 cases), creation of a new pair (8 cases), changes of multiple interactions in the affected stem (11 cases) and changes involving the interaction between the loop and stem structures (3 cases). A pathogenic mutation and its compensating substitution are fixed in a lineage in rapid succession, and often a compensatory interaction evolves convergently in different clades. At least 10%, and perhaps as many as 50%, of all nucleotide substitutions in evolving mammalian tRNAs participate in such interactions, indicating that the evolution of tRNAs proceeds along highly epistatic fitness ridges.	Univ Calif Davis, Ctr Populat Biol, Sect Evolut & Ecol, Davis, CA 95616 USA	University of California System; University of California Davis	Kondrashov, FA (corresponding author), Univ Calif Davis, Ctr Populat Biol, Sect Evolut & Ecol, Davis, CA 95616 USA.	kondrashov@ucdavis.edu	Kondrashov, Fyodor Alexeevich/H-6331-2015	Kondrashov, Fyodor Alexeevich/0000-0001-8243-4694				Andreu AL, 2003, J NEUROL, V250, P1403, DOI 10.1007/s00415-003-0281-3; Burch CL, 1999, GENETICS, V151, P921; Chen Y, 1999, GENES GENET SYST, V74, P271, DOI 10.1266/ggs.74.271; De Rijk P, 2003, BIOINFORMATICS, V19, P299, DOI 10.1093/bioinformatics/19.2.299; Florentz C, 2001, EMBO REP, V2, P481, DOI 10.1093/embo-reports/kve111; Gao LZ, 2003, TRENDS GENET, V19, P678, DOI 10.1016/j.tig.2003.10.002; GILLESPIE JH, 1986, GENETICS, V113, P1077; Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047; Higgs PG, 1998, GENETICA, V102-3, P91, DOI 10.1023/A:1017059530664; Innan H, 2001, GENETICS, V159, P389; Kelley SO, 2000, NAT STRUCT BIOL, V7, P862, DOI 10.1038/79612; KIMURA M, 1991, P NATL ACAD SCI USA, V88, P5969, DOI 10.1073/pnas.88.14.5969; Kimura M., 1985, J GENET, V64, P7, DOI [10.1007/BF02923549, DOI 10.1007/BF02923549]; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; LODISH H, 2000, MOL CELL BIOL, P265; Lynch M, 1997, MOL BIOL EVOL, V14, P914, DOI 10.1093/oxfordjournals.molbev.a025834; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Orr HA, 2001, EVOLUTION, V55, P1085; Parsch J, 2000, GENETICS, V154, P909; Reyes A, 2004, MOL BIOL EVOL, V21, P397, DOI 10.1093/molbev/msh033; ROUSSET F, 1991, P NATL ACAD SCI USA, V88, P10032, DOI 10.1073/pnas.88.22.10032; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tillier ERM, 1998, GENETICS, V148, P1993; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006; Wittenhagen LM, 2002, NAT STRUCT BIOL, V9, P586, DOI 10.1038/nsb820; ZUKER M, 1999, NATO ASI SER, P1	29	83	86	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1207	1212		10.1038/ng1451	http://dx.doi.org/10.1038/ng1451			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15502829	Bronze			2022-12-27	WOS:000224832800025
J	Graux, C; Cools, J; Melotte, C; Quentmeier, H; Ferrando, A; Levine, R; Vermeesch, JR; Stul, M; Dutta, B; Boeckx, N; Bosly, A; Heimann, P; Uyttebroeck, A; Mentens, N; Somers, R; MacLeod, RAF; Drexler, HG; Look, AT; Gilliland, DG; Michaux, L; Vandenberghe, P; Wlodarska, I; Marynen, P; Hagemeijer, A				Graux, C; Cools, J; Melotte, C; Quentmeier, H; Ferrando, A; Levine, R; Vermeesch, JR; Stul, M; Dutta, B; Boeckx, N; Bosly, A; Heimann, P; Uyttebroeck, A; Mentens, N; Somers, R; MacLeod, RAF; Drexler, HG; Look, AT; Gilliland, DG; Michaux, L; Vandenberghe, P; Wlodarska, I; Marynen, P; Hagemeijer, A			Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia	NATURE GENETICS			English	Article							DOUBLE-MINUTE CHROMOSOMES; TYROSINE KINASE; MYELOID LEUKEMIAS; GENES; PROTEIN; TRANSLOCATION; AMPLIFICATION; EXPRESSION; DELETIONS; IMATINIB	In T-cell acute lymphoblastic leukemia (T-ALL), transcription factors are known to be deregulated by chromosomal translocations, but mutations in protein tyrosine kinases have only rarely been identified(1-3). Here we describe the extrachromosomal (episomal)(4) amplification of ABL1 in 5 of 90 (5.6%) individuals with T-ALL, an aberration that is not detectable by conventional cytogenetics. Molecular analyses delineated the amplicon as a 500-kb region from chromosome band 9q34, containing the oncogenes ABL1 and NUP214 (refs.(5,6)). We identified a previously undescribed mechanism for activation of tyrosine kinases in cancer: the formation of episomes resulting in a fusion between NUP214 and ABL1. We detected the NUP214-ABL1 transcript in five individuals with the ABL1 amplification, in 5 of 85 (5.8%) additional individuals with T-ALL and in 3 of 22 T-ALL cell lines. The constitutively phosphorylated tyrosine kinase NUP214-ABL1 is sensitive to the tyrosine kinase inhibitor imatinib(7,8). The recurrent cryptic NUP214-ABL1 rearrangement is associated with increased HOX expression(1) and deletion of CDKN2A(9), consistent with a multistep pathogenesis of T-ALL. NUP214-ABL1 expression defines a new subgroup of individuals with T-ALL who could benefit from treatment with imatinib.	Univ Leuven, Dept Human Genet, Louvain, Belgium; Univ Leuven, Dept Hematol, Louvain, Belgium; Flanders Interuniv Inst Biotechnol, Dept Human Genet, Louvain, Belgium; German Collect Microorganisms & Cell Cultures, Braunschweig, Germany; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Flanders Interuniv Inst Biotechnol, Microarray Facil, Louvain, Belgium; Clin Univ UCL Mt Godinne, Dept Hematol, Brussels, Belgium; Free Univ Brussels, Erasme Hosp, Dept Med Genet, B-1050 Brussels, Belgium; Univ Leuven, Dept Pediat Hematooncol, Louvain, Belgium; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA USA; St Luc, Brussels, Belgium	KU Leuven; KU Leuven; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Universite Catholique Louvain; Universite Catholique Louvain Hospital; Universite Libre de Bruxelles; Vrije Universiteit Brussel; KU Leuven; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Marynen, P (corresponding author), Univ Leuven, Dept Human Genet, Louvain, Belgium.	peter.marynen@med.kuleuven.ac.be; anne.hagemeijer@med.kuleuven.ac.be	Melotte, Cindy/GXV-5465-2022	Cools, Jan/0000-0001-6626-5843; Vandenberghe, Peter/0000-0003-4719-1935; Vermeesch, Joris/0000-0002-3071-1191				Barber KE, 2004, LEUKEMIA, V18, P1153, DOI 10.1038/sj.leu.2403357; BENE MC, 1995, LEUKEMIA, V9, P1783; Capdeville R, 2002, NAT REV DRUG DISCOV, V1, P493, DOI 10.1038/nrd839; CARROLL SM, 1988, MOL CELL BIOL, V8, P1525, DOI 10.1128/MCB.8.4.1525; Cools J, 1999, BLOOD, V94, P1820, DOI 10.1182/blood.V94.5.1820.417k09_1820_1824; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; DEKLEIN A, 1986, BLOOD, V68, P1369; DEKLEIN A, 1982, NATURE, V300, P765, DOI 10.1038/300765a0; Dierlamm J, 1996, GENE CHROMOSOME CANC, V16, P261, DOI 10.1002/(SICI)1098-2264(199608)16:4<261::AID-GCC6>3.0.CO;2-W; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; FORNEROD M, 1995, ONCOGENE, V10, P1739; Golub TR, 1996, MOL CELL BIOL, V16, P4107; HAHN PJ, 1993, BIOESSAYS, V15, P477, DOI 10.1002/bies.950150707; HEBERT J, 1994, BLOOD, V84, P4038, DOI 10.1182/blood.V84.12.4038.bloodjournal84124038; Kelly LM, 2002, ANNU REV GENOM HUM G, V3, P179, DOI 10.1146/annurev.genom.3.032802.115046; KRAEMER D, 1994, P NATL ACAD SCI USA, V91, P1519, DOI 10.1073/pnas.91.4.1519; MAURER BJ, 1987, NATURE, V327, P434, DOI 10.1038/327434a0; MITELMAN F, 1995, INT SYSTEM HUMAN N S; Nagel S, 2003, CANCER RES, V63, P5329; Nieborowska-Skorska M, 2000, ONCOGENE, V19, P4117, DOI 10.1038/sj.onc.1203754; ODA T, 1994, J BIOL CHEM, V269, P22925; Paietta E, 2004, BLOOD, V104, P558, DOI 10.1182/blood-2004-01-0168; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Van Buggenhout G, 2004, J MED GENET, V41, P691, DOI 10.1136/jmg.2003.016865; VONLINDERN M, 1992, MOL CELL BIOL, V12, P1687, DOI 10.1128/MCB.12.4.1687	27	293	314	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2004	36	10					1084	1089		10.1038/ng1425	http://dx.doi.org/10.1038/ng1425			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	15361874	Green Published, Bronze			2022-12-27	WOS:000224156500017
J	Mansfield, JH; Harfe, BD; Nissen, R; Obenauer, J; Srineel, J; Chaudhuri, A; Farzan-Kashani, R; Zuker, M; Pasquinelli, AE; Ruvkun, G; Sharp, PA; Tabin, CJ; McManus, MT				Mansfield, JH; Harfe, BD; Nissen, R; Obenauer, J; Srineel, J; Chaudhuri, A; Farzan-Kashani, R; Zuker, M; Pasquinelli, AE; Ruvkun, G; Sharp, PA; Tabin, CJ; McManus, MT			MicroRNA-responsive 'sensor' transgenes uncover Hox-like and other developmentally regulated patterns of vertebrate microRNA expression	NATURE GENETICS			English	Article							CAENORHABDITIS-ELEGANS; MESSENGER-RNA; GENES; IDENTIFICATION; DROSOPHILA; CLEAVAGE; ELEMENT; DOMAIN; MOUSE; MIRNA	MicroRNAs (miRNAs) are a class of short (similar to22-nt) noncoding RNA molecules that downregulate expression of their mRNA targets. Since their discovery as regulators of developmental timing in Caenorhabditis elegans, hundreds of miRNAs have been identified in both animals and plants(1). Here, we report a technique for visualizing detailed miRNA expression patterns in mouse embryos. We elucidate the tissue-specific expression of several miRNAs during embryogenesis, including two encoded by genes embedded in homeobox (Hox) clusters, miR-10a and miR-196a. These two miRNAs are expressed in patterns that are markedly reminiscent of those of Hox genes. Furthermore, miR-196a negatively regulates Hoxb8, indicating that its restricted expression pattern probably reflects a role in the patterning function of the Hox complex.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; St Jude Childrens Res Hosp, Memphis, TN 38105 USA; Rensselaer Polytech Inst, Dept Comp Sci, Troy, NY 12180 USA; Rensselaer Polytech Inst, Dept Math Sci, Troy, NY 12180 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; MIT, NcGovern Inst, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; State University System of Florida; University of Florida; Massachusetts Institute of Technology (MIT); St Jude Children's Research Hospital; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu; mmcmanus@diabetes.ucsf.edu	mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Nissen, Robert/0000-0002-0591-1167	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD041826] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brend T, 2003, DEVELOPMENT, V130, P2717, DOI 10.1242/dev.00471; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Dietrich S, 1997, DEVELOPMENT, V124, P3895; ERSELIUS JR, 1990, DEVELOPMENT, V110, P629; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Johnson SM, 2003, DEV BIOL, V259, P364, DOI 10.1016/S0012-1606(03)00202-1; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; van den Akker E, 2001, DEVELOPMENT, V128, P1911; WHITING J, 1991, GENE DEV, V5, P2048, DOI 10.1101/gad.5.11.2048; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	27	345	393	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2004	36	10					1079	1083		10.1038/ng1421	http://dx.doi.org/10.1038/ng1421			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	15361871	Bronze			2022-12-27	WOS:000224156500016
J	Bergamaschi, D; Samuels, Y; Sullivan, A; Zvelebil, M; Breyssens, H; Bisso, A; Del Sal, G; Syed, N; Smith, P; Gasco, M; Crook, T; Lu, X				Bergamaschi, Daniele; Samuels, Yardena; Sullivan, Alexandra; Zvelebil, Marketa; Breyssens, Hilde; Bisso, Andrea; Del Sal, Giannino; Syed, Nelofer; Smith, Paul; Gasco, Milena; Crook, Tim; Lu, Xin			iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72 polymorphic p53	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR; MESSENGER-RNA; ETHNIC-GROUPS; CANCER RISK; EXPRESSION; DOMAIN; ASPP2; IDENTIFICATION; ASSOCIATION; HAPLOTYPES	iASPP is one of the most evolutionarily conserved inhibitors of p53, whereas ASPP1 and ASPP2 are activators of p53. We show here that, in addition to the DNA-binding domain, the ASPP family members also bind to the proline-rich region of p53, which contains the most common p53 polymorphism at codon 72. Furthermore, the ASPP family members, particularly iASPP, bind to and regulate the activity of p53Pro72 more efficiently than that of p53Arg72. Hence, escape from negative regulation by iASPP is a newly identified mechanism by which p53Arg72 activates apoptosis more efficiently than p53Pro72.	UCL, Ludwig Inst Canc Res, London W1W 7BS, England; Univ Trieste, LNCIB, I-34100 Trieste, Italy; Univ Trieste, Dipartimento Biochim Biofis & Chim Macromol, I-34100 Trieste, Italy; Inst Canc Res, Breakthrough Toby Robins Breast Canc Res Ctr, Lab Canc Genet & Epigenet, Chester Beatty Labs, London SW3 6JB, England; S Croce & Carle Hosp, Dept Med Oncol, I-12100 Cuneo, Italy	Ludwig Institute for Cancer Research; University of London; University College London; University of Trieste; University of Trieste; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Lu, X (corresponding author), UCL, Ludwig Inst Canc Res, 91 Riding House St, London W1W 7BS, England.	x.lu@ludwig.ucl.ac.uk		Bisso, Andrea/0000-0002-7158-8740; DEL SAL, GIANNINO/0000-0003-2185-6003; Samuels, Yardena/0000-0002-3349-7266; Bergamaschi, Daniele/0000-0002-3955-1091; Zvelebil, Marketa/0000-0001-8018-5591; Lu, Xin/0000-0002-6587-1152	Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE] Funding Source: Medline	Breast Cancer Now		Agirre X, 2006, ONCOGENE, V25, P1862, DOI 10.1038/sj.onc.1209236; Agorastos T, 2004, EUR J CANCER PREV, V13, P277, DOI 10.1097/01.cej.0000136717.95465.09; Baptiste N, 2002, ONCOGENE, V21, P9, DOI 10.1038/sj/onc/1205015; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Bergamaschi D, 2003, CANCER CELL, V3, P387, DOI 10.1016/S1535-6108(03)00079-5; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Cenci M, 2003, ANTICANCER RES, V23, P1385; D'Erchia AM, 1999, GENOMICS, V58, P50, DOI 10.1006/geno.1999.5794; de Oliveira WRP, 2004, INT J DERMATOL, V43, P489, DOI 10.1111/j.1365-4632.2004.02289.x; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Gorina S, 1996, SCIENCE, V274, P1001, DOI 10.1126/science.274.5289.1001; Gostissa M, 2004, J BIOL CHEM, V279, P48013, DOI 10.1074/jbc.M310801200; Granja F, 2004, CANCER LETT, V210, P151, DOI 10.1016/j.canlet.2004.01.016; IWABUCHI K, 1993, ONCOGENE, V8, P1693; Liu ZJ, 2004, LEUKEMIA, V18, P880, DOI 10.1038/sj.leu.2403300; Lossos IS, 2002, LEUKEMIA LYMPHOMA, V43, P2309, DOI 10.1080/1042819021000040017; Matakidou A, 2003, MUTAGENESIS, V18, P377, DOI 10.1093/mutage/geg008; Noma C, 2004, CANCER LETT, V210, P197, DOI 10.1016/j.canlet.2004.03.031; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Siddique MM, 2005, CANCER EPIDEM BIOMAR, V14, P2245, DOI 10.1158/1055-9965.EPI-05-0153; Sjalander A, 1996, HUM HERED, V46, P41, DOI 10.1159/000154324; SJALANDER A, 1995, HUM HERED, V45, P144, DOI 10.1159/000154275; Slee EA, 2004, ONCOGENE, V23, P2809, DOI 10.1038/sj.onc.1207516; SLEE EA, 2004, ONCOGENE; Trigiante G, 2006, NAT REV CANCER, V6, P217, DOI 10.1038/nrc1818; Venot C, 1998, EMBO J, V17, P4668, DOI 10.1093/emboj/17.16.4668; Vives V, 2006, GENE DEV, V20, P1262, DOI 10.1101/gad.374006; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; Zhang XW, 2005, LEUKEMIA RES, V29, P179, DOI 10.1016/j.leukres.2004.07.001; Zhu JH, 1999, ONCOGENE, V18, P2149, DOI 10.1038/sj.onc.1202533	30	205	217	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1133	1141		10.1038/ng1879	http://dx.doi.org/10.1038/ng1879			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16964264				2022-12-27	WOS:000241251100012
J	Pickersgill, H; Kalverda, B; de Wit, E; Talhout, W; Fornerod, M; van Steensel, B				Pickersgill, Helen; Kalverda, Bernike; de Wit, Elzo; Talhout, Wendy; Fornerod, Maarten; van Steensel, Bas			Characterization of the Drosophila melanogaster genome at the nuclear lamina	NATURE GENETICS			English	Article							3-DIMENSIONAL ORGANIZATION; SPATIAL-ORGANIZATION; COEXPRESSED GENES; BUDDING YEAST; CHROMATIN; LOCALIZATION; CHROMOSOME; HETEROCHROMATIN; TRANSCRIPTION; REPLICATION	The nuclear lamina binds chromatin in vitro and is thought to function in its organization, but genes that interact with it are unknown. Using an in vivo approach, we identified similar to 500 Drosophila melanogaster genes that interact with B-type lamin ( Lam). These genes are transcriptionally silent and late replicating, lack active histone marks and are widely spaced. These factors collectively predict lamin binding behavior, indicating that the nuclear lamina integrates variant and invariant chromatin features. Consistently, proximity of genomic regions to the nuclear lamina is partly conserved between cell types, and induction of gene expression or active histone marks reduces Lam binding. Lam target genes cluster in the genome, and these clusters are coordinately expressed during development. This genome-wide analysis gives clear insight into the nature and dynamic behavior of the genome at the nuclear lamina, and implies that intergenic DNA functions in the global organization of chromatin in the nucleus.	Netherlands Canc Inst, Dept Tumor Biol, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Dept Mol Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Fornerod, M (corresponding author), Netherlands Canc Inst, Dept Tumor Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	m.fornerod@nki.nl; b.v.steensel@nki.nl	Fornerod, Maarten/A-7503-2010; Kalverda, Bernike/A-7691-2010	Fornerod, Maarten/0000-0002-6166-3030; de Wit, Elzo/0000-0003-2883-1415				Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; BELMONT AS, 1993, J CELL BIOL, V123, P1671, DOI 10.1083/jcb.123.6.1671; Bianchi-Frias D, 2004, PLOS BIOL, V2, P975, DOI 10.1371/journal.pbio.0020178; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Cremer M, 2003, J CELL BIOL, V162, P809, DOI 10.1083/jcb.200304096; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; ECHALIER G, 1997, DROSOPHILA CELLS CUL, P393; Elgin SCR, 1996, CURR OPIN GENET DEV, V6, P193, DOI 10.1016/S0959-437X(96)80050-5; Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Heun P, 2001, J CELL BIOL, V152, P385, DOI 10.1083/jcb.152.2.385; HOCHSTRASSER M, 1987, J CELL BIOL, V104, P1471, DOI 10.1083/jcb.104.6.1471; HOCHSTRASSER M, 1986, J CELL BIOL, V102, P112, DOI 10.1083/jcb.102.1.112; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; KITTEN GT, 1991, J CELL BIOL, V113, P13, DOI 10.1083/jcb.113.1.13; Kosak ST, 2004, SCIENCE, V306, P644, DOI 10.1126/science.1103864; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; LUDERUS MEE, 1992, CELL, V70, P949, DOI 10.1016/0092-8674(92)90245-8; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; Makatsori D, 2004, J BIOL CHEM, V279, P25567, DOI 10.1074/jbc.M313606200; Marshall WF, 1997, CURR OPIN GENET DEV, V7, P259, DOI 10.1016/S0959-437X(97)80136-0; Marshall WF, 1996, MOL BIOL CELL, V7, P825, DOI 10.1091/mbc.7.5.825; Marshall WF, 2002, CURR BIOL, V12, pR185, DOI 10.1016/S0960-9822(02)00724-8; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; MATHOG D, 1989, GENETICS, V121, P293; Misteli T, 2004, CELL, V119, P153, DOI 10.1016/j.cell.2004.09.035; OKEEFE RT, 1992, J CELL BIOL, V116, P1095, DOI 10.1083/jcb.116.5.1095; PADDY MR, 1990, CELL, V62, P89, DOI 10.1016/0092-8674(90)90243-8; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Somech R, 2005, J CELL SCI, V118, P4017, DOI 10.1242/jcs.02521; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; STUURMAN N, 1995, J CELL SCI, V108, P3137; Sun LV, 2003, P NATL ACAD SCI USA, V100, P9428, DOI 10.1073/pnas.1533393100; Taddei A, 2005, EMBO REP, V6, P520, DOI 10.1038/sj.embor.7400441; Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705; Taddei A, 2004, BBA-GENE STRUCT EXPR, V1677, P120, DOI 10.1016/j.bbaexp.2003.11.014; TANIURA H, 1995, J CELL BIOL, V131, P33, DOI 10.1083/jcb.131.1.33; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; van Steensel B, 2003, P NATL ACAD SCI USA, V100, P2580, DOI 10.1073/pnas.0438000100; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107	50	398	411	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					1005	1014		10.1038/ng1852	http://dx.doi.org/10.1038/ng1852			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16878134				2022-12-27	WOS:000240112100017
J	Gutierrez-Marcos, JF; Costa, LM; Dal Pra, M; Scholten, S; Kranz, E; Perez, P; Dickinson, HG				Gutierrez-Marcos, Jose F.; Costa, Liliana M.; Dal Pra, Mauro; Scholten, Stefan; Kranz, Erhard; Perez, Pascual; Dickinson, Hugh G.			Epigenetic asymmetry of imprinted genes in plant gametes	NATURE GENETICS			English	Article							DNA METHYLATION; ARABIDOPSIS-THALIANA; POLYCOMB GENE; GLYCOSYLASE; ENDOSPERM; MEDEA; EXPRESSION; DEMETER; PROTEIN; GENOME	Plant imprinted genes show parent-of-origin expression in seed endosperm, but little is known about the nature of parental imprints in gametes before fertilization. We show here that single differentially methylated regions (DMRs) correlate with allele-specific expression of two maternally expressed genes in the seed and that one DMR is differentially methylated between gametes. Thus, plants seem to have developed similar strategies as mammals to epigenetically mark imprinted genes.	Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; Univ Hamburg, Biozentrum Klein Flottbek, D-22609 Hamburg, Germany; Univ Hamburg, Bot Garten, D-22609 Hamburg, Germany; Biogemma, F-63170 Clermont Ferrand, France	University of Oxford; University of Hamburg; University of Hamburg	Gutierrez-Marcos, JF (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	jose.gutierrez@plants.ox.ac.uk	Gutierrez-Marcos, Jose/AAE-2229-2020	Gutierrez-Marcos, Jose/0000-0002-5441-9080				Baroux U, 2006, GENE DEV, V20, P1081, DOI 10.1101/gad.378106; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Danilevskaya ON, 2003, PLANT CELL, V15, P425, DOI 10.1105/tpc.006759; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gutierrez-Marcos JF, 2003, PHILOS T ROY SOC B, V358, P1105, DOI 10.1098/rstb.2003.1292; Jullien PE, 2006, CURR BIOL, V16, P486, DOI 10.1016/j.cub.2006.01.020; JULLIEN PE, 2006, PLANT CELL; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Kohler C, 2005, NAT GENET, V37, P28, DOI 10.1038/ng1495; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7; Yadegari R, 2000, PLANT CELL, V12, P2367, DOI 10.1105/tpc.12.12.2367	15	121	133	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2006	38	8					876	878		10.1038/ng1828	http://dx.doi.org/10.1038/ng1828			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16823380				2022-12-27	WOS:000239325700015
J	Liu, PY; Wang, Y; Vikis, H; Maciag, A; Wang, DL; Lu, Y; Liu, Y; You, M				Liu, Pengyuan; Wang, Yian; Vikis, Haris; Maciag, Anna; Wang, Daolong; Lu, Yan; Liu, Yan; You, Ming			Candidate lung tumor susceptibility genes identified through whole-genome association analyses in inbred mice	NATURE GENETICS			English	Article							PULMONARY ADENOMA; LABORATORY MICE; FAMILY HISTORY; CANCER; MOUSE; COMPLEXITY; GENETICS; LOCUS; LINES	We performed a whole-genome association analysis of lung tumor susceptibility using dense SNP maps (similar to 1 SNP per 20 kb) in inbred mice. We reproduced the pulmonary adenoma susceptibility 1 (Pas1) locus identified in previous linkage studies and further narrowed this quantitative trait locus (QTL) to a region of less than 0.5 Mb in which at least two genes, Kras2 (Kirsten rat sarcoma oncogene 2) and Casc1 (cancer susceptibility candidate 1; also known as Las1), are strong candidates. Casc1 knockout mouse tumor bioassays showed that Casc1-deficient mice were susceptible to chemical induction of lung tumors. We also found three more genetic loci for lung adenoma development. Analysis of one of these candidate loci identified a previously uncharacterized gene Lasc1, bearing a nonsynonymous substitution (D102E). We found that the Lasc1 Glu102 allele preferentially promotes lung tumor cell growth. Our findings demonstrate the prospects for using dense SNP maps in laboratory mice to refine previous QTL regions and identify genetic determinants of complex traits.	Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	You, M (corresponding author), Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA.	youm@msnotes.wustl.edu			NATIONAL CANCER INSTITUTE [R01CA099147, R01CA099187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012063, R01ES013340] Funding Source: NIH RePORTER; NCI NIH HHS [CA099147, CA099187] Funding Source: Medline; NIEHS NIH HHS [ES013340, ES012063] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; CHURCHILL GA, 1994, GENETICS, V138, P963; Demant P, 2003, NAT REV GENET, V4, P721, DOI 10.1038/nrg1157; FESTING MFW, 1994, GENET RES, V64, P99, DOI 10.1017/S0016672300032705; Festing MFW, 1998, GENOMICS, V53, P129, DOI 10.1006/geno.1998.5450; GARIBOLDI M, 1993, NAT GENET, V3, P132, DOI 10.1038/ng0293-132; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; HEDRICK PW, 1987, GENETICS, V117, P331; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jin YJ, 2003, J BIOL CHEM, V278, P51587, DOI 10.1074/jbc.M309165200; Lin L, 1998, EXP LUNG RES, V24, P481, DOI 10.3109/01902149809087382; MALKINSON AM, 1989, TOXICOLOGY, V54, P241, DOI 10.1016/0300-483X(89)90062-0; MALKINSON AM, 1983, J NATL CANCER I, V70, P931; McDoniels-Silvers AL, 2001, EXP LUNG RES, V27, P297, DOI 10.1080/019021401300054064; Sekido Y, 2003, ANNU REV MED, V54, P73, DOI 10.1146/annurev.med.54.101601.152202; SELLERS TA, 1992, CANCER, V69, P86, DOI 10.1002/1097-0142(19920101)69:1<86::AID-CNCR2820690116>3.0.CO;2-S; SELLERS TA, 1990, J NATL CANCER I, V82, P1272, DOI 10.1093/jnci/82.15.1272; SELLERS TA, 1991, GENET EPIDEMIOL, V8, P199, DOI 10.1002/gepi.1370080306; Tripodis N, 2001, J NATL CANCER I, V93, P1484, DOI 10.1093/jnci/93.19.1484; Wade CM, 2005, NAT GENET, V37, P1175, DOI 10.1038/ng1666; Wang M, 2003, CANCER RES, V63, P3317; Yalcin B, 2004, P NATL ACAD SCI USA, V101, P9734, DOI 10.1073/pnas.0401189101; You M, 1998, HEMATOL ONCOL CLIN N, V12, P1037, DOI 10.1016/S0889-8588(05)70040-X; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zhang ZQ, 2003, P NATL ACAD SCI USA, V100, P12642, DOI 10.1073/pnas.2133947100	25	63	63	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2006	38	8					888	895		10.1038/ng1849	http://dx.doi.org/10.1038/ng1849			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16862160				2022-12-27	WOS:000239325700017
J	O'Neill, LP; VerMilyea, MD; Turner, BM				O'Neill, Laura P.; VerMilyea, Matthew D.; Turner, Bryan M.			Epigenetic characterization of the early embryo with a chromatin immunoprecipitation protocol applicable to small cell populations	NATURE GENETICS			English	Article							HISTONE LYSINE METHYLATION; STEM-CELLS; IN-VIVO; MOUSE BLASTOCYST; ACETYLATION; GENES; DIFFERENTIATION; PLURIPOTENCY; EXPRESSION; TROPHECTODERM	Chromatin immunoprecipitation (ChIP) defines the genomic distribution of proteins and their modifications but is limited by the cell numbers required (ideally 4107). Here we describe a protocol that uses carrier chromatin and PCR, 'carrier' ChIP (CChIP), to permit analysis of as few as 100 cells. We assayed histone modifications at key regulator genes (such as Nanog, Pou5f1 (also known as Oct4) and Cdx2) by CChIP in mouse embryonic stem (ES) cells and in inner cell mass (ICM) and trophectoderm of cultured blastocysts. Activating and silencing modifications (H4 acetylation and H3K9 methylation) mark active and silent promoters as predicted, and we find close correlation between values derived from CChIP (1,000 ES cells) and conventional ChIP (5 x 10(7) ES cells). Studies on genes silenced in both ICM and ES cells (Cdx2, Cfc1, Hhex and Nkx2-2, also known as Nkx) show that the intensity of silencing marks is relatively diminished in ES cells, indicating a possible relaxation of some components of silencing on adaptation to culture.	Univ Birmingham, Sch Med, Biomed Res Inst, Chromatin & Gene Express Grp, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Turner, BM (corresponding author), Univ Birmingham, Sch Med, Biomed Res Inst, Chromatin & Gene Express Grp, Birmingham B15 2TT, W Midlands, England.	b.m.turner@bham.ac.uk						Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Arney KL, 2004, J CELL SCI, V117, P4355, DOI 10.1242/jcs.01390; Baxter J, 2004, EMBO J, V23, P4462, DOI 10.1038/sj.emboj.7600414; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Geisberg JV, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh148; Gilbert N, 2005, INT REV CYTOL, V242, P283; Gregory R I, 1999, Nucleic Acids Res, V27, pe32, DOI 10.1093/nar/27.22.e32; Gregory RI, 2002, J BIOL CHEM, V277, P11728, DOI 10.1074/jbc.M105775200; HANDYSIDE AH, 1984, J EXP ZOOL, V231, P429, DOI 10.1002/jez.1402310317; HARVEY MB, 1990, DEVELOPMENT, V110, P963; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; Jones PA, 2005, CANCER RES, V65, P11241, DOI 10.1158/0008-5472.CAN-05-3865; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Merkenschlager M, 2004, J EXP MED, V200, P1437, DOI 10.1084/jem.20041127; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; NORRIS DP, 1994, CELL, V77, P41, DOI 10.1016/0092-8674(94)90233-X; O'Neill LP, 1999, EMBO J, V18, P2897, DOI 10.1093/emboj/18.10.2897; O'Neill LP, 2003, HUM MOL GENET, V12, P1783, DOI 10.1093/hmg/ddg193; ONEILL LP, 1995, EMBO J, V14, P3946, DOI 10.1002/j.1460-2075.1995.tb00066.x; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Perry P, 2004, CELL CYCLE, V3, P1645; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Robyr D, 2003, METHODS, V31, P83, DOI 10.1016/S1046-2023(03)00091-4; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Santos F, 2004, REPRODUCTION, V127, P643, DOI 10.1530/rep.1.00221; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Szutorisz H, 2005, BIOESSAYS, V27, P1286, DOI 10.1002/bies.20330; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; TURNER BM, 1989, EUR J BIOCHEM, V179, P131, DOI 10.1111/j.1432-1033.1989.tb14530.x; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; White DA, 1999, METHODS, V19, P417, DOI 10.1006/meth.1999.0878; Wiblin AE, 2005, J CELL SCI, V118, P3861, DOI 10.1242/jcs.02500	50	212	236	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					835	841		10.1038/ng1820	http://dx.doi.org/10.1038/ng1820			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16767102				2022-12-27	WOS:000238669300022
J	Mallory, AC; Vaucheret, H				Mallory, Allison C.; Vaucheret, Herve			Functions of microRNAs and related small RNAs in plants	NATURE GENETICS			English	Review							TRANS-ACTING SIRNAS; BINDING-PROTEIN HYL1; CLASS IIIHD-ZIP; ARABIDOPSIS DEVELOPMENT; ANTISENSE TRANSCRIPTS; DIRECTED CLEAVAGE; VIRAL SUPPRESSOR; GENE; BIOGENESIS; AUXIN	MicroRNAs (miRNAs) and short interfering RNAs (siRNAs), 20- to 27-nt in length, are essential regulatory molecules that act as sequence-specific guides in several processes in most eukaryotes (with the notable exception of the yeast Saccharomyces cerevisiae). These processes include DNA elimination, heterochromatin assembly, mRNA cleavage and translational repression. This review focuses on the regulatory roles of plant miRNAs during development, in the adaptive response to stresses and in the miRNA pathway itself. This review also covers the regulatory roles of two classes of endogenous plant siRNAs, ta-siRNAs and nat-siRNAs, which participate in post-transcriptional control of gene expression.	[Vaucheret, Herve] INRA, Inst Jean Pierre Bourgin, Biochim Cellulaire Lab, F-78026 Versailles, France; [Mallory, Allison C.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	INRAE; UDICE-French Research Universities; Universite Paris Saclay; Massachusetts Institute of Technology (MIT); Whitehead Institute	Vaucheret, H (corresponding author), INRA, Inst Jean Pierre Bourgin, Biochim Cellulaire Lab, F-78026 Versailles, France.	herve.vaucheret@versailles.inra.fr		VAUCHERET, HERVE/0000-0002-9986-0988				Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Akbergenov R, 2006, NUCLEIC ACIDS RES, V34, P462, DOI 10.1093/nar/gkj447; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Baker CC, 2005, CURR BIOL, V15, P303, DOI 10.1016/j.cub.2005.02.017; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Brennecke J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-228; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chen XM, 2002, DEVELOPMENT, V129, P1085; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Dunoyer P, 2005, CURR OPIN PLANT BIOL, V8, P415, DOI 10.1016/j.pbi.2005.05.012; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Dunoyer P, 2006, NAT GENET, V38, P258, DOI 10.1038/ng1722; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Gustafson AM, 2005, NUCLEIC ACIDS RES, V33, pD637, DOI 10.1093/nar/gki127; Han MH, 2004, P NATL ACAD SCI USA, V101, P1093, DOI 10.1073/pnas.0307969100; Hiraguri A, 2005, PLANT MOL BIOL, V57, P173, DOI 10.1007/s11103-004-6853-5; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kim J, 2005, PLANT J, V42, P84, DOI 10.1111/j.1365-313X.2005.02354.x; Kim VN, 2005, MOL CELLS, V19, P1; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li HW, 2005, FEBS LETT, V579, P5965, DOI 10.1016/j.febslet.2005.08.034; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Llave C, 2004, MOL PLANT PATHOL, V5, P361, DOI 10.1111/j.1364-3703.2004.00227.x; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu C, 2000, PLANT CELL, V12, P2351, DOI 10.1105/tpc.12.12.2351; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lynn K, 1999, DEVELOPMENT, V126, P469; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Mallory AC, 2002, P NATL ACAD SCI USA, V99, P15228, DOI 10.1073/pnas.232434999; Matzke MA, 2001, CURR OPIN GENET DEV, V11, P221, DOI 10.1016/S0959-437X(00)00183-0; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Park MY, 2005, P NATL ACAD SCI USA, V102, P3691, DOI 10.1073/pnas.0405570102; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Pruss G, 1997, PLANT CELL, V9, P859, DOI 10.1105/tpc.9.6.859; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Simon-Mateo C, 2006, J VIROL, V80, P2429, DOI 10.1128/JVI.80.5.2429-2436.2006; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Takeda A, 2005, EMBO J, V24, P3147, DOI 10.1038/sj.emboj.7600776; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Telfer A, 1998, DEVELOPMENT, V125, P1889; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vance V, 2001, SCIENCE, V292, P2277, DOI 10.1126/science.1061334; Vaucheret H, 2006, MOL CELL, V22, P129, DOI 10.1016/j.molcel.2006.03.011; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130	95	602	657	1	105	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38			6			S31	S36		10.1038/ng1791	http://dx.doi.org/10.1038/ng1791			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V44DK	16736022				2022-12-27	WOS:000202983200007
J	Smyth, DJ; Cooper, JD; Bailey, R; Field, S; Burren, O; Smink, LJ; Guja, C; Ionescu-Tirgoviste, C; Widmer, B; Dunger, DB; Savage, DA; Walker, NM; Clayton, DG; Todd, JA				Smyth, Deborah J.; Cooper, Jason D.; Bailey, Rebecca; Field, Sarah; Burren, Oliver; Smink, Luc J.; Guja, Cristian; Ionescu-Tirgoviste, Constantin; Widmer, Barry; Dunger, David B.; Savage, David A.; Walker, Neil M.; Clayton, David G.; Todd, John A.			A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region	NATURE GENETICS			English	Article							LYMPHOID TYROSINE PHOSPHATASE; GENE; DISEASE	In this study we report convincing statistical support for a sixth type 1 diabetes (T1D) locus in the innate immunity viral RNA receptor gene region IFIH1 (also known as mda-5 or Helicard) on chromosome 2q24.3. We found the association in an interim analysis of a genome-wide nonsynonymous SNP (nsSNP) scan, and we validated it in a case-control collection and replicated it in an independent family collection. In 4,253 cases, 5,842 controls and 2,134 parent-child trio genotypes, the risk ratio for the minor allele of the nsSNP rs1990760 A -> G (A946T) was 0.86 (95% confidence interval = 0.82-0.90) at P = 1.42 x 10(-10).	Addenbrookes Hosp, Cambridge Inst Med Res, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Cambridge CB2 2XY, England; Inst Diabet Nutr & Metab Dis N Paulescu, Clin Diabet, Bucharest 79811, Romania; Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Cambridge CB2 2XY, England; Queens Univ Belfast, Dept Med Genet, Belfast BT9 7AB, Antrim, North Ireland	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Queens University Belfast	Todd, JA (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	john.todd@cimr.cam.ac.uk	Todd, John A/A-3542-2010; Guja, Cristian/K-2334-2019	Todd, John A/0000-0003-2740-8148; Walker, Neil/0000-0001-9796-7688; Burren, Oliver/0000-0002-3388-5760; Dunger, Professor David/0000-0002-2566-9304; smyth, deborah/0000-0002-6330-2669	Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust [068545/Z/02] Funding Source: Medline; MRC [G0000934] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Barratt BJ, 2004, DIABETES, V53, P1884, DOI 10.2337/diabetes.53.7.1884; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cucca F, 2001, HUM MOL GENET, V10, P2025, DOI 10.1093/hmg/10.19.2025; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Weinberg CR, 1998, AM J HUM GENET, V62, P969, DOI 10.1086/301802	15	492	512	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					617	619		10.1038/ng1800	http://dx.doi.org/10.1038/ng1800			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16699517				2022-12-27	WOS:000237954800012
J	Stephens, M; Sloan, JS; Robertson, PD; Scheet, P; Nickerson, DA				Stephens, M; Sloan, JS; Robertson, PD; Scheet, P; Nickerson, DA			Automating sequence-based detection and genotyping of SNPs from diploid samples	NATURE GENETICS			English	Article							HUMAN GENOME; POLYMORPHISMS; DISCOVERY; PATTERNS; GENES; TOOL	The detection of sequence variation, for which DNA sequencing has emerged as the most sensitive and automated approach, forms the basis of all genetic analysis. Here we describe and illustrate an algorithm that accurately detects and genotypes SNPs from fluorescence-based sequence data. Because the algorithm focuses particularly on detecting SNPs through the identification of heterozygous individuals, it is especially well suited to the detection of SNPs in diploid samples obtained after DNA amplification. It is substantially more accurate than existing approaches and, notably, provides a useful quantitative measure of its confidence in each potential SNP detected and in each genotype called. Calls assigned the highest confidence are sufficiently reliable to remove the need for manual review in several contexts. For example, for sequence data from 47-90 individuals sequenced on both the forward and reverse strands, the highest-confidence calls from our algorithm detected 93% of all SNPs and 100% of high-frequency SNPs, with no false positive SNPs identified and 99.9% genotyping accuracy. This algorithm is implemented in a software package, PolyPhred version 5.0, which is freely available for academic use.	Univ Washington, Dept Stat, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stephens, M (corresponding author), Univ Washington, Dept Stat, Seattle, WA 98195 USA.	stephens@stat.washington.edu			NHGRI NIH HHS [1R01HG/LM-02585, T32 HG00035-06] Funding Source: Medline; NHLBI NIH HHS [HL-66682] Funding Source: Medline; NIEHS NIH HHS [ES-15478] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066682] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585, T32HG000035] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bhangale TR, 2005, HUM MOL GENET, V14, P59, DOI 10.1093/hmg/ddi006; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Carlson CS, 2001, CURR OPIN CHEM BIOL, V5, P78, DOI 10.1016/S1367-5931(00)00171-X; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; KWOK PY, 1994, GENOMICS, V23, P138, DOI 10.1006/geno.1994.1469; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Olden K, 2000, NAT REV GENET, V1, P149, DOI 10.1038/35038586; Parker LT, 1996, BIOTECHNIQUES, V21, P694; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005; [No title captured]	17	119	130	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2006	38	3					375	381		10.1038/ng1746	http://dx.doi.org/10.1038/ng1746			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16493422				2022-12-27	WOS:000235589600022
J	Nybakken, K; Vokes, SA; Lin, TY; McMahon, AP; Perrimon, N				Nybakken, K; Vokes, SA; Lin, TY; McMahon, AP; Perrimon, N			A genome-wide RNA interference screen in Drosophila melanogaster cells for new components of the Hh signaling pathway	NATURE GENETICS			English	Article							MESSENGER-RNA; CUBITUS INTERRUPTUS; PROTEIN-KINASE; SUBCELLULAR-LOCALIZATION; GENE-EXPRESSION; HEDGEHOG; COMPLEX; PHOSPHORYLATION; FAMILY; EXPORT	Members of the Hedgehog (Hh) family of signaling proteins are powerful regulators of developmental processes in many organisms and have been implicated in many human disease states. Here we report the results of a genome-wide RNA interference screen in Drosophila melanogaster cells for new components of the Hh signaling pathway. The screen identified hundreds of potential new regulators of Hh signaling, including many large protein complexes with pleiotropic effects, such as the coat protein complex I ( COPI) complex, the ribosome and the proteasome. We identified the multimeric protein phosphatase 2A (PP2A) and two new kinases, the D. melanogaster orthologs of the vertebrate PITSLRE and cyclin-dependent kinase-9 (CDK9) kinases, as Hh regulators. We also identified a large group of constitutive and alternative splicing factors, two nucleoporins involved in mRNA export and several RNA-regulatory proteins as potent regulators of Hh signal transduction, indicating that splicing regulation and mRNA transport have a previously unrecognized role in Hh signaling. Finally, we showed that several of these genes have conserved roles in mammalian Hh signaling.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Nybakken, K (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	knybakke@receptor.med.harvard.edu; perrimon@receptor.med.harvard.edu	McMahon, Andrew P/ABE-7520-2020	Vokes, Steven/0000-0002-1724-0102; Perrimon, Norbert/0000-0001-7542-472X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM064232] Funding Source: NIH RePORTER; NIGMS NIH HHS [F32 GM064232] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ascano M, 2002, MOL CELL BIOL, V22, P1555, DOI 10.1128/MCB.22.5.1555-1566.2002; Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029; Bastos R, 1996, J CELL BIOL, V134, P1141, DOI 10.1083/jcb.134.5.1141; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BOND BJ, 1986, MOL CELL BIOL, V6, P2080, DOI 10.1128/MCB.6.6.2080; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Burnette JM, 1999, GENETICS, V151, P1517; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Chung SY, 1999, RNA, V5, P1042, DOI 10.1017/S1355838299990635; Collins RT, 2005, GENETICS, V170, P173, DOI 10.1534/genetics.104.039420; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; De Falco G, 1998, J CELL PHYSIOL, V177, P501, DOI 10.1002/(SICI)1097-4652(199812)177:4<501::AID-JCP1>3.0.CO;2-4; De Luca A, 2003, J CELL PHYSIOL, V194, P101, DOI 10.1002/jcp.10196; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Foley E, 2004, PLOS BIOL, V2, P1091, DOI 10.1371/journal.pbio.0020203; Garriga J, 2004, GENE, V337, P15, DOI 10.1016/j.gene.2004.05.007; Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X; Hu DL, 2003, J BIOL CHEM, V278, P8623, DOI 10.1074/jbc.M210057200; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; KELLEY RL, 1993, GENE DEV, V7, P948, DOI 10.1101/gad.7.6.948; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Lahti J M, 1995, Prog Cell Cycle Res, V1, P329; Lall S, 1999, CELL, V98, P171, DOI 10.1016/S0092-8674(00)81012-0; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Noureddine MA, 2002, DEV CELL, V2, P757, DOI 10.1016/S1534-5807(02)00164-8; Nybakken K, 2002, CURR OPIN GENET DEV, V12, P503, DOI 10.1016/S0959-437X(02)00333-7; Nybakken KE, 2002, J BIOL CHEM, V277, P24638, DOI 10.1074/jbc.M110730200; Ogden SK, 2004, BIOCHEM PHARMACOL, V67, P805, DOI 10.1016/j.bcp.2004.01.002; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Pyronnet S, 2005, CELL MOL LIFE SCI, V62, P1267, DOI 10.1007/s00018-005-5020-8; Raisin-Tani S, 2002, BIOCHEM BIOPH RES CO, V296, P288, DOI 10.1016/S0006-291X(02)00863-X; Randsholt NB, 2000, MECH DEVELOP, V95, P89, DOI 10.1016/S0925-4773(00)00342-7; Robbins DJ, 1997, CELL, V90, P225, DOI 10.1016/S0092-8674(00)80331-1; Taylor FR, 2001, BIOCHEMISTRY-US, V40, P4359, DOI 10.1021/bi002487u; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; Trembley JH, 2002, J BIOL CHEM, V277, P2589, DOI 10.1074/jbc.M109755200; Ullman KS, 1999, MOL BIOL CELL, V10, P649, DOI 10.1091/mbc.10.3.649; Wang QT, 1999, DEVELOPMENT, V126, P5097; ZHANG K, 1991, GENE DEV, V5, P1080, DOI 10.1101/gad.5.6.1080	49	145	155	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2005	37	12					1323	1332		10.1038/ng1682	http://dx.doi.org/10.1038/ng1682			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16311596	Green Accepted			2022-12-27	WOS:000233657300011
J	Jeffreys, AJ; Neumann, R; Panayi, M; Myers, S; Donnelly, P				Jeffreys, AJ; Neumann, R; Panayi, M; Myers, S; Donnelly, P			Human recombination hot spots hidden in regions of strong marker association	NATURE GENETICS			English	Article							LINKAGE-DISEQUILIBRIUM; HAPLOTYPE BLOCKS; HUMAN GENOME; MEIOTIC CROSSOVER; RATES; DIVERSITY; HISTORY	The fine-scale distribution of meiotic recombination events in the human genome can be inferred from patterns of haplotype diversity in human populations(1-5) but directly studied only by high-resolution sperm typing(6-8). Both approaches indicate that crossovers are heavily clustered into narrow recombination hot spots. But our direct understanding of hot-spot properties and distributions is largely limited to sperm typing in the major histocompatibility complex (MHC)(7). We now describe the analysis of an unremarkable 206-kb region on human chromosome 1, which identified localized regions of linkage disequilibrium breakdown that mark the locations of sperm crossover hot spots. The distribution, intensity and morphology of these hot spots are markedly similar to those in the MHC. But we also accidentally detected additional hot spots in regions of strong association. Coalescent analysis of genotype data detected most of the hot spots but showed significant differences between sperm crossover frequencies and historical recombination rates. This raises the possibility that some hot spots, particularly those in regions of strong association, may have evolved very recently and not left their full imprint on haplotype diversity. These results suggest that hot spots could be very abundant and possibly fluid features of the human genome.	Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Leicester; University of Oxford	Jeffreys, AJ (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	ajj@le.ac.uk	Myers, Simon R/A-6792-2015	Myers, Simon R/0000-0002-2585-9626; Donnelly, Peter/0000-0001-9495-3408				Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Fearnhead P, 2004, GENETICS, V167, P2067, DOI 10.1534/genetics.103.021584; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GRIFFITHS RC, 1996, IMA VOLUME MATH POPU, P257; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Jeffreys AJ, 2000, HUM MOL GENET, V9, P725, DOI 10.1093/hmg/9.5.725; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Li N, 2003, GENETICS, V165, P2213; May CA, 2002, NAT GENET, V31, P272, DOI 10.1038/ng918; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Morton N. E., 1982, OUTLINE GENETIC EPID; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Ptak SE, 2004, PLOS BIOL, V2, P849, DOI 10.1371/journal.pbio.0020155; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stumpf MPH, 2004, EUR J HUM GENET, V12, P469, DOI 10.1038/sj.ejhg.5201179; Stumpf MPH, 2003, NAT REV GENET, V4, P959, DOI 10.1038/nrg1227; Wall JD, 2003, AM J HUM GENET, V73, P1330, DOI 10.1086/380311; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	30	138	146	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					601	606		10.1038/ng1565	http://dx.doi.org/10.1038/ng1565			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15880103				2022-12-27	WOS:000229495300013
J	Roepman, P; Wessels, LFA; Kettelarij, N; Kemmeren, P; Miles, AJ; Lijnzaad, P; Tilanus, MGJ; Koole, R; Hordijk, GJ; van der Vliet, PC; Reinders, MJT; Slootweg, PJ; Holstege, FCP				Roepman, P; Wessels, LFA; Kettelarij, N; Kemmeren, P; Miles, AJ; Lijnzaad, P; Tilanus, MGJ; Koole, R; Hordijk, GJ; van der Vliet, PC; Reinders, MJT; Slootweg, PJ; Holstege, FCP			An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas	NATURE GENETICS			English	Article							GENE-EXPRESSION; MOLECULAR CLASSIFICATION; TUMOR PROGRESSION; SHOULDER PAIN; CANCER; DISSECTION; SITES; PRESERVATION; REVEALS	Metastasis is the process by which cancers spread to distinct sites in the body. It is the principal cause of death in individuals suffering from cancer. For some types of cancer, early detection of metastasis at lymph nodes close to the site of the primary tumor is pivotal for appropriate treatment. Because it can be difficult to detect lymph node metastases reliably, many individuals currently receive inappropriate treatment. We show here that DNA microarray gene-expression profiling can detect lymph node metastases for primary head and neck squamous cell carcinomas that arise in the oral cavity and oropharynx. The predictor, established with an 82-tumor training set, outperforms current clinical diagnosis when independently validated. The 102 predictor genes offer unique insights into the processes underlying metastasis. The results show that the metastatic state can be deciphered from the primary tumor gene-expression pattern and that treatment can be substantially improved.	Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; Delft Univ Technol, Fac Elect Engn Math & Comp Sci, NL-2628 CD Delft, Netherlands; Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands; Univ Med Ctr utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands; Univ Med Ctr utrecht, Dept Oral & Maxillofacial Surg, NL-3584 CX Utrecht, Netherlands; Univ Med Ctr utrecht, Dept Otorhinolaryngol, NL-3584 CX Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Delft University of Technology; Netherlands Cancer Institute; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Holstege, FCP (corresponding author), Univ Med Ctr Utrecht, Dept Physiol Chem, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	f.c.p.holstege@med.uu.nl	Holstege, Frank/AAM-9944-2021; Slootweg, P.J./H-8089-2014; Lijnzaad, Philip/ABE-4205-2021	Lijnzaad, Philip/0000-0002-7535-583X; Kemmeren, Patrick/0000-0003-2237-7354				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Freier K, 2003, CANCER RES, V63, P1179; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; HAHN SS, 1987, INT J RADIAT ONCOL, V13, P1143, DOI 10.1016/0360-3016(87)90186-6; Hoffman EP, 2004, NAT REV GENET, V5, P229, DOI 10.1038/nrg1297; Huang Q, 2002, GENE CHROMOSOME CANC, V34, P224, DOI 10.1002/gcc.10062; JONES AS, 1994, CLIN OTOLARYNGOL, V19, P63, DOI 10.1111/j.1365-2273.1994.tb01150.x; JONES AS, 1993, EUR ARCH OTO-RHINO-L, V250, P446; JONES KR, 1992, ARCH OTOLARYNGOL, V118, P483; Matsuo S, 1999, PATHOL INT, V49, P383, DOI 10.1046/j.1440-1827.1999.00887.x; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pillsbury HC, 1997, LARYNGOSCOPE, V107, P1294, DOI 10.1097/00005537-199710000-00004; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Robbins KT, 2002, ARCH OTOLARYNGOL, V128, P751, DOI 10.1001/archotol.128.7.751; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Sankaranarayanan R, 1998, ANTICANCER RES, V18, P4779; SHORT SO, 1984, AM J SURG, V148, P478, DOI 10.1016/0002-9610(84)90373-8; Takes RP, 2001, J PATHOL, V194, P298, DOI 10.1002/1096-9896(200107)194:3<298::AID-PATH900>3.0.CO;2-Q; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Wilgen CP, 2003, J CRANIO MAXILL SURG, V31, P183, DOI 10.1016/S1010-5182(03)00030-1; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Woolgar JA, 1999, BRIT J ORAL MAX SURG, V37, P205, DOI 10.1054/bjom.1999.0035	30	316	334	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					182	186		10.1038/ng1502	http://dx.doi.org/10.1038/ng1502			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	15640797				2022-12-27	WOS:000226690100026
J	Oleksiak, MF; Roach, JL; Crawford, DL				Oleksiak, MF; Roach, JL; Crawford, DL			Natural variation in cardiac metabolism and gene expression in Fundulus heteroclitus	NATURE GENETICS			English	Article							GLYCOLYTIC ENZYME EXPRESSION; PATTERNS; POPULATIONS; VARIANCE; YEAST; BLOOD	Individual variation in gene expression is important for evolutionary adaptation(1,2) and susceptibility to diseases and pathologies(3,4). In this study, we address the functional importance of this variation by comparing cardiac metabolism to patterns of mRNA expression using microarrays. There is extensive variation in both cardiac metabolism and the expression of metabolic genes among individuals of the teleost fish Fundulus heteroclitus from natural outbred populations raised in a common environment: metabolism differed among individuals by a factor of more than 2, and expression levels of 94% of genes were significantly different (P < 0.01) between individuals in a population. This unexpectedly high variation in metabolic gene expression explains much of the variation in metabolism, suggesting that it is biologically relevant. The patterns of gene expression that are most important in explaining cardiac metabolism differ between groups of individuals. Apparently, the variation in metabolism seems to be related to different patterns of gene expression in the different groups of individuals. The magnitude of differences in gene expression in these groups is not important; large changes in expression have no greater predictive value than small changes. These data suggest that variation in physiological performance is related to the subtle variation in gene expression and that this relationship differs among individuals.	Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, NIEHS,Marine & Freshwater Biomed Sci Ctr, Miami, FL 33149 USA; N Carolina State Univ, Dept Environm & Mol Toxicol, Raleigh, NC 27695 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Miami; University of North Carolina; North Carolina State University	Crawford, DL (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Div Marine Biol & Fisheries, NIEHS,Marine & Freshwater Biomed Sci Ctr, Miami, FL 33149 USA.	dcrawford@rsmas.miami.edu		Crawford, Douglas/0000-0002-6239-4012	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065470] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL065470-03, R01 HL065470-02, R01 HL065470-01A2] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bray NJ, 2003, HUM GENET, V113, P149, DOI 10.1007/s00439-003-0956-y; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; BROWN BL, 1991, EVOLUTION, V45, P1147, DOI 10.1111/j.1558-5646.1991.tb04381.x; CRAWFORD DL, 1989, P NATL ACAD SCI USA, V86, P9365, DOI 10.1073/pnas.86.23.9365; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kerr MK, 2002, STAT SINICA, V12, P203; Kerr MK, 2001, GENET RES, V77, P123; Knight JC, 2004, TRENDS GENET, V20, P113, DOI 10.1016/j.tig.2004.01.001; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Oleksiak MF, 2001, MAR BIOTECHNOL, V3, pS203, DOI 10.1007/s10126-001-0043-0; PASCHALL JE, IN PRESS BMC GENOMIC; Pierce VA, 1997, SCIENCE, V276, P256, DOI 10.1126/science.276.5310.256; Podrabsky JE, 2000, AM J PHYSIOL-REG I, V279, pR2344, DOI 10.1152/ajpregu.2000.279.6.R2344; Powers Dennis A., 1993, Oxford Surveys in Evolutionary Biology, V9, P43; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; Radich JP, 2004, GENOMICS, V83, P980, DOI 10.1016/j.ygeno.2003.12.013; Sokal R. R, 1981, BIOMETRY; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Westfall P.H., 1993, RESAMPLING BASED MUL, P340; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	25	157	161	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2005	37	1					67	72		10.1038/ng1483	http://dx.doi.org/10.1038/ng1483			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15568023	Green Accepted			2022-12-27	WOS:000225997500022
J	Patrinos, A				Patrinos, A			'Race' and the human genome	NATURE GENETICS			English	Editorial Material									US DOE, Off Sci, Washington, DC 20585 USA	United States Department of Energy (DOE)	Patrinos, A (corresponding author), US DOE, Off Sci, Washington, DC 20585 USA.							Barsh GS, 2003, PLOS BIOL, V1, P19, DOI 10.1371/journal.pbio.0000027; 2001, NAT GENET, V409, P860	2	14	14	1	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2004	36	11		S			S1	S2		10.1038/ng2150	http://dx.doi.org/10.1038/ng2150			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	867PH	15510100	Bronze			2022-12-27	WOS:000224854000001
J	Koolen, DA; Vissers, LELM; Pfundt, R; de Leeuw, N; Knight, SJL; Regan, R; Kooy, RF; Reyniers, E; Romano, C; Fichera, M; Schinzel, A; Baumer, A; Anderlid, BM; Schoumans, J; Knoers, NV; van Kessel, AG; Sistermans, EA; Veltman, JA; Brunner, HG; de Vries, BBA				Koolen, David A.; Vissers, Lisenka E. L. M.; Pfundt, Rolph; de Leeuw, Nicole; Knight, Samantha J. L.; Regan, Regina; Kooy, R. Frank; Reyniers, Edwin; Romano, Corrado; Fichera, Marco; Schinzel, Albert; Baumer, Alessandra; Anderlid, Britt-Marie; Schoumans, Jacqueline; Knoers, Nine V.; van Kessel, Ad Geurts; Sistermans, Erik A.; Veltman, Joris A.; Brunner, Han G.; de Vries, Bert B. A.			A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; FRONTOTEMPORAL DEMENTIA; TAU; MAPT	Submicroscopic genomic copy number changes have been identified only recently as an important cause of mental retardation. We describe the detection of three interstitial, overlapping 17q21.31 microdeletions in a cohort of 1,200 mentally retarded individuals associated with a clearly recognizable clinical phenotype of mental retardation, hypotonia and a characteristic face. The deletions encompass the MAPT and CRHR1 genes and are associated with a common inversion polymorphism.	Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Churchill Hosp, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Antwerp VIB, Dept Med Genet, B-2610 Antwerp, Belgium; IRCCS, Oasi Inst Res Mental Retardat & Brain Aging, I-94018 Troina, Italy; Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland; Karolinska Hosp, Dept Mol Med & Surg, S-17176 Stockholm, Sweden	Radboud University Nijmegen; University of Oxford; Wellcome Centre for Human Genetics; Flanders Institute for Biotechnology (VIB); University of Antwerp; IRCCS Oasi Maria SS; University of Zurich; Karolinska Institutet; Karolinska University Hospital	de Vries, BBA (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.	b.devries@antrg.umcn.nl	Koolen, D.A./L-4448-2015; Pfundt, Rolph/L-4576-2015; Kooy, Frank/F-5276-2014; Veltman, Joris A/F-5128-2010; van Kessel, Ad Geurts/A-2810-2010; Sistermans, Erik/B-1109-2009; Vissers, Lisenka ELM/A-2598-2015; Romano, Corrado/B-9695-2008; Brunner, Han/C-9928-2013; de Leeuw, N./L-4480-2015; Fichera, Marco/K-9220-2016	Kooy, Frank/0000-0003-2024-0485; Veltman, Joris A/0000-0002-3218-8250; Sistermans, Erik/0000-0001-7187-4563; Vissers, Lisenka ELM/0000-0001-6470-5497; Romano, Corrado/0000-0003-1049-0683; Fichera, Marco/0000-0002-8225-6880; Knight, Samantha/0000-0002-6047-3462				Cruts M, 2005, HUM MOL GENET, V14, P1753, DOI 10.1093/hmg/ddi182; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Donnai D, 2000, AM J MED GENET, V97, P164, DOI 10.1002/1096-8628(200022)97:2<164::AID-AJMG8>3.0.CO;2-F; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ikegami S, 2000, NEUROSCI LETT, V279, P129, DOI 10.1016/S0304-3940(99)00964-7; Lindsay EA, 2001, NAT REV GENET, V2, P858, DOI 10.1038/35098574; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Rademakers R, 2004, HUM MUTAT, V24, P277, DOI 10.1002/humu.20086; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Varela MC, 2006, CYTOGENET GENOME RES, V114, P89, DOI 10.1159/000091934	15	331	340	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					999	1001		10.1038/ng1853	http://dx.doi.org/10.1038/ng1853			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16906164				2022-12-27	WOS:000240112100015
J	Gribouval, O; Gonzales, M; Neuhaus, T; Aziza, J; Bieth, E; Laurent, N; Bouton, JM; Feuillet, F; Makni, S; Ben Amar, H; Laube, G; Delezoide, AL; Bouvier, R; Dijoud, F; Ollgnon-Roman, E; Roume, J; Joubert, M; Antignac, C; Gubler, MC				Gribouval, O; Gonzales, M; Neuhaus, T; Aziza, J; Bieth, E; Laurent, N; Bouton, JM; Feuillet, F; Makni, S; Ben Amar, H; Laube, G; Delezoide, AL; Bouvier, R; Dijoud, F; Ollgnon-Roman, E; Roume, J; Joubert, M; Antignac, C; Gubler, MC			Mutations in genes in the renin-angiotensin system are associated with autosomal recessive renal tubular dysgenesis	NATURE GENETICS			English	Article							II TYPE-1 RECEPTOR; KIDNEY; FETAL; HYPOCALVARIA; EXPRESSION	Autosomal recessive renal tubular dysgenesis is a severe disorder of renal tubular development characterized by persistent fetal anuria and perinatal death, probably due to pulmonary hypoplasia from early- onset oligohydramnios ( Potter phenotype). Absence or paucity of differentiated proximal tubules is the histopathological hallmark of the disease and may be associated with skull ossification defects. We studied 11 individuals with renal tubular dysgenesis, belonging to nine families, and found that they had homozygous or compound heterozygous mutations in the genes encoding renin, angiotensinogen, angiotensin converting enzyme or angiotensin II receptor type 1. We propose that renal lesions and early anuria result from chronic low perfusion pressure of the fetal kidney, a consequence of renin- angiotensin system inactivity. This is the first identification to our knowledge of a renal mendelian disorder linked to genetic defects in the renin-angiotensin system, highlighting the crucial role of the renin-angiotensin system in human kidney development.	Univ Paris 05, Hop Necker Enfants Malad, INSERM, U574, F-75743 Paris, France; Hop St Antoine, Unite Foetopathol, F-75012 Paris, France; Univ Zurich, Childrens Hosp, CH-8032 Zurich, Switzerland; Hop Purpan, Serv Genet Med, F-31059 Toulouse, France; Hop Purpan, Anat Pathol Lab, F-31059 Toulouse, France; CHU, Serv Anat Pathol, F-21079 Dijon, France; Hop Prive Antony, F-92160 Antony, France; CHU Brasbois, Hop Enfants, Serv med Infantile, F-54511 Vandoeuvre Les Nancy, France; Hop Habib Bourguiba, Serv Genet Med, Sfax, Tunisia; Hop Hedi Chaker, Serv Neonatol, Sfax 3029, Tunisia; Hop Robert Debre, Unite Foetopathol, F-75019 Paris, France; Hop Edouard Herriot, Anat Pathol Lab, F-69437 Lyon, France; Hop Debrousse, Anat Pathol Lab, F-69322 Lyon, France; Hop Croix Rousse, Ctr Diagnost Antenatal, F-69317 Lyon, France; CHU Poissy St Germain, Serv Histoembryol, F-78303 Poissy, France; Hop Hotel Dieu, Serv Anat Pathol, F-44093 Nantes, France; Univ Paris 05, Hop Necker Enfants Malad, Dept Genet, F-75743 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; University Children's Hospital Zurich; University of Zurich; CHU de Toulouse; CHU de Toulouse; CHU Dijon Bourgogne; CHU de Nancy; Universite de Sfax; Hopital Habib Bourguiba; Universite de Sfax; Hopital Hedi Chaker; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; CHU Lyon; CHU Lyon; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Gubler, MC (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, INSERM, U574, 149 Rue Sevres, F-75743 Paris, France.	gubler@necker.fr	Gribouval, Olivier/A-7689-2015; ANTIGNAC, Corinne/H-8945-2017	Gribouval, Olivier/0000-0003-0238-8224; ANTIGNAC, Corinne/0000-0002-9934-4940; Gubler, Marie-Claire/0000-0002-3526-5661				ALLANSON JE, 1992, AM J MED GENET, V43, P811, DOI 10.1002/ajmg.1320430512; ALLANSON JE, 1983, AM J MED GENET, V16, P57, DOI 10.1002/ajmg.1320160110; ARIEL I, 1995, PEDIATR PATHOL LAB M, V15, P915, DOI 10.3109/15513819509027027; BARR M, 1991, TERATOLOGY, V44, P485, DOI 10.1002/tera.1420440503; GAILLARD I, 1989, DNA-J MOLEC CELL BIO, V8, P87, DOI 10.1089/dna.1.1989.8.87; GENEST DR, 1991, HUM PATHOL, V22, P147, DOI 10.1016/0046-8177(91)90036-O; Gubler MC, 1995, ANN PEDIATR-PARIS, V42, P608; HUBERT C, 1991, J BIOL CHEM, V266, P15377; Johal JS, 1998, PEDIATR DEVEL PATHOL, V1, P433, DOI 10.1007/s100249900059; Kemper M, 2001, CLIN NEPHROL, V56, pS9; Kriegsmann J, 2000, PATHOL RES PRACT, V196, P861, DOI 10.1016/S0344-0338(00)80090-4; Kumar D, 1997, J MED GENET, V34, P541, DOI 10.1136/jmg.34.7.541; LANDING BH, 1994, PEDIATR PATHOL, V14, P87, DOI 10.3109/15513819409022029; Lopez MLSS, 2004, DEV CELL, V6, P719; Mahieu-Caputo D, 2000, AM J PATHOL, V156, P629, DOI 10.1016/S0002-9440(10)64767-0; MARCUSSEN N, 1991, LAB INVEST, V65, P558; Martinovic J, 2001, LANCET, V358, P241, DOI 10.1016/S0140-6736(01)05426-5; McFadden DE, 1997, J MED GENET, V34, P846, DOI 10.1136/jmg.34.10.846; Miura S, 2003, HYPERTENS RES, V26, P937, DOI 10.1291/hypres.26.937; Morris BJ, 1984, J HYPERTENS, V2, P231; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nishimura H, 1999, MOL CELL, V3, P1, DOI 10.1016/S1097-2765(00)80169-0; Querfeld U, 1996, J Perinatol, V16, P498; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Schutz S, 1996, AM J PATHOL, V149, P2067; SEYLE H, 1946, NATURE, V158, P131; Streatfeild-James RMA, 1998, FEBS LETT, V436, P267, DOI 10.1016/S0014-5793(98)01145-4; Takahashi N, 2004, TRENDS GENET, V20, P136, DOI 10.1016/j.tig.2004.01.004; TUFROMCREDDIE A, 1993, SEMIN NEPHROL, V13, P519; TUFROMCREDDIE A, 1994, AM J PHYSIOL, V266, pF911, DOI 10.1152/ajprenal.1994.266.6.F911	30	155	171	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					964	968		10.1038/ng1623	http://dx.doi.org/10.1038/ng1623			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16116425				2022-12-27	WOS:000231591900021
J	Bystrykh, L; Weersing, E; Dontje, B; Sutton, S; Pletcher, MT; Wiltshire, T; Su, AI; Vellenga, E; Wang, JT; Manly, KF; Lu, L; Chesler, EJ; Alberts, R; Jansen, RC; Williams, RW; Cooke, MP; de Haan, G				Bystrykh, L; Weersing, E; Dontje, B; Sutton, S; Pletcher, MT; Wiltshire, T; Su, AI; Vellenga, E; Wang, JT; Manly, KF; Lu, L; Chesler, EJ; Alberts, R; Jansen, RC; Williams, RW; Cooke, MP; de Haan, G			Uncovering regulatory pathways that affect hematopoietic stem cell function using 'genetical genomics'	NATURE GENETICS			English	Article							MICE; DISSECTION; LESSONS; MOUSE	We combined large-scale mRNA expression analysis and gene mapping to identify genes and loci that control hematopoietic stem cell (HSC) function. We measured mRNA expression levels in purified HSCs isolated from a panel of densely genotyped recombinant inbred mouse strains. We mapped quantitative trait loci (QTLs) associated with variation in expression of thousands of transcripts. By comparing the physical transcript position with the location of the controlling QTL, we identified polymorphic cis-acting stem cell genes. We also identified multiple trans-acting control loci that modify expression of large numbers of genes. These groups of coregulated transcripts identify pathways that specify variation in stem cells. We illustrate this concept with the identification of candidate genes involved with HSC turnover. We compared expression QTLs in HSCs and brain from the same mice and identified both shared and tissue- specific QTLs. Our data are accessible through WebQTL, a web-based interface that allows custom genetic linkage analysis and identification of coregulated transcripts.	Univ Groningen, Dept Stem Cell Biol, NL-9713 AV Groningen, Netherlands; Novartis Res Fdn, Gen Inst, San Diego, CA 92121 USA; Acad Hosp, Dept Haematol, Groningen, Netherlands; Roswell Pk Canc Inst, Dept Mol & Cellular Biol, Buffalo, NY 14263 USA; Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; Univ Groningen, Groningen Bioinformat Ctr, Groningen, Netherlands	University of Groningen; Novartis; University of Groningen; Roswell Park Cancer Institute; University of Tennessee System; University of Tennessee Health Science Center; University of Groningen	de Haan, G (corresponding author), Univ Groningen, Dept Stem Cell Biol, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands.	g.de.haan@med.rug.nl	Chesler, Elissa/K-4641-2019; de Haan, Gerald/D-2081-2015; Jansen, Ritsert C/C-1160-2013; de Haan, Gerald/AAF-8963-2019; Williams, Robert W./H-8789-2016	Chesler, Elissa/0000-0002-5642-5062; de Haan, Gerald/0000-0001-9706-0138; Jansen, Ritsert C/0000-0003-2977-9110; de Haan, Gerald/0000-0001-9706-0138; Su, Andrew I./0000-0002-9859-4104; Williams, Robert W./0000-0001-8924-4447				BENDAVID Y, 1990, P NATL ACAD SCI USA, V87, P1332, DOI 10.1073/pnas.87.4.1332; BOULTWOOD J, 1994, BLOOD, V84, P3253; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; De Haan G, 1999, FASEB J, V13, P707, DOI 10.1096/fasebj.13.6.707; de Haan G, 2002, BLOOD, V100, P2056, DOI 10.1182/blood-2002-03-0808; deHaan G, 1997, J EXP MED, V186, P529, DOI 10.1084/jem.186.4.529; Fortunel NO, 2003, SCIENCE, V302, P393; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jansen RC, 2003, NAT REV GENET, V4, P145, DOI 10.1038/nrg996; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Kamminga LM, 2000, EXP HEMATOL, V28, P1451, DOI 10.1016/S0301-472X(00)00543-9; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; Lai F, 2001, GENOMICS, V71, P235, DOI 10.1006/geno.2000.6414; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Muller-Sieburg CE, 2000, BLOOD, V95, P2446, DOI 10.1182/blood.V95.7.2446.007k13_2446_2448; PEARCE SR, 1995, MAMM GENOME, V6, P537, DOI 10.1007/BF00356172; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Scherer A, 2003, BIOTECHNIQUES, V34, P546, DOI 10.2144/03343rr01; Wayne ML, 2002, P NATL ACAD SCI USA, V99, P14903, DOI 10.1073/pnas.222549199; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	26	310	319	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					225	232		10.1038/ng1497	http://dx.doi.org/10.1038/ng1497			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15711547				2022-12-27	WOS:000227297800013
J	Zheng, M; Messerschmidt, D; Jungblut, B; Sommer, RJ				Zheng, M; Messerschmidt, D; Jungblut, B; Sommer, RJ			Conservation and diversification of Wnt signaling function during the evolution of nematode vulva development	NATURE GENETICS			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; PRISTIONCHUS-PACIFICUS; EQUIVALENCE GROUP; GENE LIN-39; INDUCTION; ENCODES; CELLS	Cell-fate specification and cell-cell signaling have been well studied during vulva development in Caenorhabditis elegans and provide a paradigm in evolutionary developmental biology(1,2). Pristionchus pacificus has been developed as a 'satellite' organism with an integrated physical and genetic map that allows detailed comparisons to C. elegans(3-5).A common aspect of vulva formation in both species is the polarization of the P7. p lineage, which is responsible for vulval symmetry. In C. elegans, Wnt signaling is crucial for P7. p cell-fate patterning(6); nothing is known about vulval symmetry in P. pacificus. We isolated mutations that disrupt polarization of the P7. p lineage in P. pacificus and found that the corresponding gene encodes a Frizzled-like molecule. In addition, mutations in Ppa-lin-17 (encoding Frizzled) and morpholino knock-down of Ppa-lin-44 (encoding Wnt), Ppa-egl-20 (encoding Wnt), Ppa-mig-5 (encoding Dsh), Ppa-apr-1 (encoding APC) and Ppa-bar-1 (encoding beta-catenin) results in gonad-independent vulva differentiation, indicating that these genes have a role in a negative signaling process. In contrast, in C. elegans, Wnt signaling has a positive role in vulva induction, and mutations in bar-1 result in a hypoinduced phenotype(7). Therefore, whereas the molecular mechanisms that generate vulval symmetry are conserved, the genetic control of vulva induction diversified during evolution.	Max Planck Inst Entwicklungsbiol, Abt Evolut Biol, D-72076 Tubingen, Germany	Max Planck Society	Sommer, RJ (corresponding author), Max Planck Inst Entwicklungsbiol, Abt Evolut Biol, Spemannstr 37-39, D-72076 Tubingen, Germany.	ralf.sommer@tuebingen.mpg.de	Messerschmidt, Daniel Martin/W-7193-2019	Messerschmidt, Daniel Martin/0000-0003-2022-4696				Ceol CJ, 2004, DEV CELL, V6, P563, DOI 10.1016/S1534-5807(04)00065-6; Ceol CJ, 2001, MOL CELL, V7, P461, DOI 10.1016/S1097-2765(01)00194-0; Chen N, 2004, DEV CELL, V6, P183, DOI 10.1016/S1534-5807(04)00021-8; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; Eizinger A, 1997, SCIENCE, V278, P452, DOI 10.1126/science.278.5337.452; HILL RJ, 1992, NATURE, V358, P470, DOI 10.1038/358470a0; Inoue T, 2004, CELL, V118, P795, DOI 10.1016/j.cell.2004.09.001; Jungblut B, 2000, DEVELOPMENT, V127, P3295; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; LAMBSHEAD PJD, 1993, OCEANIS S D, V19, P5; Maloof JN, 1999, DEVELOPMENT, V126, P37; Pires-DaSilva A, 2004, GENE DEV, V18, P1198, DOI 10.1101/gad.293504; Sawa H, 1996, GENE DEV, V10, P2189, DOI 10.1101/gad.10.17.2189; Sigrist CB, 1999, DEV GENES EVOL, V209, P451, DOI 10.1007/s004270050278; Simpson P, 2002, NAT REV GENET, V3, P907, DOI 10.1038/nrg947; Sommer RJ, 1998, DEVELOPMENT, V125, P3865; Sommer RJ, 1996, CURR BIOL, V6, P52, DOI 10.1016/S0960-9822(02)00421-9; Sommer RJ, 2001, CURR OPIN CELL BIOL, V13, P715, DOI 10.1016/S0955-0674(00)00275-1; Srinivasan J, 2003, MOL GENET GENOMICS, V269, P715, DOI 10.1007/s00438-003-0881-8; Wang MQ, 2001, CURR TOP DEV BIOL, V51, P189, DOI 10.1016/S0070-2153(01)51006-6	20	48	56	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					300	304		10.1038/ng1512	http://dx.doi.org/10.1038/ng1512			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15696167				2022-12-27	WOS:000227297800022
J	Kohler, C; Page, DR; Gagliardini, V; Grossniklaus, U				Kohler, C; Page, DR; Gagliardini, V; Grossniklaus, U			The Arabidopsis thaliana MEDEA Polycomb group protein controls expression of PHERES1 by parental imprinting	NATURE GENETICS			English	Article							SEED DEVELOPMENT; GROUP GENE; METHYLATION; ENDOSPERM; GENOME	The maternally expressed Arabidopsis thaliana Polycomb group protein MEDEA (MEA) controls expression of the MADS-box gene PHERES1 (PHE1). Here, we show that PHE1 is mainly paternally expressed but maternally repressed and that this maternal repression of PHE1 breaks down in seeds lacking maternal MEA activity. Because Polycomb group proteins control parental imprinting in mammals as well, the independent recruitment of similar protein machineries for the imprinting of genes is a notable example of convergent evolution.	Univ Zurich, Inst Plant Biol, CH-8008 Zurich, Switzerland; Univ Zurich, Zurich Basel Plant Sci Ctr, CH-8008 Zurich, Switzerland	University of Zurich; University of Zurich	Kohler, C (corresponding author), Univ Zurich, Inst Plant Biol, Zollikerstr 107, CH-8008 Zurich, Switzerland.	ckoehler@botinst.unizh.ch	Grossniklaus, Ueli/A-2736-2012; Köhler, Claudia/G-9668-2011; Grossniklaus, Ueli/E-9995-2016	Köhler, Claudia/0000-0002-2619-4857; Grossniklaus, Ueli/0000-0002-0522-8974; Gagliardini, Valeria/0000-0001-9471-0764				Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; HAIG D, 1989, AM NAT, V134, P147, DOI 10.1086/284971; Hurst LD, 1998, CURR OPIN GENET DEV, V8, P701, DOI 10.1016/S0959-437X(98)80040-3; Kiyosue T, 1999, P NATL ACAD SCI USA, V96, P4186, DOI 10.1073/pnas.96.7.4186; Kohler C, 2003, GENE DEV, V17, P1540, DOI 10.1101/gad.257403; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Luo M, 1999, P NATL ACAD SCI USA, V96, P296, DOI 10.1073/pnas.96.1.296; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Schubert D, 2003, CURR BIOL, V13, pR638, DOI 10.1016/S0960-9822(03)00569-4; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Spielman M, 2001, TRENDS GENET, V17, P705, DOI 10.1016/S0168-9525(01)02519-7; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574	15	207	223	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2005	37	1					28	30		10.1038/ng1495	http://dx.doi.org/10.1038/ng1495			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15619622				2022-12-27	WOS:000225997500017
J	Wilder, JA; Kingan, SB; Mobasher, Z; Pilkington, MM; Hammer, MF				Wilder, JA; Kingan, SB; Mobasher, Z; Pilkington, MM; Hammer, MF			Global patterns of human mitochondrial DNA and Y-chromosome structure are not influenced by higher migration rates of females versus males	NATURE GENETICS			English	Article							POPULATION-STRUCTURE; DIVERSITY; POLYMORPHISMS; EVOLUTION; MTDNA	Global-scale patterns of human population structure may be influenced by the rate of migration among populations that is nearly eight times higher for females than for males. This difference is attributed mainly to the widespread practice of patrilocality, in which women move into their mates' residences after marriage(1). Here we directly test this hypothesis by comparing global patterns of DNA sequence variation on the Y chromosome and mitochondrial DNA (mtDNA) in the same panel of 389 individuals from ten populations (four from Africa and two each from Europe, Asia and Oceania). We introduce a new strategy to assay Y-chromosome variation that identifies a high density of single-nucleotide polymorphisms, allows complete sequencing of all individuals rather than relying on predetermined markers and provides direct sequence comparisons with mtDNA. We found the overall proportion of between-group variation (Phi(ST)) to be 0.334 for the Y chromosome and 0.382 for mtDNA. Genetic differentiation between populations was similar for the Y chromosome and mtDNA at all geographic scales that we tested. Although patrilocality may be important at the local scale(2,3), patterns of genetic structure on the continental and global scales are not shaped by the higher rate of migration among females than among males.	Univ Arizona, Div Biotechnol, Tucson, AZ 85721 USA; Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ 85721 USA; Univ Arizona, Dept Anthropol, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; University of Arizona	Hammer, MF (corresponding author), Univ Arizona, Div Biotechnol, Tucson, AZ 85721 USA.	mfh@u.arizona.edu						Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; EXCOFFIER L, 1992, GENETICS, V131, P479; Hammer MF, 1997, GENETICS, V145, P787; Hammer MF, 2003, GENETICS, V164, P1495; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; JIN L, 1995, HEREDITY, V74, P274, DOI 10.1038/hdy.1995.41; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Kayser M, 2003, AM J HUM GENET, V72, P281, DOI 10.1086/346065; LABUDA D, 1989, NUCLEIC ACIDS RES, V17, P2477, DOI 10.1093/nar/17.7.2477; LOW BS, 1988, CURR ANTHROPOL, V29, P189, DOI 10.1086/203627; Mesa NR, 2000, AM J HUM GENET, V67, P1277, DOI 10.1016/S0002-9297(07)62955-3; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Romualdi C, 2002, GENOME RES, V12, P602, DOI 10.1101/gr.214902; Salem AH, 1996, AM J HUM GENET, V59, P741; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Stoneking M, 1998, NAT GENET, V20, P219, DOI 10.1038/3012; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Urbanek M, 1996, MOL BIOL EVOL, V13, P943, DOI 10.1093/oxfordjournals.molbev.a025662; Wright S, 1931, GENETICS, V16, P0097	19	113	116	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2004	36	10					1122	1125		10.1038/ng1428	http://dx.doi.org/10.1038/ng1428			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	15378061	Bronze			2022-12-27	WOS:000224156500023
J	Renwick, A; Thompson, D; Seal, S; Kelly, P; Chagtai, T; Ahmed, M; North, B; Jayatilake, H; Barfoot, R; Spanova, K; McGuffog, L; Evans, DG; Eccles, D; Easton, DF; Stratton, MR; Rahman, N				Renwick, Anthony; Thompson, Deborah; Seal, Sheila; Kelly, Patrick; Chagtai, Tasnim; Ahmed, Munaza; North, Bernard; Jayatilake, Hiran; Barfoot, Rita; Spanova, Katarina; McGuffog, Lesley; Evans, D. Gareth; Eccles, Diana; Easton, Douglas F.; Stratton, Michael R.; Rahman, Nazneen		Breast Cancer Susceptibility	ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles	NATURE GENETICS			English	Article							EARLY-ONSET; CHEK2-ASTERISK-1100DELC; FAMILIES; MISSENSE	We screened individuals from 443 familial breast cancer pedigrees and 521 controls for ATM sequence variants and identified 12 mutations in affected individuals and two in controls (P = 0.0047). The results demonstrate that ATM mutations that cause ataxia-telangiectasia in biallelic carriers are breast cancer susceptibility alleles in monoallelic carriers, with an estimated relative risk of 2.37 (95% confidence interval (c.i.) = 1.51 - 3.78, P = 0.0003). There was no evidence that other classes of ATM variant confer a risk of breast cancer.	Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Univ Cambridge, Canc Res UK, Genet Epidemiol Unit, Strangeways Res Labs, Cambridge CB1 8RN, England; St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 6YA, Hants, England; Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England	University of London; Institute of Cancer Research - UK; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Manchester; University of Cambridge; Wellcome Trust Sanger Institute	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	nazneen.rahman@icr.ac.uk	Evans, D Gareth/AAB-4308-2022; Eccles, Diana/K-6327-2019; Rahman, Nazneen/B-8890-2012; Rahman, Nazneen/D-2802-2013	Evans, D Gareth/0000-0002-8482-5784; Eccles, Diana/0000-0002-9935-3169; Rahman, Nazneen/0000-0003-4376-0440	Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust [068545/Z/02] Funding Source: Medline; Breast Cancer Now [2003:592] Funding Source: Medline; MRC [G0000934] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Breast Cancer Now; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Becker-Catania SG, 2000, MOL GENET METAB, V70, P122, DOI 10.1006/mgme.2000.2998; Chenevix-Trench G, 2002, JNCI-J NATL CANCER I, V94, P205, DOI 10.1093/jnci/94.3.205; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; FitzGerald MG, 1997, NAT GENET, V15, P307, DOI 10.1038/ng0397-307; Gatti RA, 1999, MOL GENET METAB, V68, P419, DOI 10.1006/mgme.1999.2942; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Olsen JH, 2005, BRIT J CANCER, V93, P260, DOI 10.1038/sj.bjc.6602658; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Sommer SS, 2003, CANCER GENET CYTOGEN, V145, P115, DOI 10.1016/S0165-4608(03)00119-5; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; Teraoka SN, 2001, CANCER-AM CANCER SOC, V92, P479, DOI 10.1002/1097-0142(20010801)92:3<479::AID-CNCR1346>3.0.CO;2-G; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141	13	519	529	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2006	38	8					873	875		10.1038/ng1837	http://dx.doi.org/10.1038/ng1837			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16832357				2022-12-27	WOS:000239325700014
J	Bauer, H; Willert, JR; Koschorz, B; Herrmann, BG				Bauer, H; Willert, JR; Koschorz, B; Herrmann, BG			The t complex-encoded GTPase-activating protein Tagap1 acts as a transmission ratio distorter in mice	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; SEGREGATION DISTORTION; BINDING-PROTEIN; MOUSE; HAPLOTYPES; DROSOPHILA; RANGAP; RHO; RHOPHILIN; REGIONS	Transmission ratio distortion in the mouse is caused by several t- complex distorters ( Tcds) acting in trans on the t- complex responder ( Tcr)(1 - 4). Tcds additively affect the flagellar movement of all spermatozoa derived from t/+ males; sperm carrying Tcr are rescued, resulting in an advantage for t sperm in fertilization. Here we show that Tagap1, a GTPase- activating protein, can act as a distorter. Tagap1 maps to the Tcd1 interval and has four t loci, which encode altered proteins including a C- terminally truncated form. Overexpression of wild- type Tagap1 in sperm cells phenocopied Tcd function, whereas a loss- of- function Tagap1 allele reduced the transmission rate of the t(6) haplotype. The combined data strongly suggest that the t loci of Tagap1 produce Tcd1a. Our results unravel the molecular nature of a Tcd and demonstrate the importance of small G proteins in transmission ratio distortion in the mouse.	Max Planck Inst Mol Genet, Dept Dev Genet, D-14195 Berlin, Germany; Max Planck Inst Immunbiol, Dept Dev Biol, D-79108 Freiburg, Germany; Inst Med Genet, D-12200 Berlin, Germany	Max Planck Society; Max Planck Society	Herrmann, BG (corresponding author), Max Planck Inst Mol Genet, Dept Dev Genet, Ihnestr 73, D-14195 Berlin, Germany.	herrmann@molgen.mpg.de						CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Dinkel A, 1999, J IMMUNOL METHODS, V223, P255, DOI 10.1016/S0022-1759(99)00005-8; Fujita A, 2000, J CELL SCI, V113, P103; GILMAN M, 1997, RIBONUCLEASE PROTECT; GUMMERE GR, 1986, GENETICS, V114, P235; Herrmann BG, 1999, NATURE, V402, P141, DOI 10.1038/45970; HERRMANN BG, 1987, CELL, V48, P813, DOI 10.1016/0092-8674(87)90078-X; HINSCH KD, 1993, FEBS LETT, V334, P32, DOI 10.1016/0014-5793(93)81674-O; HOWARD T, 1993, MOL CELL BIOL, V13, P18, DOI 10.1128/MCB.13.1.18; KATZ DF, 1979, J EXP ZOOL, V210, P529, DOI 10.1002/jez.1402100316; KLEENE KC, 1989, DEVELOPMENT, V106, P367; Kusano A, 2002, P NATL ACAD SCI USA, V99, P6866, DOI 10.1073/pnas.102165099; Kusano A, 2001, DEV CELL, V1, P351, DOI 10.1016/S1534-5807(01)00042-9; Lyon C. E., 1992, J APPL POULTRY RES, V1, P27; Lyon MF, 2000, GENETICS, V155, P793; LYON MF, 1984, CELL, V37, P621, DOI 10.1016/0092-8674(84)90393-3; Lyon MF, 2003, ANNU REV GENET, V37, P393, DOI 10.1146/annurev.genet.37.110801.143030; Merrill C, 1999, SCIENCE, V283, P1742, DOI 10.1126/science.283.5408.1742; Nakamura K, 1999, FEBS LETT, V445, P9, DOI 10.1016/S0014-5793(99)00087-3; OLDSCLARKE P, 1993, DEV BIOL, V155, P14, DOI 10.1006/dbio.1993.1002; RAMIREZSOLIS R, 1993, METHOD ENZYMOL, V225, P855; SELF AJ, 1995, METHOD ENZYMOL, V256, P67; SILVER LM, 1993, TRENDS GENET, V9, P250, DOI 10.1016/0168-9525(93)90090-5; SILVER LM, 1987, GENET RES, V49, P51, DOI 10.1017/S0016672300026720; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118	26	60	64	2	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					969	973		10.1038/ng1617	http://dx.doi.org/10.1038/ng1617			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16116428				2022-12-27	WOS:000231591900022
J	Tuzun, E; Sharp, AJ; Bailey, JA; Kaul, R; Morrison, VA; Pertz, LM; Haugen, E; Hayden, H; Albertson, D; Pinkel, D; Olson, MV; Eichler, EE				Tuzun, E; Sharp, AJ; Bailey, JA; Kaul, R; Morrison, VA; Pertz, LM; Haugen, E; Hayden, H; Albertson, D; Pinkel, D; Olson, MV; Eichler, EE			Fine-scale structural variation of the human genome	NATURE GENETICS			English	Article							RECENT SEGMENTAL DUPLICATIONS; SEQUENCE; GENE; POLYMORPHISM; INVERSION; DNA; ANEUPLOIDY; GENOTYPES; DELETION; REPEATS	Inversions, deletions and insertions are important mediators of disease and disease susceptibility(1). We systematically compared the human genome reference sequence with a second genome ( represented by fosmid paired- end sequences) to detect intermediate- sized structural variants > 8 kb in length. We identified 297 sites of structural variation: 139 insertions, 102 deletions and 56 inversion breakpoints. Using combined literature, sequence and experimental analyses, we validated 112 of the structural variants, including several that are of biomedical relevance. These data provide a fine- scale structural variation map of the human genome and the requisite sequence precision for subsequent genetic studies of human disease.	Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Univ Washington Genome Sequencing Ctr, Seattle, WA 98195 USA; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA	University of Washington; University of Washington Seattle; Case Western Reserve University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, 1705 NE Pacific St, Seattle, WA 98195 USA.	eee@gs.washington.edu	Sharp, Andrew/A-5783-2008; Tuzun, Eray/B-5949-2018; Tuzun, Eray/AAD-7282-2021	Tuzun, Eray/0000-0002-5550-7816; Tuzun, Eray/0000-0002-5550-7816; Kaul, Rajinder/0000-0002-7895-9284; Haugen, Eric/0000-0001-7444-8981				Aklillu E, 1996, J PHARMACOL EXP THER, V278, P441; Badge RM, 2003, AM J HUM GENET, V72, P823, DOI 10.1086/373939; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Brewer C, 1999, AM J HUM GENET, V64, P1702, DOI 10.1086/302410; Buckland PR, 2003, ANN MED, V35, P308, DOI 10.1080/07853890310001276; COLIN Y, 1991, BLOOD, V78, P2747; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; EICHLER EE, 1994, NAT GENET, V8, P88, DOI 10.1038/ng0994-88; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Horvath JE, 2000, GENOME RES, V10, P839, DOI 10.1101/gr.10.6.839; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Koppens PFJ, 2002, HUM GENET, V111, P405, DOI 10.1007/s00439-002-0810-7; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; LACKNER C, 1993, HUM MOL GENET, V2, P933, DOI 10.1093/hmg/2.7.933; LEE GF, 1995, HUM ECOL RISK ASSESS, V1, P5; LINDSLEY DL, 1972, GENETICS, V71, P157; Locke DP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r50; McLellan RA, 1997, PHARMACOGENETICS, V7, P187, DOI 10.1097/00008571-199706000-00003; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Small K, 1997, NAT GENET, V16, P96, DOI 10.1038/ng0597-96; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Sprenger R, 2000, PHARMACOGENETICS, V10, P557, DOI 10.1097/00008571-200008000-00009; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wong GKS, 1997, P NATL ACAD SCI USA, V94, P5225, DOI 10.1073/pnas.94.10.5225	27	749	814	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					727	732		10.1038/ng1562	http://dx.doi.org/10.1038/ng1562			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15895083				2022-12-27	WOS:000230196400019
J	Firulli, BA; Krawchuk, D; Centonze, VE; Vargesson, N; Virshup, DM; Conway, SJ; Cserjesi, P; Laufer, E; Firulli, AB				Firulli, BA; Krawchuk, D; Centonze, VE; Vargesson, N; Virshup, DM; Conway, SJ; Cserjesi, P; Laufer, E; Firulli, AB			Altered Twist1 and Hand2 dimerization is associated with Saethre-Chotzen syndrome and limb abnormalities	NATURE GENETICS			English	Article							BHLH TRANSCRIPTION FACTOR; OSTEOBLAST DIFFERENTIATION; BASIC DOMAIN; DNA-BINDING; CHICK LIMB; MUTATIONS; PROTEIN; HEDGEHOG; DHAND; GENE	Autosomal dominant mutations in the gene encoding the basic helix-loop-helix transcription factor Twist1 are associated with limb and craniofacial defects in humans with Saethre-Chotzen syndrome. The molecular mechanism underlying these phenotypes is poorly understood. We show that ectopic expression of the related basic helix-loop-helix factor Hand2 phenocopies Twist1 loss of function in the limb and that the two factors have a gene dosage - dependent antagonistic interaction. Dimerization partner choice by Twist1 and Hand2 can be modulated by protein kinase A - and protein phosphatase 2A - regulated phosphorylation of conserved helix I residues. Notably, multiple Twist1 mutations associated with Saethre-Chotzen syndrome alter protein kinase A - mediated phosphorylation of Twist1, suggesting that misregulation of Twist1 dimerization through either stoichiometric or post-translational mechanisms underlies phenotypes of individuals with Saethre-Chotzen syndrome.	Indiana Univ, Sch Med, James Whitcomb Riley Hosp Children, Wells Ctr Pediat Res,Dept Pediat, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, James Whitcomb Riley Hosp Children, Wells Ctr Pediat Res,Dept Med & Mol Genet, Indianapolis, IN 46202 USA; Columbia Univ, Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Univ Texas, Hlth Sci Ctr, Dept Cellular Biol, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, Dept Biol Struct, San Antonio, TX 78229 USA; Univ Utah, Huntsman Canc Inst Ctr Children, Salt Lake City, UT 84112 USA; Tulane Univ, Dept Cell & Mol Biol, New Orleans, LA 70118 USA	Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Columbia University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Tulane University	Laufer, E (corresponding author), Indiana Univ, Sch Med, James Whitcomb Riley Hosp Children, Wells Ctr Pediat Res,Dept Pediat, 1044 W Walnut R4 371, Indianapolis, IN 46202 USA.	elaufer@columbia.edu	Virshup, David M/C-1449-2009	Virshup, David M/0000-0001-6976-850X; /0000-0001-6687-8949; Laufer, Edward/0000-0002-4933-1017; Vargesson, Neil/0000-0001-8027-114X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061677] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL061677-08, R01 HL061677] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Bourgeois P, 1998, HUM MOL GENET, V7, P945, DOI 10.1093/hmg/7.6.945; Castanon I, 2002, GENE, V287, P11, DOI 10.1016/S0378-1119(01)00893-9; Castanon I, 2001, DEVELOPMENT, V128, P3145; Centonze VE, 2003, METHOD ENZYMOL, V360, P542; Charite J, 2000, DEVELOPMENT, V127, P2461; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Corsi AK, 2002, DEVELOPMENT, V129, P2761; El Ghouzzi V, 2000, HUM MOL GENET, V9, P813, DOI 10.1093/hmg/9.5.813; El Ghouzzi V, 2001, FEBS LETT, V492, P112, DOI 10.1016/S0014-5793(01)02238-4; ElGhouzzi V, 1997, NAT GENET, V15, P42; Fernandez-Teran M, 2000, DEVELOPMENT, V127, P2133; Firulli AB, 2003, GENE, V312, P27, DOI 10.1016/S0378-1119(03)00669-3; Firulli BA, 2000, J BIOL CHEM, V275, P33567, DOI 10.1074/jbc.M005888200; Firulli BA, 2003, MOL CELL, V12, P1225, DOI 10.1016/S1097-2765(03)00425-8; Gripp KW, 2000, HUM MUTAT, V15, P150, DOI 10.1002/(SICI)1098-1004(200002)15:2<150::AID-HUMU3>3.0.CO;2-D; Hamamori Y, 1997, MOL CELL BIOL, V17, P6563, DOI 10.1128/MCB.17.11.6563; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; Jabs Ethylin Wang, 2004, P401; Johnson D, 1998, AM J HUM GENET, V63, P1282, DOI 10.1086/302122; KASPARCOVA VS, 1998, AM J HUM GENET S, V65, pA367; Kaufman M.H., 1992, ATLAS MOUSE DEV; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; McFadden DG, 2002, DEVELOPMENT, V129, P3077; O'Rourke MP, 2002, DEV BIOL, V248, P143, DOI 10.1006/dbio.2002.0730; O'Rourke MP, 2002, INT J DEV BIOL, V46, P401; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; OLSON EN, 1993, CIRC RES, V72, P1, DOI 10.1161/01.RES.72.1.1; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pathi S, 2001, MECH DEVELOP, V106, P107, DOI 10.1016/S0925-4773(01)00427-0; Spicer DB, 1996, SCIENCE, V272, P1476, DOI 10.1126/science.272.5267.1476; SRIVASTAVA D, 1995, SCIENCE, V270, P1995, DOI 10.1126/science.270.5244.1995; Srivastava D, 1997, NAT GENET, V16, P154, DOI 10.1038/ng0697-154; Tavares AT, 2001, INT J DEV BIOL, V45, P707; TICKLE C, 1981, NATURE, V289, P295, DOI 10.1038/289295a0; WOLF C, 1991, DEV BIOL, V143, P363, DOI 10.1016/0012-1606(91)90086-I; Yang Y, 1997, DEVELOPMENT, V124, P4393; Yelon D, 2000, DEVELOPMENT, V127, P2573; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Zuniga A, 2002, MECH DEVELOP, V114, P51, DOI 10.1016/S0925-4773(02)00048-5	44	144	152	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					373	381		10.1038/ng1525	http://dx.doi.org/10.1038/ng1525			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15735646	Green Accepted			2022-12-27	WOS:000228040000020
J	Sun, XD; Frierson, HF; Chen, C; Li, CL; Ran, QM; Otto, KB; Cantarel, BM; Vessella, RL; Gao, AC; Petros, J; Miura, Y; Simons, JW; Dong, JT				Sun, XD; Frierson, HF; Chen, C; Li, CL; Ran, QM; Otto, KB; Cantarel, BM; Vessella, RL; Gao, AC; Petros, J; Miura, Y; Simons, JW; Dong, JT			Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR GENES; NEURONAL DIFFERENTIATION; CARCINOMA-CELLS; PROTEIN; ACTIVATION; DELETIONS; IDENTIFICATION; BINDING; REGION; 16Q	Cancer often results from the accumulation of multiple genetic alterations. Although most malignancies are sporadic, only a small number of genes have been shown to undergo frequent mutations in sporadic cancers. The long arm of chromosome 16 is frequently deleted in human cancers, but the target gene for this deletion has not been identified(1-4). Here we report that ATBF1, which encodes a transcription factor that negatively regulates AFP and MYB5,6 but transactivates CDKN1A(7), is a good candidate for the 16q22 tumor-suppressor gene. We narrowed the region of deletion at 16q22 to 861 kb containing ATBF1. ATBF1 mRNA was abundant in normal prostates but more scarce in approximately half of prostate cancers tested. In 24 of 66 (36%) cancers examined, we identified 22 unique somatic mutations, many of which impair ATBF1 function. Furthermore, ATBF1 inhibited cell proliferation. Hence, loss of ATBF1 is one mechanism that defines the absence of growth control in prostate cancer.	Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Oncol, Atlanta, GA 30322 USA; Univ Virginia Hlth Syst, Dept Pathol, Charlottesville, VA 22901 USA; Chinese Acad Med Sci, Canc Inst Hosp, Dept Urol Oncol, Beijing 100021, Peoples R China; Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22901 USA; Univ Washington, Med Ctr, Dept Urol, Seattle, WA 98195 USA; Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA; Roswell Pk Canc Inst, Dept Pharmacol, Buffalo, NY 14263 USA; Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pathol, Atlanta, GA 30322 USA; Nagoya City Univ, Grad Sch Med Sci, Dept Mol Neurobiol, Nagoya, Aichi 4678601, Japan; Emory Univ, Sch Med, Dept Urol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Program Genet & Mol Biol, Atlanta, GA 30322 USA	Emory University; University of Virginia; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; University of Virginia; University of Washington; University of Washington Seattle; Roswell Park Cancer Institute; Roswell Park Cancer Institute; Emory University; Emory University; Nagoya City University; Emory University; Emory University	Dong, JT (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, Dept Hematol & Oncol, Atlanta, GA 30322 USA.	jdong2@emory.edu		Dong, Jin-Tang/0000-0003-2349-5782				Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Chen C, 2003, PROSTATE, V55, P81, DOI 10.1002/pros.10205; Chen CS, 2003, AM J PATHOL, V162, P1349, DOI 10.1016/S0002-9440(10)63930-2; Chen CS, 2001, GENOMICS, V77, P135, DOI 10.1006/geno.2001.6631; Coolidge CJ, 1997, NUCLEIC ACIDS RES, V25, P888, DOI 10.1093/nar/25.4.888; COUREY AJ, 1989, CELL, V59, P827, DOI 10.1016/0092-8674(89)90606-5; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Dong JT, 2000, CANCER RES, V60, P3880; Dong JT, 2001, CANCER METAST REV, V20, P173, DOI 10.1023/A:1015575125780; Goldberg EK, 2000, AM J HUM GENET, V67, P417, DOI 10.1086/302999; IDO A, 1994, DEV BIOL, V163, P184, DOI 10.1006/dbio.1994.1134; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Ishii Y, 2003, J COMP NEUROL, V465, P57, DOI 10.1002/cne.10807; Kaspar P, 1999, J BIOL CHEM, V274, P14422, DOI 10.1074/jbc.274.20.14422; Kataoka H, 2003, CANCER RES, V63, P5785; Kataoka H, 2001, ONCOGENE, V20, P869, DOI 10.1038/sj.onc.1204160; Kawaguchi M, 2001, BBA-PROTEIN STRUCT M, V1550, P164, DOI 10.1016/S0167-4838(01)00284-9; Knuutila S, 1999, AM J PATHOL, V155, P683, DOI 10.1016/S0002-9440(10)65166-8; Kukita Y, 1997, HUM MUTAT, V10, P400, DOI 10.1002/(SICI)1098-1004(1997)10:5<400::AID-HUMU11>3.3.CO;2-1; Latil A, 1997, CANCER RES, V57, P1058; Matsuyama H, 2003, PROSTATE, V54, P103, DOI 10.1002/pros.10173; MIURA Y, 1995, J BIOL CHEM, V270, P26840, DOI 10.1074/jbc.270.45.26840; MORINAGA T, 1991, MOL CELL BIOL, V11, P6041, DOI 10.1128/MCB.11.12.6041; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Ninomiya T, 2002, HEPATOLOGY, V35, P82, DOI 10.1053/jhep.2002.30420; Remacle JE, 1997, EMBO J, V16, P5722, DOI 10.1093/emboj/16.18.5722; Strup SE, 1999, J UROLOGY, V162, P590, DOI 10.1016/S0022-5347(05)68631-4; Sun SY, 1997, CANCER RES, V57, P4931; Takada N, 1999, CANCER RES, V59, P2810	29	123	133	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2005	37	4					407	412		10.1038/ng1528	http://dx.doi.org/10.1038/ng1528			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15750593				2022-12-27	WOS:000228040000024
J	Kafri, R; Bar-Even, A; Pilpel, Y				Kafri, R; Bar-Even, A; Pilpel, Y			Transcription control reprogramming in genetic backup circuits	NATURE GENETICS			English	Article							DUPLICATE GENES; SACCHAROMYCES-CEREVISIAE; EXPRESSION; EVOLUTION; PRESERVATION; CONSEQUENCES; ROBUSTNESS	A key question in molecular genetics is why severe mutations often do not result in a detectably abnormal phenotype. This robustness was partially ascribed to redundant paralogs(1,2) that may provide backup for one another in case of mutation. Mining mutant viability and mRNA expression data in Saccharomyces cerevisiae, we found that backup was provided predominantly by paralogs that are expressed dissimilarly in most growth conditions. We considered that this apparent inconsistency might be resolved by a transcriptional reprogramming mechanism that allows the intact paralog to rescue the organism upon mutation of its counterpart. We found that in wild-type cells, partial coregulation across growth conditions predicted the ability of paralogs to alter their transcription patterns and to provide backup for one another. Notably, the sets of regulatory motifs that controlled the paralogs with the most efficient backup activity deliberately overlapped only partially; paralogs with highly similar or dissimilar sets of motifs had suboptimal backup activity. Such an arrangement of partially shared regulatory motifs reconciles the differential expression of paralogs with their ability to back each other up.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Pilpel, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	pilpel@weizmann.ac.il		Bar-Even, Arren/0000-0002-1039-4328				Cavalcanti ARO, 2003, J MOL EVOL, V56, P28, DOI 10.1007/s00239-002-2377-2; Conant GC, 2004, P ROY SOC B-BIOL SCI, V271, P89, DOI 10.1098/rspb.2003.2560; Force A, 1999, GENETICS, V151, P1531; Garcia-Rodriguez LJ, 2000, FEBS LETT, V478, P84, DOI 10.1016/S0014-5793(00)01835-4; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Gu ZL, 2002, TRENDS GENET, V18, P609, DOI 10.1016/S0168-9525(02)02837-8; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Kratzer S, 1997, MOL MICROBIOL, V26, P631, DOI 10.1046/j.1365-2958.1997.5611937.x; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2001, GENETICS, V159, P1789; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; McCammon MT, 2003, ARCH BIOCHEM BIOPHYS, V419, P222, DOI 10.1016/j.abb.2003.08.022; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Ozcan S, 2002, J BIOL CHEM, V277, P46993, DOI 10.1074/jbc.M208726200; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Papp B, 2003, TRENDS GENET, V19, P417, DOI 10.1016/S0168-9525(03)00174-4; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; vandenBerg MA, 1996, J BIOL CHEM, V271, P28953, DOI 10.1074/jbc.271.46.28953; Wagner A, 2000, GENETICS, V154, P1389	30	140	147	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					295	299		10.1038/ng1523	http://dx.doi.org/10.1038/ng1523			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15723064				2022-12-27	WOS:000227297800021
J	Iafrate, AJ; Feuk, L; Rivera, MN; Listewnik, ML; Donahoe, PK; Qi, Y; Scherer, SW; Lee, C				Iafrate, AJ; Feuk, L; Rivera, MN; Listewnik, ML; Donahoe, PK; Qi, Y; Scherer, SW; Lee, C			Detection of large-scale variation in the human genome	NATURE GENETICS			English	Article							SEGMENTAL DUPLICATIONS; SEQUENCE; DISEASE	We identified 255 loci across the human genome that contain genomic imbalances among unrelated individuals. Twenty-four variants are present in >10% of the individuals that we examined. Half of these regions overlap with genes, and many coincide with segmental duplications or gaps in the human genome assembly. This previously unappreciated heterogeneity may underlie certain human phenotypic variation and susceptibility to disease and argues for a more dynamic human genome structure.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Hosp Sick Children, Dept Genet & Genom Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Toronto, ON, Canada; Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; Massachusetts Gen Hosp, Pediat Surg Res Labs, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Lee, C (corresponding author), Brigham & Womens Hosp, Dept Pathol, 20 Shattuck St,Thorn 6-28, Boston, MA 02115 USA.	clee@rics.bwh.harvard.edu	Scherer, Stephen W./B-3785-2013; Maestrini, Elena/K-7508-2012	Scherer, Stephen W./0000-0002-8326-1999; Maestrini, Elena/0000-0001-5924-3179				Albertson DG, 2003, HUM MOL GENET, V12, pR145, DOI 10.1093/hmg/ddg261; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; GROOT PC, 1991, GENOMICS, V10, P779, DOI 10.1016/0888-7543(91)90463-O; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Scherer SW, 2003, SCIENCE, V300, P767, DOI 10.1126/science.1083423; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; WRIGHT AF, 2003, NATURE ENCY HUMAN GE, V2, P959	12	2153	2306	0	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					949	951		10.1038/ng1416	http://dx.doi.org/10.1038/ng1416			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15286789	Bronze			2022-12-27	WOS:000223658100018
J	Dews, M; Homayouni, A; Yu, D; Murphy, D; Sevignani, C; Wentzel, E; Furth, EE; Lee, WM; Enders, GH; T Mendell, J; Thomas-Tikhonenko, A				Dews, Michael; Homayouni, Asal; Yu, Duonan; Murphy, Danielle; Sevignani, Cinzia; Wentzel, Erik; Furth, Emma E.; Lee, William M.; Enders, Greg H.; T Mendell, Joshua; Thomas-Tikhonenko, Andrei			Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster	NATURE GENETICS			English	Article							C-MYC; IN-VIVO; EPITHELIAL-CELLS; RAS; THROMBOSPONDIN-1; EXPRESSION; FIBROBLASTS; HYPOXIA; GENE	Human adenocarcinomas commonly harbor mutations in the KRAS and MYC proto-oncogenes and the TP53 tumor suppressor gene. All three genetic lesions are potentially pro-angiogenic, as they sustain production of vascular endothelial growth factor ( VEGF). Yet Kras-transformed mouse colonocytes lacking p53 formed indolent, poorly vascularized tumors, whereas additional transduction with a Myc-encoding retrovirus promoted vigorous vascularization and growth. In addition, VEGF levels were unaffected by Myc, but enhanced neovascularization correlated with downregulation of anti-angiogenic thrombospondin-1 ( Tsp1) and related proteins, such as connective tissue growth factor (CTGF). Both Tsp1 and CTGF are predicted targets for repression by the miR-17- 92 microRNA cluster, which was upregulated in colonocytes coexpressing K-Ras and c-Myc. Indeed, miR-17- 92 knockdown with antisense 2'-O-methyl oligoribonucleotides partly restored Tsp1 and CTGF expression; in addition, transduction of Ras-only cells with a miR-17- 2-encoding retrovirus reduced Tsp1 and CTGF levels. Notably, miR-17-92-transduced cells formed larger, better-perfused tumors. These findings establish a role for microRNAs in non - cell-autonomous Myc-induced tumor phenotypes.	Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Johns Hopkins University; University of Pennsylvania	Thomas-Tikhonenko, A (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	andreit@mail.vet.upenn.edu	Thomas-Tikhonenko, Andrei/E-5329-2011	Thomas-Tikhonenko, Andrei/0000-0002-2739-2206	NCI NIH HHS [CA 097932, R29 CA071881-05, R29 CA071881-06, R21 CA097932-02, R21 CA097932-01, R29 CA071881-04, R21 CA097932] Funding Source: Medline; NIDDK NIH HHS [DK 050306, P30 DK050306] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R29CA071881, R21CA097932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Brandvold KA, 2000, ONCOGENE, V19, P2780, DOI 10.1038/sj.onc.1203589; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Himelstein BP, 1997, ONCOGENE, V14, P1995, DOI 10.1038/sj.onc.1201012; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Janz A, 2000, NUCLEIC ACIDS RES, V28, P2268, DOI 10.1093/nar/28.11.2268; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; Knies-Bamforth UE, 2004, CANCER RES, V64, P6563, DOI 10.1158/0008-5472.CAN-03-3176; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Ngo CV, 2000, CELL GROWTH DIFFER, V11, P201; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pelengaris S, 1999, MOL CELL, V3, P565, DOI 10.1016/S1097-2765(00)80350-0; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Rak J, 2002, CANCER RES, V62, P1931; Ravi R, 2000, GENE DEV, V14, P34; Ruddell A, 2003, AM J PATHOL, V163, P2233, DOI 10.1016/S0002-9440(10)63581-X; Sevignani C, 1998, J CLIN INVEST, V101, P1572, DOI 10.1172/JCI919; Thomas-Tikhonenko A, 2004, CANCER RES, V64, P3126, DOI 10.1158/0008-5472.CAN-03-1953; Tikhonenko AT, 1996, J BIOL CHEM, V271, P30741, DOI 10.1074/jbc.271.48.30741; Tucker RP, 2004, INT J BIOCHEM CELL B, V36, P969, DOI 10.1016/j.biocel.2003.12.011; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8	30	825	900	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					1060	1065		10.1038/ng1855	http://dx.doi.org/10.1038/ng1855			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16878133	Green Accepted			2022-12-27	WOS:000240112100025
J	Frigola, J; Song, J; Stirzaker, C; Hinshelwood, RA; Peinado, MA; Clark, SJ				Frigola, J; Song, J; Stirzaker, C; Hinshelwood, RA; Peinado, MA; Clark, SJ			Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band	NATURE GENETICS			English	Article							ALTERED METHYLATION PATTERNS; DNA METHYLATION; CPG ISLANDS; EXPRESSION; HYPERMETHYLATION; INACTIVATION; P21(WAF1); RECEPTORS; MECHANISM; PROTEINS	We report a new mechanism in carcinogenesis involving coordinate long-range epigenetic gene silencing. Epigenetic silencing in cancer has always been envisaged as a local event silencing discrete genes. However, in this study of silencing in colorectal cancer, we found common repression of the entire 4-Mb band of chromosome 2q.14.2, associated with global methylation of histone H3 Lys9. DNA hypermethylation within the repressed genomic neighborhood was localized to three separate enriched CpG island `suburbs', with the largest hypermethylated suburb spanning 1 Mb. These data change our understanding of epigenetic gene silencing in cancer cells: namely, epigenetic silencing can span large regions of the chromosome, and both DNA-methylated and neighboring unmethylated genes can be coordinately suppressed by global changes in histone modification. We propose that loss of gene expression can occur through long-range epigenetic silencing, with similar implications as loss of heterozygosity in cancer.	St Vincents Hosp, Garvan Inst Med Res, Canc Program, Darlinghurst, NSW 2010, Australia; Hosp Duran & Reynals, Inst Recerca Oncol, Inst Invest Biomed Bellvitge IDIBELL, Barcelona 08907, Spain	Garvan Institute of Medical Research; St Vincents Hospital Sydney; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals	Clark, SJ (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Canc Program, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	s.clark@garvan.org.au	Frigola, Jordi/N-4602-2015; Clark, Susan J/U-7365-2019; Clark, Susan J/B-2272-2008; Peinado, Miguel A./A-5591-2008	Frigola, Jordi/0000-0002-7231-3853; Clark, Susan J/0000-0001-5925-5030; Clark, Susan J/0000-0001-5925-5030; Peinado, Miguel A./0000-0002-4090-793X; Stirzaker, Clare/0000-0001-5601-3140				Adamska M, 2004, DEV BIOL, V272, P134, DOI 10.1016/j.ydbio.2004.04.026; Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brockdorff N, 2002, TRENDS GENET, V18, P352, DOI 10.1016/S0168-9525(02)02717-8; Clark SJ, 2002, ONCOGENE, V21, P5380, DOI 10.1038/sj.onc.1205598; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Frigola J, 2005, HUM MOL GENET, V14, P319, DOI 10.1093/hmg/ddi028; Frigola J, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.7.e28; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gius D, 2004, CANCER CELL, V6, P361, DOI 10.1016/j.ccr.2004.08.029; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Huschtscha LI, 1998, CANCER RES, V58, P3508; Jaffrey RG, 2000, CANCER RES, V60, P4349; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kangas M, 1999, GENOMICS, V58, P82, DOI 10.1006/geno.1999.5811; Kondo Y, 2004, P NATL ACAD SCI USA, V101, P7398, DOI 10.1073/pnas.0306641101; Laird PW, 2005, HUM MOL GENET, V14, pR65, DOI 10.1093/hmg/ddi113; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Latham KE, 2005, TRENDS GENET, V21, P120, DOI 10.1016/j.tig.2004.12.003; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Lorincz MC, 2002, MOL CELL BIOL, V22, P7572, DOI 10.1128/MCB.22.21.7572-7580.2002; Melki JR, 1999, CANCER RES, V59, P3730; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Mylonas I, 2005, ONCOL REP, V13, P81; Nguyen C, 2001, J NATL CANCER I, V93, P1465, DOI 10.1093/jnci/93.19.1465; Nie Y, 2001, CARCINOGENESIS, V22, P1615, DOI 10.1093/carcin/22.10.1615; O'Neill MJ, 2005, HUM MOL GENET, V14, pR113, DOI 10.1093/hmg/ddi108; Palmisano WA, 2003, CANCER RES, V63, P4620; Pang RTK, 2004, MOL ENDOCRINOL, V18, P471, DOI 10.1210/me.2003-0245; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Reis FM, 2004, MOL CELL ENDOCRINOL, V225, P77, DOI 10.1016/j.mce.2004.02.016; Rush LJ, 2004, CANCER RES, V64, P2424, DOI 10.1158/0008-5472.CAN-03-2870; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Song JZ, 2002, ONCOGENE, V21, P1048, DOI 10.1038/sj.onc.1205153; Stirzaker C, 2004, CANCER RES, V64, P3871, DOI 10.1158/0008-5472.CAN-03-3690; Tang C, 1997, GUT, V40, P267, DOI 10.1136/gut.40.2.267; Tang CW, 1996, CARCINOGENESIS, V17, P2171, DOI 10.1093/carcin/17.10.2171; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; van Noesel MM, 2003, GENE CHROMOSOME CANC, V38, P226, DOI 10.1002/gcc.10278; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200	47	295	310	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					540	549		10.1038/ng1781	http://dx.doi.org/10.1038/ng1781			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16642018				2022-12-27	WOS:000237147500015
J	Palmer, CNA; Irvine, AD; Terron-Kwiatkowski, A; Zhao, YW; Liao, HH; Lee, SP; Goudie, DR; Sandilands, A; Campbell, LE; Smith, FJD; O'Regan, GM; Watson, RM; Cecil, JE; Bale, SJ; Compton, JG; DiGiovanna, JJ; Fleckman, P; Lewis-Jones, S; Arseculeratne, G; Sergeant, A; Munro, CS; El Houate, B; McElreavey, K; Halkjaer, LB; Bisgaard, H; Mukhopadhyay, S; McLean, WHI				Palmer, CNA; Irvine, AD; Terron-Kwiatkowski, A; Zhao, YW; Liao, HH; Lee, SP; Goudie, DR; Sandilands, A; Campbell, LE; Smith, FJD; O'Regan, GM; Watson, RM; Cecil, JE; Bale, SJ; Compton, JG; DiGiovanna, JJ; Fleckman, P; Lewis-Jones, S; Arseculeratne, G; Sergeant, A; Munro, CS; El Houate, B; McElreavey, K; Halkjaer, LB; Bisgaard, H; Mukhopadhyay, S; McLean, WHI			Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis	NATURE GENETICS			English	Article							PARTY DIAGNOSTIC-CRITERIA; ICHTHYOSIS VULGARIS; CORNIFIED ENVELOPE; SKIN; GENE; DIFFERENTIATION; ASTHMA; HYPERRESPONSIVENESS; EPIDEMIOLOGY; POPULATION	Atopic disease, including atopic dermatitis (eczema), allergy and asthma, has increased in frequency in recent decades(1) and now affects similar to 20% of the population in the developed world. Twin and family studies have shown that predisposition to atopic disease is highly heritable(2). Although most genetic studies have focused on immunological mechanisms, a primary epithelial barrier defect has been anticipated(3). Filaggrin is a key protein that facilitates terminal differentiation of the epidermis and formation of the skin barrier. Here we show that two independent loss-of-function genetic variants (R510X and 2282del4) in the gene encoding filaggrin (FLG) are very strong predisposing factors for atopic dermatitis. These variants are carried by similar to 9% of people of European origin. These variants also show highly significant association with asthma occurring in the context of atopic dermatitis. This work establishes a key role for impaired skin barrier function in the development of atopic disease.	Univ Dundee, Ninewells Hosp & Med Sch, Div Pathol & Neurosci, Epithelial Genet Grp, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Populat Pharmacogenet Grp, Dundee DD1 9SY, Scotland; Our Ladys Hosp Sick Children, Dept Paediat Dermatol, Dublin 12, Ireland; Univ Dundee, Ninewells Hosp & Med Sch, Tayside Univ Hosp NHS Trust, Dundee DD1 9SY, Scotland; Univ St Andrews, Bute Med Sch, St Andrews, Fife, Scotland; GeneDx, Gaithersburg, MD 20877 USA; Brown Med Sch, Dept Dermatol, Div Dermatopharmacol, Providence, RI 02903 USA; Rhode Isl Hosp, Providence, RI 02903 USA; NCI, Basic Res Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; Univ Washington, Dept Med, Div Dermatol, Seattle, WA 98195 USA; Univ Dundee, Ninewells Hosp & Med Sch, Tayside Univ Hosp NHS Trust, Dundee DD1 9SY, Scotland; S Glasgow Univ Hosp NHS Trust, Dept Dermatol, Glasgow G51 4TF, Lanark, Scotland; Inst Pasteur, F-75724 Paris, France; Copenhagen Univ Hosp, Danish Paediat Asthma Ctr, DK-2900 Copenhagen, Denmark; Univ Dundee, Ninewells Hosp & Med Sch, Childrens Asthma & Allergy Res Unit, Dundee DD1 9SY, Scotland	University of Dundee; University of Dundee; Our Ladys Children Hospital Crumlin; University of Dundee; University of St Andrews; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; University of Dundee; University of Glasgow; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Copenhagen; University of Dundee	McLean, WHI (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Pathol & Neurosci, Epithelial Genet Grp, Dundee DD1 9SY, Scotland.	w.h.i.mclean@dundee.ac.uk	Palmer, Colin NA/C-7053-2008; McLean, William HI/C-6352-2009; Bisgaard, Hans/N-4761-2016; Kronow, Joern/B-1054-2011; Cecil, Joanne E/A-3071-2010; Irvine, Alan D/A-3982-2008	Palmer, Colin NA/0000-0002-6415-6560; Bisgaard, Hans/0000-0003-4131-7592; Irvine, Alan D/0000-0002-9048-2044; Brahim, EL HOUATE/0000-0002-7781-426X; DiGiovanna, John J./0000-0002-2750-2313; McLean, William Henry Irwin/0000-0001-5539-5757	Medical Research Council [G0700314] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bisgaard H, 2004, ANN ALLERG ASTHMA IM, V93, P381, DOI 10.1016/S1081-1206(10)61398-1; BRYDENSHOLT HL, IN PRESS ARCH DERMAT; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Cecil JE, 2005, DIABETOLOGIA, V48, P1496, DOI 10.1007/s00125-005-1817-0; Compton JG, 2002, EXP DERMATOL, V11, P518, DOI 10.1034/j.1600-0625.2002.110604.x; Cookson WOCM, 2002, CURR OPIN ALLERGY CL, V2, P383, DOI 10.1097/00130832-200210000-00003; Cookson WOCM, 2001, NAT GENET, V27, P372, DOI 10.1038/86867; Emerson RM, 2000, BRIT J DERMATOL, V142, P288, DOI 10.1046/j.1365-2133.2000.03300.x; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; GAN SQ, 1990, BIOCHEMISTRY-US, V29, P9432, DOI 10.1021/bi00492a018; Ginger RS, 2005, ARCH DERMATOL RES, V297, P235, DOI 10.1007/s00403-005-0590-8; Holgate ST, 1999, NATURE, V402, pB2, DOI 10.1038/35037000; Jensen JM, 2004, J INVEST DERMATOL, V122, P1423, DOI 10.1111/j.0022-202X.2004.22621.x; Kuokkanen K, 1969, Acta Derm Venereol Suppl (Stockh), V62, P1; Kurz T, 2005, ALLERGY, V60, P192, DOI 10.1111/j.1398-9995.2005.00646.x; Listwan P, 2004, METHOD CELL BIOL, V78, P817; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Presland RB, 2000, CRIT REV ORAL BIOL M, V11, P383, DOI 10.1177/10454411000110040101; Seguchi T, 1996, ARCH DERMATOL RES, V288, P442, DOI 10.1007/s004030050080; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Sugiura H, 2005, BRIT J DERMATOL, V152, P146, DOI 10.1111/J.1365-2133.2005.06352.X; Tabata N, 1998, ACTA DERM-VENEREOL, V78, P244; Tay YK, 1999, ASIAN PAC J ALLERGY, V17, P137; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Wang LF, 1996, J IMMUNOL, V156, P4079; WELLS RS, 1966, BRIT MED J, V1, P947, DOI 10.1136/bmj.1.5493.947; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P406, DOI 10.1111/j.1365-2133.1994.tb08532.x; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P383, DOI 10.1111/j.1365-2133.1994.tb08530.x; Wuthrich B, 2003, J INVEST ALLERG CLIN, V13, P1	30	1969	2054	6	191	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2006	38	4					441	446		10.1038/ng1767	http://dx.doi.org/10.1038/ng1767			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	026LN	16550169				2022-12-27	WOS:000236340500016
J	Schubbert, S; Zenker, M; Rowe, SL; Boll, SB; Klein, C; Bollag, G; van der Burgt, I; Musante, L; Kalscheuer, V; Wehner, LE; Nguyen, H; West, B; Zhang, KYJ; Sistermans, E; Rauch, A; Niemeyer, CM; Shannon, K; Kratz, CP				Schubbert, S; Zenker, M; Rowe, SL; Boll, SB; Klein, C; Bollag, G; van der Burgt, I; Musante, L; Kalscheuer, V; Wehner, LE; Nguyen, H; West, B; Zhang, KYJ; Sistermans, E; Rauch, A; Niemeyer, CM; Shannon, K; Kratz, CP			Germline KRAS mutations cause Noonan syndrome	NATURE GENETICS			English	Article							JUVENILE MYELOMONOCYTIC LEUKEMIA; COLONY-STIMULATING FACTOR; MYELOID-LEUKEMIA; PTPN11 MUTATIONS; MOUSE MODEL; RAS; CELLS; GENE; HYPERSENSITIVITY; PROLIFERATION	Noonan syndrome (MIM 163950) is characterized by short stature, facial dysmorphism and cardiac defects(1). Heterozygous mutations in PTPN11, which encodes SHP-2, cause similar to 50% of cases of Noonan syndrome(1,2). The SHP-2 phosphatase relays signals from activated receptor complexes to downstream effectors, including Ras(3). We discovered de novo germline KRAS mutations that introduce V14I, T58I or D153V amino acid substitutions in five individuals with Noonan syndrome and a P34R alteration in a individual with cardio-faciocutaneous syndrome (MIM 115150), which has overlapping features with Noonan syndrome(1,4). Recombinant V14I and T58I K-Ras proteins show defective intrinsic GTP hydrolysis and impaired responsiveness to GTPase activating proteins, render primary hematopoietic progenitors hypersensitive to growth factors and deregulate signal transduction in a cell lineage-specific manner. These studies establish germline KRAS mutations as a cause of human disease and infer that the constellation of developmental abnormalities seen in Noonan syndrome spectrum is, in large part, due to hyperactive Ras.	Univ Freiburg, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol, D-79106 Freiburg, Germany; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; Plexxikon Inc, Berkeley, CA 94710 USA; Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Univ Gottingen, Inst Human Genet, D-37075 Gottingen, Germany; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94115 USA	University of Freiburg; University of California System; University of California San Francisco; University of Erlangen Nuremberg; Plexxikon; Radboud University Nijmegen; Max Planck Society; University of Gottingen; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Kratz, CP (corresponding author), Univ Freiburg, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol, Mathildenstr 1, D-79106 Freiburg, Germany.	shannonk@peds.ucsf.edu; christian.kratz@uniklinik-freiburg.de	Kratz, Christian/AAC-9726-2021; Rauch, Anita/C-5568-2014; Musante, Luciana/AAA-5726-2021; Sistermans, Erik/B-1109-2009; Zhang, Kam Y. J./B-3552-2012	Rauch, Anita/0000-0003-2930-3163; Musante, Luciana/0000-0002-2742-1484; Sistermans, Erik/0000-0001-7187-4563; Zhang, Kam Y. J./0000-0002-9282-8045; West, Brian/0000-0002-5320-3691; Kalscheuer, Vera/0000-0001-6898-3259	NCI NIH HHS [R01 CA104282, R01 CA72614] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072614, R01CA104282] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Bollag G, 1996, NAT GENET, V12, P144, DOI 10.1038/ng0296-144; BOLLAG G, 1991, NATURE, V351, P576, DOI 10.1038/351576a0; Bollag G, 1996, J BIOL CHEM, V271, P32491, DOI 10.1074/jbc.271.51.32491; BOS JL, 1989, CANCER RES, V49, P4682; Chan RJ, 2005, BLOOD, V105, P3737, DOI 10.1182/blood-2004-10-4002; Donovan S, 2002, CANCER CELL, V2, P507, DOI 10.1016/S1535-6108(02)00214-3; Donovan S, 2002, BBA-REV CANCER, V1602, P23, DOI 10.1016/S0304-419X(01)00041-5; FRANKEN SM, 1993, BIOCHEMISTRY-US, V32, P8411, DOI 10.1021/bi00084a005; Hiatt KK, 2001, J BIOL CHEM, V276, P7240, DOI 10.1074/jbc.M009202200; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kavamura MI, 2002, AM J MED GENET, V112, P12, DOI 10.1002/ajmg.10681; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kratz CP, 2005, BLOOD, V106, P2183, DOI 10.1182/blood-2005-02-0531; Largaespada DA, 1996, NAT GENET, V12, P137, DOI 10.1038/ng0296-137; LAUCHLE JO, 2005, PEDIAT BLOOD CANC; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mohi MG, 2005, CANCER CELL, V7, P179, DOI 10.1016/j.ccr.2005.01.010; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Schubert C, 2005, NAT MED, V11, P106, DOI 10.1038/nm0205-106a; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Side L, 1997, NEW ENGL J MED, V336, P1713, DOI 10.1056/NEJM199706123362404; STONE JC, 1993, MOL CELL BIOL, V13, P7311, DOI 10.1128/MCB.13.12.7311; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2003, NAT GENET, V34, P148, DOI 10.1038/ng1156; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Zenker M, 2004, J PEDIATR-US, V144, P368, DOI 10.1016/j.jpeds.2003.11.032	30	524	548	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					331	336		10.1038/ng1748	http://dx.doi.org/10.1038/ng1748			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16474405				2022-12-27	WOS:000235589600015
J	Peisajovich, SG; Rockah, L; Tawfik, DS				Peisajovich, SG; Rockah, L; Tawfik, DS			Evolution of new protein topologies through multistep gene rearrangements	NATURE GENETICS			English	Article							RESTRICTION-MODIFICATION SYSTEM; RANDOM CIRCULAR PERMUTATION; DNA-METHYLTRANSFERASE; MOLECULAR EVOLUTION; SEQUENCES; DOMAINS; ENZYMES; FOLD		Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tawfik, DS (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	dan.tawfik@weizmann.ac.il	Peisajovich, Sergio/C-6641-2011					Aravind L, 2002, CURR OPIN STRUC BIOL, V12, P392, DOI 10.1016/S0959-440X(02)00334-2; Bujnicki JM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-3; Choe W, 2005, BIOCHEM BIOPH RES CO, V334, P1233, DOI 10.1016/j.bbrc.2005.07.017; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; CUNNINGHAM BA, 1979, P NATL ACAD SCI USA, V76, P3218, DOI 10.1073/pnas.76.7.3218; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Graf R, 1996, P NATL ACAD SCI USA, V93, P11591, DOI 10.1073/pnas.93.21.11591; Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335; Hennecke J, 1999, J MOL BIOL, V286, P1197, DOI 10.1006/jmbi.1998.2531; Iwakura M, 2000, NAT STRUCT BIOL, V7, P580, DOI 10.1038/76811; Jeltsch A, 1999, J MOL EVOL, V49, P161, DOI 10.1007/PL00006529; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; KITA K, 1989, J BIOL CHEM, V264, P5751; KLIMASAUSKAS S, 1989, NUCLEIC ACIDS RES, V17, P9823, DOI 10.1093/nar/17.23.9823; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; KUSANO K, 1995, P NATL ACAD SCI USA, V92, P11095, DOI 10.1073/pnas.92.24.11095; Leismann O, 1998, EUR J BIOCHEM, V251, P899, DOI 10.1046/j.1432-1327.1998.2510899.x; LUGER K, 1989, SCIENCE, V243, P206, DOI 10.1126/science.2643160; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Ostermeier M, 1999, NAT BIOTECHNOL, V17, P1205, DOI 10.1038/70754; Ostermeier M, 1999, P NATL ACAD SCI USA, V96, P3562, DOI 10.1073/pnas.96.7.3562; PONTING CP, 1995, TRENDS BIOCHEM SCI, V20, P179, DOI 10.1016/S0968-0004(00)89003-9; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; ROODVELDT C, 2005, PROTEIN ENG DES SEL; SUGISAKI H, 1989, J BIOL CHEM, V264, P5757; SZOMOLANYI E, 1980, GENE, V10, P219, DOI 10.1016/0378-1119(80)90051-7; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; Wagner A, 2005, FEBS LETT, V579, P1772, DOI 10.1016/j.febslet.2005.01.063	30	80	84	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					168	174		10.1038/ng1717	http://dx.doi.org/10.1038/ng1717			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16415885				2022-12-27	WOS:000234953200010
J	Smith, UM; Consugar, M; Tee, LJ; McKee, BM; Maina, EN; Whelan, S; Morgan, NV; Goranson, E; Gissen, P; Lilliquist, S; Aligianis, IA; Ward, CJ; Pasha, S; Punyashthiti, R; Sharif, SM; Batman, PA; Bennett, CP; Woods, CG; McKeown, C; Bucourt, M; Miller, CA; Cox, P; Algazali, L; Trembath, RC; Torres, VE; Attie-Bitach, T; Kelly, DA; Maher, ER; Gattone, VH; Harris, PC; Johnson, CA				Smith, UM; Consugar, M; Tee, LJ; McKee, BM; Maina, EN; Whelan, S; Morgan, NV; Goranson, E; Gissen, P; Lilliquist, S; Aligianis, IA; Ward, CJ; Pasha, S; Punyashthiti, R; Sharif, SM; Batman, PA; Bennett, CP; Woods, CG; McKeown, C; Bucourt, M; Miller, CA; Cox, P; Algazali, L; Trembath, RC; Torres, VE; Attie-Bitach, T; Kelly, DA; Maher, ER; Gattone, VH; Harris, PC; Johnson, CA			The transmembrane protein meckelin (MKS3) is mutated in Meckel-Gruber syndrome and the wpk rat	NATURE GENETICS			English	Article							BARDET-BIEDL-SYNDROME; POLYCYSTIC KIDNEY-DISEASE; PLANAR CELL POLARITY; CILIARY; MAPS; MALFORMATION; PREDICTION; ANOMALIES; GENES; LOCUS	Meckel-Gruber syndrome is a severe autosomal, recessively inherited disorder characterized by bilateral renal cystic dysplasia, developmental defects of the central nervous system ( most commonly occipital encephalocele), hepatic ductal dysplasia and cysts and polydactyly(1-3). MKS is genetically heterogeneous, with three loci mapped: MKS1, 17q21-24 (ref. 4); MKS2, 11q13 ( ref. 5) and MKS3 ( ref. 6). We have refined MKS3 mapping to a 12.67-Mb interval (8q21.13-q22.1) that is syntenic to the Wpk locus in rat, which is a model with polycystic kidney disease, agenesis of the corpus callosum and hydrocephalus(7,8). Positional cloning of the Wpk gene suggested a MKS3 candidate gene, TMEM67, for which we identified pathogenic mutations for five MKS3-linked consanguineous families. MKS3 is a previously uncharacterized, evolutionarily conserved gene that is expressed at moderate levels in fetal brain, liver and kidney but has widespread, low levels of expression. It encodes a 995 - amino acid seven-transmembrane receptor protein of unknown function that we have called meckelin.	Univ Birmingham, Sch Med, Sect Med & Mol Genet, Div Reprod & Child Hlth, Birmingham B15 2TT, W Midlands, England; Mayo Clin, Coll Med, Div Nephrol & Hypertens, Rochester, MN 55904 USA; Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; Prince Wales Childrens Hosp, Childrens Liver Unit, Birmingham B4 6NH, W Midlands, England; Birmingham Womens Hosp, Clin Genet Unit, Birmingham B15 2TG, W Midlands, England; St James Hosp, Leeds LS9 7TF, W Yorkshire, England; Bradford Royal Infirm, Dept Histopathol, Bradford BD9 6RJ, W Yorkshire, England; Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Addenbrookes Hosp, Cambridge CB2 2BP, England; Hop Jean Verdier, Serv Anat Pathol, Bondy, France; Birmingham Womens Hosp, Dept Histopathol, Birmingham B15 2TG, W Midlands, England; United Arab Emirates Univ, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Hop Necker Enfants Malad, Dept Genet, F-75743 Paris, France; Hop Necker Enfants Malad, INSERM, U 393, F-75743 Paris, France	University of Birmingham; Mayo Clinic; Indiana University System; Indiana University-Purdue University Indianapolis; Birmingham Women's Hospital; Saint James's University Hospital; Bradford Royal Infirmary; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP; Birmingham Women's Hospital; United Arab Emirates University; University of Leicester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Johnson, CA (corresponding author), Univ Birmingham, Sch Med, Sect Med & Mol Genet, Div Reprod & Child Hlth, Birmingham B15 2TT, W Midlands, England.	harris.peter@mayo.edu; c.a.johnson@bham.ac.uk	Gissen, Paul/A-4352-2010; MAHER, EAMONN R/A-9507-2008; woods, christopher g/A-1361-2010; ATTIE-BITACH, Tania/K-1453-2017; Morgan, Neil V/A-5475-2009	Gissen, Paul/0000-0002-9712-6122; MAHER, EAMONN R/0000-0002-6226-6918; ATTIE-BITACH, Tania/0000-0002-1155-3626; Morgan, Neil V/0000-0001-6433-5692; Johnson, Colin/0000-0002-2979-8234; Trembath, Richard/0000-0003-0550-3400; Tammachote, Rachaneekorn/0000-0001-9600-9824	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AHDABBARMADA M, 1990, J NEUROPATH EXP NEUR, V49, P610, DOI 10.1097/00005072-199011000-00007; AlGazali LI, 1996, CLIN DYSMORPHOL, V5, P73, DOI 10.1097/00019605-199601000-00011; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Beales PL, 2005, CURR OPIN GENET DEV, V15, P315, DOI 10.1016/j.gde.2005.04.006; Blankenberg T A, 1987, Am J Med Genet Suppl, V3, P395; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Calvet JP, 2003, P NATL ACAD SCI USA, V100, P5583, DOI 10.1073/pnas.1031799100; Consugar MB, 2005, AM J KIDNEY DIS, V45, P77, DOI 10.1053/j.ajkd.2004.09.009; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; FRASER FC, 1981, AM J MED GENET, V9, P67, DOI 10.1002/ajmg.1320090112; Gattone VH, 2004, ANAT REC PART A, V277A, P384, DOI 10.1002/ar.a.20022; Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271; Karmous-Benailly H, 2005, AM J HUM GENET, V76, P493, DOI 10.1086/428679; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Maina EN, 2005, ONCOGENE, V24, P4549, DOI 10.1038/sj.onc.1208649; Morgan NV, 2002, HUM GENET, V111, P456, DOI 10.1007/s00439-002-0817-0; Nauta J, 2000, J AM SOC NEPHROL, V11, P2272, DOI 10.1681/ASN.V11122272; PAAVOLA P, 1995, NAT GENET, V11, P213, DOI 10.1038/ng1095-213; Pazour GJ, 2004, CURR BIOL, V14, pR575, DOI 10.1016/j.cub.2004.07.017; POVELONES M, IN PRESS GENETICS; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Roume J, 1998, AM J HUM GENET, V63, P1095, DOI 10.1086/302062; SALONEN R, 1984, AM J MED GENET, V18, P671, DOI 10.1002/ajmg.1320180414; Salonen R, 1998, J MED GENET, V35, P497, DOI 10.1136/jmg.35.6.497; Sambrook J., 2001, MOL CLONING LAB MANU; SIMPSON JL, 1991, ANN GENET-PARIS, V34, P279; Xu YK, 1998, CURR BIOL, V8, pR405, DOI 10.1016/S0960-9822(98)70262-3	30	197	204	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					191	196		10.1038/ng1713	http://dx.doi.org/10.1038/ng1713			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16415887				2022-12-27	WOS:000234953200013
J	Du, W; Bautista, JF; Yang, HH; Diez-Sampedro, A; You, SA; Wang, LJ; Kotagal, P; Luders, HO; Shi, JY; Cui, JM; Richerson, GB; Wang, QK				Du, W; Bautista, JF; Yang, HH; Diez-Sampedro, A; You, SA; Wang, LJ; Kotagal, P; Luders, HO; Shi, JY; Cui, JM; Richerson, GB; Wang, QK			Calcium-sensitive potassium channelopathy in human epilepsy and paroxysmal movement disorder	NATURE GENETICS			English	Article							BETA-SUBUNIT; ATAXIA; GENE; OSCILLATION; MUTATIONS; MYOKYMIA; FEATURES	The large conductance calcium- sensitive potassium ( BK) channel is widely expressed in many organs and tissues, but its in vivo physiological functions have not been fully defined. Here we report a genetic locus associated with a human syndrome of coexistent generalized epilepsy and paroxysmal dyskinesia on chromosome 10q22 and show that a mutation of the a subunit of the BK channel causes this syndrome. The mutant BK channel had a markedly greater macroscopic current. Single- channel recordings showed an increase in open-channel probability due to a three- to fivefold increase in Ca2+ sensitivity. We propose that enhancement of BK channels in vivo leads to increased excitability by inducing rapid repolarization of action potentials, resulting in generalized epilepsy and paroxysmal dyskinesia by allowing neurons to fire at a faster rate. These results identify a gene that is mutated in generalized epilepsy and paroxysmal dyskinesia and have implications for the pathogenesis of human epilepsy, the neurophysiology of paroxysmal movement disorders and the role of BK channels in neurological disease.	Cleveland Clin Fdn, Ctr Mol Sci, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Ctr Cardiovasc Genet, Dept Cardiovasc Med, Cleveland, OH 44195 USA; Case Western Reserve Univ, Dept Mol Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44195 USA; Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; Cleveland Clin Fdn, Dept Neurol, Cleveland, OH 44195 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; Washington Univ, Dept Biomed Engn, St Louis, MO 63130 USA; Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; Vet Adm Med Ctr, West Haven, CT 06516 USA; Huazhong Univ Sci & Technol, Human Genome Res Ctr, Wuhan, Peoples R China	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation; Case Western Reserve University; Washington University (WUSTL); Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Huazhong University of Science & Technology	Wang, QK (corresponding author), Cleveland Clin Fdn, Ctr Mol Sci, Dept Mol Cardiol, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wangq2@ccf.org	Bautista, Jocelyn F./AAP-6901-2021	Richerson, George/0000-0001-5696-1554; Yang, Huanghe/0000-0001-9521-9328	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070393] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL070393] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS PR, 1982, NATURE, V296, P746, DOI 10.1038/296746a0; [Anonymous], 1981, Epilepsia, V22, P489; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; BARRETT JN, 1982, J PHYSIOL-LONDON, V331, P211, DOI 10.1113/jphysiol.1982.sp014370; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; DEMIRKIRAN M, 1995, ANN NEUROL, V38, P571, DOI 10.1002/ana.410380405; Eunson LH, 2000, ANN NEUROL, V48, P647; Fernandez-Fernandez JM, 2004, J CLIN INVEST, V113, P1032, DOI 10.1172/JCI200420347; Guerrini R, 2002, EPILEPSIA, V43, P1224, DOI 10.1046/j.1528-1157.2002.13802.x; Guerrini R, 2001, EPILEPSIA, V42, P36, DOI 10.1046/j.1528-1157.2001.042suppl.3036.x; Guerrini R, 1999, ANN NEUROL, V45, P344, DOI 10.1002/1531-8249(199903)45:3<344::AID-ANA10>3.0.CO;2-9; Jin W, 2000, BRAIN RES, V860, P21, DOI 10.1016/S0006-8993(00)01943-0; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Lee HY, 2004, HUM MOL GENET, V13, P3161, DOI 10.1093/hmg/ddh330; LUBBERS WJ, 1995, J NEUROL NEUROSUR PS, V59, P400, DOI 10.1136/jnnp.59.4.400; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; MCMANUS OB, 1995, NEURON, V14, P645, DOI 10.1016/0896-6273(95)90321-6; Nimigean CM, 1999, J GEN PHYSIOL, V113, P425, DOI 10.1085/jgp.113.3.425; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Rutten F, 2001, J TURBUL, V2, P1, DOI 10.1088/1468-5248/2/1/003; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Szepetowski P, 1997, AM J HUM GENET, V61, P889, DOI 10.1086/514877; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956	29	407	423	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					733	738		10.1038/ng1585	http://dx.doi.org/10.1038/ng1585			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15937479				2022-12-27	WOS:000230196400020
J	Harikrishnan, KN; Chow, MZ; Baker, EK; Pal, S; Bassal, S; Brasacchio, D; Wang, L; Craig, JM; Jones, PL; Sif, S; El-Osta, A				Harikrishnan, KN; Chow, MZ; Baker, EK; Pal, S; Bassal, S; Brasacchio, D; Wang, L; Craig, JM; Jones, PL; Sif, S; El-Osta, A			Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing	NATURE GENETICS			English	Article							CPG-BINDING-PROTEIN; FRAGILE-X; DNA METHYLATION; REPRESSION; MECP2; GENE; FMR1; DEACETYLATION; PURIFICATION; RECRUITMENT	Transcriptional repression of methylated genes can be mediated by the methyl-CpG binding protein MeCP2. Here we show that human Brahma (Brm), a catalytic component of the SWI/SNF-related chromatin-remodeling complex, associates with MeCP2 in vivo and is functionally linked with repression. We used a number of different molecular approaches and chromatin immunoprecipitation strategies to show a unique cooperation between Brm, BAF57 and MeCP2. We show that Brm and MeCP2 assembly on chromatin occurs on methylated genes in cancer and the gene FMR1 in fragile X syndrome. These experimental findings identify a new role for SWI/SNF in gene repression by MeCP2.	Baker Med Res Inst, Alfred Med Res & Educ Precinct, Epigenet Human Hlth & Dis Lab, Prahran, Vic 3181, Australia; Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61802 USA	Baker Heart and Diabetes Institute; University System of Ohio; Ohio State University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Illinois System; University of Illinois Urbana-Champaign	El-Osta, A (corresponding author), Baker Med Res Inst, Alfred Med Res & Educ Precinct, Epigenet Human Hlth & Dis Lab, 2nd Floor,Commercial Rd, Prahran, Vic 3181, Australia.	assam.el-osta@baker.edu.au	Craig, Jeffrey M/B-3484-2012	Craig, Jeffrey M/0000-0003-3979-7849; El-Osta, Assam/0000-0003-2969-9137; Kaipananickal, Harikrishnan/0000-0002-4662-659X; El-Osta, Assam/0000-0001-7968-7375; Sif, Said/0000-0001-6268-1145				Ballestar E, 2003, EMBO J, V22, P6335, DOI 10.1093/emboj/cdg604; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Coffee B, 2002, AM J HUM GENET, V71, P923, DOI 10.1086/342931; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Damelin M, 2002, MOL CELL, V9, P563, DOI 10.1016/S1097-2765(02)00475-6; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; El-Osta A, 2000, GENE EXPRESSION, V9, P63; El-Osta A, 2001, BIOCHEM BIOPH RES CO, V289, P733, DOI 10.1006/bbrc.2001.6023; El-Osta A, 2001, MOL BIOL REP, V28, P209, DOI 10.1023/A:1015744625049; El-Osta A, 2002, MOL CELL BIOL, V22, P1844, DOI 10.1128/MCB.22.6.1844-1857.2002; Flaus A, 2003, MOL CELL BIOL, V23, P7767, DOI 10.1128/MCB.23.21.7767-7779.2003; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Fyodorov DV, 2004, GENE DEV, V18, P170, DOI 10.1101/gad.1139604; Godde JS, 1996, J BIOL CHEM, V271, P24325, DOI 10.1074/jbc.271.40.24325; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Jin P, 2000, HUM MOL GENET, V9, P901, DOI 10.1093/hmg/9.6.901; JONES A, 1967, ECON BOT, V21, P163, DOI 10.1007/BF02897864; Jones BE, 1998, EXTREMOPHILES, V2, P191, DOI 10.1007/s007920050060; Kass SU, 1997, CURR BIOL, V7, P157, DOI 10.1016/S0960-9822(97)70086-1; Kimura H, 2003, J BIOL CHEM, V278, P4806, DOI 10.1074/jbc.M209923200; Klose RJ, 2004, J BIOL CHEM, V279, P46490, DOI 10.1074/jbc.M408284200; KREMER EJ, 1991, SCIENCE, V252, P1711, DOI 10.1126/science.1675488; Li Q, 1999, ONCOGENE, V18, P3284, DOI 10.1038/sj.onc.1202663; Magdinier F, 2001, P NATL ACAD SCI USA, V98, P4990, DOI 10.1073/pnas.101617298; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Martens JA, 2002, GENE DEV, V16, P2231, DOI 10.1101/gad.1009902; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Ng HH, 2002, GENE DEV, V16, P806, DOI 10.1101/gad.978902; Nguyen CT, 2001, NUCLEIC ACIDS RES, V29, P4598, DOI 10.1093/nar/29.22.4598; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Valerius O, 2002, J BIOL CHEM, V277, P21440, DOI 10.1074/jbc.M201841200; VERHEIJ C, 1995, HUM MOL GENET, V4, P895, DOI 10.1093/hmg/4.5.895; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	50	226	237	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					254	264		10.1038/ng1516	http://dx.doi.org/10.1038/ng1516			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15696166				2022-12-27	WOS:000227297800016
J	Li, MZ; Elledge, SJ				Li, MZ; Elledge, SJ			MAGIC, an in vivo genetic method for the rapid construction of recombinant DNA molecules	NATURE GENETICS			English	Article							LAC OPERATOR DNA; ESCHERICHIA-COLI; CLONING; PLASMID; REPLACEMENT; MUTAGENESIS; EXPRESSION; PROMOTER; VECTOR; SYSTEM	We describe a highly engineered in vivo cloning method, mating-assisted genetically integrated cloning (MAGIC), that facilitates the rapid construction of recombinant DNA molecules. MAGIC uses bacterial mating, in vivo site-specific endonuclease cleavage and homologous recombination to catalyze the transfer of a DNA fragment between a donor vector in one bacterial strain and a recipient plasmid in a separate bacterial strain. Recombination events are genetically selected and result in placement of the gene of interest under the control of new regulatory elements with high efficiency. MAGIC eliminates the need for restriction enzymes, DNA ligases, preparation of DNA and all in vitro manipulations required for subcloning and allows the rapid construction of multiple constructs with minimal effort. We show that MAGIC can generate constructs for expression in multiple organisms. As this new method requires only the simple mixing of bacterial strains, it represents a substantial advance in high-throughput recombinant DNA production that will save time, effort and expense in functional genomics studies.	Harvard Univ, Sch Med, Harvard Partners Ctr Genet & Genom, Howard Hughes Med Inst,Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Harvard Partners Ctr Genet & Genom, Howard Hughes Med Inst,Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu						BACKMAN K, 1978, CELL, V13, P65, DOI 10.1016/0092-8674(78)90138-1; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bethke B, 1997, NUCLEIC ACIDS RES, V25, P2828, DOI 10.1093/nar/25.14.2828; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; DANNA K, 1971, P NATL ACAD SCI USA, V68, P2913, DOI 10.1073/pnas.68.12.2913; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; FROST LS, 1994, MICROBIOL REV, V58, P162, DOI 10.1128/MMBR.58.2.162-210.1994; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gumbiner-Russo LM, 2001, GENE, V273, P97, DOI 10.1016/S0378-1119(01)00565-0; Haldimann A, 1998, J BACTERIOL, V180, P1277, DOI 10.1128/JB.180.5.1277-1286.1998; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; HASHIMOTO T, 1976, J BACTERIOL, V127, P1561, DOI 10.1128/JB.127.3.1561-1563.1976; HEYNEKER HL, 1976, NATURE, V263, P748, DOI 10.1038/263748a0; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; KAISER K, 1980, MOL GEN GENET, V179, P555, DOI 10.1007/BF00271745; KAST P, 1994, GENE, V138, P109, DOI 10.1016/0378-1119(94)90790-0; KOZAK M, 1989, MOL CELL BIOL, V9, P5134, DOI 10.1128/MCB.9.11.5134; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; MARIANS KJ, 1976, NATURE, V263, P744, DOI 10.1038/263744a0; METCALF WW, 1994, GENE, V138, P1, DOI 10.1016/0378-1119(94)90776-5; Nebert D W, 2000, Ann N Y Acad Sci, V919, P148; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; Siegel RW, 2004, GENOME RES, V14, P1119, DOI 10.1101/gr.1821804; SMITH HO, 1970, J MOL BIOL, V51, P379, DOI 10.1016/0022-2836(70)90149-X; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; WINANS SC, 1985, J BACTERIOL, V161, P1219, DOI 10.1128/JB.161.3.1219-1221.1985; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang PM, 2002, NAT GENET, V30, P31, DOI 10.1038/ng797	33	95	106	1	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					311	319		10.1038/ng1505	http://dx.doi.org/10.1038/ng1505			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15731760				2022-12-27	WOS:000227297800024
J	Mountain, JL; Risch, N				Mountain, JL; Risch, N			Assessing genetic contributions to phenotypic differences among 'racial' and 'ethnic' groups	NATURE GENETICS			English	Article							NOVELTY SEEKING; POPULATION-STRUCTURE; NATURAL-SELECTION; ABSOLUTE PITCH; DISEASE; DIVERSITY; RACE; ASSOCIATION; PHARMACOGENOMICS; POLYMORPHISMS	Descriptions of human genetic variation given thirty years ago have held up well, considering the substantial accrual of DNA sequence data in the interim. Most importantly, estimates of between-group genetic variation have remained relatively low. Despite the low average level of between-group variation, clusters recently inferred from multilocus genetic data coincide closely with groups defined by self-identified race or continental ancestry. This correspondence implies that genetic factors might contribute to unexplained between-group phenotypic variation. Current understanding of the contribution of genes to variation in most complex traits is limited, however. Under these circumstances, assumptions about genetic contributions to group differences are unfounded. In the absence of detailed understanding, 'racial' and 'ethnic' categories will remain useful in biomedical research. Further, we suggest approaches and guidelines for assessing the contribution of genetic factors to between-group phenotypic differences, including studies of candidate genes and analyses of recently admixed populations.	Stanford Univ, Dept Anthropol Sci, Stanford, CA 94305 USA; Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Kaiser Permanente, Div Res, Oakland, CA 94611 USA	Stanford University; Stanford University; Kaiser Permanente	Mountain, JL (corresponding author), Stanford Univ, Dept Anthropol Sci, Stanford, CA 94305 USA.	mountain@stanford.edu						Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Bamshad MJ, 2003, AM J HUM GENET, V72, P578, DOI 10.1086/368061; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Benjamin J, 1996, NAT GENET, V12, P81, DOI 10.1038/ng0196-81; BODMER WF, 1970, SCI AM, V223, P19, DOI 10.1038/scientificamerican1070-19; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Brant SR, 2004, INFLAMM BOWEL DIS, V10, P300, DOI 10.1097/00054725-200405000-00019; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Cavalli-Sforza L.L., 1971, GENETICS HUMAN POPUL; Croucher PJP, 2003, EUR J HUM GENET, V11, P6, DOI 10.1038/sj.ejhg.5200897; Dobzhansky Theodosius, 1971, BIOL SOCIAL MEANING, P14; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Edwards AWF, 2003, BIOESSAYS, V25, P798, DOI 10.1002/bies.10315; ENTINE J, 1999, TABOO WHY BLACK ATHL; Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; FELDMAN MW, 1975, SCIENCE, V190, P1163, DOI 10.1126/science.1198102; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; Goldstein DB, 2002, ANNU REV GENOM HUM G, V3, P129, DOI 10.1146/annurev.genom.3.022502.103200; Graves JL., 2004, RACE MYTH WHY WE PRE; Gregersen PK, 1999, AM J HUM GENET, V65, P911, DOI 10.1086/302541; Haga SB, 2003, SCIENCE, V301, P466, DOI 10.1126/science.1087004; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Holden C, 2004, SCIENCE, V305, P637, DOI 10.1126/science.305.5684.637; HOWELLS WW, 1971, BIOL SOCIAL MEANING; Jorde LB, 2000, AM J HUM GENET, V66, P979, DOI 10.1086/302825; Karter AJ, 2003, INT J EPIDEMIOL, V32, P26, DOI 10.1093/ije/dyg033; Kennedy JL, 2003, SCIENCE, V302, P822, DOI 10.1126/science.1092132; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Kluger AN, 2002, MOL PSYCHIATR, V7, P712, DOI 10.1038/sj.mp.4001082; LANDER E, 2001, CRACKING CODE LIFE; Lewontin R., 1972, EVOLUTIONARY BIOL, V6; Limdi JK, 2004, QJM-INT J MED, V97, P315, DOI 10.1093/qjmed/hch065; Lin SS, 2000, EPIDEMIOL REV, V22, P187, DOI 10.1093/oxfordjournals.epirev.a018032; Long JC, 2003, HUM BIOL, V75, P449, DOI 10.1353/hub.2003.0058; MCKUSICK VA, 1967, J CHRON DIS, V20, P115, DOI 10.1016/0021-9681(67)90045-8; MCKUSICKNATHANS, 2000, ONLINE MENDELIAN INH; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; Olson S., 2002, MAPPING HUMAN HIST; Parrott RL, 2003, SOC SCI MED, V56, P1099, DOI 10.1016/S0277-9536(02)00106-5; PENROSE LS, 1951, ANN EUGENIC, V16, P134, DOI 10.1111/j.1469-1809.1951.tb02467.x; Risch N., 2002, GENOME BIOL, V3, pcomm, DOI [10.1186/gb-2002-3-7-comment2007, 10.1186/GB-2002-3-7-COMMENT2007]; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sankar P, 2004, JAMA-J AM MED ASSOC, V291, P2985, DOI 10.1001/jama.291.24.2985; SARICH V, 2004, RACE REALITY HUMAN D; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Su B, 2000, EUR J HUM GENET, V8, P975, DOI 10.1038/sj.ejhg.5200568; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761	56	99	100	1	13	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2004	36	11		S			S48	S53		10.1038/ng1456	http://dx.doi.org/10.1038/ng1456			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867PH	15508003	Bronze			2022-12-27	WOS:000224854000011
J	Lemos, B; Meiklejohn, CD; Hartl, DL				Lemos, B; Meiklejohn, CD; Hartl, DL			Regulatory evolution across the protein interaction network	NATURE GENETICS			English	Article							GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; DEPENDENCE; NUMBER	Protein-protein interactions may impose constraints on both structural and regulatory evolution. Here we show that protein-protein interactions are negatively associated with evolutionary variation in gene expression. Moreover, interacting proteins have similar levels of variation in expression, and their expression levels are positively correlated across strains. Our results suggest that interacting proteins undergo similar evolutionary dynamics, and that their expression levels are evolutionarily coupled. These patterns hold for organisms as diverse as budding yeast and fruit flies.	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Lemos, B (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 16 Divin Ave,Hartl Lab,Room 2105, Cambridge, MA 02138 USA.	blemos@oeb.harvard.edu	Lemos, Bernardo/AAL-2429-2020	Lemos, Bernardo/0000-0001-6996-9483; Meiklejohn, Colin/0000-0003-2708-8316				Bader JS, 2004, NAT BIOTECHNOL, V22, P78, DOI 10.1038/nbt924; Bloom JD, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-21; Fraser HB, 2002, SCIENCE, V296, P750, DOI 10.1126/science.1068696; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Kimura M., 1983, NEUTRAL THEORY MOL E; LANDE R, 1975, GENET RES, V26, P221, DOI 10.1017/S0016672300016037; Meiklejohn CD, 2003, P NATL ACAD SCI USA, V100, P9894, DOI 10.1073/pnas.1630690100; Pal C, 2003, NATURE, V421, P496, DOI 10.1038/421496b; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Townsend JP, 2003, MOL BIOL EVOL, V20, P955, DOI 10.1093/molbev/msg106; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023	15	51	51	0	13	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2004	36	10					1059	1060		10.1038/ng1427	http://dx.doi.org/10.1038/ng1427			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	15378060	Bronze			2022-12-27	WOS:000224156500012
J	Todd, JA				Todd, JA			Statistical false positive or true disease pathway?	NATURE GENETICS			English	Editorial Material							GENOME-WIDE ASSOCIATION; TYPE-1 DIABETES LOCUS; PARKINSON-DISEASE; GENE; VARIANT; RISK; SUSCEPTIBILITY; POLYMORPHISM; PROBABILITY; HAPLOTYPE		Univ Cambridge, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab,Addenbrooke, Cambridge Inst Med Res,Wellcome Trust Med Res Cou, Cambridge CB2 2XY, England	University of Cambridge	Todd, JA (corresponding author), Univ Cambridge, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab,Addenbrooke, Cambridge Inst Med Res,Wellcome Trust Med Res Cou, Cambridge CB2 2XY, England.	john.todd@cimr.cam.ac.uk	Todd, John A/A-3542-2010	Todd, John A/0000-0003-2740-8148	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Anjos S, 2002, J BIOL CHEM, V277, P46478, DOI 10.1074/jbc.M206894200; BRASSAT D, 2006, GENES IMMUN; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Clarimon J, 2006, AM J HUM GENET, V78, P1082, DOI 10.1086/504727; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Dahlman I, 2002, NAT GENET, V30, P149, DOI 10.1038/ng825; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; GROVES CJ, IN PRESS DIABETES; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lowe CE, 2004, GENES IMMUN, V5, P301, DOI 10.1038/sj.gene.6364064; Manly KF, 2004, GENOME RES, V14, P997, DOI 10.1101/gr.2156804; Maraganore DM, 2005, AM J HUM GENET, V77, P685, DOI 10.1086/496902; Moskvina V, 2006, HUM HERED, V61, P55, DOI 10.1159/000092553; Raymond CK, 2005, GENOMICS, V86, P759, DOI 10.1016/j.ygeno.2005.08.013; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Wong MY, 2003, INT J EPIDEMIOL, V32, P51, DOI 10.1093/ije/dyg002; 1999, NAT GENET, V22, P1; 2005, NAT GENET, V37, P1153	26	123	131	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2006	38	7					731	733		10.1038/ng0706-731	http://dx.doi.org/10.1038/ng0706-731			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16804532				2022-12-27	WOS:000238669300002
J	Cullen, BR				Cullen, Bryan R.			Viruses and microRNAs	NATURE GENETICS			English	Article							SMALL INTERFERING RNA; HERPES-SIMPLEX-VIRUS; NUCLEAR EXPORT; GENE-EXPRESSION; MESSENGER-RNAS; IDENTIFICATION; TRANSCRIPTS; INHIBIT; REQUIREMENTS; TRANSLATION	The discovery of RNA interference and cellular microRNAs (miRNAs) has not only affected how biological research is conducted but also revealed an entirely new level of post-transcriptional gene regulation. Here, I discuss the potential functions of the virally encoded miRNAs recently identified in several pathogenic human viruses and propose that cellular miRNAs may have had a substantial effect on viral evolution and may continue to influence the in vivo tissue tropism of viruses. Our increasing knowledge of the role and importance of virally encoded miRNAs will probably offer new insights into how viruses that establish latent infections, such as herpesviruses, avoid elimination by the host innate or adaptive immune system. Research into viral miRNA function might also suggest new approaches for treating some virally induced diseases.	[Cullen, Bryan R.] Duke Univ, Med Ctr, Ctr Virol, Durham, NC 27710 USA; [Cullen, Bryan R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University; Duke University	Cullen, BR (corresponding author), Duke Univ, Med Ctr, Ctr Virol, Durham, NC 27710 USA.	culle002@mc.duke.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071408] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM071408] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Aparicio O, 2006, J VIROL, V80, P1376, DOI 10.1128/JVI.80.3.1376-1384.2006; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Branco FJ, 2005, J VIROL, V79, P9019, DOI 10.1128/JVI.79.14.9019-9025.2005; Cai Xuezhong, 2006, PLoS Pathogens, V2, P236, DOI 10.1371/journal.ppat.0020023; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Cai XZ, 2006, J VIROL, V80, P2234, DOI 10.1128/JVI.80.5.2234-2242.2006; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; FRASER NW, 1992, VIROLOGY, V191, P1, DOI 10.1016/0042-6822(92)90160-Q; FURNARI FB, 1993, P NATL ACAD SCI USA, V90, P378, DOI 10.1073/pnas.90.2.378; Gitlin L, 2003, J VIROL, V77, P7159, DOI 10.1128/JVI.77.13.7159-7165.2003; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grey F, 2005, J VIROL, V79, P12095, DOI 10.1128/JVI.79.18.12095-12099.2005; Grundhoff A, 2006, RNA, V12, P733, DOI 10.1261/rna.2326106; Gwizdek C, 2001, J BIOL CHEM, V276, P25910, DOI 10.1074/jbc.M100493200; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Linial ML, 1999, J VIROL, V73, P1747, DOI 10.1128/JVI.73.3.1747-1755.1999; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Macrae AI, 2001, J VIROL, V75, P5315, DOI 10.1128/JVI.75.11.5315-5327.2001; Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005; MATHEWS MB, 1991, J VIROL, V65, P5657, DOI 10.1128/JVI.65.11.5657-5662.1991; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Samols MA, 2005, J VIROL, V79, P9301, DOI 10.1128/JVI.79.14.9301-9305.2005; Sano M, 2006, FEBS LETT, V580, P1553, DOI 10.1016/j.febslet.2006.01.085; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; THIMMAPPAYA B, 1982, CELL, V31, P543, DOI 10.1016/0092-8674(82)90310-5; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	54	323	348	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38			6			S25	S30		10.1038/ng1793	http://dx.doi.org/10.1038/ng1793			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V44DK	16736021				2022-12-27	WOS:000202983200006
J	Roscioli, T; Cliffe, ST; Bloch, DB; Bell, CG; Mullan, G; Taylor, PJ; Sarris, M; Wang, J; Donald, JA; Kirk, EP; Ziegler, JB; Salzer, U; McDonald, GB; Wong, M; Lindeman, R; Buckley, MF				Roscioli, Tony; Cliffe, Simon T.; Bloch, Donald B.; Bell, Christopher G.; Mullan, Glenda; Taylor, Peter J.; Sarris, Maria; Wang, Joanne; Donald, Jennifer A.; Kirk, Edwin P.; Ziegler, John B.; Salzer, Ulrich; McDonald, George B.; Wong, Melanie; Lindeman, Robert; Buckley, Michael F.			Mutations in the gene encoding the PML nuclear body protein Sp110 are associated with immunodeficiency and hepatic veno-occlusive disease	NATURE GENETICS			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; RECEPTOR; HUMANS	We describe mutations in the PML nuclear body protein Sp110 in the syndrome veno-occlusive disease with immunodeficiency, an autosomal recessive disorder of severe hypogammaglobulinemia, combined T and B cell immunodeficiency, absent lymph node germinal centers, absent tissue plasma cells and hepatic veno-occlusive disease. This is the first report of the involvement of a nuclear body protein in a human primary immunodeficiency and of high-penetrance genetic mutations in hepatic veno-occlusive disease.	Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia; Prince Wales Hosp, Dept Haematol & Genet, Mol & Cytogenet Unit, Sydney, NSW 2031, Australia; Univ Sydney, Royal Prince Alfred Hosp, Dept Mol & Clin Genet, Sydney, NSW 2050, Australia; Harvard Univ, Sch Med, Dept Med, Ctr Immunol & Inflammatory Dis, Boston, MA 02129 USA; Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia; Univ Washington, Sch Med, Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Sch Pharm, Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia; Sydney Childrens Hosp, Dept Med Genet, Sydney, NSW 2031, Australia; Univ New S Wales, Sch Womens & Childrens Hosp, Sydney, NSW 2052, Australia; Sydney Childrens Hosp, Dept Immunol & Infect Dis, Sydney, NSW 2031, Australia; Univ Hosp, Div Rheumatol & Clin Immunol, Ctr Med, D-79106 Freiberg, Germany; Childrens Hosp, Dept Immunol & Allergy, Westmead, NSW 2145, Australia	University of New South Wales Sydney; University of Sydney; Harvard University; Harvard Medical School; University of New South Wales Sydney; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Macquarie University; University of Sydney; University of New South Wales Sydney; University of Sydney; University of Sydney	Roscioli, T (corresponding author), Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia.	tony.roscioli@email.cs.nsw.gov.au	Bell, Christopher/C-1585-2008	Bell, Christopher/0000-0003-4601-1242; Donald, Jennifer/0000-0002-2732-1379; Kirk, Edwin/0000-0002-4662-0024; buckley, michael/0000-0002-8298-8758; Sarris, Maria/0000-0001-6961-5829; Bloch, Donald/0000-0002-6828-4754				Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bloch DB, 2000, MOL CELL BIOL, V20, P6138, DOI 10.1128/MCB.20.16.6138-6146.2000; Elder ME, 2001, J IMMUNOL, V166, P656, DOI 10.4049/jimmunol.166.1.656; Everett RD, 2005, J VIROL, V79, P5078, DOI 10.1128/JVI.79.8.5078-5089.2005; Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; KADEREIT S, 1993, J BIOL CHEM, V268, P24432; KINGSTON HM, 1983, LANCET, V2, P1200; McDonald GB, 2003, BLOOD, V101, P2043, DOI 10.1182/blood-2002-06-1860; MELLIS C, 1976, J PEDIATR-US, V88, P236, DOI 10.1016/S0022-3476(76)80988-2; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; PARK WJ, 1995, HUM MOL GENET, V4, P1229, DOI 10.1093/hmg/4.7.1229; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Watashi K, 2003, MOL CELL BIOL, V23, P7498, DOI 10.1128/MCB.23.21.7498-7509.2003	15	63	65	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					620	622		10.1038/ng1780	http://dx.doi.org/10.1038/ng1780			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16648851	Green Accepted			2022-12-27	WOS:000237954800013
J	Huber, C; Dias-Santagata, D; Glaser, A; O'Sullivan, J; Brauner, R; Wu, K; Xu, XS; Pearce, K; Wang, R; Uzielli, MLG; Dagoneau, N; Chemaitilly, W; Superti-Furga, A; Dos Santos, H; Megarbane, A; Morin, G; Gillessen-Kaesbach, G; Hennekam, R; Van der Burgt, I; Black, GCM; Clayton, PE; Read, A; Le Merrer, M; Scambler, PJ; Munnich, A; Pan, ZQ; Winter, R; Cormier-Daire, V				Huber, C; Dias-Santagata, D; Glaser, A; O'Sullivan, J; Brauner, R; Wu, K; Xu, XS; Pearce, K; Wang, R; Uzielli, MLG; Dagoneau, N; Chemaitilly, W; Superti-Furga, A; Dos Santos, H; Megarbane, A; Morin, G; Gillessen-Kaesbach, G; Hennekam, R; Van der Burgt, I; Black, GCM; Clayton, PE; Read, A; Le Merrer, M; Scambler, PJ; Munnich, A; Pan, ZQ; Winter, R; Cormier-Daire, V			Identification of mutations in CUL7 in 3-M syndrome	NATURE GENETICS			English	Article							PROTEIN; COMPLEX; CULLIN	Intrauterine growth retardation is caused by maternal, fetal or placental factors that result in impaired endovascular trophoblast invasion and reduced placental perfusion(1). Although various causes of intrauterine growth retardation have been identified, most cases remain unexplained. Studying 29 families with 3-M syndrome (OMIM 273750), an autosomal recessive condition characterized by severe pre- and postnatal growth retardation, we first mapped the underlying gene to chromosome 6p21.1 and then identified 25 distinct mutations in the gene cullin 7 (CUL7). CUL7 assembles an E3 ubiquitin ligase complex containing Skp1, Fbx29 (also called Fbw8) and ROC1 and promotes ubiquitination. Using deletion analysis, we found that CUL7 uses its central region to interact with the Skp1-Fbx29 heterodimer. Functional studies indicated that the 3-M-associated CUL7 nonsense and missense mutations R1445X and H1464P, respectively, render CUL7 deficient in recruiting ROC1. These results suggest that impaired ubiquitination may have a role in the pathogenesis of intrauterine growth retardation in humans.	Univ Paris Descartes, Fac Med, INSERM,U393, APHP,Hop Necker Enfants Malad, F-75015 Paris, France; Dept Med Genet, F-75015 Paris, France; Mt Sinai Sch Med, Dept Oncol Sci, New York, NY USA; Inst Child Hlth, London WC1N 1EH, England; St Marys Hosp, Univ Hosp NHS Trust, Dept Clin Genet, Manchester M13 0JH, Lancs, England; CHU Bicetre, Pediat Endocrinol Unit, F-94275 Le Kremlin Bicetre, France; Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Univ Florence, Dept Paediat, Genet & Mol Med Unit, Florence, Italy; CHU Vaudois, Div Mol Pediat, CH-1011 Lausanne, Switzerland; Hosp Sta Maria, Med Genet Serv, Lisbon, Portugal; Univ St Joseph, Unite Genet Med, Beirut, Lebanon; Univ Med Ctr Nijmegen, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; Univ Essen Gesamthsch, Inst Humangenet, D-45122 Essen, Germany; Amiens Univ Hosp, Dept Paediat, Clin Genet Unit, Amiens, France; Univ Manchester, Endocrine Sci Res Grp, Manchester M13 9PT, Lancs, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Icahn School of Medicine at Mount Sinai; University of London; University College London; University of Manchester; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Icahn School of Medicine at Mount Sinai; University of Florence; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universidade de Lisboa; Hospital Santa Maria; Saint Joseph University Beirut; Radboud University Nijmegen; University of Duisburg Essen; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; University of Manchester	Cormier-Daire, V (corresponding author), Univ Paris Descartes, Fac Med, INSERM,U393, APHP,Hop Necker Enfants Malad, 149 Rue Sevres, F-75015 Paris, France.	cormier@necker.fr	Scambler, Peter J/C-4998-2008; wei, wei/HHR-8613-2022; Wang, Rong/A-8721-2009; Scambler, Peter/AAZ-6026-2020; superti-furga, andrea/E-9162-2015; Megarbane, Andre/ABD-5574-2021; Chemaitilly, Wassim/AAQ-3397-2021; Chemaitilly, Wassim/N-8178-2018; Black, Graeme/K-7374-2015; cormier-daire, valerie/H-6520-2017	Scambler, Peter J/0000-0002-1487-4628; Scambler, Peter/0000-0002-1487-4628; superti-furga, andrea/0000-0002-3543-7531; Black, Graeme/0000-0001-8727-6592; Clayton, Peter/0000-0003-1225-4537; huber, celine/0000-0002-8601-9655; cormier-daire, valerie/0000-0002-2839-9856	MRC [G9901217] Funding Source: UKRI; Medical Research Council [G9901217] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Charnock-Jones DS, 2004, PLACENTA, V25, P103, DOI 10.1016/j.placenta.2003.10.004; DAUD AI, 1993, AM J PHYSIOL, V264, pH1693, DOI 10.1152/ajpheart.1993.264.5.H1693; Dias DC, 2002, P NATL ACAD SCI USA, V99, P16601, DOI 10.1073/pnas.252646399; GETIN I, 2004, PLACENTA, V25, P753; HENNEKAM RCM, 1987, AM J MED GENET, V28, P195, DOI 10.1002/ajmg.1320280127; KOHRMAN DC, 1992, J VIROL, V66, P1752, DOI 10.1128/JVI.66.3.1752-1760.1992; LEMERRER M, 1991, J MED GENET, V28, P186, DOI 10.1136/jmg.28.3.186; Miller J D, 1975, Birth Defects Orig Artic Ser, V11, P39; MUELLER RF, 1992, J MED GENET, V29, P425, DOI 10.1136/jmg.29.6.425; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; SPRANGER J, 1976, EUR J PEDIATR, V123, P115, DOI 10.1007/BF00442641; van der Wall G, 2001, CLIN DYSMORPHOL, V10, P241, DOI 10.1097/00019605-200110000-00002; WINTER RM, 1984, J MED GENET, V21, P124, DOI 10.1136/jmg.21.2.124; Wu K, 2000, MOL CELL BIOL, V20, P1382, DOI 10.1128/MCB.20.4.1382-1393.2000; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	16	134	141	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1119	1124		10.1038/ng1628	http://dx.doi.org/10.1038/ng1628			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16142236				2022-12-27	WOS:000232185600025
J	Becskei, A; Kaufmann, BB; van Oudenaarden, A				Becskei, A; Kaufmann, BB; van Oudenaarden, A			Contributions of low molecule number and chromosomal positioning to stochastic gene expression	NATURE GENETICS			English	Article							CELL-CYCLE; NUCLEAR ARCHITECTURE; NOISE-PROPAGATION; POSITIVE-FEEDBACK; SINGLE-CELL; YEAST; TRANSCRIPTION; NETWORKS; BINDING; FLUCTUATIONS	The presence of low- copy- number regulators and switch- like signal propagation in regulatory networks are expected to increase noise in cellular processes. We developed a noise amplifier that detects fluctuations in the level of low- abundance mRNAs in yeast. The observed fluctuations are not due to the low number of molecules expressed from a gene per se but originate in the random, rare events of gene activation. The frequency of these events and the correlation between stochastic expressions of genes in a single cell depend on the positioning of the genes along the chromosomes. Transcriptional regulators produced by such random expression propagate noise to their target genes.	MIT, Dept Phys, Cambridge, MA 02139 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Harvard University	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019	Becskei, Attila/0000-0002-9462-0934				Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Ahmad K, 2001, CELL, V104, P839, DOI 10.1016/S0092-8674(01)00281-1; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Basu S, 2004, P NATL ACAD SCI USA, V101, P6355, DOI 10.1073/pnas.0307571101; Becskei A, 2004, NAT CELL BIOL, V6, P451, DOI 10.1038/ncb1124; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Carr AJF, 2005, NAT CELL BIOL, V7, P319, DOI 10.1038/ncb1232; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Dernburg AF, 1996, CELL, V85, P745, DOI 10.1016/S0092-8674(00)81240-4; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; ERDI P., 1989, MATH MODELS CHEM REA; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GUPTASARMA P, 1995, BIOESSAYS, V17, P987, DOI 10.1002/bies.950171112; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hasty J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.148101; Holland MJ, 2002, J BIOL CHEM, V277, P14363, DOI 10.1074/jbc.C200101200; Hooshangi S, 2005, P NATL ACAD SCI USA, V102, P3581, DOI 10.1073/pnas.0408507102; HORSTHEMKE W, 1992, PHYS REV A, V45, P5492, DOI 10.1103/PhysRevA.45.5492; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Iyer V, 1996, P NATL ACAD SCI USA, V93, P5208, DOI 10.1073/pnas.93.11.5208; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; Martin DIK, 2001, TRENDS GENET, V17, P444, DOI 10.1016/S0168-9525(01)02368-X; Melcher K, 2001, EMBO J, V20, P841, DOI 10.1093/emboj/20.4.841; Menon BB, 2005, P NATL ACAD SCI USA, V102, P5749, DOI 10.1073/pnas.0501768102; Misteli T, 2005, BIOESSAYS, V27, P477, DOI 10.1002/bies.20226; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Pirone JR, 2004, J THEOR BIOL, V226, P111, DOI 10.1016/j.jtbi.2003.08.008; Pramila T, 2002, GENE DEV, V16, P3034, DOI 10.1101/gad.1034302; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Shibata T, 2005, P NATL ACAD SCI USA, V102, P331, DOI 10.1073/pnas.0403350102; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Sveiczer A, 2000, P NATL ACAD SCI USA, V97, P7865, DOI 10.1073/pnas.97.14.7865; Swain PS, 2004, J MOL BIOL, V344, P965, DOI 10.1016/j.jmb.2004.09.073; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Thornton BR, 2004, CELL CYCLE, V3, P629; Vashee S, 1998, CURR BIOL, V8, P452, DOI 10.1016/S0960-9822(98)70179-4; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	50	251	254	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					937	944		10.1038/ng1616	http://dx.doi.org/10.1038/ng1616			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16086016				2022-12-27	WOS:000231591900017
J	Gicquel, C; Rossignol, S; Cabrol, S; Houang, M; Steunou, V; Barbu, V; Danton, F; Thibaud, N; Le Merrer, M; Burglen, L; Bertrand, AM; Netchine, I; Le Bouc, Y				Gicquel, C; Rossignol, S; Cabrol, S; Houang, M; Steunou, V; Barbu, V; Danton, F; Thibaud, N; Le Merrer, M; Burglen, L; Bertrand, AM; Netchine, I; Le Bouc, Y			Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome	NATURE GENETICS			English	Article							BECKWITH-WIEDEMANN-SYNDROME; ENHANCER-BLOCKING ACTIVITY; FACTOR-II GENE; H19 GENE; GROWTH-DEFICIENCY; GENOMIC VARIANTS; IGF2 GENE; METHYLATION; CTCF; PHENOTYPE	Silver- Russell syndrome ( SRS, OMIM 180860) is a congenital disorder characterized by severe intrauterine and postnatal growth retardation, dysmorphic facial features and body asymmetry. SRS is genetically heterogenous with maternal uniparental disomy with respect to chromosome 7 occurring in similar to 10% of affected individuals. Given the crucial role of the 11p15 imprinted region in the control of fetal growth, we hypothesized that dysregulation of genes at 11p15 might be involved in syndromic intrauterine growth retardation. We identified an epimutation ( demethylation) in the telomeric imprinting center region ICR1 of the 11p15 region in several individuals with clinically typical SRS. This epigenetic defect is associated with, and probably responsible for, relaxation of imprinting and biallelic expression of H19 and downregulation of IGF2. These findings provide new insight into the pathogenesis of SRS and strongly suggest that the 11p15 imprinted region, in addition to those of 7p11.2- p13 and 7q31- qter, is involved in SRS.	INSERM, U515, Lab Explorat Fonctionnelles Endocriniennes, F-75012 Paris, France; Univ Paris 06, Hop Armand Trousseau, APHP, F-75012 Paris, France; Fac St Antoine, INSERM, U680, F-75012 Paris, France; Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France; Hop Armand Trousseau, Unite Genet, F-75012 Paris, France; Hop Besancon, Serv Endocrinol Pediat, F-25030 Besancon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Gicquel, C (corresponding author), INSERM, U515, Lab Explorat Fonctionnelles Endocriniennes, 26 Ave Arnold Netter, F-75012 Paris, France.	christine.gicquel@trs.aphp.fr	Rossignol, Sylvie/A-3439-2009; ROSSIGNOL, Sylvie/A-8506-2012	ROSSIGNOL, Sylvie/0000-0001-7559-5764; ROSSIGNOL, Sylvie/0000-0003-1268-0632				Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007; Eggermann T, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.028936; Engel N, 2004, NAT GENET, V36, P883, DOI 10.1038/ng1399; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; Fisher AM, 2002, HUM GENET, V111, P290, DOI 10.1007/s00439-002-0787-2; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Frevel MAE, 1999, J BIOL CHEM, V274, P29331, DOI 10.1074/jbc.274.41.29331; Gaston V, 2001, EUR J HUM GENET, V9, P409, DOI 10.1038/sj.ejhg.5200649; Grunau C, 2001, Nucleic Acids Res, V29, pE65, DOI 10.1093/nar/29.13.e65; Hannula K, 2001, J MED GENET, V38, P273, DOI 10.1136/jmg.38.4.273; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hitchins MP, 2001, J MED GENET, V38, P810, DOI 10.1136/jmg.38.12.810; Kanduri C, 2000, CURR BIOL, V10, P449, DOI 10.1016/S0960-9822(00)00442-5; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Meyer E, 2005, MOL GENET METAB, V84, P376, DOI 10.1016/j.ymgme.2004.12.002; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Murrell A, 2001, EMBO REP, V2, P1101, DOI 10.1093/embo-reports/kve248; Obermann C, 2004, MOL GENET METAB, V82, P246, DOI 10.1016/j.ymgme.2004.04.008; Price SM, 1999, J MED GENET, V36, P837; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; SCHNEID H, 1993, J MED GENET, V30, P353, DOI 10.1136/jmg.30.5.353; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Sun FL, 1997, NATURE, V389, P809, DOI 10.1038/39797; Ulaner GA, 2003, ENDOCRINOLOGY, V144, P4420, DOI 10.1210/en.2003-0681; Weksberg R, 2002, HUM MOL GENET, V11, P1317, DOI 10.1093/hmg/11.11.1317	30	374	385	0	26	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2005	37	9					1003	1007		10.1038/ng1629	http://dx.doi.org/10.1038/ng1629			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16086014				2022-12-27	WOS:000231591900028
J	Li, XF; Liu, P; Liu, WZ; Maye, P; Zhang, JH; Zhang, YH; Hurley, M; Guo, CY; Boskey, A; Sun, L; Harris, SE; Rowe, DW; Ke, HZ; Wu, DQ				Li, XF; Liu, P; Liu, WZ; Maye, P; Zhang, JH; Zhang, YH; Hurley, M; Guo, CY; Boskey, A; Sun, L; Harris, SE; Rowe, DW; Ke, HZ; Wu, DQ			Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation	NATURE GENETICS			English	Article							RECEPTOR-RELATED PROTEIN-5; HIGH-BONE-MASS; WNT SIGNALING PATHWAY; LRP5; DICKKOPF-1; GENE; MUTATION; DENSITY; AXIN; FAMILY	Human and mouse genetic and in vitro evidence has shown that canonical Wnt signaling promotes bone formation, but we found that mice lacking the canonical Wnt antagonist Dickkopf2 ( Dkk2) were osteopenic. We reaffirmed the finding that canonical Wnt signaling stimulates osteogenesis, including the differentiation from preosteoblasts to osteoblasts, in cultured osteoblast differentiation models, but we also found that canonical Wnts upregulated the expression of Dkk2 in osteoblasts. Although exogenous overexpression of Dkk before the expression of endogenous canonical Wnt ( Wnt7b) suppressed osteogenesis in cultures, its expression after peak Wnt7b expression induced a phenotype resembling terminal osteoblast differentiation leading to mineralization. In addition, osteoblasts from Dkk2- null mice were poorly mineralized upon osteogenic induction in cultures, and Dkk2 deficiency led to attenuation of the expression of osteogenic markers, which could be partially reversed by exogenous expression of Dkk2. Taken together with the finding that Dkk2- null mice have increased numbers of osteoids, these data indicate that Dkk2 has a role in late stages of osteoblast differentiation into mineralized matrices. Because expression of another Wnt antagonist, FRP3, differs from Dkk2 expression in rescuing Dkk2 deficiency and regulating osteoblast differentiation, the effects of Dkk2 on terminal osteoblast differentiation may not be entirely mediated by its Wnt signaling antagonistic activity.	Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; Univ Missouri, Sch Dent, Dept Oral Biol, Kansas City, MO 64108 USA; Univ Connecticut, Ctr Hlth, Dept Med, Farmington, CT 06030 USA; Hosp Special Surg, New York, NY 10021 USA; Welson Pharmaceut, Beijing, Peoples R China; Univ Texas, Hlth Sci Ctr, Dept Periodont & Cellular Struct Biol, San Antonio, TX 78229 USA; Pfizer Inc, Global res & Dev, Groton Labs, Groton, CT 06340 USA	University of Connecticut; University of Missouri System; University of Missouri Kansas City; University of Connecticut; University of Texas System; University of Texas Health San Antonio; Pfizer	Wu, DQ (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, 263 Farmington Ave, Farmington, CT 06030 USA.	dwu@neuron.uchc.edu	Liu, Peng/AAH-5688-2020	Maye, Peter/0000-0003-0098-4399; Boskey, Adele/0000-0002-6181-2219				Babij P, 2003, J BONE MINER RES, V18, P960, DOI 10.1359/jbmr.2003.18.6.960; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Barker N, 2000, BIOESSAYS, V22, P961; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brott BK, 2002, MOL CELL BIOL, V22, P6100, DOI 10.1128/MCB.22.17.6100-6110.2002; Dale TC, 1998, BIOCHEM J, V329, P209; Dimai HP, 1998, BONE, V22, P211, DOI 10.1016/S8756-3282(97)00268-8; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gregory CA, 2003, J BIOL CHEM, V278, P28067, DOI 10.1074/jbc.M300373200; Gumbiner BM, 1998, CURR OPIN GENET DEV, V8, P430, DOI 10.1016/S0959-437X(98)80114-7; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Jee WSS, 1997, HDB BONE MORPHOLOGY, P87; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Kannus P, 2000, OSTEOPOROSIS INT, V11, P443, DOI 10.1007/s001980070112; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Ke HZ, 2003, MOL ENDOCRINOL, V17, P1356, DOI 10.1210/me.2003-0021; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Li L, 2002, J BIOL CHEM, V277, P5977, DOI 10.1074/jbc.M111131200; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Li L, 1999, EMBO J, V18, P4233, DOI 10.1093/emboj/18.15.4233; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Lips P, 1997, Am J Med, V103, p3S; Little RD, 2002, AM J HUM GENET, V70, P11, DOI 10.1086/338450; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Monaghan AP, 1999, MECH DEVELOP, V87, P45, DOI 10.1016/S0925-4773(99)00138-0; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Nusse R, 2001, NATURE, V411, P254, DOI 10.1038/35077199; Pandur P, 2001, BIOESSAYS, V23, P207, DOI 10.1002/1521-1878(200103)23:3<207::AID-BIES1029>3.0.CO;2-0; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Van Wesenbeeck L, 2003, AM J HUM GENET, V72, P763, DOI 10.1086/368277; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wu W, 2000, CURR BIOL, V10, P1611, DOI 10.1016/S0960-9822(00)00868-X; Zhang YH, 2004, MOL CELL BIOL, V24, P4677, DOI 10.1128/MCB.24.11.4677-4684.2004; Zuckerman JD, 1996, NEW ENGL J MED, V334, P1519, DOI 10.1056/NEJM199606063342307	49	246	267	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					945	952		10.1038/ng1614	http://dx.doi.org/10.1038/ng1614			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16056226				2022-12-27	WOS:000231591900018
J	Wang, JB; Mark, S; Zhang, XH; Qian, D; Yoo, SJ; Radde-Gallwitz, K; Zhang, YP; Lin, X; Collazo, A; Wynshaw-Boris, A; Chen, P				Wang, JB; Mark, S; Zhang, XH; Qian, D; Yoo, SJ; Radde-Gallwitz, K; Zhang, YP; Lin, X; Collazo, A; Wynshaw-Boris, A; Chen, P			Regulation of polarized extension and planar cell polarity in the cochlea by the vertebrate PCP pathway	NATURE GENETICS			English	Article							DROSOPHILA TISSUE POLARITY; HAIR-CELLS; INNER-EAR; CONVERGENT EXTENSION; DEVELOPING ORGAN; GENE; STRABISMUS; PRICKLE; CLOSURE	The mammalian auditory sensory organ, the organ of Corti, consists of sensory hair cells with uniformly oriented stereocilia on the apical surfaces and has a distinct planar cell polarity ( PCP) parallel to the sensory epithelium(1-3). It is not certain how this polarity is achieved during differentiation(4,5). Here we show that the organ of Corti is formed from a thicker and shorter postmitotic primordium through unidirectional extension, characteristic of cellular intercalation known as convergent extension(6). Mutations in the PCP pathway interfere with this extension, resulting a shorter and wider cochlea as well as misorientation of stereocilia. Furthermore, parallel to the homologous pathway in Drosophila melanogaster(7,8), a mammalian PCP component Dishevelled2 shows PCPdependent polarized subcellular localization across the organ of Corti. Taken together, these data suggest that there is a conserved molecular mechanism for PCP pathways in invertebrates and vertebrates and indicate that the mammalian PCP pathway might directly couple cellular intercalations to PCP establishment in the cochlea.	Univ Calif San Diego, Sch Med, Dept Pediat & Med, La Jolla, CA 92093 USA; Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Otolaryngol, Atlanta, GA 30322 USA; House Ear Res Inst, Dept Cell & Mol Biol, Los Angeles, CA 90057 USA	University of California System; University of California San Diego; Emory University; Emory University; House Research Institute	Wynshaw-Boris, A (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat & Med, La Jolla, CA 92093 USA.	awynshawboris@ucsd.edu; pchen@cellbio.emory.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005213, R01DC004709] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD043173] Funding Source: Medline; NIDCD NIH HHS [R01 DC004709, R01 DC005213] Funding Source: Medline; NINDS NIH HHS [R01 NS073159] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Axelrod JD, 2001, GENE DEV, V15, P1182; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Chae J, 1999, DEVELOPMENT, V126, P5421; Chen P, 2002, DEVELOPMENT, V129, P2495; Chen P, 1999, DEVELOPMENT, V126, P1581; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Darken RS, 2002, EMBO J, V21, P976, DOI 10.1093/emboj/21.5.976; Goto T, 2002, DEV BIOL, V247, P165, DOI 10.1006/dbio.2002.0673; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Jiang D, 2005, CURR BIOL, V15, P79; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; KELLEY MW, 1993, DEVELOPMENT, V119, P1041; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Lewis J, 2002, J NEUROBIOL, V53, P190, DOI 10.1002/neu.10124; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; McKenzie E, 2004, DEV DYNAM, V229, P802, DOI 10.1002/dvdy.10500; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Radde-Gallwitz K, 2004, J COMP NEUROL, V477, P412, DOI 10.1002/cne.20257; Ruben R.J., 1967, ACTA OTO-LARYNGOL, DOI DOI 10.3109/00016486709127790; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Tree DRP, 2002, SEMIN CELL DEV BIOL, V13, P217, DOI 10.1016/S1084-9521(02)00042-3; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; VINSON CR, 1987, NATURE, V329, P549, DOI 10.1038/329549a0; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077	30	223	230	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					980	985		10.1038/ng1622	http://dx.doi.org/10.1038/ng1622			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16116426	Green Accepted			2022-12-27	WOS:000231591900024
J	Barrett, MT				Barrett, MT			Stacking the chips for biological discovery	NATURE GENETICS			English	Editorial Material									Agilent Labs, Palo Alto, CA 93404 USA	Agilent Technologies	Barrett, MT (corresponding author), Agilent Labs, 3500 Deer Creek Rd, Palo Alto, CA 93404 USA.								0	3	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37			S			S1	S1		10.1038/ng1574	http://dx.doi.org/10.1038/ng1574			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	932YF	15920523	Bronze			2022-12-27	WOS:000229590000001
J	van Steensel, B				van Steensel, B			Mapping of genetic and epigenetic regulatory networks using microarrays	NATURE GENETICS			English	Article							GENOME-WIDE LOCATION; DNA METHYLATION; BINDING-SITES; TRANSCRIPTION FACTOR; TARGET GENES; IN-VIVO; C-MYC; EXPRESSION; YEAST; IDENTIFICATION	The highly coordinated expression of thousands of genes in an organism is regulated by the concerted action of hundreds of transcription factors and chromatin proteins, as well as by epigenetic mechanisms. Understanding the architecture of these vastly complex regulatory networks is one of the main challenges in the postgenomic era. New microarray-based techniques have become available for the genome-wide mapping of in vivo protein-DNA interactions and epigenetic marks. Data sets obtained with these techniques begin to offer the first comprehensive views of genetic and epigenetic regulatory networks.	Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	van Steensel, B (corresponding author), Netherlands Canc Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	b.v.steensel@nki.nl						Adorjan P, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.5.e21; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Ballestar E, 2003, EMBO J, V22, P6335, DOI 10.1093/emboj/cdg604; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; Bianchi-Frias D, 2004, PLOS BIOL, V2, P975, DOI 10.1371/journal.pbio.0020178; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Euskirchen G, 2004, MOL CELL BIOL, V24, P3804, DOI 10.1128/MCB.24.9.3804-3814.2004; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gao F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-31; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Gitan RS, 2002, GENOME RES, V12, P158, DOI 10.1101/gr.202801; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hatada I, 2002, J HUM GENET, V47, P448, DOI 10.1007/s100380200063; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Humphrey EL, 2004, CHEM BIOL, V11, P295, DOI 10.1016/j.chembiol.2004.03.001; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kim JW, 2005, NAT METHODS, V2, P47, DOI 10.1038/NMETH726; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; KOLLER D, 2005, NAT GENET, V37, P38; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Leu YW, 2004, CANCER RES, V64, P8184, DOI 10.1158/0008-5472.CAN-04-2045; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; LODEN M, IN PRESS CHROM RES; Martone R, 2003, P NATL ACAD SCI USA, V100, P12247, DOI 10.1073/pnas.2135255100; Nuwaysir EF, 2002, GENOME RES, V12, P1749, DOI 10.1101/gr.362402; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Orian A, 2003, GENE DEV, V17, P1101, DOI 10.1101/gad.1066903; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Ren B, 2004, METHOD ENZYMOL, V376, P304; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Robyr D, 2004, METHOD ENZYMOL, V376, P289; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Setty Y, 2003, P NATL ACAD SCI USA, V100, P7702, DOI 10.1073/pnas.1230759100; Shi HD, 2003, CANCER RES, V63, P2164; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Sun LV, 2003, P NATL ACAD SCI USA, V100, P9428, DOI 10.1073/pnas.1533393100; Tompa R, 2002, CURR BIOL, V12, P65, DOI 10.1016/S0960-9822(01)00622-4; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; van Steensel B, 2003, BIOTECHNIQUES, V35, P346; van Steensel B, 2003, P NATL ACAD SCI USA, V100, P2580, DOI 10.1073/pnas.0438000100; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; Wei SH, 2002, CLIN CANCER RES, V8, P2246; Weil MR, 2004, GENOME RES, V14, P1374, DOI 10.1101/gr.1396104; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Wells J, 2003, ONCOGENE, V22, P1445, DOI 10.1038/sj.onc.1206264; Yan PS, 2001, CANCER RES, V61, P8375; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5	75	94	103	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37			S			S18	S24		10.1038/ng1559	http://dx.doi.org/10.1038/ng1559			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	932YF	15920525	Bronze			2022-12-27	WOS:000229590000005
J	Bond, J; Roberts, E; Springell, K; Lizarraga, S; Scott, S; Higgins, J; Hampshire, DJ; Morrison, EE; Leal, GF; Silva, EO; Costa, SMR; Baralle, D; Raponi, M; Karbani, G; Rashid, Y; Jafri, H; Bennett, C; Corry, P; Walsh, CA; Woods, CG				Bond, J; Roberts, E; Springell, K; Lizarraga, S; Scott, S; Higgins, J; Hampshire, DJ; Morrison, EE; Leal, GF; Silva, EO; Costa, SMR; Baralle, D; Raponi, M; Karbani, G; Rashid, Y; Jafri, H; Bennett, C; Corry, P; Walsh, CA; Woods, CG			A centrosomal mechanism involving CDK5RAP2 and CENPJ controls brain size	NATURE GENETICS			English	Article							MICROCEPHALIN; MUTATIONS; LOCUS; ASPM; IDENTIFICATION; MAPS	Autosomal recessive primary microcephaly is a potential model in which to research genes involved in human brain growth. We show that two forms of the disorder result from homozygous mutations in the genes CDK5RAP2 and CENPJ. We found neuroepithelial expression of the genes during prenatal neurogenesis and protein localization to the spindle poles of mitotic cells, suggesting that a centrosomal mechanism controls neuron number in the developing mammalian brain.	Univ Cambridge, Addenbrookes Hosp, Dept Med Genet, CIMR, Cambridge CB2 2BP, England; Univ Leeds, St James Hosp, Mol Med Unit, Leeds LS9 7TF, W Yorkshire, England; Harvard Univ, Sch Med, Dept Neurol, Beth Israel Deaconess Med Ctr,Harvard Inst Med, Boston, MA 02115 USA; St James Univ Hosp, Canc Res UK Ctr Leeds, Div Canc Med Res, Leeds LS9 7TF, W Yorkshire, England; Inst Maternoinfantil Pernambuco, Recife, PE, Brazil; Univ Fed Pernambuco, Dept Genet, Recife, PE, Brazil; St James Univ Hosp, Dept Clin Genet, Leeds LS9 7TF, W Yorkshire, England; Lady Wellington Hosp, Dept Obstet & Gynaecol, Lahore, Pakistan; St Lukes Hosp, Dept Paediat, Bradford BD5 0NA, W Yorkshire, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Saint James's University Hospital; University of Leeds; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Cancer Research UK; Saint James's University Hospital; Universidade Federal de Pernambuco; Saint James's University Hospital	Woods, CG (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med Genet, CIMR, Cambridge CB2 2BP, England.	cw347@cam.ac.uk	raponi, michela/E-3500-2014; woods, christopher g/A-1361-2010; Hampshire, Daniel/Q-3540-2019	raponi, michela/0000-0001-7570-828X; Baralle, Diana/0000-0003-3217-4833				Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Bond J, 2003, AM J HUM GENET, V73, P1170, DOI 10.1086/379085; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Hung LY, 2004, MOL BIOL CELL, V15, P2697, DOI 10.1091/mbc.E04-02-0121; Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283; Kumar A, 2004, CLIN GENET, V66, P341, DOI 10.1111/j.1399-0004.2004.00304.x; Leal GF, 2003, J MED GENET, V40, P540, DOI 10.1136/jmg.40.7.540; Mochida GH, 2001, CURR OPIN NEUROL, V14, P151, DOI 10.1097/00019052-200104000-00003; Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777; Pagani F, 2000, J BIOL CHEM, V275, P21041, DOI 10.1074/jbc.M910165199; Roberts E, 2002, J MED GENET, V39, P718, DOI 10.1136/jmg.39.10.718; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Wakefield JG, 2001, J CELL BIOL, V153, P637, DOI 10.1083/jcb.153.4.637; Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003; Xu XZ, 2004, J BIOL CHEM, V279, P34091, DOI 10.1074/jbc.C400139200	15	412	420	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					353	355		10.1038/ng1539	http://dx.doi.org/10.1038/ng1539			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15793586				2022-12-27	WOS:000228040000017
J	Sebastiani, P; Ramoni, MF; Nolan, V; Baldwin, CT; Steinberg, MH				Sebastiani, P; Ramoni, MF; Nolan, V; Baldwin, CT; Steinberg, MH			Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia	NATURE GENETICS			English	Article							RISK; DISEASE; CHILDREN; NETWORKS; TRANSFUSIONS; PREVENTION; PHENOTYPES; FUTURE; LOCI	Sickle cell anemia (SCA) is a paradigmatic single gene disorder caused by homozygosity with respect to a unique mutation at the beta-globin locus. SCA is phenotypically complex, with different clinical courses ranging from early childhood mortality to a virtually unrecognized condition. Overt stroke is a severe complication affecting 6 - 8% of individuals with SCA. Modifier genes might interact to determine the susceptibility to stroke, but such genes have not yet been identified. Using Bayesian networks, we analyzed 108 SNPs in 39 candidate genes in 1,398 individuals with SCA. We found that 31 SNPs in 12 genes interact with fetal hemoglobin to modulate the risk of stroke. This network of interactions includes three genes in the TGF-beta pathway and SELP, which is associated with stroke in the general population. We validated this model in a different population by predicting the occurrence of stroke in 114 individuals with 98.2% accuracy.	Harvard Univ, Sch Med, Childrens Hosp Informat Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Harvard Partners Ctr Genet & Genom, Boston, MA 02115 USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA; Boston Univ, Sch Med, Ctr Human Genet, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Boston University; Boston University; Boston University; Boston University	Ramoni, MF (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Informat Program, Boston, MA 02115 USA.	marco_ramoni@harvard.edu		Baldwin, Clinton/0000-0002-3275-9463; Steinberg, Martin/0000-0001-8800-8020; sebastiani, paola/0000-0001-6419-1545	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL080463] Funding Source: NIH RePORTER; NHLBI NIH HHS [R21 HL080463, R21 HL080463-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams RJ, 2004, BLOOD, V103, P3689, DOI 10.1182/blood-2003-08-2733; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; ADAMS RJ, 1994, AM J HEMATOL, V45, P279, DOI 10.1002/ajh.2830450402; Alexander N, 2004, BRIT J HAEMATOL, V126, P606, DOI 10.1111/j.1365-2141.2004.05025.x; Angerio Allan D, 2003, Crit Care Nurs Q, V26, P225; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; Chiu NHL, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e31; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Cowell R.G., 1999, PROBABILISTIC NETWOR; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; GASTON M, 1987, CONTROL CLIN TRIALS, V8, pS131; Hand D., 2001, ADAP COMP MACH LEARN; Hardison R., 2001, DISORDERS HEMOGLOBIN, P95, DOI 10.1017/CBO9780511596582; Hoh J, 2003, NAT REV GENET, V4, P701, DOI 10.1038/nrg1155; Hoppe C, 2004, BLOOD, V103, P2391, DOI 10.1182/blood-2003-09-3015; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Lauritzen SL, 2003, STAT SCI, V18, P489, DOI 10.1214/ss/1081443232; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Ohene-Frempong K, 1998, BLOOD, V91, P288; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Steinberg MH, 2003, BLOOD, V102, p262A; Taylor JG, 2002, BLOOD, V100, P4303, DOI 10.1182/blood-2001-12-0306; Ware RE, 1999, BLOOD, V94, P3022, DOI 10.1182/blood.V94.9.3022.421k17_3022_3026; Zee RYL, 2004, HUM MOL GENET, V13, P389, DOI 10.1093/hmg/ddh039	30	226	237	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					435	440		10.1038/ng1533	http://dx.doi.org/10.1038/ng1533			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15778708	Green Accepted			2022-12-27	WOS:000228040000029
J	Knight, CG; Zitzmann, N; Prabhakar, S; Antrobus, R; Dwek, R; Hebestreit, H; Rainey, PB				Knight, Christopher G.; Zitzmann, Nicole; Prabhakar, Sripadi; Antrobus, Robin; Dwek, Raymond; Hebestreit, Holger; Rainey, Paul B.			Unraveling adaptive evolution: how a single point mutation affects the protein coregulation network	NATURE GENETICS			English	Article							CATABOLITE REPRESSION CONTROL; PSEUDOMONAS-FLUORESCENS; LIFE-HISTORY; EXPERIMENTAL POPULATIONS; NATURAL VARIATION; EXPRESSION; PLEIOTROPY; GENES; CRC; PHOSPHORYLATION	Understanding the mechanisms of evolution requires identification of the molecular basis of the multiple ( pleiotropic) effects of specific adaptive mutations. We have characterized the pleiotropic effects on protein levels of an adaptive single-base pair substitution in the coding sequence of a signaling pathway gene in the bacterium Pseudomonas fluorescens SBW25. We find 52 proteomic changes, corresponding to 46 identified proteins. None of these proteins is required for the adaptive phenotype. Instead, many are found within specific metabolic pathways associated with fitness-reducing ( that is, antagonistic) effects of the mutation. The affected proteins fall within a single coregulatory network. The mutation `rewires' this network by drawing particular proteins into tighter coregulating relationships. Although these changes are specific to the mutation studied, the quantitatively altered proteins are also affected in a coordinated way in other examples of evolution to the same niche.	Glycobiol Inst, Dept Biochem, Oxford OX1 3QU, England; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; Dept Plant Sci, Oxford OX1 3RB, England	University of Oxford; University of Auckland	Knight, CG (corresponding author), Univ Manchester, Manchester Interdisciplinary Bioctr, 131 Princess St, Manchester M1 7DN, Lancs, England.	chris.knight@manchester.ac.uk	Knight, Chris/AAM-3228-2020; Rainey, Paul/A-3207-2008	Knight, Chris/0000-0001-9815-4267; Rainey, Paul/0000-0003-0879-5795				BARTON NH, 1990, GENETICS, V124, P773; BARTON NH, 1989, ANNU REV GENET, V23, P337, DOI 10.1146/annurev.ge.23.120189.002005; Batagelj V, 2004, MATH VIS, P77; BEAUMONT HJE, 2006, PROKARYOTIC DIVERSIT, P91; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bochdanovits Z, 2004, P ROY SOC B-BIOL SCI, V271, pS75, DOI 10.1098/rsbl.2003.0091; CASPARI E, 1952, EVOLUTION, V6, P1, DOI 10.2307/2405500; Davies AG, 2004, NEURON, V42, P731, DOI 10.1016/j.neuron.2004.05.004; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Ehrich TH, 2003, J EXP ZOOL PART B, V296B, P58, DOI 10.1002/jez.b.00009; Estes S, 2005, GENETICS, V170, P645, DOI 10.1534/genetics.104.040022; Foster KR, 2004, NATURE, V431, P693, DOI 10.1038/nature02894; Garcia A, 2004, BLOOD, V103, P2088, DOI 10.1182/blood-2003-07-2392; Goymer P, 2006, GENETICS, V173, P515, DOI 10.1534/genetics.106.055863; Hester KL, 2000, J BACTERIOL, V182, P1150, DOI 10.1128/JB.182.4.1150-1153.2000; Jenkins NL, 2004, P ROY SOC B-BIOL SCI, V271, P2523, DOI 10.1098/rspb.2004.2897; Karp NA, 2005, PROTEOMICS, V5, P3105, DOI 10.1002/pmic.200500083; Knight CG, 2001, EVOLUTION, V55, P1795, DOI 10.1111/j.0014-3820.2001.tb00828.x; LANDE R, 1980, GENETICS, V94, P203; Leroi AM, 2005, MECH AGEING DEV, V126, P421, DOI 10.1016/j.mad.2004.07.012; Leroi AM, 2001, TRENDS ECOL EVOL, V16, P24, DOI 10.1016/S0169-5347(00)02032-2; LUPAS A, 1989, J BIOL CHEM, V264, P17337; MacLean RC, 2004, P NATL ACAD SCI USA, V101, P8072, DOI 10.1073/pnas.0307195101; Marden JH, 2003, P NATL ACAD SCI USA, V100, P3369, DOI 10.1073/pnas.0634985100; McAdams HH, 2004, NAT REV GENET, V5, P169, DOI 10.1038/nrg1292; Morales G, 2004, J BACTERIOL, V186, P1337, DOI 10.1128/JB.186.5.1337-1344.2004; Nishijyo T, 2001, MOL MICROBIOL, V40, P917, DOI 10.1046/j.1365-2958.2001.02435.x; O'Neill EE, 2002, PROTEOMICS, V2, P288, DOI 10.1002/1615-9861(200203)2:3<288::AID-PROT288>3.0.CO;2-0; O'Toole GA, 2000, J BACTERIOL, V182, P425, DOI 10.1128/JB.182.2.425-431.2000; Patel MN, 2002, P NATL ACAD SCI USA, V99, P769, DOI 10.1073/pnas.012511099; Pinheiro J, 2001, MIXED EFFECTS MODELS; Promislow DEL, 2004, P ROY SOC B-BIOL SCI, V271, P1225, DOI 10.1098/rspb.2004.2732; R Development Core Team, 2005, R LANG ENV STAT COMP; Rainey PB, 2000, TRENDS ECOL EVOL, V15, P243, DOI 10.1016/S0169-5347(00)01871-1; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Rainey PB, 2004, RES MICROBIOL, V155, P370, DOI 10.1016/j.resmic.2004.01.011; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Rietsch A, 2004, INFECT IMMUN, V72, P1383, DOI 10.1128/IAI.72.3.1383-1390.2004; Spiers AJ, 2002, GENETICS, V161, P33; Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x; Spiers AJ, 2005, MICROBIOL-SGM, V151, P2829, DOI 10.1099/mic.0.27984-0; Steams S. C., 1992, EVOLUTION LIFE HIST; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Weckwerth W, 2004, P NATL ACAD SCI USA, V101, P7809, DOI 10.1073/pnas.0303415101; Welch JJ, 2003, EVOLUTION, V57, P1723, DOI 10.1554/02-673; WOLFF JA, 1991, J BACTERIOL, V173, P4700, DOI 10.1128/jb.173.15.4700-4706.1991; Wright S., 1968, GENETIC BIOMETRIC FD; ZAHN CT, 1971, IEEE T COMPUT, VC 20, P68, DOI 10.1109/T-C.1971.223083; [No title captured]	49	59	60	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					1015	1022		10.1038/ng1867	http://dx.doi.org/10.1038/ng1867			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16921374				2022-12-27	WOS:000240112100018
J	Lei, EP; Corces, VG				Lei, Elissa P.; Corces, Victor G.			RNA interference machinery influences the nuclear organization of a chromatin insulator	NATURE GENETICS			English	Article							POSITION-EFFECT VARIEGATION; GYPSY TRANSPOSABLE ELEMENT; GERMLINE STEM-CELLS; DROSOPHILA-MELANOGASTER; INTERALLELIC COMPLEMENTATION; PROTEIN; GENE; LOCALIZATION; CHROMOSOME; COMPONENTS	RNA interference (RNAi) is a conserved silencing mechanism that can act through alteration of chromatin structure. Chromatin insulators promote higher-order nuclear organization, thereby establishing DNA domains subject to distinct transcriptional controls. We present evidence for a functional relationship between RNAi and the gypsy insulator of D. melanogaster. Insulator activity is decreased when Argonaute genes required for RNAi are mutated, and insulator function is improved when the levels of the Rm62 helicase, involved in double-stranded RNA (dsRNA)-mediated silencing and heterochromatin formation, are reduced. Rm62 interacts physically with the DNA-binding insulator protein CP190 in an RNA-dependent manner. Finally, reduction of Rm62 levels results in marked nuclear reorganization of a compromised insulator. These results suggest that the RNAi machinery acts as a modulator of nuclear architecture capable of effecting global changes in gene expression.	Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University	Corces, VG (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	corces@jhu.edu		Corces, Victor/0000-0001-5140-4337	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK015601, ZIADK015601] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMERO SA, 1991, GENE DEV, V5, P188, DOI 10.1101/gad.5.2.188; Buszczak M, 2006, GENE DEV, V20, P977, DOI 10.1101/gad.1396306; Byrd K, 2003, J CELL BIOL, V162, P565, DOI 10.1083/jcb.200305013; Capelson M, 2005, MOL CELL, V20, P105, DOI 10.1016/j.molcel.2005.08.031; Cox DN, 2000, DEVELOPMENT, V127, P503; CSINK AK, 1994, GENETICS, V138, P153; FEY EG, 1986, J CELL BIOL, V102, P1654, DOI 10.1083/jcb.102.5.1654; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; GERASIMOVA TI, 1995, CELL, V82, P587, DOI 10.1016/0092-8674(95)90031-4; Grimaud C, 2006, CELL, V124, P957, DOI 10.1016/j.cell.2006.01.036; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Harlow E., 1988, ANTIBODIES LAB MANUA; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; JACK JW, 1985, CELL, V42, P869, DOI 10.1016/0092-8674(85)90283-1; Lin HF, 1997, DEVELOPMENT, V124, P2463; Malceva NI, 1997, DEV GENET, V20, P163, DOI 10.1002/(SICI)1520-6408(1997)20:2<163::AID-DVG9>3.0.CO;2-5; Mongelard F, 2002, GENETICS, V160, P1481; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Pai CY, 2004, MOL CELL, V16, P737, DOI 10.1016/j.molcel.2004.11.004; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; PARKHURST SM, 1988, GENE DEV, V2, P1205, DOI 10.1101/gad.2.10.1205; PARKHURST SM, 1986, MOL CELL BIOL, V6, P47, DOI 10.1128/MCB.6.1.47; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; SCHUPBACH T, 1991, GENETICS, V129, P1119; SHAFFER CD, 1994, METHODS CELL BIOL; Tsai SF, 1997, P NATL ACAD SCI USA, V94, P3837, DOI 10.1073/pnas.94.8.3837; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Yusufzai TM, 2004, P NATL ACAD SCI USA, V101, P8620, DOI 10.1073/pnas.0402938101	30	112	123	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2006	38	8					936	941		10.1038/ng1850	http://dx.doi.org/10.1038/ng1850			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16862159				2022-12-27	WOS:000239325700025
J	Vithana, EN; Morgan, P; Sundaresan, P; D Ebenezer, N; Tan, DTH; Mohamed, MD; Anand, S; Khine, KO; Venkataraman, D; Yong, VHK; Salto-Tellez, M; Venkatraman, A; Guo, K; Hemadevi, B; Srinivasan, M; Prajna, V; Khine, M; Casey, JR; Inglehearn, CF; Aung, T				Vithana, Eranga N.; Morgan, Patricio; Sundaresan, Periasamy; D Ebenezer, Neil; Tan, Donald T. H.; Mohamed, Moin D.; Anand, Seema; Khine, Khin O.; Venkataraman, Divya; Yong, Victor H. K.; Salto-Tellez, Manuel; Venkatraman, Anandalakshmi; Guo, Ke; Hemadevi, Boomiraj; Srinivasan, Muthiah; Prajna, Venkatesh; Khine, Myint; Casey, Joseph R.; Inglehearn, Chris F.; Aung, Tin			Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2)	NATURE GENETICS			English	Article							GENE; CHROMOSOME-20; FAMILY	Congenital hereditary endothelial dystrophy ( CHED) is a heritable, bilateral corneal dystrophy characterized by corneal opacification and nystagmus. We describe seven different mutations in the SLC4A11 gene in ten families with autosomal recessive CHED. Mutations in SLC4A11, which encodes a membrane-bound sodium-borate cotransporter, cause loss of function of the protein either by blocking its membrane targeting or nonsense-mediated decay.	Singapore Eye Res Inst, Singapore 168751, Singapore; Natl Univ Singapore, Dept Ophthalmol, Yong Soo Lin Sch Med, Singapore 117597, Singapore; Aravind Med Res Fdn, Madurai 625020, Tamil Nadu, India; Univ Alberta, Dept Physiol, Edmonton, AB T6G 2H7, Canada; UCL, Inst Ophthalmol, London EC1V 9EL, England; Singapore Natl Eye Ctr, Singapore 168751, Singapore; St James Univ Hosp, Sect Ophthalmol & Neurosci, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; St James Univ Hosp, Eye Dept, Leeds Teaching Hosp NHS Trust, Leeds LS9 7TF, W Yorkshire, England; Natl Univ Singapore, Dept Pathol, Singapore 117597, Singapore; Yangon Eye Hosp, Yangon, Myanmar; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; Inst Mol & Cell Biol, Singapore 138673, Singapore	National University of Singapore; Singapore National Eye Center; National University of Singapore; University of Alberta; University of London; University College London; Singapore National Eye Center; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; National University of Singapore; University of Alberta; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Vithana, EN (corresponding author), Singapore Eye Res Inst, 11 3rd Hosp Ave, Singapore 168751, Singapore.	evithana@yahoo.co.uk	.P, Sundaresan/AAR-8426-2021; Khine, M/AAP-1881-2021; Inglehearn, Chris/GYD-9783-2022; Casey, Joseph/A-8888-2013	Khine, M/0000-0003-2582-7306; Casey, Joseph/0000-0002-9890-5056; Salto-Tellez, Manuel/0000-0001-8586-282X; Namperumalsamy, Venkatesh Prajna/0000-0003-2019-4044				Alper SL, 2002, J NEPHROL, V15, pS41; Chan C. C., 1982, CORNEA, V1, P155; Gottsch JD, 2003, INVEST OPHTH VIS SCI, V44, P594, DOI 10.1167/iovs.02-0300; Hand CK, 1999, GENOMICS, V61, P1, DOI 10.1006/geno.1999.5920; KIRKNESS CM, 1987, BRIT J OPHTHALMOL, V71, P130, DOI 10.1136/bjo.71.2.130; Mohamed MD, 2001, BRIT J OPHTHALMOL, V85, P758; Park M, 2004, MOL CELL, V16, P331, DOI 10.1016/j.molcel.2004.09.030; Parker MD, 2001, BIOCHEM BIOPH RES CO, V282, P1103, DOI 10.1006/bbrc.2001.4692; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; TOMA NMG, 1995, HUM MOL GENET, V4, P2395, DOI 10.1093/hmg/4.12.2395; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025	11	181	186	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2006	38	7					755	757		10.1038/ng1824	http://dx.doi.org/10.1038/ng1824			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16767101				2022-12-27	WOS:000238669300010
J	Sayer, JA; Otto, EA; O'Toole, JF; Nurnberg, G; Kennedy, MA; Becker, C; Hennies, HC; Helou, J; Attanasio, M; Fausett, BV; Utsch, B; Khanna, H; Liu, Y; Drummond, I; Kawakami, I; Kusakabe, T; Tsuda, M; Ma, L; Lee, H; Larson, RG; Allen, SJ; Wilkinson, CJ; Nigg, EA; Shou, CC; Lillo, C; Williams, DS; Hoppe, B; Kemper, MJ; Neuhaus, T; Parisi, MA; Glass, IA; Petry, M; Kispert, A; Gloy, J; Ganner, A; Walz, G; Zhu, XL; Goldman, D; Nurnberg, P; Swaroop, A; Leroux, MR; Hildebrandt, F				Sayer, John A.; Otto, Edgar A.; O'Toole, John F.; Nurnberg, Gudrun; Kennedy, Michael A.; Becker, Christian; Hennies, Hans Christian; Helou, Juliana; Attanasio, Massimo; Fausett, Blake V.; Utsch, Boris; Khanna, Hemant; Liu, Yan; Drummond, Iain; Kawakami, Isao; Kusakabe, Takehiro; Tsuda, Motoyuki; Ma, Li; Lee, Hwankyu; Larson, Ronald G.; Allen, Susan J.; Wilkinson, Christopher J.; Nigg, Erich A.; Shou, Chengchao; Lillo, Concepcion; Williams, David S.; Hoppe, Bernd; Kemper, Markus J.; Neuhaus, Thomas; Parisi, Melissa A.; Glass, Ian A.; Petry, Marianne; Kispert, Andreas; Gloy, Joachim; Ganner, Athina; Walz, Gerd; Zhu, Xueliang; Goldman, Daniel; Nurnberg, Peter; Swaroop, Anand; Leroux, Michel R.; Hildebrandt, Friedhelm			The centrosomal protein nephrocystin-6 is mutated in Joubert syndrome and activates transcription factor ATF4	NATURE GENETICS			English	Article							PRIMARY CILIA; RETINITIS-PIGMENTOSA; DOMAIN PROTEIN; NEPHRONOPHTHISIS; GENE; INVERSIN; MUTATIONS; INTERACTS; ENCODES; DISEASE	The molecular basis of nephronophthisis(1), the most frequent genetic cause of renal failure in children and young adults, and its association with retinal degeneration and cerebellar vermis aplasia in Joubert syndrome(2) are poorly understood. Using positional cloning, we here identify mutations in the gene CEP290 as causing nephronophthisis. It encodes a protein with several domains also present in CENPF, a protein involved in chromosome segregation. CEP290 ( also known as NPHP6) interacts with and modulates the activity of ATF4, a transcription factor implicated in cAMP-dependent renal cyst formation. NPHP6 is found at centrosomes and in the nucleus of renal epithelial cells in a cell cycle-dependent manner and in connecting cilia of photoreceptors. Abrogation of its function in zebrafish recapitulates the renal, retinal and cerebellar phenotypes of Joubert syndrome. Our findings help establish the link between centrosome function, tissue architecture and transcriptional control in the pathogenesis of cystic kidney disease, retinal degeneration, and central nervous system development.	Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Newcastle Univ, Sch Clin Med Sci, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; Univ Cologne, Cologne Ctr Genom, D-5000 Cologne 41, Germany; RZPD Deutsch Ressourcectr Genomforsch, Berlin, Germany; Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; Univ Michigan, Inst Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Ophthalmol, Ann Arbor, MI 48109 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Renal Unit, Charlestown, MA 02129 USA; Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany; Peking Univ, Sch Oncol, Beijing Inst Canc Res, Dept Biochem & Mol Biol, Beijing 100036, Peoples R China; Univ Calif San Diego, Sch Med, Dept Pharmacol & Neurosci, La Jolla, CA 92093 USA; Univ Cologne, Dept Pediat, D-5000 Cologne 41, Germany; Univ Zurich, Dept Pediat, CH-8006 Zurich, Switzerland; Univ Washington, Dept Pediat, Seattle, WA 98105 USA; Hannover Med Sch, Inst Mol Biol, D-30625 Hannover, Germany; Univ Cologne, Inst Genet, D-5000 Cologne 41, Germany; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Newcastle University - UK; University of Cologne; Simon Fraser University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard University; Massachusetts General Hospital; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Max Planck Society; Peking University; University of California System; University of California San Diego; University of Cologne; University of Zurich; University of Washington; University of Washington Seattle; Hannover Medical School; University of Cologne; University of Michigan System; University of Michigan	Hildebrandt, F (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	fhilde@umich.edu	Hennies, Hans C/G-9424-2014; Sayer, John A./AAN-2729-2020; Lillo, Concepcion/A-6321-2009; Kusakabe, Takehiro/H-7178-2012	Hennies, Hans C/0000-0001-7210-2389; Sayer, John A./0000-0003-1881-3782; Lillo, Concepcion/0000-0001-5814-9826; Kusakabe, Takehiro/0000-0002-8325-3665; Wilkinson, Christopher/0000-0002-7448-0938; Lee, Hwankyu/0000-0002-2036-1490; Otto, Edgar/0000-0002-2387-9973; Utsch, Boris/0000-0003-4623-581X; nigg, erich/0000-0003-4835-5719; Swaroop, Anand/0000-0002-1975-1141; Attanasio, Massimo/0000-0002-1278-3650	NATIONAL EYE INSTITUTE [R29EY007961, R01EY007042, R01EY013408, R01EY007961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053093, R01DK064614] Funding Source: NIH RePORTER; NEI NIH HHS [EY13408, EY07003, R01 EY007042, EY07961, R01 EY007042-20] Funding Source: Medline; NIDDK NIH HHS [DK1068306, DK1069274, DK53093, DK064614] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Barthel LK, 2000, METHOD ENZYMOL, V316, P579; Chen DH, 2001, BIOCHEM BIOPH RES CO, V280, P99, DOI 10.1006/bbrc.2000.4087; Germino GG, 2005, NAT GENET, V37, P455, DOI 10.1038/ng0505-455; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; HILDEBRANDT F, 2001, DIS KIDNEY URINARY T; Khanna H, 2005, J BIOL CHEM, V280, P33580, DOI 10.1074/jbc.M505827200; KHANNA H, IN PRESS HUM MOL GEN; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Mazet F, 2005, DEV BIOL, V282, P494, DOI 10.1016/j.ydbio.2005.02.021; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Morgan D, 2002, HUM MOL GENET, V11, P3345, DOI 10.1093/hmg/11.26.3345; Nakashima Y, 2003, J COMP NEUROL, V460, P180, DOI 10.1002/cne.10645; Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Otto E, 2002, AM J HUM GENET, V71, P1161, DOI 10.1086/344395; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Pazour GJ, 2003, CURR OPIN CELL BIOL, V15, P105, DOI 10.1016/S0955-0674(02)00012-1; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; SARAIVA JM, 1992, AM J MED GENET, V43, P726, DOI 10.1002/ajmg.1320430415; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Utsch B, 2006, PEDIATR NEPHROL, V21, P32, DOI 10.1007/s00467-005-2054-y; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Zhou XB, 2005, J BIOL CHEM, V280, P13973, DOI 10.1074/jbc.M414310200	30	411	424	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					674	681		10.1038/ng1786	http://dx.doi.org/10.1038/ng1786			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16682973				2022-12-27	WOS:000237954800022
J	Carlborg, O; Jacobsson, L; Ahgren, P; Siegel, P; Andersson, L				Carlborg, O; Jacobsson, L; Ahgren, P; Siegel, P; Andersson, L			Epistasis and the release of genetic variation during long-term selection	NATURE GENETICS			English	Article							DROSOPHILA-MELANOGASTER; ARCHITECTURE; POPULATIONS; CHICKENS; GROWTH	It is an enigma how long-term selection in model organisms and agricultural species can lead to marked phenotypic changes without exhausting genetic variation for the selected trait. Here, we show that the genetic architecture of an apparently major locus for growth in chicken dissects into a genetic network of four interacting loci. The interactions in this radial network mediate a considerably larger selection response than predicted by a single-locus model.	Uppsala Univ, Linnaeus Ctr Bioinformat, SE-75124 Uppsala, Sweden; Swedish Univ Agr Sci, Dept Anim Breeding & Genet, SE-75124 Uppsala, Sweden; Swedish Univ Agr Sci, Dept Med Biochem & Microbiol, SE-75124 Uppsala, Sweden; Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA	Uppsala University; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Virginia Polytechnic Institute & State University	Carlborg, O (corresponding author), Uppsala Univ, Linnaeus Ctr Bioinformat, Box 598, SE-75124 Uppsala, Sweden.	orjan.carlborg@lcb.uu.se		Carlborg, Orjan/0000-0002-2722-5264; Stromstedt, Lina/0000-0002-9317-7651				Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Carlborg O, 2003, GENOME RES, V13, P413, DOI 10.1101/gr.528003; Dunnington EA, 1996, POULTRY SCI, V75, P1168, DOI 10.3382/ps.0751168; Dworkin I, 2003, CURR BIOL, V13, P1888, DOI 10.1016/j.cub.2003.10.001; Eitan Y, 2004, EVOLUTIONARY THEORY AND PROCESSES: MODERN HORIZONS, P153; FALCONER DS, 1992, ANNU REV GENET, V26, P1, DOI 10.1146/annurev.ge.26.120192.000245; Fedorowicz GM, 1998, GENETICS, V148, P1885; Flint J, 2004, MAMM GENOME, V15, P77, DOI 10.1007/s00335-003-3033-x; Jacobsson L, 2005, GENET RES, V86, P115, DOI 10.1017/S0016672305007767; Keightley P. D., 2004, Plant Breeding Reviews, V24, P227; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Ungerer MC, 2003, GENETICS, V163, P277	15	215	224	0	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2006	38	4					418	420		10.1038/ng1761	http://dx.doi.org/10.1038/ng1761			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	026LN	16532011				2022-12-27	WOS:000236340500013
J	Keshet, I; Schlesinger, Y; Farkash, S; Rand, E; Hecht, M; Segal, E; Pikarski, E; Young, RA; Niveleau, A; Cedar, H; Simon, I				Keshet, I; Schlesinger, Y; Farkash, S; Rand, E; Hecht, M; Segal, E; Pikarski, E; Young, RA; Niveleau, A; Cedar, H; Simon, I			Evidence for an instructive mechanism of de novo methylation in cancer cells	NATURE GENETICS			English	Article							DNA METHYLATION; CPG-ISLAND; DEVELOPMENTAL PATTERN; PROMOTER METHYLATION; ABERRANT METHYLATION; GENE-EXPRESSION; MOUSE EMBRYO; HYPERMETHYLATION; SITES; RECRUITMENT	DNA methylation has a role in the regulation of gene expression during normal mammalian development but can also mediate epigenetic silencing of CpG island genes in cancer and other diseases. Many individual genes ( including tumor suppressors) have been shown to undergo de novo methylation in specific tumor types, but the biological logic inherent in this process is not understood. To decipher this mechanism, we have adopted a new approach for detecting CpG island DNA methylation that can be used together with microarray technology. Genome-wide analysis by this technique demonstrated that tumor-specific methylated genes belong to distinct functional categories, have common sequence motifs in their promoters and are found in clusters on chromosomes. In addition, many are already repressed in normal cells. These results are consistent with the hypothesis that cancer-related de novo methylation may come about through an instructive mechanism.	Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Mol Biol, Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Pathol, Jerusalem, Israel; Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY USA; Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; Univ Grenoble 1, Lab Virol Struct & Mol, La Tronche, France	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Rockefeller University; Massachusetts Institute of Technology (MIT); Whitehead Institute; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Keshet, I (corresponding author), Hebrew Univ Jerusalem, Dept Cellular Biochem & Human Genet, Jerusalem, Israel.	cedar@md.huji.ac.il	pikarsky, eli/GXV-7099-2022; Young, Richard A/F-6495-2012; Segal, Eran/AAF-4855-2019	Young, Richard A/0000-0001-8855-8647; Simon, Itamar/0000-0002-8517-1903; Segal, Eran/0000-0002-6859-1164; pikarsky, eli/0000-0003-4186-7105	NHGRI NIH HHS [R01 HG002668-03, R01 HG002668] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ahuja N, 2000, HISTOL HISTOPATHOL, V15, P835, DOI 10.14670/HH-15.835; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Baylin SB, 2000, TRENDS GENET, V16, P168, DOI 10.1016/S0168-9525(99)01971-X; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chan AOO, 2002, AM J PATHOL, V160, P1823, DOI 10.1016/S0002-9440(10)61128-5; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Eden S, 1998, NATURE, V394, P842, DOI 10.1038/29680; Esteller M, 2001, HUM MOL GENET, V10, P3001, DOI 10.1093/hmg/10.26.3001; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Gidekel S, 2002, J BIOL CHEM, V277, P34521, DOI 10.1074/jbc.M203338200; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; JONES A, 1967, ECON BOT, V21, P163, DOI 10.1007/BF02897864; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Maruyama R, 2002, CLIN CANCER RES, V8, P514; MONK M, 1987, DEVELOPMENT, V99, P371; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; Notterman DA, 2001, CANCER RES, V61, P3124; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; Rush LJ, 2002, ANAL BIOCHEM, V307, P191, DOI 10.1016/S0003-2697(02)00033-7; Segal E, 2003, BIOINFORMATICS, V19, pi273, DOI 10.1093/bioinformatics/btg1038; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Smiraglia DJ, 2002, ONCOGENE, V21, P5414, DOI 10.1038/sj.onc.1205608; Stirzaker C, 2004, CANCER RES, V64, P3871, DOI 10.1158/0008-5472.CAN-03-3690; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Toyota M, 1999, CANCER RES, V59, P2307; Toyota M, 1999, CANCER RES, V59, P5438; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; VIRE E, 2005, NATURE          1214, DOI DOI 10.1038/NATURE04431; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yu L, 2005, NAT GENET, V37, P265, DOI 10.1038/ng1521; Zardo G, 2002, NAT GENET, V32, P453, DOI 10.1038/ng1007	39	364	394	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					149	153		10.1038/ng1719	http://dx.doi.org/10.1038/ng1719			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16444255				2022-12-27	WOS:000234953200007
J	Koshiba-Takeuchi, K; Takeuchi, JK; Arruda, EP; Kathiriya, IS; Mo, R; Hui, CC; Srivastava, D; Bruneau, BG				Koshiba-Takeuchi, K; Takeuchi, JK; Arruda, EP; Kathiriya, IS; Mo, R; Hui, CC; Srivastava, D; Bruneau, BG			Cooperative and antagonistic interactions between Sall4 and Tbx5 pattern the mouse limb and heart	NATURE GENETICS			English	Article							HOLT-ORAM-SYNDROME; ULNAR-MAMMARY SYNDROME; OKIHIRO-SYNDROME; TRANSCRIPTIONAL REGULATION; DIGIT IDENTITY; MUTATIONS; HINDLIMB; GENE; SHH; MORPHOGENESIS	Human mutations in TBX5, a gene encoding a T-box transcription factor, and SALL4, a gene encoding a zinc-finger transcription factor, cause similar upper limb and heart defects. Here we show that Tbx5 regulates Sall4 expression in the developing mouse forelimb and heart; mice heterozygous for a gene trap allele of Sall4 show limb and heart defects that model human disease. Tbx5 and Sall4 interact both positively and negatively to finely regulate patterning and morphogenesis of the anterior forelimb and heart. Thus, a positive and negative feed-forward circuit between Tbx5 and Sall4 ensures precise patterning of embryonic limb and heart and provides a unifying mechanism for heart/hand syndromes.	Hosp Sick Children, Program Cardiovasc Res, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Biol, Dallas, TX 75390 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Bruneau, BG (corresponding author), Hosp Sick Children, Program Cardiovasc Res, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	bbruneau@sickkids.ca		Bruneau, Benoit/0000-0002-0804-7597				Agarwal P, 2003, DEVELOPMENT, V130, P623, DOI 10.1242/dev.00191; Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; Borozdin W, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019505; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brassington AME, 2003, AM J HUM GENET, V73, P74, DOI 10.1086/376436; Bruneau BG, 2002, CIRC RES, V90, P509, DOI 10.1161/01.RES.0000013072.51957.B7; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Fan C, 2003, J BIOL CHEM, V278, P8780, DOI 10.1074/jbc.M208120200; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Ghosh TK, 2001, HUM MOL GENET, V10, P1983, DOI 10.1093/hmg/10.18.1983; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hoogaars WMH, 2004, CARDIOVASC RES, V62, P489, DOI 10.1016/j.cardiores.2004.01.030; Kaufman M.H., 1992, ATLAS MOUSE DEV; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 2002, CYTOGENET GENOME RES, V98, P274, DOI 10.1159/000071048; Kohlhase J, 2003, J MED GENET, V40, P473, DOI 10.1136/jmg.40.7.473; Lanctot C, 1999, DEVELOPMENT, V126, P1805; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; Logan M, 2003, DEVELOPMENT, V130, P6401, DOI 10.1242/dev.00956; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Minguillon C, 2005, DEV CELL, V8, P75, DOI 10.1016/j.devcel.2004.11.013; Mori AD, 2004, CURR OPIN CARDIOL, V19, P211, DOI 10.1097/00001573-200405000-00004; Naiche LA, 2003, DEVELOPMENT, V130, P2681, DOI 10.1242/dev.00504; NewburyEcob RA, 1996, J MED GENET, V33, P300, DOI 10.1136/jmg.33.4.300; Pizard A, 2005, MOL CELL BIOL, V25, P5073, DOI 10.1128/MCB.25.12.5073-5083.2005; POZNANSK AK, 1970, RADIOLOGY, V94, P45, DOI 10.1148/94.1.45; Rallis C, 2003, DEVELOPMENT, V130, P2741, DOI 10.1242/dev.00473; Seidman JG, 2002, J CLIN INVEST, V109, P451, DOI 10.1172/JC1200215043; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Suzuki T, 2004, DEV CELL, V6, P43, DOI 10.1016/S1534-5807(03)00401-5; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; Tickle C, 2003, DEV CELL, V4, P449, DOI 10.1016/S1534-5807(03)00095-9; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620	48	124	125	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					175	183		10.1038/ng1707	http://dx.doi.org/10.1038/ng1707			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16380715				2022-12-27	WOS:000234953200011
J	McCarroll, SA; Hadnott, TN; Perry, GH; Sabeti, PC; Zody, MC; Barrett, JC; Dallaire, S; Gabriel, SB; Lee, C; Daly, MJ; Altshuler, DM				McCarroll, SA; Hadnott, TN; Perry, GH; Sabeti, PC; Zody, MC; Barrett, JC; Dallaire, S; Gabriel, SB; Lee, C; Daly, MJ; Altshuler, DM		Int HapMap Consortium	Common deletion polymorphisms in the human genome	NATURE GENETICS			English	Article							SEGMENTAL DUPLICATIONS; EXPRESSION	The locations and properties of common deletion variants in the human genome are largely unknown. We describe a systematic method for using dense SNP genotype data to discover deletions and its application to data from the International HapMap Consortium to characterize and catalogue segregating deletion variants across the human genome. We identified 541 deletion variants (94% novel) ranging from 1 kb to 745 kb in size; 278 of these variants were observed in multiple, unrelated individuals, 120 in the homozygous state. The coding exons of ten expressed genes were found to be commonly deleted, including multiple genes with roles in sex steroid metabolism, olfaction and drug response. These common deletion polymorphisms typically represent ancestral mutations that are in linkage disequilibrium with nearby SNPs, meaning that their association to disease can often be evaluated in the course of SNP-based whole-genome association studies.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02141 USA; MIT, Cambridge, MA 02141 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Med, Simches Res Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Altshuler, DM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, 55 Fruit St, Boston, MA 02114 USA.	altshuler@molbio.mgh.harvard.edu	Altshuler, David M/A-4476-2009; Sabeti, Pardis/GQH-8610-2022; Daly, Mark J/B-2453-2017; McCarroll, Steven A/A-8433-2009; Pillay, Nischalan/F-9536-2012	Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; McCarroll, Steven/0000-0002-6954-8184; Harrison, Tracy Nicole Hadnott/0000-0002-5169-3930				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; DAIGER SP, 1983, AM J MED GENET, V14, P43, DOI 10.1002/ajmg.1320140108; DEBAKKER PW, IN PRESS NAT GENET; FRY B, 2005, THESIS MIT; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nunoya K, 1998, PHARMACOGENETICS, V8, P239, DOI 10.1097/00008571-199806000-00006; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; SEIDEGARD J, 1988, P NATL ACAD SCI USA, V85, P7293, DOI 10.1073/pnas.85.19.7293; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wilson W, 2004, GENOMICS, V84, P707, DOI 10.1016/j.ygeno.2004.06.011	19	562	588	1	66	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					86	92		10.1038/ng1696	http://dx.doi.org/10.1038/ng1696			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16468122				2022-12-27	WOS:000234227200022
J	Takahashi, C; Contreras, B; Iwanaga, T; Takegami, Y; Bakker, A; Bronson, RT; Noda, M; Loda, M; Hunt, JL; Ewen, ME				Takahashi, C; Contreras, B; Iwanaga, T; Takegami, Y; Bakker, A; Bronson, RT; Noda, M; Loda, M; Hunt, JL; Ewen, ME			Nras loss induces metastatic conversion of Rb1-deficient neuroendocrine thyroid tumor	NATURE GENETICS			English	Article							CELL LUNG-CANCER; N-RAS; K-RAS; DIFFERENTIATION; RB; MOUSE; PROTEIN; GENE; ACTIVATION; MUTATIONS	Mutations in the gene encoding the retinoblastoma tumor suppressor predispose humans and mice to tumor development(1,2). Here we have assessed the effect of Nras loss on tumor development in Rb1 heterozygous mice. Loss of one or two Nras alleles is shown to significantly reduce the severity of pituitary tumors arising in Rb1(+/-) animals by enhancing their differentiation. By contrast, C-cell thyroid adenomas occurring in Rb1(+/-) mice progress to metastatic medullary carcinomas after loss of Nras. In Rb1(+/-) Nras(+/-) animals, distant medullary thyroid carcinoma metastases are associated with loss of the remaining wild-type Nras allele. Loss of Nras in Rb1-deficient C cells results in elevated Ras homolog family A ( RhoA) activity, and this is causally linked to the invasiveness and metastatic behavior of these cells. These findings suggest that the loss of the proto-oncogene Nras in certain cellular contexts can promote malignant tumor progression.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Rodent Histopathol Core, Boston, MA 02115 USA; Kyoto Univ, Grad Sch Med, 21st Century Ctr Excellence Program, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Mol Oncol, Kyoto 6068501, Japan; Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA 15213 USA; Tufts Univ, Sch Vet Med, North Grafton, MA 01536 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Kyoto University; Kyoto University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tufts University	Ewen, ME (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	chtakaha@virus.kyoto-u.ac.jp; mark_ewen@dfci.harvard.edu	Bakker, Arnold B./F-8494-2010	Bakker, Arnold B./0000-0003-1489-1847	NCI NIH HHS [R01 CA065842-11A1, R01 CA065842] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA065842] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARSAGI D, 1985, CELL, V42, P841, DOI 10.1016/0092-8674(85)90280-6; BESKID M, 1979, ONCOLOGY, V36, P19, DOI 10.1159/000225312; Capen C. C., 2001, INT CLASSIFICATION R, P269; Fearon ER, 1997, SCIENCE, V278, P1043, DOI 10.1126/science.278.5340.1043; HARRISON DJ, 1995, ONCOGENE, V10, P1615; HU NP, 1994, ONCOGENE, V9, P1021; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; KODAMA T, 1988, SURGERY, V104, P997; Lee KY, 1999, MOL CELL BIOL, V19, P7724; MABRY M, 1989, J CLIN INVEST, V84, P194, DOI 10.1172/JCI114140; MacPherson D, 2004, GENE DEV, V18, P1681, DOI 10.1101/gad.1203304; Mettouchi A, 2001, MOL CELL, V8, P115, DOI 10.1016/S1097-2765(01)00285-4; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Mills SE, 2002, MODERN PATHOL, V15, P264, DOI 10.1038/modpathol.3880522; MITSUDOMI T, 1991, ONCOGENE, V6, P1352; MOLEY JF, 1991, CANCER RES, V51, P1596; NAKAGAWA T, 1987, P NATL ACAD SCI USA, V84, P5923, DOI 10.1073/pnas.84.16.5923; NODA M, 1985, NATURE, V318, P73, DOI 10.1038/318073a0; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Takahashi C, 2004, MOL CELL BIOL, V24, P10406, DOI 10.1128/MCB.24.23.10406-10415.2004; Takahashi C, 2003, MOL CELL BIOL, V23, P5256, DOI 10.1128/MCB.23.15.5256-5268.2003; UMANOFF H, 1995, P NATL ACAD SCI USA, V92, P1709, DOI 10.1073/pnas.92.5.1709; Vooijs M, 1999, ONCOGENE, V18, P5293, DOI 10.1038/sj.onc.1202999; White A, 1998, CLIN ENDOCRINOL, V48, P251, DOI 10.1046/j.1365-2265.1998.00451.x; WILLIAMS BO, 1994, NAT GENET, V7, P480, DOI 10.1038/ng0894-480; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	28	37	39	2	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					118	123		10.1038/ng1703	http://dx.doi.org/10.1038/ng1703			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16369533				2022-12-27	WOS:000234227200027
J	Choi, SS; Li, WM; Lahn, BT				Choi, SS; Li, WM; Lahn, BT			Robust signals of coevolution of interacting residues in mammalian proteomes identified by phylogeny-aided structural analysis	NATURE GENETICS			English	Article							SECONDARY STRUCTURE; COMPENSATORY EVOLUTION; CORRELATED MUTATIONS; PROTEIN EVOLUTION; RNA; SUBSTITUTIONS; PERSPECTIVE; SEQUENCES; GENOMICS; CONTACTS	The structure of a protein depends critically on the complex interactions among its amino acid residues. It has long been hypothesized that interacting residues might tend to coevolve, but it is not known whether such coevolution is a general phenomenon across the proteome. Here, we describe a novel methodology called phylogeny-aided structural analysis, which uncovers robust signals of interacting-residue coevolution in mammalian proteomes. Furthermore, this new method allows the magnitude of coevolution to be quantified. Finally, it facilitates a comprehensive evaluation of various factors that affect interacting-residue coevolution, such as the physicochemical properties of the interactions between residues, solvent accessibility of the residues and their secondary structure context.	Univ Chicago, Howard Hughes Med Inst, Dept Human Genet, Chicago, IL 60637 USA	Howard Hughes Medical Institute; University of Chicago	Lahn, BT (corresponding author), Univ Chicago, Howard Hughes Med Inst, Dept Human Genet, 5841 S Maryland Ave, Chicago, IL 60637 USA.	blahn@bsd.uchicago.edu						Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Baudry J, 2003, PROTEIN ENG, V16, P577, DOI 10.1093/protein/gzg075; Chen Y, 1999, GENES GENET SYST, V74, P271, DOI 10.1266/ggs.74.271; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Fukami-Kobayashi K, 2002, J MOL BIOL, V319, P729, DOI 10.1016/S0022-2836(02)00239-5; Gao LZ, 2003, TRENDS GENET, V19, P678, DOI 10.1016/j.tig.2003.10.002; GILLESPIE JH, 1984, P NATL ACAD SCI-BIOL, V81, P8009, DOI 10.1073/pnas.81.24.8009; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; HAAS ES, 1994, P NATL ACAD SCI USA, V91, P2527, DOI 10.1073/pnas.91.7.2527; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kern AD, 2004, NAT GENET, V36, P1207, DOI 10.1038/ng1451; Kimura M., 1985, J GENET, V64, P7, DOI [10.1007/BF02923549, DOI 10.1007/BF02923549]; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Mackerell AD, 2004, J COMPUT CHEM, V25, P1584, DOI 10.1002/jcc.20082; MALCOLM BA, 1990, NATURE, V345, P86, DOI 10.1038/345086a0; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Ortiz AR, 2000, BIOPHYS J, V79, P1787, DOI 10.1016/S0006-3495(00)76430-7; Pollock DD, 1997, PROTEIN ENG, V10, P647, DOI 10.1093/protein/10.6.647; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; STICKLE DF, 1992, J MOL BIOL, V226, P1143, DOI 10.1016/0022-2836(92)91058-W; TAYLOR WR, 1994, PROTEIN ENG, V7, P341, DOI 10.1093/protein/7.3.341; Tramontano A, 2001, PROTEINS, P22, DOI 10.1002/prot.10015; Tuffery P, 2000, MOL BIOL EVOL, V17, P1753, DOI 10.1093/oxfordjournals.molbev.a026273; Westbrook J, 2003, NUCLEIC ACIDS RES, V31, P489, DOI 10.1093/nar/gkg068; YANOFSKY C, 1964, SCIENCE, V146, P1593, DOI 10.1126/science.146.3651.1593; Zhang JZ, 2002, P NATL ACAD SCI USA, V99, P5486, DOI 10.1073/pnas.072626199	28	36	38	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2005	37	12					1367	1371		10.1038/ng1685	http://dx.doi.org/10.1038/ng1685			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16282975				2022-12-27	WOS:000233657300018
J	Hodges, CA; Revenkova, E; Jessberger, R; Hassold, TJ; Hunt, PA				Hodges, CA; Revenkova, E; Jessberger, R; Hassold, TJ; Hunt, PA			SMC1 beta-deficient female mice provide evidence that cohesins are a missing link in age-related nondisjunction	NATURE GENETICS			English	Article							SISTER-CHROMATID COHESION; MEIOTIC RECOMBINATION; MAMMALIAN OOCYTES; MATERNAL AGE; MEIOSIS I; CHROMOSOME; MECHANISM; SMC1-BETA; DYNAMICS; DIVISION	Mitotic chromosome segregation is facilitated by the cohesin complex, which maintains physical connections between sister chromatids until anaphase. Meiotic cell division is considerably more complex, as cohesion must be released sequentially to facilitate orderly segregation of chromosomes at both meiosis I and meiosis II. This necessitates meiosis-specific cohesin components; recent studies in rodents suggest that these influence chromosome behavior during both cell division and meiotic prophase(1,2). To elucidate the role of the meiosis-specific cohesin SMC1 beta ( encoded by Smc1l2) in oogenesis, we carried out meiotic studies of female SMC1 beta-deficient mice. Our results provide the first direct evidence that SMC1 beta acts as a chiasma binder in mammals, stabilizing sites of exchange until anaphase. Additionally, our observations support the hypothesis that deficient cohesion is an underlying cause of human age-related aneuploidy.	Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; Dresden Univ Technol, Dept Physiol Chem, Dresden, Germany	Washington State University; Washington State University; Case Western Reserve University; Icahn School of Medicine at Mount Sinai; Technische Universitat Dresden	Hunt, PA (corresponding author), Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA.	pathunt@wsu.edu						Angell R, 1997, AM J HUM GENET, V61, P23, DOI 10.1086/513890; Bickel SE, 2002, CURR BIOL, V12, P925, DOI 10.1016/S0960-9822(02)00846-1; Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Chan RC, 2003, NATURE, V423, P1002, DOI 10.1038/nature01697; Eijpe M, 2003, J CELL BIOL, V160, P657, DOI 10.1083/jcb.200212080; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Haering CH, 2004, MOL CELL, V15, P951, DOI 10.1016/j.molcel.2004.08.030; HENDERSON SA, 1968, NATURE, V218, P22, DOI 10.1038/218022a0; Hodges CA, 2002, CHROMOSOMA, V111, P165, DOI 10.1007/s00412-002-0195-3; HOGAN B, 1986, MANIPULATING MOUSE E; Kouznetsova A, 2005, J CELL SCI, V118, P2271, DOI 10.1242/jcs.02362; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; Lynn A, 2004, ANNU REV GENOM HUM G, V5, P317, DOI 10.1146/annurev.genom.4.070802.110217; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; MAGUIRE MP, 1974, J THEOR BIOL, V48, P485, DOI 10.1016/S0022-5193(74)80017-2; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; Parisi S, 1999, MOL CELL BIOL, V19, P3515; Pellestor F, 2003, HUM GENET, V112, P195, DOI 10.1007/s00439-002-0852-x; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; POLANI PE, 1976, CYTOGENET CELL GENET, V16, P505, DOI 10.1159/000130668; Prieto I, 2004, CHROMOSOME RES, V12, P197, DOI 10.1023/B:CHRO.0000021945.83198.0e; Prieto I, 2001, NAT CELL BIOL, V3, P761, DOI 10.1038/35087082; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Revenkova E, 2001, MOL CELL BIOL, V21, P6984, DOI 10.1128/MCB.21.20.6984-6998.2001; Sun F, 2004, AM J HUM GENET, V74, P521, DOI 10.1086/382138; TARKOWSKI AK, 1966, CYTOGENETICS, V5, P394, DOI 10.1159/000129914; Uhlmann F, 2004, EXP CELL RES, V296, P80, DOI 10.1016/j.yexcr.2004.03.005; Wolstenholme J, 2000, CHROMOSOMA, V109, P435, DOI 10.1007/s004120000088	29	230	242	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2005	37	12					1351	1355		10.1038/ng1672	http://dx.doi.org/10.1038/ng1672			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16258540				2022-12-27	WOS:000233657300015
J	Caussinus, E; Gonzalez, C				Caussinus, E; Gonzalez, C			Induction of tumor growth by altered stem-cell asymmetric division in Drosophila melanogaster	NATURE GENETICS			English	Article							GENETIC INSTABILITY; FATE DETERMINANTS; SELF-RENEWAL; POLARITY; PROLIFERATION; NEUROBLAST; CANCER; DLG; LGL; NEUROGENESIS	Loss of cell polarity and cancer are tightly correlated(1), but proof for a causative relationship has remained elusive. In stem cells, loss of polarity and impairment of asymmetric cell division could alter cell fates and thereby render daughter cells unable to respond to the mechanisms that control proliferation(2). To test this hypothesis, we generated Drosophila melanogaster larval neuroblasts containing mutations in various genes that control asymmetric cell division and then assayed their proliferative potential after transplantation into adult hosts. We found that larval brain tissue carrying neuroblasts with mutations in raps (also called pins), mira, numb or pros grew to more than 100 times their initial size, invading other tissues and killing the hosts in 2 weeks. These tumors became immortal and could be retransplanted into new hosts for years. Six weeks after the first implantation, genome instability and centrosome alterations, two traits of malignant carcinomas(3,4), appeared in these tumors. Increasing evidence suggests that some tumors may be of stem cell origin(5,6). Our results show that loss of function of any of several genes that control the fate of a stem cell's daughters may result in hyperproliferation, triggering a chain of events that subverts cell homeostasis in a general sense and leads to cancer.	ICREA & IRBB, Cell Div Grp, Barcelona, Spain; European Mol Biol Lab, Cell Biol & Biophys Program, D-69117 Heidelberg, Germany	ICREA; European Molecular Biology Laboratory (EMBL)	Gonzalez, C (corresponding author), ICREA & IRBB, Cell Div Grp, Parc Cient Barcelona,C Josep Samitier 1-5, Barcelona, Spain.	cgonzalez@pcb.ub.es	Gonzalez, Cayetano/K-3933-2019; Gonzalez, Cayetano/K-3055-2019	Gonzalez, Cayetano/0000-0002-5259-3608	ICREA Funding Source: Custom	ICREA(ICREA)		Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; Bardin AJ, 2004, CURR OPIN NEUROBIOL, V14, P6, DOI 10.1016/j.conb.2003.12.002; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Ceron J, 2001, DEV BIOL, V230, P125, DOI 10.1006/dbio.2000.0110; Chia W, 2002, CURR OPIN GENET DEV, V12, P459, DOI 10.1016/S0959-437X(02)00326-X; GATEFF E, 1974, ROUX ARCH DEV BIOL, V176, P23, DOI 10.1007/BF00577830; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Gatewood WB, 1997, AFR AM REV, V31, P365, DOI 10.2307/3042495; GATTI M, 1989, GENE DEV, V3, P438, DOI 10.1101/gad.3.4.438; GEHRING W, 1966, J EMBRYOL EXP MORPH, V15, P77; HADORN E, 1966, DEV BIOL, V13, P424, DOI 10.1016/0012-1606(66)90058-3; HADORN E, 1978, GENETICS BIOL DROS C, V2, P557; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Liu H, 2005, CELL CYCLE, V4, P646, DOI 10.4161/cc.4.5.1674; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Pihan GA, 2003, CANCER RES, V63, P1398; Pihan GA, 1998, CANCER RES, V58, P3974; Shih IM, 2001, CANCER RES, V61, P818; SUNKEL CE, 1995, EMBO J, V14, P28, DOI 10.1002/j.1460-2075.1995.tb06972.x; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; WATSON KL, 1994, J CELL SCI, P19; Wodarz A, 2000, CURR BIOL, V10, pR624, DOI 10.1016/S0960-9822(00)00658-8	30	328	341	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1125	1129		10.1038/ng1632	http://dx.doi.org/10.1038/ng1632			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16142234				2022-12-27	WOS:000232185600026
J	Reiser, J; Polu, KR; Moller, CC; Kenlan, P; Altintas, MM; Wei, CL; Faul, C; Herbert, S; Villegas, I; Avila-Casado, C; McGee, M; Sugimoto, H; Brown, D; Kalluri, R; Mundel, P; Smith, PL; Clapham, DE; Pollak, MR				Reiser, J; Polu, KR; Moller, CC; Kenlan, P; Altintas, MM; Wei, CL; Faul, C; Herbert, S; Villegas, I; Avila-Casado, C; McGee, M; Sugimoto, H; Brown, D; Kalluri, R; Mundel, P; Smith, PL; Clapham, DE; Pollak, MR			TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function	NATURE GENETICS			English	Article							PROTEIN; NEPHRIN; KIDNEY; RAT; PODOCYTES; GENE	Progressive kidney failure is a genetically and clinically heterogeneous group of disorders. Podocyte foot processes and the interposed glomerular slit diaphragm are essential components of the permeability barrier in the kidney. Mutations in genes encoding structural proteins of the podocyte lead to the development of proteinuria, resulting in progressive kidney failure and focal segmental glomerulosclerosis. Here, we show that the canonical transient receptor potential 6 ( TRPC6) ion channel is expressed in podocytes and is a component of the glomerular slit diaphragm. We identified five families with autosomal dominant focal segmental glomerulosclerosis in which disease segregated with mutations in the gene TRPC6 on chromosome 11q. Two of the TRPC6 mutants had increased current amplitudes. These data show that TRPC6 channel activity at the slit diaphragm is essential for proper regulation of podocyte structure and function.	Massachusetts Gen Hosp, Dept Med, Renal Unit, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA; Brigham & Womens Hosp, Dept Med, Div Renal, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; Inst Nacl Cardiol Ignacio Chavez, Dept Pathol, Mexico City 14080, DF, Mexico; Massachusetts Gen Hosp, Program Membrane Biol, Boston, MA 02129 USA; Beth Israel Deaconess Med Ctr, Ctr Matrix Biol, Dept Med, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Dept Cardiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai; National Institute of Cardiology - Mexico; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Reiser, J (corresponding author), Massachusetts Gen Hosp, Dept Med, Renal Unit, Boston, MA 02129 USA.	jreiser@partners.org; mpollak@rics.bwh.harvard.edu	Altintas, Mehmet Mete/T-5333-2018; Clapham, David/S-1123-2019; Faul, Christian/D-1549-2011; Clapham, David/R-5974-2019; Altintas, Mehmet Mete/ABI-5904-2020; Kalluri, Raghu/E-2677-2015	Altintas, Mehmet Mete/0000-0002-1871-6985; Clapham, David/0000-0002-4459-9428; Kalluri, Raghu/0000-0002-2190-547X	NHLBI NIH HHS [T32 HL007572] Funding Source: Medline; NIDDK NIH HHS [R01 DK055001, R01 DK057683, R56 DK054931, R01 DK054931] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK054931, R01DK057683, R01DK055001, R01DK054931] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bandyopadhyay BC, 2005, J BIOL CHEM, V280, P12908, DOI 10.1074/jbc.M410013200; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; DRENCKHAHN D, 1988, LAB INVEST, V59, P673; Facemire CS, 2004, AM J PHYSIOL-RENAL, V286, pF546, DOI 10.1152/ajprenal.00338.2003; Hamano Y, 2002, J BIOL CHEM, V277, P31154, DOI 10.1074/jbc.M204806200; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Mundel P, 1997, J CELL BIOL, V139, P193, DOI 10.1083/jcb.139.1.193; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Pavenstadt H, 2002, MICROSC RES TECHNIQ, V57, P224, DOI 10.1002/jemt.10078; Pollak MR, 2002, J AM SOC NEPHROL, V13, P3016, DOI 10.1097/01.ASN.0000039569.34360.5E; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; SCHNABEL E, 1989, EUR J CELL BIOL, V48, P313; Somlo S, 2000, NAT GENET, V24, P333, DOI 10.1038/74139; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; WINN MP, 2005, SCIENCE         0505, DOI DOI 10.1126/SCIENCE.1106215; Zandi-Nejad K, 2004, KIDNEY INT, V66, pS76, DOI 10.1111/j.1523-1755.2004.09220.x	26	604	663	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					739	744		10.1038/ng1592	http://dx.doi.org/10.1038/ng1592			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15924139	Green Accepted			2022-12-27	WOS:000230196400021
J	Ching, TT; Maunakea, AK; Jun, P; Hong, CB; Zardo, G; Pinkel, D; Albertson, DG; Fridlyand, J; Mao, JH; Shchors, K; Weiss, WA; Costello, JF				Ching, TT; Maunakea, AK; Jun, P; Hong, CB; Zardo, G; Pinkel, D; Albertson, DG; Fridlyand, J; Mao, JH; Shchors, K; Weiss, WA; Costello, JF			Epigenome analyses using BAC microarrays identify evolutionary conservation of tissue-specific methylation of SHANK3	NATURE GENETICS			English	Article							DNA METHYLTRANSFERASE GENE; 22Q13 DELETION SYNDROME; CPG-ISLANDS; HUMAN GENOME; ARRAY CGH; IMMUNODEFICIENCY SYNDROME; COPY NUMBER; GERM-LINE; MOUSE; EXPRESSION	CpG islands are present in one-half of all human and mouse genes and typically overlap with promoters or exons. We developed a method for high-resolution analysis of the methylation status of CpG islands genome-wide, using arrays of BAC clones and the methylation-sensitive restriction enzyme NotI. Here we demonstrate the accuracy and specificity of the method. By computationally mapping all NotI sites, methylation events can be defined with single-nucleotide precision throughout the genome. We also demonstrate the unique expandability of the array method using a different methylation-sensitive restriction enzyme, BssHII. We identified and validated new CpG island loci that are methylated in a tissue-specific manner in normal human tissues. The methylation status of the CpG islands is associated with gene expression for several genes, including SHANK3, which encodes a structural protein in neuronal postsynaptic densities. Defects in SHANK3 seem to underlie human 22q13 deletion syndrome. Furthermore, these patterns for SHANK3 are conserved in mice and rats.	Univ Calif San Francisco, Dept Neurol Surg, Brain Tumor Res Ctr, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Costello, JF (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, Brain Tumor Res Ctr, San Francisco, CA 94143 USA.	jcostello@cc.ucsf.edu	Mao, Jian-Hua/EIZ-8595-2022	Mao, Jian-Hua/0000-0001-9320-6021; Ching, Tsui-Ting/0000-0001-7650-1766; Weiss, William/0000-0003-2230-9132				Albertson DG, 2000, NAT GENET, V25, P144, DOI 10.1038/75985; ANTEQUERA F, 1993, P NATL ACAD SCI USA, V90, P11995, DOI 10.1073/pnas.90.24.11995; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; Bonaglia MC, 2001, AM J HUM GENET, V69, P261, DOI 10.1086/321293; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; De Smet C, 1999, MOL CELL BIOL, V19, P7327; DeSmet C, 1996, P NATL ACAD SCI USA, V93, P7149, DOI 10.1073/pnas.93.14.7149; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gartler S M, 1992, Mol Genet Med, V2, P121; Grunau C, 2001, Nucleic Acids Res, V29, pE65, DOI 10.1093/nar/29.13.e65; Hansen RS, 1999, P NATL ACAD SCI USA, V96, P14412, DOI 10.1073/pnas.96.25.14412; Hershko AY, 2003, GENE, V302, P65, DOI 10.1016/S0378111902010910; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Huang THM, 1997, CANCER RES, V57, P1030; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; LINDSAY S, 1987, NATURE, V327, P336, DOI 10.1038/327336a0; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; MARASCHIO P, 1988, J MED GENET, V25, P173, DOI 10.1136/jmg.25.3.173; MCCLELLAND M, 1982, NUCLEIC ACIDS RES, V10, P7865, DOI 10.1093/nar/10.23.7865; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Phelan MC, 2001, AM J MED GENET, V101, P91, DOI 10.1002/1096-8628(20010615)101:2<91::AID-AJMG1340>3.0.CO;2-C; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Qualmann B, 2004, J NEUROSCI, V24, P2481, DOI 10.1523/JNEUROSCI.5479-03.2004; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Snijders AM, 2005, GENOME RES, V15, P302, DOI 10.1101/gr.2902505; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Surani MA, 1998, CELL, V93, P309, DOI 10.1016/S0092-8674(00)81156-3; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Trasler JM, 1996, DEV DYNAM, V206, P239, DOI 10.1002/(SICI)1097-0177(199607)206:3<239::AID-AJA2>3.3.CO;2-M; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WATT JL, 1985, J MED GENET, V22, P283, DOI 10.1136/jmg.22.4.283; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052	43	127	138	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					645	651		10.1038/ng1563	http://dx.doi.org/10.1038/ng1563			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15895082				2022-12-27	WOS:000229495300021
J	Sweet-Cordero, A; Mukherjee, S; Subramanian, A; You, H; Roix, JJ; Ladd-Acosta, C; Mesirov, J; Golub, TR; Jacks, T				Sweet-Cordero, A; Mukherjee, S; Subramanian, A; You, H; Roix, JJ; Ladd-Acosta, C; Mesirov, J; Golub, TR; Jacks, T			An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GROWTH-FACTOR; LUNG ADENOCARCINOMA; BREAST-CANCER; RAS; CLASSIFICATION; MUTATIONS; PATTERNS; PROTEIN; TUMORS	Using advanced gene targeting methods, generating mouse models of cancer that accurately reproduce the genetic alterations present in human tumors is now relatively straightforward. The challenge is to determine to what extent such models faithfully mimic human disease with respect to the underlying molecular mechanisms that accompany tumor progression. Here we describe a method for comparing mouse models of cancer with human tumors using gene-expression profiling. We applied this method to the analysis of a model of Kras2-mediated lung cancer and found a good relationship to human lung adenocarcinoma, thereby validating the model. Furthermore, we found that whereas a gene-expression signature of KRAS2 activation was not identifiable when analyzing human tumors with known KRAS2 mutation status alone, integrating mouse and human data uncovered a gene-expression signature of KRAS2 mutation in human lung cancer. We confirmed the importance of this signature by gene-expression analysis of short hairpin RNA-mediated inhibition of oncogenic Kras2. These experiments identified both a pattern of gene expression indicative of KRAS2 mutation and potential effectors of oncogenic KRAS2 activity in human cancer. This approach provides a strategy for using genomic analysis of animal models to probe human disease.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; MIT, Eli & Edyth L Broad Inst, Cambridge, MA 02141 USA; Harvard Univ, Eli & Edyth L Broad Inst, Cambridge, MA 02141 USA	Massachusetts Institute of Technology (MIT); Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Jacks, T (corresponding author), MIT, Ctr Canc Res, Bldg E17-517,40 Ames St, Cambridge, MA 02139 USA.	tjacks@mit.edu	Mesirov, Jill/AGF-7626-2022	Mukherjee, Sayan/0000-0002-6715-3920				Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bonner AE, 2004, ONCOGENE, V23, P1166, DOI 10.1038/sj.onc.1207234; Camps M, 1998, FEBS LETT, V425, P271, DOI 10.1016/S0014-5793(98)00250-6; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Desai KV, 2002, P NATL ACAD SCI USA, V99, P6967, DOI 10.1073/pnas.102172399; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Huang E, 2003, NAT GENET, V34, P226, DOI 10.1038/ng1167; Iacobuzio-Donahue CA, 2003, AM J PATHOL, V162, P1151, DOI 10.1016/S0002-9440(10)63911-9; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kawakami Y, 2003, NAT CELL BIOL, V5, P513, DOI 10.1038/ncb989; KLIMSTRA DS, 1994, AM J PATHOL, V145, P1547; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lo RS, 2001, EMBO J, V20, P128, DOI 10.1093/emboj/20.1.128; MANTEL N, 1967, CANCER RES, V27, P209; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muda M, 1996, J BIOL CHEM, V271, P27205, DOI 10.1074/jbc.271.44.27205; Naoki K, 2002, CANCER RES, V62, P7001; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Tchernitsa OI, 2004, ONCOGENE, V23, P4536, DOI 10.1038/sj.onc.1207585; Toyoshima Y, 2004, J BIOL CHEM, V279, P25898, DOI 10.1074/jbc.M400661200; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; van 't Veer LJ, 2003, BREAST CANCER RES, V5, P57, DOI 10.1186/bcr562; Vapnik Y. N., 1998, STAT LEARNING THEORY; Zuber J, 2000, NAT GENET, V24, P144, DOI 10.1038/72799	36	330	346	1	12	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2005	37	1					48	55		10.1038/ng1490	http://dx.doi.org/10.1038/ng1490			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15608639				2022-12-27	WOS:000225997500020
J	Mukherjee, S; Berger, MF; Jona, G; Wang, XS; Muzzey, D; Snyder, M; Young, RA; Bulyk, ML				Mukherjee, S; Berger, MF; Jona, G; Wang, XS; Muzzey, D; Snyder, M; Young, RA; Bulyk, ML			Rapid analysis of the DNA-binding specificities of transcription factors with DNA microarrays	NATURE GENETICS			English	Article							PROTEIN-INTERACTION MAP; SACCHAROMYCES-CEREVISIAE; REGULATORY ELEMENTS; GENE-EXPRESSION; SNF1 KINASE; YEAST; GENOME; SITES; IDENTIFICATION; REPRESSION	We developed a new DNA microarray-based technology, called protein binding microarrays (PBMs), that allows rapid, high-throughput characterization of the in vitro DNA binding site sequence specificities of transcription factors in a single day. Using PBMs, we identified the DNA binding-site sequence specificities of the yeast transcription factors Abf1, Rap1 and Mig1. Comparison of these proteins' in vitro binding sites with their in vivo binding sites indicates that PBM-derived sequence specificities can accurately reflect in vivo DNA sequence specificities. In addition to previously identified targets, Abf1, Rap1 and Mig1 bound to 107, 90 and 75 putative new target intergenic regions, respectively, many of which were upstream of previously uncharacterized open reading frames. Comparative sequence analysis indicated that many of these newly identified sites are highly conserved across five sequenced sensu stricto yeast species and, therefore, are probably functional in vivo binding sites that may be used in a condition-specific manner. Similar PBM experiments should be useful in identifying new cis regulatory elements and transcriptional regulatory networks in various genomes.	Harvard Univ, Sch Med, Dept Med, Div Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Grad Biophys Program, Boston, MA 02115 USA; Brigham & Womens Hosp, Harvard MIT Div Hlth Sci & Technol, Boston, MA 02115 USA; Yale Univ, Dept Mol Biol, New Haven, CT 06520 USA; Yale Univ, Dept Cellular Biol, New Haven, CT 06520 USA; Yale Univ, Dept Dev Biol, New Haven, CT 06520 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Yale University; Yale University; Yale University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Brigham & Women's Hospital	Bulyk, ML (corresponding author), Harvard Univ, Sch Med, Dept Med, Div Genet, Boston, MA 02115 USA.	mlbulyk@receptor.med.harvard.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Jona, Ghil/0000-0002-4526-6182	NHGRI NIH HHS [R01 HG002966, R01 HG002966-02, R01 HG003420, R01 HG003420-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002966, R01HG003420] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; Bojunga N, 1999, MOL GEN GENET, V262, P869, DOI 10.1007/s004380051152; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Bulyk ML, 2001, P NATL ACAD SCI USA, V98, P7158, DOI 10.1073/pnas.111163698; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; DESJARLAIS JR, 1992, P NATL ACAD SCI USA, V89, P7345, DOI 10.1073/pnas.89.16.7345; Doi N, 2002, GENOME RES, V12, P487, DOI 10.1101/gr.218802; Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057; Dudley AM, 2002, P NATL ACAD SCI USA, V99, P7554, DOI 10.1073/pnas.112683499; Grauslund M, 1999, NUCLEIC ACIDS RES, V27, P4391, DOI 10.1093/nar/27.22.4391; GRIGGS DW, 1991, P NATL ACAD SCI USA, V88, P8597, DOI 10.1073/pnas.88.19.8597; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartemink Alexander J, 2002, Pac Symp Biocomput, P437; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Jiang R, 1997, MOL CELL BIOL, V17, P2099, DOI 10.1128/MCB.17.4.2099; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Linnell J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh042; Liu X, 2001, Pac Symp Biocomput, P127; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Lutfiyya LL, 1998, GENETICS, V150, P1377; MacBeath G, 2000, SCIENCE, V289, P1760; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Palecek SP, 2002, MOL MICROBIOL, V45, P453, DOI 10.1046/j.1365-2958.2002.03024.x; PHILIPPAKIS A, IN PRES PAC S BIOCOM; Planta RJ, 1997, YEAST, V13, P1505, DOI 10.1002/(SICI)1097-0061(199712)13:16<1505::AID-YEA229>3.0.CO;2-I; Rae FK, 2004, ONCOGENE, V23, P3067, DOI 10.1038/sj.onc.1207360; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Robison K, 1998, J MOL BIOL, V284, P241, DOI 10.1006/jmbi.1998.2160; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sokal R.R., 2012, BIOMETRY; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tsujimoto Y, 2000, J BACTERIOL, V182, P5121, DOI 10.1128/JB.182.18.5121-5126.2000; Udalova IA, 2002, P NATL ACAD SCI USA, V99, P8167, DOI 10.1073/pnas.102674699; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wodicka L, 1997, NAT BIOTECHNOL, V15, P1359, DOI 10.1038/nbt1297-1359; Zaragoza O, 2001, BIOCHEM J, V359, P193, DOI 10.1042/0264-6021:3590193; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	49	286	295	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2004	36	12					1331	1339		10.1038/ng1473	http://dx.doi.org/10.1038/ng1473			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15543148	Green Accepted			2022-12-27	WOS:000225354100023
J	Osborne, CS; Chakalova, L; Brown, KE; Carter, D; Horton, A; Debrand, E; Goyenechea, B; Mitchell, JA; Lopes, S; Reik, W; Fraser, P				Osborne, CS; Chakalova, L; Brown, KE; Carter, D; Horton, A; Debrand, E; Goyenechea, B; Mitchell, JA; Lopes, S; Reik, W; Fraser, P			Active genes dynamically colocalize to shared sites of ongoing transcription	NATURE GENETICS			English	Article							BETA-GLOBIN LOCUS; RNA-POLYMERASE-II; CHROMOSOME TERRITORIES; IN-VIVO; CENTROMERIC HETEROCHROMATIN; INTERGENIC TRANSCRIPTION; INTERPHASE NUCLEI; EXPRESSED GENES; CHROMATIN; CELLS	The intranuclear position of many genes has been correlated with their activity state, suggesting that migration to functional subcompartments may influence gene expression. Indeed, nascent RNA production and RNA polymerase II seem to be localized into discrete foci or '`transcription factories'. Current estimates from cultured cells indicate that multiple genes could occupy the same factory, although this has not yet been observed. Here we show that, during transcription in vivo, distal genes colocalize to the same transcription factory at high frequencies. Active genes are dynamically organized into shared nuclear subcompartments, and movement into or out of these factories results in activation or abatement of transcription. Thus, rather than recruiting and assembling transcription complexes, active genes migrate to preassembled transcription sites.	Babraham Inst, Lab Chromatin & Gene Express, Cambridge CB2 4AT, England; Imperial Coll Fac Med, Chromosome Biol Grp, London W12 0NN, England; Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB2 4AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Imperial College London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Fraser, P (corresponding author), Babraham Inst, Lab Chromatin & Gene Express, Babraham Res Campus, Cambridge CB2 4AT, England.	peter.fraser@bbsrc.ac.uk	Osborne, Cameron/N-1398-2017; Fraser, Peter/B-7549-2009; Reik, Wolf/I-6794-2012; Chakalova, Lyubomira/C-6810-2012	Osborne, Cameron/0000-0003-4126-2499; Mitchell, Jennifer/0000-0002-7147-4604; Fraser, Peter/0000-0002-0041-1227; Reik, Wolf/0000-0003-0216-9881	Medical Research Council [MC_U120081295] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Brown KE, 2001, NAT CELL BIOL, V3, P602, DOI 10.1038/35078577; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chakalova L, 2004, METHOD ENZYMOL, V375, P479; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cook PR, 2002, NAT GENET, V32, P347, DOI 10.1038/ng1102-347; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DICKERMAN HW, 1976, ARCH BIOCHEM BIOPHYS, V177, P1, DOI 10.1016/0003-9861(76)90408-2; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Grande MA, 1997, J CELL SCI, V110, P1781; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Heun P, 2001, SCIENCE, V294, P2181, DOI 10.1126/science.1065366; HUNT JA, 1974, BIOCHEM J, V138, P499, DOI 10.1042/bj1380499; Iborra FJ, 1996, J CELL SCI, V109, P1427; Jackson DA, 1998, MOL BIOL CELL, V9, P1523, DOI 10.1091/mbc.9.6.1523; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; Kihm AJ, 2002, NATURE, V417, P758, DOI 10.1038/nature00803; Kimura H, 2002, J CELL BIOL, V159, P777, DOI 10.1083/jcb.200206019; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Lukasova E, 1997, HUM GENET, V100, P525, DOI 10.1007/s004390050547; Mahy NL, 2002, J CELL BIOL, V159, P753, DOI 10.1083/jcb.200207115; Mahy NL, 2002, J CELL BIOL, V157, P579, DOI 10.1083/jcb.200111071; Milot E, 1996, CELL, V87, P105, DOI 10.1016/S0092-8674(00)81327-6; Misteli T, 2001, J CELL BIOL, V155, P181, DOI 10.1083/jcb.200108110; Neves H, 1999, BLOOD, V93, P1197, DOI 10.1182/blood.V93.4.1197.404k33_1197_1207; OSHEIM YN, 1985, CELL, V43, P143, DOI 10.1016/0092-8674(85)90019-4; Parada LA, 2002, CURR BIOL, V12, P1692, DOI 10.1016/S0960-9822(02)01166-1; Ragoczy T, 2003, CHROMOSOME RES, V11, P513, DOI 10.1023/A:1024939130361; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; ROSS IL, 1994, IMMUNOL CELL BIOL, V72, P177, DOI 10.1038/icb.1994.26; Schubeler D, 2000, GENE DEV, V14, P940; Shopland LS, 2003, J CELL BIOL, V162, P981, DOI 10.1083/jcb.200303131; Solovei I, 2002, EXP CELL RES, V276, P10, DOI 10.1006/excr.2002.5513; Sutherland HGE, 1997, MOL CELL BIOL, V17, P1607, DOI 10.1128/MCB.17.3.1607; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Verschure PJ, 1999, J CELL BIOL, V147, P13, DOI 10.1083/jcb.147.1.13; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Volpi EV, 2000, J CELL SCI, V113, P1565; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Zaidi SK, 2002, P NATL ACAD SCI USA, V99, P8048, DOI 10.1073/pnas.112664499	50	782	815	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2004	36	10					1065	1071		10.1038/ng1423	http://dx.doi.org/10.1038/ng1423			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	15361872	Bronze			2022-12-27	WOS:000224156500014
J	Sparago, A; Cerrato, F; Vernucci, M; Ferrero, GB; Silengo, MC; Riccio, A				Sparago, A; Cerrato, F; Vernucci, M; Ferrero, GB; Silengo, MC; Riccio, A			Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome	NATURE GENETICS			English	Article							CTCF-BINDING-SITES; CONTROL REGION; METHYLATION; EXPRESSION; PARENT; CANCER; LOCUS; GENE	The overgrowth- and tumor-associated Beckwith-Wiedemann syndrome results from dysregulation of imprinted genes on chromosome 11p15.5. Here we show that inherited microdeletions in the H19 differentially methylated region (DMR) that abolish two CTCF target sites cause this disease. Maternal transmission of the deletions results in hypermethylation of the H19 DMR, biallelic IGF2 expression, H19 silencing and Beckwith-Wiedemann syndrome, indicative of loss of function of the IGF2-H19 imprinting control element.	Univ Naples 2, Dipartimento Sci Ambientali, I-81100 Caserta, Italy; Univ Turin, Dipartimento Sci Pediat & Adolescenza, I-10126 Turin, Italy	Universita della Campania Vanvitelli; University of Turin	Riccio, A (corresponding author), Univ Naples 2, Dipartimento Sci Ambientali, Via Vivaldi 43, I-81100 Caserta, Italy.	andrea.riccio@unina2.it	Sparago, Angela/O-8324-2015; Riccio, Andrea/AAY-7571-2020; Riccio, Andrea/A-4991-2015; Ferrero, Giovanni Battista/K-5265-2018	Sparago, Angela/0000-0003-4352-945X; Riccio, Andrea/0000-0001-7990-3576; Riccio, Andrea/0000-0001-7990-3576; Ferrero, Giovanni Battista/0000-0002-3793-5788; Silengo, Margherita/0000-0002-6255-1532				Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Eggenschwiler J, 1997, GENE DEV, V11, P3128, DOI 10.1101/gad.11.23.3128; Feinberg AP, 2002, SEMIN CANCER BIOL, V12, P389, DOI 10.1016/S1044-579X(02)00059-7; Frevel MAE, 1999, J BIOL CHEM, V274, P29331, DOI 10.1074/jbc.274.41.29331; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Maher ER, 2000, J CLIN INVEST, V105, P247, DOI 10.1172/JCI9340; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Szabo PE, 2004, MOL CELL BIOL, V24, P4791, DOI 10.1128/MCB.24.11.4791-4800.2004; Takai D, 2001, HUM MOL GENET, V10, P2619, DOI 10.1093/hmg/10.23.2619; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Weksberg R, 2003, HUM MOL GENET, V12, pR61, DOI 10.1093/hmg/ddg067	15	219	229	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					958	960		10.1038/ng1410	http://dx.doi.org/10.1038/ng1410			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15314640	Bronze			2022-12-27	WOS:000223658100021
J	Consonni, C; Humphry, ME; Hartmann, HA; Livaja, M; Durner, J; Westphal, L; Vogel, J; Lipka, V; Kemmerling, B; Schulze-Lefert, P; Somerville, SC; Panstruga, R				Consonni, Chiara; Humphry, Matthew E.; Hartmann, H. Andreas; Livaja, Maren; Durner, Jorg; Westphal, Lore; Vogel, John; Lipka, Volker; Kemmerling, Birgit; Schulze-Lefert, Paul; Somerville, Shauna C.; Panstruga, Ralph			Conserved requirement for a plant host cell protein in powdery mildew pathogenesis	NATURE GENETICS			English	Article							NONHOST RESISTANCE; DISEASE RESISTANCE; MLO RESISTANCE; SALICYLIC-ACID; BARLEY; ARABIDOPSIS; DEFENSE; GENE; SUSCEPTIBILITY; PENETRATION	In the fungal phylum Ascomycota, the ability to cause disease in plants and animals has been gained and lost repeatedly during phylogenesis(1). In monocotyledonous barley, loss-of-function mlo alleles result in effective immunity against the Ascomycete Blumeria graminis f. sp. hordei, the causal agent of powdery mildew disease(2,3). However, mlo-based disease resistance has been considered a barley-specific phenomenon to date. Here, we demonstrate a conserved requirement for MLO proteins in powdery mildew pathogenesis in the dicotyledonous plant species Arabidopsis thaliana. Epistasis analysis showed that mlo resistance in A. thaliana does not involve the signaling molecules ethylene, jasmonic acid or salicylic acid, but requires a syntaxin, glycosyl hydrolase and ABC transporter(4-6). These findings imply that a common host cell entry mechanism of powdery mildew fungi evolved once and at least 200 million years ago, suggesting that within the Erysiphales ( powdery mildews) the ability to cause disease has been a stable trait throughout phylogenesis.	Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50829 Cologne, Germany; Carnegie Inst Washington, Dept Plant Biol, Stanford, CA 94305 USA; GSF, Natl Res Ctr Environm & Hlth, Inst Biochem Plant Pathol, Dept Plant Immun, D-85754 Oberschleissheim, Germany; Inst Plant Biochem, Dept Stress & Dev Biol, D-06120 Halle, Germany; USDA, Genom & Gene Discovery Unit, Albany, CA 94710 USA; Univ Tubingen, Dept Plant Biochem, D-72076 Tubingen, Germany	Max Planck Society; Carnegie Institution for Science; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Leibniz Institut fur Pflanzenbiochemie; United States Department of Agriculture (USDA); Eberhard Karls University of Tubingen	Panstruga, R (corresponding author), Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, Carl von Linne Weg 10, D-50829 Cologne, Germany.	panstrug@mpiz-koeln.mpg.de	Vogel, John P/B-3176-2009; Schulze-Lefert, Paul/A-7746-2008; Humphry, Matthew/A-8136-2008; Humphry, Matt/E-8072-2010; Schulze-Lefert, Paul/B-6707-2011; Bruening, Stefan/B-8505-2011; Panstruga, Ralph/F-3340-2011; Lipka, Volker/C-5874-2009	Panstruga, Ralph/0000-0002-3756-8957; Vogel, John/0000-0003-1786-2689; Kemmerling, Birgit/0000-0003-1174-0189	PHS HHS [FG32 GN19499-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Berbee ML, 2001, PHYSIOL MOL PLANT P, V59, P165, DOI 10.1006/pmpp.2001.0355; Bhat RA, 2005, P NATL ACAD SCI USA, V102, P3135, DOI 10.1073/pnas.0500012102; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Devoto A, 2003, J MOL EVOL, V56, P77, DOI 10.1007/s00239-002-2382-5; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; Freialdenhoven A, 1996, PLANT CELL, V8, P5, DOI 10.1105/tpc.8.1.5; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Glazebrook J, 2001, CURR OPIN PLANT BIOL, V4, P301, DOI 10.1016/S1369-5266(00)00177-1; Jarosch B, 1999, MOL PLANT MICROBE IN, V12, P508, DOI 10.1094/MPMI.1999.12.6.508; JORGENSEN JH, 1992, EUPHYTICA, V63, P141, DOI 10.1007/BF00023919; Kumar J, 2001, PHYTOPATHOLOGY, V91, P127, DOI 10.1094/PHYTO.2001.91.2.127; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Mori Yasuhiro, 2000, Mycoscience, V41, P437, DOI 10.1007/BF02461662; Morris K, 2000, PLANT J, V23, P677, DOI 10.1046/j.1365-313x.2000.00836.x; Panstruga R, 2005, PLANT MOL BIOL, V59, P485, DOI 10.1007/s11103-005-0353-0; Panstruga R, 2005, BIOCHEM SOC T, V33, P389, DOI 10.1042/BST0330389; Peterhansel C, 1997, PLANT CELL, V9, P1397, DOI 10.1105/tpc.9.8.1397; Piffanelli P, 2004, NATURE, V430, P887, DOI 10.1038/nature02781; Piffanelli P, 2002, PLANT PHYSIOL, V129, P1076, DOI 10.1104/pp.010954; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; van Wees SCM, 2003, PLANT J, V33, P733, DOI 10.1046/j.1365-313X.2003.01665.x; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; Vogel JP, 2004, PLANT J, V40, P968, DOI 10.1111/j.1365-313X.2004.02264.x; Vogel JP, 2002, PLANT CELL, V14, P2095, DOI 10.1105/tpc.003509; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; WOLTER M, 1993, MOL GEN GENET, V239, P122, DOI 10.1007/BF00281610; Xu ZW, 2004, PLANT MOL BIOL, V55, P343, DOI 10.1007/s11103-004-0790-1	28	342	381	8	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					716	720		10.1038/ng1806	http://dx.doi.org/10.1038/ng1806			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16732289	Green Published			2022-12-27	WOS:000237954800029
J	Rajewsky, N				Rajewsky, Nikolaus			microRNA target predictions in animals	NATURE GENETICS			English	Article							MESSENGER-RNA; MAMMALIAN MICRORNAS; GENE-EXPRESSION; C. ELEGANS; DATABASE; COMPLEMENTARY; DEADENYLATION; REPRESSION; DROSOPHILA; ZEBRAFISH	In recent years, microRNAs (miRNAs) have emerged as a major class of regulatory genes, present in most metazoans and important for a diverse range of biological functions. Because experimental identification of miRNA targets is difficult, there has been an explosion of computational target predictions. Although the initial round of predictions resulted in very diverse results, subsequent computational and experimental analyses suggested that at least a certain class of conserved miRNA targets can be confidently predicted and that this class of targets is large, covering, for example, at least 30% of all human genes when considering about 60 conserved vertebrate miRNA gene families. Most recent approaches have also shown that there are correlations between domains of miRNA expression and mRNA levels of their targets. Our understanding of miRNA function is still extremely limited, but it may be that by integrating mRNA and miRNA sequence and expression data with other comparative genomic data, we will be able to gain global and yet specific insights into the function and evolution of a broad layer of post-transcriptional control.	NYU, Dept Biol, Ctr Comparat Funct Gen, New York, NY 10003 USA	New York University	Rajewsky, N (corresponding author), NYU, Dept Biol, Ctr Comparat Funct Gen, 100 Washington Sq E, New York, NY 10003 USA.	nikolaus.rajewsky@nyu.edu	Huang, H/E-9490-2010	Rajewsky, Nikolaus/0000-0002-4785-4332				Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Burgler C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-88; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Chan CS, 2005, PLOS COMPUT BIOL, V1, P564, DOI 10.1371/journal.pcbi.0010069; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Enright AJ, 2004, GENOME BIOL, V5; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Foat BC, 2005, P NATL ACAD SCI USA, V102, P17675, DOI 10.1073/pnas.0503803102; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Hammond SM, 2006, NAT METHODS, V3, P12, DOI 10.1038/nmeth0106-12; Hsu PWC, 2006, NUCLEIC ACIDS RES, V34, pD135, DOI 10.1093/nar/gkj135; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Montgomery SB, 2006, BIOINFORMATICS, V22, P637, DOI 10.1093/bioinformatics/btk027; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Robins H, 2005, P NATL ACAD SCI USA, V102, P15557, DOI 10.1073/pnas.0507443102; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Shahi P, 2006, NUCLEIC ACIDS RES, V34, pD115, DOI 10.1093/nar/gkj093; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Watanabe Y, 2006, GENE, V365, P2, DOI 10.1016/j.gene.2005.09.035; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	48	861	921	0	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38			6			S8	S13		10.1038/ng1798	http://dx.doi.org/10.1038/ng1798			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V44DK	16736023				2022-12-27	WOS:000202983200003
J	Weiss, LA; Pan, L; Abney, M; Ober, C				Weiss, LA; Pan, L; Abney, M; Ober, C			The sex-specific genetic architecture of quantitative traits in humans	NATURE GENETICS			English	Article							WHOLE-BLOOD SEROTONIN; FOUNDER POPULATION; LINKAGE ANALYSIS; SUSCEPTIBILITY ALLELES; GENDER-DIFFERENCES; LOCI; HOMOZYGOSITY; ASSOCIATION; EXPRESSION; DEPRESSION	Mapping genetically complex traits remains one of the greatest challenges in human genetics today. In particular, gene-environment and gene-gene interactions, genetic heterogeneity and incomplete penetrance make thorough genetic dissection of complex traits difficult, if not impossible. Sex could be considered an environmental factor that can modify both penetrance and expressivity of a wide variety of traits. Sex is easily determined and has measurable effects on recognizable morphology; neurobiological circuits; susceptibility to autoimmune disease, diabetes, asthma, cardiovascular and psychiatric disease; and quantitative traits like blood pressure, obesity and lipid levels, among others. In this study, we evaluated sex-specific heritability and genome-wide linkages for 17 quantitative traits in the Hutterites. The results of this study could have important implications for mapping complex trait genes.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Chicago	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	c-ober@genetics.uchicago.edu		Ober, Carole/0000-0003-4626-9809				Abney M, 2000, AM J HUM GENET, V66, P629, DOI 10.1086/302759; Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; Abney MA, 2000, AM J HUM GENET, V67, P327; Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; Cairney J, 2002, SOC PSYCH PSYCH EPID, V37, P401, DOI 10.1007/s00127-002-0569-0; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chen Y, 2003, J CLIN EPIDEMIOL, V56, P180, DOI 10.1016/S0895-4356(02)00593-0; Fisher SA, 2002, EUR J HUM GENET, V10, P259, DOI 10.1038/sj.ejhg.5200792; Fullerton J, 2003, AM J HUM GENET, V72, P879, DOI 10.1086/374178; Korstanje R, 2004, J LIPID RES, V45, P881, DOI 10.1194/jlr.M300460-JLR200; Kurina LM, 2005, J CLIN ENDOCR METAB, V90, P4747, DOI 10.1210/jc.2005-0384; Loughlin J, 2000, RHEUMATOLOGY, V39, P377, DOI 10.1093/rheumatology/39.4.377; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Newman DL, 2004, EUR J HUM GENET, V12, P584, DOI 10.1038/sj.ejhg.5201191; Newman DL, 2003, HUM MOL GENET, V12, P137, DOI 10.1093/hmg/ddg012; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stone JL, 2004, AM J HUM GENET, V75, P1117, DOI 10.1086/426034; Stromberg Anna, 2003, Eur J Cardiovasc Nurs, V2, P7; Towne B, 1997, GENET EPIDEMIOL, V14, P1053, DOI 10.1002/(SICI)1098-2272(1997)14:6<1053::AID-GEPI82>3.0.CO;2-G; Ueno T, 2004, PHYSIOL GENOMICS, V17, P38, DOI 10.1152/physiolgenomics.00043.2003; Weiss LA, 2005, HUM GENET, V117, P81, DOI 10.1007/s00439-004-1250-3; Weiss LA, 2005, AM J HUM GENET, V76, P33, DOI 10.1086/426697; Weiss LA, 2004, EUR J HUM GENET, V12, P949, DOI 10.1038/sj.ejhg.5201239; Williams AJK, 2003, DIABETOLOGIA, V46, P1354, DOI 10.1007/s00125-003-1197-2; Woods SC, 2003, EXP BIOL MED, V228, P1175; Zubenko GS, 2003, AM J MED GENET B, V123B, P1, DOI 10.1002/ajmg.b.20073	30	311	318	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					218	222		10.1038/ng1726	http://dx.doi.org/10.1038/ng1726			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16429159				2022-12-27	WOS:000234953200018
J	Glaser, S; Anastassiadis, K; Stewart, AF				Glaser, S; Anastassiadis, K; Stewart, AF			Current issues in mouse genome engineering	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; ES CELLS; FUNCTIONAL-ANALYSIS; RNA INTERFERENCE; CRE RECOMBINASE; LARGE-SCALE; WILD-TYPE; DNA; MICE; MULTIPURPOSE	The mouse is the foremost vertebrate experimental model because its genome can be precisely and variously engineered. Now that the mouse genome has been sequenced and annotated, the task of mutating each gene is feasible, and an international cooperation is providing mutated embryonic stem cells and mice as readily available resources. Because these resources will change biomedical research, decisions about their nature will have far-reaching effects. It is therefore timely to consider topical issues for mouse genome engineering, such as the background genotype; homologous, site-specific and transpositional recombination; conditional mutagenesis; RNA-mediated interference; and functional genomics with embryonic stem cells.	Tech Univ Dresden, Bioinnovat Zentrum, D-01307 Dresden, Germany	Technische Universitat Dresden	Stewart, AF (corresponding author), Tech Univ Dresden, Bioinnovat Zentrum, Tatzberg 47, D-01307 Dresden, Germany.	stewart@biotec.tu-dresden.de	Anastassiadis, Konstantinos/A-8944-2010; Stewart, A. Francis/E-7789-2010	Anastassiadis, Konstantinos/0000-0002-9814-0559; 				Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; ALBERT H, 1995, PLANT J, V7, P649, DOI 10.1046/j.1365-313X.1995.7040649.x; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Auwerx J, 2004, NAT GENET, V36, P925, DOI 10.1038/ng0904-925; Baer A, 2001, CURR OPIN BIOTECH, V12, P473, DOI 10.1016/S0958-1669(00)00248-2; Belteki G, 2003, NAT BIOTECHNOL, V21, P321, DOI 10.1038/nbt787; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bestor TH, 2005, CELL, V122, P322, DOI 10.1016/j.cell.2005.07.024; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Buehr M, 2003, PHILOS T R SOC B, V358, P1397, DOI 10.1098/rstb.2003.1327; Chen YJ, 2000, NAT GENET, V24, P314, DOI 10.1038/73557; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Corcoran LM, 1999, J IMMUNOL, V163, P5836; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Drabek D, 2003, GENOMICS, V81, P108, DOI 10.1016/S0888-7543(02)00030-7; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Eggan K, 2003, METHOD ENZYMOL, V365, P25; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Forster A, 2003, CANCER CELL, V3, P449, DOI 10.1016/S1535-6108(03)00106-5; Fraser AG, 2004, NAT GENET, V36, P559, DOI 10.1038/ng1370; Gardner RL, 1997, INT J DEV BIOL, V41, P235; Greber B, 2005, GENOMICS, V85, P557, DOI 10.1016/j.ygeno.2005.01.011; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hansen J, 2003, P NATL ACAD SCI USA, V100, P9918, DOI 10.1073/pnas.1633296100; HASTY P, 1991, MOL CELL BIOL, V11, P5586, DOI 10.1128/MCB.11.11.5586; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; Largaespada David A, 2003, Reprod Biol Endocrinol, V1, P80, DOI 10.1186/1477-7827-1-80; Lefebvre L, 2001, NAT GENET, V27, P257, DOI 10.1038/85808; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; LOGIE C, 1995, P NATL ACAD SCI USA, V92, P5940, DOI 10.1073/pnas.92.13.5940; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Luo JL, 2001, ONCOGENE, V20, P320, DOI 10.1038/sj.onc.1204080; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; Miskey C, 2005, CELL MOL LIFE SCI, V62, P629, DOI 10.1007/s00018-004-4232-7; MOENS CB, 1992, GENE DEV, V6, P691, DOI 10.1101/gad.6.5.691; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; ORAM M, 1995, CURR BIOL, V5, P1106, DOI 10.1016/S0960-9822(95)00222-3; RIELE HT, 1992, P NATL ACAD SCI USA, V89, P5128, DOI 10.1073/pnas.89.11.5128; Ringrose L, 1999, EMBO J, V18, P6630, DOI 10.1093/emboj/18.23.6630; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sauer B, 2004, NUCLEIC ACIDS RES, V32, P6086, DOI 10.1093/nar/gkh941; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297; Schnutgen F, 2005, P NATL ACAD SCI USA, V102, P7221, DOI 10.1073/pnas.0502273102; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Seibler J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni065; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Seong E, 2004, TRENDS GENET, V20, P59, DOI 10.1016/j.tig.2003.12.006; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Smith MCM, 2002, MOL MICROBIOL, V44, P299, DOI 10.1046/j.1365-2958.2002.02891.x; Spitz F, 2005, NAT GENET, V37, P889, DOI 10.1038/ng1597; Tanaka M, 2000, METH MOL B, V158, P135; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Testa G, 2003, NAT BIOTECHNOL, V21, P443, DOI 10.1038/nbt804; THOMAS KR, 1992, MOL CELL BIOL, V12, P2919, DOI 10.1128/MCB.12.7.2919; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Van der Weyden L, 2002, PHYSIOL GENOMICS, V11, P133, DOI 10.1152/physiolgenomics.00074.2002; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; VONMELCHNER H, 2004, HDB STEM CELLS, V1, P609; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Yang Y, 2003, NAT BIOTECHNOL, V21, P447, DOI 10.1038/nbt803; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449; Zheng BH, 1999, NAT GENET, V22, P375, DOI 10.1038/11949; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	75	124	149	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1187	1193		10.1038/ng1668	http://dx.doi.org/10.1038/ng1668			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16254565				2022-12-27	WOS:000233045200015
J	Kuhlenbaumer, G; Hannibal, MC; Nelis, E; Schirmacher, A; Verpoorten, N; Meuleman, J; Watts, GDJ; De Vriendt, E; Young, P; Stogbauer, F; Halfter, H; Irobi, J; Goossens, D; Del-Favero, J; Betz, BG; Hor, H; Kurlemann, G; Bird, TD; Airaksinen, E; Mononen, T; Serradell, AP; Prats, JM; Van Broeckhoven, C; De Jonghe, P; Timmerman, V; Ringelstein, EB; Chance, PF				Kuhlenbaumer, G; Hannibal, MC; Nelis, E; Schirmacher, A; Verpoorten, N; Meuleman, J; Watts, GDJ; De Vriendt, E; Young, P; Stogbauer, F; Halfter, H; Irobi, J; Goossens, D; Del-Favero, J; Betz, BG; Hor, H; Kurlemann, G; Bird, TD; Airaksinen, E; Mononen, T; Serradell, AP; Prats, JM; Van Broeckhoven, C; De Jonghe, P; Timmerman, V; Ringelstein, EB; Chance, PF			Mutations in SEPT9 cause hereditary neuralgic amyotrophy	NATURE GENETICS			English	Article							MAMMALIAN SEPTIN; CHROMOSOME 17Q25; HNA LOCUS; MICROTUBULES; REFINEMENT; GENE	Hereditary neuralgic amyotrophy (HNA) is an autosomal dominant recurrent neuropathy affecting the brachial plexus. HNA is triggered by environmental factors such as infection or parturition. We report three mutations in the gene septin 9 (SEPT9) in six families with HNA linked to chromosome 17q25. HNA is the first monogenetic disease caused by mutations in a gene of the septin family. Septins are implicated in formation of the cytoskeleton, cell division and tumorigenesis.	Univ Munster, Dept Neurol, D-48149 Munster, Germany; Univ Munster, Leibniz Inst Atherosclerosis Res, D-48149 Munster, Germany; Univ Antwerp VIB, Dept Mol Genet, B-2020 Antwerp, Belgium; Univ Washington, Dept Pediat, Div Genet & Dev Med, Seattle, WA 98195 USA; Univ Munster, Dept Pediat Neurol, D-4400 Munster, Germany; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; Univ Kuopio, Dept Paediat, FIN-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Clin Genet, SF-70210 Kuopio, Finland; Autonome Univ Barcelona, Hosp Mar, Dept Neurol, Barcelona, Spain; Hosp Cruces, Div Child Neurol, Baracaldo, Basque Country, Spain; Univ Antwerp Hosp, Div Neurol, Antwerp, Belgium	University of Munster; University of Munster; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Washington; University of Washington Seattle; University of Munster; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Hospital Universitario Cruces; University of Antwerp	Kuhlenbaumer, G (corresponding author), Univ Munster, Dept Neurol, Domagkstr 3, D-48149 Munster, Germany.	gkuhlen@uni-muenster.de	Chance, Phillip/AAX-5826-2020; Van Broeckhoven, Christine/G-8362-2017; Van Broeckhoven, Christine/M-7853-2019; Kuhlenbäumer, Gregor/A-5110-2009; Timmerman, Vincent/O-7283-2019	Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Timmerman, Vincent/0000-0002-2162-0933; Goossens, Dirk/0000-0002-2080-7464; Hannibal, Mark/0000-0002-9077-3837; Del Favero, jurgen/0000-0002-7427-7489				Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Meuleman J, 2001, HUM GENET, V108, P390; Meuleman J, 1999, EUR J HUM GENET, V7, P920, DOI 10.1038/sj.ejhg.5200384; Montagna C, 2003, CANCER RES, V63, P2179; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Nagata K, 2003, J BIOL CHEM, V278, P18538, DOI 10.1074/jbc.M205246200; Nagata KI, 2005, ONCOGENE, V24, P65, DOI 10.1038/sj.onc.1208101; Pellegrino JE, 1997, HUM GENET, V101, P277, DOI 10.1007/s004390050629; Pellegrino JE, 1996, NEUROLOGY, V46, P1128, DOI 10.1212/WNL.46.4.1128; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Watts GDJ, 2002, HUM GENET, V110, P166, DOI 10.1007/s00439-001-0647-5; WINDEBANK AJ, 1993, PERIPHERAL NEUROPATH, V2, P1137	12	151	163	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1044	1046		10.1038/ng1649	http://dx.doi.org/10.1038/ng1649			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16186812				2022-12-27	WOS:000232185600014
J	Tsuge, M; Hamamoto, R; Silva, FP; Ohnishi, Y; Chayama, K; Kamatani, N; Furukawa, Y; Nakamura, Y				Tsuge, M; Hamamoto, R; Silva, FP; Ohnishi, Y; Chayama, K; Kamatani, N; Furukawa, Y; Nakamura, Y			A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5 ' flanking region of SMYD3 is a risk factor for human cancers	NATURE GENETICS			English	Article							BREAST-CANCER; GENE PROMOTER; VNTR MARKERS; ASSOCIATION; PROLIFERATION; METHYLATION; UPSTREAM; PATTERNS; PATHWAY; FAMILY	Histone modification is a crucial step in transcriptional regulation, and deregulation of the modification process is important in human carcinogenesis. We previously reported that upregulation of SMYD3, a histone methyltransferase, promoted cell growth in human colorectal and hepatocellular carcinomas. Here we report significant associations between homozygosity with respect to an allele with three tandem repeats of a CCGCC unit in the regulatory region of SMYD3 and increased risk of colorectal cancer (P = 9.1 x 10(-6), odds ratio 2.58), hepatocellular carcinoma (P = 2.3 x 10(-8), odds ratio 3.50) and breast cancer (P = 7.0 x 10(-10), odds ratio 4.48). This tandem-repeat sequence is a binding site for the transcriptional factor E2F-1. In a reporter assay, plasmids containing three repeats of the binding motif (corresponding to the high-risk allele) had higher activity than plasmids containing two repeats (the low-risk allele). These data suggest that the common variable number of tandem repeats polymorphism in SMYD3 is a susceptibility factor for some types of human cancer.	Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, Tokyo 1088639, Japan; Hiroshima Univ, Grad Sch Biomed Sci, Dept Med & Mol Sci,Div Frontier Med Sci, Programs Biomed Res,Minami Ku, Hiroshima 7348551, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab SNP Anal,Minato Ku, Tokyo 1088639, Japan; Tokyo Womens Med Univ, Inst Rheumatol, Shinjuku Ku, Tokyo 1620054, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Promot Genome Based Med Project,Minato Ku, Tokyo 1088639, Japan	University of Tokyo; Hiroshima University; RIKEN; Tokyo Women's Medical University; University of Tokyo	Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	yusuke@ims.u-tokyo.ac.jp	Silva, Fabio Pittella/B-2621-2013; Hamamoto, Ryuji/AAF-9600-2019; Tsuge, Masataka/G-5246-2019	Silva, Fabio Pittella/0000-0002-9644-7098; Hamamoto, Ryuji/0000-0002-2632-1334; Tsuge, Masataka/0000-0001-7591-8287; Chayama, Kazuaki/0000-0002-5530-5341				Bell LA, 2004, CELL DEATH DIFFER, V11, P137, DOI 10.1038/sj.cdd.4401324; Bernstein NA, 1999, MOTOR CONTROL, V3, P4; Black AR, 1999, GENE, V237, P281, DOI 10.1016/S0378-1119(99)00305-4; Boggs BA, 2002, NAT GENET, V30, P73, DOI 10.1038/ng787; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Cai QY, 2003, CANCER RES, V63, P5727; de la Moureyre CSV, 1999, PHARMACOGENETICS, V9, P189; De Vivo I, 2003, CANCER RES, V63, P5236; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Krippl P, 2004, CLIN CANCER RES, V10, P3518, DOI 10.1158/1078-0432.CCR-04-0010; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Nakamura Y, 1998, J HUM GENET, V43, P149, DOI 10.1007/s100380050059; NAKAMURA Y, 1988, AM J HUM GENET, V43, P854; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; Okabe H, 2003, CANCER RES, V63, P3043; Phillips AC, 2001, APOPTOSIS, V6, P173, DOI 10.1023/A:1011332625740; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Tang CJC, 2001, J BIOL CHEM, V276, P19631, DOI 10.1074/jbc.M100170200; Zehbe I, 1999, LANCET, V354, P218, DOI 10.1016/S0140-6736(99)01914-5	22	96	112	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1104	1107		10.1038/ng1638	http://dx.doi.org/10.1038/ng1638			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16155568				2022-12-27	WOS:000232185600022
J	Chesler, EJ; Lu, L; Shou, SM; Qu, YH; Gu, J; Wang, JT; Hsu, HC; Mountz, JD; Baldwin, NE; Langston, MA; Threadgill, DW; Manly, KF; Williams, RW				Chesler, EJ; Lu, L; Shou, SM; Qu, YH; Gu, J; Wang, JT; Hsu, HC; Mountz, JD; Baldwin, NE; Langston, MA; Threadgill, DW; Manly, KF; Williams, RW			Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function	NATURE GENETICS			English	Article							LOCOMOTOR-ACTIVITY; MOUSE; BXD; ETHANOL; GENOMICS; LOCI; IDENTIFICATION; LOCALIZATION; HIPPOCAMPUS; DISSECTION	Patterns of gene expression in the central nervous system are highly variable and heritable. This genetic variation among normal individuals leads to considerable structural, functional and behavioral differences. We devised a general approach to dissect genetic networks systematically across biological scale, from base pairs to behavior, using a reference population of recombinant inbred strains. We profiled gene expression using Affymetrix oligonucleotide arrays in the BXD recombinant inbred strains, for which we have extensive SNP and haplotype data. We integrated a complementary database comprising 25 years of legacy phenotypic data on these strains. Covariance among gene expression and pharmacological and behavioral traits is often highly significant, corroborates known functional relations and is often generated by common quantitative trait loci. We found that a small number of major-effect quantitative trait loci jointly modulated large sets of transcripts and classical neural phenotypes in patterns specific to each tissue. We developed new analytic and graph theoretical approaches to study shared genetic modulation of networks of traits using gene sets involved in neural synapse function as an example. We built these tools into an open web resource called WebQTL that can be used to test a broad array of hypotheses.	Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA; Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; Univ Tennessee, Dept Comp Sci, Knoxville, TN 37996 USA; Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Alabama System; University of Alabama Birmingham; University of Tennessee System; University of Tennessee Knoxville; University of North Carolina; University of North Carolina Chapel Hill	Williams, RW (corresponding author), Univ Tennessee, Ctr Hlth Sci, 855 Monroe Ave, Memphis, TN 38163 USA.	rwilliam@nb.utmem.edu	Threadgill, David W/N-4425-2013; Langston, Michael/A-9484-2011; Chesler, Elissa/K-4641-2019; Williams, Robert W./H-8789-2016	Threadgill, David W/0000-0003-3538-1635; Chesler, Elissa/0000-0002-5642-5062; Williams, Robert W./0000-0001-8924-4447				Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BALDWIN NE, IN PRESS J BIOMED BI; Bartoli M, 1999, J NEUROBIOL, V40, P234, DOI 10.1002/(SICI)1097-4695(199908)40:2<234::AID-NEU9>3.3.CO;2-K; Becamel C, 2002, EMBO J, V21, P2332, DOI 10.1093/emboj/21.10.2332; Belknap JK, 1998, BEHAV GENET, V28, P29, DOI 10.1023/A:1021404714631; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chesler EJ, 2004, INT REV NEUROBIOL, V60, P59; Chesler EJ, 2004, NAT NEUROSCI, V7, P485, DOI 10.1038/nn0504-485; Chesler EJ, 2003, NEUROINFORMATICS, V1, P343, DOI 10.1385/NI:1:4:343; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; CHURCHILL GA, 1994, GENETICS, V138, P963; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; CRABBE JC, 1983, NEUROBEH TOXICOL TER, V5, P181; CUNNINGHAM CL, 1995, PSYCHOPHARMACOLOGY, V120, P28, DOI 10.1007/BF02246142; Flint J, 2003, J NEUROBIOL, V54, P46, DOI 10.1002/neu.10161; Hitzemann R, 2003, ALCOHOL CLIN EXP RES, V27, P1, DOI 10.1097/01.ALC.000047862.40562.27; HUTSON AD, 2002, BOOTSTRAP SMOOTHING; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jones BC, 2003, NUTR NEUROSCI, V6, P369, DOI 10.1080/10284150310001624192; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; Li X, 2001, MAMM GENOME, V12, P13, DOI 10.1007/s003350010236; Lu L, 2001, J NEUROSCI, V21, P3503, DOI 10.1523/JNEUROSCI.21-10-03503.2001; Manly KF, 2004, GENOME RES, V14, P997, DOI 10.1101/gr.2156804; Mogil JS, 2003, P NATL ACAD SCI USA, V100, P4867, DOI 10.1073/pnas.0730053100; Paigen K, 2000, MAMM GENOME, V11, P715, DOI 10.1007/s003350010152; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Peirce JL, 2003, GENES BRAIN BEHAV, V2, P238, DOI 10.1034/j.1601-183X.2003.00030.x; PHILLIPS TJ, 1994, ALCOHOL CLIN EXP RES, V18, P931, DOI 10.1111/j.1530-0277.1994.tb00062.x; PHILLIPS TJ, 1995, ALCOHOL CLIN EXP RES, V19, P269, DOI 10.1111/j.1530-0277.1995.tb01502.x; Rikke BA, 1998, MAMM GENOME, V9, P963, DOI 10.1007/s003359900907; Risinger FO, 1998, ALCOHOL CLIN EXP RES, V22, P1234, DOI 10.1111/j.1530-0277.1998.tb03904.x; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Shirley RL, 2004, NAT NEUROSCI, V7, P699, DOI 10.1038/nn1271; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Threadgill DW, 2002, MAMM GENOME, V13, P175, DOI 10.1007/s00335-001-4001-Y; Visscher PM, 1999, GENET RES, V74, P81, DOI 10.1017/S0016672399003857; Visscher PM, 1996, GENETICS, V143, P1013; Wang JT, 2003, NEUROINFORMATICS, V1, P299, DOI 10.1385/NI:1:4:299; WILLIAMS RW, 2002, GENOME BIOL, V2; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Zhang B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-16	50	543	559	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					233	242		10.1038/ng1518	http://dx.doi.org/10.1038/ng1518			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15711545				2022-12-27	WOS:000227297800014
J	Lee, Y; Lee, Y; Lee, J; Bang, S; Hyun, S; Kang, J; Hong, ST; Bae, E; Kaang, BK; Kim, J				Lee, Y; Lee, Y; Lee, J; Bang, S; Hyun, S; Kang, J; Hong, ST; Bae, E; Kaang, BK; Kim, J			Pyrexia is a new thermal transient receptor potential channel endowing tolerance to high temperatures in Drosophila melanogaster	NATURE GENETICS			English	Article							HEAT-EVOKED ACTIVATION; CAPSAICIN-RECEPTOR; EXPRESSION SYSTEM; TRP CHANNEL; ION-CHANNEL; THERMOSENSATION; IDENTIFICATION; NOCICEPTION; PROTEIN; NEURONS	Several transient receptor potential channels were recently found to be activated by temperature stimuli in vitro(1-1)4. Their physiological and behavioral roles are largely unknown. From a temperature-preference behavior screen of 27, 000 Drosophila melanogaster P-insertion mutants, we isolated a gene, named pyrexia (pyx), encoding a new transient receptor potential channel. Pyx was opened by temperatures above 40 degreesC in Xenopus laevis oocytes and HEK293T cells. It was ubiquitously expressed along the dendrites of a subset of peripheral nervous system neurons and was more permeable to K+ than to Na+. Although some pyx alleles resulted in abnormal temperature preferences, pyx null flies did not have significantly different temperature preferences than wild-type flies. But 60% of pyx null flies were paralyzed within 3 min of exposure to 40 degreesC, whereas only 9% of wild-type flies were paralyzed by the same stimulus. From these findings, we propose that the primary in vivo role of Pyx is to protect flies from high-temperature stress.	Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; Seoul Natl Univ, Div Biol Sci, Seoul 151742, South Korea; Korea Adv Inst Sci & Technol, GenExel Inc, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST)	Kim, J (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 373-1 Guseong Dong, Taejon 305701, South Korea.	kjaeseob@kaist.ac.kr	Kang, Jongkyun/AAT-7581-2021	Kang, Jongkyun/0000-0003-0259-110X; Lee, Youngseok/0000-0003-0459-1138; Hong, Sung-Tae/0000-0001-5981-4859				Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Gilchrist GW, 1999, HEREDITY, V83, P15, DOI 10.1038/sj.hdy.6885330; Guler AD, 2002, J NEUROSCI, V22, P6408; HEIINRICH B, 1993, HOT BLOODED INSECTS; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Lee Y, 2003, J NEUROSCI RES, V73, P255, DOI 10.1002/jnr.10652; Liu L, 2003, NAT NEUROSCI, V6, P267, DOI 10.1038/nn1009; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Sayeed O, 1996, P NATL ACAD SCI USA, V93, P6079, DOI 10.1073/pnas.93.12.6079; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882	21	137	147	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					305	310		10.1038/ng1513	http://dx.doi.org/10.1038/ng1513			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15731759				2022-12-27	WOS:000227297800023
J	Cornett, J; Cao, FK; Wang, CE; Ross, CA; Bates, GP; Li, SH; Li, XJ				Cornett, J; Cao, FK; Wang, CE; Ross, CA; Bates, GP; Li, SH; Li, XJ			Polyglutamine expansion of huntingtin impairs its nuclear export	NATURE GENETICS			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; PORE COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN; DISEASE; BRAIN; TPR; GENE; IDENTIFICATION; ABNORMALITIES	Proteins with polyglutamine (polyQ) expansions accumulate in the nucleus and affect gene expression(1,2). The mechanism by which mutant huntingtin (htt) accumulates intranuclearly is not known; wild-type htt, a 350-kDa protein of unknown function, is normally found in the cytoplasm(3-5).N-terminal fragments of mutant htt, which contain a polyQ expansion (>37 glutamines), have no conserved nuclear localization sequences or nuclear export sequences but can accumulate in the nucleus and cause neurological problems in transgenic mice(6,7). Here we report that N-terminal htt shuttles between the cytoplasm and nucleus in a Ran GTPase-independent manner. Small N-terminal htt fragments interact with the nuclear pore protein translocated promoter region(Tpr), which is involved in nuclear export. PolyQ expansion and aggregation decrease this interaction and increase the nuclear accumulation of htt. Reducing the expression of Tpr by RNA interference or deletion of ten amino acids of N-terminal htt, which are essential for the interaction of htt with Tpr, increased the nuclear accumulation of htt. These results suggest that Tpr has a role in the nuclear export of N-terminal htt and that polyQ expansion reduces this nuclear export to cause the nuclear accumulation of htt.	Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Univ London Kings Coll, Guys Hosp, GKT Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England	Emory University; Johns Hopkins University; Johns Hopkins University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Li, XJ (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	xiaoli@genetics.emory.edu	Bates, Gillian/E-1146-2012	Bates, Gillian/0000-0002-4041-6305				Boche I, 1997, J CELL BIOL, V139, P313, DOI 10.1083/jcb.139.2.313; BYRD DA, 1994, J CELL BIOL, V127, P1515, DOI 10.1083/jcb.127.6.1515; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Jackson WS, 2003, HUM MOL GENET, V12, P1621, DOI 10.1093/hmg/ddg163; Kaytor MD, 2004, J NEUROCHEM, V89, P962, DOI 10.1111/j.1471-4159.2004.02376.x; Kose S, 1999, J BIOL CHEM, V274, P3946, DOI 10.1074/jbc.274.7.3946; Kuznetsov NV, 2002, CHROMOSOMA, V111, P236, DOI 10.1007/s00412-002-0208-2; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; OHTSUBO M, 1987, GENE DEV, V1, P585, DOI 10.1101/gad.1.6.585; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; SHARP AH, 1995, NEURON, V14, P1065, DOI 10.1016/0896-6273(95)90345-3; Shibata S, 2002, GENES CELLS, V7, P421, DOI 10.1046/j.1365-2443.2002.00525.x; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Xia JR, 2003, HUM MOL GENET, V12, P1393, DOI 10.1093/hmg/ddg156; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119; Zhou H, 2003, J CELL BIOL, V163, P109, DOI 10.1083/jcb.200306038; Zhou H, 2001, J BIOL CHEM, V276, P48417, DOI 10.1074/jbc.M104140200; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	29	132	137	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					198	204		10.1038/ng1503	http://dx.doi.org/10.1038/ng1503			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	15654337				2022-12-27	WOS:000226690100029
J	Tate, SK; Goldstein, DB				Tate, SK; Goldstein, DB			Will tomorrow's medicines work for everyone?	NATURE GENETICS			English	Review							BLOOD-PRESSURE RESPONSE; ACUTE LYMPHOBLASTIC-LEUKEMIA; CONVERTING-ENZYME-INHIBITOR; CELL LUNG-CANCER; HLA-B REGION; RACIAL-DIFFERENCES; ETHNIC-DIFFERENCES; ANTIHYPERTENSIVE RESPONSE; MULTIDRUG-RESISTANCE; ENDOTHELIAL FUNCTION	Throughout much of the world, 'race' and 'ethnicity' are key determinants of health. For example, African Americans have, by some estimates, a twofold higher incidence of fatal heart attacks and a 10% higher incidence of cancer(1,2) than European Americans, and South Asian- or Caribbean-born British are similar to3.5 times as likely to die as a direct result of diabetes than are British of European ancestry(3). The health care that people receive also depends on 'race' and 'ethnicity'. African Americans are less likely to receive cancer-screening services and more likely to have late-stage cancer when diagnosed(2) than European Americans. Health disparities such as these are one of the greatest social injustices in the developed world and one of the most important scientific and political challenges.	UCL, Dept Biol, London WC1E 6BT, England	University of London; University College London	Goldstein, DB (corresponding author), UCL, Dept Biol, Darwin Bldg,Gower St, London WC1E 6BT, England.	d.goldstein@ucl.ac.uk	Goldstein, David/AAY-8125-2020					*AG HEALTHC RES QU, NAT HEALTHC DISP REP; Aviv A, 1996, Ethn Health, V1, P275; Bhatia S, 2002, BLOOD, V100, P1957, DOI 10.1182/blood-2002-02-0395; Bjornsson TD, 2003, J CLIN PHARMACOL, V43, P943, DOI 10.1177/0091270003256065; Blann A, 1999, BRIT J HAEMATOL, V107, P207, DOI 10.1046/j.1365-2141.1999.01672.x; Blann A, 2004, J THROMB HAEMOST, V2, P525, DOI 10.1111/j.1538-7933.2003.00620.x; Bradford LD, 2002, PHARMACOGENOMICS, V3, P229, DOI 10.1517/14622416.3.2.229; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Cardillo C, 1999, CIRCULATION, V99, P90, DOI 10.1161/01.CIR.99.1.90; Carson P, 1999, J Card Fail, V5, P178, DOI 10.1016/S1071-9164(99)90001-5; Cepeda MS, 2001, CLIN PHARMACOL THER, V70, P351, DOI 10.1016/S0009-9236(01)45600-1; Chapman AB, 2002, KIDNEY INT, V61, P1047, DOI 10.1046/j.1523-1755.2002.00200.x; CHUNG H, 1995, PSYCHIATR SERV, V46, P586; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; COHN JN, 1991, NEW ENGL J MED, V325, P303, DOI 10.1056/NEJM199108013250502; Collazo Y, 1996, MT SINAI J MED, V63, P310; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Cooper RS, 2001, INT J EPIDEMIOL, V30, pS48, DOI 10.1093/ije/30.suppl_1.S48; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CUBEDDU LX, 1986, JAMA-J AM MED ASSOC, V256, P2214, DOI 10.1001/jama.256.16.2214; Cushman WC, 2000, ARCH INTERN MED, V160, P825, DOI 10.1001/archinte.160.6.825; Danoff TM, 2004, PHARMACOGENOMICS J, V4, P49, DOI 10.1038/sj.tpj.6500221; De Maria N, 2002, HEPATO-GASTROENTEROL, V49, P788; Drazen JM, 1999, NAT GENET, V22, P168, DOI 10.1038/9680; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; Evans DA, 2003, ARCH NEUROL-CHICAGO, V60, P185, DOI 10.1001/archneur.60.2.185; Evelyn B, 2001, J NATL MED ASSOC, V93, p18S; Exner DV, 2001, NEW ENGL J MED, V344, P1351, DOI 10.1056/NEJM200105033441802; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fellay J, 2002, LANCET, V359, P30, DOI 10.1016/S0140-6736(02)07276-8; Ferdinand KC, 2003, AM J HYPERTENS, V16, p50S, DOI 10.1016/S0895-7061(03)01069-0; *FOOD DRUG ADM, 2004, GUID IND PHARM DAT S; Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; FREIS ED, 1983, AM J CARDIOL, V52, P1230; FRIEDMAN B, 1983, AM J CARDIOL, V52, pD43, DOI 10.1016/0002-9149(83)90641-0; Goldstein DB, 2003, NAT REV GENET, V4, P937, DOI 10.1038/nrg1229; Goran MI, 2002, DIABETES CARE, V25, P2184, DOI 10.2337/diacare.25.12.2184; Hassaballa H, 2001, NEUROLOGY, V57, P691, DOI 10.1212/WNL.57.4.691; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Higashi MK, 2002, JAMA-J AM MED ASSOC, V287, P1690, DOI 10.1001/jama.287.13.1690; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Holtzman NA, 2003, PHARMACOGENOMICS: SOCIAL, ETHICAL, AND CLINICAL DIMENSIONS, P163, DOI 10.1002/047142613X.ch9; Hughes AR, 2004, PHARMACOGENOMICS, V5, P203, DOI 10.1517/phgs.5.2.203.27481; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; JANN MW, 1989, PSYCHIAT RES, V30, P45, DOI 10.1016/0165-1781(89)90170-4; Johnson JA, 2003, CLIN PHARMACOL THER, V74, P44, DOI 10.1016/S0009-9236(03)00068-7; JOHNSON JA, 1995, J CARDIOVASC PHARM, V25, P90, DOI 10.1097/00005344-199501000-00015; Kadan-Lottick NS, 2003, JAMA-J AM MED ASSOC, V290, P2008, DOI 10.1001/jama.290.15.2008; Kahn Jonathan, 2004, Yale J Health Policy Law Ethics, V4, P1; Kalinowski L, 2004, CIRCULATION, V109, P2511, DOI 10.1161/01.CIR.0000129087.81352.7A; Kimball P, 2001, J MED VIROL, V65, P510, DOI 10.1002/jmv.2065; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; LANG CC, 1995, NEW ENGL J MED, V333, P155, DOI 10.1056/NEJM199507203330304; Lang CC, 1997, HYPERTENSION, V30, P157, DOI 10.1161/01.HYP.30.2.157; Li RL, 2004, AM J HYPERTENS, V17, P560, DOI 10.1016/j.amjhyper.2004.02.013; LIN KM, 1989, AM J PSYCHIAT, V146, P1307; Lindpaintner K, 2003, J MOL MED-JMM, V81, P141, DOI 10.1007/s00109-002-0416-5; Liu J, 2003, CLIN PHARMACOL THER, V74, P372, DOI 10.1016/S0009-9236(03)00224-8; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; *LOND HLTH OSB, 2004, ETHN DISP HLTH HLTH; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Matsuda KT, 1996, PSYCHOPHARMACOL BULL, V32, P253; McLellan RA, 1997, PHARMACOGENETICS, V7, P187, DOI 10.1097/00008571-199706000-00003; McLeod HL, 2002, PHARMACOGENOMICS, V3, P89, DOI 10.1517/14622416.3.1.89; Millward MJ, 2003, ANN ONCOL, V14, P449, DOI 10.1093/annonc/mdg118; Mokwe E, 2004, HYPERTENSION, V43, P1202, DOI 10.1161/01.HYP.0000127924.67353.86; Muir AJ, 2004, NEW ENGL J MED, V350, P2265, DOI 10.1056/NEJMoa032502; Netland PA, 2003, ADV THER, V20, P149, DOI 10.1007/BF02850202; Oselin K, 2003, FUND CLIN PHARMACOL, V17, P463, DOI 10.1046/j.1472-8206.2003.00163.x; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pollock BH, 2000, J CLIN ONCOL, V18, P813, DOI 10.1200/JCO.2000.18.4.813; Pui CH, 2003, JAMA-J AM MED ASSOC, V290, P2001, DOI 10.1001/jama.290.15.2001; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Risch N., 2002, GENOME BIOL, V3, pcomm, DOI [10.1186/gb-2002-3-7-comment2007, 10.1186/GB-2002-3-7-COMMENT2007]; Robertson JA, 2003, PHARMACOGENOMICS: SOCIAL, ETHICAL, AND CLINICAL DIMENSIONS, P291, DOI 10.1002/047142613X.ch15; Rosenbaum DA, 2002, ARTERIOSCL THROM VAS, V22, P1023, DOI 10.1161/01.ATV.0000017704.45007.1D; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Roses AD, 2002, NAT REV DRUG DISCOV, V1, P541, DOI 10.1038/nrd840; Sakaeda T, 2003, PHARMACOGENOMICS, V4, P397, DOI 10.1517/phgs.4.4.397.22747; SAUNDERS E, 1991, PRIMARY CARE, V18, P607; Schmith VD, 2003, CELL MOL LIFE SCI, V60, P1636, DOI 10.1007/s00018-003-2369-4; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Segal SP, 1996, PSYCHIAT SERV, V47, P282; Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Sofowora GG, 2003, CLIN PHARMACOL THER, V73, P366, DOI 10.1016/S0009-9236(02)17734-4; Stein CM, 1997, CLIN PHARMACOL THER, V62, P436, DOI 10.1016/S0009-9236(97)90122-3; Stephens JC, 1998, AM J HUM GENET, V62, P1507, DOI 10.1086/301867; STRAKOWSKI SM, 1993, J CLIN PSYCHIAT, V54, P96; Takahashi H, 2003, CLIN PHARMACOL THER, V73, P253, DOI 10.1067/mcp.2003.26a; Taube J, 2000, BLOOD, V96, P1816, DOI 10.1182/blood.V96.5.1816.h8001816_1816_1819; TORNATORE KM, 1995, TRANSPLANTATION, V59, P729, DOI 10.1097/00007890-199503150-00016; Walkup JT, 2000, J CLIN PSYCHIAT, V61, P344, DOI 10.4088/JCP.v61n0504; WATKINS LL, 1995, LIFE SCI, V57, P1411, DOI 10.1016/0024-3205(95)02103-P; WEIR MR, 1995, HYPERTENSION, V26, P124, DOI 10.1161/01.HYP.26.1.124; Weir MR, 1998, AM J HYPERTENS, V11, P914, DOI 10.1016/S0895-7061(98)00087-9; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Xie HG, 2001, PHARMACOGENETICS, V11, P191, DOI 10.1097/00008571-200104000-00002; Xie HG, 2001, ANNU REV PHARMACOL, V41, P815, DOI 10.1146/annurev.pharmtox.41.1.815; Yamazaki K, 2002, J HUM GENET, V47, P469, DOI 10.1007/s100380200067; Zanchi A, 2003, CURR HYPERTENS REP, V5, P346, DOI 10.1007/s11906-003-0045-6; ZHOU HH, 1993, CLIN PHARMACOL THER, V54, P507, DOI 10.1038/clpt.1993.182	105	130	137	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11		S			S34	S42		10.1038/ng1437	http://dx.doi.org/10.1038/ng1437			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867PH	15508001	Bronze			2022-12-27	WOS:000224854000009
J	Holbrook, JA; Neu-Yilik, G; Hentze, MW; Kulozik, AE				Holbrook, JA; Neu-Yilik, G; Hentze, MW; Kulozik, AE			Nonsense-mediated decay approaches the clinic	NATURE GENETICS			English	Review							MESSENGER-RNA DECAY; PREMATURE STOP MUTATION; TUMOR-SUPPRESSOR GENE; BETA-GLOBIN GENE; CAENORHABDITIS-ELEGANS; CYSTIC-FIBROSIS; WT1 GENE; GLUTATHIONE-PEROXIDASE; PROTEIN EXPRESSION; IN-VIVO	Nonsense-mediated decay (NMD) eliminates mRNAs containing premature termination codons and thus helps limit the synthesis of abnormal proteins. New results uncover a broader role of NMD as a pathway that also affects the expression of wild-type genes and alternative-splice products. Because the mechanisms by which NMD operates have received much attention, we discuss here the emerging awareness of the impact of NMD on the manifestation of human genetic diseases. We explore how an understanding of NMD accounts for phenotypic differences in diseases caused by premature termination codons. Specifically, we consider how the protective function of NMD sometimes benefits heterozygous carriers and, in contrast, sometimes contributes to a clinical picture of protein deficiency by inhibiting expression of partially functional proteins. Potential 'NMD therapeutics' will therefore need to strike a balance between the general physiological benefits of NMD and its detrimental effects in cases of specific genetic mutations.	Heidelberg Univ, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; Mol Med Partnership Unit, D-69120 Heidelberg, Germany; European Mol Biol Lab, D-69117 Heidelberg, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL)	Hentze, MW (corresponding author), Heidelberg Univ, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany.	hentze@embl.de; andreas.kulozik@med.uni-heidelberg.de	Hentze, Matthias W/V-3980-2017; Kulozik, Andreas/AAO-2432-2020	Hentze, Matthias W/0000-0002-4023-7876; 				Asselta R, 2001, BLOOD, V98, P3685, DOI 10.1182/blood.V98.13.3685; Atkin AL, 1997, J BIOL CHEM, V272, P22163, DOI 10.1074/jbc.272.35.22163; Bamber BA, 1999, J NEUROSCI, V19, P5348; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; Bateman JF, 2003, HUM MOL GENET, V12, P217, DOI 10.1093/hmg/ddg054; Bedwell DM, 1997, NAT MED, V3, P1280, DOI 10.1038/nm1197-1280; Blaschke RJ, 2003, J BIOL CHEM, V278, P47820, DOI 10.1074/jbc.M306685200; Bono F, 2004, EMBO REP, V5, P304, DOI 10.1038/sj.embor.7400091; Brocke KS, 2002, HUM MOL GENET, V11, P331, DOI 10.1093/hmg/11.3.331; Brogna S, 1999, RNA, V5, P562, DOI 10.1017/S1355838299981359; Cardinali M, 1997, MOL CARCINOGEN, V18, P78, DOI 10.1002/(SICI)1098-2744(199702)18:2<78::AID-MC3>3.0.CO;2-M; Chan D, 1998, J CLIN INVEST, V101, P1490, DOI 10.1172/JCI1976; CHANG JC, 1979, P NATL ACAD SCI USA, V76, P2886, DOI 10.1073/pnas.76.6.2886; Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369; Chiu SY, 2003, RNA, V9, P77, DOI 10.1261/rna.2137903; CHOW VTK, 1993, CANCER LETT, V73, P141, DOI 10.1016/0304-3835(93)90256-9; Clancy JP, 2001, AM J RESP CRIT CARE, V163, P1683, DOI 10.1164/ajrccm.163.7.2004001; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Danckwardt S, 2002, BLOOD, V99, P1811, DOI 10.1182/blood.V99.5.1811; DOMINSKI Z, 1993, P NATL ACAD SCI USA, V90, P8673, DOI 10.1073/pnas.90.18.8673; Donnadieu E, 2003, IMMUNITY, V18, P665, DOI 10.1016/S1074-7613(03)00115-8; Du M, 2002, J MOL MED, V80, P595, DOI 10.1007/s00109-002-0363-1; Dunant P, 2003, MUSCLE NERVE, V27, P624, DOI 10.1002/mus.10341; Englert C, 1995, P NATL ACAD SCI USA, V92, P11960, DOI 10.1073/pnas.92.26.11960; EUSTICE DC, 1984, BIOCHEMISTRY-US, V23, P1462, DOI 10.1021/bi00302a019; Fan SJ, 2001, ONCOGENE, V20, P8215, DOI 10.1038/sj.onc.1205033; Ferraiuolo MA, 2004, P NATL ACAD SCI USA, V101, P4118, DOI 10.1073/pnas.0400933101; Flaman JM, 1996, ONCOGENE, V12, P813; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gouya L, 2002, NAT GENET, V30, P27, DOI 10.1038/ng809; Green RE, 2003, BIOINFORMATICS, V19, pi118, DOI 10.1093/bioinformatics/btg1015; HALL GW, 1994, BLOOD, V83, P2031; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; Jouanguy E, 1999, NAT GENET, V21, P370, DOI 10.1038/7701; KAWASAKI T, 1994, CANCER LETT, V82, P113, DOI 10.1016/0304-3835(94)90154-6; Keeling KM, 2001, HUM MOL GENET, V10, P291, DOI 10.1093/hmg/10.3.291; Kerr TP, 2001, HUM GENET, V109, P402, DOI 10.1007/s004390100598; Kim VN, 2001, EMBO J, V20, P2062, DOI 10.1093/emboj/20.8.2062; King-Underwood L, 1998, BLOOD, V91, P2961, DOI 10.1182/blood.V91.8.2961.2961_2961_2968; KingUnderwood L, 1996, BLOOD, V87, P2171, DOI 10.1182/blood.V87.6.2171.bloodjournal8762171; Klamt B, 1998, HUM MOL GENET, V7, P709, DOI 10.1093/hmg/7.4.709; Kohsaka T, 1999, HUM MUTAT, V14, P466, DOI 10.1002/(SICI)1098-1004(199912)14:6<466::AID-HUMU4>3.3.CO;2-Y; KUGLER W, 1995, NUCLEIC ACIDS RES, V23, P413, DOI 10.1093/nar/23.3.413; Lamba JK, 2003, HUM MOL GENET, V12, P99, DOI 10.1093/hmg/ddg011; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li SL, 1998, IMMUNITY, V8, P135, DOI 10.1016/S1074-7613(00)80466-5; LITTLE MH, 1992, P NATL ACAD SCI USA, V89, P4791, DOI 10.1073/pnas.89.11.4791; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; Lu QL, 2003, NAT MED, V9, P1009, DOI 10.1038/nm897; Lykke-Andersen J, 2001, SCIENCE, V293, P1836, DOI 10.1126/science.1062786; Magnusson KP, 2000, GENE, V246, P247, DOI 10.1016/S0378-1119(00)00068-8; Mango SE, 2001, TRENDS GENET, V17, P646, DOI 10.1016/S0168-9525(01)02479-9; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; Maquat LE, 2001, RNA, V7, P445, DOI 10.1017/S1355838201002229; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Millar DS, 2000, HUM GENET, V106, P249, DOI 10.1007/s004390051035; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Neu-Yilik G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-218; Neu-Yilik G, 2001, EMBO J, V20, P532, DOI 10.1093/emboj/20.3.532; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Page MF, 1999, MOL CELL BIOL, V19, P5943; Pal M, 2001, RNA, V7, P5, DOI 10.1017/S1355838201000127; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Pelczar P, 1998, MOL CELL BIOL, V18, P4509, DOI 10.1128/MCB.18.8.4509; Perrin-Vidoz L, 2002, HUM MOL GENET, V11, P2805, DOI 10.1093/hmg/11.23.2805; Politano L, 2003, Acta Myol, V22, P15; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; REDDY JC, 1995, J BIOL CHEM, V270, P10878, DOI 10.1074/jbc.270.18.10878; Reichenbach P, 2003, CURR BIOL, V13, P568, DOI 10.1016/S0960-9822(03)00173-8; Rivolta C, 2001, HUM MUTAT, V18, P488, DOI 10.1002/humu.1226; Romao L, 2000, BLOOD, V96, P2895; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; RuizEchevarria MJ, 1996, TRENDS BIOCHEM SCI, V21, P433, DOI 10.1016/S0968-0004(96)10055-4; Sangkuhl K, 2004, HUM MOL GENET, V13, P893, DOI 10.1093/hmg/ddh105; Schell T, 2002, GENOME BIOL, V3; Schneppenheim R, 2001, BLOOD, V97, P2059, DOI 10.1182/blood.V97.7.2059; Schwabe GC, 2000, AM J HUM GENET, V67, P822, DOI 10.1086/303084; Shibuya T, 2004, NAT STRUCT MOL BIOL, V11, P346, DOI 10.1038/nsmb750; Singh G, 2003, TRENDS BIOCHEM SCI, V28, P464, DOI 10.1016/S0968-0004(03)00176-2; Snow BE, 2003, CURR BIOL, V13, P698, DOI 10.1016/S0960-9822(03)00210-0; Sun XL, 2001, MOL BIOL CELL, V12, P1009, DOI 10.1091/mbc.12.4.1009; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785; Sylvain V, 2002, INT J ONCOL, V20, P845; THEIN SL, 1990, P NATL ACAD SCI USA, V87, P3924, DOI 10.1073/pnas.87.10.3924; Tycowski KT, 1996, NATURE, V379, P464, DOI 10.1038/379464a0; Usuda J, 2003, INT J ONCOL, V22, P81; Wagner KR, 2001, ANN NEUROL, V49, P706, DOI 10.1002/ana.1023.abs; Wang J, 2002, EMBO REP, V3, P274, DOI 10.1093/embo-reports/kvf036; Wilkinson MF, 2003, MOL CELL, V12, P1059, DOI 10.1016/S1097-2765(03)00448-9; Williams C, 1998, CLIN CHEM, V44, P455; Wilschanski M, 2000, AM J RESP CRIT CARE, V161, P860, DOI 10.1164/ajrccm.161.3.9904116; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; Zsembery A, 2002, HEPATOLOGY, V35, P95, DOI 10.1053/jhep.2002.30423	100	489	503	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					801	808		10.1038/ng1403	http://dx.doi.org/10.1038/ng1403			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15284851				2022-12-27	WOS:000222974000011
J	Carninci, P; Sandelin, A; Lenhard, B; Katayama, S; Shimokawa, K; Ponjavic, J; Semple, CAM; Taylor, MS; Engstrom, PG; Frith, MC; Forrest, ARR; Alkema, WB; Tan, SL; Plessy, C; Kodzius, R; Ravasi, T; Kasukawa, T; Fukuda, S; Kanamori-Katayama, M; Kitazume, Y; Kawaji, H; Kai, C; Nakamura, M; Konno, H; Nakano, K; Mottagui-Tabar, S; Arner, P; Chesi, A; Gustincich, S; Persichetti, F; Suzuki, H; Grimmond, SM; Wells, CA; Orlando, V; Wahlestedt, C; Liu, ET; Harbers, M; Kawai, J; Bajic, VB; Hume, DA; Hayashizaki, Y				Carninci, Piero; Sandelin, Albin; Lenhard, Boris; Katayama, Shintaro; Shimokawa, Kazuro; Ponjavic, Jasmina; Semple, Colin A. M.; Taylor, Martin S.; Engstrom, Par G.; Frith, Martin C.; Forrest, Alistair R. R.; Alkema, Wynand B.; Tan, Sin Lam; Plessy, Charles; Kodzius, Rimantas; Ravasi, Timothy; Kasukawa, Takeya; Fukuda, Shiro; Kanamori-Katayama, Mutsumi; Kitazume, Yayoi; Kawaji, Hideya; Kai, Chikatoshi; Nakamura, Mari; Konno, Hideaki; Nakano, Kenji; Mottagui-Tabar, Salim; Arner, Peter; Chesi, Alessandra; Gustincich, Stefano; Persichetti, Francesca; Suzuki, Harukazu; Grimmond, Sean M.; Wells, Christine A.; Orlando, Valerio; Wahlestedt, Claes; Liu, Edison T.; Harbers, Matthias; Kawai, Jun; Bajic, Vladimir B.; Hume, David A.; Hayashizaki, Yoshihide			Genome-wide analysis of mammalian promoter architecture and evolution	NATURE GENETICS			English	Article							RNA-POLYMERASE-II; CORE PROMOTER; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; CAP ANALYSIS; ELEMENTS; DATABASE; IDENTIFICATION; CONSTRUCTION; ENCYCLOPEDIA	Mammalian promoters can be separated into two classes, conserved TATA box-enriched promoters, which initiate at a welldefined site, and more plastic, broad and evolvable CpG-rich promoters. We have sequenced tags corresponding to several hundred thousand transcription start sites (TSSs) in the mouse and human genomes, allowing precise analysis of the sequence architecture and evolution of distinct promoter classes. Different tissues and families of genes differentially use distinct types of promoters. Our tagging methods allow quantitative analysis of promoter usage in different tissues and show that differentially regulated alternative TSSs are a common feature in protein-coding genes and commonly generate alternative N termini. Among the TSSs, we identified new start sites associated with the majority of exons and with 3' UTRs. These data permit genome-scale identification of tissue-specific promoters and analysis of the cis-acting elements associated with them.	RIKEN Yokohma Inst, GSC, Genome Explorat Res Grp, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; RIKEN Wako Inst, Discovery Res Inst, Genome Sci Lab, Wako, Saitama 3510198, Japan; Karolinska Inst, Ctr Genom & Bioinformat, S-17177 Stockholm, Sweden; Western Gen Hosp, Human Genome Unit, UK Med Res Council, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Oxford, Oxford OX3 7BN, England; Univ Queensland, Inst Mol Biosci, ARC, Special Res Ctr Funct & Appl Genome, Brisbane, Qld 4072, Australia; Inst Infocomm Res, Knowledge Extract Lab, Singapore 119613, Singapore; Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; NTT Software Corp, Network Serv Solut Business Grp, Broadband Commun Serv Business Unit, Naka Ku, Yokohama, Kanagawa 2318551, Japan; Huddinge Univ Hosp, Karolinska Inst, Dept Med, S-14186 Huddinge, Sweden; ISAS SISSA, Sector Neurobiol, Giovanni Armenise Harvard Fdn Lab, I-34012 Trieste, Italy; Epigenet & Genome Reprogramming Lab, IGB CNR, Dulbecco Telethon Inst, I-80131 Naples, Italy; Genome Inst Singapore, Singapore 138672, Singapore; Kabushiki Kaisha Dnaform, Minato Ku, Tokyo 1080073, Japan; Univ Western Cape, S African Natl Bioinformat Inst, Bellville, South Africa; Yokohama City Univ, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058577, Japan; Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia	RIKEN; RIKEN; Karolinska Institutet; University of Edinburgh; University of Oxford; University of Queensland; Agency for Science Technology & Research (A*STAR); A*STAR - Institute for Infocomm Research (I2R); University of California System; University of California San Diego; Karolinska Institutet; International School for Advanced Studies (SISSA); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Fondazione Telethon; Dulbecco Telethon Institute (DTI); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); South African National Biodiversity Institute; University of the Western Cape; Yokohama City University; University of Tsukuba; Griffith University	Hume, DA (corresponding author), RIKEN Yokohma Inst, GSC, Genome Explorat Res Grp, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	d.hume@imb.uq.edu.au; yosihide@gsc.riken.jp	Plessy, Charles/N-5054-2015; Wahlestedt, Claes/A-7039-2009; Chesi, Alessandra/AAT-8248-2020; Forrest, Alistair/A-6597-2008; Hume, David A/C-7695-2013; Carninci, Piero/K-1568-2014; Alkema, Wynand/G-5826-2018; Semple, Colin A M/A-5613-2009; Wells, Christine A/A-5071-2010; Hayashizaki, Yoshihide/N-6590-2015; Katayama, Shintaro/F-2958-2010; K, Rimantas/H-4512-2019; Kawaji, Hideya/N-5116-2015; Kasukawa, Takeya/N-5070-2015; Taylor, Martin S/C-3825-2009; Sandelin, Albin/G-2881-2011; Konno, Hideaki/A-9191-2012; Kawai, Jun/A-6451-2016; Grimmond, Sean M/J-5304-2016; Konno, Hideaki/N-4366-2014; Tomic, Nevena/AAA-2135-2021; Suzuki, Harukazu/N-9553-2015; Ravasi, Timothy/B-8777-2008; Liu, Edison/C-4141-2008; Grimmond, Sean/K-3246-2019; Bajic, Vladimir/D-2810-2009; Chesi, Alessandra/N-7693-2017	Plessy, Charles/0000-0001-7410-6295; Forrest, Alistair/0000-0003-4543-1675; Carninci, Piero/0000-0001-7202-7243; Alkema, Wynand/0000-0002-5523-9217; Semple, Colin A M/0000-0003-1765-4118; Wells, Christine A/0000-0003-3133-3628; Katayama, Shintaro/0000-0001-7581-5157; K, Rimantas/0000-0001-9417-8894; Kawaji, Hideya/0000-0002-0575-0308; Kasukawa, Takeya/0000-0001-5085-0802; Taylor, Martin S/0000-0001-7656-330X; Sandelin, Albin/0000-0002-7109-7378; Grimmond, Sean M/0000-0002-8102-7998; Konno, Hideaki/0000-0002-8470-4835; Suzuki, Harukazu/0000-0002-8087-0836; Grimmond, Sean/0000-0002-8102-7998; Harbers, Matthias/0000-0002-5613-7220; Engstrom, Par/0000-0001-5265-2121; Arner, Peter/0000-0002-6208-6220; Lenhard, Boris/0000-0002-1114-1509; Persichetti, Francesca/0000-0002-9804-644X; Fukuda, Shiro/0000-0002-0065-662X; Frith, Martin/0000-0003-0998-2859; Ravasi, Timothy/0000-0002-9950-465X; Gustincich, Stefano/0000-0002-2749-2514; Bajic, Vladimir/0000-0001-5435-4750; Hume, David/0000-0002-2615-1478; Chesi, Alessandra/0000-0002-0954-7446	Biotechnology and Biological Sciences Research Council [BB/H531586/1, S17961] Funding Source: Medline; Telethon [TCP00094] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Telethon(Fondazione Telethon)		Bajic VB, 2004, NAT BIOTECHNOL, V22, P1467, DOI 10.1038/nbt1032; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Bluthgen N, 2005, NUCLEIC ACIDS RES, V33, P272, DOI 10.1093/nar/gki167; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Brodsky AS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r64; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Carninci P, 2003, GENOME RES, V13, P1273, DOI 10.1101/gr.1119703; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Imamura T, 2004, BIOCHEM BIOPH RES CO, V322, P593, DOI 10.1016/j.bbrc.2004.07.159; Jackson DA, 2000, FASEB J, V14, P242, DOI 10.1096/fasebj.14.2.242; Kadonaga JT, 2002, EXP MOL MED, V34, P259, DOI 10.1038/emm.2002.36; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Keightley PD, 2003, P NATL ACAD SCI USA, V100, P13402, DOI 10.1073/pnas.2233252100; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Kodzius R, 2004, FEBS LETT, V559, P22, DOI 10.1016/S0014-5793(04)00018-3; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Lenhard Boris, 2003, J Biol, V2, P13, DOI 10.1186/1475-4924-2-13; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Patton J, 2006, GENE, V369, P35, DOI 10.1016/j.gene.2005.10.009; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rosmarin AG, 2005, EXP HEMATOL, V33, P131, DOI 10.1016/j.exphem.2004.08.015; Sandelin A, 2004, J MOL BIOL, V338, P207, DOI 10.1016/j.jmb.2004.02.048; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schug J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r33; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Siepel A, 2004, J COMPUT BIOL, V11, P413, DOI 10.1089/1066527041410472; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Suzuki Y, 2001, GENOME RES, V11, P677, DOI 10.1101/gr.GR-1640R; Suzuki Y, 1997, GENE, V200, P149, DOI 10.1016/S0378-1119(97)00411-3; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Wu YC, 2005, GENOMICS, V86, P329, DOI 10.1016/j.ygeno.2005.05.011; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	40	944	978	1	91	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					626	635		10.1038/ng1789	http://dx.doi.org/10.1038/ng1789			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16645617				2022-12-27	WOS:000237954800015
J	Musio, A; Selicorni, A; Focarelli, ML; Gervasini, C; Milani, D; Russo, S; Vezzoni, P; Larizza, L				Musio, A; Selicorni, A; Focarelli, ML; Gervasini, C; Milani, D; Russo, S; Vezzoni, P; Larizza, L			X-linked Cornelia de Lange syndrome owing to SMC1L1 mutations	NATURE GENETICS			English	Article							SISTER-CHROMATID COHESION; NIPPED-B; ROBERTS-SYNDROME; HUMAN HOMOLOG; CUT GENE; DROSOPHILA; PHENOTYPE; PROTEINS; NIPBL; EXPRESSION	Cornelia de Lange syndrome is a multisystem developmental disorder characterized by facial dysmorphisms, upper limb abnormalities, growth delay and cognitive retardation. Mutations in the NIPBL gene, a component of the cohesin complex, account for approximately half of the affected individuals. We report here that mutations in SMC1L1 (also known as SMC1), which encodes a different subunit of the cohesin complex, are responsible for CdLS in three male members of an affected family and in one sporadic case.	CNR, Inst Biomed Technol, Human Genome Dept, I-20090 Segrate, Italy; Univ Milan, Fdn Policlin, Clin Pediat 1, I-20122 Milan, Italy; Univ Milan, San Paolo Sch Med, Div Med Genet, I-20142 Milan, Italy; Ist Auxol Italiano, Mol Genet Lab, I-20095 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Milan; University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Istituto Auxologico Italiano	Musio, A (corresponding author), CNR, Inst Biomed Technol, Human Genome Dept, Via Fratelli Cervi,93, I-20090 Segrate, Italy.	antonio.musio@itb.cnr.it	Musio, Antonio/GRO-1712-2022; Vezzoni, Paolo/R-3416-2019; Gervasini, Cristina/A-5728-2014; Milani, Donatella/AAC-8430-2019; Vezzoni, Paolo/K-3197-2018	Gervasini, Cristina/0000-0002-1165-7935; Milani, Donatella/0000-0002-3087-8514; Russo, Silvia/0000-0002-5893-0193; MUSIO, ANTONIO/0000-0001-7701-6543; Vezzoni, Paolo/0000-0002-6382-3923				BROWN CJ, 1995, HUM MOL GENET, V4, P251, DOI 10.1093/hmg/4.2.251; Dorsett D, 2005, DEVELOPMENT, V132, P4743, DOI 10.1242/dev.02064; Egemen A, 2005, GENET COUNSEL, V16, P27; Gillis LA, 2004, AM J HUM GENET, V75, P610, DOI 10.1086/424698; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Musio A, 2005, HUM MOL GENET, V14, P525, DOI 10.1093/hmg/ddi049; Rollins RA, 2004, MOL CELL BIOL, V24, P3100, DOI 10.1128/MCB.24.8.3100-3111.2004; Schule B, 2005, AM J HUM GENET, V77, P1117, DOI 10.1086/498695; SELICORNI A, 1993, AM J MED GENET, V47, P977, DOI 10.1002/ajmg.1320470708; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548	14	330	345	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2006	38	5					528	530		10.1038/ng1779	http://dx.doi.org/10.1038/ng1779			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16604071				2022-12-27	WOS:000237147500013
J	Poland, H				Poland, H			Integrating genomics against infectious disease	NATURE GENETICS			English	Editorial Material							DIAGNOSTICS	The most recent National Academies Keck Futures Initiative Conference, entitled `The Genomics Revolution: Implications for Treatment and Control of Infectious Disease', was held at the Arnold and Mabel Beckman Center in Irvine, California. It provided strategies and opportunities for interdisciplinary collaboration and incentives to innovate.	Univ So Calif, Annenberg Sch Commun, Los Angeles, CA 90089 USA	University of Southern California	Poland, H (corresponding author), Univ So Calif, Annenberg Sch Commun, 3502 Watt Ways, Los Angeles, CA 90089 USA.	hpoland@usc.edu						Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; Fortina P, 2005, TRENDS BIOTECHNOL, V23, P168, DOI 10.1016/j.tibtech.2005.02.007; Galan JE, 2005, CURR OPIN MICROBIOL, V8, P1, DOI 10.1016/j.mib.2004.12.015; Jain KK, 2005, CLIN CHIM ACTA, V358, P37, DOI 10.1016/j.cccn.2005.03.014; Lagally ET, 2004, ANAL CHEM, V76, P3162, DOI 10.1021/ac035310p; Levene MJ, 2003, SCIENCE, V299, P682, DOI 10.1126/science.1079700; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Nabel GJ, 2005, SCIENCE, V308, P1878, DOI 10.1126/science.1114854; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Ziegler C, 2004, ANAL BIOANAL CHEM, V379, P946, DOI 10.1007/s00216-004-2694-y	13	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2006	38	5					513	514		10.1038/ng0506-513	http://dx.doi.org/10.1038/ng0506-513			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16642016				2022-12-27	WOS:000237147500008
J	Zhang, K; Zhu, J; Shendure, J; Porreca, GJ; Aach, JD; Mitra, RD; Church, GM				Zhang, K; Zhu, J; Shendure, J; Porreca, GJ; Aach, JD; Mitra, RD; Church, GM			Long-range polony haplotyping of individual human chromosome molecules	NATURE GENETICS			English	Article							POLYMERASE COLONIES; RECOMBINATION RATES; GENE; DNA; RECONSTRUCTION; CROSSOVERS; ACCURACY; BLOCKS; PCR	We report a method for multilocus long-range haplotyping on human chromosome molecules in vitro based on the DNA polymerase colony (polony) technology. By immobilizing thousands of intact chromosome molecules within a polyacrylamide gel on a microscope slide and performing multiple amplifications from single molecules, we determined long-range haplotypes spanning a 153-Mb region of human chromosome 7 and found evidence of rare mitotic recombination events in human lymphocytes. Furthermore, the parallel nature of DNA polony technology allows efficient haplotyping on pooled DNAs from a population on one slide, with a throughput three orders of magnitudes higher than current molecular haplotyping methods. Linkage disequilibrium statistics established by our pooled DNA haplotyping method are more accurate than statistically inferred haplotypes. This haplotyping method is well suited for candidate gene-based association studies as well as for investigating the pattern of recombination in mammalian cells.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; Washington Univ, Dept Genet, St Louis, MO 63108 USA	Harvard University; Harvard Medical School; Duke University; Washington University (WUSTL)	Zhang, K (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	kzhang@genetics.med.harvard.edu	Zhang, Kun/ABE-6349-2020; Shendure, Jay/AAU-3684-2021	Zhang, Kun/0000-0002-7596-5224; church, george/0000-0001-6232-9969; Shendure, Jay/0000-0002-1516-1865; Mitra, Robi/0000-0002-2680-4264				Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cram L. Scott, 2002, Methods in Cell Science, V24, P27, DOI 10.1023/A:1024108923475; Ding CM, 2003, P NATL ACAD SCI USA, V100, P7449, DOI 10.1073/pnas.1232475100; Douglas JA, 2001, NAT GENET, V28, P361, DOI 10.1038/ng582; Forton J, 2005, AM J HUM GENET, V76, P438, DOI 10.1086/428439; Hendricks CA, 2003, P NATL ACAD SCI USA, V100, P6325, DOI 10.1073/pnas.1232231100; Jeffreys AJ, 2005, NAT GENET, V37, P601, DOI 10.1038/ng1565; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Kehrer-Sawatzki H, 2004, AM J HUM GENET, V75, P410, DOI 10.1086/423624; MEYN MS, 1993, SCIENCE, V260, P1327, DOI 10.1126/science.8493577; MichalatosBeloin S, 1996, NUCLEIC ACIDS RES, V24, P4841, DOI 10.1093/nar/24.23.4841; Mitra RD, 2003, P NATL ACAD SCI USA, V100, P5926, DOI 10.1073/pnas.0936399100; Mitra RD, 2003, ANAL BIOCHEM, V320, P55, DOI 10.1016/S0003-2697(03)00291-4; Mitra RD, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.24.e34; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Prado FL, 2003, CURR GENET, V42, P185, DOI 10.1007/s00294-002-0346-3; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tishkoff SA, 2000, AM J HUM GENET, V67, P518, DOI 10.1086/303000; von Ahsen N, 2001, CLIN CHEM, V47, P1956; Wang N, 2002, AM J HUM GENET, V71, P1227, DOI 10.1086/344398; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Woolley AT, 2000, NAT BIOTECHNOL, V18, P760, DOI 10.1038/77760; Zhu J, 2003, SCIENCE, V301, P836, DOI 10.1126/science.1085792	27	59	74	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2006	38	3					382	387		10.1038/ng1741	http://dx.doi.org/10.1038/ng1741			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16493423				2022-12-27	WOS:000235589600023
J	Yu, JM; Pressoir, G; Briggs, WH; Bi, IV; Yamasaki, M; Doebley, JF; McMullen, MD; Gaut, BS; Nielsen, DM; Holland, JB; Kresovich, S; Buckler, ES				Yu, JM; Pressoir, G; Briggs, WH; Bi, IV; Yamasaki, M; Doebley, JF; McMullen, MD; Gaut, BS; Nielsen, DM; Holland, JB; Kresovich, S; Buckler, ES			A unified mixed-model method for association mapping that accounts for multiple levels of relatedness	NATURE GENETICS			English	Article							QUANTITATIVE TRAITS; POPULATION-STRUCTURE; COMPLEX TRAITS; LINKAGE DISEQUILIBRIUM; GENOME; DISSECTION; PEDIGREES; DISEASES; LOCI; MAPS	As population structure can result in spurious associations, it has constrained the use of association studies in human and plant genetics. Association mapping, however, holds great promise if true signals of functional association can be separated from the vast number of false signals generated by population structure(1,2). We have developed a unified mixed-model approach to account for multiple levels of relatedness simultaneously as detected by random genetic markers. We applied this new approach to two samples: a family-based sample of 14 human families, for quantitative gene expression dissection, and a sample of 277 diverse maize inbred lines with complex familial relationships and population structure, for quantitative trait dissection. Our method demonstrates improved control of both type I and type II error rates over other methods. As this new method crosses the boundary between family-based and structured association samples, it provides a powerful complement to currently available methods for association mapping.	Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA; Univ Calif Irvine, Agr Res Serv, USDA, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; N Carolina State Univ, Dept Stat, Raleigh, NC 27695 USA; N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA	Cornell University; University of Wisconsin System; University of Wisconsin Madison; University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); University of California System; University of California Irvine; University of California System; University of California Irvine; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Cornell University	Buckler, ES (corresponding author), Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA.	esb33@cornell.edu	Yu, Jianming/Q-6722-2019; Yamasaki, Masanori/C-5193-2018; Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019	Yu, Jianming/0000-0001-5326-3099; Yamasaki, Masanori/0000-0001-7759-3965; Buckler, Edward/0000-0002-3100-371X; Nielsen, Dahlia/0000-0003-0123-6085; Holland, James/0000-0002-4341-9675				Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Allison DB, 1997, AM J HUM GENET, V60, P676; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Cardon LR, 2000, HUM HERED, V50, P350, DOI 10.1159/000022940; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Gardiner J, 2004, PLANT PHYSIOL, V134, P1317, DOI 10.1104/pp.103.034538; George AW, 2000, GENETICS, V156, P2081; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hartl DL, 1997, PRINCIPLES OF POPULA; Henderson C. R, 1984, APPL LINEAR MODELS A; Hey J, 2003, NAT REV GENET, V4, P535, DOI 10.1038/nrg1112; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; KENNEDY BW, 1992, J ANIM SCI, V70, P2000, DOI 10.2527/1992.7072000x; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Long AD, 1999, GENOME RES, V9, P720; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Ritland K, 1996, GENET RES, V67, P175, DOI 10.1017/S0016672300033620; SAS Institute, 1999, SAS STAT US GUID VER; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P18075, DOI 10.1073/pnas.0408251102	30	2565	2666	20	385	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					203	208		10.1038/ng1702	http://dx.doi.org/10.1038/ng1702			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16380716				2022-12-27	WOS:000234953200015
J	Fischer, E; Legue, E; Doyen, A; Nato, F; Nicolas, JF; Torres, V; Yaniv, M; Pontoglio, M				Fischer, E; Legue, E; Doyen, A; Nato, F; Nicolas, JF; Torres, V; Yaniv, M; Pontoglio, M			Defective planar cell polarity in polycystic kidney disease	NATURE GENETICS			English	Article							CILIA; MODEL	Morphogenesis involves coordinated proliferation, differentiation and spatial distribution of cells. We show that lengthening of renal tubules is associated with mitotic orientation of cells along the tubule axis, demonstrating intrinsic planar cell polarization, and we demonstrate that mitotic orientations are significantly distorted in rodent polycystic kidney models. These results suggest that oriented cell division dictates the maintenance of constant tubule diameter during tubular lengthening and that defects in this process trigger renal tubular enlargement and cyst formation.	CNRS, Gene Express & Dis Unit, FRE 2850, F-75700 Paris, France; CNRS, URA 2578, Dev Mol Biol Unit, Dept Dev Biol, F-75700 Paris, France; Inst Pasteur, Struct Biol & Chem Dept, Recombinant Prot & Antibody Unit, F-75724 Paris, France; Mayo Clin, Coll Med, Div Nephrol, Rochester, MN 55905 USA	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Mayo Clinic	Fischer, E (corresponding author), CNRS, Gene Express & Dis Unit, FRE 2850, F-75700 Paris, France.		fischer, evelyne/GLT-9457-2022; Nicolas, Jean-François/AAW-9289-2020	fischer, evelyne/0000-0001-5054-1444				Ahringer J, 2003, CURR OPIN CELL BIOL, V15, P73, DOI 10.1016/S0955-0674(02)00018-2; Boletta A, 2003, TRENDS CELL BIOL, V13, P484, DOI 10.1016/S0962-8924(03)00169-7; GATTONE VH, 1988, LAB INVEST, V59, P231; Germino GG, 2005, NAT GENET, V37, P455, DOI 10.1038/ng0505-455; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Gresh L, 2004, EMBO J, V23, P1657, DOI 10.1038/sj.emboj.7600160; Jung AC, 2005, J AM SOC NEPHROL, V16, P322, DOI 10.1681/ASN.2004090729; Lager DJ, 2001, KIDNEY INT, V59, P126, DOI 10.1046/j.1523-1755.2001.00473.x; Mateescu B, 2004, EMBO REP, V5, P490, DOI 10.1038/sj.embor.7400139; Pazour GJ, 2004, J AM SOC NEPHROL, V15, P2528, DOI 10.1097/01.ASN.0000141055.57643.E0; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161	15	399	408	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2006	38	1					21	23		10.1038/ng1701	http://dx.doi.org/10.1038/ng1701			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16341222				2022-12-27	WOS:000234227200012
J	Zenker, M; Mayerle, J; Lerch, MM; Tagariello, A; Zerres, K; Durie, PR; Beier, M; Hulskamp, G; Guzman, C; Rehder, H; Beemer, FA; Hamel, B; Vanlieferinghen, P; Gershoni-Baruch, R; Vieira, MW; Dumic, M; Auslender, R; Gil-da-Silva-Lopes, VL; Steinlicht, S; Rauh, M; Shalev, SA; Thiel, C; Winterpacht, A; Kwon, YT; Varshavsky, A; Reis, A				Zenker, M; Mayerle, J; Lerch, MM; Tagariello, A; Zerres, K; Durie, PR; Beier, M; Hulskamp, G; Guzman, C; Rehder, H; Beemer, FA; Hamel, B; Vanlieferinghen, P; Gershoni-Baruch, R; Vieira, MW; Dumic, M; Auslender, R; Gil-da-Silva-Lopes, VL; Steinlicht, S; Rauh, M; Shalev, SA; Thiel, C; Winterpacht, A; Kwon, YT; Varshavsky, A; Reis, A			Deficiency of UBR1, a ubiquitin ligase of the N-end rule pathway, causes pancreatic dysfunction, malformations and mental retardation (Johanson-Blizzard syndrome)	NATURE GENETICS			English	Article							TRYPSINOGEN ACTIVATION; AUTOPSY FINDINGS; CATHEPSIN-B; PROTEIN; PREMATURE; LACKING; SYSTEM; MOUSE; E3	Johanson-Blizzard syndrome (OMIM 243800) is an autosomal recessive disorder that includes congenital exocrine pancreatic insufficiency, multiple malformations such as nasal wing aplasia, and frequent mental retardation(1). We mapped the disease-associated locus to chromosome 15q14 - 21.1 and identified mutations, mostly truncating ones, in the gene UBR1 in 12 unrelated families with Johanson-Blizzard syndrome. UBR1 encodes one of at least four functionally overlapping E3 ubiquitin ligases of the N-end rule pathway, a conserved proteolytic system whose substrates include proteins with destabilizing N-terminal residues(2-5). Pancreas of individuals with Johanson-Blizzard syndrome did not express UBR1 and had intrauterine-onset destructive pancreatitis. In addition, we found that Ubr1(-/-) mice, whose previously reported phenotypes include reduced weight and behavioral abnormalities(6,7), had an exocrine pancreatic insufficiency, with impaired stimulus-secretion coupling and increased susceptibility to pancreatic injury. Our findings indicate that deficiency of UBR1 perturbs the pancreas' acinar cells and other organs, presumably owing to metabolic stabilization of specific substrates of the N-end rule pathway.	Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; Univ Greifswald, Dept Gastroenterol Endocrinol & Nutr, D-17487 Greifswald, Germany; Univ Aachen, Inst Human Genet, Aachen, Germany; Hosp Sick Children, Res Inst, Programme Integrat Biol, Toronto, ON M5G 1X8, Canada; Univ Munster, Dept Pediat, D-4400 Munster, Germany; Univ Costa Rica, Natl Childrens Hosp, San Jose, Costa Rica; Med Univ Vienna, KIMCL, Dept Human Genet, Vienna, Austria; Univ Utrecht, Dept Med Genet, NL-3508 TC Utrecht, Netherlands; Radboud Univ Nijmegen Med Ctr, Dept Human Genet, Nijmegen, Netherlands; CHU, Hotel Dieu, Dept Pediat, Neonatol Unit, Clermont Ferrand, France; Rambam Med Ctr, Dept Genet, Haifa, Israel; Catholic Univ Sao Paolo, Dept Med Genet, Sao Paulo, Brazil; Univ Zagreb, Childrens Hosp Rebro, Zagreb 41000, Croatia; Carmel Hosp, Dept Obstet & Gynecol, Haifa, Israel; State Univ Campinas, Dept Med Genet, Sao Paulo, Brazil; Univ Childrens Hosp, Erlangen, Germany; HaEmek Med Ctr, Inst Genet, Afula, Israel; Univ Pittsburgh, Sch Pharm, Ctr Pharmacogenet, Pittsburgh, PA 15260 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	University of Erlangen Nuremberg; Ernst Moritz Arndt Universitat Greifswald; RWTH Aachen University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Munster; Universidad Costa Rica; Medical University of Vienna; Utrecht University; Radboud University Nijmegen; CHU Clermont Ferrand; Rambam Health Care Campus; Technion Israel Institute of Technology; Pontificia Universidade Catolica de Sao Paulo; University of Zagreb; Clalit Health Services; Carmel Medical Center; Universidade Estadual de Campinas; University of Erlangen Nuremberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Emek Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; California Institute of Technology	Zenker, M (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, Schwabachanlage 10, D-91054 Erlangen, Germany.	mzenker@humgenet.uni-erlangen.de	Gil-da-Silva-Lopes, Vera Lúcia L/G-2453-2012; Reis, André/D-2309-2009; Thiel, Christian T/H-8964-2012; Lerch, Markus M./E-2206-2016; Mayerle, Julia/W-7907-2019	Gil-da-Silva-Lopes, Vera Lúcia L/0000-0003-1288-0554; Reis, André/0000-0002-6301-6363; Thiel, Christian T/0000-0003-3817-7277; Lerch, Markus M./0000-0002-9643-8263; Rauh, Manfred/0000-0002-4852-7157				BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Ciechanover A, 2004, BBA-MOL CELL RES, V1695, P3, DOI 10.1016/j.bbamcr.2004.09.018; Cuschieri A, 2002, AM J MED GENET, V110, P122, DOI 10.1002/ajmg.10371; DAENTL DL, 1979, AM J MED GENET, V3, P129, DOI 10.1002/ajmg.1320030203; Guzman C, 1997, J PEDIATR GASTR NUTR, V25, P350, DOI 10.1097/00005176-199709000-00020; Halangk W, 2000, J CLIN INVEST, V106, P773, DOI 10.1172/JCI9411; Halangk W, 2002, AM J PHYSIOL-GASTR L, V282, pG367, DOI 10.1152/ajpgi.00315.2001; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; JOHANSON A, 1971, J PEDIATR-US, V79, P982, DOI 10.1016/S0022-3476(71)80194-4; JONES NL, 1994, J PEDIATR-US, V125, P406, DOI 10.1016/S0022-3476(05)83286-X; Kruger B, 1998, LAB INVEST, V78, P763; Kukor Z, 2002, J BIOL CHEM, V277, P21389, DOI 10.1074/jbc.M200878200; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Mayerle J, 2003, GASTROENTEROLOGY, V124, P949, DOI 10.1053/gast.2003.50142; MOESCHLER J B, 1987, American Journal of Medical Genetics, V26, P133, DOI 10.1002/ajmg.1320260120; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; RUDNIKSCHONEBORN S, 1991, KLIN PADIATR, V203, P33, DOI 10.1055/s-2007-1025396; Swanenburg de Veye H F, 1991, Genet Couns, V2, P21; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Vanlieferinghen P, 2001, GENET COUNSEL, V12, P245; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Vieira Marta W., 2002, J. Pediatr. (Rio J.), V78, P433, DOI 10.1590/S0021-75572002000500016; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Yin JH, 2004, HUM MOL GENET, V13, P2421, DOI 10.1093/hmg/ddh269; ZERRES K, 1986, CLIN GENET, V30, P177; Zeth K, 2002, NAT STRUCT BIOL, V9, P906, DOI 10.1038/nsb869	30	181	186	4	18	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2005	37	12					1345	1350		10.1038/ng1681	http://dx.doi.org/10.1038/ng1681			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16311597				2022-12-27	WOS:000233657300014
J	Rea, SL; Wu, DQ; Cypser, JR; Vaupel, JW; Johnson, TE				Rea, SL; Wu, DQ; Cypser, JR; Vaupel, JW; Johnson, TE			A stress-sensitive reporter predicts longevity in isogenic populations of Caenorhabditis elegans	NATURE GENETICS			English	Article							LIFE-SPAN; GENE-EXPRESSION; C-ELEGANS; NEMATODES; HORMESIS; AGE	When both genotype and environment are held constant, 'chance' variation in the lifespan of individuals in a population is still quite large. Using isogenic populations of the nematode Caenorhabditis elegans, we show that, on the first day of adult life, chance variation in the level of induction of a green fluorescent protein (GFP) reporter coupled to a promoter from the gene hsp-16.2 predicts as much as a fourfold variation in subsequent survival. The same reporter is also a predictor of ability to withstand a subsequent lethal thermal stress. The level of induction of GFP is not heritable, and GFP expression levels in other reporter constructs are not associated with differences in longevity. HSP-16.2 itself is probably not responsible for the observed differences in survival but instead probably reflects a hidden, heterogeneous, but now quantifiable, physiological state that dictates the ability of an organism to deal with the rigors of living.	Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; Max Planck Inst Demog Res, D-18057 Rostock, Germany; Univ Colorado, Dept Integrat Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; Max Planck Society; University of Colorado System; University of Colorado Boulder	Johnson, TE (corresponding author), Univ Colorado, Inst Behav Genet, Box 447, Boulder, CO 80309 USA.	johnsont@colorado.edu	Rea, Shane/F-4073-2014	Vaupel, James/0000-0003-0783-3905; /0000-0001-7147-8237; CYPSER, JAMES/0000-0001-8436-6437	NATIONAL INSTITUTE ON AGING [P01AG008761, P30AG034424, R01AG016219] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG034424, P01 AG008761, R01 AG016219] Funding Source: Medline; NICHD NIH HHS [R03 HD050374] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BAKER GT, 1988, EXP GERONTOL, V23, P223, DOI 10.1016/0531-5565(88)90025-3; BRENNER S, 1974, GENETICS, V77, P71; Calabrese EJ, 2002, HUM EXP TOXICOL, V21, P91, DOI 10.1191/0960327102ht217oa; Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109, DOI 10.1093/gerona/57.3.B109; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fedoroff N, 2002, SCIENCE, V297, P1129, DOI 10.1126/science.1075988; Finch C, 2000, CHANCE DEV AGING; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Golden TR, 2004, AGING CELL, V3, P111, DOI 10.1111/j.1474-9728.2004.00095.x; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; JOHNSON TE, 1982, P NATL ACAD SCI-BIOL, V79, P6603, DOI 10.1073/pnas.79.21.6603; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; Johnson TE, 2000, EXP GERONTOL, V35, P687, DOI 10.1016/S0531-5565(00)00138-8; Kelly WG, 1997, GENETICS, V146, P227; Kenyon C, 1996, CELL, V84, P501, DOI 10.1016/S0092-8674(00)81024-7; Kirkwood TBL, 2005, MECH AGEING DEV, V126, P439, DOI 10.1016/j.mad.2004.09.008; Kirkwood TBL, 2002, NATURE, V419, P794, DOI 10.1038/419794a; KLASS MR, 1977, MECH AGEING DEV, V6, P413, DOI 10.1016/0047-6374(77)90043-4; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; MELOV S, 1995, NUCLEIC ACIDS RES, V23, P1419, DOI 10.1093/nar/23.8.1419; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; STREHLER BL, 1960, SCIENCE, V132, P14, DOI 10.1126/science.132.3418.14; Vaupel JW, 1998, SCIENCE, V280, P855, DOI 10.1126/science.280.5365.855; Walker GA, 2003, AGING CELL, V2, P131, DOI 10.1046/j.1474-9728.2003.00045.x	29	297	306	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2005	37	8					894	898		10.1038/ng1608	http://dx.doi.org/10.1038/ng1608			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16041374	Green Accepted			2022-12-27	WOS:000230880400022
J	Schmid, M; Davison, TS; Henz, SR; Pape, UJ; Demar, M; Vingron, M; Scholkopf, B; Weigel, D; Lohmann, JU				Schmid, M; Davison, TS; Henz, SR; Pape, UJ; Demar, M; Vingron, M; Scholkopf, B; Weigel, D; Lohmann, JU			A gene expression map of Arabidopsis thaliana development	NATURE GENETICS			English	Article							DUPLICATE GENES; TRANSCRIPTION FACTORS; NEIGHBORING GENES; GENOME; DIVERGENCE; REVEALS; COEXPRESSION; SUPERFAMILY; MICROARRAY; EVOLUTION	Regulatory regions of plant genes tend to be more compact than those of animal genes, but the complement of transcription factors encoded in plant genomes is as large or larger than that found in those of animals(1). Plants therefore provide an opportunity to study how transcriptional programs control multicellular development. We analyzed global gene expression during development of the reference plant Arabidopsis thaliana in samples covering many stages, from embryogenesis to senescence, and diverse organs. Here, we provide a first analysis of this data set, which is part of the AtGenExpress expression atlas. We observed that the expression levels of transcription factor genes and signal transduction components are similar to those of metabolic genes. Examining the expression patterns of large gene families, we found that they are often more similar than would be expected by chance, indicating that many gene families have been co-opted for specific developmental processes.	Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Salk Inst Biol Studies, La Jolla, CA 92037 USA	Max Planck Society; Max Planck Society; Max Planck Society; Salk Institute	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Spemannstr 37-39, D-72076 Tubingen, Germany.	weigel@weigelworld.org	Weigel, Detlef/GSJ-0799-2022; Schmid, Markus/I-4384-2015; Lohmann, Jan/T-3776-2019; Schölkopf, Bernhard/A-7570-2013; Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021	Weigel, Detlef/0000-0002-2114-7963; Schmid, Markus/0000-0002-0068-2967; Lohmann, Jan/0000-0003-3667-187X; Schölkopf, Bernhard/0000-0002-8177-0925; Weigel, Detlef/0000-0002-2114-7963; 				Allemeersch J, 2005, PLANT PHYSIOL, V137, P588, DOI 10.1104/pp.104.051300; Becker A, 2003, MOL PHYLOGENET EVOL, V29, P464, DOI 10.1016/S1055-7903(03)00207-0; Becker JD, 2003, PLANT PHYSIOL, V133, P713, DOI 10.1104/pp.103.028241; Beyer A, 2004, MOL CELL PROTEOMICS, V3, P1083, DOI 10.1074/mcp.M400099-MCP200; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Force A, 1999, GENETICS, V151, P1531; Fransz PF, 2000, CELL, V100, P367, DOI 10.1016/S0092-8674(00)80672-8; Gagne JM, 2002, P NATL ACAD SCI USA, V99, P11519, DOI 10.1073/pnas.162339999; Gu ZL, 2002, TRENDS GENET, V18, P609, DOI 10.1016/S0168-9525(02)02837-8; Haberer G, 2004, PLANT PHYSIOL, V136, P3009, DOI 10.1104/pp.104.046466; HISING T, 2004, MACH LEARN, V52, P11; Huminiecki L, 2004, GENOME RES, V14, P1870, DOI 10.1101/gr.2705204; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lercher MJ, 2003, GENOME RES, V13, P238, DOI 10.1101/gr.553803; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Scholkopf B, 1998, NEURAL COMPUT, V10, P1299, DOI 10.1162/089976698300017467; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Tornow S, 2003, NUCLEIC ACIDS RES, V31, P6283, DOI 10.1093/nar/gkg838; Wellmer F, 2004, PLANT CELL, V16, P1314, DOI 10.1105/tpc.021741; Williams EJB, 2004, GENOME RES, V14, P1060, DOI 10.1101/gr.2131104; Wu Z., 2004, DEP BIOSTATISTICS WO; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305	30	1904	1982	6	276	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2005	37	5					501	506		10.1038/ng1543	http://dx.doi.org/10.1038/ng1543			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15806101				2022-12-27	WOS:000228862300019
J	Parker, JA; Arango, M; Abderrahmane, S; Lambert, E; Tourette, C; Catoire, H; Neri, C				Parker, JA; Arango, M; Abderrahmane, S; Lambert, E; Tourette, C; Catoire, H; Neri, C			Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons	NATURE GENETICS			English	Article							LIFE-SPAN; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTORS; SIRT1 DEACETYLASE; C-ELEGANS; DAF-16; RESTRICTION; ACTIVATORS; MODELS; GENES	We report that Sir2 activation through increased sir-2.1 dosage or treatment with the sirtuin activator resveratrol specifically rescued early neuronal dysfunction phenotypes induced by mutant polyglutamines in transgenic Caenorhabditis elegans. These effects are dependent on daf-16 ( Forkhead). Additionally, resveratrol rescued mutant polyglutamine - specific cell death in neuronal cells derived from HdhQ111 knock-in mice. We conclude that Sir2 activation may protect against mutant polyglutamines.	INSERM, Avenir Grp, Lab Genom Biol, Ctr Paul Broca, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm)	Neri, C (corresponding author), INSERM, Avenir Grp, Lab Genom Biol, Ctr Paul Broca, F-75014 Paris, France.	christian.neri@broca.inserm.fr	Tourette, Cendrine/U-2540-2017; Neri, Christian/F-6729-2013; Parker, Alex/F-4953-2014	Neri, Christian/0000-0002-3790-2978; Parker, Alex/0000-0002-3333-2445				Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Levine MS, 2004, TRENDS NEUROSCI, V27, P691, DOI 10.1016/j.tins.2004.08.008; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	15	404	426	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2005	37	4					349	350		10.1038/ng1534	http://dx.doi.org/10.1038/ng1534			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15793589				2022-12-27	WOS:000228040000015
J	Kizawa, H; Kou, I; Iida, A; Sudo, A; Miyamoto, Y; Fukuda, A; Mabuchi, A; Kotani, A; Kawakami, A; Yamamoto, S; Uchida, A; Nakamura, K; Notoya, K; Nakamura, Y; Ikegawa, S				Kizawa, H; Kou, I; Iida, A; Sudo, A; Miyamoto, Y; Fukuda, A; Mabuchi, A; Kotani, A; Kawakami, A; Yamamoto, S; Uchida, A; Nakamura, K; Notoya, K; Nakamura, Y; Ikegawa, S			An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis	NATURE GENETICS			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; TGF-BETA; SEQUENCE POLYMORPHISMS; OSTEOPHYTE FORMATION; GENE-CLUSTER; KNEE; ASSOCIATION; EXPRESSION; DECORIN; DIFFERENTIATION	Osteoarthritis is the most common form of human arthritis. We investigated the potential role of asporin, an extracellular matrix component expressed abundantly in the articular cartilage of individuals with osteoarthritis, in the pathogenesis of osteoarthritis. Here we report a significant association between a polymorphism in the aspartic acid (D) repeat of the gene encoding asporin (ASPN) and osteoarthritis. In two independent populations of individuals with knee osteoarthritis, the D14 allele of ASPN is overrepresented relative to the common D13 allele, and its frequency increases with disease severity. The D14 allele is also overrepresented in individuals with hip osteoarthritis. Asporin suppresses TGF-beta-mediated expression of the genes aggrecan (AGC1) and type II collagen (COL2A1) and reduced proteoglycan accumulation in an in vitro model of chondrogenesis. The effect on TGF-beta activity is allele-specific, with the D14 allele resulting in greater inhibition than other alleles. In vitro binding assays showed a direct interaction between asporin and TGF-beta. Taken together, these findings provide another functional link between extracellular matrix proteins, TGF-beta activity and disease, suggesting new therapeutic strategies for osteoarthritis.	RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Bone & Joint Dis,Minato Ku, Tokyo 1088639, Japan; Takeda Chem Ind Ltd, Div Pharmaceut Res, Pharmaceut Res Labs 1, Yodogawa Ku, Osaka 5328686, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Genotyping,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Mie Univ, Fac Med, Dept Orthopaed Surg, Tsu, Mie 5148507, Japan; Univ Tokyo, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138655, Japan; Kyorin Univ, Sch Med, Dept Orthopaed Surg, Tokyo 1818611, Japan; Tokyo Teishin Hosp, Dept Orthoped Surg, Chiyoda Ku, Tokyo 1028798, Japan; Tokyo Metropolitan Geriatr Hosp, Dept Orthoped Surg, Itabashi Ku, Tokyo 1730015, Japan	RIKEN; Takeda Chemical Industries; RIKEN; Mie University; University of Tokyo; Kyorin University	Ikegawa, S (corresponding author), RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Bone & Joint Dis,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Iida, Aritoshi/CAA-1373-2022; Ikegawa, Shiro/N-6895-2015	Iida, Aritoshi/0000-0001-7538-1651; Ikegawa, Shiro/0000-0003-0316-2147				Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Ameye L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0848com; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; Dugan TA, 2003, J BIOL CHEM, V278, P13655, DOI 10.1074/jbc.M300171200; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Gill MR, 2002, OSTEOARTHR CARTILAGE, V10, P751, DOI 10.1053/joca.2002.0527; Grimaud E, 2002, CYTOKINE GROWTH F R, V13, P241, DOI 10.1016/S1359-6101(02)00004-7; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Henry SP, 2001, J BIOL CHEM, V276, P12212, DOI 10.1074/jbc.M011290200; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Ikeda T, 2001, J HUM GENET, V46, P538, DOI 10.1007/s100380170036; Isaka Y, 1996, NAT MED, V2, P418, DOI 10.1038/nm0496-418; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; KELLGREN JH, 1963, ANN RHEUM DIS, V22, P237, DOI 10.1136/ard.22.4.237; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; Loughlin J, 2002, ARTHRITIS RHEUM, V46, P1519, DOI 10.1002/art.10260; Loughlin J, 2001, CURR OPIN RHEUMATOL, V13, P111, DOI 10.1097/00002281-200103000-00004; Mabuchi A, 2001, J HUM GENET, V46, P456, DOI 10.1007/s100380170045; Meulenbelt I, 1997, ARTHRITIS RHEUM, V40, P1760, DOI 10.1002/art.1780401006; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Scharstuhl A, 2002, J IMMUNOL, V169, P507, DOI 10.4049/jimmunol.169.1.507; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; Shukunami C, 1997, J BONE MINER RES, V12, P1174, DOI 10.1359/jbmr.1997.12.8.1174; Shukunami C, 1996, J CELL BIOL, V133, P457, DOI 10.1083/jcb.133.2.457; SINGH K, 1993, J BIOCHEM-TOKYO, V114, P702, DOI 10.1093/oxfordjournals.jbchem.a124240; Smith AJP, 2004, GENES IMMUN, V5, P451, DOI 10.1038/sj.gene.6364107; Spector TD, 1996, BRIT MED J, V312, P940; Spector Tim D, 2004, Osteoarthritis Cartilage, V12 Suppl A, pS39; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Uitterlinden AG, 2000, ARTHRITIS RHEUM-US, V43, P1456, DOI 10.1002/1529-0131(200007)43:7<1456::AID-ANR7>3.0.CO;2-M; VANBEUNINGEN HM, 1994, LAB INVEST, V71, P279; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Yamada R, 2001, AM J HUM GENET, V68, P674, DOI 10.1086/318789; Yang VWC, 1999, J BIOL CHEM, V274, P12454, DOI 10.1074/jbc.274.18.12454; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35	37	339	354	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					138	144		10.1038/ng1496	http://dx.doi.org/10.1038/ng1496			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	15640800				2022-12-27	WOS:000226690100019
J	Zhu, XF; Luke, A; Cooper, RS; Quertermous, T; Hanis, C; Mosley, T; Gu, CC; Tang, H; Rao, DC; Risch, N; Weder, A				Zhu, XF; Luke, A; Cooper, RS; Quertermous, T; Hanis, C; Mosley, T; Gu, CC; Tang, H; Rao, DC; Risch, N; Weder, A			Admixture mapping for hypertension loci with genome-scan markers	NATURE GENETICS			English	Article							MULTILOCUS GENOTYPE DATA; LINKAGE DISEQUILIBRIUM; BLOOD-PRESSURE; POPULATION-STRUCTURE; ADMIXED POPULATIONS; AFRICAN-AMERICANS; DISEASE; GENES; INFERENCE	Identification of genetic variants that contribute to risk of hypertension is challenging. As a complement to linkage and candidate gene association studies, we carried out admixture mapping using genome-scan microsatellite markers among the African American participants in the US National Heart, Lung, and Blood Institute's Family Blood Pressure Program. This population was assumed to have experienced recent admixture from ancestral groups originating in Africa and Europe. We used a set of unrelated individuals from Nigeria to represent the African ancestral population and used the European Americans in the Family Blood Pressure Program to provide estimates of allele frequencies for the European ancestors. We genotyped a common set of 269 microsatellite markers in the three groups at the same laboratory. The distribution of marker location-specific African ancestry, based on multipoint analysis, was shifted upward in hypertensive cases versus normotensive controls, consistent with linkage to genes conferring susceptibility. This shift was largely due to a small number of loci, including five adjacent markers on chromosome 6q and two on chromosome 21q. These results suggest that chromosome 6q24 and 21q21 may contain genes influencing risk of hypertension in African Americans.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48104 USA; Kaiser Permanente, Div Res, Oakland, CA USA; Loyola Univ, Med Ctr, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA; Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; Univ Texas, Dept Genet, Houston, TX USA; Univ Mississippi, Med Ctr, Dept Geriatr Med, Jackson, MS 39216 USA; Washington Univ, Div Biostat, St Louis, MO USA; Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA	Stanford University; University of Michigan System; University of Michigan; Kaiser Permanente; Loyola University Chicago; Stanford University; University of Texas System; University of Mississippi; University of Mississippi Medical Center; Washington University (WUSTL); Fred Hutchinson Cancer Center	Risch, N (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	risch@lahmed.stanford.edu	Zhu, Xiaofeng/O-6874-2019; Peng, Bo/A-6920-2009; Gu, C. Charles/A-7934-2010	Peng, Bo/0000-0001-8225-2284; Gu, C. Charles/0000-0002-8527-8145; Quertermous, Thomas/0000-0002-7645-9067; Zhu, Xiaofeng/0000-0003-0037-411X				Arya R, 2002, DIABETES, V51, P841, DOI 10.2337/diabetes.51.3.841; Collins-Schramm HE, 2002, AM J HUM GENET, V70, P737, DOI 10.1086/339368; Cooper RS, 2002, HYPERTENSION, V40, P629, DOI 10.1161/01.HYP.0000035708.02789.39; Doris PA, 2002, HYPERTENSION, V39, P323, DOI 10.1161/hy0202.104087; Falush D, 2003, GENETICS, V164, P1567; Fernandez JR, 2003, OBES RES, V11, P904, DOI 10.1038/oby.2003.124; Harrap SB, 2003, LANCET, V361, P2149, DOI 10.1016/S0140-6736(03)13694-X; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Krushkal J, 1999, CIRCULATION, V99, P1407, DOI 10.1161/01.CIR.99.11.1407; Lautenberger JA, 2000, AM J HUM GENET, V66, P969, DOI 10.1086/302820; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; Mountain JL, 2004, NAT GENET, V36, pS48, DOI 10.1038/ng1456; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; Pritchard JK, 2000, GENETICS, V155, P945; Province MA, 2003, AM J HYPERTENS, V16, P144, DOI 10.1016/S0895-7061(02)03248-X; Risch NJ, 1992, AM J HUM GENET S, V51, P13; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Smith MW, 2001, AM J HUM GENET, V69, P1080, DOI 10.1086/323922; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Zhu XF, 2004, AM J HUM GENET, V74, P1136, DOI 10.1086/421329	24	220	225	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					177	181		10.1038/ng1510	http://dx.doi.org/10.1038/ng1510			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	15665825				2022-12-27	WOS:000226690100025
J	Inoki, K; Corradetti, MN; Guan, KL				Inoki, K; Corradetti, MN; Guan, KL			Dysregulation of the TSC-mTOR pathway in human disease	NATURE GENETICS			English	Review							ACTIVATED PROTEIN-KINASE; TUBEROUS SCLEROSIS COMPLEX; TUMOR-SUPPRESSOR GENE; CELL-GROWTH; MAMMALIAN TARGET; CARDIAC-HYPERTROPHY; GAMMA(2) SUBUNIT; BINDING PARTNER; S6 KINASE; RAPAMYCIN	The mammalian target of rapamycin (mTOR) has a central role in the regulation of cell growth. mTOR receives input from multiple signaling pathways, including growth factors and nutrients, to stimulate protein synthesis by phosphorylating key translation regulators such as ribosomal S6 kinase and eukaryote initiation factor 4E binding protein 1. High levels of dysregulated mTOR activity are associated with several hamartoma syndromes, including tuberous sclerosis complex, the PTEN-related hamartoma syndromes and Peutz-Jeghers syndrome. These disorders are all caused by mutations in tumor-suppressor genes that negatively regulate mTOR. Here we discuss the emerging evidence for a functional relationship between the mTOR signaling pathway and several genetic diseases, and we present evidence supporting a model in which dysregulation of mTOR may be a common molecular basis, not only for hamartoma syndromes, but also for other cellular hypertrophic disorders.	Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guan, KL (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	kunliang@umich.edu	Guan, Kun-Liang/ADK-7088-2022; INOKI, KEN/A-1202-2007		NIDDK NIH HHS [R01 DK124709] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Avruch J, 2001, Prog Mol Subcell Biol, V26, P115; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Birchenall-Roberts MC, 2004, J BIOL CHEM, V279, P25605, DOI 10.1074/jbc.M402790200; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Blair E, 2001, HUM MOL GENET, V10, P1215, DOI 10.1093/hmg/10.11.1215; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Daniel T, 2002, J BIOL CHEM, V277, P51017, DOI 10.1074/jbc.M207093200; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; DEVROEDE G, 1988, GASTROENTEROLOGY, V94, P182, DOI 10.1016/0016-5085(88)90628-2; El-Hashemite N, 2003, LANCET, V361, P1348, DOI 10.1016/S0140-6736(03)13044-9; El-Hashemite N, 2003, CANCER RES, V63, P5173; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Eng C, 2003, AM J MED GENET A, V122A, P315, DOI 10.1002/ajmg.a.20477; Entius MM, 2001, J CLIN PATHOL, V54, P126, DOI 10.1136/jcp.54.2.126; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Furuta S, 2004, ONCOGENE, V23, P3898, DOI 10.1038/sj.onc.1207539; Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Garza L, 2002, CURR OPIN CARDIOL, V17, P518, DOI 10.1097/00001573-200209000-00012; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gollob MH, 2001, NEW ENGL J MED, V344, P1823, DOI 10.1056/NEJM200106143442403; GOMEZ MR, 1999, TUBEROUS SCLEROSIS C, P340; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Hancock E, 2002, RESP MED, V96, P1, DOI 10.1053/rmed.2001.1207; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hernan I, 2004, CLIN GENET, V66, P58, DOI 10.1111/j.0009-9163.2004.00266.x; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Kaelin WG, 2003, J AM SOC NEPHROL, V14, P2703, DOI 10.1097/01.ASN.0000092803.69761.41; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Kandt RS, 2003, NEUROL CLIN, V21, P982, DOI 10.1016/S0733-8619(03)00004-5; Kenerson HL, 2002, CANCER RES, V62, P5645; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Mak BC, 2003, J BIOL CHEM, V278, P5947, DOI 10.1074/jbc.C200473200; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Miyoshi H, 2002, CANCER RES, V62, P2261; NELLIST M, 1993, CELL, V75, P1305; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Niida Y, 2001, AM J HUM GENET, V69, P493, DOI 10.1086/321972; Okimoto K, 2004, P NATL ACAD SCI USA, V101, P2023, DOI 10.1073/pnas.0308071100; Pavlovich CP, 2004, NAT REV CANCER, V4, P381, DOI 10.1038/nrc1364; Podsypanina K, 2001, P NATL ACAD SCI USA, V98, P10320, DOI 10.1073/pnas.171060098; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Sawyers CL, 2003, CANCER CELL, V4, P343, DOI 10.1016/S1535-6108(03)00275-7; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shao JY, 2004, CANCER RES, V64, P229, DOI 10.1158/0008-5472.CAN-03-1859; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Stratakis CA, 2000, HORM RES, V54, P334, DOI 10.1159/000053283; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tucker M, 2000, J NATL CANCER I, V92, P530, DOI 10.1093/jnci/92.7.530; Tucker T, 2002, CLIN GENET, V62, P345, DOI 10.1034/j.1399-0004.2002.620501.x; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; van der Hoeve J., 1920, T OPHTHAL SOC UK, V20, P329; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109; Zhou XP, 2001, AM J HUM GENET, V69, P704, DOI 10.1086/323703	100	780	833	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2005	37	1					19	24		10.1038/ng1494	http://dx.doi.org/10.1038/ng1494			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15624019				2022-12-27	WOS:000225997500015
J	Parra, EJ; Kittles, RA; Shriver, MD				Parra, EJ; Kittles, RA; Shriver, MD			Implications of correlations between skin color and genetic ancestry for biomedical research	NATURE GENETICS			English	Article							POPULATION-STRUCTURE; ADMIXED POPULATIONS; ADMIXTURE; ASSOCIATION; DISEASE; PIGMENTATION; LINKAGE; DENSITY; PROPORTIONS; DIFFERENCE	Skin pigmentation is a central element of most discussions on 'race' and genetics. Research on the genetic basis of population variation in this phenotype, which is important in mediating both social experiences and environmental exposures, is sparse. We studied the relationship between pigmentation and ancestry in five populations of mixed ancestry with a wide range of pigmentation and ancestral proportions (African Americans from Washington, DC; African Caribbeans living in England; Puerto Ricans from New York; Mexicans from Guerrero; and Hispanics from San Luis Valley). The strength of the relationship between skin color and ancestry was quite variable, with the correlations ranging in intensity from moderately strong (Puerto Rico, rho = 0.633) to weak (Mexico, rho = 0.212). These results demonstrate the utility of ancestry-informative genetic markers and admixture methods and emphasize the need to be cautious when using pigmentation as a proxy of ancestry or when extrapolating the results from one admixed population to another.	Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Univ Toronto, Dept Anthropol, Mississauga, ON L5L 1C6, Canada; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Toronto; University Toronto Mississauga; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Shriver, MD (corresponding author), Penn State Univ, Dept Anthropol, 409 Carpenter Bldg, University Pk, PA 16802 USA.	mds17@psu.edu	Parra, Esteban J/A-4957-2008	parra, esteban J/0000-0002-2057-8577; Shriver, Mark/0000-0003-0006-0479				Akey JM, 2001, BIOTECHNIQUES, V30, P358, DOI 10.2144/01302tt05; Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Bonilla C, 2004, HUM GENET, V115, P57, DOI 10.1007/s00439-004-1125-7; Bonilla C, 2004, ANN HUM GENET, V68, P139, DOI 10.1046/j.1529-8817.2003.00084.x; BONILLA C, IN PRESS AM J PHYS A; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fernandez JR, 2003, OBES RES, V11, P904, DOI 10.1038/oby.2003.124; Halder Indrani, 2003, Human Genomics, V1, P52; HANIS CL, 1986, AM J PHYS ANTHROPOL, V70, P433, DOI 10.1002/ajpa.1330700404; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; LONG JC, 1991, GENETICS, V127, P417; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; Nordlund J.J., 1998, PIGMENTARY SYSTEM PH, V1st; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Relethford JH, 2002, AM J PHYS ANTHROPOL, V118, P393, DOI 10.1002/ajpa.10079; Relethford JH, 1997, AM J PHYS ANTHROPOL, V104, P449, DOI 10.1002/(SICI)1096-8644(199712)104:4<449::AID-AJPA2>3.0.CO;2-N; Risch N., 2002, GENOME BIOL, V3, pcomm, DOI [10.1186/gb-2002-3-7-comment2007, 10.1186/GB-2002-3-7-COMMENT2007]; Robins A.H., 1991, BIOL PERSPECTIVES HU; Rybicki BA, 2002, HUM HERED, V53, P187, DOI 10.1159/000066193; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Shriver MD, 2000, AM J PHYS ANTHROPOL, V112, P17, DOI 10.1002/(SICI)1096-8644(200005)112:1<17::AID-AJPA3>3.0.CO;2-D; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Sturm RA, 2001, GENE, V277, P49, DOI 10.1016/S0378-1119(01)00694-1; Ye J, 2002, J FORENSIC SCI, V47, P593	34	144	150	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11		S			S54	S60		10.1038/ng1440	http://dx.doi.org/10.1038/ng1440			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867PH	15508005	Bronze			2022-12-27	WOS:000224854000012
J	Murrell, A; Heeson, S; Reik, W				Murrell, A; Heeson, S; Reik, W			Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops	NATURE GENETICS			English	Article							CTCF; MECHANISMS; INSULATOR; UPSTREAM; DELETION; SITES; EXPRESSION; ELEMENT	Imprinted genes are expressed from only one of the parental alleles and are marked epigenetically by DNA methylation and histone modifications(1-5). The paternally expressed gene insulin-like growth-factor 2 (Igf2) is separated by similar to100 kb from the maternally expressed noncoding gene H19 on mouse distal chromosome 7. Differentially methylated regions in Igf2 and H19 contain chromatin boundaries(6-9), silencers(10,11) and activators(12) and regulate the reciprocal expression of the two genes in a methylation-sensitive manner by allowing them exclusive access to a shared set of enhancers(13-15). Various chromatin models have been proposed that separate Igf2 and H19 into active and silent domains(16-19). Here we used a GAL4 knock-in approach as well as the chromosome conformation capture technique to show that the differentially methylated regions in the imprinted genes Igf2 and H19 interact in mice. These interactions are epigenetically regulated and partition maternal and paternal chromatin into distinct loops. This generates a simple epigenetic switch for Igf2 through which it moves between an active and a silent chromatin domain.	Babraham Inst, Dev Genet Programme, Lab Dev Genet & Imprinting, Cambridge CB2 4AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Murrell, A (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	amm@sanger.ac.uk; wolf.reik@bbsrc.ac.uk	Reik, Wolf/I-6794-2012	Reik, Wolf/0000-0003-0216-9881; Murrell, adele/0000-0003-2647-3511				Banerjee Subhasis, 2001, TheScientificWorld, V1, P218; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chubb JR, 2003, CELL, V112, P403, DOI 10.1016/S0092-8674(03)00078-3; Constancia M, 2000, NAT GENET, V26, P203, DOI 10.1038/79930; Davies K, 2002, DEVELOPMENT, V129, P1657; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Eden S, 2001, EMBO J, V20, P3518, DOI 10.1093/emboj/20.13.3518; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FEIL R, 1994, DEVELOPMENT, V120, P2933; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Fournier C, 2002, EMBO J, V21, P6560, DOI 10.1093/emboj/cdf655; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kaffer CR, 2001, MOL CELL BIOL, V21, P8189, DOI 10.1128/MCB.21.23.8189-8196.2001; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Labrador M, 2002, CELL, V111, P151, DOI 10.1016/S0092-8674(02)01004-8; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Lopes S, 2003, HUM MOL GENET, V12, P295, DOI 10.1093/hmg/ddg022; Moore T, 1997, P NATL ACAD SCI USA, V94, P12509, DOI 10.1073/pnas.94.23.12509; Murrell A, 2001, EMBO REP, V2, P1101, DOI 10.1093/embo-reports/kve248; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Sasaki H, 2000, J BIOCHEM, V127, P711, DOI 10.1093/oxfordjournals.jbchem.a022661; Sleutels F, 2002, ADV GENET, V46, P119; Szabo PE, 2000, CURR BIOL, V10, P607, DOI 10.1016/S0960-9822(00)00489-9; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717; Weber M, 2003, MOL CELL BIOL, V23, P8953, DOI 10.1128/MCB.23.24.8953-8959.2003; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2	30	413	431	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2004	36	8					889	893		10.1038/ng1402	http://dx.doi.org/10.1038/ng1402			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	842AG	15273689				2022-12-27	WOS:000222974000024
J	Ruderfer, DM; Pratt, SC; Seidel, HS; Kruglyak, L				Ruderfer, Douglas M.; Pratt, Stephen C.; Seidel, Hannah S.; Kruglyak, Leonid			Population genomic analysis of outcrossing and recombination in yeast	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; SEQUENCES; EVOLUTION; HISTORY; COMPLEX; RATES	The budding yeast Saccharomyces cerevisiae has been used by humans for millennia to make wine, beer and bread(1). More recently, it became a key model organism for studies of eukaryotic biology and for genomic analysis(2). However, relatively little is known about the natural lifestyle and population genetics of yeast(3). One major question is whether genetically diverse yeast strains mate and recombine in the wild. We developed a method to infer the evolutionary history of a species from genome sequences of multiple individuals and applied it to whole-genome sequence data from three strains of Saccharomyces cerevisiae(2,4) and the sister species Saccharomyces paradoxus(5). We observed a pattern of sequence variation among yeast strains in which ancestral recombination events lead to a mosaic of segments with shared genealogy. Based on sequence divergence and the inferred median size of shared segments (similar to 2,000 bp), we estimated that although any two strains have undergone approximately 16 million cell divisions since their last common ancestor, only 314 outcrossing events have occurred during this time ( roughly one every 50,000 divisions). Local correlations in polymorphism rates indicate that linkage disequilibrium in yeast should extend over kilobases. Our results provide the initial foundation for population studies of association between genotype and phenotype in S. cerevisiae.	Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University; Princeton University	Kruglyak, L (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	leonid@genomics.princeton.edu	Pratt, Stephen/C-5418-2011; Ruderfer, Douglas M/M-5795-2016	Ruderfer, Douglas M/0000-0002-2365-386X	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059520] Funding Source: NIH RePORTER; NIMH NIH HHS [R37 MH059520] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aa E, 2006, FEMS YEAST RES, V6, P702, DOI 10.1111/j.1567-1364.2006.00059.x; BAUM LE, 1966, ANN MATH STAT, V37, P1554, DOI 10.1214/aoms/1177699147; Bray N, 2004, GENOME RES, V14, P693, DOI 10.1101/gr.1960404; Carvajal-Rodriguez A, 2006, MOL BIOL EVOL, V23, P817, DOI 10.1093/molbev/msj102; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Enjalbert J, 2000, GENETICS, V156, P1973; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Gu ZL, 2005, P NATL ACAD SCI USA, V102, P1092, DOI 10.1073/pnas.0409159102; Hein J., 2005, GENE GENEALOGIES VAR; Hey J, 1997, GENETICS, V145, P833; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1992, GENETICS, V132, P583; HUDSON RR, 1985, GENETICS, V111, P147; Johnson LJ, 2004, GENETICS, V166, P43, DOI 10.1534/genetics.166.1.43; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Landry CR, 2006, MOL ECOL, V15, P575, DOI 10.1111/j.1365-294X.2006.02778.x; Liti G, 2005, YEAST, V22, P177, DOI 10.1002/yea.1200; McVean GAT, 2002, GENETICS, V162, P987; Mortimer R, 1999, RES MICROBIOL, V150, P199, DOI 10.1016/S0923-2508(99)80036-9; Mortimer RK, 2000, GENOME RES, V10, P403, DOI 10.1101/gr.10.4.403; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Reich DE, 2002, NAT GENET, V32, P135, DOI 10.1038/ng947; RONALD J, GENETICS; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010	27	163	166	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2006	38	9					1077	1081		10.1038/ng1859	http://dx.doi.org/10.1038/ng1859			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16892060				2022-12-27	WOS:000240112100028
J	Crow, YJ; Leitch, A; Hayward, BE; Garner, A; Parmar, R; Griffith, E; Ali, M; Semple, C; Aicardi, J; Babul-Hirji, R; Baumann, C; Baxter, P; Bertini, E; Chandler, KE; Chitayat, D; Cau, D; Dery, C; Fazzi, E; Goizet, C; King, MD; Klepper, J; Lacombe, D; Lanzi, G; Lyall, H; Martinez-Frias, ML; Mathieu, M; McKeown, C; Monier, A; Oade, Y; Quarrell, OW; Rittey, CD; Rogers, RC; Sanchis, A; Stephenson, JBP; Tacke, U; Till, M; Tolmie, JL; Tomlin, P; Voit, T; Weschke, B; Woods, CG; Lebon, P; Bonthron, DT; Ponting, CP; Jackson, AP				Crow, Yanick J.; Leitch, Andrea; Hayward, Bruce E.; Garner, Anna; Parmar, Rekha; Griffith, Elen; Ali, Manir; Semple, Colin; Aicardi, Jean; Babul-Hirji, Riyana; Baumann, Clarisse; Baxter, Peter; Bertini, Enrico; Chandler, Kate E.; Chitayat, David; Cau, Daniel; Dery, Catherine; Fazzi, Elisa; Goizet, Cyril; King, Mary D.; Klepper, Joerg; Lacombe, Didier; Lanzi, Giovanni; Lyall, Hermione; Martinez-Frias, Maria Luisa; Mathieu, Michele; McKeown, Carole; Monier, Anne; Oade, Yvette; Quarrell, Oliver W.; Rittey, Christopher D.; Rogers, R. Curtis; Sanchis, Amparo; Stephenson, John B. P.; Tacke, Uta; Till, Marianne; Tolmie, John L.; Tomlin, Pam; Voit, Thomas; Weschke, Bernhard; Woods, C. Geoffrey; Lebon, Pierre; Bonthron, David T.; Ponting, Chris P.; Jackson, Andrew P.			Mutations in genes encoding ribonuclease H2 subunits cause Aicardi-Goutieres syndrome and mimic congenital viral brain infection	NATURE GENETICS			English	Article							INTRACRANIAL CALCIFICATION; SACCHAROMYCES-CEREVISIAE; INTERFERON-ALPHA; SUBSTRATE-SPECIFICITY; INTRATHECAL SYNTHESIS; CEREBROSPINAL-FLUID; DNA-REPLICATION; BASAL GANGLIA; RNASES H; CHILDREN	Aicardi-Goutieres syndrome (AGS) is an autosomal recessive neurological disorder, the clinical and immunological features of which parallel those of congenital viral infection. Here we define the composition of the human ribonuclease H2 enzyme complex and show that AGS can result from mutations in the genes encoding any one of its three subunits. Our findings demonstrate a role for ribonuclease H in human neurological disease and suggest an unanticipated relationship between ribonuclease H2 and the antiviral immune response that warrants further investigation.	Univ Leeds, St Jamess Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; Western Gen Hosp, UK MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; St Lukes Hosp, Dept Paediat, Bradford BD5 0NA, W Yorkshire, England; Hop Robert Debre, Serv Neurol Pediat & Malad Metab, F-75935 Paris 19, France; Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON MG5 1X8, Canada; Hop Robert Debre, Unite Genet Clin, F-75019 Paris, France; Sheffield Childrens Hosp, Sheffield S10 2TH, S Yorkshire, England; Bambino Gesu Pediat Hosp, Mol Med Unit, I-00165 Rome, Italy; Univ Manchester, Dept Med Genet, Manchester M13 0JH, Lancs, England; St Marys Hosp, Reg Genet Serv, Cent Manchester Healthcare Trust, Manchester M13 0JH, Lancs, England; Hop William Morey, Serv Pediat Neonatol, F-71120 Chalon Sur Saone, France; Ctr Sante & Serv Sociaux Beauce, St Georges, PQ G5Y 4T8, Canada; Univ Pavia, Dept Child Neurol & Psychiat, IRCCS S Mondino Inst Neurol, I-27100 Pavia, Italy; Pellegrin Teaching Hosp, Dept Med Genet, F-33076 Bordeaux, France; Childrens Univ Hosp, Dept Paediat Neurol, Dublin 1, Ireland; Univ Essen Gesamthsch, Dept Pediat Neurol, D-45122 Essen, Germany; St Marys Hosp, Dept Paediat Infect Dis, London W2 1NY, England; Inst Salud Carlos III, Ctr Invest Sobre Anomalias Congenitas, Madrid 28029, Spain; Hop Nord Amiens, Unite Genet Clin, F-80054 Amiens, France; Womens Hosp Med Ctr, Clin Genet Unit, Birmingham B15 2TG, W Midlands, England; Calderdale Royal Hosp, Dept Paediat, Salterhebble HX3 0PW, Halifax, England; Sheffield Childrens Hosp, Dept Clin Genet, Sheffield S10 2TH, S Yorkshire, England; Ryegate Childrens Ctr, Sheffield S10 5DD, S Yorkshire, England; Greenwood Genet Ctr, Greenwood, SC 29646 USA; Hosp Univ Doctor Peset, Serv Pediat, Valencia 46017, Spain; Royal Hosp Sick Children, Fraser Allander Neurosci Unit, Glasgow G3 8SJ, Lanark, Scotland; Univ Freiburg, Childrens Hosp, D-79106 Freiburg, Germany; Debrousse Hosp, Dept Genet, F-69322 Lyon 05, France; Royal Hosp Sick Children, Duncan Guthrie Inst Med Genet, Glasgow G3 8SJ, Lanark, Scotland; Royal Preston Hosp, Dept Paediat Neurol, Preston PR2 9HT, Lancs, England; Charite, Sch Med, Dept Neuropediat, D-13353 Berlin, Germany; E Anglian Med Genet Serv, Cambridge CB2 2QQ, England; Hop Cochin, Serv Virol, F-75674 Paris, France; Univ Paris 05, Paris, France; Univ Oxford, MRC, Funct Genet Unit, Dept Physiol Anat & Genet, Oxford OX1 3QX, England	Saint James's University Hospital; University of Leeds; University of Edinburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; IRCCS Bambino Gesu; University of Manchester; University of Manchester; University of Pavia; CHU Bordeaux; Childrens University Hospital - Temple Street; University of Duisburg Essen; Imperial College London; Instituto de Salud Carlos III; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Birmingham Women's Hospital; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Greenwood Genetic Center; University of Glasgow; University of Freiburg; CHU Lyon; University of Glasgow; Royal Preston Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Oxford	Crow, YJ (corresponding author), Univ Leeds, St Jamess Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England.	yanickcrow@mac.com; andrew.jackson@hgu.mrc.ac.uk	Ponting, Chris/AAV-2621-2021; Bertini, Enrico/ABG-1278-2020; woods, christopher g/A-1361-2010; Jackson, Andrew P/D-3442-2009; Crow, Yanick J/N-6120-2014; GOIZET, Cyril/M-4576-2014; Ali, Manir/ABE-5251-2020; Bertini, Enrico/A-2284-2014; Semple, Colin A M/A-5613-2009; Fazzi, Elisa/J-6076-2016	Jackson, Andrew P/0000-0002-8739-2646; Crow, Yanick J/0000-0001-7211-7564; GOIZET, Cyril/0000-0002-1913-889X; Ali, Manir/0000-0003-3204-3788; Bertini, Enrico/0000-0001-9276-4590; Semple, Colin A M/0000-0003-1765-4118; Fazzi, Elisa/0000-0003-4805-7906; Bonthron, David/0000-0001-8132-8179; Ponting, Chris/0000-0003-0202-7816; Weschke, Bernhard/0000-0003-4533-0743; Lacombe, Didier/0000-0002-8956-2207	Medical Research Council [MC_U137761446, MC_U127580972] Funding Source: Medline; MRC [MC_U127580972, MC_U137761446] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109; Ali M, 2006, J MED GENET, V43, P444, DOI 10.1136/jmg.2005.031880; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arudchandran A, 2000, GENES CELLS, V5, P789, DOI 10.1046/j.1365-2443.2000.00373.x; Bale J F Jr, 1985, Pediatr Neurol, V1, P42, DOI 10.1016/0887-8994(85)90008-6; BARAITSER M, 1983, J MED GENET, V20, P210, DOI 10.1136/jmg.20.3.210; BELMAN AL, 1986, NEUROLOGY, V36, P1192, DOI 10.1212/WNL.36.9.1192; Broman KW, 1999, AM J HUM GENET, V65, P1493, DOI 10.1086/302661; Campbell IL, 1999, BRAIN RES, V835, P46, DOI 10.1016/S0006-8993(99)01328-1; Chapados BR, 2001, J MOL BIOL, V307, P541, DOI 10.1006/jmbi.2001.4494; Coffin J, 1997, RETROVIRUSES; Crow YJ, 2000, AM J HUM GENET, V67, P213, DOI 10.1086/302955; Crow YJ, 2003, J MED GENET, V40, P183, DOI 10.1136/jmg.40.3.183; DUSSAIX E, 1985, ACTA NEUROL SCAND, V71, P504; EDER PS, 1993, BIOCHIMIE, V75, P123, DOI 10.1016/0300-9084(93)90033-O; EDER PS, 1991, J BIOL CHEM, V266, P6472; Frank P, 1998, P NATL ACAD SCI USA, V95, P12872, DOI 10.1073/pnas.95.22.12872; Gardner RJM, 2005, PRENATAL DIAG, V25, P362, DOI 10.1002/pd.1152; Gibson J, 2006, HUM MOL GENET, V15, P789, DOI 10.1093/hmg/ddi493; Goodstadt L, 2001, BIOINFORMATICS, V17, P845, DOI 10.1093/bioinformatics/17.9.845; Goutieres F, 1998, ANN NEUROL, V44, P900, DOI 10.1002/ana.410440608; Goutieres F, 2005, BRAIN DEV-JPN, V27, P201, DOI 10.1016/j.braindev.2003.12.011; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966; Jeong HS, 2004, NUCLEIC ACIDS RES, V32, P407, DOI 10.1093/nar/gkh209; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Krivine A, 1999, J NEUROVIROL, V5, P500, DOI 10.3109/13550289909045379; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kumar D, 1998, AM J MED GENET, V75, P508, DOI 10.1002/(SICI)1096-8628(19980217)75:5<508::AID-AJMG10>3.0.CO;2-O; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LEBON P, 1979, BIOMED EXPRESS, V31, P267; Lebon Pierre, 2002, Eur J Paediatr Neurol, V6 Suppl A, pA47, DOI 10.1053/ejpn.2002.0574; Mitchell W, 2001, MENT RETARD DEV D R, V7, P211, DOI 10.1002/mrdd.1029; Numazaki K, 2003, J CHILD NEUROL, V18, P296, DOI 10.1177/08830738030180040601; Ohtani N, 1999, BIOCHEMISTRY-US, V38, P605, DOI 10.1021/bi982207z; Parniak MA, 2003, ANAL BIOCHEM, V322, P33, DOI 10.1016/j.ab.2003.06.001; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; REARDON W, 1994, AM J MED GENET, V52, P58, DOI 10.1002/ajmg.1320520112; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Sanchis A, 2005, J PEDIATR-US, V146, P701, DOI 10.1016/j.jpeds.2005.01.033; Schwarz KB, 2002, DEV MED CHILD NEUROL, V44, P422; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; VanAelst L, 1996, EMBO J, V15, P3778, DOI 10.1002/j.1460-2075.1996.tb00751.x	45	513	524	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2006	38	8					910	916		10.1038/ng1842	http://dx.doi.org/10.1038/ng1842			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16845400				2022-12-27	WOS:000239325700020
J	Crow, YJ; Hayward, BE; Parmar, R; Robins, P; Leitch, A; Ali, M; Black, DN; van Bokhoven, H; Brunner, HG; Hamel, BC; Corry, PC; Cowan, FM; Frints, SG; Klepper, J; Livingston, JH; Lynch, SA; Massey, RF; Meritet, JF; Michaud, JL; Ponsot, G; Voit, T; Lebon, P; Bonthron, DT; Jackson, AP; Barnes, DE; Lindahl, T				Crow, Yanick J.; Hayward, Bruce E.; Parmar, Rekha; Robins, Peter; Leitch, Andrea; Ali, Manir; Black, Deborah N.; van Bokhoven, Hans; Brunner, Han G.; Hamel, Ben C.; Corry, Peter C.; Cowan, Frances M.; Frints, Suzanne G.; Klepper, Joerg; Livingston, John H.; Lynch, Sally Ann; Massey, Roger F.; Meritet, Jean Francois; Michaud, Jacques L.; Ponsot, Gerard; Voit, Thomas; Lebon, Pierre; Bonthron, David T.; Jackson, Andrew P.; Barnes, Deborah E.; Lindahl, Tomas			Mutations in the gene encoding the 3 '-5 ' DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PROGRESSIVE FAMILIAL ENCEPHALOPATHY; INTERFERON-ALPHA; INTRATHECAL SYNTHESIS; MICE; ENCEPHALITIS; INDUCTION; INFECTION; SERUM	Aicardi-Goutieres syndrome (AGS) presents as a severe neurological brain disease and is a genetic mimic of the sequelae of transplacentally acquired viral infection(1,2). Evidence exists for a perturbation of innate immunity as a primary pathogenic event in the disease phenotype(3). Here, we show that TREX1, encoding the major mammalian 3'-> 5' DNA exonuclease(4), is the AGS1 gene, and AGS-causing mutations result in abrogation of TREX1 enzyme activity. Similar loss of function in the Trex1(-/-) mouse leads to an inflammatory phenotype(5). Our findings suggest an unanticipated role for TREX1 in processing or clearing anomalous DNA structures, failure of which results in the triggering of an abnormal innate immune response.	Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; St Lukes Hosp, Dept Paediat, Bradford BD5 0NA, W Yorkshire, England; London Res Inst, Canc Res UK, S Mimms EN6 3LD, Herts, England; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; McGill Univ, Montreal Neurol Inst, Dept Neurogenet, Montreal, PQ, Canada; Radboud Univ Nijmegen, Med Ctr, Dept Human Genet 417, NL-6525 GA Nijmegen, Netherlands; St Lukes Hosp, Bradford Child Dev Ctr, Bradford BD5 0NA, W Yorkshire, England; Hammersmith Hosp, Imperial Coll, Dept Paediat, London W12 0HS, England; Univ Hosp AzM Maastricht, Dept Clin Genet, NL-6202 AZ Maastricht, Netherlands; Univ Hosp Essen, Dept Pediat & Pediat Neurol, D-45122 Essen, Germany; Gen Infirm, Dept Paediat Neurol, Leeds LS1 3EX, W Yorkshire, England; Our Ladys Hosp Sick Children, Natl Ctr Med Genet, Dublin 12, Ireland; Hull Royal Infirm, Dept Paediat, Kingston Upon Hull HU3 2JZ, N Humberside, England; Hop Cochin, Serv Virol, F-75674 Paris, France; Univ Paris 05, F-75674 Paris, France; Hop St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; Hop Cochin, Serv Neuropediat, F-75674 Paris, France	Saint James's University Hospital; University of Leeds; Cancer Research UK; University of Edinburgh; McGill University; Radboud University Nijmegen; Imperial College London; Maastricht University; Maastricht University Medical Centre (MUMC); University of Duisburg Essen; Leeds General Infirmary; Our Ladys Children Hospital Crumlin; University of Hull; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Crow, YJ (corresponding author), Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England.	yanickcrow@mac.com	Ali, Manir/ABE-5251-2020; Brunner, Han/C-9928-2013; Crow, Yanick J/N-6120-2014; van Bokhoven, Hans/D-8764-2012; Jackson, Andrew P/D-3442-2009; Bokhoven, J.H.L.M. van van/H-8015-2014	Ali, Manir/0000-0003-3204-3788; Crow, Yanick J/0000-0001-7211-7564; Jackson, Andrew P/0000-0002-8739-2646; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Bonthron, David/0000-0001-8132-8179; Frints, Suzanna G.M./0000-0002-5027-8364; Lynch, Sally Ann/0000-0003-3540-1333	Medical Research Council [MC_U127580972] Funding Source: Medline; MRC [MC_U127580972] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109; Aicardi J, 2000, NEUROPEDIATRICS, V31, P113, DOI 10.1055/s-2000-7533; Akwa Y, 1998, J IMMUNOL, V161, P5016; Ali M, 2006, J MED GENET, V43, P444, DOI 10.1136/jmg.2005.031880; Batteux F, 1999, EUR CYTOKINE NETW, V10, P509; BLACK DN, 1988, ANN NEUROL, V24, P483, DOI 10.1002/ana.410240402; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2000, AM J HUM GENET, V67, P213, DOI 10.1086/302955; Crow YJ, 2003, J MED GENET, V40, P183, DOI 10.1136/jmg.40.3.183; Dale RC, 2000, NEUROPEDIATRICS, V31, P155, DOI 10.1055/s-2000-7492; De Laet C, 2005, NEUROPEDIATRICS, V36, P399, DOI 10.1055/s-2005-873058; DUSSAIX E, 1985, ACTA NEUROL SCAND, V71, P504; Goutieres F, 1998, ANN NEUROL, V44, P900, DOI 10.1002/ana.410440608; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Ishii KJ, 2005, INT J CANCER, V117, P517, DOI 10.1002/ijc.21402; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; LEBON P, 1988, J NEUROL SCI, V84, P201, DOI 10.1016/0022-510X(88)90125-6; LEBON P, 1983, BRIT MED J, V287, P1165, DOI 10.1136/bmj.287.6400.1165; LINDAHL T, 1969, J BIOL CHEM, V244, P5014; Mazur DJ, 2001, J BIOL CHEM, V276, P14718, DOI 10.1074/jbc.M010051200; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Perrino FW, 2005, J BIOL CHEM, V280, P15212, DOI 10.1074/jbc.M500108200; PREBLE OT, 1982, SCIENCE, V216, P429, DOI 10.1126/science.6176024; Prokunina L, 2004, HUM MOL GENET, V13, pR143, DOI 10.1093/hmg/ddh076; Raymond AA, 1996, LUPUS, V5, P123, DOI 10.1177/096120339600500207; RICH SA, 1986, ARTHRITIS RHEUM, V29, P501, DOI 10.1002/art.1780290407; Sanchis A, 2005, J PEDIATR-US, V146, P701, DOI 10.1016/j.jpeds.2005.01.033; STEPHENSON J, 2002, EUR J PEDIAT NEUR SA, V6, P67; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070	30	610	638	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2006	38	8					917	920		10.1038/ng1845	http://dx.doi.org/10.1038/ng1845			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16845398				2022-12-27	WOS:000239325700021
J	Tirosh, I; Weinberger, A; Carmi, M; Barkai, N				Tirosh, Itay; Weinberger, Adina; Carmi, Miri; Barkai, Naama			A genetic signature of interspecies variations in gene expression	NATURE GENETICS			English	Article							YEAST TRANSCRIPTIONAL NETWORK; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; EVOLUTION; GENOME; EVOLVABILITY; PROMOTERS; MUTATION; REVEALS; PROTEIN	Phenotypic diversity is generated through changes in gene structure or gene regulation. The availability of full genomic sequences allows for the analysis of gene sequence evolution. In contrast, little is known about the principles driving the evolution of gene expression. Here we describe the differential transcriptional response of four closely related yeast species to a variety of environmental stresses. Genes containing a TATA box in their promoters show an increased interspecies variability in expression, independent of their functional association. Examining additional data sets, we find that this enhanced expression divergence of TATA-containing genes is consistent across all eukaryotes studied to date, including nematodes, fruit flies, plants and mammals. TATA-dependent regulation may enhance the sensitivity of gene expression to genetic perturbations, thus facilitating expression divergence at particular genetic loci.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Barkai, N (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	naama.barkai@weizmann.ac.il						Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Chin CS, 2005, GENOME RES, V15, P205, DOI 10.1101/gr.3243305; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Edwards-Ingram LC, 2004, GENOME RES, V14, P1043, DOI 10.1101/gr.2114704; Fay JC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r26; Gasch AP, 2004, PLOS BIOL, V2, P2202, DOI 10.1371/journal.pbio.0020398; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Ihmels J, 2002, NAT GENET, V31, P370, DOI 10.1038/ng941; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Kliebenstein DJ, 2006, GENETICS, V172, P1179, DOI 10.1534/genetics.105.049353; Landry CR, 2006, GENE, V366, P343, DOI 10.1016/j.gene.2005.10.042; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rifkin SA, 2005, NATURE, V438, P220, DOI 10.1038/nature04114; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Townsend JP, 2003, MOL BIOL EVOL, V20, P955, DOI 10.1093/molbev/msg106; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036	30	223	224	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2006	38	7					830	834		10.1038/ng1819	http://dx.doi.org/10.1038/ng1819			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16783381				2022-12-27	WOS:000238669300021
J	Zhang, JZ				Zhang, Jianzhi			Parallel adaptive origins of digestive RNases in Asian and African leaf monkeys	NATURE GENETICS			English	Article							POSITIVE DARWINIAN SELECTION; AMINO-ACID-SEQUENCES; PANCREATIC RIBONUCLEASE; CONVERGENT EVOLUTION; GENE; LYSOZYMES; TESTS	Similar morphological or physiological changes occurring in multiple evolutionary lineages are not uncommon. Such parallel changes are believed to be adaptive, because a complex character is unlikely to originate more than once by chance. However, the occurrence of adaptive parallel amino acid substitutions is debated(1-3). Here I propose four requirements for establishing adaptive parallel evolution at the protein sequence level and use these criteria to demonstrate such a case. I report that the gene encoding pancreatic ribonuclease was duplicated independently in Asian and African leaf-eating monkeys. Statistical analyses of DNA sequences, functional assays of reconstructed ancestral proteins and site-directed mutagenesis show that the new genes acquired enhanced digestive efficiencies through parallel amino acid replacements driven by darwinian selection. They also lost a non-digestive function independently, under a relaxed selective constraint. These results demonstrate that despite the overall stochasticity, even molecular evolution has a certain degree of repeatability and predictability under the pressures of natural selection.	Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Zhang, JZ (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, 1075 Nat Sci Bldg,830 N Univ Ave, Ann Arbor, MI 48109 USA.	jianzhi@umich.edu						BARNARD EA, 1969, NATURE, V221, P340, DOI 10.1038/221340a0; BEINTEMA JJ, 1990, MOL BIOL EVOL, V7, P470; Bull JJ, 1997, GENETICS, V147, P1497; Carroll SB, 2001, NATURE, V409, P1102, DOI 10.1038/35059227; Delson Eric, 1994, P11; DOOLITTLE RF, 1994, TRENDS BIOCHEM SCI, V19, P15, DOI 10.1016/0968-0004(94)90167-8; Futami J, 1997, DNA CELL BIOL, V16, P413, DOI 10.1089/dna.1997.16.413; Guyton A.C., 2011, HALL TXB MED PHYSL; HANG J, 2000, J MOL EVOL, V50, P56; JERMANN TM, 1995, NATURE, V374, P57, DOI 10.1038/374057a0; Kay Robin N. B., 1994, P229; Li W. H, 1997, MOL EVOLUTION; Magness CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r60; Monod J., 1972, CHANCE NECESSITY; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Rodriguez-Trelles F, 2003, P NATL ACAD SCI USA, V100, P13413, DOI 10.1073/pnas.1835646100; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Sorrentino S, 2003, BIOCHEMISTRY-US, V42, P10182, DOI 10.1021/bi030040q; SORRENTINO S, 1994, ARCH BIOCHEM BIOPHYS, V312, P340, DOI 10.1006/abbi.1994.1318; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; TAJIMA F, 1993, GENETICS, V135, P599; Tang H, 2004, MOL BIOL EVOL, V21, P1548, DOI 10.1093/molbev/msh158; YANG ZH, 1995, GENETICS, V141, P1641; YOKOYAMA R, 1990, P NATL ACAD SCI USA, V87, P9315, DOI 10.1073/pnas.87.23.9315; Zhang JZ, 1997, J MOL EVOL, V44, pS139, DOI 10.1007/PL00000067; Zhang JZ, 2003, MOL BIOL EVOL, V20, P1310, DOI 10.1093/molbev/msg143; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708; Zhang JZ, 2002, NAT GENET, V30, P411, DOI 10.1038/ng852; Zhang JZ, 1997, MOL BIOL EVOL, V14, P1335, DOI 10.1093/oxfordjournals.molbev.a025743; Zhang JZ, 1997, MOL BIOL EVOL, V14, P527, DOI 10.1093/oxfordjournals.molbev.a025789	30	148	158	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					819	823		10.1038/ng1812	http://dx.doi.org/10.1038/ng1812			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16767103				2022-12-27	WOS:000238669300019
J	Hornstein, E; Shomron, N				Hornstein, Eran; Shomron, Noam			Canalization of development by microRNAs	NATURE GENETICS			English	Article								Animal development is an extremely robust process resulting in stereotyped outcomes. Canalization is a design principle wherein developmental pathways are stabilized to increase phenotypic reproducibility. Recent revelations into microRNA (miRNA) function suggest that miRNAs act as key players in canalizing genetic programs. We suggest that miRNA interactions with the network of protein-coding genes evolved to buffer stochastic perturbations and thereby confer robustness to developmental genetic programs.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; MIT, Dept Biol, Cambridge, MA 02139 USA	Weizmann Institute of Science; Massachusetts Institute of Technology (MIT)	Hornstein, E (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	eran.hornstein@weizmann.ac.il	HORNSTEIN, ERAN/K-1340-2012	HORNSTEIN, ERAN/0000-0002-5534-1924				Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Brennecke J, 2005, GENE DEV, V19, P2261, DOI 10.1101/gad.1363905; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Flatt T, 2005, Q REV BIOL, V80, P287, DOI 10.1086/432265; Gibson G, 2000, BIOESSAYS, V22, P372, DOI 10.1002/(SICI)1521-1878(200004)22:4<372::AID-BIES7>3.0.CO;2-J; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; Gibson G, 1996, SCIENCE, V271, P200, DOI 10.1126/science.271.5246.200; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Keller EF, 2002, ANN NY ACAD SCI, V981, P189; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin SY, 2003, DEV CELL, V4, P639, DOI 10.1016/S1534-5807(03)00124-2; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Masel J, 2006, GENETICS, V172, P1985, DOI 10.1534/genetics.105.051649; Meir E, 2002, CURR BIOL, V12, P778, DOI 10.1016/S0960-9822(02)00839-4; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Nijhout HF, 2002, BIOESSAYS, V24, P553, DOI 10.1002/bies.10093; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RENDEL JM, 1965, GENETICS, V52, P1137; RENDEL JM, 1969, P NATL ACAD SCI USA, V64, P578, DOI 10.1073/pnas.64.2.578; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; WADDINGTON CH, 1956, EVOLUTION, V10, P1, DOI 10.2307/2406091; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Wagner GP, 2003, CURR BIOL, V13, pR958, DOI 10.1016/j.cub.2003.11.042; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	67	449	460	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2006	38			6			S20	S24		10.1038/ng1803	http://dx.doi.org/10.1038/ng1803			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	V44DK	16736020				2022-12-27	WOS:000202983200005
J	Tolhuis, B; Muijrers, I; de Wit, E; Teunissen, H; Talhout, W; van Steensel, B; van Lohuizen, M				Tolhuis, Bas; Muijrers, Inhua; de Wit, Elzo; Teunissen, Hans; Talhout, Wendy; van Steensel, Bas; van Lohuizen, Maarten			Genome-wide profiling of PRC1 and PRC2 polycomb chromatin binding in Drosophila melanogaster	NATURE GENETICS			English	Article							CELLULAR MEMORY; TRITHORAX GROUP; EXPRESSION; PROTEINS; GENE; IDENTIFICATION; TARGET; CANCER; CELLS; BMI1	Polycomb group (PcG) proteins maintain transcriptional repression of developmentally important genes(1) and have been implicated in cell proliferation and stem cell self-renewal2. We used a genome-wide approach(3) to map binding patterns of PcG proteins (Pc, esc and Sce) in Drosophila melanogaster Kc cells. We found that Pc associates with large genomic regions of up to similar to 150 kb in size, hereafter referred to as 'Pc domains'. Sce and esc accompany Pc in most of these domains. PcG-bound chromatin is trimethylated at histone H3 Lys27 and is generally transcriptionally silent. Furthermore, PcG proteins preferentially bind to developmental genes. Many of these encode transcriptional regulators and key components of signal transduction pathways, including Wingless, Hedgehog, Notch and Delta. We also identify several new putative functions of PcG proteins, such as in steroid hormone biosynthesis. These results highlight the extensive involvement of PcG proteins in the coordination of development through the formation of large repressive chromatin domains.	Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	van Lohuizen, M (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	m.v.lohuizen@nki.nl		de Wit, Elzo/0000-0003-2883-1415				Baehrecke EH, 2000, CELL DEATH DIFFER, V7, P1057, DOI 10.1038/sj.cdd.4400753; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breiling A, 2004, EMBO REP, V5, P976, DOI 10.1038/sj.embor.7400260; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; Ficz G, 2005, DEVELOPMENT, V132, P3963, DOI 10.1242/dev.01950; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Kirmizis A, 2003, MOL CANCER THER, V2, P113; Klebes A, 2005, DEVELOPMENT, V132, P3753, DOI 10.1242/dev.01927; Lascaris R, 2003, GENOME BIOL, V4; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Maurange C, 2002, GENE DEV, V16, P2672, DOI 10.1101/gad.242702; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Paul SM, 2003, DEVELOPMENT, V130, P4963, DOI 10.1242/dev.00691; Rietveld LEG, 2002, EMBO J, V21, P1389, DOI 10.1093/emboj/21.6.1389; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schubeler D, 2002, NAT GENET, V32, P438, DOI 10.1038/ng1005; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Sun LV, 2003, P NATL ACAD SCI USA, V100, P9428, DOI 10.1073/pnas.1533393100; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; van Steensel B, 2003, P NATL ACAD SCI USA, V100, P2580, DOI 10.1073/pnas.0438000100; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799	30	289	301	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					694	699		10.1038/ng1792	http://dx.doi.org/10.1038/ng1792			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16628213				2022-12-27	WOS:000237954800025
J	Smith, FJD; Irvine, AD; Terron-Kwiatkowski, A; Sandilands, A; Campbell, LE; Zhao, YW; Liao, HH; Evans, AT; Goudie, DR; Lewis-Jones, S; Arseculeratne, G; Munro, CS; Sergeant, A; O'Regan, G; Bale, SJ; Compton, JG; DiGiovanna, JJ; Presland, RB; Fleckman, P; McLean, WHI				Smith, FJD; Irvine, AD; Terron-Kwiatkowski, A; Sandilands, A; Campbell, LE; Zhao, YW; Liao, HH; Evans, AT; Goudie, DR; Lewis-Jones, S; Arseculeratne, G; Munro, CS; Sergeant, A; O'Regan, G; Bale, SJ; Compton, JG; DiGiovanna, JJ; Presland, RB; Fleckman, P; McLean, WHI			Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris	NATURE GENETICS			English	Article							EPIDERMAL DIFFERENTIATION COMPLEX; N-TERMINAL DOMAIN; FLAKY TAIL; GENOMIC ORGANIZATION; LAMELLAR ICHTHYOSIS; HUMAN PROFILAGGRIN; SKIN; IDENTIFICATION; EXPRESSION; PROTEINS	Ichthyosis vulgaris (OMIM 146700) is the most common inherited disorder of keratinization and one of the most frequent single-gene disorders in humans. The most widely cited incidence figure is 1 in 250 based on a survey of 6,051 healthy English schoolchildren(1). We have identified homozygous or compound heterozygous mutations R501X and 2282del4 in the gene encoding filaggrin (FLG) as the cause of moderate or severe ichthyosis vulgaris in 15 kindreds. In addition, these mutations are semidominant; heterozygotes show a very mild phenotype with incomplete penetrance. The mutations show a combined allele frequency of similar to 4% in populations of European ancestry, explaining the high incidence of ichthyosis vulgaris. Profilaggrin is the major protein of keratohyalin granules in the epidermis. During terminal differentiation, it is cleaved into multiple filaggrin peptides that aggregate keratin filaments. The resultant matrix is cross-linked to form a major component of the cornified cell envelope. We find that loss or reduction of this major structural protein leads to varying degrees of impaired keratinization.	Univ Dundee, Ninewells Hosp & Med Sch, Div Pathol & Neurosci, Human Genet Unit,Epithelial Genet Grp, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Tayside Univ Hosp NHS Trust, Dundee DD1 9SY, Scotland; Our Ladys Hosp Sick Children, Dept Paediat Dermatol, Dublin 12, Ireland; S Glasgow Univ Hosp NHS Trust, Dept Dermatol, Glasgow G51 4TF, Lanark, Scotland; Gene Dx, Gaithersburg, MD 20877 USA; Rhode Isl Hosp, Providence, RI 02903 USA; Brown Univ, Sch Med, Dept Dermatol, Div Dermatopharmacol, Providence, RI 02903 USA; NCI, Basic Res Lab, Canc Res Ctr, NIH, Bethesda, MD 20892 USA; Univ Washington, Sch Dent, Seattle, WA 98195 USA; Univ Washington, Dept Med, Div Dermatol, Seattle, WA 98195 USA	University of Dundee; University of Dundee; Our Ladys Children Hospital Crumlin; University of Glasgow; Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	McLean, WHI (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Pathol & Neurosci, Human Genet Unit,Epithelial Genet Grp, Dundee DD1 9SY, Scotland.	w.h.i.mclean@dundee.ac.uk	Irvine, Alan D/A-3982-2008; McLean, William HI/C-6352-2009	Irvine, Alan D/0000-0002-9048-2044; DiGiovanna, John J./0000-0002-2750-2313; McLean, William Henry Irwin/0000-0001-5539-5757; Presland, Richard/0000-0003-1440-7402	Medical Research Council [G0700314] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bale SJ, 1996, J INVEST DERMATOL, V107, P140, DOI 10.1111/1523-1747.ep12298430; Bitoun E, 2002, J INVEST DERMATOL, V118, P352, DOI 10.1046/j.1523-1747.2002.01603.x; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Compton JG, 2002, EXP DERMATOL, V11, P518, DOI 10.1034/j.1600-0625.2002.110604.x; DALE BA, 1985, ANN NY ACAD SCI, V455, P330, DOI 10.1111/j.1749-6632.1985.tb50420.x; Eady R. A. J., 1985, METHODS SKIN RES, P1; FLECKMAN P, 1987, J INVEST DERMATOL, V88, P640, DOI 10.1111/1523-1747.ep12470251; GAN SQ, 1990, BIOCHEMISTRY-US, V29, P9432, DOI 10.1021/bi00492a018; Ishida-Yamamoto A, 1998, LAB INVEST, V78, P1245; JUDGE MR, 2004, ROOKS TXB DERMATOLOG, V2, P56; Kuokkanen K, 1969, Acta Derm Venereol Suppl (Stockh), V62, P1; LANE PW, 1972, J HERED, V63, P135, DOI 10.1093/oxfordjournals.jhered.a108252; Listwan P, 2004, METHOD CELL BIOL, V78, P817; MARKOVA NG, 1993, MOL CELL BIOL, V13, P613, DOI 10.1128/MCB.13.1.613; MCLEAN WHI, 1994, J INVEST DERMATOL, V102, P24, DOI 10.1111/1523-1747.ep12371726; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Nirunsuksiri W, 1998, J INVEST DERMATOL, V110, P854, DOI 10.1046/j.1523-1747.1998.00208.x; Pearton DJ, 2002, J INVEST DERMATOL, V119, P661, DOI 10.1046/j.1523-1747.2002.01831.x; Penabad CP, 1998, BRIT J DERMATOL, V139, P958; Presland RB, 1997, J INVEST DERMATOL, V108, P170, DOI 10.1111/1523-1747.ep12333356; PRESLAND RB, 1992, J BIOL CHEM, V267, P23772; Presland RB, 2000, J INVEST DERMATOL, V115, P1072, DOI 10.1046/j.1523-1747.2000.00178.x; ROTHNAGEL JA, 1994, GENOMICS, V23, P450, DOI 10.1006/geno.1994.1522; ROTHNAGEL JA, 1990, J BIOL CHEM, V265, P1862; Smith FJD, 1998, J INVEST DERMATOL, V111, P817, DOI 10.1046/j.1523-1747.1998.00371.x; STEINERT PM, 1981, P NATL ACAD SCI-BIOL, V78, P4097, DOI 10.1073/pnas.78.7.4097; SYBERT VP, 1985, J INVEST DERMATOL, V84, P191, DOI 10.1111/1523-1747.ep12264813; Tay YK, 1999, ASIAN PAC J ALLERGY, V17, P137; WELLS RS, 1966, BRIT MED J, V1, P947, DOI 10.1136/bmj.1.5493.947; Zhong W, 2003, J HUM GENET, V48, P390, DOI 10.1007/s10038-003-0043-1	30	685	728	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					337	342		10.1038/ng1743	http://dx.doi.org/10.1038/ng1743			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16444271				2022-12-27	WOS:000235589600016
J	Ohgami, RS; Campagna, DR; Greer, EL; Antiochos, B; McDonald, A; Chen, J; Sharp, JJ; Fujiwara, Y; Barker, JE; Fleming, MD				Ohgami, RS; Campagna, DR; Greer, EL; Antiochos, B; McDonald, A; Chen, J; Sharp, JJ; Fujiwara, Y; Barker, JE; Fleming, MD			Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR GENE; PROSTATE-CANCER; SACCHAROMYCES-CEREVISIAE; FERRIC REDUCTASE; MEMBRANE ANTIGEN; APOPTOSIS; PROTEIN; INDUCTION; MUTATION; PRODUCT	The reduction of iron is an essential step in the transferrin (Tf) cycle, which is the dominant pathway for iron uptake by red blood cell precursors. A deficiency in iron acquisition by red blood cells leads to hypochromic, microcytic anemia. Using a positional cloning strategy, we identified a gene, six-transmembrane epithelial antigen of the prostate 3 (Steap3), responsible for the iron deficiency anemia in the mouse mutant nm1054. Steap3 is expressed highly in hematopoietic tissues, colocalizes with the Tf cycle endosome and facilitates Tf-bound iron uptake. Steap3 shares homology with F420H2:NADP(+) oxidoreductases found in archaea and bacteria, as well as with the yeast FRE family of metalloreductases. Overexpression of Steap3 stimulates the reduction of iron, and mice lacking Steap3 are deficient in erythroid ferrireductase activity. Taken together, these findings indicate that Steap3 is an endosomal ferrireductase required for efficient Tf-dependent iron uptake in erythroid cells.	Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Tosteson Med Educ Ctr, Med Scientist Training Program, Boston, MA 02115 USA; Millennium Pharmaceut Inc, Cambridge, MA 01239 USA; Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Childrens Hosp, Div Hematol, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Harvard University; Brigham & Women's Hospital; Jackson Laboratory; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Fleming, MD (corresponding author), Childrens Hosp, Dept Pathol, 300 Longwood Ave, Boston, MA 02115 USA.	mark.fleming@childrens.harvard.edu	Ohgami, R/AAE-1448-2019	Greer, Eric/0000-0002-7501-7371; Fleming, Mark/0000-0003-0948-4024	NHLBI NIH HHS [R01 HL074247-01, R01 HL074247] Funding Source: Medline; NIDDK NIH HHS [R01 DK027726, P30 DK049216] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216, R01DK027726] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Dhungana S, 2004, BIOCHEMISTRY-US, V43, P205, DOI 10.1021/bi0353631; Finegold AA, 1996, J BIOL CHEM, V271, P31021, DOI 10.1074/jbc.271.49.31021; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Goldman G L, 1976, J Forensic Sci, V21, P625; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; GUNSHIN HS, 2005, BLOOD           0616, DOI DOI 10.1182/BLOOD-2004-02-0716; Hubert RS, 1999, P NATL ACAD SCI USA, V96, P14523, DOI 10.1073/pnas.96.25.14523; INMAN RS, 1994, BIOCHEMISTRY-US, V33, P11850, DOI 10.1021/bi00205a022; Labbe RF, 1999, CLIN CHEM, V45, P2060; Lesuisse E, 1996, J BIOL CHEM, V271, P13578, DOI 10.1074/jbc.271.23.13578; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; Moldes M, 2001, J BIOL CHEM, V276, P33938, DOI 10.1074/jbc.M105726200; NUNEZ MT, 1990, J BIOL CHEM, V265, P6688; OHGAMI RS, 2005, BLOOD           0630, DOI DOI 10.1185/BLOOD-2005-01-0379; Passer BJ, 2003, P NATL ACAD SCI USA, V100, P2284, DOI 10.1073/pnas.0530298100; Ponka P, 1997, BLOOD, V89, P1; Porkka KP, 2002, LAB INVEST, V82, P1573, DOI 10.1097/01.LAB.0000038554.26102.C6; Porkka KP, 2003, INT J CANCER, V106, P729, DOI 10.1002/ijc.11278; Ross JS, 2003, CLIN CANCER RES, V9, P6357; Sanchez-Pulido L, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-98; Schwaller J, 1998, EMBO J, V17, P5321, DOI 10.1093/emboj/17.18.5321; Shatwell KP, 1996, J BIOL CHEM, V271, P14240, DOI 10.1074/jbc.271.24.14240; Steiner MS, 2000, CANCER RES, V60, P4419; Su MA, 1998, BLOOD, V92, P2157, DOI 10.1182/blood.V92.6.2157.418k16_2157_2163; Warkentin E, 2001, EMBO J, V20, P6561, DOI 10.1093/emboj/20.23.6561; Yang DM, 2001, CANCER RES, V61, P5857; Zhang XG, 2001, ONCOGENE, V20, P5982, DOI 10.1038/sj.onc.1204831	30	466	485	1	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1264	1269		10.1038/ng1658	http://dx.doi.org/10.1038/ng1658			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16227996	Green Accepted			2022-12-27	WOS:000233045200028
J	Verstrepen, KJ; Jansen, A; Lewitter, F; Fink, GR				Verstrepen, KJ; Jansen, A; Lewitter, F; Fink, GR			Intragenic tandem repeats generate functional variability	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; MAMMARY-GLAND; YEAST; DNA; GENES; RECOMBINATION; REPLICATION; MUTATIONS; PROTEINS; FREQUENCIES	Tandemly repeated DNA sequences are highly dynamic components of genomes(1). Most repeats are in intergenic regions, but some are in coding sequences or pseudogenes(2). In humans, expansion of intragenic triplet repeats is associated with various diseases, including Huntington chorea and fragile X syndrome(3,4). The persistence of intragenic repeats in genomes suggests that there is a compensating benefit. Here we show that in the genome of Saccharomyces cerevisiae, most genes containing intragenic repeats encode cell- wall proteins. The repeats trigger frequent recombination events in the gene or between the gene and a pseudogene, causing expansion and contraction in the gene size. This size variation creates quantitative alterations in phenotypes ( e. g., adhesion, flocculation or biofilm formation). We propose that variation in intragenic repeat number provides the functional diversity of cell surface antigens that, in fungi and other pathogens, allows rapid adaptation to the environment and elusion of the host immune system.	MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Katholieke Univ Leuven, Fac Appl Biosci & Engn, Dept Microbial & Mol Syst, Ctr Malting & Brewing Sci, B-3001 Leuven, Belgium	Massachusetts Institute of Technology (MIT); Whitehead Institute; KU Leuven	Fink, GR (corresponding author), MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	GFink@wi.mit.edu	Verstrepen, Kevin/AAA-4343-2021; Jansen, An/T-9228-2018	Jansen, An/0000-0003-2412-0456; Verstrepen, Kevin/0000-0002-3077-6219	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035010] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM035010] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boceta C, 2000, PARASITE IMMUNOL, V22, P55, DOI 10.1046/j.1365-3024.2000.00269.x; Callahan JL, 2003, MOL CELL BIOL, V23, P7849, DOI 10.1128/MCB.23.21.7849-7860.2003; Davis AP, 2001, GENETICS, V159, P515; Debrauwere H, 2001, P NATL ACAD SCI USA, V98, P8263, DOI 10.1073/pnas.121075598; Fondon JW, 2004, P NATL ACAD SCI USA, V101, P18058, DOI 10.1073/pnas.0408118101; Guo B, 2000, P NATL ACAD SCI USA, V97, P12158, DOI 10.1073/pnas.220420397; Harrison P, 2002, J MOL BIOL, V316, P409, DOI 10.1006/jmbi.2001.5343; Hartl DL, 2000, NAT REV GENET, V1, P145, DOI 10.1038/35038580; Hood DW, 1996, P NATL ACAD SCI USA, V93, P11121, DOI 10.1073/pnas.93.20.11121; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Keim P, 1999, J APPL MICROBIOL, V87, P215, DOI 10.1046/j.1365-2672.1999.00873.x; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kokoska RJ, 1998, MOL CELL BIOL, V18, P2779, DOI 10.1128/MCB.18.5.2779; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Liu HP, 1996, GENETICS, V144, P967; Lovett ST, 2004, MOL MICROBIOL, V52, P1243, DOI 10.1111/j.1365-2958.2004.04076.x; Marinangeli P, 2004, FEMS YEAST RES, V4, P427, DOI 10.1016/S1567-1356(03)00172-7; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Patton S, 1995, BBA-REV BIOMEMBRANES, V1241, P407, DOI 10.1016/0304-4157(95)00014-3; PAYS E, 1994, ANNU REV MICROBIOL, V48, P25, DOI 10.1146/annurev.mi.48.100194.000325; Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richard GF, 1999, MOL GEN GENET, V261, P871, DOI 10.1007/s004380050031; Sakihama N, 2004, PARASITOL INT, V53, P59, DOI 10.1016/j.parint.2003.11.002; Schroeder JA, 2004, ONCOGENE, V23, P5739, DOI 10.1038/sj.onc.1207713; SHERMAN F, 1991, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; Verstrepen KJ, 2004, NAT REV MICROBIOL, V2, P533, DOI 10.1038/nrmicro927; Viguera E, 2001, EMBO J, V20, P2587, DOI 10.1093/emboj/20.10.2587	30	424	457	1	55	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					986	990		10.1038/ng1618	http://dx.doi.org/10.1038/ng1618			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16086015	Green Published, Green Accepted			2022-12-27	WOS:000231591900025
J	Aubin, I; Adams, CP; Opsahl, S; Septier, D; Bishop, CE; Auge, N; Salvayre, R; Negre-Salvayre, A; Goldberg, M; Guenet, JL; Poirier, C				Aubin, I; Adams, CP; Opsahl, S; Septier, D; Bishop, CE; Auge, N; Salvayre, R; Negre-Salvayre, A; Goldberg, M; Guenet, JL; Poirier, C			A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse	NATURE GENETICS			English	Article							BRITTLE BONE-DISEASE; FRAGILITAS-OSSIUM; FORM; MINERALIZATION; CERAMIDE; FRO/FRO	The mouse mutation fragilitas ossium (fro) leads to a syndrome of severe osteogenesis and dentinogenesis imperfecta with no detectable collagen defect. Positional cloning of the locus identified a deletion in the gene encoding neutral sphingomyelin phosphodiesterase 3 (Smpd3) that led to complete loss of enzymatic activity. Our knowledge of SMPD3 function is consistent with the pathology observed in mutant mice and provides new insight into human pathologies.	Inst Pasteur, Unite Genet Mammiferes, F-75724 Paris, France; Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; Univ Paris 05, Fac Chirurg Dent, EA 2496, F-92120 Montrouge, France; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; CHU Rangueil, INSERM, U466, F-31059 Toulouse, France; CHU Rangueil, Dept Biochem, IFR 31, F-31059 Toulouse, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Baylor College of Medicine; UDICE-French Research Universities; Universite Paris Cite; Baylor College of Medicine; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse	Guenet, JL (corresponding author), Inst Pasteur, Unite Genet Mammiferes, 25 Rue Docteur Roux, F-75724 Paris, France.	guenet@pasteur.fr	Vital, Sibylle/AAK-3479-2021	Vital, Sibylle/0000-0001-6352-2525; Auge, Nathalie/0000-0003-2088-7211; Negre-Salvayre, Anne/0000-0003-2136-5706				Auge N, 1998, J BIOL CHEM, V273, P12893, DOI 10.1074/jbc.273.21.12893; Forlino A, 2000, MOL GENET METAB, V71, P225, DOI 10.1006/mgme.2000.3039; Glorieux FH, 2002, J BONE MINER RES, V17, P30, DOI 10.1359/jbmr.2002.17.1.30; Glorieux FH, 2000, J BONE MINER RES, V15, P1650, DOI 10.1359/jbmr.2000.15.9.1650; Goldberg M, 1996, PROG HISTOCHEM CYTOC, V31, P1; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; Grey A, 2004, CALCIFIED TISSUE INT, V74, P542, DOI 10.1007/s00223-003-0155-9; GUENET JL, 1981, J HERED, V72, P440, DOI 10.1093/oxfordjournals.jhered.a109554; MURIEL MP, 1991, BONE, V12, P241, DOI 10.1016/8756-3282(91)90070-Y; SILLENCE DO, 1993, AM J MED GENET, V45, P276, DOI 10.1002/ajmg.1320450227; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Takeda H, 1998, FEBS LETT, V422, P255, DOI 10.1016/S0014-5793(98)00005-2; Ward LM, 2002, BONE, V31, P12, DOI 10.1016/S8756-3282(02)00790-1; Wu LNY, 2002, J BIOL CHEM, V277, P5126, DOI 10.1074/jbc.M107899200	14	132	134	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2005	37	8					803	805		10.1038/ng1603	http://dx.doi.org/10.1038/ng1603			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16025116				2022-12-27	WOS:000230880400008
J	Meyre, D; Bouatia-Naji, N; Tounian, A; Samson, C; Lecoeur, C; Vatin, V; Ghoussaini, M; Wachter, C; Hercberg, S; Charpentier, G; Patsch, W; Pattou, F; Charles, MA; Tounian, P; Clement, K; Jouret, B; Weill, J; Maddux, BA; Goldfine, ID; Walley, A; Boutin, P; Dina, C; Froguel, P				Meyre, D; Bouatia-Naji, N; Tounian, A; Samson, C; Lecoeur, C; Vatin, V; Ghoussaini, M; Wachter, C; Hercberg, S; Charpentier, G; Patsch, W; Pattou, F; Charles, MA; Tounian, P; Clement, K; Jouret, B; Weill, J; Maddux, BA; Goldfine, ID; Walley, A; Boutin, P; Dina, C; Froguel, P			Variants of ENPP1 are associated with childhood and adult obesity and increase the risk of glucose intolerance and type 2 diabetes	NATURE GENETICS			English	Article							MEMBRANE GLYCOPROTEIN PC-1; GENOME-WIDE SCAN; INSULIN-RESISTANCE; SUSCEPTIBILITY GENES; SIGNIFICANT LINKAGE; FASTING INSULIN; RECEPTOR; MELLITUS; POPULATION; AMERICAN	We identified a locus on chromosome 6q16.3-q24.2 (ref. 1) associated with childhood obesity that includes 2.4 Mb common to eight genome scans for type 2 diabetes (T2D) or obesity(1-8). Analysis of the gene ENPP1 (also called PC-1), a candidate for insulin resistance(9,10), in 6,147 subjects showed association between a three-allele risk haplotype (K121Q, IVS20delT-11 and A -> G+1044TGA; QdelTG) and childhood obesity (odds ratio (OR) = 1.69, P = 0.0006), morbid or moderate obesity in adults (OR = 1.50, P = 0.006 or OR = 1.37, P = 0.02, respectively) and T2D (OR = 1.56, P = 0.00002). The Genotype IBD Sharing Test suggested that this obesity-associated ENPP1 risk haplotype contributes to the observed chromosome 6q linkage with childhood obesity. The haplotype confers a higher risk of glucose intolerance and T2D to obese children and their parents and associates with increased serum levels of soluble ENPP1 protein in children. Expression of a long ENPP1 mRNA isoform, which includes the obesity-associated A -> G+1044TGA SNP, was specific for pancreatic islet beta cells, adipocytes and liver. These findings suggest that several variants of ENPP1 have a primary role in mediating insulin resistance and in the development of both obesity and T2D, suggesting that an underlying molecular mechanism is common to both conditions.	Inst Pasteur, Inst Biol, CNRS 8090, F-59019 Lille, France; Univ London Imperial Coll Sci Technol & Med, Sect Genom Med, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Genome Ctr, London W12 0NN, England; Hop Hotel Dieu, EA3502, Paris, France; ISTNA, INRA, U1125, INSERM,U557, Paris, France; Paracelsus Private Med Sch, Salzburg, Austria; Univ Lille 2, INSERM, ERIT M 0106, Lille, France; Fac Med Paris Sud, IFR69, INSERM, U258, Villejuif, France; Trousseau Hosp, Dept Pediat Gastroenterol & Nutr, Paris, France; Childrens Hosp, INSERM, U563, Toulouse, France; Jeanne de Flandre Hosp, Pediat Endocrine Unit, Lille, France; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Imperial College London; Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Paracelsus Private Medical University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Froguel, P (corresponding author), Inst Pasteur, Inst Biol, CNRS 8090, F-59019 Lille, France.	froguel@good.ibl.fr	FROGUEL, Philippe/O-6799-2017; Charles, Marie Aline/S-1866-2019; Dina, Christian R/D-3535-2015; Serge, Hercberg/F-3038-2017; Walley, Andrew J/D-2573-2009; Jouret, Béatrice/AAC-8146-2019; Tounian, Patrick/AAF-6226-2021; Charles, Marie Aline/F-8567-2017; HERCBERG, Serge/B-4429-2008; Clément, karine/R-1120-2017; Meyre, David/D-7315-2011; BOUATIA-NAJI, NABILA/D-5863-2013; Bouatia-Naji, Nabila/AGF-1400-2022; Pattou, Francois/O-6151-2017	FROGUEL, Philippe/0000-0003-2972-0784; Charles, Marie Aline/0000-0003-4025-4390; Dina, Christian R/0000-0002-7722-7348; Serge, Hercberg/0000-0002-3168-1350; Walley, Andrew J/0000-0001-7707-7549; Charles, Marie Aline/0000-0003-4025-4390; HERCBERG, Serge/0000-0002-3168-1350; Meyre, David/0000-0003-4850-7444; Bouatia-Naji, Nabila/0000-0001-5424-2134; Pattou, Francois/0000-0001-8388-3766	MRC [G0000477] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056933] Funding Source: NIH RePORTER; Medical Research Council [G0000477] Funding Source: Medline; NIDDK NIH HHS [R01 DK056933, R01 DK056933-04S1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; Atwood LD, 2002, AM J HUM GENET, V71, P1044, DOI 10.1086/343822; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Costanzo BV, 2001, DIABETES, V50, P831, DOI 10.2337/diabetes.50.4.831; Demenais F, 2003, HUM MOL GENET, V12, P1865, DOI 10.1093/hmg/ddg195; Dong HJ, 2005, DIABETES, V54, P367, DOI 10.2337/diabetes.54.2.367; Duggirala R, 2001, AM J HUM GENET, V68, P1149, DOI 10.1086/320100; Eaves IA, 1999, NAT GENET, V22, P324, DOI 10.1038/11890; Ehm MG, 2000, AM J HUM GENET, V66, P1871, DOI 10.1086/302950; Ghosh S, 2000, AM J HUM GENET, V67, P1174, DOI 10.1016/S0002-9297(07)62948-6; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hercberg S, 1998, CONTROL CLIN TRIALS, V19, P336, DOI 10.1016/S0197-2456(98)00015-4; Johnson MS, 2001, J CLIN ENDOCR METAB, V86, P3182, DOI 10.1210/jc.86.7.3182; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Lafay L, 1997, INT J OBESITY, V21, P567, DOI 10.1038/sj.ijo.0800443; Li C, 2004, AM J HUM GENET, V74, P418, DOI 10.1086/381712; MADDUX BA, 1995, NATURE, V373, P448, DOI 10.1038/373448a0; Maddux BA, 2000, DIABETES, V49, P13, DOI 10.2337/diabetes.49.1.13; Meyre D, 2004, DIABETES, V53, P803, DOI 10.2337/diabetes.53.3.803; Oberkofler H, 2004, DIABETES, V53, P1385, DOI 10.2337/diabetes.53.5.1385; Rutsch F, 2001, AM J PATHOL, V158, P543, DOI 10.1016/S0002-9440(10)63996-X; SELTZER HS, 1967, J CLIN INVEST, V46, P323, DOI 10.1172/JCI105534; Stefanovic Vladisav, 2004, Clin Lab, V50, P271; Tregouet DA, 2004, ANN HUM GENET, V68, P165, DOI 10.1046/j.1529-8817.2003.00085.x; Weill J, 2004, ARCH DIS CHILD, V89, P502, DOI 10.1136/adc.2003.028548; Xiang KS, 2004, DIABETES, V53, P228, DOI 10.2337/diabetes.53.1.228	27	242	255	0	16	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2005	37	8					863	867		10.1038/ng1604	http://dx.doi.org/10.1038/ng1604			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16025115	Green Submitted, Green Accepted			2022-12-27	WOS:000230880400016
J	Ting, AH; Schuebel, KE; Herman, JG; Baylin, SB				Ting, AH; Schuebel, KE; Herman, JG; Baylin, SB			Short double-stranded RNA induces transcriptional gene silencing in human cancer cells in the absence of DNA methylation	NATURE GENETICS			English	Article							DE-NOVO METHYLATION; LYSINE-9 METHYLATION; X-CHROMOSOME; HISTONE H3; E-CADHERIN; INACTIVATION; PROTEIN; MAINTENANCE; MECHANISMS; EXPRESSION	Double-stranded RNA molecules targeted to gene promoter regions can induce transcriptional gene silencing in a DNA cytosine methylation-dependent manner in plants (RNA-dependent DNA methylation)(1-3). Whether a similar mechanism exists in mammalian systems is a vital and controversial issue(4-6). DNA methylation is an important component in mammalian gene silencing for normal processes such as gene imprinting and X-chromosome inactivation(7-9), and aberrant CpG island hypermethylation at tumor-suppressor promoters is associated with transcriptional silencing and loss of gene function in cancer(10). Hence, we investigated whether RNA-dependent DNA methylation might operate in human cancers to mediate epigenetic silencing using the endogenous gene CDH1 as a potential target. The loss of this cell-cell adhesion factor facilitates the metastatic process, and its promoter is frequently hypermethylated in breast and other cancers(11-13). We found that, although small double-stranded RNAs targeted exclusively to the CDH1 promoter could effectively induce transcriptional repression with chromatin changes characteristic of inactive promoters, this was entirely independent of DNA methylation. Moreover, we could accomplish such silencing in a cancer cell line genetically modified to lack virtually any capacity to methylate DNA.	Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Grad Program Cellular & Mol Med, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Div Canc Biol, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Baylin, SB (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Grad Program Cellular & Mol Med, Baltimore, MD 21231 USA.	sbaylin@jhmi.edu			NATIONAL CANCER INSTITUTE [R01CA043318] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA043318-19, R01 CA043318] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aufsatz W, 2004, PLANT MOL BIOL, V54, P793, DOI 10.1007/s11103-004-0179-1; Aufsatz W, 2002, EMBO J, V21, P6832, DOI 10.1093/emboj/cdf663; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Graff JR, 1997, J BIOL CHEM, V272, P22322, DOI 10.1074/jbc.272.35.22322; GRAFF JR, 1995, CANCER RES, V55, P5195; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hiraguri S, 1998, CANCER RES, V58, P1972; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Matzke M, 2004, BBA-GENE STRUCT EXPR, V1677, P129, DOI 10.1016/j.bbaexp.2003.10.015; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Park CW, 2004, BIOCHEM BIOPH RES CO, V323, P275, DOI 10.1016/j.bbrc.2004.08.096; Pelissier T, 1999, NUCLEIC ACIDS RES, V27, P1625, DOI 10.1093/nar/27.7.1625; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; REIK W, 1987, NATURE, V328, P248, DOI 10.1038/328248a0; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Schmelz K, 2005, LEUKEMIA, V19, P103, DOI 10.1038/sj.leu.2403552; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8	30	223	250	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2005	37	8					906	910		10.1038/ng1611	http://dx.doi.org/10.1038/ng1611			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16025112	Green Accepted			2022-12-27	WOS:000230880400024
J	Ravikumar, B; Acevedo-Arozena, A; Imarisio, S; Berger, Z; Vacher, C; O'Kane, CJ; Brown, SDM; Rubinsztein, DC				Ravikumar, B; Acevedo-Arozena, A; Imarisio, S; Berger, Z; Vacher, C; O'Kane, CJ; Brown, SDM; Rubinsztein, DC			Dynein mutations impair autophagic clearance of aggregate-prone proteins	NATURE GENETICS			English	Article							FAST AXONAL-TRANSPORT; ALPHA-SYNUCLEIN; IN-VITRO; POLYGLUTAMINE; HUNTINGTIN; NEURONS; MICROTUBULE; MICE; DEGENERATION; DISRUPTION	Mutations that affect the dynein motor machinery are sufficient to cause motor neuron disease. It is not known why there are aggregates or inclusions in affected tissues in mice with such mutations and in most forms of human motor neuron disease. Here we identify a new mechanism of inclusion formation by showing that decreased dynein function impairs autophagic clearance of aggregate- prone proteins. We show that mutations of the dynein machinery enhanced the toxicity of the mutation that causes Huntington disease in fly and mouse models. Furthermore, loss of dynein function resulted in premature aggregate formation by mutant huntingtin and increased levels of the autophagosome marker LC3- II in both cell culture and mouse models, compatible with impaired autophagosomelysosome fusion.	Addenbrookes Hosp, Dept Med Genet, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; MRC, Mammalian Genet Unit, Harwell, Oxon, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Rubinsztein, DC (corresponding author), Addenbrookes Hosp, Dept Med Genet, Cambridge Inst Med Res, Wellcome MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	dcr1000@hermes.cam.ac.uk	O'Kane, Cahir J/C-4413-2011; Rubinsztein, David C/C-3472-2011; Arozena, Abraham Acevedo/L-6584-2018; O'Kane, Cahir/Q-6681-2019	Arozena, Abraham Acevedo/0000-0001-6127-7116; O'Kane, Cahir/0000-0002-3488-2078	MRC [G0000872] Funding Source: UKRI; Medical Research Council [G0000872] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bananis E, 2000, J CELL BIOL, V151, P179, DOI 10.1083/jcb.151.1.179; Bannai H, 2004, J CELL SCI, V117, P163, DOI 10.1242/jcs.00854; Bauvy C, 2001, EXP CELL RES, V268, P139, DOI 10.1006/excr.2001.5285; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; EKSTROM P, 1984, J NEUROCHEM, V43, P1342, DOI 10.1111/j.1471-4159.1984.tb05392.x; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; LaMonte BH, 2002, NEURON, V34, P715, DOI 10.1016/S0896-6273(02)00696-7; LEIGH PN, 1991, BRAIN, V114, P775, DOI 10.1093/brain/114.2.775; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Narain Y, 1999, J MED GENET, V36, P739, DOI 10.1136/jmg.36.10.739; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Rogers DC, 2001, NEUROSCI LETT, V306, P89, DOI 10.1016/S0304-3940(01)01885-7; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Szebenyi G, 2003, NEURON, V40, P41, DOI 10.1016/S0896-6273(03)00569-5; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Webb JL, 2004, INT J BIOCHEM CELL B, V36, P2541, DOI 10.1016/j.biocel.2004.02.003; Wubbolts R, 1999, J CELL SCI, V112, P785	30	360	373	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					771	776		10.1038/ng1591	http://dx.doi.org/10.1038/ng1591			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15980862				2022-12-27	WOS:000230196400027
J	Fischer, E; Sauer, U				Fischer, E; Sauer, U			Large-scale in vivo flux analysis shows rigidity and suboptimal performance of Bacillus subtilis metabolism	NATURE GENETICS			English	Article							PENTOSE-PHOSPHATE PATHWAY; ESCHERICHIA-COLI; GROWTH; ORGANIZATION; EVOLUTION; NETWORKS; GENOME	Qualitative theoretical approaches such as graph theory(1,2) and stoichiometric analyses(3-6) are beginning to uncover the architecture and systemic functions of complex metabolic reaction networks. At present, however, only a few, largely unproven quantitative concepts propose functional design principles of the global flux distribution(7,8). As operational units of function, molecular fluxes determine the systemic cell phenotype by linking genes, proteins and metabolites to higher-level biological functions(9). In sharp contrast to other 'omics' analyses, 'fluxome' analysis remained tedious(10). By large-scale quantification of in vivo flux responses, we identified a robust flux distribution in 137 null mutants of Bacillus subtilis. On its preferred substrate, B. subtilis has suboptimal metabolism because regulators of developmental programs maintain a 'standby' mode that invests substantial resources in anticipation of changing environmental conditions at the expense of optimal growth. Network rigidity and robustness are probably universal functional design principles, whereas the standby mode may be more specific.	ETH, Inst Biotechnol, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Sauer, U (corresponding author), ETH, Inst Biotechnol, CH-8093 Zurich, Switzerland.	sauer@biotech.biol.ethz.ch	Fischer, Eliane/M-2590-2013; Sauer, Uwe/Y-3556-2019	Fischer, Eliane/0000-0002-3399-3737; 				Arita M, 2004, P NATL ACAD SCI USA, V101, P1543, DOI 10.1073/pnas.0306458101; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007; Dauner M, 2001, J BACTERIOL, V183, P7308, DOI 10.1128/JB.183.24.7308-7317.2001; Dauner M, 2001, BIOTECHNOL BIOENG, V76, P132, DOI 10.1002/bit.1153; Duetz WA, 2000, APPL ENVIRON MICROB, V66, P2641, DOI 10.1128/AEM.66.6.2641-2646.2000; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Fischer E, 2004, ANAL BIOCHEM, V325, P308, DOI 10.1016/j.ab.2003.10.036; Fischer E, 2003, J BIOL CHEM, V278, P46446, DOI 10.1074/jbc.M307968200; Fischer S.H., 2002, BACILLUS SUBTILIS IT, P181; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hellerstein MK, 2003, ANNU REV NUTR, V23, P379, DOI 10.1146/annurev.nutr.23.011702.073045; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Moritz B, 2000, EUR J BIOCHEM, V267, P3442, DOI 10.1046/j.1432-1327.2000.01354.x; Msadek T, 1999, TRENDS MICROBIOL, V7, P201, DOI 10.1016/S0966-842X(99)01479-1; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Papin JA, 2004, TRENDS BIOTECHNOL, V22, P400, DOI 10.1016/j.tibtech.2004.06.010; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Sauer U, 1997, NAT BIOTECHNOL, V15, P448, DOI 10.1038/nbt0597-448; Sauer U, 2004, CURR OPIN BIOTECH, V15, P58, DOI 10.1016/j.copbio.2003.11.001; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Servant P, 2005, MOL MICROBIOL, V55, P1435, DOI 10.1111/j.1365-2958.2005.04473.x; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Zamboni N, 2005, BIOTECHNOL BIOENG, V89, P219, DOI 10.1002/bit.20338; Zamboni N, 2004, J BACTERIOL, V186, P4528, DOI 10.1128/JB.186.14.4528-4534.2004; Zamboni N, 2003, FEMS MICROBIOL LETT, V226, P121, DOI 10.1016/S0378-1097(03)00614-1	30	243	251	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					636	640		10.1038/ng1555	http://dx.doi.org/10.1038/ng1555			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15880104				2022-12-27	WOS:000229495300019
J	Basso, K; Margolin, AA; Stolovitzky, G; Klein, U; Dalla-Favera, R; Califano, A				Basso, K; Margolin, AA; Stolovitzky, G; Klein, U; Dalla-Favera, R; Califano, A			Reverse engineering of regulatory networks in human B cells	NATURE GENETICS			English	Article							GENE-COEXPRESSION NETWORK; C-MYC; LEUKEMIA REVEALS; GENOMIC TARGETS; EXPRESSION; PROTEIN; IDENTIFICATION; YEAST; INDUCTION; DISCOVERY	Cellular phenotypes are determined by the differential activity of networks linking coregulated genes. Available methods for the reverse engineering of such networks from genome-wide expression profiles have been successful only in the analysis of lower eukaryotes with simple genomes. Using a new method called ARACNe ( algorithm for the reconstruction of accurate cellular networks), we report the reconstruction of regulatory networks from expression profiles of human B cells. The results are suggestive a hierarchical, scale-free network, where a few highly interconnected genes ( hubs) account for most of the interactions. Validation of the network against available data led to the identification of MYC as a major hub, which controls a network comprising known target genes as well as new ones, which were biochemically validated. The newly identified MYC targets include some major hubs. This approach can be generally useful for the analysis of normal and pathologic networks in mammalian cells.	Joint Ctr Syst Biol, New York, NY 10032 USA; Inst Canc Genet, New York, NY 10032 USA; IBM Corp, Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	International Business Machines (IBM); Columbia University; Columbia University	Califano, A (corresponding author), Joint Ctr Syst Biol, 1300 St Nicholas Ave,Room 912, New York, NY 10032 USA.	califano@c2b2.columbia.edu	Pillay, Nischalan/F-9536-2012	Califano, Andrea/0000-0003-4742-3679				Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Basso K, 2004, BLOOD, V104, P4088, DOI 10.1182/blood-2003-12-4291; Basso K, 2004, J EXP MED, V199, P59, DOI 10.1084/jem.20031175; Butte A J, 2000, Pac Symp Biocomput, P418; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Chen WD, 2003, NUCLEIC ACIDS RES, V31, P690, DOI 10.1093/nar/gkg145; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; D'haeseleer P, 1999, Pac Symp Biocomput, P41; Dang CV, 1999, MOL CELL BIOL, V19, P1; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gat-Viks I, 2003, BIOINFORMATICS, V19, pi108, DOI 10.1093/bioinformatics/btg1014; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hartemink A J, 2001, Pac Symp Biocomput, P422; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jarvis ED, 2002, J COMP PHYSIOL A, V188, P961, DOI 10.1007/s00359-002-0358-y; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Joe H., 1997, MULTIVARIATE MODELS, V1st; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; KEMPKES B, 1995, EMBO J, V14, P88, DOI 10.1002/j.1460-2075.1995.tb06978.x; Klein U, 2003, BLOOD, V101, P4115, DOI 10.1182/blood-2002-10-3090; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Kuppers R, 2003, J CLIN INVEST, V111, P529, DOI 10.1172/JC1200316624; Lukashin AV, 2003, BIOINFORMATICS, V19, P1909, DOI 10.1093/bioinformatics/btg333; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Niu HF, 2003, J EXP MED, V198, P211, DOI 10.1084/jem.20021395; O'Connell BC, 2003, J BIOL CHEM, V278, P12563, DOI 10.1074/jbc.M210462200; Roos J, 1997, GENE, V185, P137, DOI 10.1016/S0378-1119(96)00661-0; Smith V Anne, 2003, Pac Symp Biocomput, P164; Smith V Anne, 2002, Bioinformatics, V18 Suppl 1, pS216; Steuer R, 2002, BIOINFORMATICS, V18, pS231, DOI 10.1093/bioinformatics/18.suppl_2.S231; Stewart MJ, 2005, DEV GENES EVOL, V215, P97, DOI 10.1007/s00427-004-0447-8; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Suzuki N, 1998, P NATL ACAD SCI USA, V95, P5027, DOI 10.1073/pnas.95.9.5027; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676; Yeung MKS, 2002, P NATL ACAD SCI USA, V99, P6163, DOI 10.1073/pnas.092576199; YU J, 2002, 3 INT C SYST BIOL KA; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	46	1008	1032	1	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					382	390		10.1038/ng1532	http://dx.doi.org/10.1038/ng1532			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15778709				2022-12-27	WOS:000228040000021
J	Fraga, MF; Ballestar, E; Villar-Garea, A; Boix-Chornet, M; Espada, J; Schotta, G; Bonaldi, T; Haydon, C; Ropero, S; Petrie, K; Iyer, NG; Perez-Rosado, A; Calvo, E; Lopez, JA; Cano, A; Calasanz, MJ; Colomer, D; Piris, MA; Ahn, N; Imhof, A; Caldas, C; Jenuwein, T; Esteller, M				Fraga, MF; Ballestar, E; Villar-Garea, A; Boix-Chornet, M; Espada, J; Schotta, G; Bonaldi, T; Haydon, C; Ropero, S; Petrie, K; Iyer, NG; Perez-Rosado, A; Calvo, E; Lopez, JA; Cano, A; Calasanz, MJ; Colomer, D; Piris, MA; Ahn, N; Imhof, A; Caldas, C; Jenuwein, T; Esteller, M			Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer	NATURE GENETICS			English	Article							DNA METHYLATION; GENE-EXPRESSION; HUMAN-CELLS; HYPOMETHYLATION; METHYLTRANSFERASE; HYPERMETHYLATION; PATTERNS; HETEROCHROMATIN; DEACETYLASE; ANTIBODIES	CpG island hypermethylation and global genomic hypomethylation are common epigenetic features of cancer cells. Less attention has been focused on histone modifications in cancer cells. We characterized post-translational modifications to histone H4 in a comprehensive panel of normal tissues, cancer cell lines and primary tumors. Using immunodetection, high-performance capillary electrophoresis and mass spectrometry, we found that cancer cells had a loss of monoacetylated and trimethylated forms of histone H4. These changes appeared early and accumulated during the tumorigenic process, as we showed in a mouse model of multistage skin carcinogenesis. The losses occurred predominantly at the acetylated Lys16 and trimethylated Lys20 residues of histone H4 and were associated with the hypomethylation of DNA repetitive sequences, a well-known characteristic of cancer cells. Our data suggest that the global loss of monoacetylation and trimethylation of histone H4 is a common hallmark of human tumor cells.	Spanish Natl Canc Ctr, Canc Epigenet Lab, Mol Pathol Program, Madrid 28029, Spain; Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Munich, Histone Modificat Grp, Munich, Germany; Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; Univ Cambridge, Canc Genom Program, Dept Oncol, Hutchison MRC Res Ctr, Cambridge CB2 2XZ, England; Spanish Natl Canc Ctr, Lymphoma Lab, Mol Pathol Program, Madrid, Spain; Fdn Ctr Nacl invest Cardiovasc, Proteom Unit, Madrid, Spain; Univ Autonoma Madrid, Dept Biochem, Sch Med, Inst Invest Biomed, Madrid, Spain; Univ Navarra, Dept Genet, Sch Sci, E-31080 Pamplona, Spain; Univ Barcelona, Hematopathol Unit, Hosp Clin, Catalonia, Spain; Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA	Centro Nacional de Investigaciones Oncologicas (CNIO); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Munich; University of Colorado System; University of Colorado Boulder; University of Cambridge; Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Madrid; University of Navarra; University of Barcelona; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Esteller, M (corresponding author), Spanish Natl Canc Ctr, Canc Epigenet Lab, Mol Pathol Program, Melchor Fernandez Almagro 3, Madrid 28029, Spain.	mesteller@cnio.es	Petrie, Kevin/I-7115-2015; Caldas, Carlos/U-7250-2019; Piris, Miguel A/AAP-1445-2020; Fraga, Mario F/H-7824-2017; Lopez, Juan Antonio/G-7750-2015; Piris, Miguel A/B-7067-2008; Ballestar, Esteban/ABG-8561-2020; Esteller, Manel/L-5956-2014; COLOMER, DOLORS/ABG-6894-2020; Caldas, Carlos/A-7543-2008; Imhof, Axel/AAU-5313-2021; Espada, Jesús/AAA-3198-2019; Calasanz, MJ/R-5813-2016; jia, xu/A-8386-2016; Bonaldi, Tiziana/K-5075-2016; Eyers, Claire/C-6291-2013	Petrie, Kevin/0000-0002-9805-9152; Caldas, Carlos/0000-0003-3547-1489; Piris, Miguel A/0000-0001-5839-3634; Fraga, Mario F/0000-0001-8450-2603; Lopez, Juan Antonio/0000-0002-9097-6060; Piris, Miguel A/0000-0001-5839-3634; Esteller, Manel/0000-0003-4490-6093; Imhof, Axel/0000-0003-2993-8249; Espada, Jesús/0000-0002-4202-4938; Calasanz, MJ/0000-0002-0374-3008; Bonaldi, Tiziana/0000-0003-3556-1265; Villar Garea, Ana/0000-0001-8960-1635; Ballestar, Esteban/0000-0002-1400-2440; Schotta, Gunnar/0000-0003-4940-6135; Eyers, Claire/0000-0002-3223-5926; Iyer, N. Gopalakrishna/0000-0002-8812-6219; COLOMER, DOLORS/0000-0001-7486-8484				Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; Ballestar E, 2003, EMBO J, V22, P6335, DOI 10.1093/emboj/cdg604; Balmain A, 2000, CARCINOGENESIS, V21, P371, DOI 10.1093/carcin/21.3.371; Bannister AJ, 2004, METHOD ENZYMOL, V376, P269; Baxter J, 2004, EMBO J, V23, P4462, DOI 10.1038/sj.emboj.7600414; Belyaev ND, 1996, HUM GENET, V97, P573; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; Cho KS, 2004, CURR OPIN GENET DEV, V14, P308, DOI 10.1016/j.gde.2004.04.015; Dobosy JR, 2001, CELL MOL LIFE SCI, V58, P721, DOI 10.1007/PL00000895; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Ehrlich M, 2002, J NUTR, V132, p2424S, DOI 10.1093/jn/132.8.2424S; Espada J, 2004, J BIOL CHEM, V279, P37175, DOI 10.1074/jbc.M404842200; Esteller M, 2005, CURR OPIN ONCOL, V17, P55, DOI 10.1097/01.cco.0000147383.04709.10; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Esteller M, 2001, CANCER RES, V61, P3225; Fahrner JA, 2002, CANCER RES, V62, P7213; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Fraga MF, 2004, CANCER RES, V64, P5527, DOI 10.1158/0008-5472.CAN-03-4061; Galasinski SC, 2003, METHODS, V31, P3, DOI 10.1016/S1046-2023(03)00082-3; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Iyer NG, 2004, P NATL ACAD SCI USA, V101, P7386, DOI 10.1073/pnas.0401002101; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; JONES A, 1967, ECON BOT, V21, P163, DOI 10.1007/BF02897864; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; LINDNER H, 1992, BIOCHEM J, V283, P467, DOI 10.1042/bj2830467; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Nguyen CT, 2002, CANCER RES, V62, P6456; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Paz MF, 2003, CANCER RES, V63, P1114; Richon VM, 2004, METHOD ENZYMOL, V376, P199; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Sarg B, 2002, J BIOL CHEM, V277, P39195, DOI 10.1074/jbc.M205166200; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; THORNE AW, 1990, EUR J BIOCHEM, V193, P701, DOI 10.1111/j.1432-1033.1990.tb19390.x; TURNER BM, 1989, EUR J BIOCHEM, V179, P131, DOI 10.1111/j.1432-1033.1989.tb14530.x; TURNER BM, 1989, FEBS LETT, V253, P141, DOI 10.1016/0014-5793(89)80947-0; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Zhang DJ, 2000, MULTIBODY SYST DYN, V4, P1, DOI 10.1023/A:1009849313860	50	1319	1402	2	157	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					391	400		10.1038/ng1531	http://dx.doi.org/10.1038/ng1531			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15765097				2022-12-27	WOS:000228040000022
J	Rokyta, DR; Joyce, P; Caudle, SB; Wichman, HA				Rokyta, DR; Joyce, P; Caudle, SB; Wichman, HA			An empirical test of the mutational landscape model of adaptation using a single-stranded DNA virus	NATURE GENETICS			English	Article							POPULATION-GENETICS; EVOLUTION	The primary impediment to formulating a general theory for adaptive evolution has been the unknown distribution of fitness effects for new beneficial mutations(1). By applying extreme value theory(2), Gillespie circumvented this issue in his mutational landscape model for the adaptation of DNA sequences(3-5), and Orr recently extended Gillespie's model(1,6), generating testable predictions regarding the course of adaptive evolution. Here we provide the first empirical examination of this model, using a single-stranded DNA bacteriophage related to phi X174, and find that our data are consistent with Orr's predictions, provided that the model is adjusted to incorporate mutation bias. Orr's work suggests that there may be generalities in adaptive molecular evolution that transcend the biological details of a system, but we show that for the model to be useful as a predictive or inferential tool, some adjustments for the biology of the system will be necessary.	Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA; Univ Idaho, Program Bioinformat & Computat Biol, Moscow, ID 83844 USA; Univ Idaho, Initiat Bioinformat & Evolutionary Studies, Moscow, ID 83844 USA; Univ Idaho, Dept Math, Moscow, ID 83844 USA; Univ Idaho, Dept Stat, Moscow, ID 83844 USA	Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho	Wichman, HA (corresponding author), Univ Idaho, Dept Biol Sci, Moscow, ID 83844 USA.	hwichman@uidaho.edu		Rokyta, Darin/0000-0002-0356-2178				[Anonymous], 1958, STAT EXTREMES, DOI DOI 10.7312/GUMB92958; Fisher RA, 1930, GENETICAL THEORY NAT; Gillespie J.H., 1992, CAUSES MOL EVOLUTION; GILLESPIE JH, 1984, EVOLUTION, V38, P1116, DOI 10.1111/j.1558-5646.1984.tb00380.x; GILLESPIE JH, 1983, THEOR POPUL BIOL, V23, P202, DOI 10.1016/0040-5809(83)90014-X; Haldane JBS, 1927, P CAMB PHILOS SOC, V23, P838, DOI 10.1017/S0305004100015644; Hartl DL, 1998, GENETICA, V102-3, P525, DOI 10.1023/A:1017071901530; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; Orr HA, 2000, EVOLUTION, V54, P13, DOI 10.1111/j.0014-3820.2000.tb00002.x; Orr HA, 2003, GENETICS, V163, P1519; Orr HA, 2003, J THEOR BIOL, V220, P241, DOI 10.1006/jtbi.2003.3161; Orr HA, 2002, EVOLUTION, V56, P1317, DOI 10.1111/j.0014-3820.2002.tb01446.x; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; Rokyta D, 2002, MOL BIOL EVOL, V19, P230, DOI 10.1093/oxfordjournals.molbev.a004076; Swofford DL, 1998, PHYLOGENETIC ANAL US; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wahl LM, 2002, GENETICS, V162, P961; Wahl LM, 2001, EVOLUTION, V55, P2606	18	141	143	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					441	444		10.1038/ng1535	http://dx.doi.org/10.1038/ng1535			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15778707				2022-12-27	WOS:000228040000030
J	Metherell, LA; Chapple, JP; Cooray, S; David, A; Becker, C; Ruschendorf, F; Naville, D; Begeot, M; Khoo, B; Nurnberg, P; Huebner, A; Cheetham, ME; Clark, AJL				Metherell, LA; Chapple, JP; Cooray, S; David, A; Becker, C; Ruschendorf, F; Naville, D; Begeot, M; Khoo, B; Nurnberg, P; Huebner, A; Cheetham, ME; Clark, AJL			Mutations in MRAP, encoding a new interacting partner of the ACTH receptor, cause familial glucocorticoid deficiency type 2	NATURE GENETICS			English	Article							ADRENOCORTICOTROPIN RECEPTOR; ENDOPLASMIC-RETICULUM; CALCITONIN-RECEPTOR; LINKAGE ANALYSIS; GENE; IDENTIFICATION; ADIPOCYTES; EXPRESSION; PROTEINS; CELLS	Familial glucocorticoid deficiency (FGD), or hereditary unresponsiveness to adrenocorticotropin (ACTH; OMIM 202200), is an autosomal recessive disorder resulting from resistance to the action of ACTH on the adrenal cortex, which stimulates glucocorticoid production. Affected individuals are deficient in cortisol and, if untreated, are likely to succumb to hypoglycemia or overwhelming infection in infancy or childhood(1-3). Mutations of the ACTH receptor (melanocortin 2 receptor, MC2R) account for similar to25% of cases of FGD(4-7). FGD without mutations of MC2R is called FGD type 2. Using SNP array genotyping, we mapped a locus involved in FGD type 2 to chromosome 21q22.1. We identified mutations in a gene encoding a 19-kDa single-transmembrane domain protein(8), now known as melanocortin 2 receptor accessory protein (MRAP). We show that MRAP interacts with MC2R and may have a role in the trafficking of MC2R from the endoplasmic reticulum to the cell surface.	Barts & London Queen Mary Univ London, William Harvey Res Inst, Dept Endocrinol, London EC1A 7BE, England; UCL, Inst Ophthalmol, Div Pathol, London EC1V 9EL, England; Max Delbruck Ctr Mol Med, Mol Genet & Gene Mapping Ctr, Berlin, Germany; Hop Debrousse, INSERM, U418, F-69322 Lyon, France; Univ Med Berlin, Charite, Inst Med Genet, Berlin, Germany; Tech Univ Dresden, Childrens Hosp, D-8027 Dresden, Germany	University of London; Queen Mary University London; University of London; University College London; Helmholtz Association; Max Delbruck Center for Molecular Medicine; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Technische Universitat Dresden	Clark, AJL (corresponding author), Barts & London Queen Mary Univ London, William Harvey Res Inst, Dept Endocrinol, London EC1A 7BE, England.	a.j.clark@qmul.ac.uk	Metherell, Louise A/E-8695-2012; Naville, Danielle/N-1200-2017; Khoo, Bernard/B-1247-2009; Cheetham, Michael/B-4672-2011	Metherell, Louise A/0000-0002-0530-3524; Naville, Danielle/0000-0003-2615-6161; Khoo, Bernard/0000-0002-4223-9736; Cheetham, Michael/0000-0001-6429-654X; Huebner, Angela/0000-0003-1338-5192; Chapple, Paul/0000-0003-1876-1505				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Boston BA, 1996, ENDOCRINOLOGY, V137, P2043, DOI 10.1210/en.137.5.2043; Chapple JP, 2003, J BIOL CHEM, V278, P19087, DOI 10.1074/jbc.M212349200; Clark AJL, 1998, ENDOCR REV, V19, P828, DOI 10.1210/er.19.6.828; CLARK AJL, 1993, LANCET, V341, P461, DOI 10.1016/0140-6736(93)90208-X; Elias LLK, 1999, J CLIN ENDOCR METAB, V84, P2766, DOI 10.1210/jc.84.8.2766; Genin E, 2002, HUM GENET, V111, P428, DOI 10.1007/s00439-002-0806-3; GOZANI O, 1994, EMBO J, V13, P3356, DOI 10.1002/j.1460-2075.1994.tb06638.x; GRUNFELD C, 1985, ENDOCRINOLOGY, V116, P113, DOI 10.1210/endo-116-1-113; Longshaw VM, 2004, J CELL SCI, V117, P701, DOI 10.1242/jcs.00905; Matsuzaki H, 2004, GENOME RES, V14, P414, DOI 10.1101/gr.2014904; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Metherell Louise A., 2001, American Journal of Human Genetics, V69, P641, DOI 10.1086/323266; MIGEON CJ, 1968, PEDIATR RES, V2, P501, DOI 10.1203/00006450-196811000-00008; Muff R, 1999, ENDOCRINOLOGY, V140, P2924, DOI 10.1210/en.140.6.2924; Naville D, 1996, J CLIN ENDOCR METAB, V81, P1442, DOI 10.1210/jc.81.4.1442; Noon LA, 2004, J BIOL CHEM, V279, P22803, DOI 10.1074/jbc.M401861200; Noon LA, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740017; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; SHEPARD TH, 1959, AMA J DIS CHILD, V97, P154, DOI 10.1001/archpedi.1959.02070010156002; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; TSIGOS C, 1993, J CLIN INVEST, V92, P2458, DOI 10.1172/JCI116853; WEBER A, 1995, J CLIN ENDOCR METAB, V80, P65, DOI 10.1210/jc.80.1.65; Xu AM, 2002, BIOCHEM BIOPH RES CO, V293, P1161, DOI 10.1016/S0006-291X(02)00354-6; Yang YK, 1997, MOL ENDOCRINOL, V11, P274, DOI 10.1210/me.11.3.274	26	296	308	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					166	170		10.1038/ng1501	http://dx.doi.org/10.1038/ng1501			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	15654338				2022-12-27	WOS:000226690100023
J	Lin, S; Chakravarti, A; Cutler, DJ				Lin, S; Chakravarti, A; Cutler, DJ			Exhaustive allelic transmission disequilibrium tests as a new approach to genome-wide association studies	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE-DISEQUILIBRIUM; HIRSCHSPRUNGS-DISEASE; SEQUENCE VARIATION; RET PROTOONCOGENE; COMPLEX TRAITS; HAPLOTYPE; RECOMBINATION; GENES; DETERMINANTS	Genome-wide disease-association mapping has been heralded as the study design of the next generation, but the lack of analytical methods to use genotype data fully is a large stumbling block. Here we describe an algorithm and statistical method that efficiently and exhaustively exploits haplotype information by subjecting alleles (a marker or contiguous sets of markers) from sliding windows of all sizes to transmission disequilibrium tests. By applying our method to simulated data and to Hirschsprung disease, we show that it can detect both common and rare disease variants of small effect. These results show that the theoretical benefits of genome-wide association studies are at last realizable.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA	Johns Hopkins University	Cutler, DJ (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Broadway Res Bldg,Suite 475,733 N Broadway, Baltimore, MD 21205 USA.	dcutler@jhmi.edu		Lin, Shin/0000-0003-0118-0413				Beaudet A.R., 2001, METABOLIC MOL BASES, V8th; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; CHURCHILL GA, 1994, GENETICS, V138, P963; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Davison AC, 1997, BOOTSTRAP METHODS TH; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Falconer D. S., 1996, INTRO QUANTITATIVE G; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HUDSON RR, 1985, GENETICS, V109, P611; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Jannot AS, 2003, GENET EPIDEMIOL, V25, P158, DOI 10.1002/gepi.10256; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Liang KY, 2001, AM J HUM GENET, V68, P937, DOI 10.1086/319504; Lin S, 2004, GENOME RES, V14, P1624, DOI 10.1101/gr.2204604; Liu JS, 2001, GENOME RES, V11, P1716, DOI 10.1101/gr.194801; Long AD, 1999, GENOME RES, V9, P720; McCallion AS, 2003, COLD SPRING HARB SYM, V68, P373, DOI 10.1101/sqb.2003.68.373; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; Morris AP, 2000, AM J HUM GENET, V67, P155, DOI 10.1086/302956; MORTON NE, 1974, AM J HUM GENET, V26, P489; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; PUFFETT D, 1994, MUSIC ANAL, V13, P3; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; RISCH N, 1987, AM J HUM GENET, V40, P1; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Service SK, 1999, AM J HUM GENET, V64, P1728, DOI 10.1086/302398; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866	42	118	124	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1181	1188		10.1038/ng1457	http://dx.doi.org/10.1038/ng1457			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15502828	Bronze			2022-12-27	WOS:000224832800021
J	Mohammed, FF; Smookler, DS; Taylor, SEM; Fingleton, B; Kassiri, Z; Sanchez, OH; English, JL; Matrisian, LM; Au, B; Yeh, WC; Khokha, R				Mohammed, FF; Smookler, DS; Taylor, SEM; Fingleton, B; Kassiri, Z; Sanchez, OH; English, JL; Matrisian, LM; Au, B; Yeh, WC; Khokha, R			Abnormal TNF activity in Timp3(-/-) mice leads to chronic hepatic inflammation and failure of liver regeneration	NATURE GENETICS			English	Article							NECROSIS-FACTOR-ALPHA; SORSBYS FUNDUS DYSTROPHY; NF-KAPPA-B; CONVERTING-ENZYME TACE; TISSUE INHIBITOR; METALLOPROTEINASE INHIBITOR; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; TRANSGENIC MICE; FACTOR-RECEPTOR	Tumor-necrosis factor (TNF), a pleiotropic cytokine, triggers physiological and pathological responses in several organs. Here we show that deletion of the mouse gene Timp3 resulted in an increase in TNF-alpha converting enzyme activity, constitutive release of TNF and activation of TNF signaling in the liver. The increase in TNF in Timp3(-/-) mice culminated in hepatic lymphocyte infiltration and necrosis, features that are also seen in chronic active hepatitis in humans. This pathology was prevented when deletion of Timp3 was combined with Tnfrsf1a deficiency. In a liver regeneration model that requires TNF signaling, Timp3(-/-) mice succumbed to liver failure. Hepatocytes from Timp3(-/-) mice completed the cell cycle but then underwent cell death owing to sustained activation of TNF. This hepatocyte cell death was completely rescued by a neutralizing antibody to TNF. Dysregulation of TNF occurred specifically in Timp3(-/-), and not Timp1(-/-) mice. These data indicate that TIMP3 is a crucial innate negative regulator of TNF in both tissue homeostasis and tissue response to injury.	Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	Vanderbilt University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Khokha, R (corresponding author), Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada.	rkhokha@uhnres.utoronto.ca		Fingleton, Barbara/0000-0003-1132-0782				Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Alcamo E, 2001, J IMMUNOL, V167, P1592, DOI 10.4049/jimmunol.167.3.1592; Aldeguer X, 2002, HEPATOLOGY, V35, P40, DOI 10.1053/jhep.2002.30081; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; BLENIS J, 1984, J BIOL CHEM, V259, P1563; Bouwens L, 1988, Revis Biol Celular, V16, P69; Butler DM, 1997, J IMMUNOL, V159, P2867; Bzowska M, 2004, EUR J BIOCHEM, V271, P2808, DOI 10.1111/j.1432-1033.2004.04215.x; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Contin C, 2003, J BIOL CHEM, V278, P32801, DOI 10.1074/jbc.M209993200; d'Ortho MP, 1997, EUR J BIOCHEM, V250, P751, DOI 10.1111/j.1432-1033.1997.00751.x; Dory D, 2003, J LEUKOCYTE BIOL, V74, P49, DOI 10.1189/jlb.0302133; English WR, 2000, J BIOL CHEM, V275, P14046, DOI 10.1074/jbc.275.19.14046; Fata JE, 2001, J CLIN INVEST, V108, P831, DOI 10.1172/JCI13171; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; Georgopoulos S, 1996, J INFLAMM, V46, P86; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Haro H, 2000, J CLIN INVEST, V105, P143, DOI 10.1172/JCI7091; Higgins GM, 1931, ARCH PATHOL, V12, P186; Jevon GP, 2001, PEDIATR DEVEL PATHOL, V4, P372, DOI 10.1007/s10024001-0006-5; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jin GX, 2002, ANAL BIOCHEM, V302, P269, DOI 10.1006/abio.2001.5549; Killar L, 1999, ANN NY ACAD SCI, V878, P442, DOI 10.1111/j.1749-6632.1999.tb07701.x; Knittel T, 1999, J HEPATOL, V30, P48, DOI 10.1016/S0168-8278(99)80007-5; Kontoyiannis D, 1999, IMMUNITY, V10, P387, DOI 10.1016/S1074-7613(00)80038-2; Kyriakis JM, 2001, NATURE, V414, P265, DOI 10.1038/35104735; Leco KJ, 2001, J CLIN INVEST, V108, P817, DOI 10.1172/JCI12067; Lee DC, 2003, ANN NY ACAD SCI, V995, P22, DOI 10.1111/j.1749-6632.2003.tb03207.x; Lee MH, 2001, BIOCHEM BIOPH RES CO, V280, P945, DOI 10.1006/bbrc.2000.4192; MCGEEHAN GM, 1994, NATURE, V370, P558, DOI 10.1038/370558a0; McIntyre JO, 2004, BIOCHEM J, V377, P617, DOI 10.1042/BJ20030582; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Mueller C, 1999, J BIOL CHEM, V274, P38112, DOI 10.1074/jbc.274.53.38112; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Nuttall RK, 2004, FEBS LETT, V563, P129, DOI 10.1016/S0014-5793(04)00281-9; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Qi JH, 2002, J BIOL CHEM, V277, P13394, DOI 10.1074/jbc.M110870200; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rizvi NA, 2004, CLIN CANCER RES, V10, P1963, DOI 10.1158/1078-0432.CCR-1183-02; Rovida E, 2001, J IMMUNOL, V166, P1583, DOI 10.4049/jimmunol.166.3.1583; Ruuls SR, 2001, IMMUNITY, V15, P533, DOI 10.1016/S1074-7613(01)00215-1; TOYONAGA T, 1994, P NATL ACAD SCI USA, V91, P614, DOI 10.1073/pnas.91.2.614; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yeow KM, 2002, MATRIX BIOL, V21, P75, DOI 10.1016/S0945-053X(01)00180-9	50	230	237	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					969	977		10.1038/ng1413	http://dx.doi.org/10.1038/ng1413			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15322543	Bronze			2022-12-27	WOS:000223658100023
J	Lang, MR; Lapierre, LA; Frotscher, M; Goldenring, JR; Knapik, EW				Lang, Michael R.; Lapierre, Lynne A.; Frotscher, Michael; Goldenring, James R.; Knapik, Ela W.			Secretory COPII coat component Sec23a is essential for craniofacial chondrocyte maturation	NATURE GENETICS			English	Article							TO-GOLGI TRANSPORT; II COLLAGEN GENE; ENDOPLASMIC-RETICULUM; VESICLE FORMATION; LIVING CELLS; ZEBRAFISH; EXPRESSION; MUTATIONS; REVEALS; PATHWAY	An increasing number of human disorders have been linked to mutations in genes of the secretory pathway. The chemically induced zebrafish crusher variant results in malformed craniofacial skeleton, kinked pectoral fins and a short body length. By positional cloning, we identified a nonsense mutation converting leucine to a stop codon (L402X) in the sec23a gene, an integral component of the COPII complex, which is critical for anterograde protein trafficking between endoplasmic reticulum and Golgi apparatus. Zebrafish crusher mutants develop normally until the onset of craniofacial chondrogenesis. crusher chondrocytes accumulate proteins in a distended endoplasmic reticulum, resulting in severe reduction of cartilage extracellular matrix (ECM) deposits, including type II collagen. We demonstrate that the paralogous gene sec23b is also an essential component of the ECM secretory pathway in chondrocytes. In contrast, knockdown of the COPI complex does not hinder craniofacial morphogenesis. As SEC23A lesions cause the cranio-lenticulo-sutural dysplasia syndrome, crusher provides the first vertebrate model system that links the biology of endoplasmic reticulum to Golgi trafficking with a clinically relevant dysmorphology.	Vanderbilt Univ, Med Ctr, Dept Med, Div Med Genet, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; Univ Freiburg, Inst Biol 1, Dept Biol, D-79104 Freiburg, Germany; Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA; Univ Freiburg, Inst Anat & Cell Biol, D-79104 Freiburg, Germany; Nashville Vet Adm Med Ctr, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; University of Freiburg; Vanderbilt University; University of Freiburg	Knapik, EW (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Med Genet, Nashville, TN 37232 USA.	ela.knapik@vanderbilt.edu	Knapik, Ela W./J-6172-2014	Knapik, Ela W./0000-0002-2977-3619				Bandoh N, 2005, TISSUE ANTIGENS, V66, P185, DOI 10.1111/j.1399-0039.2005.00462.x; Barrallo-Gimeno A, 2004, DEVELOPMENT, V131, P1463, DOI 10.1242/dev.01033; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Boyadjiev SA, 2003, HUM GENET, V113, P1, DOI 10.1007/s00439-003-0932-6; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Chiang EFL, 2001, DEV BIOL, V231, P149, DOI 10.1006/dbio.2000.0129; Coutinho P, 2004, DEV CELL, V7, P547, DOI 10.1016/j.devcel.2004.07.020; Gebe JA, 2002, TISSUE ANTIGENS, V59, P78, DOI 10.1034/j.1399-0039.2002.590202.x; HICKE L, 1989, EMBO J, V8, P1677, DOI 10.1002/j.1460-2075.1989.tb03559.x; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Mironov AA, 2003, DEV CELL, V5, P583, DOI 10.1016/S1534-5807(03)00294-6; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Paccaud JP, 1996, MOL BIOL CELL, V7, P1535, DOI 10.1091/mbc.7.10.1535; Pearson J, 1996, JUVENILE FAM COURT J, V47, P15, DOI 10.1111/j.1755-6988.1996.tb00751.x; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Stephens DJ, 2002, J CELL SCI, V115, P1149; YAN YL, 1995, DEV DYNAM, V203, P363, DOI 10.1002/aja.1002030308; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644	30	144	147	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1198	1203		10.1038/ng1880	http://dx.doi.org/10.1038/ng1880			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16980978				2022-12-27	WOS:000241251100021
J	Hollanda, LM; Lima, CSP; Cunha, AF; Albuquerque, DM; Vassallo, J; Ozelo, MC; Joazeiro, PP; Saad, STO; Costa, FF				Hollanda, Luciana M.; Lima, Carmen S. P.; Cunha, Anderson F.; Albuquerque, Dulcineia M.; Vassallo, Jose; Ozelo, Margareth C.; Joazeiro, Paulo P.; Saad, Sara T. O.; Costa, Fernando F.			An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis	NATURE GENETICS			English	Article							TRANSIENT MYELOPROLIFERATIVE DISORDER; ACUTE MEGAKARYOBLASTIC LEUKEMIA; X-LINKED THROMBOCYTOPENIA; ACQUIRED MUTATIONS; DOWN-SYNDROME; MACROTHROMBOCYTOPENIA; DIAGNOSIS; CHILDREN; ANEMIA; GENE	Acquired somatic mutations(1-6) in exon 2 of the hematopoietic transcription factor GATA-1 have been found in individuals with Down syndrome with both transient myeloproliferative disorder(2-10) and acute megakaryoblastic leukemia(1-4,6,8-10). These mutations prevent the synthesis of the full-length protein but allow the synthesis of its short isoform, GATA-1s. Experiments in mice(11) suggest that GATA-1s supports normal adult megakaryopoiesis, platelet formation and erythropoiesis. Here we report a mutation, 332G -> C, in exon 2 of GATA1, leading to the synthesis of only the short isoform in seven affected males from two generations of a family. Hematological profiles of affected males demonstrate macrocytic anemia, normal platelet counts and neutropenia in most cases. Altogether, data suggest that GATA-1s alone, produced in low or normal levels, is not sufficient to support normal erythropoiesis. Moreover, this is the first study to indicate that a germline splicing mutation does not lead to leukemia in the absence of other cooperating events, such as Down syndrome.	Univ Estadual Campinas, Sch Med Sci, Hemoctr, Dept Internal Med, BR-13083970 Campinas, SP, Brazil; Univ Estadual Campinas, Sch Med Sci, Dept Anat Pathol, BR-13083970 Campinas, SP, Brazil; Univ Estadual Campinas, Inst Biol, Dept Histol, BR-13083970 Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Costa, FF (corresponding author), Univ Estadual Campinas, Sch Med Sci, Hemoctr, Dept Internal Med, BR-13083970 Campinas, SP, Brazil.	ferreira@unicamp.br	da Cunha, Anderson Ferreira/B-7931-2012; da Cunha, Anderson Ferreira/M-9038-2019; Costa, Fernando F/D-1566-2012; de Albuquerque, Dulcineia Martins/U-8601-2019; HOLLANDA, LUCIANA MARIA DE/F-7893-2011; Ozelo, Margareth C/K-5819-2012; JOAZEIRO, PAULO/C-6733-2014; VASSALLO, JOSE/AAP-4600-2021; Lima, Carmen Silvia Passos/K-4775-2013	da Cunha, Anderson Ferreira/0000-0003-3485-5659; Costa, Fernando F/0000-0002-4632-572X; HOLLANDA, LUCIANA MARIA DE/0000-0002-6047-4043; Ozelo, Margareth C/0000-0001-5938-0675; VASSALLO, JOSE/0000-0002-2192-4865; 				Ahmed M, 2004, BLOOD, V103, P2480, DOI 10.1182/blood-2003-10-3383; Balduini CL, 2004, THROMB HAEMOSTASIS, V91, P129, DOI 10.1160/TH03-05-0290; Budde U, 2002, SEMIN THROMB HEMOST, V28, P173, DOI 10.1055/s-2002-27820; CALLIGARIS R, 1995, P NATL ACAD SCI USA, V92, P11598, DOI 10.1073/pnas.92.25.11598; Centurione L, 2004, BLOOD, V104, P3573, DOI 10.1182/blood-2004-01-0193; Conran N, 2004, AM J HEMATOL, V76, P343, DOI 10.1002/ajh.20129; Crispino JD, 2005, PEDIATR BLOOD CANCER, V44, P40, DOI 10.1002/pbc.20066; dos Santos CO, 2004, EXP HEMATOL, V32, P157, DOI 10.1016/j.exphem.2003.11.002; Freson K, 2002, HUM MOL GENET, V11, P147, DOI 10.1093/hmg/11.2.147; Freson K, 2001, BLOOD, V98, P85, DOI 10.1182/blood.V98.1.85; Gao DY, 1999, CRYOBIOLOGY, V38, P225, DOI 10.1006/cryo.1999.2162; GAWAZ MP, 1991, KIDNEY INT, V40, P257, DOI 10.1038/ki.1991.208; Groet J, 2003, LANCET, V361, P1617, DOI 10.1016/S0140-6736(03)13266-7; Gurbuxani S, 2004, BLOOD, V103, P399, DOI 10.1182/blood-2003-05-1556; Hitzler JK, 2003, BLOOD, V101, P4301, DOI 10.1182/blood-2003-01-0013; Hitzler JK, 2005, NAT REV CANCER, V5, P11, DOI 10.1038/nrc1525; Li Z, 2005, NAT GENET, V37, P613, DOI 10.1038/ng1566; Mehaffey MG, 2001, BLOOD, V98, P2681, DOI 10.1182/blood.V98.9.2681; Mundschau G, 2003, BLOOD, V101, P4298, DOI 10.1182/blood-2002-12-3904; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; Pedrazzoli P, 2000, BRIT J HAEMATOL, V108, P653, DOI 10.1046/j.1365-2141.2000.01860.x; Rainis L, 2003, BLOOD, V102, P981, DOI 10.1182/blood-2002-11-3599; Rhodes J, 2005, DEV CELL, V8, P97, DOI 10.1016/j.devcel.2004.11.014; Shimada A, 2004, BLOOD, V103, P366, DOI 10.1182/blood-2003-09-3219; Shimizu R, 2001, EMBO J, V20, P5250, DOI 10.1093/emboj/20.18.5250; Stenberg PE, 1998, BLOOD, V91, P1599, DOI 10.1182/blood.V91.5.1599.1599_1599_1608; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Xu G, 2003, BLOOD, V102, P2960, DOI 10.1182/blood-2003-02-0390; Yu CN, 2002, BLOOD, V100, P2040, DOI 10.1182/blood-2002-02-0387	30	144	148	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					807	812		10.1038/ng1825	http://dx.doi.org/10.1038/ng1825			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16783379				2022-12-27	WOS:000238669300017
J	Moseley, ML; Zu, T; Ikeda, Y; Gao, WC; Mosemiller, AK; Daughters, RS; Chen, G; Weatherspoon, MR; Clark, HB; Ebner, TJ; Day, JW; Ranum, LPW				Moseley, Melinda L.; Zu, Tao; Ikeda, Yoshio; Gao, Wangcai; Mosemiller, Anne K.; Daughters, Randy S.; Chen, Gang; Weatherspoon, Marcy R.; Clark, H. Brent; Ebner, Timothy J.; Day, John W.; Ranum, Laura P. W.			Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8	NATURE GENETICS			English	Article							SCA8 REPEAT EXPANSION; CEREBELLAR CORTEX; MYOTONIC-DYSTROPHY; TRANSGENIC MICE; ANTISENSE TRANSCRIPTION; BINDING PROTEIN; PARALLEL FIBER; CTG EXPANSION; LOCUS; RNA	We previously reported that a (CTG)(n) expansion causes spinocerebellar ataxia type 8 (SCA8), a slowly progressive ataxia with reduced penetrance. We now report a transgenic mouse model in which the full-length human SCA8 mutation is transcribed using its endogenous promoter. (CTG)(116) expansion, but not (CTG)(11) control lines, develop a progressive neurological phenotype with in vivo imaging showing reduced cerebellar-cortical inhibition. 1C2-positive intranuclear inclusions in cerebellar Purkinje and brainstem neurons in SCA8 expansion mice and human SCA8 autopsy tissue result from translation of a polyglutamine protein, encoded on a previously unidentified antiparallel transcript (ataxin 8, ATXN8) spanning the repeat in the CAG direction. The neurological phenotype in SCA8 BAC expansion but not BAC control lines demonstrates the pathogenicity of the (CTG-CAG)(n) expansion. Moreover, the expression of noncoding (CUG)(n) expansion transcripts (ataxin 8 opposite strand, ATXN8OS) and the discovery of intranuclear polyglutamine inclusions suggests SCA8 pathogenesis involves toxic gain-of-function mechanisms at both the protein and RNA levels.	Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Ranum, LPW (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	ranum001@umn.edu			NINDS NIH HHS [R01 NS040389, R01 NS40389] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040389] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benzow KA, 2002, MAMM GENOME, V13, P134, DOI 10.1007/s0033501-2105-2; Brusco A, 2002, J NEUROL, V249, P923, DOI 10.1007/s00415-002-0760-y; BURRIGHT EN, 1995, CELL, V82, P937, DOI 10.1016/0092-8674(95)90273-2; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Cho DH, 2005, MOL CELL, V20, P483, DOI 10.1016/j.molcel.2005.09.002; Day JW, 2000, NEUROLOGY, V55, P649, DOI 10.1212/WNL.55.5.649; Dorsman JC, 2002, HUM MOL GENET, V11, P1487, DOI 10.1093/hmg/11.13.1487; Dunbar RL, 2004, NEUROSCIENCE, V126, P213, DOI 10.1016/j.neuroscience.2004.02.020; Ebner TJ, 2005, PROG BRAIN RES, V148, P125, DOI 10.1016/S0079-6123(04)48011-X; Gao WC, 2003, J NEUROSCI, V23, P1859; Hanson CL, 2000, NEUROSCIENCE, V96, P317, DOI 10.1016/S0306-4522(99)00470-4; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Ikeda Y, 2000, NEUROLOGY, V54, P950, DOI 10.1212/WNL.54.4.950; Ikeda Y, 2004, AM J HUM GENET, V75, P3, DOI 10.1086/422014; Ikeda Y, 2000, J NEUROL SCI, V182, P76, DOI 10.1016/S0022-510X(00)00446-9; Izumi Y, 2003, AM J HUM GENET, V72, P704, DOI 10.1086/367775; Juvonen V, 2000, ANN NEUROL, V48, P354, DOI 10.1002/1531-8249(200009)48:3<354::AID-ANA10>3.0.CO;2-A; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Koob MD, 1998, NAT GENET, V18, P72, DOI 10.1038/ng0198-72; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Margolis RL, 2004, ANN NEUROL, V56, P670, DOI 10.1002/ana.20248; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Martins S, 2005, AM J MED GENET B, V139B, P109, DOI 10.1002/ajmg.b.30235; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Moseley ML, 2000, HUM MOL GENET, V9, P2125, DOI 10.1093/hmg/9.14.2125; Nakamura K, 2001, HUM MOL GENET, V10, P1441, DOI 10.1093/hmg/10.14.1441; Nemes JP, 2000, HUM MOL GENET, V9, P1543, DOI 10.1093/hmg/9.10.1543; Orr HT, 2001, GENE DEV, V15, P925, DOI 10.1101/gad.888401; Orr HT, 2000, NEUROBIOL DIS, V7, P129, DOI 10.1006/nbdi.2000.0305; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Ranum LPW, 2004, TRENDS GENET, V20, P506, DOI 10.1016/j.tig.2004.08.004; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Reinert KC, 2004, J NEUROPHYSIOL, V92, P199, DOI 10.1152/jn.01275.2003; Schols L, 2003, ANN NEUROL, V54, P110, DOI 10.1002/ana.10608; Shakkottai VG, 2004, J CLIN INVEST, V113, P582, DOI 10.1172/JCI200420216; Silveira I, 2000, AM J HUM GENET, V66, P830, DOI 10.1086/302827; Sobrido MJ, 2001, NEUROLOGY, V57, P1310, DOI 10.1212/WNL.57.7.1310; Stevanin G, 2000, NAT GENET, V24, P213, DOI 10.1038/73408; Sulek A, 2003, AM J HUM GENET, V73, P972, DOI 10.1086/378524; Suter KJ, 2004, NEUROSCIENCE, V124, P305, DOI 10.1016/j.neuroscience.2003.11.015; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Vincent JB, 2000, AM J HUM GENET, V66, P819, DOI 10.1086/302803; Worth PF, 2000, NAT GENET, V24, P214, DOI 10.1038/73411; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zoghbi HY, 1999, CURR OPIN NEUROBIOL, V9, P566, DOI 10.1016/S0959-4388(99)00013-6	50	317	330	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					758	769		10.1038/ng1827	http://dx.doi.org/10.1038/ng1827			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16804541				2022-12-27	WOS:000238669300011
J	Babitt, JL; Huang, FW; Wrighting, DM; Xia, Y; Sidis, Y; Samad, TA; Campagna, JA; Chung, RT; Schneyer, AL; Woolf, CJ; Andrews, NC; Lin, HY				Babitt, JL; Huang, FW; Wrighting, DM; Xia, Y; Sidis, Y; Samad, TA; Campagna, JA; Chung, RT; Schneyer, AL; Woolf, CJ; Andrews, NC; Lin, HY			Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression	NATURE GENETICS			English	Article							REPULSIVE GUIDANCE MOLECULE; 1Q-LINKED JUVENILE HEMOCHROMATOSIS; ANTIMICROBIAL PEPTIDE HEPCIDIN; GROWTH-FACTOR-BETA; IRON OVERLOAD; GENE-EXPRESSION; LIVER-CELLS; I RECEPTOR; MOUSE; INFLAMMATION	Hepcidin is a key regulator of systemic iron homeostasis. Hepcidin deficiency induces iron overload, whereas hepcidin excess induces anemia. Mutations in the gene encoding hemojuvelin (HFE2, also known as HJV) cause severe iron overload and correlate with low hepcidin levels, suggesting that hemojuvelin positively regulates hepcidin expression. Hemojuvelin is a member of the repulsive guidance molecule (RGM) family, which also includes the bone morphogenetic protein (BMP) coreceptors RGMA and DRAGON (RGMB). Here, we report that hemojuvelin is a BMP coreceptor and that hemojuvelin mutants associated with hemochromatosis have impaired BMP signaling ability. Furthermore, BMP upregulates hepatocyte hepcidin expression, a process enhanced by hemojuvelin and blunted in Hfe2(-/-) hepatocytes. Our data suggest a mechanism by which HFE2 mutations cause hemochromatosis: hemojuvelin dysfunction decreases BMP signaling, thereby lowering hepcidin expression.	Harvard Univ, Sch Med, Program Membrane Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Nephrol, Massachusetts Gen Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02115 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Neural Plast Res Grp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Lin, HY (corresponding author), Harvard Univ, Sch Med, Program Membrane Biol, Boston, MA 02115 USA.	hlin@partners.org	Woolf, Clifford/A-9784-2010; Xia, Yin/M-5440-2018	Xia, Yin/0000-0003-0315-7532; Andrews, Nancy/0000-0003-0243-4462	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007623] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066373, K08DK075846, F32DK068997, R01DK069533, R01DK071837] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL07623] Funding Source: Medline; NIDDK NIH HHS [R01 DK066373, F32 DK-068997, K08 DK075846, DK-69533, R01 DK066373-03, DK-71837, F32 DK068997-02, K08 DK075846-01, F32 DK068997] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALONSO S, 1986, J MOL EVOL, V23, P11, DOI 10.1007/BF02100994; ALPINI G, 1994, HEPATOLOGY, V20, P494, DOI 10.1002/hep.1840200231; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Clarke TR, 2001, MOL ENDOCRINOL, V15, P946, DOI 10.1210/me.15.6.946; Courselaud B, 2002, J BIOL CHEM, V277, P41163, DOI 10.1074/jbc.M202653200; DeBleser PJ, 1997, J HEPATOL, V26, P886, DOI 10.1016/S0168-8278(97)80257-7; del Re E, 2004, J BIOL CHEM, V279, P22765, DOI 10.1074/jbc.M401350200; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; FROLIK CA, 1984, J BIOL CHEM, V259, P995; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Huang FW, 2004, BLOOD, V104, P2176, DOI 10.1182/blood-2004-01-0400; Kanzler S, 2001, ONCOGENE, V20, P5015, DOI 10.1038/sj.onc.1204544; KINGSLEY DM, 1994, TRENDS GENET, V10, P16, DOI 10.1016/0168-9525(94)90014-0; Knittel T, 1997, EXP CELL RES, V232, P263, DOI 10.1006/excr.1997.3504; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Krijt J, 2004, BLOOD, V104, P4308, DOI 10.1182/blood-2004-06-2422; Lanzara C, 2004, BLOOD, V103, P4317, DOI 10.1182/blood-2004-01-0192; Lee P, 2005, P NATL ACAD SCI USA, V102, P1906, DOI 10.1073/pnas.0409808102; Lee PL, 2004, BLOOD, V103, P4669, DOI 10.1182/blood-2004-01-0072; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Macias-Silva M, 1998, J BIOL CHEM, V273, P25628, DOI 10.1074/jbc.273.40.25628; Martinez AR, 2004, HAEMATOLOGICA, V89, P1441; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Miller SI, 2000, AM J ADDICTION, V9, P275; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Piscione TD, 2001, AM J PHYSIOL-RENAL, V280, pF19, DOI 10.1152/ajprenal.2001.280.1.F19; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Roetto A, 2003, NAT GENET, V33, P21, DOI 10.1038/ng1053; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Samad TA, 2004, J NEUROSCI, V24, P2027, DOI 10.1523/JNEUROSCI.4115-03.2004; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Zhang AS, 2005, J BIOL CHEM, V280, P33885, DOI 10.1074/jbc.M506207200; Zhao GQ, 2003, GENESIS, V35, P43, DOI 10.1002/gene.10167	50	790	858	3	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					531	539		10.1038/ng1777	http://dx.doi.org/10.1038/ng1777			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16604073				2022-12-27	WOS:000237147500014
J	Yeh, P; Tschumi, AI; Kishony, R				Yeh, P; Tschumi, AI; Kishony, R			Functional classification of drugs by properties of their pairwise interactions	NATURE GENETICS			English	Article							MULTICOMPONENT THERAPEUTICS; ESCHERICHIA-COLI; NETWORK MOTIFS; ANTIBIOTICS; RESISTANCE; BIOLOGY; PRINCIPLES; MECHANISMS; EPISTASIS; CANCER	Multidrug treatments are increasingly important in medicine and for probing biological systems(1-6). Although many studies have focused on interactions between specific drugs, little is known about the system properties of a full drug interaction network(6). Like their genetic counterparts, two drugs may have no interaction, or they may interact synergistically or antagonistically to increase or suppress their individual effects. Here we use a sensitive bioluminescence technique(7,8) to provide quantitative measurements of pairwise interactions among 21 antibiotics that affect growth rate in Escherichia coli. We find that the drug interaction network possesses a special property: it can be separated into classes of drugs such that any two classes interact either purely synergistically or purely antagonistically. These classes correspond directly to the cellular functions affected by the drugs. This network approach provides a new conceptual framework for understanding the functional mechanisms of drugs and their cellular targets and can be applied in systems intractable to mutant screening, biochemistry or microscopy.	Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School	Kishony, R (corresponding author), Harvard Univ, Bauer Ctr Genom Res, 7 Divin Ave, Cambridge, MA 02138 USA.	rkishony@cgr.harvard.edu						Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bjarnason J, 2003, J BACTERIOL, V185, P4973, DOI 10.1128/JB.185.16.4973-4982.2003; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hecht SM, 2000, J NAT PROD, V63, P158, DOI 10.1021/np990549f; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kishony Roy, 2003, J Biol, V2, P14, DOI 10.1186/1475-4924-2-14; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Leeb M, 2004, NATURE, V431, P892, DOI 10.1038/431892a; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Nathan C, 2004, NATURE, V431, P899, DOI 10.1038/431899a; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Remold SK, 2004, NAT GENET, V36, P423, DOI 10.1038/ng1324; Schreiber SL, 2003, CHEM ENG NEWS, V81, P51, DOI 10.1021/cen-v081n009.p051; SCOTT GM, 2001, HDB ESSENTIAL ANTIBI; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Swinney DC, 2004, NAT REV DRUG DISCOV, V3, P801, DOI 10.1038/nrd1500; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Walsh C., 2003, ANTIBIOTICS ACTIONS	30	252	256	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2006	38	4					489	494		10.1038/ng1755	http://dx.doi.org/10.1038/ng1755			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	026LN	16550172				2022-12-27	WOS:000236340500025
J	Ripperger, JRA; Schibler, U				Ripperger, JRA; Schibler, U			Rhythmic CLOCK-BMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitions	NATURE GENETICS			English	Article							HISTONE H3; GENE-EXPRESSION; LYSINE 9; CLOCK; CELLS; METHYLATION; PACEMAKER; DEMETHYLATION; ACETYLATION; MECHANISMS	Mammalian circadian rhythms are based on transcriptional and post-translational feedback loops. Essentially, the activity of the transcription factors BMAL1 (also known as MOP3) and CLOCK is rhythmically counterbalanced by Period (PER) and Cryptochrome (CRY) proteins to govern time of day - dependent gene expression(1). Here we show that circadian regulation of the mouse albumin D element-binding protein (Dbp) gene involves rhythmic binding of BMAL1 and CLOCK and marked daily chromatin transitions. Thus, the Dbp transcription cycle is paralleled by binding of BMAL1 and CLOCK to multiple extra- and intragenic E boxes, acetylation of Lys9 of histone H3, trimethylation of Lys4 of histone H3 and a reduction of histone density. In contrast, the antiphasic daily repression cycle is accompanied by dimethylation of Lys9 of histone H3, the binding of heterochromatin protein 1 alpha and an increase in histone density. The rhythmic conversion of transcriptionally permissive chromatin to facultative heterochromatin relies on the presence of functional BMAL1-CLOCK binding sites.	Univ Fribourg, Dept Med, Biochem Sect, CH-1700 Fribourg, Switzerland; Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; Univ Geneva, Natl Ctr Competence Res Frontiers Genet, CH-1211 Geneva 4, Switzerland	University of Fribourg; University of Geneva; University of Geneva	Schibler, U (corresponding author), Univ Fribourg, Dept Med, Biochem Sect, CH-1700 Fribourg, Switzerland.	Ueli.Schibler@molbio.unige.ch						Akashi M, 2000, GENE DEV, V14, P645; Albrecht U, 2004, FRONT BIOSCI-LANDMRK, V9, P48, DOI 10.2741/1196; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Kimura H, 2005, DNA REPAIR, V4, P939, DOI 10.1016/j.dnarep.2005.04.012; Kimura H, 2001, J CELL BIOL, V153, P1341, DOI 10.1083/jcb.153.7.1341; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Lowrey PL, 2000, ANNU REV GENET, V34, P533, DOI 10.1146/annurev.genet.34.1.533; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JA, 2000, GENE DEV, V14, P679; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Wirth Dagmar, 2004, Methods Mol Biol, V267, P467; WUARIN J, 1990, CELL, V63, P1257, DOI 10.1016/0092-8674(90)90421-A; Yin L, 1998, HEPATOLOGY, V27, P73, DOI 10.1002/hep.510270113; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	30	430	443	3	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					369	374		10.1038/ng1738	http://dx.doi.org/10.1038/ng1738			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16474407	Green Submitted			2022-12-27	WOS:000235589600021
J	Kyttala, M; Tallila, J; Salonen, R; Kopra, O; Kohlschmidt, N; Paavola-Sakki, P; Peltonen, L; Kestila, M				Kyttala, M; Tallila, J; Salonen, R; Kopra, O; Kohlschmidt, N; Paavola-Sakki, P; Peltonen, L; Kestila, M			MKS1, encoding a component of the flagellar apparatus basal body proteome, is mutated in Meckel syndrome	NATURE GENETICS			English	Article							DISEASE GENE; C-ELEGANS; MAPS; CILIA; INVERSUS; LOCUS; FLOW; MICE	Meckel syndrome (MKS) is a severe fetal developmental disorder reported in most populations. The clinical hallmarks are occipital meningoencephalocele, cystic kidney dysplasia, fibrotic changes of the liver and polydactyly. Here we report the identification of a gene, MKS1, mutated in MKS families linked to 17q. Mks1 expression in mouse embryos, as determined by in situ hybridization, agrees well with the tissue phenotype of MKS. Comparative genomics and proteomics data implicate MKS1 in ciliary functions.	Natl Publ Hlth Inst, Dept Mol Med, FI-00251 Helsinki, Finland; Univ Helsinki, Dept Med Genet, FI-00014 Helsinki, Finland; Dept Med Genet, FI-00101 Helsinki, Finland; Univ Helsinki Hosp, Dept Med, FI-00014 Helsinki, Finland; Harvard Univ, Broad Inst, Cambridge, MA 02139 USA; MIT, Cambridge, MA 02139 USA	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Peltonen, L (corresponding author), Natl Publ Hlth Inst, Dept Mol Med, FI-00251 Helsinki, Finland.	leena.peltonen@ktl.fi						Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Hentges KE, 2004, MAMM GENOME, V15, P252, DOI 10.1007/s00335-003-2303-y; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Morgan NV, 2002, HUM GENET, V111, P456, DOI 10.1007/s00439-002-0817-0; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; PAAVOLA P, 1995, NAT GENET, V11, P213, DOI 10.1038/ng1095-213; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Roume J, 1998, AM J HUM GENET, V63, P1095, DOI 10.1086/302062; SALONEN R, 1984, AM J MED GENET, V18, P671, DOI 10.1002/ajmg.1320180414; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0	15	182	186	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					155	157		10.1038/ng1714	http://dx.doi.org/10.1038/ng1714			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16415886				2022-12-27	WOS:000234953200008
J	Anttonen, AK; Mahjneh, I; Hamalainen, RH; Lagier-Tourenne, C; Kopra, O; Waris, L; Anttonen, M; Joensuu, T; Kalimo, H; Paetau, A; Tranebjaerg, L; Chaigne, D; Koenig, M; Eeg-Olofsson, O; Udd, B; Somer, M; Somer, H; Lehesjoki, AE				Anttonen, AK; Mahjneh, I; Hamalainen, RH; Lagier-Tourenne, C; Kopra, O; Waris, L; Anttonen, M; Joensuu, T; Kalimo, H; Paetau, A; Tranebjaerg, L; Chaigne, D; Koenig, M; Eeg-Olofsson, O; Udd, B; Somer, M; Somer, H; Lehesjoki, AE			The gene disrupted in Marinesco-Sjogren syndrome encodes SIL1, an HSPA5 cochaperone	NATURE GENETICS			English	Article							MOLECULAR CHAPERONES; PROTEIN; NEURODEGENERATION; TRANSLOCATION; BIP	We identified the gene underlying Marinesco-Sjogren syndrome, which is characterized by cerebellar ataxia, progressive myopathy and cataracts. We identified four disease-associated, predicted loss-of-function mutations in SIL1, which encodes a nucleotide exchange factor for the heat-shock protein 70 (HSP70) chaperone HSPA5. These data, together with the similar spatial and temporal patterns of tissue expression of Sil1 and Hspa5, suggest that disturbed SIL1-HSPA5 interaction and protein folding is the primary pathology in Marinesco-Sjogren syndrome.	Univ Helsinki, Folkhalsan Inst Genet, FI-00014 Helsinki, Finland; Univ Helsinki, Ctr Neurosci, FI-00014 Helsinki, Finland; Univ Helsinki, Dept Med Genet, FI-00014 Helsinki, Finland; Pietarsaari Hosp, Dept Neurol, FI-68601 Pietarsaari, Finland; Univ Oulu, Dept Neurol, Oulu, Finland; Univ Strasbourg 1, CNRS, INSERM, Inst Genet Biol Mol & Cellulaire, FR-67404 Illkirch Graffenstaden, France; Univ Helsinki, Ctr Neurosci, FI-00014 Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, Program Dev & Reprod Biol, FI-00014 Helsinki, Finland; Univ Helsinki, Childrens Hosp, FI-00014 Helsinki, Finland; Univ Helsinki, Dept Pathol, FI-00014 Helsinki, Finland; Univ Helsinki, Cent Hosp, FI-00014 Helsinki, Finland; Univ Tromso Hosp, Dept Med Genet, N-9012 Tromso, Norway; Bispebjerg Hosp, Dept Audiol, DK-2200 Copenhagen, Denmark; Univ Copenhagen, Panum Inst, Inst Med Biochem & Genet IMBG, Wilhelm Johannsen Ctr Funct Genom, DK-2200 Copenhagen, Denmark; Clin St Odile, FR-67100 Strasbourg, France; Uppsala Univ, Dept Womens & Childrens Hlth Pediat, SE-75186 Uppsala, Sweden; Vaasa Cent Hosp, Dept Neurol, Vaasa, Finland; Tampere Univ Hosp, Dept Neurol, Tampere, Finland; Family Federat Finland, FI-00101 Helsinki, Finland; Univ Helsinki, Dept Neurol, FI-00014 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Oulu; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Uppsala University; Vaasa Central Hospital; Tampere University; Tampere University Hospital; Family Federation of Finland; University of Helsinki	Lehesjoki, AE (corresponding author), Univ Helsinki, Folkhalsan Inst Genet, POB 63, FI-00014 Helsinki, Finland.	anna-elina.lehesjoki@helsinki.fi	Joensuu, Tarja/F-3059-2011; Martikainen, Riikka/AAR-8397-2020	Martikainen, Riikka/0000-0002-5102-0672; Mahjneh, Ibrahim/0000-0002-0752-9949				Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; Boisrame A, 1998, J BIOL CHEM, V273, P30903, DOI 10.1074/jbc.273.47.30903; Chung KT, 2002, J BIOL CHEM, V277, P47557, DOI 10.1074/jbc.M208377200; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Lagier-Tourenne C, 2002, J MED GENET, V39, P838, DOI 10.1136/jmg.39.11.838; Lagier-Tourenne C, 2003, EUR J HUM GENET, V11, P770, DOI 10.1038/sj.ejhg.5201068; Marinesco G, 1931, ENCEPHALE, V26, P97; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; SEWRY CA, 1988, ANN NEUROL, V24, P576, DOI 10.1002/ana.410240416; SJoGREN TORSTEN, 1950, CONFINIA NEUROL, V10, P293; Steel GJ, 2004, SCIENCE, V303, P98, DOI 10.1126/science.1092287; Suzuki Y, 1997, ACTA NEUROPATHOL, V94, P410, DOI 10.1007/s004010050727; TODOROV A, 1965, J GENET HUM, V14, P197; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; Zhao LH, 2005, NAT GENET, V37, P974, DOI 10.1038/ng1620	15	155	159	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2005	37	12					1309	1311		10.1038/ng1677	http://dx.doi.org/10.1038/ng1677			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16282978				2022-12-27	WOS:000233657300006
J	Schmitt-John, T; Drepper, C; Mussmann, A; Hahn, P; Kuhlmann, M; Thiel, C; Hafner, M; Lengeling, A; Heimann, P; Jones, JM; Meisler, MH; Jockusch, H				Schmitt-John, T; Drepper, C; Mussmann, A; Hahn, P; Kuhlmann, M; Thiel, C; Hafner, M; Lengeling, A; Heimann, P; Jones, JM; Meisler, MH; Jockusch, H			Mutation of Vps54 causes motor neuron disease and defective spermiogenesis in the wobbler mouse	NATURE GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; PROTEIN; COMPLEX	Vacuolar-vesicular protein sorting (Vps) factors are involved in vesicular trafficking in eukaryotic cells. We identified the missense mutation L967Q in Vps54 in the wobbler mouse, an animal model of amyotrophic lateral sclerosis, and also characterized a lethal allele, Vps54(beta-geo). Motoneuron survival and spermiogenesis are severely compromised in the wobbler mouse, indicating that Vps54 has an essential role in these processes.	Univ Bielefeld, D-4800 Bielefeld, Germany; German Res Ctr Biotechnol, Res Grp Infect Genet, Braunschweig, Germany; German Res Ctr Biotechnol, Dept Expt Immunol, Braunschweig, Germany; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Bielefeld; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; University of Michigan System; University of Michigan	Schmitt-John, T (corresponding author), Univ Aarhus, Dept Mol Biol, DK-8000 Aarhus, Denmark.	tsj@mb.au.dk	Hahn, Phillip/A-4812-2012; Drepper, Carsten/GSN-2009-2022; Hafner, Martin/B-9040-2008	Hahn, Phillip/0000-0002-8741-3603; Hafner, Martin/0000-0003-0769-1812; Drepper, Carsten/0000-0002-7883-6479				Augustin M, 1997, DEV DYNAM, V209, P286, DOI 10.1002/(SICI)1097-0177(199707)209:3<286::AID-AJA4>3.0.CO;2-E; Conibear E, 2003, MOL BIOL CELL, V14, P1610, DOI 10.1091/mbc.E02-10-0654; DUCHEN LW, 1968, J NEUROL NEUROSUR PS, V31, P535, DOI 10.1136/jnnp.31.6.535; Fabrizio JJ, 1998, DEVELOPMENT, V125, P1833; Falconer D.S, 1956, MOUSE NEWS LETT, V15, P22; Fuchs S, 2002, BMC GENET, V3, DOI 10.1186/1471-2156-3-14; Gissen P, 2004, NAT GENET, V36, P400, DOI 10.1038/ng1325; HEIMANN P, 1991, DIFFERENTIATION, V47, P77, DOI 10.1111/j.1432-0436.1991.tb00225.x; KAUPMANN K, 1992, GENOMICS, V13, P39, DOI 10.1016/0888-7543(92)90199-3; Li W, 2004, BIOESSAYS, V26, P616, DOI 10.1002/bies.20042; Liewen H, 2005, EXP CELL RES, V306, P24, DOI 10.1016/j.yexcr.2005.01.022; MITSUMOTO H, 1982, BRAIN, V105, P811, DOI 10.1093/brain/105.4.811; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Walter L, 2002, GENE, V285, P213, DOI 10.1016/S0378-1119(02)00405-5; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	15	173	176	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1213	1215		10.1038/ng1661	http://dx.doi.org/10.1038/ng1661			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16244655				2022-12-27	WOS:000233045200020
J	Morgante, M; Brunner, S; Pea, G; Fengler, K; Zuccolo, A; Rafalski, A				Morgante, M; Brunner, S; Pea, G; Fengler, K; Zuccolo, A; Rafalski, A			Gene duplication and exon shuffling by helitron-like transposons generate intraspecies diversity in maize	NATURE GENETICS			English	Article							ROLLING-CIRCLE TRANSPOSONS; ELEMENTS; EVOLUTION; SEQUENCES; MOVEMENT; NUMBER; RICE	We report a whole- genome comparison of gene content in allelic BAC contigs from two maize inbred lines. Genic content polymorphisms involve as many as 10,000 sequences and are mainly generated by DNA insertions. The termini of eight of the nine genic insertions that we analyzed shared the structural hallmarks of helitron rolling- circle transposons(1-3). DNA segments defined by helitron termini contained multiple gene- derived fragments and had a structure typical of nonautonomous helitron- like transposons. Closely related insertions were found in multiple genomic locations. Some of these produced transcripts containing segments of different genes, supporting the idea that these transposition events have a role in exon shuffling and the evolution of new proteins. We identified putative autonomous helitron elements and found evidence for their transcription. Helitrons in maize seem to continually produce new nonautonomous elements responsible for the duplicative insertion of gene segments into new locations and for the unprecedented genic diversity. The maize genome is in constant flux, as transposable elements continue to change both the genic and nongenic fractions of the genome, profoundly affecting genetic diversity.	Univ Udine, Dipartimento Sci Agr & Ambientali, I-33100 Udine, Italy; DuPont Crop Genet Res, Wilmington, DE 19880 USA	University of Udine; DuPont	Morgante, M (corresponding author), Univ Udine, Dipartimento Sci Agr & Ambientali, Via Sci 208, I-33100 Udine, Italy.	michele.morgante@uniud.it	Zuccolo, Andrea/H-5636-2019	Zuccolo, Andrea/0000-0001-7574-0714; MORGANTE, Michele/0000-0003-2591-2156				Bennetzen JL, 2004, CURR OPIN PLANT BIOL, V7, P732, DOI 10.1016/j.pbi.2004.09.003; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Brunner S, 2005, PLANT CELL, V17, P343, DOI 10.1105/tpc.104.025627; Craig NL, 2002, MOBILE DNA 2; Duvick DN, 2001, NAT REV GENET, V2, P69, DOI 10.1038/35047587; Feschotte C, 2001, P NATL ACAD SCI USA, V98, P8923, DOI 10.1073/pnas.171326198; Fu HH, 2002, P NATL ACAD SCI USA, V99, P9573, DOI 10.1073/pnas.132259199; Gardiner J, 2004, PLANT PHYSIOL, V134, P1317, DOI 10.1104/pp.103.034538; Gupta S, 2005, PLANT MOL BIOL, V57, P115, DOI 10.1007/s11103-004-6636-z; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Ilic K, 2003, P NATL ACAD SCI USA, V100, P12265, DOI 10.1073/pnas.1434476100; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Kapitonov VV, 2001, P NATL ACAD SCI USA, V98, P8714, DOI 10.1073/pnas.151269298; Kynast RG, 2001, PLANT PHYSIOL, V125, P1216, DOI 10.1104/pp.125.3.1216; Lai JS, 2005, P NATL ACAD SCI USA, V102, P9068, DOI 10.1073/pnas.0502923102; Lai JS, 2004, GENOME RES, V14, P1924, DOI 10.1101/gr.2701104; Lal SK, 2003, PLANT CELL, V15, P381, DOI 10.1105/tpc.008375; Le QH, 2000, P NATL ACAD SCI USA, V97, P7376, DOI 10.1073/pnas.97.13.7376; Messing J, 2004, P NATL ACAD SCI USA, V101, P14349, DOI 10.1073/pnas.0406163101; Meyers BC, 2001, GENOME RES, V11, P1660, DOI 10.1101/gr.188201; Meyers BC, 2004, NAT REV GENET, V5, P578, DOI 10.1038/nrg1404; Okagaki RJ, 2001, PLANT PHYSIOL, V125, P1228, DOI 10.1104/pp.125.3.1228; Palmer LE, 2003, SCIENCE, V302, P2115, DOI 10.1126/science.1091265; Poulter RTM, 2003, GENE, V313, P201, DOI 10.1016/S0378-1119(03)00679-6; Ramakrishna W, 2002, PLANT CELL, V14, P3213, DOI 10.1105/tpc.006338; Song R, 2002, GENOME RES, V12, P1549, DOI 10.1101/gr.268302; Song RT, 2003, P NATL ACAD SCI USA, V100, P9055, DOI 10.1073/pnas.1032999100; Swigonova Z, 2005, GENETICS, V169, P891, DOI 10.1534/genetics.104.034629; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Yu ZH, 2000, GENETICS, V156, P2019	30	360	395	2	58	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					997	1002		10.1038/ng1615	http://dx.doi.org/10.1038/ng1615			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16056225				2022-12-27	WOS:000231591900027
J	Need, AC; Motulsky, AG; Goldstein, DB				Need, AC; Motulsky, AG; Goldstein, DB			Priorities and standards in pharmacogenetic research	NATURE GENETICS			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; COMMON DISEASE GENES; LONG-QT SYNDROME; LINKAGE DISEQUILIBRIUM; RESISTANT SCHIZOPHRENIA; PULMONARY-HYPERTENSION; DRUG DEVELOPMENT; HUMAN GENOME; LUNG-CANCER; MUTATION	The current enthusiasm for pharmacogenetics draws much of its inspiration from the relatively few examples of polymorphisms that have marked and seemingly clinically relevant effects on drug response. In this regard, pharmacogenetic research has paralleled the study of human disease, which has enjoyed success in identifying mutations underlying mendelian conditions. Progress in deciphering the genetics of complex diseases, involving the interaction of multiple genes with each other and with the environment has been considerably less successful. In most instances, drug responses will probably also prove to be complex, influenced by both the environment and multiple genetic factors. For pharmacogenetics to deliver on its potential, this complexity will need to be recognized and accommodated, both in basic research and in clinical application of pharmacogenetics. As the attention of researchers begins to shift toward more systematic pharmacogenetic investigations, we suggest some priorities and standards for pharmacogenetic research.	Duke Univ, Ctr Populat Genom & Pharmacogenet, Inst Genome Sci & Policy, Durham, NC 27710 USA; Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Duke University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Need, AC (corresponding author), Duke Univ, Ctr Populat Genom & Pharmacogenet, Inst Genome Sci & Policy, 103 Res Dr,DUMC Box 3471, Durham, NC 27710 USA.		Goldstein, David/AAY-8125-2020	Need, Anna/0000-0003-3955-8207	NIEHS NIH HHS [P30ES07033] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Acuna Gonzalo, 2002, Pharmacogenomics Journal, V2, P327, DOI 10.1038/sj.tpj.6500123; Ahmadi KR, 2005, NAT GENET, V37, P84, DOI 10.1038/ng1488; Bacanu SA, 2002, GENET EPIDEMIOL, V22, P78, DOI 10.1002/gepi.1045; Belohlavkova S, 2001, J APPL PHYSIOL, V91, P755, DOI 10.1152/jappl.2001.91.2.755; Berson A, 2001, J PHARMACOL EXP THER, V299, P793; Blanpain C, 2003, CARDIOVASC RES, V60, P518, DOI 10.1016/j.cardiores.2003.09.015; Boffelli D, 2003, SCIENCE, V299, P1391, DOI 10.1126/science.1081331; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Camilleri M, 2002, GASTROENTEROLOGY, V123, P425, DOI 10.1053/gast.2002.34780; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Cipollone F, 2004, JAMA-J AM MED ASSOC, V291, P2221, DOI 10.1001/jama.291.18.2221; Conley RR, 2001, BIOL PSYCHIAT, V50, P898, DOI 10.1016/S0006-3223(01)01271-9; Dervieux T, 2004, ARTHRITIS RHEUM-US, V50, P2766, DOI 10.1002/art.20460; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Donger C, 1997, CIRCULATION, V96, P2778, DOI 10.1161/01.CIR.96.9.2778; Duggan A, 2003, BRIT J PSYCHIAT, V182, P505, DOI 10.1192/bjp.182.6.505; Fischer OM, 2003, CURR OPIN CHEM BIOL, V7, P490, DOI 10.1016/S1367-5931(03)00082-6; Flowers CR, 2004, PHARMACOECONOMICS, V22, P481, DOI 10.2165/00019053-200422080-00001; Ford GA, 2000, BRIT J CLIN PHARMACO, V50, P77, DOI 10.1046/j.1365-2125.2000.00230.x; Goldstein DB, 2003, NAT REV GENET, V4, P937, DOI 10.1038/nrg1229; Goldstein DB, 2003, TRENDS GENET, V19, P615, DOI 10.1016/j.tig.2003.09.006; Goldstein DB, 2003, NEW ENGL J MED, V348, P553, DOI 10.1056/NEJMe020173; Gross AS, 1996, BRIT J CLIN PHARMACO, V41, P311, DOI 10.1046/j.1365-2125.1996.03178.x; Holleman A, 2004, NEW ENGL J MED, V351, P533, DOI 10.1056/NEJMoa033513; Honigfeld G, 1998, J CLIN PSYCHIAT, V59, P3; Humbert M, 2002, EUR RESPIR J, V20, P518, DOI 10.1183/09031936.02.01762002; Ishikawa C, 2004, J HUM GENET, V49, P582, DOI 10.1007/s10038-004-0188-6; Jiang ZW, 2005, HUM MUTAT, V25, P196, DOI 10.1002/humu.20134; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kager L, 2005, J CLIN INVEST, V115, P110, DOI 10.1172/JCI200522477; Ke XY, 2004, HUM MOL GENET, V13, P2557, DOI 10.1093/hmg/ddh294; Kirchheiner J, 2004, MOL PSYCHIATR, V9, P442, DOI 10.1038/sj.mp.4001494; Krajinovic M, 2004, PHARMACOGENOMICS J, V4, P66, DOI 10.1038/sj.tpj.6500224; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Kumashiro R, 2003, HEPATOL RES, V26, P337, DOI 10.1016/S1386-6346(03)00165-7; Lesko LJ, 2004, NAT REV DRUG DISCOV, V3, P763, DOI 10.1038/nrd1499; Li H, 2001, ANN HUM GENET, V65, P189, DOI 10.1017/S0003480001008491; Liguori MJ, 2005, HEPATOLOGY, V41, P177, DOI 10.1002/hep.20514; Liu NJ, 2004, GENET EPIDEMIOL, V27, P385, DOI 10.1002/gepi.20026; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Makita N, 2002, CIRCULATION, V106, P1269, DOI 10.1161/01.CIR.0000027139.42087.B6; McGough JJ, 2003, J AM ACAD CHILD PSY, V42, P684, DOI 10.1097/01.CHI.0000046850.56865.CB; MELTZER HY, 1995, AM J PSYCHIAT, V152, P183; Michalski C, 2002, J BIOL CHEM, V277, P43058, DOI 10.1074/jbc.M207735200; Napolitano C, 2000, J CARDIOVASC ELECTR, V11, P691, DOI 10.1111/j.1540-8167.2000.tb00033.x; Nebert Daniel W, 2003, Am J Pharmacogenomics, V3, P361, DOI 10.2165/00129785-200303060-00002; Nebert DW, 2004, EUR J PHARMACOL, V500, P267, DOI 10.1016/j.ejphar.2004.07.031; Ni W, 2004, J PHARMACOL EXP THER, V309, P845, DOI 10.1124/jpet.103.060806; Ovcharenko I, 2004, GENOME RES, V14, P1191, DOI 10.1101/gr.1773104; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Parker SL, 1997, CA-CANCER J CLIN, V47, P5, DOI 10.3322/canjclin.47.1.5; Rajput AH, 2002, MOVEMENT DISORD, V17, P289, DOI 10.1002/mds.10031; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Roses AD, 2004, NAT REV GENET, V5, P645, DOI 10.1038/nrg1432; Roses AD, 2005, DRUG DISCOV TODAY, V10, P177, DOI 10.1016/S1359-6446(04)03321-5; Schaeffeler E, 2004, PHARMACOGENETICS, V14, P407, DOI 10.1097/01.fpc.0000114745.08559.db; Shah Rashmi R, 2005, Expert Opin Drug Saf, V4, P103, DOI 10.1517/14740338.4.1.103; Shah RR, 2004, DRUG SAFETY, V27, P145, DOI 10.2165/00002018-200427030-00001; SHAH RR, IN PRESS P R SOC L B; SHORVON S, 2004, TREATMENT EPILEPSY; Soranzo N, 2004, GENOME RES, V14, P1333, DOI 10.1101/gr.1965304; Strauss JF, 2004, NATURE, V432, P43, DOI 10.1038/432043a; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Stumpf MPH, 2003, CURR BIOL, V13, P1, DOI 10.1016/S0960-9822(02)01404-5; Tate SK, 2005, P NATL ACAD SCI USA, V102, P5507, DOI 10.1073/pnas.0407346102; Tate SK, 2004, NAT GENET, V36, pS34, DOI 10.1038/ng1437; Watanabe I, 2003, CLIN PHARMACOL THER, V73, P435, DOI 10.1016/S0009-9236(03)00014-6; Watters JW, 2004, P NATL ACAD SCI USA, V101, P11809, DOI 10.1073/pnas.0404580101; Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021; Wolbrette Deborah L, 2004, Curr Cardiol Rep, V6, P379, DOI 10.1007/s11886-004-0041-8; Wong DR, 2005, CURR OPIN PHARMACOL, V5, P204, DOI 10.1016/j.coph.2005.02.001; Zembutsu H, 2002, CANCER RES, V62, P518; Zhang JY, 2003, DRUG METAB DISPOS, V31, P652, DOI 10.1124/dmd.31.5.652; Zhen XA, 2004, CANCER RES, V64, P2904, DOI 10.1158/0008-5472.CAN-03-3754	75	89	92	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					671	681		10.1038/ng1593	http://dx.doi.org/10.1038/ng1593			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15990888				2022-12-27	WOS:000230196400013
J	Wang, YX; Putnam, CD; Kane, MF; Zhang, WJ; Edelmann, L; Russell, R; Carrion, DV; Chin, L; Kucherlapati, R; Kolodner, RD; Edelmann, W				Wang, YX; Putnam, CD; Kane, MF; Zhang, WJ; Edelmann, L; Russell, R; Carrion, DV; Chin, L; Kucherlapati, R; Kolodner, RD; Edelmann, W			Mutation in Rpa1 results in defective DNA double-strand break repair, chromosomal instability and cancer in mice	NATURE GENETICS			English	Article							REPLICATION PROTEIN-A; SACCHAROMYCES-CEREVISIAE; GENOME INSTABILITY; HOMOLOGOUS RECOMBINATION; SHORT ARM; REARRANGEMENTS; SUPPRESSION; DAMAGE; GENES; HETEROZYGOSITY	Most cancers have multiple chromosomal rearrangements; the molecular mechanisms that generate them remain largely unknown. Mice carrying a heterozygous missense change in one of the DNA- binding domains of Rpa1 develop lymphoid tumors, and their homozygous littermates succumb to early embryonic lethality. Array comparative genomic hybridization of the tumors identified large- scale chromosomal changes as well as segmental gains and losses. The Rpa1 mutation resulted in defects in DNA double- strand break repair and precipitated chromosomal breaks as well as aneuploidy in primary heterozygous mutant mouse embryonic fibroblasts. The equivalent mutation in yeast is hypomorphic and semidominant and enhanced the formation of gross chromosomal rearrangements in multiple genetic backgrounds. These results indicate that Rpa1 functions in DNA metabolism are essential for the maintenance of chromosomal stability and tumor suppression.	Univ Calif San Diego, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Harvard Univ, Sch Med, Ctr Genet & Genom, Harvard Med Sch Partners Healthcare Ctr Genet & G, Boston, MA 02115 USA; NYU, Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai; New York University; Yeshiva University; Albert Einstein College of Medicine; Harvard University; Dana-Farber Cancer Institute	Kolodner, RD (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, Ctr Canc, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu; edelmann@aecom.yu.edu	Kucherlapati, Raju/ABC-8807-2021	Wang, Yuxun/0000-0002-4252-6102; Putnam, Christopher/0000-0002-6145-1265				BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; CHEN LC, 1991, P NATL ACAD SCI USA, V88, P3847, DOI 10.1073/pnas.88.9.3847; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; COLES C, 1990, LANCET, V336, P761, DOI 10.1016/0140-6736(90)93236-I; Cory S, 1999, CANCER RES, V59, p1685S; Debrauwere H, 2001, P NATL ACAD SCI USA, V98, P8263, DOI 10.1073/pnas.121075598; DEVILEE P, 1989, GENOMICS, V5, P554, DOI 10.1016/0888-7543(89)90023-2; Flores-Rozas H, 2000, TRENDS BIOCHEM SCI, V25, P196, DOI 10.1016/S0968-0004(00)01568-1; Karlsson A, 2003, P NATL ACAD SCI USA, V100, P9974, DOI 10.1073/pnas.1732638100; Kim HS, 2001, MOL CELL BIOL, V21, P3725, DOI 10.1128/MCB.21.11.3725-3737.2001; Klein HL, 2001, GENETICS, V159, P1501; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lim DS, 1996, MOL CELL BIOL, V16, P7133; MACKAY J, 1988, LANCET, V2, P1384; METZ T, 1995, CELL, V82, P29, DOI 10.1016/0092-8674(95)90049-7; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Myung K, 2002, P NATL ACAD SCI USA, V99, P4500, DOI 10.1073/pnas.062702199; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Pennaneach V, 2004, NAT GENET, V36, P612, DOI 10.1038/ng1359; Soustelle C, 2002, GENETICS, V161, P535; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tharapel SA, 2002, AM J MED GENET, V107, P123, DOI 10.1002/ajmg.10105; Tsuzuki T, 1996, P NATL ACAD SCI USA, V93, P6236, DOI 10.1073/pnas.93.13.6236; UMBRICHT CB, 1994, GENOMICS, V20, P249, DOI 10.1006/geno.1994.1161; Umezu K, 1998, GENETICS, V148, P989; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	30	122	123	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					750	755		10.1038/ng1587	http://dx.doi.org/10.1038/ng1587			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15965476				2022-12-27	WOS:000230196400023
J	Hubner, N; Wallace, CA; Zimdahl, H; Petretto, E; Schulz, H; Maciver, F; Mueller, M; Hummel, O; Monti, J; Zidek, V; Musilova, A; Kren, V; Causton, H; Game, L; Born, G; Schmidt, S; Muller, A; Cook, SA; Kurtz, TW; Whittaker, J; Pravenec, M; Aitman, TJ				Hubner, N; Wallace, CA; Zimdahl, H; Petretto, E; Schulz, H; Maciver, F; Mueller, M; Hummel, O; Monti, J; Zidek, V; Musilova, A; Kren, V; Causton, H; Game, L; Born, G; Schmidt, S; Muller, A; Cook, SA; Kurtz, TW; Whittaker, J; Pravenec, M; Aitman, TJ			Integrated transcriptional profiling and linkage analysis for identification of genes underlying disease	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; RECOMBINANT INBRED STRAINS; SPONTANEOUSLY HYPERTENSIVE RATS; ANGIOTENSIN-CONVERTING-ENZYME; FATTY-ACID-METABOLISM; BLOOD-PRESSURE; INSULIN-RESISTANCE; CHROMOSOME 1; CONGENIC STRAINS; COMPLEX TRAITS	Integration of genome-wide expression profiling with linkage analysis is a new approach to identifying genes underlying complex traits. We applied this approach to the regulation of gene expression in the BXH/HXB panel of rat recombinant inbred strains, one of the largest available rodent recombinant inbred panels and a leading resource for genetic analysis of the highly prevalent metabolic syndrome. In two tissues important to the pathogenesis of the metabolic syndrome, we mapped cis- and transregulatory control elements for expression of thousands of genes across the genome. Many of the most highly linked expression quantitative trait loci are regulated in cis, are inherited essentially as monogenic traits and are good candidate genes for previously mapped physiological quantitative trait loci in the rat. By comparative mapping we generated a data set of 73 candidate genes for hypertension that merit testing in human populations. Mining of this publicly available data set is expected to lead to new insights into the genes and regulatory pathways underlying the extensive range of metabolic and cardiovascular disease phenotypes that segregate in these recombinant inbred strains.	Acad Sci Czech Republic, Inst Physiol, CR-14220 Prague 4, Czech Republic; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Univ London Imperial Coll Sci & Technol, Fac Med, Ctr Clin Sci, MRC, London W12 0NN, England; Ctr Appl Gen, Prague 14220 4, Czech Republic; Charles Univ Prague, Inst Biol & Med Genet, Prague 12000 2, Czech Republic; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ London Imperial Coll Sci & Technol, Dept Epidemiol & Publ Hlth, London W2 1PG, England	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Imperial College London; Charles University Prague; University of California System; University of California San Francisco; Imperial College London	Pravenec, M (corresponding author), Acad Sci Czech Republic, Inst Physiol, Videnska 1083, CR-14220 Prague 4, Czech Republic.	pravenec@biomed.cas.cz; t.aitman@csc.mrc.ac.uk	Zidek, Vaclav/C-6685-2012; Cook, Stuart/G-9567-2011; Pravenec, Michal/B-1666-2012; Whittaker, John C/B-8609-2012	Pravenec, Michal/0000-0001-9197-5871; Whittaker, John C/0000-0002-3529-2379; Aitman, Timothy/0000-0002-7875-4502; Cook, Stuart/0000-0001-6628-194X; Causton, Helen/0000-0003-4630-6569	MRC [MC_U120061454] Funding Source: UKRI; Medical Research Council [MC_U120061454, MC_U120097112] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Aitman TJ, 1997, NAT GENET, V16, P197, DOI 10.1038/ng0697-197; Belknap JK, 1996, BEHAV GENET, V26, P149, DOI 10.1007/BF02359892; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Bottger A, 1996, J CLIN INVEST, V98, P856, DOI 10.1172/JCI118858; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; CHURCHILL GA, 1994, GENETICS, V138, P963; Cowley AW, 2004, J PHYSIOL-LONDON, V554, P46, DOI 10.1113/jphysiol.2003.052613; Frantz S, 2001, HYPERTENSION, V38, P216, DOI 10.1161/01.HYP.38.2.216; Frantz SA, 1998, HYPERTENSION, V32, P639, DOI 10.1161/01.HYP.32.4.639; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Glazier AN, 2002, MAMM GENOME, V13, P108, DOI 10.1007/s00335-001-2132-9; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hubner N, 1999, HYPERTENSION, V34, P643, DOI 10.1161/01.HYP.34.4.643; HULMAN S, 1993, METABOLISM, V42, P14, DOI 10.1016/0026-0495(93)90165-K; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jirout M, 2003, MAMM GENOME, V14, P537, DOI 10.1007/s00335-003-2266-z; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Kato N, 1999, MAMM GENOME, V10, P259, DOI 10.1007/s003359900983; Kovacs P, 1997, BIOCHEM BIOPH RES CO, V235, P343, DOI 10.1006/bbrc.1997.6782; Krushkal J, 1999, CIRCULATION, V99, P1407, DOI 10.1161/01.CIR.99.11.1407; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; McBride MW, 2003, HYPERTENSION, V41, P847, DOI 10.1161/01.HYP.0000047103.07205.03; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; OKAMOTO K, 1972, SPONTANEOUS HYPERTEN; Pravenec M., 2001, American Journal of Hypertension, V14, p82A, DOI 10.1016/S0895-7061(01)01767-8; Pravenec M, 2004, PHYSIOL RES, V53, pS15; PRAVENEC M, 1989, J HYPERTENS, V7, P217; Pravenec M, 1999, FOLIA BIOL-PRAGUE, V45, P203; Pravenec M, 1996, MAMM GENOME, V7, P117, DOI 10.1007/s003359900031; Pravenec M, 2001, NAT GENET, V27, P156, DOI 10.1038/84777; PRAVENEC M, 1995, J CLIN INVEST, V96, P1973, DOI 10.1172/JCI118244; Printz MP, 2003, J APPL PHYSIOL, V94, P2510, DOI 10.1152/japplphysiol.00064.2003; RAO RH, 1993, DIABETES, V42, P1364, DOI 10.2337/diabetes.42.9.1364; Rice T, 2000, CIRCULATION, V102, P1956, DOI 10.1161/01.CIR.102.16.1956; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Silver L.M., 1995, MOUSE GENETICS CONCE; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Wallace CA, 2004, NAT GENET, V36, P441, DOI 10.1038/ng1349; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zimdahl H, 2004, SCIENCE, V303, P807, DOI 10.1126/science.1092427	50	416	433	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					243	253		10.1038/ng1522	http://dx.doi.org/10.1038/ng1522			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15711544				2022-12-27	WOS:000227297800015
J	Lewis, A; Mitsuya, K; Umlauf, D; Smith, P; Dean, W; Walter, J; Higgins, M; Feil, R; Reik, W				Lewis, A; Mitsuya, K; Umlauf, D; Smith, P; Dean, W; Walter, J; Higgins, M; Feil, R; Reik, W			Imprinting on distal chromosome 7 in the placenta involves repressive histone methylation independent of DNA methylation	NATURE GENETICS			English	Article							BECKWITH-WIEDEMANN-SYNDROME; GENE-CLUSTER; X INACTIVATION; CONTROL REGION; MOUSE; EXPRESSION; GENOME; ESTABLISHMENT; SEQUENCE; MAMMALS	Imprinted genes are expressed from only one of the parental chromosomes and are marked epigenetically by DNA methylation and histone modifications(1-9). The imprinting center 2 (IC2) on mouse distal chromosome 7 is flanked by several paternally repressed genes, with the more distant ones imprinted exclusively in the placenta. We found that most of these genes lack parent-specific DNA methylation, and genetic ablation of methylation does not lead to loss of their imprinting in the trophoblast (placenta). The silent paternal alleles of the genes are marked in the trophoblast by repressive histone modifications (dimethylation at Lys9 of histone H3 and trimethylation at Lys27 of histone H3), which are disrupted when IC2 is deleted, leading to reactivation of the paternal alleles. Thus, repressive histone methylation is recruited by IC2 (potentially through a noncoding antisense RNA) to the paternal chromosome in a region of at least 700 kb and maintains imprinting in this cluster in the placenta, independently of DNA methylation. We propose that an evolutionarily older imprinting mechanism limited to extraembryonic tissues was based on histone modifications, and that this mechanism was subsequently made more stable for use in embryonic lineages by the recruitment of DNA methylation.	Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB2 4AT, England; Tohoku Univ, Biomed Engn Res Org, Aoba Ku, Sendai, Miyagi 9808575, Japan; Inst Mol Genet, CNRS, UMR 5535, F-34293 Montpellier, France; Univ Montpellier 2, F-34293 Montpellier, France; Univ Saarland, D-66041 Saarbrucken, Germany; Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Tohoku University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Saarland University; Roswell Park Cancer Institute	Reik, W (corresponding author), Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB2 4AT, England.	wolf.reik@bbsrc.ac.uk	Reik, Wolf/I-6794-2012; Mitsuya, Kohzoh/F-4437-2010; Feil, Robert P/D-2087-2013	Feil, Robert P/0000-0002-5671-5860; Reik, Wolf/0000-0003-0216-9881; Dean, Wendy/0000-0001-9441-5044; Lewis, Annabelle/0000-0003-1876-1927; Mitsuya, Kohzoh/0000-0002-0950-5406				Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Caspary T, 1998, MOL CELL BIOL, V18, P3466, DOI 10.1128/MCB.18.6.3466; Cleary MA, 2001, NAT GENET, V29, P78, DOI 10.1038/ng715; Dao D, 1999, HUM MOL GENET, V8, P1337, DOI 10.1093/hmg/8.7.1337; Engemann S, 2000, HUM MOL GENET, V9, P2691, DOI 10.1093/hmg/9.18.2691; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Fournier C, 2002, EMBO J, V21, P6560, DOI 10.1093/emboj/cdf655; Grandjean V, 2001, FEBS LETT, V488, P165, DOI 10.1016/S0014-5793(00)02349-8; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Kanduri C, 2002, J BIOL CHEM, V277, P18106, DOI 10.1074/jbc.M200031200; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Paulsen M, 2000, HUM MOL GENET, V9, P1829, DOI 10.1093/hmg/9.12.1829; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Sado T, 2000, DEV BIOL, V225, P294, DOI 10.1006/dbio.2000.9823; Shemer R, 1997, P NATL ACAD SCI USA, V94, P10267, DOI 10.1073/pnas.94.19.10267; Sleutels F, 2002, ADV GENET, V46, P119; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Tanaka M, 1999, MECH DEVELOP, V87, P129, DOI 10.1016/S0925-4773(99)00158-6; UMLAUF D, 2004, NAT GENET       1031; Verona RI, 2003, ANNU REV CELL DEV BI, V19, P237, DOI 10.1146/annurev.cellbio.19.111401.092717; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Yatsuki H, 2002, GENOME RES, V12, P1860, DOI 10.1101/gr.110702; Zwart R, 2001, GENE DEV, V15, P2361, DOI 10.1101/gad.206201	30	352	362	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2004	36	12					1291	1295		10.1038/ng1468	http://dx.doi.org/10.1038/ng1468			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15516931				2022-12-27	WOS:000225354100016
J	Parkinson, J; Mitreva, M; Whitton, C; Thomson, M; Daub, J; Martin, J; Schmid, R; Hall, N; Barrell, B; Waterston, RH; McCarter, JP; Blaxter, ML				Parkinson, J; Mitreva, M; Whitton, C; Thomson, M; Daub, J; Martin, J; Schmid, R; Hall, N; Barrell, B; Waterston, RH; McCarter, JP; Blaxter, ML			A transcriptomic analysis of the phylum Nematoda	NATURE GENETICS			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; BRUGIA-MALAYI; GENOME; PROTEIN; EVOLUTION; RESOURCE; DATABASE; IDENTIFICATION; GENERATION	The phylum Nematoda occupies a huge range of ecological niches, from free-living microbivores to human parasites. We analyzed the genomic biology of the phylum using 265,494 expressed-sequence tag sequences, corresponding to 93,645 putative genes, from 30 species, including 28 parasites. From 35% to 70% of each species' genes had significant similarity to proteins from the model nematode Caenorhabditis elegans. More than half of the putative genes were unique to the phylum, and 23% were unique to the species from which they were derived. We have not yet come close to exhausting the genomic diversity of the phylum. We identified more than 2,600 different known protein domains, some of which had differential abundances between major taxonomic groups of nematodes. We also defined 4,228 nematode-specific protein families from nematode-restricted genes: this class of genes probably underpins species- and higher-level taxonomic disparity. Nematode-specific families are particularly interesting as drug and vaccine targets.	Univ Toronto, Hosp Sick Children, Dept Biochem, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Med Genet, Toronto, ON M5G 1X8, Canada; Univ Toronto, Hosp Sick Children, Dept Microbiol, Toronto, ON M5G 1X8, Canada; Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Wellcome Trust Sanger Inst, Pathogen Sequencing Unit, Cambridge CB10 1SA, England; Divergence, St Louis, MO 63141 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Edinburgh; Washington University (WUSTL); Wellcome Trust Sanger Institute	Parkinson, J (corresponding author), Univ Toronto, Hosp Sick Children, Dept Biochem, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jparkin@sickkids.ca	Schmid, Ralf/E-6722-2011; Blaxter, Mark L/B-4113-2010; Blaxter, Mark/O-2535-2019; Hall, Neil/A-8717-2013; Parkinson, John/A-4424-2008; /A-1783-2011; Schmid, Ralf/ABE-1065-2020	Schmid, Ralf/0000-0002-0203-4023; Blaxter, Mark L/0000-0003-2861-949X; Hall, Neil/0000-0002-7995-3810; Parkinson, John/0000-0001-9815-1189; /0000-0003-2422-1847; Schmid, Ralf/0000-0002-0203-4023; Daub, Jennifer/0000-0001-6022-563X; Hall, Neil/0000-0003-2808-0009; Mitreva, Makedonka/0000-0001-9572-3436; McCarter, James/0000-0001-7646-810X				Aboobaker AA, 2003, CURR BIOL, V13, P37, DOI 10.1016/S0960-9822(02)01399-4; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2001, GENOME RES, V11, P1425; BARKER KR, 1994, PLANT SOIL NEMATODES; BARNES TM, 1995, GENETICS, V141, P159; Blaxter M, 1998, SCIENCE, V282, P2041, DOI 10.1126/science.282.5396.2041; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Blaxter ML, 2003, ADV PARASIT, V54, P101, DOI 10.1016/S0065-308X(03)54003-9; Blaxter ML, 1996, MOL BIOCHEM PARASIT, V77, P77, DOI 10.1016/0166-6851(96)02571-6; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chan MS, 1997, PARASITOL TODAY, V13, P438, DOI 10.1016/S0169-4758(97)01144-7; Daub J, 2000, PARASITOLOGY, V120, P171, DOI 10.1017/S0031182099005375; De Ley Paul, 2002, P1; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Ghedin E, 2004, TRENDS PARASITOL, V20, P151, DOI 10.1016/j.pt.2004.01.011; Gregory WF, 2003, COMP FUNCT GENOM, V4, P194, DOI 10.1002/cfg.260; Harcus YM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r39; Hawdon JM, 1996, J BIOL CHEM, V271, P6672, DOI 10.1074/jbc.271.12.6672; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; Hutter H, 2000, SCIENCE, V287, P989, DOI 10.1126/science.287.5455.989; Johnstone IL, 1996, EMBO J, V15, P3633, DOI 10.1002/j.1460-2075.1996.tb00732.x; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; LAMBSHEAD PJD, 1993, OCEANIS S D, V19, P5; Lizotte-Waniewski M, 2000, INFECT IMMUN, V68, P3491, DOI 10.1128/IAI.68.6.3491-3501.2000; McCarter JP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r26; Mitreva M, 2004, MOL BIOCHEM PARASIT, V137, P277, DOI 10.1016/j.molbiopara.2004.05.015; Mitreva M, 2004, GENOME RES, V14, P209, DOI 10.1101/gr.1524804; Parkinson J, 2004, BIOINFORMATICS, V20, P1398, DOI 10.1093/bioinformatics/bth101; Parkinson J, 2004, NUCLEIC ACIDS RES, V32, pD427, DOI 10.1093/nar/gkh018; Parkinson J, 2003, TRENDS PARASITOL, V19, P283, DOI 10.1016/S1471-4922(03)00132-6; Parkinson J, 2003, BIOINFORMATICS, V19, P390, DOI 10.1093/bioinformatics/btf870; Parkinson J, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-31; Platt H. M., 1994, PHYLOGENETIC SYSTEMA; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; RIDDLE DL, 1997, C ELEGANS, V2, P1222; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tetteh KKA, 1999, INFECT IMMUN, V67, P4771, DOI 10.1128/IAI.67.9.4771-4779.1999; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Whitton C, 2004, MOL BIOCHEM PARASIT, V137, P215, DOI 10.1016/j.molbiopara.2004.05.013; WHITTON C, IN PRESS PARASITE GE; Williams SA, 2000, INT J PARASITOL, V30, P411, DOI 10.1016/S0020-7519(00)00014-X; WOOD WB, 1988, NEMATODE CAENORHABDI, P667; Wylie T, 2004, NUCLEIC ACIDS RES, V32, pD423, DOI 10.1093/nar/gkh010; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	49	201	225	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2004	36	12					1259	1267		10.1038/ng1472	http://dx.doi.org/10.1038/ng1472			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15543149	Bronze			2022-12-27	WOS:000225354100012
J	Kong, A; Barnard, J; Gudbjartsson, DF; Thorleifsson, G; Jonsdottir, G; Sigurdardottir, S; Richardsson, B; Jonsdottir, J; Thorgeirsson, T; Frigge, ML; Lamb, NE; Sherman, S; Gulcher, JR; Stefansson, K				Kong, A; Barnard, J; Gudbjartsson, DF; Thorleifsson, G; Jonsdottir, G; Sigurdardottir, S; Richardsson, B; Jonsdottir, J; Thorgeirsson, T; Frigge, ML; Lamb, NE; Sherman, S; Gulcher, JR; Stefansson, K			Recombination rate and reproductive success in humans	NATURE GENETICS			English	Article							MAXIMUM-LIKELIHOOD; LINKAGE ANALYSIS; MATERNAL AGE; NAIL-PATELLA; SEX; MEIOSIS; NONDISJUNCTION; CHROMOSOME-21; FRACTIONS; MAMMALS	Intergenerational mixing of DNA through meiotic recombinations of homologous chromosomes during gametogenesis is a major event that generates diversity in the eukaryotic genome. We examined genome-wide microsatellite data for 23,066 individuals, providing information on recombination events of 14,140 maternal and paternal meioses each, and found a positive correlation between maternal recombination counts of an offspring and maternal age. We postulated that the recombination rate of eggs does not increase with maternal age, but that the apparent increase is the consequence of selection. Specifically, a high recombination count increased the chance of a gamete becoming a live birth, and this effect became more pronounced with advancing maternal age. Further support for this hypothesis came from our observation that mothers with high oocyte recombination rate tend to have more children. Hence, not only do recombinations have a role in evolution by yielding diverse combinations of gene variants for natural selection, but they are also under selection themselves.	deCODE Genet, IS-101 Reykjavik, Iceland; Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA; Emory Univ, Dept Human Genet, Atlanta, GA USA	Cleveland Clinic Foundation; Emory University	Kong, A (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	kong@decode.is; kstefans@decode.is	Stefansson, Kari/AAE-7187-2019	Thorgeirsson, Thorgeir/0000-0002-5149-7040; Kong, Augustine/0000-0001-8193-5438; Gudbjartsson, Daniel/0000-0002-5222-9857				Broman KW, 2000, AM J HUM GENET, V66, P1911, DOI 10.1086/302923; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; ELSTON RC, 1976, AM J HUM GENET, V28, P69; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Haines J L, 1993, Prog Clin Biol Res, V384, P51; Hassold T, 2000, HUM MOL GENET, V9, P2409, DOI 10.1093/hmg/9.16.2409; HENDERSON SA, 1968, NATURE, V218, P22, DOI 10.1038/218022a0; Hodges CA, 2002, HUM REPROD, V17, P1171, DOI 10.1093/humrep/17.5.1171; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; IRWIN M, 1994, P NATL ACAD SCI USA, V91, P11684, DOI 10.1073/pnas.91.24.11684; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lamb NE, 1997, HUM MOL GENET, V6, P1391, DOI 10.1093/hmg/6.9.1391; Little R. J. A., 1987, STAT ANAL MISSING DA; LYNCH M, 1998, GENETICS ANAL QUANTU; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; McCulloch CE, 1997, J AM STAT ASSOC, V92, P162, DOI 10.2307/2291460; POLANI PE, 1991, HUM GENET, V88, P64, DOI 10.1007/BF00204931; POLANI PE, 1976, CYTOGENET CELL GENET, V16, P505, DOI 10.1159/000130668; Quintana FA, 1999, COMPUT STAT DATA AN, V29, P429, DOI 10.1016/S0167-9473(98)00075-9; RENWICK JH, 1965, ANN HUM GENET, V28, P379, DOI 10.1111/j.1469-1809.1965.tb00493.x; Robinson WP, 1998, HUM MOL GENET, V7, P1011, DOI 10.1093/hmg/7.6.1011; SPEED RM, 1983, CHROMOSOMA, V88, P184, DOI 10.1007/BF00285618; TANZI RE, 1992, AM J HUM GENET, V50, P551; WEITKAMP LR, 1973, HUM HERED, V23, P197, DOI 10.1159/000152574	27	141	149	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1203	1206		10.1038/ng1445	http://dx.doi.org/10.1038/ng1445			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15467721	Bronze			2022-12-27	WOS:000224832800024
J	Kleta, R; Romeo, E; Ristic, Z; Ohura, T; Stuart, C; Arcos-Burgos, M; Dave, MH; Wagner, CA; Camargo, SRM; Inoue, S; Matsuura, N; Helip-Wooley, A; Bockenhauer, D; Warth, R; Bernardini, I; Visser, G; Eggermann, T; Lee, P; Chairoungdua, A; Jutabha, P; Babu, E; Nilwarangkoon, S; Anzai, N; Kanai, Y; Verrey, F; Gahl, WA; Koizumi, A				Kleta, R; Romeo, E; Ristic, Z; Ohura, T; Stuart, C; Arcos-Burgos, M; Dave, MH; Wagner, CA; Camargo, SRM; Inoue, S; Matsuura, N; Helip-Wooley, A; Bockenhauer, D; Warth, R; Bernardini, I; Visser, G; Eggermann, T; Lee, P; Chairoungdua, A; Jutabha, P; Babu, E; Nilwarangkoon, S; Anzai, N; Kanai, Y; Verrey, F; Gahl, WA; Koizumi, A			Mutations in SLC6A19, encoding B(0)AT1, cause Hartnup disorder	NATURE GENETICS			English	Article							RECESSIVE TRAITS; TRANSPORTER; NEPHRON	Hartnup disorder, an autosomal recessive defect named after an English family described in 1956 (ref. 1), results from impaired transport of neutral amino acids across epithelial cells in renal proximal tubules and intestinal mucosa. Symptoms include transient manifestations of pellagra (rashes), cerebellar ataxia and psychosis(1,2). Using homozygosity mapping in the original family in whom Hartnup disorder was discovered, we confirmed that the critical region for one causative gene was located on chromosome 5p15 (ref. 3). This region is homologous to the area of mouse chromosome 13 that encodes the sodium-dependent amino acid transporter B(0)AT1 (ref. 4). We isolated the human homolog of B(0)AT1, called SLC6A19, and determined its size and molecular organization. We then identified mutations in SLC6A19 in members of the original family in whom Hartnup disorder was discovered and of three Japanese families. The protein product of SLC6A19, the Hartnup transporter, is expressed primarily in intestine and renal proximal tubule and functions as a neutral amino acid transporter.	NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; NIH, Off Rare Dis, Intramural Program, Off Director, Bethesda, MD 20892 USA; Univ Zurich, Inst Physiol, Zurich, Switzerland; Tohoku Univ, Sch Med, Dept Pediat, Sendai, Miyagi 980, Japan; Kyoto Univ, Grad Sch Med, Kyoto, Japan; Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; Univ Regensburg, Inst Physiol, D-8400 Regensburg, Germany; Univ Utrecht Hosp, Wilhelmina Childrens Hosp, Dept Metab Dis, Utrecht, Netherlands; Aachen Univ Hosp, Inst Human Genet, Aachen, Germany; UCL Natl Hosp Neurol & Neurosurg, Charles Dent Metab Unit, London, England; Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Tokyo, Japan	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; University of Zurich; Tohoku University; Kyoto University; Yale University; University of Regensburg; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; RWTH Aachen University; RWTH Aachen University Hospital; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Kyorin University	Kleta, R (corresponding author), NHGRI, Med Genet Branch, NIH, 10 Ctr Dr,MSC 1851,Bldg 10,Room 10C-107, Bethesda, MD 20892 USA.	kletar@mail.nih.gov	ANZAI, NAOHIKO/K-9492-2017; Jutabha, Promsuk/AFF-4363-2022; Eggermann, Thomas/F-3807-2014; Bockenhauer, Detlef/AAF-6495-2020; Bockenhauer, Detlef/C-5951-2008; Warth, Richard/N-7119-2014; Jutabha, Promsuk/AAE-9872-2022; Arcos-Burgos, Mauricio/H-1326-2017	ANZAI, NAOHIKO/0000-0003-0605-0458; Bockenhauer, Detlef/0000-0001-5878-941X; Bockenhauer, Detlef/0000-0001-5878-941X; Warth, Richard/0000-0001-6084-0659; Arcos-Burgos, Mauricio/0000-0002-8529-0574; Verrey, Francois/0000-0003-3250-9824; Camargo, Simone/0000-0003-0091-7380	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000215, ZIAHG000215] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BARON DN, 1956, LANCET, V271, P421; Bernardini I, 2001, AM J HUM GENET, V69, P486; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Kleta R, 2004, MOL GENET METAB, V82, P56, DOI 10.1016/j.ymgme.2004.01.018; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Levy DI, 2004, KIDNEY INT, V65, P918, DOI 10.1111/j.1523-1755.2004.00458.x; LEVY HL, 2001, METABOLIC MOL BASES, V3, P4957; Nozaki J, 2001, BIOCHEM BIOPH RES CO, V284, P255, DOI 10.1006/bbrc.2001.4961; PALACIN M, 2001, METABOLIC MOL BASES, V3, P4909; Schafer JA, 1997, AM J PHYSIOL-RENAL, V273, pF650, DOI 10.1152/ajprenal.1997.273.4.F650; SEOW HF, 2004, NAT GENET       0801, DOI DOI 10.1038/NG; SHIH VE, 1971, GASTROENTEROLOGY, V61, P445; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Virlon B, 1999, P NATL ACAD SCI USA, V96, P15286, DOI 10.1073/pnas.96.26.15286	17	190	194	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					999	1002		10.1038/ng1405	http://dx.doi.org/10.1038/ng1405			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15286787				2022-12-27	WOS:000223658100028
J	Dierick, HA; Greenspan, RJ				Dierick, Herman A.; Greenspan, Ralph J.			Molecular analysis of flies selected for aggressive behavior	NATURE GENETICS			English	Article							DROSOPHILA-MELANOGASTER; TERRITORIAL SUCCESS; MATING SUCCESS; HERITABLE VARIATION; FRUIT-FLIES; EXPRESSION; EXPERIENCE; MALES; GENE; POLYMORPHISM	Aggressive behavior is pervasive throughout the animal kingdom, and yet very little is known about its molecular underpinnings. To address this problem, we have developed a population-based selection procedure to increase aggression in Drosophila melanogaster. We measured changes in aggressive behavior in the selected subpopulations with a new two-male arena assay. In only ten generations of selection, the aggressive lines became markedly more aggressive than the neutral lines. After 21 generations, the fighting index increased more than 30-fold. Using microarray analysis, we identified genes with differing expression levels in the aggressive and neutral lines as candidates for this strong behavioral selection response. We tested a small set of these genes through mutant analysis and found that one significantly increased fighting frequency. These results suggest that selection for increases in aggression can be used to molecularly dissect this behavior.	Inst Neurosci, San Diego, CA 92121 USA		Dierick, HA (corresponding author), Inst Neurosci, 10640 John J Hopkins Dr, San Diego, CA 92121 USA.	dierick@nsi.edu	rosenberg, carla/N-4148-2015; de Silva, Rohan/C-1734-2008	rosenberg, carla/0000-0003-3253-4448; de Silva, Rohan/0000-0002-5052-5775				Baier A, 2002, J EXP BIOL, V205, P1233; BAKER RR, 1983, ANNU REV ENTOMOL, V28, P65, DOI 10.1146/annurev.en.28.010183.000433; BLANCHARD DC, 1990, CONT ISSUES COMP PSY; Broughton SJ, 2004, CURR BIOL, V14, pR290, DOI 10.1016/j.cub.2004.03.037; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; DOW MA, 1975, NATURE, V254, P511, DOI 10.1038/254511a0; DRONEY DC, 1994, ANIM BEHAV, V47, P351, DOI 10.1006/anbe.1994.1048; Gibson G, 2004, NAT REV GENET, V5, P681, DOI 10.1038/nrg1426; Greenspan RJ, 2003, J NEUROGENET, V17, P241, DOI 10.1080/01677060390265648; Grumbling G, 2006, NUCLEIC ACIDS RES, V34, pD484, DOI 10.1093/nar/gkj068; HALL JC, 1979, GENETICS, V92, P437; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; Harshman LG, 2000, TRENDS ECOL EVOL, V15, P32, DOI 10.1016/S0169-5347(99)01756-5; HOFFMANN AA, 1987, ANIM BEHAV, V35, P1899, DOI 10.1016/S0003-3472(87)80085-4; HOFFMANN AA, 1987, ANIM BEHAV, V35, P807, DOI 10.1016/S0003-3472(87)80117-3; HOFFMANN AA, 1990, ANIM BEHAV, V40, P526, DOI 10.1016/S0003-3472(05)80533-0; HOFFMANN AA, 1988, ANIM BEHAV, V36, P1180, DOI 10.1016/S0003-3472(88)80077-0; HOFFMANN AA, 1991, AM NAT, V138, P668, DOI 10.1086/285241; HOFFMANN AA, 1989, BEHAV GENET, V19, P241, DOI 10.1007/BF01065908; HOFFMANN AA, 1990, J INSECT BEHAV, V3, P1, DOI 10.1007/BF01049191; HOFFMANN AA, 1989, ANIM BEHAV, V38, P23, DOI 10.1016/S0003-3472(89)80062-4; JACOBS ME, 1960, ECOLOGY, V41, P182, DOI 10.2307/1931952; JACOBS ME, 1978, BEHAV GENET, V8, P487, DOI 10.1007/BF01067478; Lee G, 2000, BEHAV GENET, V30, P263, DOI 10.1023/A:1026541215546; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Lorenz K., 1963, AGGRESSION; Mackay TFC, 2005, P NATL ACAD SCI USA, V102, P6622, DOI 10.1073/pnas.0501986102; Maibeche-Coisne M, 2005, GENE, V346, P195, DOI 10.1016/j.gene.2004.11.010; Maibeche-Coisne M, 2004, P NATL ACAD SCI USA, V101, P11459, DOI 10.1073/pnas.0403537101; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Nelson RJ, 2001, TRENDS NEUROSCI, V24, P713, DOI 10.1016/S0166-2236(00)01996-2; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PARTRIDGE L, 1987, ANIM BEHAV, V35, P468, DOI 10.1016/S0003-3472(87)80272-5; POPOVA NK, 1993, BEHAV GENET, V23, P491, DOI 10.1007/BF01067985; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Sturtevant A. H., 1915, Journal of Animal Behavior Boston, V5, DOI 10.1037/h0074109; Toma DP, 2002, NAT GENET, V31, P349, DOI 10.1038/ng893; Ueda A, 2002, PHYSIOL ENTOMOL, V27, P21, DOI 10.1046/j.1365-3032.2002.00262.x; Wang Q, 1999, J BIOL CHEM, V274, P10309, DOI 10.1074/jbc.274.15.10309	43	163	164	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					1023	1031		10.1038/ng1864	http://dx.doi.org/10.1038/ng1864			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16906161				2022-12-27	WOS:000240112100019
J	Cleard, F; Moshkin, Y; Karch, F; Maeda, RK				Cleard, Fabienne; Moshkin, Yuri; Karch, Francois; Maeda, Robert K.			Probing long-distance regulatory interactions in the Drosophila melanogaster bithorax complex using Dam identification	NATURE GENETICS			English	Article							CHROMATIN DOMAIN BOUNDARY; ABDOMINAL-B; INSULATOR ACTIVITY; MCP ELEMENT; PROMOTER; FAB-7; GENE; METHYLTRANSFERASE; DNA; TRANSVECTION	A cis-regulatory region of nearly 300 kb controls the expression of the three bithorax complex (BX-C) homeotic genes: Ubx, abd-A and Abd-B-1,B-2. Interspersed between the numerous enhancers and silencers within the complex are elements called domain boundaries. Recently, many pieces of evidence have suggested that boundaries function to create autonomous domains by interacting among themselves and forming chromatin loops(3-6). In order to test this hypothesis, we used Dam identification to probe for interactions between the Fab-7 boundary and other regions in the BX-C7. We were surprised to find that the targeting of Dam methyltransferase (Dam) to the Fab-7 boundary results in a strong methylation signal at the Abd-Bm promoter, similar to 35 kb away. Moreover, this methylation pattern is found primarily in the tissues where Abd-B is not expressed and requires an intact Fab-7 boundary. Overall, our work provides the first documented example of a dynamic, long-distance physical interaction between distal regulatory elements within a living, multicellular organism.	Univ Geneva, Dept Zool & Anim Biol, CH-1211 Geneva, Switzerland; Univ Geneva, Natl Res Ctr Frontiers Genet, CH-1211 Geneva, Switzerland; Erasmus Univ, Med Ctr, Dept Biochem, NL-3015 Rotterdam, Netherlands	University of Geneva; University of Geneva; Erasmus University Rotterdam; Erasmus MC	Karch, F (corresponding author), Univ Geneva, Dept Zool & Anim Biol, 30 Quai E Ansermet, CH-1211 Geneva, Switzerland.	francois.karch@zoo.unige.ch	Moshkin, Yuri/ABA-3435-2021; Moshkin, Yuri M./M-3093-2016	Moshkin, Yuri/0000-0003-2964-8823; Moshkin, Yuri M./0000-0003-2964-8823; Cleard, Fabienne/0000-0003-0694-4822				Bantignies F, 2003, GENE DEV, V17, P2406, DOI 10.1101/gad.269503; Barges S, 2000, DEVELOPMENT, V127, P779; Bender W, 2000, DEVELOPMENT, V127, P3981; Cai HN, 2001, SCIENCE, V291, P493, DOI 10.1126/science.291.5503.493; CELNIKER SE, 1990, EMBO J, V9, P4277, DOI 10.1002/j.1460-2075.1990.tb07876.x; Chen Q, 2005, DEV BIOL, V286, P629, DOI 10.1016/j.ydbio.2005.08.025; GALLONI M, 1993, EMBO J, V12, P1087, DOI 10.1002/j.1460-2075.1993.tb05750.x; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Gruzdeva N, 2005, MOL CELL BIOL, V25, P3682, DOI 10.1128/MCB.25.9.3682-3689.2005; GYURKOVICS H, 1990, EMBO J, V9, P2579, DOI 10.1002/j.1460-2075.1990.tb07439.x; Hagstrom K, 1996, GENE DEV, V10, P3202, DOI 10.1101/gad.10.24.3202; Hogga I, 2001, MOL CELL, V8, P1145, DOI 10.1016/S1097-2765(01)00377-X; Lebrun E, 2003, MOL CELL BIOL, V23, P1498, DOI 10.1128/MCB.23.5.1498-1508.2003; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Maeda RK, 2006, DEVELOPMENT, V133, P1413, DOI 10.1242/dev.02323; MARTIN CH, 1995, P NATL ACAD SCI USA, V92, P8398, DOI 10.1073/pnas.92.18.8398; MCCALL K, 1994, GENETICS, V138, P387; Mihaly J, 1997, DEVELOPMENT, V124, P1809; Mihaly J, 1998, CELL MOL LIFE SCI, V54, P60, DOI 10.1007/s000180050125; Muller M, 1999, GENETICS, V153, P1333; Muravyova E, 2001, SCIENCE, V291, P495, DOI 10.1126/science.291.5503.495; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Siegal ML, 1996, GENETICS, V144, P715; Sipos L, 1998, GENETICS, V149, P1031; TREMML G, 1989, EMBO J, V8, P2677, DOI 10.1002/j.1460-2075.1989.tb08408.x; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; Zhou JM, 1996, GENE DEV, V10, P3195, DOI 10.1101/gad.10.24.3195; Zhou JM, 1999, DEVELOPMENT, V126, P3057; Zhou JM, 1999, CELL, V99, P567, DOI 10.1016/S0092-8674(00)81546-9	30	102	105	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2006	38	8					931	935		10.1038/ng1833	http://dx.doi.org/10.1038/ng1833			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16823379				2022-12-27	WOS:000239325700024
J	Witt, H; Sahin-Toth, M; Landt, O; Chen, JM; Kahne, T; Drenth, JPH; Kukor, Z; Szepessy, E; Halangk, W; Dahm, S; Rohde, K; Schulz, HU; Le Marechal, C; Akar, N; Ammann, RW; Truninger, K; Bargetzi, M; Bhatia, E; Castellani, C; Cavestro, GM; Cerny, M; Destro-Bisol, G; Spedini, G; Eiberg, H; Jansen, JBMJ; Koudova, M; Rausova, E; Macek, M; Malats, N; Real, FX; Menzel, HJ; Moral, P; Galavotti, R; Pignatti, PF; Rickards, O; Spicak, J; Zarnescu, NO; Bock, W; Gress, TM; Friess, H; Ockenga, J; Schmidt, H; Pfutzer, R; Lohr, M; Simon, P; Weiss, FU; Lerch, MM; Teich, N; Keim, V; Berg, T; Wiedenmann, B; Luck, W; Groneberg, DA; Becker, M; Keil, T; Kage, A; Bernardova, J; Braun, M; Guldner, C; Halangk, J; Rosendahl, J; Witt, U; Treiber, M; Nickel, R; Ferec, C				Witt, Heiko; Sahin-Toth, Miklos; Landt, Olfert; Chen, Jian-Min; Kaehne, Thilo; Drenth, Joost P. H.; Kukor, Zoltan; Szepessy, Edit; Halangk, Walter; Dahm, Stefan; Rohde, Klaus; Schulz, Hans-Ulrich; Le Marechal, Cedric; Akar, Nejat; Ammann, Rudolf W.; Truninger, Kaspar; Bargetzi, Mario; Bhatia, Eesh; Castellani, Carlo; Cavestro, Giulia Martina; Cerny, Milos; Destro-Bisol, Giovanni; Spedini, Gabriella; Eiberg, Hans; Jansen, Jan B. M. J.; Koudova, Monika; Rausova, Eva; Macek, Milan, Jr.; Malats, Nuria; Real, Francisco X.; Menzel, Hans-Jurgen; Moral, Pedro; Galavotti, Roberta; Pignatti, Pier Franco; Rickards, Olga; Spicak, Julius; Zarnescu, Narcis Octavian; Bock, Wolfgang; Gress, Thomas M.; Friess, Helmut; Ockenga, Johann; Schmidt, Hartmut; Pfutzer, Roland; Lohr, Matthias; Simon, Peter; Weiss, Frank Ulrich; Lerch, Markus M.; Teich, Niels; Keim, Volker; Berg, Thomas; Wiedenmann, Bertram; Luck, Werner; Groneberg, David Alexander; Becker, Michael; Keil, Thomas; Kage, Andreas; Bernardova, Jana; Braun, Markus; Gueldner, Claudia; Halangk, Juliane; Rosendahl, Jonas; Witt, Ulrike; Treiber, Matthias; Nickel, Renate; Ferec, Claude			A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis	NATURE GENETICS			English	Article							HUMAN CATIONIC TRYPSINOGEN; HEREDITARY PANCREATITIS; ACTIVATION; GENE; MUTATIONS	Chronic pancreatitis is a common inflammatory disease of the pancreas. Mutations in the genes encoding cationic trypsinogen (PRSS1) 1 and the pancreatic secretory trypsin inhibitor (SPINK1) 2 are associated with chronic pancreatitis. Because increased proteolytic activity owing to mutated PRSS1 enhances the risk for chronic pancreatitis, mutations in the gene encoding anionic trypsinogen (PRSS2) may also predispose to disease. Here we analyzed PRSS2 in individuals with chronic pancreatitis and controls and found, to our surprise, that a variant of codon 191 (G191R) is overrepresented in control subjects: G191R was present in 220/6,459 (3.4%) controls but in only 32/2,466 (1.3%) affected individuals (odds ratio 0.37; P = 1.1 x 10(-8)). Upon activation by enterokinase or trypsin, purified recombinant G191R protein showed a complete loss of trypsin activity owing to the introduction of a new tryptic cleavage site that renders the enzyme hypersensitive to autocatalytic proteolysis. In conclusion, the G191R variant of PRSS2 mitigates intrapancreatic trypsin activity and thereby protects against chronic pancreatitis.	Univ Hosp Berlin, Charite, Dept Gastroenterol & Hepatol, D-13353 Berlin, Germany; Univ Hosp Berlin, Charite, Dept Pediat, D-13353 Berlin, Germany; Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; TIB MOLBIOL, D-12103 Berlin, Germany; INSERM, U613, F-29220 Brest, France; Univ Bretagne Occidentale, Fac Med Brest & Sci Sante, F-29238 Brest, France; Etablissement Francais Sang Bretagne, Brest, France; CHRU, Brest, France; Hop Morvan, Lab Genet Mol & Histocompatibil, F-29220 Brest, France; Otto Von Guericke Univ, Inst Expt Internal Med, D-39120 Magdeburg, Germany; Univ Nijmegen, Radboud Med Ctr, Dept Med, Div Gastroenterol & Hepatol, NL-6500 HB Nijmegen, Netherlands; Otto Von Guericke Univ, Dept Surg, D-39120 Magdeburg, Germany; Max Delbruck Ctr Mol Med, Dept Bioinformat, D-13092 Berlin, Germany; Ankara Univ, Sch Med, Dept Pediat Mol Genet, TR-06530 Ankara, Turkey; Univ Zurich Hosp, Div Gastroenterol, Dept Med, CH-8092 Zurich, Switzerland; Kantonsspital, Div Gastroenterol, Dept Med, CH-5001 Aarau, Switzerland; Kantonsspital, Ctr Oncol Hematol, Dept Med, CH-5001 Aarau, Switzerland; Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrinol, Lucknow 226014, Uttar Pradesh, India; Osped Civile, Cyst Fibrosis Ctr, I-37126 Verona, Italy; Univ Parma, Dept Clin Sci, Gastroenterol Sect, I-43100 Parma, Italy; Univ Hosp Motol, Dept Neonatol, Clin Obstet & Gynecol, Prague 103 5, Czech Republic; Charles Univ Prague, Sch Med 2, Prague 103 5, Czech Republic; Univ Roma La Sapienza, Dept Human & Anim Biol, Sect Anthropol, I-00133 Rome, Italy; Univ Copenhagen, Panum Inst, Dept Med Biochem & Genet, DK-2200 Copenhagen, Denmark; Univ Hosp Motol, Cyst Fibrosis Ctr, Inst Biol & Med Genet, CZ-15006 Prague, Czech Republic; Charles Univ Prague, Sch Med 2, CZ-15006 Prague, Czech Republic; Univ Pompeu Fabra, Inst Municipal Invest Med, Barcelona 08003, Spain; Univ Innsbruck, Inst Med Biol & Human Genet, A-6020 Innsbruck, Austria; Univ Barcelona, Dept Anim Biol, Unitat Antropol, E-08028 Barcelona, Spain; Univ Verona, Sect Biol & Genet, DMIBG, I-37134 Verona, Italy; Univ Roma Tor Vergata, Dept Biol, I-00185 Rome, Italy; IKEM, Inst Clin & Expt Med, Clin Hepatogastroenterol, Prague 14021 4, Czech Republic; Univ Bucharest, Emergency Hsop, Dept Surg 2, Bucharest 72435, Romania; Univ Hosp Ulm, Dept Internal Med 1, D-89081 Ulm, Germany; Univ Heidelberg, Dept Gen Surg, D-69120 Heidelberg, Germany; Univ Hosp Berlin, Charite, Dept Gastroenterol Hepatol & Gastroenterol, D-10008 Berlin, Germany; Univ Hosp Munster, D-48149 Munster, Germany; Univ Heidelberg, Med Fac Mannheim, Dept Med 2, D-68167 Mannheim, Germany; Ernst Moritz Arndt Univ Greifswald, Dept Gastroenterol Endocrinol & Nutr, D-17487 Greifswald, Germany; Univ Leipzig, Dept Gastroenterol & Hepatol, D-04103 Leipzig, Germany; Deutsch Rote Kreuz Klin Westend, Dept Pediat Gastroenterol, D-14050 Berlin, Germany; Univ Hosp Berlin, Charite, Inst Social Med & Epidemiol, D-10008 Berlin, Germany; Univ Hosp Berlin, Charite, Dept Surg, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Boston University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; Otto von Guericke University; Radboud University Nijmegen; Otto von Guericke University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Ankara University; University of Zurich; University Zurich Hospital; Kantonsspital Aarau AG (KSA); Kantonsspital Aarau AG (KSA); Sanjay Gandhi Postgraduate Institute of Medical Sciences; University of Parma; Motol University Hospital; Charles University Prague; Sapienza University Rome; University of Copenhagen; Motol University Hospital; Charles University Prague; Pompeu Fabra University; University of Innsbruck; University of Barcelona; University of Verona; University of Rome Tor Vergata; Institute for Clinical & Experimental Medicine (IKEM); University of Bucharest; Ulm University; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster; Ruprecht Karls University Heidelberg; Ernst Moritz Arndt Universitat Greifswald; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Witt, H (corresponding author), Univ Hosp Berlin, Charite, Dept Gastroenterol & Hepatol, Augustenburg Pl 1, D-13353 Berlin, Germany.	heiko.witt@charite.de	Weiss, Frank Ulrich/A-6386-2009; Groneberg, David/A-5132-2018; Cavestro, Giulia Martina/AAA-9252-2019; Zarnescu, Narcis/J-4196-2015; Drenth, Joost/V-7436-2019; Rickards, Olga/L-7878-2015; Drenth, J.P.H./H-8025-2014; Teich, Niels/AAF-5104-2019; Löhr, Matthias/A-3692-2012; Akar, Nejat/H-2949-2019; Lerch, Markus M./E-2206-2016; Arribas, Francisco X Real/H-5275-2015; Kaehne, Thilo/E-4858-2012; Ferec, Claude/ABG-9699-2020; Castellani, Carlo/AAB-3847-2019; Malats, Nuria/H-7041-2015; Moral, Pedro/K-9587-2014	Weiss, Frank Ulrich/0000-0003-3369-6369; Groneberg, David/0000-0001-8551-6556; Cavestro, Giulia Martina/0000-0003-1947-9368; Zarnescu, Narcis/0000-0003-3973-6309; Rickards, Olga/0000-0003-2880-7466; Löhr, Matthias/0000-0002-7647-198X; Lerch, Markus M./0000-0002-9643-8263; Arribas, Francisco X Real/0000-0001-9501-498X; Ferec, Claude/0000-0002-2325-0710; Chen, Jian-Min/0000-0002-2424-3969; Gress, Thomas/0000-0002-9333-5461; Berg, Thomas/0000-0003-0003-6241; Malats, Nuria/0000-0003-2538-3784; Moral, Pedro/0000-0001-5072-5892; Sahin-Toth, Miklos/0000-0003-4513-9922; Wiedenmann, Bertram/0000-0002-7890-2552; Destro Bisol, Giovanni/0000-0002-4232-9715	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058088] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK058088-06, R01 DK058088-05A1, R01 DK058088-04, R01 DK058088-03, DK058088, R01 DK058088, R01 DK058088-04S1] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; CHEN JM, 2004, HDB PROTEOLYTIC ENZY, P1489; COLOMB E, 1978, BIOCHIM BIOPHYS ACTA, V525, P186, DOI 10.1016/0005-2744(78)90213-9; COLOMB E, 1979, BIOCHIM BIOPHYS ACTA, V571, P343, DOI 10.1016/0005-2744(79)90104-9; Gaboriaud C, 1996, J MOL BIOL, V259, P995, DOI 10.1006/jmbi.1996.0376; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Kenesi E, 2003, BIOCHEM BIOPH RES CO, V309, P749, DOI 10.1016/j.bbrc.2003.08.064; Kukor Z, 2003, EUR J BIOCHEM, V270, P2047, DOI 10.1046/j.1432-1033.2003.03581.x; Rowen L, 1996, SCIENCE, V272, P1755, DOI 10.1126/science.272.5269.1755; Sahin-Toth M, 2000, BIOCHEM BIOPH RES CO, V278, P286, DOI 10.1006/bbrc.2000.3797; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; SCHEELE G, 1981, GASTROENTEROLOGY, V80, P461; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 1999, GASTROENTEROLOGY, V117, P7, DOI 10.1016/S0016-5085(99)70543-3	15	164	173	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2006	38	6					668	673		10.1038/ng1797	http://dx.doi.org/10.1038/ng1797			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16699518	Green Accepted			2022-12-27	WOS:000237954800021
J	Calvo, S; Jain, M; Xie, XH; Sheth, SA; Chang, B; Goldberger, OA; Spinazzola, A; Zeviani, M; Carr, SA; Mootha, VK				Calvo, S; Jain, M; Xie, XH; Sheth, SA; Chang, B; Goldberger, OA; Spinazzola, A; Zeviani, M; Carr, SA; Mootha, VK			Systematic identification of human mitochondrial disease genes through integrative genomics	NATURE GENETICS			English	Article							RESPIRATORY-CHAIN DISORDERS; HETEROGENEITY; PROTEINS; SEQUENCE; LOCUS; PROTEOME; DATABASE; MUSCLE; MOUSE	The majority of inherited mitochondrial disorders are due to mutations not in the mitochondrial genome ( mtDNA) but rather in the nuclear genes encoding proteins targeted to this organelle. Elucidation of the molecular basis for these disorders is limited because only half(1,2) of the estimated 1,500 mitochondrial proteins(3) have been identified. To systematically expand this catalog, we experimentally and computationally generated eight genome-scale data sets, each designed to provide clues as to mitochondrial localization: targeting sequence prediction, protein domain enrichment, presence of cis-regulatory motifs, yeast homology, ancestry, tandem-mass spectrometry, coexpression and transcriptional induction during mitochondrial biogenesis. Through an integrated analysis we expand the collection to 1,080 genes, which includes 368 novel predictions with a 10% estimated false prediction rate. By combining this expanded inventory with genetic intervals linked to disease, we have identified candidate genes for eight mitochondrial disorders, leading to the discovery of mutations in MPV17 that result in hepatic mtDNA depletion syndrome(4). The integrative approach promises to better define the role of mitochondria in both rare and common human diseases.	MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02446 USA; Natl Neurol Inst C Besta, Unite Mol Neurogenet, I-20126 Milan, Italy	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; IRCCS Istituto Neurologico Besta	Mootha, VK (corresponding author), MIT, Broad Inst, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	vamsi@hms.harvard.edu	Spinazzola, Antonella/P-5298-2017; Carr, Steven A./AAH-8366-2019; Zeviani, Massimo/AAU-2632-2021; Zeviani, Massimo/K-2891-2014; Spinazzola, Antonella/P-5791-2019	Spinazzola, Antonella/0000-0003-4242-8091; Zeviani, Massimo/0000-0002-9067-5508; Spinazzola, Antonella/0000-0003-4242-8091; Xie, Xiaohui/0000-0002-5479-6345				Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Andreoli C, 2004, NUCLEIC ACIDS RES, V32, pD459, DOI 10.1093/nar/gkh137; Basel-Vanagaite L, 2004, NEUROLOGY, V62, P87, DOI 10.1212/01.WNL.0000101680.49036.69; Christodoulou K, 2001, NEUROGENETICS, V3, P127, DOI 10.1007/s100480100112; Cotter D, 2004, NUCLEIC ACIDS RES, V32, pD463, DOI 10.1093/nar/gkh048; El-Shanti H, 2000, AM J HUM GENET, V66, P1229, DOI 10.1086/302858; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x; Guda C, 2004, BIOINFORMATICS, V20, P1785, DOI 10.1093/bioinformatics/bth171; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Kerrison JB, 1999, ARCH OPHTHALMOL-CHIC, V117, P805; Kopp E, 1999, GENE DEV, V13, P2059, DOI 10.1101/gad.13.16.2059; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lopez MF, 2000, ELECTROPHORESIS, V21, P3427, DOI 10.1002/1522-2683(20001001)21:16<3427::AID-ELPS3427>3.0.CO;2-L; MARIMAN ECM, 1995, HUM GENET, V95, P56, DOI 10.1007/BF00225075; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Prokisch H, 2004, PLOS BIOL, V2, P795, DOI 10.1371/journal.pbio.0020160; Rotig A, 2003, J AM SOC NEPHROL, V14, P2995, DOI 10.1097/01.ASN.0000095481.24091.C9; Scaglia F, 2004, PEDIATRICS, V114, P925, DOI 10.1542/peds.2004-0718; Seyda A, 2001, AM J HUM GENET, V68, P386, DOI 10.1086/318196; Shoubridge EA, 2001, SEMIN NEUROL, V21, P261, DOI 10.1055/s-2001-17943; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Steinmuller R, 1998, EUR J HUM GENET, V6, P201, DOI 10.1038/sj.ejhg.5200180; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Thorburn DR, 2004, J INHERIT METAB DIS, V27, P349, DOI 10.1023/B:BOLI.0000031098.41409.55; Zeviani Massimo, 2004, Suppl Clin Neurophysiol, V57, P304; ZWACKA RM, 1994, EMBO J, V13, P5129, DOI 10.1002/j.1460-2075.1994.tb06842.x	30	261	269	1	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					576	582		10.1038/ng1776	http://dx.doi.org/10.1038/ng1776			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16582907				2022-12-27	WOS:000237147500021
J	Yi, R; O'Carroll, D; Pasolli, HA; Zhang, ZH; Dietrich, FS; Tarakhovsky, A; Fuchs, E				Yi, R; O'Carroll, D; Pasolli, HA; Zhang, ZH; Dietrich, FS; Tarakhovsky, A; Fuchs, E			Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; HAIR FOLLICLE; ENZYME DICER; ABSENCE; BIOGENESIS; INTEGRIN; TARGETS; NICHE	During embryogenesis, multipotent progenitors within the single-layered surface epithelium differentiate to form the epidermis and its appendages. Here, we show that microRNAs (miRNAs) have an essential role in orchestrating these events. We cloned more than 100 miRNAs from skin and show that epidermis and hair follicles differentially express discrete miRNA families. To explore the functional significance of this finding, we conditionally targeted Dicer1 gene ablation in embryonic skin progenitors. Within the first week after loss of miRNA expression, cell fate specification and differentiation were not markedly impaired, and in the interfollicular epidermis, apoptosis was not markedly increased. Notably, however, developing hair germs evaginate rather than invaginate, thereby perturbing the epidermal organization. Here we characterize miRNAs in skin, the existence of which was hitherto unappreciated, and demonstrate their differential expression and importance in the morphogenesis of epithelial tissues within this vital organ.	Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10021 USA; Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Duke University	Fuchs, E (corresponding author), Rockefeller Univ, Lab Lymphocyte Signaling, 1230 York Ave, New York, NY 10021 USA.	tarakho@rockfeller.edu; fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	O'Carroll, Donal/0000-0002-8626-2217; Pasolli, Hilda Amalia/0000-0003-3899-3530; YI, RUI/0000-0002-6934-7091	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR050452] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	29	420	469	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2006	38	3					356	362		10.1038/ng1744	http://dx.doi.org/10.1038/ng1744			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16462742				2022-12-27	WOS:000235589600019
J	Dumitrescu, AM; Liao, XH; Abdullah, MSY; Lado-Abeal, J; Majed, FA; Moeller, LC; Boran, G; Schomburg, L; Weiss, RE; Refetoff, S				Dumitrescu, AM; Liao, XH; Abdullah, MSY; Lado-Abeal, J; Majed, FA; Moeller, LC; Boran, G; Schomburg, L; Weiss, RE; Refetoff, S			Mutations in SECISBP2 result in abnormal thyroid hormone metabolism	NATURE GENETICS			English	Article							SELENOCYSTEINE TRANSFER-RNA; 5'-DEIODINASE ACTIVITY; TARGETED DISRUPTION; SELENOPROTEIN-P; GENE TRSP; SELENIUM; EXPRESSION; MICE; TRANSPORTER; THYROXINE	Incorporation of selenocysteine (Sec), through recoding of the UGA stop codon, creates a unique class of proteins. Mice lacking tRNA(Sec) die in utero(1), but the in vivo role of other components involved in selenoprotein synthesis is unknown, and Sec incorporation defects have not been described in humans. Deiodinases (DIOs) are selenoproteins involved in thyroid hormone metabolism. We identified three of seven siblings with clinical evidence of abnormal thyroid hormone metabolism. Their fibroblasts showed decreased DIO2 enzymatic activity not linked to the DIO2 locus. Systematic linkage analysis of genes involved in DIO2 synthesis and degradation led to the identification of an inherited Sec incorporation defect, caused by a homozygous missense mutation in SECISBP2 (also called SBP2). An unrelated child with a similar phenotype was compound heterozygous with respect to mutations in SECISBP2. Because SBP2 is epistatic to selenoprotein synthesis, these defects had a generalized effect on selenoproteins. Incomplete loss of SBP2 function probably causes the mild phenotype.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Secur Forces Hosp, Dept Pediat Endocrinol, Riyadh, Saudi Arabia; Prince Abdullah Hosp, Bisha, Saudi Arabia; Adelaide & Meath Hosp, Dept Pathol, Dublin, Ireland; Charite Univ Med Berlin, Inst Expt Endocrinol, Berlin, Germany; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA	University of Chicago; University of Chicago; Security Forces Hospital - Saudi Arabia; Trinity College Dublin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Chicago; University of Chicago	Refetoff, S (corresponding author), Univ Chicago, Dept Med, MC 3090,5841 S Maryland Ave, Chicago, IL 60637 USA.	refetoff@uchicago.edu	Schomburg, Lutz/D-8096-2013; Refetoff, Samuel/ABB-1263-2021	Schomburg, Lutz/0000-0001-9445-1555; Refetoff, Samuel/0000-0003-0164-8231; Moeller, Lars/0000-0002-9330-9036; lado-abeal, joaquin/0000-0002-3970-9696				BALZANO S, 1990, ENDOCRINOLOGY, V127, P882, DOI 10.1210/endo-127-2-882; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Botero D, 2002, MOL ENDOCRINOL, V16, P1999, DOI 10.1210/me.2002-0135; Carlson BA, 2005, J BIOL CHEM, V280, P5542, DOI 10.1074/jbc.M411725200; Carlson BA, 2004, J BIOL CHEM, V279, P8011, DOI 10.1074/jbc.M310470200; Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272; Copeland PR, 2003, GENE, V312, P17, DOI 10.1016/S0378-1119(03)00588-2; Curcio-Morelli C, 2003, J CLIN INVEST, V112, P189, DOI 10.1172/JCI200318348; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Dumitrescu A, 2004, THYROID, V14, P761; Dumitrescu AM, 2004, AM J HUM GENET, V74, P168, DOI 10.1086/380999; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Hatfield DL, 2002, MOL CELL BIOL, V22, P3565, DOI 10.1128/MCB.22.11.3565-3576.2002; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kumaraswamy E, 2003, MOL CELL BIOL, V23, P1477, DOI 10.1128/MCB.23.5.1477-1488.2003; LEONARD JL, 1988, BIOCHEM BIOPH RES CO, V151, P1164, DOI 10.1016/S0006-291X(88)80488-1; Lescure A, 2002, GENE, V291, P279, DOI 10.1016/S0378-1119(02)00629-7; Moustafa ME, 2003, J NUTR, V133, p2494S, DOI 10.1093/jn/133.7.2494S; Olson GE, 2005, BIOL REPROD, V73, P201, DOI 10.1095/biolreprod.105.040360; Sachdev SW, 2001, BIOCHEM J, V357, P851; Schneider MJ, 2001, MOL ENDOCRINOL, V15, P2137, DOI 10.1210/me.15.12.2137; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schomburg L, 2004, CELL MOL LIFE SCI, V61, P1988, DOI 10.1007/s00018-004-4114-z; Schussler GC, 2000, THYROID, V10, P141, DOI 10.1089/thy.2000.10.141; SCHUSSLER GC, 1967, J CLIN ENDOCR METAB, V27, P242, DOI 10.1210/jcem-27-2-242; Schweizer U, 2004, J NUTR, V134, P707, DOI 10.1093/jn/134.4.707	27	280	295	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1247	1252		10.1038/ng1654	http://dx.doi.org/10.1038/ng1654			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16228000				2022-12-27	WOS:000233045200025
J	Mito, Y; Henikoff, JG; Henikoff, S				Mito, Y; Henikoff, JG; Henikoff, S			Genome-scale profiling of histone H3.3 replacement patterns	NATURE GENETICS			English	Article							INTERGENIC TRANSCRIPTION; DNA-REPLICATION; ACTIVE GENES; CHROMATIN; METHYLATION; POLYCOMB; ACETYLATION; DEPOSITION; VARIANTS; ELONGATION	Histones of multicellular organisms are assembled into chromatin primarily during DNA replication. When chromatin assembly occurs at other times, the histone H3.3 variant replaces canonical H3. Here we introduce a new strategy for profiling epigenetic patterns on the basis of H3.3 replacement, using microarrays covering roughly one-third of the Drosophila melanogaster genome at 100-bp resolution. We identified patterns of H3.3 replacement over active genes and transposons. H3.3 replacement occurred prominently at sites of abundant RNA polymerase II and methylated H3 Lys4 throughout the genome and was enhanced on the dosage-compensated male X chromosome. Active genes were depleted of histones at promoters and were enriched in H3.3 from upstream to downstream of transcription units. We propose that deposition and inheritance of actively modified H3.3 in regulatory regions maintains transcriptionally active chromatin.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Howard Hughes Med Inst, Coconut Grove, FL 33133 USA	Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Henikoff, S (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA.	steveh@fhcrc.org		Henikoff, Steven/0000-0002-7621-8685				Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Ahmad K, 2001, J CELL BIOL, V153, P101, DOI 10.1083/jcb.153.1.101; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Chow CM, 2005, EMBO REP, V6, P354, DOI 10.1038/sj.embor.7400366; Copps K, 1998, EMBO J, V17, P5409, DOI 10.1093/emboj/17.18.5409; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Echalier G., 1997, DROSOPHILA CELLS CUL; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Henikoff S, 2004, TRENDS GENET, V20, P320, DOI 10.1016/j.tig.2004.05.004; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; HENIKOFF S, 1993, CELL, V72, P1, DOI 10.1016/0092-8674(93)90040-W; Hogga I, 2002, DEVELOPMENT, V129, P4915; Iwaki T, 2003, BIOTECHNIQUES, V35, P482, DOI 10.2144/03353bm08; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Johnson L, 2004, NUCLEIC ACIDS RES, V32, P6511, DOI 10.1093/nar/gkh992; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kristjuhan A, 2004, EMBO J, V23, P4243, DOI 10.1038/sj.emboj.7600433; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; LIPSHITZ HD, 1987, GENE DEV, V1, P307, DOI 10.1101/gad.1.3.307; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Rank G, 2002, MOL CELL BIOL, V22, P8026, DOI 10.1128/MCB.22.22.8026-8034.2002; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Roh TY, 2004, NAT BIOTECHNOL, V22, P1013, DOI 10.1038/nbt990; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Smith ER, 2001, J BIOL CHEM, V276, P31483, DOI 10.1074/jbc.C100351200; Straub T, 2005, FEBS LETT, V579, P3258, DOI 10.1016/j.febslet.2005.03.050; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Thiriet C, 2005, GENE DEV, V19, P677, DOI 10.1101/gad.1265205; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; van Steensel B, 2005, NAT GENET, V37, pS18, DOI 10.1038/ng1559; WATERBORG JH, 1990, J BIOL CHEM, V265, P17157; WOLFFE A, 1992, CHROMATIN STRUCTURE; Workman JL, 2004, P NATL ACAD SCI USA, V101, P1429, DOI 10.1073/pnas.0308506101; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178	50	407	424	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1090	1097		10.1038/ng1637	http://dx.doi.org/10.1038/ng1637			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16155569				2022-12-27	WOS:000232185600020
J	Reich, D; Patterson, N; De Jager, PL; McDonald, GJ; Waliszewska, A; Tandon, A; Lincoln, RR; DeLoa, C; Fruhan, SA; Cabre, P; Bera, O; Semana, G; Kelly, MA; Francis, DA; Ardlie, K; Khan, O; Cree, BAC; Hauser, SL; Oksenberg, JR; Hafler, DA				Reich, D; Patterson, N; De Jager, PL; McDonald, GJ; Waliszewska, A; Tandon, A; Lincoln, RR; DeLoa, C; Fruhan, SA; Cabre, P; Bera, O; Semana, G; Kelly, MA; Francis, DA; Ardlie, K; Khan, O; Cree, BAC; Hauser, SL; Oksenberg, JR; Hafler, DA			A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility	NATURE GENETICS			English	Article							HLA-DR LOCUS; LINKAGE-DISEQUILIBRIUM; AFRICAN-AMERICANS; ADMIXED POPULATIONS; DIAGNOSTIC-CRITERIA; ETHNIC-DIFFERENCES; DISEASE GENES; MAPPING GENES; GUIDELINES; RISK	Multiple sclerosis is a common disease with proven heritability, but, despite large-scale attempts, no underlying risk genes have been identified. Traditional linkage scans have so far identified only one risk haplotype for multiple sclerosis (at HLA on chromosome 6), which explains only a fraction of the increased risk to siblings. Association scans such as admixture mapping have much more power, in principle, to find the weak factors that must explain most of the disease risk. We describe here the first high-powered admixture scan, focusing on 605 African American cases and 1,043 African American controls, and report a locus on chromosome 1 that is significantly associated with multiple sclerosis.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02138 USA; MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Lab Mol Immunol, Boston, MA 02115 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Hop Quitman, Neurol Clin, Fort De France, France; Univ Rennes 1, Lab Univ Immunol, Rennes, France; Estab Francais Sang Bretagne, Rennes, France; Univ Hosp Birmingham, Dept Med, Div Med Sci, Birmingham, W Midlands, England; Genom Collaborat, Cambridge, MA USA; Wayne State Univ, Sch Med, Dept Neurol, Multiple Sclerosis Ctr, Detroit, MI 48201 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco; CHU Martinique; Universite de Rennes; University of Birmingham; Wayne State University	Reich, D (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	reich@receptor.med.harvard.edu	Hauser, Stephen L/J-2978-2016					BRISCOE D, 1994, J HERED, V85, P59; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Cree BAC, 2004, NEUROLOGY, V63, P2039, DOI 10.1212/01.WNL.0000145762.60562.5D; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; KELLY MA, 1995, TISSUE ANTIGENS, V45, P197, DOI 10.1111/j.1399-0039.1995.tb02439.x; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; KURTZKE JF, 1979, NEUROLOGY, V29, P1228, DOI 10.1212/WNL.29.9_Part_1.1228; LAUER K, 1994, J CLIN EPIDEMIOL, V47, P43, DOI 10.1016/0895-4356(94)90032-9; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 1997, AM J HUM GENET, V60, P188; Montana G, 2004, AM J HUM GENET, V75, P771, DOI 10.1086/425281; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Pericak-Vance MA, 2001, MULT SCLER, V7, P3; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Quelvennec E, 2003, TISSUE ANTIGENS, V61, P166, DOI 10.1046/j.0001-2815.2002.00008.x; Reich D, 2005, PHILOS T ROY SOC B, V360, P1605, DOI 10.1098/rstb.2005.1691; RIFE DC, 1954, AM J HUM GENET, V6, P26; Sawcer S, 2005, AM J HUM GENET, V77, P454; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; Wallin MT, 2004, ANN NEUROL, V55, P65, DOI 10.1002/ana.10788; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510	30	216	218	0	4	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2005	37	10					1113	1118		10.1038/ng1646	http://dx.doi.org/10.1038/ng1646			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16186815				2022-12-27	WOS:000232185600024
J	Crowder, S; Kirkegaard, K				Crowder, S; Kirkegaard, K			Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses	NATURE GENETICS			English	Article							SITE-DIRECTED MUTAGENESIS; POLIOVIRUS RNA; VPG URIDYLYLATION; POLYMERASE; MUTATIONS; PROTEIN; IDENTIFICATION; CIS; ENTEROVIRUSES; ELEMENT	The high error rates of viral RNA- dependent RNA polymerases create heterogeneous viral populations whose disparate RNA genomes affect each other's survival. We systematically screened the poliovirus genome and identified four sets of dominant mutations. Mutated alleles in capsid- and polymerase- coding regions resulted in dominant negative phenotypes, probably due to the proteins' oligomeric properties. We also identified dominant mutations in an RNA element required for priming RNA synthesis ( CRE) and in the protein primer ( VPg), suggesting that nonproductive priming intermediates are inhibitory. Mutations that inhibit the activity of viral proteinase 2A were dominant, arguing that inhibition of its known intramolecular activity creates a toxic product. Viral products that, when defective, dominantly interfere with growth of nondefective viruses will probably be excellent drug targets because drug- sensitive viruses should be dominant over drug- resistant variants. Accordingly, a virus sensitive to anticapsid compound WIN51711 dominantly inhibited the intracellular growth of a drug- resistant virus. Therefore, dominant inhibitor screening should validate or predict targets for antiviral therapy with reduced risk for drug resistance.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Stanford University	Kirkegaard, K (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	karlak@stanford.edu						AGUT H, 1989, VIROLOGY, V168, P302, DOI 10.1016/0042-6822(89)90270-5; AMBROS V, 1978, J BIOL CHEM, V253, P5263; ANDINO R, 1993, EMBO J, V12, P3587, DOI 10.1002/j.1460-2075.1993.tb06032.x; ANSARDI DC, 1995, J VIROL, V69, P1540, DOI 10.1128/JVI.69.3.1540-1547.1995; Barton DJ, 2001, EMBO J, V20, P1439, DOI 10.1093/emboj/20.6.1439; BURNS CC, 1989, J VIROL, V63, P4866, DOI 10.1128/JVI.63.11.4866-4874.1989; CHAPMAN MS, 1991, J MOL BIOL, V217, P455, DOI 10.1016/0022-2836(91)90749-V; CHARINI WA, 1991, J VIROL, V65, P2655, DOI 10.1128/JVI.65.5.2655-2665.1991; COMPTON SR, 1990, J VIROL, V64, P4067, DOI 10.1128/JVI.64.9.4067-4075.1990; Domingo E, 1997, ANNU REV MICROBIOL, V51, P151, DOI 10.1146/annurev.micro.51.1.151; FOX MP, 1986, ANTIMICROB AGENTS CH, V30, P110, DOI 10.1128/AAC.30.1.110; Goodfellow I, 2000, J VIROL, V74, P4590, DOI 10.1128/JVI.74.10.4590-4600.2000; Groarke JM, 1999, J INFECT DIS, V179, P1538, DOI 10.1086/314758; HAMBIDGE SJ, 1992, P NATL ACAD SCI USA, V89, P10272, DOI 10.1073/pnas.89.21.10272; HAMMERLE T, 1991, J BIOL CHEM, V266, P5412; Hansen JL, 1997, STRUCTURE, V5, P1109, DOI 10.1016/S0969-2126(97)00261-X; HELLEN CUT, 1992, J VIROL, V66, P3330, DOI 10.1128/JVI.66.6.3330-3338.1992; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hobson SD, 2001, EMBO J, V20, P1153, DOI 10.1093/emboj/20.5.1153; HOLLAND JJ, 1964, P NATL ACAD SCI USA, V51, P1082, DOI 10.1073/pnas.51.6.1082; HOLLAND JJ, 1989, J VIROL, V63, P5030, DOI 10.1128/JVI.63.12.5030-5036.1989; Hope DA, 1997, J VIROL, V71, P9490, DOI 10.1128/JVI.71.12.9490-9498.1997; IKEGAMI N, 1964, P NATL ACAD SCI USA, V52, P1419, DOI 10.1073/pnas.52.6.1419; JARVIS TC, 1992, EMBO J, V11, P3135, DOI 10.1002/j.1460-2075.1992.tb05386.x; JOHNSON KL, 1991, J VIROL, V65, P4341, DOI 10.1128/JVI.65.8.4341-4349.1991; JUBELT B, 1989, J INFECT DIS, V159, P866, DOI 10.1093/infdis/159.5.866; KAPLAN G, 1988, J VIROL, V62, P1687, DOI 10.1128/JVI.62.5.1687-1696.1988; KIRKEGAARD K, 1990, J VIROL, V64, P195, DOI 10.1128/JVI.64.1.195-206.1990; LEDINKO N, 1961, VIROLOGY, V14, P207, DOI 10.1016/0042-6822(61)90196-9; Lyle JM, 2002, SCIENCE, V296, P2218, DOI 10.1126/science.1070585; Lyons T, 2001, J VIROL, V75, P10696, DOI 10.1128/JVI.75.22.10696-10708.2001; MACADAM AJ, 1994, EMBO J, V13, P924, DOI 10.1002/j.1460-2075.1994.tb06336.x; MOSSER AG, 1994, J VIROL, V68, P8193, DOI 10.1128/JVI.68.12.8193-8201.1994; Murray KE, 2003, J VIROL, V77, P4739, DOI 10.1128/JVI.77.8.4739-4750.2003; NOVAK JE, 1994, GENE DEV, V8, P1726, DOI 10.1101/gad.8.14.1726; Paul Aniko V., 2002, P227; Paul AV, 2000, J VIROL, V74, P10359, DOI 10.1128/JVI.74.22.10359-10370.2000; Petersen JFW, 1999, EMBO J, V18, P5463, DOI 10.1093/emboj/18.20.5463; Pevear DC, 1999, ANTIMICROB AGENTS CH, V43, P2109, DOI 10.1128/AAC.43.9.2109; PREUGSCHAT F, 1990, J VIROL, V64, P4364, DOI 10.1128/JVI.64.9.4364-4374.1990; REYNOLDS C, 1991, VIROLOGY, V184, P391, DOI 10.1016/0042-6822(91)90856-7; ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303; ROTHBERG PG, 1978, P NATL ACAD SCI USA, V75, P4868, DOI 10.1073/pnas.75.10.4868; Thompson AA, 2004, EMBO J, V23, P3462, DOI 10.1038/sj.emboj.7600357; TOYODA H, 1986, CELL, V45, P761, DOI 10.1016/0092-8674(86)90790-7; Yin J, 2003, J VIROL, V77, P5152, DOI 10.1128/JVI.77.9.5152-5166.2003; YU SF, 1991, VIROLOGY, V182, P615, DOI 10.1016/0042-6822(91)90602-8	48	101	104	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					701	709		10.1038/ng1583	http://dx.doi.org/10.1038/ng1583			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15965477				2022-12-27	WOS:000230196400016
J	Van Steen, K; McQueen, MB; Herbert, A; Raby, B; Lyon, H; DeMeo, DL; Murphy, A; Su, J; Datta, S; Rosenow, C; Christman, M; Silverman, EK; Laird, NM; Weiss, ST; Lange, C				Van Steen, K; McQueen, MB; Herbert, A; Raby, B; Lyon, H; DeMeo, DL; Murphy, A; Su, J; Datta, S; Rosenow, C; Christman, M; Silverman, EK; Laird, NM; Weiss, ST; Lange, C			Genomic screening and replication using the same data set in family-based association testing	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; FALSE DISCOVERY RATE; GENERAL-CLASS; POWERFUL; GENETICS; ASTHMA; DISEQUILIBRIUM; PHENOTYPES	The Human Genome Project and its spin- offs are making it increasingly feasible to determine the genetic basis of complex traits using genome- wide association studies. The statistical challenge of analyzing such studies stems from the severe multiple-comparison problem resulting from the analysis of thousands of SNPs. Our methodology for genome- wide family- based association studies, using single SNPs or haplotypes, can identify associations that achieve genome- wide significance. In relation to developing guidelines for our screening tools, we determined lower bounds for the estimated power to detect the gene underlying the disease- susceptibility locus, which hold regardless of the linkage disequilibrium structure present in the data. We also assessed the power of our approach in the presence of multiple disease- susceptibility loci. Our screening tools accommodate genomic control and use the concept of haplotype- tagging SNPs. Our methods use the entire sample and do not require separate screening and validation samples to establish genome- wide significance, as population- based designs do.	Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Boston Univ, Sch Med, Dept Genet & Genom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Affymetrix Inc, Genom Collaborat Genotyping, Santa Clara, CA 95051 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Affymetrix	Van Steen, K (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	kvanstee@hsph.harvard.edu	Raby, Benjamin/AAK-3866-2021; Herbert, Alan/AAY-4286-2020; McQueen, Matthew/X-5845-2019	Herbert, Alan/0000-0002-0093-1572; Van Steen, Kristel/0000-0001-9868-5033	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060726] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD060726] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonferroni CE., 1937, VOLUME ONORE RICARRD, V2, P1; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; CHURCHILL GA, 1994, GENETICS, V138, P963; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Doerge RW, 1996, GENETICS, V142, P285; DUFFY DL, 1990, AM REV RESPIR DIS, V142, P1351, DOI 10.1164/ajrccm/142.6_Pt_1.1351; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; HOLM S, 1979, SCAND J STAT, V6, P65; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lange C, 2003, HUM HERED, V56, P10, DOI 10.1159/000073728; Lange C, 2002, GENET EPIDEMIOL, V23, P165, DOI 10.1002/gepi.209; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Lange C, 2003, AM J HUM GENET, V73, P801, DOI 10.1086/378591; Lange C, 2002, AM J HUM GENET, V71, P1330, DOI 10.1086/344696; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lange C., 2004, STAT APPL GENET MOL, V3, P17, DOI [DOI 10.2202/1544-6115.1067, 10.2202/1544-6115.1067]; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Lyon H, 2004, GENET EPIDEMIOL, V26, P155, DOI 10.1002/gepi.10298; Marnellos G, 2003, CURR OPIN DRUG DI DE, V6, P317; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Randolph AG, 2004, AM J HUM GENET, V75, P709, DOI 10.1086/424886; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Satagopan JM, 2004, BIOMETRICS, V60, P589, DOI 10.1111/j.0006-341X.2004.00207.x; Schaid DJ, 2004, AM J HUM GENET, V75, P948, DOI 10.1086/425870; Sherry ST, 1999, GENOME RES, V9, P677; SIDAK Z, 1971, ANN MATH STAT, V42, P169, DOI 10.1214/aoms/1177693504; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Van Steen Kristel, 2005, Hum Genomics, V2, P67; Weiss ST, 2004, HUM MOL GENET, V13, pR83, DOI 10.1093/hmg/ddh080; Zhai WW, 2004, GENET EPIDEMIOL, V27, P80, DOI 10.1002/gepi.20014	35	136	142	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					683	691		10.1038/ng1582	http://dx.doi.org/10.1038/ng1582			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15937480				2022-12-27	WOS:000230196400014
J	van Dijk, M; Mulders, J; Poutsma, A; Konst, AAM; Lachmeijer, AMA; Dekker, GA; Blankenstein, MA; Oudejans, CBM				van Dijk, M; Mulders, J; Poutsma, A; Konst, AAM; Lachmeijer, AMA; Dekker, GA; Blankenstein, MA; Oudejans, CBM			Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family	NATURE GENETICS			English	Article							LOW-MOLECULAR-WEIGHT; GENOME-WIDE SCAN; DNA; PHOSPHORYLATION; METHYLATION; EXPRESSION; PROTEINS; REVEALS; DISEASE; REGIONS	Preeclampsia is a pregnancy-associated disease with maternal symptoms but placental origin. Epigenetic inheritance is involved in some populations. By sequence analysis of 17 genes in the 10q22 region with maternal effects, we narrowed the minimal critical region linked with preeclampsia in the Netherlands to 444 kb. All but one gene in this region, which lies within a female-specific recombination hotspot, encode DNA- or RNA-binding proteins. One gene, STOX1 ( also called C10orf24), contained five different missense mutations, identical between affected sisters, cosegregating with the preeclamptic phenotype and following matrilineal inheritance. Four STOX1 transcripts are expressed in early placenta, including invasive extravillus trophoblast, generating three different isoforms. All contain a winged helix domain related to the forkhead ( FOX) family. The largest STOX1 isoform has exclusive nuclear or cytoplasmic expression, indicating activation and inactivation, respectively, of the PI3K-Akt-FOX pathway. Because all 38 FOX proteins and all 8 STOX1 homologs have either tyrosine or phenylalanine at position 153, the predominant Y153H variation is highly mutagenic by conservation criteria but subject to incomplete penetrance. STOX1 is a candidate for preeclampsia controlling polyploidization of extravillus trophoblast.	Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet & Human Genet, NL-1081 HV Amsterdam, Netherlands; Univ Adelaide, Dept Obstet Gynaecol, Adelaide, SA, Australia	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Adelaide	Oudejans, CBM (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Boelelaan 1117, NL-1081 HV Amsterdam, Netherlands.	cbm.oudejans@vumc.nl	van Dijk, Marie/L-1901-2014	van Dijk, Marie/0000-0003-1461-3441; Blankenstein, Marinus/0000-0003-1186-0770; Oudejans, Cees/0000-0003-0717-4946				Arngrimsson R, 1999, HUM MOL GENET, V8, P1799, DOI 10.1093/hmg/8.9.1799; Deloukas P, 2004, NATURE, V429, P375, DOI 10.1038/nature02462; Go ATJI, 2004, CLIN CHEM, V50, P1413, DOI 10.1373/clinchem.2004.032979; Guenther C, 1996, DEVELOPMENT, V122, P3509; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; Harrison GA, 1997, AM J HUM GENET, V60, P1158; Hattori N, 2000, MOL BIOL CELL, V11, P1037, DOI 10.1091/mbc.11.3.1037; Kamei T, 2002, MOL ENDOCRINOL, V16, P1469, DOI 10.1210/me.16.7.1469; Kanayama N, 2002, MOL HUM REPROD, V8, P1129, DOI 10.1093/molehr/8.12.1129; Lachmeijer AMA, 2001, EUR J HUM GENET, V9, P758, DOI 10.1038/sj.ejhg.5200706; Laivuori H, 2003, AM J HUM GENET, V72, P168, DOI 10.1086/345311; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Mello G, 2005, HYPERTENSION, V45, P86, DOI 10.1161/01.HYP.0000149950.05182.a3; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Nishimura DY, 1998, NAT GENET, V19, P140, DOI 10.1038/493; Obsil T, 2003, BIOCHEMISTRY-US, V42, P15264, DOI 10.1021/bi0352724; Oudejans CBM, 2004, MOL HUM REPROD, V10, P589, DOI 10.1093/molehr/gah080; PALDI A, 1995, CURR BIOL, V5, P1030, DOI 10.1016/S0960-9822(95)00207-7; Poon LLM, 2002, CLIN CHEM, V48, P35; Quenby S, 2004, OBSTET GYNECOL, V104, P354, DOI 10.1097/01.AOG.0000128902.84876.d4; Riyazi N, 1998, EUR J OBSTET GYN R B, V80, P49, DOI 10.1016/S0301-2115(98)00083-9; Saleem RA, 2001, AM J HUM GENET, V68, P627, DOI 10.1086/318792; Stevens K, 2000, J BIOL CHEM, V275, P30471, DOI 10.1074/jbc.M004891200; Valdez BC, 2002, GENE, V284, P53, DOI 10.1016/S0378-1119(01)00888-5; van der Vleuten G, 2004, ATHEROSCLEROSIS SUPP, V5, P61; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	30	151	163	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2005	37	5					514	519		10.1038/ng1541	http://dx.doi.org/10.1038/ng1541			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15806103				2022-12-27	WOS:000228862300021
J	Otto, EA; Loeys, B; Khanna, H; Hellemans, J; Sudbrak, R; Fan, SL; Muerb, U; O'Toole, JF; Helou, J; Attanasio, M; Utsch, B; Sayer, JA; Lillo, C; Jimeno, D; Coucke, P; De Paepe, A; Reinhardt, R; Klages, S; Tsuda, M; Kawakami, I; Kusakabe, T; Omran, H; Imm, A; Tippens, M; Raymond, PA; Hill, J; Beales, P; He, S; Kispert, A; Margolis, B; Williams, DS; Swaroop, A; Hildebrandt, F				Otto, EA; Loeys, B; Khanna, H; Hellemans, J; Sudbrak, R; Fan, SL; Muerb, U; O'Toole, JF; Helou, J; Attanasio, M; Utsch, B; Sayer, JA; Lillo, C; Jimeno, D; Coucke, P; De Paepe, A; Reinhardt, R; Klages, S; Tsuda, M; Kawakami, I; Kusakabe, T; Omran, H; Imm, A; Tippens, M; Raymond, PA; Hill, J; Beales, P; He, S; Kispert, A; Margolis, B; Williams, DS; Swaroop, A; Hildebrandt, F			Nephrocystin-5, a ciliary IQ domain protein, is mutated in Senior-Loken syndrome and interacts with RPGR and calmodulin	NATURE GENETICS			English	Article							LINKED RETINITIS-PIGMENTOSA; RENAL CYSTIC-DISEASE; JUVENILE NEPHRONOPHTHISIS; ROD PHOTORECEPTORS; GENE; ENCODES; EXPRESSION; MUTATIONS; INVERSIN	Nephronophthisis (NPHP) is the most frequent genetic cause of chronic renal failure in children(1-3). Identification of four genes mutated in NPHP subtypes 1- 4 (refs. 4- 9) has linked the pathogenesis of NPHP to ciliary functions(9). Ten percent of affected individuals have retinitis pigmentosa, constituting the renal-retinal Senior-Loken syndrome (SLSN). Here we identify, by positional cloning, mutations in an evolutionarily conserved gene, IQCB1 (also called NPHP5), as the most frequent cause of SLSN. IQCB1 encodes an IQ-domain protein, nephrocystin-5. All individuals with IQCB1 mutations have retinitis pigmentosa. Hence, we examined the interaction of nephrocystin-5 with RPGR (retinitis pigmentosa GTPase regulator), which is expressed in photoreceptor cilia and associated with 10-20% of retinitis pigmentosa. We show that nephrocystin-5, RPGR and calmodulin can be coimmunoprecipitated from retinal extracts, and that these proteins localize to connecting cilia of photoreceptors and to primary cilia of renal epithelial cells. Our studies emphasize the central role of ciliary dysfunction in the pathogenesis of SLSN.	Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Univ Michigan, Dept Ophthalmol, Ann Arbor, MI 48109 USA; Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; Max Planck Inst Mol Genet, Berlin, Germany; Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Hyogo 6781297, Japan; Univ Freiburg, Childrens Hosp, Freiburg, Germany; Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; UCL, Inst Child Hlth, Mol Med Unit, London, England; Hannover Med Sch, Inst Mol Biol, D-30625 Hannover, Germany; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Johns Hopkins University; University of Michigan System; University of Michigan; Ghent University; Ghent University Hospital; Max Planck Society; University of Kiel; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Hyogo; University of Freiburg; University of Michigan System; University of Michigan; University of London; University College London; Hannover Medical School; University of Michigan System; University of Michigan	Hildebrandt, F (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	fhilde@umich.edu	Sayer, John A./AAN-2729-2020; Lillo, Concepcion/A-6321-2009; Coucke, Paul J/AAO-2954-2020; Beales, Philip L/C-7367-2009; Loeys, Bart/B-3236-2017; Kusakabe, Takehiro/H-7178-2012; Sudbrak, Ralf/HHZ-8821-2022; Jimeno, David/D-3096-2018	Sayer, John A./0000-0003-1881-3782; Lillo, Concepcion/0000-0001-5814-9826; Coucke, Paul J/0000-0001-7119-586X; Loeys, Bart/0000-0003-3703-9518; Kusakabe, Takehiro/0000-0002-8325-3665; Utsch, Boris/0000-0003-4623-581X; Otto, Edgar/0000-0002-2387-9973; Attanasio, Massimo/0000-0002-1278-3650; Jimeno, David/0000-0001-7876-0083; Omran, Heymut/0000-0003-0282-6765; Reinhardt, Richard/0000-0001-9376-2132; Raymond, Pamela/0000-0003-1083-5530; Swaroop, Anand/0000-0002-1975-1141	NEI NIH HHS [R01 EY007042] Funding Source: Medline; NIDDK NIH HHS [R01 DK084725] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084725] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BESHARSE JC, 1990, PHOTORECEPTOR CONNEC, P409; Breuer DK, 2002, AM J HUM GENET, V70, P1545, DOI 10.1086/340848; CHEN TY, 1994, P NATL ACAD SCI USA, V91, P11757, DOI 10.1073/pnas.91.24.11757; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Cuenca N, 2002, J NEUROCYTOL, V31, P649, DOI 10.1023/A:1025791512555; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; FANCONI G, 1951, Helv Paediatr Acta, V6, P1; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Gibbs D, 2004, J CELL SCI, V117, P6473, DOI 10.1242/jcs.01580; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hildebrandt F., 2004, PEDIATR NEPHROL, P665; Hong DH, 2002, INVEST OPHTH VIS SCI, V43, P3373; Hong DH, 2003, INVEST OPHTH VIS SCI, V44, P2413, DOI 10.1167/iovs.02-1206; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Morgan D, 2002, HUM GENET, V110, P377, DOI 10.1007/s00439-002-0696-4; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Otto E, 2002, AM J HUM GENET, V71, P1161, DOI 10.1086/344395; Otto E, 2000, J AM SOC NEPHROL, V11, P270, DOI 10.1681/ASN.V112270; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Roepman R, 2000, HUM MOL GENET, V9, P2095, DOI 10.1093/hmg/9.14.2095; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; SMITH CH, 1945, AM J DIS CHILD, V69, P369; Vervoort R, 2000, NAT GENET, V25, P462, DOI 10.1038/78182; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75	25	284	297	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2005	37	3					282	288		10.1038/ng1520	http://dx.doi.org/10.1038/ng1520			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	901QU	15723066				2022-12-27	WOS:000227297800019
J	Ahmadi, KR; Weale, ME; Xue, ZYY; Soranzo, N; Yarnall, DP; Briley, JD; Maruyama, Y; Kobayashi, M; Wood, NW; Spurr, NK; Burns, DK; Roses, AD; Saunders, AM; Goldstein, DB				Ahmadi, KR; Weale, ME; Xue, ZYY; Soranzo, N; Yarnall, DP; Briley, JD; Maruyama, Y; Kobayashi, M; Wood, NW; Spurr, NK; Burns, DK; Roses, AD; Saunders, AM; Goldstein, DB			A single-nucleotide polymorphism tagging set for human drug metabolism and transport	NATURE GENETICS			English	Article							LINKAGE-DISEQUILIBRIUM; HAPLOTYPE BLOCKS; SNP	Interindividual variability in drug response, ranging from no therapeutic benefit to life-threatening adverse reactions, is influenced by variation in genes that control the absorption, distribution, metabolism and excretion of drugs(1). We genotyped 904 single-nucleotide polymorphisms (SNPs) from 55 such genes in two population samples (European and Japanese) and identified a set of tagging SNPs that represents the common variation in these genes, both known and unknown. Extensive empirical evaluations, including a direct assessment of association with candidate functional SNPs in a new, larger population sample, validated the performance of these tagging SNPs and confirmed their utility for linkage-disequilibrium mapping in pharmacogenetics. The analyses also suggest that rare variation is not amenable to tagging strategies.	UCL, Dept Biol, Galton Lab, London WC1E 6BT, England; GlaxoSmithKline, Genet Res, Res Triangle Pk, NC 27709 USA; GlaxoSmithKline, Tsukuba Res Labs, Genet Res, Tsukuba, Ibaraki 3004247, Japan; Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England	University of London; University College London; GlaxoSmithKline; Eisai Co Ltd; GlaxoSmithKline; University of London; University College London	Goldstein, DB (corresponding author), UCL, Dept Biol, Galton Lab, Darwin Bldg,Gower St, London WC1E 6BT, England.	d.goldstein@ucl.ac.uk	Wood, Nicholas W/C-2505-2009; Goldstein, David/AAY-8125-2020; Ahmadi, Kourosh R/B-6379-2012; Weale, Michael E/F-2587-2010	Wood, Nicholas W/0000-0002-9500-3348; Weale, Michael E/0000-0003-4593-1186; Soranzo, Nicole/0000-0003-1095-3852				Capelli C, 2003, CURR BIOL, V13, P979, DOI 10.1016/S0960-9822(03)00373-7; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goldstein DB, 2003, NAT REV GENET, V4, P937, DOI 10.1038/nrg1229; Goldstein DB, 2003, TRENDS GENET, V19, P615, DOI 10.1016/j.tig.2003.09.006; Kamatani N, 2004, AM J HUM GENET, V75, P190, DOI 10.1086/422853; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Salisbury BA, 2003, MUTAT RES-FUND MOL M, V526, P53, DOI 10.1016/S0027-5107(03)00014-9; Schulze TG, 2004, HUM MOL GENET, V13, P335, DOI 10.1093/hmg/ddh035; Taylor JD, 2001, BIOTECHNIQUES, V30, P661, DOI 10.2144/01303dd04; Weale ME, 2003, AM J HUM GENET, V73, P551, DOI 10.1086/378098	14	118	128	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2005	37	1					84	89		10.1038/ng1488	http://dx.doi.org/10.1038/ng1488			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15608640				2022-12-27	WOS:000225997500025
J	Ding, H; Wu, XL; Bostrom, H; Kim, I; Wong, N; Tsoi, B; O'Rourke, M; Koh, GY; Soriano, P; Betsholtz, C; Hart, TC; Marazita, ML; Field, LL; Tam, PPL; Nagy, A				Ding, H; Wu, XL; Bostrom, H; Kim, I; Wong, N; Tsoi, B; O'Rourke, M; Koh, GY; Soriano, P; Betsholtz, C; Hart, TC; Marazita, ML; Field, LL; Tam, PPL; Nagy, A			A specific requirement for PDGF-C in palate formation and PDGFR-alpha signaling	NATURE GENETICS			English	Article							CELL-CELL ADHESION; CLEFT-PALATE; KNOCKOUT MICE; BETA-RECEPTOR; EXPRESSION; ROLES; DEFICIENT; MUTATIONS; TISSUES; FUSION	PDGF-C is a member of the platelet-derived growth factor (PDGF) family, which signals through PDGF receptor (PDGFR) alphaalpha and alphabeta dimers(1,2). Here we show that Pdgfc(-/-) mice die in the perinatal period owing to feeding and respiratory difficulties associated with a complete cleft of the secondary palate. This phenotype was less severe than that of Pdgfra(-/-) embryos. Pdgfc(-/-) Pdgfa(-/-) embryos developed a cleft face, subepidermal blistering, deficiency of renal cortex mesenchyme, spina bifida and skeletal and vascular defects. Complete loss of function of both ligands, therefore, phenocopied the loss of PDGFR-alpha function, suggesting that both PDGF-A and PDGF-C signal through PDGFR-alpha to regulate the development of craniofacial structures, the neural tube and mesodermal organs. Our results also show that PDGF-C signaling is a new pathway in palatogenesis, different from, and independent of, those previously implicated.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Gothenburg Univ, Dept Biochem Med, S-41124 Gothenburg, Sweden; Korea Adv Inst Sci & Technol, Biomed Res Ctr, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; Univ Sydney, Sydney, NSW 2006, Australia; Childrens Med Res Inst, Embryol Unit, Sydney, NSW, Australia; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Program Dev Biol, Seattle, WA 98104 USA; Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD USA; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Ctr Craniofacial & Dent Genet, Pittsburgh, PA 15260 USA; Univ British Columbia, Dept Med Genet, Vancouver, BC V5Z 1M9, Canada; BC Res Inst Childrens & Womens Hlth, Vancouver, BC, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Gothenburg; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); University of Sydney; Children's Medical Research Institute - Australia; University of Sydney; Fred Hutchinson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of British Columbia; University of Toronto	Nagy, A (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	nagy@mshri.on.ca	Koh, Gou Young/C-1615-2011; Kim, Injune/C-1710-2011; Nagy, Andras/G-6465-2013; Ehrencrona, Hans/M-5619-2014; Ehrencrona, Hans/Q-4621-2019; Soriano, Philippe M/E-5797-2015	Kim, Injune/0000-0001-9244-815X; Nagy, Andras/0000-0003-4311-0413; Ehrencrona, Hans/0000-0002-5589-3622; Ehrencrona, Hans/0000-0002-5589-3622; Soriano, Philippe M/0000-0002-0427-926X	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [ZIADE000711, Z01DE000711] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aase K, 2002, MECH DEVELOP, V110, P187, DOI 10.1016/S0925-4773(01)00560-3; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Ding H, 2000, MECH DEVELOP, V96, P209, DOI 10.1016/S0925-4773(00)00425-1; Ding H, 2001, CANCER RES, V61, P3826; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Gertsenstein M, 2002, Methods Mol Biol, V185, P285; Gilbertson DG, 2001, J BIOL CHEM, V276, P27406, DOI 10.1074/jbc.M101056200; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Karlsson L, 1999, DEVELOPMENT, V126, P2611; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Marazita ML, 2002, AM J HUM GENET, V71, P349, DOI 10.1086/341944; Martinez-Alvarez C, 2000, DEV BIOL, V220, P343, DOI 10.1006/dbio.2000.9644; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Raich WB, 1999, CURR BIOL, V9, P1139, DOI 10.1016/S0960-9822(00)80015-9; Schoonjans L, 2003, STEM CELLS, V21, P90, DOI 10.1634/stemcells.21-1-90; Soriano P, 1997, DEVELOPMENT, V124, P2691; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Tallquist MD, 2003, DEVELOPMENT, V130, P507, DOI 10.1242/dev.00241; Taya Y, 1999, DEVELOPMENT, V126, P3869; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7	30	167	173	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2004	36	10					1111	1116		10.1038/ng1415	http://dx.doi.org/10.1038/ng1415			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	15361870	Bronze			2022-12-27	WOS:000224156500021
J	Freimer, N; Sabatti, C				Freimer, N; Sabatti, C			The use of pedigree, sib-pair and association studies of common diseases for genetic mapping and epidemiology	NATURE GENETICS			English	Review							CYSTIC-FIBROSIS GENE; INFLAMMATORY-BOWEL-DISEASE; SEVERE BIPOLAR DISORDER; TRAUMATIC BRAIN-INJURY; X-CHROMOSOME MARKERS; FALSE DISCOVERY RATE; HIGH-RESOLUTION MAPS; GENOME-WIDE SEARCH; LINKAGE ANALYSIS; COMPLEX TRAITS	Efforts to identify gene variants associated with susceptibility to common diseases use three approaches: pedigree and affected sib-pair linkage studies and association studies of population samples. The different aims of these study designs reflect their derivation from biological versus epidemiological traditions. Similar principles regarding determination of the evidence levels required to consider the results statistically significant apply to both linkage and association studies, however. Such determination requires explicit attention to the prior probability of particular findings, as well as appropriate correction for multiple comparisons. For most common diseases, increasing the sample size in a study is a crucial step in achieving statistically significant genetic mapping results. Recent studies suggest that the technology and statistical methodology will soon be available to make well-powered studies feasible using any of these approaches.	Univ Calif Los Angeles, Inst Neuropsychiat, Ctr Neurobehav Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Freimer, N (corresponding author), Univ Calif Los Angeles, Inst Neuropsychiat, Ctr Neurobehav Genet, Bldg Room 3506,695 Charles E Young Dr S, Los Angeles, CA 90095 USA.	nfreimer@mednet.ucla.edu						Abecasis GR, 2004, AM J HUM GENET, V74, P403, DOI 10.1086/381713; Abkevich V, 2003, AM J HUM GENET, V73, P1271, DOI 10.1086/379978; Almasy L, 2001, AM J MED GENET, V105, P42, DOI 10.1002/1096-8628(20010108)105:1<42::AID-AJMG1055>3.3.CO;2-0; [Anonymous], 2003, SCIENCE, V302, P2039; BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; BARON M, 1993, NAT GENET, V3, P49, DOI 10.1038/ng0193-49; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjornsson A, 2003, AM J HUM GENET, V73, P986, DOI 10.1086/378417; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; BREFSKY P, 2003, NEUROLOGY, V60, P1077; Carvajal-Carmona LG, 2003, HUM GENET, V112, P534, DOI 10.1007/s00439-002-0899-8; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cavanaugh J, 2001, AM J HUM GENET, V68, P1165, DOI 10.1086/320119; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; de la Chapelle A, 1998, CURR OPIN GENET DEV, V8, P298, DOI 10.1016/S0959-437X(98)80085-3; DUPUIS J, 1995, GENETICS, V140, P843; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; ELSTON RC, 1975, ANN HUM GENET, V38, P341, DOI 10.1111/j.1469-1809.1975.tb00619.x; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Funalot B, 2004, NAT GENET, V36, P3, DOI 10.1038/ng0104-3a; Garner C, 2001, AM J HUM GENET, V68, P1061, DOI 10.1086/319517; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Glatt CE, 2002, TRENDS GENET, V18, P307, DOI 10.1016/S0168-9525(02)02670-7; GOTTESMAN II, 1967, P NATL ACAD SCI USA, V58, P199, DOI 10.1073/pnas.58.1.199; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gretarsdottir S, 2002, AM J HUM GENET, V70, P593, DOI 10.1086/339252; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gudmundsson G, 2002, AM J HUM GENET, V70, P586, DOI 10.1086/339251; Gulcher JR, 2004, NAT GENET, V36, P3, DOI 10.1038/ng0104-3b; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Hakonarson H, 2002, AM J HUM GENET, V71, P483, DOI 10.1086/342205; HANSON DR, 1992, GENETIC BASIS COMMON, P816; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Hennah W, 2003, HUM MOL GENET, V12, P3151, DOI 10.1093/hmg/ddg341; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Jarvelin MR, 1997, PAEDIATR PERINAT EP, V11, P298, DOI 10.1111/j.1365-3016.1997.tb00007.x; Jawaheer D, 2003, ARTHRITIS RHEUM-US, V48, P906, DOI 10.1002/art.10989; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kallman J., 2019, EPPLUS; KALLMANN FJ, 1946, AM J PSYCHIAT, V103, P309, DOI 10.1176/ajp.103.3.309; Karason A, 2003, AM J HUM GENET, V72, P125, DOI 10.1086/345646; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; King R. A., 2002, GENETIC BASIS COMMON, V2; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; KRAEPELIN E, 1976, PSYCHIATRIE; Kristjansson K, 2002, HYPERTENSION, V39, P1044, DOI 10.1161/01.HYP.0000018580.24644.18; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Laitinen T, 2004, SCIENCE, V304, P300, DOI 10.1126/science.1090010; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MacKay K, 2002, ARTHRITIS RHEUM, V46, P632, DOI 10.1002/art.10147; Maniatis N, 2004, AM J HUM GENET, V74, P846, DOI 10.1086/383589; MCGUE M, 1983, AM J HUM GENET, V35, P1161; Meyer MR, 1998, NAT GENET, V19, P321, DOI 10.1038/1206; MORTON NE, 1955, AM J HUM GENET, V7, P277; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Ophoff RA, 2002, AM J HUM GENET, V71, P565, DOI 10.1086/342291; Ott J., 1999, ANAL HUMAN GENETIC L; Peltonen L, 2003, TWIN RES, V6, P354, DOI 10.1375/twin.6.5.354; RANTAKALLIO P, 1969, ACTA PAEDIATR SC S, V0193; RENWICK JH, 1971, ANNU REV GENET, V5, P81, DOI 10.1146/annurev.ge.05.120171.000501; Reynisdottir I, 2003, AM J HUM GENET, V73, P323, DOI 10.1086/377139; RIORDAN JR, 1989, SCIENCE, V245, P1066; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1990, AM J HUM GENET, V46, P222; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Sabatti C, 2003, GENETICS, V164, P829; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; SCHOENBERG SJ, 2002, HUM MOL GENET, V11, P2257; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; Sobel E, 1996, AM J HUM GENET, V58, P1323; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stefansson SE, 2003, AM J HUM GENET, V72, P1448, DOI 10.1086/375556; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Strittmatter WJ, 1996, ANNU REV NEUROSCI, V19, P53, DOI 10.1146/annurev.ne.19.030196.000413; Styrkarsdottir U, 2003, PLOS BIOL, V1, P351, DOI 10.1371/journal.pbio.0000069; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Terwilliger JD, 2002, CURR OPIN GENET DEV, V12, P726, DOI 10.1016/S0959-437X(02)00357-X; Thomas DC, 2004, JNCI-J NATL CANCER I, V96, P421, DOI 10.1093/jnci/djh094; Thompson E.A., 2000, STAT INFERENCE GENET; Thorgeirsson TE, 2003, AM J HUM GENET, V72, P1221, DOI 10.1086/375141; Vaessen N, 2002, DIABETES, V51, P856, DOI 10.2337/diabetes.51.3.856; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; Weller JI, 1998, GENETICS, V150, P1699; Williams JT, 1999, ANN HUM GENET, V63, P545, DOI 10.1017/S0003480099007848	100	115	117	0	5	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2004	36	10					1045	1051		10.1038/ng1433	http://dx.doi.org/10.1038/ng1433			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	15454942	Bronze			2022-12-27	WOS:000224156500009
J	Ferland, RJ; Eyaid, W; Collura, RV; Tully, LD; Hill, RS; Al-Nouri, D; Al-Rumayyan, A; Topcu, M; Gascon, G; Bodell, A; Shugart, YY; Ruvolo, M; Walsh, CA				Ferland, RJ; Eyaid, W; Collura, RV; Tully, LD; Hill, RS; Al-Nouri, D; Al-Rumayyan, A; Topcu, M; Gascon, G; Bodell, A; Shugart, YY; Ruvolo, M; Walsh, CA			Abnormal cerebellar development and axonal decussation due to mutations in AHI1 in Joubert syndrome	NATURE GENETICS			English	Article							EYE MOVEMENTS; VERMIS; LOCUS; RETARDATION; LIKELIHOOD; FAMILIES; FEATURES	Joubert syndrome is a congenital brain malformation of the cerebellar vermis and brainstem with abnormalities of axonal decussation (crossing in the brain) affecting the corticospinal tract and superior cerebellar peduncles(1-9). Individuals with Joubert syndrome have motor and behavioral abnormalities, including an inability to walk due to severe clumsiness and 'mirror' movements, and cognitive and behavioral disturbances(5-8,10-12). Here we identified a locus associated with Joubert syndrome, JBTS3, on chromosome 6q23.2-q23. 3 and found three deleterious mutations in AHI1, the first gene to be associated with Joubert syndrome. AHI1 is most highly expressed in brain, particularly in neurons that give rise to the crossing axons of the corticospinal tract and superior cerebellar peduncles. Comparative genetic analysis of AHI1 indicates that it has undergone positive evolutionary selection along the human lineage. Therefore, changes in AHI1 may have been important in the evolution of human-specific motor behaviors.	Harvard Univ, Sch Med, Div Neurogenet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Howard Hughes Med Inst,Dept Neurol, Boston, MA 02115 USA; King Fahad Natl Guard Hosp, Dept Pediat, Riyadh 11426, Saudi Arabia; Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; King Fahad Natl Guard Hosp, Dept Neurol, Riyadh 11426, Saudi Arabia; Hacettepe Univ, Fac Med, Dept Pediat, Sect Child Neurol, TR-06100 Ankara, Turkey; King Faisal Specialist Hosp & Res Ctr, Dept Neurosci, Jeddah 21499, Saudi Arabia; Brown Univ, Sch Med, Providence, RI 02908 USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Howard Hughes Medical Institute; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; Harvard University; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; Hacettepe University; King Faisal Specialist Hospital & Research Center; Brown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard Medical School	Walsh, CA (corresponding author), Harvard Univ, Sch Med, Div Neurogenet, NRB 266,77 Ave Louis Pasteur, Boston, MA 02115 USA.	cwalsh@bidmc.harvard.edu	Ferland, Russell/E-3500-2010; Ferland, Russell/Q-6793-2019	Ferland, Russell/0000-0002-8044-2479; YAO, YIN/0000-0003-3053-8429; Walsh, Christopher/0000-0002-0156-2238	NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH071801] Funding Source: NIH RePORTER; NIMH NIH HHS [K01 MH071801, K01 MH071801-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Altman J, 2001, DEV HUMAN SPINAL COR; Blair IP, 2002, AM J MED GENET, V107, P190, DOI 10.1002/ajmg.10145; CANTANI A, 1990, ANN GENET-PARIS, V33, P96; Chance PF, 1999, J CHILD NEUROL, V14, P660, DOI 10.1177/088307389901401007; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Couch J, 2002, CURR BIOL, V12, pR741, DOI 10.1016/S0960-9822(02)01253-8; FRIEDE RL, 1978, DEV MED CHILD NEUROL, V20, P758; Jiang XY, 2002, J VIROL, V76, P9046, DOI 10.1128/JVI.76.18.9046-9059.2002; JOUBERT M, 1968, NEUROLOGY, V18, P302; JOUBERT M, 1969, NEUROLOGY, V19, P813, DOI 10.1212/WNL.19.9.813; Keeler LC, 2003, AM J HUM GENET, V73, P656, DOI 10.1086/378206; KENDALL B, 1990, NEURORADIOLOGY, V31, P502, DOI 10.1007/BF00340131; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lagier-Tourenne C, 2004, J MED GENET, V41, P273, DOI 10.1136/jmg.2003.014787; Maria BL, 1999, J CHILD NEUROL, V14, P583, DOI 10.1177/088307389901400906; Maria BL, 1999, J CHILD NEUROL, V14, P368, DOI 10.1177/088307389901400605; Maria BL, 1999, J CHILD NEUROL, V14, P590; Merritt Linda, 2003, Adv Neonatal Care, V3, P178, DOI 10.1016/S1536-0903(03)00137-1; Niesen Charles E, 2002, Semin Pediatr Neurol, V9, P320, DOI 10.1053/spen.2002.32508; Ozonoff S, 1999, J CHILD NEUROL, V14, P636, DOI 10.1177/088307389901401003; Quisling RG, 1999, J CHILD NEUROL, V14, P628, DOI 10.1177/088307389901401002; Saar K, 1999, AM J HUM GENET, V65, P1666, DOI 10.1086/302655; SARAIVA JM, 1992, AM J MED GENET, V43, P726, DOI 10.1002/ajmg.1320430415; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sobel E, 1996, AM J HUM GENET, V58, P1323; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241; VANDORP DB, 1991, AM J MED GENET, V40, P100, DOI 10.1002/ajmg.1320400121; Watanabe H, 2004, NATURE, V429, P382, DOI 10.1038/nature02564; Yachnis AT, 1999, J CHILD NEUROL, V14, P655, DOI 10.1177/088307389901401006; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957	31	304	310	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					1008	1013		10.1038/ng1419	http://dx.doi.org/10.1038/ng1419			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15322546	Bronze			2022-12-27	WOS:000223658100030
J	Li, M; Atmaca-Sonmez, P; Othman, M; Branham, KEH; Khanna, R; Wade, MS; Li, Y; Liang, LM; Zareparsi, S; Swaroop, A; Abecasis, GR				Li, Mingyao; Atmaca-Sonmez, Pelin; Othman, Mohammad; Branham, Kari E. H.; Khanna, Ritu; Wade, Michael S.; Li, Yun; Liang, Liming; Zareparsi, Sepideh; Swaroop, Anand; Abecasis, Goncalo R.			CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration	NATURE GENETICS			English	Article							COMPLEMENT FACTOR-H; LINKAGE DISEQUILIBRIUM; RISK-FACTORS; GENOME SCAN; MACULOPATHY; POLYMORPHISM; DISEASE; LOC387715; SMOKING; TRAITS	In developed countries, age-related macular degeneration is a common cause of blindness in the elderly. A common polymorphism, encoding the sequence variation Y402H in complement factor H (CFH), has been strongly associated with disease susceptibility. Here, we examined 84 polymorphisms in and around CFH in 726 affected individuals (including 544 unrelated individuals) and 268 unrelated controls. In this sample, 20 of these polymorphisms showed stronger association with disease susceptibility than the Y402H variant. Further, no single polymorphism could account for the contribution of the CFH locus to disease susceptibility. Instead, multiple polymorphisms defined a set of four common haplotypes (of which two were associated with disease susceptibility and two seemed to be protective) and multiple rare haplotypes (associated with increased susceptibility in aggregate). Our results suggest that there are multiple disease susceptibility alleles in the region and that noncoding CFH variants play a role in disease susceptibility.	Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Pennsylvania; University of Michigan System; University of Michigan	Abecasis, GR (corresponding author), Univ Michigan, Dept Biostat, 1420 Washington Hts, Ann Arbor, MI 48109 USA.	swaroop@umich.edu; goncalo@umich.edu	Branham, Kari/AAA-8336-2022; Abecasis, Goncalo R/B-7840-2010	Branham, Kari/0000-0002-2492-254X; Swaroop, Anand/0000-0002-1975-1141; Abecasis, Goncalo/0000-0003-1509-1825	NATIONAL EYE INSTITUTE [R01EY016862] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY016862-01A1] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abecasis GR, 2004, AM J HUM GENET, V74, P482, DOI 10.1086/382786; Abecasis GR, 2001, AM J HUM GENET, V69, P198; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fisher SA, 2005, HUM MOL GENET, V14, P2257, DOI 10.1093/hmg/ddi230; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hirvela H, 1996, OPHTHALMOLOGY, V103, P871, DOI 10.1016/S0161-6420(96)30593-9; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Klein R, 2002, AM J EPIDEMIOL, V156, P589, DOI 10.1093/aje/kwf092; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li MY, 2006, AM J HUM GENET, V78, P778, DOI 10.1086/503711; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Li N, 2003, GENETICS, V165, P2213; Majewski J, 2003, AM J HUM GENET, V73, P540, DOI 10.1086/377701; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; RISCH N, 1990, AM J HUM GENET, V46, P222; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Schmidt S, 2006, AM J HUM GENET, V78, P852, DOI 10.1086/503822; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Valdes AM, 1997, AM J HUM GENET, V60, P703; Weeks DE, 2001, AM J OPHTHALMOL, V132, P682, DOI 10.1016/S0002-9394(01)01214-4; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	30	268	284	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2006	38	9					1049	1054		10.1038/ng1871	http://dx.doi.org/10.1038/ng1871			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16936733	Green Accepted, Green Submitted			2022-12-27	WOS:000240112100023
J	Horvath, A; Boikos, S; Giatzakis, C; Robinson-White, A; Groussin, L; Griffin, KJ; Stein, E; Levine, E; Delimpasi, G; Hsiao, HP; Keil, M; Heyerdahl, S; Matyakhina, L; Libe, R; Fratticci, A; Kirschner, LS; Cramer, K; Gaillard, RC; Bertagna, X; Carney, JA; Bertherat, J; Bossis, I; Stratakis, CA				Horvath, Anelia; Boikos, Sosipatros; Giatzakis, Christoforos; Robinson-White, Audrey; Groussin, Lionel; Griffin, Kurt J.; Stein, Erica; Levine, Elizabeth; Delimpasi, Georgia; Hsiao, Hui Pin; Keil, Meg; Heyerdahl, Sarah; Matyakhina, Ludmila; Libe, Rossella; Fratticci, Amato; Kirschner, Lawrence S.; Cramer, Kevin; Gaillard, Rolf C.; Bertagna, Xavier; Carney, J. Aidan; Bertherat, Jerome; Bossis, Ioannis; Stratakis, Constantine A.			A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia	NATURE GENETICS			English	Article							SPLICE VARIANTS; PRKAR1A GENE; EXPRESSION; SUBUNIT; DISEASE; PROTEIN; ORGANIZATION; COMPLEX; CLONING	Phosphodiesterases (PDEs) regulate cyclic nucleotide levels. Increased cyclic AMP (cAMP) signaling has been associated with PRKAR1A or GNAS mutations and leads to adrenocortical tumors and Cushing syndrome1-7. We investigated the genetic source of Cushing syndrome in individuals with adrenocortical hyperplasia that was not caused by known defects. We performed genome-wide SNP genotyping, including the adrenocortical tumor DNA. The region with the highest probability to harbor a susceptibility gene by loss of heterozygosity (LOH) and other analyses was 2q31-2q35. We identified mutations disrupting the expression of the PDE11A isoform-4 gene (PDE11A) in three kindreds. Tumor tissues showed 2q31-2q35 LOH, decreased protein expression and high cyclic nucleotide levels and cAMP-responsive element binding protein (CREB) phosphorylation. PDE11A codes for a dual-specificity PDE that is expressed in adrenal cortex and is partially inhibited by tadalafil and other PDE inhibitors(8,9); its germline inactivation is associated with adrenocortical hyperplasia, suggesting another means by which dysregulation of cAMP signaling causes endocrine tumors.	US Natl Inst Child Hlth & Human Dev, Sect Endocrinol & Genet, US Natl Inst Hlth, Bethesda, MD 20892 USA; US Natl Inst Child Hlth & Human Dev, Pediat Endocrinol Training Program, US Natl Inst Hlth, Dev Endocrinol Branch, Bethesda, MD 20892 USA; Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Univ Paris 05, Hop Cochin, INSERM, U567,Inst Cochin,Dept Endocrinol Metab & Canc, F-75679 Paris, France; Univ Paris 05, Hosp Cochin, CNRS, UMR 8104,CNRS, F-75679 Paris, France; Univ Paris 05, Hosp Cochin, Ctr Reference Malad Rare Surrenale, Serv Endocrinol, F-75679 Paris, France; Ohio State Univ, Div Endocrinol, Columbus, OH 43210 USA; Ohio State Univ, Div Human Canc Genet, Columbus, OH 43210 USA; Sapio Sci LLC, York, PA 17402 USA; CHU Vaudois, Div Endocrinol Diabetol & Metab, CH-1011 Lausanne, Switzerland	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; Mayo Clinic; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Stratakis, CA (corresponding author), US Natl Inst Child Hlth & Human Dev, Sect Endocrinol & Genet, US Natl Inst Hlth, Bethesda, MD 20892 USA.	stratakc@mail.nih.gov	Stratakis, Constantine/AAP-4745-2020	BERTHERAT, Jerome/0000-0003-2551-3008; libe, rossella/0000-0003-2881-6362; Stein, Erica/0000-0001-8778-8846; Groussin, Lionel/0000-0003-1476-475X	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD000642, Z01HD000642] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bertherat J, 2003, CANCER RES, V63, P5308; Bourdeau I, 2002, ANN NY ACAD SCI, V968, P240, DOI 10.1111/j.1749-6632.2002.tb04339.x; D'Andrea MR, 2005, J HISTOCHEM CYTOCHEM, V53, P895, DOI 10.1369/jhc.5A6625.2005; de Tejada IS, 2002, INT J IMPOT RES, V14, pS6, DOI 10.1038/sj/ijir/3900790; Fawcett L, 2000, P NATL ACAD SCI USA, V97, P3702, DOI 10.1073/pnas.050585197; Francis SH, 2005, INT J IMPOT RES, V17, P467, DOI 10.1038/sj.ijir.3901377; GAL A, 1994, NAT GENET, V7, P64, DOI 10.1038/ng0594-64; Gbekor E, 2002, J UROLOGY, V167, P246; Groussin L, 2002, J CLIN ENDOCR METAB, V87, P4324, DOI 10.1210/jc.2002-020592; Gunther DF, 2004, J CLIN ENDOCR METAB, V89, P3173, DOI 10.1210/jc.2003-032247; Hetman JM, 2000, P NATL ACAD SCI USA, V97, P12891, DOI 10.1073/pnas.200355397; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; Jin SLC, 1999, P NATL ACAD SCI USA, V96, P11998, DOI 10.1073/pnas.96.21.11998; Kawamura M, 2002, PHARMACOL TOXICOL, V90, P106, DOI 10.1034/j.1600-0773.2002.900209.x; Kirschner LS, 2000, HUM MOL GENET, V9, P3037, DOI 10.1093/hmg/9.20.3037; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Lehnart SE, 2005, CELL, V123, P25, DOI 10.1016/j.cell.2005.07.030; Loughney K, 2005, INT J IMPOT RES, V17, P320, DOI 10.1038/sj.ijir.3901317; Masciarelli S, 2004, J CLIN INVEST, V114, P196, DOI 10.1172/JCI2004210804; Michibata H, 2001, BBA-GENE STRUCT EXPR, V1517, P278, DOI 10.1016/S0167-4781(00)00293-1; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Persani L, 2000, J CLIN ENDOCR METAB, V85, P2872, DOI 10.1210/jc.85.8.2872; Stratakis CA, 2001, J CLIN ENDOCR METAB, V86, P4041, DOI 10.1210/jc.86.9.4041; Stratakis CA, 1998, HORM METAB RES, V30, P456, DOI 10.1055/s-2007-978914; Ting JC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-25; Wayman C, 2005, INT J IMPOT RES, V17, P216, DOI 10.1038/sj.ijir.3901307; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Yuasa K, 2000, J BIOL CHEM, V275, P31469, DOI 10.1074/jbc.M003041200; Yuasa K, 2001, EUR J BIOCHEM, V268, P4440, DOI 10.1046/j.1432-1327.2001.02366.x; Yuasa K, 2001, EUR J BIOCHEM, V268, P168, DOI 10.1046/j.1432-1327.2001.01866.x	30	231	245	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					794	800		10.1038/ng1809	http://dx.doi.org/10.1038/ng1809			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16767104				2022-12-27	WOS:000238669300015
J	Sebaihia, M; Wren, BW; Mullany, P; Fairweather, NF; Minton, N; Stabler, R; Thomson, NR; Roberts, AP; Cerdeno-Tarrraga, AM; Wang, HW; Holden, MTG; Wright, A; Churcher, C; Quail, MA; Baker, S; Bason, N; Brooks, K; Chillingworth, T; Cronin, A; Davis, P; Dowd, L; Fraser, A; Feltwell, T; Hance, Z; Holroyd, S; Jagels, K; Moule, S; Mungall, K; Price, C; Rabbinowitsch, E; Sharp, S; Simmonds, M; Stevens, K; Unwin, L; Whithead, S; Dupuy, B; Dougan, G; Barrell, B; Parkhill, J				Sebaihia, Mohammed; Wren, Brendan W.; Mullany, Peter; Fairweather, Neil F.; Minton, Nigel; Stabler, Richard; Thomson, Nicholas R.; Roberts, Adam P.; Cerdeno-Tarrraga, Ana M.; Wang, Hongmei; Holden, Matthew T. G.; Wright, Anne; Churcher, Carol; Quail, Michael A.; Baker, Stephen; Bason, Nathalie; Brooks, Karen; Chillingworth, Tracey; Cronin, Ann; Davis, Paul; Dowd, Linda; Fraser, Audrey; Feltwell, Theresa; Hance, Zahra; Holroyd, Simon; Jagels, Kay; Moule, Sharon; Mungall, Karen; Price, Claire; Rabbinowitsch, Ester; Sharp, Sarah; Simmonds, Mark; Stevens, Kim; Unwin, Louise; Whithead, Sally; Dupuy, Bruno; Dougan, Gordon; Barrell, Bart; Parkhill, Julian			The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome	NATURE GENETICS			English	Article							STAPHYLOCOCCUS-AUREUS; ENTEROCOCCUS-FAECALIS; CONJUGAL TRANSFER; SURFACE PROTEIN; VIRULENCE; SEQUENCE; GENE; ELEMENT; IDENTIFICATION; PERFRINGENS	We determined the complete genome sequence of Clostridium difficile strain 630, a virulent and multidrug-resistant strain. Our analysis indicates that a large proportion (11%) of the genome consists of mobile genetic elements, mainly in the form of conjugative transposons. These mobile elements are putatively responsible for the acquisition by C. difficile of an extensive array of genes involved in antimicrobial resistance, virulence, host interaction and the production of surface structures. The metabolic capabilities encoded in the genome show multiple adaptations for survival and growth within the gut environment. The extreme genome variability was confirmed by whole-genome microarray analysis; it may reflect the organism's niche in the gut and should provide information on the evolution of virulence in this organism.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; London Sch Hyg & Trop Med, Dept Infect & Trop Med, London WC1E 7HT, England; UCL, Eastman Dent Inst Oral Hlth Care Sci, London WC1X 8LD, England; Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England; Univ Nottingham, Inst Infect Immun & Inflammat, Ctr Biomol Sci, Nottingham NG7 2RD, England; Inst Pasteur, Unite Genet Mol Bacterienne, F-75724 Paris 15, France	Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Imperial College London; University of Nottingham; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Parkhill, J (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Gen Campus, Cambridge CB10 1SA, England.	parkhill@sanger.ac.uk	Holden, Matthew TG/K-6449-2014; Quail, michael/ABE-6131-2020; Sebaihia, Mohammed/AAF-6589-2019; Parkhill, Julian/G-4703-2011; Roberts, Adam/AAU-5493-2021; Roberts, Adam P/C-1787-2008; Thomson, Nicholas/P-5988-2014	Holden, Matthew TG/0000-0002-4958-2166; Sebaihia, Mohammed/0000-0002-3324-3346; Parkhill, Julian/0000-0002-7069-5958; Roberts, Adam/0000-0002-0760-3088; Roberts, Adam P/0000-0002-0760-3088; Stabler, Richard/0000-0002-2402-6630; Baker, Stephen/0000-0003-1308-5755; Thomson, Nicholas/0000-0002-4432-8505; Minton, Nigel/0000-0002-9277-1261; Cerdeno-Tarraga, Ana M./0000-0001-6635-3237; Davis, Paul/0000-0001-5545-0824	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARTHUR M, 1995, GENE, V154, P87, DOI 10.1016/0378-1119(94)00851-I; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Bell KS, 2004, P NATL ACAD SCI USA, V101, P11105, DOI 10.1073/pnas.0402424101; BORRIELLO SP, 1988, J MED MICROBIOL, V25, P191, DOI 10.1099/00222615-25-3-191; Braun V, 2000, MOL MICROBIOL, V36, P1447, DOI 10.1046/j.1365-2958.2000.01965.x; Broussolle V, 2002, ANAEROBE, V8, P89, DOI 10.1006/anae.2002.0424; Bruggemann H, 2003, P NATL ACAD SCI USA, V100, P1316, DOI 10.1073/pnas.0335853100; Burrus V, 2002, MOL MICROBIOL, V46, P601, DOI 10.1046/j.1365-2958.2002.03191.x; Calabi E, 2001, MOL MICROBIOL, V40, P1187, DOI 10.1046/j.1365-2958.2001.02461.x; Carter GP, 2005, J MED MICROBIOL, V54, P119, DOI 10.1099/jmm.0.45817-0; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Champion OL, 2005, P NATL ACAD SCI USA, V102, P16043, DOI 10.1073/pnas.0503252102; DAVIES HA, 1990, MICROB PATHOGENESIS, V9, P141, DOI 10.1016/0882-4010(90)90088-8; de Vries YP, 2005, FEMS MICROBIOL LETT, V252, P169, DOI 10.1016/j.femsle.2005.08.042; Depardieu F, 2003, MOL MICROBIOL, V50, P931, DOI 10.1046/j.1365-2958.2003.03737.x; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; ELSDEN SR, 1976, ARCH MICROBIOL, V107, P283, DOI 10.1007/BF00425340; Farrow KA, 2001, MICROBIOL-SGM, V147, P2717, DOI 10.1099/00221287-147-10-2717; FRANKE AE, 1981, J BACTERIOL, V145, P494, DOI 10.1128/JB.145.1.494-502.1981; Garnier F, 2000, MICROBIOL-UK, V146, P1481, DOI 10.1099/00221287-146-6-1481; Haraldsen JD, 2003, MOL MICROBIOL, V48, P811, DOI 10.1046/j.1365-2958.2003.03471.x; Hennequin C, 2003, MICROBIOL-SGM, V149, P2779, DOI 10.1099/mic.0.26145-0; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Lee ASY, 2005, BIOCHEM BIOPH RES CO, V335, P659, DOI 10.1016/j.bbrc.2005.07.131; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Lyon GJ, 2004, PEPTIDES, V25, P1389, DOI 10.1016/j.peptides.2003.11.026; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Moir A, 2002, CELL MOL LIFE SCI, V59, P403, DOI 10.1007/s00018-002-8432-8; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; MULLANY P, 1990, J GEN MICROBIOL, V136, P1343, DOI 10.1099/00221287-136-7-1343; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; Ohtani K, 2002, MOL MICROBIOL, V44, P171, DOI 10.1046/j.1365-2958.2002.02863.x; Paredes CJ, 2005, NAT REV MICROBIOL, V3, P969, DOI 10.1038/nrmicro1288; Poilane I, 1998, CAN J MICROBIOL, V44, P157, DOI 10.1139/cjm-44-2-157; Roberts AP, 2001, MICROBIOL-SGM, V147, P1243, DOI 10.1099/00221287-147-5-1243; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Savariau-Lacomme MP, 2003, J BACTERIOL, V185, P4461, DOI 10.1128/JB.185.15.4461-4470.2003; Selmer T, 2001, EUR J BIOCHEM, V268, P1363, DOI 10.1046/j.1432-1327.2001.02001.x; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Sleator RD, 2005, MOL MICROBIOL, V55, P1183, DOI 10.1111/j.1365-2958.2004.04454.x; van Schaik W, 2005, CURR OPIN BIOTECH, V16, P218, DOI 10.1016/j.copbio.2005.01.008; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001; Wang HM, 2000, J BACTERIOL, V182, P6577, DOI 10.1128/JB.182.23.6577-6583.2000; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; WILSON KH, 1983, J CLIN MICROBIOL, V18, P1017, DOI 10.1128/JCM.18.4.1017-1019.1983; Wright A, 2005, PROTEOMICS, V5, P2443, DOI 10.1002/pmic.200401179; WUST J, 1982, J CLIN MICROBIOL, V16, P1096	50	641	980	3	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					779	786		10.1038/ng1830	http://dx.doi.org/10.1038/ng1830			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16804543				2022-12-27	WOS:000238669300013
J	Jiang, ZR; Asplin, JR; Evan, AP; Rajendran, VM; Velazquez, H; Nottoli, TP; Binder, HJ; Aronson, PS				Jiang, ZR; Asplin, JR; Evan, AP; Rajendran, VM; Velazquez, H; Nottoli, TP; Binder, HJ; Aronson, PS			Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6	NATURE GENETICS			English	Article							BRUSH-BORDER MEMBRANE; PROXIMAL TUBULE; DIETARY OXALATE; MOUSE SLC26A6; EXCHANGER; FORMATE; IDENTIFICATION; ABSORPTION; EXCRETION; VESICLES	Urolithiasis is one of the most common urologic diseases in industrialized societies. Calcium oxalate is the predominant component in 70-80% of kidney stones(1), and small changes in urinary oxalate concentration affect the risk of stone formation(2). SLC26A6 is an anion exchanger expressed on the apical membrane in many epithelial tissues, including kidney and intestine(3-6). Among its transport activities, SLC26A6 mediates Cl--oxalate exchange(5-9). Here we show that mutant mice lacking Slc26a6 develop a high incidence of calcium oxalate urolithiasis. Slc26a6-null mice have significant hyperoxaluria and elevation in plasma oxalate concentration that is greatly attenuated by dietary oxalate restriction. In vitro flux studies indicated that mice lacking Slc26a6 have a defect in intestinal oxalate secretion resulting in enhanced net absorption of oxalate. We conclude that the anion exchanger SLC26A6 has a major constitutive role in limiting net intestinal absorption of oxalate, thereby preventing hyperoxaluria and calcium oxalate urolithiasis.	Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Litholink Corp, Chicago, IL 60612 USA; Univ Chicago, Renal Sect, Chicago, IL 60612 USA; Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46223 USA; Vet Adm Connecticut Healthcare Syst, West Haven, CT 06516 USA; Yale Univ, Sch Med, Dept Comparat Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University; University of Chicago; Indiana University System; Indiana University-Purdue University Indianapolis; Yale University; Yale University	Aronson, PS (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06520 USA.	peter.aronson@yale.edu			NIDDK NIH HHS [R37 DK033793, DK56788, DK33793, DK60699, DK17433] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK033793, R37DK033793] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asplin J, 1998, J UROLOGY, V159, P1821, DOI 10.1016/S0022-5347(01)63164-1; Asplin JR, 2002, ENDOCRIN METAB CLIN, V31, P927, DOI 10.1016/S0889-8529(02)00030-0; Chernova MN, 2005, J BIOL CHEM, V280, P8564, DOI 10.1074/jbc.M411703200; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; FREEL RW, 2005, AM J PHYSL GASTROINT; HATCH M, 1994, J AM SOC NEPHROL, V5, P1339; Holmes RP, 2005, J UROLOGY, V174, P943, DOI 10.1097/01.ju.0000169476.85935.e2; Holmes RP, 2004, UROL RES, V32, P311, DOI 10.1007/s00240-004-0437-3; Hoppe B, 1998, KIDNEY INT, V53, P1348, DOI 10.1046/j.1523-1755.1998.00891.x; Jiang Z, 2002, J BIOL CHEM, V277, P33963, DOI 10.1074/jbc.M202660200; Karniski LP, 2002, AM J PHYSIOL-RENAL, V283, pF952, DOI 10.1152/ajprenal.00182.2002; Knauf F, 2001, P NATL ACAD SCI USA, V98, P9425, DOI 10.1073/pnas.141241098; Kocinsky HS, 2005, AM J PHYSIOL-RENAL, V289, pF249, DOI 10.1152/ajprenal.00082.2004; Kuo SM, 1996, J BIOL CHEM, V271, P15491, DOI 10.1074/jbc.271.26.15491; Lohi H, 2000, GENOMICS, V70, P102, DOI 10.1006/geno.2000.6355; MCCONNELL KR, 1994, J BIOL CHEM, V269, P21489; Palgi N, 2005, COMP BIOCHEM PHYS A, V141, P48, DOI 10.1016/j.cbpb.2005.03.011; ROBERTSON WG, 1980, NEPHRON, V26, P105, DOI 10.1159/000181963; Vidyasagar S, 2004, AM J PHYSIOL-CELL PH, V287, pC612, DOI 10.1152/ajpcell.00474.2003; Waldegger S, 2001, GENOMICS, V72, P43, DOI 10.1006/geno.2000.6445; WANG T, 1992, AM J PHYSIOL, V263, pF37, DOI 10.1152/ajprenal.1992.263.1.F37; Wang T, 1996, AM J PHYSIOL-RENAL, V271, pF446, DOI 10.1152/ajprenal.1996.271.2.F446; WANG T, 1995, AM J PHYSIOL-RENAL, V268, pF204, DOI 10.1152/ajprenal.1995.268.2.F204; Wang ZH, 2005, AM J PHYSIOL-CELL PH, V288, pC957, DOI 10.1152/ajpcell.00505.2004; Wang ZH, 2002, AM J PHYSIOL-GASTR L, V282, pG573, DOI 10.1152/ajpgi.00338.2001; WERNESS PG, 1985, J UROLOGY, V134, P1242, DOI 10.1016/S0022-5347(17)47703-2; Wu MS, 1996, J BIOL CHEM, V271, P32749, DOI 10.1074/jbc.271.51.32749; Xie QH, 2002, AM J PHYSIOL-RENAL, V283, pF826, DOI 10.1152/ajprenal.00079.2002; YASUE T, 1969, Acta Histochemica et Cytochemica, V2, P83	29	235	240	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2006	38	4					474	478		10.1038/ng1762	http://dx.doi.org/10.1038/ng1762			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	026LN	16532010				2022-12-27	WOS:000236340500022
J	Boyden, ED; Dietrich, WF				Boyden, ED; Dietrich, WF			Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin	NATURE GENETICS			English	Article							STRAIN DISTRIBUTION PATTERN; SSLP MARKERS; PROTEIN; ACTIVATION; INFLAMMASOME; RESISTANCE; RELEASE; SET; MAP	The pathogenesis of Bacillus anthracis, the bacterium that causes anthrax, depends on secretion of three factors that combine to form two bipartite toxins. Edema toxin, consisting of protective antigen (PA) and edema factor (EF), causes the edema associated with cutaneous anthrax infections, whereas lethal toxin (LeTx), consisting of PA and lethal factor (LF), is believed to be responsible for causing death in systemic anthrax infections(1). EF and LF can be transported by PA into the cytosol of many cell types(2). In mouse macrophages, LF can cause rapid necrosis that may be related to the pathology of systemic infections(3-5). Inbred mouse strains display variable sensitivity to LeTx-induced macrophage necrosis(6,7). This trait difference has been mapped to a locus on chromosome 11 named Ltxs1 (refs. 7,8). Here we show that an extremely polymorphic gene in this locus, Nalp1b, is the primary mediator of mouse macrophage susceptibility to LeTx. We also show that LeTx-induced macrophage death requires caspase-1, which is activated in susceptible, but not resistant, macrophages after intoxication, suggesting that Nalp1b directly or indirectly activates caspase-1 in response to LeTx.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Dietrich, WF (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	dietrich@genetics.med.harvard.edu						Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Cordoba-Rodriguez R, 2004, J BIOL CHEM, V279, P20563, DOI 10.1074/jbc.C300539200; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; FRIEDLANDER AM, 1986, J BIOL CHEM, V261, P7123; FRIEDLANDER AM, 1993, INFECT IMMUN, V61, P245, DOI 10.1128/IAI.61.1.245-252.1993; Geddes BJ, 2001, BIOCHEM BIOPH RES CO, V284, P77, DOI 10.1006/bbrc.2001.4928; Growney JD, 2000, GENOME RES, V10, P1158, DOI 10.1101/gr.10.8.1158; HANNA PC, 1992, MOL BIOL CELL, V3, P1269, DOI 10.1091/mbc.3.11.1269; HANNA PC, 1993, P NATL ACAD SCI USA, V90, P10198, DOI 10.1073/pnas.90.21.10198; Jesenberger V, 2000, J EXP MED, V192, P1035, DOI 10.1084/jem.192.7.1035; Kim SO, 2003, J BIOL CHEM, V278, P7413, DOI 10.1074/jbc.M209279200; KLIMPEL KR, 1994, MOL MICROBIOL, V13, P1093, DOI 10.1111/j.1365-2958.1994.tb00500.x; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2001, CURR BIOL, V11, pR118, DOI 10.1016/S0960-9822(01)00056-2; Menard A, 1996, BIOCHEM J, V320, P687, DOI 10.1042/bj3200687; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Reifsnyder PC, 1999, MAMM GENOME, V10, P161, DOI 10.1007/s003359900962; Roberts JE, 1998, MOL MICROBIOL, V29, P581, DOI 10.1046/j.1365-2958.1998.00953.x; Shultz KL, 1996, MAMM GENOME, V7, P526, DOI 10.1007/s003359900156; STEPHEN J, 1981, PHARMACOL THERAPEUT, V12, P501, DOI 10.1016/0163-7258(81)90095-4; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; SVENSON KL, 1995, MAMM GENOME, V6, P867, DOI 10.1007/BF00292437; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Watters JW, 2001, CURR BIOL, V11, P1503, DOI 10.1016/S0960-9822(01)00476-6; Watters JW, 2001, GENOMICS, V73, P223, DOI 10.1006/geno.2001.6453; Yui MA, 1996, MAMM GENOME, V7, P331, DOI 10.1007/s003359900097	30	620	653	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					240	244		10.1038/ng1724	http://dx.doi.org/10.1038/ng1724			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16429160				2022-12-27	WOS:000234953200022
J	Jordanova, A; Irobi, J; Thomas, FP; Van Dijck, P; Meerschaert, K; Dewil, M; Dierick, I; Jacobs, A; De Vriendt, E; Guergueltcheva, V; Rao, CV; Tournev, I; Gondim, FAA; D'Hooghe, M; Van Gerwen, V; Callaerts, P; Van den Bosch, L; Timmermans, JPR; Robberecht, W; Gettemans, J; Thevelein, JM; De Jonghe, P; Kremensky, I; Timmerman, V				Jordanova, A; Irobi, J; Thomas, FP; Van Dijck, P; Meerschaert, K; Dewil, M; Dierick, I; Jacobs, A; De Vriendt, E; Guergueltcheva, V; Rao, CV; Tournev, I; Gondim, FAA; D'Hooghe, M; Van Gerwen, V; Callaerts, P; Van den Bosch, L; Timmermans, JPR; Robberecht, W; Gettemans, J; Thevelein, JM; De Jonghe, P; Kremensky, I; Timmerman, V			Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy	NATURE GENETICS			English	Article							PROTEIN-PROTEIN INTERACTIONS; SITE-DIRECTED MUTAGENESIS; AMINO-ACID; ENZYME STRUCTURE; CYTOKINE; DISEASE; LOCALIZATION; TRANSLATION; MUTATIONS; HOMOLOGY	Charcot-Marie-Tooth (CMT) neuropathies are common disorders of the peripheral nervous system caused by demyelination or axonal degeneration, or a combination of both features. We previously assigned the locus for autosomal dominant intermediate CMT neuropathy type C (DI-CMTC) to chromosome 1p34-p35. Here we identify two heterozygous missense mutations (G41R and E196K) and one de novo deletion ( 153 - 156delVKQV) in tyrosyl-tRNA synthetase (YARS) in three unrelated families affected with DI-CMTC. Biochemical experiments and genetic complementation in yeast show partial loss of aminoacylation activity of the mutant proteins, and mutations in YARS, or in its yeast ortholog TYS1, reduce yeast growth. YARS localizes to axonal termini in differentiating primary motor neuron and neuroblastoma cultures. This specific distribution is significantly reduced in cells expressing mutant YARS proteins. YARS is the second aminoacyl-tRNA synthetase found to be involved in CMT, thereby linking protein-synthesizing complexes with neurodegeneration.	Univ Antwerp Flanders Interuniv Inst Biotechnol, Dept Mol Genet, B-2610 Antwerp, Belgium; Med Univ Sofia, Lab Mol Pathol, Sofia 1431, Bulgaria; St Louis Univ, Dept Neurol, St Louis, MO 63110 USA; St Louis Univ, St Louis Vet Affairs Med Ctr, Spinal cord Injury Serv, Inst Mol Virol,Dept Mol Microbiol & Immunol, St Louis, MO 63110 USA; Univ Leuven Flanders Interuniv Inst Biotechnol, Mol Cell Biol Lab, Dept Mol Microbiol, B-3001 Louvain, Belgium; Univ Ghent Flanders Interuniv Inst Biotechnol, Dept Med Prot Res, B-9000 Ghent, Belgium; Univ Leuven, Dept Expt Neurol, Neurobiol Lab, B-3000 Louvain, Belgium; Med Univ Sofia, Dept Neurol, Sofia 1431, Bulgaria; St Jan Hosp, Dept Neurol, B-8000 Brugge, Belgium; Univ Leuven Flanders Interuniv Inst Biotechnol, Dept Human Genet, Lab Dev Genet, B-3000 Louvain, Belgium; Univ Leuven Flanders Interuniv Inst Biotechnol, Dept Biol, Lab Dev Genet, B-3000 Louvain, Belgium; Univ Antwerp, Cell Biol & Histol Lab, B-2020 Antwerp, Belgium; Univ Antwerp Hosp, Div Neurol, B-2650 Antwerp, Belgium	Medical University Sofia; Saint Louis University; Saint Louis University; KU Leuven; Ghent University; KU Leuven; Medical University Sofia; KU Leuven; KU Leuven; University of Antwerp; University of Antwerp	Timmerman, V (corresponding author), Univ Antwerp Flanders Interuniv Inst Biotechnol, Dept Mol Genet, Univ Pl 1, B-2610 Antwerp, Belgium.	vincent.timmerman@ua.ac.be	Thomas, Florian P/AAL-3813-2020; Thevelein, Johan M./A-7897-2013; Timmerman, Vincent/O-7283-2019; de Assis Gondim, Francisco/J-1463-2014; Callaerts, Patrick/I-8118-2013; Jordanova, Albena/H-8323-2015; Thevelein, Johan M./AAK-4203-2021; Van Den Bosch, Ludo/B-7258-2012	Thevelein, Johan M./0000-0002-2626-0180; Timmerman, Vincent/0000-0002-2162-0933; de Assis Gondim, Francisco/0000-0002-8957-5796; Jordanova, Albena/0000-0002-3833-3754; Van Den Bosch, Ludo/0000-0003-0104-4067; Callaerts, Patrick/0000-0003-4530-4561; Thomas, Florian P/0000-0002-6103-4138; Timmermans, Jean-Pierre/0000-0003-2506-6252				Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; BARBARESE E, 1995, J CELL SCI, V108, P2781; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; De Corte V, 2004, J CELL SCI, V117, P5283, DOI 10.1242/jcs.01410; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; FERSHT AR, 1975, BIOCHEMISTRY-US, V14, P1, DOI 10.1021/bi00672a001; Gaete J, 1998, NEUROSCI LETT, V251, P197, DOI 10.1016/S0304-3940(98)00538-2; Giuditta A, 2002, TRENDS NEUROSCI, V25, P400, DOI 10.1016/S0166-2236(02)02188-4; Jordanova A, 2003, AM J HUM GENET, V73, P1423, DOI 10.1086/379792; Kennerson ML, 2001, AM J HUM GENET, V69, P883, DOI 10.1086/323743; Kiga D, 2002, P NATL ACAD SCI USA, V99, P9715, DOI 10.1073/pnas.142220099; Kleeman TA, 1997, J BIOL CHEM, V272, P14420, DOI 10.1074/jbc.272.22.14420; Nair S, 1997, J MOL BIOL, V269, P1, DOI 10.1006/jmbi.1997.1025; Ohno S, 2001, J BIOCHEM-TOKYO, V130, P417, DOI 10.1093/oxfordjournals.jbchem.a003001; OlinkCoux M, 1996, J NEUROSCI, V16, P1346; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Tanghe A, 2002, APPL ENVIRON MICROB, V68, P5981, DOI 10.1128/AEM.68.12.5981-5989.2002; Van Damme P, 2003, J NEUROSCI, V23, P4942; Verhoeven K, 2001, AM J HUM GENET, V69, P889, DOI 10.1086/323742; Wakasugi K, 1998, EMBO J, V17, P297, DOI 10.1093/emboj/17.1.297; Wakasugi K, 1999, J BIOL CHEM, V274, P23155, DOI 10.1074/jbc.274.33.23155; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; WINTER G, 1982, NATURE, V299, P756, DOI 10.1038/299756a0; Yang XL, 2004, TRENDS BIOCHEM SCI, V29, P250, DOI 10.1016/j.tibs.2004.03.002; Yang XL, 2002, P NATL ACAD SCI USA, V99, P15369, DOI 10.1073/pnas.242611799; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	30	277	294	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2006	38	2					197	202		10.1038/ng1727	http://dx.doi.org/10.1038/ng1727			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16429158	Green Published			2022-12-27	WOS:000234953200014
J	Kuroki, Y; Toyoda, A; Noguchi, H; Taylor, TD; Itoh, T; Kim, DS; Kim, DW; Choi, SH; Kim, IC; Choi, HH; Kim, YS; Satta, Y; Saitou, N; Yamada, T; Morishita, S; Hattori, M; Sakaki, Y; Park, HS; Fujiyama, A				Kuroki, Y; Toyoda, A; Noguchi, H; Taylor, TD; Itoh, T; Kim, DS; Kim, DW; Choi, SH; Kim, IC; Choi, HH; Kim, YS; Satta, Y; Saitou, N; Yamada, T; Morishita, S; Hattori, M; Sakaki, Y; Park, HS; Fujiyama, A			Comparative analysis of chimpanzee and human Y chromosomes unveils complex evolutionary pathway	NATURE GENETICS			English	Article							HUMAN X-CHROMOSOME; DNA-SEQUENCE; HUMAN GENOME; GREAT APES; MOLECULAR EVOLUTION; REGION; PRIMATES; DUPLICATIONS; EXPANSION; HISTORY	The mammalian Y chromosome has unique characteristics compared with the autosomes or X chromosomes. Here we report the finished sequence of the chimpanzee Y chromosome (PTRY), including 271 kb of the Y-specific pseudoautosomal region 1 and 12.7 Mb of the male-specific region of the Y chromosome. Greater sequence divergence between the human Y chromosome (HSAY) and PTRY (1.78%) than between their respective whole genomes (1.23%) confirmed the accelerated evolutionary rate of the Y chromosome. Each of the 19 PTRY protein-coding genes analyzed had at least one nonsynonymous substitution, and 11 genes had higher nonsynonymous substitution rates than synonymous ones, suggesting relaxation of selective constraint, positive selection or both. We also identified lineage-specific changes, including deletion of a 200-kb fragment from the pericentromeric region of HSAY, expansion of young Alu families in HSAY and accumulation of young L1 elements and long terminal repeat retrotransposons in PTRY. Reconstruction of the common ancestral Y chromosome reflects the dynamic changes in our genomes in the 5 - 6 million years since speciation.	Korea Res Inst Biosci & Biotechnol, Genome Res Ctr, Taejon 305333, South Korea; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Univ Tokyo, Kashiwa, Chiba 2770882, Japan; Mitsubishi Res Inst, Tokyo 1008141, Japan; Univ Sci & Technol, Taejon 305333, South Korea; Grad Univ Adv Studies, Hayama 2400193, Japan; Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; Kitasato Univ, Sagamihara, Kanagawa 2288555, Japan; Natl Inst Informat, Tokyo 1018430, Japan	Korea Research Institute of Bioscience & Biotechnology (KRIBB); RIKEN; University of Tokyo; Mitsubishi Research Institute; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kitasato University; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan	Park, HS (corresponding author), Korea Res Inst Biosci & Biotechnol, Genome Res Ctr, Taejon 305333, South Korea.	hspark@kribb.re.kr; afujiyam@nii.ac.jp	Hattori, Masahira/C-6958-2016; Hattori, Masahira/AAD-3785-2019; Taylor, Todd/A-7121-2009; Itoh, Takehiko/E-8873-2014	Hattori, Masahira/0000-0001-9467-0344; Taylor, Todd/0000-0003-4247-6253; Itoh, Takehiko/0000-0002-6113-557X; Morishita, Shinichi/0000-0002-6201-8885; Satta, Yoko/0000-0002-5305-493X				Archidiacono N, 1998, CHROMOSOMA, V107, P241, DOI 10.1007/s004120050303; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; BISHOP C, 1984, J MOL BIOL, V173, P403, DOI 10.1016/0022-2836(84)90388-7; BONNER TI, 1982, J VIROL, V43, P914, DOI 10.1128/JVI.43.3.914-924.1982; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Ebersberger I, 2002, AM J HUM GENET, V70, P1490, DOI 10.1086/340787; Ellis N, 2002, GENOME RES, V12, P339; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Erlandsson R, 2000, MOL BIOL EVOL, V17, P804, DOI 10.1093/oxfordjournals.molbev.a026359; Filatov DA, 2004, MOL BIOL EVOL, V21, P410, DOI 10.1093/molbev/msh032; Fujiyama A, 2002, SCIENCE, V295, P131, DOI 10.1126/science.1065199; Gagneux P, 2001, MOL PHYLOGENET EVOL, V18, P2, DOI 10.1006/mpev.2000.0799; Gerrard DT, 2005, MOL BIOL EVOL, V22, P1423, DOI 10.1093/molbev/msi128; Gibbons R, 2004, J MOL BIOL, V339, P721, DOI 10.1016/j.jmb.2004.04.033; Golfier G, 2003, GENE, V312, P51, DOI 10.1016/S0378-1119(03)00673-5; GRAVES JAM, 1995, BIOESSAYS, V17, P311, DOI 10.1002/bies.950170407; Han KD, 2005, GENOME RES, V15, P655, DOI 10.1101/gr.3492605; Hedges DJ, 2004, GENOME RES, V14, P1068, DOI 10.1101/gr.2530404; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; Kittler R, 2003, EUR J HUM GENET, V11, P304, DOI 10.1038/sj.ejhg.5200960; KJELLMAN C, 1995, GENE, V161, P163, DOI 10.1016/0378-1119(95)00248-5; Kuroki Y, 1999, J HUM GENET, V44, P289, DOI 10.1007/s100380050162; Kuroki Y, 2006, NAT GENET, V38, P158, DOI 10.1038/ng1729; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lahn BT, 2001, NAT REV GENET, V2, P207, DOI 10.1038/35056058; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LI WH, 1997, MOL EVOLUTION, P237; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; NAKAHORI Y, 1996, ARES SERONO S PUBLIC, P1; Ohno S., 1967, SEX CHROMOSOMES SEX; Olson MV, 2003, NAT REV GENET, V4, P20, DOI 10.1038/nrg981; Orti R, 1998, CYTOGENET CELL GENET, V83, P262, DOI 10.1159/000015201; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; SAITOU N, 1994, MOL BIOL EVOL, V11, P504; Sakaki Y, 2003, COLD SPRING HARB SYM, V68, P455, DOI 10.1101/sqb.2003.68.455; Schweitzer F., 1998, ADV COMPLEX SYST, V1, P11, DOI DOI 10.1142/S021952599800003X; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stone AC, 2002, P NATL ACAD SCI USA, V99, P43, DOI 10.1073/pnas.012364999; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Watanabe H, 2004, NATURE, V429, P382, DOI 10.1038/nature02564; Waters PD, 2001, CYTOGENET CELL GENET, V92, P74, DOI 10.1159/000056872; Yamada Tomoyuki, 2004, J Bioinform Comput Biol, V2, P21, DOI 10.1142/S0219720004000454; Yohn CT, 2005, PLOS BIOL, V3, P577, DOI 10.1371/journal.pbio.0030110	52	88	93	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					158	+		10.1038/ng1729	http://dx.doi.org/10.1038/ng1729			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16388311				2022-12-27	WOS:000234953200009
J	Skol, AD; Scott, LJ; Abecasis, GR; Boehnke, M				Skol, AD; Scott, LJ; Abecasis, GR; Boehnke, M			Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies	NATURE GENETICS			English	Article							GENE-DISEASE ASSOCIATION; POPULATIONS; DESIGNS; SAMPLE; SNPS	Genome-wide association is a promising approach to identify common genetic variants that predispose to human disease(1-4). Because of the high cost of genotyping hundreds of thousands of markers on thousands of subjects, genome-wide association studies often follow a staged design in which a proportion (pi(samples)) of the available samples are genotyped on a large number of markers in stage 1, and a proportion ( psamples) of these markers are later followed up by genotyping them on the remaining samples in stage 2. The standard strategy for analyzing such two-stage data is to view stage 2 as a replication study and focus on findings that reach statistical significance when stage 2 data are considered alone(2). We demonstrate that the alternative strategy of jointly analyzing the data from both stages almost always results in increased power to detect genetic association, despite the need to use more stringent significance levels, even when effect sizes differ between the two stages. We recommend joint analysis for all two-stage genome-wide association studies, especially when a relatively large proportion of the samples are genotyped in stage 1 (pi(samples) >= 0.30), and a relatively large proportion of markers are selected for follow-up in stage 2 (pi(markers) >= 0.01).	Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Boehnke, M (corresponding author), Univ Michigan, Dept Biostat, 1420 Washington Hts, Ann Arbor, MI 48109 USA.	boehnke@umich.edu	Abecasis, Goncalo R/B-7840-2010	Abecasis, Goncalo/0000-0003-1509-1825				Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hinds DA, 2004, AM J HUM GENET, V74, P317, DOI 10.1086/381716; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Ke XY, 2003, BIOINFORMATICS, V19, P287, DOI 10.1093/bioinformatics/19.2.287; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Ripatti S, 2001, GENET EPIDEMIOL, V21, pS409, DOI 10.1002/gepi.2001.21.s1.s409; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Satagopan JM, 2002, BIOMETRICS, V58, P163, DOI 10.1111/j.0006-341X.2002.00163.x; Satagopan JM, 2004, BIOMETRICS, V60, P589, DOI 10.1111/j.0006-341X.2004.00207.x; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Shmulewitz D, 2004, HUM HERED, V58, P145, DOI 10.1159/000083541; Stram DO, 2003, HUM HERED, V55, P27, DOI 10.1159/000071807; Thomas D, 2004, GENET EPIDEMIOL, V27, P401, DOI 10.1002/gepi.20047; Yang BZ, 2005, GENET EPIDEMIOL, V28, P302, DOI 10.1002/gepi.20070	21	1014	1033	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					209	213		10.1038/ng1706	http://dx.doi.org/10.1038/ng1706			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16415888				2022-12-27	WOS:000234953200016
J	Helgadottir, A; Manolescu, A; Helgason, A; Thorleifsson, G; Thorsteinsdottir, U; Gudbjartsson, DF; Gretarsdottir, S; Magnusson, KP; Gudmundsson, G; Hicks, A; Jonsson, T; Grant, SFA; Sainz, J; O'Brien, SJ; Sveinbjornsdottir, S; Valdimarsson, EM; Matthiasson, SE; Levey, AI; Abramson, JL; Reilly, MP; Vaccarino, V; Wolfe, ML; Gudnason, V; Quyyumi, AA; Topol, EJ; Rader, DJ; Thorgeirsson, G; Gulcher, JR; Hakonarson, H; Kong, A; Stefansson, K				Helgadottir, A; Manolescu, A; Helgason, A; Thorleifsson, G; Thorsteinsdottir, U; Gudbjartsson, DF; Gretarsdottir, S; Magnusson, KP; Gudmundsson, G; Hicks, A; Jonsson, T; Grant, SFA; Sainz, J; O'Brien, SJ; Sveinbjornsdottir, S; Valdimarsson, EM; Matthiasson, SE; Levey, AI; Abramson, JL; Reilly, MP; Vaccarino, V; Wolfe, ML; Gudnason, V; Quyyumi, AA; Topol, EJ; Rader, DJ; Thorgeirsson, G; Gulcher, JR; Hakonarson, H; Kong, A; Stefansson, K			A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction	NATURE GENETICS			English	Article							POPULATION-STRUCTURE; ADMIXTURE; 5-LIPOXYGENASE; MYELOPEROXIDASE; INFERENCE	Variants of the gene ALOX5AP ( also known as FLAP) encoding arachidonate 5-lipoxygenase activating protein are known to be associated with risk of myocardial infarction(1). Here we show that a haplotype (HapK) spanning the LTA4H gene encoding leukotriene A4 hydrolase, a protein in the same biochemical pathway as ALOX5AP, confers modest risk of myocardial infarction in an Icelandic cohort. Measurements of leukotriene B4 (LTB4) production suggest that this risk is mediated through upregulation of the leukotriene pathway. Three cohorts from the United States also show that HapK confers a modest relative risk (1.16) in European Americans, but it confers a threefold larger risk in African Americans. About 27% of the European American controls carried at least one copy of HapK, as compared with only 6% of African American controls. Our analyses indicate that HapK is very rare in Africa and that its occurrence in African Americans is due to European admixture. Interactions with other genetic or environmental risk factors that are more common in African Americans are likely to account for the greater relative risk conferred by HapK in this group.	deCODE Genet Inc, IS-101 Reykjavik, Iceland; NCI, Lab Genom Divers, Frederick, MD 21702 USA; Natl Univ Hosp Reykjavik, Reykjavik, Iceland; Emory Univ, Sch Med, Atlanta, GA USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Iceland Heart Assoc, Reykjavik, Iceland; Cleveland Clin Fdn, Cleveland, OH 44195 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Landspitali National University Hospital; Emory University; University of Pennsylvania; Icelandic Heart Association; Cleveland Clinic Foundation	Stefansson, K (corresponding author), deCODE Genet Inc, Sturlugata 8, IS-101 Reykjavik, Iceland.	kstefans@decode.is	Magnusson, Kristinn P Pétur/X-4907-2019; OBRIEN, STEPHEN/ABD-1346-2020; Manolescu, Andrei/G-4565-2014; Magnusson, Kristinn/A-6479-2011; Helgason, Agnar/K-1522-2015; Stefansson, Kari/AAE-7187-2019; Gudnason, Vilmundur/K-6885-2015; Gudnason, Vilmundur/AAE-7126-2019; Levey, Allan/F-2104-2011; Hicks, Andrew Anthony/E-9518-2017	Magnusson, Kristinn P Pétur/0000-0003-4528-6826; Manolescu, Andrei/0000-0002-0713-4664; Magnusson, Kristinn/0000-0003-4528-6826; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Levey, Allan/0000-0002-3153-502X; Hicks, Andrew Anthony/0000-0001-6320-0411; Gudbjartsson, Daniel/0000-0002-5222-9857; Reilly, Muredach/0000-0002-3035-9386; Topol, Eric/0000-0002-1478-4729; Helgason, Agnar/0000-0002-8545-3767; Grant, Struan/0000-0003-2025-5302; OBRIEN, STEPHEN/0000-0001-7857-0757	NCRR NIH HHS [M01-RR00039] Funding Source: Medline; NHLBI NIH HHS [P50 HL077107-01] Funding Source: Medline; NIEHS NIH HHS [U54 ES012068] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES012068] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ADAMS J, 1973, SCIENCE, V180, P1137, DOI 10.1126/science.180.4091.1137; Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P443, DOI 10.1161/hq0302.105593; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; [Anonymous], 1979, Circulation, V59, P607; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Barnholtz-Sloan JS, 2005, CANCER EPIDEM BIOMAR, V14, P1545, DOI 10.1158/1055-9965.EPI-04-0832; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Falush D, 2003, GENETICS, V164, P1567; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Jorde LB, 2004, NAT GENET, V36, pS28, DOI 10.1038/ng1435; LONG JC, 1991, GENETICS, V127, P417; MANTEL N, 1959, J NATL CANCER I, V22, P719; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Reiner AP, 2005, AM J HUM GENET, V76, P463, DOI 10.1086/428654; Royal CDM, 2004, NAT GENET, V36, pS5, DOI 10.1038/ng1454; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Tang H, 2005, AM J HUM GENET, V76, P268, DOI 10.1086/427888; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096	30	285	301	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					68	74		10.1038/ng1692	http://dx.doi.org/10.1038/ng1692			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16282974				2022-12-27	WOS:000234227200019
J	Hinds, DA; Kloek, AP; Jen, M; Chen, XY; Frazer, KA				Hinds, DA; Kloek, AP; Jen, M; Chen, XY; Frazer, KA			Common deletions and SNPs are in linkage disequilibrium in the human genome	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; SEGMENTAL DUPLICATIONS; CANDIDATE GENES; DISEASE; IDENTIFICATION; ARRANGEMENT; RESOLUTION; DISORDERS; PATTERNS	Humans show great variation in phenotypic traits such as height, eye color and susceptibility to disease. Genomic DNA sequence differences among individuals are responsible for the inherited components of these complex traits. Reports suggest that intermediate and large-scale DNA copy number and structural variations are prevalent enough to be an important source of genetic variation between individuals(1-8). Because association studies to identify genomic loci associated with particular phenotypic traits have focused primarily on genotyping SNPs, it is important to determine whether common structural polymorphisms are in linkage disequilibrium with common SNPs, and thus can be assessed indirectly in SNP-based studies. Here we examine 100 deletion polymorphisms ranging from 70 bp to 7 kb. We show that common deletions and SNPs ascertained with similar criteria have essentially the same distribution of linkage disequilibrium with surrounding SNPs, indicating that these polymorphisms may share evolutionary history and that most deletion polymorphisms are effectively assayed by proxy in SNP-based association studies.	Perlegen Sci Inc, Mountain View, CA 94043 USA		Frazer, KA (corresponding author), Perlegen Sci Inc, 2021 Stierlin Court, Mountain View, CA 94043 USA.	kelly_frazer@perlegen.com	Jen, Min-Hua/AAP-4200-2021; Pillay, Nischalan/F-9536-2012	Hinds, David/0000-0002-4911-803X; Frazer, Kelly/0000-0002-6060-8902				Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bhangale TR, 2005, HUM MOL GENET, V14, P59, DOI 10.1093/hmg/ddi006; BURN J, 1995, DEVELOPMENTAL MECHANISMS OF HEART DISEASE, P559; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; CONRAD DF, 2005, NAT GENET       1204; Dhami P, 2005, AM J HUM GENET, V76, P750, DOI 10.1086/429588; duMontcel ST, 1996, J MED GENET, V33, P719, DOI 10.1136/jmg.33.8.719; Frazer KA, 2003, GENOME RES, V13, P341, DOI 10.1101/gr.554603; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Goodship J, 1998, ARCH DIS CHILD, V79, P348, DOI 10.1136/adc.79.4.348; GREEN JE, 1990, AIDS RES HUM RETROV, V6, P85; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HIGGS DR, 1980, NATURE, V284, P632, DOI 10.1038/284632a0; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; LAUER J, 1980, CELL, V20, P119, DOI 10.1016/0092-8674(80)90240-8; Liling J, 1999, J MED GENET, V36, P794, DOI 10.1136/jmg.36.10.794; MCCARROLL SA, 2005, NAT GENET       1204; Nelis E, 1996, EUR J HUM GENET, V4, P25; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Weir BS., 1996, GENETIC DATA ANAL	30	293	306	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					82	85		10.1038/ng1695	http://dx.doi.org/10.1038/ng1695			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16327809				2022-12-27	WOS:000234227200021
J	Ross, AJ; May-Simera, H; Eichers, ER; Kai, M; Hill, J; Jagger, DJ; Leitch, CC; Chapple, JP; Munro, PM; Fisher, S; Tan, PL; Phillips, HM; Leroux, MR; Henderson, DJ; Murdoch, JN; Copp, AJ; Eliot, MM; Lupski, JR; Kemp, DT; Dollfus, H; Tada, M; Katsanis, N; Forge, A; Beales, PL				Ross, AJ; May-Simera, H; Eichers, ER; Kai, M; Hill, J; Jagger, DJ; Leitch, CC; Chapple, JP; Munro, PM; Fisher, S; Tan, PL; Phillips, HM; Leroux, MR; Henderson, DJ; Murdoch, JN; Copp, AJ; Eliot, MM; Lupski, JR; Kemp, DT; Dollfus, H; Tada, M; Katsanis, N; Forge, A; Beales, PL			Disruption of Bardet-Biedl syndrome ciliary proteins perturbs planar cell polarity in vertebrates	NATURE GENETICS			English	Article							NEURAL-TUBE DEFECTS; EAR HAIR-CELLS; GENE; ZEBRAFISH; MOUSE; MICE; MOVEMENTS; IDENTIFICATION; GASTRULATION; STRABISMUS	The evolutionarily conserved planar cell polarity (PCP) pathway (or noncanonical Wnt pathway) drives several important cellular processes, including epithelial cell polarization, cell migration and mitotic spindle orientation(1). In vertebrates, PCP genes have a vital role in polarized convergent extension movements during gastrulation and neurulation(2). Here we show that mice with mutations in genes involved in Bardet-Biedl syndrome (BBS), a disorder associated with ciliary dysfunction(3,4), share phenotypes with PCP mutants including open eyelids, neural tube defects and disrupted cochlear stereociliary bundles. Furthermore, we identify genetic interactions between BBS genes and a PCP gene in both mouse (Ltap, also called Vangl2) and zebrafish (vangl2). In zebrafish, the augmented phenotype results from enhanced defective convergent extension movements. We also show that Vangl2 localizes to the basal body and axoneme of ciliated cells, a pattern reminiscent of that of the BBS proteins. These data suggest that cilia are intrinsically involved in PCP processes.	UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; UCL, Ear Inst, Ctr Auditory Res, London WC1E 6BT, England; Johns Hopkins Univ, Wilmer Eye Inst, Inst Med Genet, Baltimore, MD 21287 USA; UCL, Inst Ophthalmol, London EC1V 9EL, England; Univ Newcastle Upon Tyne, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; MRC Mammalian Genet Unit, Harwell, Berks, England; UCL, Inst Child Hlth, Neural Dev Unit, London WC1N 1EH, England; Hop Univ Strasbourg, Serv ORL, Strasbourg, France; Hop Univ Strasbourg, Serv Genet Med, Strasbourg, France; Univ Strasbourg 1, Fac Med, Med Genet Lab, Strasbourg, France	University of London; University College London; Baylor College of Medicine; University of London; University College London; University of London; University College London; Johns Hopkins University; Johns Hopkins Medicine; University of London; University College London; Newcastle University - UK; Simon Fraser University; MRC Harwell; University of London; University College London; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Beales, PL (corresponding author), UCL, Inst Child Hlth, Mol Med Unit, 30 Guilford St, London WC1N 1EH, England.	p.beales@ucl.ac.uk	Beales, Philip L/C-7367-2009; Tada, Masazumi/A-1431-2009	Forge, Andrew/0000-0002-0995-0219; Katsanis, Nicholas/0000-0002-2480-0171; Henderson, Deborah/0000-0002-2705-5998; Dollfus, Helene/0000-0002-2249-895X; Chapple, Paul/0000-0003-1876-1505; Johnson, Colin/0000-0002-2979-8234; Copp, Andrew/0000-0002-2544-9117; Phillips, Helen Margaret/0000-0003-4513-9148; Jagger, Daniel/0000-0003-2796-5526; May-Simera, Helen/0000-0002-9477-4036	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Beales PL, 1999, J MED GENET, V36, P437; Beales PL, 2005, CURR OPIN GENET DEV, V15, P315, DOI 10.1016/j.gde.2005.04.006; Bingham S, 2002, DEV BIOL, V242, P149, DOI 10.1006/dbio.2001.0532; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Carreira-Barbosa F, 2003, DEVELOPMENT, V130, P4037, DOI 10.1242/dev.00567; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Denman-Johnson K, 1999, J NEUROCYTOL, V28, P821, DOI 10.1023/A:1007061819934; Fath MA, 2005, HUM MOL GENET, V14, P1109, DOI 10.1093/hmg/ddi123; Frolenkov GI, 2004, NAT REV GENET, V5, P489, DOI 10.1038/nrg1377; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Karmous-Benailly H, 2005, AM J HUM GENET, V76, P493, DOI 10.1086/428679; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; KEMP DT, 1986, HEARING RES, V22, P95, DOI 10.1016/0378-5955(86)90087-0; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Morrell CH, 1996, J ACOUST SOC AM, V100, P1949, DOI 10.1121/1.417906; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423	30	447	455	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2005	37	10					1135	1140		10.1038/ng1644	http://dx.doi.org/10.1038/ng1644			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16170314				2022-12-27	WOS:000232185600028
J	Tischfield, MA; Bosley, TM; Salih, MAM; Alorainy, IA; Sener, EC; Nester, MJ; Oystreck, DT; Chan, WM; Andrews, C; Erickson, RP; Engle, EC				Tischfield, MA; Bosley, TM; Salih, MAM; Alorainy, IA; Sener, EC; Nester, MJ; Oystreck, DT; Chan, WM; Andrews, C; Erickson, RP; Engle, EC			Homozygous HOXA1 mutations disrupt human brainstem, inner ear, cardiovascular and cognitive development	NATURE GENETICS			English	Article							CRANIAL NERVES; MUTANT MICE; EXPRESSION; HINDBRAIN; DEFECTS; HOX-1.6; AUTISM; HOXB1; GENES; CELLS	We identified homozygous truncating mutations in HOXA1 in three genetically isolated human populations. The resulting phenotype includes horizontal gaze abnormalities, deafness, facial weakness, hypoventilation, vascular malformations of the internal carotid arteries and cardiac outflow tract, mental retardation and autism spectrum disorder. This is the first report to our knowledge of viable homozygous truncating mutations in any human HOX gene and of a mendelian disorder resulting from mutations in a human HOX gene critical for development of the central nervous system.	Childrens Hosp, Dept Med, Program Genom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Div Med Sci, Program Neurosci, Boston, MA USA; King Khalid Eye Specialist Hosp, Neuroophthalmol Div, Riyadh 11462, Saudi Arabia; King Faisal Specialist Hosp & Res Ctr, Dept Neurosci, Riyadh 11211, Saudi Arabia; King Khalid Univ Hosp, Coll Med, Dept Pediat, Div Pediat Neurol, Riyadh 11472, Saudi Arabia; King Saud Univ, Coll Med, Dept Radiol & Diagnost Imaging, Riyadh 11461, Saudi Arabia; Hacettepe Univ Hosp, Dept Ophthalmol, Ankara, Turkey; Univ Arizona, Coll Med, Dept Pediat Mol & Cellular Biol, Tucson, AZ USA; Harvard Univ, Sch Med, Childrens Hosp, Dept Neurol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; King Khaled Eye Specialist Hospital; King Faisal Specialist Hospital & Research Center; King Saud University; King Khalid University Hospital; King Saud University; Hacettepe University; University of Arizona; Harvard University; Boston Children's Hospital; Harvard Medical School	Engle, EC (corresponding author), Childrens Hosp, Dept Med, Program Genom, Boston, MA 02115 USA.	engle@enders.tch.harvard.edu	Oystreck, Darren T/Q-6135-2017; Salih, Mustafa/C-1222-2014	Oystreck, Darren T/0000-0001-6974-1091; Salih, Mustafa/0000-0002-4379-2111	NEI NIH HHS [R01 EY015298] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY015298] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		CHARIOT A, 1995, BIOCHEM BIOPH RES CO, V215, P713, DOI 10.1006/bbrc.1995.2522; CHISAKA O, 1992, NATURE, V355, P516, DOI 10.1038/355516a0; del Toro ED, 2001, J NEUROSCI, V21, P5637, DOI 10.1523/JNEUROSCI.21-15-05637.2001; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Gavalas A, 1998, DEVELOPMENT, V125, P1123; Goodman FR, 2002, AM J MED GENET, V112, P256, DOI 10.1002/ajmg.10776; Holve S, 2003, AM J MED GENET A, V120A, P169, DOI 10.1002/ajmg.a.20087; Ingram JL, 2000, TERATOLOGY, V62, P393, DOI 10.1002/1096-9926(200012)62:6<393::AID-TERA6>3.3.CO;2-M; LUFKIN T, 1991, CELL, V66, P1105, DOI 10.1016/0092-8674(91)90034-V; MARK M, 1993, DEVELOPMENT, V119, P319; McClintock JM, 2003, DEV GENES EVOL, V213, P399, DOI 10.1007/s00427-003-0335-7; MURPHY P, 1991, DEVELOPMENT, V111, P61; Rodier PM, 1996, J COMP NEUROL, V370, P247, DOI 10.1002/(SICI)1096-9861(19960624)370:2<247::AID-CNE8>3.0.CO;2-2; Shrimpton AE, 2004, AM J HUM GENET, V75, P92, DOI 10.1086/422015; Thompson AA, 2000, NAT GENET, V26, P397, DOI 10.1038/82511	15	202	211	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1035	1037		10.1038/ng1636	http://dx.doi.org/10.1038/ng1636			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16155570				2022-12-27	WOS:000232185600011
J	Torres, MA; Jones, JDG; Dangl, JL				Torres, MA; Jones, JDG; Dangl, JL			Pathogen-induced, NADPH oxidase-derived reactive oxygen intermediates suppress spread of cell death in Arabidopsis thaliana	NATURE GENETICS			English	Article							DISEASE RESISTANCE; SALICYLIC-ACID; NITRIC-OXIDE; HYPERSENSITIVE RESPONSE; OXIDATIVE STRESS; PLANT; TOBACCO; GENE; LSD1; LOCALIZATION	Plant immune responses are usually accompanied by the production of extracellular superoxide at and surrounding infection sites(1-3). Extracellular reactive oxygen intermediates (ROIs) in plants were proposed to drive programmed cell death correlated with disease resistance (the hypersensitive response). ROIs derived from this oxidative burst are generated by plasma membrane NADPH oxidases, anchored by gp91(phox) proteins related to those responsible for the respiratory oxidative burst activated in mammalian neutrophils during infection(4,5). Mutation of Arabidopsis thaliana respiratory burst oxidase (Atrboh) genes eliminated pathogen-induced ROI production but had only a modest effect on the hypersensitive response(4). We show that Atrboh function can be activated by exogenous ROIs. Unexpectedly, the subsequent oxidative burst can suppress cell death in cells surrounding sites of NADPH oxidase activation. This cell death requires salicylic acid, a plant immune system activator(6). Thus, ROIs generated by Atrboh proteins can antagonize salicylic acid-dependent pro-death signals. These results have implications for understanding how salicylic acid activates defense signaling in cells spatially removed from infection sites without causing cell death.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Univ N Carolina, Dept Microbiol & Immunol, Curriculum Genet, Chapel Hill, NC 27599 USA; Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dangl, JL (corresponding author), Univ N Carolina, Dept Biol, CB 3280,Coker Hall,Room 108, Chapel Hill, NC 27599 USA.	dangl@email.unc.edu	Lacruz, Miguel Angel Torres/H-6969-2015; Jones, Jonathan DG/J-5129-2012	Lacruz, Miguel Angel Torres/0000-0002-0435-1786; Jones, Jonathan DG/0000-0002-4953-261X				Allan AC, 1997, PLANT CELL, V9, P1559, DOI 10.1105/tpc.9.9.1559; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; AUH CK, 1995, PLANT PHYSIOL, V107, P1241, DOI 10.1104/pp.107.4.1241; Aviv DH, 2002, PLANT J, V29, P381, DOI 10.1046/j.0960-7412.2001.01225.x; Bestwick CS, 1997, PLANT CELL, V9, P209, DOI 10.1105/tpc.9.2.209; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Delledonne M, 2001, P NATL ACAD SCI USA, V98, P13454, DOI 10.1073/pnas.231178298; Dietrich RA, 1997, CELL, V88, P685, DOI 10.1016/S0092-8674(00)81911-X; DOKE N, 1983, PHYSIOL PLANT PATHOL, V23, P345, DOI 10.1016/0048-4059(83)90019-X; Dorey S, 1997, MOL PLANT MICROBE IN, V10, P646, DOI 10.1094/MPMI.1997.10.5.646; Draper J, 1997, TRENDS PLANT SCI, V2, P162, DOI 10.1016/S1360-1385(97)01030-3; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; ENYEDI AJ, 1992, P NATL ACAD SCI USA, V89, P2480, DOI 10.1073/pnas.89.6.2480; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Kliebenstein DJ, 1999, MOL PLANT MICROBE IN, V12, P1022, DOI 10.1094/MPMI.1999.12.11.1022; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Levine A, 1996, CURR BIOL, V6, P427, DOI 10.1016/S0960-9822(02)00510-9; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Rusterucci C, 2001, PLANT CELL, V13, P2211, DOI 10.1105/tpc.13.10.2211; Shirasu K, 1997, PLANT CELL, V9, P261, DOI 10.1105/tpc.9.2.261; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Torres MA, 2002, P NATL ACAD SCI USA, V99, P517, DOI 10.1073/pnas.012452499; Wendehenne D, 2004, CURR OPIN PLANT BIOL, V7, P449, DOI 10.1016/j.pbi.2004.04.002; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108	30	431	445	5	83	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1130	1134		10.1038/ng1639	http://dx.doi.org/10.1038/ng1639			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16170317				2022-12-27	WOS:000232185600027
J	Bentwich, I; Avniel, A; Karov, Y; Aharonov, R; Gilad, S; Barad, O; Barzilai, A; Einat, P; Einav, U; Meiri, E; Sharon, E; Spector, Y; Bentwich, Z				Bentwich, I; Avniel, A; Karov, Y; Aharonov, R; Gilad, S; Barad, O; Barzilai, A; Einat, P; Einav, U; Meiri, E; Sharon, E; Spector, Y; Bentwich, Z			Identification of hundreds of conserved and nonconserved human microRNAs	NATURE GENETICS			English	Article							CAENORHABDITIS-ELEGANS; GENES; RNAS	MicroRNAs are noncoding RNAs of similar to 22 nucleotides that suppress translation of target genes by binding to their mRNA and thus have a central role in gene regulation in health and disease(1-5). To date, 222 human microRNAs have been identified(6), 86 by random cloning and sequencing, 43 by computational approaches and the rest as putative microRNAs homologous to microRNAs in other species. To prove our hypothesis that the total number of microRNAs may be much larger and that several have emerged only in primates, we developed an integrative approach combining bioinformatic predictions with microarray analysis and sequence- directed cloning. Here we report the use of this approach to clone and sequence 89 new human microRNAs ( nearly doubling the current number of sequenced human microRNAs), 53 of which are not conserved beyond primates. These findings suggest that the total number of human microRNAs is at least 800.	Rosetta Genom, IL-76706 Rehovot, Israel		Bentwich, Z (corresponding author), Rosetta Genom, 10 Plaut St, IL-76706 Rehovot, Israel.	bentwich@rosettagenomics.com	Huang, H/E-9490-2010	Sharon, Eilon/0000-0002-1262-350X				Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, FASEB J, V19, P875, DOI 10.1096/fj.04-3609hyp; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Siepel A, 2004, J COMPUT BIOL, V11, P413, DOI 10.1089/1066527041410472; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441	17	1448	1700	0	79	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					766	770		10.1038/ng1590	http://dx.doi.org/10.1038/ng1590			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15965474				2022-12-27	WOS:000230196400026
J	Wang, XS; Ria, M; Kelmenson, PM; Eriksson, P; Higgins, DC; Samnegard, C; Petros, C; Rollins, J; Bennet, AM; Wiman, B; de Faire, U; Wennberg, C; Olsson, PG; Ishii, N; Sugamura, K; Hamsten, A; Forsman-Semb, K; Lagercrantz, J; Paigen, B				Wang, XS; Ria, M; Kelmenson, PM; Eriksson, P; Higgins, DC; Samnegard, C; Petros, C; Rollins, J; Bennet, AM; Wiman, B; de Faire, U; Wennberg, C; Olsson, PG; Ishii, N; Sugamura, K; Hamsten, A; Forsman-Semb, K; Lagercrantz, J; Paigen, B			Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility	NATURE GENETICS			English	Article							MYOCARDIAL-INFARCTION; STRAINS C57BL/6J; FAS LIGAND; CELLS; MICE; LESIONS; ATH-1; OVEREXPRESSION; ATHEROGENESIS; LYMPHOCYTES	Ath1 is a quantitative trait locus on mouse chromosome 1 that renders C57BL/6 mice susceptible and C3H/He mice resistant to diet-induced atherosclerosis. The quantitative trait locus region encompasses 11 known genes, including Tnfsf4 ( also called Ox40l or Cd134l), which encodes OX40 ligand. Here we report that mice with targeted mutations of Tnfsf4 had significantly ( P <= 0.05) smaller atherosclerotic lesions than did control mice. In addition, mice overexpressing Tnfsf4 had significantly ( P <= 0.05) larger atherosclerotic lesions than did control mice. In two independent human populations, the less common allele of SNP rs3850641 in TNFSF4 was significantly more frequent ( P <= 0.05) in individuals with myocardial infarction than in controls. We therefore conclude that Tnfsf4 underlies Ath1 in mice and that polymorphisms in its human homolog TNFSF4 increase the risk of myocardial infarction in humans.	Jackson Lab, Bar Harbor, ME 04609 USA; Karolinska Hosp, King Gustaf V Res Inst, Atherosclerosis Res Unit, Dept Med,Karolinska Inst, S-10401 Stockholm, Sweden; Karolinska Hosp, Div Cardiovasc Epidemiol, Inst Environm Med, Karolinska Inst, S-10401 Stockholm, Sweden; Karolinska Hosp, Div Clin Chem & Blood Coagulat, Dept Surg Sci, Karolinska Inst, S-10401 Stockholm, Sweden; Karolinska Hosp, Karolinska Inst, Dept Cardiol, S-10401 Stockholm, Sweden; AstraZeneca R&D, Molndal, Sweden; Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 980, Japan	Jackson Laboratory; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; AstraZeneca; Tohoku University	Wang, XS (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	xw@jax.org	Rollins, Jarod/B-4076-2009	Rollins, Jarod/0000-0002-6279-7831; Eriksson, Per/0000-0002-5635-2692; Bennet-Bark, Anna/0000-0003-2704-2625; Ishii, Naoto/0000-0002-0549-8245				Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Aprahamian T, 2004, J EXP MED, V199, P1121, DOI 10.1084/jem.20031557; Austen W G, 1975, Circulation, V51, P5; Boquist S, 1999, CIRCULATION, V100, P723, DOI 10.1161/01.CIR.100.7.723; Caligiuri G, 2002, J CLIN INVEST, V109, P745, DOI 10.1172/JCI200207272; Dansky HM, 1997, P NATL ACAD SCI USA, V94, P4642, DOI 10.1073/pnas.94.9.4642; Edfeldt K, 2004, EUR HEART J, V25, P1447, DOI 10.1016/j.ehj.2004.05.004; Emeson EE, 1996, AM J PATHOL, V149, P675; Eriksson P, 2004, ARTERIOSCL THROM VAS, V24, P551, DOI 10.1161/01.ATV.0000117180.57731.36; Geng Y J, 2001, Curr Atheroscler Rep, V3, P234, DOI 10.1007/s11883-001-0066-z; Geng YH, 2002, ARTERIOSCL THROM VAS, V22, P1370, DOI 10.1161/01.ATV.0000031341.84618.A4; Hauser ER, 2004, AM J HUM GENET, V75, P436, DOI 10.1086/423900; Kawai T, 1999, J IMMUNOL, V163, P3269; Kotani A, 2002, IMMUNOL LETT, V84, P1, DOI 10.1016/S0165-2478(02)00082-2; Major AS, 2002, ARTERIOSCL THROM VAS, V22, P1892, DOI 10.1161/01.ATV.0000039169.47943.EE; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Murata K, 2000, J EXP MED, V191, P365, DOI 10.1084/jem.191.2.365; Nakai Y, 2004, BLOOD, V104, P2051, DOI 10.1182/blood-2003-10-3485; NISHINA PM, 1990, J LIPID RES, V31, P859; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; PAIGEN B, 1987, ATHEROSCLEROSIS, V64, P215, DOI 10.1016/0021-9150(87)90249-8; PAIGEN B, 1987, BIOCHEM GENET, V25, P501, DOI 10.1007/BF00554352; PAIGEN B, 1987, P NATL ACAD SCI USA, V84, P3763, DOI 10.1073/pnas.84.11.3763; PAIGEN B, 1987, BIOCHEM GENET, V25, P881, DOI 10.1007/BF00502607; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P65, DOI 10.1016/0021-9150(85)90138-8; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Phelan SA, 2003, FREE RADICAL BIO MED, V35, P1110, DOI 10.1016/S0891-5849(03)00462-3; Phelan SA, 2002, MAMM GENOME, V13, P548, DOI 10.1007/s00335-002-2196-1; Reardon CA, 2001, ARTERIOSCL THROM VAS, V21, P1011, DOI 10.1161/01.ATV.21.6.1011; Reuterwall C, 1999, J INTERN MED, V246, P161, DOI 10.1046/j.1365-2796.1999.00554.x; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Schneider DB, 2000, ARTERIOSCL THROM VAS, V20, P298, DOI 10.1161/01.ATV.20.2.298; Shi WB, 2003, ARTERIOSCL THROM VAS, V23, P1901, DOI 10.1161/01.ATV.0000091249.34404.B7; Song L, 2001, J CLIN INVEST, V108, P251, DOI 10.1172/JCI11380; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Sugamura K, 2004, NAT REV IMMUNOL, V4, P420, DOI 10.1038/nri1371; Wang Q, 2004, AM J HUM GENET, V74, P262, DOI 10.1086/381560; Wang XS, 2004, ATHEROSCLEROSIS, V177, P61, DOI 10.1016/j.atherosclerosis.2004.06.007; Wang XS, 2003, J BIOL CHEM, V278, P25179, DOI 10.1074/jbc.M302706200; Wang XS, 2003, GENOME RES, V13, P1654, DOI 10.1101/gr.1185803; Weinberg AD, 2002, TRENDS IMMUNOL, V23, P102, DOI 10.1016/S1471-4906(01)02127-5; Welch CL, 2001, P NATL ACAD SCI USA, V98, P7946, DOI 10.1073/pnas.141239098; Yang J, 2004, ARTERIOSCL THROM VAS, V24, P1466, DOI 10.1161/01.ATV.0000134402.94963.2f	44	221	246	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					365	372		10.1038/ng1524	http://dx.doi.org/10.1038/ng1524			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15750594				2022-12-27	WOS:000228040000019
J	Larsson, P; Oyston, PCF; Chain, P; Chu, MC; Duffield, M; Fuxelius, HH; Garcia, E; Halltorp, G; Johansson, D; Isherwood, KE; Karp, PD; Larsson, E; Liu, Y; Michell, S; Prior, J; Prior, R; Malfatti, S; Sjostedt, A; Svensson, K; Thompson, N; Vergez, L; Wagg, JK; Wren, BW; Lindler, LE; Andersson, SGE; Forsman, M; Titball, RW				Larsson, P; Oyston, PCF; Chain, P; Chu, MC; Duffield, M; Fuxelius, HH; Garcia, E; Halltorp, G; Johansson, D; Isherwood, KE; Karp, PD; Larsson, E; Liu, Y; Michell, S; Prior, J; Prior, R; Malfatti, S; Sjostedt, A; Svensson, K; Thompson, N; Vergez, L; Wagg, JK; Wren, BW; Lindler, LE; Andersson, SGE; Forsman, M; Titball, RW			The complete genome sequence of Francisella tularensis, the causative agent of tularemia	NATURE GENETICS			English	Article							INTRACELLULAR INFECTION; METABOLIC PATHWAYS; GROWTH INITIATION; VIRULENCE FACTORS; GENE; IDENTIFICATION; ESCAPE; IRON; TRANSCRIPTION; PHAGOSOME	Francisella tularensis is one of the most infectious human pathogens known. In the past, both the former Soviet Union and the US had programs to develop weapons containing the bacterium. We report the complete genome sequence of a highly virulent isolate of F. tularensis (1,892, 819 bp). The sequence uncovers previously uncharacterized genes encoding type IV pili, a surface polysaccharide and iron-acquisition systems. Several virulence-associated genes were located in a putative pathogenicity island, which was duplicated in the genome. More than 10% of the putative coding sequences contained insertion-deletion or substitution mutations and seemed to be deteriorating. The genome is rich in IS elements, including IS630 Tc-1 mariner family transposons, which are not expected in a prokaryote. We used a computational method for predicting metabolic pathways and found an unexpectedly high proportion of disrupted pathways, explaining the fastidious nutritional requirements of the bacterium. The loss of biosynthetic pathways indicates that F. tularensis is an obligate host-dependent bacterium in its natural life cycle. Our results have implications for our understanding of how highly virulent human pathogens evolve and will expedite strategies to combat them.	Lawrence Livermore Natl Lab, Biol & Biotechnol Res Program, Livermore, CA 94550 USA; Def Sci & Technol Lab, Salisbury SP4 0JQ, Wilts, England; Swedish Def Res Agcy, SE-90182 Umea, Sweden; Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO USA; Uppsala Univ, Dept Mol Evolut, S-75236 Uppsala, Sweden; SRI Int, Bioinformat Res Grp, Menlo Pk, CA 94025 USA; Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; Umea Univ, Dept Clin Microbiol, SE-90185 Umea, Sweden; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Defence Science & Technology Laboratory; Saab Group; Centers for Disease Control & Prevention - USA; Uppsala University; SRI International; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Umea University; Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine	Titball, RW (corresponding author), Lawrence Livermore Natl Lab, Biol & Biotechnol Res Program, Livermore, CA 94550 USA.	rtitball@dstl.gov.uk	Forsman, Mats/A-1426-2016; Chain, Patrick/O-4140-2019; chain, patrick/B-9777-2013; Sjöstedt, Anders/AAC-6575-2020; Karp, Peter/C-3514-2012	Forsman, Mats/0000-0002-4466-5325; Chain, Patrick/0000-0003-3949-3634; Sjöstedt, Anders/0000-0002-0768-8405; Karp, Peter/0000-0002-5876-6418; Malfatti, Stephanie/0000-0003-4225-9857				Andersson B, 1996, ANAL BIOCHEM, V236, P107, DOI 10.1006/abio.1996.0138; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; BHATNAGAR NB, 1995, INFECT IMMUN, V63, P154, DOI 10.1128/IAI.63.1.154-159.1995; BORK P, 1994, PROTEIN SCI, V3, P1344, DOI 10.1002/pro.5560030821; Canback B, 2004, MOL BIOL EVOL, V21, P1110, DOI 10.1093/molbev/msh122; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; CIANCIOTTO NP, 1990, J INFECT DIS, V162, P121, DOI 10.1093/infdis/162.1.121; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; DOAK TG, 1994, P NATL ACAD SCI USA, V91, P942, DOI 10.1073/pnas.91.3.942; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; EIGELSBACH HT, 1951, J BACTERIOL, V61, P557, DOI 10.1128/JB.61.5.557-569.1951; Ellis J, 2002, CLIN MICROBIOL REV, V15, P631, DOI 10.1128/CMR.15.4.631-646.2002; Enright AJ, 2003, NUCLEIC ACIDS RES, V31, P4632, DOI 10.1093/nar/gkg495; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FLEMING DE, 1955, J BACTERIOL, V70, P345, DOI 10.1128/JB.70.3.345-349.1955; FORSMAN M, 1994, INT J SYST BACTERIOL, V44, P38, DOI 10.1099/00207713-44-1-38; FORTIER AH, 1995, INFECT IMMUN, V63, P1478, DOI 10.1128/IAI.63.4.1478-1483.1995; Gil H, 2004, INFECT IMMUN, V72, P3042, DOI 10.1128/IAI.72.5.3042-3047.2004; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; GORDON AH, 1980, NATURE, V286, P79, DOI 10.1038/286079a0; Green ML, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-76; HALMANN M, 1967, J GEN MICROBIOL, V49, P461, DOI 10.1099/00221287-49-3-461; Hickey EK, 1997, INFECT IMMUN, V65, P133, DOI 10.1128/IAI.65.1.133-143.1997; HOOD AM, 1977, J HYG-CAMBRIDGE, V79, P47, DOI 10.1017/S0022172400052840; Houng HSH, 1998, MICROB PATHOGENESIS, V25, P165, DOI 10.1006/mpat.1998.0222; Krieger CJ, 2004, NUCLEIC ACIDS RES, V32, pD438, DOI 10.1093/nar/gkh100; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; Lindgren H, 2004, J MED MICROBIOL, V53, P953, DOI 10.1099/jmm.0.45685-0; MAGER J, 1964, NATURE, V203, P898, DOI 10.1038/203898a0; MAGER J, 1959, BIOCHIM BIOPHYS ACTA, V36, P529, DOI 10.1016/0006-3002(59)90195-7; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; NAGLE SC, 1960, J BACTERIOL, V79, P566, DOI 10.1128/JB.79.4.566-571.1960; Nano FE, 2004, J BACTERIOL, V186, P6430, DOI 10.1128/JB.186.19.6430-6436.2004; Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9; Paley SM, 2002, BIOINFORMATICS, V18, P715, DOI 10.1093/bioinformatics/18.5.715; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Romero PR, 2004, BIOINFORMATICS, V20, P709, DOI 10.1093/bioinformatics/btg471; Russell P, 1998, J ANTIMICROB CHEMOTH, V41, P461, DOI 10.1093/jac/41.4.461; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Sjostedt A, 2004, BERGEYS MANUAL SYSTE, P200; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; Thomas R, 2003, J CLIN MICROBIOL, V41, P50, DOI 10.1128/JCM.41.1.50-57.2003; TRAUB A, 1955, J BACTERIOL, V70, P60, DOI 10.1128/JB.70.1.60-69.1955; Viswanathan VK, 2000, INFECT IMMUN, V68, P1069, DOI 10.1128/IAI.68.3.1069-1079.2000	50	364	679	2	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					153	159		10.1038/ng1499	http://dx.doi.org/10.1038/ng1499			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	15640799	Bronze			2022-12-27	WOS:000226690100021
J	Stefansson, H; Helgason, A; Thorleifsson, G; Steinthorsdottir, V; Masson, G; Barnard, J; Baker, A; Jonasdottir, A; Ingason, A; Gudnadottir, VG; Desnica, N; Hicks, A; Gylfason, A; Gudbjartsson, DF; Jonsdottir, GM; Sainz, J; Agnarsson, K; Birgisdottir, B; Ghosh, S; Olafsdottir, A; Cazier, JB; Kristjansson, K; Frigge, ML; Thorgeirsson, TE; Gulcher, JR; Kong, A; Stefansson, K				Stefansson, H; Helgason, A; Thorleifsson, G; Steinthorsdottir, V; Masson, G; Barnard, J; Baker, A; Jonasdottir, A; Ingason, A; Gudnadottir, VG; Desnica, N; Hicks, A; Gylfason, A; Gudbjartsson, DF; Jonsdottir, GM; Sainz, J; Agnarsson, K; Birgisdottir, B; Ghosh, S; Olafsdottir, A; Cazier, JB; Kristjansson, K; Frigge, ML; Thorgeirsson, TE; Gulcher, JR; Kong, A; Stefansson, K			A common inversion under selection in Europeans	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; HUMAN GENOME; NUCLEOTIDE VARIABILITY; POSITIVE SELECTION; TAU HAPLOTYPE; GENE; POPULATION; POLYMORPHISMS; EVOLUTION; ASSOCIATION	A refined physical map of chromosome 17q21.31 uncovered a 900-kb inversion polymorphism. Chromosomes with the inverted segment in different orientations represent two distinct lineages, H1 and H2, that have diverged for as much as 3 million years and show no evidence of having recombined. The H2 lineage is rare in Africans, almost absent in East Asians but found at a frequency of 20% in Europeans, in whom the haplotype structure is indicative of a history of positive selection. Here we show that the H2 lineage is undergoing positive selection in the Icelandic population, such that carrier females have more children and have higher recombination rates than noncarriers.	deCODE Genet, IS-101 Reykjavik, Iceland; Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Stefansson, H (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	kari.stefansson@decode.is; kong@decode.is	Helgason, Agnar/K-1522-2015; Hicks, Andrew Anthony/E-9518-2017; Cazier, Jean-Baptiste/F-2369-2010; Stefansson, Kari/AAE-7187-2019; Cazier, Jean-Baptiste/GLR-2949-2022	Hicks, Andrew Anthony/0000-0001-6320-0411; Cazier, Jean-Baptiste/0000-0001-7581-9051; Cazier, Jean-Baptiste/0000-0001-7581-9051; Kong, Augustine/0000-0001-8193-5438; Stefansson, Hreinn/0000-0002-9331-6666; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Helgason, Agnar/0000-0002-8545-3767; Thorgeirsson, Thorgeir/0000-0002-5149-7040; Gudbjartsson, Daniel/0000-0002-5222-9857				Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Andolfatto P, 2001, GENET RES, V77, P1, DOI 10.1017/S0016672301004955; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Carroll SB, 2003, NATURE, V422, P849, DOI 10.1038/nature01495; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Conrad C, 2004, J NEUROCHEM, V89, P179, DOI 10.1046/j.1471-4159.2004.02320.x; Conrad C, 1997, ANN NEUROL, V41, P277, DOI 10.1002/ana.410410222; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Evans W, 2004, NEUROSCI LETT, V369, P183, DOI 10.1016/j.neulet.2004.05.119; Excoffier L, 2002, CURR OPIN GENET DEV, V12, P675, DOI 10.1016/S0959-437X(02)00350-7; Farrer M, 2002, NEUROSCI LETT, V322, P83, DOI 10.1016/S0304-3940(02)00106-4; Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Giglio S, 2001, AM J HUM GENET, V68, P874, DOI 10.1086/319506; Gilad Y, 2002, P NATL ACAD SCI USA, V99, P862, DOI 10.1073/pnas.022614799; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jin H, 2004, GENOMICS, V84, P1071, DOI 10.1016/j.ygeno.2004.08.019; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Kwok JBJ, 2004, ANN NEUROL, V55, P329, DOI 10.1002/ana.10826; Laval G, 2004, BIOINFORMATICS, V20, P2485, DOI 10.1093/bioinformatics/bth264; Lewin R, 2004, PRINCIPLES HUMAN EVO; Nachman MW, 2000, GENETICS, V155, P1855; Navarro A, 2000, GENETICS, V155, P685; Oliveira SA, 2004, NEUROGENETICS, V5, P147, DOI 10.1007/s10048-004-0180-5; Osier MV, 2002, AM J PHYS ANTHROPOL, V119, P77, DOI 10.1002/ajpa.10094; Pittman AM, 2004, HUM MOL GENET, V13, P1267, DOI 10.1093/hmg/ddh138; Reed DL, 2004, PLOS BIOL, V2, P1972, DOI 10.1371/journal.pbio.0020340; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schaeffer SW, 2003, P NATL ACAD SCI USA, V100, P8319, DOI 10.1073/pnas.1432900100; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Skipper L, 2004, AM J HUM GENET, V75, P669, DOI 10.1086/424492; Slatkin M, 2001, GENETICS, V158, P865; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Thompson EE, 2004, AM J HUM GENET, V75, P1059, DOI 10.1086/426406; Toomajian C, 2003, GENETICS, V165, P287	45	582	598	0	47	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2005	37	2					129	137		10.1038/ng1508	http://dx.doi.org/10.1038/ng1508			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	893AB	15654335				2022-12-27	WOS:000226690100018
J	Umlauf, D; Goto, Y; Cao, R; Cerqueira, F; Wagschal, A; Zhang, Y; Feil, R				Umlauf, D; Goto, Y; Cao, R; Cerqueira, F; Wagschal, A; Zhang, Y; Feil, R			Imprinting along the Kcnq1 domain on mouse chromosome 7 involves repressive histone methylation and recruitment of Polycomb group complexes	NATURE GENETICS			English	Article							H3 LYSINE-27 METHYLATION; DNA METHYLATION; X-INACTIVATION; GENE; CHROMOSOME; REGION; EXPRESSION; SEQUENCE; CLUSTER	Imprinted genes are clustered in domains, and their allelic repression is mediated by imprinting control regions(1-3). These imprinting control regions are marked by DNA methylation, which is essential to maintain imprinting in the embryo(4). To explore how imprinting is regulated in placenta, we studied the Kcnq1 domain on mouse distal chromosome 7. This large domain is controlled by an intronic imprinting control region(5,6) and comprises multiple genes that are imprinted in placenta, without the involvement of promoter DNA methylation(7-10). We found that the paternal repression along the domain involves acquisition of trimethylation at Lys27 and dimethylation at Lys9 of histone H3. Eed-Ezh2 Polycomb complexes are recruited to the paternal chromosome and potentially regulate its repressive histone methylation. Studies on embryonic stem cells and early embryos support our proposal that chromatin repression is established early in development and is maintained in the placenta. In the embryo, however, imprinting is stably maintained only at genes that have promoter DNA methylation. These data underscore the importance of histone methylation in placental imprinting and identify mechanistic similarities with X-chromosome inactivation in extraembryonic tissues, suggesting that the two epigenetic mechanisms are evolutionarily linked.	Inst Mol Genet, CNRS, UMR 5535, F-34090 Montpellier, France; Univ Montpellier 2, F-34090 Montpellier, France; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; University of North Carolina; University of North Carolina Chapel Hill	Feil, R (corresponding author), Inst Mol Genet, CNRS, UMR 5535, 1919 Route de Mende, F-34090 Montpellier, France.	robert.feil@igmm.cnrs.fr	Feil, Robert P/D-2087-2013	Feil, Robert P/0000-0002-5671-5860; Zhang, Yi/0000-0002-2789-0811				Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Caspary T, 1998, MOL CELL BIOL, V18, P3466, DOI 10.1128/MCB.18.6.3466; Dean W, 1998, DEVELOPMENT, V125, P2273; Delaval K, 2004, CURR OPIN GENET DEV, V14, P188, DOI 10.1016/j.gde.2004.01.005; Engemann S, 2000, HUM MOL GENET, V9, P2691, DOI 10.1093/hmg/9.18.2691; Erhardt S, 2003, DEVELOPMENT, V130, P4235, DOI 10.1242/dev.00625; Ferguson-Smith AC, 2001, SCIENCE, V293, P1086, DOI 10.1126/science.1064020; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Fournier C, 2002, EMBO J, V21, P6560, DOI 10.1093/emboj/cdf655; Higashimoto K, 2002, GENOMICS, V80, P575, DOI 10.1006/geno.2002.7006; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Mager J, 2003, NAT GENET, V33, P502, DOI 10.1038/ng1125; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Mancini-DiNardo D, 2003, HUM MOL GENET, V12, P283, DOI 10.1093/hmg/ddg024; Mann MRW, 2004, DEVELOPMENT, V131, P3727, DOI 10.1242/dev.01241; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Paulsen M, 2000, HUM MOL GENET, V9, P1829, DOI 10.1093/hmg/9.12.1829; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Sleutels F, 2000, CURR OPIN GENET DEV, V10, P229, DOI 10.1016/S0959-437X(00)00062-9; Tanaka M, 1999, MECH DEVELOP, V87, P129, DOI 10.1016/S0925-4773(99)00158-6; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; Yatsuki H, 2002, GENOME RES, V12, P1860, DOI 10.1101/gr.110702; Zwart R, 2001, GENE DEV, V15, P2361, DOI 10.1101/gad.206201	30	339	357	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2004	36	12					1296	1300		10.1038/ng1467	http://dx.doi.org/10.1038/ng1467			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15516932				2022-12-27	WOS:000225354100017
J	Gerull, B; Heuser, A; Wichter, T; Paul, M; Basson, CT; McDermott, DA; Lerman, BB; Markowitz, SM; Ellinor, PT; MacRae, CA; Peters, S; Grossmann, KS; Michely, B; Sasse-Klaassen, S; Birchmeier, W; Dietz, R; Breithardt, G; Schulze-Bahr, E; Thierfelder, L				Gerull, B; Heuser, A; Wichter, T; Paul, M; Basson, CT; McDermott, DA; Lerman, BB; Markowitz, SM; Ellinor, PT; MacRae, CA; Peters, S; Grossmann, KS; Michely, B; Sasse-Klaassen, S; Birchmeier, W; Dietz, R; Breithardt, G; Schulze-Bahr, E; Thierfelder, L			Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy	NATURE GENETICS			English	Article							DYSPLASIA	Arrhythmogenic right ventricular cardiomyopathy (ARVC) is associated with fibrofatty replacement of cardiac myocytes, ventricular tachyarrhythmias and sudden cardiac death. In 32 of 120 unrelated individuals with ARVC, we identified heterozygous mutations in PKP2, which encodes plakophilin-2, an essential armadillo-repeat protein of the cardiac desmosome. In two kindreds with ARVC, disease was incompletely penetrant in most carriers of PKP2 mutations.	Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Humboldt Univ, Dept Clin & Mol Cardiol, Franz Volhard Clin, HELIOS Clin GmbH,Charite, D-13125 Berlin, Germany; Univ Hosp Munster, Dept Cardiol & Angiol, D-48149 Munster, Germany; Univ Munster, Inst Arteriosclerosis Res, D-48149 Munster, Germany; Cornell Univ, Greenberg Cardiol Div, Dept Med, Weill Med Coll, New York, NY 10021 USA; Massachusetts Gen Hosp, Cardiac Arrhythmia Serv, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; Klinikum Quedlinburg, Dept Cardiol, D-06484 Quedlinburg, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster; University of Munster; Cornell University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Thierfelder, L (corresponding author), Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany.	lthier@mdc-berlin.de		Heuser, Arnd/0000-0002-3334-960X; Ellinor, Patrick/0000-0002-2067-0533; Drenckhahn, Jorg-Detlef/0000-0001-8347-7696	NHLBI NIH HHS [R01 HL075431] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075431] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chen XY, 2002, J BIOL CHEM, V277, P10512, DOI 10.1074/jbc.M108765200; Fontaine G, 1999, ANNU REV MED, V50, P17, DOI 10.1146/annurev.med.50.1.17; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; GROSSMANN K, IN PRESS J CELL BIOL; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Ko KS, 2001, J BIOL CHEM, V276, P35967, DOI 10.1074/jbc.M104106200; MARCUS FI, 1982, CIRCULATION, V65, P384, DOI 10.1161/01.CIR.65.2.384; McGrath JA, 1997, NAT GENET, V17, P240, DOI 10.1038/ng1097-240; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; Mertens C, 2001, P NATL ACAD SCI USA, V98, P7795, DOI 10.1073/pnas.141219498; Mertens C, 1996, J CELL BIOL, V135, P1009, DOI 10.1083/jcb.135.4.1009; Paul M, 2003, Z KARDIOL, V92, P128, DOI 10.1007/s00392-003-0892-9; Rampazzo A, 1997, GENOMICS, V45, P259, DOI 10.1006/geno.1997.4927; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301	15	573	596	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1162	1164		10.1038/ng1461	http://dx.doi.org/10.1038/ng1461			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15489853	Bronze			2022-12-27	WOS:000224832800018
J	Hanks, S; Coleman, K; Reid, S; Plaja, A; Firth, H; FitzPatrick, D; Kidd, A; Mehes, K; Nash, R; Robin, N; Shannon, N; Tolmie, J; Swansbury, J; Irrthum, A; Douglas, J; Rahman, N				Hanks, S; Coleman, K; Reid, S; Plaja, A; Firth, H; FitzPatrick, D; Kidd, A; Mehes, K; Nash, R; Robin, N; Shannon, N; Tolmie, J; Swansbury, J; Irrthum, A; Douglas, J; Rahman, N			Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B	NATURE GENETICS			English	Article							MOSAIC VARIEGATED ANEUPLOIDY; MITOTIC CHECKPOINT GENES; BUBR1	Mosaic variegated aneuploidy is a rare recessive condition characterized by growth retardation, microcephaly, childhood cancer and constitutional mosaicism for chromosomal gains and losses. In five families with mosaic variegated aneuploidy, including two with embryonal rhabdomyosarcoma, we identified truncating and missense mutations of BUB1B, which encodes BUBR1, a key protein in the mitotic spindle checkpoint. These data are the first to relate germline mutations in a spindle checkpoint gene with a human disorder and strongly support a causal link between aneuploidy and cancer development.	Inst Canc Res, Sect Canc Genet, Surrey, England; Hosp Materno Infantil Vall dHebron, Unitat Genet, Barcelona, Spain; Addenbrookes Hosp, Dept Med Genet, Cambridge, England; Wellington Hosp, Cent Reg Genet Serv, Wellington, New Zealand; MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; Univ Pecs, Dept Med Genet & Child Dev, Pecs, Hungary; Case Western Reserve Univ, Dept Human Genet, Cleveland, OH 44106 USA; Birmingham Womens Hosp, W Midland Reg Genet Serv, Birmingham, W Midlands, England; Inst Med Genet, Glasgow, Lanark, Scotland; Inst Canc Res, Sect Haematooncol, Surrey, England	University of London; Institute of Cancer Research - UK; Hospital Universitari Vall d'Hebron; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Edinburgh; University of Pecs; Case Western Reserve University; Birmingham Women's Hospital; University of Glasgow; University of London; Institute of Cancer Research - UK	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, Surrey, England.	nazneen.rahman@icr.ac.uk	FitzPatrick, David R/C-7301-2013; Rahman, Nazneen/B-8890-2012; FitzPatrick, David R/B-8311-2008; Rahman, Nazneen/D-2802-2013	Rahman, Nazneen/0000-0003-4376-0440; FitzPatrick, David R./0000-0003-4861-969X				Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Dai W, 2004, CANCER RES, V64, P440, DOI 10.1158/0008-5472.CAN-03-3119; Draviam VM, 2004, CURR OPIN GENET DEV, V14, P120, DOI 10.1016/j.gde.2004.02.007; Jacquemont S, 2002, AM J MED GENET, V109, P17, DOI 10.1002/ajmg.10281; Kajii T, 2001, AM J MED GENET, V104, P57, DOI 10.1002/ajmg.1580; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Limwongse C, 1999, AM J MED GENET, V82, P20, DOI 10.1002/(SICI)1096-8628(19990101)82:1<20::AID-AJMG4>3.0.CO;2-5; Mao YH, 2003, CELL, V114, P87, DOI 10.1016/S0092-8674(03)00475-6; Plaja A, 2001, AM J MED GENET, V98, P216, DOI 10.1002/1096-8628(20010122)98:3<216::AID-AJMG1091>3.0.CO;2-0; Shichiri M, 2002, CANCER RES, V62, P13; Shin HJ, 2003, CANCER CELL, V4, P483, DOI 10.1016/S1535-6108(03)00302-7; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; TOLMIE JL, 1988, HUM GENET, V80, P197, DOI 10.1007/BF00702872	15	447	461	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1159	1161		10.1038/ng1449	http://dx.doi.org/10.1038/ng1449			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15475955	Bronze			2022-12-27	WOS:000224832800017
J	Seow, HF; Broer, S; Broer, A; Bailey, CG; Potter, SJ; Cavanaugh, JA; Rasko, JEJ				Seow, HF; Broer, S; Broer, A; Bailey, CG; Potter, SJ; Cavanaugh, JA; Rasko, JEJ			Hartnup disorder is caused by mutations in the gene encoding the neutral amino acid transporter SLC6A19	NATURE GENETICS			English	Article							CELL-LINE; CLONING; DISEASE; NA+; SPECIFICITY; VESICLES; PATHWAYS	Hartnup disorder (OMIM 234500) is an autosomal recessive abnormality of renal and gastrointestinal neutral amino acid transport noted for its clinical variability. We localized a gene causing Hartnup disorder to chromosome 5p15.33 and cloned a new gene, SLC6A19, in this region. SLC6A19 is a sodium-dependent and chloride-independent neutral amino acid transporter, expressed predominately in kidney and intestine, with properties of system B-0. We identified six mutations in SLC6A19 that cosegregated with disease in the predicted recessive manner, with most affected individuals being compound heterozygotes. The disease-causing mutations that we tested reduced neutral amino acid transport function in vitro. Population frequencies for the most common mutated SLC6A19 alleles are 0.007 for 517G-->A and 0.001 for 718C-->T. Our findings indicate that SLC6A19 is the long-sought gene that is mutated in Hartnup disorder; its identification provides the opportunity to examine the inconsistent multisystemic features of this disorder.	Univ Sydney, Centenary Inst Canc Med & Cell Biol, Sydney, NSW 2042, Australia; Australian Natl Univ, Fac Sci, Sch Biochem & Mol Biol, Canberra, ACT 0200, Australia; Australian Natl Univ, Sch Med, Canberra Hosp, Med Genet Res Unit, Canberra, ACT 2606, Australia; Royal Prince Alfred Hosp, Sydney Canc Ctr, Camperdown, NSW 2050, Australia	University of Sydney; Centenary Institute; Australian National University; Australian National University; Canberra Hospital; University of Sydney	Rasko, JEJ (corresponding author), Univ Sydney, Centenary Inst Canc Med & Cell Biol, Sydney, NSW 2042, Australia.	j.rasko@cenint.org	Cavanaugh, Juleen/C-9413-2009; Rasko, John EJ/F-5754-2013; Broer, Stefan/A-1286-2008	Broer, Stefan/0000-0002-8040-1634; Seow, Heng Fong/0000-0002-2189-327X; Bailey, Charles/0000-0002-4725-7829; rasko, John/0000-0003-2975-807X				Avissar NE, 2001, AM J PHYSIOL-CELL PH, V281, pC963, DOI 10.1152/ajpcell.2001.281.3.C963; BARON DN, 1956, LANCET, V2, P421; Broer A, 2004, J BIOL CHEM, V279, P24467, DOI 10.1074/jbc.M400904200; Broer Stefan, 2003, Methods Mol Biol, V227, P245, DOI 10.1385/1-59259-387-9:245; Chillaron J, 2001, AM J PHYSIOL-RENAL, V281, pF995, DOI 10.1152/ajprenal.2001.281.6.F995; DOYLE FA, 1992, BIOCHIM BIOPHYS ACTA, V1104, P55, DOI 10.1016/0005-2736(92)90131-5; Kekuda R, 1996, J BIOL CHEM, V271, P18657, DOI 10.1074/jbc.271.31.18657; KLETA R, 2004, NAT GENET       0801; Levy L. L., 2001, METABOLIC MOL BASES, P4957; MAILLIARD ME, 1995, GASTROENTEROLOGY, V108, P888, DOI 10.1016/0016-5085(95)90466-2; MUNCK LK, 1994, PHYSIOL RES, V43, P335; Nash SR, 1998, RECEPTOR CHANNEL, V6, P113; Nozaki J, 2001, BIOCHEM BIOPH RES CO, V284, P255, DOI 10.1006/bbrc.2001.4961; Pineda M, 2004, BIOCHEM J, V377, P665, DOI 10.1042/BJ20030956; Potter SJ, 2002, J INHERIT METAB DIS, V25, P437, DOI 10.1023/A:1021286714582; Rahman B, 1999, BIOCHEMISTRY-US, V38, P11577, DOI 10.1021/bi990973f; Rasko JEJ, 1999, P NATL ACAD SCI USA, V96, P2129, DOI 10.1073/pnas.96.5.2129; SCRIVER CR, 1965, NEW ENGL J MED, V273, P530, DOI 10.1056/NEJM196509022731005; SCRIVER CR, 1987, AM J HUM GENET, V40, P401; Sloan JL, 1999, J BIOL CHEM, V274, P23740, DOI 10.1074/jbc.274.34.23740; SOUBA WW, 1992, BIOCHEM BIOPH RES CO, V188, P746, DOI 10.1016/0006-291X(92)91119-B; STEVENS BR, 1982, J MEMBRANE BIOL, V66, P213, DOI 10.1007/BF01868496; TARLOW MJ, 1972, ARCH DIS CHILD, V47, P798, DOI 10.1136/adc.47.255.798; Verrey F, 2000, PFLUG ARCH EUR J PHY, V440, P503, DOI 10.1007/s004240050001; Wagner CA, 2001, AM J PHYSIOL-CELL PH, V281, pC1077, DOI 10.1152/ajpcell.2001.281.4.C1077; WARD CL, 1994, J BIOL CHEM, V269, P25710; WASSERMAN JC, 1994, AM J PHYSIOL-RENAL, V267, pF688, DOI 10.1152/ajprenal.1994.267.4.F688; WILCKEN B, 1980, J PEDIATR-US, V97, P492, DOI 10.1016/S0022-3476(80)80216-2	28	164	171	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					1003	1007		10.1038/ng1406	http://dx.doi.org/10.1038/ng1406			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15286788	Bronze			2022-12-27	WOS:000223658100029
J	Shi, S; Calhoun, HC; Xia, F; Li, JH; Le, L; Li, WX				Shi, Song; Calhoun, Healani C.; Xia, Fan; Li, Jinghong; Le, Long; Li, Willis X.			JAK signaling globally counteracts heterochromatic gene silencing	NATURE GENETICS			English	Article							HEMATOPOIETIC ONCOGENE; JAK/STAT PATHWAY; DROSOPHILA; GENOME; ACTIVATION; COMPONENTS; KINASE; CANCER; STATS; IDENTIFICATION	The JAK/STAT pathway has pleiotropic roles in animal development, and its aberrant activation is implicated in multiple human cancers(1-3). JAK/ STAT signaling effects have been attributed largely to direct transcriptional regulation by STAT of specific target genes that promote tumor cell proliferation or survival. We show here in a Drosophila melanogaster hematopoietic tumor model, however, that JAK overactivation globally disrupts heterochromatic gene silencing, an epigenetic tumor suppressive mechanism(4). This disruption allows derepression of genes that are not direct targets of STAT, as evidenced by suppression of heterochromatin-mediated position effect variegation. Moreover, mutations in the genes encoding heterochromatin components heterochromatin protein 1 (HP1) and Su(var)3-9 enhance tumorigenesis induced by an oncogenic JAK kinase without affecting JAK/ STAT signaling. Consistently, JAK loss of function enhances heterochromatic gene silencing, whereas overexpressing HP1 suppresses oncogenic JAK-induced tumors. These results demonstrate that the JAK/ STAT pathway regulates cellular epigenetic status and that globally disrupting heterochromatin-mediated tumor suppression is essential for tumorigenesis induced by JAK overactivation.	Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA	University of Rochester	Li, WX (corresponding author), Univ Rochester, Med Ctr, Dept Biomed Genet, 601 Elmwood Ave, Rochester, NY 14642 USA.	willis_li@urmc.rochester.edu	Li, Willis X/AAL-7212-2020; Li, Willis/ABC-5695-2020	Li, Willis X/0000-0001-9041-7341; Li, Willis/0000-0001-9041-7341; Li, Jinghong/0000-0003-2497-9295	NATIONAL CANCER INSTITUTE [R01CA131326] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065774, R01GM077046] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA131326, R01 CA131326-01A2] Funding Source: Medline; NIGMS NIH HHS [R01GM077046, R01 GM077046-03, R01 GM065774-04, R01 GM065774, R01 GM077046, R01GM65774] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Bach EA, 2003, GENETICS, V165, P1149; Badenhorst P, 2002, GENE DEV, V16, P3186, DOI 10.1101/gad.1032202; Baeg GH, 2005, GENE DEV, V19, P1861, DOI 10.1101/gad.1320705; Betz A, 2001, P NATL ACAD SCI USA, V98, P9563, DOI 10.1073/pnas.171302098; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Bromberg JF, 2001, BIOESSAYS, V23, P161, DOI 10.1002/1521-1878(200102)23:2<161::AID-BIES1023>3.0.CO;2-0; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Gilbert MM, 2005, MECH DEVELOP, V122, P939, DOI 10.1016/j.mod.2005.03.004; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; HANRATTY WP, 1993, MOL GEN GENET, V238, P33, DOI 10.1007/BF00279527; HARRISON DA, 1995, EMBO J, V14, P2857, DOI 10.1002/j.1460-2075.1995.tb07285.x; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li JH, 2003, DEV CELL, V5, P787, DOI 10.1016/S1534-5807(03)00328-9; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; Lund AH, 2004, GENE DEV, V18, P2315, DOI 10.1101/gad.1232504; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Ronsseray S, 2001, GENETICS, V159, P1631; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; ZINYK DL, 1993, NAT GENET, V4, P195, DOI 10.1038/ng0693-195	28	123	128	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					1071	1076		10.1038/ng1860	http://dx.doi.org/10.1038/ng1860			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16892059	Green Accepted			2022-12-27	WOS:000240112100027
J	Manning, K; Tor, M; Poole, M; Hong, Y; Thompson, AJ; King, GJ; Giovannoni, JJ; Seymour, GB				Manning, Kenneth; Tor, Mahmut; Poole, Mervin; Hong, Yiguo; Thompson, Andrew J.; King, Graham J.; Giovannoni, James J.; Seymour, Graham B.			A naturally occurring epigenetic mutation in a gene encoding an SBP-box transcription factor inhibits tomato fruit ripening	NATURE GENETICS			English	Article							DNA METHYLATION; ARABIDOPSIS; CNR; INHERITANCE	A major component in the regulatory network controlling fruit ripening is likely to be the gene at the tomato Colorless nonripening (Cnr) locus(1,2). The Cnr mutation results in colorless fruits with a substantial loss of cell-to-cell adhesion. The nature of the mutation and the identity of the Cnr gene were previously unknown. Using positional cloning and virus-induced gene silencing, here we demonstrate that an SBP-box (SQUAMOSA promoter binding protein-like) gene resides at the Cnr locus. Furthermore, the Cnr phenotype results from a spontaneous epigenetic change in the SBP-box promoter. The discovery that Cnr is an epimutation was unexpected, as very few spontaneous epimutations have been described in plants(3,4). This study demonstrates that an SBP-box gene is critical for normal ripening and highlights the likely importance of epialleles in plant development and the generation of natural variation.	Univ Nottingham, Sch Biosci, Plant Sci Div, Loughborough LE12 5RD, Leics, England; Univ Warwick, Warwick Hort Res Int, Warwick CV35 9EF, England; Rothamsted Res, Harpenden AL5 2JQ, Herts, England; Cornell Univ, Boyce Thompson Inst Plant Sci Res, Ithaca, NY 14853 USA; USDA ARS, Ithaca, NY 14853 USA	University of Nottingham; University of Warwick; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA)	Seymour, GB (corresponding author), Univ Nottingham, Sch Biosci, Plant Sci Div, Sutton Bonington Campus, Loughborough LE12 5RD, Leics, England.	Graham.Seymour@nottingham.ac.uk	Tor, Mahmut/AAF-6449-2020; Hong, Yiguo/AAI-2303-2020; Thompson, Andrew J./AAF-3017-2020; King, Graham J/AAW-3368-2020; tor, mahmut/C-1132-2009; Poole, Mervin C/A-5639-2009; Tor, Mahmut/AAU-4624-2020; Seymour, Graham B/N-4539-2014	Tor, Mahmut/0000-0002-4416-5048; Thompson, Andrew J./0000-0002-7419-3402; King, Graham J/0000-0002-5975-6051; Poole, Mervin C/0000-0001-8624-5022; Seymour, Graham/0000-0001-8365-4947	Biotechnology and Biological Sciences Research Council [D20300/2, D20300] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Eriksson EM, 2004, PLANT PHYSIOL, V136, P4184, DOI 10.1104/pp.104.045765; Fraser PD, 2001, PHYTOCHEMISTRY, V58, P75, DOI 10.1016/S0031-9422(01)00175-3; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Kalisz S, 2004, TRENDS ECOL EVOL, V19, P309, DOI 10.1016/j.tree.2004.03.034; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/BF02191820; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liljegren SJ, 2004, CELL, V116, P843, DOI 10.1016/S0092-8674(04)00217-X; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; MESSEGUER R, 1991, PLANT MOL BIOL, V16, P753, DOI 10.1007/BF00015069; Orfila C, 2002, PLANTA, V215, P440, DOI 10.1007/s00425-002-0753-1; Orfila C, 2001, PLANT PHYSIOL, V126, P210, DOI 10.1104/pp.126.1.210; Rapp RA, 2005, NEW PHYTOL, V168, P81, DOI 10.1111/j.1469-8137.2005.01491.x; Stone JM, 2005, PLANT J, V41, P744, DOI 10.1111/j.1365-313X.2005.02334.x; TANKSLEY SD, 1992, GENETICS, V132, P1141; Thompson AJ, 1999, PLANT PHYSIOL, V120, P383, DOI 10.1104/pp.120.2.383; Tor M, 2002, THEOR APPL GENET, V104, P165, DOI 10.1007/s001220100760; Unte US, 2003, PLANT CELL, V15, P1009, DOI 10.1105/tpc.010678; van Wezel R, 2001, MOL PLANT MICROBE IN, V14, P1125, DOI 10.1094/MPMI.2001.14.9.1125; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Zhang Z, 2000, GENE, V253, P145, DOI 10.1016/S0378-1119(00)00289-4; Zou NX, 2003, BIOTECHNIQUES, V35, P758, DOI 10.2144/03354st06	30	850	943	20	253	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2006	38	8					948	952		10.1038/ng1841	http://dx.doi.org/10.1038/ng1841			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16832354				2022-12-27	WOS:000239325700027
J	Birnbaum, RY; Zvulunov, A; Hallel-Halevy, D; Cagnano, E; Finer, G; Ofir, R; Geiger, D; Silberstein, E; Feferman, Y; Birk, OS				Birnbaum, Ramon Y.; Zvulunov, Alex; Hallel-Halevy, Dafna; Cagnano, Emanuella; Finer, Gal; Ofir, Rivka; Geiger, Dan; Silberstein, Eldad; Feferman, Yael; Birk, Ohad S.			Seborrhea-like dermatitis with psoriasiform elements caused by a mutation in ZNF750, encoding a putative C2H2 zinc finger protein	NATURE GENETICS			English	Article							RUNX1 BINDING-SITE; FAMILIAL PSORIASIS; SKIN; SUSCEPTIBILITY; ASSOCIATION; CELLS; 17Q	We describe an Israeli Jewish Moroccan family presenting with autosomal dominant seborrhea-like dermatosis with psoriasiform elements, including enhanced keratinocyte proliferation, parakeratosis, follicular plugging, Pityrosporum ovale overgrowth and dermal CD4 lymphocyte infiltrate. We mapped the disease gene to a 0.5-cM region overlapping the PSORS2 locus (17q25) and identified a frameshift mutation in ZNF750, which encodes a putative C2H2 zinc finger protein. ZNF750 is normally expressed in keratinocytes but not in fibroblasts and is barely detectable in CD4 lymphocytes.	Ben Gurion Univ Negev, Kahn Lab Human Genet, Natl Inst Biotechnol, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; Schneider Childrens Med Ctr, IL-49202 Petah Tiqwa, Israel; Soroka Med Ctr, Dept Dermatol, IL-84101 Beer Sheva, Israel; Soroka Med Ctr, Dept Pathol, IL-84101 Beer Sheva, Israel; Soroka Med Ctr, Dept Plast Surg, IL-84101 Beer Sheva, Israel; Technion Israel Inst Technol, Dept Comp Sci, IL-36000 Haifa, Israel; Soroka Med Ctr, Genet Inst, IL-84101 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Technion Israel Institute of Technology; Ben Gurion University; Soroka Medical Center	Birk, OS (corresponding author), Ben Gurion Univ Negev, Kahn Lab Human Genet, Natl Inst Biotechnol, IL-84105 Beer Sheva, Israel.	obirk@bgu.ac.il	Finer, Gal/C-7858-2015	Birk, Ohad/0000-0003-1430-1296; Birnbaum, Ramon/0000-0002-3792-1095				Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Braun-Falco O., 1991, DERMATOLOGY; Capon F, 2004, J MED GENET, V41, P459, DOI 10.1136/jmg.2004.018226; Cohen-Sfady M, 2005, J IMMUNOL, V175, P3594, DOI 10.4049/jimmunol.175.6.3594; Faergemann J, 2001, BRIT J DERMATOL, V144, P549, DOI 10.1046/j.1365-2133.2001.04082.x; Fishelson M, 2002, Bioinformatics, V18 Suppl 1, pS189; Gupta AK, 2004, J AM ACAD DERMATOL, V51, P785, DOI 10.1016/j.jaad.2003.12.034; Gupta AK, 2004, DERMATOLOGY, V208, P89, DOI 10.1159/000076478; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Hwu WL, 2005, J MED GENET, V42, P152, DOI 10.1136/jmg.2004.018564; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Plewig G, 1999, FITZPATRICKS DERMATO, V1, P1482; Stuart P, 2006, J MED GENET, V43, P12, DOI 10.1136/jmg.2005.032193; TOMFOHRDE J, 1994, SCIENCE, V264, P1141, DOI 10.1126/science.8178173; Watanabe S, 2001, J INVEST DERMATOL, V116, P769, DOI 10.1046/j.1523-1747.2001.01321.x	15	50	53	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					749	751		10.1038/ng1813	http://dx.doi.org/10.1038/ng1813			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16751772				2022-12-27	WOS:000238669300008
J	Clop, A; Marcq, F; Takeda, H; Pirottin, D; Tordoir, X; Bibe, B; Bouix, J; Caiment, F; Elsen, JM; Eychenne, F; Larzul, C; Laville, E; Meish, F; Milenkovic, D; Tobin, J; Charlier, C; Georges, M				Clop, Alex; Marcq, Fabienne; Takeda, Haruko; Pirottin, Dimitri; Tordoir, Xavier; Bibe, Bernard; Bouix, Jacques; Caiment, Florian; Elsen, Jean-Michel; Eychenne, Francis; Larzul, Catherine; Laville, Elisabeth; Meish, Francoise; Milenkovic, Dragan; Tobin, James; Charlier, Carole; Georges, Michel			A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; MUSCLE HYPERTROPHY; TEXEL SHEEP; SERUM; MASS	Texel sheep are renowned for their exceptional meatiness. To identify the genes underlying this economically important feature, we performed a whole-genome scan in a Romanov x Texel F2 population. We mapped a quantitative trait locus with a major effect on muscle mass to chromosome 2 and subsequently fine-mapped it to a chromosome interval encompassing the myostatin (GDF8) gene. We herein demonstrate that the GDF8 allele of Texel sheep is characterized by a G to A transition in the 3' UTR that creates a target site for mir1 and mir206, microRNAs (miRNAs) that are highly expressed in skeletal muscle. This causes translational inhibition of the myostatin gene and hence contributes to the muscular hypertrophy of Texel sheep. Analysis of SNP databases for humans and mice demonstrates that mutations creating or destroying putative miRNA target sites are abundant and might be important effectors of phenotypic variation.	Univ Liege, Fac Vet Med, Dept Anim Prod, Unit Anim Genom, B-4000 Liege, Belgium; Univ Liege, Ctr Biomed Integrat Genoprote, B-4000 Liege, Belgium; INRA, SAGA, Stn Ameliorat Genet Anim, F-31326 Castanet Tolosan, France; INRA, Rech Viande Stn, F-63122 St Genes Champanelle, France; Univ Limoges, Fac Sci, INRA, F-87060 Limoges, France; Wyeth Ayerst Res, Cardiovasc & Metab Dis, Cambridge, MA 02140 USA	University of Liege; University of Liege; INRAE; INRAE; INRAE; Universite de Limoges; Pfizer	Georges, M (corresponding author), Univ Liege, Fac Vet Med, Dept Anim Prod, Unit Anim Genom, B43,20 Blvd Colonster, B-4000 Liege, Belgium.	michel.georges@ulg.ac.be	Larzul, Catherine/AAN-6884-2021; Clop, Alex/D-1519-2009; Larzul, Catherine/AAX-8677-2020; caiment, florian/N-7623-2015; Clop, Alex/AAH-9231-2021	Clop, Alex/0000-0001-9238-2728; Larzul, Catherine/0000-0002-0533-331X; Clop, Alex/0000-0001-9238-2728; Caiment, Florian/0000-0002-3325-0466; Georges, Michel/0000-0003-4124-2375; Milenkovic, Dragan/0000-0001-6353-0912; Charlier, Carole/0000-0002-9694-094X				Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; HALEY CS, 1994, GENETICS, V136, P1195; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Johnson PL, 2005, J ANIM SCI, V83, P1988; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Laville E, 2004, J ANIM SCI, V82, P3128; Lee SJ, 1999, CURR OPIN GENET DEV, V9, P604, DOI 10.1016/S0959-437X(99)00004-0; MARCQ F, 2002, P 7 WORLD C GEN APPL, P323; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Seaton G, 2002, BIOINFORMATICS, V18, P339, DOI 10.1093/bioinformatics/18.2.339; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Tobin JF, 2005, CURR OPIN PHARMACOL, V5, P328, DOI 10.1016/j.coph.2005.01.011; Ueijma H, 2000, NAT GENET, V25, P375, DOI 10.1038/78040; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	20	946	1054	0	114	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					813	818		10.1038/ng1810	http://dx.doi.org/10.1038/ng1810			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16751773				2022-12-27	WOS:000238669300018
J	Rollmann, SM; Magwire, MM; Morgan, TJ; Ozsoy, ED; Yamamoto, A; Mackay, TFC; Anholt, RRH				Rollmann, Stephanie M.; Magwire, Michael M.; Morgan, Theodore J.; Ozsoy, Ergi D.; Yamamoto, Akihiko; Mackay, Trudy F. C.; Anholt, Robert R. H.			Pleiotropic fitness effects of the Tre1-Gr5a region in Drosophila melanogaster	NATURE GENETICS			English	Article							LIFE-SPAN; GENETIC ARCHITECTURE; RECEPTOR; INSULIN; LONGEVITY; TREHALOSE; SENSITIVITY; EVOLUTION; HOMOLOG; MUTANT	The abundance of transposable elements and DNA repeat sequences in mammalian genomes raises the question of whether such insertions represent passive evolutionary baggage or may influence the expression of complex traits. We addressed this question in Drosophila melanogaster, in which the effects of single transposable elements on complex traits can be assessed in genetically identical individuals reared in controlled environments(1). Here we demonstrate that single P-element insertions in the intergenic region between the gustatory receptor 5a (Gr5a, also known as Tre)(2-4) and trapped in endoderm 1 (Tre1)(5), which encodes an orphan receptor, exert complex pleiotropic effects on fitness traits, including selective nutrient intake, life span, and resistance to starvation and heat stress. Mutations in this region interact epistatically with downstream components of the insulin signaling pathway. Transposon-induced sex-specific and sex-antagonistic effects further accentuate the complex influences that intergenic transposable elements can contribute to quantitative trait phenotypes.	N Carolina State Univ, Dept Zool, Raleigh, NC 27695 USA; N Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; Hacettepe Univ, Dept Biol, TR-06800 Beytepe, Turkey	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Hacettepe University	Anholt, RRH (corresponding author), N Carolina State Univ, Dept Zool, Raleigh, NC 27695 USA.	anholt@ncsu.edu	Anholt, Robert/S-5977-2019	Morgan, Theodore/0000-0003-4535-2061				Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Anholt RRH, 2003, NAT GENET, V35, P180, DOI 10.1038/ng1240; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; *CHIMP SEQ AN CONS, 2005, NATURE, V1, P69; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Harbison ST, 2004, GENETICS, V166, P1807, DOI 10.1534/genetics.166.4.1807; Holzenberger M, 2004, EXP GERONTOL, V39, P1761, DOI 10.1016/j.exger.2004.08.017; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kunwar PS, 2003, PLOS BIOL, V1, P372, DOI 10.1371/journal.pbio.0000080; LARSEN PL, 1995, GENETICS, V139, P1567; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Lukacsovich T, 2001, GENETICS, V157, P727; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Partridge L, 2005, CELL, V120, P461, DOI 10.1016/j.cell.2005.01.026; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; TANIMURA T, 1982, J COMP PHYSIOL, V147, P433, DOI 10.1007/BF00612007; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Ueno K, 2001, CURR BIOL, V11, P1451, DOI 10.1016/S0960-9822(01)00450-X	27	26	26	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					824	829		10.1038/ng1823	http://dx.doi.org/10.1038/ng1823			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16783380				2022-12-27	WOS:000238669300020
J	Amundadottir, LT; Sulem, P; Gudmundsson, J; Helgason, A; Baker, A; Agnarsson, BA; Sigurdsson, A; Benediktsdottir, KR; Cazier, JB; Sainz, J; Jakobsdottir, M; Kostic, J; Magnusdottir, DN; Ghosh, S; Agnarsson, K; Birgisdottir, B; Le Roux, L; Olafsdottir, A; Blondal, T; Andresdottir, M; Gretarsdottir, OS; Bergthorsson, JT; Gudbjartsson, D; Gylfason, A; Thorleifsson, G; Manolescu, A; Kristjansson, K; Geirsson, G; Isaksson, H; Douglas, J; Johansson, JE; Balter, K; Wiklund, F; Montie, JE; Yu, XY; Suarez, BK; Ober, C; Cooney, KA; Gronberg, H; Catalona, WJ; Einarsson, GV; Barkardottir, RB; Gulcher, JR; Kong, A; Thorsteinsdottir, U; Stefansson, K				Amundadottir, Laufey T.; Sulem, Patrick; Gudmundsson, Julius; Helgason, Agnar; Baker, Adam; Agnarsson, Bjarni A.; Sigurdsson, Asgeir; Benediktsdottir, Kristrun R.; Cazier, Jean-Baptiste; Sainz, Jesus; Jakobsdottir, Margret; Kostic, Jelena; Magnusdottir, Droplaug N.; Ghosh, Shyamali; Agnarsson, Kari; Birgisdottir, Birgitta; Le Roux, Louise; Olafsdottir, Adalheidur; Blondal, Thorarinn; Andresdottir, Margret; Gretarsdottir, Olafia Svandis; Bergthorsson, Jon T.; Gudbjartsson, Daniel; Gylfason, Arnaldur; Thorleifsson, Gudmar; Manolescu, Andrei; Kristjansson, Kristleifur; Geirsson, Gudmundur; Isaksson, Helgi; Douglas, Julie; Johansson, Jan-Erik; Balter, Katarina; Wiklund, Fredrik; Montie, James E.; Yu, Xiaoying; Suarez, Brian K.; Ober, Carole; Cooney, Kathleen A.; Gronberg, Henrik; Catalona, William J.; Einarsson, Gudmundur V.; Barkardottir, Rosa B.; Gulcher, Jeffrey R.; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			A common variant associated with prostate cancer in European and African populations	NATURE GENETICS			English	Article							CONFERS RISK; GENE; INFERENCE; POLYMORPHISMS	With the increasing incidence of prostate cancer, identifying common genetic variants that confer risk of the disease is important. Here we report such a variant on chromosome 8q24, a region initially identified through a study of Icelandic families. Allele -8 of the microsatellite DG8S737 was associated with prostate cancer in three case-control series of European ancestry from Iceland, Sweden and the US. The estimated odds ratio ( OR) of the allele is 1.62 (P = 2.7 x 10(-11)). About 19% of affected men and 13% of the general population carry at least one copy, yielding a population attributable risk ( PAR) of similar to 8%. The association was also replicated in an African American case-control group with a similar OR, in which 41% of affected individuals and 30% of the population are carriers. This leads to a greater estimated PAR (16%) that may contribute to higher incidence of prostate cancer in African American men than in men of European ancestry.	DeCODE Genet, IS-101 Reykjavik, Iceland; Univ Iceland, Landspitali Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; Univ Iceland, Landspitali Hosp, Dept Urol, IS-101 Reykjavik, Iceland; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Orebro Univ Hosp, Dept Urol & Clin Med, Orebro, Sweden; Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Landspitali National University Hospital; University of Iceland; Landspitali National University Hospital; University of Iceland; University of Michigan System; University of Michigan; Orebro University; Karolinska Institutet; University of Michigan System; University of Michigan; Northwestern University; Feinberg School of Medicine; Washington University (WUSTL); University of Chicago; University of Michigan System; University of Michigan	Thorsteinsdottir, U (corresponding author), DeCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	unnur.thorsteinsdottir@decode.is; kstefans@decode.is	Helgason, Agnar/K-1522-2015; Manolescu, Andrei/G-4565-2014; Amundadottir, Laufey T/L-7656-2016; Cazier, Jean-Baptiste/F-2369-2010; Cazier, Jean-Baptiste/GLR-2949-2022; Stefansson, Kari/AAE-7187-2019	Manolescu, Andrei/0000-0002-0713-4664; Amundadottir, Laufey T/0000-0003-1859-8971; Cazier, Jean-Baptiste/0000-0001-7581-9051; Cazier, Jean-Baptiste/0000-0001-7581-9051; Gudbjartsson, Daniel/0000-0002-5222-9857; Yu, Xiaoying/0000-0003-1659-2365; Kong, Augustine/0000-0001-8193-5438; Ober, Carole/0000-0003-4626-9809; Cooney, Kathleen/0000-0003-3831-6943; Bergthorsson, Jon Thor/0000-0002-0560-2639; le Roux, Louise/0000-0002-9491-9653; Helgason, Agnar/0000-0002-8545-3767	NATIONAL CANCER INSTITUTE [R01CA105055] Funding Source: NIH RePORTER; NCI NIH HHS [1R01CA105055-01A1] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; Beebe-Dimmer JL, 2006, PROSTATE CANCER P D, V9, P50, DOI 10.1038/sj.pcan.4500840; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Crawford ED, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.10.013; Douglas JA, 2005, CANCER EPIDEM BIOMAR, V14, P2035, DOI 10.1158/1055-9965.EPI-05-0170; El Gedaily A, 2001, PROSTATE, V46, P184; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gretarsdottir S, 2002, AM J HUM GENET, V70, P593, DOI 10.1086/339252; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Gulcher J, 2001, CANCER J, V7, P61; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Helgadottir A, 2006, NAT GENET, V38, P68, DOI 10.1038/ng1692; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lindmark F, 2004, JNCI-J NATL CANCER I, V96, P1248, DOI 10.1093/jnci/djh227; MANTEL N, 1959, J NATL CANCER I, V22, P719; *NIH, 1999, NIH PUB, V99; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Schaid DJ, 2004, HUM MOL GENET, V13, pR103, DOI 10.1093/hmg/ddh072	28	589	637	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					652	658		10.1038/ng1808	http://dx.doi.org/10.1038/ng1808			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16682969				2022-12-27	WOS:000237954800018
J	Oh, SW; Mukhopadhyay, A; Dixit, BL; Raha, T; Green, MR; Tissenbaum, HA				Oh, SW; Mukhopadhyay, A; Dixit, BL; Raha, T; Green, MR; Tissenbaum, HA			Identification of direct DAF-16 targets controlling longevity, metabolism and diapause by chromatin immunoprecipitation	NATURE GENETICS			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; REGULATES LIFE-SPAN; C-ELEGANS; SIGNALING PATHWAY; OXIDATIVE STRESS; PROTEIN DAF-16; GENES; MUTANTS; SCREEN; FAMILY	DAF-16, a forkhead transcription factor, is a key regulator of longevity, metabolism and dauer diapause in Caenorhabditis elegans. The precise mechanism by which DAF-16 regulates multiple functions, however, is poorly understood. Here, we used chromatin immunoprecipitation (ChIP) to identify direct targets of DAF-16. We cloned 103 target sequences containing consensus DAF-16 binding sites and selected 33 targets for further analysis. Expression of most of these genes is regulated in a DAF-16-dependent manner, and inactivation of more than half of these genes significantly altered DAF-16-dependent functions, including life span, fat storage and dauer formation. Our results show that the ChIP-based cloning strategy leads to greater enrichment for DAF-16 target genes than previous screening strategies. We also demonstrate that DAF-16 is recruited to multiple promoters to coordinate regulation of its downstream targets. The large number of target genes discovered provides insight into how DAF-16 controls diverse biological functions.	Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Tissenbaum, HA (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	heidi.tissenbaum@umassmed.edu	Mukhopadhyay, Arnab/N-6005-2016	Mukhopadhyay, Arnab/0000-0002-5266-7849; OH, SEUNG WOOK/0000-0001-7632-6822				Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Barbieri M, 2003, AM J PHYSIOL-ENDOC M, V285, pE1064, DOI 10.1152/ajpendo.00296.2003; CONTE D, 2003, CURRENT PROTOCOLS MO; de Belle I, 2003, J BIOL CHEM, V278, P14306, DOI 10.1074/jbc.M210502200; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; GOTTLIEB S, 1994, GENETICS, V137, P107; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; HOSONO R, 1982, EXP GERONTOL, V17, P163, DOI 10.1016/0531-5565(82)90052-3; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; MALONE EA, 1994, GENETICS, V136, P879; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Mukhopadhyay A, 2005, CELL METAB, V2, P35, DOI 10.1016/j.cmet.2005.06.004; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Oka T, 1998, J BIOL CHEM, V273, P22570, DOI 10.1074/jbc.273.35.22570; Raha T, 2005, PLOS BIOL, V3, P221, DOI 10.1371/journal.pbio.0030044; Turner AJ, 2001, BIOESSAYS, V23, P261, DOI 10.1002/1521-1878(200103)23:3<261::AID-BIES1036>3.0.CO;2-K; Weinmann AS, 2004, NAT REV IMMUNOL, V4, P381, DOI 10.1038/nri1353; Yanase S, 2002, MECH AGEING DEV, V123, P1579, DOI 10.1016/S0047-6374(02)00093-3	30	269	303	3	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2006	38	2					251	257		10.1038/ng1723	http://dx.doi.org/10.1038/ng1723			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16380712				2022-12-27	WOS:000234953200024
J	Nguyen, DK; Disteche, CM				Nguyen, DK; Disteche, CM			Dosage compensation of the active X chromosome in mammals	NATURE GENETICS			English	Article							LINKED GENE-EXPRESSION; EARLY MOUSE EMBRYOS; DIFFERENTIAL EXPRESSION; TRANSCRIPTOME ANALYSIS; DOWN-SYNDROME; MUS MUSCULUS; MALE MEIOSIS; GENOME-WIDE; INACTIVATION; SPERMATOGENESIS	Monosomy of the X chromosome owing to divergence between the sex chromosomes leads to dosage compensation mechanisms to restore balanced expression between the X and the autosomes. In Drosophila melanogaster, upregulation of the male X leads to dosage compensation. It has been hypothesized that mammals likewise upregulate their active X chromosome. Together with X inactivation, this mechanism would maintain balanced expression between the X chromosome and autosomes and between the sexes. Here, we show that doubling of the global expression level of the X chromosome leads to dosage compensation in somatic tissues from several mammalian species. X-linked genes are highly expressed in brain tissues, consistent with a role in cognitive functions. Furthermore, the X chromosome is expressed but not upregulated in spermatids and secondary oocytes, preserving balanced expression of the genome in these haploid cells. Upon fertilization, upregulation of the active X must occur to achieve the observed dosage compensation in early embryos.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Disteche, CM (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	cdistech@u.washington.edu						Adler DA, 1997, P NATL ACAD SCI USA, V94, P9244, DOI 10.1073/pnas.94.17.9244; Akhtar A, 2003, CURR OPIN GENET DEV, V13, P161, DOI 10.1016/S0959-437X(03)00016-9; Amano K, 2004, HUM MOL GENET, V13, P1333, DOI 10.1093/hmg/ddh154; Birchler JA, 2005, TRENDS GENET, V21, P219, DOI 10.1016/j.tig.2005.02.010; Birchler JA, 2003, GENETICA, V117, P179, DOI 10.1023/A:1022935927763; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; Cheng MK, 2004, BIOESSAYS, V26, P821, DOI 10.1002/bies.20082; Disteche CM, 2002, CYTOGENET GENOME RES, V99, P36, DOI 10.1159/000071572; FitzPatrick DR, 2002, HUM MOL GENET, V11, P3249, DOI 10.1093/hmg/11.26.3249; Gartler S M, 1976, Adv Hum Genet, V7, P99; Gartler S M, 1972, Cell Differ, V1, P215, DOI 10.1016/0045-6039(72)90039-5; GUPTA V, IN PRESS J BIOL; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Hamra FK, 2004, DEV BIOL, V269, P393, DOI 10.1016/j.ydbio.2004.01.027; HENDRIKSEN PJM, 1995, DEV BIOL, V170, P730, DOI 10.1006/dbio.1995.1252; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Khalil AM, 2004, P NATL ACAD SCI USA, V101, P16583, DOI 10.1073/pnas.0406325101; Khil PP, 2004, NAT GENET, V36, P642, DOI 10.1038/ng1368; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Malkov M, 1998, BIOL REPROD, V59, P84, DOI 10.1095/biolreprod59.1.84; MCCARREY JR, 1992, GENET ANAL-BIOMOL E, V9, P117, DOI 10.1016/1050-3862(92)90051-6; MCMAHON A, 1981, J EMBRYOL EXP MORPH, V64, P251; MIGEON BR, 1982, NATURE, V299, P838, DOI 10.1038/299838a0; MONESI V, 1965, CHROMOSOMA, V17, P11, DOI 10.1007/BF00285153; Odorisio T, 1996, DEV BIOL, V180, P336, DOI 10.1006/dbio.1996.0305; Ohno S., 1967, SEX CHROMOSOMES SEX; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Pritchard CC, 2001, P NATL ACAD SCI USA, V98, P13266, DOI 10.1073/pnas.221465998; Rinn JL, 2004, DEV CELL, V6, P791, DOI 10.1016/j.devcel.2004.05.005; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Saran NG, 2003, HUM MOL GENET, V12, P2013, DOI 10.1093/hmg/ddg217; Schlecht U, 2004, MOL BIOL CELL, V15, P1031, DOI 10.1091/mbc.E03-10-0762; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Straub T, 2005, FEBS LETT, V579, P3258, DOI 10.1016/j.febslet.2005.03.050; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Uddin M, 2004, P NATL ACAD SCI USA, V101, P2957, DOI 10.1073/pnas.0308725100; Walker JR, 2004, GENOME RES, V14, P742, DOI 10.1101/gr.2161804; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Zechner U, 2001, TRENDS GENET, V17, P697, DOI 10.1016/S0168-9525(01)02446-5; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zheng P, 2004, BIOL REPROD, V70, P1419, DOI 10.1095/biolreprod.103.023796; Zhou X, 2005, J MED GENET, V42, P416, DOI 10.1136/jmg.2004.025353	49	356	361	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					47	53		10.1038/ng1705	http://dx.doi.org/10.1038/ng1705			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16341221				2022-12-27	WOS:000234227200016
J	Protas, ME; Hersey, C; Kochanek, D; Zhou, Y; Wilkens, H; Jeffery, WR; Zon, LI; Borowsky, R; Tabin, CJ				Protas, ME; Hersey, C; Kochanek, D; Zhou, Y; Wilkens, H; Jeffery, WR; Zon, LI; Borowsky, R; Tabin, CJ			Genetic analysis of cavefish reveals molecular convergence in the evolution of albinism	NATURE GENETICS			English	Article							PINK-EYED-DILUTION; OCULOCUTANEOUS ALBINISM; REGULATORY EVOLUTION; BLIND CAVEFISH; ASTYANAX; FISH; STICKLEBACKS; POPULATION; DIVERGENCE; UNDERLIES	The genetic basis of vertebrate morphological evolution has traditionally been very difficult to examine in naturally occurring populations. Here we describe the generation of a genome-wide linkage map to allow quantitative trait analysis of evolutionarily derived morphologies in the Mexican cave tetra, a species that has, in a series of independent caves, repeatedly evolved specialized characteristics adapted to a unique and well-studied ecological environment. We focused on the trait of albinism and discovered that it is linked to Oca2, a known pigmentation gene, in two cave populations. We found different deletions in Oca2 in each population and, using a cell-based assay, showed that both cause loss of function of the corresponding protein, OCA2. Thus, the two cave populations evolved albinism independently, through similar mutational events.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Childrens Hosp Boston, Howard Hughes Med Inst, Dept Hematol Oncol, Childrens Hosp Stem Cell Program, Boston, MA 02115 USA; NYU, Dept Biol, Cave Biol Res Grp, New York, NY 10003 USA; Univ Hamburg, Inst Zool, D-20146 Hamburg, Germany; Univ Hamburg, Zool Museum, D-20146 Hamburg, Germany; Univ Maryland, Dept Biol, College Pk, MD 20742 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; New York University; University of Hamburg; University of Hamburg; University System of Maryland; University of Maryland College Park	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu			NEI NIH HHS [R01 EY014619] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014619] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Borowsky R, 2002, J HERED, V93, P19, DOI 10.1093/jhered/93.1.19; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Culver D. C., 1982, CAVE LIFE; Dowling TE, 2002, MOL BIOL EVOL, V19, P446, DOI 10.1093/oxfordjournals.molbev.a004100; Espinasa L, 2001, ENVIRON BIOL FISH, V62, P339, DOI 10.1023/A:1011852603162; Fukamachi S, 2004, GENETICS, V168, P1519, DOI 10.1534/genetics.104.030494; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Jeffery WR, 2005, J HERED, V96, P185, DOI 10.1093/jhered/esi028; Majerus MEN, 2003, TRENDS GENET, V19, P585, DOI 10.1016/j.tig.2003.09.003; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Oetting WS, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9318; Page-McCaw PS, 2004, NAT NEUROSCI, V7, P1329, DOI 10.1038/nn1344; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; Romero A, 2001, ENVIRON BIOL FISH, V62, P13, DOI 10.1023/A:1011844404235; SADOGLU P, 1969, J HERED, V60, P10, DOI 10.1093/oxfordjournals.jhered.a107917; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Strecker U, 2004, MOL PHYLOGENET EVOL, V33, P469, DOI 10.1016/j.ympev.2004.07.001; Strecker U, 2003, MOL ECOL, V12, P699, DOI 10.1046/j.1365-294X.2003.01753.x; Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768; Sviderskaya EV, 1997, J INVEST DERMATOL, V108, P30, DOI 10.1111/1523-1747.ep12285621; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Wilkens H, 1988, EVOL BIOL, V23, P271, DOI [10.1007/978-1-4613-1043-3_8, DOI 10.1007/978-1-4613-1043-3_]; Yamamoto Y, 2003, EVOL DEV, V5, P435, DOI 10.1046/j.1525-142X.2003.03050.x; Yi ZH, 2003, AM J HUM GENET, V72, P62, DOI 10.1086/345380	26	379	388	6	133	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					107	111		10.1038/ng1700	http://dx.doi.org/10.1038/ng1700			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16341223				2022-12-27	WOS:000234227200025
J	Rosenbauer, F; Owens, BM; Yu, L; Tumang, JR; Steidl, U; Kutok, JL; Clayton, LK; Wagner, K; Scheller, M; Iwasaki, H; Liu, CH; Hackanson, B; Akashi, K; Leutz, A; Rothstein, TL; Plass, C; Tenen, DG				Rosenbauer, F; Owens, BM; Yu, L; Tumang, JR; Steidl, U; Kutok, JL; Clayton, LK; Wagner, K; Scheller, M; Iwasaki, H; Liu, CH; Hackanson, B; Akashi, K; Leutz, A; Rothstein, TL; Plass, C; Tenen, DG			Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1	NATURE GENETICS			English	Article							HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTOR PU.1; B-1 CELLS; B-LYMPHOCYTE; MICE; LEUKEMIA; METHYLATION; EXPRESSION; PROGENITORS; MACROPHAGE	Tight regulation of transcription factors, such as PU.1, is crucial for generation of all hematopoietic lineages. We previously reported that mice with a deletion of an upstream regulatory element (URE) of the gene encoding PU.1 (Sfpi1) developed acute myeloid leukemia. Here we show that the URE has an essential role in orchestrating the dynamic PU.1 expression pattern required for lymphoid development and tumor suppression. URE deletion ablated B2 cells but stimulated growth of B1 cells in mice. The URE was a PU.1 enhancer in B cells but a repressor in T cell precursors. TCF transcription factors coordinated this repressor function and linked PU.1 to Wnt signaling. Failure of appropriate PU.1 repression in T cell progenitors with URE deletion disrupted differentiation and induced thymic transformation. Genome-wide DNA methylation assessment showed that epigenetic silencing of selective tumor suppressor genes completed PU.1-initiated transformation of lymphoid progenitors with URE deletion. These results elucidate how a single transcription factor, PU.1, through the cell context - specific activity of a key cis-regulatory element, affects the development of multiple cell lineages and can induce cancer.	Harvard Inst Med, Boston, MA 02115 USA; Harvard Stem Cell Inst, Boston, MA 02115 USA; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Ohio State Univ, Div Hematol Oncol, Columbus, OH 43210 USA; Boston Univ, Med Ctr, Evans Mem Dept Clin Res, Dept Med, Boston, MA USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Immunobiol Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University System of Ohio; Ohio State University; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Rosenbauer, F (corresponding author), Harvard Inst Med, Room 954,77 Ave Louis Pasteur, Boston, MA 02115 USA.	f.rosenbauer@mdc-berlin.de; dtenen@bidmc.harvard.edu	Leutz, Achim/K-9643-2013; Plass, Christoph/H-7192-2014	Leutz, Achim/0000-0001-8259-927X; Scheller, Marina/0000-0001-6108-0831; Tenen, Daniel/0000-0002-6423-3888; Rosenbauer, Frank/0000-0001-7977-9421				Amaravadi L, 1999, DNA CELL BIOL, V18, P875, DOI 10.1089/104454999314737; Anderson MK, 2002, IMMUNITY, V16, P285, DOI 10.1016/S1074-7613(02)00277-7; Andres-Barquin PJ, 1999, EXP CELL RES, V247, P347, DOI 10.1006/excr.1998.4360; Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Boes M, 1998, J IMMUNOL, V160, P4776; Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; CALIGARISCAPPIO F, 1982, J EXP MED, V155, P623, DOI 10.1084/jem.155.2.623; Ceredig R, 2002, NAT REV IMMUNOL, V2, P888, DOI 10.1038/nri937; Chan ASW, 2003, ONCOGENE, V22, P6946, DOI 10.1038/sj.onc.1206799; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; Dahl R, 2003, NAT IMMUNOL, V4, P1029, DOI 10.1038/ni973; Dakic A, 2005, J EXP MED, V201, P1487, DOI 10.1084/jem.20050075; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Fischer GM, 2001, CELL IMMUNOL, V213, P62, DOI 10.1006/cimm.2001.1860; Hanson P, 2003, EXP HEMATOL, V31, P159, DOI 10.1016/S0301-472X(02)01021-4; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Herzenberg LA, 2000, IMMUNOL REV, V175, P9, DOI 10.1111/j.1600-065X.2000.imr017520.x; Holnthoner W, 2002, J BIOL CHEM, V277, P45847, DOI 10.1074/jbc.M209354200; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Kim HG, 2004, BLOOD, V104, P3894, DOI 10.1182/blood-2002-08-2425; Kobayashi S, 2002, J BIOL CHEM, V277, P33968, DOI 10.1074/jbc.M203350200; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Li YL, 2001, BLOOD, V98, P2958, DOI 10.1182/blood.V98.10.2958; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; MoreauGachelin F, 1996, MOL CELL BIOL, V16, P2453; MOREAUGACHELIN F, 1988, NATURE, V331, P277, DOI 10.1038/331277a0; MORRIS DL, 1993, J EXP MED, V177, P857, DOI 10.1084/jem.177.3.857; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Rosenbauer F, 2005, BLOOD, V106, P1519, DOI 10.1182/blood-2005-02-0717; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Rosenbaum PR, 2003, BIOSTATISTICS, V4, P1, DOI 10.1093/biostatistics/4.1.1; Rothstein TL, 2002, J IMMUNOL, V168, P4257, DOI 10.4049/jimmunol.168.9.4257; Schilham MW, 1998, J IMMUNOL, V161, P3984; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; STALL AM, 1988, P NATL ACAD SCI USA, V85, P7312, DOI 10.1073/pnas.85.19.7312; SUZUKI M, IN PRESS ONCOGENE; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; VANDE WM, 2002, CELL S, V109, pS13; WATANABE S, 1995, ELECTROPHORESIS, V16, P218, DOI 10.1002/elps.1150160137; Yu L, 2004, GENOMICS, V84, P647, DOI 10.1016/j.ygeno.2004.06.010; Yu L, 2005, NAT GENET, V37, P265, DOI 10.1038/ng1521	50	169	170	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					27	37		10.1038/ng1679	http://dx.doi.org/10.1038/ng1679			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16311598				2022-12-27	WOS:000234227200014
J	Zeggini, E; Rayner, W; Morris, AP; Hattersley, AT; Walker, M; Hitman, GA; Deloukas, P; Cardon, LR; McCarthy, MI				Zeggini, E; Rayner, W; Morris, AP; Hattersley, AT; Walker, M; Hitman, GA; Deloukas, P; Cardon, LR; McCarthy, MI			An evaluation of HapMap sample size and tagging SNP performance in large-scale empirical and simulated data sets	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; ASSOCIATION; MAPS	A substantial investment has been made in the generation of large public resources designed to enable the identification of tag SNP sets, but data establishing the adequacy of the sample sizes used are limited. Using large-scale empirical and simulated data sets, we found that the sample sizes used in the HapMap project are sufficient to capture common variation, but that performance declines substantially for variants with minor allele frequencies of < 5%.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; Peninsula Med Sch, Ctr Mol Genet, Exeter, Devon, England; Univ Newcastle Upon Tyne, Sch Clin Med Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Barts & London Queen Marys Sch Med & Dent, Ctr Diabet & Metab Med, London, England; Wellcome Trust Sanger Inst, Hinxton, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Exeter; Newcastle University - UK; University of London; Queen Mary University London; Wellcome Trust Sanger Institute	Zeggini, E (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	elez@well.ox.ac.uk	Deloukas, Panos/B-2922-2013; McCarthy, Mark/M-3763-2015	Deloukas, Panos/0000-0001-9251-070X; Zeggini, Eleftheria/0000-0003-4238-659X; McCarthy, Mark/0000-0002-4393-0510; Hattersley, Andrew/0000-0001-5620-473X				Ahmadi KR, 2005, NAT GENET, V37, P84, DOI 10.1038/ng1488; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Halldorsson BV, 2004, HUM HERED, V58, P190, DOI 10.1159/000083546; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Kamatani N, 2004, AM J HUM GENET, V75, P190, DOI 10.1086/422853; Ke XY, 2004, HUM MOL GENET, V13, P2557, DOI 10.1093/hmg/ddh294; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; McCarthy Mark I, 2003, Curr Diab Rep, V3, P159, DOI 10.1007/s11892-003-0040-y; Mueller JC, 2005, AM J HUM GENET, V76, P387, DOI 10.1086/427925; Nordborg M, 2001, HDB STAT GENETICS	12	77	85	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2005	37	12					1320	1322		10.1038/ng1670	http://dx.doi.org/10.1038/ng1670			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16258542				2022-12-27	WOS:000233657300010
J	Bridge, WL; Vandenberg, CJ; Franklin, RJ; Hiom, K				Bridge, WL; Vandenberg, CJ; Franklin, RJ; Hiom, K			The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair	NATURE GENETICS			English	Article							PHOSPHOPEPTIDE RECOGNITION; BACH1 PHOSPHOPEPTIDE; STRUCTURAL BASIS; PROTEIN; DAMAGE; SUSCEPTIBILITY; DOMAIN; CHECKPOINT; REPEATS	BRIP1 ( also called BACH1) is a DEAH helicase that interacts with the BRCT domain of BRCA1 ( refs. 1 - 6) and has an important role in BRCA1- dependent DNA repair and checkpoint functions(1,2,6,7). We cloned the chicken ortholog of BRIP1 and established a homozygous knockout in the avian B- cell line DT40. The phenotype of these brip1 mutant cells in response to DNA damage differs from that of brca1 mutant cells and more closely resembles that of fancc mutant cells, with a profound sensitivity to the DNA- crosslinking agent cisplatin and acute cell- cycle arrest in late S- G2 phase. These defects are corrected by expression of human BRIP1 lacking the BRCT- interaction domain. Moreover, in human cells exposed to mitomycin C, short interfering RNA - mediated knock- down of BRIP1 leads to a substantial increase in chromosome aberrations, a characteristic phenotype of cells derived from individuals with Fanconi anemia. Because brip1 mutant cells are proficient for ubiquitination of FANCD2 protein, our data indicate that BRIP1 has a function in the Fanconi anemia pathway that is independent of BRCA1 and downstream of FANCD2 activation.	MRC, Mol Biol Lab, Prot & Nucl Acid Chem Div, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Hiom, K (corresponding author), MRC, Mol Biol Lab, Prot & Nucl Acid Chem Div, Hills Rd, Cambridge CB2 2QH, England.	hiom@mrc-lmb.cam.ac.uk	Hiom, Kevin/B-4374-2009		Worldwide Cancer Research [04-0131] Funding Source: Medline	Worldwide Cancer Research		Arakawa H, 2001, BMC Biotechnol, V1, P7, DOI 10.1186/1472-6750-1-7; AUERBACH AD, 1976, NATURE, V261, P494, DOI 10.1038/261494a0; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; Botuyan MVE, 2004, STRUCTURE, V12, P1137, DOI 10.1016/j.str.2004.06.002; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; Garcia-Cabeza I, 2001, BMC PSYCHIATRY, V1, DOI 10.1186/1471-244X-1-7; ISHIDA R, 1982, CANCER RES, V42, P4000; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; JOENJE H, 1981, NATURE, V290, P142, DOI 10.1038/290142a0; Levitus M, 2004, BLOOD, V103, P2498, DOI 10.1182/blood-2003-08-2915; LEVITUS M, 2005, J NAT GENET     0821, DOI DOI 10.1038/NB1625; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; POLL EHA, 1982, HUM GENET, V61, P228, DOI 10.1007/BF00296447; SASAKI MS, 1973, CANCER RES, V33, P1829; Shiozaki EN, 2004, MOL CELL, V14, P405, DOI 10.1016/S1097-2765(04)00238-2; Simpson LJ, 2003, EMBO J, V22, P1654, DOI 10.1093/emboj/cdg161; Vandenberg CJ, 2003, MOL CELL, V12, P247, DOI 10.1016/S1097-2765(03)00281-8; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yamashita YM, 2002, EMBO J, V21, P5558, DOI 10.1093/emboj/cdf534; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004	28	161	169	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					953	957		10.1038/ng1627	http://dx.doi.org/10.1038/ng1627			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16116421				2022-12-27	WOS:000231591900019
J	Levitus, M; Waisfisz, Q; Godthelp, BC; de Vries, Y; Hussain, S; Wiegant, WW; Elghalbzouri-Maghrani, E; Steltenpool, J; Rooimans, MA; Pals, G; Arwert, F; Mathew, CG; Zdzienicka, MZ; Hiom, K; De Winter, JP; Joenje, H				Levitus, M; Waisfisz, Q; Godthelp, BC; de Vries, Y; Hussain, S; Wiegant, WW; Elghalbzouri-Maghrani, E; Steltenpool, J; Rooimans, MA; Pals, G; Arwert, F; Mathew, CG; Zdzienicka, MZ; Hiom, K; De Winter, JP; Joenje, H			The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J	NATURE GENETICS			English	Article							PROTEIN; BACH1	The protein predicted to be defective in individuals with Fanconi anemia complementation group J ( FA- J), FANCJ, is a missing component in the Fanconi anemia pathway of genome maintenance. Here we identify pathogenic mutations in eight individuals with FA- J in the gene encoding the DEAH- box DNA helicase BRIP1, also called FANCJ. This finding is compelling evidence that the Fanconi anemia pathway functions through a direct physical interaction with DNA.	Vrije Univ Amsterdam Med Ctr, Dept Clin Genet & Human Genet, NL-1081 BT Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Toxicogenet, NL-2333 AL Leiden, Netherlands; Kings Coll London, Guys Hosp, Div Med & Mol Genet, London, England; Nicholas Copernicus Univ, Coll Med L Rydygier, Dept Mol Cell Genet, Bydgoszcz, Poland; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Nicolaus Copernicus University; MRC Laboratory Molecular Biology	Joenje, H (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet & Human Genet, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	joenje@vumc.nl	Hiom, Kevin/B-4374-2009; Mathew, Christopher G/G-3434-2015	Mathew, Christopher G/0000-0003-4178-1838; Waisfisz, Quinten/0000-0002-7384-9182; Pals, Gerard/0000-0003-4091-7115				Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Doherty AMO, 2003, MAMM GENOME, V14, P583, DOI 10.1007/s00335-003-4002-0; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; Levitus M, 2004, BLOOD, V103, P2498, DOI 10.1182/blood-2003-08-2915; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Risinger MA, 2004, CANCER CELL, V6, P539, DOI 10.1016/j.ccr.2004.12.001; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	10	343	353	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					934	935		10.1038/ng1625	http://dx.doi.org/10.1038/ng1625			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16116423				2022-12-27	WOS:000231591900016
J	Zhao, LH; Longo-Guess, C; Harris, BS; Lee, JW; Ackerman, SL				Zhao, LH; Longo-Guess, C; Harris, BS; Lee, JW; Ackerman, SL			Protein accumulation and neurodegeneration in the woozy mutant mouse is caused by disruption of SIL1, a cochaperone of BiP	NATURE GENETICS			English	Article							ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH; GENE; SCA1; SUPPRESSION; ACTIVATION; DISEASE; MICE	Endoplasmic reticulum ( ER) chaperones and ER stress have been implicated in the pathogenesis of neurodegenerative disorders, such as Alzheimer and Parkinson diseases, but their contribution to neuron death remains uncertain(1,2). In this study, we establish a direct in vivo link between ER dysfunction and neurodegeneration. Mice homozygous with respect to the woozy ( wz) mutation develop adult- onset ataxia with cerebellar Purkinje cell loss. Affected cells have intracellular protein accumulations reminiscent of protein inclusions in both the ER and the nucleus. In addition, upregulation of the unfolded protein response, suggestive of ER stress, occurs in mutant Purkinje cells. We report that the wz mutation disrupts the gene Sil1 that encodes an adenine nucleotide exchange factor of BiP(3), a crucial ER chaperone(4). These findings provide evidence that perturbation of ER chaperone function in terminally differentiated neurons leads to protein accumulation, ER stress and subsequent neurodegeneration.	Jackson Lab, Bar Harbor, ME 04609 USA; Howard Hughes Med Inst, Bar Harbor, ME 04609 USA	Jackson Laboratory; Howard Hughes Medical Institute	Ackerman, SL (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	susan.ackerman@jax.org		Zhao, Lihong/0000-0002-9615-6047				Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Altman J, 1997, DEV CEREBELLAR SYSTE; Chung KT, 2002, J BIOL CHEM, V277, P47557, DOI 10.1074/jbc.M208377200; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Goldowitz D, 2000, J NEUROSCI, V20, P4129; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Kabani M, 2000, MOL CELL BIOL, V20, P6923, DOI 10.1128/MCB.20.18.6923-6934.2000; Kimata Y, 2003, MOL BIOL CELL, V14, P2559, DOI 10.1091/mbc.E02-11-0708; Kitao Y, 2004, J NEUROSCI, V24, P1486, DOI 10.1523/JNEUROSCI.4029-03.2004; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Serra HG, 2004, HUM MOL GENET, V13, P2535, DOI 10.1093/hmg/ddh268; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; Slemmer JE, 2005, PROG BRAIN RES, V148, P367, DOI 10.1016/S0079-6123(04)48029-7; Southwood CM, 2002, NEURON, V36, P585, DOI 10.1016/S0896-6273(02)01045-0; Tessitore A, 2004, MOL CELL, V15, P753, DOI 10.1016/j.molcel.2004.08.029; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	30	166	176	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2005	37	9					974	979		10.1038/ng1620	http://dx.doi.org/10.1038/ng1620			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16116427				2022-12-27	WOS:000231591900023
J	Kanno, T; Huettel, B; Mette, MF; Aufsatz, W; Jaligot, E; Daxinger, L; Kreil, DP; Matzke, M; Matzke, AJM				Kanno, T; Huettel, B; Mette, MF; Aufsatz, W; Jaligot, E; Daxinger, L; Kreil, DP; Matzke, M; Matzke, AJM			Atypical RNA polymerase subunits required for RNA-directed DNA methylation	NATURE GENETICS			English	Article							SMALL INTERFERING RNA; HUMAN-CELLS; GENE; ARABIDOPSIS; TRANSCRIPTION; TRANSPOSON; THALIANA; NUCLEAR; VIRUS	RNA- directed DNA methylation, one of several RNA interference - mediated pathways in the nucleus(1), has been documented in plants(2,3) and in human cells(4,5). Despite progress in identifying the DNA methyltransferases, histone-modifying enzymes and RNA interference proteins needed for RNA- directed DNA methylation(1), the mechanism remains incompletely understood. We screened for mutants defective in RNA- directed DNA methylation and silencing of a transgene promoter in Arabidopsis thaliana and identified three drd complementation groups(6). DRD1 is a SNF2- like protein(6) required for RNA- directed de novo methylation. We report here that DRD2 and DRD3 correspond to the second- largest subunit and largest subunit, respectively, of a fourth class of DNA- dependent RNA polymerase ( polymerase IV) that is unique to plants. DRD3 is a functionally diversified homolog of NRPD1a or SDE4, identified in a separate screen for mutants defective in post- transcriptional gene silencing(7,8). The identical DNA methylation patterns observed in all three drd mutants suggest that DRD proteins cooperate to create a substrate for RNA- directed de novo methylation.	Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, Pharm Zentrum, A-1090 Vienna, Austria; IAM, WWTF Vienna Sci Chair Bioinformat, Dept Biotechnol, A-1190 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI)	Matzke, M (corresponding author), Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, Pharm Zentrum, UZA2,Althanstr 14-2D-541, A-1090 Vienna, Austria.	marjori.matzke@gmi.oeaw.ac.at	Daxinger, Lucia/A-6840-2013; Matzke, Marjori/H-8689-2015; Kreil, D/O-1783-2013; Matzke, Antonius/H-8698-2015; Jaligot, Estelle/A-9035-2011	Kreil, D/0000-0001-7538-2056; Jaligot, Estelle/0000-0002-9252-5271; Daxinger, Lucia/0000-0001-6557-6201; KANNO, Tatsuo/0000-0001-5958-4686				Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Bellaoui M, 2004, PLANTA, V219, P819, DOI 10.1007/s00425-004-1295-5; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Jones L, 2001, CURR BIOL, V11, P747, DOI 10.1016/S0960-9822(01)00226-3; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; KANNO T, IN PRESS EMBO REP; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Lahmy S, 2004, PLANT J, V39, P809, DOI 10.1111/j.1365-313X.2004.02166.x; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Liu J, 2004, GENE DEV, V18, P2873, DOI 10.1101/gad.1217304; Mathieu O, 2004, J CELL SCI, V117, P4881, DOI 10.1242/jcs.01479; Matzke M, 2004, BBA-GENE STRUCT EXPR, V1677, P129, DOI 10.1016/j.bbaexp.2003.10.015; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Melquist S, 2003, GENE DEV, V17, P2036, DOI 10.1101/gad.1081603; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Steimer A, 2000, PLANT CELL, V12, P1165, DOI 10.1105/tpc.12.7.1165; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zorio DAR, 2001, CURR BIOL, V11, pR144, DOI 10.1016/S0960-9822(01)00063-X	29	316	330	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2005	37	7					761	765		10.1038/ng1580	http://dx.doi.org/10.1038/ng1580			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15924141				2022-12-27	WOS:000230196400025
J	Wheeler, DB; Carpenter, AE; Sabatini, DM				Wheeler, DB; Carpenter, AE; Sabatini, DM			Cell microarrays and RNA interference chip away at gene function	NATURE GENETICS			English	Article							SCALE CHROMATIN-STRUCTURE; CULTURED-MAMMALIAN-CELLS; DOUBLE-STRANDED-RNA; QUANTITATIVE-ANALYSIS; SUBCELLULAR-LOCALIZATION; TRANSFECTION MICROARRAY; AUTOMATED MICROSCOPY; TISSUE MICROARRAYS; PROTEIN-KINASE; IMAGE-ANALYSIS	The recent development of cell microarrays offers the potential to accelerate high-throughput functional genetic studies. The widespread use of RNA interference (RNAi) has prompted several groups to fabricate RNAi cell microarrays that make possible discrete, in-parallel transfection with thousands of RNAi reagents on a microarray slide. Though still a budding technology, RNAi cell microarrays promise to increase the efficiency, economy and ease of genome-wide RNAi screens in metazoan cells.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Wheeler, DB (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu	Carpenter, Anne/C-4982-2008	Carpenter, Anne/0000-0003-1555-8261; /0000-0002-1446-7256				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Armknecht S, 2005, METHOD ENZYMOL, V392, P55, DOI 10.1016/S0076-6879(04)92004-6; Bacher CP, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-45; Baghdoyan S, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh074; Belien JAM, 2002, CYTOMETRY, V49, P12, DOI 10.1002/cyto.10138; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Calegari F, 2002, P NATL ACAD SCI USA, V99, P14236, DOI 10.1073/pnas.192559699; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Carpenter AE, 2005, MOL CELL BIOL, V25, P958, DOI 10.1128/MCB.25.3.958-968.2005; Carpenter AE, 2004, CYTOM PART A, V58A, P157, DOI 10.1002/cyto.a.10113; Carpenter AE, 2004, NAT REV GENET, V5, P11, DOI 10.1038/nrg1248; Chang FH, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh029; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Conrad C, 2004, GENOME RES, V14, P1130, DOI 10.1101/gr.2383804; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Eggert US, 2004, PLOS BIOL, V2, P2135, DOI 10.1371/journal.pbio.0020379; Eils R, 2003, J CELL BIOL, V161, P477, DOI 10.1083/jcb.200302097; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Erfle H, 2004, BIOTECHNIQUES, V37, P454, DOI 10.2144/04373RT01; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Ghosh RN, 2004, ASSAY DRUG DEV TECHN, V2, P473, DOI 10.1089/adt.2004.2.473; Hartwell LH, 1997, SCIENCE, V278, P1064, DOI 10.1126/science.278.5340.1064; Houseman BT, 2002, CHEM BIOL, V9, P443, DOI 10.1016/S1074-5521(02)00124-2; Huang J, 2004, P NATL ACAD SCI USA, V101, P16594, DOI 10.1073/pnas.0407117101; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Kato K, 2004, BIOTECHNIQUES, V37, P444, DOI 10.2144/04373RR02; Kiger A A, 2003, J Biol, V2, P27, DOI 10.1186/1475-4924-2-27; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kumar R, 2003, GENOME RES, V13, P2333, DOI 10.1101/gr.1575003; Kurreck J, 2003, EUR J BIOCHEM, V270, P1628, DOI 10.1046/j.1432-1033.2003.03555.x; Kuruvilla FG, 2002, NATURE, V416, P653, DOI 10.1038/416653a; Liebel U, 2003, FEBS LETT, V554, P394, DOI 10.1016/S0014-5793(03)01197-9; Lindblad J, 2004, CYTOM PART A, V57A, P22, DOI 10.1002/cyto.a.10107; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; MARCUS PI, 1985, VIROLOGY, V142, P411, DOI 10.1016/0042-6822(85)90349-6; McManus MT, 2002, RNA, V8, P842, DOI 10.1017/S1355838202024032; Mehes G, 2000, CYTOMETRY, V42, P357, DOI 10.1002/1097-0320(20001215)42:6<357::AID-CYTO1002>3.0.CO;2-6; Mishina YM, 2004, J BIOMOL SCREEN, V9, P196, DOI 10.1177/1087057103261880; Mousses S, 2003, GENOME RES, V13, P2341, DOI 10.1101/gr.1478703; Murphy R F, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P251; Murphy RF, 2003, J VLSI SIG PROC SYST, V35, P311, DOI 10.1023/B:VLSI.0000003028.71666.44; Obenauer-Kutner LJ, 2005, MICROSC MICROANAL, V11, P37, DOI 10.1017/S1431927605050038; Oode K, 2000, AM J PATHOL, V157, P723, DOI 10.1016/S0002-9440(10)64585-3; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Palmer E, 2004, COMP FUNCT GENOM, V5, P342, DOI 10.1002/cfg.405; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Perlman ZE, 2005, CHEMBIOCHEM, V6, P145, DOI 10.1002/cbic.200400266; Redmond TM, 2004, MOL CELL PROTEOMICS, V3, P770, DOI 10.1074/mcp.M400018-MCP200; Ruckstuhl T, 2005, BIOSENS BIOELECTRON, V20, P1872, DOI 10.1016/j.bios.2004.06.050; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Searls DB, 2005, NAT REV DRUG DISCOV, V4, P45, DOI 10.1038/nrd1608; Silva JM, 2004, P NATL ACAD SCI USA, V101, P6548, DOI 10.1073/pnas.0400165101; SWAYNE DF, 2003, P 3 ANN WORKSH DISTR; Swedlow JR, 2003, SCIENCE, V300, P100, DOI 10.1126/science.1082602; Webb BL, 2003, J BIOMOL SCREEN, V8, P620, DOI 10.1177/1087057103259324; Wheeler DB, 2004, NAT METHODS, V1, P127, DOI 10.1038/NMETH711; Yarrow JC, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-21; Yoshikawa T, 2004, J CONTROL RELEASE, V96, P227, DOI 10.1016/j.jconrel.2004.01.024; Zheng LX, 2004, P NATL ACAD SCI USA, V101, P135, DOI 10.1073/pnas.2136685100; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114	66	146	150	0	22	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2005	37			S			S25	S30		10.1038/ng1560	http://dx.doi.org/10.1038/ng1560			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	932YF	15920526	Bronze			2022-12-27	WOS:000229590000006
J	Sellick, GS; Barker, KT; Stolte-Dijkstra, I; Fleischmann, C; Coleman, RJ; Garrett, C; Gloyn, AL; Edghill, EL; Hattersley, AT; Wellauer, PK; Goodwin, G; Houlston, RS				Sellick, GS; Barker, KT; Stolte-Dijkstra, I; Fleischmann, C; Coleman, RJ; Garrett, C; Gloyn, AL; Edghill, EL; Hattersley, AT; Wellauer, PK; Goodwin, G; Houlston, RS			Mutations in PTF1A cause pancreatic and cerebellar agenesis	NATURE GENETICS			English	Article							NEONATAL DIABETES-MELLITUS; GLUCOKINASE DEFICIENCY; EXOCRINE; SUBUNIT; GENE; PTF1-P48; PROTEIN	Individuals with permanent neonatal diabetes mellitus usually present within the first three months of life and require insulin treatment(1,2). We recently identified a locus on chromosome 10p13-p12.1 involved in permanent neonatal diabetes mellitus associated with pancreatic and cerebellar agenesis in a genome-wide linkage search of a consanguineous Pakistani family(3). Here we report the further linkage analysis of this family and a second family of Northern European descent segregating an identical phenotype. Positional cloning identified the mutations 705insG and C886T in the gene PTF1A, encoding pancreas transcription factor 1alpha, as disease-causing sequence changes. Both mutations cause truncation of the expressed PTF1A protein C-terminal to the basic-helix-loop-helix domain. Reporter-gene studies using a minimal PTF1A deletion mutant indicate that the deleted region defines a new domain that is crucial for the function of this protein. PTF1A is known to have a role in mammalian pancreatic development(4,5), and the clinical phenotype of the affected individuals implicated the protein as a key regulator of cerebellar neurogenesis. The essential role of PTF1A in normal cerebellar development was confirmed by detailed neuropathological analysis of Ptf1a(-/-) mice.	Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Univ Groningen Hosp, Dept Clin Genet, NL-9700 RB Groningen, Netherlands; NW London Hosp NHS Trust, NW Thames Reg Genet Serv, Kennedy Galton Ctr, Harrow HA1 3UJ, Middx, England; Peninsula Med Sch, Exeter EX2 5AX, Devon, England; Swiss Inst Expt Canc Res, CH-1066 Epalinges, Switzerland; Inst Canc Res, Sect Mol Carcinogenesis, Sutton SM2 5NG, Surrey, England	University of London; Institute of Cancer Research - UK; University of Groningen; University of Exeter; Swiss Institute Experimental Cancer Research; University of London; Institute of Cancer Research - UK	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	Richard.Houlston@icr.ac.uk		Hattersley, Andrew/0000-0001-5620-473X; Gloyn, Anna/0000-0003-1205-1844; Houlston, Richard/0000-0002-5268-0242				COCKELL M, 1989, MOL CELL BIOL, V9, P2464, DOI 10.1128/MCB.9.6.2464; Gentz J C, 1969, Adv Pediatr, V16, P345; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Hoveyda N, 1999, J MED GENET, V36, P700; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Krapp A, 1996, EMBO J, V15, P4317, DOI 10.1002/j.1460-2075.1996.tb00806.x; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; Njolstad PR, 2001, NEW ENGL J MED, V344, P1588, DOI 10.1056/NEJM200105243442104; Njolstad PR, 2003, DIABETES, V52, P2854, DOI 10.2337/diabetes.52.11.2854; Obata J, 2001, GENES CELLS, V6, P345, DOI 10.1046/j.1365-2443.2001.00422.x; Rose SD, 2001, J BIOL CHEM, V276, P44018, DOI 10.1074/jbc.M106264200; Sellick GS, 2003, DIABETES, V52, P2636, DOI 10.2337/diabetes.52.10.2636; Shield JP, 1997, ARCH DIS CHILD-FETAL, V76, P39; Sigvardsson M, 2000, MOL CELL BIOL, V20, P3640, DOI 10.1128/MCB.20.10.3640-3654.2000; Zecchin E, 2004, DEV BIOL, V268, P174, DOI 10.1016/j.ydbio.2003.12.016	16	297	309	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2004	36	12					1301	1305		10.1038/ng1475	http://dx.doi.org/10.1038/ng1475			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15543146				2022-12-27	WOS:000225354100018
J	Collins, FS				Collins, FS			What we do and don't know about 'race', 'ethnicity', genetics and health at the dawn of the genome era	NATURE GENETICS			English	Article								A true understanding of disease risk requires a thorough examination of root causes. 'Race' and 'ethnicity' are poorly defined terms that serve as flawed surrogates for multiple environmental and genetic factors in disease causation, including ancestral geographic origins, socioeconomic status, education and access to health care. Research must move beyond these weak and imperfect proxy relationships to define the more proximate factors that influence health.	NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Collins, FS (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	fc23a@nih.gov						Angier Natalie, 2000, NY TIMES        1107, pF1; Bamshad M, 2004, NAT REV GENET, V5, P598, DOI 10.1038/nrg1401; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Inoue N, 2002, GASTROENTEROLOGY, V123, P86, DOI 10.1053/gast.2002.34155; Marshall E, 1998, SCIENCE, V282, P654, DOI 10.1126/science.282.5389.654; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sankar P, 2004, JAMA-J AM MED ASSOC, V291, P2985, DOI 10.1001/jama.291.24.2985	11	196	197	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11		S			S13	S15		10.1038/ng1436	http://dx.doi.org/10.1038/ng1436			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	867PH	15507997	Bronze			2022-12-27	WOS:000224854000005
J	Mendell, JT; Sharifi, NA; Meyers, JL; Martinez-Murillo, FM; Dietz, HC				Mendell, JT; Sharifi, NA; Meyers, JL; Martinez-Murillo, FM; Dietz, HC			Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise	NATURE GENETICS			English	Article							MESSENGER-RNA DECAY; AMINO-ACID STARVATION; MEDIATED DECAY; TERMINATION-CODON; YEAST; GENE; PATHWAYS; CELLS; ABUNDANCE; MECHANISM	Premature termination codons induce rapid transcript degradation in eukaryotic cells through nonsense-mediated mRNA decay (NMD)(1,2). This pathway can modulate phenotypes arising from nonsense or frameshift mutations, but little is known about the physiologic role of NMD in higher eukaryotes. To address this issue, we examined expression profiles in mammalian cells depleted of Rent1 (also called hUpf1), a factor essential for NMD3,4. Upregulated transcripts included those with upstream open reading frames in the 5' untranslated region, alternative splicing that introduces nonsense codons or frameshifts, introns in the 3' untranslated region or selenocysteine codons. Transcripts derived from ancient transposons and endogenous retroviruses were also upregulated. These RNAs are unified by the presence of a spliced intron at least 50 nucleotides downstream of a termination codon, a context sufficient to initiate NMD5. Consistent with direct regulation by NMD, representative upregulated transcripts decayed more slowly in cells deficient in NMD. In addition, inhibition of NMD induced by amino acid starvation upregulated transcripts that promote amino acid homeostasis. These results document that nonsense surveillance is a crucial post-transcriptional regulatory event that influences the expression of broad classes of physiologic transcripts, has been functionally incorporated into essential homeostatic mechanisms and suppresses expression of evolutionary remnants.	Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Dietz, HC (corresponding author), Johns Hopkins Univ, Sch Med, Inst Med Genet, 539 Broadway Res Bldg,733 N Broadway, Baltimore, MD 21205 USA.	hdietz@jhmi.edu						Aubel C, 2003, INT J BIOCHEM CELL B, V35, P1388, DOI 10.1016/S1357-2725(03)00098-0; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; Forsberg H, 2001, CURR GENET, V40, P91, DOI 10.1007/s002940100244; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gatfield D, 2003, EMBO J, V22, P3960, DOI 10.1093/emboj/cdg371; GOODCHILD NL, 1995, VIROLOGY, V206, P164, DOI 10.1016/S0042-6822(95)80031-X; Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; Lelivelt MJ, 1999, MOL CELL BIOL, V19, P6710; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Lindeskog M, 1997, J GEN VIROL, V78, P2575, DOI 10.1099/0022-1317-78-10-2575; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Mendell JT, 2002, SCIENCE, V298, P419, DOI 10.1126/science.1074428; Moriarty PM, 1998, MOL CELL BIOL, V18, P2932, DOI 10.1128/MCB.18.5.2932; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; PAIN VM, 1994, BIOCHIMIE, V76, P718, DOI 10.1016/0300-9084(94)90076-0; Pan YX, 2003, J BIOL CHEM, V278, P38402, DOI 10.1074/jbc.M304574200; Robertson HM, 1997, GENE, V205, P219, DOI 10.1016/S0378-1119(97)00471-X; Schreve JL, 2004, BIOCHEM BIOPH RES CO, V313, P745, DOI 10.1016/j.bbrc.2003.11.172; Siu F, 2002, J BIOL CHEM, V277, P24120, DOI 10.1074/jbc.M201959200; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; Wagner E, 2002, J CELL SCI, V115, P3033; Zhang J, 1998, RNA, V4, P801, DOI 10.1017/S1355838298971849; ZHANG SA, 1995, MOL CELL BIOL, V15, P2231	30	619	629	4	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2004	36	10					1073	1078		10.1038/ng1429	http://dx.doi.org/10.1038/ng1429			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	15448691	Bronze			2022-12-27	WOS:000224156500015
J	Van Raamsdonk, CD; Fitch, KR; Fuchs, H; de Angelis, MH; Barsh, GS				Van Raamsdonk, CD; Fitch, KR; Fuchs, H; de Angelis, MH; Barsh, GS			Effects of G-protein mutations on skin color	NATURE GENETICS			English	Article							ENDOTHELIN RECEPTOR-B; CREST-DERIVED MELANOCYTES; NERVOUS-SYSTEM; GENOME-WIDE; COAT COLOR; MOUSE; MICE; EXPRESSION; KIT; MIGRATION	A new class of dominant dark skin (Dsk) mutations discovered in a screen of similar to30,000 mice is caused by increased dermal melanin. We identified three of four such mutations as hypermorphic alleles of Gnaq and Gna11, which encode widely expressed Galphaq subunits, act in an additive and quantitative manner, and require Ednrb. Interactions between Gq and Kit receptor tyrosine kinase signaling can mediate coordinate or independent control of skin and hair color. Our results provide a mechanism that can explain several aspects of human pigmentary variation and show how polymorphism of essential proteins and signaling pathways can affect a single physiologic system.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; GSF Natl res Ctr Environm & Hlth, Inst Expt Genet, D-85764 Neuherberg, Germany	Stanford University; Stanford University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Barsh, GS (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	gbarsh@cmgm.stanford.edu	Fuchs, Helmut/M-7347-2014; de Angelis, Martin Hrabe/F-5531-2012; Van Raamsdonk, Catherine D./B-6207-2017	Fuchs, Helmut/0000-0002-5143-2677; de Angelis, Martin Hrabe/0000-0002-7898-2353; Van Raamsdonk, Catherine D./0000-0002-4309-3513	NIGMS NIH HHS [R01 GM068882] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bastiani CA, 2003, GENETICS, V165, P1805; Bennett DC, 2003, PIGM CELL RES, V16, P333, DOI 10.1034/j.1600-0749.2003.00067.x; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Coghill EL, 2002, NAT GENET, V30, P255, DOI 10.1038/ng847; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Doi M, 2002, NEURON, V33, P249, DOI 10.1016/S0896-6273(01)00587-6; Dong QH, 1996, J CLIN ENDOCR METAB, V81, P1134, DOI 10.1210/jc.81.3.1134; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; HIROBE T, 1984, ANAT REC, V208, P589, DOI 10.1002/ar.1092080414; Hornyak TJ, 2001, MECH DEVELOP, V101, P47, DOI 10.1016/S0925-4773(00)00569-4; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Hou L, 2004, DEVELOPMENT, V131, P3239, DOI 10.1242/dev.01193; Hou L, 2000, DEVELOPMENT, V127, P5379; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Ivey K, 2003, DEV BIOL, V255, P230, DOI 10.1016/S0012-1606(02)00097-0; Jordan SA, 2000, DEV BIOL, V225, P424, DOI 10.1006/dbio.2000.9856; Kunisada T, 2000, MECH DEVELOP, V94, P67, DOI 10.1016/S0925-4773(00)00308-7; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; MAYER TC, 1973, DEV BIOL, V34, P39, DOI 10.1016/0012-1606(73)90337-0; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Nolan PM, 2000, NAT GENET, V25, P440, DOI 10.1038/78140; Offermanns S, 1997, NATURE, V389, P183, DOI 10.1038/38284; Offermanns S, 1998, EMBO J, V17, P4304, DOI 10.1093/emboj/17.15.4304; Opdecamp K, 1997, DEVELOPMENT, V124, P2377; Opdecamp K, 1998, BIOCHEM CELL BIOL, V76, P1093, DOI 10.1139/bcb-76-6-1093; PAVAN WJ, 1994, P NATL ACAD SCI USA, V91, P7159, DOI 10.1073/pnas.91.15.7159; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Shiroishi T, 2001, Tanpakushitsu Kakusan Koso, V46, P2613; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Wilkie AL, 2002, DEVELOPMENT, V129, P3349; WILKIE TM, 1991, P NATL ACAD SCI USA, V88, P10049, DOI 10.1073/pnas.88.22.10049; WILKIE TM, 1994, SOC GEN PHY, V49, P249; Yoshida H, 2001, J INVEST DERM SYMP P, V6, P1, DOI 10.1046/j.0022-202x.2001.00006.x; Yoshida H, 1996, DEVELOPMENT, V122, P1207; Yoshida R, 2002, ZOOL SCI, V19, P1079, DOI 10.2108/zsj.19.1079; [No title captured]	43	130	134	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					961	968		10.1038/ng1412	http://dx.doi.org/10.1038/ng1412			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15322542	Bronze, Green Accepted			2022-12-27	WOS:000223658100022
J	Manak, JR; Dike, S; Sementchenko, V; Kapranov, P; Biemar, F; Long, J; Cheng, J; Bell, I; Ghosh, S; Piccolboni, A; Gingeras, TR				Manak, J. Robert; Dike, Sujit; Sementchenko, Victor; Kapranov, Philipp; Biemar, Frederic; Long, Jeff; Cheng, Jill; Bell, Ian; Ghosh, Srinka; Piccolboni, Antonio; Gingeras, Thomas R.			Biological function of unannotated transcription during the early development of Drosophila melanogaster	NATURE GENETICS			English	Article							GENE-EXPRESSION; SERIAL ANALYSIS; GENOME; IDENTIFICATION	Many animal and plant genomes are transcribed much more extensively than current annotations predict. However, the biological function of these unannotated transcribed regions is largely unknown. Approximately 7% and 23% of the detected transcribed nucleotides during D. melanogaster embryogenesis map to unannotated intergenic and intronic regions, respectively. Based on computational analysis of coordinated transcription, we conservatively estimate that 29% of all unannotated transcribed sequences function as missed or alternative exons of well-characterized protein-coding genes. We estimate that 15.6% of intergenic transcribed regions function as missed or alternative transcription start sites (TSS) used by 11.4% of the expressed protein-coding genes. Identification of P element mutations within or near newly identified 5' exons provides a strategy for mapping previously uncharacterized mutations to their respective genes. Collectively, these data indicate that at least 85% of the fly genome is transcribed and processed into mature transcripts representing at least 30% of the fly genome.	Affymetrix Inc, Santa Clara, CA 95051 USA; Univ Calif Berkeley, Ctr Integrat Genom, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Affymetrix; University of California System; University of California Berkeley	Manak, JR (corresponding author), Affymetrix Inc, Santa Clara, CA 95051 USA.	John_Manak@affymetrix.com		Manak, John/0000-0002-6562-7694; Gingeras, Thomas/0000-0001-9106-3573; Kapranov, Philipp/0000-0003-2647-4856	NCI NIH HHS [N01-CO-12400] Funding Source: Medline; NHGRI NIH HHS [U01 HG003147] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG003147] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Bertone P, 2004, SCIENCE, V306, P2242, DOI 10.1126/science.1103388; BEYER AL, 1988, GENE DEV, V2, P754, DOI 10.1101/gad.2.6.754; Celniker SE, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0079; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Denholm B, 2005, DEVELOPMENT, V132, P2389, DOI 10.1242/dev.01829; FOE VE, 1989, DEVELOPMENT, V107, P1; Hild M, 2004, GENOME BIOL, V5; JIANG J, 1991, GENE DEV, V5, P1881, DOI 10.1101/gad.5.10.1881; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; MISRA S, 2002, GENOME BIOL, V3, P83, DOI [DOI 10.1186/GB-2002-3-12-RESEARCH0083, 10.1186/gb-2002-3-12-research0083]; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Shamloula HK, 2002, GENETICS, V161, P693; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Strapps WR, 2001, DEVELOPMENT, V128, P4829; Su YH, 2004, J NEUROSCI, V24, P3627, DOI 10.1523/JNEUROSCI.4644-03.2004; Tadros W, 2005, DEV DYNAM, V232, P593, DOI 10.1002/dvdy.20297; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wei CL, 2004, P NATL ACAD SCI USA, V101, P11701, DOI 10.1073/pnas.0403514101	26	148	154	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1151	1158		10.1038/ng1875	http://dx.doi.org/10.1038/ng1875			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16951679				2022-12-27	WOS:000241251100014
J	Deutscher, D; Meilijson, I; Kupiec, M; Ruppin, E				Deutscher, David; Meilijson, Isaac; Kupiec, Martin; Ruppin, Eytan			Multiple knockout analysis of genetic robustness in the yeast metabolic network	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; GENOME; DISPENSABILITY; MUTATIONS; EVOLUTION; SEQUENCE; DELETION; RECONSTRUCTION; PRINCIPLES; DISCOVERY	Genetic robustness characterizes the constancy of the phenotype in face of heritable perturbations. Previous investigations have used comprehensive single and double gene knockouts to study gene essentiality and pairwise gene interactions in the yeast Saccharomyces cerevisiae. Here we conduct an in silico multiple knockout investigation of a flux balance analysis model of the yeast's metabolic network. Cataloging gene sets that provide mutual functional backup, we identify sets of up to eight interacting genes and characterize the 'k robustness' ( the depth of backup interactions) of each gene. We find that 74% ( 360) of the metabolic genes participate in processes that are essential to growth in a standard laboratory environment, compared with only 13% previously found to be essential using single knockouts. The genes' k robustness is shown to be a solid indicator of their biological buffering capacity and is correlated with both the genes' environmental specificity and their evolutionary retention.	Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sch Math Sci, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sch Med, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University; Tel Aviv University	Ruppin, E (corresponding author), Tel Aviv Univ, Sch Comp Sci, POB 39040, IL-69978 Tel Aviv, Israel.	ruppin@post.tau.ac.il	Ruppin, Eytan/R-9698-2017	Ruppin, Eytan/0000-0002-7862-3940				BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blank LM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r49; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; Forster Jochen, 2003, OMICS A Journal of Integrative Biology, V7, P193, DOI 10.1089/153623103322246584; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kauffman KJ, 2003, CURR OPIN BIOTECH, V14, P491, DOI 10.1016/j.copbio.2003.08.001; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Klamt S, 2004, BIOINFORMATICS, V20, P226, DOI 10.1093/bioinformatics/btg395; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Nelson DL, 2000, LEHNINGER PRINCIPLES; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Pal C, 2003, NATURE, V421, P496, DOI 10.1038/421496b; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; SCHAAFFGERSTENSCHLAGER I, 1993, EUR J BIOCHEM, V217, P487, DOI 10.1111/j.1432-1033.1993.tb18268.x; Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Sharan R, 2005, P NATL ACAD SCI USA, V102, P1974, DOI 10.1073/pnas.0409522102; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Thiele I, 2005, J BACTERIOL, V187, P5818, DOI 10.1128/JB.187.16.5818-5830.2005; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wolf YI, 2006, P ROY SOC B-BIOL SCI, V273, P1507, DOI 10.1098/rspb.2006.3472	33	144	149	2	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					993	998		10.1038/ng1856	http://dx.doi.org/10.1038/ng1856			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16941010				2022-12-27	WOS:000240112100014
J	Ozaki, K; Sato, H; Iida, A; Mizuno, H; Nakamura, T; Miyamoto, Y; Takahashi, A; Tsunoda, T; Ikegawa, S; Kamatani, N; Hori, M; Nakamura, Y; Tanaka, T				Ozaki, Kouichi; Sato, Hiroshi; Iida, Aritoshi; Mizuno, Hiroya; Nakamura, Takahiro; Miyamoto, Yoshinari; Takahashi, Atsushi; Tsunoda, Tatsuhiko; Ikegawa, Shiro; Kamatani, Naoyuki; Hori, Masatsugu; Nakamura, Yusuke; Tanaka, Toshihiro			A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population	NATURE GENETICS			English	Article							CORONARY-ARTERY-DISEASE; NF-KAPPA-B; LINKAGE ANALYSIS; HUMAN GENOME; PROTEASOME INHIBITION; GENE; ATHEROSCLEROSIS; STRATIFICATION; SUSCEPTIBILITY; CHROMOSOME-2	Inflammation is now considered critical in the pathogenesis of myocardial infarction. One of the mechanisms regulating the inflammatory process is the ubiquitin-proteasome system. We investigated whether variants of the 20S proteasome are associated with susceptibility to myocardial infarction and found a common SNP (minor allele frequency of 0.35) in the proteasome subunit a type 6 gene (PSMA6) conferring risk of myocardial infarction in the Japanese population (chi(2) = 21.1, P = 0.0000044, 2,592 affected individuals versus 2,851 controls). We replicated this association in another panel of myocardial infarction and control subjects, although its relevance to other ethnic groups remains to be clarified. The SNP, located in the 5' untranslated region of exon 1 in this gene, enhanced the transcription of PSMA6. Moreover, suppression of PSMA6 expression using short interfering RNA in cultured cells reduced activation of the transcription factor NF-kappa B by stabilizing phosphorylated I kappa B. Our results implicate this PSMA6 SNP as a previously unknown genetic risk factor for myocardial infarction.	RIKEN, Inst Phys & Chem Res, Lab Cardiovasc Dis, SNP Res Ctr,Minato Ku, Tokyo 1088639, Japan; Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; RIKEN, Inst Phys & Chem Res, Lab Bone & Joint Dis, SNP Res Ctr,Minato Ku, Tokyo 1088639, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Med Informat,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	RIKEN; Osaka University; RIKEN; RIKEN	Tanaka, T (corresponding author), RIKEN, Inst Phys & Chem Res, Lab Cardiovasc Dis, SNP Res Ctr,Minato Ku, 4-6-1,Shirokanedai, Tokyo 1088639, Japan.	toshitan@ims.u-tokyo.ac.jp	Ikegawa, Shiro/N-6895-2015; Iida, Aritoshi/CAA-1373-2022; Tsunoda, Tatsuhiko/K-2061-2014; Tanaka, Toshihiro/J-9310-2014	Ikegawa, Shiro/0000-0003-0316-2147; Iida, Aritoshi/0000-0001-7538-1651; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Tanaka, Toshihiro/0000-0001-6201-9784; Ozaki, Kouichi/0000-0003-0028-1570				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Beinke S, 2004, BIOCHEM J, V382, P393, DOI 10.1042/BJ20040544; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Cipollone F, 2004, JAMA-J AM MED ASSOC, V291, P2221, DOI 10.1001/jama.291.18.2221; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Elliott PJ, 2003, J MOL MED, V81, P235, DOI 10.1007/s00109-003-0422-2; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harrap SB, 2002, ARTERIOSCL THROM VAS, V22, P874, DOI 10.1161/01.ATV.0000016258.40568.F1; Hauser ER, 2004, AM J HUM GENET, V75, P436, DOI 10.1086/423900; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Herrmann J, 2004, CARDIOVASC RES, V61, P11, DOI 10.1016/j.cardiores.2003.09.033; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Maki CG, 1996, CANCER RES, V56, P2649; Meiners S, 2002, CIRCULATION, V105, P483, DOI 10.1161/hc0402.102951; Ozaki K, 2004, NATURE, V429, P72, DOI 10.1038/nature02502; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pajukanta P, 2000, AM J HUM GENET, V67, P1481, DOI 10.1086/316902; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pye J, 2003, AM J PHYSIOL-HEART C, V284, pH919, DOI 10.1152/ajpheart.00851.2002; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Samani NJ, 2005, AM J HUM GENET, V77, P1011; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; Wang Q, 2004, AM J HUM GENET, V74, P262, DOI 10.1086/381560; Yamada Y, 2002, NEW ENGL J MED, V347, P1916, DOI 10.1056/NEJMoa021445	30	72	81	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2006	38	8					921	925		10.1038/ng1846	http://dx.doi.org/10.1038/ng1846			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16845397				2022-12-27	WOS:000239325700022
J	Valdar, W; Solberg, LC; Gauguier, D; Burnett, S; Klenerman, P; O Cookson, W; Taylor, MS; Rawlins, JNP; Mott, R; Flint, J				Valdar, William; Solberg, Leah C.; Gauguier, Dominique; Burnett, Stephanie; Klenerman, Paul; O Cookson, William; Taylor, Martin S.; Rawlins, J. Nicholas P.; Mott, Richard; Flint, Jonathan			Genome-wide genetic association of complex traits in heterogeneous stock mice	NATURE GENETICS			English	Article							AIRWAY HYPERRESPONSIVENESS; MODEL SELECTION; LOCUS ANALYSIS; QTL; RESOLUTION; C57BL/6J; DISSECTION; IDENTIFY; STRAINS; ANXIETY	Difficulties in fine-mapping quantitative trait loci (QTLs) are a major impediment to progress in the molecular dissection of complex traits in mice. Here we show that genome-wide high-resolution mapping of multiple phenotypes can be achieved using a stock of genetically heterogeneous mice. We developed a conservative and robust bootstrap analysis to map 843 QTLs with an average 95% confidence interval of 2.8 Mb. The QTLs contribute to variation in 97 traits, including models of human disease (asthma, type 2 diabetes mellitus, obesity and anxiety) as well as immunological, biochemical and hematological phenotypes. The genetic architecture of almost all phenotypes was complex, with many loci each contributing a small proportion to the total variance. Our data set, freely available at http://gscan.well.ox.ac.uk, provides an entry point to the functional characterization of genes involved in many complex traits.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Nuffield Dept Med, Oxford OX1 3SY, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford	Flint, J (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	rmott@well.ox.ac.uk; jf@well.ox.ac.uk	Gauguier, Dominique/G-2190-2016; Taylor, Martin S/C-3825-2009; Valdar, William/AAE-4354-2019	Gauguier, Dominique/0000-0001-6156-9530; Taylor, Martin S/0000-0001-7656-330X; Mott, Richard/0000-0002-1022-9330; klenerman, paul/0000-0003-4307-9161; Flint, Jonathan/0000-0002-9427-4429				Ackerman KG, 2005, PHYSIOL GENOMICS, V21, P105, DOI 10.1152/physiolgenomics.00267.2004; Balding DJ, 2002, J R STAT SOC B, V64, P737; Ball RD, 2001, GENETICS, V159, P1351; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Broman KW, 2002, J R STAT SOC B, V64, P641, DOI 10.1111/1467-9868.00354; Caldarone B, 1997, NAT GENET, V17, P335, DOI 10.1038/ng1197-335; Cervino AC, 2005, GENOMICS, V86, P505, DOI 10.1016/j.ygeno.2005.07.010; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Cohen RM, 2001, MAMM GENOME, V12, P501, DOI 10.1007/s00335-001-2047-5; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Demarest K, 2001, BEHAV GENET, V31, P79, DOI 10.1023/A:1010261909853; DESANCTIS GT, 1995, NAT GENET, V11, P150, DOI 10.1038/ng1095-150; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; DiPetrillo K, 2005, TRENDS GENET, V21, P683, DOI 10.1016/j.tig.2005.09.008; DOOLITTLE MH, 1990, J BIOL CHEM, V265, P16380; Ewart SL, 2000, AM J RESP CELL MOL, V23, P537, DOI 10.1165/ajrcmb.23.4.4199; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Foreman JE, 2005, PHYSIOL GENOMICS, V23, P295, DOI 10.1152/physiolgenomics.00062.2005; Gershenfeld HK, 1997, BEHAV GENET, V27, P201, DOI 10.1023/A:1025653812535; Hackett CA, 2001, GENET RES, V77, P95, DOI 10.1017/S0016672300004869; Henderson ND, 2004, BEHAV GENET, V34, P267, DOI 10.1023/B:BEGE.0000017872.25069.44; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Morris KH, 1999, MAMM GENOME, V10, P225, DOI 10.1007/s003359900977; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Mott R, 2002, GENETICS, V160, P1609; Petkov PM, 2005, PLOS GENET, V1, P312, DOI 10.1371/journal.pgen.0010033; *R DEV COR TEAM, 2004, LANG ENV STAT COMP; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Sillanpaa MJ, 2002, TRENDS GENET, V18, P301, DOI 10.1016/S0168-9525(02)02688-4; Singer JB, 2005, GENETICS, V169, P855, DOI 10.1534/genetics.104.031492; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Solberg LC, 2006, MAMM GENOME, V17, P129, DOI 10.1007/s00335-005-0112-1; Steinberger D, 2003, J NEUROSCI, V23, P2426; Talbot CJ, 2003, MAMM GENOME, V14, P223, DOI 10.1007/s00335-002-3059-5; Talbot CJ, 1999, NAT GENET, V21, P305, DOI 10.1038/6825; Taylor BA, 1997, GENOMICS, V43, P249, DOI 10.1006/geno.1997.4835; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Valdar W, 2006, GENETICS, V172, P1783, DOI 10.1534/genetics.104.039313; VALDAR W, IN PRESS GENETICS; Visscher PM, 1996, THEOR APPL GENET, V93, P691, DOI 10.1007/BF00224064; Visscher PM, 1996, GENETICS, V143, P1013; Wang XS, 2005, CIRC RES, V96, P27, DOI 10.1161/01.RES.0000151332.39871.13; Wang XS, 2004, GENOME RES, V14, P1767, DOI 10.1101/gr.2668204; WARDEN CH, 1993, SCIENCE, V261, P469, DOI 10.1126/science.8332912; Wehner JM, 1997, NAT GENET, V17, P331, DOI 10.1038/ng1197-331; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100; Yalcin B, 2005, GENETICS, V171, P673, DOI 10.1534/genetics.104.028902; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450	48	406	410	2	33	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2006	38	8					879	887		10.1038/ng1840	http://dx.doi.org/10.1038/ng1840			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16832355				2022-12-27	WOS:000239325700016
J	Gilbert, SL; Zhang, L; Forster, ML; Iwase, T; Soliven, B; Donahue, LR; Sweet, HO; Bronson, RT; Davisson, MT; Wollmann, RL; Lahn, BT				Gilbert, SL; Zhang, L; Forster, ML; Iwase, T; Soliven, B; Donahue, LR; Sweet, HO; Bronson, RT; Davisson, MT; Wollmann, RL; Lahn, BT			Trak1 mutation disrupts GABA(A) receptor homeostasis in hypertonic mice	NATURE GENETICS			English	Article							HUNTINGTIN-ASSOCIATED PROTEIN; COIL DOMAIN PROTEINS; INHIBITORY SYNAPSES; TRAFFICKING; TRANSPORT; GEPHYRIN; SUBUNIT; CLONING; HAP1; IDENTIFICATION	Hypertonia, which results from motor pathway defects in the central nervous system (CNS), is observed in numerous neurological conditions, including cerebral palsy, stroke, spinal cord injury, stiff-person syndrome, spastic paraplegia, dystonia and Parkinson disease. Mice with mutation in the hypertonic (hyrt) gene exhibit severe hypertonia as their primary symptom. Here we show that hyrt mutant mice have much lower levels of gamma-aminobutyric acid type A (GABA(A)) receptors in their CNS, particularly the lower motor neurons, than do wild-type mice, indicating that the hypertonicity of the mutants is likely to be caused by deficits in GABA-mediated motor neuron inhibition. We cloned the responsible gene, trafficking protein, kinesin binding 1 (Trak1), and showed that its protein product interacts with GABAA receptors. Our data implicate Trak1 as a crucial regulator of GABA(A) receptor homeostasis and underscore the importance of hyrt mice as a model for studying the molecular etiology of hypertonia associated with human neurological diseases.	Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Jackson Lab, Bar Harbor, ME 04609 USA	Howard Hughes Medical Institute; University of Chicago; University of Chicago; University of Chicago; University of Chicago; Jackson Laboratory	Lahn, BT (corresponding author), Univ Chicago, Howard Hughes Med Inst, 5841 S Maryland Ave, Chicago, IL 60637 USA.	blahn@bsd.uchicago.edu						Barnes EM, 2001, INT REV NEUROBIOL, V48, P1, DOI 10.1016/S0074-7742(01)48012-3; Beck M, 2002, J BIOL CHEM, V277, P30079, DOI 10.1074/jbc.M200438200; Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; BlockGalarza J, 1997, NEUROREPORT, V8, P2247, DOI 10.1097/00001756-199707070-00031; Brickley K, 2005, J BIOL CHEM, V280, P14723, DOI 10.1074/jbc.M409095200; Colomer V, 1997, HUM MOL GENET, V6, P1519, DOI 10.1093/hmg/6.9.1519; Engelender S, 1997, HUM MOL GENET, V6, P2205, DOI 10.1093/hmg/6.13.2205; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Fritschy JM, 2003, PHARMACOL THERAPEUT, V98, P299, DOI 10.1016/S0163-7258(03)00037-8; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gorska-Andrzejak J, 2003, J COMP NEUROL, V463, P372, DOI 10.1002/cne.10750; Hadano S, 2001, GENOMICS, V71, P200, DOI 10.1006/geno.2000.6392; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; Kittler JT, 2002, MOL NEUROBIOL, V26, P251, DOI 10.1385/MN:26:2-3:251; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Levy Lucien M., 1999, Annals of Internal Medicine, V131, P522; Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Li YK, 2002, J BIOL CHEM, V277, P28212, DOI 10.1074/jbc.M111612200; LORISH TR, 1989, MAYO CLIN PROC, V64, P629, DOI 10.1016/S0025-6196(12)65339-7; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; Marcora E, 2003, P NATL ACAD SCI USA, V100, P9578, DOI 10.1073/pnas.1133382100; Mayer R J, 1989, Prog Clin Biol Res, V317, P809; McKernan RM, 1996, TRENDS NEUROSCI, V19, P139, DOI 10.1016/S0166-2236(96)80023-3; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; WZIESENDANGER M, 1972, PATHOPHYSIOLOGY MUSC	30	48	50	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					245	250		10.1038/ng1715	http://dx.doi.org/10.1038/ng1715			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16380713				2022-12-27	WOS:000234953200023
J	Liu, LP; Ni, JQ; Shi, YD; Oakeley, EJ; Sun, FL				Liu, LP; Ni, JQ; Shi, YD; Oakeley, EJ; Sun, FL			Sex-specific role of Drosophila melanogaster HP1 in regulating chromatin structure and gene transcription	NATURE GENETICS			English	Article							CHROMOSOMAL PROTEIN; DOSAGE COMPENSATION; HETEROCHROMATIN; EXPRESSION; METHYLATION; EUCHROMATIN	Drosophila melanogaster heterochromatin protein 1 (HP1a or HP1)(1) is believed to be involved in active transcription, transcriptional gene silencing and the formation of heterochromatin(2-7). But little is known about the function of HP1 during development. Using a Gal4-induced RNA interference system, we showed that conditional depletion of HP1 in transgenic flies resulted in preferential lethality in male flies. Cytological analysis of mitotic chromosomes showed that HP1 depletion caused sex-biased chromosomal defects, including telomere fusions. The global levels of specific histone modifications, particularly the hallmarks of active chromatin, were preferentially increased in males as well. Expression analysis showed that approximately twice as many genes were specifically regulated by HP1 in males than in females. Furthermore, HP1-regulated genes showed greater enrichment for HP1 binding in males. Taken together, these results indicate that HP1 modulates chromosomal integrity, histone modifications and transcription in a sex-specific manner.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Sun, FL (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	fang-lin.sun@fmi.ch						Akhtar A, 2000, MOL CELL, V5, P367, DOI 10.1016/S1097-2765(00)80431-1; Bergmann A, 2003, CURR OPIN CELL BIOL, V15, P717, DOI 10.1016/j.ceb.2003.10.002; Bongiorni S, 2001, DEVELOPMENT, V128, P3809; Christensen TW, 2003, MOL BIOL CELL, V14, P2206, DOI 10.1091/mbc.E02-11-0706; Cryderman DE, 2005, DEV DYNAM, V232, P767, DOI 10.1002/dvdy.20310; De Lucia F, 2005, NUCLEIC ACIDS RES, V33, P2852, DOI 10.1093/nar/gki584; Delattre M, 2004, J CELL SCI, V117, P6239, DOI 10.1242/jcs.01549; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; Giordano E, 2002, GENETICS, V160, P637; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Hauck B, 1999, P NATL ACAD SCI USA, V96, P564, DOI 10.1073/pnas.96.2.564; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kelley RL, 1997, NATURE, V387, P195, DOI 10.1038/387195a0; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Perrini B, 2004, MOL CELL, V15, P467, DOI 10.1016/j.molcel.2004.06.036; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Piacentini L, 2003, J CELL BIOL, V161, P707, DOI 10.1083/jcb.200303012; RAFTERY LA, 1991, DEVELOPMENT, V113, P27; Schotta G, 2002, EMBO J, V21, P1121, DOI 10.1093/emboj/21.5.1121; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; SHAFFER CD, 1994, METHOD CELL BIOL, V44, P99, DOI 10.1016/S0091-679X(08)60908-5; Stennicke HR, 2002, TRENDS BIOCHEM SCI, V27, P94, DOI 10.1016/S0968-0004(01)02045-X; Sun FL, 2000, P NATL ACAD SCI USA, V97, P5340, DOI 10.1073/pnas.090530797; Th'ng JPH, 2001, BIOCHEM CELL BIOL, V79, P305, DOI 10.1139/bcb-79-3-305	30	62	62	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2005	37	12					1361	1366		10.1038/ng1662	http://dx.doi.org/10.1038/ng1662			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16258543				2022-12-27	WOS:000233657300017
J	Curran, JE; Jowett, JBM; Elliott, KS; Gao, Y; Gluschenko, K; Wang, JM; Azim, DMA; Cai, GW; Mahaney, MC; Comuzzie, AG; Dyer, TD; Walder, KR; Zimmet, P; MacCluer, JW; Collier, GR; Kissebah, AH; Blangero, J				Curran, JE; Jowett, JBM; Elliott, KS; Gao, Y; Gluschenko, K; Wang, JM; Azim, DMA; Cai, GW; Mahaney, MC; Comuzzie, AG; Dyer, TD; Walder, KR; Zimmet, P; MacCluer, JW; Collier, GR; Kissebah, AH; Blangero, J			Genetic variation in selenoprotein S influences inflammatory response	NATURE GENETICS			English	Article							ENDOPLASMIC-RETICULUM STRESS; 15Q26 IDDM3; PROTEIN; POPULATION; COMPLEX; RISK; SUSCEPTIBILITY; POLYMORPHISM; METABOLISM; EXPRESSION	Chronic inflammation has a pathological role in many common diseases and is influenced by both genetic and environmental factors. Here we assess the role of genetic variation in selenoprotein S (SEPS1, also called SELS or SELENOS), a gene involved in stress response in the endoplasmic reticulum and inflammation control. After resequencing SEPS1, we genotyped 13 SNPs in 522 individuals from 92 families. As inflammation biomarkers, we measured plasma levels of IL-6, IL-1 beta and TNF-alpha. Bayesian quantitative trait nucleotide analysis identified associations between SEPS1 polymorphisms and all three proinflammatory cytokines. One promoter variant, -105G-->A, showed strong evidence for an association with each cytokine (multivariate P = 0.0000002). Functional analysis of this polymorphism showed that the A variant significantly impaired SEPS1 expression after exposure to endoplasmic reticulum stress agents (P = 0.00006). Furthermore, suppression of SEPS1 by short interfering RNA in macrophage cells increased the release of IL-6 and TNF-alpha. To investigate further the significance of the observed associations, we genotyped -105G-->A in 419 Mexican American individuals from 23 families for replication. This analysis confirmed a significant association with both TNF-alpha (P = 0.0049) and IL- 1 beta (P = 0.0101). These results provide a direct mechanistic link between SEPS1 and the production of inflammatory cytokines and suggest that SEPS1 has a role in mediating inflammation.	SW Fdn Biomed Res, San Antonio, TX 78227 USA; Int Diabet Inst, Caulfield, Vic, Australia; ChemGenex Pharmaceut, Geelong, Vic, Australia; Deakin Univ, Sch Hlth Sci, Metab Res Unit, Waurn Ponds, Vic, Australia	Texas Biomedical Research Institute; Deakin University	Blangero, J (corresponding author), SW Fdn Biomed Res, San Antonio, TX 78227 USA.	john@darwin.sfbr.org	Jowett, Jeremy/A-3809-2009; Blangero, John/ABA-7175-2021; Zimmet, Paul/O-8486-2019	Zimmet, Paul/0000-0003-0627-0776; Curran, Joanne/0000-0002-6898-155X				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Arthur JR, 2003, P NUTR SOC, V62, P393, DOI 10.1079/PNS2003254; Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007; Blangero J, 2003, J THROMB HAEMOST, V1, P1391, DOI 10.1046/j.1538-7836.2003.00310.x; BLANGERO J, IN PRESS HUM BIOL; Buetow KH, 2001, P NATL ACAD SCI USA, V98, P581, DOI 10.1073/pnas.021506298; Caspersen C, 2000, J BIOL CHEM, V275, P22363, DOI 10.1074/jbc.M001569200; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; de Maat MPM, 2004, ARTERIOSCL THROM VAS, V24, P2168, DOI 10.1161/01.ATV.0000143856.01669.e7; Ferencik M, 2003, FOLIA MICROBIOL, V48, P417, DOI 10.1007/BF02931378; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; Gao Y, 2004, FEBS LETT, V563, P185, DOI 10.1016/S0014-5793(04)00296-0; Gao Y, 2003, DIABETES, V52, P929, DOI 10.2337/diabetes.52.4.929; Karlsson HKR, 2004, DIABETES, V53, P1424, DOI 10.2337/diabetes.53.6.1424; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; Kokame K, 2001, J BIOL CHEM, V276, P9199, DOI 10.1074/jbc.M010486200; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Long AD, 1998, GENETICS, V149, P999; MacCluer JW, 1999, NUTR REV, V57, pS59, DOI 10.1111/j.1753-4887.1999.tb01790.x; Pahl HL, 1997, TRENDS BIOCHEM SCI, V22, P63, DOI 10.1016/S0968-0004(96)10073-6; Pantsulaia I, 2002, CYTOKINE, V19, P138, DOI 10.1006/cyto.2002.1959; Phillips PC, 1999, TRENDS GENET, V15, P6, DOI 10.1016/S0168-9525(98)01622-9; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Roy B, 1999, NUCLEIC ACIDS RES, V27, P1437, DOI 10.1093/nar/27.6.1437; Saadeddin Salam M, 2002, Med Sci Monit, V8, pRA5; Stengard JH, 2002, AM J HUM GENET, V71, P501, DOI 10.1086/342217; Susi M, 2001, SCAND J GASTROENTERO, V36, P372, DOI 10.1080/003655201300051153; Walder K, 2002, DIABETES, V51, P1859, DOI 10.2337/diabetes.51.6.1859; Williams-Blangero S, 2004, HUM BIOL, V76, P515, DOI 10.1353/hub.2004.0062; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zamani M, 1996, HUM GENET, V98, P491, DOI 10.1007/s004390050245	35	284	297	3	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1234	1241		10.1038/ng1655	http://dx.doi.org/10.1038/ng1655			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16227999	Green Published			2022-12-27	WOS:000233045200023
J	Wade, CM; Daly, MJ				Wade, CM; Daly, MJ			Genetic variation in laboratory mice	NATURE GENETICS			English	Article							SEQUENCE VARIATION; MOUSE GENOME; INBRED MICE; WORMY MICE; STRAINS; TRAITS; POLYMORPHISMS; HAPLOTYPES; RESOLUTION; EVOLUTION	Characterizing the patterns of genetic variation in an organism provides fundamental insight into the evolutionary history of the organism and defines the scope and nature of studies that must be designed to correlate genotype to phenotype. Given the pre-eminent role of the inbred mouse in biomedical research, considerable effort has been undertaken in recent years to describe more fully the nature and amount of genetic variation among the numerous strains of mice that are in widest use. Here, we discuss recent studies that have contributed to an emerging understanding of the unique variation patterns found in inbred strains of mice and how they have arisen through a combination of natural evolution and human-directed breeding. These preliminary results have ramifications for genetic research into complex biomedical traits and are the basis for the development of future variation resources.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Simches Res Ctr,Ctr Human Genet Res, Boston, MA 02114 USA; Broad Inst Harvard & MIT, Cambridge, MA 02141 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Daly, MJ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Simches Res Ctr,Ctr Human Genet Res, CPZN-6818,185 Cambridge St, Boston, MA 02114 USA.	mjdaly@chgr.mgh.harvard.edu	Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752; Wade, Claire/0000-0003-3413-4771				Adams DJ, 2005, NAT GENET, V37, P532, DOI 10.1038/ng1551; BISHOP CE, 1985, NATURE, V315, P70, DOI 10.1038/315070a0; BONHOMME F, 1987, BIOL J LINN SOC, V30, P51, DOI 10.1111/j.1095-8312.1987.tb00288.x; BOURSOT P, 1993, ANNU REV ECOL SYST, V24, P119, DOI 10.1146/annurev.es.24.110193.001003; CERVINO AC, 2005, GENOMICS        0829, DOI DOI 10.1016/J.YGENO.2005.07.010; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r47; Chung YJ, 2004, GENOME RES, V14, P188, DOI 10.1101/gr.1878804; Cooper D. N., 1993, HUMAN GENE MUTATION; Darvasi A, 2001, SCIENCE, V294; Dietrich WF, 1996, NATURE, V380, P149, DOI 10.1038/380149a0; FERRIS SD, 1982, NATURE, V295, P163, DOI 10.1038/295163a0; FERRIS SD, 1983, GENETICS, V105, P681; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; FOREJT J, 1991, MAMM GENOME, V1, P84, DOI 10.1007/BF02443783; Frazer KA, 2004, GENOME RES, V14, P1493, DOI 10.1101/gr.2627804; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grupe A, 2001, SCIENCE, V292, P1915, DOI 10.1126/science.1058889; Ideraabdullah FY, 2004, GENOME RES, V14, P1880, DOI 10.1101/gr.2519704; KEELER CE, 1931, LAB MOUSE ITS ORIGIN; LANDER ES, 1989, GENETICS, V121, P185; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; MORSE HC, 1978, ORIGINS INBRED MICE, P1; MOULIA C, 1991, J EVOLUTION BIOL, V4, P679, DOI 10.1046/j.1420-9101.1991.4040679.x; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; Pletcher MT, 2004, PLOS BIOL, V2, P2159, DOI 10.1371/journal.pbio.0020393; Prager EM, 1998, GENETICS, V150, P835; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SAGE RD, 1986, NATURE, V324, P60, DOI 10.1038/324060a0; Silver L. M., 1995, MOUSE GENETICS; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Snijders AM, 2005, GENOME RES, V15, P302, DOI 10.1101/gr.2902505; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yalcin B, 2004, P NATL ACAD SCI USA, V101, P9734, DOI 10.1073/pnas.0401189101; YOKENAWA H, 1980, JPN J GENET, V55, P289; Zhang JH, 2005, GENOME RES, V15, P241, DOI 10.1101/gr.2901705	36	115	118	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1175	1180		10.1038/ng1666	http://dx.doi.org/10.1038/ng1666			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16254563				2022-12-27	WOS:000233045200013
J	Levran, O; Attwooll, C; Henry, RT; Milton, KL; Neveling, K; Rio, P; Batish, SD; Kalb, R; Velleuer, E; Barral, S; Ott, J; Petrini, J; Schindler, D; Hanenberg, H; Auerbach, AD				Levran, O; Attwooll, C; Henry, RT; Milton, KL; Neveling, K; Rio, P; Batish, SD; Kalb, R; Velleuer, E; Barral, S; Ott, J; Petrini, J; Schindler, D; Hanenberg, H; Auerbach, AD			The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia	NATURE GENETICS			English	Article							BRCA1; PROTEIN; BACH1	Seven Fanconi anemia - associated proteins ( FANCA, FANCB, FANCC, FANCE, FANCF, FANCG and FANCL) form a nuclear Fanconi anemia core complex that activates the monoubiquitination of FANCD2, targeting FANCD2 to BRCA1-containing nuclear foci. Cells from individuals with Fanconi anemia of complementation groups D1 and J ( FA- D1 and FA- J) have normal FANCD2 ubiquitination. Using genetic mapping, mutation identification and western- blot data, we identify the defective protein in FA- J cells as BRIP1 ( also called BACH1), a DNA helicase that is a binding partner of the breast cancer tumor suppressor BRCA1.	Rockefeller Univ, Lab Human Genet & Hematol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Univ Wurzburg, Inst Human Genet, Wurzburg, Germany; Univ Dusseldorf, Dept Pediat Oncol Hematol & Immunol, Dusseldorf, Germany; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; University of Wurzburg; Heinrich Heine University Dusseldorf; Rockefeller University	Auerbach, AD (corresponding author), Rockefeller Univ, Lab Human Genet & Hematol, 1230 York Ave, New York, NY 10021 USA.	auerbac@rockefeller.edu	Levran, Orna/H-2772-2019; Velleuer, Eunike/U-6355-2019; Rio, Paula/G-8681-2015; Kalb, Reinhard/AAR-3249-2021; 高, 雨莉/HGU-8187-2022	Velleuer, Eunike/0000-0003-4328-9556; Rio, Paula/0000-0002-5424-5543; Kalb, Reinhard/0000-0003-3906-6907; Auerbach, Arleen/0000-0002-6911-8379; Petrini, John/0000-0001-5102-5679				Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chen JJ, 1999, CANCER RES, V59, p1752S; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gschwend M, 1996, AM J HUM GENET, V59, P377; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Levitus M, 2004, BLOOD, V103, P2498, DOI 10.1182/blood-2003-08-2915; Liu YL, 2004, SCIENCE, V303, P243, DOI 10.1126/science.1093037; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Meetei AR, 2004, NAT GENET, V36, P1219, DOI 10.1038/ng1458; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Rutter JL, 2003, HUM MUTAT, V22, P121, DOI 10.1002/humu.10238	13	288	293	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2005	37	9					931	933		10.1038/ng1624	http://dx.doi.org/10.1038/ng1624			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	960LK	16116424				2022-12-27	WOS:000231591900015
J	Skibinski, G; Parkinson, NJ; Brown, JM; Chakrabarti, L; Lloyd, SL; Hummerich, H; Nielsen, JE; Hodges, JR; Spillantini, MG; Thusgaard, T; Brandner, S; Brun, A; Rossor, MN; Gade, A; Johannsen, P; Sorensen, SA; Gydesen, S; Fisher, EMC; Collinge, J				Skibinski, G; Parkinson, NJ; Brown, JM; Chakrabarti, L; Lloyd, SL; Hummerich, H; Nielsen, JE; Hodges, JR; Spillantini, MG; Thusgaard, T; Brandner, S; Brun, A; Rossor, MN; Gade, A; Johannsen, P; Sorensen, SA; Gydesen, S; Fisher, EMC; Collinge, J			Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia	NATURE GENETICS			English	Article							PROTEIN; TRAFFICKING; DISEASE; FTD-3	We have previously reported a large Danish pedigree with autosomal dominant frontotemporal dementia (FTD) linked to chromosome 3 (FTD3). Here we identify a mutation in CHMP2B, encoding a component of the endosomal ESCRTIII complex, and show that it results in aberrant mRNA splicing in tissue samples from affected members of this family. We also describe an additional missense mutation in an unrelated individual with FTD. Aberration in the endosomal ESCRTIII complex may result in FTD and neurodegenerative disease.	UCL, Inst Neurol, Dept Neurodegenerat Dis, London WC1E 6BT, England; UCL, Inst Neurol, MRC, Prion Unit, London, England; Addenbrookes Hosp, Dept Neurol, MRC, Cognit & Brain Sci Unit, Cambridge, England; Univ Copenhagen, Panum Inst, Dept Med Biochem & Genet, Neurogenet Sect, DK-1168 Copenhagen, Denmark; Univ Copenhagen Hosp, Rigshosp, Ctr Neurosci, Memory Disorders Res Unit, DK-2100 Copenhagen, Denmark; Univ Cambridge, Dept Clin Neurosci, Ctr Brain Repair, Cambridge, England; Parkvaenget Nursing Home, Holstebro, Denmark; Univ Lund Hosp, Dept Pathol, S-22185 Lund, Sweden; Univ Copenhagen, Rigshosp, Dept Psychol, DK-1168 Copenhagen, Denmark; Cent Hosp, Dept Psychiat, Holbaek, Denmark	University of London; University College London; University of London; University College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Cambridge; Lund University; Skane University Hospital; Rigshospitalet; University of Copenhagen; Holbaek Hospital	Fisher, EMC (corresponding author), UCL, Inst Neurol, Dept Neurodegenerat Dis, London WC1E 6BT, England.	e.fisher@prion.ucl.ac.uk	Johannsen, Peter/G-1079-2011; Fisher, Elizabeth MC/C-2168-2008; Brandner, Sebastian/J-4562-2014; Chakrabarti, Lisa/G-4236-2011; Rossor, Martin/C-1598-2008	Johannsen, Peter/0000-0002-0528-1070; Fisher, Elizabeth MC/0000-0003-2850-9936; Brandner, Sebastian/0000-0002-9821-0342; Nielsen, Jorgen Erik/0000-0003-0453-5582; Chakrabarti, Lisa/0000-0001-7213-6837; Rossor, Martin/0000-0001-8215-3120				Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; COLLINGE J, 1994, J NEUROL NEUROSUR PS, V57, P762, DOI 10.1136/jnnp.57.6.762; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; Gydesen S, 2002, NEUROLOGY, V59, P1585, DOI 10.1212/01.WNL.0000034763.54161.1F; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; KNOPMAN DS, 1990, NEUROLOGY, V40, P251, DOI 10.1212/WNL.40.2.251; Kunita R, 2004, J BIOL CHEM, V279, P38626, DOI 10.1074/jbc.M406120200; Martin-Serrano J, 2003, P NATL ACAD SCI USA, V100, P12414, DOI 10.1073/pnas.2133846100; Nixon RA, 2005, NEUROBIOL AGING, V26, P373, DOI 10.1016/j.neurobiolaging.2004.09.018; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; WILHELMSEN KC, 1994, AM J HUM GENET, V55, P1159; Yancopoulu D, 2003, J NEUROPATH EXP NEUR, V62, P878, DOI 10.1093/jnen/62.8.878	15	606	624	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2005	37	8					806	808		10.1038/ng1609	http://dx.doi.org/10.1038/ng1609			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16041373	Green Published			2022-12-27	WOS:000230880400009
J	Allen, E; Xie, ZX; Gustafson, AM; Sung, GH; Spatafora, JW; Carrington, JC				Allen, E; Xie, ZX; Gustafson, AM; Sung, GH; Spatafora, JW; Carrington, JC			Evolution of microRNA genes by inverted duplication of target gene sequences in Arabidopsis thaliana	NATURE GENETICS			English	Article							TRANS-ACTING SIRNAS; PLANT DEVELOPMENT; RNA-INTERFERENCE; MIRNA; PROTEIN; DICER; ACCUMULATION; BIOGENESIS; EXPRESSION; GENOMICS	MicroRNAs (miRNAs) in plants and animals function as post-transcriptional regulators of target genes, many of which are involved in multicellular development. miRNAs guide effector complexes to target mRNAs through base-pair complementarity, facilitating site-specific cleavage or translational repression. Biogenesis of miRNAs involves nucleolytic processing of a precursor transcript with extensive foldback structure. Here, we provide evidence that genes encoding miRNAs in plants originated by inverted duplication of target gene sequences. Several recently evolved genes encoding miRNAs in Arabidopsis thaliana and other small RNA-generating loci possess the hallmarks of inverted duplication events that formed the arms on each side of their respective foldback precursors. We propose a model for miRNA evolution that suggests a mechanism for de novo generation of new miRNA genes with unique target specificities.	Oregon State Univ, Ctr Gene Res & Biotechnol, Corvallis, OR 97331 USA; Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Carrington, JC (corresponding author), Oregon State Univ, Ctr Gene Res & Biotechnol, Corvallis, OR 97331 USA.	carrington@cgrb.oregonstate.edu	Carrington, James C/A-4656-2012	Carrington, James C/0000-0003-3572-129X; Allen, Edwards/0000-0002-8318-6319; Xie, Zhixin/0000-0002-6191-5170				Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Finnegan EJ, 2003, J CELL SCI, V116, P4689, DOI 10.1242/jcs.00838; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Herbert A, 2004, NAT GENET, V36, P19, DOI 10.1038/ng1275; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Holder M, 2003, NAT REV GENET, V4, P275, DOI 10.1038/nrg1044; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Laufs P, 2004, DEVELOPMENT, V131, P4311, DOI 10.1242/dev.01320; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; LIN JT, 1988, STATISTICIAN, V37, P413, DOI 10.2307/2348766; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Meyerowitz EM, 2002, SCIENCE, V295, P1482, DOI 10.1126/science.1066609; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Papp I, 2003, PLANT PHYSIOL, V132, P1382, DOI 10.1104/pp.103.021980; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Poethig RS, 2001, GENOME RES, V11, P313, DOI 10.1101/gr.180001; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; SCHANK RC, 1991, J LEARN SCI, V1, P7; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1	50	451	504	2	58	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2004	36	12					1282	1290		10.1038/ng1478	http://dx.doi.org/10.1038/ng1478			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15565108				2022-12-27	WOS:000225354100015
J	Ioannidis, JPA; Ntzani, EE; Trikalinos, TA				Ioannidis, JPA; Ntzani, EE; Trikalinos, TA			'Racial' differences in genetic effects for complex diseases	NATURE GENETICS			English	Article							POPULATION STRATIFICATION; CANCER; ASSOCIATIONS; VALIDITY; RACE	'Racial' differences are frequently debated in clinical, epidemiological and molecular research and beyond(1,2). In particular, there is considerable controversy regarding the existence and importance of 'racial' differences in genetic effects for complex diseases(3-6) influenced by a large number of genes(7). An important question is whether ancestry influences the impact of each gene variant on the disease risk. Here, we addressed this question by examining the genetic effects for 43 validated gene-disease associations across 697 study populations of various descents. The frequencies of the genetic marker of interest in the control populations often (58%) showed large heterogeneity (statistical variability) between 'races'. Conversely, we saw large heterogeneity in the genetic effects (odds ratios) between 'races' in only 14% of cases. Genetic markers for proposed gene-disease associations vary in frequency across populations, but their biological impact on the risk for common diseases may usually be consistent across traditional 'racial' boundaries.	Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece; Fdn Res & Technol Hellas, Biomed Res Inst, Ioannina 45110, Greece; Tufts Univ, Sch Med, Tufts New England Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA	University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); Tufts Medical Center; Tufts University	Ioannidis, JPA (corresponding author), Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece.	jioannid@cc.uoi.gr	Ntzani, Evangelina E./K-1565-2019; Trikalinos, Thomas A/A-1217-2009; Ioannidis, John P. A./G-9836-2011	Ntzani, Evangelia/0000-0003-3712-4181				Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Feldman MW, 2003, NATURE, V424, P374, DOI 10.1038/424374a; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ioannidis JPA, 2003, LANCET, V361, P567, DOI 10.1016/S0140-6736(03)12516-0; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kaufman JS, 2001, AM J EPIDEMIOL, V154, P291, DOI 10.1093/aje/154.4.291; King MC, 2002, SCIENCE, V298, P2342, DOI 10.1126/science.1080373; Kressin NR, 2003, AM J PUBLIC HEALTH, V93, P1734, DOI 10.2105/AJPH.93.10.1734; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; PETTITI D, 1999, META ANAL DECISION A; Risch N., 2002, GENOME BIOL, V3, pcomm, DOI [10.1186/gb-2002-3-7-comment2007, 10.1186/GB-2002-3-7-COMMENT2007]; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Thomas DC, 2002, CANCER EPIDEM BIOMAR, V11, P505; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513	20	354	361	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2004	36	12					1312	1318		10.1038/ng1474	http://dx.doi.org/10.1038/ng1474			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15543147				2022-12-27	WOS:000225354100020
J	Wessells, RJ; Fitzgerald, E; Cypser, JR; Tatar, M; Bodmer, R				Wessells, RJ; Fitzgerald, E; Cypser, JR; Tatar, M; Bodmer, R			Insulin regulation of heart function in aging fruit flies	NATURE GENETICS			English	Article							LIFE-SPAN; DROSOPHILA-MELANOGASTER; GENETIC-ANALYSIS; RECEPTOR; GROWTH; CELL; ELEGANS; HOMOLOG; TINMAN; MUTANT	Insulin-IGF receptor (InR) signaling has a conserved role in regulating lifespan, but little is known about the genetic control of declining organ function. Here, we describe progressive changes of heart function in aging fruit flies: from one to seven weeks of a fly's age, the resting heart rate decreases and the rate of stress-induced heart failure increases. These age-related changes are minimized or absent in long-lived flies when systemic levels of insulin-like peptides are reduced and by mutations of the only receptor, InR, or its substrate, chico. Moreover, interfering with InR signaling exclusively in the heart, by overexpressing the phosphatase dPTEN or the forkhead transcription factor dFOXO, prevents the decline in cardiac performance with age. Thus, insulin-IGF signaling influences age-dependent organ physiology and senescence directly and autonomously, in addition to its systemic effect on lifespan. The aging fly heart is a model for studying the genetics of age-sensitive organ-specific pathology.	Burnham Inst, Ctr Neurosci & Aging, La Jolla, CA 92037 USA; Brown Univ, Dept Ecol & Evolutionary Biol, Providence, RI 02912 USA	Sanford Burnham Prebys Medical Discovery Institute; Brown University	Bodmer, R (corresponding author), Burnham Inst, Ctr Neurosci & Aging, 10901 Torrey Pines Rd, La Jolla, CA 92037 USA.	rolf@burnham.org	Wessells, Robert/AAG-3406-2020	Tatar, Marc/0000-0003-3232-6884; CYPSER, JAMES/0000-0001-8436-6437; Wessells, Robert/0000-0002-4516-3183				Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; BODMER R, 1993, DEVELOPMENT, V118, P719; BODMER R, 1995, TRENDS CARDIOVAS MED, V5, P21, DOI 10.1016/1050-1738(94)00032-Q; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Chen C, 1996, ENDOCRINOLOGY, V137, P846, DOI 10.1210/en.137.3.846; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Dowse H, 1995, J NEUROGENET, V10, P153, DOI 10.3109/01677069509083461; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; Gao XS, 2000, DEV BIOL, V221, P404, DOI 10.1006/dbio.2000.9680; Garigan D, 2002, GENETICS, V161, P1101; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Hassan BA, 2000, NEURON, V25, P549, DOI 10.1016/S0896-6273(00)81059-4; Helfand SL, 2003, BIOESSAYS, V25, P134, DOI 10.1002/bies.10225; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Khan AS, 2002, CARDIOVASC RES, V54, P25, DOI 10.1016/S0008-6363(01)00533-8; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Leevers SJ, 2001, CURR BIOL, V11, pR209, DOI 10.1016/S0960-9822(01)00107-5; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Molina MR, 2001, MECH DEVELOP, V109, P51, DOI 10.1016/S0925-4773(01)00509-3; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Oldham S, 2002, DEVELOPMENT, V129, P4103; Paternostro G, 2001, CIRC RES, V88, P1053, DOI 10.1161/hh1001.090857; Promislow DEL, 1996, GENETICS, V143, P839; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Siegmund T, 2001, J COMP NEUROL, V431, P481, DOI 10.1002/1096-9861(20010319)431:4<481::AID-CNE1084>3.0.CO;2-7; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Tatar M, 2001, AM NAT, V158, P248, DOI 10.1086/321320; Tu MP, 2002, AGING CELL, V1, P75, DOI 10.1046/j.1474-9728.2002.00010.x; Tu MP, 2002, AGING CELL, V1, P158, DOI 10.1046/j.1474-9728.2002.00016.x; Venkatesh TV, 2000, GENESIS, V26, P55, DOI 10.1002/(SICI)1526-968X(200001)26:1<55::AID-GENE8>3.0.CO;2-A; Wessel RJ, 2004, BIOTECHNIQUES, V37, P58, DOI 10.2144/04371ST01; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147	41	226	238	0	25	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2004	36	12					1275	1281		10.1038/ng1476	http://dx.doi.org/10.1038/ng1476			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15565107				2022-12-27	WOS:000225354100014
J	Burki, F; Kaessmann, H				Burki, F; Kaessmann, H			Birth and adaptive evolution of a hominoid gene that supports high neurotransmitter flux	NATURE GENETICS			English	Article							HUMAN GLUTAMATE-DEHYDROGENASES; TISSUE-SPECIFIC GLUD2; MECHANISMS; ASTROCYTES; SIZE	The enzyme glutamate dehydrogenase (GDH) is important for recycling the chief excitatory neurotransmitter, glutamate, during neurotransmission. Human GDH exists in housekeeping and brain-specific isotypes encoded by the genes GLUD1 and GLUD2, respectively. Here we show that GLUD2 originated by retroposition from GLUD1 in the hominoid ancestor less than 23 million years ago. The amino acid changes responsible for the unique brain-specific properties of the enzyme derived from GLUD2 occurred during a period of positive selection after the duplication event.	Univ Lausanne, Ctr Integrat Genom, BEP, CH-1015 Lausanne, Switzerland	University of Lausanne	Kaessmann, H (corresponding author), Univ Lausanne, Ctr Integrat Genom, BEP, CH-1015 Lausanne, Switzerland.	Henrik.Kaessmann@cig.unil.ch	Burki, Fabien/F-4818-2010; Kaessmann, Henrik/B-4989-2013	Kaessmann, Henrik/0000-0001-7563-839X				Burbaeva GS, 2003, PROG NEURO-PSYCHOPH, V27, P675, DOI 10.1016/S0278-5846(03)00078-2; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Cavallaro S, 1997, P NATL ACAD SCI USA, V94, P9669, DOI 10.1073/pnas.94.18.9669; Evans PD, 2004, HUM MOL GENET, V13, P1139, DOI 10.1093/hmg/ddh126; Evans PD, 2004, HUM MOL GENET, V13, P489, DOI 10.1093/hmg/ddh055; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Hertz L, 1999, J NEUROSCI RES, V57, P417, DOI 10.1002/(SICI)1097-4547(19990815)57:4<417::AID-JNR1>3.3.CO;2-E; LI WH, 1997, MOL EVOLUTION ROLES; NOBACK CR, 1970, PRIMATE BRAIN EVOLUT; Plaitakis A, 2000, J NEUROCHEM, V75, P1862, DOI 10.1046/j.1471-4159.2000.0751862.x; Plaitakis A, 2003, NEUROCHEM INT, V43, P401, DOI 10.1016/S0197-0186(03)00028-7; SHASHIDHARAN P, 1994, J BIOL CHEM, V269, P16971; Sonnewald U, 1997, GLIA, V21, P56, DOI 10.1002/(SICI)1098-1136(199709)21:1<56::AID-GLIA6>3.0.CO;2-#; Wan MH, 1998, AM J MED GENET, V78, P169, DOI 10.1002/(SICI)1096-8628(19980630)78:2<169::AID-AJMG14>3.3.CO;2-D; Zhang ZL, 2004, TRENDS GENET, V20, P62, DOI 10.1016/j.tig.2003.12.005	15	149	159	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2004	36	10					1061	1063		10.1038/ng1431	http://dx.doi.org/10.1038/ng1431			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	15378063	Bronze			2022-12-27	WOS:000224156500013
J	Hekimi, S				Hekimi, Siegfried			How genetic analysis tests theories of animal aging	NATURE GENETICS			English	Article							REGULATES LIFE-SPAN; CAENORHABDITIS-ELEGANS; C-ELEGANS; OXIDATIVE STRESS; CALORIC RESTRICTION; SACCHAROMYCES-CEREVISIAE; LARVAL DEVELOPMENT; BODY-WEIGHT; LONGEVITY; CANCER	Each animal species displays a specific life span, rate of aging and pattern of development of age-dependent diseases. The genetic bases of these related features are being studied experimentally in invertebrate and vertebrate model systems as well as in humans through medical records. Three types of mutants are being analyzed: (i) short-lived mutants that are prone to age-dependent diseases and might be models of accelerated aging; (ii) mutants that show overt molecular defects but that do not live shorter lives than controls, and can be used to test specific theories about the molecular causes of aging and age-dependent diseases; and (iii) long-lived mutants that might advance the understanding of the molecular physiology of slow-aging animals and aid the discovery of molecular targets that could be used to manipulate rates of aging to benefit human health. Here, I analyze some of what we know today and discuss what we should try to find out in the future to understand the aging phenomenon.	McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Hekimi, S (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	siegfried.hekimi@mcgill.ca		Hekimi, Siegfried/0000-0002-3592-5711				Andersen SL, 2005, MECH AGEING DEV, V126, P263, DOI 10.1016/j.mad.2004.08.019; Atzmon G, 2006, PLOS BIOL, V4, P562, DOI 10.1371/journal.pbio.0040113; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Barger JL, 2003, EXP GERONTOL, V38, P1343, DOI 10.1016/j.exger.2003.10.017; Bartke A, 2005, ENDOCRINOLOGY, V146, P3718, DOI 10.1210/en.2005-0411; Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; BLACKWELL BN, 1995, TOXICOL PATHOL, V23, P570, DOI 10.1177/019262339502300503; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Boehm M, 2005, SCIENCE, V310, P1954, DOI 10.1126/science.1115596; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Branicky R, 2000, BIOESSAYS, V22, P48, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;48::AID-BIES9&gt;3.0.CO;2-F; Carriere A, 2006, AGE, V28, P201, DOI 10.1007/s11357-006-9006-8; Chin CH, 2004, GENE DEV, V18, P1970, DOI 10.1101/gad.1213104; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; COSGROVE GE, 1978, J GERONTOL, V33, P178, DOI 10.1093/geronj/33.2.178; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Epstein C J, 1965, Trans Assoc Am Physicians, V78, P73; EPSTEIN CJ, 1966, MEDICINE, V45, P177, DOI 10.1097/00005792-196605000-00001; Evert J, 2003, J GERONTOL A-BIOL, V58, P232; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FRIEDMAN DB, 1988, GENETICS, V118, P75; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; HARDING AE, 1992, NAT GENET, V2, P251, DOI 10.1038/ng1292-251; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Hayflick L, 2004, J GERONTOL A-BIOL, V59, P547, DOI 10.1093/gerona/59.6.B547; Hekimi S, 2001, TRENDS GENET, V17, P712, DOI 10.1016/S0168-9525(01)02523-9; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; HODGKIN J, 1991, P ROY SOC B-BIOL SCI, V246, P19, DOI 10.1098/rspb.1991.0119; Holliday R, 2004, J GERONTOL A-BIOL, V59, P543, DOI 10.1093/gerona/59.6.B543; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Keaney M, 2004, FREE RADICAL BIO MED, V37, P239, DOI 10.1016/j.freeradbiomed.2004.04.005; Kennedy BK, 1996, TRENDS GENET, V12, P355, DOI 10.1016/0168-9525(96)10039-1; Kenney WL, 2003, J APPL PHYSIOL, V95, P2598, DOI 10.1152/japplphysiol.00202.2003; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; KOHN RR, 1982, JAMA-J AM MED ASSOC, V247, P2793, DOI 10.1001/jama.247.20.2793; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Liang HY, 2003, EXP GERONTOL, V38, P1353, DOI 10.1016/j.exger.2003.10.019; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905; Lombard DB, 2000, MOL CELL BIOL, V20, P3286, DOI 10.1128/MCB.20.9.3286-3291.2000; Ludewig AH, 2004, GENE DEV, V18, P2120, DOI 10.1101/gad.312604; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; Magwere T, 2006, MECH AGEING DEV, V127, P356, DOI 10.1016/j.mad.2005.12.009; Marden JH, 2003, P NATL ACAD SCI USA, V100, P3369, DOI 10.1073/pnas.0634985100; Martin GM, 2005, CELL, V120, P523, DOI 10.1016/j.cell.2005.01.031; Martin GM, 1997, MOL MED, V3, P356, DOI 10.1007/BF03401682; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Miller RA, 2005, J AM GERIATR SOC, V53, pS284, DOI 10.1111/j.1532-5415.2005.53490.x; Miller RA, 2002, AGING CELL, V1, P22, DOI 10.1046/j.1474-9728.2002.00006.x; MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Patil CK, 2005, MECH AGEING DEV, V126, P1040, DOI 10.1016/j.mad.2005.08.001; Perls T, 2000, J AM GERIATR SOC, V48, P1483, DOI 10.1111/jgs.2000.48.11.1483; Perls T, 2003, EXP GERONTOL, V38, P725, DOI 10.1016/S0531-5565(03)00098-6; Perls TT, 2002, P NATL ACAD SCI USA, V99, P8442, DOI 10.1073/pnas.122587599; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rogina B, 2000, SCIENCE, V290, P2137, DOI 10.1126/science.290.5499.2137; Rollo CD, 2002, EVOL DEV, V4, P55, DOI 10.1046/j.1525-142x.2002.01053.x; Rottiers V, 2006, DEV CELL, V10, P473, DOI 10.1016/j.devcel.2006.02.008; Rubner M., 1908, PROBLEM LEBENSDAUR S; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Samaras TT, 2003, LIFE SCI, V72, P1781, DOI 10.1016/S0024-3205(02)02503-1; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; SMITH GS, 1973, J NATL CANCER I, V50, P1195, DOI 10.1093/jnci/50.5.1195; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P573, DOI 10.1016/S0891-5849(02)00885-7; SOHAL RS, 1990, EXP GERONTOL, V25, P499, DOI 10.1016/0531-5565(90)90017-V; Strigini L, 1996, CLIN DERMATOL, V14, P197; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Terry DF, 2004, J AM GERIATR SOC, V52, P2074, DOI 10.1111/j.1532-5415.2004.52561.x; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Van Remmen H, 2004, FREE RADICAL BIO MED, V36, P1625, DOI 10.1016/j.freeradbiomed.2004.03.016; Walker DW, 2000, NATURE, V405, P296, DOI 10.1038/35012693; Wallace D C, 2001, Novartis Found Symp, V235, P247; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WONG A, 1995, GENETICS, V139, P1247	99	45	46	0	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					985	991		10.1038/ng1881	http://dx.doi.org/10.1038/ng1881			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	078OC	16941009				2022-12-27	WOS:000240112100013
J	Price, AL; Patterson, NJ; Plenge, RM; Weinblatt, ME; Shadick, NA; Reich, D				Price, Alkes L.; Patterson, Nick J.; Plenge, Robert M.; Weinblatt, Michael E.; Shadick, Nancy A.; Reich, David			Principal components analysis corrects for stratification in genome-wide association studies	NATURE GENETICS			English	Article							SAMPLE COVARIANCE MATRICES; HUMAN-POPULATION STRUCTURE; GENETIC ASSOCIATION; LARGEST EIGENVALUE; COMPLEX TRAITS; FREQUENCIES; DIFFERENTIATION; PREVALENCE; INFERENCE; GENOTYPE	Population stratification-allele frequency differences between cases and controls due to systematic ancestry differences-can cause spurious associations in disease studies. We describe a method that enables explicit detection and correction of population stratification on a genome-wide scale. Our method uses principal components analysis to explicitly model ancestry differences between cases and controls. The resulting correction is specific to a candidate marker's variation in frequency across ancestral populations, minimizing spurious associations while maximizing power to detect true associations. Our simple, efficient approach can easily be applied to disease studies with hundreds of thousands of markers.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital	Price, AL (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	aprice@broad.mit.edu						Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Angastiniotis M, 1998, ANN NY ACAD SCI, V850, P251, DOI 10.1111/j.1749-6632.1998.tb10482.x; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; BENITOGARCIA E, IN PRESS J RHEUMATOL; Bernardi F, 1997, ARTERIOSCL THROM VAS, V17, P2548, DOI 10.1161/01.ATV.17.11.2548; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; Cimmino MA, 1998, ANN RHEUM DIS, V57, P315, DOI 10.1136/ard.57.5.315; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Jackson JE, 2003, USERS GUIDE PRINCIPA; Johnstone IM, 2001, ANN STAT, V29, P295, DOI 10.1214/aos/1009210544; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Panza F, 2003, J NEUROL NEUROSUR PS, V74, P1159, DOI 10.1136/jnnp.74.8.1159; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Pritchard JK, 2000, GENETICS, V155, P945; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Serre D, 2004, GENOME RES, V14, P1679, DOI 10.1101/gr.2529604; Setakis E, 2006, GENOME RES, V16, P290, DOI 10.1101/gr.4346306; Soshnikov A, 2002, J STAT PHYS, V108, P1033, DOI 10.1023/A:1019739414239; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; WRIGHT S, 1951, ANN EUGENIC, V15, P323	39	6633	6784	26	727	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2006	38	8					904	909		10.1038/ng1847	http://dx.doi.org/10.1038/ng1847			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16862161				2022-12-27	WOS:000239325700019
J	Senee, V; Chelala, C; Duchatelet, S; Feng, DR; Blanc, H; Cossec, JC; Charon, C; Nicolino, M; Boileau, P; Cavener, DR; Bougneres, P; Taha, D; Julier, C				Senee, Valerie; Chelala, Claude; Duchatelet, Sabine; Feng, Daorong; Blanc, Herve; Cossec, Jack-Christophe; Charon, Celine; Nicolino, Marc; Boileau, Pascal; Cavener, Douglas R.; Bougneres, Pierre; Taha, Doris; Julier, Cecile			Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism	NATURE GENETICS			English	Article							GLUTAMATE TRANSPORTER; REPRESSOR FUNCTIONS; GLAUCOMA; AGENESIS; MICE; TRANSACTIVATION; DELETION; PROTEIN; PATHWAY; DISEASE	We recently described a new neonatal diabetes syndrome associated with congenital hypothyroidism, congenital glaucoma, hepatic fibrosis and polycystic kidneys(1). Here, we show that this syndrome results from mutations in GLIS3, encoding GLI similar 3, a recently identified transcription factor(2). In the original family, we identified a frameshift mutation predicted to result in a truncated protein. In two other families with an incomplete syndrome, we found that affected individuals harbor deletions affecting the 11 or 12 5'-most exons of the gene. The absence of a major transcript in the pancreas and thyroid ( deletions from both families) and an eye-specific transcript ( deletion from one family), together with residual expression of some GLIS3 transcripts, seems to explain the incomplete clinical manifestations in these individuals. GLIS3 is expressed in the pancreas from early developmental stages, with greater expression in beta cells than in other pancreatic tissues. These results demonstrate a major role for GLIS3 in the development of pancreatic b cells and the thyroid, eye, liver and kidney.	Inst Pasteur, F-75015 Paris, France; INSERM, U730, F-75015 Paris, France; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Hop Debrousse, Dept Endocrinol Pediat, F-69005 Lyon, France; Ctr Natl Genotypage, F-91054 Evry, France; Hop Cochin St Vincent de Paul, Dept Endocrinol Pediat, F-75014 Paris, France; INSERM, U561, F-75014 Paris, France; King Faisal Specialist Hosp & Res Ctr, Div Pediat Endocrinol, Jeddah 21499, Saudi Arabia	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; CHU Lyon; CEA; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); King Faisal Specialist Hospital & Research Center	Julier, C (corresponding author), Inst Pasteur, F-75015 Paris, France.	cjulier@pasteur.fr	Boileau, Pascal/H-7508-2015; DUCHATELET, Sabine/V-2605-2019; JULIER, Cécile/M-9824-2017; Boileau, Pascal/AAG-9683-2021; Senée, Valérie/M-9854-2017; Cavener, Douglas R/E-3524-2010	Boileau, Pascal/0000-0001-9755-6467; JULIER, Cécile/0000-0002-1538-0240; Boileau, Pascal/0000-0001-9755-6467; Senée, Valérie/0000-0001-7012-3944; chelala, claude/0000-0002-2488-0669; Cossec, Jack-Christophe/0000-0002-0836-1009	PHS HHS [NIDDK62049] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Cohn Amy C, 2005, Ophthalmic Genet, V26, P45, DOI 10.1080/13816810590918398; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Haumaitre C, 2005, P NATL ACAD SCI USA, V102, P1490, DOI 10.1073/pnas.0405776102; Hebrok M, 2003, MECH DEVELOP, V120, P45, DOI 10.1016/S0925-4773(02)00331-3; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KATSUSHIMA H, 1987, ARCH OPHTHALMOL-CHIC, V105, P323; Kim YS, 2003, NUCLEIC ACIDS RES, V31, P5513, DOI 10.1093/nar/gkg776; Kim YS, 2002, J BIOL CHEM, V277, P30901, DOI 10.1074/jbc.M203563200; Lees C, 2005, GASTROENTEROLOGY, V129, P1696, DOI 10.1053/j.gastro.2005.05.010; Park SM, 2005, J MED GENET, V42, P379, DOI 10.1136/jmg.2004.024158; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Sellick GS, 2004, NAT GENET, V36, P1301, DOI 10.1038/ng1475; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Taha D, 2003, AM J MED GENET A, V122A, P269, DOI 10.1002/ajmg.a.20267; Takahashi Masazumi, 2003, J Bioinform Comput Biol, V1, P253, DOI 10.1142/S021972000300006X; VERBRAAK FD, 1992, OPHTHALMIC PAED GEN, V13, P165, DOI 10.3109/13816819209046485; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Zhang F, 2002, J BIOL CHEM, V277, P10139, DOI 10.1074/jbc.M108062200	19	243	256	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					682	687		10.1038/ng1802	http://dx.doi.org/10.1038/ng1802			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16715098				2022-12-27	WOS:000237954800023
J	Graham, RR; Kozyrev, SV; Baechler, EC; Reddy, MPL; Plenge, RM; Bauer, JW; Ortmann, WA; Koeuth, T; Escribano, MF; Pons-Estel, B; Petri, M; Daly, M; Gregersen, PK; Martin, J; Altshuler, D; Behrens, TW; Alarcon-Riquelme, ME				Graham, RR; Kozyrev, SV; Baechler, EC; Reddy, MPL; Plenge, RM; Bauer, JW; Ortmann, WA; Koeuth, T; Escribano, MF; Pons-Estel, B; Petri, M; Daly, M; Gregersen, PK; Martin, J; Altshuler, D; Behrens, TW; Alarcon-Riquelme, ME		Argentine Collaborative Grp; Spanish Collaborative Grp	A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus	NATURE GENETICS			English	Article							HUMAN GENE-EXPRESSION; INDUCTION; ALPHA; GENOME; DISEQUILIBRIUM; ACTIVATION; LINKAGE; BLOOD; CELLS	Systemic lupus erythematosus (SLE) is a complex autoimmune disease(1) characterized by activation of the type I interferon (IFN) pathway(2-4). Here we convincingly replicate association of the IFN regulatory factor 5 (IRF5) rs2004640 T allele with SLE5 in four independent case-control cohorts (P = 4.4 x 10(-16)) and by family-based transmission disequilibrium test analysis (P = 0.0006). The rs2004640 T allele creates a 5' donor splice site in an alternate exon 1 of IRF5, allowing expression of several unique IRF5 isoforms. We also identify an independent cis-acting variant associated with elevated expression of IRF5 and linked to the exon 1B splice site. Haplotypes carrying the variant associated with elevated expression and lacking the exon 1B donor site do not confer risk of SLE. Thus, a common IRF5 haplotype driving elevated expression of multiple unique isoforms of IRF5 is an important genetic risk factor for SLE, establishing a causal role for type I IFN pathway genes in human autoimmunity.	Uppsala Univ, Rudbcek Lab, Unit Med Genet, Dept Genet & Pathol, S-75185 Uppsala, Sweden; MIT, Cambridge, MA 02142 USA; Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Ctr Human Genet Res & Mol Biol, Boston, MA 02114 USA; Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA; Hosp Virgen del Rocio, Serv Inmunol, Seville 41013, Spain; Sanatorio Parque, RA-2000 Rosario, Santa Fe, Argentina; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA; CSIC, Inst Biomed Lopez Neyra, Granada 18100, Spain	Uppsala University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of Minnesota System; University of Minnesota Twin Cities; Virgen del Rocio University Hospital; Johns Hopkins University; Northwell Health; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN)	Alarcon-Riquelme, ME (corresponding author), Uppsala Univ, Rudbcek Lab, Unit Med Genet, Dept Genet & Pathol, S-75185 Uppsala, Sweden.	behre001@umn.edu; marta.alarcon@genpat.uu.se	Daly, Mark J/B-2453-2017; REDDY, M.V. PRASAD LINGA/H-6330-2012; Alarcón-Riquelme, Marta E./ABF-8163-2020; Martin, Javier/B-8141-2008; Martín, María/HDL-9512-2022; Gillespie, Emily/N-1265-2013; González-Escribano, María Francisca/X-5554-2019; Martín, Javier/AAV-5209-2021; Altshuler, David M/A-4476-2009	Daly, Mark J/0000-0002-0949-8752; Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Martin, Javier/0000-0002-2202-0622; Gillespie, Emily/0000-0001-5261-3931; Altshuler, David M/0000-0002-7250-4107; Kozyrev, Sergey/0000-0001-6209-4100; Pons-Estel, Bernardo/0000-0003-2518-0266	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043727, R55AR043727] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR-00052] Funding Source: Medline; NIAMS NIH HHS [AR 43727] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alarcon-Segovia D, 2005, ARTHRITIS RHEUM-US, V52, P1138, DOI 10.1002/art.20999; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Barnes BJ, 2003, J BIOL CHEM, V278, P16630, DOI 10.1074/jbc.M212609200; Barnes BJ, 2002, MOL CELL BIOL, V22, P5721, DOI 10.1128/MCB.22.16.5721-5740.2002; Barnes BJ, 2001, J BIOL CHEM, V276, P23382, DOI 10.1074/jbc.M101216200; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Kirou KA, 2004, ARTHRITIS RHEUM, V50, P3958, DOI 10.1002/art.20798; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mancl ME, 2005, J BIOL CHEM, V280, P21078, DOI 10.1074/jbc.M500543200; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Ronnblom L, 2001, J EXP MED, V194, pF59, DOI 10.1084/jem.194.12.f59; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Woolson R F, 1982, Stat Med, V1, P37, DOI 10.1002/sim.4780010106	24	520	536	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					550	555		10.1038/ng1782	http://dx.doi.org/10.1038/ng1782			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16642019				2022-12-27	WOS:000237147500016
J	Kraytsberg, Y; Kudryavtseva, E; Mckee, AC; Geula, C; Kowall, NW; Khrapko, K				Kraytsberg, Y; Kudryavtseva, E; Mckee, AC; Geula, C; Kowall, NW; Khrapko, K			Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons	NATURE GENETICS			English	Article							PARKINSONIAN SIGNS; HUMAN BRAIN; MUTATIONS	Using a novel single-molecule PCR approach to quantify the total burden of mitochondrial DNA (mtDNA) molecules with deletions, we show that a high proportion of individual pigmented neurons in the aged human substantia nigra contain very high levels of mtDNA deletions. Molecules with deletions are largely clonal within each neuron; that is, they originate from a single deleted mtDNA molecule that has expanded clonally. The fraction of mtDNA deletions is significantly higher in cytochrome c oxidase (COX)- deficient neurons than in COX-positive neurons, suggesting that mtDNA deletions may be directly responsible for impaired cellular respiration.	Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Bedford, MA 01730 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Boston University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Khrapko, K (corresponding author), Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	khrapko@hms.harvard.edu	Kowall, Neil/M-5378-2019; Khrapko, Konstantin/A-3244-2009	Kowall, Neil/0000-0002-6624-0213; 	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013846, R01AG019787] Funding Source: NIH RePORTER; NIA NIH HHS [AG19787, AG13846] Funding Source: Medline; NIEHS NIH HHS [ES11343] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bennett DA, 1996, NEW ENGL J MED, V334, P71, DOI 10.1056/NEJM199601113340202; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Itoh K, 1996, NEUROBIOL AGING, V17, P843, DOI 10.1016/S0197-4580(96)00168-6; Jacobs HT, 2003, AGING CELL, V2, P11, DOI 10.1046/j.1474-9728.2003.00032.x; Khrapko K, 2005, REJUV RES, V8, P6, DOI 10.1089/rej.2005.8.6; Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434; KHRAPKO K, IN PRESS AGING CELL; Kraytsberg Y, 2005, EXPERT REV MOL DIAGN, V5, P809, DOI 10.1586/14737159.5.5.809; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; Nekhaeva E, 2002, MECH AGEING DEV, V123, P891, DOI 10.1016/S0047-6374(02)00026-X; Ross GW, 2004, ANN NEUROL, V56, P532, DOI 10.1002/ana.20226; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; SOONG NW, 1992, NAT GENET, V2, P318	15	661	682	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2006	38	5					518	520		10.1038/ng1778	http://dx.doi.org/10.1038/ng1778			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	037LE	16604072				2022-12-27	WOS:000237147500010
J	Dunoyer, P; Himber, C; Voinnet, O				Dunoyer, P; Himber, C; Voinnet, O			Induction, suppression and requirement of RNA silencing pathways in virulent Agrobacterium tumefaciens infections	NATURE GENETICS			English	Article							T-DNA INTEGRATION; INTERFERING RNA; CO-SUPPRESSION; GENE; ARABIDOPSIS; MICRORNA; VIRUS; PLANTS; TRANS; STEP	Regulation of gene expression through microRNAs ( miRNAs) and antiviral defense through small interfering RNAs (siRNAs) are aspects of RNA silencing(1), a process originally discovered as an unintended consequence of plant transformation by disarmed Agrobacterium tumefaciens strains(2). Although RNA silencing protects cells against foreign genetic elements(3), its defensive role against virulent, tumor-inducing bacteria has remained unexplored. Here, we show that siRNAs corresponding to transferred-DNA oncogenes initially accumulate in virulent A. tumefaciens - infected tissues and that RNA interference - deficient plants are hypersusceptible to the pathogen. Successful infection relies on a potent antisilencing state established in tumors whereby siRNA synthesis is specifically inhibited. This inhibition has only modest side effects on the miRNA pathway, shown here to be essential for disease development. The similarities and specificities of the A. tumefaciens RNA silencing interaction are discussed and contrasted with the situation encountered with plant viruses.	IBMP, CNRS, UPR2357, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Voinnet, O (corresponding author), IBMP, CNRS, UPR2357, Strasbourg, France.	olivier.voinnet@ibmp-ulp.u-strasbg.fr		Voinnet, Olivier/0000-0001-6982-9544				Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chateau S, 2000, J EXP BOT, V51, P1961, DOI 10.1093/jexbot/51.353.1961; Cluster PD, 1996, PLANT MOL BIOL, V32, P1197, DOI 10.1007/BF00041406; Dalmay T, 2000, PLANT CELL, V12, P369, DOI 10.1105/tpc.12.3.369; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dunoyer P, 2004, PLANT CELL, V16, P1235, DOI 10.1105/tpc.020719; Ekwall K, 2004, MOL CELL, V13, P304, DOI 10.1016/S1097-2765(04)00057-7; Escobar MA, 2003, TRENDS PLANT SCI, V8, P380, DOI 10.1016/S1360-1385(03)00162-6; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Gelvin SB, 2005, NATURE, V433, P583, DOI 10.1038/433583a; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; HOOD EE, 1986, J BACTERIOL, V168, P1291, DOI 10.1128/jb.168.3.1291-1301.1986; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Nam J, 1997, PLANT CELL, V9, P317, DOI 10.1105/tpc.9.3.317; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; OOMS G, 1982, CELL, V30, P589, DOI 10.1016/0092-8674(82)90255-0; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Tzfira T, 2004, TRENDS GENET, V20, P375, DOI 10.1016/j.tig.2004.06.004; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130	30	96	106	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2006	38	2					258	263		10.1038/ng1722	http://dx.doi.org/10.1038/ng1722			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16429161				2022-12-27	WOS:000234953200025
J	Nowack, MK; Grini, PE; Jakoby, MJ; Lafos, M; Koncz, C; Schnittger, A				Nowack, MK; Grini, PE; Jakoby, MJ; Lafos, M; Koncz, C; Schnittger, A			A positive signal from the fertilization of the egg cell sets off endosperm proliferation in angiosperm embryogenesis	NATURE GENETICS			English	Article							SEED DEVELOPMENT; ARABIDOPSIS-THALIANA; FEMALE GAMETOPHYTE; PLANT DEVELOPMENT; MUTANTS; IDENTIFICATION; EXPRESSION; KINASE; CYCLE; DIVISION	Double fertilization of the egg cell and the central cell by one sperm cell each produces the diploid embryo and the typically triploid endosperm and is one of the defining characteristics of flowering plants (angiosperms). Endosperm and embryo develop in parallel to form the mature seed, but little is known about the coordination between these two organisms. We characterized a mutation of the Arabidopsis thaliana Cdc2 homolog CDC2A ( also called CDKA; 1), which has a paternal effect. In cdc2a mutant pollen, only one sperm cell, instead of two, is produced. Mutant pollen is viable but can fertilize only one cell in the embryo sac, allowing for a genetic dissection of the double fertilization process. We observed exclusive fertilization of the egg cell by cdc2a sperm cells. Moreover, we found that unfertilized endosperm developed, suggesting that a previously unrecognized positive signal from the fertilization of the egg cell initiates proliferation of the central cell.	Univ Cologne, Lehrstuhl Bot 3, Max Delbruck Lab, Unigrp Max Planck Inst, D-50829 Cologne, Germany; Univ Oslo, Dept Mol Biosci, N-0316 Oslo, Norway; Max Planck Inst Zuchtungsforsch, D-50829 Cologne, Germany	Max Planck Society; University of Cologne; University of Oslo; Max Planck Society	Schnittger, A (corresponding author), Univ Cologne, Lehrstuhl Bot 3, Max Delbruck Lab, Unigrp Max Planck Inst, Carl Von Linne Weg 10, D-50829 Cologne, Germany.	schnitt@mpiz-koeln.mpg.de	Schnittger, Arp/AAO-6920-2020; chang, grace/E-2047-2012; Grini, Paul/N-5948-2019; Schnittger, Arp/F-8989-2010; Grini, Paul/H-9471-2016	Schnittger, Arp/0000-0001-7067-0091; Grini, Paul/0000-0003-3898-6277; Schnittger, Arp/0000-0001-7067-0091; Grini, Paul/0000-0003-3898-6277; Nowack, Moritz/0000-0001-8918-7577				Berger F, 2003, CURR OPIN PLANT BIOL, V6, P42, DOI 10.1016/S1369526602000043; Chaudhury AM, 1997, P NATL ACAD SCI USA, V94, P4223, DOI 10.1073/pnas.94.8.4223; Chaudhury AM, 2001, ANNU REV CELL DEV BI, V17, P677, DOI 10.1146/annurev.cellbio.17.1.677; Drews GN, 2002, ANNU REV GENET, V36, P99, DOI 10.1146/annurev.genet.36.040102.131941; Ebel C, 2004, NATURE, V429, P776, DOI 10.1038/nature02637; FERREIRA PCG, 1991, PLANT CELL, V3, P531, DOI 10.1105/tpc.3.5.531; Friedman WE, 1999, DEVELOPMENT, V126, P1065; Grini PE, 2002, GENETICS, V162, P1911; Grossniklaus U, 2001, CURR OPIN PLANT BIOL, V4, P21, DOI 10.1016/S1369-5266(00)00130-8; Guitton AE, 2004, DEVELOPMENT, V131, P2971, DOI 10.1242/dev.01168; HEMERLY A, 1995, EMBO J, V14, P3925, DOI 10.1002/j.1460-2075.1995.tb00064.x; Hemerly AS, 2000, PLANT J, V23, P123, DOI 10.1046/j.1365-313x.2000.00800.x; HIRAYAMA T, 1991, GENE, V105, P159, DOI 10.1016/0378-1119(91)90146-3; Hsieh TF, 2003, TRENDS PLANT SCI, V8, P439, DOI 10.1016/S1360-1385(03)00189-4; Leiva-Neto JT, 2004, PLANT CELL, V16, P1854, DOI 10.1105/tpc.022178; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Rios G, 2002, PLANT J, V32, P243, DOI 10.1046/j.1365-313X.2002.01416.x; Rotman N, 2005, CURR BIOL, V15, P244, DOI 10.1016/j.cub.2005.01.013; Sessions A, 1999, PLANT J, V20, P259, DOI 10.1046/j.1365-313x.1999.00594.x; Vandepoele K, 2002, PLANT CELL, V14, P903, DOI 10.1105/tpc.010445; Vinkenoog R, 2003, MOL BIOTECHNOL, V25, P149, DOI 10.1385/MB:25:2:149	22	203	214	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2006	38	1					63	67		10.1038/ng1694	http://dx.doi.org/10.1038/ng1694			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16311592	Green Published			2022-12-27	WOS:000234227200018
J	Rovelet-Lecrux, A; Hannequin, D; Raux, G; Le Meur, N; Laquerriere, A; Vital, A; Dumanchin, C; Feuillette, S; Brice, A; Vercelletto, M; Dubas, F; Frebourg, T; Campion, D				Rovelet-Lecrux, A; Hannequin, D; Raux, G; Le Meur, N; Laquerriere, A; Vital, A; Dumanchin, C; Feuillette, S; Brice, A; Vercelletto, M; Dubas, F; Frebourg, T; Campion, D			APP locus duplication causes autosomal dominant early-onset Alzheimer disease with cerebral amyloid angiopathy	NATURE GENETICS			English	Article							DOWNS-SYNDROME; DIAGNOSIS; TAU	We report duplication of the APP locus on chromosome 21 in five families with autosomal dominant early-onset Alzheimer disease (ADEOAD) and cerebral amyloid angiopathy (CAA). Among these families, the duplicated segments had a minimal size ranging from 0.58 to 6.37 Mb. Brains from individuals with APP duplication showed abundant parenchymal and vascular deposits of amyloid-beta peptides. Duplication of the APP locus, resulting in accumulation of amyloid-beta peptides, causes ADEOAD with CAA.	INSERM, U614, IFRMP, Fac Med, Rouen, France; Univ Hosp, Dept Neurol, Rouen, France; EFS Normandy, Lab Cytogenet, Bois Guillaume, France; Univ Hosp, Dept Pathol, Rouen, France; Univ Hosp, Dept Pathol, Bordeaux, France; Salpetriere Hosp, INSERM, U679, Paris, France; Univ Hosp, Dept Neurol, Nantes, France; Univ Hosp, Dept Neurol, Angers, France; CHSR, Dept Res, Sotteville Les Rouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Rouen; CHU de Rouen; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Nantes Universite; CHU de Nantes; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Campion, D (corresponding author), INSERM, U614, IFRMP, Fac Med, Rouen, France.	dominique.campion@univ-rouen.fr	brice, alexis/AAE-8275-2019; Rovelet-Lecrux, Anne/AAL-4305-2020; Frebourg, Thierry/AAK-8390-2020; Brice, Alexis/A-2170-2009	brice, alexis/0000-0002-0941-3990; Frebourg, Thierry/0000-0003-0399-4007; FEUILLETTE, Sebastien/0000-0001-8042-2745				BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; DELABAR JM, 1987, SCIENCE, V235, P1390, DOI 10.1126/science.2950593; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; JACKSON JF, 1976, CLIN GENET, V9, P483; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; OYAMA F, 1994, J NEUROCHEM, V62, P1062; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; Raux G, 2005, J MED GENET, V42, P793, DOI 10.1136/jmg.2005.033456; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tapiola T, 2001, NEUROLOGY, V56, P979, DOI 10.1212/WNL.56.7.979; Tournier I, 2004, CANCER RES, V64, P8143, DOI 10.1158/0008-5472.CAN-04-2467; VONSATTEL JPG, 1991, ANN NEUROL, V30, P637, DOI 10.1002/ana.410300503	15	865	904	0	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2006	38	1					24	26		10.1038/ng1718	http://dx.doi.org/10.1038/ng1718			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	997EG	16369530				2022-12-27	WOS:000234227200013
J	Deutschbauer, AM; Davis, RW				Deutschbauer, AM; Davis, RW			Quantitative trait loci mapped to single-nucleotide resolution in yeast	NATURE GENETICS			English	Article							DELETION STRAINS; GENE DISRUPTION; SACCHAROMYCES; SPORULATION; GENOME; ARCHITECTURE; MUTAGENESIS; EXPRESSION; DISEASES; MEIOSIS	Identifying the genetic variation underlying quantitative trait loci remains problematic. Consequently, our molecular understanding of genetically complex, quantitative traits is limited. To address this issue directly, we mapped three quantitative trait loci that control yeast sporulation efficiency to single-nucleotide resolution in a noncoding regulatory region (RME1) and to two missense mutations (TAO3 and MKT1). For each quantitative trait locus, the responsible polymorphism is rare among a diverse set of 13 yeast strains, suggestive of genetic heterogeneity in the control of yeast sporulation. Additionally, under optimal conditions, we reconstituted similar to 92% of the sporulation efficiency difference between the two genetically distinct parents by engineering three nucleotide changes in the appropriate yeast genome. Our results provide the highest resolution to date of the molecular basis of a quantitative trait, showing that the interaction of a few genetic variants can have a profound phenotypic effect.	Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA	Stanford University; Stanford University	Deutschbauer, AM (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.	AMDeutschbauer@lbl.gov; dbowe@stanford.edu						Brachmann CB, 1998, YEAST, V14, P115; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Briza P, 2002, YEAST, V19, P403, DOI 10.1002/yea.843; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; CODON AC, 1995, APPL ENVIRON MICROB, V61, P630; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; Du LL, 2002, MOL BIOL CELL, V13, P503, DOI 10.1091/mbc.01-07-0365; Enyenihi AH, 2003, GENETICS, V163, P47; ESPOSITO RE, 1981, MEIOSIS ASCOSPORE DE; Farrall M, 2004, HUM MOL GENET, V13, pR1, DOI 10.1093/hmg/ddh084; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gray M, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-7; Guthrie C, 1991, GUIDE YEAST GENETICS; HERSKOWITZ I, 1991, METHOD ENZYMOL, V194, P132; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Issel-Tarver L, 2002, METHOD ENZYMOL, V350, P329, DOI 10.1016/S0076-6879(02)50972-1; Jorgensen P, 2002, GENETICS, V162, P1091; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; MCCUSKER JH, 1994, GENETICS, V136, P1261; Mewes HW, 1997, NUCLEIC ACIDS RES, V25, P28, DOI 10.1093/nar/25.1.28; MITCHELL AP, 1986, NATURE, V319, P738, DOI 10.1038/319738a0; Page GP, 2003, AM J HUM GENET, V73, P711, DOI 10.1086/378900; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Rozen S, 2000, Methods Mol Biol, V132, P365; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837; Tabor HK, 2002, NAT REV GENET, V3, P391, DOI 10.1038/nrg796; Tadauchi T, 2004, MOL CELL BIOL, V24, P3670, DOI 10.1128/MCB.24.9.3670-3681.2004; WICKNER RB, 1987, J BACTERIOL, V169, P4941, DOI 10.1128/jb.169.11.4941-4945.1987; Winzeler EA, 2003, GENETICS, V163, P79; Winzeler EA, 1998, SCIENCE, V281, P1194, DOI 10.1126/science.281.5380.1194; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	43	177	229	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2005	37	12					1333	1340		10.1038/ng1674	http://dx.doi.org/10.1038/ng1674			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16273108				2022-12-27	WOS:000233657300012
J	Maisnier-Patin, S; Roth, JR; Fredriksson, A; Nystrom, T; Berg, OG; Andersson, DI				Maisnier-Patin, S; Roth, JR; Fredriksson, A; Nystrom, T; Berg, OG; Andersson, DI			Genomic buffering mitigates the effects of deleterious mutations in bacteria	NATURE GENETICS			English	Article							ESCHERICHIA-COLI; SYNERGISTIC EPISTASIS; GENETIC INTERACTIONS; ADAPTIVE MUTATION; FITNESS; POPULATIONS; LOAD; RECOMBINATION; DROSOPHILA; CAPACITOR	The relationship between the number of randomly accumulated mutations in a genome and fitness is a key parameter in evolutionary biology(1-5). Mutations may interact such that their combined effect on fitness is additive ( no epistasis), reinforced ( synergistic epistasis) or mitigated ( antagonistic epistasis). We measured the decrease in fitness caused by increasing mutation number in the bacterium Salmonella typhimurium using a regulated, error-prone DNA polymerase ( polymerase IV, DinB). As mutations accumulated, fitness costs increased at a diminishing rate. This suggests that random mutations interact such that their combined effect on fitness is mitigated and that the genome is buffered against the fitness reduction caused by accumulated mutations. Levels of the heat shock chaperones DnaK and GroEL increased in lineages that had accumulated many mutations, and experimental overproduction of GroEL further increased the fitness of lineages containing deleterious mutations. These findings suggest that overexpression of chaperones contributes to antagonistic epistasis.	Swedish Inst Infect Dis Control, Dept Bacteriol, S-17182 Stockholm, Sweden; Karolinska Inst, Microbiol & Tumor Ctr, S-17182 Stockholm, Sweden; Univ Calif Davis, DBS Sect Microbiol, Davis, CA 95616 USA; Univ Gothenburg, Lundberg Lab, Dept Microbiol, S-40530 Gothenburg, Sweden; Uppsala Univ, Dept Mol Evolut, S-75236 Uppsala, Sweden; Univ Uppsala, Dept Med Biochem & Microbiol, S-75123 Uppsala, Sweden	Swedish Institute for Infectious Disease Control; Karolinska Institutet; University of California System; University of California Davis; University of Gothenburg; Uppsala University; Uppsala University	Andersson, DI (corresponding author), Swedish Inst Infect Dis Control, Dept Bacteriol, S-17182 Stockholm, Sweden.	Dan.Andersson@imbim.uu.se	Fredriksson, Asa U/B-8614-2011	Andersson, Dan/0000-0001-6640-2174				Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Burch CL, 2004, GENETICS, V167, P559, DOI 10.1534/genetics.103.021196; Carroll R.J., 1988, TRANSFORMATION WEIGH; Davidian M., 1995, NONLINEAR MODELS REP; deVisser JAGM, 1997, GENETICS, V145, P815; deVisser JAGM, 1997, EVOLUTION, V51, P1499, DOI 10.1111/j.1558-5646.1997.tb01473.x; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Fares MA, 2002, NATURE, V417, P398, DOI 10.1038/417398a; Kibota TT, 1996, NATURE, V381, P694, DOI 10.1038/381694a0; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; KIMURA M, 1966, GENETICS, V54, P1337; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; LANDE R, 1994, EVOLUTION, V48, P1460, DOI [10.2307/2410240, 10.1111/j.1558-5646.1994.tb02188.x]; Lenski RE, 1999, NATURE, V400, P661, DOI 10.1038/23245; MUKAI T, 1969, GENETICS, V61, P749; MULLER HJ, 1964, MUTAT RES, V16, P2; Peters AD, 2000, GENETICS, V156, P1635; Poon A, 2000, EVOLUTION, V54, P1467, DOI 10.1111/j.0014-3820.2000.tb00693.x; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Roth JR, 2003, GENETICS, V163, P1483; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Szafraniec K, 2003, GENET RES, V82, P19, DOI 10.1017/S001667230300630X; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Torkelson J, 1997, EMBO J, V16, P3303, DOI 10.1093/emboj/16.11.3303; WAGNER GP, 1990, EVOLUTION, V44, P715, DOI 10.1111/j.1558-5646.1990.tb05950.x; WHITLOCK MC, 1995, ANNU REV ECOL SYST, V26, P601, DOI 10.1146/annurev.es.26.110195.003125; Whitlock MC, 2000, EVOLUTION, V54, P1654, DOI 10.1111/j.0014-3820.2000.tb00709.x; Wilke CO, 2001, P ROY SOC B-BIOL SCI, V268, P1469, DOI 10.1098/rspb.2001.1690; Wolf J.B., 2000, EPISTASIS EVOLUTIONA	30	118	121	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2005	37	12					1376	1379		10.1038/ng1676	http://dx.doi.org/10.1038/ng1676			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	989FC	16273106				2022-12-27	WOS:000233657300020
J	Dickins, RA; Hemann, MT; Zilfou, JT; Simpson, DR; Ibarra, I; Hannon, GJ; Lowe, SW				Dickins, RA; Hemann, MT; Zilfou, JT; Simpson, DR; Ibarra, I; Hannon, GJ; Lowe, SW			Probing tumor phenotypes using stable and regulated synthetic microRNA precursors	NATURE GENETICS			English	Article							SHORT HAIRPIN RNAS; MAMMALIAN-CELLS; GENE-EXPRESSION; POLYMERASE-II; IN-VITRO; SYSTEM; INTERFERENCE; SENESCENCE; P53; CHEMORESISTANCE	RNA interference is a powerful method for suppressing gene expression in mammalian cells. Stable knock-down can be achieved by continuous expression of synthetic short hairpin RNAs, typically from RNA polymerase III promoters. But primary microRNA transcripts, which are endogenous triggers of RNA interference, are normally synthesized by RNA polymerase II. Here we show that RNA polymerase II promoters expressing rationally designed primary microRNA based short hairpin RNAs produce potent, stable and regulatable gene knock-down in cultured cells and in animals, even when present at a single copy in the genome. Most notably, by tightly regulating Trp53 knock-down using tetracycline-based systems, we show that cultured mouse fibroblasts can be switched between proliferative and senescent states and that tumors induced by Trp53 suppression and cooperating oncogenes regress upon re-expression of Trp53. In practice, this primary microRNA-based short hairpin RNA vector system is markedly similar to cDNA overexpression systems and is a powerful tool for studying gene function in cells and animals.	Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory	Lowe, SW (corresponding author), Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Hannon, Gregory/AAB-3568-2019; Dickins, Ross A/K-2852-2012	Dickins, Ross A/0000-0003-4112-5304	NCI NIH HHS [P30 CA008748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Boden D, 2004, NUCLEIC ACIDS RES, V32, P1154, DOI 10.1093/nar/gkh278; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chen YC, 2003, CANCER RES, V63, P4801; Czauderna F, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng127; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Felsher DW, 2004, CURR OPIN GENET DEV, V14, P37, DOI 10.1016/j.gde.2003.12.008; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Gupta S, 2004, P NATL ACAD SCI USA, V101, P1927, DOI 10.1073/pnas.0306111101; HARVEY M, 1993, ONCOGENE, V8, P2457; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hosono T, 2004, HUM GENE THER, V15, P813, DOI 10.1089/1043034041648462; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Ling X, 2004, BIOTECHNIQUES, V36, P450, DOI 10.2144/04363RR01; Matsukura S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng077; Miyagishi M, 2004, J GENE MED, V6, P715, DOI 10.1002/jgm.556; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Schmitt CA, 2002, CELL, V109, P335, DOI 10.1016/S0092-8674(02)00734-1; Schmitt CA, 2000, NAT MED, V6, P1029, DOI 10.1038/79542; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Song J, 2004, CANCER RES, V64, P7661, DOI 10.1158/0008-5472.CAN-04-1751; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Unwalla HJ, 2004, NAT BIOTECHNOL, V22, P1573, DOI 10.1038/nbt1040; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739; Zeng Y, 2005, METHOD ENZYMOL, V392, P371, DOI 10.1016/S0076-6879(04)92022-8; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	35	417	442	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1289	1295		10.1038/ng1651	http://dx.doi.org/10.1038/ng1651			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16200064				2022-12-27	WOS:000233045200032
J	Zvetkova, I; Apedaile, A; Ramsahoye, B; Mermoud, JE; Crompton, LA; John, R; Feil, R; Brockdorff, N				Zvetkova, I; Apedaile, A; Ramsahoye, B; Mermoud, JE; Crompton, LA; John, R; Feil, R; Brockdorff, N			Global hypomethylation of the genome in XX embryonic stem cells	NATURE GENETICS			English	Article							METHYLATION PATTERNS; DNA METHYLTRANSFERASES; CHROMOSOME; EXPRESSION; DNMT3A; GENE; MAINTENANCE; MICE	Embryonic stem (ES) cells are important tools in the study of gene function and may also become important in cell therapy applications(1). Establishment of stable XX ES cell lines from mouse blastocysts is relatively problematic owing to frequent loss of one of the two X chromosomes. Here we show that DNA methylation is globally reduced in XX ES cell lines and that this is attributable to the presence of two active X chromosomes. Hypomethylation affects both repetitive and unique sequences, the latter including differentially methylated regions that regulate expression of parentally imprinted genes. Methylation of differentially methylated regions can be restored coincident with elimination of an X chromosome in early-passage parthenogenetic ES cells, suggesting that selection against loss of methylation may provide the basis for X-chromosome instability. Finally, we show that hypomethylation is associated with reduced levels of the de novo DNA methyltransferases Dnmt3a and Dnmt3b and that ectopic expression of these factors restores global methylation levels.	Hammersmith Hosp, ICFM, MRC, Ctr Clin Sci, London W12 0NN, England; Univ Edinburgh, Western Gen Hosp, John Hughes Bennett Lab, Edinburgh EH4 2XU, Midlothian, Scotland; Cardiff Sch Biosci, Cardiff CF10 3US, Wales; Inst Mol Genet, CNRS, UMR 5535, Montpellier, France; Univ Montpellier 2, Montpellier, France	Imperial College London; University of Edinburgh; Cardiff University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier	Brockdorff, N (corresponding author), Hammersmith Hosp, ICFM, MRC, Ctr Clin Sci, DuCane Rd, London W12 0NN, England.	neil.brockdorff@csc.mrc.ac.uk	John, Rosalind M/A-4491-2010; John, Ros/AAF-4229-2022; Feil, Robert P/D-2087-2013; John, Ros/AFI-8619-2022; John, Rosalind/AAQ-8221-2021	John, Rosalind M/0000-0002-3827-7617; John, Ros/0000-0002-3827-7617; Feil, Robert P/0000-0002-5671-5860; John, Ros/0000-0002-3827-7617; Brockdorff, Neil/0000-0003-4838-2653; CROMPTON, LUCY/0000-0002-2642-1183; Mermoud, Jacqueline/0000-0002-7718-646X				BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; Dean W, 1998, DEVELOPMENT, V125, P2273; Durcova-Hills G, 2001, DIFFERENTIATION, V68, P220, DOI 10.1046/j.1432-0436.2001.680409.x; Durcova-Hills G, 2004, DEV BIOL, V268, P105, DOI 10.1016/j.ydbio.2003.12.018; Fitzpatrick GV, 2002, NAT GENET, V32, P426, DOI 10.1038/ng988; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; LUBINSKY MS, 1991, LANCET, V337, P1288, DOI 10.1016/0140-6736(91)92956-3; Mermoud JE, 1999, J CELL BIOL, V147, P1399, DOI 10.1083/jcb.147.7.1399; NORRIS DP, 1994, CELL, V77, P41, DOI 10.1016/0092-8674(94)90233-X; O'Neill LP, 2003, HUM MOL GENET, V12, P1783, DOI 10.1093/hmg/ddg193; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Ramsahoye Bernard H, 2002, Methods Mol Biol, V200, P9; ROBERTSON EJ, 1983, J EMBRYOL EXP MORPH, V74, P297; Sado T, 1996, DEV DYNAM, V205, P421, DOI 10.1002/(SICI)1097-0177(199604)205:4<421::AID-AJA6>3.0.CO;2-K; SANFORD J, 1984, NUCLEIC ACIDS RES, V12, P2823, DOI 10.1093/nar/12.6.2823; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SURANI MA, 1993, PHILOS T R SOC B, V339, P165, DOI 10.1098/rstb.1993.0013; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Warnecke PM, 1998, GENOMICS, V51, P182, DOI 10.1006/geno.1998.5371; Weksberg R, 2002, HUM MOL GENET, V11, P1317, DOI 10.1093/hmg/11.11.1317; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631	28	187	194	0	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1274	1279		10.1038/ng1663	http://dx.doi.org/10.1038/ng1663			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16244654				2022-12-27	WOS:000233045200030
J	Harvey, NL; Srinivasan, RS; Dillard, ME; Johnson, NC; Witte, MH; Boyd, K; Sleeman, MW; Oliver, G				Harvey, NL; Srinivasan, RS; Dillard, ME; Johnson, NC; Witte, MH; Boyd, K; Sleeman, MW; Oliver, G			Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity	NATURE GENETICS			English	Article							ENDOTHELIAL-CELL-LINEAGE; ADIPOSE-TISSUE; LYMPHOID-CELLS; LIVER; RECEPTOR; NODES; GENE; DIFFERENTIATION; LYMPHEDEMA; EXPRESSION	Multiple organs cooperate to regulate appetite, metabolism, and glucose and fatty acid homeostasis. Here, we identified and characterized lymphatic vasculature dysfunction as a cause of adult-onset obesity. We found that functional inactivation of a single allele of the homeobox gene Prox1 led to adult-onset obesity due to abnormal lymph leakage from mispatterned and ruptured lymphatic vessels. Prox1 heterozygous mice are a new model for adult-onset obesity and lymphatic vascular disease.	St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Anim Resources Ctr, Memphis, TN 38105 USA; Univ Arizona, Coll Med, Dept Surg, Tucson, AZ 85724 USA; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Arizona; Regeneron	Oliver, G (corresponding author), St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.	guillermo.oliver@stjude.org		Harvey, Natasha/0000-0001-9839-8966				Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Brorson H, 2003, Scand J Surg, V92, P287; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Burke Z, 2002, MECH DEVELOP, V118, P147, DOI 10.1016/S0925-4773(02)00240-X; DIGIROLAMO M, 1971, AM J PHYSIOL, V221, P850, DOI 10.1152/ajplegacy.1971.221.3.850; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Esther CR, 2004, PEDIATR PULM, V38, P308, DOI 10.1002/ppul.20100; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; HO MK, 1982, J IMMUNOL, V128, P1221; Jandacek RJ, 2004, GASTROENTEROLOGY, V127, P139, DOI 10.1053/j.gastro.2004.04.007; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mattacks CA, 2003, J ANAT, V202, P551, DOI 10.1046/j.1469-7580.2003.00188.x; NOUGUES J, 1988, INT J OBESITY, V12, P321; POND CM, 1995, J LIPID RES, V36, P2219; Pond CM, 2003, BRIT J NUTR, V89, P375, DOI 10.1079/BJN2002784; Pond CM, 2003, TRENDS IMMUNOL, V24, P13, DOI 10.1016/S1471-4906(02)00004-2; Rosen ED, 2002, ANN NY ACAD SCI, V979, P143, DOI 10.1111/j.1749-6632.2002.tb04875.x; SATO TN, 1993, P NATL ACAD SCI USA, V90, P9355, DOI 10.1073/pnas.90.20.9355; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; SCHNURCH H, 1993, DEVELOPMENT, V119, P957; Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan L, 2002, DEVELOPMENT, V129, P4797; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	33	392	412	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2005	37	10					1072	1081		10.1038/ng1642	http://dx.doi.org/10.1038/ng1642			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16170315				2022-12-27	WOS:000232185600018
J	Lincoln, MR; Montpetit, A; Cader, MZ; Saarela, J; Dyment, DA; Tiislar, M; Ferretti, V; Tienari, PJ; Sadovnick, AD; Peltonen, L; Ebers, GC; Hudson, TJ				Lincoln, MR; Montpetit, A; Cader, MZ; Saarela, J; Dyment, DA; Tiislar, M; Ferretti, V; Tienari, PJ; Sadovnick, AD; Peltonen, L; Ebers, GC; Hudson, TJ			A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis	NATURE GENETICS			English	Article							GENETIC SUSCEPTIBILITY; HAPLOTYPES; DISEASE; MAPS; DISSECTION; FAMILIES; PROJECT; LINKAGE; GENOME; LOCUS	Genetic susceptibility to multiple sclerosis is associated with genes of the major histocompatibility complex (MHC), particularly HLA-DRB1 and HLA-DQB1 (ref. 1). Both locus and allelic heterogeneity have been reported in this genomic region(2,3). To clarify whether HLA-DRB1 itself, nearby genes in the region encoding the MHC or combinations of these loci underlie susceptibility to multiple sclerosis, we genotyped 1,185 Canadian and Finnish families with multiple sclerosis (n = 4,203 individuals) with a high-density SNP panel spanning the genes encoding the MHC and flanking genomic regions. Strong associations in Canadian and Finnish samples were observed with blocks in the HLA class II genomic region (P < 4.9 x 10(-13) and P < 2.0 x 10(-16), respectively), but the strongest association was with HLA-DRB1 (P < 4.4 x 10(-17)). Conditioning on either HLA-DRB1 or the most significant HLA class II haplotype block found no additional block or SNP association independent of the HLA class II genomic region. This study therefore indicates that MHC-associated susceptibility to multiple sclerosis is determined by HLA class II alleles, their interactions and closely neighboring variants.	Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Oxford OX2 6HE, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; McGill Univ, Montreal, PQ H3A 1A4, Canada; Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; McGill Univ, Ctr Hlth, Res Inst, Dept Med, Montreal, PQ H3G 1A4, Canada; McGill Univ, Ctr Hlth, Res Inst, Dept Human Genet, Montreal, PQ H3G 1A4, Canada; Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; Univ Helsinki, Dept Neurol, Neurosci Programme, Biomedicum Helsinki, Helsinki, Finland; Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 2B5, Canada; Univ British Columbia, Fac Med, Div Neurol, Vancouver, BC V6T 2B5, Canada; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland	Radcliffe Infirmary; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; McGill University; McGill University; McGill University; Finland National Institute for Health & Welfare; University of Helsinki; University of British Columbia; University of British Columbia; University of California System; University of California Los Angeles; University of Helsinki	Ebers, GC (corresponding author), Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Oxford OX2 6HE, England.	george.ebers@clneuro.ox.ac.uk	Tienari, Pentti J/A-4893-2012; Lincoln, Matthew R/ABD-1504-2020; Saarela, Janna S/E-5369-2014	Lincoln, Matthew R/0000-0003-2962-6253; Ebers, George/0000-0003-4771-4177; Hudson, Thomas/0000-0002-1376-4849; Cader, Zameel/0000-0002-6952-406X; Saarela, Janna/0000-0002-0853-6219; Sadovnick, Dessa/0000-0003-2987-2008				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Allcock RJN, 1999, HUM IMMUNOL, V60, P1266, DOI 10.1016/S0198-8859(99)00127-5; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Caballero A, 1999, TISSUE ANTIGENS, V54, P524, DOI 10.1034/j.1399-0039.1999.540511.x; Cordell HJ, 2004, GENET EPIDEMIOL, V26, P186, DOI 10.1002/gepi.10306; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; De la Vega FM, 2005, GENOME RES, V15, P454, DOI 10.1101/gr.3241705; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Fan JB, 2004, GENOME RES, V14, P878, DOI 10.1101/gr.2167504; Fernandez-Arquero M, 1999, NEUROLOGY, V53, P1361, DOI 10.1212/WNL.53.6.1361; Fogdell-Hahn A, 2000, TISSUE ANTIGENS, V55, P140, DOI 10.1034/j.1399-0039.2000.550205.x; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Harbo HF, 2004, TISSUE ANTIGENS, V63, P237, DOI 10.1111/j.0001-2815.2004.00173.x; Johannesson M, 2005, GENES IMMUN, V6, P175, DOI 10.1038/sj.gene.6364155; Koeleman BPC, 2000, ANN HUM GENET, V64, P207, DOI 10.1017/S0003480000008095; Kuokkanen S, 1997, AM J HUM GENET, V61, P1379, DOI 10.1086/301637; Laaksonen M, 2002, J NEUROIMMUNOL, V122, P140, DOI 10.1016/S0165-5728(01)00456-8; Ligers A, 2001, AM J HUM GENET, V69, P900, DOI 10.1086/323480; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Rubio JP, 2002, AM J HUM GENET, V70, P1125, DOI 10.1086/339932; Saarela J, 2002, HUM MOL GENET, V11, P2257, DOI 10.1093/hmg/11.19.2257; Sadovnick AD, 1998, CAN J NEUROL SCI, V25, P216, DOI 10.1017/S0317167100034041; Stewart CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/gr.2188104; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100	30	245	249	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1108	1112		10.1038/ng1647	http://dx.doi.org/10.1038/ng1647			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16186814				2022-12-27	WOS:000232185600023
J	Syvanen, AC				Syvanen, AC			Toward genome-wide SNP genotyping	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; OLIGONUCLEOTIDE ARRAYS; HAPLOTYPE DIVERSITY; MUTATION DETECTION; PRIMER EXTENSION; PADLOCK PROBES; DNA; DENSITY; ASSAY; GENE	Genome-wide association studies with SNP markers are expected to allow identification of genes that underlie complex disorders. Hundreds of thousands of SNP markers will be required for comprehensive genome-wide association studies. The development of microarray-based methods for SNP genotyping on this scale remains a demanding task, despite many recent advances in technology for the production of high-density microarrays. A key technical obstacle is the PCR amplification step, which is required to reduce the complexity of and gain sufficient sensitivity for genotyping SNPs in large, diploid genomes. The multiplexing level that can be achieved in PCR does not match that of current microarray-based methods, making PCR the limiting step in the assays. Highly multiplexed microarray systems for SNP genotyping have recently been developed by combining well-known reaction principles for DNA amplification and SNP genotyping in clever ways. These new methods offer the potential of genome-wide SNP mapping of genes involved in complex diseases in the foreseeable future, provided that issues related to selection of the optimal SNP markers, sample throughput and the cost of the assays can be addressed.	Uppsala Univ, Dept Med Sci Mol Med, Univ Hosp, S-75185 Uppsala, Sweden	Uppsala University; Uppsala University Hospital	Syvanen, AC (corresponding author), Uppsala Univ, Dept Med Sci Mol Med, Univ Hosp, Entr 70, S-75185 Uppsala, Sweden.	Ann-Christine.Syvanen@medsci.uu.se						Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Baner J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng104; Bell PA, 2002, BIOTECHNIQUES, P70; Brownie J, 1997, NUCLEIC ACIDS RES, V25, P3235, DOI 10.1093/nar/25.16.3235; Cai H, 2000, GENOMICS, V66, P135, DOI 10.1006/geno.2000.6218; Chen JW, 2000, GENOME RES, V10, P549, DOI 10.1101/gr.10.4.549; Chen XN, 1997, NUCLEIC ACIDS RES, V25, P347, DOI 10.1093/nar/25.2.347; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Cutler DJ, 2001, GENOME RES, V11, P1913, DOI 10.1101/gr.197201; Dong SL, 2001, GENOME RES, V11, P1418, DOI 10.1101/gr.171101; Evans DM, 2004, GENET EPIDEMIOL, V27, P375, DOI 10.1002/gepi.20045; Evans DM, 2004, AM J HUM GENET, V75, P687, DOI 10.1086/424696; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fan JB, 2000, GENOME RES, V10, P853, DOI 10.1101/gr.10.6.853; Favis R, 2000, NAT BIOTECHNOL, V18, P561, DOI 10.1038/75452; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gerry NP, 1999, J MOL BIOL, V292, P251, DOI 10.1006/jmbi.1999.3063; Gunderson KL, 2004, GENOME RES, V14, P870, DOI 10.1101/gr.2255804; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hinds David A., 2004, Human Genomics, V1, P421; Hirschhorn JN, 2000, P NATL ACAD SCI USA, V97, P12164, DOI 10.1073/pnas.210394597; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; John S, 2004, AM J HUM GENET, V75, P54, DOI 10.1086/422195; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Koed K, 2005, CANCER RES, V65, P34; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Kurg A, 2000, GENET TEST, V4, P1, DOI 10.1089/109065700316408; Kwok PY, 2001, ANNU REV GENOM HUM G, V2, P235, DOI 10.1146/annurev.genom.2.1.235; LANDEGREN U, 1988, SCIENCE, V241, P1077, DOI 10.1126/science.3413476; Lin ZW, 1996, P NATL ACAD SCI USA, V93, P2582, DOI 10.1073/pnas.93.6.2582; Lindroos K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf069; Liu WM, 2003, BIOINFORMATICS, V19, P2397, DOI 10.1093/bioinformatics/btg332; Matsuzaki H, 2004, GENOME RES, V14, P414, DOI 10.1101/gr.2014904; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; Middleton FA, 2004, AM J HUM GENET, V74, P886, DOI 10.1086/420775; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; Murray SS, 2004, NAT METHODS, V1, P113, DOI 10.1038/NMETH712; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; OLIPHANT A, 2002, BIOTECHNIQUES S, V56, P60; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pastinen T, 1997, GENOME RES, V7, P606, DOI 10.1101/gr.7.6.606; Pastinen T, 2000, GENOME RES, V10, P1031, DOI 10.1101/gr.10.7.1031; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; PEASE AC, 1994, P NATL ACAD SCI USA, V91, P5022, DOI 10.1073/pnas.91.11.5022; Pinkel D, 2005, NAT GENET, V37, pS11, DOI 10.1038/ng1569; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Saba TG, 2005, HUM GENET, V116, P167, DOI 10.1007/s00439-004-1193-8; SAIKI RK, 1989, P NATL ACAD SCI USA, V86, P6230, DOI 10.1073/pnas.86.16.6230; Schaid DJ, 2004, AM J HUM GENET, V75, P948, DOI 10.1086/425870; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Shumaker JM, 1996, HUM MUTAT, V7, P346, DOI 10.1002/(SICI)1098-1004(1996)7:4<346::AID-HUMU9>3.3.CO;2-9; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; SOUTHERN EM, 1992, GENOMICS, V13, P1008, DOI 10.1016/0888-7543(92)90014-J; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; SYVANEN AC, 1990, GENOMICS, V8, P684, DOI 10.1016/0888-7543(90)90255-S; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	68	304	374	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37			S			S5	S10		10.1038/ng1558	http://dx.doi.org/10.1038/ng1558			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	932YF	15920530	Bronze			2022-12-27	WOS:000229590000003
J	Denver, DR; Morris, K; Streelman, JT; Kim, SK; Lynch, M; Thomas, WK				Denver, DR; Morris, K; Streelman, JT; Kim, SK; Lynch, M; Thomas, WK			The transcriptional consequences of mutation and natural selection in Caenorhabditis elegans	NATURE GENETICS			English	Article							GENE-EXPRESSION PROFILES; EVOLUTION; GENOME; BIOLOGY; MODEL; DNA	The evolutionary importance of gene-expression divergence is unclear: some studies suggest that it is an important mechanism for evolution by natural selection(1,2), whereas others claim that most between-species regulatory changes are neutral or nearly neutral(3). We examined global transcriptional divergence patterns in a set of Caenorhabditis elegans mutation-accumulation lines and natural isolate lines to provide insights into the evolutionary importance of transcriptional variation and to discriminate between the forces of mutation and natural selection in shaping the evolution of gene expression. We detected the effects of selection on transcriptional divergence patterns and characterized them with respect to coexpressed gene sets, chromosomal clustering of expression changes and functional gene categories. We directly compared observed transcriptional variation patterns in the mutation-accumulation and natural isolate lines to a neutral model of transcriptome evolution to show that strong stabilizing selection dominates the evolution of transcriptional change for thousands of C. elegans expressed sequences.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Univ New Hampshire, Hubbard Ctr Genome Studies, Durham, NH 03824 USA; Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; Stanford Univ, Med Ctr, Dept Dev Biol, Stanford, CA 94305 USA	Indiana University System; Indiana University Bloomington; University System Of New Hampshire; University of New Hampshire; University System of Georgia; Georgia Institute of Technology; Stanford University	Denver, DR (corresponding author), Massey Univ, Allan Wilson Ctr Mol Ecol & Evolut, Auckland, New Zealand.	d.denver@massey.ac.nz						Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BARNES TM, 1995, GENETICS, V141, P159; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Charlesworth B, 2002, CURR BIOL, V12, pR716, DOI 10.1016/S0960-9822(02)01244-7; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Denver DR, 2003, MOL BIOL EVOL, V20, P393, DOI 10.1093/molbev/msg044; Denver DR, 2004, NATURE, V430, P679, DOI 10.1038/nature02697; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; FABIAN TJ, 1994, J GERONTOL BIOL SC B, V49, P145; Graustein A, 2002, GENETICS, V161, P99; Harris TW, 2004, NUCLEIC ACIDS RES, V32, pD411, DOI 10.1093/nar/gkh066; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Hsieh WP, 2003, GENETICS, V165, P747; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Kerr M K, 2001, Biostatistics, V2, P183, DOI 10.1093/biostatistics/2.2.183; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Koch R, 2000, GENOME RES, V10, P1690, DOI 10.1101/gr.GR-1471R; Lercher MJ, 2003, GENOME RES, V13, P238, DOI 10.1101/gr.553803; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; LYNCH M, 1986, EVOLUTION, V40, P915, DOI 10.1111/j.1558-5646.1986.tb00561.x; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Vassilieva LL, 2000, EVOLUTION, V54, P1234, DOI 10.1111/j.0014-3820.2000.tb00557.x; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140	27	205	205	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2005	37	5					544	548		10.1038/ng1554	http://dx.doi.org/10.1038/ng1554			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15852004				2022-12-27	WOS:000228862300026
J	Jadeja, S; Smyth, I; Pitera, JE; Taylor, MS; van Haelst, M; Bentley, E; McGregor, L; Hopkins, J; Chalepakis, G; Philip, N; Aytes, AP; Watt, FM; Darling, SM; Jackson, I; Woolf, AS; Scambler, PJ				Jadeja, S; Smyth, I; Pitera, JE; Taylor, MS; van Haelst, M; Bentley, E; McGregor, L; Hopkins, J; Chalepakis, G; Philip, N; Aytes, AP; Watt, FM; Darling, SM; Jackson, I; Woolf, AS; Scambler, PJ			Identification of a new gene mutated in Fraser syndrome and mouse myelencephalic blebs	NATURE GENETICS			English	Article							CRYPTOPHTHALMOS; PHENOTYPE; ADHESION; MOLECULE; CADHERIN; PROTEIN; DOMAIN; MICE	Fraser syndrome is a recessive, multisystem disorder presenting with cryptophthalmos, syndactyly and renal defects(1,2) and associated with loss-of-function mutations of the extracellular matrix protein FRAS1. Fras1 mutant mice have a blebbed phenotype characterized by intrauterine epithelial fragility generating serous and, later, hemorrhagic blisters. The myelencephalic blebs ( my) strain has a similar phenotype. We mapped my to Frem2, a gene related to Fras1 and Frem1, and showed that a Frem2 gene-trap mutation was allelic to my. Expression of Frem2 in adult kidneys correlated with cyst formation in my homozygotes, indicating that the gene is required for maintaining the differentiated state of renal epithelia. Two individuals with Fraser syndrome were homozygous with respect to the same missense mutation of FREM2, confirming genetic heterogeneity. This is the only missense mutation reported in any blebbing mutant or individual with Fraser syndrome, suggesting that calcium binding in the CALX beta-cadherin motif is important for normal functioning of FREM2.	UCL, Mol Med Unit, Inst Child Hlth, London WC1N 1EH, England; CR UK London Res Inst, London WC2A 3PX, England; UCL, Nephrourol Unit, Inst Child Hlth, London WC1N 1EH, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England; Univ Crete, Dept Biol, Iraklion 71409, Greece; Hosp Enfants Timone, Marseille, France; Hosp Infantil La Fe, Valencia, Spain; Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of London; University College London; University of London; University College London; University of Oxford; Wellcome Centre for Human Genetics; University of Crete; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Edinburgh	Scambler, PJ (corresponding author), UCL, Mol Med Unit, Inst Child Hlth, London WC1N 1EH, England.	p.scambler@ich.ucl.ac.uk	Scambler, Peter J/C-4998-2008; Woolf, Adrian S./AAZ-1075-2020; Scambler, Peter/AAZ-6026-2020; Watt, Fiona/AHB-0226-2022; Taylor, Martin S/C-3825-2009; Philip, Nicole/I-2881-2016	Scambler, Peter J/0000-0002-1487-4628; Woolf, Adrian S./0000-0001-5541-1358; Scambler, Peter/0000-0002-1487-4628; Watt, Fiona/0000-0001-9151-5154; Taylor, Martin S/0000-0001-7656-330X; Jackson, Ian/0000-0001-6526-0688; Perez-Aytes, Antonio/0000-0003-3401-6943; Smyth, Ian/0000-0002-1727-7829				Darling S, 1994, Clin Dysmorphol, V3, P91; FRASER GR, 1962, ANN HUM GENET, V25, P387, DOI 10.1111/j.1469-1809.1962.tb01774.x; Hodor PG, 2000, DEV BIOL, V222, P181, DOI 10.1006/dbio.2000.9696; Little CC, 1923, AM J ROENTGENOL RADI, V10, P975; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; McGregor L, 2003, NAT GENET, V34, P203, DOI 10.1038/ng1142; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Philipson KD, 2002, ANN NY ACAD SCI, V976, P1; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Slavotinek AM, 2002, J MED GENET, V39, P623, DOI 10.1136/jmg.39.9.623; Smyth I, 2004, P NATL ACAD SCI USA, V101, P13560, DOI 10.1073/pnas.0402760101; Takamiya K, 2004, NAT GENET, V36, P172, DOI 10.1038/ng1292; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Vrontou S, 2003, NAT GENET, V34, P209, DOI 10.1038/ng1168; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75	15	122	127	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2005	37	5					520	525		10.1038/ng1549	http://dx.doi.org/10.1038/ng1549			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15838507				2022-12-27	WOS:000228862300022
J	van Bokhoven, H; Celli, J; van Reeuwijk, J; Rinne, T; Glaudemans, B; van Beusekom, E; Rieu, P; Newbury-Ecob, RA; Chiang, C; Brunner, HG				van Bokhoven, H; Celli, J; van Reeuwijk, J; Rinne, T; Glaudemans, B; van Beusekom, E; Rieu, P; Newbury-Ecob, RA; Chiang, C; Brunner, HG			MYCN haploinsufficiency is associated with reduced brain size and intestinal atresias in Feingold syndrome	NATURE GENETICS			English	Article							N-MYC; SONIC HEDGEHOG; ESOPHAGEAL ATRESIA; PROLIFERATION; PRECURSORS; DNA	Feingold syndrome is characterized by variable combinations of esophageal and duodenal atresias, microcephaly, learning disability, syndactyly and cardiac defect. We show here that heterozygous mutations in the gene MYCN are present in Feingold syndrome. All mutations are predicted to disrupt both the full-length protein and a new shortened MYCN isoform, suggesting that multiple aspects of early embryogenesis and postnatal brain growth in humans are tightly regulated by MYCN dosage.	Radboud Univ Nijmegen Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen Med Ctr, Dept Pediat Surg, NL-6500 HB Nijmegen, Netherlands; Royal United Hosp, Genet Ctr, Bath BA1 3NG, Avon, England; Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN USA	Radboud University Nijmegen; Radboud University Nijmegen; Vanderbilt University	van Bokhoven, H (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Human Genet, Box 9101, NL-6500 HB Nijmegen, Netherlands.	H.vanBokhoven@antrg.umcn.nl	Rinne, Tuula/B-6339-2018; van Reeuwijk, Jeroen/P-8665-2015; van Bokhoven, Hans/D-8764-2012; Bokhoven, J.H.L.M. van van/H-8015-2014; van Beusekom, Ellen/AAF-2687-2019; Brunner, Han/C-9928-2013	van Reeuwijk, Jeroen/0000-0002-0658-4399; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; 				Celli J, 2000, AM J HUM GENET, V66, P436, DOI 10.1086/302779; Celli J, 2003, AM J MED GENET A, V122A, P294, DOI 10.1002/ajmg.a.20471; DANG CV, 1992, P NATL ACAD SCI USA, V89, P599, DOI 10.1073/pnas.89.2.599; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; HIRVONEN H, 1990, ONCOGENE, V5, P1787; Jopling CL, 2001, ONCOGENE, V20, P2664, DOI 10.1038/sj.onc.1204404; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Merei JM, 2002, PEDIATR SURG INT, V18, P319, DOI 10.1007/s00383-002-0751-1; MOENS CB, 1992, GENE DEV, V6, P691, DOI 10.1101/gad.6.5.691; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; STANTON BR, 1992, GENE DEV, V6, P2235, DOI 10.1101/gad.6.12a.2235; Torfs CP, 1995, TERATOLOGY, V52, P220, DOI 10.1002/tera.1420520408	15	109	113	0	6	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2005	37	5					465	467		10.1038/ng1546	http://dx.doi.org/10.1038/ng1546			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15821734				2022-12-27	WOS:000228862300013
J	Valentonyte, R; Hampe, J; Huse, K; Rosenstiel, P; Albrecht, M; Stenzel, A; Nagy, M; Gaede, KI; Franke, A; Haesler, R; Koch, A; Lengauer, T; Seegert, D; Reiling, N; Ehlers, S; Schwinger, E; Platzer, M; Krawczak, M; Muller-Quernheim, J; Schurmann, M; Schreiber, S				Valentonyte, R; Hampe, J; Huse, K; Rosenstiel, P; Albrecht, M; Stenzel, A; Nagy, M; Gaede, KI; Franke, A; Haesler, R; Koch, A; Lengauer, T; Seegert, D; Reiling, N; Ehlers, S; Schwinger, E; Platzer, M; Krawczak, M; Muller-Quernheim, J; Schurmann, M; Schreiber, S			Sarcoidosis is associated with a truncating splice site mutation in BTNL2	NATURE GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; EPITHELIAL-CELLS; ALLELIC ASSOCIATION; CRYSTAL-STRUCTURE; DUTCH PATIENTS; TNF-ALPHA; GENE; SUSCEPTIBILITY; DISEASE; MARKER	Sarcoidosis is a polygenic immune disorder with predominant manifestation in the lung. Genome-wide linkage analysis previously indicated that the extended major histocompatibility locus on chromosome 6p was linked to susceptibility to sarcoidosis. Here, we carried out a systematic three-stage SNP scan of 16.4 Mb on chromosome 6p21 in as many as 947 independent cases of familial and sporadic sarcoidosis and found that a 15-kb segment of the gene butyrophilin-like 2 (BTNL2) was associated with the disease. The primary disease-associated variant (rs2076530; P-TDT = 3 x 10(-6), Pcase-control = 1.1 x 10(-8); replication P-TDT = 0.0018, Pcase-control = 1.8 x 10(-6)) represents a risk factor that is independent of variation in HLA-DRB1. BTNL2 is a member of the immunoglobulin superfamily and has been implicated as a costimulatory molecule involved in T-cell activation on the basis of its homology to B7-1. The G --> A transition constituting rs2076530 leads to the use of a cryptic splice site located 4 bp upstream of the affected wild-type donor site. Transcripts of the risk-associated allele have a premature stop in the spliced mRNA. The resulting protein lacks the C-terminal IgC domain and transmembrane helix, thereby disrupting the membrane localization of the protein, as shown in experiments using green fluorescent protein and V5 fusion proteins.	Univ Kiel, Univ Klinikum Schleswig Holstein, Inst Clin Mol Biol, D-24105 Kiel, Germany; Univ Kiel, Univ Klinikum Schleswig Holstein, Kiel Ctr German Natl Genotyping Platform, D-24105 Kiel, Germany; Inst Mol Biotechnol, D-07745 Jena, Germany; Max Planck Inst Informat, D-66123 Saarbrucken, Germany; Charite Univ Hosp, Inst Forens Med, D-10115 Berlin, Germany; Res Ctr Borstel, D-23845 Borstel, Germany; Univ Freiburg, Dept Pneumol, D-79106 Freiburg, Germany; Conaris Res Inst AG, D-24118 Kiel, Germany; Univ Lubeck, Inst Human Genet, D-23538 Lubeck, Germany; Univ Kiel, Univ Klinikum Schleswig Holstein, Inst Med Stat & Informat, D-24105 Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Forschungszentrum Borstel; University of Freiburg; University of Lubeck; University of Kiel; Schleswig Holstein University Hospital	Hampe, J (corresponding author), Univ Kiel, Univ Klinikum Schleswig Holstein, Inst Clin Mol Biol, Campus Kiel,Schittenhelmstr 12, D-24105 Kiel, Germany.	j.hampe@mucosa.de	Hampe, Jochen/A-2555-2010; Häsler, Robert/A-4908-2009; Franke, Andre/B-2151-2010; Seegert, Dirk/B-8826-2011; Krawczak, Michael/A-8964-2010; Müller-Quernheim, Joachim/H-1983-2011; Reiling, Norbert/D-6796-2013; Albrecht, Mario/B-6694-2008; Ehlers, Stefan/B-4075-2010; Rosenstiel, Philip/A-5137-2009	Hampe, Jochen/0000-0002-2421-6127; Häsler, Robert/0000-0003-4174-8229; Franke, Andre/0000-0003-1530-5811; Krawczak, Michael/0000-0003-2603-1502; Reiling, Norbert/0000-0001-6673-4291; Albrecht, Mario/0000-0002-3103-9624; Rosenstiel, Philip/0000-0002-9692-8828; Huse, Klaus/0000-0003-3854-1884				Abdallah A, 2003, GENES IMMUN, V4, P450, DOI 10.1038/sj.gene.6364001; Agadjanyan MG, 2003, J IMMUNOL, V171, P4311, DOI 10.4049/jimmunol.171.8.4311; Albrecht M, 2003, FEBS LETT, V538, P173, DOI 10.1016/S0014-5793(03)00161-3; Bajorath J, 2001, J MOL GRAPH MODEL, V19, P619; Borriello F, 1997, IMMUNITY, V6, P303, DOI 10.1016/S1074-7613(00)80333-7; Clayton D, 1999, AM J HUM GENET, V65, P1161, DOI 10.1086/302566; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Costabel U, 1999, EUR RESPIR J, V14, P735, DOI 10.1034/j.1399-3003.1999.14d02.x; Foley PJ, 2001, AM J RESP CELL MOL, V25, P272, DOI 10.1165/ajrcmb.25.3.4261; Grutters JC, 2002, AM J RESP CRIT CARE, V165, P1119, DOI 10.1164/ajrccm.165.8.200110-0320; Hampe J, 2004, BIOTECHNIQUES, V36, P148, DOI 10.2144/04361DD01; Hampe J, 2001, BIOINFORMATICS, V17, P654, DOI 10.1093/bioinformatics/17.7.654; Hampe J, 2002, P NATL ACAD SCI USA, V99, P321, DOI 10.1073/pnas.261567999; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; HUNNINGHAKE GW, 1979, AM J PATHOL, V97, P149; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; KRAWCZAK M, 1992, HUM GENET, V90, P41; KRAWCZAK M, 1988, HUM GENET, V80, P78, DOI 10.1007/BF00451461; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Legouis R, 2003, EMBO REP, V4, P1096, DOI 10.1038/sj.embor.7400006; Long MY, 1999, MOL BIOL EVOL, V16, P1528, DOI 10.1093/oxfordjournals.molbev.a026065; Morton NE, 1998, P NATL ACAD SCI USA, V95, P11389, DOI 10.1073/pnas.95.19.11389; Newman LS, 1997, NEW ENGL J MED, V336, P1224, DOI 10.1056/NEJM199704243361706; Reiling N, 2001, J IMMUNOL, V167, P3339, DOI 10.4049/jimmunol.167.6.3339; Rhodes DA, 2001, GENOMICS, V71, P351, DOI 10.1006/geno.2000.6406; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; Rossman MD, 2003, AM J HUM GENET, V73, P720, DOI 10.1086/378097; Rybicki BA, 2003, AM J RESP CRIT CARE, V167, P444, DOI 10.1164/rccm.2112060; Rybicki BA, 2001, AM J RESP CRIT CARE, V164, P2085, DOI 10.1164/ajrccm.164.11.2106001; Sato H, 2002, AM J RESP CELL MOL, V27, P406, DOI 10.1165/rcmb.4782; Schurmann M, 2001, AM J RESP CRIT CARE, V164, P840, DOI 10.1164/ajrccm.164.5.2007056; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Stammers M, 2000, IMMUNOGENETICS, V51, P373, DOI 10.1007/s002510050633; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Stenzel A, 2004, HUM GENET, V114, P377, DOI 10.1007/s00439-003-1075-5; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; Zhang XW, 2003, P NATL ACAD SCI USA, V100, P2586, DOI 10.1073/pnas.252771499; Ziegenhagen MW, 2003, J INTERN MED, V253, P18, DOI 10.1046/j.1365-2796.2003.01074.x; Zissel G, 2000, J INVEST MED, V48, P66	42	346	362	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					357	364		10.1038/ng1519	http://dx.doi.org/10.1038/ng1519			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15735647				2022-12-27	WOS:000228040000018
J	Bamforth, SD; Braganca, J; Farthing, CR; Schneider, JE; Broadbent, C; Michell, AC; Clarke, K; Neubauer, S; Norris, D; Brown, NA; Anderson, RH; Bhattacharya, S				Bamforth, SD; Braganca, J; Farthing, CR; Schneider, JE; Broadbent, C; Michell, AC; Clarke, K; Neubauer, S; Norris, D; Brown, NA; Anderson, RH; Bhattacharya, S			Cited2 controls left-right patterning and heart development through a Nodal-Pitx2c pathway	NATURE GENETICS			English	Article							LEFT-RIGHT ASYMMETRY; RUBINSTEIN-TAYBI SYNDROME; LEFT-RIGHT AXIS; CARDIAC-MALFORMATIONS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; LATERAL PLATE; PITX2; COACTIVATOR; MORPHOGENESIS	Malformations of the septum, outflow tract and aortic arch are the most common congenital cardiovascular defects and occur in mice lacking Cited2, a transcriptional coactivator of TFAP2. Here we show that Cited2(-/-) mice also develop laterality defects, including right isomerism, abnormal cardiac looping and hyposplenia, which are suppressed on a mixed genetic background. Cited2(-/-) mice lack expression of the Nodal target genes Pitx2c, Nodal and Ebaf in the left lateral plate mesoderm, where they are required for establishing laterality and cardiovascular development. CITED2 and TFAP2 were detected at the Pitx2c promoter in embryonic hearts, and they activate Pitx2c transcription in transient transfection assays. We propose that an abnormal Nodal-Pitx2c pathway represents a unifying mechanism for the cardiovascular malformations observed in Cited2(-/-) mice, and that such malformations may be the sole manifestation of a laterality defect.	Univ Oxford, Dept Cardiovasc Med, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Dept Physiol, Oxford OX1 3QU, England; MRC, Mammalian Genet Unit, Harwell OX11 0RD, Berks, England; Univ London St Georges Hosp, Sch Med, London SW17 0RE, England; UCL, Cardiac Unit, Inst Child Hlth, London WC1N 1EH, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; St Georges University London; University of London; University College London	Bhattacharya, S (corresponding author), Univ Oxford, Dept Cardiovasc Med, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	shoumo.bhattacharya@well.ox.ac.uk	Neubauer, Stefan/B-8448-2011; Braganca, Jose/F-4410-2012; Bamforth, Simon David/I-1277-2019; Bhattacharya, Shoumo/F-4127-2010	Braganca, Jose/0000-0001-9566-400X; Bamforth, Simon David/0000-0002-5666-4485; Bhattacharya, Shoumo/0000-0002-5571-0478	British Heart Foundation [PS/02/002/14893] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Ausubel FM, 1995, SHORT PROTOCOLS MOL, V3rd; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Barbera JPM, 2002, HUM MOL GENET, V11, P283, DOI 10.1093/hmg/11.3.283; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Braganca J, 2003, J BIOL CHEM, V278, P16021, DOI 10.1074/jbc.M208144200; Brennan J, 2002, GENE DEV, V16, P2339, DOI 10.1101/gad.1016202; Brewer S, 2002, MECH DEVELOP, V110, P139, DOI 10.1016/S0925-4773(01)00579-2; Brown N, 1999, HEART DEV, P447; Bruneau BG, 2002, CIRC RES, V90, P509, DOI 10.1161/01.RES.0000013072.51957.B7; CALRK EB, 2001, MOSS ADAMS HEART DIS, P64; Dunwoodie SL, 1998, MECH DEVELOP, V72, P27, DOI 10.1016/S0925-4773(98)00011-2; Freedman SJ, 2003, NAT STRUCT BIOL, V10, P504, DOI 10.1038/nsb936; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Gaio U, 1999, CURR BIOL, V9, P1339, DOI 10.1016/S0960-9822(00)80059-7; Glenn DJ, 1999, J BIOL CHEM, V274, P36159, DOI 10.1074/jbc.274.51.36159; Goodman RH, 2000, GENE DEV, V14, P1553; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; KAUFMAN M, 1999, ANATOMICAL BASIS MOU, P33; KENT GC, 2001, COMP ANATOMY VERTEBR, P314; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Kranc KR, 2003, MOL CELL BIOL, V23, P7658, DOI 10.1128/MCB.23.21.7658-7666.2003; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Liu CY, 2002, DEVELOPMENT, V129, P5081; Liu CY, 2001, DEVELOPMENT, V128, P2039; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Meno C, 2001, DEV CELL, V1, P127, DOI 10.1016/S1534-5807(01)00006-5; Norris DP, 2002, DEVELOPMENT, V129, P3455; Pena P, 1999, MOL ENDOCRINOL, V13, P1402, DOI 10.1210/me.13.8.1402; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Saijoh Y, 2003, DEV BIOL, V256, P160, DOI 10.1016/S0012-1606(02)00121-5; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Satoda M, 2000, NAT GENET, V25, P42, DOI 10.1038/75578; Schneider JE, 2003, J MOL CELL CARDIOL, V35, P217, DOI 10.1016/S0022-2828(02)00291-2; Shen MM, 1997, DEVELOPMENT, V124, P429; Shiratori H, 2001, MOL CELL, V7, P137, DOI 10.1016/S1097-2765(01)00162-9; STEVENS CA, 1995, AM J MED GENET, V59, P346, DOI 10.1002/ajmg.1320590313; Sun HB, 1998, P NATL ACAD SCI USA, V95, P13555, DOI 10.1073/pnas.95.23.13555; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Thomas T, 1998, DEV BIOL, V196, P228, DOI 10.1006/dbio.1998.8849; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weninger WJ, 2002, NAT GENET, V30, P59, DOI 10.1038/ng785; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; Yamamoto M, 2003, DEVELOPMENT, V130, P1795, DOI 10.1242/dev.00408; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799	48	161	171	1	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2004	36	11					1189	1196		10.1038/ng1446	http://dx.doi.org/10.1038/ng1446			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15475956	Bronze			2022-12-27	WOS:000224832800022
J	Hellemans, J; Preobrazhenska, O; Willaert, A; Debeer, P; Verdonk, PCM; Costa, T; Janssens, K; Menten, B; Van Roy, N; Vermeulen, SJT; Savarirayan, R; Van Hul, W; Vanhoenacker, F; Huylebroeck, D; De Paepe, A; Naeyaert, JM; Vandesompele, J; Speleman, F; Verschueren, K; Coucke, PJ; Mortier, GR				Hellemans, J; Preobrazhenska, O; Willaert, A; Debeer, P; Verdonk, PCM; Costa, T; Janssens, K; Menten, B; Van Roy, N; Vermeulen, SJT; Savarirayan, R; Van Hul, W; Vanhoenacker, F; Huylebroeck, D; De Paepe, A; Naeyaert, JM; Vandesompele, J; Speleman, F; Verschueren, K; Coucke, PJ; Mortier, GR			Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis	NATURE GENETICS			English	Article							AUTOSOMAL-DOMINANT OSTEOPOIKILOSIS; TYPE-2 SEGMENTAL MANIFESTATION; CAMURATI-ENGELMANN-DISEASE; NUCLEAR-MEMBRANE PROTEIN; FAMILY; GENE; SCLEROSTEOSIS; FIBROBLASTS; DENSITY; PRIMER	Osteopoikilosis, Buschke-Ollendorff syndrome (BOS) and melorheostosis are disorders characterized by increased bone density(1). The occurrence of one or more of these phenotypes in the same individual or family suggests that these entities might be allelic(2-4). We collected data from three families in which affected individuals had osteopoikilosis with or without manifestations of BOS or melorheostosis. A genome-wide linkage analysis in these families, followed by the identification of a microdeletion in an unrelated individual with these diseases, allowed us to map the gene that is mutated in osteopoikilosis. All the affected individuals that we investigated were heterozygous with respect to a loss-of-function mutation in LEMD3 (also called MAN1), which encodes an inner nuclear membrane protein. A somatic mutation in the second allele of LEMD3 could not be identified in fibroblasts from affected skin of an individual with BOS and an individual with melorheostosis. XMAN1, the Xenopus laevis ortholog, antagonizes BMP signaling during embryogenesis(5). In this study, LEMD3 interacted with BMP and activin-TGFP receptor-activated Smads and antagonized both signaling pathways in human cells.	Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; Univ Leuven VIB, Dept Dev Biol, Lab Mol Biol, Louvain, Belgium; Univ Leuven, Ctr Human Genet, Louvain, Belgium; Ghent Univ Hosp, Dept Orthoped Surg, Ghent, Belgium; Univ Montreal, Hop St Justine, Med Genet Serv, Montreal, PQ H3T 1C5, Canada; Univ Hosp, Dept Med Genet, Antwerp, Belgium; Univ Antwerp, Antwerp, Belgium; Murdoch Childrens Res Inst, Genet Hlth Serv Victoria, Melbourne, Vic, Australia; Univ Melbourne, Parkville, Vic 3052, Australia; Univ Hosp, Dept Radiol, Antwerp, Belgium; Ghent Univ Hosp, Dept Dermatol, Ghent, Belgium	Ghent University; Ghent University Hospital; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Ghent University; Ghent University Hospital; Universite de Montreal; University of Antwerp; Murdoch Children's Research Institute; University of Melbourne; Ghent University; Ghent University Hospital	Mortier, GR (corresponding author), Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium.	geert.mortier@ugent.be	Willaert, Andy/AAZ-9111-2020; speleman, frank/AAR-5184-2020; Coucke, Paul J/AAO-2954-2020; Vandesompele, Jo/W-3411-2018; Mortier, Geert/D-2542-2012; Menten, Björn/B-3072-2013	speleman, frank/0000-0002-6628-8559; Coucke, Paul J/0000-0001-7119-586X; Vandesompele, Jo/0000-0001-6274-0184; Mortier, Geert/0000-0001-9871-4578; Van Hul, Wim/0000-0002-5065-7858; Vermeulen, Stefan/0000-0003-3710-800X; Huylebroeck, Danny/0000-0003-4862-1079; Willaert, Andy/0000-0002-9543-1932; verdonk, peter/0000-0001-6057-8590				Asano Y, 2004, J CLIN INVEST, V113, P253, DOI 10.1172/JCI200416269; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; BERLIN R, 1967, ACTA MED SCAND, V181, P305; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; Butkus CE, 1997, AM J MED GENET, V72, P43, DOI 10.1002/(SICI)1096-8628(19971003)72:1<43::AID-AJMG9>3.0.CO;2-W; CAMPBELL CJ, 1968, J BONE JOINT SURG AM, VA 50, P1281, DOI 10.2106/00004623-196850070-00001; Canalis E, 2003, ENDOCR REV, V24, P218, DOI 10.1210/er.2002-0023; Debeer P, 2003, AM J MED GENET A, V119A, P188, DOI 10.1002/ajmg.a.20072; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ehrig T, 2003, J AM ACAD DERMATOL, V49, P1163, DOI 10.1016/S0190-9622(03)00481-X; Freyschmidt J, 2001, EUR RADIOL, V11, P474, DOI 10.1007/s003300000562; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hall CM, 2002, AM J MED GENET, V113, P65, DOI 10.1002/ajmg.10828; Happle R, 2004, AM J MED GENET A, V125A, P221, DOI 10.1002/ajmg.a.20454; Janssens K, 2000, NAT GENET, V26, P273, DOI 10.1038/81563; Kinoshita A, 2000, NAT GENET, V26, P19, DOI 10.1038/79128; LAGIER R, 1984, SKELETAL RADIOL, V11, P161, DOI 10.1007/BF00349489; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lin F, 2000, J BIOL CHEM, V275, P4840, DOI 10.1074/jbc.275.7.4840; Matsuzaki H, 2004, GENOME RES, V14, P414, DOI 10.1101/gr.2014904; MELNICK JC, 1959, AMER J ROENTGENOL RA, V82, P229; Mori Y, 2003, ARTHRITIS RHEUM-US, V48, P1964, DOI 10.1002/art.11157; Nevin NC, 1999, AM J MED GENET, V82, P409, DOI 10.1002/(SICI)1096-8628(19990219)82:5<409::AID-AJMG10>3.0.CO;2-2; Osada SI, 2003, DEVELOPMENT, V130, P1783, DOI 10.1242/dev.00401; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; Rozencwaig R, 1997, Am J Orthop (Belle Mead NJ), V26, P83; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANROY N, 1994, GENE CHROMOSOME CANC, V10, P103, DOI 10.1002/gcc.2870100205; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489	29	293	318	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11					1213	1218		10.1038/ng1453	http://dx.doi.org/10.1038/ng1453			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867HI	15489854	Bronze			2022-12-27	WOS:000224832800026
J	Austin, CP; Battey, JF; Bradley, A; Bucan, M; Capecchi, M; Collins, FS; Dove, WF; Duyk, G; Dymecki, S; Eppig, JT; Grieder, FB; Heintz, N; Hicks, G; Insel, TR; Joyner, A; Koller, BH; Lloyd, KCK; Magnuson, T; Moore, MW; Nagy, A; Pollock, JD; Roses, AD; Sands, AT; Seed, B; Skarnes, WC; Snoddy, J; Soriano, P; Stewart, DJ; Stewart, F; Stillman, B; Varmus, H; Varticovski, L; Verma, IM; Vogt, TF; von Melchner, H; Witkowski, J; Woychik, RP; Wurst, W; Yancopoulos, GD; Young, SG; Zambrowicz, B				Austin, CP; Battey, JF; Bradley, A; Bucan, M; Capecchi, M; Collins, FS; Dove, WF; Duyk, G; Dymecki, S; Eppig, JT; Grieder, FB; Heintz, N; Hicks, G; Insel, TR; Joyner, A; Koller, BH; Lloyd, KCK; Magnuson, T; Moore, MW; Nagy, A; Pollock, JD; Roses, AD; Sands, AT; Seed, B; Skarnes, WC; Snoddy, J; Soriano, P; Stewart, DJ; Stewart, F; Stillman, B; Varmus, H; Varticovski, L; Verma, IM; Vogt, TF; von Melchner, H; Witkowski, J; Woychik, RP; Wurst, W; Yancopoulos, GD; Young, SG; Zambrowicz, B		Comprehensive Knockout Mouse Proje	The knockout mouse project	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; GENE-TRAP MUTAGENESIS; GENOME; MICE; SEQUENCE; IDENTIFICATION; DEFICIENCY; PHENOTYPE; INSIGHTS; RESOURCE	Mouse knockout technology provides a powerful means of elucidating gene function in vivo, and a publicly available genome-wide collection of mouse knockouts would be significantly enabling for biomedical discovery. To date, published knockouts exist for only about 10% of mouse genes. Furthermore, many of these are limited in utility because they have not been made or phenotyped in standardized ways, and many are not freely available to researchers. It is time to harness new technologies and efficiencies of production to mount a high-throughput international effort to produce and phenotype knockouts for all mouse genes, and place these resources into the public domain.	NHGRI, NIH, Bethesda, MD 20892 USA; Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD 20892 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; Univ Utah, Eccles Inst Human Genet, Salt Lake City, UT 85112 USA; Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; TPG Ventures, San Francisco, CA 94104 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Jackson Lab, Bar Harbor, ME 04609 USA; NIH, Natl Ctr Res Resources, Bethesda, MD 20817 USA; Rockefeller Univ, Mol Biol Lab, New York, NY 10021 USA; Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada; NIMH, Bethesda, MD 20892 USA; Skirball Inst Biomol Med, New York, NY 10016 USA; Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; Univ Calif Davis, Sch Vet Med, Davis, CA 95616 USA; Deltagen, Redwood City, CA 94063 USA; Univ Toronto, Samuel Lumenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Natl Inst Drug Abuse, Bethesda, MD 20892 USA; GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA; Lexicon Genet, The Woodlands, TX 77381 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Oak Ridge Natl Lab, Univ Tennessee ORNL Grad Sch Genome Sci & Technol, Oak Ridge, TN 37831 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Cold Spring Harbor Lab, Banbury Ctr, Cold Spring Harbor, NY 11724 USA; Univ Technol, Bioz, MPI CBG, D-1307 Dresden, Germany; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; NCI, NIH, Bethesda, MD 20892 USA; Salk Inst Biol Studies, Mol Biol & Virol Lab, La Jolla, CA 92037 USA; Merck Res Labs, West Point, PA 19486 USA; Goethe Univ Frankfurt, Sch Med, Lab Mol Hematol, D-60590 Frankfurt, Germany; Jackson Lab, Bar Harbor, ME 04609 USA; Max Planck Inst Psychiat, GSF Res Ctr, Inst Dev Genet, D-85764 Munich, Germany; Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; Univ Calif San Francisco, Gladstone Fdn Cardiovasc Dis, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Wellcome Trust Sanger Institute; University of Pennsylvania; Utah System of Higher Education; University of Utah; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Harvard Medical School; Jackson Laboratory; National Institutes of Health (NIH) - USA; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Davis; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); GlaxoSmithKline; Lexicon Pharmaceuticals; Harvard University; Massachusetts General Hospital; United States Department of Energy (DOE); Oak Ridge National Laboratory; Fred Hutchinson Cancer Center; Cold Spring Harbor Laboratory; Max Planck Society; Technische Universitat Dresden; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Salk Institute; Merck & Company; Goethe University Frankfurt; Jackson Laboratory; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; Regeneron; University of California System; University of California San Francisco; The J David Gladstone Institutes	Austin, CP (corresponding author), NHGRI, NIH, Bldg 31,Room 4B09,31 Ctr Dr, Bethesda, MD 20892 USA.	austinc@mail.nih.gov	Soriano, Philippe M/E-5797-2015; Witkowski, Jan/FHJ-8549-2022; Stewart, A. Francis/E-7789-2010; Nagy, Andras/G-6465-2013; Pollock, Jonathan D/B-1554-2009; Woychik, Richard P/C-8345-2019	Soriano, Philippe M/0000-0002-0427-926X; Nagy, Andras/0000-0003-4311-0413; Woychik, Richard P/0000-0001-8196-1732; Hicks, Geoffrey/0000-0003-4688-2312; Bradley, Allan/0000-0002-2349-8839; Stillman, Bruce/0000-0002-9453-4091; Young, Stephen/0000-0001-7270-3176; Witkowski, Jan/0000-0002-8159-2874; Wurst, Wolfgang/0000-0003-4422-7410; Varticovski, Lyuba/0000-0002-5105-9008	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS003004] Funding Source: NIH RePORTER; Wellcome Trust [077188] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission)		BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; Clark J., 2000, PATENT POOLS SOLUTIO; D'Orleans-Juste P, 2003, CURR OPIN PHARMACOL, V3, P181, DOI 10.1016/S1471-4892(03)00017-1; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; Eggan K, 2002, NAT BIOTECHNOL, V20, P455, DOI 10.1038/nbt0502-455; Goldstein JL, 2001, NAT MED, V7, P1079, DOI 10.1038/nm1001-1079; Hansen J, 2003, P NATL ACAD SCI USA, V100, P9918, DOI 10.1073/pnas.1633296100; Horton WA, 2003, LANCET, V362, P560, DOI 10.1016/S0140-6736(03)14119-0; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Nadeau JH, 2001, SCIENCE, V291, P1251, DOI 10.1126/science.1058244; Seong E, 2004, TRENDS GENET, V20, P59, DOI 10.1016/j.tig.2003.12.006; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Stanford WL, 2001, NAT REV GENET, V2, P756, DOI 10.1038/35093548; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wallace DC, 2001, AM J MED GENET, V106, P71, DOI 10.1002/ajmg.1393; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wiles MV, 2000, NAT GENET, V24, P13, DOI 10.1038/71622; Zambrowicz BP, 2003, P NATL ACAD SCI USA, V100, P14109, DOI 10.1073/pnas.2336103100; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	25	440	480	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2004	36	9					921	924		10.1038/ng0904-921	http://dx.doi.org/10.1038/ng0904-921			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15340423	Green Accepted			2022-12-27	WOS:000223658100005
J	Ioshikhes, IP; Albert, I; Zanton, SJ; Pugh, BF				Ioshikhes, Ilya P.; Albert, Istvan; Zanton, Sara J.; Pugh, B. Franklin			Nucleosome positions predicted through comparative genomics	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; MULTIPLE ALIGNMENT; PROMOTER REGIONS; DNA PATTERN; YEAST; IDENTIFICATION; SEQUENCES; GENES; SITES; CORE	DNA sequence has long been recognized as an important contributor to nucleosome positioning, which has the potential to regulate access to genes. The extent to which the nucleosomal architecture at promoters is delineated by the underlying sequence is now being worked out. Here we use comparative genomics to report a genome-wide map of nucleosome positioning sequences (NPSs) located in the vicinity of all Saccharomyces cerevisiae genes. We find that the underlying DNA sequence provides a very good predictor of nucleosome locations that have been experimentally mapped to a small fraction of the genome. Notably, distinct classes of genes possess characteristic arrangements of NPSs that may be important for their regulation. In particular, genes that have a relatively compact NPS arrangement over the promoter region tend to have a TATA box buried in an NPS and tend to be highly regulated by chromatin modifying and remodeling factors.	Penn State Univ, Ctr Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; Penn State Univ, Huck Inst Life Sci, Bioinformat Consulting Ctr, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Pugh, BF (corresponding author), Penn State Univ, Ctr Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	bfp2@psu.edu	Albert, Istvan/J-3734-2015	Albert, Istvan/0000-0001-8366-984X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059055] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM059055, GM59055] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bolshoy A, 1996, COMPUT APPL BIOSCI, V12, P383; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Cohanim AB, 2005, J BIOMOL STRUCT DYN, V22, P687, DOI 10.1080/07391102.2005.10507035; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Ioshikhes I, 1996, J MOL BIOL, V262, P129, DOI 10.1006/jmbi.1996.0503; Ioshikhes I, 1999, P NATL ACAD SCI USA, V96, P2891, DOI 10.1073/pnas.96.6.2891; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Lowary PT, 1997, P NATL ACAD SCI USA, V94, P1183, DOI 10.1073/pnas.94.4.1183; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Sabet N, 2004, MOL CELL BIOL, V24, P8823, DOI 10.1128/MCB.24.20.8823-8833.2004; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Widom J, 1996, J MOL BIOL, V259, P579, DOI 10.1006/jmbi.1996.0341; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583	21	255	263	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1210	1215		10.1038/ng1878	http://dx.doi.org/10.1038/ng1878			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16964265				2022-12-27	WOS:000241251100023
J	Morgan, NV; Westaway, SK; Morton, JEV; Gregory, A; Gissen, P; Sonek, S; Cangul, H; Coryell, J; Canham, N; Nardocci, N; Zorzi, G; Pasha, S; Rodriguez, D; Desguerre, I; Mubaidin, A; Bertini, E; Trembath, RC; Simonati, A; Schanen, C; Johnson, CA; Levinson, B; Woods, CG; Wilmot, B; Kramer, P; Gitschier, J; Maher, ER; Hayflick, SJ				Morgan, Neil V.; Westaway, Shawn K.; Morton, Jenny E. V.; Gregory, Allison; Gissen, Paul; Sonek, Scott; Cangul, Hakan; Coryell, Jason; Canham, Natalie; Nardocci, Nardo; Zorzi, Giovanna; Pasha, Shanaz; Rodriguez, Diana; Desguerre, Isabelle; Mubaidin, Amar; Bertini, Enrico; Trembath, Richard C.; Simonati, Alessandro; Schanen, Carolyn; Johnson, Colin A.; Levinson, Barbara; Woods, C. Geoffrey; Wilmot, Beth; Kramer, Patricia; Gitschier, Jane; Maher, Eamonn R.; Hayflick, Susan J.			PLA2G6, encoding a phospholipase A(2), is mutated in neurodegenerative disorders with high brain iron	NATURE GENETICS			English	Article							INFANTILE NEUROAXONAL DYSTROPHY; HALLERVORDEN-SPATZ-SYNDROME; INVOLVEMENT	Neurodegenerative disorders with high brain iron include Parkinson disease, Alzheimer disease and several childhood genetic disorders categorized as neuroaxonal dystrophies. We mapped a locus for infantile neuroaxonal dystrophy ( INAD) and neurodegeneration with brain iron accumulation (NBIA) to chromosome 22q12-q13 and identified mutations in PLA2G6, encoding a calcium-independent group VI phospholipase A(2), in NBIA, INAD and the related Karak syndrome. This discovery implicates phospholipases in the pathogenesis of neurodegenerative disorders with iron dyshomeostasis.	Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; Univ Birmingham, Sch Med, Sect Med & Mol Genet, Birmingham B15 2TT, W Midlands, England; Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; Uludag Univ, Sch Med, Dept Med Genet, TR-16036 Bursa, Turkey; Ist Nazl Neurol Carlo Besta, Dept Child Neurol, I-20133 Milan, Italy; Hop Armand Trousseau, Dept Pediat Neurol, F-75571 Paris, France; Hop Necker Enfants Malad, Dept Pediat Neurol, F-75270 Paris, France; Bambino Gesu Pediat Hosp, Mol Med Unit, I-00165 Rome, Italy; King Hussein Med Ctr, Dept Neurol, Amman, Jordan; Univ London Kings Coll, Div Genet & Mol Med, Sch Med, Guys Hosp, London SE1 9RT, England; Univ Verona, Sch Med, Dept Neurol & Visual Sci, I-37129 Verona, Italy; AI DuPont Hosp Children, Nemours Res Programs, Wilmington, DE 19899 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 1TN, England; Oregon Hlth Sci Univ, Dept Neurol, Portland, OR 97239 USA; Oregon Hlth Sci Univ, Dept Pediat, Portland, OR 97239 USA; Howard Hughes Med Inst, Coconut Grove, FL 33133 USA	Oregon Health & Science University; University of Birmingham; Birmingham Women's Hospital; Uludag University; IRCCS Istituto Neurologico Besta; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; IRCCS Bambino Gesu; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Verona; Nemours Alfred I. duPont Hospital for Children; University of California System; University of California San Francisco; University of Cambridge; Oregon Health & Science University; Oregon Health & Science University; Howard Hughes Medical Institute	Hayflick, SJ (corresponding author), Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA.	hayflick@ohsu.edu	woods, christopher g/A-1361-2010; MAHER, EAMONN R/A-9507-2008; Morgan, Neil V/A-5475-2009; Nardocci, Nardo/AAB-9903-2019; Bertini, Enrico/A-2284-2014; Bertini, Enrico/ABG-1278-2020; Zorzi, Giovanna/AAM-4138-2021; Gissen, Paul/A-4352-2010	MAHER, EAMONN R/0000-0002-6226-6918; Morgan, Neil V/0000-0001-6433-5692; Nardocci, Nardo/0000-0001-5863-5592; Bertini, Enrico/0000-0001-9276-4590; Zorzi, Giovanna/0000-0001-7041-5365; Gissen, Paul/0000-0002-9712-6122; Trembath, Richard/0000-0003-0550-3400	NCRR NIH HHS [M01 RR000334] Funding Source: Medline; NEI NIH HHS [R01 EY012353, R01 EY012353-07] Funding Source: Medline; NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NIA NIH HHS [P30 AG008017] Funding Source: Medline; NICHD NIH HHS [R01 HD050832-01A1, R01 HD050832] Funding Source: Medline; Telethon [GTF04002] Funding Source: Medline; Wellcome Trust Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050832] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000334] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012353] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008017] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Farina L, 1999, NEURORADIOLOGY, V41, P376, DOI 10.1007/s002340050768; Farooqui AA, 2004, NEUROCHEM RES, V29, P1961, DOI 10.1007/s11064-004-6871-3; Hayflick SJ, 2003, NEW ENGL J MED, V348, P33, DOI 10.1056/NEJMoa020817; Larsson PKA, 1998, J BIOL CHEM, V273, P207, DOI 10.1074/jbc.273.1.207; Mubaidin A, 2003, J MED GENET, V40, P543, DOI 10.1136/jmg.40.7.543; Nardocci N, 1999, NEUROLOGY, V52, P1472, DOI 10.1212/WNL.52.7.1472; Simonati A, 1999, NEUROPEDIATRICS, V30, P151, DOI 10.1055/s-2007-973482; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	11	365	388	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2006	38	7					752	754		10.1038/ng1826	http://dx.doi.org/10.1038/ng1826			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16783378	Green Accepted			2022-12-27	WOS:000238669300009
J	Clee, SM; Yandell, BS; Schueler, KM; Rabaglia, ME; Richards, OC; Raines, SM; Kabara, EA; Klass, DM; Mui, ETK; Stapleton, DS; Gray-Keller, MP; Young, MB; Stoehr, JP; Lan, H; Boronenkov, I; Raess, PW; Flowers, MT; Attie, AD				Clee, Susanne M.; Yandell, Brian S.; Schueler, Kathryn M.; Rabaglia, Mary E.; Richards, Oliver C.; Raines, Summer M.; Kabara, Edward A.; Klass, Daniel M.; Mui, Eric T-K; Stapleton, Donald S.; Gray-Keller, Mark P.; Young, Matthew B.; Stoehr, Jonathan P.; Lan, Hong; Boronenkov, Igor; Raess, Philipp W.; Flowers, Matthew T.; Attie, Alan D.			Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus	NATURE GENETICS			English	Article							GENETIC-ANALYSIS; PROPEPTIDE CLEAVAGE; PANCREATIC-ISLETS; MELLITUS; INSULIN; RECEPTOR; CELLS; CROSSES; OBESITY; DOMAIN	We previously mapped the type 2 diabetes mellitus-2 locus (T2dm2), which affects fasting insulin levels, to distal chromosome 19 in a leptin-deficient obese F-2 intercross derived from C57BL/6 (B6) and BTBR T+ tf/J (BTBR) mice(1). Introgression of a 7-Mb segment of the B6 chromosome 19 into the BTBR background (strain 1339A) replicated the reduced insulin linked to T2dm2. The 1339A mice have markedly impaired insulin secretion in vivo and disrupted islet morphology. We used subcongenic strains derived from 1339A to localize the T2dm2 quantitative trait locus (QTL) to a 242-kb segment comprising the promoter, first exon and most of the first intron of the Sorcs1 gene. This was the only gene in the 1339A strain for which we detected amino acid substitutions and expression level differences between mice carrying B6 and BTBR alleles of this insert, thereby identifying variation within the Sorcs1 gene as underlying the phenotype associated with the T2dm2 locus. SorCS1 binds platelet-derived growth factor, a growth factor crucial for pericyte recruitment to the microvasculature, and may thus have a role in expanding or maintaining the islet vasculature. Our identification of the Sorcs1 gene provides insight into the pathway underlying the pathophysiology of obesity-induced type 2 diabetes mellitus.	Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; Univ Wisconsin, Dept Stat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Attie, AD (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	attie@biochem.wisc.edu	Clee, Susanne/AAC-4278-2020; Clee, Susanne/F-7312-2010	Clee, Susanne/0000-0001-7946-688X; Raess, Philipp/0000-0002-6841-4993	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER; PHS HHS [58037, 66369] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Barroso I, 2003, PLOS BIOL, V1, P41, DOI 10.1371/journal.pbio.0000020; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; CHURCHILL GA, 1994, GENETICS, V138, P963; Clee Susanne M, 2005, Am J Ther, V12, P491, DOI 10.1097/01.mjt.0000178781.89789.25; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Florez JC, 2003, ANNU REV GENOM HUM G, V4, P257, DOI 10.1146/annurev.genom.4.070802.110436; Galli J, 1996, NAT GENET, V12, P31, DOI 10.1038/ng0196-31; Hampe W, 2001, HUM GENET, V108, P529, DOI 10.1007/s004390100504; Hermey G, 2006, BIOCHEM J, V395, P285, DOI 10.1042/BJ20051364; Hermey G, 2003, J BIOL CHEM, V278, P7390, DOI 10.1074/jbc.M210851200; Jacobsen L, 2001, J BIOL CHEM, V276, P22788, DOI 10.1074/jbc.M100857200; Kim JH, 2001, GENOMICS, V74, P273, DOI 10.1006/geno.2001.6569; Kluge R, 2000, DIABETOLOGIA, V43, P1565, DOI 10.1007/s001250051570; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; Liu YF, 2000, GENET RES, V75, P345, DOI 10.1017/S0016672300004493; Parikh H, 2004, REV ENDOCR METAB DIS, V5, P151, DOI 10.1023/B:REMD.0000021437.46773.26; Permutt MA, 2005, J CLIN INVEST, V115, P1431, DOI 10.1172/JCI24758; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Rabaglia ME, 2005, AM J PHYSIOL-ENDOC M, V289, pE218, DOI 10.1152/ajpendo.00573.2004; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Stoehr JP, 2000, DIABETES, V49, P1946, DOI 10.2337/diabetes.49.11.1946; Wei SW, 1999, MAMM GENOME, V10, P249, DOI 10.1007/s003359900982; Westergaard UB, 2004, J BIOL CHEM, V279, P50221, DOI 10.1074/jbc.M408873200; Westergaard UB, 2005, FEBS LETT, V579, P1172, DOI 10.1016/j.febslet.2004.12.088; Wiltshire S, 2001, AM J HUM GENET, V69, P553, DOI 10.1086/323249; Zou F, 2001, GENETICS, V158, P1339	30	125	145	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2006	38	6					688	693		10.1038/ng1796	http://dx.doi.org/10.1038/ng1796			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16682971				2022-12-27	WOS:000237954800024
J	Park, TJ; Haigo, SL; Wallingford, JB				Park, TJ; Haigo, SL; Wallingford, JB			Ciliogenesis defects in embryos lacking inturned or fuzzy function are associated with failure of planar cell polarity and Hedgehog signaling	NATURE GENETICS			English	Article							DROSOPHILA TISSUE POLARITY; INTRAFLAGELLAR TRANSPORT PROTEINS; NEURAL-TUBE CLOSURE; CONVERGENT EXTENSION; XENOPUS-LAEVIS; SONIC HEDGEHOG; QUAIL OVIDUCT; FLOOR PLATE; GENE; CILIA	The vertebrate planar cell polarity (PCP) pathway has previously been found to control polarized cell behaviors rather than cell fate. We report here that disruption of Xenopus laevis orthologs of the Drosophila melanogaster PCP effectors inturned (in) or fuzzy (fy) affected not only PCP-dependent convergent extension but also elicited embryonic phenotypes consistent with defective Hedgehog signaling. These defects in Hedgehog signaling resulted from a broad requirement for Inturned and Fuzzy in ciliogenesis. We show that these proteins govern apical actin assembly and thus control the orientation, but not assembly, of ciliary microtubules. Finally, accumulation of Dishevelled and Inturned near the basal apparatus of cilia suggests that these proteins function in a common pathway with core PCP components to regulate ciliogenesis. Together, these data highlight the interrelationships between cell polarity, cellular morphogenesis, signal transduction and cell fate specification.	Univ Texas, Dept Mol Cell & Dev Biol, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of California System; University of California Berkeley	Wallingford, JB (corresponding author), Univ Texas, Dept Mol Cell & Dev Biol, Austin, TX 78712 USA.	wallingford@mail.utexas.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074104] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM074104] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adler PN, 2004, CURR BIOL, V14, P2046, DOI 10.1016/j.cub.2004.11.007; Adler PN, 2001, CURR OPIN CELL BIOL, V13, P635, DOI 10.1016/S0955-0674(00)00263-5; ASSHETON R, 1896, Q J MICROSC SCI, V38, P465; BOISVIEUXULRICH E, 1990, CELL TISSUE RES, V259, P443, DOI 10.1007/BF01740770; BOISVIEUXULRICH E, 1991, BIOL CELL, V72, P3, DOI 10.1016/0248-4900(91)90072-U; CHAILLEY B, 1989, BIOL CELL, V67, P81, DOI 10.1111/j.1768-322X.1989.tb03012.x; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Collier S, 1997, DEVELOPMENT, V124, P4029; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Eaton S, 1996, J CELL BIOL, V135, P1277, DOI 10.1083/jcb.135.5.1277; EKKER SC, 1995, DEVELOPMENT, V121, P2337; Feiguin F, 2001, DEV CELL, V1, P93, DOI 10.1016/S1534-5807(01)00010-7; Hagiwara H, 2004, INT REV CYTOL, V234, P101, DOI 10.1016/S0074-7696(04)34003-9; Hallonet M, 1999, GENE DEV, V13, P3106, DOI 10.1101/gad.13.23.3106; Han YG, 2003, CURR BIOL, V13, P1679, DOI 10.1016/j.cub.2003.08.034; Hu D, 1999, DEVELOPMENT, V126, P4873; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Jenny A, 2005, NAT CELL BIOL, V7, P691, DOI 10.1038/ncb1271; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; KELLER R, 1992, DEV DYNAM, V193, P199, DOI 10.1002/aja.1001930302; Keller R, 2000, PHILOS T R SOC B, V355, P897, DOI 10.1098/rstb.2000.0626; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; KONIG G, 1993, DEV BIOL, V160, P355, DOI 10.1006/dbio.1993.1312; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Kulaga HM, 2004, NAT GENET, V36, P994, DOI 10.1038/ng1418; Lee H, 2002, GENETICS, V160, P1535; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Lopez SL, 2003, DEVELOPMENT, V130, P2225, DOI 10.1242/dev.00443; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Murdoch JN, 2001, HUM MOL GENET, V10, P2593, DOI 10.1093/hmg/10.22.2593; NISHIKAWA S, 1992, HISTOCHEMISTRY, V98, P355, DOI 10.1007/BF00271070; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Pan JM, 2005, LAB INVEST, V85, P452, DOI 10.1038/labinvest.3700253; Park WJ, 1996, DEVELOPMENT, V122, P961; Pichon B, 2002, DEV GENES EVOL, V212, P491, DOI 10.1007/s00427-002-0270-z; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Take-uchi M, 2003, DEVELOPMENT, V130, P955, DOI 10.1242/dev.00305; TAMM S, 1988, J CELL SCI, V89, P67; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; TRUEB L, 1992, J MORPHOL, V214, P1, DOI 10.1002/jmor.1052140102; Wada N, 2005, DEVELOPMENT, V132, P3977, DOI 10.1242/dev.01943; Wallingford JB, 2005, AM J MED GENET C, V135C, P59, DOI 10.1002/ajmg.c.30054; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2001, DEVELOPMENT, V128, P2581; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407	50	292	302	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					303	311		10.1038/ng1753	http://dx.doi.org/10.1038/ng1753			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16493421				2022-12-27	WOS:000235589600011
J	Sato, TK; Yamada, RG; Ukai, H; Baggs, JE; Miraglia, LJ; Kobayashi, TJ; Welsh, DK; Kay, SA; Ueda, HR; Hogenesch, JB				Sato, TK; Yamada, RG; Ukai, H; Baggs, JE; Miraglia, LJ; Kobayashi, TJ; Welsh, DK; Kay, SA; Ueda, HR; Hogenesch, JB			Feedback repression is required for mammalian circadian clock function	NATURE GENETICS			English	Article							KAIC PHOSPHORYLATION; GENE-EXPRESSION; TRANSCRIPTION; MPER1; LOOP; CRYPTOCHROMES; MECHANISM; RHYTHMS; PROTEIN; PERIOD	Direct evidence for the requirement of transcriptional feedback repression in circadian clock function has been elusive. Here, we developed a molecular genetic screen in mammalian cells to identify mutants of the circadian transcriptional activators CLOCK and BMAL1, which were uncoupled from CRYPTOCHROME (CRY)- mediated transcriptional repression. Notably, mutations in the PER-ARNT-SIM domain of CLOCK and the C terminus of BMAL1 resulted in synergistic insensitivity through reduced physical interactions with CRY. Coexpression of these mutant proteins in cultured fibroblasts caused arrhythmic phenotypes in population and single-cell assays. These data demonstrate that CRY-mediated repression of the CLOCK/BMAL1 complex activity is required for maintenance of circadian rhythmicity and provide formal proof that transcriptional feedback is required for mammalian clock function.	Genom Inst, San Diego, CA 92121 USA; Novartis Res Fdn, San Diego, CA 92121 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Genome Technol, Jupiter, FL 33458 USA; RIKEN, Ctr Dev Biol, Lab Syst Biol, Kobe, Hyogo 6500047, Japan; Scripps Res Inst, Dept Biochem, Jupiter, FL 33458 USA; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92037 USA; Vet Adm San Diego Healthcare Syst, La Jolla, CA 92161 USA; Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA	Novartis; Scripps Research Institute; Scripps Research Institute; RIKEN; Scripps Research Institute; University of California System; University of California San Diego; Scripps Research Institute	Ueda, HR (corresponding author), Genom Inst, 10675 John J Hopkins Dr, San Diego, CA 92121 USA.	uedah-tky@umin.ac.jp; hogenesch@scripps.edu	Kay, Steve A/F-6025-2011; Ueda, Hiroki R/C-5037-2014; Welsh, David K/G-2277-2011	Kay, Steve A/0000-0002-0402-2878; Ueda, Hiroki R/0000-0001-8342-9176; 	NIMH NIH HHS [P50 MH074924, P50 MH074924-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074924] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Cook E. R., 1981, Tree-Ring Bulletin, V41, P45; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Yildiz O, 2005, MOL CELL, V17, P69, DOI 10.1016/j.molcel.2004.11.022; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	33	274	279	3	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2006	38	3					312	319		10.1038/ng1745	http://dx.doi.org/10.1038/ng1745			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	015ZG	16474406	Green Accepted			2022-12-27	WOS:000235589600012
J	Davierwala, AP; Haynes, J; Li, ZJ; Brost, RL; Robinson, MD; Yu, L; Mnaimneh, S; Ding, HM; Zhu, HW; Chen, YQ; Cheng, X; Brown, GW; Boone, C; Andrews, BJ; Hughes, TR				Davierwala, AP; Haynes, J; Li, ZJ; Brost, RL; Robinson, MD; Yu, L; Mnaimneh, S; Ding, HM; Zhu, HW; Chen, YQ; Cheng, X; Brown, GW; Boone, C; Andrews, BJ; Hughes, TR			The synthetic genetic interaction spectrum of essential genes	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST; COMPLEX; IDENTIFICATION; PATHWAY; GENOME; COMPONENT; VACUOLE; REPAIR; AP-3	The nature of synthetic genetic interactions involving essential genes (those required for viability) has not been previously examined in a broad and unbiased manner. We crossed yeast strains carrying promoter-replacement alleles for more than half of all essential yeast genes(1) to a panel of 30 different mutants with defects in diverse cellular processes. The resulting genetic network is biased toward interactions between functionally related genes, enabling identification of a previously uncharacterized essential gene (PGA1) required for specific functions of the endoplasmic reticulum. But there are also many interactions between genes with dissimilar functions, suggesting that individual essential genes are required for buffering many cellular processes. The most notable feature of the essential synthetic genetic network is that it has an interaction density five times that of nonessential synthetic genetic networks(2,3), indicating that most yeast genetic interactions involve at least one essential gene.	Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University of Toronto	Hughes, TR (corresponding author), Univ Toronto, Banting & Best Dept Med Res, 112 Coll St, Toronto, ON M5G 1L6, Canada.	t.hughes@utoronto.ca	Robinson, Mark D/A-6432-2015; Haynes, Jennifer/P-8565-2019; Robinson, Mark D./O-2254-2019	Robinson, Mark D/0000-0002-3048-5518; Robinson, Mark D./0000-0002-3048-5518; Brown, Grant/0000-0002-9002-5003				Avaro S, 2002, YEAST, V19, P351, DOI 10.1002/yea.838; Belgareh-Touze N, 2003, TRAFFIC, V4, P607, DOI 10.1034/j.1600-0854.2003.00116.x; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r23; Christie KR, 2004, NUCLEIC ACIDS RES, V32, pD311, DOI 10.1093/nar/gkh033; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; FIEN K, 1992, MOL CELL BIOL, V12, P155, DOI 10.1128/MCB.12.1.155; Finger FP, 2000, GENETICS, V156, P943; Fujioka Y, 2002, J BIOL CHEM, V277, P21585, DOI 10.1074/jbc.M201523200; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goddijn M, 2000, BEST PRACT RES CL OB, V14, P855, DOI 10.1053/beog.2000.0124; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hartwell L, 2004, SCIENCE, V303, P774, DOI 10.1126/science.1094731; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; HENNESSY KM, 1991, GENE DEV, V5, P958, DOI 10.1101/gad.5.6.958; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Kile BT, 2003, NATURE, V425, P81, DOI 10.1038/nature01865; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; Phillips PC, 1998, GENETICS, V150, P449; Popolo L, 1999, BBA-GEN SUBJECTS, V1426, P385, DOI 10.1016/S0304-4165(98)00138-X; Stepp JD, 1997, J CELL BIOL, V139, P1761, DOI 10.1083/jcb.139.7.1761; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810	29	170	176	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2005	37	10					1147	1152		10.1038/ng1640	http://dx.doi.org/10.1038/ng1640			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	968TP	16155567				2022-12-27	WOS:000232185600030
J	Hillebrandt, S; Wasmuth, HE; Weiskirchen, R; Hellerbrand, C; Keppeler, H; Werth, A; Schirin-Sokhan, R; Wilkens, G; Geier, A; Lorenzen, J; Kohl, J; Gressner, AM; Matern, S; Lammert, F				Hillebrandt, S; Wasmuth, HE; Weiskirchen, R; Hellerbrand, C; Keppeler, H; Werth, A; Schirin-Sokhan, R; Wilkens, G; Geier, A; Lorenzen, J; Kohl, J; Gressner, AM; Matern, S; Lammert, F			Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans	NATURE GENETICS			English	Article							CHRONIC HEPATITIS-C; FIBROSIS PROGRESSION; C5A; RECEPTOR; EXPRESSION; RESPONSES; REGENERATION; ANTAGONISTS; COMPONENT; GENOTYPES	Fibrogenesis or scarring of the liver is a common consequence of all chronic liver diseases. Here we refine a quantitative trait locus that confers susceptibility to hepatic fibrosis by in silico mapping and show, using congenic mice and transgenesis with recombined artificial chromosomes, that the gene Hc (encoding complement factor C5) underlies this locus. Small molecule inhibitors of the C5a receptor had antifibrotic effects in vivo, and common haplotype-tagging polymorphisms of the human gene C5 were associated with advanced fibrosis in chronic hepatitis C virus infection. Thus, the mouse quantitative trait gene led to the identification of an unknown gene underlying human susceptibility to liver fibrosis, supporting the idea that C5 has a causal role in fibrogenesis across species.	Univ Aachen, Univ Hosp Aachen, Dept Med 3, D-5100 Aachen, Germany; Univ Bonn, Bonner Forum Biomed, Univ Hosp Bonn, Dept Internal Med 1, D-53127 Bonn, Germany; Univ Aachen, Univ Hosp Aachen, Inst Clin Chem & Pathobiochem, D-5100 Aachen, Germany; Univ Regensburg, Univ Hosp Regensburg, Dept Med 1, D-8400 Regensburg, Germany; Univ Aachen, Univ Hosp Aachen, Inst Pathol, D-5100 Aachen, Germany; Univ Cincinnati, Dept Pediat, Cincinnati Childrens Hosp Res Fdn, Div Mol Immunol, Cincinnati, OH 45221 USA	RWTH Aachen University; RWTH Aachen University Hospital; University of Bonn; RWTH Aachen University; RWTH Aachen University Hospital; University of Regensburg; RWTH Aachen University; RWTH Aachen University Hospital; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Lammert, F (corresponding author), Univ Aachen, Univ Hosp Aachen, Dept Med 3, D-5100 Aachen, Germany.	frank.lammert@ukb.uni-bonn.de	Koehl, Joerg/C-8531-2011; Weiskirchen, Ralf/O-1734-2018	Koehl, Joerg/0000-0003-1121-3178; Weiskirchen, Ralf/0000-0003-3888-0931				Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; CHURCHILL GA, 1994, GENETICS, V138, P963; Czermak BJ, 1998, J LEUKOCYTE BIOL, V64, P40, DOI 10.1002/jlb.64.1.40; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; ELLISON RT, 1990, DIGEST DIS SCI, V35, P231, DOI 10.1007/BF01536768; ELSTON RC, 1977, BIOMETRICS, V33, P536, DOI 10.2307/2529370; Fehrenbach H, 2001, HEPATOLOGY, V34, P943, DOI 10.1053/jhep.2001.28788; Finch AM, 1999, J MED CHEM, V42, P1965, DOI 10.1021/jm9806594; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Geier A, 2004, LIVER INT, V24, P285, DOI 10.1111/j.1478-3231.2004.0928.x; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; Hillebrandt S, 2002, GASTROENTEROLOGY, V123, P2041, DOI 10.1053/gast.2002.37069; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; Huber-Lang MS, 2002, FASEB J, V16, P1567, DOI 10.1096/fj.02-0209com; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Kohl J, 2001, MOL IMMUNOL, V38, P175, DOI 10.1016/S0161-5890(01)00041-4; KONTEATIS ZD, 1994, J IMMUNOL, V153, P4200; Korstanje R, 2002, NAT GENET, V31, P235, DOI 10.1038/ng0702-235; Manly KF, 1999, MAMM GENOME, V10, P327, DOI 10.1007/s003359900997; Mastellos D, 2001, J IMMUNOL, V166, P2479, DOI 10.4049/jimmunol.166.4.2479; Neumann UP, 2004, J HEPATOL, V41, P830, DOI 10.1016/j.jhep.2004.06.029; PHAN SH, 1982, AM J PATHOL, V107, P25; Pletcher MT, 2004, PLOS BIOL, V2, P2159, DOI 10.1371/journal.pbio.0020393; POUPON R, 1996, HEPATOLOGY TXB LIVER, V2, P1329; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Riedemann NC, 2002, J CLIN INVEST, V110, P101, DOI 10.1172/JCI200215409; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Schlaf G, 2003, HISTOL HISTOPATHOL, V18, P299, DOI 10.14670/HH-18.299; Schulz KF, 2002, LANCET, V359, P431, DOI 10.1016/S0140-6736(02)07605-5; Sebastiani P, 2003, P NATL ACAD SCI USA, V100, P9900, DOI 10.1073/pnas.1633613100; SENALDI G, 1989, GASTROENTEROLOGY, V97, P1430, DOI 10.1016/0016-5085(89)90386-7; Sheerin NS, 2002, CLIN EXP IMMUNOL, V130, P1, DOI 10.1046/j.1365-2249.2002.01979.x; Shi ZD, 1997, P NATL ACAD SCI USA, V94, P10663, DOI 10.1073/pnas.94.20.10663; Smithies O, 2005, NAT REV GENET, V6, P419, DOI 10.1038/nrg1605; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Strey CW, 2003, J EXP MED, V198, P913, DOI 10.1084/jem.20030374; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wasmuth HE, 2004, HEPATOLOGY, V39, P604, DOI 10.1002/hep.20150; Wasmuth HE, 2004, J MOL MED-JMM, V82, P64, DOI 10.1007/s00109-003-0505-0; WETSEL RA, 1990, J BIOL CHEM, V265, P2435; Whaley K, 1997, SEMIN LIVER DIS, V17, P297, DOI 10.1055/s-2007-1007206; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	50	205	215	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2005	37	8					835	843		10.1038/ng1599	http://dx.doi.org/10.1038/ng1599			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	15995705				2022-12-27	WOS:000230880400013
J	Cheslock, PS; Kemp, BJ; Boumil, RM; Dawson, DS				Cheslock, PS; Kemp, BJ; Boumil, RM; Dawson, DS			The roles of MAD1, MAD2 and MAD3 in meiotic progression and the segregation of nonexchange chromosomes	NATURE GENETICS			English	Article							SPINDLE ASSEMBLY CHECKPOINT; MOUSE OOCYTES; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; MEIOSIS-I; RECOMBINATION; ANEUPLOIDY; BUBR1; MICE; AGE	Errors in meiotic chromosome segregation are the leading cause of spontaneous abortions and birth defects(1). In humans, chromosomes that fail to experience crossovers ( or exchanges) are error- prone, more likely than exchange chromosomes to mis- segregate in meiosis. We used a yeast model to investigate the mechanisms that partition nonexchange chromosomes. These studies showed that the spindle checkpoint genes MAD1, MAD2 and MAD3 have different roles. We identified a new meiotic role for MAD3; though dispensable for the segregation of exchange chromosomes, it is essential for the segregation of nonexchange chromosomes. This function of Mad3p could also be carried out by human BubR1. MAD1 and MAD2 act in a surveillance mechanism that mediates a metaphase delay in response to nonexchange chromosomes, whereas MAD3 acts as a crucial meiotic timer, mediating a prophase delay in every meiosis. These findings suggest plausible models for the basis of errant meiotic segregation in humans.	Tufts Univ, Sch Med, Sackler Sch Biomed Sci, Genet Program, Boston, MA 02111 USA; Tufts Univ, Sch Med, Sackler Sch Biomed Sci, Program Mol Microbiol, Boston, MA 02111 USA; Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University	Dawson, DS (corresponding author), Tufts Univ, Sch Med, Sackler Sch Biomed Sci, Genet Program, 136 Harrison Ave, Boston, MA 02111 USA.	dean.dawson@tufts.edu						Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; Boumil RM, 2003, MOL GENET GENOMICS, V268, P750, DOI 10.1007/s00438-002-0796-9; Brunet S, 1999, J CELL BIOL, V146, P1, DOI 10.1083/jcb.146.1.1; Burke D., 2000, METHODS YEAST GENETI; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Gillett ES, 2004, J CELL BIOL, V164, P535, DOI 10.1083/jcb.200308100; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hodges CA, 2002, HUM REPROD, V17, P1171, DOI 10.1093/humrep/17.5.1171; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; KABACK DB, 1992, SCIENCE, V256, P228, DOI 10.1126/science.1566070; Kemp B, 2004, GENE DEV, V18, P1946, DOI 10.1101/gad.1227304; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; NICKLAS RB, 1969, J CELL BIOL, V43, P40, DOI 10.1083/jcb.43.1.40; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Shonn MA, 2003, CURR BIOL, V13, P1979, DOI 10.1016/j.cub.2003.10.057; Steuerwald N, 2001, MOL HUM REPROD, V7, P49, DOI 10.1093/molehr/7.1.49; Volarcik K, 1998, HUM REPROD, V13, P154, DOI 10.1093/humrep/13.1.154; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052; Wells WAE, 1996, J CELL BIOL, V133, P75, DOI 10.1083/jcb.133.1.75; Zhang D, 2005, BIOL REPROD, V72, P58, DOI 10.1095/biolreprod.104.032987	30	50	52	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					756	760		10.1038/ng1588	http://dx.doi.org/10.1038/ng1588			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15951820				2022-12-27	WOS:000230196400024
J	Seki, S; Kawaguchi, Y; Chiba, K; Mikami, Y; Kizawa, H; Oya, T; Mio, F; Mori, M; Miyamoto, Y; Masuda, I; Tsunoda, T; Kamata, M; Kubo, T; Toyama, Y; Kimura, T; Nakamura, Y; Ikegawa, S				Seki, S; Kawaguchi, Y; Chiba, K; Mikami, Y; Kizawa, H; Oya, T; Mio, F; Mori, M; Miyamoto, Y; Masuda, I; Tsunoda, T; Kamata, M; Kubo, T; Toyama, Y; Kimura, T; Nakamura, Y; Ikegawa, S			A functional SNP in CILP, encoding cartilage intermediate layer protein, is associated with susceptibility to lumbar disc disease	NATURE GENETICS			English	Article							CHONDROCYTE DIFFERENTIATION; II RECEPTOR; DEGENERATION; EXPRESSION; POLYMORPHISM; MUTATIONS; TISSUE	Lumbar disc disease (LDD) is caused by degeneration of intervertebral discs of the lumbar spine. One of the most common musculoskeletal disorders(1), LDD has strong genetic determinants(2-4). Using a case-control association study, we identified a functional SNP ( 1184T --> C, resulting in the amino acid substitution I395T) in CILP, which encodes the cartilage intermediate layer protein, that acts as a modulator of LDD susceptibility. CILP was expressed abundantly in intervertebral discs, and its expression increased as disc degeneration progressed. CILP colocalized with TGF-beta 1 in clustering chondrocytes and their territorial matrices in intervertebral discs. CILP inhibited TGF-beta 1-mediated induction of cartilage matrix genes through direct interaction with TGF-beta 1 and inhibition of TGF-beta 1 signaling. The susceptibility-associated 1184C allele showed increased binding and inhibition of TGF-beta 1. Therefore, we conclude that the extracellular matrix protein CILP regulates TGF-beta signaling and that this regulation has a crucial role in the etiology and pathogenesis of LDD. Our study also adds to the list of connective tissue diseases that are associated with TGF-beta.	Inst Phys & Chem Res, SNP Res Ctr, Lab Bone & Joint Dis, Minato Ku, Tokyo 1088639, Japan; Toyama Med & Pharmaceut Univ, Fac Med, Dept Orthopaed Surg, Toyama 9300194, Japan; Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1608582, Japan; Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kamigyo Ku, Kyoto 6028566, Japan; Toyama Med & Pharmaceut Univ, Fac Med, Dept Pathol 2, Toyama 9300194, Japan; Med Coll Wisconsin, Dept Med, Div Rheumatol, Milwaukee, WI 53226 USA; RIKEN, SNP Res Ctr, Lab Med Informat, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; RIKEN, SNP Res Ctr, Lab Genotyping, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	RIKEN; University of Toyama; Keio University; Kyoto Prefectural University of Medicine; University of Toyama; Medical College of Wisconsin; RIKEN; RIKEN	Ikegawa, S (corresponding author), Inst Phys & Chem Res, SNP Res Ctr, Lab Bone & Joint Dis, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Toyama, Yoshiaki/K-5743-2013; Tsunoda, Tatsuhiko/K-2061-2014; Ikegawa, Shiro/N-6895-2015	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Ikegawa, Shiro/0000-0003-0316-2147				Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Annunen S, 1999, SCIENCE, V285, P409, DOI 10.1126/science.285.5426.409; Baffi MO, 2004, DEV BIOL, V276, P124, DOI 10.1016/j.ydbio.2004.08.027; BATTIE MC, 1995, J BONE JOINT SURG AM, V77A, P1662, DOI 10.2106/00004623-199511000-00004; BORDER WA, 1992, NATURE, V360, P361, DOI 10.1038/360361a0; Chen J, 2004, MATRIX BIOL, V22, P573, DOI 10.1016/j.matbio.2003.11.008; Chiba K, 1997, SPINE, V22, P2885, DOI 10.1097/00007632-199712150-00011; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Isaka Y, 1996, NAT MED, V2, P418, DOI 10.1038/nm0496-418; Johnson K, 2003, ARTHRITIS RHEUM-US, V48, P1302, DOI 10.1002/art.10927; Kawaguchi Y, 1999, SPINE, V24, P2456, DOI 10.1097/00007632-199912010-00006; Kimura T, 1996, INT ORTHOP, V20, P177, DOI 10.1007/s002640050058; Kinoshita A, 2000, NAT GENET, V26, P19, DOI 10.1038/79128; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Lorenzo P, 1998, J BIOL CHEM, V273, P23469, DOI 10.1074/jbc.273.36.23469; MASUDA I, 1995, J CLIN INVEST, V95, P699, DOI 10.1172/JCI117716; Matsui H, 1998, SPINE, V23, P1029, DOI 10.1097/00007632-199805010-00013; Mizuguchi T, 2004, NAT GENET, V36, P855, DOI 10.1038/ng1392; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Pattison ST, 2001, CELL BIOL INT, V25, P679, DOI 10.1006/cbir.2000.0718; SAAL JA, 1989, SPINE, V14, P431, DOI 10.1097/00007632-198904000-00018; Sambrook PN, 1999, ARTHRITIS RHEUM-US, V42, P366, DOI 10.1002/1529-0131(199902)42:2<366::AID-ANR20>3.0.CO;2-6; SCHNEIDERMAN G, 1987, SPINE, V12, P276, DOI 10.1097/00007632-198704000-00016; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Tolonen J, 2001, EUR SPINE J, V10, P172, DOI 10.1007/s005860000213; Watanabe H, 1997, P NATL ACAD SCI USA, V94, P6943, DOI 10.1073/pnas.94.13.6943; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Young GD, 2004, J BIOL CHEM, V279, P47633, DOI 10.1074/jbc.M404918200	29	165	187	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					607	612		10.1038/ng1557	http://dx.doi.org/10.1038/ng1557			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15864306				2022-12-27	WOS:000229495300014
J	Stephens, P; Edkins, S; Davies, H; Greenman, C; Cox, C; Hunter, C; Bignell, G; Teague, J; Smith, R; Stevens, C; O'Meara, S; Parker, A; Tarpey, P; Avis, T; Barthorpe, A; Brackenbury, L; Buck, G; Butler, A; Clements, J; Cole, J; Dicks, E; Edwards, K; Forbes, S; Gorton, M; Gray, K; Halliday, K; Harrison, R; Hills, K; Hinton, J; Jones, D; Kosmidou, V; Laman, R; Lugg, R; Menzies, A; Perry, J; Petty, R; Raine, K; Shepherd, R; Small, A; Solomon, H; Stephens, Y; Tofts, C; Varian, J; Webb, A; West, S; Widaa, S; Yates, A; Brasseur, F; Cooper, CS; Flanagan, AM; Green, A; Knowles, M; Leung, SY; Looijenga, LHJ; Malkowicz, B; Pierotti, MA; Teh, B; Yuen, ST; Nicholson, AG; Lakhani, S; Easton, DF; Weber, BL; Stratton, MR; Futreal, PA; Wooster, R				Stephens, P; Edkins, S; Davies, H; Greenman, C; Cox, C; Hunter, C; Bignell, G; Teague, J; Smith, R; Stevens, C; O'Meara, S; Parker, A; Tarpey, P; Avis, T; Barthorpe, A; Brackenbury, L; Buck, G; Butler, A; Clements, J; Cole, J; Dicks, E; Edwards, K; Forbes, S; Gorton, M; Gray, K; Halliday, K; Harrison, R; Hills, K; Hinton, J; Jones, D; Kosmidou, V; Laman, R; Lugg, R; Menzies, A; Perry, J; Petty, R; Raine, K; Shepherd, R; Small, A; Solomon, H; Stephens, Y; Tofts, C; Varian, J; Webb, A; West, S; Widaa, S; Yates, A; Brasseur, F; Cooper, CS; Flanagan, AM; Green, A; Knowles, M; Leung, SY; Looijenga, LHJ; Malkowicz, B; Pierotti, MA; Teh, B; Yuen, ST; Nicholson, AG; Lakhani, S; Easton, DF; Weber, BL; Stratton, MR; Futreal, PA; Wooster, R			A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; GENOME	We examined the coding sequence of 518 protein kinases, similar to 1.3 Mb of DNA per sample, in 25 breast cancers. In many tumors, we detected no somatic mutations. But a few had numerous somatic mutations with distinctive patterns indicative of either a mutator phenotype or a past exposure.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Ludwig Inst Canc Res, B-1200 Brussels, Belgium; Inst Canc Res, Sutton SM2 5NG, Surrey, England; UCL, Inst Orthopaed, Stanmore, Middx, England; Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England; St James Univ Hosp, Canc Res UK Clin Ctr, Leeds LS9 7TF, W Yorkshire, England; Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; Erasmus Univ, Josephine Nefkens Inst, NL-3015 GE Rotterdam, Netherlands; Univ Penn, Div Urol, Philadelphia, PA 19104 USA; Nazl Tumori & FIRC Inst Mol Oncol, Milan, Italy; Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI 49503 USA; Royal Brompton Hosp, London SW3 6NP, England; Inst Canc Res, Chester Beatty Labs, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; Strangeways Res Labs, Canc Res UK Genet Epidemiol Grp, Cambridge CB1 4RN, England; Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA	Wellcome Trust Sanger Institute; Ludwig Institute for Cancer Research; University of London; Institute of Cancer Research - UK; University of London; University College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cancer Research UK; Saint James's University Hospital; University of Leeds; University of Hong Kong; Erasmus University Rotterdam; Erasmus MC; University of Pennsylvania; Fondazione IRCCS Istituto Nazionale Tumori Milan; Van Andel Institute; Royal Brompton Hospital; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; University of Pennsylvania	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	mrs@sanger.ac.uk	Leung, Suet Yi/C-4340-2009; Lakhani, Sunil R/I-1970-2018; Yuen, Siu/K-6311-2014; Looijenga, Leendert/B-8145-2019; Pierotti, Marco Alessandro/AAC-4728-2022; Leung, Suet Yi/T-9620-2019	Lakhani, Sunil R/0000-0003-4067-2760; Looijenga, Leendert/0000-0002-8146-1911; Pierotti, Marco Alessandro/0000-0002-7431-8332; Teh, Bin Tean/0000-0003-1514-1124; Laman, Ross/0000-0003-0545-0521; Knowles, Margaret/0000-0002-9363-8657; Buck, Gemma/0000-0001-5289-1050; Hunter, Christopher/0000-0002-1335-0881; Flanagan, Adrienne/0000-0002-2832-1303; Raine, Keiran/0000-0002-5634-1539; Leung, Suet Yi/0000-0001-8614-4619; Edkins, Sarah/0000-0003-0717-1972; Green, Anthony/0000-0002-9795-0218; Avis, Tim/0000-0001-6120-5729; Gray, Kristian/0000-0002-7035-7107; Yates, Andrew/0000-0002-8886-4772				Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Persons DL, 1997, MODERN PATHOL, V10, P720; Wagner E, 2002, J CELL SCI, V115, P3033; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699; Xiao W, 1999, MUTAT RES-FUND MOL M, V431, P155, DOI 10.1016/S0027-5107(99)00203-1	7	273	299	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2005	37	6					590	592		10.1038/ng1571	http://dx.doi.org/10.1038/ng1571			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15908952				2022-12-27	WOS:000229495300011
J	Simons, M; Gloy, J; Ganner, A; Bullerkotte, A; Bashkurov, M; Kronig, C; Schermer, B; Benzing, T; Cabello, OA; Jenny, A; Mlodzik, M; Polok, B; Driever, W; Obara, T; Walz, G				Simons, M; Gloy, J; Ganner, A; Bullerkotte, A; Bashkurov, M; Kronig, C; Schermer, B; Benzing, T; Cabello, OA; Jenny, A; Mlodzik, M; Polok, B; Driever, W; Obara, T; Walz, G			Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; BETA-CATENIN; PRIMARY CILIUM; COMPLEX; CADHERIN; INV	Cystic renal diseases are caused by mutations of proteins that share a unique subcellular localization: the primary cilium of tubular epithelial cells(1). Mutations of the ciliary protein inversin cause nephronophthisis type II, an autosomal recessive cystic kidney disease characterized by extensive renal cysts, situs inversus and renal failure(2). Here we report that inversin acts as a molecular switch between different Wnt signaling cascades. Inversin inhibits the canonical Wnt pathway by targeting cytoplasmic dishevelled (Dsh or Dvl1) for degradation; concomitantly, it is required for convergent extension movements in gastrulating Xenopus laevis embryos and elongation of animal cap explants, both regulated by noncanonical Wnt signaling. In zebrafish, the structurally related switch molecule diversin ameliorates renal cysts caused by the depletion of inversin, implying that an inhibition of canonical Wnt signaling is required for normal renal development. Fluid flow increases inversin levels in ciliated tubular epithelial cells and seems to regulate this crucial switch between Wnt signaling pathways during renal development.	Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; CUNY Mt Sinai Sch Med, Brookdale Dept Mol Cell & Dev Biol, New York, NY 10029 USA; Univ Freiburg, Dept Biol, D-79104 Freiburg, Germany; Case Western Reserve Univ, Dept Med, Cleveland, OH 44109 USA	University of Freiburg; Baylor College of Medicine; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of Freiburg; Case Western Reserve University	Walz, G (corresponding author), Univ Hosp Freiburg, Div Renal, Hugstetter Str 55, D-79106 Freiburg, Germany.	gerd.walz@uniklinik-freiburg.de	Schermer, Bernhard/E-9972-2014; Benzing, Thomas/X-5476-2019; Simons, Matias/I-2038-2017	Schermer, Bernhard/0000-0002-5194-9000; Simons, Matias/0000-0003-3959-6350; Driever, Wolfgang/0000-0002-9551-9141	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK069604, R01DK078209] Funding Source: NIH RePORTER; NIDDK NIH HHS [R21 DK069604, R01 DK078209] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Das G, 2004, DEVELOPMENT, V131, P4467, DOI 10.1242/dev.01317; Feiguin F, 2001, DEV CELL, V1, P93, DOI 10.1016/S1534-5807(01)00010-7; FRIEDBERG V, 1955, GYNAECOLOGIA, V140, P34, DOI 10.1159/000308054; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Imai Y, 2001, DEVELOPMENT, V128, P2407; Kim E, 1999, J BIOL CHEM, V274, P4947, DOI 10.1074/jbc.274.8.4947; Leung TC, 2003, DEV DYNAM, V228, P424, DOI 10.1002/dvdy.10408; Liu W, 2003, AM J PHYSIOL-RENAL, V285, pF998, DOI 10.1152/ajprenal.00067.2003; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Mochizuki T, 1998, NATURE, V395, P177, DOI 10.1038/26006; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Morgan D, 1998, NAT GENET, V20, P149, DOI 10.1038/2450; Morgan D, 2002, HUM MOL GENET, V11, P3345, DOI 10.1093/hmg/11.26.3345; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nurnberger J, 2002, MOL BIOL CELL, V13, P3096, DOI 10.1091/mbc.E02-04-0195; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Perantoni AO, 2003, SEMIN CELL DEV BIOL, V14, P201, DOI 10.1016/S1084-9521(03)00022-3; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Qian CN, 2005, J BIOL CHEM, V280, P3938, DOI 10.1074/jbc.M410697200; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Schwarz-Romond T, 2002, GENE DEV, V16, P2073, DOI 10.1101/gad.230402; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; Wharton KA, 2003, DEV BIOL, V253, P1, DOI 10.1006/dbio.2002.0869; Zachariae W, 2004, MOL CELL, V13, P2, DOI 10.1016/S1097-2765(03)00530-6	28	565	588	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2005	37	5					537	543		10.1038/ng1552	http://dx.doi.org/10.1038/ng1552			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15852005	Green Accepted			2022-12-27	WOS:000228862300025
J	Marchini, J; Donnelly, P; Cardon, LR				Marchini, J; Donnelly, P; Cardon, LR			Genome-wide strategies for detecting multiple loci that influence complex diseases	NATURE GENETICS			English	Article							GENETIC ASSOCIATION; QUANTITATIVE TRAIT; SUSCEPTIBILITY; EPISTASIS; MODELS; POLYMORPHISM; METABOLISM; SNPS	After nearly 10 years of intense academic and commercial research effort, large genome-wide association studies for common complex diseases are now imminent. Although these conditions involve a complex relationship between genotype and phenotype, including interactions between unlinked loci(1), the prevailing strategies for analysis of such studies focus on the locus-by-locus paradigm. Here we consider analytical methods that explicitly look for statistical interactions between loci. We show first that they are computationally feasible, even for studies of hundreds of thousands of loci, and second that even with a conservative correction for multiple testing, they can be more powerful than traditional analyses under a range of models for interlocus interactions. We also show that plausible variations across populations in allele frequencies among interacting loci can markedly affect the power to detect their marginal effects, which may account in part for the well-known difficulties in replicating association results. These results suggest that searching for interactions among genetic loci can be fruitfully incorporated into analysis strategies for genome-wide association studies.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Cardon, LR (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	lon.cardon@well.ox.ac.uk	Marchini, Jonathan/ABE-9024-2020	Marchini, Jonathan/0000-0003-0610-8322; Donnelly, Peter/0000-0001-9495-3408				Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Carlson CS, 2001, CURR OPIN CHEM BIOL, V5, P78, DOI 10.1016/S1367-5931(00)00171-X; CLAYTON D, 2001, HDB STAT GENETICS, P519; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Hoh J, 2003, NAT REV GENET, V4, P701, DOI 10.1038/nrg1155; Hoh J, 2000, ANN HUM GENET, V64, P413, DOI 10.1046/j.1469-1809.2000.6450413.x; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kempthorne O, 1957, INTRO GENETIC STAT; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Moore JH, 2003, HUM HERED, V56, P73, DOI 10.1159/000073735; Moore JH, 2004, JAMA-J AM MED ASSOC, V291, P1642, DOI 10.1001/jama.291.13.1642; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Phillips PC, 1998, GENETICS, V149, P1167; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; ROSES A, 2003, NAT GENET S2, V33, P217; Routman EJ, 1997, EVOLUTION, V51, P1654, DOI 10.1111/j.1558-5646.1997.tb01488.x; Schlesselman JJ, 1982, CASE CONTROL STUDIES; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930; SHAM PC, 1997, STAT HUMAN GENETICS; SING CF, 1985, AM J HUM GENET, V37, P268; Templeton A. R., 2000, EPISTASIS EVOLUTIONA, P41; Thomas DC, 2004, STAT METHODS GENETIC; Tiwari HK, 1997, GENET EPIDEMIOL, V14, P1131, DOI 10.1002/(SICI)1098-2272(1997)14:6<1131::AID-GEPI95>3.3.CO;2-7; Williams SM, 2004, BIOESSAYS, V26, P170, DOI 10.1002/bies.10401; Zerba KE, 2000, HUM GENET, V107, P466, DOI 10.1007/s004390000394; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	29	683	709	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					413	417		10.1038/ng1537	http://dx.doi.org/10.1038/ng1537			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15793588				2022-12-27	WOS:000228040000025
J	Cho, MK; Sankar, P				Cho, MK; Sankar, P			Forensic genetics and ethical, legal and social implications beyond the clinic	NATURE GENETICS			English	Article							HUMAN-GENOME; RACE; ETHNICITY; DIVERSITY	Data on human genetic variation help scientists to understand human origins, susceptibility to illness and genetic causes of disease. Destructive episodes in the history of genetic research make it crucial to consider the ethical and social implications of research in genomics, especially human genetic variation. The analysis of ethical, legal and social implications should be integrated into genetic research, with the participation of scientists who can anticipate and monitor the full range of possible applications of the research from the earliest stages. The design and implementation of research directs the ways in which its results can be used, and data and technology, rather than ethical considerations or social needs, drive the use of science in unintended ways. Here we examine forensic genetics and argue that all geneticists should anticipate the ethical and social issues associated with nonmedical applications of genetic variation research.	Stanford Ctr Biomed Eth, Palo Alto, CA 94304 USA; Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA	Stanford University; University of Pennsylvania; Pennsylvania Medicine	Cho, MK (corresponding author), Stanford Ctr Biomed Eth, 701A Welch Rd,Suite 1105, Palo Alto, CA 94304 USA.	micho@stanford.edu			NHGRI NIH HHS [R01 HG002189-02, R01 HG002189-03, R01 HG003191-01, R01 HG003191, R01 HG002189-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003191, R01HG002189] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		[Anonymous], 2004, NAT GENET, V36, P541; [Anonymous], 2000, NAT GENET, V24, P97; [Anonymous], 1995, FED REG, V60; Braun L, 2002, PERSPECT BIOL MED, V45, P159, DOI 10.1353/pbm.2002.0023; BROWN J, 2001, OKLAHOMA POLICE BEGI; BUDOWLE B, 1999, FORNSIC SCI COM, P1; Burchard EG, 2003, NEW ENGL J MED, V348, P1170, DOI 10.1056/NEJMsb025007; Caplan J., 2001, DOCUMENTING INDIVIDU; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Cooper RS, 2003, NEW ENGL J MED, V348, P1166, DOI 10.1056/NEJMsb022863; EDWARDS EE, 2004, COMMUNICATION; FAIGMAN D, 2002, MODERN SCI EVIDENCE, P207; Feldman MW, 2003, NATURE, V424, P374, DOI 10.1038/424374a; Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; Foster MW, 2002, GENOME RES, V12, P844, DOI 10.1101/gr.99202; FRAZIER RRE, 1997, P 8 INT S HUM ID ORL; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Greely HT, 2001, NAT REV GENET, V2, P222, DOI 10.1038/35056071; Kaye D. H., 1993, HARVARD J LAW TECHNO, V7, P101; KAYE DH, 2000, JURIMETRICS J, V40, P193; Kevles D., 1985, NAME EUGENICS; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Knoppers BM, 1996, GENOMICS, V34, P272, DOI 10.1006/geno.1996.0287; LANDER ES, 1994, NATURE, V371, P735, DOI 10.1038/371735a0; LANDER ES, 1993, SCIENCE, V260, P1221, DOI 10.1126/science.8493559; LANDER ES, 1989, NATURE, V339, P501, DOI 10.1038/339501a0; Lee S S, 2001, Yale J Health Policy Law Ethics, V1, P33; LEECH K, 1989, RUNNYMEADE RES REPOR; LEONARD J, 2001, LA TIMES        0310, pA1; Lowe AL, 2001, FORENSIC SCI INT, V119, P17, DOI 10.1016/S0379-0738(00)00387-X; National Research Council Committee on DNA Forensic Science, 1996, UPD EV FOR DNA EV; National Research Council Committee on DNA Technology in Forensic Science, 1992, DNA TECHN FOR SCI; NOVICK GE, 1995, ELECTROPHORESIS, V16, P1596, DOI 10.1002/elps.11501601263; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; RISCH N, 2003, GENOME BIOL, V3; Romualdi C, 2002, GENOME RES, V12, P602, DOI 10.1101/gr.214902; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sankar P, 2002, SCIENCE, V298, P1337, DOI 10.1126/science.1074447; Sankar P, 1997, AM J PUBLIC HEALTH, V87, P336, DOI 10.2105/AJPH.87.3.336; Triggs CM, 2002, FORENSIC SCI INT, V128, P108, DOI 10.1016/S0379-0738(02)00168-8; WADE N, 2003, NY TIMES        0603, pA28; WILLING R, 2003, USA TODAY; Wilson JF, 2001, NAT GENET, V29, P265, DOI 10.1038/ng761; Wood AJJ, 2001, NEW ENGL J MED, V344, P1393, DOI 10.1056/NEJM200105033441811	44	58	61	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2004	36	11		S			S8	S12		10.1038/ng1594	http://dx.doi.org/10.1038/ng1594			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	867PH	15510102	Green Accepted, Bronze			2022-12-27	WOS:000224854000004
J	Grinberg, I; Northrup, H; Ardinger, H; Prasad, C; Dobyns, WB; Millen, KJ				Grinberg, I; Northrup, H; Ardinger, H; Prasad, C; Dobyns, WB; Millen, KJ			Heterozygous deletion of the linked genes ZIC1 and ZIC4 is involved in Dandy-Walker malformation	NATURE GENETICS			English	Article							CEREBELLAR DEVELOPMENT; CLASSIFICATION	Dandy-Walker malformation (DWM; OMIM #220200) is a common but poorly understood congenital cerebellar malformation in humans. Through physical mapping of 3q2 interstitial deletions in several individuals with DWM, we defined the first critical region associated with DWM, encompassing two adjacent Zinc finger in cerebellum genes, ZIC1 and ZIC4. Mice with a heterozygous deletion of these two linked genes have a phenotype that closely resembles DWM, providing a mouse model for this malformation.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Texas, Sch Med, Dept Pediat Med Genet, Houston, TX USA; Univ Kansas, Dept Pediat, Kansas City, KS USA; London Hlth Sci Ctr, Dept Pediat, London, ON, Canada; London Hlth Sci Ctr, Med Genet Program SW Ontario, London, ON, Canada; Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Chicago; University of Texas System; University of Kansas; London Health Sciences Centre; London Health Sciences Centre; University of Chicago; University of Chicago	Millen, KJ (corresponding author), Univ Chicago, Dept Human Genet, Room 319 CLSC,920 E 58th St, Chicago, IL 60637 USA.	kmillen@genetics.bsd.uchicago.edu	Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021	Dobyns, William/0000-0002-7681-2844; Millen, Kathleen/0000-0001-9978-675X				Anikster Y, 2001, NAT GENET, V28, P376, DOI 10.1038/ng576; Aruga J, 2002, J NEUROSCI, V22, P218, DOI 10.1523/JNEUROSCI.22-01-00218.2002; Aruga J, 1998, J NEUROSCI, V18, P284; Aruga J, 2002, DEV BIOL, V244, P329, DOI 10.1006/dbio.2002.0598; Aruga J, 1996, GENE, V172, P291, DOI 10.1016/0378-1119(96)00111-4; Chen XM, 1997, AM J PHYSIOL-RENAL, V272, pF299, DOI 10.1152/ajprenal.1997.272.3.F299; CHITAYAT D, 1994, AM J MED GENET, V52, P406, DOI 10.1002/ajmg.1320520404; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; Ebert PJ, 2003, DEVELOPMENT, V130, P1949, DOI 10.1242/dev.00419; MARIA BL, 1987, PEDIATR NEUROSCI, V13, P45, DOI 10.1159/000120300; MURRAY JC, 1985, CLIN GENET, V28, P272; Parisi MA, 2003, MOL GENET METAB, V80, P36, DOI 10.1016/j.ymgme.2003.08.010; Patel S, 2002, AM J NEURORADIOL, V23, P1074; Shim H, 2003, J NUTR, V133, p1527S, DOI 10.1093/jn/133.5.1527S; Sudha T, 2001, CLIN DYSMORPHOL, V10, P193, DOI 10.1097/00019605-200107000-00008	15	156	163	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2004	36	10					1053	1055		10.1038/ng1420	http://dx.doi.org/10.1038/ng1420			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	15338008	Bronze			2022-12-27	WOS:000224156500010
J	Hughes, AE; Orr, N; Esfandiary, H; Diaz-Torres, M; Goodship, T; Chakravarthy, U				Hughes, Anne E.; Orr, Nick; Esfandiary, Hossein; Diaz-Torres, Martha; Goodship, Timothy; Chakravarthy, Usha			A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration	NATURE GENETICS			English	Article							COMPLEMENT FACTOR-H; SUSCEPTIBILITY; POLYMORPHISM; MACULOPATHY; VARIANT; GENE	Age-related macular degeneration (AMD; OMIM #603075) is the most frequent cause of visual impairment in the elderly population, with severe disease affecting nearly 10% of individuals of European descent over the age of 75 years. It is a complex disease in which genetic and environmental factors contribute to susceptibility. Complement factor H (CFH) has recently been identified as a major AMD susceptibility gene, and the Y402H polymorphism has been proposed as the likely causative factor. We genotyped polymorphisms spanning the cluster of CFH and five CFH-related genes on chromosome 1q23 in 173 individuals with severe neovascular AMD and 170 elderly controls with no signs of AMD. Detailed analysis showed a common haplotype associated with decreased risk of AMD that was present on 20% of chromosomes of controls and 8% of chromosomes of individuals with AMD. We found that this haplotype carried a deletion of CFHR1 and CFHR3, and the proteins encoded by these genes were absent in serum of homozygotes. The protective effect of the deletion haplotype cannot be attributed to linkage disequilibrium with Y402H and was replicated in an independent sample.	Queens Univ Belfast, Dept Med Genet, Belfast BT12 6BL, Antrim, North Ireland; Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; Queens Univ Belfast, Ctr Vis Sci & Vasc Biol, Belfast BT12 6BL, Antrim, North Ireland	Queens University Belfast; Newcastle University - UK; Queens University Belfast	Hughes, AE (corresponding author), Queens Univ Belfast, Dept Med Genet, Belfast BT12 6BL, Antrim, North Ireland.	A.Hughes@qub.ac.uk	Hughes, Anne/A-1307-2012	Chakravarthy, Usha/0000-0002-2606-3734				Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; DISCIPIO RG, 1992, J IMMUNOL, V149, P2592; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Heinen Stefan, 2006, Hum Mutat, V27, P292, DOI 10.1002/humu.9408; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Jozsi M, 2005, EUR J HUM GENET, V13, P321, DOI 10.1038/sj.ejhg.5201324; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Mullins RF, 2001, EYE, V15, P390, DOI 10.1038/eye.2001.142; REID KBM, 1986, IMMUNOL TODAY, V7, P230, DOI 10.1016/0167-5699(86)90110-6; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; van Leeuwen R, 2003, ARCH OPHTHALMOL-CHIC, V121, P519, DOI 10.1001/archopht.121.4.519; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426	16	359	383	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1173	1177		10.1038/ng1890	http://dx.doi.org/10.1038/ng1890			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16998489				2022-12-27	WOS:000241251100017
J	Lee, K; Jeong, J; Kwak, I; Yu, CT; Lanske, B; Soegiarto, DW; Toftgard, R; Tsai, MJ; Tsai, S; Lydon, JP; DeMayo, FJ				Lee, Kevin; Jeong, JaeWook; Kwak, Inseok; Yu, Cheng-Tai; Lanske, Beate; Soegiarto, Desi W.; Toftgard, Rune; Tsai, Ming-Jer; Tsai, Sophia; Lydon, John P.; DeMayo, Francesco J.			Indian hedgehog is a major mediator of progesterone signaling in the mouse uterus	NATURE GENETICS			English	Article							GROWTH-FACTOR RECEPTOR; CANCER-CELLS; GENE; ANGIOGENESIS; ENDOMETRIUM; EXPRESSION; MICE	The hedgehog family of morphogens are regulators of cell proliferation, differentiation and cell-cell communication. These morphogens have been shown to have important roles in organogenesis, spermatogenesis, stem cell maintenance and oncogenesis(1-9). Indian hedgehog (encoded by Ihh) has been shown to be expressed in the uterine epithelium under the control of the steroid hormone, progesterone(10,11). Although in vivo and in vitro studies have shown that progesterone achieves its effects on uterine function through epithelial-stromal cross-talk, molecular mediator(s) for this cellular communication pathway have not been elucidated(12,13). Using new experimental approaches that ablate Ihh specifically in Pgr-positive uterine cells of the mouse, we demonstrate that Ihh is an essential mediator of Pgr action in the uterus, and expression of this factor is critical in mediating the communication between the uterine epithelium and stroma required for embryo implantation.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; Max Planck Inst Biochem, D-82152 Martinsried, Germany; Karolinska Inst, Ctr Nutr & Toxicol, Novum, Dept Biosci, S-14157 Huddinge, Sweden	Baylor College of Medicine; Harvard University; Harvard School of Dental Medicine; Max Planck Society; Karolinska Institutet	DeMayo, FJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	fdemayo@bcm.tmc.edu	DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336; Lee, Kevin/0000-0002-1528-7417; Lanske, Beate/0000-0003-4638-804X	NCI NIH HHS [R01-CA77530] Funding Source: Medline; NICHD NIH HHS [5 T32 HD07165, U01HD042311] Funding Source: Medline; NIDDK NIH HHS [R01-DK55636, R01 DK45641] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007165] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD042311] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA077530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045641, R01DK055636] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BIGSBY RM, 1993, STROMAL EPITHELIAL I, P71; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; COOKE PS, 1986, P NATL ACAD SCI USA, V83, P2109, DOI 10.1073/pnas.83.7.2109; DEY SK, 2003, MANIPULATING MOUSE E; FINN CA, 1972, BIOL REPROD, V7, P82, DOI 10.1093/biolreprod/7.1.82; FINN CA, 1964, J REPROD FERTIL, V53, P331; Hebrok M, 2000, DEVELOPMENT, V127, P4905; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; Lewis MT, 1999, DEVELOPMENT, V126, P5181; Lydon JP, 1999, CANCER RES, V59, P4276; MARTIN L, 1973, J ENDOCRINOL, V56, P303, DOI 10.1677/joe.0.0560303; Matsumoto H, 2002, DEV BIOL, V245, P280, DOI 10.1006/dbio.2002.0645; Mimeault M, 2006, INT J CANCER, V118, P1022, DOI 10.1002/ijc.21440; Mimeault M, 2005, PANCREAS, V31, P301, DOI 10.1097/01.mpa.0000175893.04660.1b; Niemann C, 2003, P NATL ACAD SCI USA, V100, P11873, DOI 10.1073/pnas.1834202100; Palma V, 2004, DEVELOPMENT, V131, P337, DOI 10.1242/dev.00930; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Perron M, 2003, DEVELOPMENT, V130, P1565, DOI 10.1242/dev.00391; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Razzaque MS, 2005, J PATHOL, V207, P453, DOI 10.1002/path.1870; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Sui GP, 2006, J SURG RES, V134, P1, DOI 10.1016/j.jss.2005.12.029; SURVEYOR GA, 1995, ENDOCRINOLOGY, V136, P3639, DOI 10.1210/en.136.8.3639; Takamoto N, 2002, MOL ENDOCRINOL, V16, P2338, DOI 10.1210/me.2001-0154; Talbi S, 2006, ENDOCRINOLOGY, V147, P1097, DOI 10.1210/en.2005-1076; Walter LM, 2005, REPRODUCTION, V129, P765, DOI 10.1530/rep.1.00625; Wijgerde M, 2005, ENDOCRINOLOGY, V146, P3558, DOI 10.1210/en.2005-0311	29	196	206	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2006	38	10					1204	1209		10.1038/ng1874	http://dx.doi.org/10.1038/ng1874			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16951680				2022-12-27	WOS:000241251100022
J	Ramsey, SA; Smith, JJ; Orrell, D; Marelli, M; Petersen, TW; de Atauri, P; Bolouri, H; Aitchison, JD				Ramsey, Stephen A.; Smith, Jennifer J.; Orrell, David; Marelli, Marcello; Petersen, Timothy W.; de Atauri, Pedro; Bolouri, Hamid; Aitchison, John D.			Dual feedback loops in the GAL regulon suppress cellular heterogeneity in yeast	NATURE GENETICS			English	Article							EUKARYOTIC GENE-EXPRESSION; GREEN FLUORESCENT PROTEIN; SACCHAROMYCES-CEREVISIAE; QUANTITATIVE-ANALYSIS; REGULATORY PROTEINS; NOISE; AUTOREGULATION; GALACTOSE; NETWORKS; SWITCH	Transcriptional noise is known to be an important cause of cellular heterogeneity and phenotypic variation. The extent to which molecular interaction networks may have evolved to either filter or exploit transcriptional noise is a much debated question. The yeast genetic network regulating galactose metabolism involves two proteins, Gal3p and Gal80p, that feed back positively and negatively, respectively, on GAL gene expression. Using kinetic modeling and experimental validation, we demonstrate that these feedback interactions together are important for (i) controlling the cell-to-cell variability of GAL gene expression and (ii) ensuring that cells rapidly switch to an induced state for galactose uptake.	Inst Syst Biol, Seattle, WA 98103 USA	Institute for Systems Biology (ISB)	Bolouri, H (corresponding author), Inst Syst Biol, 1441 N 34th St, Seattle, WA 98103 USA.	hbolouri@systemsbiology.org; jaitchison@systemsbiology.org	de Atauri, Pedro Ramón/R-3957-2019; de Atauri, Pedro/AAG-2384-2020	de Atauri, Pedro Ramón/0000-0002-7754-7851; Marelli, Marcello/0000-0001-7095-8263	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067228, P50GM076547] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM067228, GM076547] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Brachmann CB, 1998, YEAST, V14, P115; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; de Atauri P., 2004, Systems Biology, V1, P28, DOI 10.1049/sb:20045013; Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; GUARENTE L, 1982, P NATL ACAD SCI-BIOL, V79, P7410, DOI 10.1073/pnas.79.23.7410; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; LUE NF, 1987, MOL CELL BIOL, V7, P3446, DOI 10.1128/MCB.7.10.3446; Melcher K, 1997, YEAST SUGAR METABOLI, P235; Orrell D, 2004, J THEOR BIOL, V230, P301, DOI 10.1016/j.jtbi.2004.05.013; Orrell D, 2006, PHYSICA D, V217, P64, DOI 10.1016/j.physd.2006.03.010; Ostergaard S, 2000, MICROBIOL MOL BIOL R, V64, P34, DOI 10.1128/MMBR.64.1.34-50.2000; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peng G, 2002, P NATL ACAD SCI USA, V99, P8548, DOI 10.1073/pnas.142100099; Platt A, 1998, EMBO J, V17, P4086, DOI 10.1093/emboj/17.14.4086; Ramsey Stephen, 2005, J Bioinform Comput Biol, V3, P437, DOI 10.1142/S0219720005001144; Rao CV, 2003, J CHEM PHYS, V118, P4999, DOI 10.1063/1.1545446; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4; Ruhela A, 2004, FEBS LETT, V576, P119, DOI 10.1016/j.febslet.2004.09.001; Scholz O, 2000, EUR J BIOCHEM, V267, P1565, DOI 10.1046/j.1432-1327.2000.01170.x; Verma M, 2004, EUR J BIOCHEM, V271, P4064, DOI 10.1111/j.1432-1033.2004.04344.x; Verma M, 2003, J BIOL CHEM, V278, P48764, DOI 10.1074/jbc.M303526200; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281	30	69	72	2	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2006	38	9					1082	1087		10.1038/ng1869	http://dx.doi.org/10.1038/ng1869			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16936734				2022-12-27	WOS:000240112100029
J	Mehrabian, M; Allayee, H; Stockton, J; Lum, PY; Drake, TA; Castellani, LW; Suh, M; Armour, C; Edwards, S; Lamb, J; Lusis, AJ; Schadt, EE				Mehrabian, M; Allayee, H; Stockton, J; Lum, PY; Drake, TA; Castellani, LW; Suh, M; Armour, C; Edwards, S; Lamb, J; Lusis, AJ; Schadt, EE			Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits	NATURE GENETICS			English	Article							GENOMICS APPROACH; MICE; ATHEROSCLEROSIS; IDENTIFICATION; DISSECTION; RESISTANCE; DISCOVERY; NETWORKS; LOCUS	Forward genetic approaches to identify genes involved in complex traits such as common human diseases have met with limited success. Fine mapping of linkage regions and validation of positional candidates are time-consuming and not always successful. Here we detail a hybrid procedure to map loci involved in complex traits that leverages the strengths of forward and reverse genetic approaches. By integrating genotypic and expression data in a segregating mouse population, we show how clusters of expression quantitative trait loci linking to regions of the genome accurately reflect the underlying perturbation to the transcriptional network induced by DNA variations in genes that control the complex traits. By matching patterns of gene expression in a segregating population with expression responses induced by single-gene perturbation experiments, we show how genes controlling clusters of expression and clinical quantitative trait loci can be mapped directly. We demonstrate the utility of this approach by identifying 5-lipoxygenase as underlying previously identified quantitative trait loci in an F-2 cross between strains C57BL/6J and DBA/2J and showing that it has pleiotropic effects on body fat, lipid levels and bone density.	Rosetta Inpharmat, Seattle, WA 98109 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Inst Med Genet, Los Angeles, CA 90089 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA	Merck & Company; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Schadt, EE (corresponding author), Rosetta Inpharmat, 401 Terry Ave N, Seattle, WA 98109 USA.	eric_schadt@merck.com	Edwards, Stephen W/G-4482-2011	Edwards, Stephen/0000-0002-7985-111X				Beattie JH, 1998, P NATL ACAD SCI USA, V95, P358, DOI 10.1073/pnas.95.1.358; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Drake TA, 2001, PHYSIOL GENOMICS, V5, P205, DOI 10.1152/physiolgenomics.2001.5.4.205; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Grupe A, 2001, SCIENCE, V292, P1915, DOI 10.1126/science.1058889; He YDD, 2003, BIOINFORMATICS, V19, P956, DOI 10.1093/bioinformatics/btg126; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Klein RF, 2004, SCIENCE, V303, P229, DOI 10.1126/science.1090985; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; Kuhn H, 2003, ARTERIOSCL THROM VAS, V23, P1072, DOI 10.1161/01.ATV.0000074167.01184.48; Liao GC, 2004, SCIENCE, V306, P690, DOI 10.1126/science.1100636; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Mehrabian M, 2003, CURR OPIN LIPIDOL, V14, P447, DOI 10.1097/00041433-200310000-00005; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Mehrabian M, 2001, CIRC RES, V89, P125, DOI 10.1161/hh1401.093458; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mural RJ, 2002, SCIENCE, V296, P1661, DOI 10.1126/science.1069193; Parhami F, 2001, J BONE MINER RES, V16, P182, DOI 10.1359/jbmr.2001.16.1.182; Pei LM, 2004, J CLIN INVEST, V113, P805, DOI 10.1172/JCI200421311; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Toth A, 2000, CELL, V103, P1155, DOI 10.1016/S0092-8674(00)00217-8; Villa-Colinayo V, 2000, Curr Atheroscler Rep, V2, P380, DOI 10.1007/s11883-000-0076-2; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yoshitake H, 1999, P NATL ACAD SCI USA, V96, P8156, DOI 10.1073/pnas.96.14.8156; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; Zhu J, 2004, CYTOGENET GENOME RES, V105, P363, DOI 10.1159/000078209	41	174	175	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1224	1233		10.1038/ng1619	http://dx.doi.org/10.1038/ng1619			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16200066				2022-12-27	WOS:000233045200022
J	Williams, TN; Mwangi, TW; Wambua, S; Peto, TEA; Weatherall, DJ; Gupta, S; Recker, M; Penman, BS; Uyoga, S; Macharia, A; Mwacharo, JK; Snow, RW; Marsh, K				Williams, TN; Mwangi, TW; Wambua, S; Peto, TEA; Weatherall, DJ; Gupta, S; Recker, M; Penman, BS; Uyoga, S; Macharia, A; Mwacharo, JK; Snow, RW; Marsh, K			Negative epistasis between the malaria-protective effects of alpha(+)-thalassemia and the sickle cell trait	NATURE GENETICS			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ALPHA-THALASSEMIA; MORBIDITY; SUSCEPTIBILITY; MECHANISM; CHILDREN; GENE; HEMOGLOBIN; RESISTANCE; DISEASE	The hemoglobinopathies, disorders of hemoglobin structure and production, protect against death from malaria(1). In sub-Saharan Africa, two such conditions occur at particularly high frequencies: presence of the structural variant hemoglobin S and alpha(+)-thalassemia, a condition characterized by reduced production of the normal alpha-globin component of hemoglobin. Individually, each is protective against severe Plasmodium falciparum malaria(2-4), but little is known about their malaria-protective effects when inherited in combination. We investigated this question by studying a population on the coast of Kenya and found that the protection afforded by each condition inherited alone was lost when the two conditions were inherited together, to such a degree that the incidence of both uncomplicated and severe P. falciparum malaria was close to baseline in children heterozygous with respect to the mutation underlying the hemoglobin S variant and homozygous with respect to the mutation underlying alpha(+)-thalassemia. Negative epistasis could explain the failure of alpha(+)-thalassemia to reach fixation in any population in sub-Saharan Africa.	Kilifi Dist Hosp, Kenya Med Res Inst, Wellcome Trust Programme, Ctr Geog Med Res, Kilifi, Kenya; John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DS, England; John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DS, England; John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Kenya Medical Research Institute; University of Oxford; University of Oxford; University of Oxford; University of Oxford	Williams, TN (corresponding author), Kilifi Dist Hosp, Kenya Med Res Inst, Wellcome Trust Programme, Ctr Geog Med Res, POB 230, Kilifi, Kenya.	twilliams@kilifi.mimcom.net	Snow, Robert William/AFR-1436-2022; Wambua, Sammy/AAA-9713-2020	Snow, Robert William/0000-0003-3725-6088; Wambua, Sammy/0000-0002-3041-2714; peto, tim/0000-0003-3477-8307; Uyoga, Sophie/0000-0003-1746-7873; Recker, Mario/0000-0001-9489-1315; Penman, Bridget/0000-0001-9803-5209	Wellcome Trust [058992] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; Allen SJ, 1997, P NATL ACAD SCI USA, V94, P14736, DOI 10.1073/pnas.94.26.14736; ALLEN SJ, 1993, T ROY SOC TROP MED H, V87, P282, DOI 10.1016/0035-9203(93)90129-E; ALLISON AC, 1964, COLD SPRING HARB SYM, V29, P137, DOI 10.1101/SQB.1964.029.01.018; Armitage P, 2001, STAT METHODS MED RES, V4th; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; BRITTENHAM G, 1979, AM J HEMATOL, V6, P107, DOI 10.1002/ajh.2830060203; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Cho JH, 1998, P NATL ACAD SCI USA, V95, P7502, DOI 10.1073/pnas.95.13.7502; Chong SS, 2000, BLOOD, V95, P360; Cockburn IA, 2004, P NATL ACAD SCI USA, V101, P272, DOI 10.1073/pnas.0305306101; CORDELL HJ, 1995, AM J HUM GENET, V57, P920; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Flint J, 1998, BAILLIERE CLIN HAEM, V11, P1, DOI 10.1016/S0950-3536(98)80069-3; FRIEDMAN MJ, 1978, P NATL ACAD SCI USA, V75, P1994, DOI 10.1073/pnas.75.4.1994; Mockenhaupt FP, 2004, BLOOD, V104, P2003, DOI 10.1182/blood-2003-11-4090; MODIANO G, 1991, AM J HUM GENET, V48, P390; PASVOL G, 1978, NATURE, V274, P701, DOI 10.1038/274701a0; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; SHEAR HL, 1993, EXPERIENTIA, V49, P37, DOI 10.1007/BF01928786; SHEAR HL, 1993, BLOOD, V81, P222; Snow RW, 1999, HEALTH POLICY PLANN, V14, P18, DOI 10.1093/heapol/14.1.18; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 2000, TROP MED INT HEALTH, V5, P377, DOI 10.1046/j.1365-3156.2000.00568.x; Tiffert T, 2005, BLOOD, V105, P4853, DOI 10.1182/blood-2004-12-4948; TIRET L, 1994, LANCET, V344, P910, DOI 10.1016/S0140-6736(94)92268-3; WHO Expert Committee on Malaria, 2000, WHO TECH REP SER, V892, P1; Williams TN, 2005, BLOOD, V106, P368, DOI 10.1182/blood-2005-01-0313; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; Williams TN, 1996, NATURE, V383, P522, DOI 10.1038/383522a0	30	182	188	1	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2005	37	11					1253	1257		10.1038/ng1660	http://dx.doi.org/10.1038/ng1660			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	980VB	16227994	Green Accepted			2022-12-27	WOS:000233045200026
J	Salzer, U; Chapel, HM; Webster, ADB; Pan-Hammarstrom, Q; Schmitt-Graeff, A; Schlesier, M; Peter, HH; Rockstroh, JK; Schneider, P; Schaffer, AA; Hammarstrom, L; Grimbacher, B				Salzer, U; Chapel, HM; Webster, ADB; Pan-Hammarstrom, Q; Schmitt-Graeff, A; Schlesier, M; Peter, HH; Rockstroh, JK; Schneider, P; Schaffer, AA; Hammarstrom, L; Grimbacher, B			Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans	NATURE GENETICS			English	Article							TNF RECEPTOR; B-CELLS; LYMPHOPROLIFERATIVE SYNDROME; LINKAGE ANALYSIS; IGA DEFICIENCY; T-CELL; BAFF-R; FAMILY; APRIL; MEMBERS	The functional interaction of BAFF and APRIL with TNF receptor superfamily members BAFFR, TACI and BCMA is crucial for development and maintenance of humoral immunity in mice and humans. Using a candidate gene approach, we identified homozygous and heterozygous mutations in TNFRSF13B, encoding TACI, in 13 individuals with common variable immunodeficiency. Homozygosity with respect to mutations causing the amino acid substitutions S144X and C104R abrogated APRIL binding and resulted in loss of TACI function, as evidenced by impaired proliferative response to IgM-APRIL costimulation and defective class switch recombination induced by IL-10 and APRIL or BAFF. Family members heterozygous with respect to the C104R mutation and individuals with sporadic common variable immunodeficiency who were heterozygous with respect to the amino acid substitutions A181E, S194X and R202H had humoral immunodeficiency. Although signs of autoimmunity and lymphoproliferation are evident, the human phenotype differs from that of the Tnfrsf13b(-/-) mouse model.	Univ Hosp, Med Ctr, Div Clin Immunol & Rheumatol, D-79106 Freiburg, Germany; Oxford Radcliffe Hosp, Dept Immunol, Oxford, England; Royal Free Hosp, Dept Clin Immunol, London NW3 2QG, England; Karolinska Inst Huddinge, Div Clin Immunol, Stockholm, Sweden; Univ Freiburg, Inst Pathol, D-7800 Freiburg, Germany; Med Univ Klin 1, Bonn, Germany; Univ Lausanne, Dept Biochem, CH-1015 Lausanne, Switzerland; NIH, Natl Ctr Biotechnol Informat, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	University of Freiburg; University of Oxford; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Karolinska Institutet; University of Freiburg; University of Bonn; University of Lausanne; National Institutes of Health (NIH) - USA	Grimbacher, B (corresponding author), Univ Hosp, Med Ctr, Div Clin Immunol & Rheumatol, Hugstetterstr 55, D-79106 Freiburg, Germany.	grimbacher@medizin.ukl.uni-freiburg.de	hammarstrom, qiang pan/ABA-4589-2021; Schaffer, Alejandro/N-1222-2019; Schaffer, Alejandro A/F-2902-2012	Schneider, Pascal/0000-0003-0677-9409; pan-hammarstrom, qiang/0000-0003-1990-8804	NATIONAL LIBRARY OF MEDICINE [Z01LM000097, ZIALM000097] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Avery DT, 2003, J CLIN INVEST, V112, P286, DOI 10.1172/JCI200318025; Baker KP, 2003, ARTHRITIS RHEUM-US, V48, P3253, DOI 10.1002/art.11299; Burrows PD, 1997, ADV IMMUNOL, V65, P245, DOI 10.1016/S0065-2776(08)60744-0; Castigli E, 2005, J EXP MED, V201, P35, DOI 10.1084/jem.20032000; Castigli E, 2004, P NATL ACAD SCI USA, V101, P3903, DOI 10.1073/pnas.0307348101; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Ferrari S, 2001, P NATL ACAD SCI USA, V98, P12614, DOI 10.1073/pnas.221456898; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Gross JA, 2001, IMMUNITY, V15, P289, DOI 10.1016/S1074-7613(01)00183-2; HANNELIUS U, IN PRESS J MED GENET; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Hymowitz SG, 2005, J BIOL CHEM, V280, P7218, DOI 10.1074/jbc.M411714200; Infante AJ, 1998, J PEDIATR-US, V133, P629, DOI 10.1016/S0022-3476(98)70102-7; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; Kralovicova J, 2003, J IMMUNOL, V170, P2765, DOI 10.4049/jimmunol.170.5.2765; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Mackay F, 2003, CYTOKINE GROWTH F R, V14, P311, DOI 10.1016/S1359-6101(03)00023-6; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pan Q, 1997, EUR J IMMUNOL, V27, P2920, DOI 10.1002/eji.1830271126; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Riva A, 2002, BIOINFORMATICS, V18, P1681, DOI 10.1093/bioinformatics/18.12.1681; Salzer U, 2004, CLIN IMMUNOL, V113, P234, DOI 10.1016/j.clim.2004.07.002; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Seshasayee D, 2003, IMMUNITY, V18, P279, DOI 10.1016/S1074-7613(03)00025-6; Shulga-Morskaya S, 2004, J IMMUNOL, V173, P2331, DOI 10.4049/jimmunol.173.4.2331; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Varfolomeev E, 2004, MOL CELL BIOL, V24, P997, DOI 10.1128/MCB.24.3.997-1006.2004; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Vorechovsky I, 2000, J IMMUNOL, V164, P4408, DOI 10.4049/jimmunol.164.8.4408; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Wu H, 2004, ADV PROTEIN CHEM, V68, P225; Wu YM, 2000, J BIOL CHEM, V275, P35478, DOI 10.1074/jbc.M005224200; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790	41	488	502	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2005	37	8					820	828		10.1038/ng1600	http://dx.doi.org/10.1038/ng1600			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	16007087				2022-12-27	WOS:000230880400011
J	Schadt, EE; Lamb, J; Yang, X; Zhu, J; Edwards, S; GuhaThakurta, D; Sieberts, SK; Monks, S; Reitman, M; Zhang, CS; Lum, PY; Leonardson, A; Thieringer, R; Metzger, JM; Yang, LM; Castle, J; Zhu, HY; Kash, SF; Drake, TA; Sachs, A; Lusis, AJ				Schadt, EE; Lamb, J; Yang, X; Zhu, J; Edwards, S; GuhaThakurta, D; Sieberts, SK; Monks, S; Reitman, M; Zhang, CS; Lum, PY; Leonardson, A; Thieringer, R; Metzger, JM; Yang, LM; Castle, J; Zhu, HY; Kash, SF; Drake, TA; Sachs, A; Lusis, AJ			An integrative genomics approach to infer causal associations between gene expression and disease	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; TRANSFORMING GROWTH FACTOR-BETA(1); SELECTIVE-INHIBITION; INSULIN SENSITIVITY; HYPERGLYCEMIC MICE; SERUM COMPLEMENT; MICROARRAYS; OBESITY; ACTIVATION; MARKERS	A key goal of biomedical research is to elucidate the complex network of gene interactions underlying complex traits such as common human diseases. Here we detail a multistep procedure for identifying potential key drivers of complex traits that integrates DNA- variation and gene- expression data with other complex trait data in segregating mouse populations. Ordering gene expression traits relative to one another and relative to other complex traits is achieved by systematically testing whether variations in DNA that lead to variations in relative transcript abundances statistically support an independent, causative or reactive function relative to the complex traits under consideration. We show that this approach can predict transcriptional responses to single gene- perturbation experiments using gene- expression data in the context of a segregating mouse population. We also demonstrate the utility of this approach by identifying and experimentally validating the involvement of three new genes in susceptibility to obesity.	Rosetta Inpharmat, Seattle, WA 98109 USA; Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA; Merck Res Labs, Dept Metab Disorders, Rahway, NJ 07065 USA; Merck Res Labs, Dept Cardiovasc Dis, Rahway, NJ 07065 USA; Merck Res Labs, Dept Pharmacol, Rahway, NJ 07065 USA; Deltagen Inc, San Carlos, CA 94070 USA; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	Merck & Company; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Oklahoma State University System; Oklahoma State University - Stillwater; Merck & Company; Merck & Company; Merck & Company; University of California System; University of California Los Angeles	Schadt, EE (corresponding author), Rosetta Inpharmat, Seattle, WA 98109 USA.	eric_schadt@merck.com	Edwards, Stephen W/G-4482-2011; Pillay, Nischalan/F-9536-2012; Longo, Kenneth A/A-5631-2010; Reitman, Marc/B-4448-2013; Califano, Andrea/F-7239-2012	Reitman, Marc/0000-0002-0426-9475; Edwards, Stephen/0000-0002-7985-111X	NHLBI NIH HHS [P01 HL028481-21A1, P01 HL028481, P01 HL028481-21A10010, R01 HL094322, P01 HL030568-220009, P01 HL030568, P01 HL030568-220011] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, P01HL028481, R01HL094322] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alberts P, 2003, ENDOCRINOLOGY, V144, P4755, DOI 10.1210/en.2003-0344; Alberts P, 2002, DIABETOLOGIA, V45, P1528, DOI 10.1007/s00125-002-0959-6; Alessi MC, 2000, DIABETES, V49, P1374, DOI 10.2337/diabetes.49.8.1374; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; BROMAN KW, 1997, THESIS U CALIFORNIA; Carlborg O, 2005, BIOINFORMATICS, V21, P2383, DOI 10.1093/bioinformatics/bti241; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Choy LN, 1996, OBES RES, V4, P521, DOI 10.1002/j.1550-8528.1996.tb00266.x; DePrimo SE, 2003, BMC CANCER, V3, DOI 10.1186/1471-2407-3-3; Drake TA, 2001, PHYSIOL GENOMICS, V5, P205, DOI 10.1152/physiolgenomics.2001.5.4.205; GHAZALPOUR A, IN PRESS GENOME BIOL; Goodarzi MO, 2004, DIABETES, V53, P214, DOI 10.2337/diabetes.53.1.214; Grant GR, 2005, BIOINFORMATICS, V21, P2684, DOI 10.1093/bioinformatics/bti407; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; He YDD, 2003, BIOINFORMATICS, V19, P956, DOI 10.1093/bioinformatics/btg126; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Jiang CJ, 1997, GENETICA, V101, P47, DOI 10.1023/A:1018394410659; JIANG CJ, 1995, GENETICS, V140, P1111; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kao CH, 2002, GENETICS, V160, P1243; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; Langfitt T W, 1981, Prog Neurol Surg, V10, P14, DOI 10.1159/000384767; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Miller A., 1990, SUBSET SELECTION REG; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Pomeroy C, 1997, CLIN EXP IMMUNOL, V108, P507, DOI 10.1046/j.1365-2249.1997.3921287.x; Rask E, 2002, J CLIN ENDOCR METAB, V87, P3330, DOI 10.1210/jc.87.7.3330; Romano M, 2003, J CLIN ENDOCR METAB, V88, P5321, DOI 10.1210/jc.2003-030508; Rosmond R, 2003, HORM RES, V59, P191, DOI 10.1159/000069323; Sakamoto Y, 1986, AKAIKE INFORMATION C; Samad TA, 1997, P NATL ACAD SCI USA, V94, P14349, DOI 10.1073/pnas.94.26.14349; Schadt EE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r73; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; SCHUPF N, 1983, J NEUROIMMUNOL, V5, P305, DOI 10.1016/0165-5728(83)90051-6; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Sillanpaa MJ, 2002, TRENDS GENET, V18, P301, DOI 10.1016/S0168-9525(02)02688-4; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Waring JF, 2002, TOXICOLOGY, V181, P537, DOI 10.1016/S0300-483X(02)00477-8; Ylitalo K, 1997, ATHEROSCLEROSIS, V129, P271, DOI 10.1016/S0021-9150(96)06054-6; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zeng ZB, 2000, GENETICS, V154, P299; Zhu J, 2004, CYTOGENET GENOME RES, V105, P363, DOI 10.1159/000078209	49	735	764	1	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2005	37	7					710	717		10.1038/ng1589	http://dx.doi.org/10.1038/ng1589			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	941EA	15965475	Green Accepted			2022-12-27	WOS:000230196400017
J	Rhodes, DR; Kalyana-Sundaram, S; Mahavisno, V; Barrette, TR; Ghosh, D; Chinnaiyan, AM				Rhodes, DR; Kalyana-Sundaram, S; Mahavisno, V; Barrette, TR; Ghosh, D; Chinnaiyan, AM			Mining for regulatory programs in the cancer transcriptome	NATURE GENETICS			English	Article							NEOPLASTIC TRANSFORMATION; MAMMALIAN EMBRYO; STEM-CELLS; N-MYC; C-MYC; GENE; EXPRESSION; PATTERNS; PROGRESSION; ACTIVATION	DNA microarrays have been widely applied to cancer transcriptome analysis. The Oncomine database contains a large collection of such data, as well as hundreds of derived gene-expression signatures. We studied the regulatory mechanisms responsible for gene deregulation in these cancer signatures by searching for the coordinate regulation of genes with common transcription factor binding sites. We found that genes with binding sites for the archetypal cancer transcription factor, E2F, were disproportionately overexpressed in a wide variety of cancers, whereas genes with binding sites for other transcription factors, such as Myc-Max, c-Rel and ATF, were disproportionately overexpressed in specific cancer types. These results suggest that alterations in pathways activating these transcription factors may be responsible for the observed gene deregulation and cancer pathogenesis.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Bioinformat Program, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Kalyana-Sundaram, Shanker/F-6860-2012	Ghosh, Debashis/0000-0001-6618-1316; Kalyana-Sundaram, Shanker/0000-0002-7309-3848				Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Caamano J, 2002, CLIN MICROBIOL REV, V15, P414, DOI 10.1128/CMR.15.3.414-429.2002; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chae HD, 2004, ONCOGENE, V23, P4084, DOI 10.1038/sj.onc.1207482; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Elkon R, 2003, GENOME RES, V13, P773, DOI 10.1101/gr.947203; Gilmore TD, 2004, ONCOGENE, V23, P2275, DOI 10.1038/sj.onc.1207410; Houldsworth J, 2004, BLOOD, V103, P1862, DOI 10.1182/blood-2003-04-1359; Jean D, 2001, CRIT REV IMMUNOL, V21, P275; JOHNSON DG, 1994, P NATL ACAD SCI USA, V91, P12823, DOI 10.1073/pnas.91.26.12823; Keenan SM, 2004, J BIOL CHEM, V279, P5387, DOI 10.1074/jbc.M310383200; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; La Thangue NB, 2003, NAT CELL BIOL, V5, P587, DOI 10.1038/ncb0703-587; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lossos IS, 2002, P NATL ACAD SCI USA, V99, P8886, DOI 10.1073/pnas.132253599; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Muller M J, 2001, Obes Rev, V2, P15; NAU MM, 1985, NATURE, V318, P69, DOI 10.1038/318069a0; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; SCHWAB M, 1985, NATURE, V316, P160, DOI 10.1038/316160a0; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; SETH A, 1990, ONCOGENE, V5, P1761; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; SYLLA BS, 1986, MOL CELL BIOL, V6, P4709, DOI 10.1128/MCB.6.12.4709; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; WONG AJ, 1986, SCIENCE, V233, P461, DOI 10.1126/science.3014659; XANTHOPOULOS KG, 1991, P NATL ACAD SCI USA, V88, P3807, DOI 10.1073/pnas.88.9.3807; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459; ZUCMAN J, 1993, NAT GENET, V4, P341, DOI 10.1038/ng0893-341	36	138	148	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					579	583		10.1038/ng1578	http://dx.doi.org/10.1038/ng1578			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15920519				2022-12-27	WOS:000229495300008
J	Rugg-Gunn, PJ; Ferguson-Smith, AC; Pedersen, RA				Rugg-Gunn, PJ; Ferguson-Smith, AC; Pedersen, RA			Epigenetic status of human embryonic stem cells	NATURE GENETICS			English	Article							IMPRINTED GENES; MOUSE EMBRYOS; EXPRESSION; CULTURE; H19; METHYLATION	We examined the allele-specific expression of six imprinted genes and the methylation profiles of three imprinting control regions to assess the epigenetic status of human embryonic stem cells. We identified generally monoallelic gene expression and normal methylation patterns. During prolonged passage, one cell line became biallelic with respect to H19, but without loss of the gametic methylation imprint. These data argue for a substantial degree of epigenetic stability in human embryonic stem cells.	Univ Cambridge, Dept Surg, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge; University of Cambridge	Rugg-Gunn, PJ (corresponding author), Univ Cambridge, Dept Surg, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	pjr36@cam.ac.uk	Ferguson-Smith, Anne C/G-7534-2011	Ferguson-Smith, Anne/0000-0002-7608-5894; Rugg-Gunn, Peter/0000-0002-9601-5949	Medical Research Council [G0800784, G0100501] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Dean W, 1998, DEVELOPMENT, V125, P2273; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Khosla S, 2001, BIOL REPROD, V64, P918, DOI 10.1095/biolreprod64.3.918; Lee MP, 1999, HUM MOL GENET, V8, P683, DOI 10.1093/hmg/8.4.683; Maher ER, 2003, HUM REPROD, V18, P2508, DOI 10.1093/humrep/deg486; Mann MRW, 2004, DEVELOPMENT, V131, P3727, DOI 10.1242/dev.01241; Onyango P, 2002, P NATL ACAD SCI USA, V99, P10599, DOI 10.1073/pnas.152327599; Sasaki H, 1995, DEVELOPMENT, V121, P4195; Smilinich NJ, 1999, P NATL ACAD SCI USA, V96, P8064, DOI 10.1073/pnas.96.14.8064; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Young LE, 2001, NAT GENET, V27, P153, DOI 10.1038/84769	15	131	136	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2005	37	6					585	587		10.1038/ng1556	http://dx.doi.org/10.1038/ng1556			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15864307				2022-12-27	WOS:000229495300009
J	Adams, DJ; Dermitzakis, ET; Cox, T; Smith, J; Davies, R; Banerjee, R; Bonfield, J; Mullikin, JC; Chung, YJ; Rogers, J; Bradley, A				Adams, DJ; Dermitzakis, ET; Cox, T; Smith, J; Davies, R; Banerjee, R; Bonfield, J; Mullikin, JC; Chung, YJ; Rogers, J; Bradley, A			Complex haplotypes, copy number polymorphisms and coding variation in two recently divergent mouse strains	NATURE GENETICS			English	Article							INBRED STRAINS; GENOME; MICE; EVOLUTION; MUTATIONS; DISCOVERY; GENES	Inbred mouse strains provide the foundation for mouse genetics. By selecting for phenotypic features of interest, inbreeding drives genomic evolution and eliminates individual variation, while fixing certain sets of alleles that are responsible for the trait characteristics of the strain. Mouse strains 129Sv (129S5) and C57BL/6J, two of the most widely used inbred lines, diverged from common ancestors within the last century(1-5), yet very little is known about the genomic differences between them. By comparative genomic hybridization and sequence analysis of 129S5 short insert libraries, we identified substantial structural variation, a complex fine-scale haplotype pattern with a continuous distribution of diversity blocks, and extensive nucleotide variation, including nonsynonymous coding SNPs and stop codons. Collectively, these genomic changes denote the level and direction of allele fixation that has occurred during inbreeding and provide a basis for defining what makes these mouse strains unique.	Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; NHGRI, Bethesda, MD 20892 USA	Wellcome Trust Sanger Institute; University of Geneva; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Bradley, A (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England.	abradley@sanger.ac.uk	Dermitzakis, Emmanouil/B-7687-2013	Davies, Robert/0000-0002-9983-1378; Bonfield, James/0000-0002-6447-4112; Smith, James/0000-0002-0445-8305; Bradley, Allan/0000-0002-2349-8839; Adams, David/0000-0001-9490-0306	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200330, ZIAHG200330] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; AEBI M, 1986, CELL, V47, P555, DOI 10.1016/0092-8674(86)90620-3; ATTMAN PLK, 1979, INBRED GENETICALLY D, P1; ATWEH GF, 1985, NUCLEIC ACIDS RES, V13, P777, DOI 10.1093/nar/13.3.777; Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Bernardi G, 2000, GENE, V259, P31, DOI 10.1016/S0378-1119(00)00441-8; Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604; BONHOMME F, 1987, BIOL J LINN SOC, V30, P51, DOI 10.1111/j.1095-8312.1987.tb00288.x; Chung YJ, 2004, GENOME RES, V14, P188, DOI 10.1101/gr.1878804; Dermitzakis ET, 2001, MOL BIOL EVOL, V18, P557, DOI 10.1093/oxfordjournals.molbev.a003835; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Force A, 1999, GENETICS, V151, P1531; Frazer KA, 2004, GENOME RES, V14, P1493, DOI 10.1101/gr.2627804; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Silver L. M., 1995, MOUSE GENETICS; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; STEVENS LC, 1973, J NATL CANCER I, V50, P235, DOI 10.1093/jnci/50.1.235; Van der Weyden L, 2002, PHYSIOL GENOMICS, V11, P133, DOI 10.1152/physiolgenomics.00074.2002; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100; Yalcin B, 2004, P NATL ACAD SCI USA, V101, P9734, DOI 10.1073/pnas.0401189101; Zeniou M, 2004, NUCLEIC ACIDS RES, V32, P1214, DOI 10.1093/nar/gkh272; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354	28	56	58	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2005	37	5					532	536		10.1038/ng1551	http://dx.doi.org/10.1038/ng1551			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15852006				2022-12-27	WOS:000228862300024
J	Kochi, Y; Yamada, R; Suzuki, A; Harley, JB; Shirasawa, S; Sawada, T; Bae, SC; Tokuhiro, S; Chang, XT; Sekine, A; Takahashi, A; Tsunoda, T; Ohnishi, Y; Kaufman, KM; Kang, CSP; Kang, CW; Otsubo, S; Yumura, W; Mimori, A; Koike, T; Nakamura, Y; Sasazuki, T; Yamamoto, K				Kochi, Y; Yamada, R; Suzuki, A; Harley, JB; Shirasawa, S; Sawada, T; Bae, SC; Tokuhiro, S; Chang, XT; Sekine, A; Takahashi, A; Tsunoda, T; Ohnishi, Y; Kaufman, KM; Kang, CSP; Kang, CW; Otsubo, S; Yumura, W; Mimori, A; Koike, T; Nakamura, Y; Sasazuki, T; Yamamoto, K			A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities	NATURE GENETICS			English	Article							REVISED CRITERIA; SUSCEPTIBILITY; GENE; POLYMORPHISMS; FAMILY; IDENTIFICATION; POPULATION; PSORIASIS; LOCI; CLASSIFICATION	Rheumatoid arthritis is a common autoimmune disease with a complex genetic etiology. Here we identify a SNP in the promoter region of FCRL3, a member of the Fc receptor-like family, that is associated with susceptibility to rheumatoid arthritis ( odds ratio = 2.15, P = 0.00000085). This polymorphism alters the binding affinity of nuclear factor-kappa B and regulates FCRL3 expression. We observed high FCRL3 expression on B cells and augmented autoantibody production in individuals with the disease-susceptible genotype. We also found associations between the SNP and susceptibility to autoimmune thyroid disease and systemic lupus erythematosus. FCRL3 may therefore have a pivotal role in autoimmunity.	RIKEN, SNP Res Ctr, Lab Rheumat Dis, Yokohama, Kanagawa 2300045, Japan; Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo 1130033, Japan; Univ Oklahoma, Oklahoma City, OK 73104 USA; US Dept Vet Affairs, Oklahoma City, OK 73104 USA; Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; Int Med Ctr Japan, Tokyo 1628655, Japan; Hanyang Univ, Hosp Rheumat Dis, Div Rheumatol, Dept Internal Med, Seoul 133792, South Korea; RIKEN, SNP Res Ctr, Lab SNP Anal, Yokohama, Kanagawa 2300045, Japan; RIKEN, SNP Res Ctr, Lab Genotyping, Yokohama, Kanagawa 2300045, Japan; RIKEN, SNP Res Ctr, Lab Med Informat, Yokohama, Kanagawa 2300045, Japan; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo 1088639, Japan; Tokyo Womens Med Univ, Kidney Ctr, Dept Med, Tokyo 1628666, Japan; Hokkaido Univ, Sch Med, Dept Med 2, Sapporo, Hokkaido 0608638, Japan; RIKEN, SNP Res Ctr, Res Grp Personalized Med, Yokohama, Kanagawa 2300045, Japan	RIKEN; University of Tokyo; University of Oklahoma System; University of Oklahoma Health Sciences Center; US Department of Veterans Affairs; Oklahoma Medical Research Foundation; National Center for Global Health & Medicine - Japan; Hanyang University; RIKEN; RIKEN; RIKEN; Korea Advanced Institute of Science & Technology (KAIST); University of Tokyo; Tokyo Women's Medical University; Hokkaido University; RIKEN	Yamada, R (corresponding author), RIKEN, SNP Res Ctr, Lab Rheumat Dis, Yokohama, Kanagawa 2300045, Japan.	ryamada@src.riken.go.jp	Kang, Changwon/C-1938-2011; Yamamoto, Kazuhiko/N-5096-2015; Tsunoda, Tatsuhiko/K-2061-2014; Suzuki, Akari/N-5389-2015; Kochi, Yuta/P-4487-2018; Sawed, Tetsuji/GRX-6582-2022	Kang, Changwon/0000-0002-0867-6385; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Yamada, Ryo/0000-0002-1587-630X; Bae, Sang-Cheol/0000-0003-4658-1093	NCRR NIH HHS [P20 RR020143] Funding Source: Medline; NIAID NIH HHS [R01 AI024717] Funding Source: Medline; NIAMS NIH HHS [P01 AR049084, R01 AR042460] Funding Source: Medline; NIDCR NIH HHS [R01 DE015223] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042460, P01AR049084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015223] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aikawa Y, 2002, INFLAMM RES, V51, P188, DOI 10.1007/PL00000291; ALARCON GS, 1990, ARTHRITIS RHEUM, V33, P1156; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barton A, 2004, ARTHRITIS RHEUM, V50, P1117, DOI 10.1002/art.20169; Becker KG, 1998, P NATL ACAD SCI USA, V95, P9979, DOI 10.1073/pnas.95.17.9979; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bowcock AM, 2004, HUM MOL GENET, V13, pR43, DOI 10.1093/hmg/ddh094; Capon F, 2001, J INVEST DERMATOL, V116, P728, DOI 10.1046/j.1523-1747.2001.01311.x; Capon F, 1999, AM J HUM GENET, V65, P1798, DOI 10.1086/302653; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Dai KZ, 2001, GENES IMMUN, V2, P263, DOI 10.1038/sj.gene.6363774; Davis RS, 2001, P NATL ACAD SCI USA, V98, P9772, DOI 10.1073/pnas.171308498; Davis RS, 2002, IMMUNOL REV, V190, P123, DOI 10.1034/j.1600-065X.2002.19009.x; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gray D, 1997, Semin Immunol, V9, P249, DOI 10.1006/smim.1997.0077; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hatzivassiliou G, 2001, IMMUNITY, V14, P277, DOI 10.1016/S1074-7613(01)00109-1; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hoshinoso M, 1999, J BIOL CHEM, V274, P17837, DOI 10.1074/jbc.274.25.17837; Jirholt J, 1998, EUR J IMMUNOL, V28, P3321, DOI 10.1002/(SICI)1521-4141(199810)28:10<3321::AID-IMMU3321>3.0.CO;2-M; Jorgensen RA, 2004, PLANT CELL, V16, P787, DOI 10.1105/tpc.160490; Kaijzel EL, 2001, GENES IMMUN, V2, P135, DOI 10.1038/sj.gene.6363747; Kochi Y, 2004, ARTHRITIS RHEUM, V50, P63, DOI 10.1002/art.11366; Kyogoku C, 2002, ARTHRITIS RHEUM, V46, P1242, DOI 10.1002/art.10257; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; Miller I, 2002, BLOOD, V99, P2662, DOI 10.1182/blood.V99.8.2662; Newton JL, 2004, GENES IMMUN, V5, P151, DOI 10.1038/sj.gene.6364045; Nieto A, 2000, ARTHRITIS RHEUM, V43, P735, DOI 10.1002/1529-0131(200004)43:4<735::AID-ANR3>3.0.CO;2-Q; Podolin PL, 1997, J IMMUNOL, V159, P1835; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Pritchard JK, 2000, GENETICS, V155, P945; Radstake TRDJ, 2003, J RHEUMATOL, V30, P926; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Sebastiani P, 2003, P NATL ACAD SCI USA, V100, P9900, DOI 10.1073/pnas.1633613100; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; SUNDVALL M, 1995, NAT GENET, V10, P313, DOI 10.1038/ng0795-313; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Suzuki K, 2003, SCAND J RHEUMATOL, V32, P197, DOI 10.1080/03009740310003677; Takemura S, 2001, J IMMUNOL, V167, P1072, DOI 10.4049/jimmunol.167.2.1072; Teuscher C, 1997, J IMMUNOL, V159, P4930; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Tsao BP, 2003, TRENDS IMMUNOL, V24, P595, DOI 10.1016/j.it.2003.09.006; Tsunoda T, 2004, HUM MOL GENET, V13, P1623, DOI 10.1093/hmg/ddh177; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; van Eijk M, 2001, TRENDS IMMUNOL, V22, P677, DOI 10.1016/S1471-4906(01)02086-5; Weyand CM, 2003, ANN NY ACAD SCI, V987, P140, DOI 10.1111/j.1749-6632.2003.tb06042.x; Xu MJ, 2002, BIOCHEM BIOPH RES CO, V293, P1037, DOI 10.1016/S0006-291X(02)00332-7	50	287	314	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2005	37	5					478	485		10.1038/ng1540	http://dx.doi.org/10.1038/ng1540			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15838509	Green Accepted			2022-12-27	WOS:000228862300016
J	Vega, H; Waisfisz, Q; Gordillo, M; Sakai, N; Yanagihara, I; Yamada, M; van Gosliga, D; Kayserili, H; Xu, CZ; Ozono, K; Jabs, EW; Inui, K; Joenje, H				Vega, H; Waisfisz, Q; Gordillo, M; Sakai, N; Yanagihara, I; Yamada, M; van Gosliga, D; Kayserili, H; Xu, CZ; Ozono, K; Jabs, EW; Inui, K; Joenje, H			Roberts syndrome is caused by mutations in ESCO2, a human homolog of yeast ECO1 that is essential for the establishment of sister chromatid cohesion	NATURE GENETICS			English	Article							SYNDROME FIBROBLASTS; DNA-REPLICATION; ACETYLTRANSFERASE; ABNORMALITIES	Roberts syndrome is an autosomal recessive disorder characterized by craniofacial anomalies, tetraphocomelia and loss of cohesion at heterochromatic regions of centromeres and the Y chromosome. We identified mutations in a new human gene, ESCO2, associated with Roberts syndrome in 15 kindreds. The ESCO2 protein product is a member of a conserved protein family that is required for the establishment of sister chromatid cohesion during S phase and has putative acetyltransferase activity.	Univ Nacl Colombia, Inst Genet, Bogota, Colombia; Osaka Univ, Grad Sch Med, Dept Dev Med Pediat D5, Suita, Osaka 5650871, Japan; Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, NL-1081 BT Amsterdam, Netherlands; Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Osaka Med Ctr Maternal & Child Hlth, Dept Dev Infect Dis, Res Inst, Osaka 5941101, Japan; Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34390 Istanbul, Turkey	Universidad Nacional de Colombia; Osaka University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Johns Hopkins University; Istanbul University	Vega, H (corresponding author), Univ Nacl Colombia, Inst Genet, Ciudad Univ, Bogota, Colombia.	hhvegaf@unal.edu.co; ejabs1@jhem.jhmi.edu		Jabs, Ethylin/0000-0001-8983-5466; Waisfisz, Quinten/0000-0002-7384-9182	Telethon [GTF04002] Funding Source: Medline	Telethon(Fondazione Telethon)		Bellows AM, 2003, NUCLEIC ACIDS RES, V31, P6334, DOI 10.1093/nar/gkg811; BURNS MA, 1989, MUTAT RES, V216, P243, DOI 10.1016/0165-1161(89)90049-6; GERMAN J, 1979, CLIN GENET, V16, P441; Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052; Hoque MT, 2002, J BIOL CHEM, V277, P42306, DOI 10.1074/jbc.M206836200; Ivanov D, 2002, CURR BIOL, V12, P323, DOI 10.1016/S0960-9822(02)00681-4; JABS EW, 1991, CHROMOSOMA, V100, P251, DOI 10.1007/BF00344159; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; TOMKINS D, 1979, AM J MED GENET, V4, P17, DOI 10.1002/ajmg.1320040104; TOMKINS DJ, 1984, AM J HUM GENET, V36, P1332; VANDENBERG DJ, 1993, AM J MED GENET, V47, P1104, DOI 10.1002/ajmg.1320470735; Williams BC, 2003, CURR BIOL, V13, P2025, DOI 10.1016/j.cub.2003.11.018	15	271	285	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2005	37	5					468	470		10.1038/ng1548	http://dx.doi.org/10.1038/ng1548			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	922TU	15821733				2022-12-27	WOS:000228862300014
J	Schonberger, J; Wang, L; Shin, TJ; Kim, SD; Depreux, FFS; Zhu, H; Zon, L; Pizard, A; Kim, JB; MacRae, CA; Mungall, AJ; Seidman, JG; Seidman, CE				Schonberger, J; Wang, L; Shin, TJ; Kim, SD; Depreux, FFS; Zhu, H; Zon, L; Pizard, A; Kim, JB; MacRae, CA; Mungall, AJ; Seidman, JG; Seidman, CE			Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss	NATURE GENETICS			English	Article							DROSOPHILA-EYES-ABSENT; PROTEIN; GENE; PHOSPHATASE; HOMOLOGS; REVEALS; DFNA10	We identified a human mutation that causes dilated cardiomyopathy and heart failure preceded by sensorineural hearing loss (SNHL). Unlike previously described mutations causing dilated cardiomyopathy that affect structural proteins, this mutation deletes 4,846 bp of the human transcriptional coactivator gene EYA4. To elucidate the roles of eya4 in heart function, we studied zebrafish embryos injected with antisense morpholino oligonucleotides. Attenuated eya4 transcript levels produced morphologic and hemodynamic features of heart failure. To determine why previously described mutated EYA4 alleles(1,2) cause SNHL without heart disease, we examined biochemical interactions of mutant Eya4 peptides. Eya4 peptides associated with SNHL, but not the shortened 193 amino acid peptide associated with dilated cardiomyopathy and SNHL, bound wild-type Eya4 and associated with Six proteins. These data define unrecognized and crucial roles for Eya4-Six-mediated transcriptional regulation in normal heart function.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Univ Hosp Wurzburg, Dept Med, D-97080 Wurzburg, Germany; Inst Clin Biochem & Pathobiochem, D-97080 Wurzburg, Germany; Massachusetts Gen Hosp, Dev Biol Lab, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charlestown, MA 02129 USA; Childrens Hosp, Div Pulm Med, Boston, MA 02115 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Wurzburg; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Wellcome Trust Sanger Institute	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu	Mungall, Andrew J./U-7067-2018; Pizard, Anne CM/P-4754-2016; Zhu, Hao/L-5114-2013	Mungall, Andrew J./0000-0002-0905-2742; Pizard, Anne CM/0000-0003-2705-6365; Zhu, Hao/0000-0002-8417-9698				BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Borsani G, 1999, HUM MOL GENET, V8, P11, DOI 10.1093/hmg/8.1.11; Bui QT, 2000, GENETICS, V155, P709; Hanson IM, 2001, SEMIN CELL DEV BIOL, V12, P475, DOI 10.1006/scdb.2001.0271; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Jowett T, 1999, METHOD CELL BIOL, V59, P63; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Pfister M, 2002, MOL MED, V8, P607, DOI 10.1007/BF03402171; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Schonberger J, 2000, CIRCULATION, V101, P1812, DOI 10.1161/01.CIR.101.15.1812; Schwerte T, 2000, J EXP BIOL, V203, P1659; Silver SJ, 2003, MOL CELL BIOL, V23, P5989, DOI 10.1128/MCB.23.17.5989-5999.2003; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Wayne S, 2001, HUM MOL GENET, V10, P195, DOI 10.1093/hmg/10.3.195; Xu XL, 2002, NAT GENET, V30, P205, DOI 10.1038/ng816	16	148	162	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2005	37	4					418	422		10.1038/ng1527	http://dx.doi.org/10.1038/ng1527			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	911XL	15735644				2022-12-27	WOS:000228040000026
J	Hiller, M; Huse, K; Szafranski, K; Jahn, N; Hampe, J; Schreiber, S; Backofen, R; Platzer, M				Hiller, M; Huse, K; Szafranski, K; Jahn, N; Hampe, J; Schreiber, S; Backofen, R; Platzer, M			Widespread occurrence of alternative splicing at NAGNAG acceptors contributes to proteome plasticity	NATURE GENETICS			English	Article							MESSENGER-RNA; VARIANTS; IMPACT	Splice acceptors with the genomic NAGNAG motif may cause NAG insertion-deletions in transcripts, occur in 30% of human genes and are functional in at least 5% of human genes. We found five significant biases indicating that their distribution is nonrandom and that they are evolutionarily conserved and tissue-specific. Because of their subtle effects on mRNA and protein structures, these splice acceptors are often overlooked or underestimated, but they may have a great impact on biology and disease.	Inst Mol Biotechnol, D-07745 Jena, Germany; Univ Jena, Chair Bioinformat, Inst Comp Sci, D-07743 Jena, Germany; Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany	Friedrich Schiller University of Jena; University of Kiel	Platzer, M (corresponding author), Inst Mol Biotechnol, Beutenbergstr 11, D-07745 Jena, Germany.	mplatzer@imb-jena.de	Hampe, Jochen/A-2555-2010	Hampe, Jochen/0000-0002-2421-6127; Backofen, Rolf/0000-0001-8231-3323; Huse, Klaus/0000-0003-3854-1884				Chen SY, 2000, P NATL ACAD SCI USA, V97, P593, DOI 10.1073/pnas.97.2.593; CONDORELLI G, 1994, J BIOL CHEM, V269, P8510; Ferranti P, 1999, J PROTEIN CHEM, V18, P595, DOI 10.1023/A:1020659518748; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Karinch AM, 1997, BIOCHEM J, V321, P39, DOI 10.1042/bj3210039; Li L, 2001, PLANT MOL BIOL, V46, P409, DOI 10.1023/A:1010645330275; Long MY, 1999, MOL BIOL EVOL, V16, P1528, DOI 10.1093/oxfordjournals.molbev.a026065; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Resch A, 2004, J PROTEOME RES, V3, P76, DOI 10.1021/pr034064v; ROGINA B, 1995, BIOCHEM MOL BIOL INT, V35, P825; Stamm S, 2000, DNA CELL BIOL, V19, P739, DOI 10.1089/104454900750058107; Sugnet C W, 2004, Pac Symp Biocomput, P66; Zavolan M, 2003, GENOME RES, V13, P1290, DOI 10.1101/gr.1017303; Zhang HB, 1996, RNA, V2, P380	15	149	152	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2004	36	12					1255	1257		10.1038/ng1469	http://dx.doi.org/10.1038/ng1469			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15516930				2022-12-27	WOS:000225354100011
J	McClelland, M; Sanderson, KE; Clifton, SW; Latreille, P; Porwollik, S; Sabo, A; Meyer, R; Bieri, T; Ozersky, P; McLellan, M; Harkins, CR; Wang, CY; Nguyen, C; Berghoff, A; Elliott, G; Kohlberg, S; Strong, C; Du, FY; Carter, J; Kremizki, C; Layman, D; Leonard, S; Sun, H; Fulton, L; Nash, W; Miner, T; Minx, P; Delehaunty, K; Fronick, C; Magrini, V; Nhan, M; Warren, W; Florea, L; Spieth, J; Wilson, RK				McClelland, M; Sanderson, KE; Clifton, SW; Latreille, P; Porwollik, S; Sabo, A; Meyer, R; Bieri, T; Ozersky, P; McLellan, M; Harkins, CR; Wang, CY; Nguyen, C; Berghoff, A; Elliott, G; Kohlberg, S; Strong, C; Du, FY; Carter, J; Kremizki, C; Layman, D; Leonard, S; Sun, H; Fulton, L; Nash, W; Miner, T; Minx, P; Delehaunty, K; Fronick, C; Magrini, V; Nhan, M; Warren, W; Florea, L; Spieth, J; Wilson, RK			Comparison of genome degradation in Paratyphi A and Typhi, human-restricted serovars of Salmonella enterica that cause typhoid	NATURE GENETICS			English	Article							SEROTYPE TYPHIMURIUM; ESCHERICHIA-COLI; CAUSATIVE AGENT; SEQUENCE; FEVER; EVOLUTION; STRAINS; GENES; IDENTIFICATION; CHEMOTAXIS	Salmonella enterica serovars often have a broad host range, and some cause both gastrointestinal and systemic disease. But the serovars Paratyphi A and Typhi are restricted to humans and cause only systemic disease. It has been estimated that Typhi arose in the last few thousand years. The sequence and microarray analysis of the Paratyphi A genome indicates that it is similar to the Typhi genome but suggests that it has a more recent evolutionary origin. Both genomes have independently accumulated many pseudogenes among their similar to4,400 protein coding sequences: 173 in Paratyphi A and similar to210 in Typhi. The recent convergence of these two similar genomes on a similar phenotype is subtly reflected in their genotypes: only 30 genes are degraded in both serovars. Nevertheless, these 30 genes include three known to be important in gastroenteritis, which does not occur in these serovars, and four for Salmonella-translocated effectors, which are normally secreted into host cells to subvert host functions. Loss of function also occurs by mutation in different genes in the same pathway (e.g., in chemotaxis and in the production of fimbriae).	Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Celera Appl Biosyst, Informat Res, Rockville, MD 20850 USA	University of Calgary; Washington University (WUSTL); Thermo Fisher Scientific; Applied Biosystems	McClelland, M (corresponding author), Sidney Kimmel Canc Ctr, 10835 Altman Row, San Diego, CA 92121 USA.	mmcclelland@skcc.org	Wilson, Richard K./AAF-4139-2019; McClelland, Michael/A-8583-2011; Magrini, Vincent/AAT-5830-2020	Wilson, Richard K./0000-0002-1992-1358; Magrini, Vincent/0000-0002-2019-4872; McClelland, Michael/0000-0003-1788-9347; Kremitzki, Colin/0000-0001-9175-3136; MCLELLAN, MICHAEL/0000-0002-2703-8784				Akinyemi KO, 2000, Z NATURFORSCH C, V55, P489; Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; Andersson JO, 2001, MOL BIOL EVOL, V18, P829, DOI 10.1093/oxfordjournals.molbev.a003864; BOYD EF, 1993, J GEN MICROBIOL, V139, P1125, DOI 10.1099/00221287-139-6-1125; Boyd EF, 2003, J CLIN MICROBIOL, V41, P3823, DOI 10.1128/JCM.41.8.3823-3828.2003; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; Brumell JH, 2003, TRAFFIC, V4, P36, DOI 10.1034/j.1600-0854.2003.40106.x; BUCHWALD DS, 1984, REV INFECT DIS, V6, P345; Butler SM, 2004, P NATL ACAD SCI USA, V101, P5018, DOI 10.1073/pnas.0308052101; Chan K, 2003, J BACTERIOL, V185, P553, DOI 10.1128/JB.185.2.553-563.2003; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; EDELMAN R, 1986, REV INFECT DIS, V8, P329; Freeman JA, 2003, INFECT IMMUN, V71, P418, DOI 10.1128/IAI.71.1.418-427.2003; Hafiz Saleem, 1993, JPMA (Journal of the Pakistan Medical Association), V43, P178; HOFFMAN TA, 1975, AM J MED, V59, P481, DOI 10.1016/0002-9343(75)90255-7; Ivanoff B., 1995, SE ASIAN J TROP MED, V26, P1; Jin Q, 2002, NUCLEIC ACIDS RES, V30, P4432, DOI 10.1093/nar/gkf566; JONES BD, 1992, INFECT IMMUN, V60, P2475, DOI 10.1128/IAI.60.6.2475-2480.1992; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Kingsley RA, 2003, INFECT IMMUN, V71, P629, DOI 10.1128/IAI.71.2.629-640.2003; Konadu EY, 2000, INFECT IMMUN, V68, P1529, DOI 10.1128/IAI.68.3.1529-1534.2000; LIU SL, 1995, J BACTERIOL, V177, P6585, DOI 10.1128/jb.177.22.6585-6592.1995; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; Miao EA, 2000, P NATL ACAD SCI USA, V97, P7539, DOI 10.1073/pnas.97.13.7539; Miao EA, 2003, MOL MICROBIOL, V48, P401, DOI 10.1046/j.1365-2958.2003.t01-1-03456.x; Mmolawa PT, 2003, J BACTERIOL, V185, P6481, DOI 10.1128/JB.185.21.6481-6485.2003; Naderer M, 2002, J BACTERIOL, V184, P2411, DOI 10.1128/JB.184.9.2411-2419.2002; Nair S, 2004, J BACTERIOL, V186, P3214, DOI 10.1128/JB.186.10.3214-3223.2004; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; PEARSON RD, 1995, PRINCIPLES PRACTICE, P998; Porwollik S, 2002, P NATL ACAD SCI USA, V99, P8956, DOI 10.1073/pnas.122153699; Porwollik S, 2004, J BACTERIOL, V186, P5883, DOI 10.1128/JB.186.17.5883-5898.2004; Porwollik S, 2003, NUCLEIC ACIDS RES, V31, P1869, DOI 10.1093/nar/gkg298; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; REEVES P, 1993, TRENDS GENET, V9, P17, DOI 10.1016/0168-9525(93)90067-R; SILVERMAN M, 1980, CELL, V19, P845, DOI 10.1016/0092-8674(80)90075-6; Smith J, 2004, B WORLD HEALTH ORGAN, V82, P24; Sood S, 1999, EMERG INFECT DIS, V5, P483, DOI 10.3201/eid0503.990329; Thomson N, 2004, J MOL BIOL, V339, P279, DOI 10.1016/j.jmb.2004.03.058; Threlfall EJ, 2003, INT J ANTIMICROB AG, V22, P487, DOI 10.1016/S0924-8579(03)00262-0; Tsolis RM, 1999, INFECT IMMUN, V67, P6385; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wren BW, 2003, NAT REV MICROBIOL, V1, P55, DOI 10.1038/nrmicro730; Zhang SP, 2002, INFECT IMMUN, V70, P3843, DOI 10.1128/IAI.70.7.3843-3855.2002	49	292	1240	0	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2004	36	12					1268	1274		10.1038/ng1470	http://dx.doi.org/10.1038/ng1470			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	874MI	15531882				2022-12-27	WOS:000225354100013
J	Kulaga, HM; Leitch, CC; Eichers, ER; Badano, JL; Lesemann, A; Hoskins, BE; Lupski, JR; Beales, PL; Reed, RR; Katsanis, N				Kulaga, HM; Leitch, CC; Eichers, ER; Badano, JL; Lesemann, A; Hoskins, BE; Lupski, JR; Beales, PL; Reed, RR; Katsanis, N			Loss of BBS proteins causes anosmia in humans and defects in olfactory cilia structure and function in the mouse	NATURE GENETICS			English	Article							BARDET-BIEDL-SYNDROME; HUMAN OBESITY SYNDROME; INTRAFLAGELLAR TRANSPORT; ADENYLYL-CYCLASE; DISEASE GENE; IDENTIFICATION; MUTATIONS; HOMOLOG; CLONING	Defects in cilia are associated with several human disorders, including Kartagener syndrome(1), polycystic kidney disease(2,3), nephronophthisis(4) and hydrocephalus(5). We proposed that the pleiotropic phenotype of Bardet-Biedl syndrome (BBS), which encompasses retinal degeneration, truncal obesity, renal and limb malformations and developmental delay, is due to dysfunction of basal bodies and cilia(6,7). Here we show that individuals with BBS have partial or complete anosmia. To test whether this phenotype is caused by ciliary defects of olfactory sensory neurons, we examined mice with deletions of Bbs1 or Bbs4. Loss of function of either BBS protein affected the olfactory, but not the respiratory, epithelium, causing severe reduction of the ciliated border, disorganization of the dendritic microtubule network and trapping of olfactory ciliary proteins in dendrites and cell bodies. Our data indicate that BBS proteins have a role in the microtubule organization of mammalian ciliated cells and that anosmia might be a useful determinant of other pleiotropic disorders with a suspected ciliary involvement.	Johns Hopkins Univ, Inst Med Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; UCL, Inst Child Hlth, Mol Med Unit, London WC1 1EH, England; Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21287 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Baylor College of Medicine; University of London; University College London; Baylor College of Medicine; Baylor College of Medicine; Johns Hopkins University; Johns Hopkins Medicine	Katsanis, N (corresponding author), Johns Hopkins Univ, Inst Med Genet, 533 Broadway St Bldg,733 N Broadway, Baltimore, MD 21205 USA.	katsanis@jhmi.edu	Katsanis, Nicholas/E-1837-2012; Beales, Philip L/C-7367-2009; Reed, Russell/HGU-0528-2022	Katsanis, Nicholas/0000-0002-2480-0171; Badano, Jose/0000-0002-0706-8652				AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Badano JL, 2003, AM J HUM GENET, V72, P650, DOI 10.1086/368204; BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; Beales PL, 1999, J MED GENET, V36, P437; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Chen JC, 1998, J CLIN INVEST, V102, P1077, DOI 10.1172/JCI4786; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Goldstein BJ, 2003, JARO-J ASSOC RES OTO, V4, P74, DOI 10.1007/s10162-002-2039-5; GRAZIADEI PPC, 1978, OLFACTORY SYSTEM MOD, P131; Haycraft CJ, 2003, EXP CELL RES, V284, P251, DOI 10.1016/S0014-4827(02)00089-7; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Menco Bert P. M., 1994, Seminars in Cell Biology, V5, P11, DOI 10.1006/scel.1994.1003; Moore AB, 1999, J CLIN EXP NEUROPSYC, V21, P341, DOI 10.1076/jcen.21.3.341.918; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; RUGARLI EI, 1993, NAT GENET, V4, P19, DOI 10.1038/ng0593-19; Signor D, 2000, Essays Biochem, V35, P89; Slavotinek AM, 2000, NAT GENET, V26, P15, DOI 10.1038/79116; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X	30	255	262	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					994	998		10.1038/ng1418	http://dx.doi.org/10.1038/ng1418			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15322545	Bronze			2022-12-27	WOS:000223658100027
J	Mandal, L; Banerjee, U; Hartenstein, V				Mandal, L; Banerjee, U; Hartenstein, V			Evidence for a fruit fly hemangioblast and similarities between lymph-gland hematopoiesis in fruit fly and mammal aorta-gonadal-mesonephros mesoderm	NATURE GENETICS			English	Article							DROSOPHILA EMBRYO; ENDOTHELIAL-CELLS; HEART DEVELOPMENT; REGION; GENES; DIFFERENTIATION; SPECIFICATION; VERTEBRATES; INDUCTION; PANNIER	The Drosophila melanogaster lymph gland is a hematopoietic organ(1) and, together with prospective vascular cells (cardioblasts) and excretory cells (pericardial nephrocytes), arises from the cardiogenic mesoderm. Clonal analysis provided evidence for a hemangioblast(2,3) that can give rise to two daughter cells: one that differentiates into heart or aorta and another that differentiates into blood. In addition, the GATA factor gene pannier (pnr) and the homeobox gene tinman (tin), which are controlled by the convergence of Decapentaplegic (Dpp), fibroblast growth factor (FGF), Wingless (Wg) and Notch signaling, are required for the development of all cardiogenic mesoderm, including the lymph gland. Here we show that an essential genetic switch that differentiates between the blood or nephrocyte and vascular lineages involves the Notch pathway. Further specification occurs through specific expression of the GATA factor Serpent (Srp) in the lymph-gland primordium. Our findings suggest that there is a close parallel between the molecular mechanisms functioning in the D. melanogaster cardiogenic mesoderm and those functioning in the mammalian aorta-gonadal-mesonephros mesoderm(4).	Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Banerjee, U (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu; volkerh@mcdb.ucla.edu		MANDAL, LOLITIKA/0000-0002-7711-6090				Alvarez AD, 2003, DEVELOPMENT, V130, P3015, DOI 10.1242/dev.00488; Beiman M, 1996, GENE DEV, V10, P2993, DOI 10.1101/gad.10.23.2993; Chartier A, 2002, DEVELOPMENT, V129, P3241; Choi K, 1998, DEVELOPMENT, V125, P725; CROSSLEY AC, 1972, TISSUE CELL, V4, P529, DOI 10.1016/S0040-8166(72)80029-6; Ema M, 2003, GENE DEV, V17, P380, DOI 10.1101/gad.1049803; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Fossett N, 2001, DIFFERENTIATION, V69, P83, DOI 10.1046/j.1432-0436.2001.690202.x; FRASCH M, 1995, NATURE, V374, P464, DOI 10.1038/374464a0; HARTENSTEIN AY, 1992, DEVELOPMENT, V116, P1203; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; Klinedinst SL, 2003, DEVELOPMENT, V130, P3027, DOI 10.1242/dev.00517; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lo PCH, 2002, DEV BIOL, V251, P307, DOI 10.1006/dbio.2002.0839; Marshall CJ, 2000, BLOOD, V96, P1591, DOI 10.1182/blood.V96.4.1591.h8001591_1591_1593; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MURRAY PDF, 1932, P R SOC LOND, V11, P497; Nishikawa M, 2001, ANN NY ACAD SCI, V938, P109; Orelio C, 2003, BLOOD, V101, P2246, DOI 10.1182/blood-2002-07-2260; Rehorn KP, 1996, DEVELOPMENT, V122, P4023; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Ward EJ, 2000, DEVELOPMENT, V127, P4959; WU XS, 1995, DEV BIOL, V169, P619, DOI 10.1006/dbio.1995.1174; Yin ZZ, 1997, DEVELOPMENT, V124, P4971	28	158	164	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					1019	1023		10.1038/ng1404	http://dx.doi.org/10.1038/ng1404			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15286786	Bronze			2022-12-27	WOS:000223658100032
J	Padiath, QS; Saigoh, K; Schiffmann, R; Asahara, H; Yamada, T; Koeppen, A; Hogan, K; Ptacek, LJ; Fu, YH				Padiath, Quasar S.; Saigoh, Kazumasa; Schiffmann, Raphael; Asahara, Hideaki; Yamada, Takeshi; Koeppen, Anulf; Hogan, Kirk; Ptacek, Louis J.; Fu, Ying-Hui			Lamin B1 duplications cause autosomal dominant leukodystrophy	NATURE GENETICS			English	Article							PROGRESSIVE MULTIPLE-SCLEROSIS; DREIFUSS MUSCULAR-DYSTROPHY; PELIZAEUS-MERZBACHER-DISEASE; NUCLEAR LAMINS; PARTIAL LIPODYSTROPHY; GENE-EXPRESSION; DNA-SEQUENCES; HUMAN TISSUES; DROSOPHILA; PROTEIN	Adult-onset autosomal dominant leukodystrophy (ADLD) is a slowly progressive neurological disorder characterized by symmetrical widespread myelin loss in the central nervous system, with a phenotype similar to chronic progressive multiple sclerosis. In this study, we identify a genomic duplication that causes ADLD. Affected individuals carry an extra copy of the gene for the nuclear laminar protein lamin B1, resulting in increased gene dosage in brain tissue from individuals with ADLD. Increased expression of lamin B1 in Drosophila melanogaster resulted in a degenerative phenotype. In addition, an abnormal nuclear morphology was apparent when cultured cells overexpressed this protein. This is the first human disease attributable to mutations in the gene encoding lamin B1. Antibodies to lamin B are found in individuals with autoimmune diseases, and it is also an antigen recognized by a monoclonal antibody raised against plaques from brains of individuals with multiple sclerosis. This raises the possibility that lamin B may be a link to the autoimmune attack that occurs in multiple sclerosis.	Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; NINDS, Dev & Metab Neurol Branch, NIH, Bethesda, MD 20892 USA; Kyushu Univ, Fac Med, Dept Neurol, Fukuoka 812, Japan; Iizuka Hosp, Dept Neurol, Iizuka, Fukuoka, Japan; Albany Med Coll, Vet Adm Med Ctr, Albany, NY 12208 USA; Albany Med Coll, Dept Neurol, Albany, NY 12208 USA; Univ Wisconsin, Dept Anesthesiol, Madison, WI 53792 USA; Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Kyushu University; Albany Medical College; US Department of Veterans Affairs; Veterans Health Administration (VHA); Albany Medical College; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute	Fu, YH (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.	yhf@neugenes.org	saigoh, Kazumasa/AAG-4678-2022; saigoh, Kazumasa/AFK-6417-2022; Saigoh, Kazumasa/AAG-2956-2020	Saigoh, Kazumasa/0000-0002-0905-5935	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002984, R01NS041331] Funding Source: NIH RePORTER; NINDS NIH HHS [NS41331] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aarskog NK, 2000, HUM GENET, V107, P494, DOI 10.1007/s004390000399; Asahara H, 1996, Rinsho Shinkeigaku, V36, P968; Ausubel F., 1999, CURRENT PROTOCOLS MO; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Boor PKI, 2005, J NEUROPATH EXP NEUR, V64, P412; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broers JLV, 1997, HISTOCHEM CELL BIOL, V107, P505, DOI 10.1007/s004180050138; Coffeen CM, 2000, HUM MOL GENET, V9, P787, DOI 10.1093/hmg/9.5.787; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; ELDRIDGE R, 1984, NEW ENGL J MED, V311, P948, DOI 10.1056/NEJM198410113111504; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Favreau C, 2003, EXP CELL RES, V282, P14, DOI 10.1006/excr.2002.5669; Garcia DM, 2003, BRAIN RES, V976, P9, DOI 10.1016/S0006-8993(03)02597-6; Gillert E, 1999, ONCOGENE, V18, P4663, DOI 10.1038/sj.onc.1202842; Glatt CE, 2001, NAT GENET, V27, P435, DOI 10.1038/86948; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Guillemin K, 2001, NAT CELL BIOL, V3, P848, DOI 10.1038/ncb0901-848; Haithcock E, 2005, P NATL ACAD SCI USA, V102, P16690, DOI 10.1073/pnas.0506755102; Hegele RA, 2006, AM J HUM GENET, V79, P383, DOI 10.1086/505885; Inoue K, 2002, AM J HUM GENET, V71, P838, DOI 10.1086/342728; Inoue K, 2005, NEUROGENETICS, V6, P1, DOI 10.1007/s10048-004-0207-y; Lin F, 1997, EXP CELL RES, V236, P378, DOI 10.1006/excr.1997.3735; LIN F, 1995, GENOMICS, V27, P230, DOI 10.1006/geno.1995.1036; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Mignot C, 2004, CELL MOL LIFE SCI, V61, P369, DOI 10.1007/s00018-003-3143-3; Moisan E, 2006, J LEUKOCYTE BIOL, V79, P489, DOI 10.1189/jlb.0405190; POLLARD KM, 1990, MOL CELL BIOL, V10, P2164, DOI 10.1128/MCB.10.5.2164; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Schiffmann R, 2004, CURR OPIN NEUROL, V17, P187, DOI 10.1097/00019052-200404000-00017; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; SCHWANKHAUS JD, 1994, ARCH NEUROL-CHICAGO, V51, P757, DOI 10.1001/archneur.1994.00540200033013; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; SEBOUN E, 1997, MOL GENETIC BASIS NE, P631; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; Somech R, 2005, PEDIATR RES, V57, p8R, DOI 10.1203/01.PDR.0000159566.54287.6C; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Super HG, 1997, GENE CHROMOSOME CANC, V20, P185, DOI 10.1002/(SICI)1098-2264(199710)20:2<185::AID-GCC9>3.0.CO;2-#; TAN EM, 1988, ANN INTERN MED, V108, P897, DOI 10.7326/0003-4819-108-6-897; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; Woodward KJ, 2005, AM J HUM GENET, V77, P966, DOI 10.1086/498048; Worman HJ, 2005, INT REV CYTOL, V246, P231, DOI 10.1016/S0074-7696(05)46006-4; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981	50	282	295	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1114	1123		10.1038/ng1872	http://dx.doi.org/10.1038/ng1872			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16951681				2022-12-27	WOS:000241251100010
J	Shaw-Smith, C; Pittman, AM; Willatt, L; Martin, H; Rickman, L; Gribble, S; Curley, R; Cumming, S; Dunn, C; Kalaitzopoulos, D; Porter, K; Prigmore, E; Krepischi-Santos, ACV; Varela, MC; Koiffmann, CP; Lees, AJ; Rosenberg, C; Firth, HV; de Silva, R; Carter, NP				Shaw-Smith, Charles; Pittman, Alan M.; Willatt, Lionel; Martin, Howard; Rickman, Lisa; Gribble, Susan; Curley, Rebecca; Cumming, Sally; Dunn, Carolyn; Kalaitzopoulos, Dimitrios; Porter, Keith; Prigmore, Elena; Krepischi-Santos, Ana C. V.; Varela, Monica C.; Koiffmann, Celia P.; Lees, Andrew J.; Rosenberg, Carla; Firth, Helen V.; de Silva, Rohan; Carter, Nigel P.			Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; LOW-COPY REPEATS; TAU GENE; FRONTOTEMPORAL DEMENTIA; SOTOS-SYNDROME; HAPLOTYPE; REARRANGEMENTS; ARCHITECTURE; MICROARRAY; MUTATIONS	Recently, the application of array-based comparative genomic hybridization ( array CGH) has improved rates of detection of chromosomal imbalances in individuals with mental retardation and dysmorphic features(1-4). Here, we describe three individuals with learning disability and a heterozygous deletion at chromosome 17q21.3, detected in each case by array CGH. FISH analysis demonstrated that the deletions occurred as de novo events in each individual and were between 500 kb and 650 kb in size. A recently described 900- kb inversion that suppresses recombination between ancestral H1 and H2 haplotypes(5) encompasses the deletion. We show that, in each trio, the parent of origin of the deleted chromosome 17 carries at least one H2 chromosome. This region of 17q21.3 shows complex genomic architecture with well-described low-copy repeats (LCRs)(5,6). The orientation of LCRs flanking the deleted segment in inversion heterozygotes is likely to facilitate the generation of this microdeletion by means of non-allelic homologous recombination.	Univ Cambridge, Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 2QQ, England; UCL, Reta Lila Weston Inst Neurol Studies, London WC1N 1PJ, England; Addenbrookes Hosp, Reg Cytogenet Lab, Cambridge CB2 2QQ, England; Addenbrookes Hosp, Reg Mol Genet Lab, Cambridge CB2 2QQ, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Sao Paulo, Dept Genet & Evolutionary Biol, BR-05422970 Sao Paulo, Brazil; Univ Sao Paulo, Human Genome Res Ctr, BR-05508900 Sao Paulo, Brazil	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Universidade de Sao Paulo; Universidade de Sao Paulo	Shaw-Smith, C (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 2QQ, England.	css@sanger.ac.uk	KOIFFMANN, CELIA/F-9828-2012; Pittman, Alan M/D-6231-2012; Lees, Andrew J/A-6605-2009; Pittman, Alan/AAP-2534-2020; Krepischi, Ana C V/E-4976-2012; rosenberg, carla/N-4148-2015	Pittman, Alan M/0000-0002-8112-2987; Lees, Andrew J/0000-0002-2476-4385; Pittman, Alan/0000-0002-8112-2987; Krepischi, Ana C V/0000-0003-2931-8605; rosenberg, carla/0000-0003-3253-4448	Medical Research Council [G0501560, G0501560(76517)] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0501560] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Bishop GA, 1999, EXP NEUROL, V160, P489, DOI 10.1006/exnr.1999.7227; Cassidy S. B., 2005, MANAGEMENT GENETIC S; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; Cruts M, 2005, HUM MOL GENET, V14, P1753, DOI 10.1093/hmg/ddi182; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Evans W, 2004, NEUROSCI LETT, V369, P183, DOI 10.1016/j.neulet.2004.05.119; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; Gimelli G, 2003, HUM MOL GENET, V12, P849, DOI 10.1093/hmg/ddg101; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Hardy J, 2005, BIOCHEM SOC T, V33, P582, DOI 10.1042/BST0330582; Hurles M E, 2001, BMC Genomics, V2, P11, DOI 10.1186/1471-2164-2-11; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ikegami S, 2000, NEUROSCI LETT, V279, P129, DOI 10.1016/S0304-3940(99)00964-7; KHALIFA MM, 1993, CLIN GENET, V44, P258; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Kurotaki N, 2003, HUM MUTAT, V22, P378, DOI 10.1002/humu.10270; Lopes J, 1999, HUM MOL GENET, V8, P2285, DOI 10.1093/hmg/8.12.2285; Myers AJ, 2005, HUM MOL GENET, V14, P2399, DOI 10.1093/hmg/ddi241; Phelan MC, 2001, AM J MED GENET, V101, P91, DOI 10.1002/1096-8628(20010615)101:2<91::AID-AJMG1340>3.0.CO;2-C; Pittman AM, 2005, J MED GENET, V42, P837, DOI 10.1136/jmg.2005.031377; Pittman AM, 2004, HUM MOL GENET, V13, P1267, DOI 10.1093/hmg/ddh138; Rosenberg C, 2006, J MED GENET, V43, P180, DOI 10.1136/jmg.2005.032268; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Varela MC, 2006, CYTOGENET GENOME RES, V114, P89, DOI 10.1159/000091934; Visser R, 2005, AM J HUM GENET, V76, P52, DOI 10.1086/426950; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977	29	280	283	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2006	38	9					1032	1037		10.1038/ng1858	http://dx.doi.org/10.1038/ng1858			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	078OC	16906163				2022-12-27	WOS:000240112100020
J	Hay, A; Tsiantis, M				Hay, Angela; Tsiantis, Miltos			The genetic basis for differences in leaf form between Arabidopsis thaliana and its wild relative Cardamine hirsuta	NATURE GENETICS			English	Article							ROUGH-SHEATH2 GENE; LATERAL ORGANS; HOMEOBOX GENE; EXPRESSION; LEAVES; ASYMMETRIC-LEAVES1; EFFICIENT; IDENTITY; PROTEIN; SYSTEM	A key question in biology is how differences in gene function or regulation produce new morphologies during evolution. Here we investigate the genetic basis for differences in leaf form between two closely related plant species, Arabidopsis thaliana and Cardamine hirsuta. We report that in C. hirsuta, class I KNOTTED1-like homeobox (KNOX) proteins are required in the leaf to delay cellular differentiation and produce a dissected leaf form, in contrast to A. thaliana, in which KNOX exclusion from leaves results in a simple leaf form. These differences in KNOX expression arise through changes in the activity of upstream gene regulatory sequences. The function of ASYMMETRIC LEAVES1/ROUGHSHEATH2/PHANTASTICA (ARP) proteins to repress KNOX expression is conserved between the two species, but in C. hirsuta the ARP-KNOX regulatory module controls new developmental processes in the leaf. Thus, evolutionary tinkering with KNOX regulation, constrained by ARP function, may have produced diverse leaf forms by modulating growth and differentiation patterns in developing leaf primordia.	Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	University of Oxford	Tsiantis, M (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	miltos.tsiantis@plants.ox.ac.uk						Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; Byrne ME, 2000, NATURE, V408, P967, DOI 10.1038/35050091; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; Chen JJ, 1997, PLANT CELL, V9, P1289, DOI 10.1105/tpc.9.8.1289; Chuck G, 1996, PLANT CELL, V8, P1277, DOI 10.1105/tpc.8.8.1277; Craft J, 2005, PLANT J, V41, P899, DOI 10.1111/j.1365-313X.2005.02342.x; Dinneny JR, 2004, DEVELOPMENT, V131, P1101, DOI 10.1242/dev.00949; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Hareven D, 1996, CELL, V84, P735, DOI 10.1016/S0092-8674(00)81051-X; Hay A, 2003, PLANT PHYSIOL, V131, P1671, DOI 10.1104/pp.102.017434; Kim JY, 2003, DEVELOPMENT, V130, P4351, DOI 10.1242/dev.00618; Kim M, 2003, NATURE, V424, P438, DOI 10.1038/nature01820; Koch M, 2001, AM J BOT, V88, P534, DOI 10.2307/2657117; Lenhard M, 2002, DEVELOPMENT, V129, P3195; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Ori N, 2000, DEVELOPMENT, V127, P5523; Scanlon MJ, 1996, DEVELOPMENT, V122, P1683; Schneeberger R, 1998, DEVELOPMENT, V125, P2857; SMITH LG, 1992, DEVELOPMENT, V116, P21; Theodoris G, 2003, P NATL ACAD SCI USA, V100, P6837, DOI 10.1073/pnas.1132113100; Timmermans MCP, 1999, SCIENCE, V284, P151, DOI 10.1126/science.284.5411.151; Tsiantis M, 1999, SCIENCE, V284, P154, DOI 10.1126/science.284.5411.154; Waites R, 1998, CELL, V93, P779, DOI 10.1016/S0092-8674(00)81439-7; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Xu L, 2003, DEVELOPMENT, V130, P4097, DOI 10.1242/dev.00622	26	276	297	5	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2006	38	8					942	947		10.1038/ng1835	http://dx.doi.org/10.1038/ng1835			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	067TO	16823378				2022-12-27	WOS:000239325700026
J	Rees, MI; Harvey, K; Pearce, BR; Chung, SK; Duguid, IC; Thomas, P; Beatty, S; Graham, GE; Armstrong, L; Shiang, R; Abbott, KJ; Zuberi, SM; Stephenson, JBP; Owen, MJ; Tijssen, MAJ; van den Maagdenberg, AMJM; Smart, TG; Supplisson, S; Harvey, RJ				Rees, Mark I.; Harvey, Kirsten; Pearce, Brian R.; Chung, Seo-Kyung; Duguid, Ian C.; Thomas, Philip; Beatty, Sarah; Graham, Gail E.; Armstrong, Linlea; Shiang, Rita; Abbott, Kim J.; Zuberi, Sameer M.; Stephenson, John B. P.; Owen, Michael J.; Tijssen, Marina A. J.; van den Maagdenberg, Arn M. J. M.; Smart, Trevor G.; Supplisson, Stephane; Harvey, Robert J.			Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease	NATURE GENETICS			English	Article							INHIBITORY GLYCINE RECEPTOR; GABA TRANSPORTER; DIFFERENT STOICHIOMETRIES; XENOPUS OOCYTES; HYPEREKPLEXIA; EXPRESSION; PROTEIN; LOCALIZATION; PHENOTYPE; INTERACTS	Hyperekplexia is a human neurological disorder characterized by an excessive startle response and is typically caused by missense and nonsense mutations in the gene encoding the inhibitory glycine receptor (GlyR) alpha 1 subunit (GLRA1)(1-3). Genetic heterogeneity has been confirmed in rare sporadic cases, with mutations affecting other postsynaptic glycinergic proteins including the GlyR beta subunit (GLRB) 4, gephyrin (GPHN)(5) and RhoGEF collybistin (ARHGEF9)(6). However, many individuals diagnosed with sporadic hyperekplexia do not carry mutations in these genes(2-7). Here we show that missense, nonsense and frameshift mutations in SLC6A5 (ref. 8), encoding the presynaptic glycine transporter 2 (GlyT2), also cause hyperekplexia. Individuals with mutations in SLC6A5 present with hypertonia, an exaggerated startle response to tactile or acoustic stimuli, and life-threatening neonatal apnea episodes. SLC6A5 mutations result in defective subcellular GlyT2 localization, decreased glycine uptake or both, with selected mutations affecting predicted glycine and Na(+) binding sites.	Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; Univ Coll Swansea, Sch Med, Swansea SA2 8PP, W Glam, Wales; Univ Auckland, Fac Med & Hlth Sci, Dept Mol Med, Auckland 1, New Zealand; UCL, Dept Pharmacol, London WC1E 6BT, England; Childrens & Womens Hlth Ctr British, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; Virginia Commonwealth Univ, Med Ctr, Dept Human Genet, Richmond, VA 23298 USA; Womens & Childrens Hosp, Adelaide, SA, Australia; Royal Hosp Sick Children, Fraser Allander Neurosci Unit, Glasgow G3 8SJ, Lanark, Scotland; Univ Wales Coll Cardiff, Coll Med, Cardiff CF14 4XN, Wales; Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1100 DD Amsterdam, Netherlands; Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; Ecole Normale Super, CNRS, Neurobiol Lab, UMR8544, F-75005 Paris, France	University of London; University College London; University of London School of Pharmacy; Swansea University; University of Auckland; University of London; University College London; Virginia Commonwealth University; Womens & Childrens Hospital Australia; University of Glasgow; Cardiff University; University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Harvey, RJ (corresponding author), Sch Pharm, Dept Pharmacol, 29-39 Brunswick Sq, London WC1N 1AX, England.	m.i.rees@swansea.ac.uk; robert.harvey@pharmacy.ac.uk	Chung, Seo-Kyung/I-3329-2017; Chung, Seo-Kyung/AAT-4693-2021; Rees, Mark I/J-3129-2012; van den Maagdenberg, Arn M.J.M./AAE-9052-2019; SUPPLISSON, Stéphane/L-6658-2017; Harvey, Robert/D-3994-2016; SUPPLISSON, Stéphane/AAD-7482-2019	Chung, Seo-Kyung/0000-0002-5008-8384; Chung, Seo-Kyung/0000-0002-5008-8384; Rees, Mark I/0000-0003-3570-5986; SUPPLISSON, Stéphane/0000-0002-0062-9752; Harvey, Robert/0000-0001-5956-6664; SUPPLISSON, Stéphane/0000-0002-0062-9752; Armstrong, Linlea/0000-0002-8191-6429; Duguid, Ian/0000-0001-6966-2641	Medical Research Council [G0400869, G9810900, G0601585(79887), G9603438, G0601585] Funding Source: Medline; MRC [G0400869, G9810900, G9603438] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barker Eric L., 1995, P321; Eulenburg V, 2005, TRENDS BIOCHEM SCI, V30, P325, DOI 10.1016/j.tibs.2005.04.004; Gabernet L, 2005, NEUROSCI LETT, V373, P79, DOI 10.1016/j.neulet.2004.09.064; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Hahn KA, 2002, AM J HUM GENET, V70, P1349, DOI 10.1086/340092; Hahn M. K., 2002, Pharmacogenomics Journal, V2, P217, DOI 10.1038/sj.tpj.6500106; Hahn MK, 2005, MOL PHARMACOL, V68, P457, DOI 10.1124/mol.105.011270; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Horiuchi M, 2005, J NEUROCHEM, V94, P307, DOI 10.1111/j.1471-4159.2005.03198.x; Horiuchi M, 2001, P NATL ACAD SCI USA, V98, P1448, DOI 10.1073/pnas.041329498; Krogsgaard-Larsen P, 2000, CURR PHARM DESIGN, V6, P1193, DOI 10.2174/1381612003399608; Mager S, 1996, J NEUROSCI, V16, P5405; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Morrow JA, 1998, FEBS LETT, V439, P334, DOI 10.1016/S0014-5793(98)01390-8; Ohno K, 2004, MOL CELL NEUROSCI, V26, P518, DOI 10.1016/j.mcn.2004.04.007; Rees MI, 2003, J BIOL CHEM, V278, P24688, DOI 10.1074/jbc.M301070200; Rees MI, 2002, HUM MOL GENET, V11, P853, DOI 10.1093/hmg/11.7.853; Rees MI, 2001, HUM GENET, V109, P267, DOI 10.1007/s004390100569; Richerson GB, 2004, ADV EXP MED BIOL, V548, P76; Rosen GM, 2005, SLEEP MED, V6, P75, DOI 10.1016/j.sleep.2004.08.010; Roux MJ, 2000, NEURON, V25, P373, DOI 10.1016/S0896-6273(00)80901-0; Roux MJ, 2001, J BIOL CHEM, V276, P17699, DOI 10.1074/jbc.M009196200; SHIANG R, 1995, ANN NEUROL, V38, P85, DOI 10.1002/ana.410380115; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; Supplisson S, 2002, FEBS LETT, V529, P93, DOI 10.1016/S0014-5793(02)03251-9; Tsai G, 2004, P NATL ACAD SCI USA, V101, P8485, DOI 10.1073/pnas.0402662101; Tunnicliff G, 2003, J BIOMED SCI, V10, P30, DOI 10.1159/000068084; Vergouwe MN, 1997, CLIN NEUROL NEUROSUR, V99, P172, DOI 10.1016/S0303-8467(97)00022-X; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	30	163	173	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2006	38	7					801	806		10.1038/ng1814	http://dx.doi.org/10.1038/ng1814			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	058MO	16751771	Green Accepted			2022-12-27	WOS:000238669300016
J	Arking, DE; Pfeufer, A; Post, W; Kao, WHL; Newton-Cheh, C; Ikeda, M; West, K; Kashuk, C; Akyol, M; Perz, S; Jalilzadeh, S; Illig, T; Gieger, C; Guo, CY; Larson, MG; Wichmann, HE; Marban, E; O'Donnell, CJ; Hirschhorn, JN; Kaab, S; Spooner, PM; Meitinger, T; Chakravarti, A				Arking, Dan E.; Pfeufer, Arne; Post, Wendy; Kao, W. H. Linda; Newton-Cheh, Christopher; Ikeda, Morna; West, Kristen; Kashuk, Carl; Akyol, Mahmut; Perz, Siegfried; Jalilzadeh, Shapour; Illig, Thomas; Gieger, Christian; Guo, Chao-Yu; Larson, Martin G.; Wichmann, H. Erich; Marban, Eduardo; O'Donnell, Christopher J.; Hirschhorn, Joel N.; Kaeaeb, Stefan; Spooner, Peter M.; Meitinger, Thomas; Chakravarti, Aravinda			A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization	NATURE GENETICS			English	Article							NITRIC-OXIDE SYNTHASE; CORONARY-HEART-DISEASE; FACTOR-H POLYMORPHISM; ALL-CAUSE MORTALITY; QT-INTERVAL; MACULAR DEGENERATION; CARDIOVASCULAR MORTALITY; QUANTITATIVE TRAIT; ELDERLY-MEN; K+ CHANNEL	Extremes of the electrocardiographic QT interval, a measure of cardiac repolarization, are associated with increased cardiovascular mortality. We identified a common genetic variant influencing this quantitative trait through a genome-wide association study on 200 subjects at the extremes of a population-based QT interval distribution of 3,966 subjects from the KORA cohort in Germany, with follow-up screening of selected markers in the remainder of the cohort. We validated statistically significant findings in two independent samples of 2,646 subjects from Germany and 1,805 subjects from the US Framingham Heart Study. This genome-wide study identified NOS1AP ( CAPON), a regulator of neuronal nitric oxide synthase, as a new target that modulates cardiac repolarization. Approximately 60% of subjects of European ancestry carry at least one minor allele of the NOS1AP genetic variant, which explains up to 1.5% of QT interval variation.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; GSF, Natl Res Ctr Environm & Hlth, Inst Human Genet, D-85764 Neuherberg, Germany; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; Harvard Univ, Broad Inst, Cambridge, MA 02139 USA; MIT, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; GSF, Natl Res Ctr Environm & Hlth, Inst Epidemiol, D-85764 Neuherberg, Germany; Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; Univ Munich, Inst Informat Management Biometry & Epidemiol, D-81377 Munich, Germany; Childrens Hosp, Div Genet, Boston, MA 02115 USA; Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; Childrens Hosp, Program Genom, Boston, MA 02115 USA; Univ Munich, Dept Med 1, D-81377 Munich, Germany; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins University; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Boston University; University of Munich; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Munich; Harvard University; Harvard Medical School	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	aravinda@jhmi.edu	AKYOL, Mahmut/C-2490-2016; Meitinger, Thomas/O-1318-2015; Kaab, Stefan/H-3915-2012; Pfeufer, Arne/B-6634-2013; Marban, Eduardo/GWC-8514-2022; Wichmann, Heinz Erich/AAA-5695-2022	AKYOL, Mahmut/0000-0003-1156-5384; Larson, Martin/0000-0002-9631-1254; Meitinger, Thomas/0000-0002-8838-8403; Guo, Chao-Yu/0000-0002-9066-9933; Gieger, Christian/0000-0001-6986-9554	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066582, K23HL080025] Funding Source: NIH RePORTER; NHLBI NIH HHS [K23HL080025, N01-HC-25195, 5U01HL066582] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BAILEY JJ, 1990, CIRCULATION, V81, P730, DOI 10.1161/01.CIR.81.2.730; Bezzina CR, 2003, CARDIOVASC RES, V59, P27, DOI 10.1016/S0008-6363(03)00342-0; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Busjahn A, 1999, CIRCULATION, V99, P3161, DOI 10.1161/01.CIR.99.24.3161; Carter N, 2000, J HUM HYPERTENS, V14, P389, DOI 10.1038/sj.jhh.1001026; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; de Bruyne MC, 1999, EUR HEART J, V20, P278, DOI 10.1053/euhj.1998.1276; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; DEKKER JM, 1994, CIRCULATION, V90, P779, DOI 10.1161/01.CIR.90.2.779; Dekker JM, 2004, J AM COLL CARDIOL, V43, P565, DOI 10.1016/j.jacc.2003.09.040; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Elming H, 1998, EUR HEART J, V19, P1391, DOI 10.1053/euhj.1998.1094; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Khan SA, 2004, P NATL ACAD SCI USA, V101, P15944, DOI 10.1073/pnas.0404136101; Kim E, 1996, NEUROPHARMACOLOGY, V35, P993, DOI 10.1016/0028-3908(96)00093-7; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klugbauer N, 2003, J BIOENERG BIOMEMBR, V35, P639, DOI 10.1023/B:JOBB.0000008028.41056.58; Leonoudakis D, 2001, J CELL SCI, V114, P987; Lesage F, 1996, EMBO J, V15, P1004, DOI 10.1002/j.1460-2075.1996.tb00437.x; Massion PB, 2005, COMP BIOCHEM PHYS A, V142, P144, DOI 10.1016/j.cbpb.2005.05.048; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; Mortara D W, 1992, J Electrocardiol, V25 Suppl, P200, DOI 10.1016/0022-0736(92)90102-6; Murata M, 2001, AM J PHYSIOL-HEART C, V281, pH2575, DOI 10.1152/ajpheart.2001.281.6.H2575; Newton-Cheh C, 2005, HEART RHYTHM, V2, P277, DOI 10.1016/j.hrthm.2004.11.009; Okin PM, 2000, CIRCULATION, V101, P61, DOI 10.1161/01.CIR.101.1.61; Page GP, 1999, AM J HUM GENET, V64, P1194, DOI 10.1086/302331; PERZ S, 2004, ANAL BIOMEDICAL SIGN, V17, P47; Pfeufer A, 2005, CIRC RES, V96, P693, DOI 10.1161/01.RES.0000161077.53751.e6; Priori SG, 2004, ANN NY ACAD SCI, V1015, P96, DOI 10.1196/annals.1302.008; Risch NJ, 1996, AM J HUM GENET, V58, P836; Robertson A., 1967, Heritage from Mendel., P265; Satagopan JM, 2004, BIOMETRICS, V60, P589, DOI 10.1111/j.0006-341X.2004.00207.x; SCHOUTEN EG, 1991, CIRCULATION, V84, P1516, DOI 10.1161/01.CIR.84.4.1516; Sharp DS, 1998, ANN EPIDEMIOL, V8, P99, DOI 10.1016/S1047-2797(97)00121-X; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Weir BS., 1996, GENETIC DATA ANAL; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Yang P, 2002, CIRCULATION, V105, P1943, DOI 10.1161/01.CIR.0000014448.19052.4C	45	403	416	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					644	651		10.1038/ng1790	http://dx.doi.org/10.1038/ng1790			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16648850				2022-12-27	WOS:000237954800017
J	Pe'er, I; de Bakker, PIW; Maller, J; Yelensky, R; Altshuler, D; Daly, MJ				Pe'er, Itsik; de Bakker, Paul I. W.; Maller, Julian; Yelensky, Roman; Altshuler, David; Daly, Mark J.			Evaluating and improving power in whole-genome association studies using fixed marker sets	NATURE GENETICS			English	Article							LINKAGE-DISEQUILIBRIUM; WIDE ASSOCIATION; COMPLEX TRAITS; TAGGING SNPS; DISEASE; POLYMORPHISM; MODELS; FUTURE; GENES; TESTS	Emerging technologies make it possible for the first time to genotype hundreds of thousands of SNPs simultaneously, enabling whole-genome association studies. Using empirical genotype data from the International HapMap Project, we evaluate the extent to which the sets of SNPs contained on three whole-genome genotyping arrays capture common SNPs across the genome, and we find that the majority of common SNPs are well captured by these products either directly or through linkage disequilibrium. We explore analytical strategies that use HapMap data to improve power of association studies conducted with these fixed sets of markers and show that limited inclusion of specific haplotype tests in association analysis can increase the fraction of common variants captured by 25-100%. Finally, we introduce a Bayesian approach to association analysis by weighting the likelihood of each statistical test to reflect the number of putative causal alleles to which it is correlated.	Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Daly, MJ (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	altshul@broad.mit.edu; mjdaly@chgr.mgh.harvard.edu	de Bakker, Paul IW/B-8730-2009; maller, julian B/A-9323-2009; Altshuler, David M/A-4476-2009; Daly, Mark J/B-2453-2017	de Bakker, Paul IW/0000-0001-7735-7858; Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; Maller, Julian/0000-0002-1565-9559				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Kruglyak L, 2005, NAT GENET, V37, P1299, DOI 10.1038/ng1205-1299; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Matsuzaki H, 2004, NAT METHODS, V1, P109, DOI 10.1038/nmeth718; Pe'er I, 2006, AM J HUM GENET, V78, P588, DOI 10.1086/502803; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Sham PC, 2000, AM J HUM GENET, V66, P1616, DOI 10.1086/302891; Stram DO, 2003, HUM HERED, V55, P27, DOI 10.1159/000071807; Weale ME, 2003, AM J HUM GENET, V73, P551, DOI 10.1086/378098; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158	30	220	247	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2006	38	6					663	667		10.1038/ng1816	http://dx.doi.org/10.1038/ng1816			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	048NW	16715096				2022-12-27	WOS:000237954800020
J	Bonnen, PE; Pe'er, I; Plenge, RM; Salit, J; Lowe, JK; Shapero, MH; Lifton, RP; Breslow, JL; Daly, MJ; Reich, DE; Jones, KW; Stoffel, M; Altshuler, D; Friedman, JM				Bonnen, PE; Pe'er, I; Plenge, RM; Salit, J; Lowe, JK; Shapero, MH; Lifton, RP; Breslow, JL; Daly, MJ; Reich, DE; Jones, KW; Stoffel, M; Altshuler, D; Friedman, JM			Evaluating potential for whole-genome studies in Kosrae, an isolated population in Micronesia	NATURE GENETICS			English	Article							COMMON DISEASE GENES; LINKAGE-DISEQUILIBRIUM; ASSOCIATION; TESTS; PATTERNS; FINLAND; TRAITS; LOCI	Whole-genome association studies are predicted to be especially powerful in isolated populations owing to increased linkage disequilibrium (LD) and decreased allelic diversity, but this possibility has not been empirically tested(1-3). We compared genome-wide data on 113,240 SNPs typed on 30 trios from the Pacific island of Kosrae to the same markers typed in the 270 samples from the International HapMap Project(4,5). The extent of LD is longer and haplotype diversity is lower in Kosrae than in the HapMap populations. More than 98% of Kosraen haplotypes are present in HapMap populations, indicating that HapMap will be useful for genetic studies on Kosrae. The long-range LD around common alleles and limited diversity result in improved efficiency in genetic studies in this population and augments the power to detect association of 'hidden SNPs'.	Rockefeller Univ, New York, NY 10021 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Harvard Univ, Broad Inst, Cambridge, MA 02138 USA; MIT, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Affymetrix Inc, Santa Clara, CA 95051 USA; Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Rockefeller University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Affymetrix; Yale University; Yale University; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Friedman, JM (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	friedj@rockefeller.edu	Altshuler, David M/A-4476-2009; Breslow, Jan L/B-7544-2008; Daly, Mark J/B-2453-2017	Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; Stoffel, Markus/0000-0003-1304-5817				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Angius A, 2002, HUM GENET, V111, P9, DOI 10.1007/s00439-002-0753-z; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; CHURCHILL GA, 1994, GENETICS, V138, P963; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; Doerge RW, 1996, GENETICS, V142, P285; Eaves IA, 2000, NAT GENET, V25, P320; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; JORDE LB, 1995, AM J HUM GENET, V56, P11; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; Lee N, 2001, AM J HUM GENET, V68, P397, DOI 10.1086/318197; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Ober C, 2001, AM J HUM GENET, V69, P1068, DOI 10.1086/324025; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SEGAL HG, 1995, SLEEPING LADY AWAKEN; Shifman S, 2003, HUM MOL GENET, V12, P771, DOI 10.1093/hmg/ddg088; Shifman S, 2001, NAT GENET, V28, P309, DOI 10.1038/91060; SHMULEWITZ D, IN PRESS P NATL ACAD; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Van Steen K, 2005, NAT GENET, V37, P683, DOI 10.1038/ng1582; Wilk JB, 2001, GENET EPIDEMIOL, V21, pS364, DOI 10.1002/gepi.2001.21.s1.s364; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501; Zhang J, 2005, GENET EPIDEMIOL, V29, P128, DOI 10.1002/gepi.20081	27	54	54	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					214	217		10.1038/ng1712	http://dx.doi.org/10.1038/ng1712			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16429162				2022-12-27	WOS:000234953200017
J	Malek, RL; Wang, HY; Kwitek, AE; Greene, AS; Bhagabati, N; Borchardt, G; Cahill, L; Currier, T; Frank, B; Fu, XP; Hasinoff, M; Howe, E; Letwin, N; Luu, TV; Saeed, A; Sajadi, H; Salzberg, SL; Sultana, R; Thiagarajan, M; Tsai, J; Veratti, K; White, J; Quackenbush, J; Jacob, HJ; Lee, NH				Malek, RL; Wang, HY; Kwitek, AE; Greene, AS; Bhagabati, N; Borchardt, G; Cahill, L; Currier, T; Frank, B; Fu, XP; Hasinoff, M; Howe, E; Letwin, N; Luu, TV; Saeed, A; Sajadi, H; Salzberg, SL; Sultana, R; Thiagarajan, M; Tsai, J; Veratti, K; White, J; Quackenbush, J; Jacob, HJ; Lee, NH			Physiogenomic resources for rat models of heart, lung and blood disorders	NATURE GENETICS			English	Article							HYPERTENSION; GENES; MAP; SINGLE	Cardiovascular disorders are influenced by genetic and environmental factors. The TIGR rodent expression web-based resource (TREX) contains over 2,200 microarray hybridizations, involving over 800 animals from 18 different rat strains. These strains comprise genetically diverse parental animals and a panel of chromosomal substitution strains derived by introgressing individual chromosomes from normotensive Brown Norway (BN/NHsdMcwi) rats into the background of Dahl salt sensitive (SS/JrHsdMcwi) rats. The profiles document gene-expression changes in both genders, four tissues ( heart, lung, liver, kidney) and two environmental conditions (normoxia, hypoxia). This translates into almost 400 high-quality direct comparisons ( not including replicates) and over 100,000 pairwise comparisons. As each individual chromosomal substitution strain represents on average less than a 5% change from the parental genome, consomic strains provide a useful mechanism to dissect complex traits and identify causative genes. We performed a variety of data-mining manipulations on the profiles and used complementary physiological data from the PhysGen resource to demonstrate how TREX can be used by the cardiovascular community for hypothesis generation.	TREX Inst Genom Res, Rockville, MD 20850 USA; Med Coll Wisconsin, PhysGen, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Lee, NH (corresponding author), TREX Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	nhlee@tigr.org	Salzberg, Steven/Q-6514-2019; Greene, Andrew S/B-9696-2015; Salzberg, Steven L/F-6162-2011	Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432; Kwitek, Anne/0000-0003-1024-4116; Quackenbush, John/0000-0002-2702-5879; Greene, Andrew/0000-0002-3191-2112	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066619] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006845] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01 HL066619-04S1, U01 HL066619] Funding Source: Medline; NLM NIH HHS [R01 LM006845-08, R01 LM006845] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Chen YF, 1997, HYPERTENSION, V29, P75, DOI 10.1161/01.HYP.29.1.75; Cowley AW, 2001, HYPERTENSION, V37, P456, DOI 10.1161/01.HYP.37.2.456; Cui ZH, 1997, ALLERGY, V52, P739, DOI 10.1111/j.1398-9995.1997.tb01231.x; de la Cruz N, 2005, NUCLEIC ACIDS RES, V33, pD485, DOI 10.1093/nar/gki050; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GROVER RF, 1963, AM HEART J, V66, P1, DOI 10.1016/0002-8703(63)90062-0; Guryev V, 2004, GENOME RES, V14, P1438, DOI 10.1101/gr.2154304; Hoshikawa Y, 2003, PHYSIOL GENOMICS, V12, P209, DOI 10.1152/physiolgenomics.00081.2001; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; KUIJPERS MHM, 1986, J HYPERTENS, V4, pS41; Kwitek-Black A E, 2001, Curr Hypertens Rep, V3, P12, DOI 10.1007/s11906-001-0072-0; Madjdpour C, 2003, AM J PHYSIOL-LUNG C, V284, pL360, DOI 10.1152/ajplung.00158.2002; Malek RL, 2001, J BIOL CHEM, V276, P5692, DOI 10.1074/jbc.M003964200; Molthen RC, 2004, J APPL PHYSIOL, V97, P2372, DOI 10.1152/japplphysiol.00454.2004; Moreno C, 2003, PHYSIOL GENOMICS, V15, P243, DOI 10.1152/physiolgenomics.00105.2003; Rapp JP, 2000, PHYSIOL REV, V80, P135, DOI 10.1152/physrev.2000.80.1.135; Rozen S, 2000, Methods Mol Biol, V132, P365; Steen RG, 1999, GENOME RES, V9, pAP1; Stoll M, 2001, SCIENCE, V294, P1723, DOI 10.1126/science.1062117; Thomas MA, 2003, MAMM GENOME, V14, P61, DOI 10.1007/s00335-002-2204-5; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Twigger SN, 2004, GENOME RES, V14, P651, DOI 10.1101/gr.1974504; Wildhirt SM, 1999, CARDIOVASC RES, V43, P698, DOI 10.1016/S0008-6363(99)00080-2; Zan YH, 2003, NAT BIOTECHNOL, V21, P645, DOI 10.1038/nbt830; Zimdahl H, 2004, SCIENCE, V303, P807, DOI 10.1126/science.1092427	30	40	42	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2006	38	2					234	239		10.1038/ng1693	http://dx.doi.org/10.1038/ng1693			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	007FE	16415889				2022-12-27	WOS:000234953200021
J	Cam, HP; Sugiyama, T; Chen, ES; Chen, X; FitzGerald, PC; Grewal, SIS				Cam, HP; Sugiyama, T; Chen, ES; Chen, X; FitzGerald, PC; Grewal, SIS			Comprehensive analysis of heterochromatin- and RNAi-mediated epigenetic control of the fission yeast genome	NATURE GENETICS			English	Article							HISTONE LYSINE METHYLATION; SCHIZOSACCHAROMYCES-POMBE; TRANSPOSABLE ELEMENTS; CHROMODOMAIN PROTEIN; DNA METHYLATION; H3 METHYLATION; INTERFERENCE; DISTINCT; DOMAIN; POLYMERASE	The organization of eukaryotic genomes into distinct structural and functional domains is important for the regulation and transduction of genetic information. Here, we investigated heterochromatin and euchromatin profiles of the entire fission yeast genome and explored the role of RNA interference (RNAi) in genome organization. Histone H3 methylated at Lys4, which defines euchromatin, was not only distributed across most of the chromosomal landscape but was also present at the centromere core, the site of kinetochore assembly. In contrast, histone H3 methylated at Lys9 and its interacting protein Swi6/HP1, which define heterochromatin, coated extended domains associated with a variety of repeat elements and small islands corresponding to meiotic genes. Notably, RNAi components were distributed throughout all these heterochromatin domains, and their localization depended on Clr4/Suv39h histone methyltransferase. Sequencing of small interfering RNAs (siRNAs) associated with the RITS RNAi effector complex identified hot spots of siRNAs, which mapped to a diverse array of elements in these RNAi-heterochromatin domains. We found that Clr4/Suv39h predominantly silenced repeat elements whose derived transcripts, transcribed mainly by RNA polymerase II, serve as a source for siRNAs. Our analyses also uncover an important role for the RNAi machinery in maintaining genomic integrity.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA; NCI, Genome Anal Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Grewal, SIS (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	grewals@mail.nih.gov		Sugiyama, Tomoyasu/0000-0001-5704-6606	NATIONAL CANCER INSTITUTE [ZIABC010523, Z01BC010523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059772] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bowen NJ, 2003, GENOME RES, V13, P1984, DOI 10.1101/gr.1191603; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Grewal SIS, 2004, CURR OPIN CELL BIOL, V16, P230, DOI 10.1016/j.ceb.2004.04.002; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Jia ST, 2004, CELL, V119, P469, DOI 10.1016/j.cell.2004.10.020; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; KANNO T, 2005, NAT GENET       0529; Kanoh J, 2001, CURR BIOL, V11, P1624, DOI 10.1016/S0960-9822(01)00503-6; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Mandell JG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r1; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Mochizuki K, 2004, CURR OPIN GENET DEV, V14, P181, DOI 10.1016/j.gde.2004.01.004; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Partridge JF, 2000, GENE DEV, V14, P783; Petrie VJ, 2005, MOL CELL BIOL, V25, P2331, DOI 10.1128/MCB.25.6.2331-2346.2005; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Sullivan BA, 2004, NAT STRUCT MOL BIOL, V11, P1076, DOI 10.1038/nsmb845; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Thon G, 2000, GENETICS, V155, P551; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	49	381	395	0	15	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2005	37	8					809	819		10.1038/ng1602	http://dx.doi.org/10.1038/ng1602			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	950TK	15976807				2022-12-27	WOS:000230880400010
J	Davies, W; Isles, A; Smith, R; Karunadasa, D; Burrmann, D; Humby, T; Ojarikre, O; Biggin, C; Skuse, D; Burgoyne, P; Wilkinson, L				Davies, W; Isles, A; Smith, R; Karunadasa, D; Burrmann, D; Humby, T; Ojarikre, O; Biggin, C; Skuse, D; Burgoyne, P; Wilkinson, L			Xlr3b is a new imprinted candidate for X-linked parent-of-origin effects on cognitive function in mice	NATURE GENETICS			English	Article							TURNERS-SYNDROME; CHROMOSOME; MOUSE; SEQUENCE; GENOME; AUTISM; GENES; BRAIN; SCHIZOPHRENIA; REGIONS	Imprinted genes show differential expression between maternal and paternal alleles as a consequence of epigenetic modification that can result in 'parent-of-origin' effects on phenotypic traits(1). There is increasing evidence from mouse and human studies that imprinted genes may influence behavior and cognitive functioning(2). Previous work in girls with Turner syndrome (45,XO) has suggested that there are X-linked parent-of-origin effects on brain development(3) and cognitive functioning(4), although the interpretation of these data in terms of imprinted gene effects has been questioned(5). We used a 39,XO mouse model to examine the influence of the parental origin of the X chromosome on cognitive behaviors and expression of X-linked genes in brain. Our findings confirm the existence of X-linked imprinted effects on cognitive processes and identify a new maternally expressed imprinted gene candidate on the X chromosome, Xlr3b, which may be of importance in mediating the behavioral effects.	Babraham Inst, Lab Cognit & Behav Neurosci, Cambridge CB2 4AT, England; Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB2 4AT, England; Natl Inst Med Res, MRC, Div Dev Genet, London NW7 1AA, England; Inst Child Hlth, Behav Sci Unit, London WC1N 1EH, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; MRC National Institute for Medical Research; University of London; University College London	Wilkinson, L (corresponding author), Babraham Inst, Lab Cognit & Behav Neurosci, Babraham Res Campus, Cambridge CB2 4AT, England.	lawrence.wilkinson@bbsrc.ac.uk	Davies, William/A-8006-2009; Humby, Trevor/A-1698-2010	Davies, William/0000-0002-7714-2440; Isles, Anthony/0000-0002-7587-5712; HUMBY, trevor/0000-0002-1840-1799	MRC [MC_U117532009] Funding Source: UKRI; Medical Research Council [MC_U117532009] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BERGSAGEL PL, 1994, GENE, V150, P345, DOI 10.1016/0378-1119(94)90450-2; Burgoyne PS, 2000, CYTOGENET CELL GENET, V91, P57, DOI 10.1159/000056819; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P920, DOI 10.1037/0735-7044.111.5.920; Crider A, 1997, SCHIZOPHRENIA BULL, V23, P63, DOI 10.1093/schbul/23.1.63; EVANS EP, 1975, NATURE, V256, P40, DOI 10.1038/256040a0; Ford CE, 1966, TISSUE GRAFTING RADI, P197; Haig D, 2000, ANNU REV ECOL SYST, V31, P9, DOI 10.1146/annurev.ecolsys.31.1.9; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Henn W, 1997, NATURE, V390, P569, DOI 10.1038/37514; Hill EL, 2003, PHILOS T R SOC B, V358, P281, DOI 10.1098/rstb.2002.1209; Ishikawa H, 2003, BIOL REPROD, V69, P483, DOI 10.1095/biolreprod.102.012641; Isles AR, 2000, TRENDS COGN SCI, V4, P309, DOI 10.1016/S1364-6613(00)01504-7; Jamieson RV, 1998, DEV BIOL, V201, P13, DOI 10.1006/dbio.1998.8972; Ke XY, 2002, MAMM GENOME, V13, P639, DOI 10.1007/s00335-002-3038-x; Kesler SR, 2003, BIOL PSYCHIAT, V54, P636, DOI 10.1016/S0006-3223(03)00289-0; Lercher MJ, 2003, GENETICS, V165, P1629; Levin ML, 1996, GENOME RES, V6, P465, DOI 10.1101/gr.6.6.465; Lockhart DJ, 2001, NAT REV NEUROSCI, V2, P63, DOI 10.1038/35049070; Mallon AM, 2000, GENOME RES, V10, P758, DOI 10.1101/gr.10.6.758; Martinez-Garay I, 2002, GENOMICS, V80, P259, DOI 10.1006/geno.2002.6834; Milunsky J, 1999, CLIN GENET, V55, P455, DOI 10.1034/j.1399-0004.1999.550610.x; Murray TK, 1999, BEHAV BRAIN RES, V99, P103, DOI 10.1016/S0166-4328(98)00077-1; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Skuse DH, 2000, PEDIATR RES, V47, P9, DOI 10.1203/00006450-200001000-00006; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; Thomas NS, 1999, HUM GENET, V104, P43, DOI 10.1007/s004390050908; THORNHILL AR, 1993, DEVELOPMENT, V118, P171; Zechner U, 2001, TRENDS GENET, V17, P697, DOI 10.1016/S0168-9525(01)02446-5	30	159	161	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					625	629		10.1038/ng1577	http://dx.doi.org/10.1038/ng1577			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15908950				2022-12-27	WOS:000229495300017
J	Thomson, JM; Gaucher, EA; Burgan, MF; De Kee, DW; Li, T; Aris, JP; Benner, SA				Thomson, JM; Gaucher, EA; Burgan, MF; De Kee, DW; Li, T; Aris, JP; Benner, SA			Resurrecting ancestral alcohol dehydrogenases from yeast	NATURE GENETICS			English	Article							GENOME	Modern yeast living in fleshy fruits rapidly convert sugars into bulk ethanol through pyruvate. Pyruvate loses carbon dioxide to produce acetaldehyde, which is reduced by alcohol dehydrogenase 1 (Adh1) to ethanol, which accumulates. Yeast later consumes the accumulated ethanol, exploiting Adh2, an Adh1 homolog differing by 24 ( of 348) amino acids. As many microorganisms cannot grow in ethanol, accumulated ethanol may help yeast defend resources in the fruit(1). We report here the resurrection of the last common ancestor(2) of Adh1 and Adh2, called Adh(A). The kinetic behavior of Adh(A) suggests that the ancestor was optimized to make ( not consume) ethanol. This is consistent with the hypothesis that before the Adh1-Adh2 duplication, yeast did not accumulate ethanol for later consumption but rather used Adh(A) to recycle NADH generated in the glycolytic pathway. Silent nucleotide dating suggests that the Adh1-Adh2 duplication occurred near the time of duplication of several other proteins involved in the accumulation of ethanol, possibly in the Cretaceous age when fleshy fruits arose. These results help to connect the chemical behavior of these enzymes through systems analysis to a time of global ecosystem change, a small but useful step towards a planetary systems biology.	Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; Fdn Appl Mol Evolut, Gainesville, FL 32601 USA; Univ Florida, Dept Chem, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Benner, SA (corresponding author), Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA.	benner@chem.ufl.edu	Gaucher, Eric/I-7313-2013	Aris, John/0000-0002-6475-064X; Green, Michelle/0000-0002-6055-4342	NATIONAL INSTITUTE ON AGING [R21AG023719] Funding Source: NIH RePORTER; NIA NIH HHS [R21 AG023719-02] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ashburner M, 1998, BIOESSAYS, V20, P949, DOI 10.1002/(SICI)1521-1878(199811)20:11&lt;949::AID-BIES10&gt;3.0.CO;2-0; Barrett PM, 2001, BIOL REV, V76, P411, DOI 10.1017/S1464793101005735; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Benner SA, 2003, ADV ENZYME REGUL, V43, P271, DOI 10.1016/S0065-2571(02)00024-9; Benner SA, 2002, SCIENCE, V296, P864, DOI 10.1126/science.1069863; BERBEE ML, 1993, CAN J BOT, V71, P1114, DOI 10.1139/b93-131; Boulton R.B., 1996, PRINCIPLES PRACTICES, P139; Bozzi A, 1997, BBA-PROTEIN STRUCT M, V1339, P133, DOI 10.1016/S0167-4838(96)00225-7; COLLINSON ME, 1991, PHILOS T ROY SOC B, V333, P197, DOI 10.1098/rstb.1991.0068; ELLINGTON AD, 1987, J THEOR BIOL, V127, P491, DOI 10.1016/S0022-5193(87)80145-5; Fernandez-Espinar MT, 2003, YEAST, V20, P1213, DOI 10.1002/yea.1034; Fersht AR., 1977, ENZYME STRUCTURE MEC; Fleet G.H., 1993, WINE MICROBIOLOGY BI; GANZHORN AJ, 1987, J BIOL CHEM, V262, P3754; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; KREITMAN M, 1995, ANNU REV ECOL SYST, V26, P403, DOI 10.1146/annurev.es.26.110195.002155; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; McGovern PE, 2004, P NATL ACAD SCI USA, V101, P17593, DOI 10.1073/pnas.0407921102; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; SCHAAFF I, 1989, YEAST, V5, P285, DOI 10.1002/yea.320050408; SEGAL IH, 1975, ENZYME KINETICS; Stryer L., 1988, BIOCHEMISTRY-US; Sun G, 2002, SCIENCE, V296, P899, DOI 10.1126/science.1069439; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; THOMSON JM, 2002, THESIS U FLORIDA GAI; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; WEINHOLD EG, 1991, P NATL ACAD SCI USA, V88, P8420, DOI 10.1073/pnas.88.19.8420; WILLS C, 1976, NATURE, V261, P26, DOI 10.1038/261026a0; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	30	222	232	2	112	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2005	37	6					630	635		10.1038/ng1553	http://dx.doi.org/10.1038/ng1553			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	931OT	15864308	Green Accepted			2022-12-27	WOS:000229495300018
J	Helgason, A; Yngvadottir, B; Hrafnkelsson, B; Gulcher, J; Stefansson, K				Helgason, A; Yngvadottir, B; Hrafnkelsson, B; Gulcher, J; Stefansson, K			An Icelandic example of the impact of population structure on association studies	NATURE GENETICS			English	Article							GENETIC ASSOCIATION; GAELIC ANCESTRY; CONFERS RISK; DIFFERENTIATION; STRATIFICATION; STROKE; MTDNA; DRIFT	The impact of population structure on association studies undertaken to identify genetic variants underlying common human diseases is an issue of growing interest(1-4). Spurious associations of alleles with disease phenotypes may be obtained or true associations overlooked when allele frequencies differ notably among subpopulations that are not represented equally among cases and controls. Population structure influences even carefully designed studies and can affect the validity of association results(1,2). Most study designs address this problem by sampling cases and controls from groups that share the same nationality or self-reported ethnic background, with the implicit assumption that no substructure exists within such groups. We examined population structure in the Icelandic gene pool using extensive genealogical and genetic data. Our results indicate that sampling strategies need to take account of substructure even in a relatively homogenous(5) genetic isolate(6). This will probably be even more important in larger populations.	deCODE Genet, IS-101 Reykjavik, Iceland; Univ Iceland, IS-101 Reykjavik, Iceland	University of Iceland	Helgason, A (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	agnar@decode.is	Stefansson, Kari/AAE-7187-2019; Peng, Bo/A-6920-2009; Helgason, Agnar/K-1522-2015	Peng, Bo/0000-0001-8225-2284; Helgason, Agnar/0000-0002-8545-3767				Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; BARBUJANI G, 1991, AM J HUM GENET, V48, P398; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CLAYTON D, 2001, HDB STAT GENETICS, P519; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; EXCOFFIER L, 1992, GENETICS, V131, P491; Excoffier L, 2001, HDB STAT GENETICS, P271; FALSETTI AB, 1993, ANN HUM BIOL, V20, P215, DOI 10.1080/03014469300002652; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Helgason A, 2003, ANN HUM GENET, V67, P281, DOI 10.1046/j.1469-1809.2003.00046.x; Helgason A, 2003, AM J HUM GENET, V72, P1370, DOI 10.1086/375453; Helgason A, 2001, AM J HUM GENET, V68, P723, DOI 10.1086/318785; JORDE LB, 1982, HUM HERED, V32, P1, DOI 10.1159/000153251; JORDE LB, 1980, CURRENT DEV ANTHR GE, V1, P133; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Nicholson G, 2002, J ROY STAT SOC B, V64, P695, DOI 10.1111/1467-9868.00357; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Steffensen J., 1975, MENNING MEINSEMDIR R; TILLS D, 1982, ANN HUM BIOL, V9, P507, DOI 10.1080/03014468200006041; TILLS D, 1977, HUM HERED, V27, P153, DOI 10.1159/000152865; WILLIAMS JT, 1993, HUM BIOL, V65, P167; WORKMAN PL, 1976, AM J PHYS ANTHROPOL, V44, P341, DOI 10.1002/ajpa.1330440216; Ziv E, 2003, PHARMACOGENOMICS, V4, P431, DOI 10.1517/phgs.4.4.431.22758	30	205	208	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2005	37	1					90	95		10.1038/ng1492	http://dx.doi.org/10.1038/ng1492			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	883FX	15608637				2022-12-27	WOS:000225997500026
J	Yu, WQ; Ginjala, V; Pant, V; Chernukhin, I; Whitehead, J; Docquier, F; Farrar, D; Tavoosidana, G; Mukhopadhyay, R; Kanduri, C; Oshimura, M; Feinberg, AP; Lobanenkov, V; Klenova, E; Ohlsson, R				Yu, WQ; Ginjala, V; Pant, V; Chernukhin, I; Whitehead, J; Docquier, F; Farrar, D; Tavoosidana, G; Mukhopadhyay, R; Kanduri, C; Oshimura, M; Feinberg, AP; Lobanenkov, V; Klenova, E; Ohlsson, R			Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation	NATURE GENETICS			English	Article							IMPRINTING CONTROL REGION; METHYLATION-FREE DOMAINS; PROTEIN CTCF; GENE; H19; EXPRESSION; TRANSCRIPTION; BINDING; PARP; ASSOCIATION	Chromatin insulators demarcate expression domains by blocking the cis effects of enhancers or silencers in a position-dependent manner(1,2). We show that the chromatin insulator protein CTCF carries a post-translational modification: poly(ADP-ribosyl)ation. Chromatin immunoprecipitation analysis showed that a poly(ADP-ribosyl)ation mark, which exclusively segregates with the maternal allele of the insulator domain in the H19 imprinting control region, requires the bases that are essential for interaction with CTCF3. Chromatin immunoprecipitation-on-chip analysis documented that the link between CTCF and poly(ADP-ribosyl)ation extended to more than 140 mouse CTCF target sites. An insulator trap assay showed that the insulator function of most of these CTCF target sites is sensitive to 3-aminobenzamide, an inhibitor of poly(ADP-ribose) polymerase activity. We suggest that poly(ADP-ribosyl)ation imparts chromatin insulator properties to CTCF at both imprinted and nonimprinted loci, which has implications for the regulation of expression domains and their demise in pathological lesions.	Uppsala Univ, Evolut Biol Ctr, Dept Genet & Dev, S-75236 Uppsala, Sweden; Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England; Tottori Univ, Dept Mol & Cellular Biol, Tottori, Japan; Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; NIAID, Mol PAthol Sect, Immunopathol Lab, NIH, Bethesda, MD 20892 USA	Uppsala University; University of Essex; Tottori University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ohlsson, R (corresponding author), Uppsala Univ, Evolut Biol Ctr, Dept Genet & Dev, Norbyvagen 18A, S-75236 Uppsala, Sweden.	Rolf.Ohlsson@ebc.uu.se	Tavoosidana, Gholamreza/AAV-3893-2020; Lobanenkov, Victor V./AGQ-8903-2022; Ginjala, Vasudeva/E-5869-2019; Lobanenkov, Victor/ABD-5710-2021; Whitehead, Joanne/A-8597-2008; Feinberg, Andrew/AAY-7666-2020	Tavoosidana, Gholamreza/0000-0002-1079-7434; Whitehead, Joanne/0000-0002-9602-2081; Feinberg, Andrew/0000-0002-8364-1991; Pant, Vinod/0000-0002-3286-1804; Kanduri, Chandrasekhar/0000-0001-6271-9078; Lobanenkov, Victor/0000-0001-6665-3635	NATIONAL CANCER INSTITUTE [R37CA054358, R01CA054358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000860] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA054358, R37 CA054358, R37 CA054358-14] Funding Source: Medline; Worldwide Cancer Research [99-0514] Funding Source: Medline; Breast Cancer Now [2000:137] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Worldwide Cancer Research; Breast Cancer Now		Allen MD, 2003, J MOL BIOL, V330, P503, DOI 10.1016/S0022-2836(03)00473-X; Bell AC, 2001, SCIENCE, V291, P447, DOI 10.1126/science.291.5503.447; Chernukhin IV, 2000, J BIOL CHEM, V275, P29915, DOI 10.1074/jbc.M001538200; CONSTANZI C, 1998, NATURE, V393, P599; Davidovic L, 2001, EXP CELL RES, V268, P7, DOI 10.1006/excr.2001.5263; Dean W, 1998, DEVELOPMENT, V125, P2273; FRANKLIN GC, 1991, EMBO J, V10, P1365, DOI 10.1002/j.1460-2075.1991.tb07656.x; Holmgren C, 2001, CURR BIOL, V11, P1128, DOI 10.1016/S0960-9822(01)00314-1; Horike S, 2000, HUM MOL GENET, V9, P2075, DOI 10.1093/hmg/9.14.2075; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kanduri C, 2000, CURR BIOL, V10, P449, DOI 10.1016/S0960-9822(00)00442-5; Kanduri C, 2002, CANCER RES, V62, P4545; Kanduri C, 2002, J BIOL CHEM, V277, P18106, DOI 10.1074/jbc.M200031200; Kanduri M, 2002, MOL CELL BIOL, V22, P3339, DOI 10.1128/MCB.22.10.3339-3344.2002; KLENOVA EM, 1993, MOL CELL BIOL, V13, P7612, DOI 10.1128/MCB.13.12.7612; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Li YM, 1998, J BIOL CHEM, V273, P28247, DOI 10.1074/jbc.273.43.28247; Lynch Catherine A, 2002, Mol Cancer, V1, P2, DOI 10.1186/1476-4598-1-2; MIRANDA EA, 1995, BIOCHEM BIOPH RES CO, V212, P317, DOI 10.1006/bbrc.1995.1972; Mukhopadhyay R, 2004, GENOME RES, V14, P1594, DOI 10.1101/gr.2408304; OHLSSON R, 1989, EMBO J, V8, P1993, DOI 10.1002/j.1460-2075.1989.tb03606.x; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Quitschke WW, 2000, NUCLEIC ACIDS RES, V28, P3370, DOI 10.1093/nar/28.17.3370; Sallmann FR, 2000, J BIOL CHEM, V275, P15504, DOI 10.1074/jbc.275.20.15504; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tulin A, 2002, GENE DEV, V16, P2108, DOI 10.1101/gad.1003902; YUSUFZAI T, 2001, MOL CELL, V13, P291; Ziegler M, 2001, BIOESSAYS, V23, P543, DOI 10.1002/bies.1074	30	206	212	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2004	36	10					1105	1110		10.1038/ng1426	http://dx.doi.org/10.1038/ng1426			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	857YN	15361875	Bronze			2022-12-27	WOS:000224156500020
J	Mehta, T; Tanik, M; Allison, DB				Mehta, T; Tanik, M; Allison, DB			Towards sound epistemological foundations of statistical methods for high-dimensional biology	NATURE GENETICS			English	Article							MICROARRAY EXPRESSION DATA; GENE-EXPRESSION; INFORMATION; DISSECTION; GUIDELINES; SELECTION; TESTS; BIAS		Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Dept Elect & Comp Engn, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Clin Nutr Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Allison, DB (corresponding author), Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Ryals Publ Hlth Bldg,Suite 327,1665 Univ Blvd, Birmingham, AL 35294 USA.	dallison@uab.edu		Allison, David/0000-0003-3566-9399				Allison DB, 2002, AM J HUM GENET, V70, P575, DOI 10.1086/339273; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Baggerly KA, 2003, PROTEOMICS, V3, P1667, DOI 10.1002/pmic.200300522; Bailey LR, 1999, AM J HUM GENET, V65, pA91; Balagurunathan Y, 2002, J BIOMED OPT, V7, P507, DOI 10.1117/1.1486246; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BEMOULLI J, 1713, ARS CONJECTANDI; Benes V, 2003, TRENDS BIOCHEM SCI, V28, P244, DOI 10.1016/S0968-0004(03)00068-9; BERRY WD, 1993, UNDERSTANDING REGRES, P3; Blashfield RK., 1988, HDB MULTIVARIATE EXP, P447, DOI [10.1007/978-1-4613-0893-5_14, DOI 10.1007/978-1-4613-0893-5_14]; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Catellier DJ, 2000, STAT MED, V19, P1101, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1101::AID-SIM415>3.3.CO;2-8; Cherepinsky V, 2003, P NATL ACAD SCI USA, V100, P9668, DOI 10.1073/pnas.1633770100; Davies PI, 2000, BIT, V40, P640, DOI 10.1023/A:1022384216930; EDWARDS AWF, 1969, NATURE, V222, P1233, DOI 10.1038/2221233a0; Ertas A, 2003, IEEE T EDUC, V46, P289, DOI 10.1109/TE.2002.808232; Evans GA, 2000, NAT BIOTECHNOL, V18, P127, DOI 10.1038/72480; Famili AF, 2004, BIOINFORMATICS, V20, P1535, DOI 10.1093/bioinformatics/bth124; Gadbury GL, 2003, J R STAT SOC C-APPL, V52, P365, DOI 10.1111/1467-9876.00410; GADBURY GL, IN PRESS STAT METHOD; Gracey AY, 2003, ANNU REV PHYSIOL, V65, P231, DOI 10.1146/annurev.physiol.65.092101.142716; HALL P, 1991, BIOMETRICS, V47, P757, DOI 10.2307/2532163; Headrick TC, 1999, PSYCHOMETRIKA, V64, P25, DOI 10.1007/BF02294317; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Karian Z. A, 2000, FITTING STAT DISTRIB, P1; Kowalski J, 2004, BIOINFORMATICS, V20, P364, DOI 10.1093/bioinformatics/btg418; LAKATOS I, 1963, BRIT J PHILOS SCI, V14, P1; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Malley JD, 2002, HUM HERED, V54, P174, DOI 10.1159/000070663; Mendes P, 2003, BIOINFORMATICS, V19, pII122, DOI 10.1093/bioinformatics/btg1069; MICCERI T, 1989, PSYCHOL BULL, V105, P156, DOI 10.1037/0033-2909.105.1.156; Michaud DJ, 2003, BIOINFORMATICS, V19, P1140, DOI 10.1093/bioinformatics/btg132; Newton MA, 2004, BIOSTATISTICS, V5, P155, DOI 10.1093/biostatistics/5.2.155; Perez-Enciso M, 2003, GENETICS, V164, P1597; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rockett JC, 2004, GENOMICS, V83, P541, DOI 10.1016/j.ygeno.2003.09.017; Roy T, 2002, J STAT COMPUT SIM, V72, P23; RUSSELL B, 1961, BASIC WRITINGS, P149; Singhal S, 2003, CANCER BIOL THER, V2, P383, DOI 10.4161/cbt.2.4.431; Smolkin M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-36; Spence MA, 2003, AM J HUM GENET, V72, P1084, DOI 10.1086/374826; Tilstone C, 2003, NATURE, V424, P610, DOI 10.1038/424610a; Toda K, 2003, ANAL SCI, V19, P1529, DOI 10.2116/analsci.19.1529; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van den Oord EJCG, 2003, TRENDS GENET, V19, P537, DOI 10.1016/j.tig.2003.08.003; Witte JS, 1996, NAT GENET, V12, P355, DOI 10.1038/ng0496-355; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Xu RH, 2003, BIOINFORMATICS, V19, P1284, DOI 10.1093/bioinformatics/btg155; Yang Dongyan, 2004, Am J Pharmacogenomics, V4, P53, DOI 10.2165/00129785-200404010-00006	49	88	92	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2004	36	9					943	947		10.1038/ng1422	http://dx.doi.org/10.1038/ng1422			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	851AY	15340433	Bronze			2022-12-27	WOS:000223658100017
